PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Agusti, A; Edwards, LD; Rennard, SI; MacNee, W; Tal-Singer, R; Miller, BE; Vestbo, J; Lomas, DA; Calverley, PMA; Wouters, E; Crim, C; Yates, JC; Silverman, EK; Coxson, HO; Bakke, P; Mayer, RJ; Celli, B				Agusti, Alvar; Edwards, Lisa D.; Rennard, Stephen I.; MacNee, William; Tal-Singer, Ruth; Miller, Bruce E.; Vestbo, Jorgen; Lomas, David A.; Calverley, Peter M. A.; Wouters, Emiel; Crim, Courtney; Yates, Julie C.; Silverman, Edwin K.; Coxson, Harvey O.; Bakke, Per; Mayer, Ruth J.; Celli, Bartolome		Evaluation COPD Longitudinally Ide	Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GLOBAL BURDEN; BIOMARKERS; FUTURE; PREVALENCE; MEDICINE; MARKERS; POINTS; RISK	Background: Because chronic obstructive pulmonary disease (COPD) is a heterogeneous condition, the identification of specific clinical phenotypes is key to developing more effective therapies. To explore if the persistence of systemic inflammation is associated with poor clinical outcomes in COPD we assessed patients recruited to the well-characterized ECLIPSE cohort (NCT00292552). Methods and Findings: Six inflammatory biomarkers in peripheral blood (white blood cells (WBC) count and CRP, IL-6, IL-8, fibrinogen and TNF-alpha levels) were quantified in 1,755 COPD patients, 297 smokers with normal spirometry and 202 nonsmoker controls that were followed-up for three years. We found that, at baseline, 30% of COPD patients did not show evidence of systemic inflammation whereas 16% had persistent systemic inflammation. Even though pulmonary abnormalities were similar in these two groups, persistently inflamed patients during follow-up had significantly increased all-cause mortality (13% vs. 2%, p, 0.001) and exacerbation frequency (1.5 (1.5) vs. 0.9 (1.1) per year, p, 0.001) compared to non-inflamed ones. As a descriptive study our results show associations but do not prove causality. Besides this, the inflammatory response is complex and we studied only a limited panel of biomarkers, albeit they are those investigated by the majority of previous studies and are often and easily measured in clinical practice. Conclusions: Overall, these results identify a novel systemic inflammatory COPD phenotype that may be the target of specific research and treatment.	[Agusti, Alvar] Univ Barcelona, Thorax Inst, Hosp Clin, Inst Invest Biomed August & Pi Sunyer IDIBAPS, Barcelona, Spain; [Agusti, Alvar] Ctr Invest Red Enfermedades Resp CIBERES, Barcelona, Spain; [Agusti, Alvar] FISIB, Palma De Mallorca, Spain; [Edwards, Lisa D.; Crim, Courtney; Yates, Julie C.; Mayer, Ruth J.] GlaxoSmithKline, Res Triangle Pk, NC USA; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Omaha, NE USA; [MacNee, William] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Tal-Singer, Ruth; Miller, Bruce E.] GlaxoSmithKline, King Of Prussia, PA USA; [Vestbo, Jorgen] Univ Copenhagen, Hvidovre Hosp, Resp Sect, DK-1168 Copenhagen, Denmark; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Lomas, David A.] Univ Cambridge, Cambridge, England; [Calverley, Peter M. A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Wouters, Emiel] Univ Maastricht, Maastricht, Netherlands; [Silverman, Edwin K.; Celli, Bartolome] Brigham & Womens Hosp, Boston, MA 02115 USA; [Silverman, Edwin K.; Celli, Bartolome] Harvard Univ, Sch Med, Boston, MA USA; [Coxson, Harvey O.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Bakke, Per] Univ Bergen, Bergen, Norway	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; GlaxoSmithKline; University of Nebraska System; University of Nebraska Medical Center; University of Edinburgh; GlaxoSmithKline; University of Copenhagen; University of Manchester; University of Cambridge; University of Liverpool; Maastricht University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of British Columbia; University of Bergen	Agusti, A (corresponding author), Univ Barcelona, Thorax Inst, Hosp Clin, Inst Invest Biomed August & Pi Sunyer IDIBAPS, Barcelona, Spain.	alvar.agusti@clinic.ub.es	Wouters, Emiel/ABD-6200-2021; Garcia-Navarro, Alvar Agusti/F-4474-2015; Vestbo, Jorgen/Y-2912-2019; Coxson, Harvey O/A-9861-2017; Tal-Singer, Ruth/AAQ-2925-2021	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Coxson, Harvey O/0000-0001-5750-9711; Tal-Singer, Ruth/0000-0002-5275-8062; Vestbo, Jorgen/0000-0001-6355-6362; Edwards, Lisa/0000-0002-4867-2151; MacNee, William/0000-0002-3692-1448	GlaxoSmithKline; Altana; AstraZeneca; Boehringer-Ingelheim; NycoMed; Pfizer; Boehringer Ingelheim; Canadian Institutes of Health Industry (Wyeth); AstraZeneca (Australia); GSK Clinical Scientist Award [06/2010-07/2011]; Almirall; APT Pharma; Aradigm; Argenta; Chiesi; Dey; Forest; HoffmanLaRoche; MedImmune; Mpex; Oriel; Otsuka; Pearl; Pharmaxis; Merck; Talecris; MRC [G0901786, G0901697] Funding Source: UKRI; Medical Research Council [G0901786, G0901697] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Altana; AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); NycoMed; Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Canadian Institutes of Health Industry (Wyeth)(Wyeth); AstraZeneca (Australia)(AstraZeneca); GSK Clinical Scientist Award; Almirall(Almirall); APT Pharma; Aradigm; Argenta; Chiesi(Chiesi Pharmaceuticals Inc); Dey; Forest; HoffmanLaRoche; MedImmune(AstraZenecaMedimmune); Mpex; Oriel; Otsuka(Otsuka Pharmaceutical); Pearl(Luxembourg National Research Fund); Pharmaxis; Merck(Merck & Company); Talecris; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BRC: Received consulting fees from Altana, AstraZeneca, Boehringer-Ingelheim and GlaxoSmithKline; speaking fees from Altana, AstraZeneca, Boehringer-Ingelheim and GlaxoSmithKline; and grant support from Boehringer-Ingelheim and GlaxoSmithKline. NL, JY, RT-S, BEM, CC, RJM and LDE: Full-time employees of GlaxoSmithKline and hold stock or stock options in GlaxoSmithKline. PB: Received lecture fees from AstraZeneca, GlaxoSmithKline and NycoMed; has participated in clinical research studies sponsored by GlaxoSmithKline, Pfizer and Boehringer-Ingelheim; is currently member of the Steering Committee and the Scientific Committee of the ECLIPSE study which is sponsored by GlaxoSmithKline PC: Received fees for serving on advisory boards for GlaxoSmithKline, AstraZeneca, Nycomed, Novartis and Boehringer Ingelheim, for expert testimony for Forest/Nycomed, and has received speaker fees from GlaxoSmithKline and Nycomed; has received travel assistance from GlaxoSmithKline to attend ECLIPSE study meetings and from Boehringer Ingelheim to attend a scientific conference. HC: Received an honorarium for serving on the steering committee for the ECLIPSE project for GlaxoSmithKline; was the co-investigator on two multi-center studies sponsored by GlaxoSmithKline and has received travel expenses to attend meetings related to the project; has three contract service agreements with GlaxoSmithKline to quantify the CT scans in subjects with COPD and a service agreement with Spiration Inc to measure changes in lung volume in subjects with severe emphysema; was the co-investigator (D Sin PI) on a Canadian Institutes of Health Industry (Wyeth) partnership grant; has received a fee for speaking at a conference and related travel expenses from AstraZeneca (Australia); was the recipient of a GSK Clinical Scientist Award (06/2010-07/2011). DAL: Received grant support, honoraria and consultancy fees from GlaxoSmithKline. WM: Received travel assistance from GlaxoSmithKline to attend ECLIPSE study meetings. SR: Received fees for serving on advisory boards, consulting or honoraria from Almirall, APT Pharma, Aradigm, Argenta, AstraZeneca, Boehringer Ingelheim, Chiesi, Dey, Forest, GlaxoSmitkKlein, HoffmanLaRoche, MedImmune, Mpex, Novartis, Nycomed, Oriel, Otsuka, Pearl, Pfizer, Pharmaxis, Merck and Talecris. ES: Received an honorarium for a talk on COPD genetics, grant support for two studies of COPD genetics, and consulting fees from GlaxoSmithKline; honoraria for talks and consulting fees from AstraZeneca. JV: Received fees for serving on advisory boards for GlaxoSmithKline, AstraZeneca, Nycomed and Boehringer Ingelheim, and has received speaker fees from GlaxoSmithKline, AstraZeneca, Pfizer, Boehringer-Ingelheim, Chiesi, Novartis and Nycomed; has received travel assistance from GlaxoSmithKline to attend ECLIPSE study meetings; his wife has previously worked in pharmaceutical companies, including GSK and AstraZeneca. EW: Serves on an advisory board for Nycomed; has received lecture fees from GlaxoSmithKline, AstraZeneca and Novartis, and has received research grants from GlaxoSmithKline and AstraZeneca. AA: Received travel assistance from GlaxoSmithKline to attend ECLIPSE study meetings and honorarium for speaking at conferences and participating in advisory boards from Almirall, Astra-Zeneca, Boheringer-Ingelheim, Chiesi, Esteve, GSK, Medimmune, Novartis, Nycomed, Pfizer, Roche and Procter & Gamble.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM; Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; American Association of Immunologists, 2008, AM ASS IMM NEWSL; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Auffray C, 2010, CHEST, V137, P1410, DOI 10.1378/chest.09-1850; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bousquet J, 2011, GENOME MED, V3, DOI 10.1186/gm259; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Dahl M, 2011, THORAX, V66, P197, DOI 10.1136/thx.2009.131193; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; De Martinis M, 2006, EXP MOL PATHOL, V80, P219, DOI 10.1016/j.yexmp.2005.11.004; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kolsum Umme, 2009, Int J Chron Obstruct Pulmon Dis, V4, P149; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Man SF, 2008, EUR RESP J; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Marshall W.J., 2008, CLIN BIOCH METABOLIC, P17; Muir K, 2004, PHARMACOKINETICS DRU, P235; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pinto-Plata Victor, 2006, Proc Am Thorac Soc, V3, P465, DOI 10.1513/pats.200603-030MS; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rosenbaum L, 2011, NEW ENGLAND J MED; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058; Wouters EFM, 2002, CHEST, V121, p127S, DOI 10.1378/chest.121.5_suppl.127S	46	527	554	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37483	10.1371/journal.pone.0037483	http://dx.doi.org/10.1371/journal.pone.0037483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624038	gold, Green Accepted, Green Published			2022-12-27	WOS:000305343500123
J	Meng, FX; Sun, YN; Liu, XZ; Wang, JX; Xu, TJ; Wang, RX				Meng, Fanxing; Sun, Yuena; Liu, Xuezhu; Wang, Jianxin; Xu, Tianjun; Wang, Rixin			Analysis of C3 Suggests Three Periods of Positive Selection Events and Different Evolutionary Patterns between Fish and Mammals	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; MULTIPLE SEQUENCE ALIGNMENT; GENOME DUPLICATION; ACQUIRED-IMMUNITY; INNATE IMMUNITY; ANCIENT ORIGIN; SEA-ANEMONE; 2 PARTS; SYSTEM; ACTIVATION	Background: The third complement component (C3) is a central protein of the complement system conserved from fish to mammals. It also showed distinct characteristics in different animal groups. Striking features of the fish complement system were unveiled, including prominent levels of extrahepatic expression and isotypic diversity of the complement components. The evidences of the involvement of complement system in the enhancement of B and T cell responses found in mammals indicated that the complement system also serves as a bridge between the innate and adaptive responses. For the reasons mentioned above, it is interesting to explore the evolutionary process of C3 genes and to investigate whether the huge differences between aquatic and terrestrial environments affected the C3 evolution between fish and mammals. Methodology/Principal Findings: Analysis revealed that these two groups of animals had experienced different evolution patterns. The mammalian C3 genes were under purifying selection pressure while the positive selection pressure was detected in fish C3 genes. Three periods of positive selection events of C3 genes were also detected. Two happened on the ancestral lineages to all vertebrates and mammals, respectively, one happened on early period of fish evolutionary history. Conclusions/Significance: Three periods of positive selection events had happened on C3 genes during history and the fish and mammals C3 genes experience different evolutionary patterns for their distinct living environments.	[Meng, Fanxing; Sun, Yuena; Liu, Xuezhu; Wang, Jianxin; Xu, Tianjun; Wang, Rixin] Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China	Zhejiang Ocean University	Meng, FX (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Marine Living Resources & Mol Engn, Zhoushan, Peoples R China.	tianjunxu@163.com; wangrixin1123@126.com	Meng, Fanxing/Q-8294-2017; Xu, Tianjun/G-2545-2013	Meng, Fanxing/0000-0003-3656-2905; 	National Nature Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013, Y12C030014]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by National Nature Science Foundation of China (31001120) and Zhejiang Provincial Natural Science Foundation of China (Y3100013, Y12C030014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Al-Sharif WZ, 1998, J IMMUNOL, V160, P2983; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; CHU CT, 1994, LAB INVEST, V71, P792; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Fujito NT, 2010, DEV COMP IMMUNOL, V34, P775, DOI 10.1016/j.dci.2010.02.011; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Holland MCH, 2002, FISH SHELLFISH IMMUN, V12, P399, DOI 10.1006/fsim.2001.0408; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Janssen BJC, 2007, MOL IMMUNOL, V44, P3, DOI 10.1016/j.molimm.2006.06.017; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Law SKA, 1997, PROTEIN SCI, V6, P263; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Long MY, 2001, SCIENCE, V293, P1551; Marino R, 2002, IMMUNOGENETICS, V53, P1055, DOI 10.1007/s00251-001-0421-9; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nakao M, 2000, EUR J IMMUNOL, V30, P858, DOI 10.1002/1521-4141(200003)30:3&lt;858::AID-IMMU858&gt;3.0.CO;2-M; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen CH, 2002, J LEUKOCYTE BIOL, V72, P249; Nielsen R, 1998, GENETICS, V148, P929; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; Nonaka M, 1999, J IMMUNOL, V162, P387; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Pride D.T., 2004, SWAPP 1 0 2 TOOL ANA; REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	61	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37489	10.1371/journal.pone.0037489	http://dx.doi.org/10.1371/journal.pone.0037489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624039	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500124
J	Punj, V; Matta, H; Chaudhary, PM				Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.			A Computational Profiling of Changes in Gene Expression and Transcription Factors Induced by vFLIP K13 in Primary Effusion Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; ENDOTHELIAL-CELLS; REGULATORY MOTIFS; INDUCED APOPTOSIS; PROTEIN; ACTIVATION; INDUCTION; PATHWAYS	Infection with Kaposi's sarcoma associated herpesvirus (KSHV) has been linked to the development of primary effusion lymphoma (PEL), a rare lymphoproliferative disorder that is characterized by loss of expression of most B cell markers and effusions in the body cavities. This unique clinical presentation of PEL has been attributed to their distinctive plasmablastic gene expression profile that shows overexpression of genes involved in inflammation, adhesion and invasion. KSHV-encoded latent protein vFLIP K13 has been previously shown to promote the survival and proliferation of PEL cells. In this study, we employed gene array analysis to characterize the effect of K13 on global gene expression in PEL-derived BCBL1 cells, which express negligible K13 endogenously. We demonstrate that K13 upregulates the expression of a number of NF-kappa B responsive genes involved in cytokine signaling, cell death, adhesion, inflammation and immune response, including two NF-kappa B subunits involved in the alternate NF-kappa B pathway, RELB and NFKB2. In contrast, CD19, a B cell marker, was one of the genes downregulated by K13. A comparison with K13-induced genes in human vascular endothelial cells revealed that although there was a considerable overlap among the genes induced by K13 in the two cell types, chemokines genes were preferentially induced in HUVEC with few exceptions, such as RANTES/CCL5, which was induced in both cell types. Functional studies confirmed that K13 activated the RANTES/CCL5 promoter through the NF-kappa B pathway. Taken collectively, our results suggest that K13 may contribute to the unique gene expression profile, immunophenotype and clinical presentation that are characteristics of KSHV-associated PEL.	[Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; [Punj, Vasu; Matta, Hittu; Chaudhary, Preet M.] Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA; [Punj, Vasu] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Bioinformat Core,USC Epigenome Ctr, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Punj, V (corresponding author), Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018		United States National Institutes of Health [DE019811, CA139119]; NATIONAL CANCER INSTITUTE [R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the United States National Institutes of Health (DE019811 and CA139119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Ballon G, 2011, J CLIN INVEST, V121, P1141, DOI 10.1172/JCI44417; Baxter A, 2004, BIOORG MED CHEM LETT, V14, P2817, DOI 10.1016/j.bmcl.2004.03.058; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Carbone A, 2009, HIV ASS LYMPHOMAS GA, P1213; Carbone A, 2007, ACTA HAEMATOL-BASEL, V117, P129, DOI 10.1159/000097459; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chaudhary Preet M., 2008, V1, P186, DOI 10.1159/000141519; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Crawford A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002098; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Jenner RG, 2003, P NATL ACAD SCI USA, V100, P10399, DOI 10.1073/pnas.1630810100; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Keller SA, 2000, BLOOD, V96, P2537; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Matta H, 2011, J BIOL CHEM, V286, P21555, DOI 10.1074/jbc.M111.224048; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Punj V, 2010, ONCOGENE, V29, P1835, DOI 10.1038/onc.2009.460; Punj V, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-50; Punj V, 2009, BLOOD, V113, P5660, DOI 10.1182/blood-2008-10-186403; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sinha S, 2008, GENOME RES, V18, P477, DOI 10.1101/gr.6828808; Smith AJ, 2011, J IMMUNOL, V186, P6576, DOI 10.4049/jimmunol.1100277; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suffee N, 2011, BIOCHEM SOC T, V39, P1649, DOI 10.1042/BST20110651; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tong H, 2010, IMMUNOL LETT, V128, P108, DOI 10.1016/j.imlet.2010.01.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Warner JB, 2008, NAT METHODS, V5, P347, DOI [10.1038/NMETH.1188, 10.1038/nmeth.1188]; Wen KW, 2010, CANCER LETT, V289, P140, DOI 10.1016/j.canlet.2009.07.004; Xu YY, 2007, J GEN VIROL, V88, P46, DOI 10.1099/vir.0.82375-0; Yang YQ, 2011, J BIOL CHEM, V286, P27988, DOI 10.1074/jbc.M110.213363; Yin L, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12584; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	69	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37498	10.1371/journal.pone.0037498	http://dx.doi.org/10.1371/journal.pone.0037498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624040	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500125
J	Titulaer, M; Spoelstra, K; Lange, CYMJG; Visser, ME				Titulaer, Mieke; Spoelstra, Kamiel; Lange, Cynthia Y. M. J. G.; Visser, Marcel E.			Activity Patterns during Food Provisioning Are Affected by Artificial Light in Free Living Great Tits (Parus major)	PLOS ONE			English	Article							BIRDS; POLLUTION; PETRELS; CLUTCH; NIGHT	Artificial light may have severe ecological consequences but there is limited experimental work to assess these consequences. We carried out an experimental study on a wild population of great tits (Parus major) to assess the impact of light pollution on daily activity patterns during the chick provisioning period. Pairs that were provided with a small light outside their nest box did not alter the onset, cessation or duration of their working day. There was however a clear effect of artificial light on the feeding rate in the second half of the nestling period: when provided with artificial light females increased their feeding rate when the nestlings were between 9 and 16 days old. Artificial light is hypothesised to have affected the perceived photoperiod of either the parents or the offspring which in turn led to increased parental care. This may have negative fitness consequences for the parents, and light pollution may thus create an ecological trap for breeding birds.	[Titulaer, Mieke; Spoelstra, Kamiel; Lange, Cynthia Y. M. J. G.; Visser, Marcel E.] Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Netherlands; [Spoelstra, Kamiel] Wageningen Univ, Nat Conservat & Plant Ecol Dept, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Titulaer, M (corresponding author), Netherlands Inst Ecol, Dept Anim Ecol, Wageningen, Netherlands.	m.visser@nioo.knaw.nl	Spoelstra, Kamiel/B-4222-2015; Visser, Marcel E/A-9151-2009; KNAW, NIOO-KNAW/A-4320-2012	Spoelstra, Kamiel/0000-0001-8614-4387; Visser, Marcel E/0000-0002-1456-1939; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Technology Foundation STW, division of NWO; Ministry of Economic Affairs	Dutch Technology Foundation STW, division of NWO(Technologiestichting STW); Ministry of Economic Affairs	This research is supported by the Dutch Technology Foundation STW, which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassone VM, 2009, GEN COMP ENDOCR, V163, P109, DOI 10.1016/j.ygcen.2009.01.003; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; De Molenaar JG, 2000, 064 ALT RES I GROEN; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; FOSTER RG, 2004, RHYTHMS LIFE BIOL CL; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; Kempenaers B, 2010, CURR BIOL, V20, P1; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Lebbin DJ, 2007, WILSON J ORNITHOL, V119, P506, DOI 10.1676/06-139.1; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Miles W, 2010, BIRD STUDY, V57, P244, DOI 10.1080/00063651003605064; Miller MW, 2006, CONDOR, V108, P130, DOI 10.1650/0010-5422(2006)108[0130:AEOLPO]2.0.CO;2; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Poot H, 2008, ECOL SOC, V13; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Verhulst S, 1998, FUNCT ECOL, V12, P132, DOI 10.1046/j.1365-2435.1998.00165.x	19	70	71	4	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37377	10.1371/journal.pone.0037377	http://dx.doi.org/10.1371/journal.pone.0037377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624023	Green Published, gold			2022-12-27	WOS:000305343500107
J	Wang, YX; Xu, L; Sun, XY; Zou, Y; Zhang, HT; Jonas, JB				Wang, Ya Xing; Xu, Liang; Sun, Xiu Ying; Zou, Yang; Zhang, Hai Tao; Jonas, Jost B.			Five Year Incidence of Visual Field Loss in Adult Chinese. The Beijing Eye Study	PLOS ONE			English	Article							FREQUENCY-DOUBLING PERIMETRY; LOW-VISION; TECHNOLOGY PERIMETRY; PREVALENCE; POPULATION; IMPAIRMENT; GLAUCOMA; BLINDNESS; CHINA; URBAN	Purpose: To describe the cumulative 5 year incidence of visual field loss in adult Chinese in Greater Beijing. Methods: The Beijing Eye Study 2006 included 3251 subjects (mean age 60.4 +/- 10.1 years) who had participated in the Beijing Eye Study 2001 and returned for re-examination. All participants underwent a comprehensive eye examination, including visual field test by frequency doubling threshold perimetry. An abnormal visual field was defined as reduced sensitivity in at least one test location. Incident visual field loss was defined as a change in visual field from normal at baseline to abnormal at follow-up. Results: An incident visual field loss was detected in 273 eyes ( 4.3 +/- 0.5%) /235 subjects (7.3 +/- 0.5%). It was significantly associated with higher age (P = 0.001), higher intraocular pressure (P < 0.001), and higher fasting blood glucose concentration (P = 0.019). Considering only eyes (n = 140) with a detected cause for visual field loss, the most frequent causes were cataract (68 (48.6%) eyes) followed by glaucoma (23 (16.4%) eyes), diabetic retinopathy (13 (9.3%) eyes), age-related macular degeneration (10 (7.1%) eyes), and myopic degenerative retinopathy (9 (6.4%) eyes). For 133 (48.7%) eyes with a visual field loss, the cause for the VFL remained unclear. Conclusions: The 5-year incidence of visual field loss was 4.3 +/- 0.5% per eye or 7.3 +/- 0.5% per subject. It increased significantly with age, intraocular pressure, and fasting blood glucose level. Major causes for the incidence of visual field loss were cataract, glaucoma and diabetic retinopathy.	[Wang, Ya Xing; Xu, Liang; Sun, Xiu Ying; Zou, Yang; Zhang, Hai Tao; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio1@gmail.com; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China(Beijing Natural Science Foundation)	Supported by the National Key Laboratory Fund, Beijing, China, and the Beijing Natural Science Foundation, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Czudowska MA, 2010, OPHTHALMOLOGY, V117, P1705, DOI 10.1016/j.ophtha.2010.01.034; Dimitrov PN, 2003, INVEST OPHTH VIS SCI, V44, P5075, DOI 10.1167/iovs.02-0457; Foran S, 2003, OPHTHALMOLOGY, V110, P41, DOI 10.1016/S0161-6420(02)01295-2; Gunnlaugsdottir E, 2010, ACTA OPHTHALMOL, V88, P358, DOI 10.1111/j.1755-3768.2008.01445.x; Hennis AJ, 2009, OPHTHALMOLOGY, V116, P1461, DOI 10.1016/j.ophtha.2009.02.017; Huang SS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1362, DOI 10.1001/archophthalmol.2009.138; Hyman L, 2010, ARCH OPHTHALMOL-CHIC, V128, P601, DOI 10.1001/archophthalmol.2010.78; Iester M, 2000, AM J OPHTHALMOL, V130, P160, DOI 10.1016/S0002-9394(00)00464-5; Iwasaki A, 2002, AM J OPHTHALMOL, V134, P529, DOI 10.1016/S0002-9394(02)01684-7; Iwase A, 2007, OPHTHALMOLOGY, V114, P27, DOI 10.1016/j.ophtha.2006.06.041; JOHNSON CA, 1983, ARCH OPHTHALMOL-CHIC, V101, P371; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; Kogure S, 2003, BRIT J OPHTHALMOL, V87, P604, DOI 10.1136/bjo.87.5.604; Leske MC, 2007, OPHTHALMOLOGY, V114, P1058, DOI 10.1016/j.ophtha.2006.08.051; Li YB, 2008, AM J OPHTHALMOL, V146, P329, DOI 10.1016/j.ajo.2008.04.015; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Liu WW, 2007, OPHTHALMOLOGY, V114, P1795, DOI 10.1016/j.ophtha.2007.03.010; Mansberger SL, 2007, J GLAUCOMA, V16, P73, DOI 10.1097/01.ijg.0000243481.75155.97; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; Ramrattan RS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1788, DOI 10.1001/archopht.119.12.1788; Realini T, 2004, OPHTHALMOLOGY, V111, P2133, DOI 10.1016/j.ophtha.2004.05.024; Roy MS, 2007, ARCH OPHTHALMOL-CHIC, V125, P1061, DOI 10.1001/archopht.125.8.1061; Saw SM, 2004, OPHTHALMOLOGY, V111, P1161, DOI 10.1016/j.ophtha.2003.09.040; Skenduli-Bala E, 2005, ARCH OPHTHALMOL-CHIC, V123, P233, DOI 10.1001/archopht.123.2.233; Thomas D, 2001, AM J OPHTHALMOL, V131, P734, DOI 10.1016/S0002-9394(01)00837-6; Topouzis F, 2004, AM J OPHTHALMOL, V137, P420, DOI 10.1016/j.ajo.2003.09.045; Varma R, 2010, AM J OPHTHALMOL, V149, P713, DOI 10.1016/j.ajo.2009.12.011; Wang YX, 2007, ARCH OPHTHALMOL-CHIC, V125, P1402, DOI 10.1001/archopht.125.10.1402; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wang YX, 2006, AM J OPHTHALMOL, V141, P1078, DOI 10.1016/j.ajo.2006.01.023; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Xu L, 2006, AM J OPHTHALMOL, V141, P591, DOI 10.1016/j.ajo.2005.10.018; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37232	10.1371/journal.pone.0037232	http://dx.doi.org/10.1371/journal.pone.0037232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624000	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500082
J	Zhou, DX; Bennett, SW; Keller, AA				Zhou, Dongxu; Bennett, Samuel W.; Keller, Arturo A.			Increased Mobility of Metal Oxide Nanoparticles Due to Photo and Thermal Induced Disagglomeration	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; AGGREGATION KINETICS; ENVIRONMENTAL IMPLICATIONS; DIVALENT ELECTROLYTES; SILVER NANOPARTICLES; ZNO NANOPARTICLES; IONIC-STRENGTH; DLVO THEORY; TIO2; STABILITY	Significant advances have been made on our understanding of the fate and transport of engineered nanomaterials. One unexplored aspect of nanoparticle aggregation is how environmental stimuli such as light exposure and temperature variations affect the mobility of engineered nanoparticles. In this study, TiO2, ZnO, and CeO2 were chosen as model materials for investigating the mobility of nanoparticles under three external stimuli: heat, light and sonication. Sunlight and high power sonication were able to partially disagglomerate metal oxide clusters, but primary particles bonded by solid state necks were left intact. A cycle of temperature increase from 25 degrees C to 65 degrees C and then decrease back was found to disagglomerate the compact clusters in the heating phase and reagglomerate them as more open fractal structures during the cooling phase. A fractal model summing the pair-wise DLVO interactions between primary particles within two fractal agglomerates predicts weak attractions on the order of a few kT. Our study shows that common environmental stimuli such as light exposure or temperature variation can disagglomerate nanoparticle clusters and enhance their mobility in open waters. This phenomenon warrants attention since it is likely that metal oxide nanoparticles will experience these natural stimuli during their transport in the environment.	[Zhou, Dongxu] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Zhou, DX (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu	Zhou, Dongxu/C-1255-2013		National Science Foundation; U.S. Environmental Protection Agency [DBI-0830117]	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the U.S. Environmental Protection Agency under Cooperative Agreement Number DBI-0830117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of NSF or USEPA. This work has not been subjected to USEPA review and no official endorsement should be inferred.	AKRATOPULU KC, 1990, J CHEM SOC FARADAY T, V86, P3437, DOI 10.1039/ft9908603437; Bennett SW, 2012, PLOS ONE IN PRESS; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Brasil AM, 2001, J AEROSOL SCI, V32, P489, DOI 10.1016/S0021-8502(00)00097-5; Buettner KM, 2010, COLLOID SURFACE A, V366, P74, DOI 10.1016/j.colsurfa.2010.05.024; Chen KL, 2006, ENVIRON SCI TECHNOL, V40, P1516, DOI 10.1021/es0518068; Chowdhury I, 2010, COLLOID SURFACE A, V368, P91, DOI 10.1016/j.colsurfa.2010.07.019; Croll S, 2002, PROG ORG COAT, V44, P131, DOI 10.1016/S0300-9440(01)00261-2; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Elimelech M., 1995, PARTICLE DEPOSITION, DOI [10.1016/B978-0-7506-7024-1.X5000-6, DOI 10.1016/B978-0-7506-7024-1.X5000-6]; Findlay AD, 1996, COLLOID SURFACE A, V118, P97, DOI 10.1016/0927-7757(96)03708-9; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Grass RN, 2006, AICHE J, V52, P1318, DOI 10.1002/aic.10739; Horst AM, 2010, APPL ENVIRON MICROB, V76, P7292, DOI 10.1128/AEM.00324-10; Hotze EM, 2010, J ENVIRON QUAL, V39, P1909, DOI 10.2134/jeq2009.0462; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Ji ZX, 2010, ENVIRON SCI TECHNOL, V44, P7309, DOI 10.1021/es100417s; KAJIHARA M, 1971, Journal of the Oceanographical Society of Japan, V27, P158, DOI 10.1007/BF02109135; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim AY, 2000, LANGMUIR, V16, P2101, DOI 10.1021/la990841n; Kim T, 2008, J COLLOID INTERF SCI, V318, P238, DOI 10.1016/j.jcis.2007.10.029; Lattuada M, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061404; Li XA, 2010, LANGMUIR, V26, P16690, DOI 10.1021/la101768n; Liu HH, 2011, ENVIRON SCI TECHNOL, V45, P9284, DOI 10.1021/es202134p; Mandzy N, 2005, POWDER TECHNOL, V160, P121, DOI 10.1016/j.powtec.2005.08.020; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; Petosa AR, 2010, ENVIRON SCI TECHNOL, V44, P6532, DOI 10.1021/es100598h; Saleh NB, 2008, ENVIRON SCI TECHNOL, V42, P7963, DOI 10.1021/es801251c; Teleki A, 2008, POWDER TECHNOL, V181, P292, DOI 10.1016/j.powtec.2007.05.016; Thio BJR, 2011, J HAZARD MATER, V189, P556, DOI 10.1016/j.jhazmat.2011.02.072; WARREN PB, 1994, NUOVO CIMENTO D, V16, P1231, DOI 10.1007/BF02458805; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; YOTSUMOTO H, 1993, J COLLOID INTERF SCI, V157, P426, DOI 10.1006/jcis.1993.1205; Zhang Y, 2009, WATER RES, V43, P4249, DOI 10.1016/j.watres.2009.06.005; Zhou DX, 2010, WATER RES, V44, P2948, DOI 10.1016/j.watres.2010.02.025	37	49	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37363	10.1371/journal.pone.0037363	http://dx.doi.org/10.1371/journal.pone.0037363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624021	Green Published, gold			2022-12-27	WOS:000305343500105
J	Dall'Olio, S; Norscia, I; Antonacci, D; Palagi, E				Dall'Olio, Stefania; Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta			Sexual Signalling in Propithecus verreauxi: Male "Chest Badge" and Female Mate Choice	PLOS ONE			English	Article							SCENT-MARKING; LEMUR-CATTA; REPRODUCTIVE SUCCESS; RECEIVER PSYCHOLOGY; TESTOSTERONE LEVELS; EVOLUTION; BEHAVIOR; PRIMATE; SIFAKA; COUNTERMARKING	Communication, an essential prerequisite for sociality, involves the transmission of signals. A signal can be defined as any action or trait produced by one animal, the sender, that produces a change in the behaviour of another animal, the receiver. Secondary sexual signals are often used for mate choice because they may inform on a potential partner's quality. Verreaux's sifaka (Propithecus verreauxi) is characterized by the presence of two different morphs of males (bimorphism), which can show either a stained or clean chest. The chest becomes stained by secretions of the sternal gland during throat marking (rubbing throat and chest on a vertical substrate while smearing the scent deposition). The role of the chest staining in guiding female mate choice was previously hypothesized but never demonstrated probably due to the difficulty of observing sifaka copulations in the wild. Here we report that stained-chested males had a higher throat marking activity than clean-chested males during the mating season, but not during the birth season. We found that females copulated more frequently with stained-chested males than the clean-chested males. Finally, in agreement with the biological market theory, we found that clean-chested males, with a lower scent-releasing potential, offered more grooming to females. This "grooming for sex" tactic was not completely unsuccessful; in fact, half of the clean-chested males copulated with females, even though at low frequency. In conclusion, the chest stain, possibly correlated with different cues targeted by females, could be one of the parameters which help females in selecting mates.	[Dall'Olio, Stefania; Norscia, Ivan; Antonacci, Daniela; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale, Museo Storia Nat & Terr, Pisa, Italy; [Dall'Olio, Stefania] Univ Florence, Dipartimento Biol Evoluzionist, Florence, Italy; [Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	University of Pisa; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Dall'Olio, S (corresponding author), Univ Pisa, Ctr Interdipartimentale, Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717	Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy)	Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy)	The present study was funded by Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (Italy). The funding covered only field and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, ore preparation of the manuscript.	Andersson Malte, 1994; Antonacci D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013218; Bigoni F, 2010, ARCH ANTROPOLOGIA ET, P7; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Buesching CD, 1998, FOLIA PRIMATOL, V69, P295, DOI 10.1159/000052718; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Darwin C., 1871, P423; Dixson BJ, 2010, ARCH SEX BEHAV, V39, P798, DOI 10.1007/s10508-008-9441-y; Drea CM, 2008, CHEM SIGNAL, V11, P91, DOI 10.1007/978-0-387-73945-8_8; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Fisher HS, 2003, BEHAV ECOL SOCIOBIOL, V53, P123, DOI 10.1007/s00265-002-0552-5; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Gonzalez G, 2001, BEHAV ECOL SOCIOBIOL, V50, P557; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hemelrijk C., 2007, HDB PALEOANTHROPOL 2, P1321; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly Alison, 2006, P32, DOI 10.1007/978-0-387-34126-2_3; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; KAPPELER PM, 1990, ANIM BEHAV, V40, P774, DOI 10.1016/S0003-3472(05)80706-7; Kappeler PM, 2004, SEXUAL SELECTION PRI; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; Lewis RJ, 2009, PHYSIOL BEHAV, V96, P586, DOI 10.1016/j.physbeh.2008.12.020; Lewis RJ, 2005, AM J PHYS ANTHROPOL, V128, P389, DOI 10.1002/ajpa.20206; Lewis RJ, 2002, Q REV BIOL, V77, P149, DOI 10.1086/343899; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; Manly BFJ, 1997, RANDOMIZATION BOOTST; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Mertl-Millhollen AS, 2006, AM J PRIMATOL, V68, P605, DOI 10.1002/ajp.20255; MOLLER AP, 1995, ETHOL SOCIOBIOL, V16, P207, DOI 10.1016/0162-3095(95)00002-3; Morris D., 1967, NAKED APE; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2011, J TROP ECOL, V27, P103, DOI 10.1017/S0266467410000519; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Palagi E, 2005, BEHAV ECOL SOCIOBIOL, V58, P437, DOI 10.1007/s00265-005-0963-1; Palagi E, 2004, INT J PRIMATOL, V25, P1019, DOI 10.1023/B:IJOP.0000043349.23082.c0; Palagi E, 2003, INT J PRIMATOL, V24, P335, DOI 10.1023/A:1023001316988; Palagi E, 2006, ANN ZOOL FENN, V43, P280; Pochron ST, 2005, AM J PRIMATOL, V65, P103, DOI 10.1002/ajp.20102; Pochron ST, 2003, BEHAV ECOL SOCIOBIOL, V54, P285, DOI 10.1007/s00265-003-0634-z; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; RICHARD AF, 1992, J HUM EVOL, V22, P395, DOI 10.1016/0047-2484(92)90067-J; Rowe C, 1999, ANIM BEHAV, V57, P341, DOI 10.1006/anbe.1998.0974; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Singh D, 1995, ETHOL SOCIOBIOL, V16, P483, DOI 10.1016/0162-3095(95)00074-7; Stopka Pavel, 2001, Animal Behaviour Forum, V61, pF19; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V258, P267, DOI 10.1098/rspb.1994.0172; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; Utami Atmoko Suci, 2004, P196; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Wilson E.O., 1975, P1; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Zahavi A., 2007, REPROD BIOL PHYLOGEN; Zala SM, 2004, BEHAV ECOL, V15, P338, DOI 10.1093/beheco/arh022	63	8	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37332	10.1371/journal.pone.0037332	http://dx.doi.org/10.1371/journal.pone.0037332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615982	Green Published, gold			2022-12-27	WOS:000305341200062
J	Fotiou, V; Malissiova, E; Minas, A; Petinaki, E; Hadjichristodoulou, C				Fotiou, Vasilios; Malissiova, Eleni; Minas, Anastasios; Petinaki, Efthimia; Hadjichristodoulou, Christos			Seroprevalence of IgG Antibodies against Echinococcus granulosus in the Population of the Region of Thessaly, Central Greece	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; INFECTION; DIAGNOSIS	Echinococcosis notification rate in Greece, based on the most recent data, is below 0.25 per 100,000 population. To further investigate the epidemiology of echinococcosis in Greece a study was designed to determine the seroprevalence of Echinococcus granulosus antibodies in the population of Thessaly, Central Greece. Five hundred and forty two left over blood samples in Thessaly laboratories, were collected using a stratified convenient sampling procedure. Samples were analyzed with enzyme linked immunosorbent assay. The seropositivity found was 1.1%(95% C.I., 0.5-2.5), with 5 out of 6 seropositive results to be in the age group of over 65 (OR = 17.95, 95% CI 2.04-157.11, p value 0.009). Rural residence was also found as a risk factor to seropositivity (RR = 7.60, 95% CI 0.89-64.64, p value 0.039). Surveillance data and our study results converge that echinococcosis is being reduced in Greece, with older population to be affected mostly. These might be due to the disease transmission restriction, by the control measures being implemented. Efforts should be continued, in both animals and humans side, by increasing training campaigns and public awareness.	[Fotiou, Vasilios; Malissiova, Eleni; Hadjichristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece; [Minas, Anastasios] Inst Educ Technol, Dept Med Labs, Larisa, Greece; [Petinaki, Efthimia] Gen Univ Hosp Larissa, Dept Microbiol, Larisa, Greece	University of Thessaly; General University Hospital of Larissa	Fotiou, V (corresponding author), Univ Thessaly, Dept Hyg & Epidemiol, Fac Med, Larisa, Greece.	xhatzi@med.uth.gr	Malissiova, Eleni/AAM-3634-2021	Hadjichristodoulou, Christos/0000-0002-4769-8376				Antoniou M, 2002, AM J TROP MED HYG, V66, P80, DOI 10.4269/ajtmh.2002.66.80; Carmena D, 2006, ACTA TROP, V98, P74, DOI 10.1016/j.actatropica.2006.02.002; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; ECDC, 2010, ANN EP REP COMM DIS, P69; Gavidia CM, 2008, EMERG INFECT DIS, V14, P260, DOI 10.3201/eid1402.061101; Greek Ministry of Health, 2010, HYD REP GREEC 1998 2; Gutierrez MP, 2003, ENFERM INFEC MICR CL, V21, P563, DOI 10.1157/13054549; HCDCP, 2011, HELLENIC CTR DIS CON, V2, P8; Logar J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-63; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Nardone A, 2004, EUROSURVEILLANCE, V9, P4; Sotiraki S, 2010, PARASITE, V17, P205, DOI 10.1051/parasite/2010173205; Varbobitis IC, 2010, EUR J CLIN MICROBIOL, V29, P307, DOI 10.1007/s10096-009-0858-6; Zhang WB, 2003, CLIN MICROBIOL REV, V16, P18, DOI 10.1128/CMR.16.1.18-36.2003	15	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37112	10.1371/journal.pone.0037112	http://dx.doi.org/10.1371/journal.pone.0037112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615913	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200042
J	Alvarez-Alfageme, F; Luthi, C; Romeis, J				Alvarez-Alfageme, Fernando; Luethi, Christoph; Romeis, Joerg			Characterization of Digestive Enzymes of Bruchid Parasitoids-Initial Steps for Environmental Risk Assessment of Genetically Modified Legumes	PLOS ONE			English	Article							ALPHA-AMYLASE INHIBITOR; CALLOSOBRUCHUS-MACULATUS F; PLANT PROTEASE INHIBITORS; BOWMAN-BIRK INHIBITOR; ACANTHOSCELIDES-OBTECTUS; PHASEOLUS-VULGARIS; ZABROTES-SUBFASCIATUS; CYSTEINE PROTEINASES; ORYZACYSTATIN-I; PHAGE DISPLAY	Genetically modified (GM) legumes expressing the alpha-amylase inhibitor 1 (alpha AI-1) from Phaseolus vulgaris L. or cysteine protease inhibitors are resistant to several bruchid pests (Coleoptera: Chrysomelidae). In addition, the combination of plant resistance factors together with hymenopteran parasitoids can substantially increase the bruchid control provided by the resistance alone. If the strategy of combining a bruchid-resistant GM legume and biological control is to be effective, the insecticidal trait must not adversely affect bruchid antagonists. The environmental risk assessment of such GM legumes includes the characterization of the targeted enzymes in the beneficial species and the assessment of the in vitro susceptibility to the resistance factor. The digestive physiology of bruchid parasitoids remain relatively unknown, and their susceptibility to alpha AI-1 has never been investigated. We have detected alpha-amylase and serine protease activities in all five bruchid parasitoid species tested. Thus, the deployment of GM legumes expressing cysteine protease inhibitors to control bruchids should be compatible with the use of parasitoids. In vitro inhibition studies showed that sensitivity of alpha-amylase activity to alpha AI-1 in the parasitoids was comparable to that in the target species. Direct feeding assays revealed that harmful effects of alpha-amylase inhibitors on bruchid parasitoids cannot be discounted and need further evaluation.	[Alvarez-Alfageme, Fernando; Luethi, Christoph; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Alvarez-Alfageme, F (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	fernando.alvarez@art.admin.ch	Romeis, Joerg/J-5360-2013; Lüthi, Christoph/M-6841-2013	Romeis, Joerg/0000-0003-3652-8360; Lüthi, Christoph/0000-0003-3228-7424; Alvarez, Fernando/0000-0001-8932-3823	National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation	National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation	This study was partly funded by the National Center of Competence in Research (NCCR) Plant Survival, a research program of the Swiss National Science Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Amirhusin B, 2004, J ECON ENTOMOL, V97, P2095, DOI 10.1603/0022-0493-97.6.2095; Amirhusin B, 2007, J INSECT PHYSIOL, V53, P734, DOI 10.1016/j.jinsphys.2007.03.008; Azzouz H, 2005, J INSECT PHYSIOL, V51, P941, DOI 10.1016/j.jinsphys.2005.04.009; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; Baker JE, 2000, INSECT BIOCHEM MOLEC, V30, P937, DOI 10.1016/S0965-1748(00)00066-7; Bell HA, 2004, AGR FOREST ENTOMOL, V6, P215, DOI 10.1111/j.1461-9555.2004.00225.x; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Beynon R.J., 1989, PROTEOLYTIC ENZYMES, P241; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPOS FAP, 1989, COMP BIOCHEM PHYS B, V92, P51, DOI 10.1016/0305-0491(89)90312-X; Down RE, 1999, PARASITOLOGY, V119, P157, DOI 10.1017/S0031182099004515; FERREIRA C, 1989, INSECT BIOCHEM, V19, P383, DOI 10.1016/0020-1790(89)90043-7; Franco OL, 2005, J AGR FOOD CHEM, V53, P1585, DOI 10.1021/jf049343x; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; Giron D, 2004, PHYSIOL ENTOMOL, V29, P436, DOI 10.1111/j.0307-6962.2004.00414.x; Ishii S., 1952, B NATL I AGR SCI SER, V1, P185; ISHIMOTO M, 1989, APPL ENTOMOL ZOOL, V24, P281, DOI 10.1303/aez.24.281; ISHIMOTO M, 1992, APPL ENTOMOL ZOOL, V27, P243, DOI 10.1303/aez.27.243; Ishimoto M, 1996, ENTOMOL EXP APPL, V79, P309, DOI 10.1007/BF00186289; Ishimoto M, 1996, PLANT PHYSIOL, V111, P393, DOI 10.1104/pp.111.2.393; JANZEN DH, 1976, SCIENCE, V192, P795, DOI 10.1126/science.1265481; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; JERVIS MA, 1996, BIOCONTROL NEWS INFO, V17, pN1; KITCH LW, 1986, ARCH INSECT BIOCHEM, V3, P561, DOI 10.1002/arch.940030607; Kluh I, 2005, PHYTOCHEMISTRY, V66, P31, DOI 10.1016/j.phytochem.2004.11.001; Koiwa H, 1998, PLANT J, V14, P371, DOI 10.1046/j.1365-313X.1998.00119.x; Kuroda M, 1996, BIOSCI BIOTECH BIOCH, V60, P209, DOI 10.1271/bbb.60.209; Luthi C., 2010, Julius-Kuhn-Archiv, P977; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; MARSHALL JJ, 1975, J BIOL CHEM, V250, P8030; Melo FR, 2003, BBA-PROTEINS PROTEOM, V1651, P146, DOI 10.1016/S1570-9639(03)00264-4; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; Morton RL, 2000, P NATL ACAD SCI USA, V97, P3820, DOI 10.1073/pnas.070054597; Nukenine E. N., 2010, Julius-Kuhn-Archiv, P26; Odogola WR, 1994, POSTHARVEST MANAGEME; Oliveira JA, 2006, B ENTOMOL RES, V96, P251, DOI 10.1079/BER2006420; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; PODOLER H, 1971, BIOCHEM J, V121, P321, DOI 10.1042/bj1210321; Popelka JC, 2004, PLANT SCI, V167, P195, DOI 10.1016/j.plantsci.2004.03.027; Sarmah BK, 2004, MOL BREEDING, V14, P73, DOI 10.1023/B:MOLB.0000037996.01494.12; Schmale I, 2003, J STORED PROD RES, V39, P401, DOI 10.1016/S0022-474X(02)00034-6; Schmale I, 2001, BIOL CONTROL, V21, P134, DOI 10.1006/bcon.2000.0911; SCHROEDER HE, 1995, PLANT PHYSIOL, V107, P1233, DOI 10.1104/pp.107.4.1233; SILVA CP, 1991, COMP BIOCHEM PHYS B, V99, P529, DOI 10.1016/0305-0491(91)90333-9; Solleti SK, 2008, PLANT CELL REP, V27, P1841, DOI 10.1007/s00299-008-0606-x; Velten G, 2008, BIOL CONTROL, V47, P133, DOI 10.1016/j.biocontrol.2008.07.009; Whitworth ST, 1998, J BIOL CHEM, V273, P14430, DOI 10.1074/jbc.273.23.14430; Zeng F, 2000, ARCH INSECT BIOCHEM, V44, P136, DOI 10.1002/1520-6327(200007)44:3&lt;136::AID-ARCH5&gt;3.0.CO;2-2	50	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36862	10.1371/journal.pone.0036862	http://dx.doi.org/10.1371/journal.pone.0036862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615826	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300033
J	Barnett, A; Abrantes, KG; Seymour, J; Fitzpatrick, R				Barnett, Adam; Abrantes, Katya G.; Seymour, Jamie; Fitzpatrick, Richard			Residency and Spatial Use by Reef Sharks of an Isolated Seamount and Its Implications for Conservation	PLOS ONE			English	Article							MARINE PROTECTED AREAS; NORTHERN LINE ISLANDS; GREAT-BARRIER-REEF; TRIAENODON-OBESUS; CORAL-REEF; CARCHARHINUS-AMBLYRHYNCHOS; SPHYRNA-LEWINI; NURSERY AREA; KANEOHE BAY; HOME-RANGE	Although marine protected areas (MPAs) are a common conservation strategy, these areas are often designed with little prior knowledge of the spatial behaviour of the species they are designed to protect. Currently, the Coral Sea area and its seamounts (north-east Australia) are under review to determine if MPAs are warranted. The protection of sharks at these seamounts should be an integral component of conservation plans. Therefore, knowledge on the spatial ecology of sharks at the Coral Sea seamounts is essential for the appropriate implementation of management and conservation plans. Acoustic telemetry was used to determine residency, site fidelity and spatial use of three shark species at Osprey Reef: whitetip reef sharks Triaenodon obesus, grey reef sharks Carcharhinus amblyrhynchos and silvertip sharks Carcharhinus albimarginatus. Most individuals showed year round residency at Osprey Reef, although five of the 49 individuals tagged moved to the neighbouring Shark Reef (similar to 14 km away) and one grey reef shark completed a round trip of similar to 250 km to the Great Barrier Reef. Additionally, individuals of white tip and grey reef sharks showed strong site fidelity to the areas they were tagged, and there was low spatial overlap between groups of sharks tagged at different locations. Spatial use at Osprey Reef by adult sharks is generally restricted to the north-west corner. The high residency and limited spatial use of Osprey Reef suggests that reef sharks would be highly vulnerable to targeted fishing pressure and that MPAs incorporating no-take of sharks would be effective in protecting reef shark populations at Osprey and Shark Reef.	[Barnett, Adam] Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia; [Abrantes, Katya G.; Seymour, Jamie; Fitzpatrick, Richard] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Barnett, Adam; Fitzpatrick, Richard] Reef Channel, Townsville, Qld, Australia	University of Tasmania; James Cook University	Barnett, A (corresponding author), Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia.	adam.barnett@utas.edu.au	Seymour, Jamie E/C-9748-2013	Seymour, Jamie E/0000-0002-4805-3289; , Adam/0000-0001-7430-8428	Digital Dimensions, Australia; Worldwide Fund for Nature (WWF) Australia; Digital Dimensions	Digital Dimensions, Australia; Worldwide Fund for Nature (WWF) Australia; Digital Dimensions	Funding was supplied by Digital Dimensions, Australia, through the production of the Discovery Channel Shark Week special 'Mysteries of the Shark Coast' and by the Worldwide Fund for Nature (WWF) Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was from a commercial source, Digital Dimensions. Richard Fitzpatrick and Adam Barnett are affiliated with a commercial company The Reef Channel. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson R. C., 1999, CASE STUDIES MANAGEM; Ashe E, 2010, ANIM CONSERV, V13, P196, DOI 10.1111/j.1469-1795.2009.00321.x; Australian Government Department of Sustainability Environment Water Population and Communities website Australian Fisheries management Authority, 2010, COR SEA STRAT ASS RE; Australian Government Department of Sustainability Environment Water Population and Communities website. Australian Fisheries management Authority, 2009, COR SEA FISH ANN STA; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BLACKMAN R, 1958, MEASUREMENT POWER SP; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Dale JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016962; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Field IC, 2009, ADV MAR BIOL, V56, P275, DOI 10.1016/S0065-2881(09)56004-X; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gotelli N. J., 2010, ECOSIM NULL MODELS S; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; HOBSON EDMUND S., 1963, PACIFIC SCI, V17, P171; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Jepsen N, 2002, HYDROBIOLOGIA, V483, P239, DOI 10.1023/A:1021356302311; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Klimley PA, 1988, J FISH BIOL, V33, P751; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lowe CG, 2002, J EXP MAR BIOL ECOL, V278, P141, DOI 10.1016/S0022-0981(02)00331-3; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Pillans RD, 2009, IUCN 2011 IUCN RED L; RANDALL JE, 1977, PAC SCI, V31, P143; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Smale MJ, 2005, IUCN 2011 IUCN RED L; Smale MJ, 2009, IUCN 2011 IUCN RED L; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Stoeckl N, 2010, TOURISM ECON, V16, P995, DOI 10.5367/te.2010.0005; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Watson JT, 2009, CONSERV BIOL, V23, P626, DOI 10.1111/j.1523-1739.2008.01121.x; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; White WT, 2010, J FISH BIOL, V76, P2090, DOI 10.1111/j.1095-8649.2010.02654.x; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Whitney NM, 2012, J BIOGEOGR, V39, P1144, DOI 10.1111/j.1365-2699.2011.02660.x; Whitney N, 2012, ENVIRON BIOL FISH, V93, P121, DOI 10.1007/s10641-011-9897-9	67	88	89	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36574	10.1371/journal.pone.0036574	http://dx.doi.org/10.1371/journal.pone.0036574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615782	Green Published, gold, Green Accepted			2022-12-27	WOS:000305341300019
J	Plener, L; Boistard, P; Gonzalez, A; Boucher, C; Genin, S				Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane			Metabolic Adaptation of Ralstonia solanacearum during Plant Infection: A Methionine Biosynthesis Case Study	PLOS ONE			English	Article							III EFFECTOR PROTEINS; PSEUDOMONAS-SOLANACEARUM; SALMONELLA-TYPHIMURIUM; PATHOGENICITY GENES; ESCHERICHIA-COLI; SECRETION SYSTEM; METE; VIRULENCE; IDENTIFICATION; MUTAGENESIS	MetE and MetH are two distinct enzymes that catalyze a similar biochemical reaction during the last step of methionine biosynthesis, MetH being a cobalamin-dependent enzyme whereas MetE activity is cobalamin-independent. In this work, we show that the last step of methionine synthesis in the plant pathogen Ralstonia solanacearum is under the transcriptional control of the master pathogenicity regulator HrpG. This control is exerted essentially on metE expression through the intermediate regulator MetR. Expression of metE is strongly and specifically induced in the presence of plant cells in a hrpG- and metR-dependent manner. metE and metR mutants are not auxotrophic for methionine and not affected for growth inside the plant but produce significantly reduced disease symptoms on tomato whereas disruption of metH has no impact on pathogenicity. The finding that the pathogen preferentially induces metE expression rather than metH in the presence of plant cells is indicative of a probable metabolic adaptation to physiological host conditions since this induction of metE occurs in an environment in which cobalamin, the required co-factor for MetH, is absent. It also shows that MetE and MetH are not functionally redundant and are deployed during specific stages of the bacteria lifecycle, the expression of metE and metH being controlled by multiple and distinct signals.	[Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane] INRA, UMR441, LIPM, F-31326 Castanet Tolosan, France; [Plener, Laure; Boistard, Pierre; Gonzalez, Adriana; Boucher, Christian; Genin, Stephane] CNRS, UMR2594, LIPM, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse	Plener, L (corresponding author), INRA, UMR441, LIPM, F-31326 Castanet Tolosan, France.	sgenin@toulouse.inra.fr		Genin, Stephane/0000-0003-2498-2400; Gonzalez Almario, Adriana/0000-0003-2261-8912	European Community Alban program; Ministere de l'Enseignement Superieur et la Recherche	European Community Alban program; Ministere de l'Enseignement Superieur et la Recherche	This work is part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR -10-LABX-41) and was funded by grants from the European Community Alban program to AG and by a grant of the Ministere de l'Enseignement Superieur et la Recherche to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2001, ARCH MICROBIOL, V176, P151, DOI 10.1007/s002030100293; Andersen GL, 1998, J BACTERIOL, V180, P4497, DOI 10.1128/JB.180.17.4497-4507.1998; Ausubel FM, 1988, MOL REPROD DEV; Barbagallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027226; BEATTIE GA, 1994, APPL ENVIRON MICROB, V60, P3790, DOI 10.1128/AEM.60.10.3790-3798.1994; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Brito B, 1999, MOL MICROBIOL, V31, P237, DOI 10.1046/j.1365-2958.1999.01165.x; BYERLY KA, 1991, J BACTERIOL, V173, P3547, DOI 10.1128/jb.173.11.3547-3553.1991; CAI XY, 1989, P NATL ACAD SCI USA, V86, P4407, DOI 10.1073/pnas.86.12.4407; COPLIN DL, 1974, CAN J MICROBIOL, V20, P519, DOI 10.1139/m74-080; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Figge RM, 2006, AMINO ACID BIOSYNTHE, P163; Flavier AB, 1997, MOL MICROBIOL, V26, P251, DOI 10.1046/j.1365-2958.1997.5661945.x; Flores-Cruz Z, 2009, MOL PLANT MICROBE IN, V22, P773, DOI 10.1094/MPMI-22-7-0773; GENIN S, 1992, MOL MICROBIOL, V6, P3065, DOI 10.1111/j.1365-2958.1992.tb01764.x; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Gonzalez A, 2011, ENVIRON MICROBIOL, V13, P3172, DOI 10.1111/j.1462-2920.2011.02636.x; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lavie M, 2002, MOL PLANT MICROBE IN, V15, P1058, DOI 10.1094/MPMI.2002.15.10.1058; LIPPINCOTT JA, 1965, J BACTERIOL, V90, P1155, DOI 10.1128/JB.90.4.1155-1156.1965; Mukaihara T, 2010, MOL PLANT MICROBE IN, V23, P251, DOI 10.1094/MPMI-23-3-0251; Plener L, 2010, J BACTERIOL, V192, P1011, DOI 10.1128/JB.01189-09; Poueymiro M, 2009, CURR OPIN MICROBIOL, V12, P44, DOI 10.1016/j.mib.2008.11.008; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Remigi P, 2011, NEW PHYTOL, V192, P976, DOI 10.1111/j.1469-8137.2011.03854.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; SAINTGIRONS I, 1984, J BIOL CHEM, V259, P4282; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Somylai G, 1986, PHYSIOL MOL PLANT P, V29, P369; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; URBANOWSKI ML, 1987, J BACTERIOL, V169, P5841, DOI 10.1128/jb.169.12.5841-5844.1987; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; URBANOWSKI ML, 1987, J BACTERIOL, V169, P1391, DOI 10.1128/jb.169.4.1391-1397.1987; Valls M, 2006, PLOS PATHOG, V2, P798, DOI 10.1371/journal.ppat.0020082; Vasse J, 2000, MOL PLANT MICROBE IN, V13, P259, DOI 10.1094/MPMI.2000.13.3.259; WEISSBACH H, 1991, MOL MICROBIOL, V5, P1593, DOI 10.1111/j.1365-2958.1991.tb01905.x; Wu JL, 2009, BIOL TRACE ELEM RES, V129, P239, DOI 10.1007/s12011-008-8277-6; WU WF, 1992, J BACTERIOL, V174, P4833, DOI 10.1128/JB.174.14.4833-4837.1992	50	27	27	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36877	10.1371/journal.pone.0036877	http://dx.doi.org/10.1371/journal.pone.0036877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615832	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300036
J	Zarybnicka, M; Korpimaki, E; Griesser, M				Zarybnicka, Marketa; Korpimaki, Erkki; Griesser, Michael			Dark or Short Nights: Differential Latitudinal Constraints in Nestling Provisioning Patterns of a Nocturnally Hunting Bird Species	PLOS ONE			English	Article							OWLS AEGOLIUS-FUNEREUS; TENGMALMS OWLS; LIFE-HISTORY; GEOGRAPHIC-VARIATION; FOOD ABUNDANCE; CLUTCH SIZE; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; HATCHING ASYNCHRONY; BROOD REDUCTION	In diurnal bird species, individuals breeding at high latitudes have larger broods than at lower latitudes, which has been linked to differences in the daily time available for foraging. However, it remains unclear how latitude is linked with parental investment in nocturnal species. Here, we investigate nestling provisioning rates of male Tengmalm's owls in two populations at different latitudes (Czech Republic 50 degrees N; Finland 63 degrees N) with the help of cameras integrated into nest boxes. Clutch sizes were smaller in the Czech population (CZ: 5.1+/-0.1; FIN: 6.6+/-0.1), but given the higher nestling mortality in the Finnish population, the number of fledglings did not differ between the two populations (CZ: 3.5+/-0.3; FIN: 3.9+/-0.2). Nestling provisioning patterns varied within days, over the reproductive season and between the two sites. Males delivered most food at dusk and dawn, having peak delivery rates at sun angles of -11 degrees to -15 degrees at both sites, and males increased the prey delivery rates with higher nestling requirements. Given the longer nights during summer in the Czech Republic compared to Finland, Czech males only showed a small shift in their delivery peak during the night from -17 degrees in April to -14 degrees in July. In contrast, Finnish males shifted their peak of prey delivery from -11 degrees in April to -1 degrees in July. Consequently, Czech males had a longer hunting time per night around midsummer when feeding young (360 min) than Finnish males (270 min). This suggests that nocturnal owl species in northern populations are constrained by the short nights during the breeding season, which can limit the number of young they can raise. Moreover, owls in northern populations are additionally constrained through the unpredictable changes in food availability between years, and both these factors are likely to influence the reproductive investment between populations.	[Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Griesser, Michael] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Griesser, Michael] Univ Bern, Dept Ecol & Evolut, Bern, Switzerland	Czech University of Life Sciences Prague; University of Turku; Swedish University of Agricultural Sciences; University of Bern	Zarybnicka, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	zarybnicka.marketa@seznam.cz	Griesser, Michael/J-6042-2019; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020; Griesser, Michael/J-4542-2012	Griesser, Michael/0000-0002-2220-2637; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague [CIGA 41110-1313-3156, VGA 41110-1643-6457]; Ministry of Education, Youth and Sports of the Czech Republic [FRVS 41110-1161-1625]; Swiss National Research Foundation [PBSKA I02705, PPOOP3 123520]; Swedish Research Council [621-2008-5349]; Helge Ax: son Stiftelse; Basler Stiftung fur Zoologische Forschung; Academy of Finland	Czech University of Life Sciences Prague; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax: son Stiftelse; Basler Stiftung fur Zoologische Forschung; Academy of Finland(Academy of Finland)	This work was supported by grants from the Czech University of Life Sciences Prague (CIGA 41110-1313-3156, VGA 41110-1643-6457 to MZ), the Ministry of Education, Youth and Sports of the Czech Republic (FRVS 41110-1161-1625 to MZ), the Swiss National Research Foundation (PBSKA I02705 & PPOOP3 123520 to MG), the Swedish Research Council (621-2008-5349 to MG), Helge Ax: son Stiftelse (to MG), Basler Stiftung fur Zoologische Forschung (to MG) and the Academy of Finland (to EK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Bezouska V, 2005, AUTOMATIC SYSTEM MON, P173; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BYE FN, 1992, BEHAV ECOL, V3, P266, DOI 10.1093/beheco/3.3.266; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Drdakova Marketa, 2003, Sylvia, V39, P35; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Evans KL, 2005, FUNCT ECOL, V19, P616, DOI 10.1111/j.1365-2435.2005.01016.x; Ferretti V, 2005, P ROY SOC B-BIOL SCI, V272, P769, DOI 10.1098/rspb.2004.3039; FRANZ A, 1984, Vogelwarte, V32, P260; HAKKARAINEN H, 1994, OECOLOGIA, V98, P362, DOI 10.1007/BF00324225; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; Hudec K, PTACI AVES; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Koivunen V, 1996, CAN J ZOOL, V74, P816, DOI 10.1139/z96-094; Korpimaki E, 2005, P ROY SOC B-BIOL SCI, V272, P193, DOI 10.1098/rspb.2004.2860; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1989, IBIS, V131, P41, DOI 10.1111/j.1474-919X.1989.tb02742.x; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; KORPIMAKI E, 1986, Ornis Fennica, V63, P42; KORPIMAKI E, 1988, ORNIS SCAND, V19, P21, DOI 10.2307/3676522; Korpimaki E, 1981, ACTA U OULUENSIS 118, V13, P1; Korpimaki Erkki, 2008, Scottish Birds, V28, P19; Laaksonen T, 2002, J ANIM ECOL, V71, P23, DOI 10.1046/j.0021-8790.2001.00570.x; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Martin G., 1990, BIRDS NIGHT; Martin TE, 2006, EVOLUTION, V60, P390; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Martin TE, 2004, AUK, V121, P289, DOI 10.1642/0004-8038(2004)121[0289:ALEHAE]2.0.CO;2; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Mikkola H., 2020, OWLS, P97; NORBERG R A, 1970, Ornis Scandinavica, V1, P51, DOI 10.2307/3676334; Norrdahl K, 2002, OIKOS, V96, P331, DOI 10.1034/j.1600-0706.2002.960215.x; Pavey CR, 1998, ANIM BEHAV, V55, P313, DOI 10.1006/anbe.1997.0633; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; PUCEK Z, 1993, ACTA THERIOL, V38, P199, DOI 10.4098/AT.arch.93-18; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Russell EM, 2004, BEHAV ECOL, V15, P831, DOI 10.1093/beheco/arh088; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; Sanz JJ, 1997, IBIS, V139, P107, DOI 10.1111/j.1474-919X.1997.tb04509.x; Sanz JJ, 2000, OECOLOGIA, V122, P149, DOI 10.1007/PL00008842; *SAS I INC, 2006, GLIMMIX PROC; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Stastny K., 2006, ATLAS BREEDING BIRDS; Sunde P, 2003, J AVIAN BIOL, V34, P409, DOI 10.1111/j.0908-8857.2003.03105.x; Tkadlec E, 2011, ZOOLOGICAL DAYS; Valkama J, 2002, OECOLOGIA, V133, P334, DOI 10.1007/s00442-002-1033-2; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	51	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36932	10.1371/journal.pone.0036932	http://dx.doi.org/10.1371/journal.pone.0036932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615850	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300045
J	Mahar, I; Bagot, RC; Davoli, MA; Miksys, S; Tyndale, RF; Walker, CD; Maheu, M; Huang, SH; Wong, TP; Mechawar, N				Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Miksys, Sharon; Tyndale, Rachel F.; Walker, Claire-Dominique; Maheu, Marissa; Huang, Sheng-Hai; Wong, Tak Pan; Mechawar, Naguib			Developmental Hippocampal Neuroplasticity in a Model of Nicotine Replacement Therapy during Pregnancy and Breastfeeding	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SMOKING-CESSATION; SPATIAL MEMORY; CIGARETTE-SMOKING; RECEPTOR SUBTYPES; MATERNAL SMOKING; BIRTH COHORT; CELL-DEATH; RAT-BRAIN; IN-VIVO	Rationale: The influence of developmental nicotine exposure on the brain represents an important health topic in light of the popularity of nicotine replacement therapy (NRT) as a smoking cessation method during pregnancy. Objectives: In this study, we used a model of NRT during pregnancy and breastfeeding to explore the consequences of chronic developmental nicotine exposure on cerebral neuroplasticity in the offspring. We focused on two dynamic lifelong phenomena in the dentate gyrus (DG) of the hippocampus that are highly sensitive to the environment: granule cell neurogenesis and long-term potentiation (LTP). Methods: Pregnant rats were implanted with osmotic mini-pumps delivering either nicotine or saline solutions. Plasma nicotine and metabolite levels were measured in dams and offspring. Corticosterone levels, DG neurogenesis (cell proliferation, survival and differentiation) and glutamatergic electrophysiological activity were measured in pups. Results: Juvenile (P15) and adolescent (P41) offspring exposed to nicotine throughout prenatal and postnatal development displayed no significant alteration in DG neurogenesis compared to control offspring. However, NRT-like nicotine exposure significantly increased LTP in the DG of juvenile offspring as measured in vitro from hippocampal slices, suggesting that the mechanisms underlying nicotine-induced LTP enhancement previously described in adult rats are already functional in pups. Conclusions: These results indicate that synaptic plasticity is disrupted in offspring breastfed by dams passively exposed to nicotine in an NRT-like fashion.	[Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Walker, Claire-Dominique; Maheu, Marissa; Wong, Tak Pan; Mechawar, Naguib] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada; [Mahar, Ian; Bagot, Rosemary C.; Davoli, Maria Antonietta; Walker, Claire-Dominique; Maheu, Marissa; Wong, Tak Pan; Mechawar, Naguib] McGill Univ, Dept Neurol & Neurosurg, Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Ctr Addict & Mental Hlth, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Miksys, Sharon; Tyndale, Rachel F.] Univ Toronto, Toronto, ON, Canada; [Huang, Sheng-Hai] Anhui Med Univ, Coll Basic Med, Dept Microbiol, Hefei, Anhui, Peoples R China; [Wong, Tak Pan] McGill Univ, Dept Pharmacol & Therapeut, Douglas Mental Hlth Univ Inst, Verdun, PQ, Canada	McGill University; McGill University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Anhui Medical University; McGill University	Mahar, I (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada.	takpan.wong@mcgill.ca; naguib.mechawar@mcgill.ca	Mahar, Ian/R-8226-2017; Davoli, Marina/K-1975-2016; Bagot, Rosemary/V-4325-2019	Mahar, Ian/0000-0002-8792-0437; Davoli, Marina/0000-0003-4521-032X; Tyndale, Rachel/0000-0003-1297-2053; Wong, Tak Pan/0000-0001-8611-4911	Canadian Institutes of Health Research (CIHR); Institute of Human Development, Child and Youth Health; Fonds de recherche du Quebec - Sante chercheursboursiers; Center for Addiction & Mental Health, Canada Research Chair and CIHR [MOP97751]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute of Human Development, Child and Youth Health(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante chercheursboursiers; Center for Addiction & Mental Health, Canada Research Chair and CIHR	This work was supported by a Canadian Institutes of Health Research (CIHR) priority operating grant for new investigators from the Institute of Human Development, Child and Youth Health to NM, and a CIHR operating grant to TPW and NM. TPW and NM are Fonds de recherche du Quebec - Sante chercheursboursiers. We also acknowledge the support of Center for Addiction & Mental Health, Canada Research Chair and CIHR grant MOP97751 funding to RFT. All other authors received no additional external funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2002, J NEUROSCI, V22, P3656; Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Aramakis VB, 2000, J NEUROSCI, V20, P6106, DOI 10.1523/JNEUROSCI.20-16-06106.2000; BARDY AH, 1993, BRIT J OBSTET GYNAEC, V100, P721, DOI 10.1111/j.1471-0528.1993.tb14262.x; Batstra L, 2003, EARLY HUM DEV, V75, P21, DOI 10.1016/j.earlhumdev.2003.09.001; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Benowitz NL, 2000, TOB CONTROL, V9, P91, DOI 10.1136/tc.9.suppl_3.iii91; BENOWITZ NL, 1992, MED CLIN N AM, V76, P415, DOI 10.1016/S0025-7125(16)30360-1; Berger F, 1998, J NEUROSCI, V18, P6871; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Britton AF, 2007, J PHARMACOL EXP THER, V320, P871, DOI 10.1124/jpet.106.112730; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Christie BR, 2005, EUR J NEUROSCI, V21, P1719, DOI 10.1111/j.1460-9568.2005.04004.x; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Coleman T, 2004, BMJ-BRIT MED J, V328, P965, DOI 10.1136/bmj.328.7446.965; Coleman T, 2011, ADDICTION, V106, P52, DOI 10.1111/j.1360-0443.2010.03179.x; Cornelius MD, 2001, J DEV BEHAV PEDIATR, V22, P217, DOI 10.1097/00004703-200108000-00002; Dempsey D, 2000, CLIN PHARMACOL THER, V67, P458, DOI 10.1067/mcp.2000.106129; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Falk L, 2002, J NEUROCHEM, V80, P457, DOI 10.1046/j.0022-3042.2001.00714.x; Franke RM, 2008, EUR J NEUROSCI, V27, P2952, DOI 10.1111/j.1460-9568.2008.06253.x; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Hanganu IL, 2004, J NEUROPHYSIOL, V92, P189, DOI 10.1152/jn.00010.2004; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Huang LZ, 2007, NEUROSCIENCE, V146, P1854, DOI 10.1016/j.neuroscience.2007.03.008; Hussein J, 2007, TOXICOL APPL PHARM, V218, P1, DOI 10.1016/j.taap.2006.10.019; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lagace DC, 2006, BIOL PSYCHIAT, V60, P1121, DOI 10.1016/j.biopsych.2006.04.009; Langley K, 2005, Minerva Pediatr, V57, P359; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lerman C, 2006, CLIN PHARMACOL THER, V79, P600, DOI 10.1016/j.clpt.2006.02.006; Liang K, 2006, EUR J NEUROSCI, V24, P857, DOI 10.1111/j.1460-9568.2006.04945.x; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LUCK W, 1985, J PEDIATR-US, V107, P816, DOI 10.1016/S0022-3476(85)80427-3; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Machaalani R, 2005, NEUROSCIENCE, V132, P325, DOI 10.1016/j.neuroscience.2004.12.039; Mahar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026610; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mudo G, 2007, NEUROSCIENCE, V145, P470, DOI 10.1016/j.neuroscience.2006.12.012; Narayanan U, 2002, NEUROREPORT, V13, P961, DOI 10.1097/00001756-200205240-00012; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Sanghavi D M, 1995, J Ky Med Assoc, V93, P286; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Siu ECK, 2006, PSYCHOPHARMACOLOGY, V184, P401, DOI 10.1007/s00213-006-0306-6; Siu ECK, 2007, MOL PHARMACOL, V71, P826, DOI 10.1124/mol.106.032086; Slotkin TA, 2008, NEUROTOXICOL TERATOL, V30, P1, DOI 10.1016/j.ntt.2007.09.002; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Strandberg-Larsen K, 2008, BJOG-INT J OBSTET GY, V115, P1405, DOI 10.1111/j.1471-0528.2008.01867.x; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Tribollet E, 2004, NEUROSCIENCE, V124, P405, DOI 10.1016/j.neuroscience.2003.09.028; Vaillend C, 2004, NEUROBIOL DIS, V17, P10, DOI 10.1016/j.nbd.2004.05.004; Walker CD, 2003, DEV BRAIN RES, V140, P253, DOI 10.1016/S0165-3806(02)00611-9; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995	66	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37219	10.1371/journal.pone.0037219	http://dx.doi.org/10.1371/journal.pone.0037219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615944	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300080
J	Wang, X; Li, GZ				Wang, Xiao; Li, Guo-Zheng			A Multi-Label Predictor for Identifying the Subcellular Locations of Singleplex and Multiplex Eukaryotic Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; COUPLED RECEPTOR CLASSES; GRAM-NEGATIVE-BACTERIA; TOP-DOWN APPROACH; ENSEMBLE CLASSIFIER; APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; FUSION CLASSIFIER; WAVELET TRANSFORM	Subcellular locations of proteins are important functional attributes. An effective and efficient subcellular localization predictor is necessary for rapidly and reliably annotating subcellular locations of proteins. Most of existing subcellular localization methods are only used to deal with single-location proteins. Actually, proteins may simultaneously exist at, or move between, two or more different subcellular locations. To better reflect characteristics of multiplex proteins, it is highly desired to develop new methods for dealing with them. In this paper, a new predictor, called Euk-ECC-mPLoc, by introducing a powerful multi-label learning approach which exploits correlations between subcellular locations and hybridizing gene ontology with dipeptide composition information, has been developed that can be used to deal with systems containing both singleplex and multiplex eukaryotic proteins. It can be utilized to identify eukaryotic proteins among the following 22 locations: (1) acrosome, (2) cell membrane, (3) cell wall, (4) centrosome, (5) chloroplast, (6) cyanelle, (7) cytoplasm, (8) cytoskeleton, (9) endoplasmic reticulum, (10) endosome, (11) extracellular, (12) Golgi apparatus, (13) hydrogenosome, (14) lysosome, (15) melanosome, (16) microsome, (17) mitochondrion, (18) nucleus, (19) peroxisome, (20) spindle pole body, (21) synapse, and (22) vacuole. Experimental results on a stringent benchmark dataset of eukaryotic proteins by jackknife cross validation test show that the average success rate and overall success rate obtained by Euk-ECC-mPLoc were 69.70% and 81.54%, respectively, indicating that our approach is quite promising. Particularly, the success rates achieved by Euk-ECC-mPLoc for small subsets were remarkably improved, indicating that it holds a high potential for simulating the development of the area. As a user-friendly web-server, Euk-ECC-mPLoc is freely accessible to the public at the website http://levis.tongji.edu.cn:8080/bioinfo/Euk-ECC-mPLoc/. We believe that Euk-ECC-mPLoc may become a useful high-throughput tool, or at least play a complementary role to the existing predictors in identifying subcellular locations of eukaryotic proteins.	[Wang, Xiao; Li, Guo-Zheng] Tongji Univ, Dept Control Sci & Engn, MOE Key Lab Embedded Syst & Serv Comp, Shanghai 200092, Peoples R China	Tongji University	Wang, X (corresponding author), Tongji Univ, Dept Control Sci & Engn, MOE Key Lab Embedded Syst & Serv Comp, Shanghai 200092, Peoples R China.	gzli@tongji.edu.cn	Li, Guo-Zheng/D-5744-2011	Li, Guo-Zheng/0000-0001-5568-0347	Natural Science Foundation of China [61005006]; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China under grant no. 61005006, and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2009, NATURAL SCI, V1, P6392; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2006, BIOCHEM BIOPH RES CO, V347, P150, DOI 10.1016/j.bbrc.2006.06.059; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2001, CURR OPIN STRUC BIOL, V11, P327, DOI 10.1016/S0959-440X(00)00209-8; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lin J, 2011, AFR J BIOTECHNOL, V10, P16963, DOI 10.5897/AJB11.429; Lin J, 2011, PROTEIN PEPTIDE LETT, V18, P1219, DOI 10.2174/092986611797642797; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; Nanni L, 2011, IEEE ACM T COMPUTATI; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2011, J MOL GRAPH MODEL, V30, P129, DOI 10.1016/j.jmgm.2011.06.014; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Read J, 2009, LECT NOTES ARTIF INT, V5782, P254, DOI 10.1007/978-3-642-04174-7_17; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2010, J BIOMOL STRUCT DYN, V28, P175, DOI 10.1080/07391102.2010.10507351; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen HB, 2009, PROTEIN PEPTIDE LETT, V16, P1478, DOI 10.2174/092986609789839322; SMITH C, 2008, SUBCELLULAR TARGETIN; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Wang JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-174; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhang SW, 2008, AMINO ACIDS, V35, P591, DOI 10.1007/s00726-008-0086-x; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhang S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-127; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	90	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36317	10.1371/journal.pone.0036317	http://dx.doi.org/10.1371/journal.pone.0036317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629314	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300007
J	Golias, J; Schwarzer, M; Wallner, M; Kverka, M; Kozakova, H; Srutkova, D; Klimesova, K; Sotkovsky, P; Palova-Jelinkova, L; Ferreira, F; Tuckova, L				Golias, Jaroslav; Schwarzer, Martin; Wallner, Michael; Kverka, Miloslav; Kozakova, Hana; Srutkova, Dagmar; Klimesova, Klara; Sotkovsky, Petr; Palova-Jelinkova, Lenka; Ferreira, Fatima; Tuckova, Ludmila			Heat-Induced Structural Changes Affect OVA-Antigen Processing and Reduce Allergic Response in Mouse Model of Food Allergy	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANES; BIRCH POLLEN ALLERGEN; MURINE MODEL; ORAL TOLERANCE; EGG ALLERGY; ALKALINE-PHOSPHATASE; DENDRITIC CELLS; CELIAC-DISEASE; MICE; SENSITIZATION	Background and Aims: The egg protein ovalbumin (OVA) belongs to six most frequent food allergens. We investigated how thermal processing influences its ability to induce allergic symptoms and immune responses in mouse model of food allergy. Methodology/Principal Findings: Effect of increased temperature (70 degrees C and 95 degrees C) on OVA secondary structure was characterized by circular dichroism and by the kinetics of pepsin digestion with subsequent HPLC. BALB/c mice were sensitized intraperitoneally and challenged with repeated gavages of OVA or OVA heated to 70 degrees C (h-OVA). Levels of allergen-specific serum antibodies were determined by ELISA (IgA and IgGs) or by beta-hexosaminidase release test (IgE). Specific activities of digestive enzymes were determined in brush border membrane vesicles of jejunal enterocytes. Cytokine production and changes in regulatory T cells in mesenteric lymph nodes and spleen were assessed by ELISA and FACS. Heating of OVA to 70 degrees C caused mild irreversible changes in secondary structure compared to boiling to 95 degrees C (b-OVA), but both OVA treatments led to markedly different digestion kinetics and Tregs induction ability in vitro, compared to native OVA. Heating of OVA significantly decreased clinical symptoms (allergic diarrhea) and immune allergic response on the level of IgE, IL-4, IL-5, IL-13. Furthermore, h-OVA induced lower activities of serum mast cell protease-1 and enterocyte brush border membrane alkaline phosphatase as compared to native OVA. On the other hand h-OVA stimulated higher IgG2a in sera and IFN-gamma secretion by splenocytes. Conclusions: Minor irreversible changes in OVA secondary structure caused by thermal processing changes both its digestion and antigenic epitopes formation, which leads to activation of different T cell subpopulations, induces shift towards Th1 response and ultimately reduces its allergenicity.	[Golias, Jaroslav; Kverka, Miloslav; Klimesova, Klara; Sotkovsky, Petr; Palova-Jelinkova, Lenka; Tuckova, Ludmila] Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Prague, Czech Republic; [Schwarzer, Martin; Kozakova, Hana; Srutkova, Dagmar] Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Novy Hradek, Czech Republic; [Wallner, Michael; Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Salzburg University	Golias, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Dept Immunol & Gnotobiol, Vvi, Prague, Czech Republic.	schwarzer@biomed.cas.cz	Wallner, Michael/L-5437-2015; Šrůtková, Dagmar/H-8511-2014; Goliáš, Jaroslav/J-6896-2014; Ferreira, Fatima/E-4889-2011; Ferreira, Fatima/AAB-4321-2019; Schwarzer, Martin/P-9871-2017; Kozakova, Hana/I-1153-2014; Kverka, Miloslav/H-2507-2014; Kostovcikova, Klara/J-6851-2014	Wallner, Michael/0000-0001-6568-7892; Šrůtková, Dagmar/0000-0003-0054-5396; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Schwarzer, Martin/0000-0002-1401-6578; Kozakova, Hana/0000-0001-7352-5922; Kverka, Miloslav/0000-0002-1335-5252; Kostovcikova, Klara/0000-0003-1821-398X	Czech Science Foundation [GA310/07/0414, 310/08/H077]; Synlab; Academy of Sciences of the Czech Republic [IAA500200801, IAA500200710, KJB500200904]; Czech Ministry of Education, Youth and Sports [2B06155, LC07017]; Institutional Research Concept [AV0Z50200510]	Czech Science Foundation(Grant Agency of the Czech Republic); Synlab; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Institutional Research Concept	This work was supported by grants from the Czech Science Foundation (GA310/07/0414, 310/08/H077 and 310/08/H077), http://www.gacr.cz/; Synlab (http:www.synlab.cz), the Academy of Sciences of the Czech Republic (IAA500200801, IAA500200710 and KJB500200904), http://www.gaav.cz/; the Czech Ministry of Education, Youth and Sports (2B06155 and LC07017), http://www.msmt.cz; and by Institutional Research Concept Grant AV0Z50200510, http://www.isvav.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Brunner R, 2009, ALLERGY, V64, P890, DOI 10.1111/j.1398-9995.2008.01933.x; Dearman RJ, 2007, METHODS, V41, P91, DOI 10.1016/j.ymeth.2006.07.008; Detel D, 2007, J PEDIATR GASTR NUTR, V45, P65, DOI 10.1097/MPG.0b013e318054b085; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Herouet-Guicheney C, 2009, J APPL TOXICOL, V29, P141, DOI 10.1002/jat.1391; Himly M, 2009, ALLERGY, V64, P1038, DOI 10.1111/j.1398-9995.2009.01957.x; Hudcovic T, 2009, PHYSIOL RES, V58, P101, DOI 10.33549/physiolres.931340; Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6; Johansen P, 2005, EUR J IMMUNOL, V35, P3591, DOI 10.1002/eji.200535076; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Kozakova H, 2001, FOLIA MICROBIOL, V46, P573, DOI 10.1007/BF02818005; Kozakova H, 2006, MICROBES INFECT, V8, P2629, DOI 10.1016/j.micinf.2006.07.008; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lee SY, 2001, CLIN IMMUNOL, V101, P220, DOI 10.1006/clim.2001.5122; Lehrer SB, 2004, J IMMUNOL METHODS, V284, P1, DOI 10.1016/j.jim.2003.08.017; Lemon-Mule H, 2008, J ALLERGY CLIN IMMUN, V122, P977, DOI 10.1016/j.jaci.2008.09.007; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Lied GA, 2011, INT J GEN MED, V4, P389, DOI 10.2147/IJGM.S17655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynes MD, 2011, LIFE SCI, V88, P384, DOI 10.1016/j.lfs.2010.12.015; Martos G, 2011, J ALLERGY CLIN IMMUN, V127, P990, DOI 10.1016/j.jaci.2011.01.057; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Pali-Scholl I, 2010, CLIN EXP ALLERGY, V40, P1091, DOI 10.1111/j.1365-2222.2010.03468.x; Perrier C, 2010, CLIN EXP ALLERGY, V40, P153, DOI 10.1111/j.1365-2222.2009.03329.x; Repa A, 2008, IMMUNOL LETT, V117, P50, DOI 10.1016/j.imlet.2007.11.025; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Saldanha JCS, 2004, BRAZ J MED BIOL RES, V37, P809, DOI 10.1590/S0100-879X2004000600005; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; SIMON PM, 1979, BIOCHEM J, V178, P407, DOI 10.1042/bj1780407; SMITH MW, 1990, EXP PHYSIOL, V75, P613, DOI 10.1113/expphysiol.1990.sp003439; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Vaali K, 2006, SCAND J GASTROENTERO, V41, P1405, DOI 10.1080/00365520600815639; van der Ventel ML, 2011, MOL IMMUNOL, V48, P637, DOI 10.1016/j.molimm.2010.11.001; Viney JL, 1998, J IMMUNOL, V160, P5815; WHITACRE CC, 1991, J IMMUNOL, V147, P2155; Wiedermann U, 1999, J ALLERGY CLIN IMMUN, V103, P1202, DOI 10.1016/S0091-6749(99)70200-9; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x	44	40	45	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37156	10.1371/journal.pone.0037156	http://dx.doi.org/10.1371/journal.pone.0037156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629361	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100015
J	Hure, AJ; Powers, JR; Mishra, GD; Herbert, DL; Byles, JE; Loxton, D				Hure, Alexis J.; Powers, Jennifer R.; Mishra, Gita D.; Herbert, Danielle L.; Byles, Julie E.; Loxton, Deborah			Miscarriage, Preterm Delivery, and Stillbirth: Large Variations in Rates within a Cohort of Australian Women	PLOS ONE			English	Article							RISK-FACTORS; PREGNANCY; BIRTH	Objectives: We aimed to use simple clinical questions to group women and provide their specific rates of miscarriage, preterm delivery, and stillbirth for reference. Further, our purpose was to describe who has experienced particularly low or high rates of each event. Methods: Data were collected as part of the Australian Longitudinal Study on Women's Health, a national prospective cohort. Reproductive histories were obtained from 5806 women aged 31-36 years in 2009, who had self-reported an outcome for one or more pregnancy. Age at first birth, number of live births, smoking status, fertility problems, use of in vitro fertilisation (IVF), education and physical activity were the variables that best separated women into groups for calculating the rates of miscarriage, preterm delivery, and stillbirth. Results: Women reported 10,247 live births, 2544 miscarriages, 1113 preterm deliveries, and 113 stillbirths. Miscarriage was correlated with stillbirth (r = 0.09, P<0.001). The calculable rate of miscarriage ranged from 11.3 to 86.5 miscarriages per 100 live births. Women who had high rates of miscarriage typically had fewer live births, were more likely to smoke and were more likely to have tried unsuccessfully to conceive for >= 12 months. The highest proportion of live preterm delivery (32.2%) occurred in women who had one live birth, had tried unsuccessfully to conceive for >= 12 months, had used IVF, and had 12 years education or equivalent. Women aged 14-19.99 years at their first birth and reported low physical activity had 38.9 stillbirths per 1000 live births, compared to the lowest rate at 5.5 per 1000 live births. Conclusion: Different groups of women experience vastly different rates of each adverse pregnancy event. We have used simple questions and established reference data that will stratify women into low-and high-rate groups, which may be useful in counselling those who have experienced miscarriage, preterm delivery, or stillbirth, plus women with fertility intent.	[Hure, Alexis J.; Powers, Jennifer R.; Byles, Julie E.; Loxton, Deborah] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Mishra, Gita D.; Herbert, Danielle L.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia	University of Newcastle; University of Queensland	Hure, AJ (corresponding author), Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia.	alexis.hure@newcastle.edu.au	Powers, Jennifer R/A-8108-2011; Herbert, Danielle/A-1685-2010; Byles, Julie E/C-5062-2008	Herbert, Danielle/0000-0001-5133-9731; Byles, Julie E/0000-0002-3984-6877; Hure, Alexis/0000-0003-2225-0986	Department of Health and Ageing [G0189875]; National Health and Medical Research Council [APP1000986]	Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Australian Longitudinal Study on Women's Health was funded by the Department of Health and Ageing (G0189875), http://www.health.gov.au/. This work was undertaken as part of the Centre for Research Excellence in Women's Health in the 21st Century (CREWH21), funded by the National Health and Medical Research Council (APP1000986), http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen K, 2004, AM J EPIDEMIOL, V159, P155, DOI 10.1093/aje/kwh034; [Anonymous], 2008, FERTIL STERIL, V89, P1603, DOI 10.1016/j.fertnstert.2008.03.002; Australian Government, 2012, FAM ASS GUID VERS 11; Australian Institute of Health and Welfare, 2000, NAT HLTH DAT DICT VE; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; Brown WJ, 1998, WOMEN HEALTH, V28, P23; Brown WJBL, 1996, J WOMENS HEALTH, V5, P467, DOI DOI 10.1089/JWH.1996.5.467; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; El-Sayed MM, 2009, J OBSTET GYNAECOL, V29, P681, DOI 10.3109/01443610903215399; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Forbes LS, 1997, TRENDS ECOL EVOL, V12, P446, DOI 10.1016/S0169-5347(97)01179-8; George L, 2006, PAEDIATR PERINAT EP, V20, P119, DOI 10.1111/j.1365-3016.2006.00703.x; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2011, LANCET, V377, P1798, DOI 10.1016/S0140-6736(10)62235-0; Gray RH, 2000, AM J PUBLIC HEALTH, V90, P1452, DOI 10.2105/AJPH.90.9.1452; GUERNERI S, 1987, HUM REPROD, V2, P735, DOI 10.1093/oxfordjournals.humrep.a136623; Herbert D, 2009, WOMEN HEALTH ISS, V19, P21, DOI 10.1016/j.whi.2008.08.007; JOFFE M, 1994, FERTIL STERIL, V62, P71; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lee C, 2005, INT J EPIDEMIOL, V34, P987, DOI 10.1093/ije/dyi098; Li Z, 2011, AUSTRALIAS MOTHERS B; Miranda ML, 2011, PUBLIC HEALTH REP, V126, P797, DOI 10.1177/003335491112600605; MORRISON J, 1989, BRIT J OBSTET GYNAEC, V96, P298, DOI 10.1111/j.1471-0528.1989.tb02389.x; National Health and Medical Research Council, 2001, AUSTR AL GUID HLTH R; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Simmons RK, 2006, SOC SCI MED, V63, P1934, DOI 10.1016/j.socscimed.2006.04.024; Tulandi T., 2011, UPTODATE; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; World Health Organization, 2006, GLOB DAT BOD MASS IN	33	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37109	10.1371/journal.pone.0037109	http://dx.doi.org/10.1371/journal.pone.0037109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VD	22629355	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100012
J	Wong, KFE				Wong, Kin Fai Ellick			Negative Priming Under Rapid Serial Visual Presentation	PLOS ONE			English	Article							ATTENTIONAL BLINK; REPETITION BLINDNESS; SELECTIVE ATTENTION; DISTRACTOR INHIBITION; EPISODIC RETRIEVAL; CONTEXTUAL SIMILARITY; RATER GOALS; DISTINCTIVENESS; MECHANISMS; FAILURE	Negative priming (NP) was examined under a new paradigm wherein a target and distractors were temporally separated using rapid serial visual presentation (RSVP). The results from the two experiments revealed that (a) NP was robust under RSVP, such that the responses to a target were slower when the target served as a distractor in a previous trial than when it did not; (b) NP was found regardless of whether the distractors appeared before or after the targets; and (c) NP was stronger when the distractor was more distinctive. These findings are generally similar to those on NP in the spatial search task. The implications for the processes causing NP under RSVP are discussed in the current paper.	Hong Kong Univ Sci & Technol, Dept Management, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Wong, KFE (corresponding author), Hong Kong Univ Sci & Technol, Dept Management, Hong Kong, Hong Kong, Peoples R China.	mnewong@ust.hk		Wong, Kin Fai Ellick/0000-0002-7887-8732	HKUST from the Research Grants Council of the Hong Kong Special Administrative Region, China [643509]	HKUST from the Research Grants Council of the Hong Kong Special Administrative Region, China	This research was partially supported by Grant HKUST#643509 from the Research Grants Council of the Hong Kong Special Administrative Region, China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG IT, 1995, J EXP PSYCHOL HUMAN, V21, P1044, DOI 10.1037/0096-1523.21.5.1044; BIRNBAUM MH, 1974, J EXP PSYCHOL, V102, P543, DOI 10.1037/h0036014; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 1997, J EXP PSYCHOL HUMAN, V23, P738, DOI 10.1037/0096-1523.23.3.738; Dux PE, 2007, PSYCHON B REV, V14, P723, DOI 10.3758/BF03196828; Dux PE, 2006, COGNITION, V99, P355, DOI 10.1016/j.cognition.2005.04.002; FAGOT C, 1995, J EXP PSYCHOL HUMAN, V21, P275, DOI 10.1037/0096-1523.21.2.275; Folk CL, 2008, VIS COGN, V16, P616, DOI 10.1080/13506280601134018; Fox E, 1998, PSYCHON B REV, V5, P107, DOI 10.3758/BF03209464; FOX E, 1995, PSYCHON B REV, V2, P145, DOI 10.3758/BF03210958; Frederick SW, 2012, J EXP PSYCHOL GEN, V141, P124, DOI 10.1037/a0024006; Frings C, 2007, MEM COGNITION, V35, P504, DOI 10.3758/BF03193290; Frings C, 2011, J EXP PSYCHOL HUMAN, V37, P72, DOI 10.1037/a0020673; HABERLANDT K, 1989, MEM COGNITION, V17, P186, DOI 10.3758/BF03197068; HABERLANDT KF, 1985, J EXP PSYCHOL GEN, V114, P357, DOI 10.1037/0096-3445.114.3.357; Harris IM, 2010, J EXP PSYCHOL HUMAN, V36, P1595, DOI 10.1037/a0019218; Houghton G, 1996, VIS COGN, V3, P119, DOI 10.1080/713756733; HUNT RR, 1982, J EXP PSYCHOL-HUM L, V8, P81, DOI 10.1037/0278-7393.8.1.81; HUNT RR, 1980, J EXP PSYCHOL GEN, V109, P49, DOI 10.1037/0096-3445.109.1.49; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Jolicoeur P, 1998, MEM COGNITION, V26, P1014, DOI 10.3758/BF03201180; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kane MJ, 1997, J EXP PSYCHOL HUMAN, V23, P632, DOI 10.1037/0096-1523.23.3.632; KANWISHER N, 1991, J EXP PSYCHOL HUMAN, V17, P404, DOI 10.1037/0096-1523.17.2.404; KANWISHER NG, 1990, J EXP PSYCHOL HUMAN, V16, P30, DOI 10.1037/0096-1523.16.1.30; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Kihara K, 2011, J EXP PSYCHOL HUMAN, V37, P168, DOI 10.1037/a0019948; Lavie N, 2000, J EXP PSYCHOL HUMAN, V26, P1038, DOI 10.1037//0096-1523.26.3.1038; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Loach D, 2003, VIS COGN, V10, P513, DOI 10.1080/13506280244000203; LOGAN GD, 1990, COGNITIVE PSYCHOL, V22, P1, DOI 10.1016/0010-0285(90)90002-L; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LOWE DG, 1979, MEM COGNITION, V7, P382, DOI 10.3758/BF03196943; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1393, DOI 10.1037/0096-1523.23.5.1393; MAY CP, 1995, PSYCHOL BULL, V118, P35, DOI 10.1037/0033-2909.118.1.35; MELLERS BA, 1994, J EXP PSYCHOL HUMAN, V20, P1055, DOI 10.1037/0096-1523.20.5.1055; Milliken B, 1998, PSYCHOL REV, V105, P203, DOI 10.1037/0033-295X.105.2.203; MOORE CM, 1994, PERCEPT PSYCHOPHYS, V56, P133, DOI 10.3758/BF03213892; Morris AL, 2004, J EXP PSYCHOL HUMAN, V30, P913, DOI 10.1037/0096-1523.30.5.913; NEILL WT, 1979, MEM COGNITION, V7, P283, DOI 10.3758/BF03197601; Neill WT, 1997, J EXP PSYCHOL LEARN, V23, P1291, DOI 10.1037/0278-7393.23.6.1291; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P565, DOI 10.1037/0278-7393.18.3.565; NEILL WT, 1977, J EXP PSYCHOL HUMAN, V3, P444, DOI 10.1037/0096-1523.3.3.444; NEILL WT, 1996, CONVERGING OPERATION, P77, DOI DOI 10.1037/10187-003; PARK JY, 1994, J EXP PSYCHOL HUMAN, V20, P613, DOI 10.1037/0096-1523.20.3.613; PASHLER H, 1989, COGNITIVE PSYCHOL, V21, P469, DOI 10.1016/0010-0285(89)90016-9; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; Rajaram S, 1996, J EXP PSYCHOL LEARN, V22, P365, DOI 10.1037/0278-7393.22.2.365; Rajaram S, 1998, PSYCHON B REV, V5, P71, DOI 10.3758/BF03209458; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tse CS, 2011, J EXP PSYCHOL HUMAN, V37, P180, DOI 10.1037/a0019930; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Wang XM, 2010, J APPL PSYCHOL, V95, P546, DOI 10.1037/a0018866; Whittlesea BWA, 2005, J EXP PSYCHOL LEARN, V31, P54, DOI 10.1037/0278-7393.31.1.54; WHITTLESEA BWA, 1995, J EXP PSYCHOL LEARN, V21, P1689, DOI 10.1037/0278-7393.21.6.1689; Wong KFE, 2000, J EXP PSYCHOL LEARN, V26, P1411, DOI 10.1037//0278-7393.26.6.1411; Wong KFE, 1999, LANG COGNITIVE PROC, V14, P461, DOI 10.1080/016909699386158; Wong KFE, 2005, J APPL PSYCHOL, V90, P284, DOI 10.1037/0021-9010.90.2.284; Wong KFE, 2002, J EXP PSYCHOL HUMAN, V28, P54, DOI 10.1037//0096-1523.28.1.54; Wong KFE, 2005, ORGAN BEHAV HUM DEC, V98, P54, DOI 10.1016/j.obhdp.2005.04.002; Wong KFE, 2009, J EXPT PSYCHOL HUMAN, V35, P913; Wong KFE, 2007, J APPL PSYCHOL, V92, P577, DOI 10.1037/0021-9010.92.2.577	67	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37023	10.1371/journal.pone.0037023	http://dx.doi.org/10.1371/journal.pone.0037023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VD	22629351	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100010
J	Guo, N; Lang, LX; Li, WH; Kiesewetter, DO; Gao, HK; Niu, G; Xie, QG; Chen, XY				Guo, Ning; Lang, Lixin; Li, Weihua; Kiesewetter, Dale O.; Gao, Haokao; Niu, Gang; Xie, Qingguo; Chen, Xiaoyuan			Quantitative Analysis and Comparison Study of [F-18]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [Ga-68]Ga-NOTA-PRGD2 Using a Reference Tissue Model	PLOS ONE			English	Article							CYCLIC RGD PEPTIDES; GRAPHICAL ANALYSIS; INTEGRIN; TRACER; TUMORS; ANGIOGENESIS; EXPRESSION; STRATEGIES; REGRESSION; KINETICS	With favorable pharmacokinetics and binding affinity for alpha(v)beta(3) integrin, F-18-labeled dimeric cyclic RGD peptide ([F-18]FPPRGD2) has been intensively used as a PET imaging probe for lesion detection and therapy response monitoring. A recently introduced kit formulation method, which uses an F-18-fluoride-aluminum complex labeled RGD tracer ([F-18]AlF-NOTA-PRGD2), provides a strategy for simplifying the labeling procedure to facilitate clinical translation. Meanwhile, an easy-to-prepare Ga-68-labeled NOTA-PRGD2 has also been reported to have promising properties for imaging integrin alpha(v)beta(3). The purpose of this study is to quantitatively compare the pharmacokinetic parameters of [F-18]FPPRGD2, [F-18]AlF-NOTA-PRGD2, and [Ga-68]Ga-NOTA-PRGD2. U87MG tumor-bearing mice underwent 60-min dynamic PET scans following the injection of three tracers. Kinetic parameters were calculated using Logan graphical analysis with reference tissue. Parametric maps were generated using voxel-level modeling. All three compounds showed high binding potential (Bp(ND) = k(3)/k(4)) in tumor voxels. [F-18]AlF-NOTA-PRGD2 showed comparable Bp(ND) value (3.75 +/- 0.65) with those of [F-18]FPPRGD2 (3.39 +/- 0.84) and [Ga-68]Ga-NOTA-PRGD2 (3.09 +/- 0.21) (p > 0.05). Little difference was found in volume of distribution (V-T) among these three RGD tracers in tumor, liver and muscle. Parametric maps showed similar kinetic parameters for all three tracers. We also demonstrated that the impact of non-specific binding could be eliminated in the kinetic analysis. Consequently, kinetic parameter estimation showed more comparable results among groups than static image analysis. In conclusion, [F-18]AlF-NOTA-PRGD2 and [Ga-68]Ga-NOTA-PRGD2 have comparable pharmacokinetics and quantitative parameters compared to those of [F-18]FPPRGD2. Despite the apparent difference in tumor uptake (%ID/g determined from static images) and clearance pattern, the actual specific binding component extrapolated from kinetic modeling appears to be comparable for all three dimeric RGD tracers.	[Guo, Ning; Lang, Lixin; Li, Weihua; Kiesewetter, Dale O.; Gao, Haokao; Niu, Gang; Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA; [Guo, Ning; Xie, Qingguo] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China; [Guo, Ning; Xie, Qingguo] Wuhan Natl Lab Optoelect, Wuhan, Hubei, Peoples R China; [Chen, Xiaoyuan] Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, Xiamen, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Huazhong University of Science & Technology; Huazhong University of Science & Technology; Xiamen University	Guo, N (corresponding author), Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD 20892 USA.	shawn.chen@nih.gov	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; International Cooperative Program of the National Science Foundation of China (NSFC) [81028009]; NSFC [60972099, 61027006]; China Scholarship Council; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Cooperative Program of the National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by the Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering, the National Institutes of Health, the International Cooperative Program of the National Science Foundation of China (NSFC) (81028009), and NSFC Grants (60972099, 61027006). NG was partially sponsored by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MR, 2011, J NUCL MED, V52, P424, DOI 10.2967/jnumed.110.077479; Beer AJ, 2005, J NUCL MED, V46, P1333; Beer AJ, 2011, THERANOSTICS, V1, P48, DOI 10.7150/thno/v01p0048; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Chen XY, 2006, MINI-REV MED CHEM, V6, P227, DOI 10.2174/138955706775475975; Chen XY, 2004, NUCL MED BIOL, V31, P179, DOI 10.1016/j.nucmedbio.2003.10.002; Chen XY, 2004, MOL IMAGING BIOL, V6, P350, DOI 10.1016/j.mibio.2004.06.004; Chin FT, 2012, MOL IMAGING BIOL, V14, P88, DOI 10.1007/s11307-011-0477-3; D'Souza CA, 2011, BIOCONJUGATE CHEM, V22, P1793, DOI 10.1021/bc200175c; Ferl GZ, 2009, J NUCL MED, V50, P250, DOI 10.2967/jnumed.108.054049; Gao HK, 2012, EUR J NUCL MED MOL I, V39, P683, DOI 10.1007/s00259-011-2052-1; Guo N, 2012, MOL IMAGING BIOL, V14, P743, DOI 10.1007/s11307-012-0541-7; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Jacobson O, 2011, BIOCONJUGATE CHEM, V22, P422, DOI 10.1021/bc100437q; Jacobson O, 2011, MOL IMAGING BIOL, V13, P1224, DOI 10.1007/s11307-010-0458-y; Jacobson O, 2010, CURR TOP MED CHEM, V10, P1048, DOI 10.2174/156802610791384298; Jeong JM, 2008, J NUCL MED, V49, P830, DOI 10.2967/jnumed.107.047423; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Kimura Y, 2007, ANN NUCL MED, V21, P1, DOI 10.1007/BF03033993; Kostikov AP, 2012, BIOCONJUGATE CHEM, V23, P106, DOI 10.1021/bc200525x; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lang LX, 2011, BIOCONJUGATE CHEM, V22, P2415, DOI 10.1021/bc200197h; Lang LX, 2011, THERANOSTICS, V1, P341, DOI 10.7150/thno/v01p0341; Li ZB, 2008, EUR J NUCL MED MOL I, V35, P1100, DOI 10.1007/s00259-007-0692-y; Liu SL, 2011, THERANOSTICS, V1, P403, DOI 10.7150/thno/v01p0403; Liu SL, 2011, EUR J NUCL MED MOL I, V38, P1732, DOI 10.1007/s00259-011-1847-4; Logan J, 2003, NUCL MED BIOL, V30, P833, DOI 10.1016/S0969-8051(03)00114-8; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mittra ES, 2011, RADIOLOGY, V260, P182, DOI 10.1148/radiol.11101139; Morrison M, 2011, THERANOSTICS, V1, P149, DOI 10.7150/thno/v01p0149; Niu G, 2011, THERANOSTICS, V1, P30, DOI 10.7150/thno/v01p0030; Shi JY, 2011, THERANOSTICS, V1, P322, DOI 10.7150/thno/v01p0322; Tomasi G, 2012, MOL IMAGING BIOL, V14, P131, DOI 10.1007/s11307-011-0514-2; Zhang XZ, 2006, J NUCL MED, V47, P113; Zhou Y, 2011, THERANOSTICS, V1, P58, DOI 10.7150/thno/v01p0058; Zhou Y, 2010, NEUROIMAGE, V49, P2947, DOI 10.1016/j.neuroimage.2009.11.028; Zhou Y, 2009, NEUROIMAGE, V44, P661, DOI 10.1016/j.neuroimage.2008.09.021	38	47	48	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37506	10.1371/journal.pone.0037506	http://dx.doi.org/10.1371/journal.pone.0037506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624041	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500126
J	Kratzat, S; Nikolova, V; Miething, C; Hoellein, A; Schoeffmann, S; Gorka, O; Pietschmann, E; Illert, AL; Ruland, J; Peschel, C; Nilsson, J; Duyster, J; Keller, U				Kratzat, Susanne; Nikolova, Viktoriya; Miething, Cornelius; Hoellein, Alexander; Schoeffmann, Stephanie; Gorka, Oliver; Pietschmann, Elke; Illert, Anna-Lena; Ruland, Juergen; Peschel, Christian; Nilsson, Jonas; Duyster, Justus; Keller, Ulrich			Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies	PLOS ONE			English	Article							CDK INHIBITOR P27; RETRACTED ARTICLE. SEE; BOX PROTEIN SKP2; BREAST-CANCER; MICE LACKING; P27(KIP1); EXPRESSION; SURVIVAL; LYMPHOMAGENESIS; TUMORIGENESIS	The Cks1 component of the SCFSkp2 complex is necessary for p27(Kip1) ubiquitylation and degradation. Cks1 expression is elevated in various B cell malignancies including Burkitt lymphoma and multiple myeloma. We have previously shown that loss of Cks1 results in elevated p27(Kip1) levels and delayed tumor development in a mouse model of Myc-induced B cell lymphoma. Surprisingly, loss of Skp2 in the same mouse model also resulted in elevated p27(Kip1) levels but exhibited no impact on tumor onset. This raises the possibility that Cks1 could have other oncogenic activities than suppressing p27(Kip1). To challenge this notion we have targeted overexpression of Cks1 to B cells using a conditional retroviral bone marrow transduction-transplantation system. Despite potent ectopic overexpression, Cks1 was unable to promote B cell hyperproliferation or B cell malignancies, indicating that Cks1 is not oncogenic when overexpressed in B cells. Since Skp2 overexpression can drive T-cell tumorigenesis or other cancers we also widened the quest for oncogenic activity of Cks1 by ubiquitously expressing Cks1 in hematopoetic progenitors. At variance with c-Myc overexpression, which caused acute myeloid leukemia, Cks1 overexpression did not induce myeloproliferation or leukemia. Therefore, despite being associated with a poor prognosis in various malignancies, sole Cks1 expression is insufficient to induce lymphoma or a myeloproliferative disease in vivo.	[Kratzat, Susanne; Nikolova, Viktoriya; Miething, Cornelius; Hoellein, Alexander; Schoeffmann, Stephanie; Pietschmann, Elke; Illert, Anna-Lena; Peschel, Christian; Duyster, Justus; Keller, Ulrich] Tech Univ Munich, Dept Med 3, Munich, Germany; [Gorka, Oliver; Ruland, Juergen] Tech Univ Munich, Inst Clin Chem & Biochem, Munich, Germany; [Nilsson, Jonas] Univ Gothenburg, Sahlgrenska Canc Ctr, Gothenburg, Sweden	Technical University of Munich; Technical University of Munich; University of Gothenburg	Kratzat, S (corresponding author), Tech Univ Munich, Dept Med 3, Munich, Germany.	ulrich.keller@lrz.tum.de	Miething, Cornelius/F-9498-2014; Illert, Anna L/G-8127-2019; Gorka, Oliver/AAF-1633-2020; Ruland, Jürgen/Q-6680-2018; Nilsson, Jonas/E-5346-2013	Miething, Cornelius/0000-0003-4699-3805; Ruland, Jürgen/0000-0002-8381-3597; Gorka, Oliver/0000-0002-8245-3008; Nilsson, Jonas/0000-0003-0346-6837; Hollein, Alexander/0000-0002-9799-7809	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB-TRR54]; Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS) [R11/18]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS)	This work was supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) (SFB-TRR54) and the Deutsche Jose Carreras Leukamie Stiftung (Jose Carreras International Leukemia Foundation) (DJCLS, R11/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chang H, 2006, BRIT J HAEMATOL, V135, P486, DOI 10.1111/j.1365-2141.2006.06325.x; Chang H, 2010, HAEMATOL-HEMATOL J, V95, P1542, DOI 10.3324/haematol.2010.022210; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; den Hollander J, 2010, BLOOD; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Inui N, 2003, BIOCHEM BIOPH RES CO, V303, P978, DOI 10.1016/S0006-291X(03)00469-8; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Krek W, 1998, CURR OPIN GENET DEV, V8, P36, DOI 10.1016/S0959-437X(98)80059-2; Lan YS, 2008, INT J CANCER, V123, P543, DOI 10.1002/ijc.23548; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Li MH, 2004, INT J ONCOL, V24, P305; Liberal V, 2011, P NATL ACAD SCI US; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Miething C, 2006, LEUKEMIA, V20, P650, DOI 10.1038/sj.leu.2404151; Morris MC, 1998, BIOCHEMISTRY-US, V37, P14257, DOI 10.1021/bi980913u; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim EH, 2003, CANCER RES, V63, P1583; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Slotky M, 2005, BREAST CANCER RES, V7, pR737, DOI 10.1186/bcr1278; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Su AI, 2001, CANCER RES, V61, P7388; Supriatno, 2003, ONCOL REP, V10, P527; Wang XC, 2009, J CANCER RES CLIN, V135, P1393, DOI 10.1007/s00432-009-0582-8; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660	41	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37433	10.1371/journal.pone.0037433	http://dx.doi.org/10.1371/journal.pone.0037433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624029	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500114
J	Liu, XY; Ren, BA; Gao, H; Liu, M; Dai, HQ; Song, FH; Yu, ZY; Wang, SJ; Hu, JC; Kokare, CR; Zhang, LX				Liu, Xiangyang; Ren, Biao; Gao, Hong; Liu, Mei; Dai, Huanqin; Song, Fuhang; Yu, Zhenyan; Wang, Shujin; Hu, Jiangchun; Kokare, Chandrakant R.; Zhang, Lixin			Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity	PLOS ONE			English	Article							BACILLUS-NATTO TK-1; LIPOPEPTIDE BIOSURFACTANT; MICROBIAL SURFACTANTS; SUBTILIS; INHIBITION; ISOFORMS; MODELS	Background: Two of our long term efforts are to discover compounds with synergistic antifungal activity from metabolites of marine derived microbes and to optimize the production of the interesting compounds produced by microorganisms. In this respect, new applications or mechanisms of already known compounds with a high production yield could be continually identified. Surfactin is a well-known lipopeptide biosurfactant with a broad spectrum of antimicrobial and antiviral activity; however, there is less knowledge on surfactin's antifungal activity. In this study, we investigated the synergistic antifungal activity of C-15-surfactin and the optimization of its production by the response surface method. Methodology/Principal Findings: Using a synergistic antifungal screening model, we found that the combination of C-15-surfactin and ketoconazole (KTC) showed synergistic antifungal effect on Candida albicans SC5314 when the concentrations of C-15-surfactin and KTC were 6.25 mu g/mL and 0.004 mu g/mL, respectively. These concentrations were lower than their own efficient antifungal concentrations, which are >100 mu g/mL and 0.016 mu g/mL, respectively. The production of C-15-surfactin from Bacillus amyloliquefaciens was optimized by the response surface methodology in shaker flask cultivation. The Plackett-Burman design found sucrose, ammonium nitrate and NaH2PO4 center dot 2H(2)O to have significant effects on C-15-surfactin production. The optimum values of the tested variables were 21.17 g/L sucrose, 2.50 g/L ammonium nitrate and 11.56 g/L NaH2PO4 center dot 2H(2)O. A production of 134.2 mg/L, which were in agreement with the prediction, was observed in a verification experiment. In comparison to the production of original level (88.6 mg/L), a 1.52-fold increase had been obtained. Conclusion/Significance: This work first found that C-15-surfactin was an efficient synergistic antifungal agent, and demonstrated that response surface methodology was an effective method to improve the production of C-15-surfactin.	[Liu, Xiangyang; Ren, Biao; Gao, Hong; Liu, Mei; Dai, Huanqin; Song, Fuhang; Zhang, Lixin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Shujin; Hu, Jiangchun] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China; [Yu, Zhenyan] Shengli Oilfield Xinhai Xingda Ind Grp Co Ltd, Dongying, Shandong, Peoples R China; [Ren, Biao; Zhang, Lixin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Kokare, Chandrakant R.] Bharati Vidyapeeth Univ, Pune, Maharashtra, India	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Bharati Vidyapeeth Deemed University	Liu, XY (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	Zhanglixin@im.ac.cn	Ren, Biao/P-1067-2015; Kokare, Chandrakant/ADT-7205-2022	Ren, Biao/0000-0003-4215-2873; Zhang, Lixin/0000-0003-0894-9520; Gao, Hong/0000-0002-8544-7826	National Natural Science Foundation of China [30973665, 30901849, 30873129, 30911120483, 30911120484, 81011120046, 81102356, 31100075, 81102369, 81102362, 31170095, 31000004]; CAS Pillar Program [XDA04074000]; Ministry of Science and Technology of China [2007DFB31620, 2011ZX11102]; National Distinguished Young Scholar Program in China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Pillar Program; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Distinguished Young Scholar Program in China	This work was supported in part by grants from National Natural Science Foundation of China (30973665, 30901849, 30873129, 30911120483, 30911120484, 81011120046, 81102356, 31100075, 81102369, 81102362, 31170095, and 31000004), the CAS Pillar Program (XDA04074000) and the Ministry of Science and Technology of China (2007DFB31620, 2011ZX11102). L. Z. is an Awardee for National Distinguished Young Scholar Program in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolato M, 1997, BIOTECHNOL LETT, V19, P433, DOI 10.1023/A:1018387909310; Cao XH, 2010, CHEM-BIOL INTERACT, V183, P357, DOI 10.1016/j.cbi.2009.11.027; Cao XH, 2009, BRAZ J MICROBIOL, V40, P373, DOI 10.1590/S1517-838220090002000030; Cao XH, 2009, BIOTECHNOL APPL BIOC, V52, P97, DOI 10.1042/BA20070227; Cao XH, 2009, CELL BIOCHEM BIOPHYS, V55, P163, DOI 10.1007/s12013-009-9065-4; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Chakraborty S, 2011, J MOL CATAL B-ENZYM, V68, P52, DOI 10.1016/j.molcatb.2010.09.009; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Christofi N, 2002, J APPL MICROBIOL, V93, P915, DOI 10.1046/j.1365-2672.2002.01774.x; Deleu M, 2003, LANGMUIR, V19, P3377, DOI 10.1021/la026543z; Eeman M, 2006, LANGMUIR, V22, P11337, DOI 10.1021/la061969p; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonseca RR, 2007, APPL BIOCHEM BIOTECH, V137, P471, DOI 10.1007/s12010-007-9073-z; Gheshlaghi R, 2005, BIOTECHNOL BIOENG, V90, P754, DOI 10.1002/bit.20474; Grau A, 1999, BBA-BIOMEMBRANES, V1418, P307, DOI 10.1016/S0005-2736(99)00039-5; Haddad NIA, 2008, PROTEIN PEPTIDE LETT, V15, P265, DOI 10.2174/092986608783744225; Hwang YH, 2007, EUR J PHARMACOL, V556, P166, DOI 10.1016/j.ejphar.2006.10.031; Jacques P, 1999, APPL BIOCHEM BIOTECH, V77-9, P223, DOI 10.1385/ABAB:77:1-3:223; Keenan B, 2011, BACTERIAL PRODUCTION, P158; Khopade A, 2012, J COLLOID INTERF SCI, V367, P311, DOI 10.1016/j.jcis.2011.11.009; KIM J, 1993, EVOLUTION, V47, P471, DOI 10.1111/j.1558-5646.1993.tb02107.x; Kim SY, 2007, FEBS LETT, V581, P865, DOI 10.1016/j.febslet.2007.01.059; Kiran GS, 2010, COLLOID SURFACE B, V78, P8, DOI 10.1016/j.colsurfb.2010.01.028; Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613; Liu XY, 2008, J PEPT SCI, V14, P864, DOI 10.1002/psc.1017; Liu XY, 2010, APPL MICROBIOL BIOT, V87, P1881, DOI 10.1007/s00253-010-2653-9; MAGETDANA R, 1995, BIOPHYS J, V68, P1937, DOI 10.1016/S0006-3495(95)80370-X; MAGETDANA R, 1992, BIOCHIMIE, V74, P1047, DOI 10.1016/0300-9084(92)90002-V; Razafindralambo H, 2004, J SURFACTANTS DETERG, V7, P41, DOI 10.1007/s11743-004-0286-x; Seydlova G, 2008, CENT EUR J MED, V3, P123, DOI 10.2478/s11536-008-0002-5; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Takahashi T, 2006, J ANTIBIOT, V59, P35, DOI 10.1038/ja.2006.6; Tang JS, 2007, MAGN RESON CHEM, V45, P792, DOI 10.1002/mrc.2048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yoneda T, 2001, J COSMET SCI, V52, P153; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104	36	75	87	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34430	10.1371/journal.pone.0034430	http://dx.doi.org/10.1371/journal.pone.0034430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629294	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500001
J	Pistritto, G; Papaleo, V; Sanchez, P; Ceci, C; Barbaccia, ML				Pistritto, Giuseppa; Papaleo, Veruska; Sanchez, Pilar; Ceci, Claudia; Barbaccia, Maria Luisa			Divergent Modulation of Neuronal Differentiation by Caspase-2 and-9	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ICE/CED-3 PROTEASE; EXPRESSION; INHIBITION; TERATOCARCINOMA; ACTIVATION; MATURATION; SYSTEM; ROLES; LINE	Human Ntera2/cl.D1 (NT2) cells treated with retinoic acid (RA) differentiate towards a well characterized neuronal phenotype sharing many features with human fetal neurons. In view of the emerging role of caspases in murine stem cell/neural precursor differentiation, caspases activity was evaluated during RA differentiation. Caspase-2, -3 and -9 activity was transiently and selectively increased in differentiating and non-apoptotic NT2-cells. SiRNA-mediated selective silencing of either caspase-2 (si-Casp2) or -9 (si-Casp9) was implemented in order to dissect the role of distinct caspases. The RA-induced expression of neuronal markers, i.e. neural cell adhesion molecule (NCAM), microtubule associated protein-2 (MAP2) and tyrosine hydroxylase (TH) mRNAs and proteins, was decreased in si-Casp9, but markedly increased in si-Casp2 cells. During RA-induced NT2 differentiation, the class III histone deacetylase Sirt1, a putative caspase substrate implicated in the regulation of the proneural bHLH MASH1 gene expression, was cleaved to a similar to 100 kDa fragment. Sirt1 cleavage was markedly reduced in si-Casp9 cells, even though caspase-3 was normally activated, but was not affected (still cleaved) in si-Casp2 cells, despite a marked reduction of caspase-3 activity. The expression of MASH1 mRNA was higher and occurred earlier in si-Casp2 cells, while was reduced at early time points during differentiation in si-Casp9 cells. Thus, caspase-2 and -9 may perform opposite functions during RA-induced NT2 neuronal differentiation. While caspase-9 activation is relevant for proper neuronal differentiation, likely through the fine tuning of Sirt1 function, caspase-2 activation appears to hinder the RA-induced neuronal differentiation of NT2 cells.	[Pistritto, Giuseppa; Papaleo, Veruska; Ceci, Claudia; Barbaccia, Maria Luisa] Univ Roma Tor Vergata, Sch Med, Dept Neurosci, Rome, Italy; [Sanchez, Pilar] Univ Granada, Dept Biochem & Mol Biol, Fac Med, E-18071 Granada, Spain	University of Rome Tor Vergata; University of Granada	Pistritto, G (corresponding author), Univ Roma Tor Vergata, Sch Med, Dept Neurosci, Rome, Italy.	pistritto@med.uniroma2.it		BARBACCIA, MARIA LUISA/0000-0002-5378-3972; Ceci, Claudia/0000-0002-5958-7497	Regione Calabria-Italy [212413102008]; Tor Vergata University, Rome, Italy	Regione Calabria-Italy; Tor Vergata University, Rome, Italy	This work was partially supported by a grant (n. 212413102008) from Regione Calabria-Italy and from the Research Fund of Tor Vergata University, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Aranha MM, 2009, J CELL BIOCHEM, V107, P748, DOI 10.1002/jcb.22172; Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007350; Baratchi S, 2010, CRIT REV BIOCHEM MOL, V45, P535, DOI 10.3109/10409238.2010.516740; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chauvier D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.87; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Dorstyn Loretta, 2009, F1000 Biol Rep, V1, P96, DOI 10.3410/B1-96; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Garcia-Calvo M, 1999, CELL DEATH DIFFER, V6, P362, DOI 10.1038/sj.cdd.4400497; Guillemain I, 2003, J NEUROSCI RES, V71, P38, DOI 10.1002/jnr.10458; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Kim MJ, 2009, FEBS LETT, V583, P1183, DOI 10.1016/j.febslet.2009.03.007; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kurinaga E, 2009, TRENDS CELL BIOL, V17, P135; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Megiorni F, 2005, NEUROSCI LETT, V373, P105, DOI 10.1016/j.neulet.2004.09.070; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Ohsawa S, 2010, P NATL ACAD SCI USA, V107, P13366, DOI 10.1073/pnas.0910488107; Oomman S, 2006, BRAIN RES, V1078, P19, DOI 10.1016/j.brainres.2006.01.041; Paquet-Durand F, 2003, DEV BRAIN RES, V142, P161, DOI 10.1016/S0165-3806(03)00065-8; Pistritto G, 2009, EXP NEUROL, V217, P302, DOI 10.1016/j.expneurol.2009.03.008; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; POLLERBERG EG, 1985, J CELL BIOL, V101, P1921, DOI 10.1083/jcb.101.5.1921; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Srinivasula SM, 2001, METHOD CELL BIOL, V66, P1; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Zhang Y, 2011, BIOCHEM BIOPH RES CO, V404, P610, DOI 10.1016/j.bbrc.2010.12.014; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	50	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36002	10.1371/journal.pone.0036002	http://dx.doi.org/10.1371/journal.pone.0036002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629307	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500008
J	An, JY; Kim, E; Zakrzewska, A; Yoo, YD; Jang, JM; Han, DH; Lee, MJ; Seo, JW; Lee, YJ; Kim, TY; de Rooij, DG; Kim, BY; Kwon, YT				An, Jee Young; Kim, Euna; Zakrzewska, Adriana; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Lee, Min Jae; Seo, Jai Wha; Lee, Yong Jun; Kim, Tae-You; de Rooij, Dirk G.; Kim, Bo Yeon; Kwon, Yong Tae			UBR2 of the N-End Rule Pathway Is Required for Chromosome Stability via Histone Ubiquitylation in Spermatocytes and Somatic Cells	PLOS ONE			English	Article							E3 UBIQUITIN LIGASES; DOUBLE-STRAND BREAKS; PROPHASE-I; MOLECULAR PRINCIPLES; MEIOTIC CHROMOSOMES; SEX-CHROMOSOMES; CROSSING-OVER; X-CHROMOSOME; MOUSE; MICE	The N-end rule pathway is a proteolytic system in which its recognition components (N-recognins) recognize destabilizing N-terminal residues of short-lived proteins as an essential element of specific degrons, called N-degrons. The RING E3 ligases UBR2 and UBR1 are major N-recognins that share size (200 kDa), conserved domains and substrate specificities to N-degrons. Despite the known function of the N-end rule pathway in degradation of cytosolic proteins, the major phenotype of UBR2-deficient male mice is infertility caused by arrest of spermatocytes at meiotic prophase I. UBR2-deficient spermatocytes are impaired in transcriptional silencing of sex chromosome-linked genes and ubiquitylation of histone H2A. In this study we show that the recruitment of UBR2 to meiotic chromosomes spatiotemporally correlates to the induction of chromatin-associated ubiquitylation, which is significantly impaired in UBR2-deficient spermatocytes. UBR2 functions as a scaffold E3 that promotes HR6B/UbcH2-dependent ubiquitylation of H2A and H2B but not H3 and H4, through a mechanism distinct from typical polyubiquitylation. The E3 activity of UBR2 in histone ubiquitylation is allosterically activated by dipeptides bearing destabilizing N-terminal residues. Insufficient monoubiquitylation and polyubiquitylation on UBR2-deficient meiotic chromosomes correlate to defects in double strand break (DSB) repair and other meiotic processes, resulting in pachytene arrest at stage IV and apoptosis. Some of these functions of UBR2 are observed in somatic cells, in which UBR2 is a chromatin-binding protein involved in chromatin-associated ubiquitylation upon DNA damage. UBR2-deficient somatic cells show an array of chromosomal abnormalities, including hyperproliferation, chromosome instability, and hypersensitivity to DNA damage-inducing reagents. UBR2-deficient mice enriched in C57 background die upon birth with defects in lung expansion and neural development. Thus, UBR2, known as the recognition component of a major cellular proteolytic system, is associated with chromatin and controls chromatin dynamics and gene expression in both germ cells and somatic cells.	[An, Jee Young; Zakrzewska, Adriana; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA; [An, Jee Young; Zakrzewska, Adriana; Seo, Jai Wha; Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Kim, Euna; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Kim, Tae-You; Kwon, Yong Tae] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, World Class Univ WCU Program, Seoul, South Korea; [Kim, Euna; Yoo, Young Dong; Jang, Jun Min; Han, Dong Hoon; Kim, Tae-You] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Lee, Min Jae] Kyung Hee Univ, Coll Appl Sci, Dept Appl Chem, Yongin, South Korea; [Lee, Yong Jun] Univ Pittsburgh, Sch Med, Dept Surg & Pharmacol, Hillman Canc Ctr, Pittsburgh, PA USA; [Kim, Tae-You] Seoul Natl Univ, Canc Hosp, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Coll Med, Seoul, South Korea; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, Reprod Biol Lab,Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Chem Biol Res Ctr, World Class Inst, Ochang, Cheongwon, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); Seoul National University (SNU); University of Amsterdam; Academic Medical Center Amsterdam; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	An, JY (corresponding author), Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA.	bykim@kribb.re.kr; yok5@pitt.edu	Kim, Tae-You/J-2750-2012; de Rooij, D.G./AAW-1195-2021; han, donghoon/AAU-8725-2021; Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467; de Rooij, Dirk/0000-0003-3932-4419	NIH [HL083365]; World Class University [R31-2008-000-10103-0]; World Class Institute; Basic Science Research programs through the National Research Foundation [2011-0007990]; Ministry of Education, Science and Technology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University; World Class Institute; Basic Science Research programs through the National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH grant HL083365 (to Y.T.K.) and World Class University (R31-2008-000-10103-0 to Y.T.K. and T.Y.K.), World Class Institute (to B.Y.K.), and Basic Science Research programs (2011-0007990 to M.J.L.) through the National Research Foundation funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Baarends WM, 2007, J CELL SCI, V120, P1841, DOI 10.1242/jcs.03451; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow C, 1998, DEVELOPMENT, V125, P4007; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kneitz B, 2000, GENE DEV, V14, P1085; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moens PB, 2002, J CELL SCI, V115, P1611; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; RAMAN R, 1991, SOMAT CELL MOLEC GEN, V17, P429, DOI 10.1007/BF01233166; Roest HP, 1996, CELL, V86, P799, DOI 10.1016/S0092-8674(00)80154-3; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2012, ANN REV BIO IN PRESS; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wiltshire T, 1998, MOL REPROD DEV, V49, P70, DOI 10.1002/(SICI)1098-2795(199801)49:1&lt;70::AID-MRD8&gt;3.0.CO;2-L; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014017; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2	61	24	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37414	10.1371/journal.pone.0037414	http://dx.doi.org/10.1371/journal.pone.0037414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616001	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305341200073
J	Moreau, M; Le Tortorec, A; Deleage, C; Brown, C; Denis, H; Satie, AP; Bourry, O; Deureuddre-Bosquet, N; Roques, P; Le Grand, R; Dejucq-Rainsford, N				Moreau, Marina; Le Tortorec, Anna; Deleage, Claire; Brown, Charles; Denis, Helene; Satie, Anne-Pascale; Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger; Dejucq-Rainsford, Nathalie			Impact of Short-Term HAART Initiated during the Chronic Stage or Shortly Post-Exposure on SIV Infection of Male Genital Organs	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SEMEN-PRODUCING ORGANS; HIV RNA; SEXUAL TRANSMISSION; REPRODUCTIVE-TRACT; T-LYMPHOCYTES; SEMINAL CELLS; MACAQUES; BLOOD	Background: The male genital tract is suspected to constitute a viral sanctuary as persistent HIV shedding is found in the semen of a subset of HIV-infected men receiving effective antiretroviral therapy (HAART). The origin of this persistent shedding is currently unknown. Phylogenetic studies indicated that HIV in semen from untreated men arises from local sources and/or passive diffusion from the blood. We previously demonstrated in human and macaque low levels and localized infection of several semen-producing organs by HIV/SIV. Using a macaque model, this study investigates the impact of short term HAART (2-4 weeks) initiated either during the asymptomatic chronic stage or 4 h post-intravenous inoculation of SIVmac251 on the infection of male genital organs. Methodology/Principal Findings: Short term HAART during the chronic stage decreased blood viral load. No major impact of HAART was observed on SIV DNA levels in male genital organs using a sensitive nested PCR assay. Using in situ hybridization, SIV RNA+ cells were detected in all male genital tract organs from untreated and treated animals with undetectable blood viral load following HAART. Infected CD68+ myeloid cells and CD3+ T lymphocytes were detected pre-and post-HAART. In contrast, short term HAART initiated 4 h post-SIV exposure led to a drastic decrease of the male genital tissues infection, although it failed to prevent systemic infection. In both cases, HAART tended to decrease the number of CD3+ T cells in the male organs. Conclusions: Our results indicate that the established infection of male genital organs is not greatly impacted by short term HAART, whereas the same treatment during pre-acute phase of the infection efficiently impairs viral dissemination to the male genital tract. Further investigations are now needed to determine whether infection of male genital organs is responsible for long term persistent HIV shedding in semen despite HAART.	[Moreau, Marina; Le Tortorec, Anna; Deleage, Claire; Denis, Helene; Satie, Anne-Pascale; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, IRSET U1085, Inst Federatif Rech 140, Rennes, France; [Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger] CEA, DSV, Inst Emerging Dis & Innovat Therapies, Div Immunovirol, Fontenay Aux Roses, France; [Brown, Charles] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Bourry, Olivier; Deureuddre-Bosquet, Nathalie; Roques, Pierre; Le Grand, Roger] Univ Paris 11, UMR E1, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CEA; UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; Universite Paris Saclay	Moreau, M (corresponding author), Univ Rennes 1, INSERM, IRSET U1085, Inst Federatif Rech 140, Rennes, France.	nathalie.dejucq-rainsford@inserm.fr	Le Tortorec, Anna/J-5291-2015; Roques, Pierre/M-2212-2013; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015	Roques, Pierre/0000-0003-1825-1054; 	ANRS; Sidaction; Inserm; Region Bretagne	ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bretagne(Region Bretagne)	This work was funded by ANRS, Sidaction, Inserm and Region Bretagne. Marina Moreau is the recipient of stipends from Region Bretagne and Sidaction. Claire Deleage and Helene Denis are supported by ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; Annamalai L, 2010, AM J PATHOL, V177, P777, DOI 10.2353/ajpath.2010.091248; Aquaro S, 2006, J LEUKOCYTE BIOL, V80, P1103, DOI 10.1189/jlb.0606376; Barroso PF, 2000, ANN INTERN MED, V133, P280, DOI 10.7326/0003-4819-133-4-200008150-00012; BASKERVILLE A, 1992, J COMP PATHOL, V107, P49, DOI 10.1016/0021-9975(92)90095-C; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Bourry O, 2009, AIDS, V23, P447, DOI 10.1097/QAD.0b013e328321302d; Brown CR, 2007, J VIROL, V81, P5594, DOI 10.1128/JVI.00202-07; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Caufour P, 2001, MICROBES INFECT, V3, P181, DOI 10.1016/S1286-4579(01)01370-3; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Clay CC, 2005, J VIROL, V79, P13759, DOI 10.1128/JVI.79.21.13759-13768.2005; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Deleage C, 2011, AM J PATHOL, V179, P2397, DOI 10.1016/j.ajpath.2011.08.005; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Halfon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010569; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Kotler DP, 1998, AIDS, V12, P597, DOI 10.1097/00002030-199806000-00008; Kwa S, 2011, BLOOD, V118, P2763, DOI 10.1182/blood-2011-02-339515; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Le Grand R, 2000, AIDS, V14, P1864; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Le Tortorec A, 2010, M S-MED SCI, V26, P861, DOI 10.1051/medsci/20102610861; Le Tortorec A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-119; Leruez-Ville M, 2002, AIDS, V16, P486, DOI 10.1097/00002030-200202150-00023; Livni E, 2004, NUCL MED BIOL, V31, P613, DOI 10.1016/j.nucmedbio.2003.11.006; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; MILLER CJ, 1994, LAB INVEST, V70, P255; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Nunnari G, 2002, AIDS, V16, P39, DOI 10.1097/00002030-200201040-00006; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Pasquier C, 2012, ANTIVIRAL T IN PRESS; Pasquier C, 2009, J CLIN MICROBIOL, V47, P2883, DOI 10.1128/JCM.02131-08; Pasquier CJM, 2008, AIDS, V22, P1894, DOI 10.1097/QAD.0b013e3283101281; Pasternak AO, 2008, J CLIN MICROBIOL, V46, P2206, DOI 10.1128/JCM.00055-08; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; PUDNEY J, 1991, AM J PATHOL, V139, P149; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Sellier P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010570; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shen CL, 2010, VIROLOGY, V401, P190, DOI 10.1016/j.virol.2010.01.033; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Taylor S, 2010, CURR OPIN HIV AIDS, V5, P335, DOI 10.1097/COH.0b013e32833a0b69; Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025; Thiebot H, 2001, J VIROL, V75, P11594, DOI 10.1128/JVI.75.23.11594-11602.2001; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Whitney JB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001293; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; Yeni P, 2008, PRISE CHARGE MED PER; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhou SH, 2004, J VIROL, V78, P3578, DOI 10.1128/JVI.78.7.3578-3600.2004	65	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37348	10.1371/journal.pone.0037348	http://dx.doi.org/10.1371/journal.pone.0037348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615988	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200066
J	Gu, CG; Liu, ZH; Schwartz, WJ; Indic, P				Gu, Changgui; Liu, Zonghua; Schwartz, William J.; Indic, Premananda			Photic Desynchronization of Two Subgroups of Circadian Oscillators in a Network Model of the Suprachiasmatic Nucleus with Dispersed Coupling Strengths	PLOS ONE			English	Article							MOTOR-ACTIVITY RHYTHM; FORCED DESYNCHRONIZATION; DESIGN PRINCIPLES; SYNCHRONIZATION; ENTRAINMENT; CLOCK; DISSOCIATION; CYCLE; RELAXATION; EXPRESSION	The suprachiasmatic nucleus (SCN) is the master circadian clock in mammals and is composed of thousands of neuronal oscillators expressing different intrinsic periods. These oscillators form a coupled network with a free-running period around 24 h in constant darkness and entrainable to the external light-dark cycle (T cycle). Coupling plays an important role in setting the period of the network and its range of entrainment. Experiments in rats have shown that two subgroups of oscillators within the SCN, a ventrolateral (VL) subgroup that receives photic input and a dorsomedial (DM) subgroup that is coupled to VL, can be desynchronized under a short (22-h) T cycle, with VL entrained to the cycle and DM free-running. We use a modified Goodwin model to understand how entrainment of the subgroups to short (22-h) and long (26-h) T cycles is influenced by light intensity, the proportion of neurons that receives photic input, and coupling heterogeneity. We find that the model's critical value for the proportion of photically-sensitive neurons is in accord with actual experimental estimates, while the model's inclusion of dispersed coupling can account for the experimental observation that VL and DM desynchronize more readily under the 22-h than under the 26-h T cycle. Heterogeneous intercellular coupling within the SCN is likely central to the generation of complex behavioral patterns.	[Gu, Changgui; Liu, Zonghua] E China Normal Univ, Inst Theoret Phys, Shanghai 200062, Peoples R China; [Gu, Changgui; Liu, Zonghua] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Gu, Changgui; Schwartz, William J.; Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	East China Normal University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester	Gu, CG (corresponding author), E China Normal Univ, Inst Theoret Phys, Shanghai 200062, Peoples R China.	zhliu@phy.ecnu.edu.cn			National Natural Science Foundation (NNSF) of China [10975053]; PHD program scholarship fund of East China Normal University [2010027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094109] Funding Source: NIH RePORTER	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); PHD program scholarship fund of East China Normal University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation (NNSF) of China under grant No. 10975053 (http://www.nsfc.gov.cn/Portal0/default106.htm) and by the PHD program scholarship fund of East China Normal University under grant No. 2010027 (http://www.ecnu.edu.cn/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Abrams DM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.084103; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Aylett M, 1999, BRIT J GEN PRACT, V49, P725; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Cambras T, 2000, PHYSIOL BEHAV, V70, P227, DOI 10.1016/S0031-9384(00)00241-9; Campuzano A, 1998, PHYSIOL BEHAV, V63, P171, DOI 10.1016/S0031-9384(97)00416-2; Casiraghi LP, 2012, J BIOL RHYTHM, V27, P59, DOI 10.1177/0748730411429447; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; DAIDO H, 1992, PHYS REV LETT, V68, P1073, DOI 10.1103/PhysRevLett.68.1073; Daido H, 2000, PHYS REV E, V61, P2145, DOI 10.1103/PhysRevE.61.2145; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Granada A, 2009, METHOD ENZYMOL, V454, P1, DOI 10.1016/S0076-6879(08)03801-9; Granada AE, 2011, INTERFACE FOCUS, V1, P153, DOI 10.1098/rsfs.2010.0002; Gu CG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046224; Gu CG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.030904; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Indic P, 2008, J R SOC INTERFACE, V5, P873, DOI 10.1098/rsif.2007.1248; Lee WS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.044101; Li JD, 2009, AM J PHYSIOL-REG I, V296, pR824, DOI 10.1152/ajpregu.90463.2008; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; Martens EA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.044101; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Noguchi T, 2004, EUR J NEUROSCI, V20, P3199, DOI 10.1111/j.1460-9568.2004.03784.x; Noguchi T, 2008, BRAIN RES, V1239, P119, DOI 10.1016/j.brainres.2008.08.082; Ott E, 2008, CHAOS, V18, DOI 10.1063/1.2930766; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Rohling JHT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025437; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Ruoff P, 2001, J THEOR BIOL, V209, P29, DOI 10.1006/jtbi.2000.2239; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Schwartz MD, 2009, P NATL ACAD SCI USA, V106, P17540, DOI 10.1073/pnas.0906382106; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Usui S, 2000, AM J PHYSIOL-REG I, V278, pR1148, DOI 10.1152/ajpregu.2000.278.5.R1148; Vilaplana J, 1997, CHRONOBIOL INT, V14, P9, DOI 10.3109/07420529709040537; Vivanco P, 2010, CHRONOBIOL INT, V27, P1580, DOI 10.3109/07420528.2010.510228; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	25	27	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36900	10.1371/journal.pone.0036900	http://dx.doi.org/10.1371/journal.pone.0036900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615838	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300039
J	Karki, S; Li, MMH; Schoggins, JW; Tian, SY; Rice, CM; MacDonald, MR				Karki, Sophiya; Li, Melody M. H.; Schoggins, John W.; Tian, Suyan; Rice, Charles M.; MacDonald, Margaret R.			Multiple Interferon Stimulated Genes Synergize with the Zinc Finger Antiviral Protein to Mediate Anti-Alphavirus Activity	PLOS ONE			English	Article							SINDBIS VIRUS-INFECTION; RNA HELICASE; CELL LINES; REPLICATION; INDUCTION; LAMBDA; IDENTIFICATION; RECOGNITION; INHIBITION; PROTECTION	The zinc finger antiviral protein (ZAP) is a host factor that mediates inhibition of viruses in the Filoviridae, Retroviridae and Togaviridae families. We previously demonstrated that ZAP blocks replication of Sindbis virus (SINV), the prototype Alphavirus in the Togaviridae family at an early step prior to translation of the incoming genome and that synergy between ZAP and one or more interferon stimulated genes (ISGs) resulted in maximal inhibitory activity. The present study aimed to identify those ISGs that synergize with ZAP to mediate Alphavirus inhibition. Using a library of lentiviruses individually expressing more than 350 ISGs, we screened for inhibitory activity in interferon defective cells with or without ZAP overexpression. Confirmatory tests of the 23 ISGs demonstrating the largest infection reduction in combination with ZAP revealed that 16 were synergistic. Confirmatory tests of all potentially synergistic ISGs revealed 15 additional ISGs with a statistically significant synergistic effect in combination with ZAP. These 31 ISGs are candidates for further mechanistic studies. The number and diversity of the identified ZAP-synergistic ISGs lead us to speculate that ZAP may play an important role in priming the cell for optimal ISG function.	[Karki, Sophiya; Li, Melody M. H.; Schoggins, John W.; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA; [Tian, Suyan] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Karki, S (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	macdonm@rockefeller.edu	Li, Melody/AAV-1802-2021; Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	grants from the National Institutes of Health [AI057905, AI091707]; Northeast Biodefense Center [U54-AI057158-Lipkin]; Center for Clinical and Translational Science Award (CTSA) from the National Center for Research Resources [UL1 RR024143]; Irma T. Hirschl/Monique Weill-Caulier Trust; Greenberg Medical Research Institute; Starr Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057905, R01AI091707, U54AI057158] Funding Source: NIH RePORTER	grants from the National Institutes of Health; Northeast Biodefense Center; Center for Clinical and Translational Science Award (CTSA) from the National Center for Research Resources; Irma T. Hirschl/Monique Weill-Caulier Trust; Greenberg Medical Research Institute; Starr Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by grants from the National Institutes of Health including grant AI057905 to M. R. M., grant AI091707 to C. M. R., grant U54-AI057158-Lipkin from the Northeast Biodefense Center, and Center for Clinical and Translational Science Award (CTSA) UL1 RR024143 (to the Rockefeller University) from the National Center for Research Resources. The work was also supported in part by the Irma T. Hirschl/Monique Weill-Caulier Trust, the Greenberg Medical Research Institute and the Starr Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDZHAPARIDZE OG, 1981, J VIROL, V37, P1; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; CLARKE JB, 1983, VET MICROBIOL, V8, P259, DOI 10.1016/0378-1135(83)90078-0; Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Giannakopoulos NV, 2009, J VIROL, V83, P1602, DOI 10.1128/JVI.01590-08; Grieder FB, 1999, VIROLOGY, V257, P106, DOI 10.1006/viro.1999.9662; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1023; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Huang Z, 2010, PROTEIN CELL, V1, P752, DOI 10.1007/s13238-010-0096-9; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Law LMJ, 2010, J VIROL, V84, P4504, DOI 10.1128/JVI.02018-09; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; MacDonald MR, 2007, J VIROL, V81, P13509, DOI 10.1128/JVI.00402-07; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; OTSUKI K, 1979, ARCH VIROL, V60, P249, DOI 10.1007/BF01317496; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; STANWICK TL, 1974, INFECT IMMUN, V10, P810, DOI 10.1128/IAI.10.4.810-815.1974; TRUANT AL, 1977, J MED VIROL, V1, P49, DOI 10.1002/jmv.1890010108; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Ye PY, 2010, PROTEIN CELL, V1, P956, DOI 10.1007/s13238-010-0117-8; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	39	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37398	10.1371/journal.pone.0037398	http://dx.doi.org/10.1371/journal.pone.0037398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615998	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300110
J	Stewart, FJ; Dalsgaard, T; Young, CR; Thamdrup, B; Revsbech, NP; Ulloa, O; Canfield, DE; DeLong, EF				Stewart, Frank J.; Dalsgaard, Tage; Young, Curtis R.; Thamdrup, Bo; Revsbech, Niels Peter; Ulloa, Osvaldo; Canfield, Don E.; DeLong, Edward F.			Experimental Incubations Elicit Profound Changes in Community Transcription in OMZ Bacterioplankton	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; OXYGEN MINIMUM ZONES; SEA-WATER; EVOLUTIONARY RELATIONSHIPS; DIFFERENTIAL EXPRESSION; BACTERIA; NITROGEN; PATTERNS; MICROBES; METATRANSCRIPTOMICS	Sequencing of microbial community RNA (metatranscriptome) is a useful approach for assessing gene expression in microorganisms from the natural environment. This method has revealed transcriptional patterns in situ, but can also be used to detect transcriptional cascades in microcosms following experimental perturbation. Unambiguously identifying differential transcription between control and experimental treatments requires constraining effects that are simply due to sampling and bottle enclosure. These effects remain largely uncharacterized for "challenging" microbial samples, such as those from anoxic regions that require special handling to maintain in situ conditions. Here, we demonstrate substantial changes in microbial transcription induced by sample collection and incubation in experimental bioreactors. Microbial communities were sampled from the water column of a marine oxygen minimum zone by a pump system that introduced minimal oxygen contamination and subsequently incubated in bioreactors under near in situ oxygen and temperature conditions. Relative to the source water, experimental samples became dominated by transcripts suggestive of cell stress, including chaperone, protease, and RNA degradation genes from diverse taxa, with strong representation from SAR11-like alphaproteobacteria. In tandem, transcripts matching facultative anaerobic gammaproteobacteria of the Alteromonadales (e. g., Colwellia) increased 4-13 fold up to 43% of coding transcripts, and encoded a diverse gene set suggestive of protein synthesis and cell growth. We interpret these patterns as taxon-specific responses to combined environmental changes in the bioreactors, including shifts in substrate or oxygen availability, and minor temperature and pressure changes during sampling with the pump system. Whether such changes confound analysis of transcriptional patterns may vary based on the design of the experiment, the taxonomic composition of the source community, and on the metabolic linkages between community members. These data highlight the impressive capacity for transcriptional changes within complex microbial communities, underscoring the need for caution when inferring in situ metabolism based on transcript abundances in experimental incubations.	[Stewart, Frank J.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Dalsgaard, Tage] Aarhus Univ, Dept Biosci, Silkeborg, Denmark; [Young, Curtis R.; DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Thamdrup, Bo; Canfield, Don E.] Univ So Denmark, Inst Biol, Odense, Denmark; [Thamdrup, Bo; Canfield, Don E.] Univ So Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Revsbech, Niels Peter] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico S Oriental, Concepcion, Chile	University System of Georgia; Georgia Institute of Technology; Aarhus University; Massachusetts Institute of Technology (MIT); University of Southern Denmark; University of Southern Denmark; Aarhus University; Universidad de Concepcion; Universidad de Concepcion	Stewart, FJ (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	frank.stewart@biology.gatech.edu	Dalsgaard, Tage/J-6258-2014; Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016; Revsbech, Niels P/I-8040-2013; Ulloa, Osvaldo/E-1821-2011	Dalsgaard, Tage/0000-0003-2604-6499; Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077; Ulloa, Osvaldo/0000-0002-9501-5576; Revsbech, Niels Peter/0000-0002-2193-262X	Agouron Institute	Agouron Institute(Pfizer)	This work was supported by a grant from the Agouron Institute. Additional support for this study came from the Gordon and Betty Moore Foundation (EFD), the Danish National Research Foundation (Danmarks Grundforskningsfond; BT, DEC), and the Chilean Fondap Program from CONICYT (OU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Allers E, 2007, ENVIRON MICROBIOL, V9, P2417, DOI 10.1111/j.1462-2920.2007.01360.x; AMY PS, 1989, APPL ENVIRON MICROB, V55, P788, DOI 10.1128/AEM.55.4.788-793.1989; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Calvo-Diaz A, 2011, APPL ENVIRON MICROB, V77, P5739, DOI 10.1128/AEM.00066-11; Canfield DE, 2005, ADV MAR BIOL, V48, P313; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105, DOI 10.1128/AEM.63.5.2105-2108.1997; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Feike J, 2012, ISME J, V6, P461, DOI 10.1038/ismej.2011.94; FOGG GE, 1989, HYDROBIOLOGIA, V173, P89, DOI 10.1007/BF00015518; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GIESKES WWC, 1979, NETH J SEA RES, V13, P58, DOI 10.1016/0077-7579(79)90033-4; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jensen MM, 2008, LIMNOL OCEANOGR, V53, P23, DOI 10.4319/lo.2008.53.1.0023; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Marshall KC., 1996, BACTERIAL ADHESION M, P59; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; PACE ML, 1994, MICROBIAL ECOL, V28, P181, DOI 10.1007/BF00166807; Pernthaler A, 2001, APPL ENVIRON MICROB, V67, P4077, DOI 10.1128/AEM.67.9.4077-4083.2001; Pernthaler J, 2005, MICROBIOL MOL BIOL R, V69, P440, DOI 10.1128/MMBR.69.3.440-461.2005; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; R Core Team, 2016, R FDN STAT COMP; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Ron EZ, 2000, MICROBIAL BIOSYSTEMS, P649; Shi YM, 2012, ENVIRON MICROBIOL, V14, P191, DOI 10.1111/j.1462-2920.2011.02598.x; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Uher G, 1997, LIMNOL OCEANOGR, V42, P432, DOI 10.4319/lo.1997.42.3.0432; Ulloa O, 2009, DEEP-SEA RES PT II, V56, P987, DOI 10.1016/j.dsr2.2008.12.004; Vila-Costa M, 2010, ISME J, V4, P1410, DOI 10.1038/ismej.2010.62; Zobell CE, 1936, BIOL BULL-US, V71, P324, DOI 10.2307/1537438; Zollner E, 2009, LIMNOL OCEANOGR, V54, P262, DOI 10.4319/lo.2009.54.1.0262	59	56	56	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37118	10.1371/journal.pone.0037118	http://dx.doi.org/10.1371/journal.pone.0037118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615914	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300074
J	Vogel, A; Scherer-Lorenzen, M; Weigelt, A				Vogel, Anja; Scherer-Lorenzen, Michael; Weigelt, Alexandra			Grassland Resistance and Resilience after Drought Depends on Management Intensity and Species Richness	PLOS ONE			English	Article							PLANT DIVERSITY; ECOSYSTEM STABILITY; PRODUCTIVITY; BIODIVERSITY; COMMUNITIES; SOIL; SUSCEPTIBILITY; COMPLEXITY; EXTREMES; SYSTEMS	The degree to which biodiversity may promote the stability of grasslands in the light of climatic variability, such as prolonged summer drought, has attracted considerable interest. Studies so far yielded inconsistent results and in addition, the effect of different grassland management practices on their response to drought remains an open question. We experimentally combined the manipulation of prolonged summer drought (sheltered vs. unsheltered sites), plant species loss (6 levels of 60 down to 1 species) and management intensity (4 levels varying in mowing frequency and amount of fertilizer application). Stability was measured as resistance and resilience of aboveground biomass production in grasslands against decreased summer precipitation, where resistance is the difference between drought treatments directly after drought induction and resilience is the difference between drought treatments in spring of the following year. We hypothesized that (i) management intensification amplifies biomass decrease under drought, (ii) resistance decreases with increasing species richness and with management intensification and (iii) resilience increases with increasing species richness and with management intensification. We found that resistance and resilience of grasslands to summer drought are highly dependent on management intensity and partly on species richness. Frequent mowing reduced the resistance of grasslands against drought and increasing species richness decreased resistance in one of our two study years. Resilience was positively related to species richness only under the highest management treatment. We conclude that low mowing frequency is more important for high resistance against drought than species richness. Nevertheless, species richness increased aboveground productivity in all management treatments both under drought and ambient conditions and should therefore be maintained under future climates.	[Vogel, Anja] Friedrich Schiller Univ Jena, Inst Ecol, Jena, Germany; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol Geobot, D-79106 Freiburg, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, Leipzig, Germany	Friedrich Schiller University of Jena; University of Freiburg; Leipzig University	Vogel, A (corresponding author), Friedrich Schiller Univ Jena, Inst Ecol, Jena, Germany.	anja.vogel@uni-jena.de	Scherer-Lorenzen, Michael/AGB-4140-2022	Scherer-Lorenzen, Michael/0000-0001-9566-590X	University of Jena within the ProChance program; Friedrich Schiller University of Jena; ETH Zurich; Deutsche Forschungsgemeinschaft [FOR 456]	University of Jena within the ProChance program; Friedrich Schiller University of Jena; ETH Zurich(ETH Zurich); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The University of Jena funded the drought experiment within the ProChance program (www.uni-jena.de, grant to AW) and the University of Zurich gave additional support (www.uzh.de). The management experiment was supported by the Friedrich Schiller University of Jena and the ETH Zurich (funds from N. Buchmann). The Jena Experiment was funded by the Deutsche Forschungsgemeinschaft (FOR 456, www.dfg.de) with additional support from the Friedrich Schiller University of Jena, the Max Planck Society, the University of Zurich and the Swiss National Science Foundation (3100AQ-107531 to B. Schmid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Cop J, 2009, GRASS FORAGE SCI, V64, P454, DOI 10.1111/j.1365-2494.2009.00713.x; De Boeck HJ, 2006, PLANT SOIL, V288, P249, DOI 10.1007/s11104-006-9112-5; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; FOULDS W, 1978, NEW PHYTOL, V80, P535, DOI 10.1111/j.1469-8137.1978.tb01585.x; Gilgen AK, 2009, BIOGEOSCIENCES, V6, P2525, DOI 10.5194/bg-6-2525-2009; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2011, OECOLOGIA, V165, P771, DOI 10.1007/s00442-010-1877-9; Jacob D., 2008, CLIMATE CHANGE 11 08; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Joshi J, 2000, J ECOL, V88, P634, DOI 10.1046/j.1365-2745.2000.00487.x; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kreyling J, 2008, PLANT SOIL, V308, P175, DOI 10.1007/s11104-008-9617-1; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Millennium Ecosystem Assessment M, 2005, EC HUM WELL BEING SY; MOLYNEUX DE, 1983, OECOLOGIA, V58, P220, DOI 10.1007/BF00399220; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Pfisterer AB, 2003, OECOLOGIA, V135, P234, DOI 10.1007/s00442-002-1169-0; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pinheiro J, MIXED EFFECTS MODELS; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Scherber C, 2010, OECOLOGIA, V163, P707, DOI 10.1007/s00442-010-1625-1; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.2007.0030-1299.16005.x, 10.1111/j.0030-1299.2007.16005.x]; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Wang YF, 2007, ECOL LETT, V10, P401, DOI 10.1111/j.1461-0248.2007.01031.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Weisshuhn K, 2011, BASIC APPL ECOL, V12, P21, DOI 10.1016/j.baae.2010.11.005; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	44	144	149	10	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36992	10.1371/journal.pone.0036992	http://dx.doi.org/10.1371/journal.pone.0036992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615865	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300052
J	Griff, ER; Kleene, NK; Kleene, SJ				Griff, Edwin R.; Kleene, Nancy K.; Kleene, Steven J.			A Selective PMCA Inhibitor Does Not Prolong the Electroolfactogram in Mouse	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; ULTRASTRUCTURAL-LOCALIZATION; SODIUM/CALCIUM EXCHANGER; CA2+ EXTRUSION; CA2+-ATPASE; TERMINATION; CILIA; PUMP	Background: Within the cilia of vertebrate olfactory receptor neurons, Ca2+ accumulates during odor transduction. Termination of the odor response requires removal of this Ca2+, and prior evidence suggests that both Na+/Ca2+ exchange and plasma membrane Ca2+-ATPase (PMCA) contribute to this removal. Principal Findings: In intact mouse olfactory epithelium, we measured the time course of termination of the odor-induced field potential. Replacement of mucosal Na+ with Li+, which reduces the ability of Na+/Ca2+ exchange to expel Ca2+, prolonged the termination as expected. However, treating the epithelium with the specific PMCA inhibitor caloxin 1b1 caused no significant increase in the time course of response termination. Conclusions: Under these experimental conditions, PMCA does not contribute detectably to the termination of the odor response.	[Griff, Edwin R.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kleene, Nancy K.; Kleene, Steven J.] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Griff, ER (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	steve@syrano.acb.uc.edu		Kleene, Nancy/0000-0001-5642-509X	University Research Council; Department of Cancer and Cell Biology of the University of Cincinnati	University Research Council; Department of Cancer and Cell Biology of the University of Cincinnati	This work was supported by the University Research Council and the Department of Cancer and Cell Biology of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin S, 2007, J PHYSIOL-LONDON, V581, P495, DOI 10.1113/jphysiol.2007.131094; Antolin S, 2010, J GEN PHYSIOL, V135, P367, DOI 10.1085/jgp.200910337; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Castillo K, 2007, EUR J NEUROSCI, V26, P2524, DOI 10.1111/j.1460-9568.2007.05863.x; GATTO C, 1995, BIOCHEMISTRY-US, V34, P965, DOI 10.1021/bi00003a031; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; JUNG A, 1994, NEUROREPORT, V5, P1741, DOI 10.1097/00001756-199409080-00013; KERN RC, 1991, BRAIN RES, V546, P8, DOI 10.1016/0006-8993(91)91153-R; Kleene SJ, 2010, PLOS ONE, V5; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Lindemann B, 2001, BIOPHYS J, V80, P1712, DOI 10.1016/S0006-3495(01)76142-5; Menco BPM, 1998, CHEM SENSES, V23, P137, DOI 10.1093/chemse/23.2.137; Noe J, 1997, NEUROCHEM INT, V30, P523, DOI 10.1016/S0197-0186(96)00090-3; Ogan JT, 2007, BLOOD CELL MOL DIS, V38, P229, DOI 10.1016/j.bcmd.2007.01.001; OTTOSON D, 1956, ACTA PHYSIOL SCAND, V35, P7; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Pande J, 2008, J CELL MOL MED, V12, P1049, DOI 10.1111/j.1582-4934.2008.00140.x; Pande Jyoti, 2011, World J Biol Chem, V2, P39, DOI 10.4331/wjbc.v2.i3.39; Pifferi S, 2010, NEUROBIOLOGY OLFACTI, P203; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Saidu SP, 2009, CHEM SENSES, V34, P349, DOI 10.1093/chemse/bjp008; Scott JW, 2002, MICROSC RES TECHNIQ, V58, P152, DOI 10.1002/jemt.10133; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; SZEWCZYK M, 2007, PFLUGERS ARCH, V456, P255; Weeraratne SD, 2006, CHEM SENSES, V31, P725, DOI 10.1093/chemse/bjl014	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37148	10.1371/journal.pone.0037148	http://dx.doi.org/10.1371/journal.pone.0037148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615924	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300076
J	Kong, J; Kong, JG; Pan, B; Ke, S; Dong, SY; Li, XL; Zhou, AM; Zheng, LM; Sun, WB				Kong, Jian; Kong, Jinge; Pan, Bing; Ke, Shan; Dong, Shuying; Li, Xiuli; Zhou, Aimin; Zheng, Lemin; Sun, Wen-bing			Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1 alpha/VEGFA	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLORECTAL LIVER METASTASES; INDUCIBLE FACTOR 1-ALPHA; SQUAMOUS-CELL CARCINOMA; TUMOR ANGIOGENESIS; RAPID PROGRESSION; THERMAL ABLATION; VEGF EXPRESSION; KEY MEDIATOR; HYPOXIA	Background: The mechanism of rapid growth of the residual tumor after radiofrequency (RF) ablation is poorly understood. In this study, we investigated the effect of hyperthermia on HepG2 cells and generated a subline with enhanced viability and dys-regulated angiogenesis in vivo, which was used as a model to further determine the molecular mechanism of the rapid growth of residual HCC after RF ablation. Methodology/Principal Findings: Heat treatment was used to establish sublines of HepG2 cells. A subline (HepG2 k) with a relatively higher viability and significant heat tolerance was selected. The cellular protein levels of VEGFA, HIF-1 alpha and p-Akt, VEGFA mRNA and secreted VEGFA were measured, and all of these were up-regulated in this subline compared to parental HepG2 cells. HIF-1 alpha inhibitor YC-1 and VEGFA siRNA inhibited the high viability of the subline. The conditioned media from the subline exerted stronger pro-angiogenic effects. Bevacizumab, VEGFA siRNA and YC-1 inhibited proangiogenic effects of the conditioned media of HepG2 k cells and abolished the difference between parental HepG2 cells and HepG2 k cells. For in vivo studies, a nude mouse model was used, and the efficacy of bavacizumab was determined. HepG2 k tumor had stronger pro-angiogenic effects than parental HepG2 tumor. Bevacizumab could inhibit the tumor growth and angiogenesis, and also eliminate the difference in tumor growth and angiogenesis between parental HepG2 tumor and HepG2 k tumor in vivo. Conclusions/Significance: The angiogenesis induced by HIF1 alpha/VEGFA produced by altered cells after hyperthermia treatment may play an important role in the rapid growth of residual HCC after RF ablation. Bevacizumab may be a good candidate drug for preventing and treating the process.	[Kong, Jian; Ke, Shan; Dong, Shuying; Sun, Wen-bing] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100871, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Syst Biomed,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Kong, Jinge; Pan, Bing; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100871, Peoples R China; [Li, Xiuli] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Zhou, Aimin] Cleveland State Univ, Dept Chem, Clin Chem Program, Cleveland, OH 44115 USA	Capital Medical University; Peking University; Peking University; Peking University; Chinese People's Liberation Army General Hospital; University System of Ohio; Cleveland State University	Kong, J (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, West Campus, Beijing, Peoples R China.	zhengl@bjmu.edu.cn; wb.sun@yahoo.com.cn			National Natural Science Foundation of China [30872490, 30900595, 81172500, 81170101]; "973" National S&T Major Project [2010CB912504, 2011CB503900]; Natural Science Foundation of Beijing [7102104]; Natural Science Foundation of Fujian [2009J01112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973" National S&T Major Project; Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province)	This project was supported by the National Natural Science Foundation of China (30872490; 30900595; 81172500; 81170101), "973" National S&T Major Project (2010CB912504; 2011CB503900), the Natural Science Foundation of Beijing (7102104), and the Natural Science Foundation of Fujian (2009J01112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Basile A, 2008, J CELL BIOCHEM, V103, P212, DOI 10.1002/jcb.21401; CAMUSSI G, 1995, J IMMUNOL, V154, P6492; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cui J, 2004, WORLD J GASTROENTERO, V10, P1533; Dawson W O, 1990, Adv Virus Res, V38, P307, DOI 10.1016/S0065-3527(08)60865-9; Deli G, 2005, WORLD J GASTROENTERO, V11, P960, DOI 10.3748/wjg.v11.i7.960; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Finn RS, 2009, EXPERT REV ANTICANC, V9, P503, DOI 10.1586/ERA.09.6; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Guo RP, 2006, J CANCER RES CLIN, V132, P547, DOI 10.1007/s00432-006-0097-5; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang GW, 2005, WORLD J GASTROENTERO, V11, P1705; Kanematsu M, 2004, AM J ROENTGENOL, V183, P1585, DOI 10.2214/ajr.183.6.01831585; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kaseb AO, 2009, CANCER-AM CANCER SOC, V115, P4895, DOI 10.1002/cncr.24537; Kasugai H, 2007, ONCOLOGY-BASEL, V72, P72, DOI 10.1159/000111710; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Niho S, 2012, LUNG CANC; Nijkamp MW, 2010, J HEPATOL, V53, P1069, DOI 10.1016/j.jhep.2010.04.040; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Obara K, 2008, HEPATOL INT, V2, P116, DOI 10.1007/s12072-007-9040-3; Park YN, 2000, ARCH PATHOL LAB MED, V124, P1061; Poon RTP, 2003, CANCER RES, V63, P3121; Renouf DJ, 2012, CANC CHEMOTHER PHARM; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; Schefter TE, 2012, INT J RAD ONCOL BIOL; Seki T, 2001, EUR J GASTROEN HEPAT, V13, P291, DOI 10.1097/00042737-200103000-00014; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheen IS, 2005, WORLD J GASTROENTERO, V11, P187, DOI 10.3748/wjg.v11.i2.187; Sun WJ, 2011, CANCER-AM CANCER SOC, V117, P3187, DOI 10.1002/cncr.25889; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; VECCHIETTI V, 1979, FARMACO-ED SCI, V34, P829; von Breitenbuch P, 2005, SURGERY, V138, P882, DOI 10.1016/j.surg.2005.05.006; Wada H, 2006, LIVER INT, V26, P414, DOI 10.1111/j.1478-3231.2006.01243.x; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zavaglia C, 2008, EUR J GASTROEN HEPAT, V20, P196, DOI 10.1097/MEG.0b013e3282f1cc4a; Zhou HB, 2011, JPN J RADIOL, V29, P615, DOI 10.1007/s11604-011-0603-9; Zhou JW, 2010, J OBSTET GYNAECOL RE, V36, P232, DOI 10.1111/j.1447-0756.2010.01196.x; Zhu AX, 2006, J CLIN ONCOL, V24, P1898, DOI 10.1200/JCO.2005.04.9130; Zhu GQ, 2010, CLIN CANCER RES, V16, P4732, DOI 10.1158/1078-0432.CCR-10-1408; Zhu H, 2011, CANCER BIOL THER, V11, P981, DOI 10.4161/cbt.11.11.15707	51	98	108	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37266	10.1371/journal.pone.0037266	http://dx.doi.org/10.1371/journal.pone.0037266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615958	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300087
J	Li, ZX; Qu, LY; Dong, QZ; Huang, B; Li, HY; Tang, ZP; Xu, Y; Luo, WT; Liu, LF; Qiu, XS; Wang, EH				Li, Zixuan; Qu, Lianyue; Dong, Qianze; Huang, Bo; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Liu, Lifeng; Qiu, Xueshan; Wang, Enhua			Overexpression of CARMA3 in Non-Small-Cell Lung Cancer Is Linked for Tumor Progression	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; FAMILY MEMBER; ACTIVATION; BCL10; INFLAMMATION; PROGNOSIS; INHIBITOR; PATHWAYS; THERAPY	We aimed to investigate the clinical significance of the expression of novel scaffold protein CARMA3 in non-small-cell lung cancer (NSCLC) and the biological function of CARMA3 in NSCLC cell lines. We observed moderate to high CARMA3 staining in 68.8% of 141 NSCLC specimens compared to corresponding normal tissues. The overexpression of CARMA3 was significantly correlated with TNM stage (P = 0.022) and tumor status (P = 0.013). CARMA3 upregulation also correlated with a shorter survival rate of patients of nodal status N0 (P = 0.042) as well as the expression of epidermal growth factor receptor (EGFR) (P = 0.009). In EGFR mutation positive cases, CARMA3 expression was much higher (87.5%) compared to non-mutation cases (66.1%). In addition, we observed that knockdown of CARMA3 inhibits tumor cell proliferation and invasion, and induces cell cycle arrest at the boundary between the G1 and S phase. We further demonstrated a direct link between CARMA3 and NF-kappa B activation. The change of biological behavior in CARMA3 knockdown cells may be NF-kappa B-related. Our findings demonstrated, for the first time, that CARMA3 was overexpressed in NSCLC and correlated with lung cancer progression, EGFR expression, and EGFR mutation. CARMA3 could serve as a potential companion drug target, along with NF-kappa B and EGFR in EGFR-mutant lung cancers.	[Li, Zixuan; Dong, Qianze; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Qiu, Xueshan; Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Li, Zixuan; Dong, Qianze; Li, Haiying; Tang, Zhongping; Xu, Ying; Luo, Wenting; Qiu, Xueshan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Qu, Lianyue] China Med Univ, Affiliated Hosp 1, Dept Pharm, Shenyang, Peoples R China; [Huang, Bo] Liaoning Canc Hosp, Dept Pathol, Shenyang, Peoples R China; [Liu, Lifeng] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	qiuxues1963@hotmail.com			National Natural Science Foundation of China [30972967]; Research Fund for the Doctoral Program of the Higher Education of China [20092104110018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of the Higher Education of China	This work was supported by grants from National Natural Science Foundation of China (No. 30972967) and Research Fund for the Doctoral Program of the Higher Education of China (No. 20092104110018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Ando S, 2003, ANTICANCER RES, V23, P2869; Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Barlesi F, 2004, RESP MED, V98, P357, DOI 10.1016/j.rmed.2003.11.003; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cho WCS, 2007, BIOMED PHARMACOTHER, V61, P515, DOI 10.1016/j.biopha.2007.08.005; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang LJ, 2006, LUNG CANCER, V54, P87, DOI 10.1016/j.lungcan.2006.06.011; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Li Z, 2011, MOL CARCINOG; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2010, J BIOL CHEM, V285, P25880, DOI 10.1074/jbc.C110.109421; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nishio K, 2005, CANCER CHEMOTH PHARM, V56, pS90, DOI 10.1007/s00280-005-0104-6; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Pujol L, 2004, BRIT J CANCER, V90, P2097, DOI 10.1038/sj.bjc.6601851; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; WICHLINS.L, 1969, ACTA POL PHARM, V26, P617	44	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36903	10.1371/journal.pone.0036903	http://dx.doi.org/10.1371/journal.pone.0036903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615840	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300048
J	Awoniyi, M; Miller, SI; Wilson, CB; Hajjar, AM; Smith, KD				Awoniyi, Muyiwa; Miller, Samuel I.; Wilson, Christopher B.; Hajjar, Adeline M.; Smith, Kelly D.			Homeostatic Regulation of Salmonella-Induced Mucosal Inflammation and Injury by IL-23	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; IMMUNE-RESPONSE; INTESTINAL INFLAMMATION; BACTERIAL-INFECTION; BARRIER SURFACES; GAMMA-INTERFERON; IL-17 PRODUCTION; HOST-DEFENSE; INNATE; MICE	IL-12 and IL-23 regulate innate and adaptive immunity to microbial pathogens through influencing the expression of IFN-gamma, IL-17, and IL-22. Herein we define the roles of IL-12 and IL-23 in regulating host resistance and intestinal inflammation during acute Salmonella infection. We find that IL-23 alone is dispensable for protection against systemic spread of bacteria, but synergizes with IL-12 for optimal protection. IL-12 promotes the production of IFN-gamma by NK cells, which is required for resistance against Salmonella and also for induction of intestinal inflammation and epithelial injury. In contrast, IL-23 controls the severity of inflammation by inhibiting IL-12A expression, reducing IFN-gamma and preventing excessive mucosal injury. Our studies demonstrate that IL-23 is a homeostatic regulator of IL-12-dependent, IFN-gamma-mediated intestinal inflammation.	[Awoniyi, Muyiwa; Smith, Kelly D.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Awoniyi, Muyiwa; Smith, Kelly D.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Wilson, Christopher B.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Hajjar, Adeline M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Awoniyi, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kelsmith@uw.edu		Hajjar, Adeline/0000-0002-4838-8070	National Institutes of Health [R01AI062859, R21AI083558, F31AI083042, U54AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI083042, R01AI062859, R21AI083558, U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01AI062859 and R21AI083558 (K.D.S.), F31AI083042 (M.A.) and U54AI057141 (S.I.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, J ALLERGY CLIN IMMUN, V120, P916, DOI 10.1016/j.jaci.2007.05.023; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; de Jong R, 1998, SCIENCE, V280, P1435; Dubin Patricia J, 2007, Expert Rev Respir Med, V1, P121, DOI 10.1586/17476348.1.1.121; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Harrington L, 2007, FEMS IMMUNOL MED MIC, V51, P372, DOI 10.1111/j.1574-695X.2007.00313.x; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003; Kirby AC, 2002, J IMMUNOL, V169, P4450, DOI 10.4049/jimmunol.169.8.4450; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lehmann J, 2001, J IMMUNOL, V167, P5304, DOI 10.4049/jimmunol.167.9.5304; Lugering A, 2003, J IMMUNOL, V171, P2208, DOI 10.4049/jimmunol.171.5.2208; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; MCGOVERN VJ, 1979, AM J SURG PATHOL, V3, P483, DOI 10.1097/00000478-197912000-00001; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Metzger DW, 2010, CYTOKINE, V52, P102, DOI 10.1016/j.cyto.2010.06.011; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	45	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37311	10.1371/journal.pone.0037311	http://dx.doi.org/10.1371/journal.pone.0037311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624013	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500096
J	Chu, YZ; Yao, JZ; Guo, H				Chu, Yuzhuo; Yao, Jianzhuang; Guo, Hong			QM/MM MD and Free Energy Simulations of G9a-Like Protein (GLP) and Its Mutants: Understanding the Factors that Determine the Product Specificity	PLOS ONE			English	Article							LYSINE METHYLTRANSFERASE SET7/9; MOLECULAR-DYNAMICS SIMULATIONS; HISTONE MODIFICATIONS; CATALYTIC MECHANISM; METHYLATION; BINDING; CHROMATIN; INSIGHTS; REVEAL; WATER	Certain lysine residues on histone tails could be methylated by protein lysine methyltransferases (PKMTs) using S-adenosyl-L-methionine (AdoMet) as the methyl donor. Since the methylation states of the target lysines play a fundamental role in the regulation of chromatin structure and gene expression, it is important to study the property of PKMTs that allows a specific number of methyl groups (one, two or three) to be added (termed as product specificity). It has been shown that the product specificity of PKMTs may be controlled in part by the existence of specific residues at the active site. One of the best examples is a Phe/Tyr switch found in many PKMTs. Here quantum mechanical/molecular mechanical (QM/MM) molecular dynamics (MD) and free energy simulations are performed on wild type G9a-like protein (GLP) and its F1209Y and Y1124F mutants for understanding the energetic origin of the product specificity and the reasons for the change of product specificity as a result of single-residue mutations at the Phe/Tyr switch as well as other positions. The free energy barriers of the methyl transfer processes calculated from our simulations are consistent with experimental data, supporting the suggestion that the relative free energy barriers may determine, at least in part, the product specificity of PKMTs. The changes of the free energy barriers as a result of the mutations are also discussed based on the structural information obtained from the simulations. The results suggest that the space and active-site interactions around the e-amino group of the target lysine available for methyl addition appear to among the key structural factors in controlling the product specificity and activity of PKMTs.	[Chu, Yuzhuo; Yao, Jianzhuang; Guo, Hong] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37920 USA; [Chu, Yuzhuo] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN USA; [Guo, Hong] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Chu, YZ (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37920 USA.	hguo1@utk.edu	Guo, Hong/E-6357-2010		National Science Foundation Award [0817940]; National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee; National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]	National Science Foundation Award(National Science Foundation (NSF)); National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award	This work is supported in part by the National Science Foundation Award (Grant number: 0817940 to HG) and NSF TeraGrid resources provided by University of Texas at Austin. YZC is supported by a fellowship from the National Institute for Mathematical and Biological Synthesis (NIMBioS) at University of Tennessee sponsored by the National Science Foundation, the U.S. Department of Homeland Security and the U.S. Department of Agriculture through NSF Award #EF-0832858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019856; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1985, BIOPOLYMERS, V24, P843, DOI 10.1002/bip.360240509; Chu YZ, 2010, J CHEM THEORY COMPUT, V6, P1380, DOI 10.1021/ct9006458; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Glowacki DR, 2009, J PHYS CHEM B, V113, P16603, DOI 10.1021/jp9074898; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Ricchiuto P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624928; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Wang SL, 2007, J PHYS CHEM B, V111, P3758, DOI 10.1021/jp067147i; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xu Q, 2009, CHEM-EUR J, V15, P12596, DOI 10.1002/chem.200902297; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhang XD, 2008, BIOCHEMISTRY-US, V47, P6671, DOI 10.1021/bi800244s; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105	38	15	16	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37674	10.1371/journal.pone.0037674	http://dx.doi.org/10.1371/journal.pone.0037674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624060	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500149
J	Krause, MA; Diakite, SAS; Lopera-Mesa, TM; Amaratunga, C; Arie, T; Traore, K; Doumbia, S; Konate, D; Keefer, JR; Diakite, M; Fairhurst, RM				Krause, Michael A.; Diakite, Seidina A. S.; Lopera-Mesa, Tatiana M.; Amaratunga, Chanaki; Arie, Takayuki; Traore, Karim; Doumbia, Saibou; Konate, Drissa; Keefer, Jeffrey R.; Diakite, Mahamadou; Fairhurst, Rick M.			alpha-Thalassemia Impairs the Cytoadherence of Plasmodium falciparum- Infected Erythrocytes	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; ALPHA(+)-THALASSEMIA PROTECTS; HEMOGLOBIN-E; RED-CELLS; CHILDREN; SURFACE; PHAGOCYTOSIS; EXPRESSION; SEVERITY; GROWTH	Background: alpha-thalassemia results from decreased production of alpha-globin chains that make up part of hemoglobin tetramers (Hb; alpha(2)beta(2)) and affects up to 50% of individuals in some regions of sub-Saharan Africa. Heterozygous (-alpha/alpha alpha) and homozygous (-alpha/-alpha) genotypes are associated with reduced risk of severe Plasmodium falciparum malaria, but the mechanism of this protection remains obscure. We hypothesized that alpha-thalassemia impairs the adherence of parasitized red blood cells (RBCs) to microvascular endothelial cells (MVECs) and monocytes - two interactions that are centrally involved in the pathogenesis of severe disease. Methods and Findings: We obtained P. falciparum isolates directly from Malian children with malaria and used them to infect alpha alpha/alpha alpha (normal), -alpha/alpha alpha and -alpha/-alpha RBCs. We also used laboratory-adapted P. falciparum clones to infect -/-alpha RBCs obtained from patients with HbH disease. Following a single cycle of parasite invasion and maturation to the trophozoite stage, we tested the ability of parasitized RBCs to bind MVECs and monocytes. Compared to parasitized alpha alpha/alpha alpha RBCs, we found that parasitized -alpha/alpha alpha, -alpha/-alpha and -/-alpha RBCs showed, respectively, 22%, 43% and 63% reductions in binding to MVECs and 13%, 33% and 63% reductions in binding to monocytes. alpha-thalassemia was associated with abnormal display of P. falciparum erythrocyte membrane protein 1 (PfEMP1), the parasite's main cytoadherence ligand and virulence factor, on the surface of parasitized RBCs. Conclusions: Parasitized alpha-thalassemic RBCs show PfEMP1 display abnormalities that are reminiscent of those on the surface of parasitized sickle HbS and HbC RBCs. Our data suggest a model of malaria protection in which alpha-thalassemia ameliorates the pro-inflammatory effects of cytoadherence. Our findings also raise the possibility that other unstable hemoglobins such as HbE and unpaired alpha-globin chains (in the case of beta-thalassemia) protect against life-threatening malaria by a similar mechanism.	[Krause, Michael A.; Lopera-Mesa, Tatiana M.; Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Diakite, Seidina A. S.; Traore, Karim; Doumbia, Saibou; Konate, Drissa; Diakite, Mahamadou] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Arie, Takayuki] Osaka Prefecture Univ, Dept Phys & Elect, Sch Engn, Osaka, Japan; [Keefer, Jeffrey R.] Johns Hopkins Sch Med, Div Pediat Hematol, Dept Pediat, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; Osaka Metropolitan University; Johns Hopkins University; Johns Hopkins Medicine	Krause, MA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov		Diakite, Seidina A. S./0000-0003-1193-6501	Intramural Research Program of the NIAID; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062, ZIAAI001000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIAID, NIH. The authors wish to acknowledge Jennifer M. Anderson, Steve Beaudry, Mory Doumbia, Seydou Doumbia, Robert W. Gwadz, Carole A. Long, Sam Moretz, Dick Sakai, Cheick Traore, and Thomas E. Wellems for their efforts in support of this work.; This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLEN SJ, 1993, T ROY SOC TROP MED H, V87, P282, DOI 10.1016/0035-9203(93)90129-E; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BROWN AE, 1990, EUR J HAEMATOL, V45, P120; CAMPWALA HQ, 1982, J LAB CLIN MED, V99, P25; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Enevold A, 2008, AM J TROP MED HYG, V78, P714, DOI 10.4269/ajtmh.2008.78.714; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; HEBBEL RP, 1985, CLIN HAEMATOL, V14, P129; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Imrie H, 2006, AM J TROP MED HYG, V74, P965, DOI 10.4269/ajtmh.2006.74.965; Jenkins N, 2007, J INFECT DIS, V196, P321, DOI 10.1086/518795; KITAYAPORN D, 1992, T ROY SOC TROP MED H, V86, P240, DOI 10.1016/0035-9203(92)90292-K; LUZZI GA, 1991, J EXP MED, V173, P785, DOI 10.1084/jem.173.4.785; MACDONALD VW, 1982, BIOCHIM BIOPHYS ACTA, V701, P39, DOI 10.1016/0167-4838(82)90309-0; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mockenhaupt FP, 1999, J INFECT DIS, V180, P925, DOI 10.1086/314959; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 1999, TROP MED INT HEALTH, V4, P302, DOI 10.1046/j.1365-3156.1999.00386.x; Mockenhaupt FP, 2001, TROP MED INT HEALTH, V6, P102, DOI 10.1046/j.1365-3156.2001.00688.x; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; Oo M, 1995, B WORLD HEALTH ORGAN, V73, P659; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Pattanapanyasat K, 1999, BLOOD, V93, P3116; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TURNER GDH, 1994, AM J PATHOL, V145, P1057; UDOMSANGPETCH R, 1993, BLOOD, V82, P3752; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2002, BRIT J HAEMATOL, V118, P663, DOI 10.1046/j.1365-2141.2002.03610.x; YUTHAVONG Y, 1988, AM J CLIN PATHOL, V89, P521, DOI 10.1093/ajcp/89.4.521	52	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37214	10.1371/journal.pone.0037214	http://dx.doi.org/10.1371/journal.pone.0037214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623996	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500076
J	Mohler, E; Frei, P; Frolich, J; Braun-Fahrlander, C; Roosli, M				Mohler, Evelyn; Frei, Patrizia; Froehlich, Juerg; Braun-Fahrlaender, Charlotte; Roeoesli, Martin		QUALIFEX-Team	Exposure to Radiofrequency Electromagnetic Fields and Sleep Quality: A Prospective Cohort Study	PLOS ONE			English	Article							PHONE BASE STATIONS; DOUBLE-BLIND; PERSONAL EXPOSURE; MOBILE PHONES; SYMPTOMS; HEALTH; PREVALENCE; SIGNALS	Background: There is persistent public concern about sleep disturbances due to radiofrequency electromagnetic field (RF-EMF) exposure. The aim of this prospective cohort study was to investigate whether sleep quality is affected by mobile phone use or by other RF-EMF sources in the everyday environment. Methods: We conducted a prospective cohort study with 955 study participants aged between 30 and 60 years. Sleep quality and daytime sleepiness was assessed by means of standardized questionnaires in May 2008 (baseline) and May 2009 (follow-up). We also asked about mobile and cordless phone use and asked study participants for consent to obtain their mobile phone connection data from the mobile phone operators. Exposure to environmental RF-EMF was computed for each study participant using a previously developed and validated prediction model. In a nested sample of 119 study participants, RF-EMF exposure was measured in the bedroom and data on sleep behavior was collected by means of actigraphy during two weeks. Data were analyzed using multivariable regression models adjusted for relevant confounders. Results: In the longitudinal analyses neither operator-recorded nor self-reported mobile phone use was associated with sleep disturbances or daytime sleepiness. Also, exposure to environmental RF-EMF did not affect self-reported sleep quality. The results from the longitudinal analyses were confirmed in the nested sleep study with objectively recorded exposure and measured sleep behavior data. Conclusions: We did not find evidence for adverse effects on sleep quality from RF-EMF exposure in our everyday environment.	[Mohler, Evelyn; Frei, Patrizia; Braun-Fahrlaender, Charlotte; Roeoesli, Martin] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mohler, Evelyn; Frei, Patrizia; Braun-Fahrlaender, Charlotte; Roeoesli, Martin] Univ Basel, Basel, Switzerland; [Froehlich, Juerg] ETH, Lab Electromagnet Fields & Microwave Elect, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mohler, E (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	martin.roosli@unibas.ch	Röösli, Martin/A-2658-2008	Röösli, Martin/0000-0002-7475-1531; Frohlich, Jurg/0000-0002-5923-3410	Swiss National Science Foundation [405740-113595]; Swiss School of Public Health+ (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health+ (SSPH+)	The study was funded by the Swiss National Science Foundation (Grant 405740-113595, www.snf.ch). Martin Roosli is supported by the Swiss School of Public Health+ (SSPH+, http://www.ssphplus.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, HEALTH PHYS, V74, P494; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Borbely AA, 1999, NEUROSCI LETT, V275, P207, DOI 10.1016/S0304-3940(99)00770-3; Burgi A, 2010, BIOELECTROMAGNETICS, V31, P226, DOI 10.1002/bem.20552; Danker-Hopfe H, 2010, AM J HUM BIOL, V22, P613, DOI 10.1002/ajhb.21053; Eltiti S, 2007, ENVIRON HEALTH PERSP, V115, P1603, DOI 10.1289/ehp.10286; Frei P, 2010, ENVIRON INT, V36, P714, DOI 10.1016/j.envint.2010.05.005; Frei P, 2009, SCI TOTAL ENVIRON, V408, P102, DOI 10.1016/j.scitotenv.2009.09.023; Frei P, 2009, ENVIRON RES, V109, P779, DOI 10.1016/j.envres.2009.04.015; Hinrichs H, 2005, SOMNOLOGY, V9, P185, DOI [10.1111/j.1439-054X.2005.00069.x, DOI 10.1111/J.1439-054X.2005.00069.X]; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Huss A, 2004, INT J HYG ENVIR HEAL, V207, P245, DOI 10.1078/1438-4639-00286; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Infas, 2010, ERM BEF ANGST BREIT; Jean-Louis G, 2000, SLEEP, V23, P1115; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; Loughran SP, 2005, NEUROREPORT, V16, P1973, DOI 10.1097/01.wnr.0000186593.79705.3c; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Mohler E, 2010, RADIAT RES, V174, P347, DOI 10.1667/RR2153.1; Neubauer G, 2007, BIOELECTROMAGNETICS, V28, P224, DOI 10.1002/bem.20298; Oftedal G, 2007, CEPHALALGIA, V27, P447, DOI 10.1111/j.1468-2982.2007.01336.x; Oftedal G, 2000, OCCUP MED-OXFORD, V50, P237, DOI 10.1093/occmed/50.4.237; Regel SJ, 2007, J SLEEP RES, V16, P253, DOI 10.1111/j.1365-2869.2007.00603.x; Roosli M, 2008, BIOELECTROMAGNETICS, V29, P471, DOI 10.1002/bem.20417; Roosli M, 2010, CR PHYS, V11, P576, DOI 10.1016/j.crhy.2010.10.007; Roosli M, 2010, B WORLD HEALTH ORGAN, V88, P887, DOI 10.2471/BLT.09.071852; Roosli M, 2004, INT J HYG ENVIR HEAL, V207, P141, DOI 10.1078/1438-4639-00269; Rubin GJ, 2010, BIOELECTROMAGNETICS, V31, P1, DOI 10.1002/bem.20536; Schmitt BE, 2000, SCHWEIZ MED WSCHR, V130, P772; Schreier N, 2006, SOZ PRAVENTIV MED, V51, P202, DOI 10.1007/s00038-006-5061-2; Thomas S, 2008, BIOELECTROMAGNETICS, V29, P463, DOI 10.1002/bem.20414; Wallace D, 2010, ENVIRON HEALTH PERSP, V118, P735, DOI 10.1289/ehp.0901416	33	35	35	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37455	10.1371/journal.pone.0037455	http://dx.doi.org/10.1371/journal.pone.0037455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624036	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305343500121
J	Wang, ZQ; Liang, PP; Jia, XQ; Jin, GW; Song, HQ; Han, Y; Lu, J; Li, KC				Wang, Zhiqun; Liang, Peipeng; Jia, Xiuqin; Jin, Guangwei; Song, Haiqing; Han, Ying; Lu, Jie; Li, Kuncheng			The Baseline and Longitudinal Changes of PCC Connectivity in Mild Cognitive Impairment: A Combined Structure and Resting-State fMRI Study	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; MRI; DEMENTIA; CORTEX; MEMORY	The baseline and longitudinal changes of the posterior cingulate cortex (PCC) connectivity were assessed in order to clarify the neural mechanism of mild cognitive impairment (MCI). Twenty-eight right-handed subjects (14 MCI patients and 14 healthy elders) participated in this study. Clinical and neuropsychological examinations were performed on all the subjects. PCC functional connectivity was studied by examining the correlation between low frequency fMRI signal fluctuations in the PCC and those in all the other brain regions. Additionally, we traced all the MCI patients and compared their PCC connectivity in the initial stage and that in 3 years later. We also explored the relationship between the PCC functional connectivity strength and cognitive performances. Our results are as follows: Functional connectivity between the PCC and a set of regions is decreased in MCI patients. Most of these regions are within the default mode network (DMN). Three years later, the regions of superior frontal gyrus (SFG) and middle frontal gyrus (MFG) presented further decreased connectivity to the PCC in MCI. In addition, we also find enhanced functional connectivity between PCC and medial prefrontal cortex (MPFC), PCC and anterior cingulate cortex (ACC) in MCI patients. At last, our research also shows that the PCC connectivity with some regions significantly correlates with the cognitive performances of patients as measured by mini-mental state examination (MMSE), and California verbal learning test (CVLT) scores. The baseline and longitudinal changes of the PCC connectivity in our study suggest that impairment and compensation coexist in the disease progress of MCI patients.	[Wang, Zhiqun; Liang, Peipeng; Jia, Xiuqin; Jin, Guangwei; Lu, Jie; Li, Kuncheng] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [Song, Haiqing; Han, Ying] Capital Med Univ, Dept Neurol, Xuanwu Hosp, Beijing, Peoples R China; [Li, Kuncheng] Minist Educ, Key Lab Neurodegenerat Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, ZQ (corresponding author), Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China.	likuncheng@xwh.ccmu.edu.cn	Lu, Jie/GNW-3367-2022; Liang, Peipeng/A-9502-2015; Han, Ying/H-7111-2017; , xiuqin/T-8052-2018	Liang, Peipeng/0000-0003-3795-4134; , xiuqin/0000-0003-3920-2884	Natural Science Foundation of China [81000606, 61105118, 81141018]; State Key Laboratory of Cognitive Neuroscience and Learning [CNKOPZD1001]; CAS Key Laboratory of Brain Function and Disease; Key Work of Special Project [Z101107052210002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cognitive Neuroscience and Learning; CAS Key Laboratory of Brain Function and Disease; Key Work of Special Project	This work was supported by the Natural Science Foundation of China (Grant Nos. 81000606, 61105118, 81141018), Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (No.CNKOPZD1001), Open Research Fund of CAS Key Laboratory of Brain Function and Disease, and Key Work of Special Project (Z101107052210002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, NEUROBIOL AGING; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Binnewijzend M.A., 2011, NEUROBIOL AGING; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; Mevel K, 2011, INT J ALZHEIMERS DIS, V2011; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang Z, 2010, EUR J RADIOL; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	37	53	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36838	10.1371/journal.pone.0036838	http://dx.doi.org/10.1371/journal.pone.0036838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629335	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500030
J	Yokoyama, M; Naganawa, S; Yoshimura, K; Matsushita, S; Sato, H				Yokoyama, Masaru; Naganawa, Satoshi; Yoshimura, Kazuhisa; Matsushita, Shuzo; Sato, Hironori			Structural Dynamics of HIV-1 Envelope Gp120 Outer Domain with V3 Loop	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-ACID SUBSTITUTIONS; CORECEPTOR USAGE; NEUTRALIZATION EPITOPE; EXTERNAL GLYCOPROTEIN; MONOCLONAL-ANTIBODY; CHEMOKINE RECEPTORS; MOLECULAR-DYNAMICS; CRYPTIC NATURE; FORCE-FIELDS	Background: The net charge of the hypervariable V3 loop on the HIV-1 envelope gp120 outer domain plays a key role in modulating viral phenotype. However, the molecular mechanisms underlying the modulation remain poorly understood. Methodology/Principal Findings: By combining computational and experimental approaches, we examined how V3 net charge could influence the phenotype of the gp120 interaction surface. Molecular dynamics simulations of the identical gp120 outer domain, carrying a V3 loop with net charge of +3 or +7, showed that the V3 change alone could induce global changes in fluctuation and conformation of the loops involved in binding to CD4, coreceptor and antibodies. A neutralization study using the V3 recombinant HIV-1 infectious clones showed that the virus carrying the gp120 with +3 V3, but not with +7 V3, was resistant to neutralization by anti-CD4 binding site monoclonal antibodies. An information entropy study shows that otherwise variable surface of the gp120 outer domain, such as V3 and a region around the CD4 binding loop, are less heterogeneous in the gp120 subpopulation with +3 V3. Conclusions/Significance: These results suggest that the HIV-1 gp120 V3 loop acts as an electrostatic modulator that influences the global structure and diversity of the interaction surface of the gp120 outer domain. Our findings will provide a novel structural basis to understand how HIV-1 adjusts relative replication fitness by V3 mutations.	[Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan; [Naganawa, Satoshi] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Yoshimura, Kazuhisa; Matsushita, Shuzo] Kumamoto Univ, Ctr AIDS Res, Div Clin Retrovirol & Infect Dis, Kumamoto, Japan	National Institute of Infectious Diseases (NIID); Tokyo Metropolitan Institute of Medical Science; Kumamoto University	Yokoyama, M (corresponding author), Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, 4-7-1 Gakuen, Musashimurayama, Tokyo, Japan.	yokoyama@nih.go.jp; hirosato@nih.go.jp	Matsushita, Shuzo/F-5782-2013; Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X	Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Brown LS, 1997, P NATL ACAD SCI USA, V94, P5040, DOI 10.1073/pnas.94.10.5040; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Burns D P, 1994, Curr Top Microbiol Immunol, V188, P185; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cavacini LA, 2002, AIDS, V16, P2409, DOI 10.1097/00002030-200212060-00005; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; HWANG SS, 1992, SCIENCE, V257, P535, DOI 10.1126/science.1636088; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kato K, 1999, J VIROL, V73, P5520, DOI 10.1128/JVI.73.7.5520-5526.1999; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; LUKASHOV VV, 1995, J VIROL, V69, P6911, DOI 10.1128/JVI.69.11.6911-6916.1995; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Milich L, 1997, VIROLOGY, V239, P108, DOI 10.1006/viro.1997.8821; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Miyamoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022779; Motomura K, 2008, J VIROL, V82, P11247, DOI 10.1128/JVI.00897-08; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Ode H, 2011, J MOL MODEL, V17, P391, DOI 10.1007/s00894-010-0739-z; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Oka T, 2009, VIROLOGY, V394, P119, DOI 10.1016/j.virol.2009.08.018; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Sato H, 1999, VIROLOGY, V257, P491, DOI 10.1006/viro.1999.9670; Shannon CE, 1997, M D COMPUT, V14, P306; Shibata J, 2007, J VIROL, V81, P3757, DOI 10.1128/JVI.01544-06; Shiino T, 2000, J VIROL, V74, P1069, DOI 10.1128/JVI.74.3.1069-1078.2000; SHIODA T, 1994, J VIROL, V68, P7689, DOI 10.1128/JVI.68.12.7689-7696.1994; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; VERONESE FD, 1992, AIDS RES HUM RETROV, V8, P1125, DOI 10.1089/aid.1992.8.1125; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; WILLEY RL, 1994, J VIROL, V68, P1029, DOI 10.1128/JVI.68.2.1029-1039.1994; WILLEY RL, 1994, J VIROL, V68, P4409, DOI 10.1128/JVI.68.7.4409-4419.1994; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Xiao LH, 1998, VIROLOGY, V240, P83, DOI 10.1006/viro.1997.8924; Yoshimura K, 2010, J VIROL	63	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37530	10.1371/journal.pone.0037530	http://dx.doi.org/10.1371/journal.pone.0037530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624045	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500132
J	Duchin, Y; Abosch, A; Yacoub, E; Sapiro, G; Harel, N				Duchin, Yuval; Abosch, Aviva; Yacoub, Essa; Sapiro, Guillermo; Harel, Noam			Feasibility of Using Ultra-High Field (7 T) MRI for Clinical Surgical Targeting	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; AFFINE REGISTRATION; IMAGES; DISTORTION	The advantages of ultra-high magnetic field (7 Tesla) MRI for basic science research and neuroscience applications have proven invaluable. Structural and functional MR images of the human brain acquired at 7 T exhibit rich information content with potential utility for clinical applications. However, (1) substantial increases in susceptibility artifacts, and (2) geometrical distortions at 7 T would be detrimental for stereotactic surgeries such as deep brain stimulation (DBS), which typically use 1.5 T images for surgical planning. Here, we explore whether these issues can be addressed, making feasible the use of 7 T MRI to guide surgical planning. Twelve patients with Parkinson's disease, candidates for DBS, were scanned on a standard clinical 1.5 T MRI and a 7 T MRI scanner. Qualitative and quantitative assessments of global and regional distortion were evaluated based on anatomical landmarks and transformation matrix values. Our analyses show that distances between identical landmarks on 1.5 T vs. 7 T, in the mid-brain region, were less than one voxel, indicating a successful co-registration between the 1.5 T and 7 T images under these specific imaging parameter sets. On regional analysis, the central part of the brain showed minimal distortion, while inferior and frontal areas exhibited larger distortion due to proximity to air-filled cavities. We conclude that 7 T MR images of the central brain regions have comparable distortions to that observed on a 1.5 T MRI, and that clinical applications targeting structures such as the STN, are feasible with information-rich 7 T imaging.	[Duchin, Yuval; Yacoub, Essa; Harel, Noam] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Abosch, Aviva; Harel, Noam] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Sapiro, Guillermo] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Duchin, Y (corresponding author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.	noam@cmrr.umn.edu	Yacoub, Essa/AAS-7757-2021; Abosch, Aviva/U-7963-2019; Harel, Noam/R-7391-2018	Harel, Noam/0000-0002-6034-3801	NIH grants: The Human Connectome Project [U54 MH091657, R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079]; W.M. Keck Foundation; Office of Naval Research; National Geospatial Intelligence Agency; National Science Foundation; Defense Advanced Research Projects Agency; National Security Science and Engineering Faculty Fellowship; Army Research Office; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023247, S10RR026783, P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008432, R01EB008645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	NIH grants: The Human Connectome Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Office of Naval Research(Office of Naval Research); National Geospatial Intelligence Agency; National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Security Science and Engineering Faculty Fellowship; Army Research Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the NIH grants: The Human Connectome Project (U54 MH091657), R01 EB008645, R01 EB008432, K12 RR023247, S10 RR026783, P30 NS057091, P41 RR008079 and by the W.M. Keck Foundation, Office of Naval Research, National Geospatial Intelligence Agency, National Science Foundation, Defense Advanced Research Projects Agency, National Security Science and Engineering Faculty Fellowship, Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Aganj I, 2012, MAGN RESON MED, V67, P1167, DOI 10.1002/mrm.23086; Ashkan K, 2007, BRIT J NEUROSURG, V21, P197, DOI 10.1080/02688690701272240; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Dammann P, 2011, ACAD RADIOL, V18, P910, DOI 10.1016/j.acra.2011.02.011; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P571, DOI 10.1109/42.730402; GERDES JS, 1994, STEREOT FUNCT NEUROS, V63, P124, DOI 10.1159/000100303; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haddar D, 2004, J RADIOL, V85, P1901; Harel N, 2006, NEUROIMAGE, V29, P879, DOI 10.1016/j.neuroimage.2005.08.016; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kerchner GA, 2011, J ALZHEIMERS DIS, V26, P91, DOI 10.3233/JAD-2011-0023; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Manova ES, 2009, AM J NEURORADIOL, V30, P569, DOI 10.3174/ajnr.A1401; Metzger CD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00138; Patel NK, 2008, STEREOT FUNCT NEUROS, V86, P153, DOI 10.1159/000120427; Pitiot A, 2006, MED IMAGE ANAL, V10, P465, DOI 10.1016/j.media.2005.03.008; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541; Robitaille P-M, 2006, ULTRA HIGH FIELD MAG, p[xxiii, 475, 249]; Rodriguez RL, 2007, NEUROLOGIST, V13, P253, DOI 10.1097/NRL.0b013e318095a4d5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Starr PA, 1999, NEUROSURGERY, V44, P303, DOI 10.1097/00006123-199902000-00031; Wang DM, 2005, CURR MED IMAGING REV, V1, P49, DOI 10.2174/1573405052953029; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	30	65	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37328	10.1371/journal.pone.0037328	http://dx.doi.org/10.1371/journal.pone.0037328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615980	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200060
J	Wu, DH; Jiang, SM; Bowler, MW; Song, HW				Wu, Donghui; Jiang, Shimin; Bowler, Matthew W.; Song, Haiwei			Crystal Structures of Lsm3, Lsm4 and Lsm5/6/7 from Schizosaccharomyces pombe	PLOS ONE			English	Article							SM-LIKE PROTEINS; MESSENGER-RNA DEGRADATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; 3' URIDYLATION; CORE DOMAIN; U6 SNRNA; COMPLEX; YEAST; MICRORNA	Sm-like (Lsm) proteins are ubiquitous and function in many aspects of RNA metabolism, including pre-mRNA splicing, nuclear RNA processing, mRNA decay and miRNA biogenesis. Here three crystal structures including Lsm3, Lsm4 and Lsm5/6/7 sub-complex from S. pombe are reported. These structures show that all the five individual Lsm subunits share a conserved Sm fold, and Lsm3, Lsm4, and Lsm5/6/7 form a heptamer, a trimer and a hexamer within the crystal lattice, respectively. Analytical ultracentrifugation indicates that Lsm3 and Lsm5/6/7 sub-complex exist in solution as a heptamer and a hexamer, respectively while Lsm4 undergoes a dynamic equilibrium between monomer and trimer in solution. RNA binding assays show that Lsm2/3 and Lsm5/6/7 bind to oligo(U) whereas no RNA binding is observed for Lsm3 and Lsm4. Analysis of the inter-subunit interactions in Lsm5/6/7 reveals the organization order among Lsm5, Lsm6 and Lsm7.	[Wu, Donghui; Jiang, Shimin; Song, Haiwei] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Song, Haiwei] Zhejiang Univ, Inst Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Song, Haiwei] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Bowler, Matthew W.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Song, Haiwei] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Zhejiang University; Zhejiang University; European Synchrotron Radiation Facility (ESRF); National University of Singapore	Wu, DH (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	haiwei@imcb.a-star.edu.sg	Bowler, Matthew/B-5722-2011; Bowler, Matthew/I-7461-2019	Bowler, Matthew/0000-0003-0465-3351; Bowler, Matthew/0000-0003-0465-3351	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore)	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR))	This work is financially supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research, Singapore) to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bergman N, 2007, NAT STRUCT MOL BIOL, V14, P824, DOI 10.1038/nsmb1287; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez CF, 2004, MOL BIOL CELL, V15, P2842, DOI 10.1091/mbc.E04-02-0116; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herrero AB, 2011, EMBO J, V30, P2008, DOI 10.1038/emboj.2011.117; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Mund M, 2011, J MOL BIOL, V414, P165, DOI 10.1016/j.jmb.2011.09.051; Naidoo N, 2008, J MOL BIOL, V377, P1357, DOI 10.1016/j.jmb.2008.01.007; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sobti M, 2010, BIOCHEMISTRY-US, V49, P2335, DOI 10.1021/bi901767w; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36768	10.1371/journal.pone.0036768	http://dx.doi.org/10.1371/journal.pone.0036768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615807	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200017
J	Becker, PA; Miller, PS; Gunther, MS; Somers, MJ; Wildt, DE; Maldonado, JE				Becker, Penny A.; Miller, Philip S.; Gunther, Micaela Szykman; Somers, Michael J.; Wildt, David E.; Maldonado, Jesus E.			Inbreeding Avoidance Influences the Viability of Reintroduced Populations of African Wild Dogs (Lycaon pictus)	PLOS ONE			English	Article							KIN DISCRIMINATION; REPRODUCTIVE SKEW; GENETIC DIVERSITY; SELECTION; FITNESS; CONSEQUENCES; RECOGNITION; ASSOCIATION; PATTERNS; SIZE	The conservation of many fragmented and small populations of endangered African wild dogs (Lycaon pictus) relies on understanding the natural processes affecting genetic diversity, demographics, and future viability. We used extensive behavioural, life-history, and genetic data from reintroduced African wild dogs in South Africa to (1) test for inbreeding avoidance via mate selection and (2) model the potential consequences of avoidance on population persistence. Results suggested that wild dogs avoided mating with kin. Inbreeding was rare in natal packs, after reproductive vacancies, and between sibling cohorts (observed on 0.8%, 12.5%, and 3.8% of occasions, respectively). Only one of the six (16.7%) breeding pairs confirmed as third-order (or closer) kin consisted of animals that were familiar with each other, while no other paired individuals had any prior association. Computer-simulated populations allowed to experience inbreeding had only a 1.6% probability of extinction within 100 years, whereas all populations avoiding incestuous matings became extinct due to the absence of unrelated mates. Populations that avoided mating with first-order relatives became extinct after 63 years compared with persistence of 37 and 19 years for those also prevented from second-order and third-order matings, respectively. Although stronger inbreeding avoidance maintains significantly more genetic variation, our results demonstrate the potentially severe demographic impacts of reduced numbers of suitable mates on the future viability of small, isolated wild dog populations. The rapid rate of population decline suggests that extinction may occur before inbreeding depression is observed.	[Becker, Penny A.; Maldonado, Jesus E.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Becker, Penny A.; Gunther, Micaela Szykman; Wildt, David E.] Smithsonian Inst, Natl Zool Pk, Ctr Species Survival, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Becker, Penny A.; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Miller, Philip S.] Int Union Conservat Nat, Species Survival Commiss, Conservat Breeding Specialist Grp, Apple Valley, MN USA; [Gunther, Micaela Szykman] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Maldonado, Jesus E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Pretoria; California State University System; California State Polytechnic University, Humboldt; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Pretoria	Becker, PA (corresponding author), Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA.	SpieringP@si.edu	Maldonado, Jesus/AIE-8664-2022; /A-1523-2008	Maldonado, Jesus/0000-0002-4282-1072; /0000-0002-5836-8823; Becker, Penny/0000-0001-5037-5044; Szykman Gunther, Micaela/0000-0002-7822-8094	Smithsonian Institution Undersecretary for Science Endowment Fund; University of Pretoria; Rotterdam Zoo Thandiza Fund; Humboldt State University; Conservation Endowment Fund of the Association of Zoos and Aquariums; Disney Wildlife Conservation Fund; Knowsley Safari Park; DST-NRF Centre of Excellence for Invasion Biology; Khaki Fever Work Wear; Pittsburgh Zoo Conservation Fund; Morris Animal Foundation	Smithsonian Institution Undersecretary for Science Endowment Fund; University of Pretoria; Rotterdam Zoo Thandiza Fund; Humboldt State University; Conservation Endowment Fund of the Association of Zoos and Aquariums; Disney Wildlife Conservation Fund; Knowsley Safari Park; DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); Khaki Fever Work Wear; Pittsburgh Zoo Conservation Fund; Morris Animal Foundation	This research was supported by the Smithsonian Institution Undersecretary for Science Endowment Fund, University of Pretoria, Rotterdam Zoo Thandiza Fund, Humboldt State University, Conservation Endowment Fund of the Association of Zoos and Aquariums, Disney Wildlife Conservation Fund, Knowsley Safari Park, DST-NRF Centre of Excellence for Invasion Biology, Khaki Fever Work Wear, Pittsburgh Zoo Conservation Fund, and the Morris Animal Foundation. International travel was generously provided by British Airways. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for this study was provided by the following commercial sources: Disney Wildlife Conservation Fund, Knowsley Safari Park, Khaki Fever Work Wear, and Rotterdam Zoo Thandiza Fund. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], [No title captured]; Blaustein A.R., 1987, P287; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Clarke FM, 1999, P ROY SOC B-BIOL SCI, V266, P1995, DOI 10.1098/rspb.1999.0877; Cooney R, 2000, P ROY SOC B-BIOL SCI, V267, P801, DOI 10.1098/rspb.2000.1074; Courchamp F, 2000, ANIM CONSERV, V3, P277, DOI 10.1017/S1367943000001001; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S., 2002, AFRICAN WILD DOG BEH; Daniels SJ, 2000, CONSERV BIOL SER, V4, P129; Davies-Mostert HT, 2009, REINTRODUCTION TOP O; de Villiers MS, 2003, J ZOOL, V260, P377, DOI 10.1017/S0952836903003832; Flacke G, 2007, THESIS MURDOCH U; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; FRAME LH, 1979, Z TIERPSYCHOL, V50, P225; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Girman DJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P187, DOI 10.1007/s002650050332; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Graf JA, 2006, ANIM CONSERV, V9, P398, DOI 10.1111/j.1469-1795.2006.00048.x; Gusset M, 2006, J ZOOL, V270, P502, DOI 10.1111/j.1469-7998.2006.00168.x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; HOOGLAND JL, 1982, SCIENCE, V215, P1639, DOI 10.1126/science.215.4540.1639; Kalinowski ST, 1998, ZOO BIOL, V17, P481, DOI 10.1002/(SICI)1098-2361(1998)17:6<481::AID-ZOO2>3.0.CO;2-G; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keller LF, 1998, EVOLUTION, V52, P240, DOI 10.1111/j.1558-5646.1998.tb05157.x; Koenig Walter D., 2004, P142, DOI 10.1017/CBO9780511606816.010; Koenig WD, 1999, ANIM BEHAV, V57, P1287, DOI 10.1006/anbe.1999.1093; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Komdeur J, 2004, P ROY SOC B-BIOL SCI, V271, P963, DOI 10.1098/rspb.2003.2665; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Maddock A, 1999, CONSERV BIOL, V13, P412, DOI 10.1046/j.1523-1739.1999.013002412.x; Maddock A, 1996, 535 ZC NAT PARKS BOA; Maddock A, 1995, REINTRODUCTION NEWS, V11, P16; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; McNutt JW, 2008, S AFR J WILDL RES, V38, P109, DOI 10.3957/0379-4369-38.2.109; McNutt JW, 1996, ANIM BEHAV, V52, P1067, DOI 10.1006/anbe.1996.0254; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller KA, 2009, MOL ECOL, V18, P3792, DOI 10.1111/j.1365-294X.2009.04315.x; Miller PS., 2005, VORTEX STOCHASTIC SI; MILLS M. G. L., 2004, WILD CANIDS STATUS S, P174; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reich A, 1981, NATL ACCOUNTS EC VAL; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Sharp SP, 2005, NATURE, V434, P1127, DOI 10.1038/nature03522; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Somers M, 1999, AFR WILDL, V53, P24; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spiering PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P583, DOI 10.1007/s00265-009-0875-6; Spiering PA, 2009, CONSERV GENET, V10, P2005, DOI 10.1007/s10592-009-9880-6; Stephens P.A., 2000, VERTEBRATE MATING SY, P186, DOI [DOI 10.1142/9789812793584_0009, 10.1142/9789812793584_0009]; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Vucetich JA, 1999, CONSERV BIOL, V13, P1172, DOI 10.1046/j.1523-1739.1999.98366.x; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Williams RN, 2000, J MAMMAL, V81, P895, DOI 10.1644/1545-1542(2000)081<0895:AOGVAS>2.3.CO;2; Woodroffe Rosie, 1997, P58; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	64	11	12	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37181	10.1371/journal.pone.0037181	http://dx.doi.org/10.1371/journal.pone.0037181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615933	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300085
J	Huttner, B; Jones, M; Rubin, MA; Neuhauser, MM; Gundlapalli, A; Samore, M				Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Neuhauser, Melinda M.; Gundlapalli, Adi; Samore, Matthew			Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005-2010	PLOS ONE			English	Article							INFECTIONS; RESISTANT; COLISTIN; ENTEROBACTERIACEAE; SUSCEPTIBILITY; SURVEILLANCE; METAANALYSIS; BACTERIA; EFFICACY; ENZYMES	Multidrug-resistant (MDR) and carbapenem-resistant (CR) Gram-negative pathogens are becoming increasingly prevalent around the globe. Polymyxins and tigecycline are among the few antibiotics available to treat infections with these bacteria but little is known about the frequency of their use. We therefore aimed to estimate the parenteral use of these two drugs in Veterans Affairs medical centers (VAMCs) and to describe the pathogens associated with their administration. For this purpose we retrospectively analyzed barcode medication administration data of parenteral administrations of polymyxins and tigecycline in 127 acute-care VAMCs between October 2005 and September 2010. Overall, polymyxin and tigecycline use were relatively low at 0.8 days of therapy (DOT)/1000 patient days (PD) and 1.6 DOT/1000PD, respectively. Use varied widely across facilities, but increased overall during the study period. Eight facilities accounted for three-quarters of all polymyxin use. The same statistic for tigecycline use was twenty-six VAMCs. There were 1,081 MDR or CR isolates during 747 hospitalizations associated with polymyxin use (1.4/hospitalization). For tigecycline these number were slightly lower: 671 MDR or CR isolates during 500 hospitalizations (1.3/hospitalization) (p = 0.06). An ecological correlation between the two antibiotics and combined CR and MDR Gram-negative isolates per 1000PD during the study period was also observed (Pearson's correlation coefficient r = 0.55 polymyxin, r = 0.19 tigecycline). In summary, while polymyxin and tigecycline use is low in most VAMCs, there has been an increase over the study period. Polymyxin use in particular is associated with the presence of MDR Gram-negative pathogens and may be useful as a surveillance measure in the future.	[Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Gundlapalli, Adi; Samore, Matthew] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84108 USA; [Huttner, Benedikt; Jones, Makoto; Rubin, Michael A.; Gundlapalli, Adi; Samore, Matthew] Univ Utah, Salt Lake City, UT USA; [Neuhauser, Melinda M.] Pharm Benefit Management Serv, Dept Vet Affairs, Hines, IL USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Huttner, B (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84108 USA.	Makoto.jones@hsc.utah.edu	Huttner, Benedikt/M-5616-2014	Huttner, Benedikt/0000-0002-1749-9464	Pew Charitable Trusts; VA Informatics and Computing Infrastructure (VINCI) [VA HSR HIR 08-204]; Consortium for Healthcare Informatics Research (CHIR) [VA HSR HIR 08-374]; Centers for Disease Control and Prevention1s Prevention Epicenters Program [5U01CI000334, 07FED706504]; Geneva University Hospitals, Switzerland;  [CDA 10-030-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000334] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Pew Charitable Trusts; VA Informatics and Computing Infrastructure (VINCI); Consortium for Healthcare Informatics Research (CHIR)(Canadian Institutes of Health Research (CIHR)); Centers for Disease Control and Prevention1s Prevention Epicenters Program; Geneva University Hospitals, Switzerland; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this work was provided by The Pew Charitable Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This material is also the result of work supported with resources and the use of facilities at the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT and funding support from the VA Informatics and Computing Infrastructure (VINCI - VA HSR HIR 08-204), the Consortium for Healthcare Informatics Research (CHIR - VA HSR HIR 08-374) and the Centers for Disease Control and Prevention1s Prevention Epicenters Program, (5U01CI000334 and 07FED706504). In addition, M.J. was supported by a career development award (CDA 10-030-02) and B.H. was supported in part by a fellowship grant from Geneva University Hospitals, Switzerland.	Bertrand X, 2012, CLIN THER, V34, P124, DOI 10.1016/j.clinthera.2011.11.023; Bogdanovich T, 2011, CLIN INFECT DIS, V53, P373, DOI 10.1093/cid/cir401; Carlet J, 2009, INFECT CONT HOSP EP, V30, P737, DOI 10.1086/598682; Chiang T, 2007, MICROB DRUG RESIST, V13, P235, DOI 10.1089/mdr.2007.767; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Falagas ME, 2011, FUTURE MICROBIOL, V6, P653, DOI [10.2217/fmb.11.49, 10.2217/FMB.11.49]; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gagliotti C, 2011, EURO SURVEILL, V16; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Hombach M, 2012, J ANTIMICROB CHEMOTH, V67, P622, DOI 10.1093/jac/dkr524; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnson Connie L, 2002, J Healthc Inf Manag, V16, P46; Jones M, 2012, BMC MED INF IN PRESS; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Lim LM, 2010, PHARMACOTHERAPY, V30, P1279, DOI 10.1592/phco.30.12.1279; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2011, ANTIMICROB AGENTS CH, V55, P593, DOI 10.1128/AAC.01020-10; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640; Prasad P, 2012, CLIN INFECT IN PRESS; Tasina E, 2011, LANCET INFECT DIS, V11, P834, DOI 10.1016/S1473-3099(11)70177-3; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; Wilson J, 2011, J HOSP INFECT, V79, P211, DOI 10.1016/j.jhin.2011.05.013; Yahav D, 2012, CLIN MICROBIOL INFEC, V18, P18, DOI 10.1111/j.1469-0691.2011.03734.x; Yahav D, 2011, J ANTIMICROB CHEMOTH, V66, P1963, DOI 10.1093/jac/dkr242	29	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36649	10.1371/journal.pone.0036649	http://dx.doi.org/10.1371/journal.pone.0036649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615789	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300022
J	Meisinger, C; Doring, A; Stockl, D; Thorand, B; Kowall, B; Rathmann, W				Meisinger, Christa; Doering, Angela; Stoeckl, Doris; Thorand, Barbara; Kowall, Bernd; Rathmann, Wolfgang			Uric Acid Is More Strongly Associated with Impaired Glucose Regulation in Women than in Men from the General Population: The KORA F4-Study	PLOS ONE			English	Article							DIABETES-MELLITUS; FASTING GLUCOSE; SERUM GLUCOSE; HYPERTENSION; RISK; INSULIN; LEVEL	Objective: High serum uric acid (UA) levels are associated with the metabolic syndrome, type 2 diabetes and cardiovascular disease. It is largely unknown whether there are gender-specific differences regarding the association between UA and prediabetic states. We examined the possible association between UA levels and known as well as newly diagnosed diabetes (NDD), isolated impaired fasting glucose (i-IFG), isolated impaired glucose tolerance (i-IGT), and combined IFG/IGT in a population-based sample of 32-to-81-year-old men and women. Research Design and Methods: An oral glucose tolerance test was carried out in all 2,740 participants without known diabetes of the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study conducted between 2006 and 2008 in Southern Germany. Serum UA was analysed by the uricase method. Results: In women after multivariable adjustment the associations between UA and i-IFG (OR 1.57, 95% CI 1.15-2.14), IFG/IGT (OR 1.52, 1.07-2.16), NDD (OR 1.67, 95% CI 1.28-2.17), and known diabetes (OR 1.47, 95% CI 1.18-1.82) remained significant, but the association with i-IGT (OR 1.14, 95% CI 0.95-1.36) lost significance. In contrast in men, after multivariable adjustment there was only a significant association between UA levels and i-IFG (OR 1.49, 95% CI 1.21-1.84), all other associations were non-significant (i-IGT: OR 1.09, IFG/IGT: OR 1.06, NDD: OR 0.91, known diabetes: OR 1.04; all p-values > 0.05). Conclusions: Serum UA concentrations were associated with different categories of impaired glucose regulation in individuals from the general population, particularly in women. Further studies investigating the role of UA in the development of derangements in glucose metabolism are needed.	[Meisinger, Christa; Stoeckl, Doris; Thorand, Barbara] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Doering, Angela] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Kowall, Bernd; Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Meisinger, C (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.	doris.stoeckl@helmholtz-muenchen.de	Meisinger, Christine/B-5358-2014; Thorand, Barbara/B-5349-2014; Stöckl, Doris/B-5352-2014	Thorand, Barbara/0000-0002-8416-6440; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation [201/05/07]	Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH)(Helmholtz Association); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Diabetes Foundation	The KORA research platform studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. The Diabetes Study was funded by a German Diabetes Foundation project grant (201/05/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Cai XL, 2010, CHINESE MED J-PEKING, V123, P3118, DOI 10.3760/cma.j.issn.0366-6999.2010.21.030; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Chou P, 2001, J RHEUMATOL, V28, P571; COOK DG, 1986, POSTGRAD MED J, V62, P1001, DOI 10.1136/pgmj.62.733.1001; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; FOX IH, 1981, METABOLISM, V30, P616, DOI 10.1016/0026-0495(81)90142-6; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Lin KC, 2004, J RHEUMATOL, V31, P1159; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Mellen PB, 2006, HYPERTENSION, V48, P1037, DOI 10.1161/01.HYP.0000249768.26560.66; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Nan HR, 2008, DIABETES RES CLIN PR, V80, P321, DOI 10.1016/j.diabres.2008.01.002; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Pfister R, 2011, DIABETOLOGIA, V54, P2561, DOI 10.1007/s00125-011-2235-0; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Rathmann W, 1998, ANN EPIDEMIOL, V8, P250, DOI 10.1016/S1047-2797(97)00204-4; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Taniguchi Y, 2001, J HYPERTENS, V19, P1209, DOI 10.1097/00004872-200107000-00005; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHITEHEAD TP, 1992, ANN CLIN BIOCHEM, V29, P159, DOI 10.1177/000456329202900206; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009	30	34	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37180	10.1371/journal.pone.0037180	http://dx.doi.org/10.1371/journal.pone.0037180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615932	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300084
J	Urasaki, Y; Heath, L; Xu, CW				Urasaki, Yasuyo; Heath, Linda; Xu, C. Wilson			Coupling of Glucose Deprivation with Impaired Histone H2B Monoubiquitination in Tumors	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MONO-UBIQUITINATION; CELLS; METABOLISM; REPAIR	Metabolic reprogramming is associated with tumorigenesis. However, glucose metabolism in tumors is poorly understood. Here, we report that glucose levels are significantly lower in bulk tumor specimens than those in normal tissues of the same tissue origins. We show that mono-ubiquitinated histone H2B (uH2B) is a semi-quantitative histone marker for glucose. We further show that loss of uH2B occurs specifically in cancer cells from a wide array of tumor specimens of breast, colon, lung and additional 23 anatomic sites. In contrast, uH2B levels remain high in stromal tissues or non-cancerous cells in the tumor specimens. Taken together, our data suggest that glucose deficiency and loss of uH2B are novel properties of cancer cells in vivo, which may represent important regulatory mechanisms of tumorigenesis.	[Urasaki, Yasuyo; Heath, Linda; Xu, C. Wilson] Nevada Canc Inst, Las Vegas, NV 89135 USA; [Xu, C. Wilson] Biol Res Inst, Pasadena, CA USA	University of California System; University of California San Diego	Urasaki, Y (corresponding author), Nevada Canc Inst, Las Vegas, NV 89135 USA.	xu@biologicalresearch.org			Department of Defense grant [W81XWH-10-1-0046]; ProteinLinks; Steven and Mary Birch Foundation	Department of Defense grant(United States Department of Defense); ProteinLinks; Steven and Mary Birch Foundation	The work is supported by a Department of Defense grant (W81XWH-10-1-0046), ProteinLinks, and the Steven and Mary Birch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broggini-Tenzer A, 2011, RADIOTHER ONCOL, V99, P398, DOI 10.1016/j.radonc.2011.05.041; Chernikova SB, 2010, RADIAT RES, V174, P558, DOI 10.1667/RR2184.1; Dong L, 2004, J BIOL CHEM, V279, P1577, DOI 10.1074/jbc.C300505200; Gao Z, 2011, BIOCHEM BIOPH RES CO, V407, P271, DOI 10.1016/j.bbrc.2011.02.008; Gao Z, 2011, BIOCHEM BIOPH RES CO, V404, P428, DOI 10.1016/j.bbrc.2010.11.138; GULLINO PM, 1964, CANCER RES, V24, P780; HABERKORN U, 1994, J NUCL MED, V35, P1842; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jackson DH, 2010, PROTEOM CLIN APPL, V4, P250, DOI 10.1002/prca.200900220; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Waltregny D, 2004, EUR J HISTOCHEM, V48, P273; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg RA, 2007, GARLAND SCI; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	17	72	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36775	10.1371/journal.pone.0036775	http://dx.doi.org/10.1371/journal.pone.0036775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615809	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300028
J	French, DM; Lin, BC; Wang, MP; Adams, C; Shek, T; Hotzel, K; Bolon, B; Ferrando, R; Blackmore, C; Schroeder, K; Rodriguez, LA; Hristopoulos, M; Venook, R; Ashkenazi, A; Desnoyers, LR				French, Dorothy M.; Lin, Benjamin C.; Wang, Manping; Adams, Camellia; Shek, Theresa; Hoetzel, Kathy; Bolon, Brad; Ferrando, Ronald; Blackmore, Craig; Schroeder, Kurt; Rodriguez, Luis A.; Hristopoulos, Maria; Venook, Rayna; Ashkenazi, Avi; Desnoyers, Luc R.			Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3; ACTIVATING MUTATIONS; POTENTIAL TARGET; STRUCTURAL BASIS; TUMOR-GROWTH; EXPRESSION; PROGRESSION; FGF19; GENE	The fibroblast growth factor (FGF)-FGF receptor (FGFR) signaling system plays critical roles in a variety of normal developmental and physiological processes. It is also well documented that dysregulation of FGF-FGFR signaling may have important roles in tumor development and progression. The FGFR4-FGF19 signaling axis has been implicated in the development of hepatocellular carcinomas (HCCs) in mice, and potentially in humans. In this study, we demonstrate that FGFR4 is required for hepatocarcinogenesis; the progeny of FGF19 transgenic mice, which have previously been shown to develop HCCs, bred with FGFR4 knockout mice fail to develop liver tumors. To further test the importance of FGFR4 in HCC, we developed a blocking anti-FGFR4 monoclonal antibody (LD1). LD1 inhibited: 1) FGF1 and FGF19 binding to FGFR4, 2) FGFR4-mediated signaling, colony formation, and proliferation in vitro, and 3) tumor growth in a preclinical model of liver cancer in vivo. Finally, we show that FGFR4 expression is elevated in several types of cancer, including liver cancer, as compared to normal tissues. These findings suggest a modulatory role for FGFR4 in the development and progression of hepatocellular carcinoma and that FGFR4 may be an important and novel therapeutic target in treating this disease.	[French, Dorothy M.; Hoetzel, Kathy; Ferrando, Ronald; Rodriguez, Luis A.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Lin, Benjamin C.; Wang, Manping; Blackmore, Craig; Ashkenazi, Avi; Desnoyers, Luc R.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [Adams, Camellia; Shek, Theresa; Schroeder, Kurt] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Hristopoulos, Maria; Venook, Rayna] Genentech Inc, Dept Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA; [Bolon, Brad] GEMpath Inc, Longmont, CO USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	French, DM (corresponding author), Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA.	lin.ben@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589	Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. funded this research. The study was funded by Genentech, Inc. through the employment (at the time of the study) of Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hotzel, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi, and Luc R. Desnoyers and by GEMpath, Inc. through the employment of Brad Bolon. These authors contributed to all aspects of the study.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Bange J, 2002, CANCER RES, V62, P840; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Chesi M, 2001, BLOOD, V97, P729, DOI 10.1182/blood.V97.3.729; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Ibrahimi OA, 2005, MOL CELL BIOL, V25, P671, DOI 10.1128/MCB.25.2.671-684.2005; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Jang JH, 2000, CANCER RES, V60, P4049; Jang JH, 2001, CANCER RES, V61, P3541; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ornitz DM, 2001, GENOME BIOL, V2; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Roidl A, 2009, CLIN CANCER RES, V15, P2058, DOI 10.1158/1078-0432.CCR-08-0890; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu XL, 2007, J BIOL CHEM, V282, P29069, DOI 10.1074/jbc.C700130200; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	33	145	193	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36713	10.1371/journal.pone.0036713	http://dx.doi.org/10.1371/journal.pone.0036713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615798	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336300030
J	Noisa, P; Ramasamy, TS; Lamont, FR; Yu, JSL; Sheldon, MJ; Russell, A; Jin, X; Cui, W				Noisa, Parinya; Ramasamy, Thamil Selvee; Lamont, Fiona R.; Yu, Jason S. L.; Sheldon, Michael J.; Russell, Alison; Jin, Xin; Cui, Wei			Identification and Characterisation of the Early Differentiating Cells in Neural Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; EFFICIENT DIFFERENTIATION; GERM LAYERS; ES CELLS; PLURIPOTENCY; EXPRESSION; ENDODERM; MARKERS; OCT-4; SOX2	One of the challenges in studying early differentiation of human embryonic stem cells (hESCs) is being able to discriminate the initial differentiated cells from the original pluripotent stem cells and their committed progenies. It remains unclear how a pluripotent stem cell becomes a lineage-specific cell type during early development, and how, or if, pluripotent genes, such as Oct4 and Sox2, play a role in this transition. Here, by studying the dynamic changes in the expression of embryonic surface antigens, we identified the sequential loss of Tra-1-81 and SSEA4 during hESC neural differentiation and isolated a transient Tra-1-81(-)/SSEA4(+) (TR-/S4+) cell population in the early stage of neural differentiation. These cells are distinct from both undifferentiated hESCs and their committed neural progenitor cells (NPCs) in their gene expression profiles and response to extracellular signalling; they co-express both the pluripotent gene Oct4 and the neural marker Pax6. Furthermore, these TR-/S4+ cells are able to produce cells of both neural and non-neural lineages, depending on their environmental cues. Our results demonstrate that expression of the pluripotent factor Oct4 is progressively downregulated and is accompanied by the gradual upregulation of neural genes, whereas the pluripotent factor Sox2 is consistently expressed at high levels, indicating that these pluripotent factors may play different roles in the regulation of neural differentiation. The identification of TR-S4+ cells provides a cell model for further elucidation of the molecular mechanisms underlying hESC neural differentiation.	[Noisa, Parinya; Ramasamy, Thamil Selvee; Lamont, Fiona R.; Yu, Jason S. L.; Sheldon, Michael J.; Russell, Alison; Jin, Xin; Cui, Wei] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, Inst Reprod & Dev Biol, London, England	Imperial College London	Noisa, P (corresponding author), Suranaree Univ Technol, Embryo Technol & Stem Cell Res Ctr, Sch Biotechnol, Nakhon Ratchasima, Thailand.	wei.cui@imperial.ac.uk	Sewell, Fiona/AAY-8020-2021; Ramasamy, Thamil Selvee TS/F-3044-2012; Cui, Wei/AAD-1690-2019	Sewell, Fiona/0000-0001-5589-9453; Yu, Jason/0000-0001-5203-3603; Cui, Wei/0000-0003-2019-380X; Noisa, Parinya/0000-0002-1474-7792	Genesis Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Royal Thai government; University of Malaya/Ministry of Higher Education Malaysia; MRC [G0802537] Funding Source: UKRI; Medical Research Council [G0802537, 1106831] Funding Source: researchfish	Genesis Research Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai government; University of Malaya/Ministry of Higher Education Malaysia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the Genesis Research Trust and Biotechnology and Biological Sciences Research Council (BBSRC). PN and TSR are PhD students funded by the Royal Thai government and University of Malaya/Ministry of Higher Education Malaysia, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAUB O, 1991, DEVELOPMENT, V112, P397; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rathjen J, 1999, J CELL SCI, V112, P601; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zafarana G, 2009, STEM CELLS, V27, P776, DOI 10.1002/stem.5	46	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37129	10.1371/journal.pone.0037129	http://dx.doi.org/10.1371/journal.pone.0037129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615918	gold, Green Published			2022-12-27	WOS:000305336300074
J	Qian, XL; Li, CL; Pang, B; Xue, M; Wang, J; Zhou, JG				Qian, Xiaolong; Li, Changling; Pang, Bo; Xue, Meng; Wang, Jian; Zhou, Jianguang			Spondin-2 (SPON2), a More Prostate-Cancer-Specific Diagnostic Biomarker	PLOS ONE			English	Article							MATRIX PROTEIN MINDIN; CELL-LINES; PROTEOMIC ANALYSIS; ANTIGEN; SERUM; DISCOVERY; LNCAP; MEN; IDENTIFICATION; MARKERS	Background: Prostate-specific antigen (PSA) screening, although common, has recently been called into question. To find prostate cancer (PCa) diagnostic biomarkers that can make up for the defects of PSA, we compared the secretomes of several benign and PCa cell lines, selected candidate molecules, and then confirmed their clinical value. Methodology/Principal Findings: We first identified extracellular proteins by two-dimensional gel electrophoresis (2-DE) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS) identification. We then validated the secreted proteins on a cellular level, and finally determined whether they could be used as PCa diagnostic biomarkers using prostate tissue and serum specimens of Chinese volunteers by immunohistostaining and sandwich ELISA. We obtained credible extracellular protein 2-DE graphs of prostate cell lines. The 5 spots that showed superior repeatability were selected for LC-MS/MS analysis, which identified seven candidate molecules. One of the candidate molecules, spondin-2 (SPON2), was only expressed in the conditioned media (CM) of androgen receptor (AR) positive PCa cell lines. Using tissue microarray by immunohistostaining, we found SPON2 to be over-expressed in PCa. SPON2 staining was more intense in Gleason score sum 7-8 and in PCa patients with metastasis. By receiver operator characteristic (ROC) curve analysis, we found that the serum SPON2 level was elevated in PCa patients, showing sensitivity and specificity suitable for diagnostic use. We also found that SPON2 could be used to identify PCa patients with serum PSA levels no higher than 10 ng/ml from healthy elderly men. Conclusion/Significance: SPON2 is a new serum and histological diagnostic biomarker for PCa. It can avoid some of the problems of PSA testing and was here found to offer relatively high sensitivity and specificity relative to PSA.	[Qian, Xiaolong; Pang, Bo; Xue, Meng; Wang, Jian; Zhou, Jianguang] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China; [Qian, Xiaolong] Tianjin Med Univ, Canc Hosp, State Key Lab Breast Canc Res, Dept Breast Pathol & Res, Tianjin, Peoples R China; [Li, Changling] Peking Union Med Coll, Inst Canc, Beijing 100021, Peoples R China; [Li, Changling] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Qian, XL (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	newgeno2003@yahoo.com.cn; zhou.jianguang@yahoo.com.cn			National Natural Science Foundation of China [30870961, 81172445]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a research grant to Jianguang Zhou and Jian Wang from National Natural Science Foundation of China (No. 30870961 and 81172445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Game X, 2003, EUR UROL, V43, P702, DOI 10.1016/S0302-2838(03)00158-1; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; Mbeunkui F, 2006, J PROTEOME RES, V5, P899, DOI 10.1021/pr050375p; Pang B, 2009, PROSTATE, V69, P1176, DOI 10.1002/pros.20969; Parry R, 2005, CANCER RES, V65, P8397, DOI 10.1158/0008-5472.CAN-05-1203; Roehrborn CG, 2000, J UROLOGY, V163, P13, DOI 10.1016/S0022-5347(05)67962-1; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sardana G, 2008, J PROTEOME RES, V7, P3329, DOI 10.1021/pr8003216; Sardana G, 2007, CLIN CHEM, V53, P429, DOI 10.1373/clinchem.2006.077370; Schmid HP, 2004, CRIT REV ONCOL HEMAT, V50, P71, DOI 10.1016/j.critrevonc.2003.11.001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon I, 2007, GYNECOL ONCOL, V106, P112, DOI 10.1016/j.ygyno.2007.03.007; Thalmann GN, 2000, PROSTATE, V44, P91; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Wang RX, 2004, CANCER RES, V64, P1589, DOI 10.1158/0008-5472.CAN-03-3331; Wu Q, 2008, BJU INT, V101, P497, DOI 10.1111/j.1464-410X.2007.07340.x	26	48	51	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37225	10.1371/journal.pone.0037225	http://dx.doi.org/10.1371/journal.pone.0037225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615945	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336300081
J	Rodriguez, AD; McCabe, ML; Nocera, JR; Reilly, J				Rodriguez, Amy D.; McCabe, Matthew L.; Nocera, Joe R.; Reilly, Jamie			Concurrent Word Generation and Motor Performance: Further Evidence for Language-Motor Interaction	PLOS ONE			English	Article							REPRESENTATION; TALKING; WALKING; YOUNG	Embodied/modality-specific theories of semantic memory propose that sensorimotor representations play an important role in perception and action. A large body of evidence supports the notion that concepts involving human motor action (i.e., semantic-motor representations) are processed in both language and motor regions of the brain. However, most studies have focused on perceptual tasks, leaving unanswered questions about language-motor interaction during production tasks. Thus, we investigated the effects of shared semantic-motor representations on concurrent language and motor production tasks in healthy young adults, manipulating the semantic task (motor-related vs. nonmotor-related words) and the motor task (i.e., standing still and finger-tapping). In Experiment 1 (n = 20), we demonstrated that motor-related word generation was sufficient to affect postural control. In Experiment 2 (n = 40), we demonstrated that motor-related word generation was sufficient to facilitate word generation and finger tapping. We conclude that engaging semantic-motor representations can have a reciprocal influence on motor and language production. Our study provides additional support for functional language-motor interaction, as well as embodied/modality-specific theories.	[Rodriguez, Amy D.; Reilly, Jamie] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32610 USA; [Rodriguez, Amy D.; Nocera, Joe R.] Malcom Randall VA Med Ctr VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA; [McCabe, Matthew L.] Columbus State Univ, Schwob Sch Mus, Columbus, GA USA; [Nocera, Joe R.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA	State University System of Florida; University of Florida; University System of Georgia; Columbus State University; State University System of Florida; University of Florida	Rodriguez, AD (corresponding author), Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL 32610 USA.	amy.rodriguez@uq.edu.au	Rodriguez, Amy/F-8332-2011; Rodriguez, Amy/ABH-8007-2020		US Public Health Service [K23 DC010197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC010197] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by US Public Health Service grant K23 DC010197 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armieri A, 2009, GAIT POSTURE, V29, P346, DOI 10.1016/j.gaitpost.2008.09.004; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; BOBBERT MF, 1990, J BIOMECH, V23, P705, DOI 10.1016/0021-9290(90)90169-4; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Esopenko C, 2008, BRAIN TOPOGR, V21, P22, DOI 10.1007/s10548-008-0043-8; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Kemper S, 2003, PSYCHOL AGING, V18, P181, DOI 10.1037/0882-7974.18.2.181; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Morsella EE, THESIS COLUMBIA U; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oliveri M, 2004, J COGNITIVE NEUROSCI, V16, P374, DOI 10.1162/089892904322926719; Peran P, 2010, BRAIN RES, V1328, P89, DOI 10.1016/j.brainres.2010.02.082; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Pulvermuller F, 2001, BRAIN LANG, V78, P143, DOI 10.1006/brln.2000.2390; Pulvermuller F, 1999, NEUROSCI LETT, V275, P81, DOI 10.1016/S0304-3940(99)00724-7; Rocchi L, 2006, NEUROSCI LETT, V394, P140, DOI 10.1016/j.neulet.2005.10.020; Rougler PR, 2007, J BIOMECH, V40, P2477, DOI 10.1016/j.jbiomech.2006.11.003; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Vigliocco G, 2006, CEREB CORTEX, V16, P1790, DOI 10.1093/cercor/bhj115; Vitali P, 2005, BRAIN LANG, V93, P32, DOI 10.1016/j.bandl.2004.08.005; Willems RM, 2010, J COGNITIVE NEUROSCI, V22, P2387, DOI 10.1162/jocn.2009.21386	25	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37094	10.1371/journal.pone.0037094	http://dx.doi.org/10.1371/journal.pone.0037094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615907	Green Published, gold			2022-12-27	WOS:000305336300072
J	He, JY; Votruba, S; Pomeroy, J; Bonfiglio, S; Krakoff, J				He, Jianying; Votruba, Susanne; Pomeroy, Jeremy; Bonfiglio, Susan; Krakoff, Jonathan			Measurement of Ad Libitum Food Intake, Physical Activity, and Sedentary Time in Response to Overfeeding	PLOS ONE			English	Article							ENERGY-BALANCE; BODY-WEIGHT; GHRELIN CONCENTRATIONS; RESPIRATORY CHAMBER; SHORT-TERM; HUMANS; APPETITE; OBESITY; LEPTIN; FAT	Given the wide availability of highly palatable foods, overeating is common. Energy intake and metabolic responses to overfeeding may provide insights into weight gain prevention. We hypothesized a down-regulation in subsequent food intake and sedentary time, and up-regulation in non-exercise activity and core temperature in response to overfeeding in order to maintain body weight constant. In a monitored inpatient clinical research unit using a cross over study design, we investigated ad libitum energy intake (EI, using automated vending machines), core body temperature, and physical activity (using accelerometry) following a short term (3-day) weight maintaining (WM) vs overfeeding (OF) diet in healthy volunteers (n = 21, BMI, mean +/- SD, 33.2 +/- 8.6 kg/m(2), 73.6% male). During the ad libitum periods following the WM vs. OF diets, there was no significant difference in mean 3-d EI (4061 +/- 1084 vs. 3926 +/- 1284 kcal/day, p = 0.41), and there were also no differences either in core body temperature (37.0 +/- 0.2 degrees C vs. 37.1 +/- 0.2 degrees C, p = 0.75) or sedentary time (70.9 +/- 12.9 vs. 72.0 +/- 7.4%, p = 0.88). However, during OF (but not WM), sedentary time was positively associated with weight gain (r = 0.49, p = 0.05, adjusted for age, sex, and initial weight). In conclusion, short term overfeeding did not result in a decrease in subsequent ad libitum food intake or overall change in sedentary time although in secondary analysis sedentary time was associated with weight gain during OF. Beyond possible changes in sedentary time, there is minimal attempt to restore energy balance during or following short term overfeeding.	[He, Jianying; Votruba, Susanne; Pomeroy, Jeremy; Bonfiglio, Susan; Krakoff, Jonathan] NIDDK, Phoenix Epidemiol & Clin Res Branch, US Dept HHS, NIH, Phoenix, AZ USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	He, JY (corresponding author), NIDDK, Phoenix Epidemiol & Clin Res Branch, US Dept HHS, NIH, Phoenix, AZ USA.	hejianying@mail.nih.gov			Intramural Research Program of the National Institute of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069091] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Intramural Research Program of the National Institute of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The study was approved by the National Institute of Diabetes and Digestive and Kidney Diseases Institutional Review Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Christy LA, 2009, PLANT CELL REP, V28, P175, DOI 10.1007/s00299-008-0628-4; Crouter SE, 2008, BRIT J SPORT MED, V42, P217, DOI 10.1136/bjsm.2006.033399; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Geary N, 2004, PHYSIOL BEHAV, V81, P719, DOI 10.1016/j.physbeh.2004.04.013; Geiselman PJ, 1998, PHYSIOL BEHAV, V63, P919, DOI 10.1016/S0031-9384(97)00542-8; HARRIS RBS, 1986, J NUTR, V116, P2536, DOI 10.1093/jn/116.12.2536; Havel PJ, 2001, EXP BIOL MED, V226, P963, DOI 10.1177/153537020122601102; HOEBEL BG, 1966, J COMP PHYSIOL PSYCH, V61, P189, DOI 10.1037/h0023126; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Jebb SA, 2006, INT J OBESITY, V30, P1160, DOI 10.1038/sj.ijo.0803194; Johnstone AM, 1996, EUR J CLIN NUTR, V50, P418; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Klaus S, 1998, AM J PHYSIOL-REG I, V274, pR287, DOI 10.1152/ajpregu.1998.274.2.R287; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Levitsky DA, 2005, PHYSIOL BEHAV, V84, P669, DOI 10.1016/j.physbeh.2005.01.004; Livingstone MBE, 2003, P NUTR SOC, V62, P681, DOI 10.1079/PNS2003291; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; Murgatroyd PR, 1999, INT J OBESITY, V23, P1269, DOI 10.1038/sj.ijo.0801062; Nguyen T, 2003, MED BIOL ENG COMPUT, V41, P572, DOI 10.1007/BF02345320; NORGAN NG, 1980, AM J CLIN NUTR, V33, P978, DOI 10.1093/ajcn/33.5.978; Pannacciulli N, 2007, AM J CLIN NUTR, V86, P625; Penesova A, 2011, EUR J NUTR, V50, P455, DOI 10.1007/s00394-010-0152-5; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RISING R, 1992, AM J CLIN NUTR, V55, P343, DOI 10.1093/ajcn/55.2.343; Salbe AD, 2004, J CLIN ENDOCR METAB, V89, P2951, DOI 10.1210/jc.2003-032145; Savastano DM, 2009, AM J CLIN NUTR, V90, P1124, DOI 10.3945/ajcn.2009.27567; Seeley RJ, 1996, AM J PHYSIOL-REG I, V271, pR819, DOI 10.1152/ajpregu.1996.271.3.R819; Stubbs RJ, 1996, EUR J CLIN NUTR, V50, P409; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; Venti CA, 2010, AM J CLIN NUTR, V91, P343, DOI 10.3945/ajcn.2009.28315; Vettor R, 2002, J ENDOCRINOL INVEST, V25, P836, DOI 10.1007/BF03344047; Votruba SB, 2009, AM J CLIN NUTR, V89, P801, DOI 10.3945/ajcn.2008.27011; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992	39	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36225	10.1371/journal.pone.0036225	http://dx.doi.org/10.1371/journal.pone.0036225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629311	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300005
J	McDonald, AT				McDonald, Andrew T.			Phylogeny of Basal Iguanodonts (Dinosauria: Ornithischia): An Update	PLOS ONE			English	Article							KHOK KRUAT FORMATION; HADROSAUROID DINOSAUR; NORTHEASTERN THAILAND; SOUTHERN ENGLAND; INCOMPLETE TAXA; NORTH-AMERICA; MISSING DATA; ORNITHOPODA; CHINA; CHARACTERS	The precise phylogenetic relationships of many non-hadrosaurid members of Iguanodontia, i.e., basal iguanodonts, have been unclear. Therefore, to investigate the global phylogeny of basal iguanodonts a comprehensive data matrix was assembled, including nearly every valid taxon of basal iguanodont. The matrix was analyzed in the program TNT, and the maximum agreement subtree of the resulting most parsimonious trees was then calculated in PAUP. Ordering certain multistate characters and omitting taxa through safe taxonomic reduction did not markedly improve resolution. The results provide some new information on the phylogeny of basal iguanodonts, pertaining especially to obscure or recently described taxa, and support some recent taxonomic revisions, such as the splitting of traditional "Camptosaurus'' and "Iguanodon''. The maximum agreement subtree also shows a close relationship between the Asian Probactrosaurus gobiensis and the North American Eolambia, supporting the previous hypothesis of faunal interchange between Asia and North America in the early Late Cretaceous. Nevertheless, the phylogenetic relationships of many basal iguanodonts remain ambiguous due to the high number of taxa removed from the maximum agreement subtree and poor resolution of consensus trees.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	This research was supported by funds from the Jurassic Foundation (http://jurassicfoundation.org), Evolving Earth Foundation (http://www.evolvingearth.org), University of Pennsylvania Paleobiology Summer Stipend (http://www.sas.upenn.edu/earth/), and Utah Friends of Paleontology (http://www.utahpaleo.org/greatbasin.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez-Velasco AA, 2012, CAN J EARTH SCI, V49, P379, DOI 10.1139/E11-062; Barrett PM, 2011, SPEC PAP PALAEONTOL, P131, DOI 10.1111/j.1475-4983.2011.01076.x; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Butler RJ, 2007, J VERTEBR PALEONTOL, V27, P253, DOI 10.1671/0272-4634(2007)27[253:HITATP]2.0.CO;2; Carpenter K, 2010, J IBER GEOL, V36, P145, DOI 10.5209/rev_JIGE.2010.v36.n2.3; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Godefroit Pascal, 2004, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V74, P139; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Mantell GA., 1825, PHILOS T ROY SOC LON, VCXV, P179, DOI DOI 10.1098/RSTL.1825.0010; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2012, CRETACEOUS RES, V33, P1, DOI 10.1016/j.cretres.2011.03.002; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Paul G., 2006, HORNS BEAKS, P69; Prieto-Marquez A, 2010, ZOOTAXA, P1; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Ruiz-Ome?aca JI., 2006, HORNS BEAKS CERATOPS, P3; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Sereno P. C, 2005, STEM ARCHOSAURIA VER; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Swofford DL, 2005, PAUP PHYLOGENETIC AN; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Wiens JJ, 2003, J VERTEBR PALEONTOL, V23, P297, DOI 10.1671/0272-4634(2003)023[0297:ITICAP]2.0.CO;2; WILKINSON M, 1992, CLADISTICS, V8, P375, DOI 10.1111/j.1096-0031.1992.tb00079.x; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Wu W.H., 2010, GEOLOGY RESOURCES, V19, P127; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X	40	54	57	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36745	10.1371/journal.pone.0036745	http://dx.doi.org/10.1371/journal.pone.0036745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629328	Green Published, gold			2022-12-27	WOS:000305345300012
J	Rubinger, D; Backenroth, R; Sapoznikov, D				Rubinger, Dvora; Backenroth, Rebecca; Sapoznikov, Dan			Sympathetic Activation and Baroreflex Function during Intradialytic Hypertensive Episodes	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ALTERED NOREPINEPHRINE TURNOVER; BLOOD-PRESSURE; NERVE ACTIVITY; NITRIC-OXIDE; SENSITIVITY; HEMODIALYSIS; ASSOCIATION; CALCIUM; VOLUME	Background: The mechanisms of intradialytic increases in blood pressure are not well defined. The present study was undertaken to assess the role of autonomic nervous system activation during intradialytic hypertensive episodes. Methodology/Principal Findings: Continuous interbeat intervals (IBI) and systolic blood pressure (SBP) were monitored during hemodialysis in 108 chronic patients. Intradialytic hypertensive episodes defined as a period of at least 10 mmHg increase in SBP between the beginning and the end of a dialysis session or hypertension resistant to ultrafiltration occurring during or immediately after the dialysis procedure, were detected in 62 out of 113 hemodialysis sessions. SBP variability, IBI variability and baroreceptor sensitivity (BRS) in the low (LF) and high (HF) frequency ranges were assessed using the complex demodulation technique (CDM). Intradialytic hypertensive episodes were associated with an increased (n = 45) or decreased (n = 17) heart rate. The maximal blood pressure was similar in both groups. In patients with increased heart rate the increase in blood pressure was associated with marked increases in SBP and IBI variability, with suppressed BRS indices and enhanced sympatho-vagal balance. In contrast, in those with decreased heart rate, there were no significant changes in the above parameters. End-of-dialysis blood pressure in all sessions associated with hypertensive episode was significantly higher than in those without such episodes. In logistic regression analysis, predialysis BRS in the low frequency range was found to be the main predictor of intradialytic hypertension. Conclusion/Significance: Our data point to sympathetic overactivity with feed-forward blood pressure enhancement as an important mechanism of intradialytic hypertension in a significant proportion of patients. The triggers of increased sympathetic activity during hemodialysis remain to be determined. Intradialytic hypertensive episodes are associated with higher end-of-dialysis blood pressure, suggesting that intradialytic hypertension may play a role in generation of interdialytic hypertension.	[Rubinger, Dvora] Hadassah Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel; Hadassah Univ Med Ctr, Dept Med, Hypertens Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rubinger, D (corresponding author), Hadassah Univ Med Ctr, Dept Med, Serv Nephrol, Jerusalem, Israel.	rdvora@hadassah.org.il						Agarwal R, 2010, NEPHROL DIAL TRANSPL, V25, P3355, DOI 10.1093/ndt/gfq210; Amerling R., 1995, CLIN DIALYSIS, P235; Augustyniak RA, 2002, J HYPERTENS, V20, P3, DOI 10.1097/00004872-200201000-00002; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1896; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1901; Boulanger CM, 2007, HYPERTENSION, V49, P902, DOI 10.1161/01.HYP.0000259667.22309.df; Brychta RJ, 2007, AM J PHYSIOL-HEART C, V292, pH1193, DOI 10.1152/ajpheart.00645.2006; Camm AJ, 1996, CIRCULATION, V93, P1043; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; Castiglioni P, 2011, J ELECTROCARDIOL, V44, P391, DOI 10.1016/j.jelectrocard.2011.01.006; Chazot C, 2010, NEPHRON CLIN PRACT, V115, pC182, DOI 10.1159/000313031; Chen J, 2006, SEMIN DIALYSIS, V19, P141, DOI 10.1111/j.1525-139X.2006.00140.x; Chern CM, 2006, J CARDIOVASC PHARM, V47, P169, DOI 10.1097/01.fjc.0000199225.17928.f5; Chou KJ, 2006, KIDNEY INT, V69, P1833, DOI 10.1038/sj.ki.5000266; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; CONVERSE RL, 1992, J CLIN INVEST, V90, P1657, DOI 10.1172/JCI116037; Desir GV, 2011, CURR OPIN NEPHROL HY, V20, P31, DOI 10.1097/MNH.0b013e3283412721; Ding YF, 2011, J PHYSIOL-LONDON, V589, P245, DOI 10.1113/jphysiol.2010.200584; DOLSON GM, 1995, AM J KIDNEY DIS, V26, P321, DOI 10.1016/0272-6386(95)90652-5; Dubin R, 2011, HEMODIAL INT, V15, P350, DOI 10.1111/j.1542-4758.2011.00560.x; Eguchi K, 2007, J CARDIOVASC PHARM, V49, P394, DOI 10.1097/FJC.0b013e31804d1cf1; Eisenhofer G, 2005, KIDNEY INT, V67, P668, DOI 10.1111/j.1523-1755.2005.67123.x; Elghozi JL, 2007, FUND CLIN PHARMACOL, V21, P337, DOI 10.1111/j.1472-8206.2007.00502.x; Gori T, 2002, J AM COLL CARDIOL, V40, P2000, DOI 10.1016/S0735-1097(02)02532-9; Grassi G, 2003, HYPERTENSION, V41, P558, DOI 10.1161/01.HYP.0000058003.27729.5A; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883; Hart EC, 2011, J PHYSIOL-LONDON, V589, P3395, DOI 10.1113/jphysiol.2011.208538; HAYANO J, 1994, J APPL PHYSIOL, V77, P2879, DOI 10.1152/jappl.1994.77.6.2879; HEGBRANT J, 1993, NEPHRON, V63, P303, DOI 10.1159/000187214; Hering D, 2007, J HYPERTENS, V25, P157, DOI 10.1097/HJH.0b013e3280102d92; Horl MP, 2002, AM J KIDNEY DIS, V39, P227, DOI 10.1053/ajkd.2002.30542; Huang BS, 2011, CURR HYPERTENS REP, V13, P214, DOI 10.1007/s11906-011-0192-0; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Inrig JK, 2011, CLIN J AM SOC NEPHRO, V6, P2016, DOI 10.2215/CJN.11351210; Inrig JK, 2010, AM J KIDNEY DIS, V55, P580, DOI 10.1053/j.ajkd.2009.08.013; Inrig JK, 2009, AM J KIDNEY DIS, V54, P881, DOI 10.1053/j.ajkd.2009.05.012; Kara T, 2003, ACTA PHYSIOL SCAND, V177, P377, DOI 10.1046/j.1365-201X.2003.01083.x; Katzarski KS, 1999, CLIN NEPHROL, V52, P304; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; La Rovere MT, 1998, LANCET, V351, P478; LAROVERE MT, 1995, J CARDIOVASC ELECTR, V6, P761; Legramante JM, 1999, CIRCULATION, V99, P1760, DOI 10.1161/01.CIR.99.13.1760; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1058, DOI 10.1093/ndt/gfh103; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Matzke GR, 2011, KIDNEY INT, V80, P1122, DOI 10.1038/ki.2011.322; Michael F, 2004, SEMIN DIALYSIS, V17, P279, DOI 10.1111/j.0894-0959.2004.17327.x; Munakata M, 2003, CLIN EXP HYPERTENS, V25, P169, DOI 10.1081/CEH-120019149; Munger MA, 2000, AM J KIDNEY DIS, V36, P130, DOI 10.1053/ajkd.2000.8285; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Norton MR, 2005, J APPL PHYSIOL, V98, P2298, DOI 10.1152/japplphysiol.00772.2004; Pagani M, 1997, CIRCULATION, V95, P1441; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Penaz, 1973, P 10 INT C MED BIOL; Pitzalis MV, 1998, CHEST, V114, P185, DOI 10.1378/chest.114.1.185; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Raj DSC, 2002, KIDNEY INT, V61, P697, DOI 10.1046/j.1523-1755.2002.00150.x; Rubinger D, 2008, J AM SOC NEPHROL, V19, p725A; Rubinger D, 2009, NEPHROL DIAL TRANSPL, V24, P1305, DOI 10.1093/ndt/gfn732; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Sapoznikov D, 2010, J HYPERTENS, V28, P314, DOI 10.1097/HJH.0b013e328332b7af; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Stocker SD, 2010, PHYSIOL BEHAV, V100, P519, DOI 10.1016/j.physbeh.2010.04.024; Van Buren PN, 2011, CLIN J AM SOC NEPHRO, V6, P1684, DOI 10.2215/CJN.11041210; vanKuijk WHM, 1997, CLIN NEPHROL, V47, P190; WESSELING KH, 1995, HOMEOSTASIS HLTH DIS, V36, P67; Ylitalo A, 2000, J AM COLL CARDIOL, V35, P194, DOI 10.1016/S0735-1097(99)00506-9	71	29	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36943	10.1371/journal.pone.0036943	http://dx.doi.org/10.1371/journal.pone.0036943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629345	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300016
J	Annegarn, J; Spruit, MA; Savelberg, HHCM; Willems, PJB; van de Bool, C; Schols, AMWJ; Wouters, EFM; Meijer, K				Annegarn, Janneke; Spruit, Martijn A.; Savelberg, Hans H. C. M.; Willems, Paul J. B.; van de Bool, Coby; Schols, Annemie M. W. J.; Wouters, Emiel F. M.; Meijer, Kenneth			Differences in Walking Pattern during 6-Min Walk Test between Patients with COPD and Healthy Subjects	PLOS ONE			English	Article							STEP WIDTH; GAIT; REHABILITATION; DETERMINANTS; PHYSIOLOGY; STABILITY; DISTANCE; FAILURE; DYSPNEA	Background: To date, detailed analyses of walking patterns using accelerometers during the 6-min walk test (6MWT) have not been performed in patients with chronic obstructive pulmonary disease (COPD). Therefore, it remains unclear whether and to what extent COPD patients have an altered walking pattern during the 6MWT compared to healthy elderly subjects. Methodology/Principal Findings: 79 COPD patients and 24 healthy elderly subjects performed the 6MWT wearing an accelerometer attached to the trunk. The accelerometer features (walking intensity, cadence, and walking variability) and subject characteristics were assessed and compared between groups. Moreover, associations were sought with 6-min walk distance (6MWD) using multiple ordinary least squares (OLS) regression models. COPD patients walked with a significantly lower walking intensity, lower cadence and increased walking variability compared to healthy subjects. Walking intensity and height were the only two significant determinants of 6MWD in healthy subjects, explaining 85% of the variance in 6MWD. In COPD patients also age, cadence, walking variability measures and their interactions were included were significant determinants of 6MWD (total variance in 6MWD explained: 88%). Conclusions/Significance: COPD patients have an altered walking pattern during 6MWT compared to healthy subjects. These differences in walking pattern partially explain the lower 6MWD in patients with COPD.	[Annegarn, Janneke; Savelberg, Hans H. C. M.; Willems, Paul J. B.; van de Bool, Coby; Schols, Annemie M. W. J.; Wouters, Emiel F. M.; Meijer, Kenneth] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Spruit, Martijn A.; Wouters, Emiel F. M.] Ctr Expertise Chron Organ Failure, Program Dev Ctr, CIRO, Horn, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Annegarn, J (corresponding author), Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	kenneth.meijer@maastrichtuniversity.nl	Wouters, Emiel/ABD-6200-2021; Meijer, Kenneth/A-8573-2014	Meijer, Kenneth/0000-0001-8236-8754				Alkjaer T, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-2; Annegarn J, 2011, ARCH PHYS MED REHAB, V92, P1852, DOI 10.1016/j.apmr.2011.06.021; Annegarn J, 2012, J AM MED DIR ASSOC, V13, P284, DOI 10.1016/j.jamda.2011.01.002; Bouten CVC, 1997, MED BIOL ENG COMPUT, V35, P50, DOI 10.1007/BF02510392; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010; Janssen Daisy J A, 2010, Chron Respir Dis, V7, P147, DOI 10.1177/1479972310369285; Jehn M, 2009, J CARD FAIL, V15, P334, DOI 10.1016/j.cardfail.2008.11.011; Kang HG, 2006, GAIT POSTURE, V24, P386, DOI 10.1016/j.gaitpost.2005.11.004; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Marquis N, 2009, MED SCI SPORT EXER, V41, P1540, DOI 10.1249/MSS.0b013e31819c717f; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; Ortega JD, 2008, J BIOMECH, V41, P3303, DOI 10.1016/j.jbiomech.2008.06.039; Pitta F, 2008, CHEST, V134, P273, DOI 10.1378/chest.07-2655; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022; Spruit MA, 2008, LANCET, V371, P12, DOI 10.1016/S0140-6736(08)60048-3; Spruit MA, 2007, RESP MED, V101, P2454, DOI 10.1016/j.rmed.2007.07.003; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Spruit MA, 2010, RESP MED, V104, P849, DOI 10.1016/j.rmed.2009.12.007; Steiner MC, 2002, EUR RESPIR J, V19, P626, DOI 10.1183/09031936.02.00279602; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; Troosters T, 2002, EUR RESPIR J, V20, P564, DOI 10.1183/09031936.02.02092001; Vaes AW, 2011, CHEST, V140, P970, DOI 10.1378/chest.10-3005; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Yentes JM, 2011, RESP MED, V105, P80, DOI 10.1016/j.rmed.2010.06.007; Zijlstra W, 2004, EUR J APPL PHYSIOL, V92, P39, DOI 10.1007/s00421-004-1041-5	35	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37329	10.1371/journal.pone.0037329	http://dx.doi.org/10.1371/journal.pone.0037329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624017	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500100
J	Francey, D; Bergmuller, R				Francey, Damien; Bergmueller, Ralph			Images of Eyes Enhance Investments in a Real-Life Public Good	PLOS ONE			English	Article							INDIRECT RECIPROCITY; COMPETITIVE ALTRUISM; PARTNER CHOICE; COOPERATION; TRAGEDY; COMMONS; CUES; PUNISHMENT; EVOLUTION; CLIMATE	A key issue in cooperation research is to determine the conditions under which individuals invest in a public good. Here, we tested whether cues of being watched increase investments in an anonymous public good situation in real life. We examined whether individuals would invest more by removing experimentally placed garbage (paper and plastic bottles) from bus stop benches in Geneva in the presence of images of eyes compared to controls (images of flowers). We provided separate bins for each of both types of garbage to investigate whether individuals would deposit more items into the appropriate bin in the presence of eyes. The treatment had no effect on the likelihood that individuals present at the bus stop would remove garbage. However, those individuals that engaged in garbage clearing, and were thus likely affected by the treatment, invested more time to do so in the presence of eyes. Images of eyes had a direct effect on behaviour, rather than merely enhancing attention towards a symbolic sign requesting removal of garbage. These findings show that simple images of eyes can trigger reputational effects that significantly enhance on non-monetary investments in anonymous public goods under real life conditions. We discuss our results in the light of previous findings and suggest that human social behaviour may often be shaped by relatively simple and potentially unconscious mechanisms instead of very complex cognitive capacities.	[Francey, Damien; Bergmueller, Ralph] Univ Neuchatel, Dept Ecoethol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Francey, D (corresponding author), Univ Neuchatel, Dept Ecoethol, CH-2000 Neuchatel, Switzerland.	ralph.bergmueller@unine.ch						Alexander R., 2008, ESSAYS PEDAGOGY; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bergmuller R, 2007, BEHAV PROCESS, V76, P170, DOI 10.1016/j.beproc.2007.06.013; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Colander D, 2009, CRIT REV, V21, P249, DOI 10.1080/08913810902934109; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; Coulson A., 1995, INT J BANK MARK, V13, P22, DOI DOI 10.1108/02652329510078668; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kurzban R, 2001, J NONVERBAL BEHAV, V25, P241, DOI 10.1023/A:1012563421824; Lamba S, 2010, EVOL HUM BEHAV, V31, P271, DOI 10.1016/j.evolhumbehav.2010.02.002; Mifune N, 2010, EVOL HUM BEHAV, V31, P109, DOI 10.1016/j.evolhumbehav.2009.09.004; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Raihani NJ, 2010, OIKOS, V119, P1391, DOI 10.1111/j.1600-0706.2010.18279.x; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rankin DJ, 2011, TRENDS ECOL EVOL, V26, P1, DOI 10.1016/j.tree.2010.10.005; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sherratt TN, 2009, FRONT BIOSCI-LANDMRK, V14, P4557, DOI 10.2741/3548; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209; TESSMAN I, 1995, OIKOS, V74, P157, DOI 10.2307/3545685; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2009, CURR DIR PSYCHOL SCI, V18, P169, DOI 10.1111/j.1467-8721.2009.01630.x; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	46	49	50	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37397	10.1371/journal.pone.0037397	http://dx.doi.org/10.1371/journal.pone.0037397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624026	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500111
J	Liu, QZ; Han, LZ; Li, B; Sun, JY; Ni, YX				Liu, Qingzhong; Han, Lizhong; Li, Bin; Sun, Jingyong; Ni, Yuxing			Virulence Characteristic and MLST-agr Genetic Background of High-Level Mupirocin-Resistant, MRSA Isolates from Shanghai and Wenzhou, China	PLOS ONE			English	Article							SENSITIVE STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; ENTEROTOXIN GENE; BINDING PROTEIN; CLONAL DISTRIBUTION; SUPERANTIGEN GENES; SLIME PRODUCTION; TOXIN GENES	The emergence and prevalence of high-level mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MuH MRSA) is challenging the eradication of MRSA nasal carriage and the treatment of skin and soft tissue infections. To understand the potentially pathogenetic capacity and the genetic basis of MuH MRSA, it is important to have a detailed knowledge of the molecular traits of this organism. Fifty three MuH MRSA isolates were gathered from Shanghai (28 isolates) and Wenzhou (25 isolates) in China. These isolates, consisting of 27 different PFGE-SCCmec-spa patterns, were examined by PCR for 35 virulence genes and further typed using agr (accessory gene regulator) typing and MLST (multilocus sequence typing). All 53 strains were positive for the genes hlg/hlg variant and icaD, and negative for seb, sed, see, seh, eta, etb, hld, cap-5, and ACME-arcA. Compared with Wenzhou isolates, Shanghai isolates were more likely to carry seg (P = 0.002) and several other genes which were not found in Wenzhou strains such as sec, sei, tst (P < 0.001 each), and pvl (P = 0.012), and less likely to contain sea (P < 0.001), cna (P = 0.031), and efb (P = 0.045). MLST and agr typing showed that ST239-agr1, ST5-agr1, and ST239-agr2 were the common lineages in MuH MRSA isolates from these two different regions. Our results indicated that MuH MRSA strains from two different geographic regions of China have differences in distribution of some virulence genes, while their major MLST-agr genetic backgrounds were accordant.	[Liu, Qingzhong] Shanghai Jiao Tong Univ, Dept Clin Lab, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Han, Lizhong; Li, Bin; Sun, Jingyong; Ni, Yuxing] Ruijin Hosp, Sch Med, Dept Clin Microbiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, QZ (corresponding author), Shanghai Jiao Tong Univ, Dept Clin Lab, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	yuxinni53@yahoo.com.cn			Shanghai First People's Hospital [10B10]; Natural Science Foundation; Science and Technology Commission of Shanghai [09ZR1419200]; Ministry of Health and Public Welfare Industry Research Fund, China [200802107]	Shanghai First People's Hospital; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Health and Public Welfare Industry Research Fund, China	This work was supported by grants from Shanghai First People's Hospital Research Fund (No. 10B10), Natural Science Foundation, Science and Technology Commission of Shanghai (No. 09ZR1419200), and the Ministry of Health and Public Welfare Industry Research Fund, China (No. 200802107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001; Atkins KL, 2008, MOL IMMUNOL, V45, P1600, DOI 10.1016/j.molimm.2007.10.021; Ben Nejma M, 2006, DIAGN MICR INFEC DIS, V55, P21, DOI 10.1016/j.diagmicrobio.2005.10.017; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; Ghebremedhin B, 2007, J MED MICROBIOL, V56, P365, DOI 10.1099/jmm.0.46883-0; Goerke C, 2006, ANTIMICROB AGENTS CH, V50, P171, DOI 10.1128/AAC.50.1.171-177.2006; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harraghy N, 2003, MICROBIOL-SGM, V149, P2701, DOI 10.1099/mic.0.26465-0; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Holtfreter S, 2004, INFECT IMMUN, V72, P4061, DOI 10.1128/IAI.72.7.4061-4071.2004; Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1016/S0378-1097(99)00079-8; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Lee LY, 2002, J CLIN INVEST, V110, P1461, DOI 10.1172/JC1200216318; Liu M, 2010, CURR MICROBIOL, V61, P435, DOI 10.1007/s00284-010-9635-0; Liu QZ, 2010, INT J ANTIMICROB AG, V35, P114, DOI 10.1016/j.ijantimicag.2009.09.018; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Monday SR, 1999, J CLIN MICROBIOL, V37, P3411, DOI 10.1128/JCM.37.10.3411-3414.1999; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Morgan WR, 2007, J CLIN MICROBIOL, V45, P668, DOI 10.1128/JCM.01657-06; Murray CK, 2009, BURNS, V35, P1112, DOI 10.1016/j.burns.2009.02.013; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Perez-Roth E, 2006, ANTIMICROB AGENTS CH, V50, P3207, DOI 10.1128/AAC.00059-06; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Salasia Siti Isrina Oktavia, 2004, J Vet Sci, V5, P103; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; van Leeuwen W, 2000, J BACTERIOL, V182, P5721, DOI 10.1128/JB.182.20.5721-5729.2000; Verdier I, 2007, J CLIN MICROBIOL, V45, P725, DOI 10.1128/JCM.01572-06; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Yao D, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-133; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhang SP, 1998, FEMS MICROBIOL LETT, V168, P227, DOI 10.1111/j.1574-6968.1998.tb13278.x; Zmantar T, 2008, J BASIC MICROB, V48, P308, DOI 10.1002/jobm.200700289	44	18	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37005	10.1371/journal.pone.0037005	http://dx.doi.org/10.1371/journal.pone.0037005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623969	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500046
J	Tong, A; Tong, SYC; Zhang, YR; Lamlertthon, S; Sharma-Kuinkel, BK; Rude, T; Ahn, SH; Ruffin, F; Llorens, L; Tamarana, G; Biek, D; Critchley, I; Fowler, VG				Tong, Amy; Tong, Steven Y. C.; Zhang, Yurong; Lamlertthon, Supaporn; Sharma-Kuinkel, Batu K.; Rude, Thomas; Ahn, Sun Hee; Ruffin, Felicia; Llorens, Lily; Tamarana, Ganesh; Biek, Donald; Critchley, Ian; Fowler, Vance G., Jr.			Panton-Valentine Leukocidin Is Not the Primary Determinant of Outcome for Staphylococcus aureus Skin Infections: Evaluation from the CANVAS Studies	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; COMPLICATED SKIN; DOUBLE-BLIND; NECROTIZING PNEUMONIA; CEFTAROLINE FOSAMIL; PHASE-III; VIRULENCE; OSTEOMYELITIS; SEVERITY; STRAINS	The impact of Panton-Valentine leukocidin (PVL) on the severity of complicated skin and skin structure infections (cSSSI) caused by Staphylococcus aureus is controversial. We evaluated potential associations between clinical outcome and PVL presence in both methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates from patients enrolled in two large, multinational phase three clinical trials assessing ceftaroline fosamil for the treatment of cSSSI (the CANVAS 1 and 2 programs). Isolates from all microbiologically evaluable patients with monomicrobial MRSA or MSSA infections (n = 473) were genotyped by PCR for pvl and underwent pulsed-field gel electrophoresis (PFGE). Genes encoding pvl were present in 266/473 (56.2%) isolates. Infections caused by pvl-positive S. aureus were associated with younger patient age, North American acquisition, and presence of major abscesses (P<0.001 for each). Cure rates of patients infected with pvl-positive and pvl-negative S. aureus were similar overall (93.6% versus 92.8%; P = 0.72), and within MRSA-infected (94.5% vs. 93.1%; P = 0.67) and MSSA-infected patients (92.2% vs. 92.7%; P = 1.00). This finding persisted after adjustment for multiple patient characteristics. Outcomes were also similar when USA300 PVL+ and non-USA300 PVL+ infections were compared. The results of this contemporary, international study suggest that pvl presence was not the primary determinant of outcome in patients with cSSSI due to either MRSA or MSSA.	[Tong, Amy; Tong, Steven Y. C.; Zhang, Yurong; Lamlertthon, Supaporn; Sharma-Kuinkel, Batu K.; Rude, Thomas; Ahn, Sun Hee; Ruffin, Felicia; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC USA; [Lamlertthon, Supaporn] Naresuan Univ, Phitsanulok, Thailand; [Tong, Steven Y. C.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Llorens, Lily; Tamarana, Ganesh; Biek, Donald; Critchley, Ian] Cerexa Inc, Oakland, CA USA	Duke University; Duke University; Naresuan University; Charles Darwin University; Menzies School of Health Research	Tong, A (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA.	fowle003@mc.duke.edu	Fowler, Vance/AAW-2017-2021; Tong, Steven/N-2353-2013	Tong, Steven/0000-0002-1368-8356; Lamlertthon, Supaporn/0000-0002-5504-3433	Australian National Health and Medical Research Council Postdoctoral Training Fellowship [508829]; Australian-American Fulbright Scholarship; Royal Australasian College of Physicians Bayer Australia Medical Research Fellowship; Cerexa, Inc.; Oakland, CA; Forest Laboratories, Inc., New York, NY; Forest Laboratories, Inc.; Forest Research Institute, Inc.; Astellas Pharma, Inc.; Cubist Pharmaceuticals; Merck Co., Inc.; Theravance, Inc.; MedImmune; Pfizer; United States National Institutes of Health;  [K24-AI093969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI093969] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council Postdoctoral Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian-American Fulbright Scholarship; Royal Australasian College of Physicians Bayer Australia Medical Research Fellowship; Cerexa, Inc.; Oakland, CA; Forest Laboratories, Inc., New York, NY; Forest Laboratories, Inc.; Forest Research Institute, Inc.; Astellas Pharma, Inc.(Astellas Pharmaceuticals); Cubist Pharmaceuticals; Merck Co., Inc.(Merck & Company); Theravance, Inc.; MedImmune(AstraZenecaMedimmune); Pfizer(Pfizer); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.G.F. was supported in part by K24-AI093969 (http://grants.nih.gov/) .S.Y.C.T. was supported by an Australian National Health and Medical Research Council Postdoctoral Training Fellowship (508829) (http://www.nhmrc.gov.au/grants), an Australian-American Fulbright Scholarship and a Royal Australasian College of Physicians Bayer Australia Medical Research Fellowship. This work was supported by Cerexa, Inc., Oakland, CA, (http://www.cerexa.com/) wholly owned subsidiary of Forest Laboratories, Inc. (New York, NY). The CANVAS clinical program was funded by Forest Laboratories, Inc., New York, NY. Forest Laboratories, Inc., was involved in the design, collection, analysis, and decision to present these results. Forest Laboratories, Inc., had no involvement in the interpretation of the data. Scientific Therapeutics Information, Inc., provided editorial coordination, which was funded by Forest Research Institute, Inc. Laboratory isolates were obtained from Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA).; L.L., G.T., D.B., and I.C. are employees of Cerexa, Inc. V.G.F. has received grants or research support from Astellas Pharma, Inc., Cubist Pharmaceuticals, Merck & Co., Inc., Theravance, Inc., MedImmune, Cerexa, Inc., Pfizer, and the United States National Institutes of Health. He is a consultant for Astellas Pharma, Inc., Biosynexus, Novartis, Cubist Pharmaceuticals, Inimex, Merck & Co., Inc., Galderma, Johnson & Johnson, Medicines Company, Novartis and is on the speaker's bureau and advisory committee for Cubist Pharmaceuticals. He has received honoraria from Achaogen, Arpida, Astellas Pharma, Inc., Cubist Pharmaceuticals, Durata, Inhibitex, Leo Pharma, Merck & Co., Inc., Pfizer, Targanta, Theravance, Inc., and Ortho-McNeil. Scientific Therapeutics Information, Inc., provided editorial coordination (which was funded by Forest Research Institute, Inc.). A.T., S.Y.C.T., Y.Z., S.L., B.K.S., T.R., and F.R. have no competing interests to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Corey GR, 2010, J ANTIMICROB CHEMOTH, V65, piv41, DOI 10.1093/jac/dkq254; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086/655827; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Fontanilla JM, 2010, J CLIN MICROBIOL, V48, P609, DOI 10.1128/JCM.02297-09; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Otto M, 2011, NAT MED, V17, P169, DOI 10.1038/nm0211-169; Perez-Roth E, 2010, J CLIN MICROBIOL, V48, P329, DOI 10.1128/JCM.00622-09; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Tinelli M, 2009, EMERG INFECT DIS, V15, P250, DOI 10.3201/eid1502.080010; Tong SYC, 2010, J INFECT DIS, V202, P760, DOI 10.1086/655396; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wilcox MH, 2010, J ANTIMICROB CHEMOTH, V65, piv53, DOI 10.1093/jac/dkq255; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Yoong P, 2010, P NATL ACAD SCI USA, V107, P2241, DOI 10.1073/pnas.0910344107	32	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37212	10.1371/journal.pone.0037212	http://dx.doi.org/10.1371/journal.pone.0037212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623995	gold, Green Published			2022-12-27	WOS:000305343500075
J	Jiang, WL; Xie, H; Ghoorah, D; Shang, YL; Shi, HJ; Liu, F; Yang, XL; Xu, HB				Jiang, Weili; Xie, Hui; Ghoorah, Devina; Shang, Yalei; Shi, Haojun; Liu, Fang; Yang, Xiangliang; Xu, Haibo			Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETIC-RESONANCE DETECTION; IN-VIVO; DRUG-DELIVERY; CONTRAST AGENTS; RECEPTOR; BARRIER; CANCER; TISSUE; FERUMOXTRAN-10	Currently, effective and specific diagnostic imaging of brain glioma is a major challenge. Nanomedicine plays an essential role by delivering the contrast agent in a targeted manner to specific tumor cells, leading to improvement in accurate diagnosis by good visualization and specific demonstration of tumor cells. This study investigated the preparation and characterization of a targeted MR contrast agent, transferrin-conjugated superparamagnetic iron oxide nanoparticles (Tf-SPIONs), for brain glioma detection. MR imaging showed the obvious contrast change of brain glioma before and after administration of Tf-SPIONs in C6 glioma rat model in vivo on T2 weighted imaging. Significant contrast enhancement of brain glioma could still be clearly seen even 48 h post injection, due to the retention of Tf-SPIONs in cytoplasm of tumor cells which was proved by Prussian blue staining. Thus, these results suggest that Tf-SPIONs could be a potential targeting MR contrast agent for the brain glioma.	[Jiang, Weili; Ghoorah, Devina; Shang, Yalei; Shi, Haojun; Liu, Fang; Xu, Haibo] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Wuhan 430074, Hubei, Peoples R China; [Xie, Hui] China Patent Informat Ctr, Dept Informat Proc, Wuhan, Peoples R China; [Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Jiang, WL (corresponding author), Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Wuhan 430074, Hubei, Peoples R China.	nanomedicine@mail.hust.edu.cn; xuhaibo1120@hotmail.com			National 973 Projection of China [2011CB933103]; National Natural Science Foundation in China [81171386, 30770623]; Hubei Key Laboratory Foundation of Molecular Imaging [2008-69]; Hubei Natural Science Foundation [2009CDB008]	National 973 Projection of China(National Basic Research Program of China); National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Hubei Key Laboratory Foundation of Molecular Imaging; Hubei Natural Science Foundation(Natural Science Foundation of Hubei Province)	This work was supported by National 973 Projection of China (grant number: 2011CB933103), National Natural Science Foundation in China (grant number: 81171386 and 30770623), Hubei Key Laboratory Foundation of Molecular Imaging (grant number: 2008-69), as well as Hubei Natural Science Foundation (grant number: 2009CDB008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Burtea Carmen, 2008, V185, P135, DOI 10.1007/978-3-540-72718-7_7; Cao Y, 2006, J CLIN ONCOL, V24, P1228, DOI 10.1200/JCO.2005.04.7233; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Chirasani SR, 2009, J MOL MED, V87, P153, DOI 10.1007/s00109-008-0414-3; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Descamps L, 1996, AM J PHYSIOL-HEART C, V270, pH1149, DOI 10.1152/ajpheart.1996.270.4.H1149; Gao HL, 2010, ACTA PHARMACOL SIN, V31, P237, DOI 10.1038/aps.2009.199; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hu FQ, 2006, ADV MATER, V18, P2553, DOI 10.1002/adma.200600385; Huh YM, 2005, J AM CHEM SOC, V127, P12387, DOI 10.1021/ja052337c; INOUE T, 1993, J CELL PHYSIOL, V156, P212, DOI 10.1002/jcp.1041560128; JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B; Koo YEL, 2006, ADV DRUG DELIVER REV, V58, P1556, DOI 10.1016/j.addr.2006.09.012; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568; Muldoon LL, 1999, AM J NEURORADIOL, V20, P217; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Rees J, 2003, CURR OPIN NEUROL, V16, P643, DOI 10.1097/00019052-200312000-00001; Sun C, 2008, SMALL, V4, P372, DOI 10.1002/smll.200700784; Ulbrich K, 2009, EUR J PHARM BIOPHARM, V71, P251, DOI 10.1016/j.ejpb.2008.08.021; Varallyay P, 2002, AM J NEURORADIOL, V23, P510; Xia Q., 2009, J CHIN PHARM SCI, V18, P7; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Yoon DJ, 2010, CANCER RES, V70, P4520, DOI 10.1158/0008-5472.CAN-09-4311	28	53	57	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37376	10.1371/journal.pone.0037376	http://dx.doi.org/10.1371/journal.pone.0037376			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615995	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200070
J	Yilmaz, O; Tripathy, SP; Ogmen, H				Yilmaz, Ozgur; Tripathy, Srimant P.; Ogmen, Haluk			Misperceptions in the Trajectories of Objects undergoing Curvilinear Motion	PLOS ONE			English	Article							FLASH-LAG; REPRESENTATIONAL MOMENTUM; POSITIONAL INFORMATION; MOVING STIMULI; DIRECTION; TRACKING; EXTRAPOLATION; DISPLACEMENT; DEVIATIONS; ATTENTION	Trajectory perception is crucial in scene understanding and action. A variety of trajectory misperceptions have been reported in the literature. In this study, we quantify earlier observations that reported distortions in the perceived shape of bilinear trajectories and in the perceived positions of their deviation. Our results show that bilinear trajectories with deviation angles smaller than 90 deg are perceived smoothed while those with deviation angles larger than 90 degrees are perceived sharpened. The sharpening effect is weaker in magnitude than the smoothing effect. We also found a correlation between the distortion of perceived trajectories and the perceived shift of their deviation point. Finally, using a dual-task paradigm, we found that reducing attentional resources allocated to the moving target causes an increase in the perceived shift of the deviation point of the trajectory. We interpret these results in the context of interactions between motion and position systems.	[Yilmaz, Ozgur] Natl Res Ctr Magnet Resonance UMRAM, Ankara, Turkey; [Tripathy, Srimant P.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Ogmen, Haluk] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Ogmen, Haluk] Univ Houston, Ctr Neuroengn & Cognit Sci, Houston, TX USA	University of Bradford; University of Houston System; University of Houston; University of Houston System; University of Houston	Yilmaz, O (corresponding author), Natl Res Ctr Magnet Resonance UMRAM, Bilkent Cyberpk, Ankara, Turkey.	S.P.Tripathy@bradford.ac.uk	Ogmen, Haluk/C-4739-2018	Ogmen, Haluk/0000-0002-5369-1752; Tripathy, Srimant/0000-0002-2988-6840				Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Brown JF, 1937, AM J PSYCHOL, V49, P543, DOI 10.2307/1416380; Carr H, 1907, PSYCHOL REV, V14, P169, DOI 10.1037/h0072630; Chung STL, 2007, VISION RES, V47, P231, DOI 10.1016/j.visres.2006.10.008; Dodge R, 1904, PSYCHOL REV, V11, P1, DOI 10.1037/h0071641; Dodge R, 1910, PSYCHOL BULL, V7, P390; FINKE RA, 1988, J EXP PSYCHOL LEARN, V14, P112, DOI 10.1037/0278-7393.14.1.112; FINKE RA, 1985, J EXP PSYCHOL LEARN, V11, P780, DOI 10.1037/0278-7393.11.1-4.780; Ford AS, 1910, PSYCHOL REV, V17, P192, DOI 10.1037/h0075327; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Frohlich FW., 1923, Z SINNESPHYSIOL, V54, P58; Hayes AE, 2002, VIS COGN, V9, P8, DOI 10.1080/13506280143000296; Hess C, 1904, ARCH GESAMTE PHYSIOL, V101, P226; Hohnsbein J, 1998, VISION RES, V38, P2569, DOI 10.1016/S0042-6989(98)00014-5; Horowitz TS, 2010, ATTEN PERCEPT PSYCHO, V72, P1765, DOI 10.3758/APP.72.7.1765; Howard CJ, 2008, VISION RES, V48, P1164, DOI 10.1016/j.visres.2008.01.023; Kirschfeld K, 1999, VISION RES, V39, P3702, DOI 10.1016/S0042-6989(99)00089-9; Levi DM, 2006, J VISION, V6, P1367, DOI 10.1167/6.12.3; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; Mack A, 1986, HDB PERCEPTION HUMAN, V1; MACKAY DM, 1958, NATURE, V181, P507, DOI 10.1038/181507a0; Mateeff S, 1999, EXP BRAIN RES, V124, P391, DOI 10.1007/s002210050636; MATEEFF S, 1988, VISION RES, V28, P711, DOI 10.1016/0042-6989(88)90050-8; McGraw PV, 2002, CURR BIOL, V12, P2042, DOI 10.1016/S0960-9822(02)01354-4; Metzger W, 1932, PSYCHOL FORSCH, V16, P176, DOI 10.1007/BF00409732; Murakami I, 2001, VISION RES, V41, P3101, DOI 10.1016/S0042-6989(01)00193-6; Musseler J, 2002, VIS COGN, V9, P120, DOI 10.1080/13506280143000359; Narasimhan S, 2009, VISION RES, V49, P10, DOI 10.1016/j.visres.2008.09.023; Nieman D, 2010, J VISION, V10, DOI 10.1167/10.6.9; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nishida S, 1999, NATURE, V397, P610, DOI 10.1038/17600; Ogmen H, 2004, VISION RES, V44, P2109, DOI 10.1016/j.visres.2004.04.003; Patel S S, 2000, Science, V290, P1051; Purushothaman G, 1998, NATURE, V396, P424, DOI 10.1038/24766; RAMACHANDRAN VS, 1990, PERCEPTION, V19, P611, DOI 10.1068/p190611; SEKULER AB, 1990, PERCEPTION, V19, P181, DOI 10.1068/p190181; Shooner C, 2010, J VISION, V10, DOI 10.1167/10.6.8; Tripathy SP, 2006, PERCEPTION, V35, P137, DOI 10.1068/P5519; Tripathy SP, 2004, J VISION, V4, P1020, DOI 10.1167/4.12.4; Tripathy SP, 2003, PERCEPTION, V32, P1403, DOI 10.1068/p5161; Tripathy SP, 2007, J VISION, V7, DOI 10.1167/7.6.2; Tripathy SP, 2008, J VISION, V8, DOI 10.1167/8.4.8; WALKER JT, 1982, HUM FACTORS, V24, P213, DOI 10.1177/001872088202400207; Whitney D, 2002, TRENDS COGN SCI, V6, P211, DOI 10.1016/S1364-6613(02)01887-9; Whitney D, 1998, NAT NEUROSCI, V1, P656, DOI 10.1038/3659; Yilmaz O, 2007, VISION RES, V47, P2603, DOI 10.1016/j.visres.2007.06.017	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36511	10.1371/journal.pone.0036511	http://dx.doi.org/10.1371/journal.pone.0036511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615775	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200009
J	Cancino-Rodezno, A; Lozano, L; Oppert, C; Castro, JI; Lanz-Mendoza, H; Encarnacion, S; Evans, AE; Gill, SS; Soberon, M; Jurat-Fuentes, JL; Bravo, A				Cancino-Rodezno, Angeles; Lozano, Luis; Oppert, Cris; Castro, Julieta I.; Lanz-Mendoza, Humberto; Encarnacion, Sergio; Evans, Amy E.; Gill, Sarjeet S.; Soberon, Mario; Jurat-Fuentes, Juan L.; Bravo, Alejandra			Comparative Proteomic Analysis of Aedes aegypti Larval Midgut after Intoxication with Cry11Aa Toxin from Bacillus thuringiensis	PLOS ONE			English	Article							CRY1AC BINDING-PROTEINS; GENE-EXPRESSION; CHORISTONEURA-FUMIFERANA; STATISTICAL-MODEL; MANDUCA-SEXTA; IDENTIFICATION; INSECT	Cry toxins produced by Bacillus thuringiensis bacteria are environmentally safe alternatives to control insect pests. They are pore-forming toxins that specifically affect cell permeability and cellular integrity of insect-midgut cells. In this work we analyzed the defensive response of Aedes aegypti larva to Cry11Aa toxin intoxication by proteomic and functional genomic analyses. Two dimensional differential in-gel electrophoresis (2D-DIGE) was utilized to analyze proteomic differences among A. aegypti larvae intoxicated with different doses of Cry11Aa toxin compared to a buffer treatment. Spots with significant differential expression (p<0.05) were then identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS), revealing 18 up-regulated and seven down-regulated proteins. The most abundant subcategories of differentially expressed proteins were proteins involved in protein turnover and folding, energy production, and cytoskeleton maintenance. We selected three candidate proteins based on their differential expression as representatives of the different functional categories to perform gene silencing by RNA interference and analyze their functional role. The heat shock protein HSP90 was selected from the proteins involved in protein turnover and chaperones; actin, was selected as representative of the cytoskeleton protein group, and ATP synthase subunit beta was selected from the group of proteins involved in energy production. When we affected the expression of ATP synthase subunit beta and actin by silencing with RNAi the larvae became hypersensitive to toxin action. In addition, we found that mosquito larvae displayed a resistant phenotype when the heat shock protein was silenced. These results provide insight into the molecular components influencing the defense to Cry toxin intoxication and facilitate further studies on the roles of identified genes.	[Cancino-Rodezno, Angeles; Soberon, Mario; Bravo, Alejandra] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Lozano, Luis; Encarnacion, Sergio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Evolut, Cuernavaca 62191, Morelos, Mexico; [Oppert, Cris; Jurat-Fuentes, Juan L.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Castro, Julieta I.; Lanz-Mendoza, Humberto] Inst Nacl Salud Publ, Ctr Invest Sobre Enfermedades Infecciosas, Unidad Proteom, Cuernavaca, Morelos, Mexico; [Evans, Amy E.; Gill, Sarjeet S.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Instituto Nacional de Salud Publica; University of California System; University of California Riverside	Cancino-Rodezno, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico.	bravo@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017; Jurat-Fuentes, Juan Luis/A-5104-2014; Lanz-Mendoza, Humberto/GLV-1737-2022	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Bravo, Alejandra/0000-0002-7573-7475	National Institutes of Health [1R01 AI066014]; Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM [IN218608, IN210208-N]; Consejo Nacional de Ciencia y Tecnologia CONACyT [U48631-Q 478]; National Sciences Foundation [IOS-0718807]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM; Consejo Nacional de Ciencia y Tecnologia CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Sciences Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was funded in part through grants from the National Institutes of Health, 1R01 AI066014, Direccion General Apoyo al Personal Academico/Universidad Nacional Autonoma de Mexico DGAPA/UNAM IN218608 and IN210208-N, Consejo Nacional de Ciencia y Tecnologia CONACyT U48631-Q 478, and the National Sciences Foundation grant number IOS-0718807. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Cancino-Rodezno A, 2010, BIOTECHNOL GENET ENG, V26, P65; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Candas M, 2003, MOL CELL PROTEOMICS, V2, P19, DOI 10.1074/mcp.M200069-MCP200; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Chen LZ, 2010, ARCH INSECT BIOCHEM, V73, P61, DOI 10.1002/arch.20340; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Rozen S, 2000, Methods Mol Biol, V132, P365; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; THOMAS WE, 1983, J CELL SCI, V60, P181; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Yuan C, 2011, BIOCONTROL SCI TECHN, V21, P139, DOI 10.1080/09583157.2010.527318	30	42	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37034	10.1371/journal.pone.0037034	http://dx.doi.org/10.1371/journal.pone.0037034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615881	gold, Green Published			2022-12-27	WOS:000305341300057
J	Clark, JJ; Nasrallah, NA; Hart, AS; Collins, AL; Bernstein, IL; Phillips, PEM				Clark, Jeremy J.; Nasrallah, Nicholas A.; Hart, Andrew S.; Collins, Anne L.; Bernstein, Ilene L.; Phillips, Paul E. M.			Altered Risk-Based Decision Making following Adolescent Alcohol Use Results from an Imbalance in Reinforcement Learning in Rats	PLOS ONE			English	Article							CRITICAL PERIOD; ADDICTION; BRAIN; PREFERENCE; FRAMEWORK; REWARDS; COSTS	Alcohol use during adolescence has profound and enduring consequences on decision-making under risk. However, the fundamental psychological processes underlying these changes are unknown. Here, we show that alcohol use produces over-fast learning for better-than-expected, but not worse-than-expected, outcomes without altering subjective reward valuation. We constructed a simple reinforcement learning model to simulate altered decision making using behavioral parameters extracted from rats with a history of adolescent alcohol use. Remarkably, the learning imbalance alone was sufficient to simulate the divergence in choice behavior observed between these groups of animals. These findings identify a selective alteration in reinforcement learning following adolescent alcohol use that can account for a robust change in risk-based decision making persisting into later life.	[Clark, Jeremy J.; Hart, Andrew S.; Collins, Anne L.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Nasrallah, Nicholas A.; Bernstein, Ilene L.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Hart, Andrew S.; Bernstein, Ilene L.; Phillips, Paul E. M.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Hart, Andrew S.; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Clark, JJ (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	jjc1@u.washington.edu	Phillips, Paul/E-7813-2013; Clark, Jeremy/J-9552-2015; Phillips, Paul E. M./A-4463-2008	Phillips, Paul/0000-0002-8749-7026; Phillips, Paul E. M./0000-0002-8749-7026	National Institute of Health [R01-DA027858]; Alcohol and Drug Abuse Institute small grant program at the University of Washington; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027858] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcohol and Drug Abuse Institute small grant program at the University of Washington; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institute of Health grant R01-DA027858 (http://www.nih.gov/) and the Alcohol and Drug Abuse Institute small grant program at the University of Washington, http://adai.washington.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chiu PH, 2008, NAT NEUROSCI, V11, P514, DOI 10.1038/nn2067; Corrado GS, 2008, NEUROECONOMICS DECIS, P463; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Johnson CA, 2008, NEUROPSYCHOLOGIA, V46, P714, DOI 10.1016/j.neuropsychologia.2007.09.012; Kakade S, 2002, PSYCHOL REV, V109, P533, DOI 10.1037//0033-295X.109.3.533; March JG, 1996, PSYCHOL REV, V103, P309, DOI 10.1037/0033-295X.103.2.309; McKinzie DL, 1999, ALCOHOL AND ALCOHOLISM, P135; Mihatsch O, 2002, MACH LEARN, V49, P267, DOI 10.1023/A:1017940631555; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Nasrallah NA, 2009, P NATL ACAD SCI USA, V106, P17600, DOI 10.1073/pnas.0906629106; National Institute on Alcohol Abuse and Alcoholism, 2009, NIH PUB; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Niv Y, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P331, DOI 10.1016/B978-0-12-374176-9.00022-1; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Peris J, 2006, PHARMACOL BIOCHEM BE, V85, P562, DOI 10.1016/j.pbb.2006.10.010; Philpot RM, 2009, INT J DEV NEUROSCI, V27, P805, DOI 10.1016/j.ijdevneu.2009.08.009; Piray P, 2010, NEURAL COMPUT, V22, P2334, DOI 10.1162/NECO_a_00009; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Reilly S, 1999, PHARMACOL BIOCHEM BE, V63, P301, DOI 10.1016/S0091-3057(99)00009-X; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rowland NE, 2005, PHARMACOL BIOCHEM BE, V80, P109, DOI 10.1016/j.pbb.2004.10.010; Schultz W, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P323; Sclafani A, 2003, PHYSIOL BEHAV, V79, P663, DOI 10.1016/S0031-9384(03)00143-4; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stout JC, 2005, PSYCHOL ADDICT BEHAV, V19, P148, DOI 10.1037/0893-164X.19.2.148; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Wanat MJ, 2010, J NEUROSCI, V30, P12020, DOI 10.1523/JNEUROSCI.2691-10.2010; Witt ED, 2010, ALCOHOL, V44, P119, DOI 10.1016/j.alcohol.2009.08.011; Yechiam E, 2005, PSYCHON B REV, V12, P387, DOI 10.3758/BF03193783	40	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37357	10.1371/journal.pone.0037357	http://dx.doi.org/10.1371/journal.pone.0037357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615989	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300105
J	Goerlich, KS; Aleman, A; Martens, S				Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander			The Sound of Feelings: Electrophysiological Responses Emotional Speech in Alexithymia	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; MISMATCH NEGATIVITY; FACIAL EXPRESSIONS; BRAIN POTENTIALS; SEX-DIFFERENCES; PROSODY; RECOGNITION; PERCEPTION; ACTIVATION; ATTENTION	Background: Alexithymia is a personality trait characterized by difficulties in the cognitive processing of emotions (cognitive dimension) and in the experience of emotions (affective dimension). Previous research focused mainly on visual emotional processing in the cognitive alexithymia dimension. We investigated the impact of both alexithymia dimensions on electrophysiological responses to emotional speech in 60 female subjects. Methodology: During unattended processing, subjects watched a movie while an emotional prosody oddball paradigm was presented in the background. During attended processing, subjects detected deviants in emotional prosody. The cognitive alexithymia dimension was associated with a left-hemisphere bias during early stages of unattended emotional speech processing, and with generally reduced amplitudes of the late P3 component during attended processing. In contrast, the affective dimension did not modulate unattended emotional prosody perception, but was associated with reduced P3 amplitudes during attended processing particularly to emotional prosody spoken in high intensity. Conclusions: Our results provide evidence for a dissociable impact of the two alexithymia dimensions on electrophysiological responses during the attended and unattended processing of emotional prosody. The observed electrophysiological modulations are indicative of a reduced sensitivity to the emotional qualities of speech, which may be a contributing factor to problems in interpersonal communication associated with alexithymia.	[Goerlich, Katharina Sophia; Aleman, Andre; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, Groningen, Netherlands	University of Groningen; University of Groningen	Goerlich, KS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, Groningen, Netherlands.	K.Goerlich@med.umcg.nl	Goerlich, Katharina S./J-6040-2016	Martens, Sander/0000-0001-8237-7984	European Science Foundation (NWO) [044035001]	European Science Foundation (NWO)(European Science Foundation (ESF)Netherlands Organization for Scientific Research (NWO))	This work was supported by a European Science Foundation EURYI grant (NWO no. 044035001) awarded to Andre Aleman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftanas L, 2004, INT J NEUROSCI, V114, P1443, DOI 10.1080/00207450490509230; Aftanas L I, 2007, Neurosci Behav Physiol, V37, P67, DOI 10.1007/s11055-007-0151-z; ALHO K, 1994, BIOL PSYCHOL, V38, P73, DOI 10.1016/0301-0511(94)90050-7; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Bailey PE, 2007, PSYCHIAT RES, V150, P13, DOI 10.1016/j.psychres.2006.05.024; BEAR DM, 1983, ARCH NEUROL-CHICAGO, V40, P195, DOI 10.1001/archneur.1983.04050040025003; Bekker MHJ, 2007, J CLIN PSYCHOL, V63, P507, DOI 10.1002/jclp.20363; Bermond B, 2005, COGNITION EMOTION, V19, P151, DOI 10.1080/02699930441000193; Bermond B, 2008, NETH J PSYCHOL, V64, P65, DOI DOI 10.1007/BF03076408; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; BERTHOZ S, 2005, EUROPEAN J PSYCHIAT, V20, P281; Berthoz S., 2000, EUROPEAN REV APPL PS, V50, P359; Besson M, 2002, TRENDS COGN SCI, V6, P405, DOI 10.1016/S1364-6613(02)01975-7; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Boersma P., 1996, 132 I PHON SCI U AMS; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; De Gucht V, 2004, PERS INDIV DIFFER, V36, P1655, DOI 10.1016/j.paid.2003.06.012; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; Franz M, 2004, AM J PSYCHIAT, V161, P728, DOI 10.1176/appi.ajp.161.4.728; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; GAINOTTI G, 1993, COGNITION EMOTION, V7, P71, DOI 10.1080/02699939308409178; Gainotti G, 1989, HDB NEUROPSYCHOLOGY, V5; Gazzaniga Michael S., 1995, P1391; GAZZANIGA MS, 1989, SCIENCE, V245, P947, DOI 10.1126/science.2672334; Goerlich KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019501; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; HOPPE KD, 1988, PSYCHIAT CLIN N AM, V11, P303; Jessimer M, 1997, BRAIN COGNITION, V34, P246, DOI 10.1006/brcg.1997.0900; Joseph R., 1992, RIGHT BRAIN UNCONSCI, DOI [10.1007/978-1-4899-5996-6, DOI 10.1007/978-1-4899-5996-6]; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kircher TTJ, 2004, AM J PSYCHIAT, V161, P294, DOI 10.1176/appi.ajp.161.2.294; Kolb B., 2015, FUNDAMENTALS HUMAN N; Korpilahti P, 2001, BRAIN LANG, V76, P332, DOI 10.1006/brln.2000.2426; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kotz SA, 2011, LANG LINGUIST COMPAS, V5, P108, DOI 10.1111/j.1749-818x.2010.00267.x; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; Moormann P., 2008, EMOTION REGULATION C, P27, DOI [10.1007/978-0-387-29986-0_3, DOI 10.1007/978-0-387-29986-0_3]; NAATANEN R, 1992, NEUROREPORT, V3, P493; NAATANEN R, 1995, EAR HEARING, V16, P6; NEMIAH JC, 1970, PSYCHOTHER PSYCHOSOM, V18, P154, DOI 10.1159/000286074; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker PD, 2005, J PERS, V73, P1087, DOI 10.1111/j.1467-6494.2005.00339.x; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Pell MD, 1997, BRAIN LANG, V57, P195, DOI 10.1006/brln.1997.1736; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; Pihan H, 2000, BRAIN, V123, P2338, DOI 10.1093/brain/123.11.2338; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Pollatos O, 2012, PSYCHOPHYSIOLOGY, V49, P651, DOI 10.1111/j.1469-8986.2011.01348.x; Pollatos O, 2011, BIOL PSYCHOL, V87, P113, DOI 10.1016/j.biopsycho.2011.02.016; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Rinne T, 2005, HUM BRAIN MAPP, V26, P94, DOI 10.1002/hbm.20123; Ross ED, 2011, NEUROPSYCHOLOGIA, V49, P866, DOI 10.1016/j.neuropsychologia.2010.12.024; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Schafer R, 2007, J PSYCHOSOM RES, V63, P357, DOI 10.1016/j.jpsychores.2007.03.015; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schneider W., 2002, E PRIME VERSION 20 C; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spalletta G, 2001, PSYCHOSOM MED, V63, P944, DOI 10.1097/00006842-200111000-00013; Spitzer C, 2005, PSYCHOTHER PSYCHOSOM, V74, P240, DOI 10.1159/000085148; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Taylor G.J., 1997, DISORDERS AFFECT REG; Thonnessen H, 2010, NEUROIMAGE, V50, P250, DOI 10.1016/j.neuroimage.2009.11.082; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; Vermeulen N, 2008, COGNITION EMOTION, V22, P1052, DOI 10.1080/02699930701597635; Vermeulen N, 2010, EUR J PERSONALITY, V24, P551, DOI 10.1002/per.758; Vermeulen N, 2009, PERS INDIV DIFFER, V47, P305, DOI 10.1016/j.paid.2009.03.018; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Walker S, 2011, COGN AFFECT BEHAV NE, V11, P463, DOI 10.3758/s13415-011-0042-1; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998; Wingbermuhle E, 2012, ACTA NEUROPSYCHIATR, V24, P67, DOI 10.1111/j.1601-5215.2011.00613.x; WIRSEN A, 1990, BRAIN COGNITION, V12, P229, DOI 10.1016/0278-2626(90)90017-I; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028; Wunderlich A, 2003, APHASIOLOGY, V17, P861, DOI 10.1080/02687030344000283	88	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36951	10.1371/journal.pone.0036951	http://dx.doi.org/10.1371/journal.pone.0036951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615853	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300052
J	He, BL; Yuan, JM; Yang, LY; Xie, JF; Weng, SP; Yu, XQ; He, JG				He, Bai-Liang; Yuan, Ji-Min; Yang, Lu-Yun; Xie, Jun-Feng; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			The Viral TRAF Protein (ORF111L) from Infectious Spleen and Kidney Necrosis Virus Interacts with TRADD and Induces Caspase 8-mediated Apoptosis	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; COMPLETE GENOME SEQUENCE; IRIDOVIRUS-DISEASE; SPRING VIREMIA; CELL-SURVIVAL; FROG VIRUS; MODEL; EXPRESSION; INDUCTION; RECEPTOR	Infectious spleen and kidney necrosis virus (ISKNV) is the type species of the Megalocytivirus genus of the Iridoviridae family. It causes a serious and potentially pandemic disease in wild and cultured fishes. ISKNV infection induces evident apoptosis in mandarin fish (Siniperca chuatsi) and zebrafish (Danio renio). However, the mechanism is still unknown. After a genome-wide bioinformatics analysis of ISKNV-encoded proteins, the ISKNV open reading frame 111L (ORF111L) shows a high similarity to the tumour necrosis factor receptor-associated factor (TRAF) encoded by fish, mice and mammals, which is essential for apoptotic signal transduction. Moreover, ORF111L was verified to directly interact with the zebrafish TNF receptor type 1 associated death domain protein (TRADD). A recombinant plasmid containing the DNA sequence of ORF111L was constructed and microinjected into zebrafish embryos at the 1-2 cell stage to investigate its biological function in vivo. ORF111L overexpression in the embryos resulted in increased apoptosis. ORF111L-induced apoptosis was clearly associated with significant caspase 8 upregulation and activation. The knockdown of zebrafish caspase 8 expression effectively blocked the apoptosis induced by ORF111L overexpression. Significantly, ORF111L overexpression resulted in much stronger effect on caspase 8 and caspase 3 upregulation compared to zebrafish TRAF2. This is the first report of a viral protein similar to TRAF that interacts with TRADD and induces caspase 8-mediated apoptosis, which may provide novel insights into the pathogenesis of ISKNV infection.	[He, Bai-Liang; Yuan, Ji-Min; Yang, Lu-Yun; Xie, Jun-Feng; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Div Cell Biol & Biophys, Sch Biol Sci, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	He, BL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; Xie, Jun-Feng/AGO-8942-2022; YU, XIAO-QIANG/AAL-1797-2021	Xie, Jun-Feng/0000-0002-0669-5339; YU, XIAO-QIANG/0000-0003-1419-9009; He, Bai-Liang/0000-0001-6497-884X; He, Bai-Liang/0000-0001-8453-2351	National Natural Science Foundation of China [30325035, U0631008, 30800855]; National Basic Research Program of China [2006CB101802]; National High Technology Research and Development Program of China (863 Program) [2006AA09Z445, 2006AA100309]; Guangdong Province Natural Science Foundation [20023002]; Science and Technology Bureau of Guangdong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under grant no. 30325035, U0631008 and 30800855; the National Basic Research Program of China under grant no. 2006CB101802; the National High Technology Research and Development Program of China (863 Program) under grant no. 2006AA09Z445 and 2006AA100309; the Guangdong Province Natural Science Foundation under grant no. 20023002; and the Science and Technology Bureau of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Burgos JS, 2008, ZEBRAFISH, V5, P323, DOI 10.1089/zeb.2008.0552; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Chen XH, 2003, J FISH DIS, V26, P615, DOI 10.1046/j.1365-2761.2003.00494.x; Chinchar VG, 2003, VIROLOGY, V306, P303, DOI 10.1016/S0042-6822(02)00039-9; Chitnis NS, 2008, VIROLOGY, V370, P333, DOI 10.1016/j.virol.2007.09.010; Chung JY, 2002, J CELL SCI, V115, P679; Dong CF, 2008, VIRUS RES, V135, P273, DOI 10.1016/j.virusres.2008.04.004; Essbauer S, 2002, J VET MED B, V49, P25, DOI 10.1046/j.1439-0450.2002.00531.x; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; He JG, 2001, VIROLOGY, V291, P126, DOI 10.1006/viro.2001.1208; Hsiao CD, 2001, DEV DYNAM, V220, P323, DOI 10.1002/dvdy.1113; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hubbard S, 2010, ZEBRAFISH, V7, P181, DOI 10.1089/zeb.2009.0621; Ji W, 2005, ANAL BIOCHEM, V344, P240, DOI 10.1016/j.ab.2005.06.046; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; LaPatra SE, 2000, BLOOD CELL MOL DIS, V26, P445, DOI 10.1006/bcmd.2000.0320; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liu XY, 2002, J VIROL, V76, P492, DOI 10.1128/JVI.76.2.492-498.2002; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Lopez-Munoz A, 2010, DEV COMP IMMUNOL, V34, P546, DOI 10.1016/j.dci.2009.12.015; Lu L, 2005, VIROLOGY, V339, P81, DOI 10.1016/j.virol.2005.05.021; Lu MW, 2008, MOL IMMUNOL, V45, P1146, DOI 10.1016/j.molimm.2007.07.018; Lua DT, 2005, J VIROL, V79, P15151, DOI 10.1128/JVI.79.24.15151-15164.2005; Ludwig M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001269; Luo YW, 2009, VIRUS RES, V144, P171, DOI 10.1016/j.virusres.2009.04.016; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Margo CE, 2004, ARCH OPHTHALMOL-CHIC, V122, P665, DOI 10.1001/archopht.122.4.665; McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Notch EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029462; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Oever MJV, 2010, J VIROL, V84, P3116, DOI 10.1128/JVI.01726-09; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Paul TA, 2010, MAR BIOTECHNOL NY; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sanders GE, 2003, COMPARATIVE MED, V53, P514; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Shi CY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-159; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Stanton SE, 2006, J BIOL CHEM, V281, P28782, DOI 10.1074/jbc.M603348200; Sudthongkong C, 2002, DIS AQUAT ORGAN, V48, P163, DOI 10.3354/dao048163; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vicat JM, 2003, BIOCHEM PHARMACOL, V65, P423, DOI 10.1016/S0006-2952(02)01449-1; Wang L, 2006, J INTERF CYTOK RES, V26, P256, DOI 10.1089/jir.2006.26.256; Wang YQ, 2007, ARCH VIROL, V152, P763, DOI 10.1007/s00705-006-0870-4; Wang ZL, 2008, J VIROL, V82, P4371, DOI 10.1128/JVI.02027-07; Xiong XP, 2011, DEV COMP IMMUNOL, V35, P431, DOI 10.1016/j.dci.2010.11.006; Xu XP, 2008, VIROLOGY, V376, P1, DOI 10.1016/j.virol.2007.12.026; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yuan S, 2009, J VIS EXP; Zapata JM, 2007, ADV EXP MED BIOL, V597, P1; Zeller R., 2008, CSH PROTOC, V2008, DOI [10.1101/pdb.prot4986, DOI 10.1101/PDB.PROT4986]; Zhan HQ, 2010, MAR BIOTECHNOL, V12, P640, DOI 10.1007/s10126-009-9251-9; Zhao XQ, 2008, J VIROL, V82, P2586, DOI 10.1128/JVI.02291-07	69	25	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37001	10.1371/journal.pone.0037001	http://dx.doi.org/10.1371/journal.pone.0037001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615868	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300060
J	O'Malley, AJ; Arbesman, S; Steiger, DM; Fowler, JH; Christakis, NA				O'Malley, A. James; Arbesman, Samuel; Steiger, Darby Miller; Fowler, James H.; Christakis, Nicholas A.			Egocentric Social Network Structure, Health, and Pro-Social Behaviors in a National Panel Study of Americans	PLOS ONE			English	Article							CORE	Using a population-based, panel survey, we study how egocentric social networks change over time, and the relationship between egocentric network properties and health and pro-social behaviors. We find that the number of prosocial activities is strongly positively associated with having more friends, or an increase in degree, with approximately 0.04 more prosocial behaviors expected for every friend added. Moreover, having more friends is associated with an improvement in health, while being healthy and prosocial is associated with closer relationships. Specifically, a unit increase in health is associated with an expected 0.45 percentage-point increase in average closeness, while adding a prosocial activity is associated with a 0.46 percentage-point increase in the closeness of one's relationships. Furthermore, a tradeoff between degree and closeness of social contacts was observed. As the number of close social contacts increases by one, the estimated average closeness of each individual contact decreases by approximately three percentage-points. The increased awareness of the importance of spillover effects in health and health care makes the ascertainment of egocentric social networks a valuable complement to investigations of the relationship between socioeconomic factors and health.	[O'Malley, A. James; Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Arbesman, Samuel] Ewing Marion Kauffman Fdn, Kansas City, MO USA; [Steiger, Darby Miller] Gallup Govt, Cleveland, OH USA; [Fowler, James H.] Univ Calif San Diego, Dept Med Genet, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University	O'Malley, AJ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	omalley@hcp.med.harvard.edu; arbesman@gmail.com	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638	National Institutes of Health (NIH) [R01 AG024448, P01 AG031093]; Robert Wood Johnson Foundation [58729]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024448, P01AG031093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research for this paper was supported by National Institutes of Health (NIH) Grants R01 AG024448 and P01 AG031093 and by Robert Wood Johnson Foundation Award #58729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Eisenberg N., 1989, ROOTS PROSOCIAL BEHA; Feld SL, 2007, FIELD METHOD, V19, P218, DOI 10.1177/1525822X06299134; Fowler JH, 2009, P NATL ACAD SCI USA, V106, P1720, DOI 10.1073/pnas.0806746106; Harris KM, 2009, NATL LONGITUDINAL ST; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; LAUMANN EO, 1995, NATL HLTH SOCIAL LIF; Laumann EO, 2008, NATL HLTH SOCIAL LIF; Lubbers MJ, 2010, SOC NETWORKS, V32, P91, DOI 10.1016/j.socnet.2009.05.001; MARSDEN PV, 1987, AM SOCIOL REV, V52, P122, DOI 10.2307/2095397; Marsden PV, 1992, RELIABILITY NETWORK; Matzat U, 2010, SOC NETWORKS, V32, P105, DOI 10.1016/j.socnet.2009.08.002; McPherson M, 2006, AM SOCIOL REV, V71, P353, DOI 10.1177/000312240607100301; O'Malley AJ, 2008, HEALTH SERV OUTCOME, V8, P222, DOI 10.1007/s10742-008-0041-z; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Smith Tom W., 2011, GEN SOCIAL SURVEYS 1; Wasserman S., MODELS METHODS SOCIA, P8, DOI DOI 10.1017/CBO9780511811395.002; Wellman B, 2007, FIELD METHOD, V19, P111, DOI 10.1177/1525822X06299133	24	62	63	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36250	10.1371/journal.pone.0036250	http://dx.doi.org/10.1371/journal.pone.0036250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615760	Green Published, gold			2022-12-27	WOS:000305336300011
J	Ferrer, P; Tripathi, AK; Clark, MA; Hand, CC; Rienhoff, HY; Sullivan, DJ				Ferrer, Patricia; Tripathi, Abhai K.; Clark, Martha A.; Hand, Carla Cerami; Rienhoff, Hugh Young, Jr.; Sullivan, David J., Jr.			Antimalarial Iron Chelator, FBS0701, Shows Asexual and Gametocyte Plasmodium falciparum Activity and Single Oral Dose Cure in a Murine Malaria Model	PLOS ONE			English	Article							CELLS; POOL; FLUORESCENCE; PARASITEMIA; ARTEMISININ; OVERLOAD; THERAPY; YOELII	Iron chelators for the treatment of malaria have proven therapeutic activity in vitro and in vivo in both humans and mice, but their clinical use is limited by the unsuitable absorption and pharmacokinetic properties of the few available iron chelators. FBS0701, (S)3 ''-(HO)-desazadesferrithiocin-polyether [DADFT-PE], is an oral iron chelator currently in Phase 2 human studies for the treatment of transfusional iron overload. The drug has very favorable absorption and pharmacokinetic properties allowing for once-daily use to deplete circulating free iron with human plasma concentrations in the high mu M range. Here we show that FBS0701 has inhibition concentration 50% (IC50) of 6 mu M for Plasmodium falciparum in contrast to the IC50 for deferiprone and deferoxamine at 15 and 30 mu M respectively. In combination, FBS0701 interfered with artemisinin parasite inhibition and was additive with chloroquine or quinine parasite inhibition. FBS0701 killed early stage P. falciparum gametocytes. In the P. berghei Thompson suppression test, a single dose of 100 mg/kg reduced day three parasitemia and prolonged survival, but did not cure mice. Treatment with a single oral dose of 100 mg/kg one day after infection with 10 million lethal P. yoelii 17XL cured all the mice. Pretreatment of mice with a single oral dose of FBS0701 seven days or one day before resulted in the cure of some mice. Plasma exposures and other pharmacokinetics parameters in mice of the 100 mg/kg dose are similar to a 3 mg/kg dose in humans. In conclusion, FBS0701 demonstrates a single oral dose cure of the lethal P. yoelii model. Significantly, this effect persists after the chelator has cleared from plasma. FBS0701 was demonstrated to remove labile iron from erythrocytes as well as enter erythrocytes to chelate iron. FBS0701 may find clinically utility as monotherapy, a malarial prophylactic or, more likely, in combination with other antimalarials.	[Ferrer, Patricia; Tripathi, Abhai K.; Sullivan, David J., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Clark, Martha A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Hand, Carla Cerami] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Rienhoff, Hugh Young, Jr.] FerroKin BioSci Inc, San Carlos, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ferrer, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	dsulliva@jhsph.edu		Tripathi, Abhai/0000-0001-9848-0142; Cerami, Carla/0000-0002-7634-0955	Bloomberg Foundation via the Johns Hopkins Malaria Research Institute; National Institutes of Health [5U01 HD061241-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD061241] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061235] Funding Source: NIH RePORTER	Bloomberg Foundation via the Johns Hopkins Malaria Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors acknowledge partial support by the Bloomberg Foundation via the Johns Hopkins Malaria Research Institute and partial support by the National Institutes of Health 5U01 HD061241-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Bergeron RJ, 2008, J MED CHEM, V51, P3913, DOI 10.1021/jm800154m; Bergeron RJ, 2011, BIOMETALS, V24, P239, DOI 10.1007/s10534-010-9389-y; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Darbari D, 2003, BLOOD, V102, P357, DOI 10.1182/blood-2002-03-0914; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; ELION GB, 1954, J BIOL CHEM, V208, P477; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Goma J, 1996, PARASITOLOGY, V112, P165, DOI 10.1017/S0031182000084729; GORDEUK V, 1992, NEW ENGL J MED, V327, P1473, DOI 10.1056/NEJM199211193272101; GORDEUK VR, 1992, BLOOD, V79, P308; HORKY J, 1978, PHYSIOL BOHEMOSLOV, V27, P209; Loyevsky M, 1999, MOL BIOCHEM PARASIT, V101, P43, DOI 10.1016/S0166-6851(99)00053-5; Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0; MESHNICK SR, 1993, ANTIMICROB AGENTS CH, V37, P1108, DOI 10.1128/AAC.37.5.1108; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Petritus PM, 2008, J IMMUNOL, V180, P444, DOI 10.4049/jimmunol.180.1.444; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prus E, 2008, BRIT J HAEMATOL, V142, P301, DOI 10.1111/j.1365-2141.2008.07192.x; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Rienhoff HY, 2011, HAEMATOL-HEMATOL J, V96, P521, DOI 10.3324/haematol.2010.034405; Shvartsman M, 2010, BIOCHEM J, V429, P185, DOI 10.1042/BJ20100213; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Thuma PE, 1998, AM J TROP MED HYG, V58, P358, DOI 10.4269/ajtmh.1998.58.358; WALKER WS, 1984, BRIT J HAEMATOL, V58, P259, DOI 10.1111/j.1365-2141.1984.tb06084.x; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582	27	31	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37171	10.1371/journal.pone.0037171	http://dx.doi.org/10.1371/journal.pone.0037171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629364	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100016
J	van der Lelie, D; Taghavi, S; McCorkle, SM; Li, LL; Malfatti, SA; Monteleone, D; Donohoe, BS; Ding, SY; Adney, WS; Himmel, ME; Tringe, SG				van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Malfatti, Stephanie A.; Monteleone, Denise; Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.; Tringe, Susannah G.			The Metagenome of an Anaerobic Microbial Community Decomposing Poplar Wood Chips	PLOS ONE			English	Article							AROMATIC-COMPOUNDS; GLYCOSIDE HYDROLASES; CELLOBIOSE DEHYDROGENASE; HIGHER TERMITES; LIGNIN DEGRADATION; GUT MICROBIOME; BIOMASS; GENOMES; POLYSACCHARIDES; CELLULOSOMES	This study describes the composition and metabolic potential of a lignocellulosic biomass degrading community that decays poplar wood chips under anaerobic conditions. We examined the community that developed on poplar biomass in a non-aerated bioreactor over the course of a year, with no microbial inoculation other than the naturally occurring organisms on the woody material. The composition of this community contrasts in important ways with biomass-degrading communities associated with higher organisms, which have evolved over millions of years into a symbiotic relationship. Both mammalian and insect hosts provide partial size reduction, chemical treatments (low or high pH environments), and complex enzymatic 'secretomes' that improve microbial access to cell wall polymers. We hypothesized that in order to efficiently degrade coarse untreated biomass, a spontaneously assembled free-living community must both employ alternative strategies, such as enzymatic lignin depolymerization, for accessing hemicellulose and cellulose and have a much broader metabolic potential than host-associated communities. This would suggest that such a community would make a valuable resource for finding new catalytic functions involved in biomass decomposition and gaining new insight into the poorly understood process of anaerobic lignin depolymerization. Therefore, in addition to determining the major players in this community, our work specifically aimed at identifying functions potentially involved in the depolymerization of cellulose, hemicelluloses, and lignin, and to assign specific roles to the prevalent community members in the collaborative process of biomass decomposition. A bacterium similar to Magnetospirillum was identified among the dominant community members, which could play a key role in the anaerobic breakdown of aromatic compounds. We suggest that these compounds are released from the lignin fraction in poplar hardwood during the decay process, which would point to lignin-modification or depolymerization under anaerobic conditions.	[van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Monteleone, Denise] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [van der Lelie, Daniel; Taghavi, Safiyh; McCorkle, Sean M.; Li, Luen-Luen; Monteleone, Denise; Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [van der Lelie, Daniel; Taghavi, Safiyh; Adney, William S.] RTI Int, Ctr Agr & Environm Biotechnol, Res Triangle Pk, NC USA; [Malfatti, Stephanie A.; Tringe, Susannah G.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Donohoe, Bryon S.; Ding, Shi-You; Adney, William S.; Himmel, Michael E.] Natl Renewable Energy Lab, Golden, CO USA	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Research Triangle Institute; United States Department of Energy (DOE); United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	van der Lelie, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	vdlelied@rti.org	Tringe, Susannah Green/T-9431-2019; Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021	Tringe, Susannah Green/0000-0001-6479-8427; DING, SHIYOU/0000-0002-1102-1507; Malfatti, Stephanie/0000-0003-4225-9857	United States Department of Energy's Office of Science, Biological and Environmental Research Program; University of California; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the DOE Office of Science; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	United States Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	Metagenome sequencing of poplar biomass decaying community was performed at the Joint Genome Institute (JGI) under the auspices of the United States Department of Energy's Office of Science, Biological and Environmental Research Program; and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, the Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and the Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The BioEnergy Science Center (BESC) funded the microbial/biochemical aspects of this work. BESC is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Amann R.J., 1990, APPL ENVIRON MICROB, V56, P1910; Barragan MJL, 2004, MICROBIOL-SGM, V150, P2018, DOI 10.1099/mic.0.27186-0; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BIGNELL DE, 1995, INSECT SOC, V42, P57, DOI 10.1007/BF01245699; BRON S, 1972, MUTAT RES, V15, P395, DOI 10.1016/0027-5107(72)90004-8; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Decou R, 2009, PHYTOCHEMISTRY, V70, P163, DOI 10.1016/j.phytochem.2008.12.019; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Erb A, 2009, PHYTOCHEMISTRY, V70, P1812, DOI 10.1016/j.phytochem.2009.05.019; Geelhoed JS, 2009, FEMS MICROBIOL ECOL, V70, P54, DOI 10.1111/j.1574-6941.2009.00739.x; Geib SM, 2008, P NATL ACAD SCI USA, V105, P12932, DOI 10.1073/pnas.0805257105; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gilbert JA, 2011, ISME J, V5, P777, DOI 10.1038/ismej.2010.178; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; Heidelberg KB, 2010, MICROB BIOTECHNOL, V3, P531, DOI 10.1111/j.1751-7915.2010.00193.x; Henriksson G, 2000, BBA-PROTEIN STRUCT M, V1480, P83, DOI 10.1016/S0167-4838(00)00096-0; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hilden L, 2000, FEBS LETT, V477, P79, DOI 10.1016/S0014-5793(00)01757-9; Himmel M. E., 2008, BIOMASS RECALCITRANC; Himmel ME, 1997, ACS SYM SER, V666, P2; Huang DL, 2010, BIORESOURCE TECHNOL, V101, P4062, DOI 10.1016/j.biortech.2009.12.145; Juarez JF, 2010, APPL ENVIRON MICROB, V76, P383, DOI 10.1128/AEM.02255-09; Kshattriya S, 1996, ECOPRINT, V3, P41; Kunin V, 2010, OPEN J, V1; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li LL, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-23; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Mansfield SD, 1997, APPL ENVIRON MICROB, V63, P3804, DOI 10.1128/AEM.63.10.3804-3809.1997; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mratyunjay Majumder, 2008, Communications in Biometry and Crop Science, V3, P45; Pati A, 2011, STAND GENOMIC SCI, V5, P248, DOI 10.4056/sigs.2075298; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramsak A, 2000, FEMS MICROBIOL ECOL, V33, P69, DOI 10.1111/j.1574-6941.2000.tb00728.x; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Shinoda Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1483, DOI 10.1271/bbb.69.1483; Shinoda Y, 2000, APPL ENVIRON MICROB, V66, P1286, DOI 10.1128/AEM.66.4.1286-1291.2000; Sjostrom J, 1993, WOOD CHEM FUNDAMENTA; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Thongaram T, 2005, EXTREMOPHILES, V9, P229, DOI 10.1007/s00792-005-0440-9; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WEIMER PJ, 1977, APPL ENVIRON MICROB, V33, P289, DOI 10.1128/AEM.33.2.289-297.1977; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8; Molina MTZ, 2009, NEW BIOTECHNOL, V25, pS100, DOI 10.1016/j.nbt.2009.06.685; Zeng YN, 2010, BIOENERG RES, V3, P272, DOI 10.1007/s12155-010-9079-1	68	77	78	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36740	10.1371/journal.pone.0036740	http://dx.doi.org/10.1371/journal.pone.0036740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629327	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100007
J	Adriani, KS; Brouwer, MC; Baas, F; Zwinderman, AH; van der Ende, A; van de Beek, D				Adriani, Kirsten S.; Brouwer, Matthijs C.; Baas, Frank; Zwinderman, Aeilko H.; van der Ende, Arie; van de Beek, Diederik			Genetic Variation in the beta 2-Adrenocepter Gene Is Associated with Susceptibility to Bacterial Meningitis in Adults	PLOS ONE			English	Article							PNEUMOCOCCAL MENINGITIS; MENINGOCOCCAL DISEASE; POLYMORPHISMS; RECEPTOR; METAANALYSIS; PREVENTION; BARRIER; PATHWAY	Recently, the biased beta 2-adrenoceptor/beta-arrestin pathway was shown to play a pivotal role in crossing of the blood brain barrier by Neisseria meningitidis. We hypothesized that genetic variation in the beta 2-adrenoceptor gene (ADRB2) may influence susceptibility to bacterial meningitis. In a prospective genetic association study we genotyped 542 patients with CSF culture proven community acquired bacterial meningitis and 376 matched controls for 2 functional single nucleotide polymorphisms in the beta 2-adrenoceptor gene (ADRB2). Furthermore, we analyzed if the use of non-selective beta-blockers, which bind to the beta 2-adrenoceptor, influenced the risk of bacterial meningitis. We identified a functional polymorphism in ADRB2 (rs1042714) to be associated with an increased risk for bacterial meningitis (Odds ratio [OR] 1.35, 95% confidence interval [CI] 1.04-1.76; p = 0.026). The association remained significant after correction for age and was more prominent in patients with pneumococcal meningitis (OR 1.52, 95% CI 1.12-2.07; p = 0.007). For meningococcal meningitis the difference in genotype frequencies between patients and controls was similar to that in pneumococcal meningitis, but this was not statistically significant (OR 1.43, 95% CI 0.60-3.38; p = 0.72). Patients with bacterial meningitis had a lower frequency of nonselective beta-blockers use compared to the age matched population (0.9% vs. 1.8%), although this did not reach statistical significance (OR 1.96 [95% CI 0.88-4.39]; p = 0.09). In conclusion, we identified an association between a genetic variant in the beta 2-adrenoceptor and increased susceptibility to bacterial meningitis. The potential benefit of pharmacological treatment targeting the beta 2-adrenoceptor to prevent bacterial meningitis in the general population or patients with bacteraemia should be further studied in both experimental studies and observational cohorts.	[Adriani, Kirsten S.; Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Biostat, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Adriani, KS (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Baas, Frank/F-9574-2010; van de Beek, Diederik/Y-2713-2019	Baas, Frank/0000-0003-3912-5428; van de Beek, Diederik/0000-0002-4571-044X	Netherlands Organization for Health Research and Development [2006 [916.76.023], 2010 [917.11.358]]; Academic Medical Center (AMC); European Society Clinical of Microbiology and Infectious Diseases; European Federatin of Neurologic Societies	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Academic Medical Center (AMC); European Society Clinical of Microbiology and Infectious Diseases; European Federatin of Neurologic Societies	This study was funded by grants from the Netherlands Organization for Health Research and Development (ZonMw NWO-Veni grant 2006 [916.76.023] and ZonMw NWO-Vidi grant 2010 [917.11.358], both to DB) and the Academic Medical Center (AMC Fellowship 2008 to DB). Matthijs C. Brouwer was supported by the European Society Clinical of Microbiology and Infectious Diseases (Research Grant) and European Federatin of Neurologic Societies (Scientific Fellowship Grant). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; Foundation for Pharmaceutical Statistics (SFK), FACTS FIG 2010; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Hall IP, 2006, LANCET, V368, P771, DOI 10.1016/S0140-6736(06)69287-8; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Jalba MS, 2008, OBESITY, V16, P2096, DOI 10.1038/oby.2008.327; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; *STAT NETH, 2001, STATL; Tourret J, 2011, DEV CELL, V20, P7, DOI 10.1016/j.devcel.2010.12.011; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Weisfelt M, 2006, LANCET NEUROL, V5, P332, DOI 10.1016/S1474-4422(06)70409-4	20	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37618	10.1371/journal.pone.0037618	http://dx.doi.org/10.1371/journal.pone.0037618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624056	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500145
J	Avanzini, P; Fabbri-Destro, M; Dalla Volta, R; Daprati, E; Rizzolatti, G; Cantalupo, G				Avanzini, Pietro; Fabbri-Destro, Maddalena; Dalla Volta, Riccardo; Daprati, Elena; Rizzolatti, Giacomo; Cantalupo, Gaetano			The Dynamics of Sensorimotor Cortical Oscillations during the Observation of Hand Movements: An EEG Study	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PRIMARY MOTOR CORTEX; SELF-PACED MOVEMENT; HIGH-RESOLUTION EEG; PREMOTOR CORTEX; MU-RHYTHM; VOLUNTARY MOVEMENT; INFERIOR PARIETAL; PRECISION GRIP; HUMAN BRAIN	Background: The observation of action done by others determines a desynchronization of the rhythms recorded from cortical central regions. Here, we examined whether the observation of different types of hand movements (target directed, non-target directed, cyclic and non-cyclic) elicits different EEG cortical temporal patterns. Methodology: Video-clips of four types of hand movements were shown to right-handed healthy participants. Two were target directed (grasping and pointing) motor acts; two were non-target directed (supinating and clenching) movements. Grasping and supinating were performed once, while pointing and clenching twice (cyclic movements). High-density EEG was recorded and analyzed by means of wavelet transform, subdividing the time course in time bins of 200 ms. The observation of all presented movements produced a desynchronization of alpha and beta rhythms in central and parietal regions. The rhythms desynchronized as soon as the hand movement started, the nadir being reached around 700 ms after movement onset. At the end of the movement, a large power rebound occurred for all bands. Target and non-target directed movements produced an alpha band desynchronization in the central electrodes at the same time, but with a stronger desynchronization and a prolonged rebound for target directed motor acts. Most interestingly, there was a clear correlation between the velocity profile of the observed movements and beta band modulation. Significance: Our data show that the observation of motor acts determines a modulation of cortical rhythm analogous to that occurring during motor act execution. In particular, the cortical motor system closely follows the velocity of the observed movements. This finding provides strong evidence for the presence in humans of a mechanism (mirror mechanism) mapping action observation on action execution motor programs.	[Avanzini, Pietro; Dalla Volta, Riccardo; Rizzolatti, Giacomo] Univ Parma, Dipartimento Neurosci Sez Fisiol, I-43100 Parma, Italy; [Fabbri-Destro, Maddalena; Rizzolatti, Giacomo] Italian Inst Technol, Brain Ctr Motor & Social Cognit, Parma, Italy; [Dalla Volta, Riccardo] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Ctr Biomed Spaziale, Rome, Italy; [Cantalupo, Gaetano] Univ Parma, Dipartimento Neurosci Neuropsichiat Infantile, I-43100 Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Parma	Avanzini, P (corresponding author), Univ Parma, Dipartimento Neurosci Sez Fisiol, I-43100 Parma, Italy.	pietro.avanzini@unipr.it	daprati, elena/AAA-2224-2019; Cantalupo, Gaetano/N-8617-2019; Cantalupo, Gaetano/A-4231-2010; Fabbri-Destro, Maddalena/J-4988-2018	Cantalupo, Gaetano/0000-0003-1343-8434; Cantalupo, Gaetano/0000-0003-1343-8434; DALLA VOLTA, Riccardo/0000-0002-2621-4459; Fabbri Destro, Maddalena/0000-0001-8321-4634; Avanzini, Pietro/0000-0001-9371-451X	Fondo Regionale per le Neuroscienze; Compagnia di San Paolo (Neuroscience Program); European Union grant "Cogsystem"	Fondo Regionale per le Neuroscienze; Compagnia di San Paolo (Neuroscience Program)(Compagnia di San Paolo); European Union grant "Cogsystem"	This study was supported by Fondo Regionale per le Neuroscienze, by Compagnia di San Paolo (Neuroscience Program), and by European Union grant "Cogsystem" to GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULER EL, 1997, 27 ANN M SOC NEUR NE; [Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Arnstein D, 2011, J NEUROSCI, V31, P14243, DOI 10.1523/JNEUROSCI.0963-11.2011; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; CHATRIAN GE, 1959, ELECTROEN CLIN NEURO, V11, P497, DOI 10.1016/0013-4694(59)90048-3; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fischer T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012514; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; GASTAUT H, 1952, Mars Med, V89, P296; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2006, PROG BRAIN RES, V159, P253, DOI 10.1016/S0079-6123(06)59017-X; HYVARINEN J, 1982, PHYSIOL REV, V62, P1060, DOI 10.1152/physrev.1982.62.3.1060; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Kilavik B.E., 2011, CEREB CORTEX; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Nunez PL, 2006, CLIN NEUROPHYSIOL, V117, P2424, DOI 10.1016/j.clinph.2006.06.754; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perry A, 2010, NEUROREPORT, V21, P1050, DOI 10.1097/WNR.0b013e32833fcb71; Perry A, 2009, BRAIN RES, V1282, P126, DOI 10.1016/j.brainres.2009.05.059; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V102, P316, DOI 10.1016/S0013-4694(96)96612-2; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Press C, 2011, J NEUROSCI, V31, P2792, DOI 10.1523/JNEUROSCI.1595-10.2011; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Stancak A, 1997, ELECTROEN CLIN NEURO, V102, P495, DOI 10.1016/S0013-4694(96)96623-0; Streltsova A, 2010, EXP BRAIN RES, V205, P363, DOI 10.1007/s00221-010-2371-7; TIIHONEN J, 1989, NEUROSCIENCE, V32, P793, DOI 10.1016/0306-4522(89)90299-6; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Yuan H, 2010, IEEE ENG MED BIO, P142, DOI 10.1109/IEMBS.2010.5627414; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001	61	115	118	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37534	10.1371/journal.pone.0037534	http://dx.doi.org/10.1371/journal.pone.0037534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624046	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500133
J	Lyng, MB; Laenkholm, AV; Sokilde, R; Gravgaard, KH; Litman, T; Ditzel, HJ				Lyng, Maria B.; Laenkholm, Anne-Vibeke; Sokilde, Rolf; Gravgaard, Karina H.; Litman, Thomas; Ditzel, Henrik J.			Global MicroRNA Expression Profiling of High-Risk ER plus Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; RESISTANCE; TARGETS; TUMORS; DEREGULATION; GUIDELINES; EXPERIENCE; DATABASE; PATHWAY	Purpose: Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been suggested as promising biomarkers and we here evaluated whether a miRNA profile could be identified, sub-grouping ER+ breast cancer patients treated with adjuvant Tamoxifen with regards to probability of recurrence. Experimental Design: Global miRNA analysis was performed on 152 ER+ primary tumors from high-risk breast cancer patients with an initial discovery set of 52 patients, followed by two independent test sets (N = 60 and N = 40). All patients had received adjuvant Tamoxifen as mono-therapy (median clinical follow-up: 4.6 years) and half had developed distant recurrence (median time-to-recurrence: 3.5 years). MiRNA expression was examined by unsupervised hierarchical clustering and supervised analysis, including clinical parameters as co-variables. Results: The discovery set identified 10 highly significant miRNAs that discriminated between the patient samples according to outcome. However, the subsequent two independent test sets did not confirm the predictive potential of these miRNAs. A significant correlation was identified between miR-7 and the tumor grade. Investigation of the microRNAs with the most variable expression between patients in different runs yielded a list of 31 microRNAs, eight of which are associated with stem cell characteristics. Conclusions: Based on the large sample size, our data strongly suggests that there is no single miRNA profile predictive of outcome following adjuvant Tamoxifen treatment in a broad cohort of ER+ breast cancer patients. We identified a subgroup of Tamoxifen-treated breast cancer patients with miRNA-expressing tumors associated with cancer stem cell characteristics.	[Lyng, Maria B.; Gravgaard, Karina H.; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Sokilde, Rolf; Litman, Thomas] Exiqon AS, Dept Biomarker Discovery, Vedbaek, Denmark; [Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; Exiqon; University of Southern Denmark; Odense University Hospital	Lyng, MB (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	mlyng@health.sdu.dk; hditzel@health.sdu.dk	Søkilde, Rolf/F-5138-2015	Søkilde, Rolf/0000-0003-3010-3599; Gravgaard Thomsen, Karina/0000-0002-9593-7239; Litman, Thomas/0000-0002-6068-901X; Laenkholm, Anne-Vibeke/0000-0003-2166-8686; Ditzel, Henrik J./0000-0003-3927-5135	Danish Cancer Society; Danish Cancer Research Foundation; Danish Research Council; Danish Strategic Research Council; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Danish Center for Translational Breast Cancer research (DCTB)	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Danish Center for Translational Breast Cancer research (DCTB)	This work was supported in part by the Danish Cancer Society, the Danish Cancer Research Foundation, the Danish Research Council, the Danish Strategic Research Council, A Race Against Breast Cancer, Sino-Danish Breast Cancer Research Centre, NanoCAN Lundbeck Center of Excellence, Region of Southern Denmark Research Foundation, and Danish Center for Translational Breast Cancer research (DCTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Andersen J, 2008, ACTA ONCOL, V47, P718, DOI 10.1080/02841860802014882; Baum M, 2002, LANCET, V359, P2131; Blamey RW, 2002, EUR J CANCER, V38, P615, DOI 10.1016/S0959-8049(02)00011-4; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Elston C W, 2002, Histopathology, V41, P154; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lyng MB, 2011, PREDICTION OUT UNPUB; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Masri S, 2010, BREAST CANCER RES TR, V124, P89, DOI 10.1007/s10549-009-0716-3; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; MOURIDSEN HT, 2008, BIG 1 98 RANDOMIZED; O'Brien CS, 2009, J MAMMARY GLAND BIOL, V14, P45, DOI 10.1007/s10911-009-9115-y; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rodriguez-Gonzalez FG, 2010, BREAST CANC RES TREA; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Sachdeva M, 2011, ONCOGENE, V30, P822, DOI 10.1038/onc.2010.463; Tessel MA, 2010, CURR OPIN ONCOL; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	33	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36170	10.1371/journal.pone.0036170	http://dx.doi.org/10.1371/journal.pone.0036170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623953	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500012
J	Mesquita, RC; Han, SW; Miller, J; Schenkel, SS; Pole, A; Esipova, TV; Vinogradov, SA; Putt, ME; Yodh, AG; Busch, TM				Mesquita, Rickson C.; Han, Sung Wan; Miller, Joann; Schenkel, Steven S.; Pole, Andrew; Esipova, Tatiana V.; Vinogradov, Sergei A.; Putt, Mary E.; Yodh, Arjun G.; Busch, Theresa M.			Tumor Blood Flow Differs between Mouse Strains: Consequences for Vasoresponse to Photodynamic Therapy	PLOS ONE			English	Article							FLUCTUATIONS; HYPOXIA; MUSCLE; HETEROGENEITY; VASOMOTION; RADIATION; RESPONSES; PERFUSION; SIGNAL; DAMAGE	Fluctuations in tumor blood flow are common and attributed to factors such as vasomotion or local vascular structure, yet, because vessel structure and physiology are host-derived, animal strain of tumor propagation may further determine blood flow characteristics. In the present report, baseline and stress-altered tumor hemodynamics as a function of murine strain were studied using radiation-induced fibrosacomas (RIF) grown in C3H or nude mice. Fluctuations in tumor blood flow during one hour of baseline monitoring or during vascular stress induced by photodynamic therapy (PDT) were measured by diffuse correlation spectroscopy. Baseline monitoring revealed fluctuating tumor blood flow highly correlated with heart rate and with similar median periods (i.e. similar to 9 and 14 min in C3H and nudes, respectively). However, tumor blood flow in C3H animals was more sensitive to physiologic or stress-induced perturbations. Specifically, PDT-induced vascular insults produced greater decreases in blood flow in the tumors of C3H versus nude mice; similarly, during baseline monitoring, fluctuations in blood flow were more regular and more prevalent within the tumors of C3H mice versus nude mice; finally, the vasoconstrictor L-NNA reduced tumor blood flow in C3H mice but did not affect tumor blood flow in nudes. Underlying differences in vascular structure, such as smaller tumor blood vessels in C3H versus nude animals, may contribute to strain-dependent variation in vascular function. These data thus identify clear effects of mouse strain on tumor hemodynamics with consequences to PDT and potentially other vascular-mediated therapies.	[Mesquita, Rickson C.; Schenkel, Steven S.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Mesquita, Rickson C.] Univ Estadual Campinas, Inst Phys, Sao Paulo, Brazil; [Han, Sung Wan; Putt, Mary E.] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Miller, Joann; Busch, Theresa M.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pole, Andrew] New Jersey Inst Technol, Dept Math Sci, Newark, NJ 07102 USA; [Esipova, Tatiana V.; Vinogradov, Sergei A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Universidade Estadual de Campinas; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; New Jersey Institute of Technology; University of Pennsylvania	Mesquita, RC (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	buschtm@mail.med.upenn.edu	Busch, Theresa/J-5591-2019; Mesquita, Rickson C/N-9119-2013	Mesquita, Rickson C/0000-0003-1945-6713	National Institutes of Health [CA-085831, CA-087971, CA-087971-S1]; NATIONAL CANCER INSTITUTE [R01CA085831, P01CA087971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health through CA-085831, CA-087971, and CA-087971-S1. Some of the authors also acknowledge the following sources: P41-RR002305 (AGY) and R01-NS060653 (RCM, AGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudelet C, 2004, MAGN RESON IMAGING, V22, P905, DOI 10.1016/j.mri.2004.02.005; Baudelet C, 2006, NMR BIOMED, V19, P69, DOI 10.1002/nbm.1002; Becker TL, 2011, BIOMED OPT EXPRESS, V2, P123, DOI 10.1364/BOE.2.000123; Braun RD, 1999, AM J PHYSIOL-HEART C, V277, pH551, DOI 10.1152/ajpheart.1999.277.2.H551; Busch TM, 2009, PHOTOCH PHOTOBIO SCI, V8, P1683, DOI 10.1039/b9pp00004f; Busch TM, 2010, RADIAT RES, V174, P331, DOI 10.1667/RR2075.1; Busch TM, 2002, CANCER RES, V62, P7273; Campen MJ, 2005, J APPL PHYSIOL, V99, P807, DOI 10.1152/japplphysiol.00039.2005; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; CHAPLIN DJ, 1995, BRIT J CANCER, V71, P1210, DOI 10.1038/bjc.1995.235; CHAPLIN DJ, 1986, INT J RADIAT ONCOL, V12, P1279, DOI 10.1016/0360-3016(86)90153-7; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Chen B, 2006, CRIT REV EUKAR GENE, V16, P279, DOI 10.1615/CritRevEukarGeneExpr.v16.i4.10; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; Durand RE, 1997, RADIOTHER ONCOL, V42, P171, DOI 10.1016/S0167-8140(96)01878-6; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Ferretti S, 2009, NEOPLASIA, V11, P874, DOI 10.1593/neo.09554; Fingar VH, 2000, IN VIVO, V14, P93; Guerkan E, 2008, MAMM GENOME, V19, P366, DOI 10.1007/s00335-008-9118-9; GUICHARD M, 1991, RADIOTHER ONCOL, V20, P117, DOI 10.1016/0167-8140(91)90145-7; Hahn SM, 2006, CLIN CANCER RES, V12, P5464, DOI 10.1158/1078-0432.CCR-06-0953; He C, 2008, PHARM RES-DORDR, V25, P1873, DOI 10.1007/s11095-008-9604-5; Hill SA, 1996, BRIT J CANCER, V74, pS260; Khurana M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3262521; KIANI MF, 1994, AM J PHYSIOL, V266, pH1822, DOI 10.1152/ajpheart.1994.266.5.H1822; Kimura H, 1996, CANCER RES, V56, P5522; Korbelik M, 1999, CANCER RES, V59, P1941; Lanzen J, 2006, CANCER RES, V66, P2219, DOI 10.1158/0008-5472.CAN-03-2958; Marrero A, 2011, PHOTOCHEM PHOTOBIOL, V87, P910, DOI 10.1111/j.1751-1097.2011.00943.x; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; MEYER JU, 1988, MICROVASC RES, V35, P193, DOI 10.1016/0026-2862(88)90062-3; Pigott KH, 1996, RADIOTHER ONCOL, V40, P45, DOI 10.1016/0167-8140(96)01730-6; Pogue BW, 2001, PHOTOCHEM PHOTOBIOL, V74, P700, DOI 10.1562/0031-8655(2001)074<0700:AOTHOP>2.0.CO;2; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; SCHECHNER JS, 1992, MICROVASC RES, V44, P27, DOI 10.1016/0026-2862(92)90099-B; Schumacher J, 2001, J CRIT CARE, V16, P1, DOI 10.1053/jcrc.2001.21790; Seshadri M, 2008, CLIN CANCER RES, V14, P2796, DOI 10.1158/1078-0432.CCR-07-4705; Shang Y, 2011, OPT EXPRESS, V19, P20301, DOI 10.1364/OE.19.020301; Skala MC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285584; SOLESVIK OV, 1985, EUR J CANCER CLIN ON, V21, P499, DOI 10.1016/0277-5379(85)90044-6; Standish BA, 2007, GASTROINTEST ENDOSC, V66, P326, DOI 10.1016/j.gie.2007.02.040; VAAGE J, 1992, INT J CANCER, V50, P69, DOI 10.1002/ijc.2910500115; Van Bogaert MJV, 2006, GENES BRAIN BEHAV, V5, P139, DOI 10.1111/j.1601-183X.2005.00143.x; Vinogradov SA, 2011, REV SCI INSTRUM, V72, P3396; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Yu GQ, 2005, CLIN CANCER RES, V11, P3543, DOI 10.1158/1078-0432.CCR-04-2582	47	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37322	10.1371/journal.pone.0037322	http://dx.doi.org/10.1371/journal.pone.0037322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624014	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500097
J	Schulz, TC; Young, HY; Agulnick, AD; Babin, MJ; Baetge, EE; Bang, AG; Bhoumik, A; Cepa, I; Cesario, RM; Haakmeester, C; Kadoya, K; Kelly, JR; Kerr, J; Martinson, LA; McLean, AB; Moorman, MA; Payne, JK; Richardson, M; Ross, KG; Sherrer, ES; Song, XH; Wilson, AZ; Brandon, EP; Green, CE; Kroon, EJ; Kelly, OG; D'Amour, KA; Robins, AJ				Schulz, Thomas C.; Young, Holly Y.; Agulnick, Alan D.; Babin, M. Josephine; Baetge, Emmanuel E.; Bang, Anne G.; Bhoumik, Anindita; Cepa, Igor; Cesario, Rosemary M.; Haakmeester, Carl; Kadoya, Kuniko; Kelly, Jonathan R.; Kerr, Justin; Martinson, Laura A.; McLean, Amanda B.; Moorman, Mark A.; Payne, Janice K.; Richardson, Mike; Ross, Kelly G.; Sherrer, Eric S.; Song, Xuehong; Wilson, Alistair Z.; Brandon, Eugene P.; Green, Chad E.; Kroon, Evert J.; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.			A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells	PLOS ONE			English	Article							SUSPENSION-CULTURE; GENE-EXPRESSION; DIFFERENTIATION; EXPANSION; ENDODERM; TRANSPLANTATION; GROWTH; COLONY	Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated that hESC can be directed to differentiate into pancreatic progenitors that mature into functional glucose-responsive, insulin-secreting cells in vivo. In this study we describe hESC expansion and banking methods and a suspension-based differentiation system, which together underpin an integrated scalable manufacturing process for producing pancreatic progenitors. This system has been optimized for the CyT49 cell line. Accordingly, qualified large-scale single-cell master and working cGMP cell banks of CyT49 have been generated to provide a virtually unlimited starting resource for manufacturing. Upon thaw from these banks, we expanded CyT49 for two weeks in an adherent culture format that achieves 50-100 fold expansion per week. Undifferentiated CyT49 were then aggregated into clusters in dynamic rotational suspension culture, followed by differentiation en masse for two weeks with a four-stage protocol. Numerous scaled differentiation runs generated reproducible and defined population compositions highly enriched for pancreatic cell lineages, as shown by examining mRNA expression at each stage of differentiation and flow cytometry of the final population. Islet-like tissue containing glucose-responsive, insulin-secreting cells was generated upon implantation into mice. By four- to five-months post-engraftment, mature neo-pancreatic tissue was sufficient to protect against streptozotocin (STZ)-induced hyperglycemia. In summary, we have developed a tractable manufacturing process for the generation of functional pancreatic progenitors from hESC on a scale amenable to clinical entry.	[Schulz, Thomas C.; Sherrer, Eric S.; Song, Xuehong; Robins, Allan J.] Viacyte Inc, Athens, GA USA; [Young, Holly Y.; Agulnick, Alan D.; Babin, M. Josephine; Baetge, Emmanuel E.; Bang, Anne G.; Bhoumik, Anindita; Cepa, Igor; Cesario, Rosemary M.; Haakmeester, Carl; Kadoya, Kuniko; Kelly, Jonathan R.; Kerr, Justin; Martinson, Laura A.; Moorman, Mark A.; Payne, Janice K.; Richardson, Mike; Ross, Kelly G.; Wilson, Alistair Z.; Brandon, Eugene P.; Green, Chad E.; Kroon, Evert J.; Kelly, Olivia G.; D'Amour, Kevin A.; Robins, Allan J.] Viacyte Inc, San Diego, CA USA; [McLean, Amanda B.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schulz, TC (corresponding author), Viacyte Inc, Athens, GA USA.	tschulz@viacyte.com		KROON, EVERT/0000-0002-4069-3644	California Institute for Regenerative Medicine [DR1-01423, TR1-01215]; National Institutes of Health (NIGMS) [5P01GM085354-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Studies were performed in part with funding derived from the California Institute for Regenerative Medicine (DR1-01423, TR1-01215), and the National Institutes of Health (NIGMS, 5P01GM085354-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y; Barbaric I, 2011, CRYOBIOLOGY, V63, P298, DOI 10.1016/j.cryobiol.2011.10.002; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Chen XL, 2010, STEM CELLS DEV, V19, P1781, DOI 10.1089/scd.2010.0077; Clark GO, 2007, BIOCHEM BIOPH RES CO, V356, P587, DOI 10.1016/j.bbrc.2007.03.017; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EIZIRIK DL, 1994, P NATL ACAD SCI USA, V91, P9253, DOI 10.1073/pnas.91.20.9253; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hosokawa M, 2001, BIOCHEM BIOPH RES CO, V289, P1114, DOI 10.1006/bbrc.2001.6145; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LEY K, 1989, BLOOD, V73, P1324; Li L, 2010, BIOPHYS J, V98, P2442, DOI 10.1016/j.bpj.2010.02.029; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Matsumoto S, 2011, DIABETES METAB J, V35, P199, DOI 10.4093/dmj.2011.35.3.199; McCall MD, 2010, CLIN SCI, V118, P87, DOI 10.1042/CS20090072; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; OKAMOTO H, 1985, BIOMED BIOCHIM ACTA, V44, P15; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Schulz TC, 2009, EMERGING TECHNOLOGY, P251; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Singh H, 2010, STEM CELL RES, V4, P165, DOI 10.1016/j.scr.2010.03.001; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Ungrin MD, 2012, BIOTECHNOL BIOENG, V109, P853, DOI 10.1002/bit.24375; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; Verdier C, 2009, J MATH BIOL, V58, P235, DOI 10.1007/s00285-008-0164-4; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wquimby F, 2007, MOUSE BIOMEDICAL RES, P171, DOI DOI 10.1016/B978-012369454-6/50060-1; Young H, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, P397, DOI 10.1016/B978-0-12-374729-7.00044-5	47	290	329	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37004	10.1371/journal.pone.0037004	http://dx.doi.org/10.1371/journal.pone.0037004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623968	gold, Green Published			2022-12-27	WOS:000305343500045
J	Tovilla-Zarate, C; Juarez-Rojop, I; Jimenez, YP; Jimenez, MA; Vazquez, S; Bermudez-Ocana, D; Ramon-Frias, T; Mendoza, ADG; Garcia, SP; Narvaez, LL				Tovilla-Zarate, Carlos; Juarez-Rojop, Isela; Peralta Jimenez, Yesenia; Antonia Jimenez, Maria; Vazquez, Silvia; Bermudez-Ocana, Deysi; Ramon-Frias, Teresa; Genis Mendoza, Alma D.; Pool Garcia, Sherezada; Lopez Narvaez, Lilia			Prevalence of Anxiety and Depression among Outpatients with Type 2 Diabetes in the Mexican Population	PLOS ONE			English	Article							RISK-FACTORS; COMORBID DEPRESSION; RATING-SCALE; COMPLICATIONS; ASSOCIATION; DISORDERS; DISEASES; HEALTH; STATES; WORLD	Background: Depression and anxiety are common in diabetic patients; however, in recent years the frequency of these symptoms has markedly increased worldwide. Therefore, it is necessary to establish the frequency and factors associated with depression and anxiety, since they can be responsible for premature morbidity, mortality, risk of developing comorbidities, complications, suffering of patients, as well as escalation of costs. We studied the frequency of depression and anxiety in Mexican outpatients with type 2 diabetes and identified the risk factors for depression and anxiety. Methods and Findings: We performed a study in 820 patients with type 2 diabetes. The prevalence of depression and anxiety was estimated using the Hamilton Depression Rating Scale and the Hamilton Anxiety Rating Scale, respectively. We calculated the proportions for depression and anxiety and, after adjusting for confounding variables, we performed multivariate analysis using multiple logistic regressions to evaluate the combined effect of the various factors associated with anxiety and depression among persons with type 2 diabetes. The rates for depression and anxiety were 48.27% (95% CI: 44.48-52.06) and 55.10% (95% CI: 51.44-58.93), respectively. Occupation and complications in diabetes were the factors associated with anxiety, whereas glucose level and complications in diabetes were associated with depression. Complications in diabetes was a factor common to depression and anxiety (p < 0.0001; OR 1.79, 95% CI 1.29-2.4). Conclusions: Our findings demonstrate that a large proportion of diabetic patients present depression and/or anxiety. We also identified a significant association between complications in diabetes with depression and anxiety. Interventions are necessary to hinder the appearance of complications in diabetes and in consequence prevent depression and anxiety.	[Tovilla-Zarate, Carlos; Peralta Jimenez, Yesenia; Antonia Jimenez, Maria; Vazquez, Silvia; Bermudez-Ocana, Deysi; Ramon-Frias, Teresa] Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico; [Juarez-Rojop, Isela] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Salud, Villahermosa, Tabasco, Mexico; [Genis Mendoza, Alma D.] Serv Atenc Psiquiatr, Secretaria Salud, Mexico City, DF, Mexico; [Pool Garcia, Sherezada] Hosp Gen Comalcalco, Tabasco Secretaria Salud, Comalcalco, Tabasco, Mexico; [Tovilla-Zarate, Carlos; Lopez Narvaez, Lilia] Ctr Invest Genom, Comalcalco, Tabasco, Mexico	Universidad Juarez Autonoma de Tabasco; Universidad Juarez Autonoma de Tabasco	Tovilla-Zarate, C (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Multidisciplinaria Comalcalco, Comalcalco, Tabasco, Mexico.	alfonso_tovillaz@yahoo.com.mx	Tovilla-Zárate, Carlos Alfonso/AAC-3260-2021; Juarez Rojop, Isela Esther/G-4832-2016	Tovilla-Zárate, Carlos Alfonso/0000-0001-8170-8171; Juarez Rojop, Isela Esther/0000-0003-3760-7394; Genis-Mendoza, Alma/0000-0001-8180-477X; Bermudez-Ocana, Deysi/0000-0002-9750-7670	Universidad Juarez Autonoma de Tabasco P.O.A. [20111282]	Universidad Juarez Autonoma de Tabasco P.O.A.	This study was supported by Universidad Juarez Autonoma de Tabasco P.O.A. 20111282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi W, 2008, J ENDOCRINOL INVEST, V31, P1020, DOI 10.1007/BF03345642; Balhara Yatan Pal Singh, 2011, Indian J Endocrinol Metab, V15, pS50, DOI 10.4103/2230-8210.83057; Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971; Castro-Ake Gilberto Alejandro, 2009, Rev Med Inst Mex Seguro Soc, V47, P377; Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Colunga-Rodríguez Cecilia, 2008, Rev. salud pública, V10, P137, DOI 10.1590/S0124-00642008000100013; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Furuya M, 2010, ACTA DIABETOLOGICA; Garduno-Espinosa J, 1998, REV INVEST CLIN, V50, P287; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Iype T, 2009, ANN INDIAN ACAD NEUR, V12, P25, DOI 10.4103/0972-2327.48848; JoaquIn Z, 2007, SALUD MENT, V30, P4; Katon W, 2010, DEPRESS ANXIETY, V27, P19, DOI 10.1002/da.20613; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Khuwaja AK, 2010, CHRONIC ILLN, V6, P163, DOI 10.1177/1742395309352255; Kim TS, 2011, PSYCHIAT INVEST, V8, P1, DOI 10.4306/pi.2011.8.1.1; Kummer A, 2010, ARQ NEURO-PSIQUIAT, V68, P495, DOI 10.1590/S0004-282X2010000400005; Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Maharaj RG, 2005, W INDIAN MED J, V54, P369; McDade-Montez EA, 2011, ANN BEHAV MED PUBLIC; Medina-Mora ME, 2003, SALUD MENT, V26, P1; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mosaku K, 2008, J NATL MED ASSOC, V100, P73, DOI 10.1016/S0027-9684(15)31178-0; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Olaiz G, 2006, ENCUESTA NACL SALUD; Pulido-Criollo F, 2009, REV PANAM SALUD PUBL, V26, P209, DOI 10.1590/S1020-49892009000900004; Shear MK, 2001, DEPRESS ANXIETY, V13, P166, DOI 10.1002/da.1033.abs; Stein DJ, 2004, LANCET, V364, P233, DOI 10.1016/S0140-6736(04)16693-2; Trento M, 2011, CROSS SECTIONAL SURV; Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009	36	69	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36887	10.1371/journal.pone.0036887	http://dx.doi.org/10.1371/journal.pone.0036887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629339	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500034
J	Winter, C; Kerros, ME; Weinbauer, MG				Winter, Christian; Kerros, Marie-Emmanuelle; Weinbauer, Markus G.			Effects of Sodium Azide on the Abundance of Prokaryotes and Viruses in Marine Samples	PLOS ONE			English	Article							PRESERVED SEAWATER SAMPLES; EPIFLUORESCENCE MICROSCOPY; BACTERIA; COUNTS	Flow cytometry is set to become the standard method for enumerating prokaryotes and viruses in marine samples. However, the samples need to be flash-frozen in liquid nitrogen directly after aldehyde fixation. Because liquid nitrogen may not always be available, we tested the potential of sodium azide as a preservative for prokaryotes and viruses in marine samples as a possible alternative. For that we conducted incubation experiments with untreated and sodium azide treated marine water samples at 4 degrees C and room temperature. The data indicate that sodium azide cannot be used to maintain marine samples used for the enumeration of prokaryotes and viruses.	[Winter, Christian] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Kerros, Marie-Emmanuelle; Weinbauer, Markus G.] CNRS, Microbial Ecol & Biogeochem Grp, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Kerros, Marie-Emmanuelle; Weinbauer, Markus G.] Univ Paris 06, Lab Oceanog Villefranche, Villefranche Sur Mer, France	University of Vienna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Winter, C (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	christian.winter@univie.ac.at	Weinbauer, Markus/ABC-7017-2020	Weinbauer, Markus/0000-0002-7697-5571; Winter, Christian/0000-0001-6327-0209	European Commission [007712]; Institut National des Sciences de l'Univers - Centre National de la Recherche Scientifique	European Commission(European CommissionEuropean Commission Joint Research Centre); Institut National des Sciences de l'Univers - Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Financial support was provided by the European Commission in the form of a Marie Curie postdoctoral fellowship to CW (project ILVIROMAB, no. 007712). The cruises were financed by Institut National des Sciences de l'Univers - Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; GERENCSER VF, 1959, APPL MICROBIOL, V7, P113, DOI 10.1128/AEM.7.2.113-115.1959; Gundersen K, 1996, MAR ECOL PROG SER, V137, P305, DOI 10.3354/meps137305; HEIM WG, 1956, AM J PHYSIOL, V186, P19, DOI 10.1152/ajplegacy.1956.186.1.19; HENNES KP, 1995, LIMNOL OCEANOGR, V40, P1050, DOI 10.4319/lo.1995.40.6.1050; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Lichstein HC, 1944, J BACTERIOL, V47, P239, DOI 10.1128/JB.47.3.239-251.1944; Marie D, 1999, CURRENT PROTOCOLS CY; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; ROHLF FJ, 1994, BIOMETRY; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; TURLEY CM, 1992, DEEP-SEA RES, V39, P375, DOI 10.1016/0198-0149(92)90079-9; Wen K, 2004, APPL ENVIRON MICROB, V70, P3862, DOI 10.1128/AEM.70.7.3862-3867.2004	16	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37597	10.1371/journal.pone.0037597	http://dx.doi.org/10.1371/journal.pone.0037597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624052	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500141
J	Zhu, HP; Xia, X; Xiang, HY; Yu, CH; Du, YK				Zhu, Hui-ping; Xia, Xin; Xiang, Hui-yun; Yu, Chuan-hua; Du, Yu-kai			Disability, Home Physical Environment and Non-Fatal Injuries among Young Children in China	PLOS ONE			English	Article							UNINTENTIONAL INJURY; PUBLIC-HEALTH; US CHILDREN; RISK; PREVALENCE; COUNTRIES; MOTHERS; RECALL; PEOPLE; ADULTS	Objectives: We compared the patterns of medically attended injuries between children with and without disabilities and explored the residential environment risks in five counties of Hubei Province in the People's Republic of China by a 1: 1 matched case-control study based on the biopsychosocial model of the International Classification of Functioning, Disability and Health - ICF. Methods: 1201 children aged 1-14 with disabilities and 1201 their healthy counterparts matched as having the same gender, same age, and lived in the same neighborhood were recruited in our study. Characteristics of injuries in the past 12 months were compared between children with and without disabilities. The associations among disability status, home environment factors and injuries were examined in logistic regression analysis taking into account sociodemographic factors. Results: Children with disabilities had a significantly higher prevalence of injury than children without disabilities (10.2% vs. 4.4%; P<.001). The two groups differed significantly in terms of number of injury episodes, injury place and activity at time of injury. Falls were the leading mechanism of injury regardless of disability status. Most of the injury events happened inside the home and leisure activities were the most reported activity when injured for both groups. The univariate OR for injury was 4.46 (2.57-7.74) for the disabled children compared with the non-disabled children. Disabled children whose family raised cat/dog(s) were 76% more likely to be injured during the last 12 months (OR = 1.76; 95% CI = 1.02, 3.02), comparing with those whose family did not have any cat/dog. And for children without disabilities, those whose family had cat/dog(s) were over 3 times more likely to having injuries comparing with those whose family did not have any cat/dog. Conclusions: Children with disabilities had a significantly increased risk for injury. Interventions to prevent residential injury are an important public health priority in children with disabilities.	[Zhu, Hui-ping; Du, Yu-kai] Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xia, Xin] Wuhan Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430072, Peoples R China; [Xiang, Hui-yun] Ohio State Univ, Res Inst, Ctr Injury Res & Policy, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Yu, Chuan-hua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Wuhan 430072, Peoples R China	Huazhong University of Science & Technology; Wuhan University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Wuhan University	Zhu, HP (corresponding author), Huazhong Univ Sci & Technol, Dept Maternal & Child Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	birdping@163.com	Xiang, Huiyun/E-4335-2011		USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center [1D43TW007257-01A2]; FOGARTY INTERNATIONAL CENTER [D43TW007257] Funding Source: NIH RePORTER	USA-China Agricultural Injury Research Training Project; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	HYX's effort in this project was supported by the USA-China Agricultural Injury Research Training Project, funded by the National Institutes of Health Fogarty International Center (Grant #: 1D43TW007257-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmed MK, 1999, INT J EPIDEMIOL, V28, P306, DOI 10.1093/ije/28.2.306; Bang RL, 1997, EUR J EPIDEMIOL, V13, P33, DOI 10.1023/A:1007368014623; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Gauchard GC, 2006, NEUROEPIDEMIOLOGY, V26, P108, DOI 10.1159/000090445; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; HAREL Y, 1994, AM J PUBLIC HEALTH, V84, P599, DOI 10.2105/AJPH.84.4.599; Hawkins ER, 2007, PEDIATR EMERG CARE, V23, P790, DOI 10.1097/PEC.0b013e318159ffd9; Hsieh K, 2001, J INTELL DISABIL RES, V45, P76, DOI 10.1046/j.1365-2788.2001.00277.x; Jette AM, 2009, J GERONTOL A-BIOL, V64, P1165, DOI 10.1093/gerona/glp093; Jin HQ, 1999, CHIN J ERGONOMICS, V1, P1; Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; LeBlanc JC, 2006, CAN MED ASSOC J, V175, P883, DOI 10.1503/cmaj.050592; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Leff M, 2010, INJURY PREV, V16, DOI 10.1136/ip.2010.028522; Legood R, 2002, INJ PREV, V8, P155, DOI 10.1136/ip.8.2.155; Limbos MAP, 2004, ARCH PEDIAT ADOL MED, V158, P1057, DOI 10.1001/archpedi.158.11.1057; Lollar DJ, 2002, PUBLIC HEALTH REP, V117, P131, DOI 10.1093/phr/117.2.131; Lyons RA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003600.pub2; Mehta A, 1996, J Indian Med Assoc, V94, P219; Mull DS, 2001, SOC SCI MED, V52, P1081, DOI 10.1016/S0277-9536(00)00215-X; National Bureau of Statistics of China and China Disabled Person's Federation, MAJ DAT COMM 2 2 NAT; Petridou E, 2003, INJURY PREV, V9, P226, DOI 10.1136/ip.9.3.226; Qiu HX, 1998, CHIN J EPIDEMIOL, V4, P211; Ramirez M, 2010, ACAD PEDIATR, V10, P317, DOI 10.1016/j.acap.2010.06.003; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Schwebel DC, 2006, J SAFETY RES, V37, P167, DOI 10.1016/j.jsr.2005.11.004; Schwebel David C, 2009, Int Emerg Nurs, V17, P47, DOI 10.1016/j.ienj.2008.07.003; Sherrard J, 2001, Inj Prev, V7, P56; Sherrard J, 2002, J INTELL DISABIL RES, V46, P6, DOI 10.1046/j.1365-2788.2002.00346.x; Sinclair SA, 2008, AM J PUBLIC HEALTH, V98, P1510, DOI 10.2105/AJPH.2006.097097; Slayter EM, 2006, MENT RETARD, V44, P212, DOI 10.1352/0047-6765(2006)44[212:IPACAA]2.0.CO;2; Soubhi H, 2004, AM J HEALTH BEHAV, V28, P397; UN Enable, FREQ ASK QUEST REG C; United Nations Children's Fund. Early Child Development Unit, PROGR EXP EARL CHILD; Wang SY, 1998, LIT INFORMATION PREV, V4, P299; Wilber N, 2002, MILBANK Q, V80, P393, DOI 10.1111/1468-0009.00009; World Health Organization, 2002, COMMON LANGUAGE FUNC; World Health Organization. Disability and Rehabilitation Team, WORLD REP DIS REH; Xiang H, 2005, INJURY PREV, V11, P157, DOI 10.1136/ip.2004.006429; Xiang HY, 2005, AM J PUBLIC HEALTH, V95, P1970, DOI 10.2105/AJPH.2004.057505	42	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37766	10.1371/journal.pone.0037766	http://dx.doi.org/10.1371/journal.pone.0037766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624063	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500152
J	Billong, SC; Fokam, J; Nkwescheu, AS; Kembou, E; Milenge, P; Tsomo, Z; Dion, GN; Aghokeng, AF; Mpoudi, EN; Ndumbe, PM; Colizzi, V; Nfetam, JBE				Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Kembou, Etienne; Milenge, Pascal; Tsomo, Zephirin; Dion, Grace Ngute; Aghokeng, Avelin F.; Mpoudi, Eitel N.; Ndumbe, Peter M.; Colizzi, Vittorio; Nfetam, Jean B. Elat			Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; ANTIRETROVIRAL TREATMENT; SURVEILLANCE; PREVENTION	Background: Rapid scale-up of antiretroviral therapy (ART) in resource-limited settings is accompanied with an increasing risk of HIV drug resistance (HIVDR), which in turn could compromise the performance of national ART rollout programme. In order to sustain the effectiveness of ART in a resource-limited country like Cameroon, HIVDR early warning indicators (EWI) may provide relevant corrective measures to support the control and therapeutic management of AIDS. Methods: A retrospective study was conducted in 2010 among 40 ART sites (12 Approved Treatment Centers and 28 Management Units) distributed over the 10 regions of Cameroon. Five standardized EWIs were selected for the evaluation using data from January through December, among which: (1) Good ARV prescribing practices: target = 100%; (2) Patient lost to follow-up: target <= 20%; (3) Patient retention on first line ART: target >= 70%; (4) On-time drug pick-up: target >= 90%; (5) ARV drug supply continuity: target = 100%. Analysis was performed using a Data Quality Assessment tool, following WHO protocol. Results: The number of sites attaining the required performance are: 90% (36/40) for EWI1, 20% (8/40) for EWI2; 20% (8/40) for EWI3; 0% (0/37) for EWI4; and 45% (17/38) for EWI 5. ARV prescribing practices were in conformity with the national guidelines in almost all the sites, whereas patient adherence to ART (EWI2, EWI3, and EWI4) was very low. A high rate of patients was lost-to-follow-up and others failing first line ART before 12 months of initiation. Discontinuity in drug supply observed in about half of the sites may negatively impact ARV prescription and patient adherence. These poor ART performances may also be due to low number of trained staff and community disengagement. Conclusions: The poor performance of the national ART programme, due to patient non-adherence and drug stock outs, requires corrective measures to limit risks of HIVDR emergence in Cameroon.	[Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Kembou, Etienne; Milenge, Pascal; Tsomo, Zephirin; Dion, Grace Ngute; Aghokeng, Avelin F.; Nfetam, Jean B. Elat] NACC, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon; [Billong, Serge C.; Dion, Grace Ngute; Nfetam, Jean B. Elat] Minist Publ Hlth, NACC, CTG, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Nkwescheu, Armand S.; Ndumbe, Peter M.] Univ Yaounde I, FMBS, Yaounde, Cameroon; [Fokam, Joseph; Ndumbe, Peter M.; Colizzi, Vittorio] Chantal BIYA Int Reference Ctr CIRCB Res HIV AIDS, Yaounde, Cameroon; [Nkwescheu, Armand S.] Minist Publ Hlth, Div Operat Hlth Res DROS, Yaounde, Cameroon; [Kembou, Etienne; Milenge, Pascal] WHO, Reg Off Africa AFRO, Natl Off, Yaounde, Cameroon; [Tsomo, Zephirin] Yaounde Cent Hosp, ATC, Yaounde, Cameroon; [Dion, Grace Ngute] Yaounde Gen Hosp, ATC, Yaounde, Cameroon; [Aghokeng, Avelin F.; Mpoudi, Eitel N.] CREMER, Virol Lab, Yaounde, Cameroon; [Ndumbe, Peter M.] Univ Buea, FHS, Buea, Cameroon; [Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, Fac Sci, I-00173 Rome, Italy; [Colizzi, Vittorio] Univ Roma Tor Vergata, UNESCO Chair Biotechnol, Rome, Italy	University of Yaounde I; World Health Organization; University of Rome Tor Vergata; University of Rome Tor Vergata	Billong, SC (corresponding author), NACC, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon.	sergebillong@yahoo.fr		AGHOKENG FOBANG, Avelin/0000-0002-1414-0237	World Health Organization (WHO) Resistance Surveillance network	World Health Organization (WHO) Resistance Surveillance network	This work was supported by the World Health Organization (WHO) Resistance Surveillance network, through funding to the National AIDS Control Committee of Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID EST SIZ POP MOS; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Comite National de lutte contre le SIDA, 2009, PROF EST PAYS VIH SI; Comite Nationale de Lutte contre le SIDA au Cameroun, 2010, PROP VIH CAM SER 10; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Hedt BL, 2009, ANTIVIR THER S, V13, P69; HIV Drug Resistance Working Group, 2010, GUID EV EARL WARN IN; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Ministere de la Sante Publique du Cameroun, 2010, DIR NAT PRIS CHARG A; WHO, 2010, ANT THER HIV INF AD; *WHO UNAIDS, 2003, WHO UNAIDS GLOB IN P; World Health Organization, 2010, HIV DRUG RES EARL WA; World Health Organization, 2010, ANT THER HIV INF INF; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10	21	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36777	10.1371/journal.pone.0036777	http://dx.doi.org/10.1371/journal.pone.0036777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615810	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200019
J	Katsakou, C; Marougka, S; Barnicot, K; Savill, M; White, H; Lockwood, K; Priebe, S				Katsakou, Christina; Marougka, Stamatina; Barnicot, Kirsten; Savill, Mark; White, Hayley; Lockwood, Kate; Priebe, Stefan			Recovery in Borderline Personality Disorder (BPD): A Qualitative Study of Service Users' Perspectives	PLOS ONE			English	Article							DIALECTICAL BEHAVIOR-THERAPY; FOLLOW-UP; PSYCHOTHERAPY; OUTPATIENT; PREVALENCE	Background: Symptom improvement in Borderline Personality Disorder (BPD) is more common than previously hypothesised. However, it remains unclear whether it reflects service users' personal goals of recovery. The present study aimed to explore what service users with BPD view as recovery. Methods: 48 service users were recruited from secondary mental health services and their views on their personal goals and the meaning of recovery were explored in in-depth semi-structured interviews. The study drew on grounded theory and thematic analysis. Results: Service users believed that recovery involved developing self-acceptance and self-confidence, gaining control over emotions, improving relationships, employment, and making progress in symptoms like suicidality and self-harming. They felt that psychotherapies for BPD often had an extreme focus on specific areas, like self-harming or relationships, and that some of their goals were neglected. Although full recovery was seen as a distant goal, interviewees felt that they could learn how to deal with their problems in more effective ways and make meaningful progress in their lives. Conclusions: Specialist therapies for BPD explicitly address some of the recovery goals that are important to service users, whereas other goals are only indirectly or poorly addressed. Professionals might need to work with service users towards devising comprehensive individualised case formulations, including all treatment targets that are important to service users, their priorities, and long-term plans on how their targets might be met and which services might be involved.	[Katsakou, Christina; Barnicot, Kirsten; Savill, Mark; Priebe, Stefan] Queen Mary Univ London, Unit Social & Community Psychiat, London, England; [Marougka, Stamatina] Together Mental Hlth Char, London, England; [White, Hayley; Lockwood, Kate] E London Fdn NHS Trust, London, England	University of London; Queen Mary University London	Katsakou, C (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, London, England.	c.katsakou@qmul.ac.uk		Barnicot, Kirsten/0000-0001-5083-5135; Barnicot, Kirsten/0000-0003-2950-1389; Priebe, Stefan/0000-0001-9864-3394	East London National Health Service (NHS) Foundation Trust; National Institute for Health Research [PB-PG-0906-10540, DRF-2009-02-11] Funding Source: researchfish	East London National Health Service (NHS) Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the East London National Health Service (NHS) Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi S, 2009, RETHINK RECOVERY SER, V2; Anthony WilliamA, 1993, PSYCHOSOC REHABIL, V16, P11, DOI [10.1037/h0095655, DOI 10.1037/H0095655]; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barnicot K, 2011, ACTA PSYCHIAT SCAND, V123, P327, DOI 10.1111/j.1600-0447.2010.01652.x; Bartak A, 2011, PSYCHOTHER PSYCHOSOM, V80, P28, DOI 10.1159/000321999; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brazier J, 2006, HEALTH TECHNOL ASSES, V10, P1; Charmaz K., 2000, HDB QUALITATIVE RES, V2nd, P509, DOI DOI 10.1177/0891241609342193; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Coid J, 2006, BRIT J PSYCHIAT, V188, P423, DOI 10.1192/bjp.188.5.423; Davidson K, 2006, J PERS DISORD, V20, P450, DOI 10.1521/pedi.2006.20.5.450; Davidson KM, 2010, BRIT J PSYCHIAT, V197, P456, DOI 10.1192/bjp.bp.109.074286; Doering S, 2010, BRIT J PSYCHIAT, V196, P389, DOI 10.1192/bjp.bp.109.070177; Farrell JM, 2009, J BEHAV THER EXP PSY, V40, P317, DOI 10.1016/j.jbtep.2009.01.002; Frances A, 1986, Ann N Y Acad Sci, V487, P281, DOI 10.1111/j.1749-6632.1986.tb27907.x; Giesen-Bloo J, 2006, ARCH GEN PSYCHIAT, V63, P649, DOI 10.1001/archpsyc.63.6.649; Gilbert P., 2022, COMPASSION FOCUSED T; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gunderson J, 1984, BORDERLINE PERSONALI; Henwood K., 2006, CHOOSING METHODS MEN, P68; HIGGITT A, 1992, BRIT J PSYCHIAT, V161, P23, DOI 10.1192/bjp.161.1.23; Huang YQ, 2009, BRIT J PSYCHIAT, V195, P46, DOI 10.1192/bjp.bp.108.058552; Kliem S, 2010, J CONSULT CLIN PSYCH, V78, P936, DOI 10.1037/a0021015; Lynch TR, 2007, ANNU REV CLIN PSYCHO, V3, P181, DOI 10.1146/annurev.clinpsy.2.022305.095229; Markham D, 2003, BRIT J CLIN PSYCHOL, V42, P243, DOI 10.1348/01446650360703366; National Institute for Health and Clinical Excellence (NICE), 2009, BORD PERS DIS TREATM; NIMHE, 2003, PERS DIS LONG DIAGN; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Slade M, 2008, EPIDEMIOL PSICHIAT S, V17, P128, DOI 10.1017/S1121189X00002827; Slade M, 2007, ACTA PSYCHIAT SCAND, V116, P81, DOI 10.1111/j.1600-0447.2007.01047.x; Strauss A., 1998, BASICS QUALITATIVE R; Turner K., 2011, UNDERSTANDING PERSON; Turton P, 2011, SOC PSYCH PSYCH EPID, V46, P127, DOI 10.1007/s00127-009-0174-6; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zanarini MC, 2008, ACTA PSYCHIAT SCAND, V117, P177, DOI 10.1111/j.1600-0447.2008.01155.x; Zanarini MC, 2003, AM J PSYCHIAT, V160, P274, DOI 10.1176/appi.ajp.160.2.274	39	62	62	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36517	10.1371/journal.pone.0036517	http://dx.doi.org/10.1371/journal.pone.0036517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615776	Green Published, gold, Green Accepted			2022-12-27	WOS:000305341200010
J	Volpe, S; Cameroni, E; Moepps, B; Thelen, S; Apuzzo, T; Thelen, M				Volpe, Silvia; Cameroni, Elisabetta; Moepps, Barbara; Thelen, Sylvia; Apuzzo, Tiziana; Thelen, Marcus			CCR2 Acts as Scavenger for CCL2 during Monocyte Chemotaxis	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 RECEPTOR; AGONIST-INDUCED ENDOCYTOSIS; CHEMOKINE RECEPTOR; INTRACELLULAR TRAFFICKING; FLUORESCENT PROTEINS; DIRECTED MIGRATION; IN-VIVO; INTERNALIZATION; PHOSPHORYLATION; ANTAGONISTS	Background: Leukocyte migration is essential for effective host defense against invading pathogens and during immune homeostasis. A hallmark of the regulation of this process is the presentation of chemokines in gradients stimulating leukocyte chemotaxis via cognate chemokine receptors. For efficient migration, receptor responsiveness must be maintained whilst the cells crawl on cell surfaces or on matrices along the attracting gradient towards increasing concentrations of agonist. On the other hand agonist-induced desensitization and internalization is a general paradigm for chemokine receptors which is inconsistent with the prolonged migratory capacity. Methodology/Principal Findings: Chemotaxis of monocytes was monitored in response to fluorescent CCL2-mCherry by time-lapse video microscopy. Uptake of the fluorescent agonist was used as indirect measure to follow the endogenous receptor CCR2 expressed on primary human monocytes. During chemotaxis CCL2-mCherry becomes endocytosed as cargo of CCR2, however, the internalization of CCR2 is not accompanied by reduced responsiveness of the cells due to desensitization. Conclusions/Significance: During chemotaxis CCR2 expressed on monocytes internalizes with the bound chemoattractant, but cycles rapidly back to the plasma membrane to maintain high responsiveness. Moreover, following relocation of the source of attractant, monocytes can rapidly reverse their polarization axis organizing a new leading edge along the newly formed gradient, suggesting a uniform distribution of highly receptive CCR2 on the plasma membrane. The present observations further indicate that during chemotaxis CCR2 acts as scavenger consuming the chemokine forming the attracting cue.	[Volpe, Silvia; Cameroni, Elisabetta; Thelen, Sylvia; Apuzzo, Tiziana; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Moepps, Barbara] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Ulm, Germany	Universita della Svizzera Italiana; Ulm University	Volpe, S (corresponding author), Fdn Salvatore Maugeri, IRCCS, Cellular & Mol Oncol Lab, Pavia, Italy.	marcus.thelen@irb.usi.ch	apuzzo, tiziana/K-3395-2018	apuzzo, tiziana/0000-0002-2852-5461	European Community through a Marie Curie Action (INTEGRAMM); 6th Framework Program, Network of Excellence Grant (MAIN) [LSHG-CT-2003-502935]; Helmut Horten Foundation; Novartis Foundation; Roche Research Foundation; Fondazione Ticinese per la Ricerca sul Cancro	European Community through a Marie Curie Action (INTEGRAMM); 6th Framework Program, Network of Excellence Grant (MAIN); Helmut Horten Foundation; Novartis Foundation(Novartis); Roche Research Foundation; Fondazione Ticinese per la Ricerca sul Cancro	This work was co-financed by the European Community through a Marie Curie Action (INTEGRAMM) and the 6th Framework Program, Network of Excellence Grant (MAIN) LSHG-CT-2003-502935 and by the Helmut Horten Foundation. E.C. and M.T. were supported by the Novartis Foundation and the Roche Research Foundation, and the Fondazione Ticinese per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Dubois PM, 1996, J IMMUNOL, V156, P1356; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; FRANCI C, 1995, J IMMUNOL, V154, P6511; Franci C, 1996, J IMMUNOL, V157, P5606; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; GAROTTA G, 1991, J LEUKOCYTE BIOL, V49, P294, DOI 10.1002/jlb.49.3.294; Godiska R, 1997, J LEUKOCYTE BIOL, V61, P353, DOI 10.1002/jlb.61.3.353; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Maus UA, 2005, AM J PHYSIOL-LUNG C, V288, pL350, DOI 10.1152/ajplung.00061.2004; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murphy PM, 2000, PHARMACOL REV, V52, P145; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Panzer U, 2004, EUR J IMMUNOL, V34, P3682, DOI 10.1002/eji.200425226; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Turner SJ, 1998, J BIOL CHEM, V273, P25987, DOI 10.1074/jbc.273.40.25987; VALENTE AJ, 1991, BIOCHEM BIOPH RES CO, V176, P309, DOI 10.1016/0006-291X(91)90925-W; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Volpe S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010159; WANG JM, 1993, CYTOKINE, V5, P264, DOI 10.1016/1043-4666(93)90014-V; YOSHIMURA T, 1990, J IMMUNOL, V145, P292; Zhang N, 2006, BLOOD, V108, P38, DOI 10.1182/blood-2005-06-2599	50	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37208	10.1371/journal.pone.0037208	http://dx.doi.org/10.1371/journal.pone.0037208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615942	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200050
J	Balasingham, SV; Zegeye, ED; Homberset, H; Rossi, ML; Laerdahl, JK; Bohr, VA; Tonjum, T				Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Rossi, Marie L.; Laerdahl, Jon K.; Bohr, Vilhelm A.; Tonjum, Tone			Enzymatic Activities and DNA Substrate Specificity of Mycobacterium tuberculosis DNA Helicase XPB	PLOS ONE			English	Article							NUCLEOTIDE-EXCISION-REPAIR; STRAND BREAK REPAIR; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; COCKAYNE-SYNDROME; XERODERMA-PIGMENTOSUM; RNA HELICASES; PROTEIN; TFIIH; PREDICTION	XPB, also known as ERCC3 and RAD25, is a 3'-->5' DNA repair helicase belonging to the superfamily 2 of helicases. XPB is an essential core subunit of the eukaryotic basal transcription factor complex TFIIH. It has two well-established functions: in the context of damaged DNA, XPB facilitates nucleotide excision repair by unwinding double stranded DNA (dsDNA) surrounding a DNA lesion; while in the context of actively transcribing genes, XPB facilitates initiation of RNA polymerase II transcription at gene promoters. Human and other eukaryotic XPB homologs are relatively well characterized compared to conserved homologs found in mycobacteria and archaea. However, more insight into the function of bacterial helicases is central to understanding the mechanism of DNA metabolism and pathogenesis in general. Here, we characterized Mycobacterium tuberculosis XPB (Mtb XPB), a 3'-->5' DNA helicase with DNA-dependent ATPase activity. Mtb XPB efficiently catalyzed DNA unwinding in the presence of significant excess of enzyme. The unwinding activity was fueled by ATP or dATP in the presence of Mg2+/Mn2+. Consistent with the 3'-->5' polarity of this bacterial XPB helicase, the enzyme required a DNA substrate with a 3' overhang of 15 nucleotides or more. Although Mtb XPB efficiently unwound DNA model substrates with a 3' DNA tail, it was not active on substrates containing a 3' RNA tail. We also found that Mtb XPB efficiently catalyzed ATP-independent annealing of complementary DNA strands. These observations significantly enhance our understanding of the biological roles of Mtb XPB.	[Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Laerdahl, Jon K.; Tonjum, Tone] Univ Oslo, CMBN, Oslo, Norway; [Balasingham, Seetha V.; Zegeye, Ephrem Debebe; Homberset, Havard; Laerdahl, Jon K.; Tonjum, Tone] Univ Oslo, Dept Microbiol, Oslo, Norway; [Balasingham, Seetha V.; Laerdahl, Jon K.; Tonjum, Tone] Oslo Univ Hosp, Rikshosp, Dept Microbiol, Oslo, Norway; [Rossi, Marie L.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Laerdahl, Jon K.] Univ Oslo, Dept Informat, Bioinformat Core Facil, N-0316 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oslo	Balasingham, SV (corresponding author), Univ Oslo, CMBN, Oslo, Norway.	tone.tonjum@medisin.uio.no	Bohr, Vilhelm/AAP-5931-2020; Zegeye, Ephrem Debebe/GQB-3565-2022; Tønjum, Tone/J-4581-2014	Tonjum, Tone/0000-0002-1709-6921; Laerdahl, Jon Kristen/0000-0002-0826-9464	EU 6th Framework project TBadapt; Research Council of Norway Centre of Excellence funding; Norwegian State Educational Loan Fund; Intramural Program of the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000727] Funding Source: NIH RePORTER	EU 6th Framework project TBadapt; Research Council of Norway Centre of Excellence funding; Norwegian State Educational Loan Fund; Intramural Program of the National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the EU 6th Framework project TBadapt, the Research Council of Norway Centre of Excellence funding, and the Norwegian State Educational Loan Fund. Support from the Intramural Program of the National Institute on Aging, NIH is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berquist BR, 2009, J MOL BIOL, V391, P820, DOI 10.1016/j.jmb.2009.06.078; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; LESNIK EA, 1993, BIOCHEMISTRY-US, V32, P7832, DOI 10.1021/bi00081a031; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MATSON SW, 1987, J BIOL CHEM, V262, P2066; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mazloum N, 2011, BIOCHEMISTRY-US, V50, P1329, DOI 10.1021/bi101674c; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Olsen I, 2009, FEMS IMMUNOL MED MIC, V56, P151, DOI 10.1111/j.1574-695X.2009.00562.x; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Poterszman A, 1997, TRENDS BIOCHEM SCI, V22, P418, DOI 10.1016/S0968-0004(97)01124-9; Rouillon C, 2010, J BIOL CHEM, V285, P11013, DOI 10.1074/jbc.M109.094763; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Sinha KM, 2008, BIOCHEMISTRY-US, V47, P9355, DOI 10.1021/bi800725q; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Weel-Sneve R, 2008, NUCLEIC ACIDS RES, V36, P6249, DOI 10.1093/nar/gkn633; Yang W, 2008, CELL RES, V18, P184, DOI 10.1038/cr.2007.116	57	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36960	10.1371/journal.pone.0036960	http://dx.doi.org/10.1371/journal.pone.0036960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615856	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300048
J	Bohme, M; Aiglstorfer, M; Uhl, D; Kullmer, O				Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter; Kullmer, Ottmar			The Antiquity of the Rhine River: Stratigraphic Coverage of the Dinotheriensande (Eppelsheim Formation) of the Mainz Basin (Germany)	PLOS ONE			English	Article							ALPINE FORELAND BASIN; HIGH-RESOLUTION STRATIGRAPHY; MIDDLE MIOCENE; SOUTHERN GERMANY; CENTRAL PART; ARTIODACTYLA; MAMMALIA; SYSTEMATICS; COMMUNITY; EVOLUTION	Background: Mammalian fossils from the Eppelsheim Formation (Dinotheriensande) have been a benchmark for Neogene vertebrate palaeontology since 200 years. Worldwide famous sites like Eppelsheim serve as key localities for biochronologic, palaeobiologic, environmental, and mammal community studies. So far the formation is considered to be of early Late Miocene age (similar to 9.5 Ma, Vallesian), representing the oldest sediments of the Rhine River. The stratigraphic unity of the formation and of its fossil content was disputed at times, but persists unresolved. Principal Findings: Here we investigate a new fossil sample from Sprendlingen, composed by over 300 mammalian specimens and silicified wood. The mammals comprise entirely Middle Miocene species, like cervids Dicrocerus elegans, Paradicrocerus elegantulus, and deinotheres Deinotherium bavaricum and D. levius. A stratigraphic evaluation of Miocene Central European deer and deinothere species proof the stratigraphic inhomogenity of the sample, and suggest late Middle Miocene (similar to 12.5 Ma) reworking of early Middle Miocene (similar to 15 Ma) sediments. This results agree with taxonomic and palaeoclimatic analysis of plant fossils from above and within the mammalian assemblage. Based on the new fossil sample and published data three biochronologic levels within the Dinotheriensand fauna can be differentiated, corresponding to early Middle Miocene (late Orleanian to early Astaracian), late Middle Miocene (late Astaracian), and early Late Miocene (Vallesian) ages. Conclusions/Significance: This study documents complex faunal mixing of classical Dinotheriensand fauna, covering at least six million years, during a time of low subsidence in the Mainz Basin and shifts back the origination of the Rhine River by some five million years. Our results have severe implications for biostratigraphy and palaeobiology of the Middle to Late Miocene. They suggest that turnover events may be obliterated and challenge the proposed 'supersaturated' biodiversity, caused by Middle Miocene superstites, of Vallesian ecosystems in Central Europe.	[Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine; Aiglstorfer, Manuela; Uhl, Dieter; Kullmer, Ottmar] Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Tubingen, Germany; [Uhl, Dieter; Kullmer, Ottmar] Senckenberg Forschungsinst, Frankfurt, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN)	Bohme, M (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de		Aiglstorfer, Manuela/0000-0002-5231-3450; Kullmer, Ottmar/0000-0002-5929-8070; Uhl, Dieter/0000-0002-9938-5339				Abdul Aziz H., 2008, INT J EARTH SCI, DOI 10.1007/s00531-009-0475-8; Abusch-Siewert S., 1983, Courier Forschungsinstitut Senckenberg, V62, P1; [Anonymous], SCHRIFTENREIHE DTSCH; Azanza B, 1997, PALAEONTOLOGY, V40, P461; AZANZA B, 1993, CR ACAD SCI II, V316, P1163; Aziz HA, 2010, INT J EARTH SCI, V99, P1859, DOI 10.1007/s00531-009-0475-8; Bergounioux F. M., 1962, ANN PALEONTOL, V48; Bohme M, 2007, PALAEOGEOGR PALAEOCL, V253, P91, DOI 10.1016/j.palaeo.2007.03.035; Bohme M, 2011, PALAEOGEOGR PALAEOCL, V304, P212, DOI 10.1016/j.palaeo.2010.09.028; Bohme M, 2008, EARTH PLANET SC LETT, V275, P393, DOI 10.1016/j.epsl.2008.09.011; Boenigk W, 1982, RHEINISCHE ZEITSCHRI, V42, P167; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Casanovas-Vilar I., 2005, MIGRATIONS ORGANISMS, P247; Cuvier G., 1812, RECHERCHES OSSEMENS; Eronen JT, 2007, EVOL ECOL RES, V9, P471; Fortelius M., 1996, P414; Franzen Jens Lorenz, 2003, Deinsea (Rotterdam), V10, P217; Franzen Jens Lorenz, 2003, Senckenbergiana Lethaea, V83, P95; Franzen Jens Lorenz, 2000, Natur und Museum (Frankfurt am Main), V130, P169; Franzen Jens Lorenz, 1999, P165; Franzen JL, 2006, BIOL UNSERER Z, V36, P234; Fuhrmann U, 1987, GEOL JB HESSEN, V115, P245; Gentry A.W., 1994, Historical Biology, V7, P115; GINSBURG L, 1991, CR ACAD SCI II, V313, P121; Ginsburg L., 1976, B MUSEUM NATL HIST N, V399, P345; Ginsburg Leonard, 2000, Symbioses, V2, P3; Ginsburg Leonard, 2001, Symbioses, V5, P9; Ginsburg Leonard, 2000, Geodiversitas, V22, P597; Graf I. E., 1957, Palaeontographica, V108A, P131; Grimm KI, 2003, DIE FOSSILEN WIRBELL; Grimm MC., 2005, GEOL JB HESSEN, V132, P79; Gross M, 2011, INT J EARTH SCI, V100, P1895, DOI 10.1007/s00531-010-0615-1; Harzhauser M., 2004, STRATIGRAPHY, V1, P65; Harzhauser Mathias, 2011, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V113A, P167; Haupt O, 1935, NOTIZBLATT HESSISCHE, V5; Haupt O, 1914, GEOL RUNDSCH, V1914; Heissig K., 1989, MITTEILUNGEN BAYERIS, V29, P235; Holzfoerster F., 2008, Mainzer Naturwissenschaftliches Archiv, V46, P37; Hunenrmann K. A., 1968, SCHWEIZERISCHE PALAO, V86, P1; Huttunen Kati, 2002, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V103A, P251; Ivanov M, 2011, GEODIVERSITAS, V33, P411, DOI 10.5252/g2011n3a2; Jung W, 1980, GEOLOGIE, V20, P159; Jung W., 1968, BER NATURWISS VER LA, V25, P43; Jung W, 1984, BERICHTE NATURWISSEN, V30, P31; Jung W, 1963, PALAEONTOGR ABT B, V12, P166; Jung W, 1970, NEUES JB GEOLOGIE PA, V9, P542; Jung W., 1986, MITT BAYER STAATSLG, V26, P89; Kalin D, 2009, NEUES JAHRB GEOL P-A, V254, P177, DOI 10.1127/0077-7749/2009/0010; Kaup J, 1829, ISIS, V1829, P401; Kerp H., 2007, POLLICHIA SONDERVERO, V10, P76; Klahn H, 1931, GEOLOGISCHE PALAONTO, V18, P279; Knobloch E., 1988, DOC NAT, V42, P1; Knobloch E, 1986, DOC NAT, V30, P14; Koenigswald R. von, 1929, Senckenbergiana Frankfurt a M, V11, P267; Korotkevich O, 1988, GENESIS HIPPARION FA; KOROTKIEVICH E L, 1990, Acta Palaeontologica Polonica, V35, P91; Kovar-Eder J., 1988, BEITRAGE PALAONTOLOG, V14, P19; Kullmer O, 2008, J VERTEBR PALEONTOL, V28, P928, DOI 10.1671/0272-4634(2008)28[928:TSSOSD]2.0.CO;2; Meller B, 2007, FAZIES BRAUNKOHLE FU, V2007, P113; Meller B, 1989, DOC NAT, V54, P1; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Mottl M, 1958, GEOLOGIE TECHNIK LAN, V19, P16; Mottl M, 1970, MITTEILUNGEN MUSEUMS, V31, P3; Mottl M, 1969, DENKSCHRIFTEN, V115, P50; Mustoe GE, 2003, MICROSC TODAY, V11, P34, DOI DOI 10.1017/51551929500053438; Paulissen WE, 2011, GEOL CARPATH, V62, P155, DOI 10.2478/v10096-011-0013-z; Preusser F, 2008, NETH J GEOSCI, V87, P7, DOI 10.1017/S0016774600024008; Prieto J, 2009, INT J EARTH SCI, V98, P1767, DOI 10.1007/s00531-008-0331-2; Radtke G, 2008, GEOL JB HESSEN, V135, P47; Radtke G, 2004, GEOL JB HESSEN, V131, P27; Richter H. G., 2004, IAWA LIST MICROSCOPI; Rossner GE, 2006, PALAEONTOGR ABT A, V277, P103; Rossner GE, 2010, PALAEONTOL Z, V84, P123, DOI 10.1007/s12542-010-0052-2; Roger O, 1904, BERICHT NATURWISSENS, V36, P22; Rossner GE, 1995, MUNCHNER GEOWISSEN A, V29, P127; Sandberger F, 1853, UNTERSUCHUNGEN MAINZ; Schafer P., 2012, MAINZER BECKEN STRAT; Schirmer W, 2003, GEOARCHAEORHEIN, P21; SCURFIELD G, 1984, SEDIMENT GEOL, V39, P149, DOI 10.1016/0037-0738(84)90048-4; Seehuber U, 2008, THESIS LUDWIG MAXIMI; Sommer J, 2007, SEDIMENTOLOGIE TAPHO; Sommer Jens, 2009, Mainzer Naturwissenschaftliches Archiv, V47, P327; Stehlin H. G., 1937, Verhandlungen der Naturforschenden Gesellschaft in Basel, V48, P193; Stehlin H. G., 1928, Eclogae Geologicae Helvetiae, V21, P245; Stehlin H. G., 1939, Eclogae Geologicae Helvetiae, V32, P162; Stiefel J, 1957, GEOL JB SH, V26, P201; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; THENIUS E., 1948, ANN NATURHIST STAATMUS WIEN, V56, P262; Thenius E, 1960, MITT GEOL GES WIEN, V52, P203; THENIUS ERICH, 1950, SITZUNGSBER OSTERREICH AKAD WISS MATH NAT KL ABT I, V159, P219; Tobien H., 1953, Notizblatt des Hessischen Landesamtes fuer Bodenforschung, V81, P52; Tobien H., 1980, Mainzer Geowissenschaftliche Mitteilungen, V9, P187; Tobien H., 1983, BEMERKUNGEN TAPHONOM, P191; Tobien H, 1961, NEUES JB GEOLOGIE PA, V9, P483; Tobien H, 1988, PALAEOVERTEBRATA MEM, P135; Uhl D, 2007, PALAEOGEOGR PALAEOCL, V248, P24, DOI 10.1016/j.palaeo.2006.11.005; Utescher T, 1997, PALAEOFLORA DATA BAS; v Goethe JW, 1816, KUNST ALTERTHUM RHEI; van der Made J, 1996, GEOLOGY, V33, P3; Wagner W., 1973, Mainzer Geowiss Mitt, V2, P149; WAGNER W, 1947, NATURWISSENSCHAFTEN, V34, P171, DOI 10.1007/BF00602572; Weinsheimer O, 1883, PALAONTOLOGISCHE ABH, V1, P207; Zapfe H, 1979, NEUE DENKSCHRIFTEN N, V2, P3; Ziegler Reinhard, 2006, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V107A, P93	104	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36817	10.1371/journal.pone.0036817	http://dx.doi.org/10.1371/journal.pone.0036817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615819	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300030
J	Higaki, S; Hirota, M				Higaki, Shogo; Hirota, Masahiro			Decontamination Efficiencies of Pot-Type Water Purifiers for I-131, Cs-134 and Cs-137 in Rainwater Contaminated during Fukushima Daiichi Nuclear Disaster	PLOS ONE			English	Article							CHEMICAL FORMS; REMOVAL; IODINE	Rainwater was contaminated by a large release of radionuclides into the environment during the Fukushima Daiichi nuclear disaster. It became a matter of concern for Japan when several water purification plants detected I-131 contamination in the drinking water. In the present study, the decontamination efficiency of two easily obtainable commercial water purifiers were examined for rainwater contaminated with I-131, Cs-134 and Cs-137. The water purifiers removed 94.2-97.8% of the I-131 and 84.2-91.5% of the Cs-134 and Cs-137 after one filtration. Seven filtrations removed 98.2-99.6% of the I-131 and over 98.0% of the Cs-134 and Cs-137. From a practical perspective, over the fourth filtrations were not needed because of no significant improvements after the third filtration.	[Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Hirota, Masahiro] Univ Tokyo, Sch Engn, Tokyo, Japan	University of Tokyo; University of Tokyo	Higaki, S (corresponding author), Univ Tokyo, Radioisotope Ctr, Tokyo, Japan.	shogo@ric.u-tokyo.ac.jp	Higaki, Shogo/G-5100-2013; Higaki, Shogo/N-8792-2019	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475				COOPER JA, 1970, NUCL INSTRUM METHODS, V82, P273, DOI 10.1016/0029-554X(70)90361-7; GOOSSENS R, 1989, WATER RES, V23, P693, DOI 10.1016/0043-1354(89)90201-7; International Atomic Energy Agency, 2010, INT AT EN AG TECHN R, V472; ITO T, 1989, Radioisotopes, V38, P237; Japan Water Works Association, 2009, WAT SUPPL JAP 2009 J; Ministry of Education Culture Sports Science Technology, 2002, RAD MEAS SER; Nakahara O, 1998, J JPN SOC IRRIGAT DR, V66, P191; Nishizawa K, 2009, JPN J RAD SAF MANAG, V8, P149; Ohta T, 2012, J ENVIRON RADIOACTIV, V111, P38, DOI 10.1016/j.jenvrad.2011.11.017; PRICHARD HM, 1981, AM J PUBLIC HEALTH, V71, P47, DOI 10.2105/AJPH.71.1.47; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; TACHIKAWA E, 1971, J NUCL SCI TECHNOL-T, V8, P371; WATARI K, 1988, J NUCL SCI TECHNOL, V25, P495, DOI 10.3327/jnst.25.495; Yoshida S, 2007, J RADIOANAL NUCL CH, V273, P211, DOI 10.1007/s10967-007-0738-4	14	2	2	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37184	10.1371/journal.pone.0037184	http://dx.doi.org/10.1371/journal.pone.0037184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615935	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300086
J	Liu, XH; Wu, Y; Li, Z; Yang, JL; Xue, JF; Hu, YJ; Feng, M; Niu, WB; Yang, QR; Lei, M; Xia, JH; Wu, LQ; Liang, DS				Liu, Xionghao; Wu, Yong; Li, Zhuo; Yang, Junlin; Xue, Jinfeng; Hu, Youjin; Feng, Mai; Niu, Wenbin; Yang, Qiurui; Lei, Ming; Xia, Jiahui; Wu, Lingqian; Liang, Desheng			Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RNA-POLYMERASE-I; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; EXPRESSION; LINE; IDENTIFICATION; CHROMATIN; KNOCKOUT; SURVIVAL	Background: Genetic modification is a prerequisite to realizing the full potential of human embryonic stem cells (hESCs) in human genetic research and regenerative medicine. Unfortunately, the random integration methods that have been the primary techniques used keep creating problems, and the primary alternative method, gene targeting, has been effective in manipulating mouse embryonic stem cells (mESCs) but poorly in hESCs. Methodology/Principal Findings: Human ribosomal DNA (rDNA) repeats are clustered on the short arm of acrocentric chromosomes. They consist of approximately 400 copies of the 45S pre-RNA (rRNA) gene per haploid. In the present study, we targeted a physiological gene, human coagulation factor IX, into the rDNA locus of hESCs via homologous recombination. The relative gene targeting efficiency (>50%) and homologous recombination frequency (>10(-5)) were more than 10-fold higher than those of loci targeted in previous reports. Meanwhile, the targeted clones retained both a normal karyotype and the main characteristics of ES cells. The transgene was found to be stably and ectopically expressed in targeted hESCs. Conclusion/Significance: This is the first targeting of a human physiological gene at a defined locus on the hESC genome. Our findings indicate that the rDNA locus may serve as an ideal harbor for transgenes in hESCs.	[Liu, Xionghao; Wu, Yong; Li, Zhuo; Yang, Junlin; Xue, Jinfeng; Hu, Youjin; Feng, Mai; Niu, Wenbin; Yang, Qiurui; Lei, Ming; Xia, Jiahui; Wu, Lingqian; Liang, Desheng] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Liu, XH (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.	wulingqian@sklmg.edu.cn; liangdesheng@sklmg.edu.cn	liu, xionghao/HGD-7444-2022; Liu, Xionghao/X-8424-2019; Liang, Desheng/ABH-2349-2021; Wu, Ling/GZN-2235-2022	Liang, Desheng/0000-0002-9451-8585; 	National Basic Research Program of China [2010CB529903]; National Natural Science Foundation of China [30700458, 30971298, 31071301, 81000208, 81000782]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 2010CB529903 and National Natural Science Foundation of China 30700458, 30971298, 31071301, 81000208 and 81000782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu L, 2010, CELL RES, V20, P379, DOI 10.1038/cr.2010.23; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Connelly JP, 2010, MOL THER, V18, P1103, DOI 10.1038/mt.2010.57; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Khan IF, 2004, MOL THER, V22, P635; Mak TW, 2007, CELL, V131, P1027, DOI 10.1016/j.cell.2007.11.033; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; SAKAI K, 1995, GENOMICS, V26, P521, DOI 10.1016/0888-7543(95)80170-Q; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; ZHENG H, 1990, NATURE, V344, P170, DOI 10.1038/344170a0; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	32	17	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37071	10.1371/journal.pone.0037071	http://dx.doi.org/10.1371/journal.pone.0037071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615895	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300063
J	Shi, W; Kerdelhue, C; Ye, H				Shi, Wei; Kerdelhue, Carole; Ye, Hui			Genetic Structure and Inferences on Potential Source Areas for Bactrocera dorsalis (Hendel) Based on Mitochondrial and Microsatellite Markers	PLOS ONE			English	Article							ORIENTAL FRUIT-FLY; POPULATION-STRUCTURE; CUCURBITAE DIPTERA; COMPUTER-PROGRAM; DNA MARKERS; TEPHRITIDAE; INVASION; COLONIZATION; HAPLOTYPES; HISTORY	Bactrocera dorsalis (Diptera: Tephritidae) is mainly distributed in tropical and subtropical Asia and in the Pacific region. Despite its economic importance, very few studies have addressed the question of the wide genetic structure and potential source area of this species. This pilot study attempts to infer the native region of this pest and its colonization pathways in Asia. Combining mitochondrial and microsatellite markers, we evaluated the level of genetic diversity, genetic structure, and the gene flow among fly populations collected across Southeast Asia and China. A complex and significant genetic structure corresponding to the geographic pattern was found with both types of molecular markers. However, the genetic structure found was rather weak in both cases, and no pattern of isolation by distance was identified. Multiple long-distance dispersal events and miscellaneous host selection by this species may explain the results. These complex patterns may have been influenced by human-mediated transportation of the pest from one area to another and the complex topography of the study region. For both mitochondrial and microsatellite data, no signs of bottleneck or founder events could be identified. Nonetheless, maximal genetic diversity was observed in Myanmar, Vietnam and Guangdong (China) and asymmetric migration patterns were found. These results provide indirect evidence that the tropical regions of Southeast Asia and southern coast of China may be considered as the native range of the species and the population expansion is northward. Yunnan (China) is a contact zone that has been colonized from different sources. Regions along the southern coast of Vietnam and China probably served to colonize mainly the southern region of China. Southern coastal regions of China may also have colonized central parts of China and of central Yunnan.	[Shi, Wei; Ye, Hui] Yunnan Univ, Sch Agr Res, Lab Biol Invas & Transboundary Ecosecur, Kunming, Peoples R China; [Kerdelhue, Carole] UMR CBGP, INRA, Montferrier Sur Lez, France	Yunnan University; INRAE; Institut de Recherche pour le Developpement (IRD)	Shi, W (corresponding author), Yunnan Univ, Sch Agr Res, Lab Biol Invas & Transboundary Ecosecur, Kunming, Peoples R China.	Huiye889@126.com	Kerdelhue, Carole/GVS-0309-2022	Kerdelhue, Carole/0000-0001-7667-902X	National Basic Research Program of China [30260023, 30860055]; Applied Basic Research Foundation of Yunnan Province [2009CD010]	National Basic Research Program of China(National Basic Research Program of China); Applied Basic Research Foundation of Yunnan Province	This study was supported by the National Basic Research Program of China (30260023, 30860055) and the Applied Basic Research Foundation of Yunnan Province (2009CD010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Alberti AC, 2008, GENETICA, V132, P1, DOI 10.1007/s10709-007-9143-8; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chao WM, 1987, SOIL RESOURCES YUNNA; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford MH, 2007, AM J HUM BIOL, V19, P203, DOI 10.1002/ajhb.20631; Dai SM, 2004, MOL ECOL NOTES, V4, P629, DOI 10.1111/j.1471-8286.2004.00732.x; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2008, BIOL J LINN SOC, V93, P217, DOI 10.1111/j.1095-8312.2007.00952.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; *EPPO, 2005, DAT SHEETS QUAR PEST; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Fu GH, 2008, TROPICAL AGR SCI TEC, V4, P27; Fu ML, 1994, CHINA ATLAS, P49; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HALL T, 2004, BIOEDIT BIOL SEQUENC; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Hou BH, 2005, ACTA ECOL SINICA, V7, P1570; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x; Langella O., 1999, POPULATIONS 1 2 32; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Legendre P., 2012, NUMERICAL ECOLOGY; Li H, 2000, J YUNNAN U, V22, P473; Li SM, 1994, WORLD ATLAS; Li Wei-Feng, 2007, Acta Entomologica Sinica, V50, P1255; Liang G-H, 2003, ENTOMOLOGICAL J E CH, V12, P90; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Nakahara Shigehito, 2000, Research Bulletin of the Plant Protection Service Japan, P37; Nakahara Shigehito, 2001, Research Bulletin of the Plant Protection Service Japan, V37, P69; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roderick GK, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P97, DOI 10.1079/9780851997353.0097; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; [施伟 SHI Wei], 2007, [生态学报, Acta Ecologica Sinica], V27, P2477; Shi Wei, 2004, Acta Entomologica Sinica, V47, P384; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; TAJIMA F, 1983, GENETICS, V105, P437; TEMPLETON AR, 1992, GENETICS, V132, P619; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Virgilio M, 2010, MOL ECOL, V19, P2713, DOI 10.1111/j.1365-294X.2010.04662.x; Wan XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025238; Wang NB, 2009, INT FED INFO PROC, V293, P399; Wang SY, 2002, YUNNAN DILI, P21; Wang X, 1996, ACTA ZOOTAXONOMICA S, V21, P49; Ye H., 2009, RES BIOL INVASIONS C, P90; Ye Hui, 2001, Entomologia Sinica, V8, P175; [周国梁 ZHOU GuoLiang], 2007, [生态学报, Acta Ecologica Sinica], V27, P3362; Zia Y., 1937, SINENSIA, V8, P103	70	40	46	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37083	10.1371/journal.pone.0037083	http://dx.doi.org/10.1371/journal.pone.0037083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615898	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300065
J	Woo, YC; Tso, AWK; Xu, AM; Law, LSC; Fong, CHY; Lam, TH; Lo, SV; Wat, NMS; Cheung, BMY; Lam, KSL				Woo, Yu-Cho; Tso, Annette W. K.; Xu, Aimin; Law, Lawrence S. C.; Fong, Carol H. Y.; Lam, Tai-Hing; Lo, Su-Vui; Wat, Nelson M. S.; Cheung, Bernard M. Y.; Lam, Karen S. L.			Combined Use of Serum Adiponectin and Tumor Necrosis Factor-Alpha Receptor 2 Levels Was Comparable to 2-Hour Post-Load Glucose in Diabetes Prediction	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LIFE-STYLE INTERVENTION; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; FOLLOW-UP; CHINESE SUBJECTS; ADIPOSE-TISSUE; TYPE-2; RISK	Background: Adipose tissue inflammation and dysregulated adipokine secretion are implicated in obesity-related insulin resistance and type 2 diabetes. We evaluated the use of serum adiponectin, an anti-inflammatory adipokine, and several proinflammatory adipokines, as biomarkers of diabetes risk and whether they add to traditional risk factors in diabetes prediction. Methods: We studied 1300 non-diabetic subjects from the prospective Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS). Serum adiponectin, tumor necrosis factor-alpha receptor 2 (TNF-alpha R2), interleukin-6 (IL-6), adipocyte-fatty acid binding protein (A-FABP) and high-sensitivity C-reactive protein (hsCRP) were measured in baseline samples. Results: Seventy-six participants developed diabetes over 5.3 years (median). All five biomarkers significantly improved the log-likelihood of diabetes in a clinical diabetes prediction (CDP) model including age, sex, family history of diabetes, smoking, physical activity, hypertension, waist circumference, fasting glucose and dyslipidaemia. In ROC curve analysis, "adiponectin + TNF-alpha R2" improved the area under ROC curve (AUC) of the CDP model from 0.802 to 0.830 (P = 0.03), rendering its performance comparable to the "CDP + 2-hour post-OGTT glucose" model (AUC = 0.852, P = 0.30). A biomarker risk score, derived from the number of biomarkers predictive of diabetes (low adiponectin, high TNF-alpha R2), had similar performance when added to the CDP model (AUC = 0.829 [95% CI: 0.808-0.849]). Conclusions: The combined use of serum adiponectin and TNF-alpha R2 as biomarkers provided added value over traditional risk factors for diabetes prediction in Chinese and could be considered as an alternative to the OGTT.	[Woo, Yu-Cho; Tso, Annette W. K.; Xu, Aimin; Law, Lawrence S. C.; Fong, Carol H. Y.; Wat, Nelson M. S.; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Tso, Annette W. K.; Xu, Aimin; Cheung, Bernard M. Y.; Lam, Karen S. L.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Lam, Tai-Hing] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Lo, Su-Vui] Hosp Author, Kowloon, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Woo, YC (corresponding author), Univ Hong Kong, Dept Med, Pokfulam, Hong Kong, Peoples R China.	mycheung@hku.hk; ksllam@hku.hk	Xu, Aimin/D-3291-2013; /E-9829-2010; Lam, Tai Hing/C-4317-2009	Xu, Aimin/0000-0002-0668-033X; Law, Lawrence Siu-Chun/0000-0002-0429-2632; /0000-0001-9106-7363; Lam, Tai Hing/0000-0002-2033-9971	Health and Health Services Research Fund [06070951]; General Research Fund of the Hong Kong Research Grant Council [HKU 780210M]	Health and Health Services Research Fund; General Research Fund of the Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This study was supported by the Health and Health Services Research Fund (#06070951) and the General Research Fund of the Hong Kong Research Grant Council (HKU 780210M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Law LSC, 2011, DIABETES RES CLIN PR, V91, pE53, DOI 10.1016/j.diabres.2010.11.014; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; Ong KL, 2011, DIABETOLOGIA; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snehalatha C, 2003, DIABETES CARE, V26, P3226, DOI 10.2337/diacare.26.12.3226; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Tso AWK, 2008, BIOMARK MED, V2, P239, DOI 10.2217/17520363.2.3.239; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Wat NMS, 2001, INT J OBESITY, V25, P1789, DOI 10.1038/sj.ijo.0801834; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650	40	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36868	10.1371/journal.pone.0036868	http://dx.doi.org/10.1371/journal.pone.0036868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615828	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341300035
J	Chu, R; Walter, SD; Guyatt, G; Devereaux, PJ; Walsh, M; Thorlund, K; Thabane, L				Chu, Rong; Walter, Stephen D.; Guyatt, Gordon; Devereaux, P. J.; Walsh, Michael; Thorlund, Kristian; Thabane, Lehana			Assessment and Implication of Prognostic Imbalance in Randomized Controlled Trials with a Binary Outcome - A Simulation Study	PLOS ONE			English	Article							INCREASES STATISTICAL POWER; COVARIATE ADJUSTMENT; SAMPLE-SIZE; CONSORT STATEMENT; REGRESSION; INJURY	Background: Chance imbalance in baseline prognosis of a randomized controlled trial can lead to over or underestimation of treatment effects, particularly in trials with small sample sizes. Our study aimed to (1) evaluate the probability of imbalance in a binary prognostic factor (PF) between two treatment arms, (2) investigate the impact of prognostic imbalance on the estimation of a treatment effect, and (3) examine the effect of sample size (n) in relation to the first two objectives. Methods: We simulated data from parallel-group trials evaluating a binary outcome by varying the risk of the outcome, effect of the treatment, power and prevalence of the PF, and n. Logistic regression models with and without adjustment for the PF were compared in terms of bias, standard error, coverage of confidence interval and statistical power. Results: For a PF with a prevalence of 0.5, the probability of a difference in the frequency of the PF >= 5% reaches 0.42 with 125/arm. Ignoring a strong PF (relative risk = 5) leads to underestimating the strength of a moderate treatment effect, and the underestimate is independent of n when n is >50/arm. Adjusting for such PF increases statistical power. If the PF is weak (RR = 2), adjustment makes little difference in statistical inference. Conditional on a 5% imbalance of a powerful PF, adjustment reduces the likelihood of large bias. If an absolute measure of imbalance >= 5% is deemed important, including 1000 patients/arm provides sufficient protection against such an imbalance. Two thousand patients/arm may provide an adequate control against large random deviations in treatment effect estimation in the presence of a powerful PF. Conclusions: The probability of prognostic imbalance in small trials can be substantial. Covariate adjustment improves estimation accuracy and statistical power, and hence should be performed when strong PFs are observed.	[Chu, Rong; Walter, Stephen D.; Guyatt, Gordon; Devereaux, P. J.; Walsh, Michael; Thorlund, Kristian; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Hamilton, ON, Canada; [Devereaux, P. J.; Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada	McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University	Chu, R (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Fac Hlth Sci, Hamilton, ON, Canada.	chur@mcmaster.ca	Walsh, Michael/ABE-1278-2021; Devereaux, PJ/AAY-1757-2021; Walter, Stephen/AAB-5548-2022; Devereaux, PJ/AAF-2862-2019	Walsh, Michael/0000-0001-8292-2014; Walter, Stephen/0000-0003-4157-8928; Devereaux, PJ/0000-0003-2935-637X	Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally (CANNeCTIN)	Rong Chu is a recipient of the Canadian Institutes of Health Research (CIHR) Doctoral Research Award. http://www.cihr.ca/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous reviewers for their constructive comments that helped to strengthen the manuscript. Rong Chu holds a doctoral research award from the Canadian Institutes of Health Research. This work was partially supported by a research grant from the Canadian Network and Centre for Trials Internationally (CANNeCTIN).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 1999, STAT MED, V18, P1905; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P142, DOI 10.1016/j.jclinepi.2009.06.002; Brower RG, 2004, NEW ENGL J MED, V351, P327; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Ciolino J, 2011, CONTEMP CLIN TRIALS, V32, P250, DOI 10.1016/j.cct.2010.11.005; Cui Lu, 2002, J Biopharm Stat, V12, P347, DOI 10.1081/BIP-120014565; Demchuk AM, 2001, NEUROLOGY, V57, P474, DOI 10.1212/WNL.57.3.474; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Dodge Y., 2003, OXFORD DICT STAT TER; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; GAIL MH, 1984, BIOMETRIKA, V71, P431; Greenland S, 1999, STAT SCI, V14, P29; Grouin JM, 2004, STAT MED, V23, P701; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hauck WW, 1998, CONTROL CLIN TRIALS, V19, P249, DOI 10.1016/S0197-2456(97)00147-5; HAUCK WW, 1991, J CLIN EPIDEMIOL, V44, P77, DOI 10.1016/0895-4356(91)90203-L; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Keen HI, 2005, J RHEUMATOL, V32, P2083; Lingsma H, 2010, J CLIN EPIDEMIOL, V63, P1391, DOI 10.1016/j.jclinepi.2010.05.003; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Negassa A, 2007, CONTEMP CLIN TRIALS, V28, P242, DOI 10.1016/j.cct.2006.08.007; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; WALTER SD, 1985, STAT MED, V4, P437, DOI 10.1002/sim.4780040405; Wang SJ, 2010, CLIN TRIALS, V7, P525, DOI 10.1177/1740774510375455; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	35	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36677	10.1371/journal.pone.0036677	http://dx.doi.org/10.1371/journal.pone.0036677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629322	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300010
J	Dwivedi, SK; Sengupta, S				Dwivedi, Sanjiv K.; Sengupta, Supratim			Classification of HIV-1 Sequences Using Profile Hidden Markov Models	PLOS ONE			English	Article							CIRCULATING RECOMBINANT FORM; SUBTYPE ANALYZER STAR; PHYLOGENETIC ANALYSIS; TYPE-1; VIRUS; IDENTIFICATION; BRAZIL; PREDICTION; GENOMES; ORIGIN	Accurate classification of HIV-1 subtypes is essential for studying the dynamic spatial distribution pattern of HIV-1 subtypes and also for developing effective methods of treatment that can be targeted to attack specific subtypes. We propose a classification method based on profile Hidden Markov Model that can accurately identify an unknown strain. We show that a standard method that relies on the construction of a positive training set only, to capture unique features associated with a particular subtype, can accurately classify sequences belonging to all subtypes except B and D. We point out the drawbacks of the standard method; namely, an arbitrary choice of threshold to distinguish between true positives and true negatives, and the inability to discriminate between closely related subtypes. We then propose an improved classification method based on construction of a positive as well as a negative training set to improve discriminating ability between closely related subtypes like B and D. Finally, we show how the improved method can be used to accurately determine the subtype composition of Common Recombinant Forms of the virus that are made up of two or more subtypes. Our method provides a simple and highly accurate alternative to other classification methods and will be useful in accurately annotating newly sequenced HIV-1 strains.	[Dwivedi, Sanjiv K.; Sengupta, Supratim] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Dwivedi, Sanjiv K.] Indian Inst Technol, Sch Sci, Indore, Madhya Pradesh, India; [Sengupta, Supratim] Indian Inst Sci Educ & Res, Dept Phys Sci, Mohanpur, W Bengal, India	Jawaharlal Nehru University, New Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; Indian Institute of Science Education & Research (IISER) - Kolkata	Dwivedi, SK (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	supratim.sen@gmail.com	Dwivedi, Sanjiv/GXG-1080-2022					Bulla I, 2010, BIOINFORMATICS, V26, P1409, DOI 10.1093/bioinformatics/btq159; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gale CV, 2004, AIDS RES HUM RETROV, V20, P457, DOI 10.1089/088922204323087697; Gao F, 1998, J VIROL, V72, P10234, DOI 10.1128/JVI.72.12.10234-10241.1998; Goudsmit J., 1997, VIRAL SEX NATURE AID; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Hraber P, 2008, J GEN VIROL, V89, P2098, DOI 10.1099/vir.0.83657-0; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P877, DOI 10.1089/aid.1994.10.877; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KOSTRIKIS LG, 1995, J VIROL, V69, P6122, DOI 10.1128/JVI.69.10.6122-6130.1995; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; LEITNER T, 1995, AIDS RES HUM RETROV, V11, P995, DOI 10.1089/aid.1995.11.995; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; MYERS G, 1992, AIDS RES HUM RETROV, V8, P373, DOI 10.1089/aid.1992.8.373; Myers RE, 2005, BIOINFORMATICS, V21, P3535, DOI 10.1093/bioinformatics/bti569; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pandit A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S26; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parry JV, 2001, J ACQ IMMUN DEF SYND, V26, P381, DOI 10.1097/00126334-200104010-00017; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Santos AF, 2006, AIDS, V20, P2011; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Singh P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-325; Spang R, 2002, J COMPUT BIOL, V9, P747, DOI 10.1089/106652702761034172; Takebe Y, 2008, ADV PHARMACOL, V56, P1, DOI 10.1016/S1054-3589(07)56001-1; Thomson MA, 2005, AIDS, V19, P1155, DOI 10.1097/01.aids.0000176215.95119.1d; Triques K, 2000, AIDS RES HUM RETROV, V16, P139, DOI 10.1089/088922200309485; Truszkowski J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-168; Westesson O, 2011, PLOS COMPUTATIONAL B, V5	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36566	10.1371/journal.pone.0036566	http://dx.doi.org/10.1371/journal.pone.0036566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623958	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500018
J	Yang, Y; Shi, ZY; Reheman, A; Jin, JW; Li, CL; Wang, YM; Andrews, MC; Chen, PG; Zhu, GH; Ling, WH; Ni, HY				Yang, Yan; Shi, Zhenyin; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ling, Wenhua; Ni, Heyu			Plant Food Delphinidin-3-Glucoside Significantly Inhibits Platelet Activation and Thrombosis: Novel Protective Roles against Cardiovascular Diseases	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; PROTEIN-KINASE; DIETARY POLYPHENOLS; SIGNALING PATHWAY; ALPHA-GRANULES; GRAPE JUICE; IN-VITRO; ANTHOCYANINS; SUPPLEMENTATION; FIBRINOGEN	Delphinidin-3-glucoside (Dp-3-g) is one of the predominant bioactive compounds of anthocyanins in many plant foods. Although several anthocyanin compounds have been reported to be protective against cardiovascular diseases (CVDs), the direct effect of anthocyanins on platelets, the key players in atherothrombosis, has not been studied. The roles of Dp-3-g in platelet function are completely unknown. The present study investigated the effects of Dp-3-g on platelet activation and several thrombosis models in vitro and in vivo. We found that Dp-3-g significantly inhibited human and murine platelet aggregation in both platelet-rich plasma and purified platelets. It also markedly reduced thrombus growth in human and murine blood in perfusion chambers at both low and high shear rates. Using intravital microscopy, we observed that Dp-3-g decreased platelet deposition, destabilized thrombi, and prolonged the time required for vessel occlusion. Dp-3-g also significantly inhibited thrombus growth in a carotid artery thrombosis model. To elucidate the mechanisms, we examined platelet activation markers via flow cytometry and found that Dp-3-g significantly inhibited the expression of P-selectin, CD63, CD40L, which reflect platelet alpha- and delta-granule release, and cytosol protein secretion, respectively. We further demonstrated that Dp-3-g downregulated the expression of active integrin alpha IIb beta 3 on platelets, and attenuated fibrinogen binding to platelets following agonist treatment, without interfering with the direct interaction between fibrinogen and integrin alpha IIb beta 3. We found that Dp-3-g reduced phosphorylation of adenosine monophosphate-activated protein kinase, which may contribute to the observed inhibitory effects on platelet activation. Thus, Dp-3-g significantly inhibits platelet activation and attenuates thrombus growth at both arterial and venous shear stresses, which likely contributes to its protective roles against thrombosis and CVDs.	[Yang, Yan; Jin, Joseph W.; Wang, Yiming; Chen, Pingguo; Ni, Heyu] Canadian Blood Serv, Toronto, ON, Canada; [Yang, Yan; Shi, Zhenyin; Ling, Wenhua; Ni, Heyu] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yan; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ni, Heyu] St Michaels Hosp, Toronto Platelet Immunobiol Grp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Yang, Yan; Reheman, Adili; Jin, Joseph W.; Li, Conglei; Wang, Yiming; Andrews, Marc C.; Chen, Pingguo; Zhu, Guangheng; Ni, Heyu] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Yang, Yan; Li, Conglei; Wang, Yiming; Ni, Heyu] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Andrews, Marc C.; Ni, Heyu] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ni, Heyu] Univ Toronto, Dept Med, Toronto, ON, Canada	Canadian Blood Services; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Yang, Y (corresponding author), Canadian Blood Serv, Toronto, ON, Canada.	yangyan3@mail.sysu.edu.cn; Nih@smh.ca		Ni, Heyu/0000-0002-7621-2945; Wang, Yiming/0000-0001-8031-6184; Yang, Yan/0000-0002-5662-4600	Canadian Institutes of Health Research; National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program); Heart and Stroke Foundation of Canada (Ontario); National Natural Science Foundation of China Research [30972481]; St. Michael's Hospital, Canadian Blood Services; Canada Foundation for Innovation; Canadian Blood Services postdoctoral fellowship award; Ph.D. Graduate Fellowship from Canadian Blood Services; Connaught Scholarships, University of Toronto; Heart and Stroke Foundation of Canada postdoctoral fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program); Heart and Stroke Foundation of Canada (Ontario)(Heart & Stroke Foundation of Canada); National Natural Science Foundation of China Research(National Natural Science Foundation of China (NSFC)); St. Michael's Hospital, Canadian Blood Services; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Blood Services postdoctoral fellowship award; Ph.D. Graduate Fellowship from Canadian Blood Services; Connaught Scholarships, University of Toronto; Heart and Stroke Foundation of Canada postdoctoral fellowship(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes of Health Research and National Natural Science Foundation of China (China-Canada Joint Health Research Initiative Program), Heart and Stroke Foundation of Canada (Ontario), and National Natural Science Foundation of China Research Grants (No. 30972481). Equipment Funds from St. Michael's Hospital, Canadian Blood Services and Canada Foundation for Innovation. YY is a recipient of the Canadian Blood Services postdoctoral fellowship award. YW is a recipient of a Ph.D. Graduate Fellowship from Canadian Blood Services. CL is a recipient of Connaught Scholarships, University of Toronto. JWJ is a recipient of the Canadian Blood Services postdoctoral fellowship award, and the Heart and Stroke Foundation of Canada postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Aal ESM, 2008, J AGR FOOD CHEM, V56, P11171, DOI 10.1021/jf802168c; Auger C, 2010, MOL NUTR FOOD RES, V54, pS171, DOI 10.1002/mnfr.200900602; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bishayee A, 2010, NAT PROD COMMUN, V5, P1613; Bitsch R, 2004, J BIOMED BIOTECHNOL, P293, DOI 10.1155/S1110724304403106; Bouaziz A, 2007, ARCH BIOCHEM BIOPHYS, V457, P235, DOI 10.1016/j.abb.2006.10.020; Chang H, 2010, NUTR CANCER, V62, P1128, DOI 10.1080/01635581.2010.494821; Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244; COLLER BS, 1989, CIRCULATION, V80, P1766, DOI 10.1161/01.CIR.80.6.1766; Conquer JA, 1998, J NUTR, V128, P593, DOI 10.1093/jn/128.3.593; DEMROW HS, 1995, CIRCULATION, V91, P1182, DOI 10.1161/01.CIR.91.4.1182; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; Garcia-Alonso M, 2009, J NUTR BIOCHEM, V20, P521, DOI 10.1016/j.jnutbio.2008.05.011; Griep LMO, 2011, BRIT J NUTR, V106, P1562, DOI 10.1017/S0007114511001942; Guerrero JA, 2007, BRIT J CLIN PHARMACO, V64, P133, DOI 10.1111/j.1365-2125.2007.02881.x; Guo HH, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-10; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hosseinian FS, 2007, J AGR FOOD CHEM, V55, P10832, DOI 10.1021/jf072529m; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Hubbard GP, 2003, P NUTR SOC, V62, P469, DOI 10.1079/PNS2003253; Hwang YP, 2011, NUTR RES, V31, P896, DOI 10.1016/j.nutres.2011.09.026; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Janssen PLTMK, 1998, AM J CLIN NUTR, V67, P255, DOI 10.1093/ajcn/67.2.255; Jirouskova M, 2004, BLOOD, V103, P1995, DOI 10.1182/blood-2003-10-3401; Lamy S, 2008, CARCINOGENESIS, V29, P1033, DOI 10.1093/carcin/bgn070; Langer HF, 2008, THROMB HAEMOSTASIS, V99, P480, DOI 10.1160/TH07-11-0685; Li CL, 2011, J CLIN INVEST, V121, P4537, DOI 10.1172/JCI57850; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466, DOI 10.1093/ajcn/77.6.1466; Navarro-Nunez L, 2009, BRIT J PHARMACOL, V158, P1548, DOI 10.1111/j.1476-5381.2009.00440.x; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Ni HY, 2003, BLOOD, V102, P3609, DOI 10.1182/blood-2003-03-0850; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Ostertag LM, 2011, MOL NUTR FOOD RES, V55, P1624, DOI 10.1002/mnfr.201100135; Ostertag LM, 2010, MOL NUTR FOOD RES, V54, P60, DOI 10.1002/mnfr.200900172; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Randriamboavonjy V, 2010, BLOOD, V116, P2134, DOI 10.1182/blood-2010-04-279612; Rechner AR, 2005, THROMB RES, V116, P327, DOI 10.1016/j.thromres.2005.01.002; Reheman A, 2005, J THROMB HAEMOST, V3, P875, DOI 10.1111/j.1538-7836.2005.01217.x; Reheman A, 2010, THROMB RES, V125, pE177, DOI 10.1016/j.thromres.2010.01.009; Reheman A, 2009, BLOOD, V113, P1809, DOI 10.1182/blood-2008-04-148361; Rein D, 2000, J NUTR, V130, p2120S, DOI 10.1093/jn/130.8.2120S; Rein D, 2000, AM J CLIN NUTR, V72, P30; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Wang Q, 2007, ASIA PAC J CLIN NUTR, V16, P295; Wei XY, 2011, J SCI FOOD AGR, V91, P1006, DOI 10.1002/jsfa.4275; Xia M, 2009, ATHEROSCLEROSIS, V202, P41, DOI 10.1016/j.atherosclerosis.2008.04.005; Yamamoto J, 2006, PLATELETS, V17, P555, DOI 10.1080/09537100600759295; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x; Yang H, 2009, BLOOD, V114, P425, DOI 10.1182/blood-2008-03-145821; Yang Y, 2011, J AGR FOOD CHEM, V59, P6759, DOI 10.1021/jf201079h; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511001437, 10.1017/S0007114511006386]; Zhang YH, 2010, INFLAMM RES, V59, P723, DOI 10.1007/s00011-010-0183-7; Zhu YN, 2011, CLIN CHEM, V57, P1524, DOI 10.1373/clinchem.2011.167361; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	60	63	69	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37323	10.1371/journal.pone.0037323	http://dx.doi.org/10.1371/journal.pone.0037323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624015	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500098
J	Cohen, JF; Leis, A; Lecarpentier, T; Raymond, J; Gendrel, D; Chalumeau, M				Cohen, Jeremie F.; Leis, Alexander; Lecarpentier, Thibault; Raymond, Josette; Gendrel, Dominique; Chalumeau, Martin			Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BACTERIAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; SERUM PROCALCITONIN; ETIOLOGY; CHILDHOOD; MANAGEMENT; INFECTION; DIAGNOSIS	Background: Antibiotic treatment of community-acquired pneumonia (CAP) in children remains mostly empirical because clinical and paraclinical findings poorly discriminate the principal causes of CAP. Fast response to beta-lactam treatment can be considered a proxy of pneumococcal aetiology. We aimed to identify the best biological predictor of response to beta-lactam therapy in children hospitalized for CAP. Methods: A retrospective, single-centre cohort study included all consecutive patients 1 month to 16 years old hospitalized in a teaching hospital in Paris, France, because of CAP empirically treated with a beta-lactam alone from 2003 to 2010. Uni-and multivariate analyses were used to study the ability of routine biological parameters available in the Emergency Department to predict a favourable response to beta-lactam (defined as apyrexia within 48 hours of treatment onset). Results: Among the 125 included patients, 85% (106) showed a favourable response to beta-lactam. In multivariate logistic regression, we found procalcitonin (PCT) the only independent predictor of apyrexia (p = 0.008). The adjusted odds ratio for the decadic logarithm of PCT was 4.3 (95% CI 1.5-12.7). At >= 3 ng/mL, PCT had 55.7% sensitivity (45.7-65.3), 78.9% specificity (54.4-93.9), 93.7% positive predictive value (84.5-98.2), 24.2% negative predictive value (14.2-36.7), 2.64 positive likelihood ratio (1.09-6.42) and 0.56 negative likelihood ratio (0.41-0.77). In the 4 children with a PCT level >= 3 ng/mL and who showed no response to beta-lactam treatment, secondary pleural effusion had developed in 3, and viral co-infection was documented in 1. Conclusions: PCT is the best independent biologic predictor of favourable response to beta-lactam therapy in children hospitalized for CAP. Thus, a high PCT level is highly suggestive of pneumococcal aetiology. However, a 3-ng/mL cut-off does not seem compatible with daily medical practice, and additional research is needed to further define the role of PCT in managing CAP in children.	[Cohen, Jeremie F.; Lecarpentier, Thibault; Gendrel, Dominique; Chalumeau, Martin] Univ Paris 05, AP HP, St Vincent De Paul & Necker Enfants Malades Hosp, Dept Pediat, Paris, France; [Cohen, Jeremie F.; Leis, Alexander; Chalumeau, Martin] INSERM, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, U953, Paris, France; [Raymond, Josette] Univ Paris 05, AP HP, Cochin Hosp, Dept Microbiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Cohen, JF (corresponding author), Univ Paris 05, AP HP, St Vincent De Paul & Necker Enfants Malades Hosp, Dept Pediat, Paris, France.	jeremie.cohen@inserm.fr	Chalumeau, Martin/F-4293-2017; Cohen, Jérémie/H-4707-2019	Chalumeau, Martin/0000-0001-8175-3706; Cohen, Jérémie/0000-0003-3572-8985				AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Balfour-Lynn IM, 2005, THORAX, V60, P1, DOI 10.1136/thx.2004.030676; Bekri H, 2007, ARCH PEDIATRIE, V14, P239, DOI 10.1016/j.arcped.2006.12.010; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; British Thoracic Society Standards of Care Committee, 2002, THORAX, V57, P1, DOI DOI 10.1136/THX.57.SUPPL_1.I1; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; CLAESSON BA, 1989, PEDIATR INFECT DIS J, V8, P856, DOI 10.1097/00006454-198912000-00006; Don M, 2009, PEDIATR INT, V51, P91, DOI 10.1111/j.1442-200X.2008.02678.x; Esposito S, 2011, RESP MED, DOI 101016/jrmed201109003; Gendrel D, 1997, EUR J CLIN MICROBIOL, V16, P388, DOI 10.1007/BF01726370; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Hosmer W. D., 2000, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Khan DA, 2010, J CLIN LAB ANAL, V24, P1, DOI 10.1002/jcla.20333; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Korppi M, 2003, PEDIATR PULM, V35, P56, DOI 10.1002/ppul.10201; KORPPI M, 1993, ACTA PAEDIATR, V82, P360, DOI 10.1111/j.1651-2227.1993.tb12697.x; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; McCracken GH, 2000, PEDIATR INFECT DIS J, V19, P924, DOI 10.1097/00006454-200009000-00036; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Moulin F, 2001, ARCH DIS CHILD, V84, P332, DOI 10.1136/adc.84.4.332; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P644, DOI 10.3109/00365541003796775; Niederman MS, 2008, CLIN INFECT DIS, V47, pS127, DOI 10.1086/591393; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; Ostapchuk M, 2004, AM FAM PHYSICIAN, V70, P899; Prat C, 2003, PEDIATR INFECT DIS J, V22, P963, DOI 10.1097/01.inf.0000095197.72976.4f; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; RUUSKANEN O, 1992, EUR J CLIN MICROBIOL, V11, P217, DOI 10.1007/BF02098083; Toikka P, 1999, CLIN INFECT DIS, V29, P568, DOI 10.1086/598635; Toikka P, 2000, PEDIATR INFECT DIS J, V19, P598, DOI 10.1097/00006454-200007000-00003	33	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36927	10.1371/journal.pone.0036927	http://dx.doi.org/10.1371/journal.pone.0036927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615848	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200027
J	Hunt, D; Wilson, JE; Weih, KA; Ishido, S; Harton, JA; Roche, PA; Drake, JR				Hunt, Danielle; Wilson, Justin E.; Weih, Karis A.; Ishido, Satoshi; Harton, Jonathan A.; Roche, Paul A.; Drake, James R.			Francisella tularensis Elicits IL-10 via a PGE2-Inducible Factor, to Drive Macrophage MARCH1 Expression and Class II Down-Regulation	PLOS ONE			English	Article							MHC CLASS-II; PROSTAGLANDIN E-2; UBIQUITINATION; RELEASE; CELLS	Francisella tularensis is a bacterial pathogen that uses host-derived PGE(2) to subvert the host's adaptive immune responses in multiple ways. Francisella-induced PGE(2) acts directly on CD4 T cells to blunt production of IFN-gamma. Francisella-induced PGE(2) can also elicit production of a > 10 kDa soluble host factor termed FTMempty setSN (F. tularensis macrophage supernatant), which acts on IFN-gamma pre-activated Mempty set to down-regulate MHC class II expression via a ubiquitin-dependent mechanism, blocking antigen presentation to CD4 T cells. Here, we report that FTMempty setSN-induced down-regulation of Mempty set class II is the result of the induction of MARCH1, and that Mempty set expressing MARCH1 "resistant" class II molecules are resistant to FTMempty setSN-induced class II down-regulation. Since PGE(2) can induce IL-10 production and IL-10 is the only reported cytokine able to induce MARCH1 expression in monocytes and dendritic cells, these findings suggested that IL-10 is the active factor in FTMempty setSN. However, use of IL-10 knockout Mempty set established that IL-10 is not the active factor in FTMempty setSN, but rather that Francisella-elicited PGE(2) drives production of a > 10 kDa host factor distinct from IL-10. This factor then drives Mempty set IL-10 production to induce MARCH1 expression and the resultant class II down-regulation. Since many human pathogens such as Salmonella typhi, Mycobacterium tuberculosis and Legionella pneumophila also induce production of host PGE(2), these results suggest that a yet-to-be-identified PGE(2)-inducible host factor capable of inducing IL-10 is central to the immune evasion mechanisms of multiple important human pathogens.	[Hunt, Danielle; Harton, Jonathan A.; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Wilson, Justin E.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Weih, Karis A.; Roche, Paul A.] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Lab Infect Immun, Yokohama, Kanagawa, Japan; [Ishido, Satoshi] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Albany Medical College; University of North Carolina; University of North Carolina Chapel Hill; RIKEN; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunt, D (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	drakej@mail.amc.edu	Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021	Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Roche, Paul/0000-0002-8949-9172	National Institutes of Health [PO1 AI-056321]; Intramural Research Program of the National Institutes of Health; T32 training grant [AI-49822]; NATIONAL CANCER INSTITUTE [ZIABC009404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049822, P01AI056320, R03AI056321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by National Institutes of Health grant PO1 AI-056321 to the Center for Immunology and Microbial Disease and by the Intramural Research Program of the National Institutes of Health. J.E.W. was supported by a T32 training grant (AI-49822) to the Center for Immunology and Microbial Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Harizi H, 2006, CELL MOL IMMUNOL, V3, P271; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; N'Guessan PD, 2007, AM J PHYSIOL-LUNG C, V292, pL267, DOI 10.1152/ajplung.00100.2006; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; PANG T, 1991, MICROBIOL IMMUNOL, V35, P267, DOI 10.1111/j.1348-0421.1991.tb01556.x; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; YUSOF WNW, 1993, MICROBIOL IMMUNOL, V37, P667, DOI 10.1111/j.1348-0421.1993.tb01690.x	17	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37330	10.1371/journal.pone.0037330	http://dx.doi.org/10.1371/journal.pone.0037330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615981	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200061
J	Kang, SO; Wright, JO; Tesorero, RA; Lee, H; Beall, B; Cho, KH				Kang, Song Ok; Wright, Jordan O.; Tesorero, Rafael A.; Lee, Hyunwoo; Beall, Bernard; Cho, Kyu Hong			Thermoregulation of Capsule Production by Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; HYALURONIC-ACID CAPSULE; VIRULENCE GENE-EXPRESSION; LISTERIA-MONOCYTOGENES; H-NS; MOLECULAR CHARACTERIZATION; M-PROTEIN; SHIGELLA-FLEXNERI; BACILLUS-SUBTILIS; TRANSCRIPTIONAL CONTROL	The capsule of Streptococcus pyogenes serves as an adhesin as well as an anti-phagocytic factor by binding to CD44 on keratinocytes of the pharyngeal mucosa and the skin, the main entry sites of the pathogen. We discovered that S. pyogenes HSC5 and MGAS315 strains are further thermoregulated for capsule production at a post-transcriptional level in addition to the transcriptional regulation by the CovRS two-component regulatory system. When the transcription of the hasABC capsular biosynthetic locus was de-repressed through mutation of the covRS system, the two strains, which have been used for pathogenesis studies in the laboratory, exhibited markedly increased capsule production at sub-body temperature. Employing transposon mutagenesis, we found that CvfA, a previously identified membrane-associated endoribonuclease, is required for the thermoregulation of capsule synthesis. The mutation of the cvfA gene conferred increased capsule production regardless of temperature. However, the amount of the capsule transcript was not changed by the mutation, indicating that a post-transcriptional regulator mediates between CvfA and thermoregulated capsule production. When we tested naturally occurring invasive mucoid strains, a high percentage (11/53, 21%) of the strains exhibited thermoregulated capsule production. As expected, the mucoid phenotype of these strains at sub-body temperature was due to mutations within the chromosomal covRS genes. Capsule thermoregulation that exhibits high capsule production at lower temperatures that occur on the skin or mucosal surface potentially confers better capability of adhesion and invasion when S. pyogenes penetrates the epithelial surface.	[Kang, Song Ok; Wright, Jordan O.; Tesorero, Rafael A.; Cho, Kyu Hong] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Lee, Hyunwoo] Univ Illinois, Ctr Pharmaceut Biotechnol, Chicago, IL USA; [Beall, Bernard] Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA USA	Southern Illinois University System; Southern Illinois University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA	Kang, SO (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.	cho@micro.siu.edu		Tesorero, Rafael/0000-0002-1636-0954	Scientist Development Grant from the American Heart Association [11SDG7440083]	Scientist Development Grant from the American Heart Association(American Heart Association)	This work was supported by Scientist Development Grant 11SDG7440083 from the American Heart Association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Ashbaugh CD, 1998, J BACTERIOL, V180, P4955, DOI 10.1128/JB.180.18.4955-4959.1998; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BENCHETRIT LC, 1977, ANAL BIOCHEM, V79, P431, DOI 10.1016/0003-2697(77)90418-3; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Cho KH, 2008, INFECT IMMUN, V76, P3176, DOI 10.1128/IAI.01721-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; CRATER DL, 1995, J BIOL CHEM, V270, P18452, DOI 10.1074/jbc.270.31.18452; CRATER DL, 1995, J BIOL CHEM, V270, P28676, DOI 10.1074/jbc.270.48.28676; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; DONS L, 1992, MOL MICROBIOL, V6, P2919, DOI 10.1111/j.1365-2958.1992.tb01751.x; DONS L, 1994, DNA SEQUENCE, V4, P301, DOI 10.3109/10425179409020856; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; DOUGHERTY BA, 1994, J BIOL CHEM, V269, P169; DOUGHERTY BA, 1993, J BIOL CHEM, V268, P7118; DOUGHERTY BA, 1992, J EXP MED, V175, P1291, DOI 10.1084/jem.175.5.1291; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; HULTON CSJ, 1990, CELL, V63, P631, DOI 10.1016/0092-8674(90)90458-Q; Hurme R, 1997, CELL, V90, P55, DOI 10.1016/S0092-8674(00)80313-X; Husmann LK, 1997, INFECT IMMUN, V65, P1422, DOI 10.1128/IAI.65.4.1422-1430.1997; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; HYNES WL, 1995, INFECT IMMUN, V63, P3015, DOI 10.1128/IAI.63.8.3015-3020.1995; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Kass EH, 1944, J EXP MED, V79, P319, DOI 10.1084/jem.79.3.319; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Lambers H., 2006, International Journal of Cosmetic Science, V28, P359, DOI 10.1111/j.1467-2494.2006.00344.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Los DA, 2004, CELL MOL BIOL, V50, P605; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PORTER ME, 1994, J BACTERIOL, V176, P4187, DOI 10.1128/JB.176.13.4187-4191.1994; Rohde JR, 1999, J BACTERIOL, V181, P4198, DOI 10.1128/JB.181.14.4198-4204.1999; Schmidt KH, 1996, MED MICROBIOL IMMUN, V184, P169, DOI 10.1007/PL00008248; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SCOTT JR, 1974, VIROLOGY, V62, P344, DOI 10.1016/0042-6822(74)90397-3; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Shen A, 2006, PLOS PATHOG, V2, P282, DOI 10.1371/journal.ppat.0020030; SMITH RF, 1968, APPL MICROBIOL, V16, P1434, DOI 10.1128/AEM.16.9.1434-1436.1968; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Starr CR, 2006, INFECT IMMUN, V74, P40, DOI 10.1128/IAI.74.1.40-48.2006; TOBE T, 1995, J BACTERIOL, V177, P1094, DOI 10.1128/jb.177.4.1094-1097.1995; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994	78	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37367	10.1371/journal.pone.0037367	http://dx.doi.org/10.1371/journal.pone.0037367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615992	Green Published, gold			2022-12-27	WOS:000305341200069
J	Nahhas, M; Bhopal, R; Anandan, C; Elton, R; Sheikh, A				Nahhas, Mahmoud; Bhopal, Raj; Anandan, Chantelle; Elton, Rob; Sheikh, Aziz			Prevalence of Allergic Disorders among Primary School-Aged Children in Madinah, Saudi Arabia: Two-Stage Cross-Sectional Survey	PLOS ONE			English	Article							ASTHMA; EPIDEMIOLOGY; TRENDS; SCHOOLCHILDREN; MEDICATION; CHILDHOOD; RHINITIS; DISEASE; BURDEN	Background: There are limited data on the epidemiology of allergic disorders in Saudi Arabia. Such data are needed for, amongst other things, helping to plan service provision at a time when there is considerable investment taking place in national healthcare development. We sought to estimate the prevalence of atopic eczema, allergic rhinitis and asthma in primary school children in Madinah, Saudi Arabia. Methods and Findings: We conducted a two-stage cross-sectional survey of schoolchildren in Madinah. Children were recruited from 38 randomly selected schools. Questionnaires were sent to the parents of all 6,139 6-8 year old children in these schools. These parental-completed questionnaires incorporated questions from the International Study of Asthma and Allergies in Childhood (ISAAC), which had previously been validated for use in Arab populations. We undertook descriptive analyses, using the Generalized Estimating Equation (GEE) to calculate 95% confidence intervals. The overall response rate was 85.9% (n = 5,188), 84.6% for girls and 86.2% for boys, respectively. Overall, parents reported symptoms suggestive of a history of eczema in 10.3% (95% CI 9.4, 11.4), rhinitis in 24.2% (95% CI 22.3, 26.2) and asthma in 23.6% (95% CI 21.3, 26.0) of children. Overall, 41.7% (95% CI 39.1, 44.4) of children had symptoms suggestive of at least one allergic disorder, with a substantial minority manifesting symptoms indicative of co-morbid allergic disease. Comparison of these symptom-based prevalence estimates with reports of clinician-diagnosed disease suggested that the majority of children with eczema and asthma had been diagnosed, but only a minority (17.4%) of children had been diagnosed with rhinitis. International comparisons indicated that children in Madinah have amongst the highest prevalence of allergic problems in the world. Conclusions: Symptoms indicative of allergic disease are very common in primary school-aged children in Madinah, Saudi Arabia, with figures comparable to the highest risk regions in the world.	[Nahhas, Mahmoud; Anandan, Chantelle; Elton, Rob; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Bhopal, Raj] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh Ethn Hlth & Res Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Nahhas, M (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Nahhas, Prof. Dr. Ahmed/0000-0002-2887-8187	Saudi Arabia Ministry of Higher Education Scholarship	Saudi Arabia Ministry of Higher Education Scholarship	Funding came from a Saudi Arabia Ministry of Higher Education Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled Nadia, 2007, Int J Chron Obstruct Pulmon Dis, V2, P141; Al Frayh AR, 2001, ANN ALLERG ASTHMA IM, V86, P292, DOI 10.1016/S1081-1206(10)63301-7; Al-Dawood KM, 2001, SAUDI MED J, V22, P61; ALFRAYH A, 1992, SAUDI MED J, V13, P521; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anandan C, 2009, J ROY SOC MED, V102, P431, DOI 10.1258/jrsm.2009.090027; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burney P, 1996, EUR RESPIR J, V9, P687; Ghouri N, 2008, J ROY SOC MED, V101, P466, DOI 10.1258/jrsm.2008.080096; Gupta R, 2004, CLIN EXP ALLERGY, V34, P520, DOI 10.1111/j.1365-2222.2004.1935.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hasan MMS, 2000, J ASTHMA, V37, P353, DOI 10.3109/02770900009055459; Hijazi N, 1998, EUR RESPIR J, V12, P41, DOI 10.1183/09031936.98.12010041; Janahi IA, 2006, PEDIATR PULM, V41, P80, DOI 10.1002/ppul.20331; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1889, DOI 10.1111/j.1365-2222.2009.03366.x; Punekar YS, 2009, CLIN EXP ALLERGY, V39, P1209, DOI 10.1111/j.1365-2222.2009.03248.x; Ryan Dermot, 2005, Prim Care Respir J, V14, P195, DOI 10.1016/j.pcrj.2005.01.003; Ryan Dermot, 2005, Prim Care Respir J, V14, P204, DOI 10.1016/j.pcrj.2005.03.009; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Simpson CR, 2009, J ROY SOC MED, V102, P108, DOI 10.1258/jrsm.2009.080211; von Mutius E, 2000, ARCH DIS CHILD, V82, pS2; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034	24	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36848	10.1371/journal.pone.0036848	http://dx.doi.org/10.1371/journal.pone.0036848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615824	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200022
J	Wang, J; Tricoche, N; Du, LY; Hunter, M; Zhan, B; Goud, G; Didier, ES; Liu, J; Lu, L; Marx, PA; Jiang, SB; Lustigman, S				Wang, Jing; Tricoche, Nancy; Du, Lanying; Hunter, Meredith; Zhan, Bin; Goud, Gaddam; Didier, Elizabeth S.; Liu, Jing; Lu, Lu; Marx, Preston A.; Jiang, Shibo; Lustigman, Sara			The Adjuvanticity of an O-volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; HELMINTH ONCHOCERCA-VOLVULUS; LINKING INFLUENZA M2E; COV S-PROTEIN; VACCINE ADJUVANTS; IMMUNE-RESPONSES; RECOMBINANT PROTEIN; DENDRITIC CELLS; CROSS-TALK; ACTIVATION	Adjuvants potentiate antigen-specific protective immune responses and can be key elements promoting vaccine effectiveness. We previously reported that the Onchocerca volvulus recombinant protein rOv-ASP-1 can induce activation and maturation of naive human DCs and therefore could be used as an innate adjuvant to promote balanced Th1 and Th2 responses to bystander vaccine antigens in mice. With a few vaccine antigens, it also promoted a Th1-biased response based on pronounced induction of Th1-associated IgG2a and IgG2b antibody responses and the upregulated production of Th1 cytokines, including IL-2, IFN-gamma, TNF-alpha and IL-6. However, because it is a protein, the rOv-ASP-1 adjuvant may also induce anti-self-antibodies. Therefore, it was important to verify that the host responses to self will not affect the adjuvanticity of rOv-ASP-1 when it is used in subsequent vaccinations with the same or different vaccine antigens. In this study, we have established rOv-ASP-1's adjuvanticity in mice during the course of two sequential vaccinations using two vaccine model systems: the receptor-binding domain (RBD) of SARS-CoV spike protein and a commercial influenza virus hemagglutinin (HA) vaccine comprised of three virus strains. Moreover, the adjuvanticity of rOv-ASP-1 was retained with an efficacy similar to that obtained when it was used for a first vaccination, even though a high level of anti-rOv-ASP-1 antibodies was present in the sera of mice before the administration of the second vaccine. To further demonstrate its utility as an adjuvant for human use, we also immunized non-human primates (NHPs) with RBD plus rOv-ASP-1 and showed that rOv-ASP-1 could induce high titres of functional and protective anti-RBD antibody responses in NHPs. Notably, the rOv-ASP-1 adjuvant did not induce high titer antibodies against self in NHPs. Thus, the present study provided a sound scientific foundation for future strategies in the development of this novel protein adjuvant.	[Wang, Jing; Tricoche, Nancy; Du, Lanying; Liu, Jing; Lu, Lu; Jiang, Shibo; Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Hunter, Meredith; Didier, Elizabeth S.; Marx, Preston A.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Zhan, Bin; Goud, Gaddam] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Zhan, Bin; Goud, Gaddam] Sabin Vaccine Inst, Washington, DC USA	New York Blood Center; Tulane University; George Washington University	Wang, J (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	slustigman@nybloodcenter.org	lu, lu/HGA-0894-2022; Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014; lu, lu/HII-7530-2022	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135; Wolf, Nathaniel/0000-0001-6567-2447; Didier, Elizabeth/0000-0002-8343-7202; Wang, Jing/0000-0002-0079-0773	VP fund for New Initiatives (Mohandas Narla); New York Blood Center; National Center for Research Resources; National Institutes of Health [P51 RR00164-50, R01 AI068002]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068002] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	VP fund for New Initiatives (Mohandas Narla); New York Blood Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the VP fund for New Initiatives (Mohandas Narla), New York Blood Center, and by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164-50. It was also supported by a grant from the National Institutes of Health (R01 AI068002) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; Davis HL, 1998, J IMMUNOL, V160, P870; Delavallee L, 2010, SWISS MED WKLY, V140, P28, DOI 10.4414/smw.2010.13108; Dissanayake S, 2004, MOL IMMUNOL, V41, P391, DOI 10.1016/j.molimm.2004.03.020; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2008, VACCINE, V26, P1644, DOI 10.1016/j.vaccine.2008.01.025; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2011, JOVE-J VIS EXP, DOI 10.3791/2444; Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Harnett W, 2004, IMMUNOL LETT, V94, P27, DOI 10.1016/j.imlet.2004.04.008; Hauguel TM, 2008, FRONT BIOSCI-LANDMRK, V13, P2806, DOI 10.2741/2887; He YX, 2009, J IMMUNOL, V182, P4005, DOI 10.4049/jimmunol.0800531; Holland MJ, 2000, EUR J IMMUNOL, V30, P1977, DOI 10.1002/1521-4141(200007)30:7&lt;1977::AID-IMMU1977&gt;3.0.CO;2-3; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kenney R., 2010, NEW GENERATION VACCI, V4th ed., P250; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; MacDonald AJ, 2008, CLIN EXP IMMUNOL, V152, P265, DOI 10.1111/j.1365-2249.2008.03623.x; MacDonald AJ, 2005, VACCINE, V23, P3446, DOI 10.1016/j.vaccine.2005.01.098; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2001, INT J PARASITOL, V31, P889, DOI 10.1016/S0020-7519(01)00213-2; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marchand M, 2003, EUR J CANCER, V39, P70, DOI 10.1016/S0959-8049(02)00479-3; Marciani DJ, 2003, DRUG DISCOV TODAY, V8, P934, DOI 10.1016/S1359-6446(03)02864-2; Mbow ML, 2011, NAT MED, V17, P415, DOI 10.1038/nm0411-415; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Myc LA, 2011, ARCH IMMUNOL THER EX, V59, P249, DOI 10.1007/s00005-011-0129-y; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Paterson JCM, 2002, INFECT IMMUN, V70, P6058, DOI 10.1128/IAI.70.11.6058-6067.2002; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Segura-Velazquez R, 2006, VACCINE, V24, P1073, DOI 10.1016/j.vaccine.2005.09.014; Shibaki A, 2002, EXP DERMATOL, V11, P126, DOI 10.1034/j.1600-0625.2002.110204.x; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Teleshova N, 2006, J LEUKOCYTE BIOL, V79, P257, DOI 10.1189/jlb.0205084; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Vasilakos JP, 2000, CELL IMMUNOL, V204, P64, DOI 10.1006/cimm.2000.1689; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Waite DC, 2001, VACCINE, V19, P3957, DOI 10.1016/S0264-410X(01)00142-6; Xiao WJ, 2008, VACCINE, V26, P5022, DOI 10.1016/j.vaccine.2008.07.028; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yip HC, 1999, J IMMUNOL, V162, P3942; Zhan B, 2005, INFECT IMMUN, V73, P6903, DOI 10.1128/IAI.73.10.6903-6911.2005; Zhao GY, 2010, VACCINE, V28, P7233, DOI 10.1016/j.vaccine.2010.08.049	61	23	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37019	10.1371/journal.pone.0037019	http://dx.doi.org/10.1371/journal.pone.0037019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615877	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200033
J	Ge, JY; Budowle, B				Ge, Jianye; Budowle, Bruce			Kinship Index Variations among Populations and Thresholds for Familial Searching	PLOS ONE			English	Article							DNA PROFILES	Current familial searching strategies are developed primarily based on autosomal STR loci, since most of the offender profiles in the forensic DNA databases do not contain Y-STR or mitochondrial DNA data. There are generally two familial searching methods, Identity-by-State (IBS) based methods or kinship index (KI) based methods. The KI based method is an analytically superior method because the allele frequency information is considered as opposed to solely allele counting. However, multiple KIs should be calculated if the unknown forensic profile may be attributed to multiple possible relevant populations. An important practical issue is the KI threshold to select for limiting the list of candidates from a search. There are generally three strategies of setting the KI threshold for familial searching: (1) SWGDAM recommendation 6; (2) minimum KI >= KI threshold; and (3) maximum KI >= KI threshold. These strategies were evaluated and compared by using both simulation data and empirical data. The minimum KI will tend to be closer to the KI appropriate for the population of which the forensic profile belongs. The minimum KI >= KI threshold performs better than the maximum KI >= KI threshold. The SWGDAM strategy may be too stringent for familial searching with large databases (e. g., 1 million or more profiles), because its KI thresholds depend on the database size and the KI thresholds of large databases have a higher probability to exclude true relatives than smaller databases. Minimum KI >= KI threshold strategy is a better option, as it provides the flexibility to adjust the KI threshold according to a pre-determined number of candidates or false positive/negative rates. Joint use of both IBS and KI does not significantly reduce the chance of including true relatives in a candidate list, but does provide a higher efficiency of familial searching.	[Ge, Jianye; Budowle, Bruce] Univ N Texas, Hlth Sci Ctr, Inst Appl Genet, Dept Forens & Invest Genet, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Ge, JY (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Appl Genet, Dept Forens & Invest Genet, Ft Worth, TX 76107 USA.	Jianye.Ge@unthsc.edu		MacDonald, Heather/0000-0003-2105-5919; Ghosh, Sumita/0000-0001-6488-9329; Budowle, Bruce/0000-0003-4116-2930	University of North Texas Health Science Center	University of North Texas Health Science Center	The University of North Texas Health Science Center supported this study by providing salaries for the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber FR, 2006, SCIENCE, V312, P1315, DOI 10.1126/science.1122655; Budowle B, 2001, J FORENSIC SCI, V46, P453; Budowle B, 2001, FORENSIC SCI COMMUNI, V3; Cowen S, 2008, FORENS SCI INT-GEN S, V1, P643, DOI 10.1016/j.fsigss.2007.10.196; Curran JM, 2008, SCI JUSTICE, V48, P164, DOI 10.1016/j.scijus.2008.04.004; EVETT IW, 1992, J FORENSIC SCI SOC, V32, P301, DOI 10.1016/S0015-7368(92)73087-4; Ge JY, 2011, J FORENSIC SCI, V56, P1448, DOI 10.1111/j.1556-4029.2011.01867.x; Ge Jianye, 2010, Investig Genet, V1, P8, DOI 10.1186/2041-2223-1-8; Hicks T, 2010, FORENSIC SCI INT-GEN, V4, P316, DOI 10.1016/j.fsigen.2009.11.006; Hicks T, 2010, FORENSIC SCI INT-GEN, V4, P232, DOI 10.1016/j.fsigen.2009.10.002; Karlsson AO, 2007, FORENSIC SCI INT, V172, P144, DOI 10.1016/j.forsciint.2006.12.015; Myers SP, 2011, FORENSIC SCI INT-GEN, V5, P493, DOI 10.1016/j.fsigen.2010.10.010; Paoletti DR, 2006, JURIMETRICS J, V42, P161; Reid TM, 2008, FORENSIC SCI INT-GEN, V2, P340, DOI 10.1016/j.fsigen.2008.04.008; Rohlfs RV, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002469; Scientific Working Group on DNA Analysis Methods Ad Hoc Committee on Partial Matches, 2009, FORENSIC SCI COMM, V11; Slooten K, ARXIV12014261V2	17	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37474	10.1371/journal.pone.0037474	http://dx.doi.org/10.1371/journal.pone.0037474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616014	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300117
J	Recordon-Pinson, P; Papuchon, J; Reigadas, S; Deshpande, A; Fleury, H				Recordon-Pinson, Patricia; Papuchon, Jennifer; Reigadas, Sandrine; Deshpande, Alaka; Fleury, Herve			K65R in Subtype C HIV-1 Isolates from Patients Failing on a First-Line Regimen Including d4T or AZT: Comparison of Sanger and UDP Sequencing Data	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESISTANCE MUTATION; VARIANTS	Background: We and others have shown that subtype C HIV-1 isolates from patients failing on a regimen containing stavudine (d4T) or zidovudine (AZT) exhibit thymidine-associated mutations (TAMs) and K65R which can impair the efficacy of Tenofovir (TDF) at second line. Depending on the various studies, the prevalence of K65R substitution as determined by the Sanger method ranges from 4 to 30%. Our aim was to determine whether ultra-deep pyrosequencing (UDPS) could provide more information than the Sanger method about selection of K65R in this population of patients. Methods: 27 subtype C HIV-1 isolates from treated patients failing on a regimen with d4T or AZT plus lamivudine (3TC) plus nevirapine (NVP) or efavirenz (EFV) and who had been sequenced by Sanger were investigated by UDPS at codon 65 of the reverse transcriptase (RT). 18 isolates from naive patients and dilutions of a control K65R plasmid were analysed by Sanger plus UDPS. Results: Analysis of Sanger sequences of subtype C HIV-1 isolates from naive patients exhibited expected polymorphic substitutions compared to subtype B but no drug resistance mutations (DRMs). Quantitation of K65R variants by UDPS ranged from <0.4% to 3.08%. Sanger sequences of viral isolates from patients at failure of d4T or AZT plus 3TC plus NVP or EFV showed numerous DRMs to nucleoside reverse transcriptase inhibitors (NRTIs) including M184V, thymidine-associated mutations (TAMs) plus DRMs to non-nucleoside reverse transcriptase inhibitors (NNRTIs). Two K65R were observed by Sanger in this series of 27 samples with UDPS percentages of 27 and 87%. Other samples without K65R by Sanger exhibited quantities of K65R variants ranging from <0.4% to 0.80%, which were below the values observed in isolates from naive patients. Conclusions: While Sanger sequencing of subtype C isolates from treated patients at failure of d4T or AZT plus 3TC plus NVP or EFV exhibited numerous mutations including TAMs and 8% K65R, UDPS quantitation of K65R variants in the same series did not provide any more information than Sanger.	[Recordon-Pinson, Patricia; Papuchon, Jennifer; Reigadas, Sandrine; Fleury, Herve] CNRS, UMR 5234, Bordeaux, France; [Recordon-Pinson, Patricia; Papuchon, Jennifer; Reigadas, Sandrine; Fleury, Herve] CHU Bordeaux, Virol Lab, Bordeaux, France; [Deshpande, Alaka] JJ Hosp, Bombay, Maharashtra, India	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Recordon-Pinson, P (corresponding author), CNRS, UMR 5234, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr	Recordon-Pinson, Patricia/AAV-1295-2021	Recordon-Pinson, Patricia/0000-0001-6002-0941	Merck Sharp and Dohme-Chibret [3Z22204938]; Agence Nationale de Recherches sur le Sida et les Hepatites Virales	Merck Sharp and Dohme-Chibret; Agence Nationale de Recherches sur le Sida et les Hepatites Virales(ANRSFrench National Research Agency (ANR))	This study was funded by Merck Sharp and Dohme-Chibret (grant 3Z22204938). JP and SR were supported by Agence Nationale de Recherches sur le Sida et les Hepatites Virales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have received funding from Merck Sharp and Dohme-Chibret for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Brenner Bluma G., 2009, HIV Therapy, V3, P583, DOI [10.2217/hiv.09.40, 10.2217/HIV.09.40]; Coutsinos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020208; Coutsinos Dimitrios, 2010, Antiviral Chemistry & Chemotherapy, V20, P117, DOI 10.3851/IMP1443; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Deshpande A, 2011, AIDS RES HUM RETROV, V27, P1345, DOI 10.1089/aid.2011.0066; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Kozal MJ, 2011, ANTIVIR THER, V16, P925, DOI 10.3851/IMP1851; Kumarasamy N, 2009, CLIN INFECT DIS, V49, P306, DOI 10.1086/600044; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Toni TA, 2010, ANTIMICROB AGENTS CH, V54, P907, DOI 10.1128/AAC.01080-09; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992	18	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36549	10.1371/journal.pone.0036549	http://dx.doi.org/10.1371/journal.pone.0036549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615779	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300018
J	Yu, JH; Miao, Y; Xu, HT; Liu, Y; Jiang, GY; Stoecker, M; Wang, E; Wang, EH				Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Stoecker, Maggie; Wang, Endi; Wang, Enhua			N-Terminal 1-54 Amino Acid Sequence and Armadillo Repeat Domain Are Indispensable for P120-Catenin Isoform 1A in Regulating E-Cadherin	PLOS ONE			English	Article							P120 CATENIN; CELL-ADHESION; HUMAN CANCER; TUMOR-CELL; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPTION FACTOR; LUNG-CANCER; EXPRESSION; P120(CTN); COMPLEX	P120-catenin (p120ctn) exerts important roles in regulating E-cadherin and invasiveness in cancer cells. However, the mechanisms by which p120ctn isoforms 1 and 3 modulate E-cadherin expression are poorly understood. In the current study, HBE, H460, SPC and LTE cell lines were used to examine the effects of p120ctn isoforms 1A and 3A on E-cadherin expression and cell invasiveness. E-cadherin was localized on the cell membrane of HBE and H460 cells, while it was confined to the cytoplasm in SPC and LTE cells. Depletion of endogenous p120ctn resulted in reduced E-cadherin expression; however, p120ctn ablation showed opposite effects on invasiveness in the cell lines by decreasing invasiveness in SPC and LTE cells and increasing it in HBE and H460 cells. Restitution of 120ctn isoform 1A restored E-cadherin on the cell membrane and blocked cell invasiveness in H460 and HBE cells, while it restored cytoplasmic E-cadherin and enhanced cell invasiveness in SPC and LTE cells. P120ctn isoform 3A increased the invasiveness in all four cell lines despite the lack of effect on E-cadherin expression, suggesting a regulatory pathway independent of E-cadherin. Moreover, five p120ctn isoform 1A deletion mutants were constructed and expressed in H460 and SPC cells. The results showed that only the M4 mutant, which contains N-terminal 1-54 amino acids and the Armadillo repeat domain, was functional in regulating E-cadherin and cell invasiveness, as observed in p120ctn isoform 1A. In conclusion, the N-terminal 1-54 amino acid sequence and Armadillo repeat domain of p120ctn isoform 1A are indispensable for regulating E-cadherin protein. P120ctn isoform 1A exerts opposing effects on cell invasiveness, corresponding to the subcellular localization of E-cadherin.	[Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; [Yu, Juanhan; Miao, Yuan; Xu, Hongtao; Liu, Yang; Jiang, Guiyang; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Stoecker, Maggie; Wang, Endi] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Yu, JH (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	于, 涓瀚/GZM-5474-2022; Xu, Hong-Tao/AAI-7055-2020; Miao, Yuan/AAG-9754-2021	于, 涓瀚/0000-0002-5219-6725; Xu, Hong-Tao/0000-0001-5062-3108; 	National Natural Science Foundation of China [30870977, 81071905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 30870977 and no. 81071905 to En-Hua Wang]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2002, J CELL SCI, V115, P1391; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Mo YY, 1996, CANCER RES, V56, P2633; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Stanczak A, 2011, PATHOL ONCOL RES, V17, P955, DOI 10.1007/s12253-011-9409-4; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	30	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37008	10.1371/journal.pone.0037008	http://dx.doi.org/10.1371/journal.pone.0037008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615871	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300053
J	Bakker, PR; Bakker, E; Amin, N; van Duijn, CM; van Os, J; van Harten, PN				Bakker, P. Roberto; Bakker, Egbert; Amin, Najaf; van Duijn, Cornelia M.; van Os, Jim; van Harten, Peter N.			Candidate Gene-Based Association Study of Antipsychotic-Induced Movement Disorders in Long-Stay Psychiatric Patients: A Prospective Study	PLOS ONE			English	Article							CURACAO EXTRAPYRAMIDAL SYNDROMES; GENOME-WIDE ASSOCIATION; TARDIVE-DYSKINESIA; SCHIZOPHRENIA; PHARMACOGENETICS; DOPAMINE; PARKINSONISM; ENVIRONMENT; PREVALENCE; PREDICTORS	Objective: Four types of antipsychotic-induced movement disorders: tardive dyskinesia (TD), parkinsonism, akathisia and tardive dystonia, subtypes of TD (orofacial and limb truncal dyskinesia), subtypes of parkinsonism (rest tremor, rigidity, and bradykinesia), as well as a principal-factor of the movement disorders and their subtypes, were examined for association with variation in 10 candidate genes (PPP1R1B, BDNF, DRD3, DRD2, HTR2A, HTR2C, COMT, MnSOD, CYP1A2, and RGS2). Methods: Naturalistic study of 168 white long-stay patients with chronic mental illness requiring long-term antipsychotic treatment, examined by the same rater at least two times over a 4-year period, with a mean follow-up time of 1.1 years, with validated scales for TD, parkinsonism, akathisia, and tardive dystonia. The authors genotyped 31 SNPs, associated with movement disorders or schizophrenia in previous studies. Genotype and allele frequency comparisons were performed with multiple regression methods for continuous movement disorders. Results: Various SNPs reached nominal significance: TD and orofacial dyskinesia with rs6265 and rs988748, limb truncal dyskinesia with rs6314, rest tremor with rs6275, rigidity with rs6265 and rs4680, bradykinesia with rs4795390, akathisia with rs4680, tardive dystonia with rs1799732, rs4880 and rs1152746. After controlling for multiple testing, no significant results remained. Conclusions: The findings suggest that selected SNPs are not associated with a susceptibility to movement disorders. However, as the sample size was small and previous studies show inconsistent results, definite conclusions cannot be made. Replication is needed in larger study samples, preferably in longitudinal studies which take the fluctuating course of movement disorders and gene-environment interactions into account.	[Bakker, P. Roberto; van Harten, Peter N.] Psychiat Ctr GGZ Cent, Amersfoort, Netherlands; [Bakker, Egbert] LUMC, Ctr Human & Clin Genet, Leiden, Netherlands; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Os, Jim; van Harten, Peter N.] Maastricht Univ, Med Ctr, S Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, Kings Hlth Partners, London WC2R 2LS, England	Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of London; King's College London	Bakker, PR (corresponding author), Psychiat Ctr GGZ Cent, Amersfoort, Netherlands.	robertobakker@gmail.com	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/I-9496-2012; Bakker, Egbert/D-3525-2009; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Bakker, Egbert/0000-0002-2843-7357; Amin, Najaf/0000-0002-8944-1771; Bakker, P. Roberto/0000-0002-9964-9939; Van Duijn, Cornelia/0000-0002-2374-9204	Foundation "the Open Ankh'', the Netherlands [SG 21.02]; Eli Lilly; BMS; Lundbeck; Organon; Janssen-Cilag; GSK; AstraZeneca; Pfizer; Servier	Foundation "the Open Ankh'', the Netherlands; Eli Lilly(Eli Lilly); BMS(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GSK(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier)	This work was supported by a grant from the Foundation "the Open Ankh'', the Netherlands (grant number SG 21.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Jim van Os is/has been an unrestricted research grant holder with, or has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Lundbeck, Organon, Janssen-Cilag, GSK, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Peter N. van Harten has received financial compensation as an independent symposium speaker from Eli Lilly, BMS, Janssen-Cilag, GSK, and AstraZeneca, companies that have an interest in the treatment of psychosis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. P. Roberto Bakker, Egbert Bakker, Najaf Amin and Cornelia M. van Duijn have declared that no competing interests exist.	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Al Hadithy AF, 2009, HUM PSYCHOPHARM CLIN, V24, P123, DOI 10.1002/hup.997; Al Hadithy AF, 2008, AM J MED GENET B, V147B, P890, DOI 10.1002/ajmg.b.30746; Alkelai A, 2009, PSYCHOPHARMACOLOGY; ANDREASEN NC, 1993, SCHIZOPHRENIA BULL, V19, P199, DOI 10.1093/schbul/19.2.199; Bakker PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025588; Benjamini Y., 2004, RECENT DEV MULTIPLE; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casey DE, 2006, CNS SPECTRUMS, V11, P25, DOI 10.1017/S1092852900026651; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Factor SA., 2005, DRUG INDUCED MOVEMEN, V2nd; Fahn S., 1987, RECENT DEV PARKINSON, P153; Faraone SV, 1999, GENETIC MENTAL DISOR; Fenton WS, 2000, J CLIN PSYCHIAT, V61, P10; Guy W, 1975, ECDEU ASSESSMENT MAN, P534; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Halliday J, 2002, BRIT J PSYCHIAT, V181, P422, DOI 10.1192/bjp.181.5.422; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Khoury MJ, 2009, AM J EPIDEMIOL, V169, P227, DOI 10.1093/aje/kwn351; Koning J. P., 2010, Journal of Medical Engineering & Technology, V34, P71, DOI 10.3109/03091900903402105; Koning JP, 2012, PSYCHOPHARMACOLOGY, V219, P727, DOI 10.1007/s00213-011-2394-1; Koning JPF, 2010, SCHIZOPHRENIA BULL, V36, P723, DOI 10.1093/schbul/sbn146; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Lehoux Pascale, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P76; Lencer R, 2004, BRIT J PSYCHIAT, V185, P465, DOI 10.1192/bjp.185.6.465; Lerer B., 2002, PHARMACOGENETICS PSY; Lerer Bernard, 2006, Dialogues Clin Neurosci, V8, P85; McCormick Laurie M, 2005, Curr Psychiatry Rep, V7, P311, DOI 10.1007/s11920-005-0086-4; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P45, DOI 10.1192/bjp.183.1.45; Muller DJ, 2001, ACTA PSYCHIAT SCAND, V104, P375, DOI 10.1034/j.1600-0447.2001.00401.x; Murray RM, 1998, J CLIN PSYCHOPHARM, V18, p2S, DOI 10.1097/00004714-199804001-00002; Ohmori O, 2003, PROG NEURO-PSYCHOPH, V27, P581, DOI 10.1016/S0278-5846(03)00082-4; OWENS DC, 1999, GUIDE EXTRAPYRAMIDAL; Ozdemir V, 2006, EXPERT OPIN PHARMACO, V7, P119, DOI 10.1517/14656566.7.2.119; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Reynolds GP, 2007, DRUG DISCOV TODAY, V12, P953, DOI 10.1016/j.drudis.2007.07.018; Robinson DG, 2002, SCHIZOPHR RES, V57, P209, DOI 10.1016/S0920-9964(01)00312-7; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sachdev PS, 2005, PSYCHIAT CLIN N AM, V28, P255, DOI 10.1016/j.psc.2004.10.004; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; StataCorp, 2009, STAT REL 11 STAT SOF; Steyerberg E., 2009, CLIN PREDICTION MODE; Van Harten P. N., 1996, Schizophrenia Research, V19, P195; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wilffert B, 2009, J PSYCHOPHARMACOL, V23, P652, DOI 10.1177/0269881108091594; Ziegler A, 2006, STAT APPROACH GENETI	52	18	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36561	10.1371/journal.pone.0036561	http://dx.doi.org/10.1371/journal.pone.0036561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615781	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300022
J	Kim, SJ; Moon, GJ; Cho, YH; Kang, HY; Hyung, NK; Kim, D; Lee, JH; Nam, JY; Bang, OY				Kim, Suk Jae; Moon, Gyeong Joon; Cho, Yeon Hee; Kang, Ho Young; Hyung, Na Kyum; Kim, Donghee; Lee, Ji Hyun; Nam, Ji Yoon; Bang, Oh Young			Circulating Mesenchymal Stem Cells Microparticles in Patients with Cerebrovascular Disease	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERIPHERAL-BLOOD; BONE-MARROW; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; P-SELECTIN; MOBILIZATION; TRANSPLANTATION; ANGIOGENESIS; ACTIVATION	Preclinical and clinical studies have shown that the application of CD105(+) mesenchymal stem cells (MSCs) is feasible and may lead to recovery after stroke. In addition, circulating microparticles are reportedly functional in various disease conditions. We tested the levels of circulating CD105+ microparticles in patients with acute ischemic stroke. The expression of CD105 (a surface marker of MSCs) and CXCR4 (a CXC chemokine receptor for MSC homing) on circulating microparticles was evaluated by flow cytometry of samples from 111 patients and 50 healthy subjects. The percentage of apoptotic CD105 microparticles was determined based on annexin V (AV) expression. The relationship between serum levels of CD105(+)/AV(-) microparticles, stromal cells derived factor-1 alpha (SDF-1 alpha), and the extensiveness of cerebral infarcts was also evaluated. CD105(+)/AV(-) microparticles were higher in stroke patients than control subjects. Correlation analysis showed that the levels of CD105(+)/AV(-) microparticles increased as the baseline stroke severity increased. Multivariate testing showed that the initial severity of stroke was independently associated with circulating CD105(+)/AV(-) microparticles (OR, 1.103 for 1 point increase in the NIHSS score on admission; 95% CI, 1.032-1.178) after adjusting for other variables. The levels of CD105(+)/CXCR4(+)/AV(-) microparticles were also increased in patients with severe disability (r = 0.192, p = 0.046 for NIHSS score on admission), but were decreased with time after stroke onset (r = -0.204, p = 0.036). Risk factor profiles were not associated with the levels of circulating microparticles or SDF-1 alpha. In conclusion, our data showed that stroke triggers the mobilization of MSC-derived microparticles, especially in patients with extensive ischemic stroke.	[Kim, Suk Jae; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Moon, Gyeong Joon; Cho, Yeon Hee; Kang, Ho Young; Kim, Donghee; Lee, Ji Hyun; Nam, Ji Yoon] Samsung Biomed Res Inst, Clin Res Ctr, Seoul, South Korea; [Hyung, Na Kyum] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Clin Trial Ctr, Seoul, South Korea; [Kim, Donghee; Lee, Ji Hyun; Bang, Oh Young] Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr	Moon, Gyeong Joon/P-7878-2019	Moon, Gyeong Joon/0000-0002-2851-9563	Ministry of Health Welfare [A110208]; National Research Foundation of Korea, Ministry of Education, Science and Technology [2010-0007979]	Ministry of Health Welfare; National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (A110208) and the Basic Science Research Program through the National Research Foundation of Korea, Ministry of Education, Science and Technology (2010-0007979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Carbonare LD, 2009, ARTHRITIS RHEUM-US, V60, P3356, DOI 10.1002/art.24884; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Choudhury A, 2007, CHEST, V131, P809, DOI 10.1378/chest.06-2039; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Connor DE, 2010, THROMB HAEMOSTASIS, V103, P1044, DOI 10.1160/TH09-09-0644; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Hennemann B, 2008, CYTOTHERAPY, V10, P303, DOI 10.1080/14653240801949994; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jung KH, 2008, ANN NEUROL, V63, P312, DOI 10.1002/ana.21303; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Kalinkovich A, 2006, CANCER RES, V66, P11013, DOI 10.1158/0008-5472.CAN-06-2006; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kucia M, 2006, LEUKEMIA, V20, P18, DOI 10.1038/sj.leu.2404011; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Leone AM, 2005, EUR HEART J, V26, P1196, DOI 10.1093/eurheartj/ehi164; Leroyer AS, 2009, CIRCULATION, V119, P2808, DOI 10.1161/CIRCULATIONAHA.108.816710; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mieno S, 2006, CIRCULATION, V114, pI186, DOI 10.1161/CIRCULATIONAHA.105.001610; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pirro M, 2008, ATHEROSCLEROSIS, V197, P757, DOI 10.1016/j.atherosclerosis.2007.07.012; Ramirez M, 2006, BRIT J SPORT MED, V40, P719, DOI 10.1136/bjsm.2006.028639; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ripa RS, 2007, INT J CARDIOL, V120, P181, DOI 10.1016/j.ijcard.2006.09.011; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Simak J, 2006, J THROMB HAEMOST, V4, P1296, DOI 10.1111/j.1538-7836.2006.01911.x; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wang Y, 2006, HEART, V92, P768, DOI 10.1136/hrt.2005.069799; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	41	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37036	10.1371/journal.pone.0037036	http://dx.doi.org/10.1371/journal.pone.0037036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615882	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300064
J	Wang, X; Gu, WP; Cui, ZG; Luo, LZ; Cheng, P; Xiao, YC; Tang, LY; Kan, BA; Jing, HQ				Wang, Xin; Gu, Wenpeng; Cui, Zhigang; Luo, Longze; Cheng, Peng; Xiao, Yuchun; Tang, Liuying; Kan, Biao; Jing, Huaiqi			Multiple-Locus Variable-Number Tandem-Repeat Analysis of Pathogenic Yersinia enterocolitica in China	PLOS ONE			English	Article							GENETIC-RELATIONSHIPS; STRAINS; DIVERSITY; POLYMORPHISM; OUTBREAK	The predominant bioserotypes of pathogenic Yersinia enterocolitica in China are 2/O: 9 and 3/O: 3; no pathogenic O: 8 strains have been found to date. Multiple-Locus Variable-Number Tandem-Repeat Analysis (MLVA) based on seven loci was able to distinguish 104 genotypes among 218 pathogenic Y. enterocolitica isolates in China and from abroad, showing a high resolution. The major pathogenic serogroups in China, O: 3 and O: 9, were divided into two clusters based on MLVA genotyping. The different distribution of Y. enterocolitica MLVA genotypes maybe due to the recent dissemination of specific clones of 2/O: 9 and 3/O: 3 strains in China. MLVA was a helpful tool for bacterial pathogen surveillance and investigation of pathogenic Y. enterocolitica outbreaks.	[Wang, Xin; Cui, Zhigang; Xiao, Yuchun; Kan, Biao; Jing, Huaiqi] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Gu, Wenpeng] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Luo, Longze] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Cheng, Peng] Huangshan Municipal Ctr Dis Control & Prevent, Huangshan, Peoples R China; [Tang, Liuying] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	jinghuaiqi@icdc.cn	Tang, Liuying/GXF-3556-2022; Gu, Wenpeng/U-5367-2017		National Natural Science Foundation of China [30970094]; National Sci-Tech Key Project [2009ZX10004-201, 2009ZX10004-203, 2008ZX10004-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sci-Tech Key Project	This work was supported by the National Natural Science Foundation of China (General Project, No. 30970094) and the National Sci-Tech Key Project (2009ZX10004-201, 2009ZX10004-203, 2008ZX10004-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gierczynski R, 2007, J CLIN MICROBIOL, V45, P2508, DOI 10.1128/JCM.02252-06; Gulati P, 2009, J APPL MICROBIOL, V107, P875, DOI 10.1111/j.1365-2672.2009.04267.x; Hallanvuo S, 2002, INT J MED MICROBIOL, V292, P215, DOI 10.1078/1438-4221-00207; Horisaka T, 2004, J CLIN MICROBIOL, V42, P5349, DOI 10.1128/JCM.42.11.5349-5352.2004; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iteman I, 1996, J MED MICROBIOL, V45, P48, DOI 10.1099/00222615-45-1-48; KAPPERUD G, 1990, J CLIN MICROBIOL, V28, P1125, DOI 10.1128/JCM.28.6.1125-1131.1990; Kotetishvili M, 2005, J CLIN MICROBIOL, V43, P2674, DOI 10.1128/JCM.43.6.2674-2684.2005; Kuehni-Boghenbor K, 2006, APPL ENVIRON MICROB, V72, P4061, DOI 10.1128/AEM.01996-05; Le Fleche P, 2001, BMC Microbiol, V1, P2; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; PICARDPASQUIER N, 1990, J GEN MICROBIOL, V136, P1655, DOI 10.1099/00221287-136-8-1655; Pourcel C, 2003, J CLIN MICROBIOL, V41, P1819, DOI 10.1128/JCM.41.5.1819-1826.2003; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Sihvonen LM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-42; Velazquez L, 1995, CONTRIB TO MICROBIOL, V13, P59; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wang X, 2008, INT J FOOD MICROBIOL, V125, P259, DOI 10.1016/j.ijfoodmicro.2008.04.016; Wang X, 2011, J CLIN MICROBIOL, V49, P1251, DOI 10.1128/JCM.01921-10; Wang X, 2010, J CLIN MICROBIOL, V48, P1604, DOI 10.1128/JCM.01789-09	25	8	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37309	10.1371/journal.pone.0037309	http://dx.doi.org/10.1371/journal.pone.0037309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615971	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300091
J	Xue, JY; Wang, Y; Wu, P; Wang, Q; Yang, LT; Pan, XH; Wang, B; Chen, JQ				Xue, Jia-Yu; Wang, Yue; Wu, Ping; Wang, Qiang; Yang, Le-Tian; Pan, Xiao-Han; Wang, Bin; Chen, Jian-Qun			A Primary Survey on Bryophyte Species Reveals Two Novel Classes of Nucleotide-Binding Site (NBS) Genes	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RESISTANCE GENE; LRR PROTEINS; IDENTIFICATION; LAND; ARABIDOPSIS; EXPANSION; ANCIENT; FAMILY	Due to their potential roles in pathogen defense, genes encoding nucleotide-binding site (NBS) domain have been particularly surveyed in many angiosperm genomes. Two typical classes were found: one is the TIR-NBS-LRR (TNL) class and the other is the CC-NBS-LRR (CNL) class. It is seldom known, however, what kind of NBS-encoding genes are mainly present in other plant groups, especially the most ancient groups of land plants, that is, bryophytes. To fill this gap of knowledge, in this study, we mainly focused on two bryophyte species: the moss Physcomitrella patens and the liverwort Marchantia polymorpha, to survey their NBS-encoding genes. Surprisingly, two novel classes of NBS-encoding genes were discovered. The first novel class is identified from the P. patens genome and a typical member of this class has a protein kinase (PK) domain at the N-terminus and a LRR domain at the C-terminus, forming a complete structure of PK-NBS-LRR (PNL), reminiscent of TNL and CNL classes in angiosperms. The second class is found from the liverwort genome and a typical member of this class possesses an alpha/beta-hydrolase domain at the N-terminus and also a LRR domain at the C-terminus (Hydrolase-NBS-LRR, HNL). Analysis on intron positions and phases also confirmed the novelty of HNL and PNL classes, as reflected by their specific intron locations or phase characteristics. Phylogenetic analysis covering all four classes of NBS-encoding genes revealed a closer relationship among the HNL, PNL and TNL classes, suggesting the CNL class having a more divergent status from the others. The presence of specific introns highlights the chimerical structures of HNL, PNL and TNL genes, and implies their possible origin via exon-shuffling during the quick lineage separation processes of early land plants.	[Xue, Jia-Yu; Wang, Yue; Wu, Ping; Wang, Qiang; Yang, Le-Tian; Pan, Xiao-Han; Wang, Bin; Chen, Jian-Qun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Xue, JY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	binwang@nju.edu.cn; chenjq@nju.edu.cn		Xue, Jia-Yu/0000-0002-7128-9935	National Natural Science Founding of China [30930008, 31000105]; National Postdoctoral Science Founding of China [20110491392]; Nanjing University	National Natural Science Founding of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Science Founding of China; Nanjing University(Nanjing University)	This work was supported by grants from the National Natural Science Founding of China (30930008) to JQC and BW (31000105), the National Postdoctoral Science Founding of China (20110491392) and Nanjing University Start Grants to JYX. (http://www.nsfc.gov.cn); (http://www.chinapostdoctor.org.cn); (www.nju.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2002, J MOL EVOL, V55, P595, DOI 10.1007/s00239-002-2355-8; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Haque MA, 2008, PHYSIOL MOL PLANT P, V73, P101, DOI 10.1016/j.pmpp.2009.03.001; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Meyers BC, 1998, PLANT CELL, V10, P1817, DOI 10.1105/tpc.10.11.1817; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 1998, NATURE, V394, P671, DOI 10.1038/29286; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Yue JX, 2012, NEW PHYTOL, V193, P1049, DOI 10.1111/j.1469-8137.2011.04006.x; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	41	46	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36700	10.1371/journal.pone.0036700	http://dx.doi.org/10.1371/journal.pone.0036700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615795	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300028
J	Swapna, LS; Srikeerthana, K; Srinivasan, N				Swapna, Lakshmipuram Seshadri; Srikeerthana, Kuchi; Srinivasan, Narayanaswamy			Extent of Structural Asymmetry in Homodimeric Proteins: Prevalence and Relevance	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; CRYSTAL-STRUCTURE; DNA RECOGNITION; EVOLUTIONARY CONSERVATION; COMPLEX REVEALS; BINDING MOAD; SYMMETRY; SEQUENCE; CHIP; IDENTIFICATION	Most homodimeric proteins have symmetric structure. Although symmetry is known to confer structural and functional advantage, asymmetric organization is also observed. Using a non-redundant dataset of 223 high-resolution crystal structures of biologically relevant homodimers, we address questions on the prevalence and significance of asymmetry. We used two measures to quantify global and interface asymmetry, and assess the correlation of several molecular and structural parameters with asymmetry. We have identified rare cases (11/223) of biologically relevant homodimers with pronounced global asymmetry. Asymmetry serves as a means to bring about 2:1 binding between the homodimer and another molecule; it also enables cellular signalling arising from asymmetric macromolecular ligands such as DNA. Analysis of these cases reveals two possible mechanisms by which possible infinite array formation is prevented. In case of homodimers associating via non-topologically equivalent surfaces in their tertiary structures, ligand-dependent mechanisms are used. For stable dimers binding via large surfaces, ligand-dependent structural change regulates polymerisation/depolymerisation; for unstable dimers binding via smaller surfaces that are not evolutionarily well conserved, dimerisation occurs only in the presence of the ligand. In case of homodimers associating via interaction surfaces with parts of the surfaces topologically equivalent in the tertiary structures, steric hindrance serves as the preventive mechanism of infinite array. We also find that homodimers exhibiting grossly symmetric organization rarely exhibit either perfect local symmetry or high local asymmetry. Binding of small ligands at the interface does not cause any significant variation in interface asymmetry. However, identification of biologically relevant interface asymmetry in grossly symmetric homodimers is confounded by the presence of similar small magnitude changes caused due to artefacts of crystallisation. Our study provides new insights regarding accommodation of asymmetry in homodimers.	[Swapna, Lakshmipuram Seshadri; Srikeerthana, Kuchi; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Swapna, LS (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in		Kuchi, Srikeerthana/0000-0003-3265-9355; Seshadri, Swapna/0000-0001-5906-7574	Department of Biotechnology, New Delhi; Mathematical Biology Programme; Department of Science and Technology (DST), New Delhi; Mathematical Biology Programme, DST	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Mathematical Biology Programme; Department of Science and Technology (DST), New Delhi(Department of Science & Technology (India)); Mathematical Biology Programme, DST	This research is supported by the Department of Biotechnology, New Delhi and the Mathematical Biology Programme sponsored by the Department of Science and Technology (DST), New Delhi. LSS is supported by the Mathematical Biology Programme, DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AL, 2009, J MOL BIOL, V394, P522, DOI 10.1016/j.jmb.2009.09.031; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Birck C, 2003, J BACTERIOL, V185, P254, DOI 10.1128/JB.185.1.254-261.2003; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Brown JH, 2010, PROTEIN SCI, V19, P1366, DOI 10.1002/pro.415; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLuca HF, 1998, NUTR REV, V56, pS4; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Ha N, 1996, NUCLEIC ACIDS RES, V24, P1453, DOI 10.1093/nar/24.8.1453; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Ispolatov I, 2005, NUCLEIC ACIDS RES, V33, P3629, DOI 10.1093/nar/gki678; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kanellopoulos PN, 1996, J MOL BIOL, V257, P1, DOI 10.1006/jmbi.1996.0141; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Khare SD, 2007, CURR PROTEIN PEPT SC, V8, P573, DOI 10.2174/138920307783018703; King DA, 1999, NAT STRUCT BIOL, V6, P64; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lukatsky DB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178101; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; Madrazo J, 2001, P NATL ACAD SCI USA, V98, P11967, DOI 10.1073/pnas.211439798; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagradova NK, 2001, FEBS LETT, V487, P327, DOI 10.1016/S0014-5793(00)02338-3; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pednekar D, 2010, PROTEINS, V78, P3048, DOI 10.1002/prot.22828; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Soding J, 2003, BIOESSAYS, V25, P837, DOI 10.1002/bies.10321; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swaminathan K, 1997, NAT STRUCT BIOL, V4, P751, DOI 10.1038/nsb0997-751; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKER PA, 1994, EMBO J, V13, P2994, DOI 10.1002/j.1460-2075.1994.tb06598.x; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WINKLER H, 1988, EMBO J, V7, P1799, DOI 10.1002/j.1460-2075.1988.tb03011.x; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhang L, 1996, EMBO J, V15, P4676, DOI 10.1002/j.1460-2075.1996.tb00844.x; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhao H, 2002, STRUCTURE, V10, P1041, DOI 10.1016/S0969-2126(02)00803-1; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; ZITOMER RS, 1987, MOL CELL BIOL, V7, P2212, DOI 10.1128/MCB.7.6.2212	77	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36688	10.1371/journal.pone.0036688	http://dx.doi.org/10.1371/journal.pone.0036688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629324	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300011
J	Burgers, P; Alexander, DE				Burgers, Phillip; Alexander, David E.			Normalized Lift: An Energy Interpretation of the Lift Coefficient Simplifies Comparisons of the Lifting Ability of Rotating and Flapping Surfaces	PLOS ONE			English	Article								For a century, researchers have used the standard lift coefficient C-L to evaluate the lift, L, generated by fixed wings over an area S against dynamic pressure, 1/2 rho v2, where v is the effective velocity of the wing. Because the lift coefficient was developed initially for fixed wings in steady flow, its application to other lifting systems requires either simplifying assumptions or complex adjustments as is the case for flapping wings and rotating cylinders. This paper interprets the standard lift coefficient of a fixed wing slightly differently, as the work exerted by the wing on the surrounding flow field (L/rho.S), compared against the total kinetic energy required for generating said lift, 1/2v(2). This reinterpreted coefficient, the normalized lift, is derived from the work-energy theorem and compares the lifting capabilities of dissimilar lift systems on a similar energy footing. The normalized lift is the same as the standard lift coefficient for fixed wings, but differs for wings with more complex motions; it also accounts for such complex motions explicitly and without complex modifications or adjustments. We compare the normalized lift with the previously-reported values of lift coefficient for a rotating cylinder in Magnus effect, a bat during hovering and forward flight, and a hovering dipteran. The maximum standard lift coefficient for a fixed wing without flaps in steady flow is around 1.5, yet for a rotating cylinder it may exceed 9.0, a value that implies that a rotating cylinder generates nearly 6 times the maximum lift of a wing. The maximum normalized lift for a rotating cylinder is 1.5. We suggest that the normalized lift can be used to evaluate propellers, rotors, flapping wings of animals and micro air vehicles, and underwater thrust-generating fins in the same way the lift coefficient is currently used to evaluate fixed wings.	[Burgers, Phillip] Embry Riddle Aeronaut Univ, Dept Arts & Sci, San Diego, CA USA; [Alexander, David E.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Embry-Riddle Aeronautical University; University of Kansas	Burgers, P (corresponding author), Embry Riddle Aeronaut Univ, Dept Arts & Sci, San Diego, CA USA.	philburgers@yahoo.com							0	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36732	10.1371/journal.pone.0036732	http://dx.doi.org/10.1371/journal.pone.0036732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629326	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100006
J	Rhyne, AL; Tlusty, MF; Schofield, PJ; Kaufman, L; Morris, JA; Bruckner, AW				Rhyne, Andrew L.; Tlusty, Michael F.; Schofield, Pamela J.; Kaufman, Les; Morris, James A., Jr.; Bruckner, Andrew W.			Revealing the Appetite of the Marine Aquarium Fish Trade: The Volume and Biodiversity of Fish Imported into the United States	PLOS ONE			English	Article							PROPAGULE PRESSURE; RISKS	The aquarium trade and other wildlife consumers are at a crossroads forced by threats from global climate change and other anthropogenic stressors that have weakened coastal ecosystems. While the wildlife trade may put additional stress on coral reefs, it brings income into impoverished parts of the world and may stimulate interest in marine conservation. To better understand the influence of the trade, we must first be able to quantify coral reef fauna moving through it. Herein, we discuss the lack of a data system for monitoring the wildlife aquarium trade and analyze problems that arise when trying to monitor the trade using a system not specifically designed for this purpose. To do this, we examined an entire year of import records of marine tropical fish entering the United States in detail, and discuss the relationship between trade volume, biodiversity and introduction of non-native marine fishes. Our analyses showed that biodiversity levels are higher than previous estimates. Additionally, more than half of government importation forms have numerical or other reporting discrepancies resulting in the overestimation of trade volumes by 27%. While some commonly imported species have been introduced into the coastal waters of the USA (as expected), we also found that some uncommon species in the trade have also been introduced. This is the first study of aquarium trade imports to compare commercial invoices to government forms and provides a means to, routinely and in real time, examine the biodiversity of the trade in coral reef wildlife species.	[Rhyne, Andrew L.; Tlusty, Michael F.; Kaufman, Les] New England Aquarium, Res Dept, Boston, MA USA; [Rhyne, Andrew L.] Roger Williams Univ, Dept Biol & Marine Biol, Bristol, RI 02809 USA; [Schofield, Pamela J.] United States Geol Survey, SE Ecol Sci Ctr, Gainesville, FL USA; [Kaufman, Les] Boston Univ, Dept Biol, Boston Univ Marine Program, Boston, MA 02215 USA; [Kaufman, Les] Conservat Int, Arlington, VA USA; [Morris, James A., Jr.] Natl Ocean & Atmospher Adm, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Beaufort, NC USA; [Bruckner, Andrew W.] Khaled Bin Sultan Living Oceans Fdn, Landover, MD USA	United States Department of the Interior; United States Geological Survey; Boston University; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS)	Rhyne, AL (corresponding author), New England Aquarium, Res Dept, Boston, MA USA.	arhyne@rwu.edu	Tlusty, Michael/AAF-9635-2021	Tlusty, Michael/0000-0002-7493-2025; Rhyne, Andrew/0000-0001-7252-3431	Environmental Defense Fund (EDF) as part of the International Marine Conservation Congress workshop "International Trade in Coral Reef Species"; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program [NA09NMF4000385]; EDF; NOAA	Environmental Defense Fund (EDF) as part of the International Marine Conservation Congress workshop "International Trade in Coral Reef Species"; National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); EDF(Electricite de France (EDF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Seed funds to initiate this work were from the Environmental Defense Fund (EDF) as part of the 2009 International Marine Conservation Congress workshop "International Trade in Coral Reef Species." A National Oceanic and Atmospheric Administration (NOAA) Coral Reef Conservation Program NA09NMF4000385 to Rhyne provided funding for the project. Two authors of this work are employees of the United States Government, but neither they nor their respective offices had a role in the funding of the research beyond provision of salary. The funder EDF had no role in the study's design, data acquisition, data collection, analysis, decision to publish, or preparation of the manuscript. The funder NOAA Office of Habitat Conservation provided the data used in the study but had no role in the analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2011, WORLD REGISTER MARIN; Aronson RB, 2009, AIP CONF PROC, V1157, P48, DOI 10.1063/1.3208031; AZA, 2010, MAR FISH TAX ADV GRO; Barber CV, 1998, CORAL REEFS CHALLENG, P39; Bickford D, 2011, SCIENCE, V331, P857, DOI 10.1126/science.331.6019.857-c; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Breder C.M., 1966, MODES REPROD FISHES; Bruckner AW, 2005, REV BIOL TROP, V53, P127; Burke L., 2011, REEFS RISK REVISITED; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Drew J, 2008, CONSERV BIOL, V22, P965, DOI 10.1111/j.1523-1739.2008.01011.x; Duggan IC, 2006, BIOL INVASIONS, V8, P377, DOI 10.1007/s10530-004-2310-2; Erdmann MV, 2001, CORAL REEFS, V20, P252, DOI 10.1007/s003380100174; GAO, 2010, LIV AN IMP AG NEED B; Gertzen E, 2008, CAN J FISH AQUAT SCI, V65, P1265, DOI 10.1139/F08-056; Ho L, 2011, PEPPERMINT ANGELFISH; Hoeksema Bert W., 2007, V29, P117; Jaremo J, 2011, ECOL MODEL, V222, P485, DOI 10.1016/j.ecolmodel.2010.11.012; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kolm N, 2003, CONSERV BIOL, V17, P910, DOI 10.1046/j.1523-1739.2003.01522.x; Liao YC, 2010, BIOL INVASIONS, V12, P1961, DOI 10.1007/s10530-009-9642-x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lunn KE, 2004, CORAL REEFS, V23, P344, DOI 10.1007/s00338-004-0393-y; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Murray JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029543; Nagendra H, 2002, APPL GEOGR, V22, P175, DOI 10.1016/S0143-6228(02)00002-4; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Prosek J, 2010, NATL GEOGR, P120; Randall JE, 1987, B MAR SCI, V41, P13; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Schofield P.J., 2009, FIELD GUIDE NONINDIG; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Teitelbaum A., 2010, SPC LIVE REEF FISH I, V19, P3; Thresher RE, 1984, REPROD REEF FISHES; Tissot BN, 2003, CONSERV BIOL, V17, P1759, DOI 10.1111/j.1523-1739.2003.00379.x; Tissot BN, 2010, MAR POLICY, V34, P1385, DOI 10.1016/j.marpol.2010.06.002; Tlusty M, 2002, AQUACULTURE, V205, P203, DOI 10.1016/S0044-8486(01)00683-4; US Fish and Wildlife Service, 2003, US WILDL TRAD OV 199; Vagelli Alejandro A., 2008, SPC Live Reef Fish Information Bulletin, V18, P17; Wabnitz C, 2003, OCEAN AQUARIUM; Walsh W, 2000, AQUARIUM COLLECTING; Weber ES, 2009, J VET DIAGN INVEST, V21, P306, DOI 10.1177/104063870902100302; Wood E.M., 2001, AQUARIUM SCI CONSERV, V3, P65, DOI DOI 10.1023/A:1011391700880	49	172	183	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35808	10.1371/journal.pone.0035808	http://dx.doi.org/10.1371/journal.pone.0035808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629303	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100003
J	Docquier, A; Augereau, P; Lapierre, M; Harmand, PO; Badia, E; Annicotte, JS; Fajas, L; Cavailles, V				Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent			The RIP140 Gene Is a Transcriptional Target of E2F1	PLOS ONE			English	Article							RECEPTOR COREPRESSOR RIP140; CELL-CYCLE CONTROL; CANCER-CELLS; INTERACTING PROTEIN-140; FAMILY-MEMBERS; EMERGING ROLES; SP1; ESTROGEN; ACTIVATION; EXPRESSION	RIP140 is a transcriptional coregulator involved in energy homeostasis and ovulation which is controlled at the transcriptional level by several nuclear receptors. We demonstrate here that RIP140 is a novel target gene of the E2F1 transcription factor. Bioinformatics analysis, gel shift assay, and chromatin immunoprecipitation demonstrate that the RIP140 promoter contains bona fide E2F response elements. In transiently transfected MCF-7 breast cancer cells, the RIP140 promoter is transactivated by overexpression of E2F1/DP1. Interestingly, RIP140 mRNA is finely regulated during cell cycle progression (5-fold increase at the G1/S and G2/M transitions). The positive regulation by E2F1 requires sequences located in the proximal region of the promoter (-73/+167), involves Sp1 transcription factors, and undergoes a negative feedback control by RIP140. Finally, we show that E2F1 participates in the induction of RIP140 expression during adipocyte differentiation. Altogether, this work identifies the RIP140 gene as a new transcriptional target of E2F1 which may explain some of the effect of E2F1 in both cancer and metabolic diseases.	[Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] IRCM, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] INSERM, U896, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] Univ Montpellier I, Montpellier, France; [Docquier, Aurelie; Augereau, Patrick; Lapierre, Marion; Harmand, Pierre-Olivier; Badia, Eric; Annicotte, Jean-Sebastien; Fajas, Lluis; Cavailles, Vincent] CRLC Ctr Reg Lutte Canc Val dAurelle Paul Lamarqu, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Docquier, A (corresponding author), IRCM, Montpellier, France.	vincent.cavailles@inserm.fr	Lapierre, Marion/AAB-2845-2020; Cavailles, Vincent/Y-5379-2019; cavailles, vincent/C-6277-2017; Annicotte, Jean-Sébastien/H-4641-2018; Coll, Lluis Fajas/C-8567-2014	Lapierre, Marion/0000-0002-4708-805X; Cavailles, Vincent/0000-0002-7160-3074; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Fajas, Lluis/0000-0002-1283-9503; BADIA, Eric/0000-0002-8922-9834	Institut National de la Sante et de la Recherche Medicale; University of Montpellier 1; Association pour la Recherche sur le Cancer [3494, 3169]; Institut National du Cancer [610-3D1616]; Association Le cancer du sein, parlons-en!; Ligue Nationale contre le Cancer; Ministere de la Recherche et de l'Enseignement Superieur [26059-2007]	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Association Le cancer du sein, parlons-en!; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de la Recherche et de l'Enseignement Superieur	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the University of Montpellier 1, the Association pour la Recherche sur le Cancer [grant numbers 3494, 3169], the Institut National du Cancer [grant number 610-3D1616], the Association Le cancer du sein, parlons-en! [Pink Ribbon Prize 2009], the Ligue Nationale contre le Cancer [grant to POH], and the Ministere de la Recherche et de l'Enseignement Superieur [grant number 26059-2007 to AD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Augereau Patrick, 2006, Nucl Recept Signal, V4, pe024; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Blanchet E, 2009, CELL CYCLE, V8, P4029, DOI 10.4161/cc.8.24.10110; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Docquier A, 2010, CLIN CANCER RES, V16, P2959, DOI 10.1158/1078-0432.CCR-09-3153; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Hitchens MR, 2003, APOPTOSIS, V8, P461, DOI 10.1023/A:1025586207239; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Liao L, 2002, J STEROID BIOCHEM, V83, P3, DOI 10.1016/S0960-0760(02)00254-6; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896; Thenot S, 1999, MOL CELL ENDOCRINOL, V156, P85, DOI 10.1016/S0303-7207(99)00139-2; Tsantoulis PK, 2005, EUR J CANCER, V41, P2403, DOI 10.1016/j.ejca.2005.08.005; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu CL, 1996, MOL CELL BIOL, V16, P3698; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	39	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35839	10.1371/journal.pone.0035839	http://dx.doi.org/10.1371/journal.pone.0035839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629304	Green Published, gold			2022-12-27	WOS:000305343500007
J	Pincede, I; Pollin, B; Meert, T; Plaghki, L; Le Bars, D				Pincede, Ivanne; Pollin, Bernard; Meert, Theo; Plaghki, Leon; Le Bars, Daniel			Psychophysics of a Nociceptive Test in the Mouse: Ambient Temperature as a Key Factor for Variation	PLOS ONE			English	Article							SPINAL-CORD NEURONS; TAIL-FLICK; BODY-TEMPERATURE; ANIMAL-MODELS; DAILY TORPOR; BEHAVIORAL THERMOREGULATION; LABORATORY ENVIRONMENT; THERMAL INHIBITION; SKIN TEMPERATURE; NERVE-FIBERS	Background: The mouse is increasingly used in biomedical research, notably in behavioral neurosciences for the development of tests or models of pain. Our goal was to provide the scientific community with an outstanding tool that allows the determination of psychophysical descriptors of a nociceptive reaction, which are inaccessible with conventional methods: namely the true threshold, true latency, conduction velocity of the peripheral fibers that trigger the response and latency of the central decision-making process. Methodology/Principal Findings: Basically, the procedures involved heating of the tail with a CO2 laser, recording of tail temperature with an infrared camera and stopping the heating when the animal reacted. The method is based mainly on the measurement of three observable variables, namely the initial temperature, the heating rate and the temperature reached at the actual moment of the reaction following random variations in noxious radiant heat. The initial temperature of the tail, which itself depends on the ambient temperature, very markedly influenced the behavioral threshold, the behavioral latency and the conduction velocity of the peripheral fibers but not the latency of the central decision-making. Conclusions/Significance: We have validated a psychophysical approach to nociceptive reactions for the mouse, which has already been described for rats and Humans. It enables the determination of four variables, which contribute to the overall latency of the response. The usefulness of such an approach was demonstrated by providing new fundamental findings regarding the influence of ambient temperature on nociceptive processes. We conclude by challenging the validity of using as "pain index" the reaction time of a behavioral response to an increasing heat stimulus and emphasize the need for a very careful control of the ambient temperature, as a prevailing environmental source of variation, during any behavioral testing of mice.	[Pincede, Ivanne; Pollin, Bernard; Le Bars, Daniel] CNRS UMR 7225, INSERM UMRS 975, Team Pain, Paris, France; [Pincede, Ivanne; Pollin, Bernard; Le Bars, Daniel] Univ Paris 06, Fac Med, Paris, France; [Meert, Theo] Univ Louvain, Dept Psychol, Louvain, Belgium; [Plaghki, Leon] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain	Pincede, I (corresponding author), CNRS UMR 7225, INSERM UMRS 975, Team Pain, Paris, France.	daniel.le_bars@upmc.fr			l'Institut National de la Sante et de la Recherche Medicale; Institut UPSA de la Douleur	l'Institut National de la Sante et de la Recherche Medicale; Institut UPSA de la Douleur	This work was supported by "l'Institut National de la Sante et de la Recherche Medicale" (http://www.inserm.fr) and a grant from the "Institut UPSA de la Douleur" (www.institut-upsa-douleur.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, PAIN, V9, P141; Benoist JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003125; BERGE OG, 1994, PAIN, V57, P256, DOI 10.1016/0304-3959(94)90234-8; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Carrive P, 2011, PAIN, V152, P676, DOI 10.1016/j.pain.2010.12.019; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; DANNEMAN PJ, 1994, PAIN, V58, P39, DOI 10.1016/0304-3959(94)90183-X; DEJESUS PV, 1973, NEUROLOGY, V23, P1182, DOI 10.1212/WNL.23.11.1182; DEVOR M, 1982, EXP NEUROL, V76, P483, DOI 10.1016/0014-4886(82)90118-2; Falmagne J.-C., 1985, ELEMENTS PSYCHOPHYSI; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GORDON CJ, 1985, PHYSIOL BEHAV, V34, P687, DOI 10.1016/0031-9384(85)90365-8; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; HAIMICOHEN R, 1983, J NEUROSCI METH, V8, P127, DOI 10.1016/0165-0270(83)90113-9; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HARRIS LS, 1964, J PHARMACOL EXP THER, V143, P141; Hart JS, 1971, COMP PHYSL THERMOREG, P1; HOLE K, 1993, PAIN, V53, P247, DOI 10.1016/0304-3959(93)90220-J; HOLE K, 1990, PAIN, V43, P391, DOI 10.1016/0304-3959(90)90039-G; HUDSON JW, 1979, PHYSIOL ZOOL, V52, P205, DOI 10.1086/physzool.52.2.30152564; KANUI TI, 1985, PAIN, V21, P231, DOI 10.1016/0304-3959(85)90087-9; KANUI TI, 1987, BRAIN RES, V402, P160, DOI 10.1016/0006-8993(87)91060-2; Kirk J A, 1968, Ann Phys Med, V9, P270; Kumazawa T, 1998, NEUROSCI RES, V32, P9, DOI 10.1016/S0168-0102(98)00060-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; Le Bars D, 2001, PHARMACOL REV, V53, P597; Le Bars D, 2009, PHARM PAIN, P475; LICHTMAN AH, 1993, PAIN, V55, P283, DOI 10.1016/0304-3959(93)90003-8; Luce R, 1986, RESPONSE TIMES THEIR, DOI [10.1093/acprof:oso/9780195070019.001.0001, DOI 10.1093/ACPROF:OSO/9780195070019.001.0001]; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Nuhr M, 2004, SPINE, V29, P1499, DOI 10.1097/01.BRS.0000131439.87553.99; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; PAINTAL AS, 1967, J PHYSIOL-LONDON, V193, P523, DOI 10.1113/jphysiol.1967.sp008376; Paintal AS, 1973, PATHOLOGICAL CONDUCT, P19; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Plaghki L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010269; Qiu CS, 2011, ANTINOCICEPTIVE EFFE; REN MF, 1979, CHINESE MED J-PEKING, V92, P576; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; Swoap SJ, 2008, BIOCHEM PHARMACOL, V76, P817, DOI 10.1016/j.bcp.2008.06.017; Swoap Steven J, 2009, Am J Physiol Regul Integr Comp Physiol, V297, pR769, DOI 10.1152/ajpregu.00131.2009; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; Tjolsen A, 1997, HANDB EXP PHARM, V130, P1; Tomlinson S, 2007, COMP BIOCHEM PHYS A, V148, P645, DOI 10.1016/j.cbpa.2007.08.013; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008; Vinkers CH, 2008, EUR J PHARMACOL, V585, P407, DOI 10.1016/j.ejphar.2008.02.097; WALTERS ET, 1994, INT REV NEUROBIOL, V36, P325, DOI 10.1016/S0074-7742(08)60307-4; Walters ET, 2008, PAIN, P175; Wilson SG, 2001, BEHAV BRAIN RES, V125, P65, DOI 10.1016/S0166-4328(01)00281-9; Yoda T, 2000, AM J PHYSIOL-REG I, V278, pR134, DOI 10.1152/ajpregu.2000.278.1.R134; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	66	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36699	10.1371/journal.pone.0036699	http://dx.doi.org/10.1371/journal.pone.0036699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629325	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500024
J	Robinson, BG; Khurana, S; Pohl, JB; Li, WK; Ghezzi, A; Cady, AM; Najjar, K; Hatch, MM; Shah, RR; Bhat, A; Hariri, O; Haroun, KB; Young, MC; Fife, K; Hooten, J; Tran, T; Goan, D; Desai, F; Husain, F; Godinez, RM; Sun, JC; Corpuz, J; Moran, J; Zhong, AC; Chen, WY; Atkinson, NS				Robinson, Brooks G.; Khurana, Sukant; Pohl, Jascha B.; Li, Wen-ke; Ghezzi, Alfredo; Cady, Amanda M.; Najjar, Kristina; Hatch, Michael M.; Shah, Ruchita R.; Bhat, Amar; Hariri, Omar; Haroun, Kareem B.; Young, Melvin C.; Fife, Kathryn; Hooten, Jeff; Tran, Tuan; Goan, Daniel; Desai, Foram; Husain, Farhan; Godinez, Ryan M.; Sun, Jeffrey C.; Corpuz, Jonathan; Moran, Jacxelyn; Zhong, Allen C.; Chen, William Y.; Atkinson, Nigel S.			A Low Concentration of Ethanol Impairs Learning but Not Motor and Sensory Behavior in Drosophila Larvae	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; ANIMAL-MODELS; ENVIRONMENTAL ETHANOL; MELANOGASTER LARVAE; ALCOHOL-DRINKING; HONEY-BEE; RESPONSES; DEHYDROGENASE; PERFORMANCE; TOLERANCE	Drosophila melanogaster has proven to be a useful model system for the genetic analysis of ethanol-associated behaviors. However, past studies have focused on the response of the adult fly to large, and often sedating, doses of ethanol. The pharmacological effects of low and moderate quantities of ethanol have remained understudied. In this study, we tested the acute effects of low doses of ethanol (similar to 7 mM internal concentration) on Drosophila larvae. While ethanol did not affect locomotion or the response to an odorant, we observed that ethanol impaired associative olfactory learning when the heat shock unconditioned stimulus (US) intensity was low but not when the heat shock US intensity was high. We determined that the reduction in learning at low US intensity was not a result of ethanol anesthesia since ethanol-treated larvae responded to the heat shock in the same manner as untreated animals. Instead, low doses of ethanol likely impair the neuronal plasticity that underlies olfactory associative learning. This impairment in learning was reversible indicating that exposure to low doses of ethanol does not leave any long lasting behavioral or physiological effects.	[Robinson, Brooks G.; Khurana, Sukant; Pohl, Jascha B.; Li, Wen-ke; Ghezzi, Alfredo; Cady, Amanda M.; Najjar, Kristina; Hatch, Michael M.; Shah, Ruchita R.; Bhat, Amar; Hariri, Omar; Haroun, Kareem B.; Young, Melvin C.; Fife, Kathryn; Hooten, Jeff; Tran, Tuan; Goan, Daniel; Desai, Foram; Husain, Farhan; Godinez, Ryan M.; Sun, Jeffrey C.; Corpuz, Jonathan; Moran, Jacxelyn; Zhong, Allen C.; Chen, William Y.; Atkinson, Nigel S.] Univ Texas Austin, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Robinson, BG (corresponding author), Univ Texas Austin, Inst Neurosci, Neurobiol Sect, Austin, TX 78712 USA.	nigela@mail.utexas.edu	Ghezzi, Alfredo/I-4620-2012	Ghezzi, Alfredo/0000-0001-9176-1320; Robinson, Brooks/0000-0001-5020-531X; Zhong, Allen/0000-0002-8102-6696; Moran, Jacxelyn/0000-0002-3453-0566; Khurana, Sukant/0000-0002-6665-6892	NIH [R01 AA018037]; NSF [IOS-0641370]; NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant [5T32AA007471]; The University of Texas Undergraduate Research Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018037, T32AA007471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas Undergraduate Research Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by NIH R01 AA018037 to NSA and NSF grant IOS-0641370 to NSA supported the undergraduate contribution. BGR and JBP were supported by the NIH Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant # 5T32AA007471. AC and RG received The University of Texas Undergraduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Atkinson NS, 2009, J NEUROGENET, V23, P293, DOI 10.1080/01677060802572937; Barr CS, 2006, ADDICT BIOL, V11, P374, DOI 10.1111/j.1369-1600.2005.00034.x; Bell RL, 2006, ADDICT BIOL, V11, P270, DOI 10.1111/j.1369-1600.2005.00029.x; Lopez MAC, 2011, ACCIDENT ANAL PREV, V43, P1104, DOI 10.1016/j.aap.2010.12.019; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DEPIEREUX E, 1985, BEHAV GENET, V15, P181, DOI 10.1007/BF01065898; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GIBSON WE, 1985, PHYSIOL BEHAV, V35, P1003, DOI 10.1016/0031-9384(85)90273-2; GIVENS B, 1995, ALCOHOL CLIN EXP RES, V19, P763, DOI 10.1111/j.1530-0277.1995.tb01580.x; Givens B, 1997, BEHAV NEUROSCI, V111, P275; Givens B, 1996, NEUROSCIENCE, V71, P417, DOI 10.1016/0306-4522(95)00443-2; Heberlein U, 2000, ALCOHOL RES HEALTH, V24, P185; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Hunt PS, 2009, ALCOHOL, V43, P465, DOI 10.1016/j.alcohol.2009.08.004; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; Khurana S, 2012, BEHAV GENET, V42, P151, DOI 10.1007/s10519-011-9487-9; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015259; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; KOELEGA HS, 1995, PSYCHOPHARMACOLOGY, V118, P233, DOI 10.1007/BF02245951; Koob GF, 2000, ADDICTION, V95, pS73; LISTER RG, 1991, NEUROPSYCHOLOGIA, V29, P1205, DOI 10.1016/0028-3932(91)90034-6; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Matthews DB, 2004, NEUROBIOL LEARN MEM, V82, P299, DOI 10.1016/j.nlm.2004.06.007; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; McClure KD, 2011, DIS MODEL MECH, V4, P335, DOI 10.1242/dmm.006411; McIntire Steven L, 2010, WormBook, P1, DOI 10.1895/wormbook.1.40.1; MCKENZIE JA, 1979, OECOLOGIA, V40, P299, DOI 10.1007/BF00345326; MELCHIOR CL, 1993, ALCOHOL, V10, P491, DOI 10.1016/0741-8329(93)90071-U; MILLER ME, 1978, J EXP PSYCHOL-HUM L, V4, P246, DOI 10.1037/0278-7393.4.3.246; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; PARSONS PA, 1980, BEHAV GENET, V10, P183, DOI 10.1007/BF01066268; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; Pecsenye K, 1997, MOL GEN GENET, V255, P258, DOI 10.1007/s004380050496; Phillips DP, 2011, ADDICTION, V106, P1614, DOI 10.1111/j.1360-0443.2011.03472.x; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; RICHTER R, 1975, SCHWEIZ MED WSCHR, V105, P884; Rodan AR, 2010, INT REV NEUROBIOL, V91, P25, DOI 10.1016/S0074-7742(10)91002-7; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schweizer TA, 2008, EXP CLIN PSYCHOPHARM, V16, P240, DOI 10.1037/1064-1297.16.3.240; VANDERZEL A, 1991, ARCH BIOCHEM BIOPHYS, V287, P121, DOI 10.1016/0003-9861(91)90396-Z; VIGUE CL, 1982, BIOCHEM GENET, V20, P681, DOI 10.1007/BF00483965; White AM, 1997, PSYCHOPHARMACOLOGY, V133, P256, DOI 10.1007/s002130050399; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166	51	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37394	10.1371/journal.pone.0037394	http://dx.doi.org/10.1371/journal.pone.0037394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624024	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500109
J	Rowe, HC; Ro, DK; Rieseberg, LH				Rowe, Heather C.; Ro, Dae-kyun; Rieseberg, Loren H.			Response of Sunflower (Helianthus annuus L.) Leaf Surface Defenses to Exogenous Methyl Jasmonate	PLOS ONE			English	Article							CAPITATE GLANDULAR TRICHOMES; SESQUITERPENE LACTONES; GENE-EXPRESSION; PHENOTYPIC PLASTICITY; NATURAL VARIATION; SEED PREDATION; PLANT DEFENSE; WILD; DOMESTICATION; SPECIALIST	Helianthus annuus, the common sunflower, produces a complex array of secondary compounds that are secreted into glandular trichomes, specialized structures found on leaf surfaces and anther appendages of flowers. The primary components of these trichome secretions are sesquiterpene lactones (STL), a diverse class of compounds produced abundantly by the plant family Compositae and believed to contribute to plant defense against herbivory. We treated wild and cultivated H. annuus accessions with exogenous methyl jasmonate, a plant hormone that mediates plant defense against insect herbivores and certain classes of fungal pathogens. The wild sunflower produced a higher density of glandular trichomes on its leaves than the cultivar. Comparison of the profiles of glandular trichome extracts obtained by liquid chromatography-mass spectroscopy (LC-MS) showed that wild and cultivated H. annuus were qualitatively similar in surface chemistry, although differing in the relative size and proportion of various compounds detected. Despite observing consistent transcriptional responses to methyl jasmonate treatment, we detected no significant effect on glandular trichome density or LC-MS profile in cultivated or wild sunflower, with wild sunflower exhibiting a declining trend in overall STL production and foliar glandular trichome density of jasmonate-treated plants. These results suggest that glandular trichomes and associated compounds may act as constitutive defenses or require greater levels of stimulus for induction than the observed transcriptional responses to exogenous jasmonate. Reduced defense investment in domesticated lines is consistent with predicted tradeoffs caused by selection for increased yield; future research will focus on the development of genetic resources to explicitly test the ecological roles of glandular trichomes and associated effects on plant growth and fitness.	[Rowe, Heather C.; Rieseberg, Loren H.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ro, Dae-kyun] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Rieseberg, Loren H.] Indiana Univ, Dept Biol, Bloomington, IN USA	University of British Columbia; University of Calgary; Indiana University System; Indiana University Bloomington	Rowe, HC (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	loren.rieseberg@botany.ubc.ca	Rieseberg, Loren H/B-3591-2013; Ro, Dae-Kyun/G-9289-2012	Rieseberg, Loren H/0000-0002-2712-2417; Ro, Dae-Kyun/0000-0003-1288-5347	Genome Canada; U.S. National Science Foundation [0421630]; U.S. National Institutes of Health NRSA Fellowship [5F32GM089058]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089058] Funding Source: NIH RePORTER	Genome Canada(Genome Canada); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Genome Canada (www.genomecanada.ca) and the U.S. National Science Foundation (www.nsf.gov; 0421630). A U.S. National Institutes of Health NRSA Fellowship (www.nih.gov; 5F32GM089058) awarded to H.C. Rowe also provided support during the course of manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P251; Alexander HM, 2001, AM J BOT, V88, P623, DOI 10.2307/2657061; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnason JT, 2010, CAN J ZOOL, V88, P615, DOI 10.1139/Z10-038; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Blackman BK, 2011, P NATL ACAD SCI USA, V108, P14360, DOI 10.1073/pnas.1104853108; Bosu PP, 2007, ENVIRON ENTOMOL, V36, P595, DOI 10.1603/0046-225X(2007)36[595:EOIWSO]2.0.CO;2; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Burke JM, 2002, GENETICS, V161, P1257; Chaturvedi D., 2011, SESQUITERPENE LACTON, P313; CHOU JC, 1993, J CHEM ECOL, V19, P1439, DOI 10.1007/BF00984888; Cummings CL, 1999, OECOLOGIA, V121, P330, DOI 10.1007/s004420050936; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; Dempewolf H, 2008, GENET RESOUR CROP EV, V55, P1141, DOI 10.1007/s10722-008-9315-0; Gershenzon J, 1985, INSECT ANTIFEEDANT T, P433; Gopfert JC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-86; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gonzalez WL, 2008, ACTA OECOL, V33, P128, DOI 10.1016/j.actao.2007.10.004; Gopfert JC, 2005, PLANT BIOLOGY, V7, P148, DOI 10.1055/s-2005-837575; Harter AV, 2004, NATURE, V430, P201, DOI 10.1038/nature02710; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Henery ML, 2008, OECOLOGIA, V156, P847, DOI 10.1007/s00442-008-1042-x; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Holeski LM, 2010, AM NAT, V175, P391, DOI 10.1086/651300; Ikezawa N, 2011, J BIOL CHEM, V286, P21601, DOI 10.1074/jbc.M110.216804; Ito K, 2009, J THEOR BIOL, V260, P453, DOI 10.1016/j.jtbi.2009.07.002; Karray-Bouraoui N, 2009, IND CROP PROD, V30, P338, DOI 10.1016/j.indcrop.2009.06.003; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koschier EH, 2003, CROP PROT, V22, P929, DOI 10.1016/S0261-2194(03)00092-9; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lai Z, 2008, GENETICS, V179, P1881, DOI 10.1534/genetics.108.091041; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; LANGENHEIM JH, 1994, J CHEM ECOL, V20, P1223, DOI 10.1007/BF02059809; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Macias FA, 1996, PHYTOCHEMISTRY, V43, P1205, DOI 10.1016/S0031-9422(96)00392-5; Maes L, 2011, NEW PHYTOL, V189, P176, DOI 10.1111/j.1469-8137.2010.03466.x; Maes L, 2010, PLANT SIGNAL BEHAV, V5, P205, DOI 10.4161/psb.5.2.11214; Mayrose M, 2011, MOL ECOL, V20, P4683, DOI 10.1111/j.1365-294X.2011.05301.x; MELEK FR, 1985, PHYTOCHEMISTRY, V24, P1537, DOI 10.1016/S0031-9422(00)81061-4; Mercer KL, 2007, ECOL LETT, V10, P383, DOI 10.1111/j.1461-0248.2007.01029.x; MULLIN CA, 1991, ACS SYM SER, V449, P278; Pak HS, 2009, PLANTA, V231, P79, DOI 10.1007/s00425-009-1029-9; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Rieseberg LH, 1998, EVOLUTION, V52, P713, DOI [10.2307/2411266, 10.1111/j.1558-5646.1998.tb03696.x]; RODRIGUEZ AE, 1993, J ECON ENTOMOL, V86, P34, DOI 10.1093/jee/86.1.34; ROGERS CE, 1987, ENVIRON ENTOMOL, V16, P586, DOI 10.1093/ee/16.3.586; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Said SA, 2011, FLORA, V206, P397, DOI 10.1016/j.flora.2010.08.002; SEAMAN FC, 1983, TAXON, V32, P1, DOI 10.2307/1219846; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; SPRING O, 1989, BIOCHEM SYST ECOL, V17, P519, DOI 10.1016/0305-1978(89)90094-X; SPRING O, 1989, PHYTOCHEMISTRY, V28, P745, DOI 10.1016/0031-9422(89)80107-4; SPRING O, 1982, PHYTOCHEMISTRY, V21, P2551, DOI 10.1016/0031-9422(82)85254-0; Tang SX, 2003, THEOR APPL GENET, V106, P990, DOI 10.1007/s00122-002-1127-6; THURSTON R, 1970, J ECON ENTOMOL, V63, P272, DOI 10.1093/jee/63.1.272; THURSTON R, 1966, ENTOMOL EXP APPL, V9, P428, DOI 10.1007/BF00347813; Traw MB, 2003, PLANT PHYSIOL, V133, P1367, DOI 10.1104/pp.103.027086; WAGNER GJ, 1991, PLANT PHYSIOL, V96, P675, DOI 10.1104/pp.96.3.675; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Yao YL, 2011, PLANT CELL, V23, P3842, DOI 10.1105/tpc.111.089003; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	68	15	18	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37191	10.1371/journal.pone.0037191	http://dx.doi.org/10.1371/journal.pone.0037191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623991	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500070
J	Sun, HF; Hou, HL; Lu, P; Zhang, LX; Zhao, FY; Ge, C; Wang, TP; Yao, M; Li, JJ				Sun, Hefen; Hou, Helei; Lu, Ping; Zhang, Lixing; Zhao, Fangyu; Ge, Chao; Wang, Tingpu; Yao, Ming; Li, Jinjun			Isocorydine Inhibits Cell Proliferation in Hepatocellular Carcinoma Cell Lines by Inducing G2/M Cell Cycle Arrest and Apoptosis	PLOS ONE			English	Article							CANCER STEM-CELLS; PHASE; DNA; CHECKPOINT; EXPRESSION; MECHANISM; PHOSPHORYLATION; INACTIVATION; ALKALOIDS; PATHWAYS	The treatment of human hepatocellular carcinoma (HCC) cell lines with (+)-isocorydine, which was isolated and purified from Papaveraceae sp. plants, resulted in a growth inhibitory effect caused by the induction of G2/M phase cell cycle arrest and apoptosis. We report that isocorydine induces G2/M phase arrest by increasing cyclin B1 and p-CDK1 expression levels, which was caused by decreasing the expression and inhibiting the activation of Cdc25C. The phosphorylation levels of Chk1 and Chk2 were increased after ICD treatment. Furthermore, G2/M arrest induced by ICD can be disrupted by Chk1 siRNA but not by Chk2 siRNA. In addition, isocorydine treatment led to a decrease in the percentage of CD133(+) PLC/PRF/5 cells. Interestingly, isocorydine treatment dramatically decreased the tumorigenicity of SMMC-7721 and Huh7 cells. These findings indicate that isocorydine might be a potential therapeutic drug for the chemotherapeutic treatment of HCC.	[Sun, Hefen; Hou, Helei; Lu, Ping; Zhang, Lixing; Ge, Chao; Li, Jinjun] Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Zhao, Fangyu; Yao, Ming] Jiao Tong Univ, Sch Med, Expt Pathol Lab, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Tingpu] Tianshui Normal Univ, Coll Life Sci & Chem, Tianshui, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tianshui Normal University	Sun, HF (corresponding author), Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China.	jjli@shsci.org			National Key Sci-Tech Special Project of China [2008ZX10002-022]; National Key Program for Basic Research of China (973) [2009CB521803]; Program Of Shanghai Subject Chief Scientist (A) [09XD1403600]	National Key Sci-Tech Special Project of China; National Key Program for Basic Research of China (973)(National Basic Research Program of China); Program Of Shanghai Subject Chief Scientist (A)	This work was supported in part by grants from the National Key Sci-Tech Special Project of China (2008ZX10002-022), the National Key Program for Basic Research of China (973) (2009CB521803), the Program Of Shanghai Subject Chief Scientist (A) (09XD1403600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Cummings M, 2002, BRIT J HAEMATOL, V116, P421, DOI 10.1046/j.1365-2141.2002.03262.x; Dang Y, 2009, CHINESE CHEM LETT, V20, P1218, DOI 10.1016/j.cclet.2009.05.020; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hoet S, 2004, PLANTA MED, V70, P407, DOI 10.1055/s-2004-818967; HOFFMAN RM, 1980, P NATL ACAD SCI-BIOL, V77, P7306, DOI 10.1073/pnas.77.12.7306; HOFFMAN RM, 1983, BIOCHIM BIOPHYS ACTA, V738, P49, DOI 10.1016/0304-419X(84)90019-2; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ruiz EJ, 2010, CURR BIOL, V20, P717, DOI 10.1016/j.cub.2010.02.050; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Luo Y, 2001, NEOPLASIA, V3, P411, DOI 10.1038/sj.neo.7900175; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Moon DO, 2010, ONCOL REP, V24, P271, DOI 10.3892/or_00000856; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Ruo X, 1981, CHINESE PHARMACOL B, V16, P118; Saito H, 1998, HEPATOLOGY, V27, P1233, DOI 10.1002/hep.510270508; Scovassi AI, 1998, EUR J HISTOCHEM, V42, P251; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Sotnikova R, 1997, METHOD FIND EXP CLIN, V19, P589; STERN PH, 1986, J NATL CANCER I, V76, P629, DOI 10.1093/jnci/76.4.629; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Visanji JM, 2006, CANCER LETT, V237, P130, DOI 10.1016/j.canlet.2005.05.045; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; YANG L, 1990, Yaoxue Xuebao, V25, P859; Yang Yue, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P686, DOI 10.3760/cma.j.issn.1007-3418.2011.09.013; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang W, 2010, NAT SCI, V2, P457, DOI [DOI 10.4236/NS.2010.25056, 10.4236/ns.2010.25056]; ZHAO YQ, 1991, ACTA PHARM SINIC, V12, P324	36	45	52	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36808	10.1371/journal.pone.0036808	http://dx.doi.org/10.1371/journal.pone.0036808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623962	Green Published, gold			2022-12-27	WOS:000305343500029
J	Wan, CH; Fu, J; Wang, Y; Miao, SY; Song, W; Wang, LF				Wan, Chunhua; Fu, Jun; Wang, Yong; Miao, Shiying; Song, Wei; Wang, Linfang			Exosome-Related Multi-Pass Transmembrane Protein TSAP6 Is a Target of Rhomboid Protease RHBDD1-Induced Proteolysis	PLOS ONE			English	Article							MEMBRANE-VESICLES; INTRAMEMBRANE PROTEOLYSIS; DIRECT STIMULATION; CELL-DEATH; T-CELLS; SECRETION; MICROVESICLES; ACTIVATION; APOPTOSIS; RELEASE	We have previously reported that rhomboid domain containing 1 (RHBDD1), a mammalian rhomboid protease highly expressed in the testis, can cleave the Bcl-2 protein Bik. In this study, we identified a multi-pass transmembrane protein, tumor suppressor activated pathway-6 (TSAP6) as a potential substrate of RHBDD1. RHBDD1 was found to induce the proteolysis of TSAP6 in a dose- and activity-dependent manner. The cleavage of TSAP6 was not restricted to its glycosylated form and occurred in three different regions. In addition, mass spectrometry and mutagenesis analyses both indicated that the major cleavage site laid in the C-terminal of the third transmembrane domain of TSAP6. A somatic cell knock-in approach was used to genetically inactivate the endogenous RHBDD1 in HCT116 and RKO colon cancer cells. Exosome secretion was significantly elevated when RHBDD1 was inactivated in the two cells lines. The increased exosome secretion was verfied through the detection of certain exosomal components, including Tsg101, Tf-R, FasL and Trail. In addition, the elevation of exosome secretion by RHBDD1 inactivation was reduced when TSAP6 was knocked down, indicating that the role of RHBDD1 in regulating exosomal trafficking is very likely to be TSAP6-dependent. We found that the increase in FasL and Trail increased exosome-induced apoptosis in Jurkat cells. Taken together, our findings suggest that RHBDD1 is involved in the regulation of a nonclassical exosomal secretion pathway through the restriction of TSAP6.	[Wan, Chunhua; Fu, Jun; Wang, Yong; Miao, Shiying; Song, Wei; Wang, Linfang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; [Wan, Chunhua] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nantong University	Wan, CH (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China.	roy_sw0925@yahoo.com.cn; wang.linfang@imicams.ac.cn			National Important Research Plan of China [2011CB944302]; National Natural Science Foundation of China [81101855]; State Key Laboratory Special fund from the Ministry of Science [2060204]; Research Fund for the Doctoral Program of High Education [20111106110023]	National Important Research Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Special fund from the Ministry of Science; Research Fund for the Doctoral Program of High Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from the National Important Research Plan of China (2011CB944302), grant for the youth (81101855) from the National Natural Science Foundation of China, the State Key Laboratory Special fund (2060204) from the Ministry of Science, and the Research Fund for the Doctoral Program of High Education (20111106110023). The experimental study was performed in compliance with the laws of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Alonso R, 2005, J BIOL CHEM, V280, P28439, DOI 10.1074/jbc.M501112200; Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Erez E, 2009, BIOCHEMISTRY-US, V48, P12314, DOI 10.1021/bi901648g; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Huber V, 2005, GASTROENTEROLOGY, V128, P1796, DOI 10.1053/j.gastro.2005.03.045; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kovar M, 2006, P NATL ACAD SCI USA, V103, P11671, DOI 10.1073/pnas.0603466103; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pascall JC, 2004, BIOCHEM BIOPH RES CO, V317, P244, DOI 10.1016/j.bbrc.2004.03.039; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wang Y, 2008, CELL MOL LIFE SCI, V65, P3822, DOI 10.1007/s00018-008-8452-0; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-25; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	44	27	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37452	10.1371/journal.pone.0037452	http://dx.doi.org/10.1371/journal.pone.0037452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624035	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500120
J	Funamizu, N; Lacy, CR; Fujita, K; Furukawa, K; Misawa, T; Yanaga, K; Manome, Y				Funamizu, Naotake; Lacy, Curtis Ray; Fujita, Kaori; Furukawa, Kenei; Misawa, Takeyuki; Yanaga, Katsuhiko; Manome, Yoshinobu			Tetrahydrouridine Inhibits Cell Proliferation through Cell Cycle Regulation Regardless of Cytidine Deaminase Expression Levels	PLOS ONE			English	Article							JAPANESE CANCER-PATIENTS; CYTOSINE-ARABINOSIDE; PANCREATIC-CANCER; PLASMA PHARMACOKINETICS; DEOXYCYTIDINE KINASE; ORAL BIOAVAILABILITY; FORCED EXPRESSION; SOLID TUMORS; LUNG-CANCER; PHASE-II	Tetrahydrouridine (THU) is a well characterized and potent inhibitor of cytidine deaminase (CDA). Highly expressed CDA catalyzes and inactivates cytidine analogues, ultimately contributing to increased gemcitabine resistance. Therefore, a combination therapy of THU and gemcitabine is considered to be a potential and promising treatment for tumors with highly expressed CDA. In this study, we found that THU has an alternative mechanism for inhibiting cell growth which is independent of CDA expression. Three different carcinoma cell lines (MIAPaCa-2, H441, and H1299) exhibited decreased cell proliferation after sole administration of THU, while being unaffected by knocking down CDA. To investigate the mechanism of THU-induced cell growth inhibition, cell cycle analysis using flow cytometry was performed. This analysis revealed that THU caused an increased rate of G1-phase occurrence while S-phase occurrence was diminished. Similarly, Ki-67 staining further supported that THU reduces cell proliferation. We also found that THU regulates cell cycle progression at the G1/S checkpoint by suppressing E2F1. As a result, a combination regimen of THU and gemcitabine might be a more effective therapy than previously believed for pancreatic carcinoma since THU works as a CDA inhibitor, as well as an inhibitor of cell growth in some types of pancreatic carcinoma cells.	[Funamizu, Naotake; Manome, Yoshinobu] Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Sch Med, Tokyo, Japan; [Lacy, Curtis Ray] Univ Calif Irvine, Irvine, CA USA; [Fujita, Kaori] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Funamizu, Naotake; Furukawa, Kenei; Misawa, Takeyuki; Yanaga, Katsuhiko] Jikei Univ, Dept Surg, Sch Med, Tokyo, Japan	Jikei University; University of California System; University of California Irvine; Kyoto University; Jikei University	Funamizu, N (corresponding author), Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Sch Med, Tokyo, Japan.	funamizujikei@yahoo.co.jp	Yanaga, Katsuhiko/Y-6290-2019	Yanaga, Katsuhiko/0000-0001-8918-4720; Manome, Yoshinobu/0000-0002-8755-8976				Bardenheuer W, 2005, LEUKEMIA, V19, P2281, DOI 10.1038/sj.leu.2403977; Besnard T, 2008, J CHROMATOGR B, V870, P117, DOI 10.1016/j.jchromb.2008.05.040; Beumer JH, 2008, CANCER CHEMOTH PHARM, V62, P457, DOI 10.1007/s00280-007-0625-2; Beumer JH, 2008, CLIN CANCER RES, V14, P3529, DOI 10.1158/1078-0432.CCR-07-4885; Beumer JH, 2011, CANCER CHEMOTH PHARM, V67, P421, DOI 10.1007/s00280-010-1337-6; BOUFFARD DY, 1993, BIOCHEM PHARMACOL, V45, P1857, DOI 10.1016/0006-2952(93)90444-2; CAMIENER GW, 1968, BIOCHEM PHARMACOL, V17, P1981, DOI 10.1016/0006-2952(68)90114-7; COHEN RM, 1971, J BIOL CHEM, V246, P7561; Eliopoulos N, 1998, CANCER CHEMOTH PHARM, V42, P373, DOI 10.1007/s002800050832; Funamizu N, 2011, PANCREAS        0907; Funamizu N, 2010, ONCOL REP, V23, P471, DOI 10.3892/or_00000657; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Giovannetti E, 2007, PHARMACOL RES, V55, P343, DOI 10.1016/j.phrs.2007.01.003; Gourdeau H, 2001, CANCER CHEMOTH PHARM, V47, P236, DOI 10.1007/s002800000223; Guo DL, 2010, AAPS PHARMSCITECH, V11, P247, DOI 10.1208/s12249-010-9383-2; Gusella M, 2011, BRIT J CLIN PHARMACO, V71, P437, DOI 10.1111/j.1365-2125.2010.03838.x; Herbst RS, 2002, J CLIN ONCOL, V20, P3815, DOI 10.1200/JCO.2002.03.038; Hilger R A, 2002, Int J Clin Pharmacol Ther, V40, P567; HO DHW, 1977, CANCER TREAT REP, V61, P717; Horn T, 1998, NOTES UNDERGR, V37, P1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Kanno SI, 2007, CLIN CHIM ACTA, V377, P144, DOI 10.1016/j.cca.2006.09.014; Kaubisch A, 2004, CANCER CHEMOTH PHARM, V53, P337, DOI 10.1007/s00280-003-0727-4; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ludovini V, 2011, J THORAC ONCOL, V6, P2018, DOI 10.1097/JTO.0b013e3182307e1f; Morita T, 2003, ONCOLOGY-BASEL, V65, P267, DOI 10.1159/000074480; Navarra P, 1999, CRIT REV ONCOL HEMAT, V29, P249, DOI 10.1016/S1040-8428(98)00032-8; Neff T, 1996, EXP HEMATOL, V24, P1340; Ng SSW, 2002, MOL CANCER THER, V1, P777; O'Byrne KJ, 1999, ANN ONCOL, V10, P981, DOI 10.1023/A:1008330302535; Ohta T, 2004, ONCOL REP, V12, P1115; Picot J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15410; Schroder JK, 1998, BRIT J HAEMATOL, V103, P1096, DOI 10.1046/j.1365-2141.1998.01084.x; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; STOLLER RG, 1978, BIOCHEM PHARMACOL, V27, P53, DOI 10.1016/0006-2952(78)90256-3; Sugiyama E, 2010, CLIN PHARMACOKINET, V49, P549, DOI 10.2165/11532970-000000000-00000; Tibaldi C, 2011, ANN ONCOL       0607; Ueno H, 2009, BRIT J CANCER, V100, P870, DOI 10.1038/sj.bjc.6604971; Un F, 2006, ANTICANCER RES, V26, P2761; WONG PP, 1979, CANCER TREAT REP, V63, P1245	42	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37424	10.1371/journal.pone.0037424	http://dx.doi.org/10.1371/journal.pone.0037424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616006	Green Published, gold			2022-12-27	WOS:000305341300113
J	Hong, C; Jiang, HG; Lu, EG; Wu, YF; Guo, LH; Xie, YM; Wang, CS; Yang, YM				Hong, Chuan; Jiang, Hongen; Lu, Enguo; Wu, Yunfei; Guo, Lihai; Xie, Yongming; Wang, Changsui; Yang, Yimin			Identification of Milk Component in Ancient Food Residue by Proteomics	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; OLD-WORLD; LACTOSE-MALABSORPTION; PROTEIN BINDERS; ANTIQUITY; EUROPE; CATTLE; PRODUCTS; HISTORY; POTTERY	Background: Proteomic approaches based on mass spectrometry have been recently used in archaeological and art researches, generating promising results for protein identification. Little information is known about eastward spread and eastern limits of prehistoric milking in eastern Eurasia. Methodology/Principal Finding: In this paper, an ancient visible food remain from Subeixi Cemeteries (cal. 500 to 300 years BC) of the Turpan Basin in Xinjiang, China, preliminarily determined containing 0.432 mg/kg cattle casein with ELISA, was analyzed by using an improved method based on liquid chromatography (LC) coupled with MALDI-TOF/TOF-MS to further identify protein origin. The specific sequence of bovine casein and the homology sequence of goat/sheep casein were identified. Conclusions/Significance: The existence of milk component in ancient food implies goat/sheep and cattle milking in ancient Subeixi region, the furthest eastern location of prehistoric milking in the Old World up to date. It is envisioned that this work provides a new approach for ancient residue analysis and other archaeometry field.	[Hong, Chuan; Jiang, Hongen; Wang, Changsui; Yang, Yimin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Lab Human Evolut, Beijing, Peoples R China; [Hong, Chuan; Jiang, Hongen; Wang, Changsui; Yang, Yimin] Grad Univ, Dept Sci Hist & Archaeometry, Beijing, Peoples R China; [Lu, Enguo] Xinjiang Inst Archaeol, Urumqi, Peoples R China; [Wu, Yunfei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Guo, Lihai; Xie, Yongming] AB SCIEX, Asia Pacific Applicat Support Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hong, C (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Lab Human Evolut, Beijing, Peoples R China.	yiminyang@gucas.ac.cn		yang, yimin/0000-0003-2745-9498	CAS Strategic Priority Research Program [XDA05130303]; National Science Foundation in China [41172164]; President Fund of GUCAS [O95101DY00]; Max Planck Society; Chinese Academy of Sciences	CAS Strategic Priority Research Program; National Science Foundation in China(National Natural Science Foundation of China (NSFC)); President Fund of GUCAS; Max Planck Society(Max Planck SocietyFoundation CELLEX); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the CAS Strategic Priority Research Program grant no. XDA05130303, the National Science Foundation in China (41172164), the President Fund of GUCAS (O95101DY00), and the partnership between the Max Planck Society and the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasse M, 1997, CR ACAD SCI II A, V325, P1005, DOI 10.1016/S1251-8050(97)82382-8; Boros-Major A, 2011, J ARCHAEOL SCI, V38, P197, DOI 10.1016/j.jas.2010.09.008; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Chambery A, 2009, ANAL BIOANAL CHEM, V395, P2281, DOI 10.1007/s00216-009-3183-0; Chuan H., 2011, SCI CONSERVATION ARC, V23, P25; Copley M. S., 2005, CHANGING MAT CATALHO, P169; Copley MS, 2005, ANTIQUITY, V79, P895, DOI 10.1017/S0003598X00115029; Copley MS, 2005, J ARCHAEOL SCI, V32, P523, DOI 10.1016/j.jas.2004.08.006; Copley MS, 2005, J ARCHAEOL SCI, V32, P505, DOI 10.1016/j.jas.2004.07.005; Copley MS, 2005, J ARCHAEOL SCI, V32, P485, DOI 10.1016/j.jas.2004.07.004; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; Craig O, 2000, NATURE, V408, P312, DOI 10.1038/35042684; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2005, J ARCHAEOL SCI, V32, P91, DOI 10.1016/j.jas.2004.06.009; Craig OE, 2000, J IMMUNOL METHODS, V236, P89, DOI 10.1016/S0022-1759(99)00242-2; Craig OE, 2002, J ARCHAEOL SCI, V29, P1077, DOI 10.1006/jasc.2001.0757; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Fremout W, 2011, RAPID COMMUN MASS SP, V25, P1631, DOI 10.1002/rcm.5027; Fremout W, 2010, ANAL CHIM ACTA, V658, P156, DOI 10.1016/j.aca.2009.11.010; Gong YW, 2011, J ARCHAEOL SCI, V38, P470, DOI 10.1016/j.jas.2010.10.006; Greenfield H.J., 2005, ZOOARCHAEOLOGY MILK, P14; Greenfield HJ, 2010, WORLD ARCHAEOL, V42, P29, DOI 10.1080/00438240903429722; GREENFIELD HJ, 1988, CURR ANTHROPOL, V29, P573, DOI 10.1086/203676; Heginbotham A, 2006, J AM INST CONSERV, V45, P89, DOI 10.1179/019713606806112522; Krausmann F, 2004, HUM ECOL, V32, P735, DOI 10.1007/s10745-004-6834-y; Kuckova S, 2009, INT J MASS SPECTROM, V284, P42, DOI 10.1016/j.ijms.2009.01.011; Lu EG, 2006, NEW DISCUSSIONS TURP, P239; Miller L., 2004, THESIS NEW YORK U NE; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Sherratt A. G., 1981, PATTERN OF THE PAST, P261; SIMOONS FJ, 1979, ANTHROPOS, V74, P61; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095; SIMOONS FJ, 1970, ANTHROPOS, V65, P547; Solazzo C, 2008, ANAL CHEM, V80, P4590, DOI 10.1021/ac800515v; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Stevens SM, 2010, ANAL BIOANAL CHEM, V396, P1491, DOI 10.1007/s00216-009-3341-4; Tokarski C, 2006, ANAL CHEM, V78, P1494, DOI 10.1021/ac051181w; Vigne Jean-Denis, 2007, Anthropozoologica, V42, P9; [XIA (Xinjiang Institute of Archaeology) MT (Museum of Turpan)], 2002, KAOGU, V6, P42; [袁靖 Yuan Jing], 2010, [第四纪研究, Quaternary Sciences], V30, P298	42	29	34	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37053	10.1371/journal.pone.0037053	http://dx.doi.org/10.1371/journal.pone.0037053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959UR	22615887	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300058
J	Hunter, JM; Kwan, J; Malek-Ahmadi, M; Maarouf, CL; Kokjohn, TA; Belden, C; Sabbagh, MN; Beach, TG; Roher, AE				Hunter, Jesse M.; Kwan, Jason; Malek-Ahmadi, Michael; Maarouf, Chera L.; Kokjohn, Tyler A.; Belden, Christine; Sabbagh, Marwan N.; Beach, Thomas G.; Roher, Alex E.			Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; APOLIPOPROTEIN-E; MICROVASCULAR PATHOLOGY; VASCULAR DEMENTIA; SENILE PLAQUES; TYPE-4 ALLELE; RISK-FACTORS; DEGENERATION; DIAGNOSIS; AGE	Key pathological hallmarks of Alzheimer's disease (AD), including amyloid plaques, cerebral amyloid angiopathy (CAA) and neurofibrillary tangles do not completely account for cognitive impairment, therefore other factors such as cardiovascular and cerebrovascular pathologies, may contribute to AD. In order to elucidate the microvascular changes that contribute to aging and disease, direct neuropathological staining and immunohistochemistry, were used to quantify the structural integrity of the microvasculature and its innervation in three oldest-old cohorts: 1) nonagenarians with AD and a high amyloid plaque load; 2) nonagenarians with no dementia and a high amyloid plaque load; 3) nonagenarians without dementia or amyloid plaques. In addition, a non-demented (ND) group (average age 71 years) with no amyloid plaques was included for comparison. While gray matter thickness and overall brain mass were reduced in AD compared to ND control groups, overall capillary density was not different. However, degenerated string capillaries were elevated in AD, potentially suggesting greater microvascular "dysfunction" compared to ND groups. Intriguingly, apolipoprotein epsilon 4 carriers had significantly higher string vessel counts relative to non-epsilon 4 carriers. Taken together, these data suggest a concomitant loss of functional capillaries and brain volume in AD subjects. We also demonstrated a trend of decreasing vesicular acetylcholine transporter staining, a marker of cortical cholinergic afferents that contribute to arteriolar vasoregulation, in AD compared to ND control groups, suggesting impaired control of vasodilation in AD subjects. In addition, tyrosine hydroxylase, a marker of noradrenergic vascular innervation, was reduced which may also contribute to a loss of control of vasoconstriction. The data highlight the importance of the brain microcirculation in the pathogenesis and evolution of AD.	[Hunter, Jesse M.; Kwan, Jason; Maarouf, Chera L.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA; [Malek-Ahmadi, Michael; Belden, Christine; Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Cleo Roberts Ctr Clin Res, Sun City, AZ USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Civin Lab Neuropathol, Sun City, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Midwestern University; Banner Research; Banner Health; Banner Sun Health Research Institute	Hunter, JM (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ 85351 USA.	alex.roher@bannerhealth.com	Malek-Ahmadi, Michael/AAT-1052-2020	Malek-Ahmadi, Michael/0000-0001-9901-3650	National Institute on Aging [R01 AG019795, R21 AG035078, P30 AG19610]; National Institute of Neurological Disorders and Stroke [U24 NS072026]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019795, R21AG035078, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants R01 AG019795, R21 AG035078 (AER). The Brain Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akkawia NM, 2003, DEMENT GERIATR COGN, V16, P163, DOI 10.1159/000071005; Alsop DC, 2010, J ALZHEIMERS DIS, V20, P871, DOI 10.3233/JAD-2010-091699; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Beach TG, 2000, NEUROSCI LETT, V283, P9, DOI 10.1016/S0304-3940(00)00916-2; Beach TG, 2003, BRAIN PATHOL, V13, P263; Beach TG, 2000, J NEUROPATH EXP NEUR, V59, P308, DOI 10.1093/jnen/59.4.308; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Belohlavek M, 2009, J ULTRAS MED, V28, P1493, DOI 10.7863/jum.2009.28.11.1493; BENZING WC, 1993, BRAIN RES, V625, P125, DOI 10.1016/0006-8993(93)90145-D; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Brown WR, 2010, J ALZHEIMERS DIS, V21, P725, DOI 10.3233/JAD-2010-100219; BURKE WJ, 1990, BRAIN RES, V537, P83, DOI 10.1016/0006-8993(90)90342-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dong JH, 2010, NEUROPHARMACOLOGY, V59, P268, DOI 10.1016/j.neuropharm.2010.04.007; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c; HIXSON JE, 1990, J LIPID RES, V31, P545; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; KALARIA RN, 1995, NEUROREPORT, V6, P477, DOI 10.1097/00001756-199502000-00018; KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X; Kokjohn TA, 2011, ALZHEIMERS IN PRESS; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Maarouf CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027291; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirra SS, 1997, NEUROBIOL AGING, V18, pS91, DOI 10.1016/S0197-4580(97)00058-4; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paris D, 2005, MOL BRAIN RES, V136, P212, DOI 10.1016/j.molbrainres.2005.02.011; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Patel NS, 2008, AMYLOID, V15, P5, DOI 10.1080/13506120701814723; Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x; Purandare N, 2006, BMJ-BRIT MED J, V332, P1119, DOI 10.1136/bmj.38814.696493.AE; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roher AE, 2006, NEUROL RES, V28, P672, DOI 10.1179/016164106X130470; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Roman GC, 2006, NEUROBIOL AGING, V27, P1769, DOI 10.1016/j.neurobiolaging.2005.10.004; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Sparks DL, 1997, ANN NY ACAD SCI, V826, P128, DOI 10.1111/j.1749-6632.1997.tb48466.x; Spilt A, 2005, RADIOLOGY, V236, P990, DOI 10.1148/radiol.2363041454; Stone J, 2008, MED HYPOTHESES, V71, P347, DOI 10.1016/j.mehy.2008.04.007; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TEJANIBUTT SM, 1995, NEUROREPORT, V6, P1207, DOI 10.1097/00001756-199505300-00033; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Van Beek AHEA, 2011, BEHAV BRAIN RES, V221, P537, DOI 10.1016/j.bbr.2009.12.047; van Beek AHEA, 2010, J ALZHEIMERS DIS, V21, P519, DOI 10.3233/JAD-2010-100288; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203	74	112	116	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36893	10.1371/journal.pone.0036893	http://dx.doi.org/10.1371/journal.pone.0036893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615835	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300037
J	Simm, R; Voros, A; Ekman, JV; Sodring, M; Nes, I; Kroeger, JK; Saidijam, M; Bettaney, KE; Henderson, PJF; Salkinoja-Salonen, M; Kolsto, AB				Simm, Roger; Voros, Aniko; Ekman, Jaakko V.; Sodring, Marianne; Nes, Ingerid; Kroeger, Jasmin K.; Saidijam, Massoud; Bettaney, Kim E.; Henderson, Peter J. F.; Salkinoja-Salonen, Mirja; Kolsto, Anne-Brit			BC4707 Is a Major Facilitator Superfamily Multidrug Resistance Transport Protein from Bacillus cereus Implicated in Fluoroquinolone Tolerance	PLOS ONE			English	Article							CARBONYL CYANIDE PHENYLHYDRAZONES; EFFLUX PUMPS; OXIDATIVE-PHOSPHORYLATION; M-CHLOROPHENYLHYDRAZONE; AMPLIFIED EXPRESSION; STRESS RESPONSES; DRUG-RESISTANCE; STRAINS; ANTHRAX; PURIFICATION	Transcriptional profiling highlighted a subset of genes encoding putative multidrug transporters in the pathogen Bacillus cereus that were up-regulated during stress produced by bile salts. One of these multidrug transporters (BC4707) was selected for investigation. Functional characterization of the BC4707 protein in Escherichia coli revealed a role in the energized efflux of xenobiotics. Phenotypic analyses after inactivation of the gene bc4707 in Bacillus cereus ATCC14579 suggested a more specific, but modest role in the efflux of norfloxacin. In addition to this, transcriptional analyses showed that BC4707 is also expressed during growth of B. cereus under non-stressful conditions where it may have a role in the normal physiology of the bacteria. Altogether, the results indicate that bc4707, which is part of the core genome of the B. cereus group of bacteria, encodes a multidrug resistance efflux protein that is likely involved in maintaining intracellular homeostasis during growth of the bacteria.	[Simm, Roger; Voros, Aniko; Sodring, Marianne; Nes, Ingerid; Kroeger, Jasmin K.; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Lab Microbial Dynam, Oslo, Norway; [Ekman, Jaakko V.; Salkinoja-Salonen, Mirja] Univ Helsinki, Dept Biosci, Bioctr 1, Helsinki, Finland; [Saidijam, Massoud; Bettaney, Kim E.; Henderson, Peter J. F.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Saidijam, Massoud] Hamedan Univ Med Sci, Sch Med, Hamadan, Iran	University of Oslo; University of Helsinki; University of Leeds	Simm, R (corresponding author), Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Lab Microbial Dynam, Oslo, Norway.	a.b.kolsto@farmasi.uio.no	Henderson, Peter JF/Q-1907-2018; Simm, Roger/AAN-8965-2020; Saidijam, Massoud/G-2646-2017	Simm, Roger/0000-0001-5187-2456; Saidijam, Massoud/0000-0001-8910-556X; Salkinoja-Salonen, Mirja/0000-0003-1853-5268; Kroeger, Jasmin Kaori/0000-0002-7747-3223; Sodring, Marianne/0000-0003-0236-8549; Henderson, Peter/0000-0002-9187-0938	Norwegian Research Council (Functional Genomics FUGE II grant) [183421]; European Drug Initiative on Channels and Transporters (EDICT) consortium [201924]	Norwegian Research Council (Functional Genomics FUGE II grant); European Drug Initiative on Channels and Transporters (EDICT) consortium	Work in the Kolsto laboratory is supported by the Norwegian Research Council (Functional Genomics FUGE II grant 183421; http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1226993493114&p=1226993493114&pagename=fuge%2FHovedsidemal). Work in the PJFH laboratory is supported by the European Drug Initiative on Channels and Transporters (EDICT) consortium grant number 201924 (http://www.edict-project.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; CAVARI BZ, 1967, BIOCHEM J, V103, P601, DOI 10.1042/bj1030601; Chan YY, 2007, J BACTERIOL, V189, P4320, DOI 10.1128/JB.00003-07; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GHOSH AC, 1978, J HYG-CAMBRIDGE, V80, P233; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GOLDSBY RA, 1963, BIOCHEMISTRY-US, V2, P1142, DOI 10.1021/bi00905a041; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kristoffersen SM, 2007, J BACTERIOL, V189, P5302, DOI 10.1128/JB.00239-07; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mols M, 2007, ENVIRON MICROBIOL, V9, P2933, DOI 10.1111/j.1462-2920.2007.01404.x; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; NAKAMURA H, 1965, J BACTERIOL, V90, P8, DOI 10.1128/JB.90.1.8-14.1965; NAKAMURA H, 1968, J BACTERIOL, V96, P987, DOI 10.1128/JB.96.4.987-996.1968; Neyfakh AA, 1997, TRENDS MICROBIOL, V5, P309, DOI 10.1016/S0966-842X(97)01064-0; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Reiter L, 2011, J MICROBIOL METH, V86, P210, DOI 10.1016/j.mimet.2011.05.006; Ren QH, 2007, J MOL MICROB BIOTECH, V12, P165, DOI 10.1159/000099639; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Serizawa M, 2010, ANTIMICROB AGENTS CH, V54, P2787, DOI 10.1128/AAC.01405-09; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Szakonyi G, 2007, J ANTIMICROB CHEMOTH, V59, P1265, DOI 10.1093/jac/dkm036; TURNBULL PCB, 1985, J HYG-CAMBRIDGE, V95, P629, DOI 10.1017/S0022172400060733; von Stetten F, 1999, ENVIRON MICROBIOL, V1, P503, DOI 10.1046/j.1462-2920.1999.00070.x; Ward A, 2000, PRACT APPROACH SER, P141; Ward A, 2001, J MOL MICROB BIOTECH, V3, P193; Zhang Y, J BIOL CHEM, V286, P26576	51	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36720	10.1371/journal.pone.0036720	http://dx.doi.org/10.1371/journal.pone.0036720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615800	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300026
J	Hayden, HS; Lim, R; Brittnacher, MJ; Sims, EH; Ramage, ER; Fong, C; Wu, ZN; Crist, E; Chang, J; Zhou, Y; Radey, M; Rohmer, L; Haugen, E; Gillett, W; Wuthiekanun, V; Peacock, SJ; Kaul, R; Miller, SI; Manoil, C; Jacobs, MA				Hayden, Hillary S.; Lim, Regina; Brittnacher, Mitchell J.; Sims, Elizabeth H.; Ramage, Elizabeth R.; Fong, Christine; Wu, Zaining; Crist, Eva; Chang, Jean; Zhou, Yang; Radey, Matthew; Rohmer, Laurence; Haugen, Eric; Gillett, Will; Wuthiekanun, Vanaporn; Peacock, Sharon J.; Kaul, Rajinder; Miller, Samuel I.; Manoil, Colin; Jacobs, Michael A.			Evolution of Burkholderia pseudomallei in Recurrent Melioidosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL RESISTANCE; STRUCTURAL VARIATION; SEQUENCE; GENOME; CEFTAZIDIME; MALLEI; STRAIN; SUSCEPTIBILITY; THAILANDENSIS	Burkholderia pseudomallei, the etiologic agent of human melioidosis, is capable of causing severe acute infection with overwhelming septicemia leading to death. A high rate of recurrent disease occurs in adult patients, most often due to recrudescence of the initial infecting strain. Pathogen persistence and evolution during such relapsing infections are not well understood. Bacterial cells present in the primary inoculum and in late infections may differ greatly, as has been observed in chronic disease, or they may be genetically similar. To test these alternative models, we conducted whole-genome comparisons of clonal primary and relapse B. pseudomallei isolates recovered six months to six years apart from four adult Thai patients. We found differences within each of the four pairs, and some, including a 330 Kb deletion, affected substantial portions of the genome. Many of the changes were associated with increased antibiotic resistance. We also found evidence of positive selection for deleterious mutations in a TetR family transcriptional regulator from a set of 107 additional B. pseudomallei strains. As part of the study, we sequenced to base-pair accuracy the genome of B. pseudomallei strain 1026b, the model used for genetic studies of B. pseudomallei pathogenesis and antibiotic resistance. Our findings provide new insights into pathogen evolution during long-term infections and have important implications for the development of intervention strategies to combat recurrent melioidosis.	[Hayden, Hillary S.; Brittnacher, Mitchell J.; Sims, Elizabeth H.; Fong, Christine; Radey, Matthew; Rohmer, Laurence; Miller, Samuel I.; Jacobs, Michael A.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Lim, Regina; Wu, Zaining; Crist, Eva; Chang, Jean; Zhou, Yang; Gillett, Will] Univ Washington, Genome Ctr, Seattle, WA 98195 USA; [Ramage, Elizabeth R.; Haugen, Eric; Kaul, Rajinder; Miller, Samuel I.; Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kaul, Rajinder; Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Wuthiekanun, Vanaporn; Peacock, Sharon J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Peacock, Sharon J.] Mahidol Univ, Dept Microbiol & Immunol, Fac Trop Med, Bangkok 10700, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; University of Cambridge	Hayden, HS (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hhayden@u.washington.edu	Jacobs, Michael A/G-2901-2010; Peacock, Sharon J/ABE-6331-2020	Jacobs, Michael A/0000-0002-1125-1644; Haugen, Eric/0000-0001-7444-8981; Peacock, Sharon/0000-0002-1718-2782; Kaul, Rajinder/0000-0002-7895-9284	National Institutes of Health, National Institute of Allergy and Infectious Diseases [U54 AI057141]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health, National Institute of Allergy and Infectious Diseases award for the Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research grant U54 AI057141. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Brittnacher MJ, 2011, BIOINFORMATICS, V27, P2429, DOI 10.1093/bioinformatics/btr418; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dobrindt U, 2010, INT J MED MICROBIOL, V300, P363, DOI 10.1016/j.ijmm.2010.04.010; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Goerke C, 2010, INT J MED MICROBIOL, V300, P520, DOI 10.1016/j.ijmm.2010.08.003; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; HAASE A, 1995, EPIDEMIOL INFECT, V115, P115, DOI 10.1017/S0950268800058179; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hayden HS, 2008, GENOMICS, V91, P530, DOI 10.1016/j.ygeno.2008.02.005; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KOPONEN MA, 1991, ARCH INTERN MED, V151, P605, DOI 10.1001/archinte.151.3.605; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Kumar A, 2006, ANTIMICROB AGENTS CH, V50, P3460, DOI 10.1128/AAC.00440-06; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XW, 1997, ANTIMICROB AGENTS CH, V41, P1158, DOI 10.1128/AAC.41.5.1158; Lillebaek T, 2003, J INFECT DIS, V188, P1032, DOI 10.1086/378240; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Pearson T, 2007, INFECT GENET EVOL, V7, P416, DOI 10.1016/j.meegid.2006.12.002; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; Pumpuang A, 2011, T ROY SOC TROP MED H, V105, P598, DOI 10.1016/j.trstmh.2011.06.004; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Song H, 2009, MOL CELLS, V27, P237, DOI 10.1007/s10059-009-0029-8; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thongdee M, 2008, APPL ENVIRON MICROB, V74, P2985, DOI 10.1128/AEM.00030-08; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Tuanyok A, 2007, J BACTERIOL, V189, P9044, DOI 10.1128/JB.01264-07; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; Vesaratchavest M, 2006, J CLIN MICROBIOL, V44, P2553, DOI 10.1128/JCM.00629-06; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445; Wuthiekanun V, 2011, ANTIMICROB AGENTS CH, V55, P5388, DOI 10.1128/AAC.05517-11; Wuthiekanun V, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000496; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078	66	81	95	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36507	10.1371/journal.pone.0036507	http://dx.doi.org/10.1371/journal.pone.0036507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615773	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300020
J	Kim, J; Tooker, JF; Luthe, DS; De Moraes, CM; Felton, GW				Kim, Jinwon; Tooker, John F.; Luthe, Dawn S.; De Moraes, Consuelo M.; Felton, Gary W.			Insect Eggs Can Enhance Wound Response in Plants: A Study System of Tomato Solanum lycopersicum L. and Helicoverpa zea Boddie	PLOS ONE			English	Article							PIERID BUTTERFLIES; INDUCED RESISTANCE; DEFENSE; OVIPOSITION; DEPOSITION; HERBIVORE; HYPERSENSITIVITY; TEMPERATURE; INDUCTION; MECHANISM	Insect oviposition on plants frequently precedes herbivory. Accumulating evidence indicates that plants recognize insect oviposition and elicit direct or indirect defenses to reduce the pressure of future herbivory. Most of the oviposition-triggered plant defenses described thus far remove eggs or keep them away from the host plant or their desirable feeding sites. Here, we report induction of antiherbivore defense by insect oviposition which targets newly hatched larvae, not the eggs, in the system of tomato Solanum lycopersicum L., and tomato fruitworm moth Helicoverpa zea Boddie. When tomato plants were oviposited by H. zea moths, pin2, a highly inducible gene encoding protease inhibitor2, which is a representative defense protein against herbivorous arthropods, was expressed at significantly higher level at the oviposition site than surrounding tissues, and expression decreased with distance away from the site of oviposition. Moreover, more eggs resulted in higher pin2 expression in leaves, and both fertilized and unfertilized eggs induced pin2 expression. Notably, when quantified daily following deposition of eggs, pin2 expression at the oviposition site was highest just before the emergence of larvae. Furthermore, H. zea oviposition primed the wound-induced increase of pin2 transcription and a burst of jasmonic acid (JA); tomato plants previously exposed to H. zea oviposition showed significantly stronger induction of pin2 and higher production of JA upon subsequent simulated herbivory than without oviposition. Our results suggest that tomato plants recognize H. zea oviposition as a signal of impending future herbivory and induce defenses to prepare for this herbivory by newly hatched neonate larvae.	[Kim, Jinwon; Tooker, John F.; De Moraes, Consuelo M.; Felton, Gary W.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Luthe, Dawn S.] Penn State Univ, Dept Soil & Crop Sci, University Pk, PA 16802 USA; [Kim, Jinwon; Tooker, John F.; Luthe, Dawn S.; De Moraes, Consuelo M.; Felton, Gary W.] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kim, J (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	gwf10@psu.edu	Tooker, John/P-6421-2014; Felton, Gary W./E-8575-2013	Tooker, John/0000-0002-9303-6699; 	United States Department of Agriculture's USDA-NRI [2007-35302-18218]; David and Lucile Packard Foundation	United States Department of Agriculture's USDA-NRI; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by the United States Department of Agriculture's USDA-NRI Grant 2007-35302-18218 (http://www.csrees.usda.gov/funding/nri/nri.html), which contributed to all of the study design, data collection and analysis, decision to publish, and preparation of the manuscript. It was also supported by the the David and Lucile Packard Foundation, which had no role in study design, data collection and decision to publish.	ADLER PH, 1991, ENTOMOL EXP APPL, V58, P159, DOI 10.1007/BF00164940; Agrawal AA, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P45; Andersson J, 2003, J CHEM ECOL, V29, P1489, DOI 10.1023/A:1024277823101; Balbyshev NF, 1997, J ECON ENTOMOL, V90, P652, DOI 10.1093/jee/90.2.652; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Beyaert I, 2012, P ROY SOC B-BIOL SCI, V279, P101, DOI 10.1098/rspb.2011.0468; Bown AW, 2002, PLANT PHYSIOL, V129, P1430, DOI 10.1104/pp.006114; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; CHIPPENDALE GM, 1970, J INSECT PHYSIOL, V16, P1057, DOI 10.1016/0022-1910(70)90198-8; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; De Puysseleyr V, 2011, ARTHROPOD-PLANT INTE, V5, P71, DOI 10.1007/s11829-010-9117-0; Desurmont GA, 2011, ECOL ENTOMOL, V36, P335, DOI 10.1111/j.1365-2311.2011.01277.x; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2009, P NATL ACAD SCI USA, V106, P935, DOI 10.1073/pnas.0812182106; Fatouros NE, 2008, P NATL ACAD SCI USA, V105, P10033, DOI 10.1073/pnas.0707809105; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Fowler JH, 2009, PLANT CELL, V21, P1239, DOI 10.1105/tpc.108.065029; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hilker M, 2002, J EXP BIOL, V205, P455; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kim J, 2011, PHYTOCHEMISTRY, V72, P1624, DOI 10.1016/j.phytochem.2011.03.026; Little D, 2007, PLANT PHYSIOL, V143, P784, DOI 10.1104/pp.106.090837; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; Petzold-Maxwell J, 2011, ECOL ENTOMOL, V36, P700, DOI 10.1111/j.1365-2311.2011.01315.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Rhainds M, 2010, ENTOMOL EXP APPL, V136, P211, DOI 10.1111/j.1570-7458.2010.01032.x; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Seino Y, 1996, APPL ENTOMOL ZOOL, V31, P467, DOI 10.1303/aez.31.467; SHAPIRO AM, 1987, OECOLOGIA, V71, P631, DOI 10.1007/BF00379310; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Videla M, 2007, INT J PEST MANAGE, V53, P259, DOI 10.1080/09670870701439594; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zheng SJ, 2008, PLANT PHYSIOL, V146, P812, DOI 10.1104/pp.107.111542; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177	52	49	50	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37420	10.1371/journal.pone.0037420	http://dx.doi.org/10.1371/journal.pone.0037420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22616005	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300094
J	McGarry, RC; Ayre, BG				McGarry, Roisin C.; Ayre, Brian G.			Geminivirus-Mediated Delivery of Florigen Promotes Determinate Growth in Aerial Organs and Uncouples Flowering from Photoperiod in Cotton	PLOS ONE			English	Article							LEAF-CRUMPLE-VIRUS; FT GENE; HD3A; EXPRESSION; ORTHOLOG; PROTEIN; TIME; INFLORESCENCE; ASSOCIATION; MOVEMENT	Background: Plant architecture and the timing and distribution of reproductive structures are fundamental agronomic traits shaped by patterns of determinate and indeterminate growth. Florigen, encoded by FLOWERING LOCUS T (FT) in Arabidopsis and SINGLE FLOWER TRUSS (SFT) in tomato, acts as a general growth hormone, advancing determinate growth. Domestication of upland cotton (Gossypium hirsutum) converted it from a lanky photoperiodic perennial to a highly inbred, compact day-neutral plant that is managed as an annual row-crop. This dramatic change in plant architecture provides a unique opportunity to analyze the transition from perennial to annual growth. Methodology/Principal Findings: To explore these architectural changes, we addressed the role of day-length upon flowering in an ancestral, perennial accession and in a domesticated variety of cotton. Using a disarmed Cotton leaf crumple virus (CLCrV) as a transient expression system, we delivered FT to both cotton accessions. Ectopic expression of FT in ancestral cotton mimicked the effects of day-length, promoting photoperiod-independent flowering, precocious determinate architecture, and lanceolate leaf shape. Domesticated cotton infected with FT demonstrated more synchronized fruiting and enhanced "annualization''. Transient expression of FT also facilitated simple crosses between wild photoperiodic and domesticated day-neutral accessions, effectively demonstrating a mechanism to increase genetic diversity among cultivated lines of cotton. Virus was not detected in the F-1 progeny, indicating that crosses made by this approach do not harbor recombinant DNA molecules. Conclusions: These findings extend our understanding of FT as a general growth hormone that regulates shoot architecture by advancing organ-specific and age-related determinate growth. Judicious manipulation of FT could benefit cotton architecture to improve crop management.	[McGarry, Roisin C.; Ayre, Brian G.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	McGarry, RC (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	bgayre@unt.edu		Ayre, Brian/0000-0002-7399-200X	Cotton Incorporated [10-768]	Cotton Incorporated(Cotton R&D Corp)	This work was supported by Cotton Incorporated (Cooperative Agreement 10-768 to BGA), a not-for-profit producers organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Cotton Incorporated (Cooperative Agreement 10-768 to BGA), a not-for-profit producers organization. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors declare there are no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products etc.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Ayre B, 2010, PLANT HORMONES BIOSY, P539; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; CHAILAKH.MK, 1968, ANN REV PLANT PHYSIO, V19, P1, DOI 10.1146/annurev.pp.19.060168.000245; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cothren JT, 2010, PHYSIOLOGY OF COTTON, P289, DOI 10.1007/978-90-481-3195-2_26; Danilevskaya ON, 2011, PLANT SIGNAL BEHAV, V6, P1267, DOI 10.4161/psb.6.9.16423; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Endo T, 2005, TRANSGENIC RES, V14, P703, DOI 10.1007/s11248-005-6632-3; Fry WE, 1997, BIOSCIENCE, V47, P363, DOI 10.2307/1313151; Gore UR, 1935, BOT GAZ, V97, P118, DOI 10.1086/334540; Guo YF, 2008, EUPHYTICA, V163, P113, DOI 10.1007/s10681-007-9613-1; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Idris AM, 2010, PHYSIOL MOL PLANT P, V75, P13, DOI 10.1016/j.pmpp.2010.07.002; John ME, 2010, PHYSIOLOGY OF COTTON, P394, DOI 10.1007/978-90-481-3195-2_35; Jost P, U GEORGIA COOPERATIV, V1305; Kerby TA, 2010, PHYSIOLOGY OF COTTON, P304, DOI 10.1007/978-90-481-3195-2_27; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Lubbers Edward L., 2009, V3, P23, DOI 10.1007/978-0-387-70810-2_2; MAUNEY J. R., 1963, BOT GAZ, V124, P278, DOI 10.1086/336206; McGarry RC, 2012, PLANT SCI, V188, P71, DOI 10.1016/j.plantsci.2012.03.002; MINK GI, 1993, ANNU REV PHYTOPATHOL, V31, P375, DOI 10.1146/annurev.py.31.090193.002111; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; OOSTERHUIS DM, 1990, NITROGEN NUTRITION OF COTTON : PRACTICAL ISSUES, P1; Paterson AH, 2004, CROP SCI, V44, P1900, DOI 10.2135/cropsci2004.1900; Percy Richard G., 2009, V3, P53, DOI 10.1007/978-0-387-70810-2_3; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; RICK CM, 1978, SCI AM, V239, P77; Sambrook J., 2001, MOL CLONING LAB MANU; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shurley D, 2004, U GEORGIA COOPERATIV, V1252; Sudarshana MR, 1998, MOL PLANT MICROBE IN, V11, P277, DOI 10.1094/MPMI.1998.11.4.277; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; TROLINDER NL, 1987, PLANT CELL REP, V6, P231, DOI 10.1007/BF00268487; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Wallace TP, 2009, GENET RESOUR CROP EV, V56, P507, DOI 10.1007/s10722-008-9382-2; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Wilkins TA, 2004, J FOOD AGRIC ENVIRON, V2, P179; Yamagishi N, 2011, PLANT MOL BIOL, V75, P193, DOI 10.1007/s11103-010-9718-0; Yamagishi N, 2011, PLANTA, V233, P561, DOI 10.1007/s00425-010-1318-3; Yeager AF, 1927, J HERED, V18, P263, DOI 10.1093/oxfordjournals.jhered.a102869; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092	60	33	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36746	10.1371/journal.pone.0036746	http://dx.doi.org/10.1371/journal.pone.0036746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615805	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300034
J	Plouffe, V; Mohamed, NV; Rivest-McGraw, J; Bertrand, J; Lauzon, M; Leclerc, N				Plouffe, Vanessa; Nguyen-Vi Mohamed; Rivest-McGraw, Jessica; Bertrand, Johanne; Lauzon, Michel; Leclerc, Nicole			Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion	PLOS ONE			English	Article							HUMAN CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; NEUROFIBRILLARY TANGLES; DIFFERENTIAL-DIAGNOSIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; CSF-TAU; PROTEIN; ASSOCIATION	It is well established that tau pathology propagates in a predictable manner in Alzheimer's disease (AD). Moreover, tau accumulates in the cerebrospinal fluid (CSF) of AD's patients. The mechanisms underlying the propagation of tau pathology and its accumulation in the CSF remain to be elucidated. Recent studies have reported that human tau was secreted by neurons and non-neuronal cells when it was overexpressed indicating that tau secretion could contribute to the spreading of tau pathology in the brain and could lead to its accumulation in the CSF. In the present study, we showed that the overexpression of human tau resulted in its secretion by Hela cells. The main form of tau secreted by these cells was cleaved at the C-terminal. Surprisingly, secreted tau was dephosphorylated at several sites in comparison to intracellular tau which presented a strong immunoreactivity to all phospho-dependent antibodies tested. Our data also revealed that phosphorylation and cleavage of tau favored its secretion by Hela cells. Indeed, the mimicking of phosphorylation at 12 sites known to be phosphorylated in AD enhanced tau secretion. A mutant form of tau truncated at D421, the preferential cleavage site of caspase-3, was also significantly more secreted than wild-type tau. Taken together, our results indicate that hyperphosphorylation and cleavage of tau by favoring its secretion could contribute to the propagation of tau pathology in the brain and its accumulation in the CSF.	[Plouffe, Vanessa; Nguyen-Vi Mohamed; Rivest-McGraw, Jessica; Bertrand, Johanne; Lauzon, Michel; Leclerc, Nicole] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada	Universite de Montreal	Plouffe, V (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada.	nicole.leclerc@umontreal.ca			Canadian Institute of Health Research [MOP-114874]; Natural Sciences and Engineering Research of Canada; Alzheimer Society of Canada; FRSQ; GRSNC; NSERC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer Society of Canada; FRSQ(Fonds de la Recherche en Sante du Quebec); GRSNC; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research (MOP-114874) (N.L.), Natural Sciences and Engineering Research of Canada (N.L.), the Alzheimer Society of Canada (N.L.) and an FRSQ infrastructure grant to the Groupe de Recherche sur le systeme nerveux central (GRSNC) (N.L.). V.P. has a studentship from GRSNC, J.B. has a post-doctoral fellowship from the Alzheimer Society of Canada and J.R.-M. obtained a summer studentship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Borroni B, 2009, NEUROBIOL AGING, V30, P34, DOI 10.1016/j.neurobiolaging.2007.05.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buerger K, 2003, AM J PSYCHIAT, V160, P376, DOI 10.1176/appi.ajp.160.2.376; Buerger K, 2002, ARCH NEUROL-CHICAGO, V59, P1267, DOI 10.1001/archneur.59.8.1267; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hampel H, 2005, ARCH NEUROL-CHICAGO, V62, P770, DOI 10.1001/archneur.62.5.770; Hampel H, 2004, ARCH GEN PSYCHIAT, V61, P95, DOI 10.1001/archpsyc.61.1.95; Hampel H, 2004, DEMENT GERIATR COGN, V17, P350, DOI 10.1159/000077170; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Ishiguro K, 1999, NEUROSCI LETT, V270, P91, DOI 10.1016/S0304-3940(99)00476-0; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; Kohnken R, 2000, NEUROSCI LETT, V287, P187, DOI 10.1016/S0304-3940(00)01178-2; Lauckner J, 2003, NEUROBIOL AGING, V24, P767, DOI 10.1016/S0197-4580(02)00228-2; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Mandell JW, 1996, PERSPECT DEV NEUROBI, V4, P125; Maurage CA, 2003, ACTA NEUROPATHOL, V105, P89, DOI 10.1007/s00401-002-0608-7; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P97, DOI 10.1080/096878031000104935; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Tanudji M, 2002, J CELL SCI, V115, P3849, DOI 10.1242/jcs.00047; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	52	113	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36873	10.1371/journal.pone.0036873	http://dx.doi.org/10.1371/journal.pone.0036873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615831	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300045
J	Zhang, YH; Ma, WJ; Thomas, GN; Xu, YJ; Lao, XQ; Xu, XJ; Song, XL; Xu, HF; Cai, QM; Xia, L; Nie, SP; Deng, HH; Yu, ITS				Zhang, Yong Hui; Ma, Wen Jun; Thomas, G. Neil; Xu, Yan Jun; Lao, Xiang Qian; Xu, Xiao Jun; Song, Xiu Ling; Xu, Hao Feng; Cai, Qiu Mao; Xia, Liang; Nie, Shao Ping; Deng, Hui Hong; Yu, Ignatius Tak Sun			Diabetes and Pre-Diabetes as Determined by Glycated Haemoglobin A1c and Glucose Levels in a Developing Southern Chinese Population	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CARDIOVASCULAR RISK; NATIONAL NUTRITION; HEALTH SURVEY; PREVALENCE; ADULTS; DIAGNOSIS; HYPERTENSION; AWARENESS	Background: The American Diabetes Association and World Health Organization have recently adopted the HbA1c measurement as one method of diagnostic criteria for diabetes. The change in diagnostic criteria has important implications for diabetes treatment and prevention. We therefore investigate diabetes using HbA1c and glucose criteria together, and assess the prevalent trend in a developing southern Chinese population with 85 million residents. Methods: A stratified multistage random sampling method was applied and a representative sample of 3590 residents 18 years of age or above was obtained in 2010. Each participant received a full medical check-up, including measurement of fasting plasma glucose, 2-hour post-load plasma glucose, and HbA1c. Information on history of diagnosis and treatment of diabetes was collected. The prevalence of diabetes obtained from the present survey was compared with the data from the survey in 2002. Results: The prevalence of diabetes based on both glucose and HbA1c measurements was 21.7% (95% CI: 17.4%-26.1%) in 2010, which suggests that more than 1 in 5 adult residents were suffering from diabetes in this developing population. Only 12.9% (95% CI: 8.3%-17.6%) of diabetic residents were aware of their condition. The prevalence of pre-diabetes was 66.3% (95% CI: 62.7%-69.8%). The prevalence of diabetes and pre-diabetes which met all the three diagnostic thresholds (fast plasma glucose, 2 hour post-load plasma glucose, and HbA1c) was 3.1% and 5.2%, respectively. Diabetes and pre-diabetes as determined by HbA1c measurement had higher vascular risk than those determined by glucose levels. The prevalence of diabetes increased from 2.9% (95% CI: 2.0%-3.7%) in 2002 to 13.8% (95% CI: 10.2%-17.3%) in 2010 based on the same glucose criteria. Conclusions: Our results show that the diabetes epidemic is accelerating in China. The awareness of diabetes is extremely low. The glucose test and HbA1c measurement should be used together to increase detection of diabetes and pre-diabetes.	[Zhang, Yong Hui; Ma, Wen Jun; Xu, Yan Jun; Xu, Xiao Jun; Song, Xiu Ling; Xu, Hao Feng; Cai, Qiu Mao; Xia, Liang; Nie, Shao Ping; Deng, Hui Hong] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Ma, Wen Jun] Guangdong Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Thomas, G. Neil] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston, England; [Lao, Xiang Qian; Yu, Ignatius Tak Sun] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Lao, Xiang Qian] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China	University of Birmingham; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Zhang, YH (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	xqlao@cuhk.edu.hk	Thomas, G. Neil/A-1879-2013; Nie, S/K-1124-2019; Lao, Xiang Qian/M-5817-2017; Zhang, Yonghui/AGY-9072-2022; Yu, Ignatius Tak Sun/A-9936-2008; 马, 文军/GQQ-7852-2022	Thomas, G. Neil/0000-0002-2777-1847; Lao, Xiang Qian/0000-0002-2645-0128; 	Ministry of Finance of the People's Republic of China, Beijing, China	Ministry of Finance of the People's Republic of China, Beijing, China	This survey was supported by the Ministry of Finance of the People's Republic of China, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Chalmers J, 1999, J HYPERTENS, V17, P151; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lao XQ, 2011, J VIRAL HEPATITIS, V18, P571, DOI 10.1111/j.1365-2893.2010.01347.x; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lee JWR, 2011, DIABETES CARE, V34, P353, DOI 10.2337/dc10-0746; Liu SQ, 2011, PREV CHRONIC DIS, V8; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Ma WJ, 2004, FINAL REPORT GUANGDO; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Misra A, 2011, LANCET, V378, P104, DOI 10.1016/S0140-6736(11)60789-7; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Glycohemoglobin Standardization Program, LIST NGSP CERT LAB; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Statistics Bureau of Guangdong Province, 2001, GUANGD STAT YB; Thomas GN, 1999, NEW ENGL J MED, V341, P2097; World Health Organization, 2011, US GLYC HAEM HBA1C D; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	31	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37260	10.1371/journal.pone.0037260	http://dx.doi.org/10.1371/journal.pone.0037260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615957	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300086
J	Satti, H; McLaughlin, MM; Omotayo, DB; Keshavjee, S; Becerra, MC; Mukherjee, JS; Seung, KJ				Satti, Hind; McLaughlin, Megan M.; Omotayo, David B.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.			Outcomes of Comprehensive Care for Children Empirically Treated for Multidrug-Resistant Tuberculosis in a Setting of High HIV Prevalence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECONSTITUTION INFLAMMATORY SYNDROME; WESTERN CAPE PROVINCE; NEW-YORK-CITY; IMMUNE RECONSTITUTION; ANTIRETROVIRAL THERAPY; TUBERCLE-BACILLI; SOUTH-AFRICA; MDR-TB; OUTBREAK	Background: Few studies have examined outcomes for children treated for multidrug-resistant tuberculosis (MDR-TB), including those receiving concomitant treatment for MDR-TB and HIV co-infection. In Lesotho, where the adult HIV seroprevalence is estimated to be 24%, we sought to measure outcomes and adverse events in a cohort of children treated for MDR-TB using a community-based treatment delivery model. Methods: We reviewed retrospectively the clinical charts of children <= 15 years of age treated for culture-confirmed or suspected MDR-TB between July 2007 and January 2011. Results: Nineteen children, ages two to 15, received treatment. At baseline, 74% of patients were co-infected with HIV, 63% were malnourished, 84% had severe radiographic findings, and 21% had extrapulmonary disease. Five (26%) children had culture-confirmed MDR-TB, ten (53%) did not have culture results available, and four (21%) subsequently had results indicating drug-susceptible TB. All children with HIV co-infection who were not already on antiretroviral therapy (ART) were initiated on ART a median of two weeks after the start of the MDR-TB regimen. Among the 17 patients with final outcomes, 15 (88%) patients were cured or completed treatment, two (12%) patients died, and none defaulted or were lost to follow-up. The majority of patients (95%) experienced adverse events; only two required permanent discontinuation of the offending agent, and only one required suspension of MDR-TB treatment for more than one week. Conclusions: Pediatric MDR-TB and MDR-TB/HIV co-infection can be successfully treated using a combination of social support, close monitoring by community health workers and clinicians, and inpatient care when needed. In this cohort, adverse events were well tolerated and treatment outcomes were comparable to those reported in children with drug-susceptible TB and no HIV infection.	[Satti, Hind; McLaughlin, Megan M.; Omotayo, David B.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.] Partners Hlth, Maseru, Lesotho; [Satti, Hind; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [McLaughlin, Megan M.; Keshavjee, Salmaan; Becerra, Mercedes C.; Mukherjee, Joia S.; Seung, Kwonjune J.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Satti, H (corresponding author), Partners Hlth, Maseru, Lesotho.	hsatti@pih.org		Keshavjee, Salmaan/0000-0002-6967-3305				Al-Dabbagh M, 2011, PEDIATR INFECT DIS J, V30, P501, DOI 10.1097/INF.0b013e31820b583d; [Anonymous], 2008, GUID PROGR MAN DRUG; BLANC FX, 2010, 18 INT AIDS C VIENN; Boulware DR, 2008, CURR OPIN HIV AIDS, V3, P461, DOI 10.1097/COH.0b013e3282fe9693; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Centers for Disease Control and Prevention, 1992, MMWR-MORBID MORTAL W, V41, P961; Centers for Disease Control and Prevention, 2002, VIT HLTH STAT; Cilliers K, 2010, ACTA PAEDIATR, V99, P705, DOI 10.1111/j.1651-2227.2010.01696.x; Cruz AT, 2007, PAEDIATR RESPIR REV, V8, P107, DOI 10.1016/j.prrv.2007.04.008; DEBRE R, 1959, AM REV RESPIR DIS, V80, P326; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Eamranond P, 2001, INT J TUBERC LUNG D, V5, P594; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Ettehad D, 2012, LANCET INFECT DIS; Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28; Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca; FISCHL MA, 1992, ANN INTERN MED, V117, P177, DOI 10.7326/0003-4819-117-3-177; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Graham SM, 2005, INT J TUBERC LUNG D, V9, P592; Graham SM, 2004, INT J TUBERC LUNG D, V8, P648; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hallbauer U. M., 2011, Southern African Journal of Epidemiology & Infection, V26, P161; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Ministry of Health and Social Welfare, 2009, DEM HLTH SURV; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Mukherjee JS, 2003, INT J TUBERC LUNG D, V7, P637; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Partners In Health, 2011, PARTN HLTH 2011 ANN; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Puthanakit T, 2006, PEDIATR INFECT DIS J, V25, P53, DOI 10.1097/01.inf.0000195618.55453.9a; Satti H, 2012, INT J TUBERC LUNG D, V16, P468, DOI 10.5588/ijtld.11.0615; Schaaf HS, 2011, PAEDIATR RESPIR REV, V12, P31, DOI 10.1016/j.prrv.2010.09.010; Schaaf HS, 2009, AM J PUBLIC HEALTH, V99, P1486, DOI 10.2105/AJPH.2008.143271; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Schaaf HS, 2006, ACTA PAEDIATR, V95, P523, DOI 10.1080/08035250600675741; Schaaf HS, 2003, ARCH DIS CHILD, V88, P1106, DOI 10.1136/adc.88.12.1106; Schaaf HS, 2000, INT J TUBERC LUNG D, V4, P1149; Schluger NW, 1996, PEDIATR PULM, V21, P138, DOI 10.1002/(SICI)1099-0496(199602)21:2<138::AID-PPUL9>3.0.CO;2-N; Seddon JA, 2012, CLIN INFECT DIS, V54, P157, DOI 10.1093/cid/cir772; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Shin SY, 2004, CHEST, V125, P974, DOI 10.1378/chest.125.3.974; STEINER P, 1983, AM REV RESPIR DIS, V128, P425, DOI 10.1164/arrd.1983.128.3.425; Thee S, 2011, INT J TUBERC LUNG D, V15, P1191, DOI 10.5588/ijtld.10.0707; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; USAID TB Care II, 2011, COMM BAS CAR DRUG RE; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; WHO, 2010, ANT THER HIV INF AD; WHO/IUATLD, 2010, GUID NAT TUB HIV PRO; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2011, TB DAT TUB COUNTR PR; Zampoli M, 2007, INT J TUBERC LUNG D, V11, P417	62	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37114	10.1371/journal.pone.0037114	http://dx.doi.org/10.1371/journal.pone.0037114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629356	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300021
J	Bi, W; Jing, XN; Zhu, LH; Liang, YR; Liu, J; Yang, LH; Xiao, SH; Xu, AD; Shi, QY; Tao, EX				Bi, Wei; Jing, Xiuna; Zhu, Lihong; Liang, Yanran; Liu, Jun; Yang, Lianhong; Xiao, Songhua; Xu, Anding; Shi, Qiaoyun; Tao, Enxiang			Inhibition of 26S Protease Regulatory Subunit 7 (MSS1) Suppresses Neuroinflammation	PLOS ONE			English	Article							NF-KAPPA-B; RAW 264.7 CELLS; TRANSCRIPTION FACTORS; RIFAMPICIN; EXPRESSION; DEGRADATION; RECEPTOR; INFLAMMATION; MICROGLIA; SURVIVAL	Recently, researchers have focused on immunosuppression induced by rifampicin. Our previous investigation found that rifampicin was neuroprotective by inhibiting the production of pro-inflammatory mediators, thereby suppressing microglial activation. In this study, using 2-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS), we discovered that 26S protease regulatory subunit 7 (MSS1) was decreased in rifampicin-treated microglia. Western blot analysis verified the downregulation of MSS1 expression by rifampicin. As it is indicated that the modulation of the ubiquitin-26S proteasome system (UPS) with proteasome inhibitors is efficacious for the treatment of neuro-inflammatory disorders, we next hypothesized that silencing MSS1 gene expression might inhibit microglial inflammation. Using RNA interference (RNAi), we showed significant reduction of IkB alpha degradation and NF-kB activation. The production of lipopolysaccharides-induced pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS), nitric oxide, cyclooxygenase-2, and prostaglandin E-2 were also reduced by MSS1 gene knockdown. Taken together, our findings suggested that rifampicin inhibited microglial inflammation by suppressing MSS1 protein production. Silencing MSS1 gene expression decreased neuroinflammation. We concluded that MSS1 inhibition, in addition to anti-inflammatory rifampicin, might represent a novel mechanism for the treatment of neuroinflammatory disorders.	[Bi, Wei; Jing, Xiuna; Liang, Yanran; Liu, Jun; Yang, Lianhong; Xiao, Songhua; Tao, Enxiang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Wei; Xu, Anding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhu, Lihong] Jinan Univ, Joint Lab Brain Funct & Hlth, Guangzhou, Guangdong, Peoples R China; [Zhu, Lihong] Jinan Univ, Univ Hong Kong, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shi, Qiaoyun] Stanford Univ, Sch Med, Div Cardiovasc Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA	Sun Yat Sen University; Jinan University; Jinan University; Jinan University; University of Hong Kong; Stanford University	Bi, W (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	tao_enxiang@yahoo.cn	Zhu, Li/GXH-9801-2022	Xu, An-Ding/0000-0003-3154-0985	Guangdong Provincial Department of Science and Technology [0400935505B33801003]; Ph.D. Programs Foundation of Ministry of Education of China [20070558257]; National Natural Science Foundation of China [81102449]	Guangdong Provincial Department of Science and Technology; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Guangdong Provincial Department of Science and Technology (0400935505B33801003), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20070558257), and the National Natural Science Foundation of China (81102449). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An N, 2008, IMMUNOPHARM IMMUNOT, V30, P437, DOI 10.1080/08923970802135146; BELLAHSENE A, 1980, INFECT IMMUN, V27, P15; Bi W, 2011, BRAIN RES, V1395, P12, DOI 10.1016/j.brainres.2011.04.019; Blanchard JS, 1998, NAT MED, V4, P14, DOI 10.1038/nm0198-014; Brinkmann KC, 2005, PEDIATR RES, V57, P419, DOI 10.1203/01.PDR.0000153946.97159.79; Calleja C, 1998, NAT MED, V4, P92, DOI 10.1038/nm0198-092; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; DAJANI BM, 1972, LANCET, V2, P1094; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jessie K, 2010, INT J MOL SCI, V11, P4488, DOI 10.3390/ijms11114488; Kim SK, 2009, KOREAN J PHYSIOL PHA, V13, P475, DOI 10.4196/kjpp.2009.13.6.475; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; KRAUSE DL, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/732806VOL; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Mambo G, 2003, INT IMMUNOPHARMACOL, V3, P513, DOI 10.1016/S1567-5769(03)00022-5; Namazi H, 2008, J PAIN, V9, P380, DOI 10.1016/j.jpain.2008.01.325; Ozato K, 2002, BIOTECHNIQUES, P66; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sujashvili R., 2008, GEORGIAN MED NEWS, V161, P48; Tsankov N, 2006, J DERMATOL TREAT, V17, P18, DOI 10.1080/09546630500375643; Tsankov N, 2003, CLIN DERMATOL, V21, P50, DOI 10.1016/S0738-081X(02)00328-0; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Tsiskarishvili N V, 2009, Georgian Med News, P25; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024377; Williams AJ, 2006, NEUROCHEM INT, V49, P106, DOI 10.1016/j.neuint.2006.03.018; Woo MS, 2003, MOL BRAIN RES, V113, P86, DOI 10.1016/S0169-328X(03)00095-0; Xu J, 2007, BRAIN RES, V1139, P220, DOI 10.1016/j.brainres.2006.12.074; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yanagi S, 2000, BIOCHEM BIOPH RES CO, V279, P568, DOI 10.1006/bbrc.2000.3969; Zhang W, 2011, BIOCHEM BIOPH RES CO, V407, P668, DOI 10.1016/j.bbrc.2011.03.071	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36142	10.1371/journal.pone.0036142	http://dx.doi.org/10.1371/journal.pone.0036142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629310	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500011
J	Cunningham, J; Estrella, V; Lloyd, M; Gillies, R; Frieden, BR; Gatenby, R				Cunningham, Jessica; Estrella, Veronica; Lloyd, Mark; Gillies, Robert; Frieden, B. Roy; Gatenby, Robert			Intracellular Electric Field and pH Optimize Protein Localization and Movement	PLOS ONE			English	Article							MEMBRANE; DYNAMICS; PATHWAY; TIME	Mammalian cell function requires timely and accurate transmission of information from the cell membrane (CM) to the nucleus (N). These pathways have been intensively investigated and many critical components and interactions have been identified. However, the physical forces that control movement of these proteins have received scant attention. Thus, transduction pathways are typically presented schematically with little regard to spatial constraints that might affect the underlying dynamics necessary for protein-protein interactions and molecular movement from the CM to the N. We propose messenger protein localization and movements are highly regulated and governed by Coulomb interactions between: 1. A recently discovered, radially directed E-field from the NM into the CM and 2. Net protein charge determined by its isoelectric point, phosphorylation state, and the cytosolic pH. These interactions, which are widely applied in elecrophoresis, provide a previously unknown mechanism for localization of messenger proteins within the cytoplasm as well as rapid shuttling between the CM and N. Here we show these dynamics optimize the speed, accuracy and efficiency of transduction pathways even allowing measurement of the location and timing of ligand binding at the CM -previously unknown components of intracellular information flow that are, nevertheless, likely necessary for detecting spatial gradients and temporal fluctuations in ligand concentrations within the environment. The model has been applied to the RAF-MEK-ERK pathway and scaffolding protein KSR1 using computer simulations and in-vitro experiments. The computer simulations predicted distinct distributions of phosphorylated and unphosphorylated components of this transduction pathway which were experimentally confirmed in normal breast epithelial cells (HMEC).	[Cunningham, Jessica; Estrella, Veronica; Gillies, Robert; Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA; [Cunningham, Jessica; Gillies, Robert; Gatenby, Robert] H Lee Moffitt Canc Ctr & Res Inst, Dept Math Oncol, Tampa, FL USA; [Lloyd, Mark] H Lee Moffitt Canc Ctr & Res Inst, Dept Analyt Microscopy, Tampa, FL USA; [Frieden, B. Roy] Univ Arizona, Coll Opt Sci, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Arizona	Cunningham, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA.	Robert.Gatenby@Moffitt.org		Cunningham, Jessica/0000-0001-8704-8848	National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by a National Institutes of Health grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman D, 1995, HDB BIOL PHYS, V1, P612; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Bray D, 2008, CELL MOVEMENTS MOL M; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gagliardi LJ, 2005, J ELECTROSTAT, V63, P309, DOI 10.1016/j.elstat.2004.09.007; Gatenby RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012084; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; LOEWENSTEIN WR, 1963, J GEN PHYSIOL, V46, P1123, DOI 10.1085/jgp.46.6.1123; LOEWENSTEIN WR, 1962, NATURE, V195, P462, DOI 10.1038/195462a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARTINEZZAGUILAN R, 1991, AM J PHYSIOL, V260, pC297, DOI 10.1152/ajpcell.1991.260.2.C297; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; MCLAUGHLIN S, 1988, J PHYSIOL-LONDON, V396, P189, DOI 10.1113/jphysiol.1988.sp016958; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Takeuchi A, 2009, CHANNELS, V3, P383, DOI 10.4161/chan.3.6.9775; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Zhu L, 2007, BIOCHEM BIOPH RES CO, V356, P1038, DOI 10.1016/j.bbrc.2007.03.092	26	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36894	10.1371/journal.pone.0036894	http://dx.doi.org/10.1371/journal.pone.0036894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623963	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500035
J	Ishii, J; Yoshimoto, N; Tatematsu, K; Kuroda, S; Ogino, C; Fukuda, H; Kondo, A				Ishii, Jun; Yoshimoto, Nobuo; Tatematsu, Kenji; Kuroda, Shun'ichi; Ogino, Chiaki; Fukuda, Hideki; Kondo, Akihiko			Cell Wall Trapping of Autocrine Peptides for Human G-Protein-Coupled Receptors on the Yeast Cell Surface	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC IMMOBILIZATION; DISPLAY TECHNOLOGY; MOLECULAR DISPLAY; SOMATOSTATIN; DOMAIN; IDENTIFICATION; CONSTRUCTION; EXPRESSION; SUBTYPE-5	G-protein-coupled receptors (GPCRs) regulate a wide variety of physiological processes and are important pharmaceutical targets for drug discovery. Here, we describe a unique concept based on yeast cell-surface display technology to selectively track eligible peptides with agonistic activity for human GPCRs (Cell Wall Trapping of Autocrine Peptides (CWTrAP) strategy). In our strategy, individual recombinant yeast cells are able to report autocrine-positive activity for human GPCRs by expressing a candidate peptide fused to an anchoring motif. Following expression and activation, yeast cells trap autocrine peptides onto their cell walls. Because captured peptides are incapable of diffusion, they have no impact on surrounding yeast cells that express the target human GPCR and non-signaling peptides. Therefore, individual yeast cells can assemble the autonomous signaling complex and allow single-cell screening of a yeast population. Our strategy may be applied to identify eligible peptides with agonistic activity for target human GPCRs.	[Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 657, Japan; [Yoshimoto, Nobuo; Tatematsu, Kenji; Kuroda, Shun'ichi] Osaka Univ, Dept Struct Mol Biol, Inst Sci & Ind Res, Osaka, Japan; [Yoshimoto, Nobuo; Kuroda, Shun'ichi] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ogino, Chiaki; Fukuda, Hideki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 657, Japan	Kobe University; Osaka University; Nagoya University; Kobe University	Ishii, J (corresponding author), Kobe Univ, Org Adv Sci & Technol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp	Ishii, Jun/D-7670-2016; Ogino, Chiaki/G-9932-2014; Kondo, Akihiko/A-2130-2015	Ishii, Jun/0000-0003-2568-515X; Ogino, Chiaki/0000-0002-8906-7724; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Regional Innovative Consortium Project of the Ministry of Economy, Trade and Industry (METI); MEXT of Japan; AS ONE Corporation; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Regional Innovative Consortium Project of the Ministry of Economy, Trade and Industry (METI); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AS ONE Corporation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (Life surveyor) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Regional Innovative Consortium Project of the Ministry of Economy, Trade and Industry (METI) and a Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK) from the MEXT of Japan, and funded in part by AS ONE Corporation and the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov E, 2008, P NATL ACAD SCI USA, V105, P17694, DOI 10.1073/pnas.0809851105; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Brachmann CB, 1998, YEAST, V14, P115; BURGUS R, 1973, P NATL ACAD SCI USA, V70, P684, DOI 10.1073/pnas.70.3.684; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Fukuda N, 2011, ANAL BIOCHEM, V417, P182, DOI 10.1016/j.ab.2011.06.006; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Ishii J, 2006, BIOTECHNOL PROGR, V22, P954, DOI 10.1021/bp0601387; Ishii J, 2010, FEBS J, V277, P1982, DOI 10.1111/j.1742-4658.2010.07625.x; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Leberer E, 1997, CURR OPIN GENET DEV, V7, P59, DOI 10.1016/S0959-437X(97)80110-4; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Matsumoto T, 2002, APPL ENVIRON MICROB, V68, P4517, DOI 10.1128/AEM.68.9.4517-4522.2002; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Murai T, 1997, APPL MICROBIOL BIOT, V48, P499, DOI 10.1007/s002530051086; Nakamura Y, 2001, APPL MICROBIOL BIOT, V57, P500; NAKAYAMA N, 1987, EMBO J, V6, P249, DOI 10.1002/j.1460-2075.1987.tb04746.x; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ryo S, 2012, ANAL BIOCHEM, V424, P27, DOI 10.1016/j.ab.2012.02.005; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Shibasaki S, 2009, ANAL SCI, V25, P41, DOI 10.2116/analsci.25.41; Tanino T, 2004, J MOL CATAL B-ENZYM, V28, P259, DOI 10.1016/j.molcatb.2003.12.028; Togawa S, 2010, J BIOCHEM, V147, P867, DOI 10.1093/jb/mvq022; Ueda M, 2000, BIOTECHNOL ADV, V18, P121, DOI 10.1016/S0734-9750(00)00031-8; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	36	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37136	10.1371/journal.pone.0037136	http://dx.doi.org/10.1371/journal.pone.0037136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623985	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500062
J	Pawar, SD; Tandale, BV; Raut, CG; Parkhi, SS; Barde, TD; Gurav, YK; Kode, SS; Mishra, AC				Pawar, Shailesh D.; Tandale, Babasaheb V.; Raut, Chandrashekhar G.; Parkhi, Saurabh S.; Barde, Tanaji D.; Gurav, Yogesh K.; Kode, Sadhana S.; Mishra, Akhilesh C.			Avian Influenza H9N2 Seroprevalence among Poultry Workers in Pune, India, 2010	PLOS ONE			English	Article							A H5N1 VIRUS; HUMAN INFECTION; HONG-KONG; TRANSMISSION; ANTIBODIES; CHINA	Avian influenza (AI) H9N2 has been reported from poultry in India. A seroepidemiological study was undertaken among poultry workers to understand the prevalence of antibodies against AI H9N2 in Pune, Maharashtra, India. A total of 338 poultry workers were sampled. Serum samples were tested for presence of antibodies against AI H9N2 virus by hemagglutination inhibition (HI) and microneutralization (MN) assays. A total of 249 baseline sera from general population from Pune were tested for antibodies against AI H9N2 and were negative by HI assay using >= 40 cut-off antibody titre. Overall 21 subjects (21/338 = 6.2%) were positive for antibodies against AI H9N2 by either HI or MN assays using >= 40 cut-off antibody titre. A total of 4.7% and 3.8% poultry workers were positive for antibodies against AI H9N2 by HI and MN assay respectively using 40 as cut-off antibody titre. This is the first report of seroprevalence of antibodies against AI H9N2 among poultry workers in India.	[Pawar, Shailesh D.; Tandale, Babasaheb V.; Raut, Chandrashekhar G.; Parkhi, Saurabh S.; Barde, Tanaji D.; Gurav, Yogesh K.; Kode, Sadhana S.; Mishra, Akhilesh C.] Natl Inst Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Pawar, SD (corresponding author), Natl Inst Virol, Microbial Containment Complex, Pune, Maharashtra, India.	acm1750@rediffmail.com	Tandale, Babasaheb Vishwanath/AAT-7336-2021; Tandale, Babasaheb/K-8229-2018	Tandale, Babasaheb Vishwanath/0000-0003-0468-4879; Tandale, Babasaheb/0000-0003-0468-4879	Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	Financial support from the Indian Council of Medical Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; [Anonymous], 2011, FAOAIDE NEWS    0209; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Chen Y, 2011, CLIN MICROBIOL INFEC, V17, P1347, DOI 10.1111/j.1469-0691.2011.03538.x; CIYONG L, 2008, CHIN MED J, V121, P2050; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P5; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Naila Siddique, 2008, International Journal of Poultry Science, V7, P1122; Naing L, SAMPLE SIZE CALCULAT; Pawar SD, 2010, NATL I VIROLOGY ANN; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Riedel Stefan, 2006, Proc (Bayl Univ Med Cent), V19, P16; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Schultsz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007948; Shinde PV, 2012, AVIAN DIS, V56, P257, DOI 10.1637/9878-080511-Case.1; SHORTRIDGE KF, 1982, B WORLD HEALTH ORGAN, V60, P129; Tosh C, 2008, ARCH VIROL, V153, P1433, DOI 10.1007/s00705-008-0131-9; Uyeki TM, 2002, EMERG INFECT DIS, V8, P154, DOI 10.3201/eid0802.010148; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; WHO, 2002, 270 WHOCDSCSRNCS2002, V270	29	57	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36374	10.1371/journal.pone.0036374	http://dx.doi.org/10.1371/journal.pone.0036374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623954	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500014
J	Rascalou, G; Pontier, D; Menu, F; Gourbiere, S				Rascalou, Guilhem; Pontier, Dominique; Menu, Frederic; Gourbiere, Sebastien			Emergence and Prevalence of Human Vector-Borne Diseases in Sink Vector Populations	PLOS ONE			English	Article							DOMICILIATED TRIATOMA-DIMIDIATA; NEGLECTED TROPICAL DISEASES; ECOLOGICAL NICHE MODELS; CHAGAS-DISEASE; YUCATAN PENINSULA; CLIMATE-CHANGE; MALARIA TRANSMISSION; TRYPANOSOMA-CRUZI; JAPANESE ENCEPHALITIS; KALA-AZAR	Vector-borne diseases represent a major public health concern in most tropical and subtropical areas, and an emerging threat for more developed countries. Our understanding of the ecology, evolution and control of these diseases relies predominantly on theory and data on pathogen transmission in large self-sustaining 'source' populations of vectors representative of highly endemic areas. However, there are numerous places where environmental conditions are less favourable to vector populations, but where immigration allows them to persist. We built an epidemiological model to investigate the dynamics of six major human vector borne-diseases in such non self-sustaining 'sink' vector populations. The model was parameterized through a review of the literature, and we performed extensive sensitivity analysis to look at the emergence and prevalence of the pathogen that could be encountered in these populations. Despite the low vector abundance in typical sink populations, all six human diseases were able to spread in 15-55% of cases after accidental introduction. The rate of spread was much more strongly influenced by vector longevity, immigration and feeding rates, than by transmission and virulence of the pathogen. Prevalence in humans remained lower than 5% for dengue, leishmaniasis and Japanese encephalitis, but substantially higher for diseases with longer duration of infection; malaria and the American and African trypanosomiasis. Vector-related parameters were again the key factors, although their influence was lower than on pathogen emergence. Our results emphasize the need for ecology and evolution to be thought in the context of metapopulations made of a mosaic of sink and source habitats, and to design vector control program not only targeting areas of high vector density, but working at a larger spatial scale.	[Rascalou, Guilhem; Gourbiere, Sebastien] Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, F-66025 Perpignan, France; [Pontier, Dominique; Menu, Frederic] Univ Lyon 1, UMR CNRS UCBL Lab Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Sussex	Rascalou, G (corresponding author), Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, Via Domitia, F-66025 Perpignan, France.	gourbiere@univ-perp.fr	Gourbière, Sébastien/C-4320-2011; MENU, Frédéric/C-3107-2016	Gourbiere, Sebastien/0000-0002-6701-4795; Pontier, Dominique/0000-0003-4700-3543	EU [253483]; French National Research Agency [ANR-08-MIE-007]	EU(European Commission); French National Research Agency(French National Research Agency (ANR))	This work has been supported by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483, and by the French National Research Agency (grant reference "ANR-08-MIE-007"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000620; Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2010, 1 WHO REP NEGL TROP; [Anonymous], VECT BORN HUM INF EU; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Artzrouni M, 2001, IMA J MATH APPL MED, V18, P99; Artzrouni Marc, 1996, Journal of Biological Systems, V4, P459, DOI 10.1142/S0218339096000314; Baber I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010270; Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Bowman J, 2002, CONSERV ECOL, V6; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Carbajo AE, 2001, TROP MED INT HEALTH, V6, P170, DOI 10.1046/j.1365-3156.2001.00693.x; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Castellon TD, 2006, CONSERV BIOL, V20, P135, DOI 10.1111/j.1523-1739.2006.00332.x; Caswell H., 2006, MATRIX POPULATION MO; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Coelho FC, 2008, CAD SAUDE PUBLICA, V24, P853, DOI 10.1590/S0102-311X2008000400016; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Devillers H, 2008, J THEOR BIOL, V255, P307, DOI 10.1016/j.jtbi.2008.08.023; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Dieckmann U., 2002, ADAPTIVE DYNAMICS IN; Dumonteil E, 2004, AM J TROP MED HYG, V70, P514, DOI 10.4269/ajtmh.2004.70.514; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; Dumonteil E, 2009, J PARASITOL, V95, P469, DOI 10.1645/GE-1712.1; Edelstein-Keshet L., 1998, MATH MODELS BIOL; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2; Ewald PW, 2002, CA ST AD DY, V2, P10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farrell JP, 2002, LEISHMANIA; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Fox JW, 2007, AM NAT, V170, P396, DOI 10.1086/519855; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; GOMES AD, 1986, REV SAUDE PUBL, V20, P280, DOI 10.1590/S0034-89101986000400003; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Gourbiere S, 2002, J THEOR BIOL, V217, P351, DOI 10.1006/jtbi.2002.3033; Gourbiere S, 2008, AM J TROP MED HYG, V78, P133, DOI 10.4269/ajtmh.2008.78.133; GOUTEUX JP, 1993, TROP MED PARASITOL, V44, P213; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000427; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Hanski I., 1999, METAPOPULATION ECOLO; Hargrove JW., 2003, TSETSE ERADICATION S; Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen Gerry F, 2002, Malar J, V1, P8, DOI 10.1186/1475-2875-1-8; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kumar V, 2009, MEM I OSWALDO CRUZ, V104, P1019, DOI 10.1590/S0074-02762009000700014; Lambrechts L, 2009, TROP MED INT HEALTH, V14, P1505, DOI 10.1111/j.1365-3156.2009.02401.x; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Mackenzie JS, 2002, JAPANESE ENCEPHALITI, DOI 10.1007/978-3-642-59403-8; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Menu F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000691; MOLYNEUX DH, 1979, ACTA TROP, V36, P53; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Norman FF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000762; Nouvellet P, 2011, ESTIMATING UNO UNPUB; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Otto SP, 2007, BIOL GUIDE MATH MODE; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Paz-Bailey G, 2002, T ROY SOC TROP MED H, V96, P48, DOI 10.1016/S0035-9203(02)90236-1; Pedrini MRS, 2011, BIOTECHNOL PROGR, V27, P614, DOI 10.1002/btpr.602; Peterson AM, 2011, MALARIA ETIOLOGY PAT; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Pongsumpun P, 2008, TROP MED INT HEALTH, V13, P1180, DOI 10.1111/j.1365-3156.2008.02124.x; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rabinovich JE, 2004, AM J TROP MED HYG, V70, P373, DOI 10.4269/ajtmh.2004.70.373; RAWLINGS P, 1982, B ENTOMOL RES, V72, P139, DOI 10.1017/S0007485300050367; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; ROGERS DJ, 1984, B ENTOMOL RES, V74, P403, DOI 10.1017/S0007485300015674; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rosenthal J, 2009, ECOHEALTH, V6, P489, DOI 10.1007/s10393-010-0314-1; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Ruiz D, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-66; Rutar T, 2004, AM J TROP MED HYG, V70, P15, DOI 10.4269/ajtmh.2004.70.15; Sanchez-Martin MJ, 2006, TROP MED INT HEALTH, V11, P1585, DOI 10.1111/j.1365-3156.2006.01717.x; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Seed JR, 2001, AFRICAN TRYPANOSOMES; Sepulveda AJ, 2011, OECOLOGIA, V166, P1043, DOI 10.1007/s00442-011-1935-y; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Stratton L, 2008, SOC SCI MED, V67, P854, DOI 10.1016/j.socscimed.2008.05.013; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; TAPASWI PK, 1995, ECOL MODEL, V83, P295, DOI 10.1016/0304-3800(94)00102-X; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Telleria J, 2010, ELSEV INSIGHT, P1, DOI 10.1016/B978-0-12-384876-5.00021-6; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Tittler R, 2006, ECOLOGY, V87, P3029, DOI 10.1890/0012-9658(2006)87[3029:EOLSDA]2.0.CO;2; van den Berg H, 2011, CIENC SAUDE COLETIVA, V16, P575, DOI 10.1590/S1413-81232011000200021; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; Varmus H, 2003, SCIENCE, V302, P398, DOI 10.1126/science.1091769; Vazquez-Prokopec GM, 2005, J MED ENTOMOL, V42, P571, DOI 10.1603/0022-2585(2005)042[0571:SPORBT]2.0.CO;2; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO, 2005, WORLD MAL REP; Wolfram Research Inc., 2008, MATH VERS 7 0; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	123	43	45	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36858	10.1371/journal.pone.0036858	http://dx.doi.org/10.1371/journal.pone.0036858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629337	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500032
J	Robertson, HT; Allison, DB				Robertson, Henry T.; Allison, David B.			A Novel Generalized Normal Distribution for Human Longevity and other Negatively Skewed Data	PLOS ONE			English	Article							MORTALITY	Negatively skewed data arise occasionally in statistical practice; perhaps the most familiar example is the distribution of human longevity. Although other generalizations of the normal distribution exist, we demonstrate a new alternative that apparently fits human longevity data better. We propose an alternative approach of a normal distribution whose scale parameter is conditioned on attained age. This approach is consistent with previous findings that longevity conditioned on survival to the modal age behaves like a normal distribution. We derive such a distribution and demonstrate its accuracy in modeling human longevity data from life tables. The new distribution is characterized by 1. An intuitively straightforward genesis; 2. Closed forms for the pdf, cdf, mode, quantile, and hazard functions; and 3. Accessibility to non-statisticians, based on its close relationship to the normal distribution.	[Robertson, Henry T.; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Robertson, HT (corresponding author), Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.	hrobertson@ms.soph.uab.edu		Allison, David/0000-0003-3566-9399	NIH [T32HL079888, T32HL072757, P30DK056336, R01DK076771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757, T32HL079888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, R01DK076771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The opinions expressed are those of the authors and not necessarily those of the National Institutes of Health (NIH) or any other organization with which the authors are affiliated. This research was supported by NIH grants T32HL079888, T32HL072757, P30DK056336, and R01DK076771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias E, 2006, NATL VITAL STAT REPO, V58, P15; Azzalini A, 2005, SCAND J STAT, V32, P159, DOI 10.1111/j.1467-9469.2005.00426.x; Coles S, 2012, VALIDATED LIVING SUP; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Douglas RJ, 2005, METROLOGIA, V42, pL35, DOI 10.1088/0026-1394/42/5/L03; Edwards RD, 2009, BERKELEY ELECT J MAC, V9; FOLKS JL, 1978, J ROY STAT SOC B MET, V40, P263; GEHAN EA, 1973, J AM STAT ASSOC, V68, P848, DOI 10.2307/2284511; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Horiuchi S, 1998, DEMOGRAPHY, V35, P391, DOI 10.2307/3004009; Hougaard, 2000, ANAL MULTIVARIATE SU; Ishwaran H, 2002, J AM STAT ASSOC, V97, P1154, DOI 10.1198/016214502388618951; JUCKETT DA, 1993, MECH AGEING DEV, V69, P1, DOI 10.1016/0047-6374(93)90068-3; Kannisto V, DEMOGRAPHIC RES, V3; Makeham W.M., 1860, J I ACTUAR, V8, P301, DOI DOI 10.1017/S204616580000126X; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Nadarajah S, 2005, J APPL STAT, V32, P685, DOI 10.1080/02664760500079464; National Institute of Standards and Technology, 2011, MEAS SKEWN KURT; Plotnik R., 2013, INTRO PSYCHOL, V10th; Shkolnikov VM, 2011, HUMAN LIFE TABLE DAT; Teasdale TW, 2008, INTELLIGENCE, V36, P121, DOI 10.1016/j.intell.2007.01.007; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224	24	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37025	10.1371/journal.pone.0037025	http://dx.doi.org/10.1371/journal.pone.0037025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623974	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500051
J	Zhang, H; Xu, LL; Zhang, RS; Hui, MQ; Long, ZY; Zhao, XJ; Yao, L				Zhang, Hang; Xu, Lele; Zhang, Rushao; Hui, Mingqi; Long, Zhiying; Zhao, Xiaojie; Yao, Li			Parallel Alterations of Functional Connectivity during Execution and Imagination after Motor Imagery Learning	PLOS ONE			English	Article							BRAIN ACTIVATION; PREMOTOR CORTEX; PARIETAL CORTEX; SCHEMA THEORY; MOVEMENTS; NETWORKS; CIRCUITS; AREAS; FMRI; MODULATION	Background: Neural substrates underlying motor learning have been widely investigated with neuroimaging technologies. Investigations have illustrated the critical regions of motor learning and further revealed parallel alterations of functional activation during imagination and execution after learning. However, little is known about the functional connectivity associated with motor learning, especially motor imagery learning, although benefits from functional connectivity analysis attract more attention to the related explorations. We explored whether motor imagery (MI) and motor execution (ME) shared parallel alterations of functional connectivity after MI learning. Methodology/Principal Findings: Graph theory analysis, which is widely used in functional connectivity exploration, was performed on the functional magnetic resonance imaging (fMRI) data of MI and ME tasks before and after 14 days of consecutive MI learning. The control group had no learning. Two measures, connectivity degree and interregional connectivity, were calculated and further assessed at a statistical level. Two interesting results were obtained: (1) The connectivity degree of the right posterior parietal lobe decreased in both MI and ME tasks after MI learning in the experimental group; (2) The parallel alterations of interregional connectivity related to the right posterior parietal lobe occurred in the supplementary motor area for both tasks. Conclusions/Significance: These computational results may provide the following insights: (1) The establishment of motor schema through MI learning may induce the significant decrease of connectivity degree in the posterior parietal lobe; (2) The decreased interregional connectivity between the supplementary motor area and the right posterior parietal lobe in post-test implicates the dissociation between motor learning and task performing. These findings and explanations further revealed the neural substrates underpinning MI learning and supported that the potential value of MI learning in motor function rehabilitation and motor skill learning deserves more attention and further investigation.	[Zhang, Hang] Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China; [Xu, Lele; Zhang, Rushao; Zhao, Xiaojie; Yao, Li] Beijing Normal Univ, Sch Informat Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Hang; Hui, Mingqi; Long, Zhiying; Yao, Li] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Peking University; Beijing Normal University; Beijing Normal University	Zhang, H (corresponding author), Peking Univ, Dept Biomed Engn, Beijing 100871, Peoples R China.	yaoli0316@gmail.com	Xu, Le/HDN-9623-2022		National Natural Science Foundation of China [60931003, 61075111, 61071178, 90820019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of National Natural Science Foundation of China (grant number 60931003) and National Natural Science Foundation of China (grant numbers 61075111, 61071178 and 90820019), URL:http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Argyelan M, 2008, J NEUROSCI, V28, P10687, DOI 10.1523/JNEUROSCI.2933-08.2008; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Cauda F, 2011, HUM BRAIN MAPP, V32, P1566, DOI 10.1002/hbm.21132; Chafee MV, 2007, CEREB CORTEX, V17, P2914, DOI 10.1093/cercor/bhm017; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Fleming MK, 2010, EXP BRAIN RES, V201, P499, DOI 10.1007/s00221-009-2062-4; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Haslinger B, 2002, COGNITIVE BRAIN RES, V13, P159, DOI 10.1016/S0926-6410(01)00104-5; Hattori N, 2009, J NEUROPHYSIOL, V101, P1267, DOI 10.1152/jn.90249.2008; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hoshi E, 2006, J NEUROPHYSIOL, V95, P3596, DOI 10.1152/jn.01126.2005; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Johansson RS, 2006, PLOS BIOL, V4, P1025, DOI 10.1371/journal.pbio.0040158; Kantak SS, 2012, NEUROREHAB NEURAL RE, V26, P282, DOI 10.1177/1545968311420845; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; Li CSR, 2000, NEUROSCI LETT, V287, P13, DOI 10.1016/S0304-3940(00)01164-2; Lopez L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036107; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Matelli M, 1998, J COMP NEUROL, V402, P327; Ogawa K, 2011, NEUROIMAGE, V56, P728, DOI 10.1016/j.neuroimage.2010.10.043; Parkinson A, 2010, NEUROPSYCHOLOGIA, V48, P3228, DOI 10.1016/j.neuropsychologia.2010.06.039; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Prabhu G, 2007, J PHYSIOL-LONDON, V581, P189, DOI 10.1113/jphysiol.2006.123356; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sakai K, 1998, J NEUROSCI, V18, P1827; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; Schmidt RA, 2003, RES Q EXERCISE SPORT, V74, P366, DOI 10.1080/02701367.2003.10609106; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Soliveri P, 1997, BRAIN, V120, P1325, DOI 10.1093/brain/120.8.1325; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Wenderoth N, 2006, NEUROIMAGE, V31, P264, DOI 10.1016/j.neuroimage.2005.11.033; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zhang H, 2011, BRAIN RES, V1407, P38, DOI 10.1016/j.brainres.2011.06.038	62	20	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36052	10.1371/journal.pone.0036052	http://dx.doi.org/10.1371/journal.pone.0036052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629308	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500009
J	Annoura, T; Makiuchi, T; Sariego, I; Aoki, T; Nara, T				Annoura, Takeshi; Makiuchi, Takashi; Sariego, Idalia; Aoki, Takashi; Nara, Takeshi			SUMOylation of Paraflagellar Rod Protein, PFR1, and Its Stage-Specific Localization in Trypanosoma cruzi	PLOS ONE			English	Article							DIFFERENTIAL ENERGETIC METABOLISM; GENE-PRODUCT; UBIQUITIN; SUMO; DEHYDROGENASE; INHIBITION; SYSTEMS	Background: The flagellate protozoan parasite, Trypanosoma cruzi, is a causative agent of Chagas disease that is transmitted by reduviid bugs to humans. The parasite exists in multiple morphological forms in both vector and host, and cell differentiation in T. cruzi is tightly associated with stage-specific protein synthesis and degradation. However, the specific molecular mechanisms responsible for this coordinated cell differentiation are unclear. Methodology/Principal Findings: The SUMO conjugation system plays an important role in specific protein expression. In T. cruzi, a subset of SUMOlylated protein candidates and the nuclear localization of SUMO have been shown. Here, we examined the biological roles of SUMO in T. cruzi. Site-directed mutagenesis analysis of SUMO consensus motifs within T. cruzi SUMO using a bacterial SUMOylation system revealed that T. cruzi SUMO can polymerize. Indirect fluorescence analysis using T. cruzi SUMO-specific antibody showed the extra-nuclear localization of SUMO on the flagellum of epimastigote and metacyclic and bloodstream trypomastigote stages. In the short-flagellate intracellular amastigote, an extra-nuclear distribution of SUMO is associated with basement of the flagellum and becomes distributed along the flagellum as amastigote transforms into trypomastigote. We examined the flagellar target protein of SUMO and show that a paraflagellar rod protein, PFR1, is SUMOylated. Conclusions: These findings indicate that SUMOylation is associated with flagellar homeostasis throughout the parasite life cycle, which may play an important role in differentiation of T. cruzi.	[Annoura, Takeshi; Makiuchi, Takashi; Sariego, Idalia; Aoki, Takashi; Nara, Takeshi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo 113, Japan	Juntendo University	Annoura, T (corresponding author), Leiden Univ, Med Ctr, Leiden Malaria Res Grp, Dept Parasitol,Ctr Infect Dis, Leiden, Netherlands.	tnara@juntendo.ac.jp	Annoura, Takeshi/AAS-7911-2021		21st Century COE Research [20790327, 18890188, 19590436]; Foundation of Strategic Research Projects in Private Universities [S0991013]; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT)	21st Century COE Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Strategic Research Projects in Private Universities; Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research Nos. 20790327, 18890188 (to T. Annoura) and 19590436 (to T. Nara), by the 21st Century COE Research (to T. Annoura, T. Makiuchi and T. Aoki), and by the Foundation of Strategic Research Projects in Private Universities (S0991013; to T. Nara) from the Ministry of Education, Culture, Sport, Science, and Technology, Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADROHER FJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P252, DOI 10.1016/0003-9861(88)90030-6; ADROHER FJ, 1990, MOL CELL BIOCHEM, V94, P71, DOI 10.1007/BF00223564; Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Annoura T, 2007, BIOCHEM BIOPH RES CO, V358, P253, DOI 10.1016/j.bbrc.2007.04.102; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bayona JC, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.007369-1, 10.1074/mcp.M110.007369]; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; KANEDA Y, 1986, COMP BIOCHEM PHYS B, V83, P533, DOI 10.1016/0305-0491(86)90292-0; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Liao S, EXP CELL RES, V316, P704; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Nakajima-Shimada J, 2000, BBA-GEN SUBJECTS, V1475, P175, DOI 10.1016/S0304-4165(00)00059-3; NakajimaShimada J, 1996, ANTIMICROB AGENTS CH, V40, P2455, DOI 10.1128/AAC.40.11.2455; Obado SO, 2011, NUCLEIC ACIDS RES, V39, P1023, DOI 10.1093/nar/gkq839; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; ROBINSON D, 1991, METHOD ENZYMOL, V196, P285; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Wang Y, 2008, GENETICS, V179, P177, DOI 10.1534/genetics.108.089128; Windecker H, 2008, J MOL BIOL, V376, P221, DOI 10.1016/j.jmb.2007.12.008	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37183	10.1371/journal.pone.0037183	http://dx.doi.org/10.1371/journal.pone.0037183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615934	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200046
J	Carrion, VJ; Arrebola, E; Cazorla, FM; Murillo, J; de Vicente, A				Carrion, Victor J.; Arrebola, Eva; Cazorla, Francisco M.; Murillo, Jesus; de Vicente, Antonio			The mbo Operon Is Specific and Essential for Biosynthesis of Mangotoxin in Pseudomonas syringae	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-CLUSTER; PV. SYRINGAE; PHYTOTOXIN CORONATINE; BETA-LACTAM; FUNCTIONAL-CHARACTERIZATION; PHASEOLOTOXIN PRODUCTION; GENOME SEQUENCE; PEPTIDE; VIRULENCE	Mangotoxin is an antimetabolite toxin produced by certain Pseudomonas syringae pv. syringae strains. This toxin is an oligopeptide that inhibits ornithine N-acetyl transferase, a key enzyme in the biosynthesis of ornithine and arginine. Previous studies have reported the involvement of the putative nonribosomal peptide synthetase MgoA in virulence and mangotoxin production. In this study, we analyse a new chromosomal region of P. syringae pv. syringae UMAF0158, which contains six coding sequences arranged as an operon (mbo operon). The mbo operon was detected in only mangotoxin-producing strains, and it was shown to be essential for the biosynthesis of this toxin. Mutants in each of the six ORFs of the mbo operon were partially or completely impaired in the production of the toxin. In addition, Pseudomonas spp. mangotoxin non-producer strains transformed with the mbo operon gained the ability to produce mangotoxin, indicating that this operon contains all the genetic information necessary for mangotoxin biosynthesis. The generation of a single transcript for the mbo operon was confirmed and supported by the allocation of a unique promoter and Rho-independent terminator. The phylogenetic analysis of the P. syringae strains harbouring the mbo operon revealed that these strains clustered together.	[Carrion, Victor J.; Cazorla, Francisco M.; de Vicente, Antonio] Univ Malaga, Fac Ciencias, Dept Microbiol, Inst Hortofruticultura Subtrop & Mediterranea La, E-29071 Malaga, Spain; [Arrebola, Eva] Inst Hortofruticultura Subtrop & Mediterranea La, Estn Expt La Mayora, Malaga, Spain; [Murillo, Jesus] Univ Publ Navarra, ETS Ingenieros Agr, Lab Patol Vegetal, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental La Mayora (EELM); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Universidad Publica de Navarra	Carrion, VJ (corresponding author), Univ Malaga, Fac Ciencias, Dept Microbiol, Inst Hortofruticultura Subtrop & Mediterranea La, E-29071 Malaga, Spain.	adevicente@uma.es	Bravo, Victor Carrion/A-9387-2014; Murillo, Jesus/D-2901-2009; Arrebola-Diez, Eva/H-1628-2011; Arrebola, Eva/AGY-5955-2022; Carrion, Victor/GPG-1248-2022; de Vicente, Antonio/G-4405-2011; Cazorla, Francisco M./G-3907-2011	Bravo, Victor Carrion/0000-0002-4093-0355; Murillo, Jesus/0000-0001-6585-2421; Arrebola-Diez, Eva/0000-0002-2308-7829; Arrebola, Eva/0000-0002-2308-7829; de Vicente, Antonio/0000-0003-2716-9861; Cazorla, Francisco M./0000-0003-0798-0964	Regional Government of Andalucia (Spain); CICE - Junta de Andalucia, Ayudas Grupo PAIDI [AGR-169]; Proyecto de Excelencia [P07-AGR-23 02471]; FEDER (EU); Public University of Navarra, Spain; Junta de Andalucia, Spain; CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios; ESF	Regional Government of Andalucia (Spain)(Junta de Andalucia); CICE - Junta de Andalucia, Ayudas Grupo PAIDI(Junta de Andalucia); Proyecto de Excelencia; FEDER (EU)(European Commission); Public University of Navarra, Spain; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios; ESF(European Commission)	This work has been supported through grants from the Regional Government of Andalucia (Spain), grants from CICE - Junta de Andalucia, Ayudas Grupo PAIDI AGR-169 and Proyecto de Excelencia (P07-AGR-23 02471), and co-financed by FEDER (EU). Plan Propio of the University of Malaga funded visitation of VJC to the Public University of Navarra, Spain. VJC was granted with a fellowship from Junta de Andalucia, Spain. EA was supported through grants from the CSIC programme mode JAEDoc - Junta para la Ampliacion de Estudios, and co-financed by ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arai T, 2008, BIOSCIENCE BIOTECHNO, V72; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arrebola E, 2003, PHYSIOL MOL PLANT P, V63, P117, DOI 10.1016/j.pmpp.2003.11.003; Arrebola E, 2007, MOL PLANT MICROBE IN, V20, P500, DOI 10.1094/MPMI-20-5-0500; Arrebola E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-10; Arrebola E, 2011, TOXINS, V3, P1089, DOI 10.3390/toxins3091089; Arrebola E, 2009, INT MICROBIOL, V12, P87, DOI 10.2436/20.1501.01.85; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; BARTA TM, 1992, J BACTERIOL, V174, P3021, DOI 10.1128/JB.174.9.3021-3029.1992; BENDER CL, 1986, J BACTERIOL, V165, P534, DOI 10.1128/jb.165.2.534-541.1986; BENDER CL, 1991, APPL ENVIRON MICROB, V57, P993, DOI 10.1128/AEM.57.4.993-999.1991; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cazorla FM, 1998, PHYTOPATHOLOGY, V88, P614, DOI 10.1094/PHYTO.1998.88.7.614; Cazorla FM, 1997, PSEUDOMONAS SYRINGAE, P82; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dassler T, 2000, MOL MICROBIOL, V36, P1101, DOI 10.1046/j.1365-2958.2000.01924.x; Davinic M, 2009, MICROBIOL-SGM, V155, P2265, DOI 10.1099/mic.0.028373-0; De la Torre-Zavala S, 2011, RES MICROBIOL, V162, P488, DOI 10.1016/j.resmic.2011.04.010; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreira AO, 2006, MOL PLANT MICROBE IN, V19, P1167, DOI 10.1094/MPMI-19-1167; Ferrell E, 2008, MICROBIOL-SGM, V154, P431, DOI 10.1099/mic.0.2007/011577-0; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Fox A, 2008, APPL ENVIRON MICROB, V74, P1902, DOI 10.1128/AEM.02539-07; Franke I, 2003, J BACTERIOL, V185, P1161, DOI 10.1128/JB.185.4.1161-1166.2003; FUKUCHI N, 1992, J CHEM SOC PERK T 1, P1149, DOI 10.1039/p19920001149; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Hutchison ML, 1997, MOL PLANT MICROBE IN, V10, P347, DOI 10.1094/MPMI.1997.10.3.347; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Kennelly MM, 2007, PLANT DIS, V91, P4, DOI 10.1094/PD-91-0004; KING EO, 1954, J LAB CLIN MED, V44, P301; Kinscherf TG, 2005, J ANTIBIOT, V58, P817, DOI 10.1038/ja.2005.109; Konz D, 1999, CHEM BIOL, V6, pR39, DOI 10.1016/S1074-5521(99)80002-7; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685; LO SF, 1994, J BACTERIOL, V176, P460, DOI 10.1128/JB.176.2.460-468.1994; Lu SE, 2002, MOL PLANT MICROBE IN, V15, P43, DOI 10.1094/MPMI.2002.15.1.43; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miller JH., 1972, EXPT MOL GENETICS; MITCHELL RE, 1982, PHYSIOL PLANT PATHOL, V20, P83, DOI 10.1016/0048-4059(82)90026-1; MITCHELL RE, 1983, PHYSIOL PLANT PATHOL, V23, P315, DOI 10.1016/0048-4059(83)90017-6; MITCHELL RE, 1984, ANNU REV PHYTOPATHOL, V22, P215; MITCHELL RE, 1991, EXPERIENTIA, V47, P791, DOI 10.1007/BF01922459; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nowak-Thompson B, 2003, J BACTERIOL, V185, P860, DOI 10.1128/JB.185.3.860-869.2003; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Rodriguez-Palenzuela P, 2010, ENVIRON MICROBIOL, V12, P1604, DOI 10.1111/j.1462-2920.2010.02207.x; ROTH P, 1990, HELV CHIM ACTA, V73, P476, DOI 10.1002/hlca.19900730228; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Sambrook J., 2001, MOL CLONING LAB MANU; Scholz-Schroeder BK, 2003, MOL PLANT MICROBE IN, V16, P271, DOI 10.1094/MPMI.2003.16.4.271; Scholz-Schroeder BK, 2001, MOL PLANT MICROBE IN, V14, P336, DOI 10.1094/MPMI.2001.14.3.336; SEGRE A, 1989, FEBS LETT, V255, P27, DOI 10.1016/0014-5793(89)81054-3; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; Tamura K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/pmpp.2002.0405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; UNKEFER CJ, 1987, J BIOL CHEM, V262, P4994; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; YOUNG SA, 1992, J BACTERIOL, V174, P1837, DOI 10.1128/jb.174.6.1837-1843.1992; Zhang JH, 1997, APPL ENVIRON MICROB, V63, P2771, DOI 10.1128/AEM.63.7.2771-2778.1997; Zhang YX, 1997, MOL PLANT MICROBE IN, V10, P947, DOI 10.1094/MPMI.1997.10.8.947	96	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36709	10.1371/journal.pone.0036709	http://dx.doi.org/10.1371/journal.pone.0036709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615797	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200014
J	Chunta, JL; Vistisen, KS; Yazdi, Z; Braun, RD				Chunta, John L.; Vistisen, Kerry S.; Yazdi, Zeinab; Braun, Rod D.			Uptake Rate of Cationic Mitochondrial Inhibitor MKT-077 Determines Cellular Oxygen Consumption Change in Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; RHODACYANINE MKT-077; ANTITUMOR-ACTIVITY; LIPOPHILIC CATION; IN-VITRO; PHASE-I; MKT 077; TUMORS; RADIATION; TRANSPORT	Objective: Since tumor radiation response is oxygen-dependent, radiosensitivity can be enhanced by increasing tumor oxygenation. Theoretically, inhibiting cellular oxygen consumption is the most efficient way to increase oxygen levels. The cationic, rhodacyanine dye-analog MKT-077 inhibits mitochondrial respiration and could be an effective metabolic inhibitor. However, the relationship between cellular MKT-077 uptake and metabolic inhibition is unknown. We hypothesized that rat and human mammary carcinoma cells would take up MKT-077, causing a decrease in oxygen metabolism related to drug uptake. Methods: R3230Ac rat breast adenocarcinoma cells were exposed to MKT-077. Cellular MKT-077 concentration was quantified using spectroscopy, and oxygen consumption was measured using polarographic electrodes. MKT-077 uptake kinetics were modeled by accounting for uptake due to both the concentration and potential gradients across the plasma and mitochondrial membranes. These kinetic parameters were used to model the relationship between MKT-077 uptake and metabolic inhibition. MKT-077-induced changes in oxygen consumption were also characterized in MDA-MB231 human breast carcinoma cells. Results: Cells took up MKT-077 with a time constant of similar to 1 hr, and modeling showed that over 90% of intracellular MKT-077 was bound or sequestered, likely by the mitochondria. The uptake resulted in a rapid decrease in oxygen consumption, with a time constant of similar to 30 minutes. Surprisingly the change in oxygen consumption was proportional to uptake rate, not cellular concentration. MKT-077 proved a potent metabolic inhibitor, with dose-dependent decreases of 45-73% (p = 0.003). Conclusions: MKT-077 caused an uptake rate-dependent decrease in cellular metabolism, suggesting potential efficacy for increasing tumor oxygen levels and radiosensitivity in vivo.	[Chunta, John L.; Vistisen, Kerry S.; Yazdi, Zeinab; Braun, Rod D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Chunta, John L.; Braun, Rod D.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Chunta, JL (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	jchunta@molecularimaging.com		Yazdi, Zeinab/0000-0003-3533-912X	Department of Defense Breast Cancer Research Program [W81XWH-05-1-0264 (BC043817)]	Department of Defense Breast Cancer Research Program(United States Department of Defense)	This work was supported by the Department of Defense Breast Cancer Research Program W81XWH-05-1-0264 (BC043817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Britten CD, 2000, CLIN CANCER RES, V6, P42; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chiba Y, 1998, ANTICANCER RES, V18, P1047; Chiba Y, 1998, J SURG ONCOL, V69, P105, DOI 10.1002/(SICI)1096-9098(199810)69:2<105::AID-JSO11>3.0.CO;2-0; Chiba Yohei, 1999, International Journal of Clinical Oncology, V4, P65, DOI 10.1007/s101470050028; Crokart N, 2007, CLIN CANCER RES, V13, P630, DOI 10.1158/1078-0432.CCR-06-0802; Deocaris CC, 2007, CANCER LETT, V252, P259, DOI 10.1016/j.canlet.2006.12.038; Emri M, 1998, EUR BIOPHYS J BIOPHY, V28, P78, DOI 10.1007/s002490050186; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstick TK, 1973, ENG PRINCIPLES PHYSL, P257; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; HILF R, 1965, CANCER RES, V25, P286; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Kaul SC, 2001, NEOPLASIA, V3, P110, DOI 10.1038/sj.neo.7900139; Koya K, 1996, CANCER RES, V56, P538; Loetchutinat C, 2003, EUR J BIOCHEM, V270, P476, DOI 10.1046/j.1432-1033.2003.03403.x; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Modica-Napolitano JS, 1998, CANCER RES, V58, P71; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; Naasani I, 1999, CANCER RES, V59, P4004; Nuydens R, 1999, J NEUROSCI METH, V92, P153, DOI 10.1016/S0165-0270(99)00107-7; OKUNIEFF P, 1993, INT J RADIAT ONCOL, V26, P631, DOI 10.1016/0360-3016(93)90280-9; Okunieff P, 1996, BRIT J CANCER, V74, pS185; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; SCHUMACKER PT, 1993, AM J PHYSIOL, V265, pL395, DOI 10.1152/ajplung.1993.265.4.L395; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; SECOMB TW, 1993, INT J RADIAT ONCOL, V25, P481, DOI 10.1016/0360-3016(93)90070-C; Secomb TW, 1998, ADV EXP MED BIOL, V454, P629; Tatsuta N, 1999, CANCER CHEMOTH PHARM, V43, P295, DOI 10.1007/s002800050898; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tikoo A, 2000, CANCER J, V6, P162; Wadhwa R, 2000, CANCER RES, V60, P6818; Weisberg EL, 1996, CANCER RES, V56, P551	37	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37471	10.1371/journal.pone.0037471	http://dx.doi.org/10.1371/journal.pone.0037471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616013	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200078
J	Petit, G; Kornreich, C; Noel, X; Verbanck, P; Campanella, S				Petit, Geraldine; Kornreich, Charles; Noel, Xavier; Verbanck, Paul; Campanella, Salvatore			Alcohol-Related Context Modulates Performance of Social Drinkers in a Visual Go/No-Go Task: A Preliminary Assessment of Event-Related Potentials	PLOS ONE			English	Article							CUE-REACTIVITY; RESPONSE-INHIBITION; ADDICTIVE BEHAVIORS; ATTENTIONAL BIAS; USE DISORDERS; IMPULSIVITY; DRINKING; HEAVY; INDIVIDUALS; ACTIVATION	Background: Increased alcohol cue-reactivity and altered inhibitory processing have been reported in heavy social drinkers and alcohol-dependent patients, and are associated with relapse. In social drinkers, these two processes have been usually studied separately by recording event-related potentials (ERPs) during rapid picture presentation. The aim of our study was to confront social drinkers to a task triggering high alcohol cue-reactivity, to verify whether it specifically altered inhibitory performance, by using long-lasting background picture presentation. Methods: ERP were recorded during visual Go/No-Go tasks performed by social drinkers, in which a frequent Go signal (letter "M''), and a rare No-Go signal (letter "W'') were superimposed on three different types of background pictures: neutral (black background), alcohol-related and non alcohol-related. Results: Our data suggested that heavy social drinkers made more commission errors than light drinkers, but only in the alcohol-related context. Neurophysiologically, this was reflected by a delayed No-Go P3 component. Conclusions: Elevated alcohol cue-reactivity may lead to poorer inhibitory performance in heavy social drinkers, and may be considered as an important vulnerability factor in developing alcohol misuse. Prevention programs should be designed to decrease the high arousal of alcohol stimuli and strengthen cognitive control in young, at-risk individuals.	[Petit, Geraldine; Kornreich, Charles; Noel, Xavier; Verbanck, Paul; Campanella, Salvatore] Free Univ Brussels, Lab Psychol Med, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Petit, G (corresponding author), Free Univ Brussels, Lab Psychol Med, Brussels, Belgium.	salvatore.campanella@chu-brugmann.be		Kornreich, Charles/0000-0002-4898-5588	FNRS	FNRS(Fonds de la Recherche Scientifique - FNRS)	Geraldine Petit is Research Fellow, and Xavier Noel as well as Salvatore Campanella are Research Associates at the Belgian Fund of Scientific Research (FNRS). This study was financially supported by FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Babor T, LEXICON ALCOHOL DRUG; Bartholow BD, 2007, PSYCHOL ADDICT BEHAV, V21, P555, DOI 10.1037/0893-164X.21.4.555; Bartholow BD, 2010, PSYCHOL ADDICT BEHAV, V24, P220, DOI 10.1037/a0017705; Beck A.T., 1987, BECK DEPRESSION INVE; BERTRAND O, 1985, ELECTROEN CLIN NEURO, V62, P462, DOI 10.1016/0168-5597(85)90058-9; Beste C, 2008, NEUROPSYCHOLOGIA, V46, P1290, DOI 10.1016/j.neuropsychologia.2007.12.008; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Carretie L, 2006, EXP BRAIN RES, V174, P630, DOI 10.1007/s00221-006-0510-y; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Cirilli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026699; Cox WM, 1999, DRUG ALCOHOL DEPEN, V55, P85, DOI 10.1016/S0376-8716(98)00186-0; Crego A, 2009, BINGE DRINKING AFFEC; Dawe S, 2004, ADDICT BEHAV, V29, P1389, DOI 10.1016/j.addbeh.2004.06.004; Euser AS, 2012, PSYCHOPHARMACOLOGY, V222, P459, DOI 10.1007/s00213-012-2664-6; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Garland EL, 2012, PSYCHOPHARMACOLOGY, V222, P17, DOI 10.1007/s00213-011-2618-4; GREELEY JD, 1993, J STUD ALCOHOL, V54, P359, DOI 10.15288/jsa.1993.54.359; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Herrmann MJ, 2000, ALCOHOL CLIN EXP RES, V24, P1724, DOI 10.1111/j.1530-0277.2000.tb01974.x; Herrmann MJ, 2001, ALCOHOL ALCOHOLISM, V36, P588, DOI 10.1093/alcalc/36.6.588; KAHLER CW, 1995, ADDICTION, V90, P1025, DOI 10.1046/j.1360-0443.1995.90810252.x; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kamarajan C, 2005, CLIN NEUROPHYSIOL, V116, P1049, DOI 10.1016/j.clinph.2004.12.015; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Korpelainen JT, 2000, ACTA NEUROL SCAND, V101, P202, DOI 10.1034/j.1600-0404.2000.101003202.x; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Maurage P, 2007, CLIN NEUROPHYSIOL, V118, P633, DOI 10.1016/j.clinph.2006.11.007; Maurage P, 2009, J PSYCHIATR NEUROSCI, V34, P111; McKenzie M, 2011, MED J AUSTRALIA, V195, pS27; Mechtcheriakov S, 2007, J NEUROL NEUROSUR PS, V78, P610, DOI 10.1136/jnnp.2006.095869; Miller MA, 2011, DRUG ALCOHOL DEPEN, V117, P184, DOI 10.1016/j.drugalcdep.2011.01.016; Noel X, 2001, ARCH GEN PSYCHIAT, V58, P1152, DOI 10.1001/archpsyc.58.12.1152; Noel X, 2007, PSYCHOPHARMACOLOGY, V192, P291, DOI 10.1007/s00213-006-0695-6; Oddy BW, 2009, INT J PSYCHOPHYSIOL, V72, P323, DOI 10.1016/j.ijpsycho.2009.02.002; Pandey AK, 2012, BIOL PSYCHOL, V89, P170, DOI 10.1016/j.biopsycho.2011.10.009; Papachristou H, 2012, PSYCHOPHARMACOLOGY, V219, P511, DOI 10.1007/s00213-011-2240-5; Petit G, 2012, CLIN NEUROPHYSIOL, V123, P925, DOI 10.1016/j.clinph.2011.10.042; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rugg M., 1995, ELECTROPHYSIOLOGY MI; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shin E, 2010, PSYCHOL ADDICT BEHAV, V24, P508, DOI 10.1037/a0019663; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51; Smolka MN, 2006, PSYCHOPHARMACOLOGY, V184, P577, DOI 10.1007/s00213-005-0080-x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; Thomas SE, 2005, J STUD ALCOHOL, V66, P354, DOI 10.15288/jsa.2005.66.354; Verdejo-Garcia A, 2010, PSYCHOPHARMACOLOGY, V210, P377, DOI 10.1007/s00213-010-1833-8; Vollstadt-Klein S, 2011, BIOL PSYCHIAT, V69, P1060, DOI 10.1016/j.biopsych.2010.12.016; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Whiteside SP, 2003, EXP CLIN PSYCHOPHARM, V11, P210, DOI 10.1037/1064-1297.11.3.210; WHO, 2012, ICD 10 CLASS MENT BE; Wiers RW, 2007, PHARMACOL BIOCHEM BE, V86, P263, DOI 10.1016/j.pbb.2006.09.021; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; YEE CM, 1994, J ABNORM PSYCHOL, V103, P625, DOI 10.1037/0021-843X.103.4.625; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Zhang WH, 2012, BIOL PSYCHOL, V89, P444, DOI 10.1016/j.biopsycho.2011.12.011; Zironi I, 2006, BEHAV BRAIN RES, V167, P150, DOI 10.1016/j.bbr.2005.09.007	61	80	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37466	10.1371/journal.pone.0037466	http://dx.doi.org/10.1371/journal.pone.0037466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22616012	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200077
J	Ruckert, F; Grutzmann, R; Pilarsky, C				Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian			Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas	PLOS ONE			English	Article							NF-KAPPA-B; K-RAS; PANCREATIC-CANCER; MOLECULAR PATHOGENESIS; MOUSE MODEL; MICROENVIRONMENT; PROGRESSION; CELLS; ADENOCARCINOMA; INFLAMMATION	The classical somatic mutation theory (SMT) of carcinogenesis and metastasis postulates that malignant transformation occurs in cells that accumulate a sufficient amount of mutations in the appropriate oncogenes and/or tumor suppressor genes. These mutations result in cell-autonomous activation of the mutated cell and a growth advantage relative to neighboring cells. However, the SMT cannot completely explain many characteristics of carcinomas. Contrary to the cell-centered view of the SMT with respect to carcinogenesis, recent research has revealed evidence that the tumor microenvironment plays a role in carcinogenesis as well. In this review, we present a new model that accommodates the role of the tumor microenvironment in carcinogenesis and complements the classical SMT. Our "feedback'' model emphasizes the role of an altered spatiotemporal communication between epithelial and stromal cells during carcinogenesis: a dysfunctional intracellular signaling in tumorigenic epithelial cells leads to inappropriate cellular responses to stimuli from associated stromal or inflammatory cells. Thus, a positive feedback loop of the information flow between parenchymal and stromal cells results. This constant communication between the stromal cells and the tumor cells causes a perpetually activated state of tumor cells analogous to resonance disaster.	[Rueckert, Felix; Gruetzmann, Robert; Pilarsky, Christian] Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Ruckert, F (corresponding author), Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, Dresden, Germany.	Felix.Rueckert@umm.de		Pilarsky, Christian/0000-0002-7968-3283				Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arvanitakis M, 2004, ENDOSCOPY, V36, P535, DOI 10.1055/s-2004-814401; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bilimoria MM, 2001, ARCH SURG-CHICAGO, V136, P528, DOI 10.1001/archsurg.136.5.528; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; CHO KR, 1992, CANCER, V70, P1727, DOI 10.1002/1097-0142(19920915)70:4+<1727::AID-CNCR2820701613>3.0.CO;2-P; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dergham ST, 1997, INT J PANCREATOL, V21, P127; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Ewing J., 1928, NEOPLASTIC DIS; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fendrich V, 2010, GUT, V59, P630, DOI 10.1136/gut.2009.188961; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Greer JB, 2009, CURR OPIN PHARMACOL, V9, P411, DOI 10.1016/j.coph.2009.06.011; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Gyorffy B, 2010, CURR CANCER DRUG TAR, V10, P858, DOI 10.2174/156800910793357916; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jackson L, 2006, CANC TREAT, V130, P39; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; LEE YTN, 1984, ARCH PATHOL LAB MED, V108, P584; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Magee CJ, 2001, SURG ONCOL, V10, P1, DOI 10.1016/S0960-7404(01)00016-0; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Monti P, 2003, CANCER RES, V63, P7451; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naumov GN, 2002, CANCER RES, V62, P2162; Nowell PC, 2002, SEMIN CANCER BIOL, V12, P261, DOI 10.1016/S1044-579X(02)00012-3; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; PARSONS DF, 1983, TISSUE CELL, V15, P499, DOI 10.1016/0040-8166(83)90001-0; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; RENAN MJ, 1993, MOL CARCINOGEN, V7, P139; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ruckert F, 2011, ESTABLISHMENT PRIMAR; Ruckert F, 2011, J SURG RES; Ruckert F, 2012, J SURG RES, V172, P29, DOI 10.1016/j.jss.2011.04.021; Savagner P, 2009, B ACAD NATL MED, V193, P1992; Savagner P, 2009, B ACAD NAT MED PARIS, V193, P1981, DOI 10.1016/S0001-4079(19)32373-8; Sethi G, 2006, CURR CANC THER REV, V2; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; SHIBATA D, 1990, CANCER RES, V50, P1279; Sonnenschein C, 2011, CANCER RES, V71, P4334, DOI 10.1158/0008-5472.CAN-11-0639; Sporn MB, 2011, NATURE, V471, pS10, DOI 10.1038/471S10a; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Talar-Wojnarowska R, 2006, MED SCI MONITOR, V12, pRA186; TARIN D, 1984, CANCER RES, V44, P3584; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weinberg R A, 1998, ONE RENEGADE CELL CA; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	72	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36719	10.1371/journal.pone.0036719	http://dx.doi.org/10.1371/journal.pone.0036719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615799	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200015
J	Smits, A; Jin, Z; Elsir, T; Pedder, H; Nister, M; Alafuzoff, I; Dimberg, A; Edqvist, PH; Ponten, F; Aronica, E; Birnir, B				Smits, Anja; Jin, Zhe; Elsir, Tamador; Pedder, Hugo; Nister, Monica; Alafuzoff, Irina; Dimberg, Anna; Edqvist, Per-Henrik; Ponten, Fredrik; Aronica, Eleonora; Birnir, Bryndis			GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome	PLOS ONE			English	Article							RECEPTORS; SURVIVAL; CELLS; CLASSIFICATION; PROLIFERATION; PHARMACOLOGY; MANAGEMENT; PROTEINS; STEM	GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in the CNS and is present in high concentrations in presynaptic terminals of neuronal cells. More recently, GABA has been ascribed a more widespread role in the control of cell proliferation during development where low concentrations of extrasynaptic GABA induce a tonic activation of GABA receptors. The GABA-A receptor consists of a ligand-gated chloride channel, formed by five subunits that are selected from 19 different subunit isoforms. The functional and pharmacological properties of the GABA-A channels are dictated by their subunit composition. Here we used qRT-PCR to compare mRNA levels of all 19 GABA-A channel subunits in samples of human glioma (n = 29) and peri-tumoral tissue (n = 5). All subunits except the rho 1 and rho 3 subunit were consistently detected. Lowest mRNA levels were found in glioblastoma compared to gliomas of lower malignancy, except for the theta subunit. The expression and cellular distribution of the alpha 1, gamma 1, rho 2 and theta subunit proteins was investigated by immunohistochemistry on tissue microarrays containing 87 gliomas grade II. We found a strong co-expression of rho 2 and theta subunits in both astrocytomas (r = 0.86, p<0.0001) and oligodendroglial tumors (r = 0.66, p<0.0001). Kaplan-Meier analysis and Cox proportional hazards modeling to estimate the impact of GABA-A channel subunit expression on survival identified the rho 2 subunit (p = 0.043) but not the theta subunit (p = 0.64) as an independent predictor of improved survival in astrocytomas, together with established prognostic factors. Our data give support for the presence of distinct GABA-A channel subtypes in gliomas and provide the first link between specific composition of the A-channel and patient survival.	[Smits, Anja; Elsir, Tamador; Pedder, Hugo] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Jin, Zhe; Birnir, Bryndis] Uppsala Univ, Dept Neurosci Mol Physiol & Neurosci, Uppsala, Sweden; [Elsir, Tamador; Nister, Monica] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden; [Alafuzoff, Irina; Dimberg, Anna; Edqvist, Per-Henrik; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University; University of Amsterdam; Academic Medical Center Amsterdam	Smits, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anja.smits@neuro.uu.se	Pedder, Hugo/AAH-4552-2019; Jin, Zhe/C-5150-2008	Pedder, Hugo/0000-0002-7813-3749; Jin, Zhe/0000-0002-4717-1558; Birnir, Bryndis/0000-0002-1763-0266; Aronica, Eleonora/0000-0002-3542-3770; Dimberg, Anna/0000-0003-4422-9125	Uppsala University; Uppsala University Hospital; Selanders Foundation; Lions Cancer Foundation at the Uppsala University Hospital; King Gustav V Jubilee Fund, Stockholm; Swedish Research Council; Swedish Society for Medical Research; KIKA (Stichting Kinderen Kankervrij)	Uppsala University; Uppsala University Hospital; Selanders Foundation; Lions Cancer Foundation at the Uppsala University Hospital; King Gustav V Jubilee Fund, Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research; KIKA (Stichting Kinderen Kankervrij)	This work has been supported by funds from the Uppsala University (AS, BB), the Uppsala University Hospital (AS), the Selanders Foundation (AS), the Lions Cancer Foundation at the Uppsala University Hospital (AS), the King Gustav V Jubilee Fund, Stockholm (MN, AS), Swedish Research Council (BB), the Swedish Society for Medical Research (ZJ), and the KIKA (Stichting Kinderen Kankervrij) (EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo MC, 2008, PROG NEUROBIOL, V86, P297, DOI 10.1016/j.pneurobio.2008.08.002; Aronica E, 2007, EPILEPSY RES, V74, P33, DOI 10.1016/j.eplepsyres.2006.12.002; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; BUREAU M, 1995, J NEUROCHEM, V65, P2006; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Colombo JA, 2006, BRAIN RES, V1100, P93, DOI 10.1016/j.brainres.2006.04.116; Elsir T, 2011, BRIT J CANCER, V104, P1747, DOI 10.1038/bjc.2011.162; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; JUSSOFIE A, 1994, J NEURAL TRANSM-GEN, V96, P233, DOI 10.1007/BF01294790; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Martinez-Delgado G, 2010, CURR NEUROPHARMACOL, V8, P422, DOI 10.2174/157015910793358141; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Okamoto Y, 2004, ACTA NEUROPATHOL, V108, P49, DOI 10.1007/s00401-004-0861-z; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Paavilainen L, 2008, APPL IMMUNOHISTO M M, V16, P493, DOI 10.1097/PAI.0b013e31817c645e; Pan Y, 2006, CELL MOL NEUROBIOL, V26, P289, DOI 10.1007/s10571-006-9001-8; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Qu MQ, 2009, EPILEPSY RES, V84, P33, DOI 10.1016/j.eplepsyres.2008.12.004; Rosas-Arellano A, 2011, NEUROSCI LETT, V500, P20, DOI 10.1016/j.neulet.2011.05.235; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; SHAW EG, 1989, J NEUROSURG, V70, P853, DOI 10.3171/jns.1989.70.6.0853; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Synowitz M, 2001, EUR J NEUROSCI, V14, P1294, DOI 10.1046/j.0953-816x.2001.01764.x; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P384, DOI 10.1074/mcp.R500009-MCP200; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Yang HJ, 2003, ACTA NEUROCHIR, V145, P1097, DOI 10.1007/s00701-003-0149-4; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009	39	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37041	10.1371/journal.pone.0037041	http://dx.doi.org/10.1371/journal.pone.0037041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615883	Green Published, gold			2022-12-27	WOS:000305341200035
J	van den Driesche, S; Walker, M; McKinnell, C; Scott, HM; Eddie, SL; Mitchell, RT; Seckl, JR; Drake, AJ; Smith, LB; Anderson, RA; Sharpe, RM				van den Driesche, Sander; Walker, Marion; McKinnell, Chris; Scott, Hayley M.; Eddie, Sharon L.; Mitchell, Rod T.; Seckl, Jonathan R.; Drake, Amanda J.; Smith, Lee B.; Anderson, Richard A.; Sharpe, Richard M.			Proposed Role for COUP-TFII in Regulating Fetal Leydig Cell Steroidogenesis, Perturbation of Which Leads to Masculinization Disorders in Rodents	PLOS ONE			English	Article							IN-UTERO EXPOSURE; PROMOTER-TRANSCRIPTION FACTOR; RECEPTORS DETERMINE ACTIVITY; ORPHAN RECEPTORS; GENE-EXPRESSION; DI(N-BUTYL) PHTHALATE; TESTICULAR DYSGENESIS; RAT TESTES; PRENATAL TESTOSTERONE; PROGRAMMING WINDOW	Reproductive disorders that are common/increasing in prevalence in human males may arise because of deficient androgen production/action during a fetal `masculinization programming window'. We identify a potentially important role for Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) in Leydig cell (LC) steroidogenesis that may partly explain this. In rats, fetal LC size and intratesticular testosterone (ITT) increased, similar to 3-fold between e15.5-e21.5 which associated with a progressive decrease in the percentage of LC expressing COUP-TFII. Exposure of fetuses to dibutyl phthalate (DBP), which induces masculinization disorders, dose-dependently prevented the age-related decrease in LC COUP-TFII expression and the normal increases in LC size and ITT. We show that nuclear COUP-TFII expression in fetal rat LC relates inversely to LC expression of steroidogenic factor-1 (SF-1)-dependent genes (StAR, Cyp11a1, Cyp17a1) with overlapping binding sites for SF-1 and COUP-TFII in their promoter regions, but does not affect an SF-1 dependent LC gene (3 beta-HSD) without overlapping sites. We also show that once COUP-TFII expression in LC has switched off, it is re-induced by DBP exposure, coincident with suppression of ITT. Furthermore, other treatments that reduce fetal ITT in rats (dexamethasone, diethylstilbestrol (DES)) also maintain/induce LC nuclear expression of COUP-TFII. In contrast to rats, in mice DBP neither causes persistence of fetal LC COUP-TFII nor reduces ITT, whereas DES-exposure of mice maintains COUPT-FII expression in fetal LC and decreases ITT, as in rats. These findings suggest that lifting of repression by COUP-TFII may be an important mechanism that promotes increased testosterone production by fetal LC to drive masculinization. As we also show an age-related decline in expression of COUP-TFII in human fetal LC, this mechanism may also be functional in humans, and its susceptibility to disruption by environmental chemicals, stress and pregnancy hormones could explain the origin of some human male reproductive disorders.	[van den Driesche, Sander; Walker, Marion; McKinnell, Chris; Scott, Hayley M.; Eddie, Sharon L.; Mitchell, Rod T.; Smith, Lee B.; Anderson, Richard A.; Sharpe, Richard M.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Seckl, Jonathan R.; Drake, Amanda J.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	van den Driesche, S (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	S.vandenDriesche@ed.ac.uk	van den Driesche, Sander/H-7094-2019; Sharpe, Richard M/D-2725-2013; Smith, Lee B/J-4861-2013; Seckl, Jonathan R/C-3555-2013	Sharpe, Richard M/0000-0003-1686-8085; Smith, Lee/0000-0002-4103-3074; Mitchell, Rod/0000-0003-4650-3765; van den Driesche, Sander/0000-0002-8092-6588; Eddie, Sharon/0000-0002-6119-0480	European Union [FP7-ENV-2007-1-212844]; UK Medical Research Council [G33253, G0501904]; MRC [G1100354, G1002033, G1002118, G1100358, G1100357, G0501904] Funding Source: UKRI; Medical Research Council [G0501904, G1002033, G1100357, G1002118, G1100354, G1100358] Funding Source: researchfish	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Grant FP7-ENV-2007-1-212844 from the European Union and Grants G33253 and G0501904 (to AJD) from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; BAKKE M, 1995, ENDOCR RES, V21, P509, DOI 10.3109/07435809509030468; BAKKE M, 1995, MOL ENDOCRINOL, V9, P327, DOI 10.1210/me.9.3.327; Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087; Buholzer CF, 2005, MOL ENDOCRINOL, V19, P65, DOI 10.1210/me.2004-0061; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049; Haavisto T, 2001, MOL CELL ENDOCRINOL, V178, P169, DOI 10.1016/S0303-7207(01)00425-7; Haavisto TE, 2003, REPROD TOXICOL, V17, P593, DOI 10.1016/S0890-6238(03)00103-5; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Lehraiki A, 2009, TOXICOL SCI, V111, P372, DOI 10.1093/toxsci/kfp153; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366; Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; MAJDIC G, 1995, J ENDOCRINOL, V147, P285, DOI 10.1677/joe.0.1470285; Mendiola J, 2011, ENVIRON HEALTH PERSP, V119, P958, DOI 10.1289/ehp.1103421; Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411; Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062; Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285; Sato Y, 2003, J CLIN ENDOCR METAB, V88, P3415, DOI 10.1210/jc.2002-021723; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe RM, 2003, INT J ANDROL, V26, P26, DOI 10.1046/j.1365-2605.2003.00385.x; Shibata H, 2000, ENDOCR RES, V26, P1039, DOI 10.3109/07435800009048636; Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233; Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382; Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; WEHRENBERG U, 1994, P NATL ACAD SCI USA, V91, P1440, DOI 10.1073/pnas.91.4.1440; Weisser J, 2011, MOL CELL ENDOCRINOL, V341, P18, DOI 10.1016/j.mce.2011.03.008; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x; Welsh M, 2009, ENDOCRINOLOGY, V150, P2472, DOI 10.1210/en.2008-0529; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zheng WM, 2010, MOL CELL ENDOCRINOL, V330, P59, DOI 10.1016/j.mce.2010.08.010	48	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37064	10.1371/journal.pone.0037064	http://dx.doi.org/10.1371/journal.pone.0037064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615892	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200040
J	Kittelmann, S; Naylor, GE; Koolaard, JP; Janssen, PH				Kittelmann, Sandra; Naylor, Graham E.; Koolaard, John P.; Janssen, Peter H.			A Proposed Taxonomy of Anaerobic Fungi (Class Neocallimastigomycetes) Suitable for Large-Scale Sequence-Based Community Structure Analysis	PLOS ONE			English	Article							RUMEN FUNGI; GUT FUNGI; RIBOSOMAL ITS1; RUMINAL FUNGI; RNA SEQUENCE; GEN-NOV; DIVERSITY; CATTLE; FERMENTATION; DEGRADATION	Anaerobic fungi are key players in the breakdown of fibrous plant material in the rumen, but not much is known about the composition and stability of fungal communities in ruminants. We analyzed anaerobic fungi in 53 rumen samples from farmed sheep (4 different flocks), cattle, and deer feeding on a variety of diets. Denaturing gradient gel electrophoresis fingerprinting of the internal transcribed spacer 1 (ITS1) region of the rrn operon revealed a high diversity of anaerobic fungal phylotypes across all samples. Clone libraries of the ITS1 region were constructed from DNA from 11 rumen samples that had distinctly different fungal communities. A total of 417 new sequences were generated to expand the number and diversity of ITS1 sequences available. Major phylogenetic groups of anaerobic fungi in New Zealand ruminants belonged to the genera Piromyces, Neocallimastix, Caecomyces and Orpinomyces. In addition, sequences forming four novel clades were obtained, which may represent so far undetected genera or species of anaerobic fungi. We propose a revised phylogeny and pragmatic taxonomy for anaerobic fungi, which was tested and proved suitable for analysis of datasets stemming from high-throughput next-generation sequencing methods. Comparing our revised taxonomy to the taxonomic assignment of sequences deposited in the GenBank database, we believe that >29% of ITS1 sequences derived from anaerobic fungal isolates or clones are misnamed at the genus level.	[Kittelmann, Sandra; Naylor, Graham E.; Koolaard, John P.; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	AgResearch - New Zealand	Kittelmann, S (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.	peter.janssen@agresearch.co.nz		Kittelmann, Sandra/0000-0002-6019-9854; Janssen, Peter/0000-0002-1022-3502	Pastoral Greenhouse Gas Research Consortium (PGgRc)	Pastoral Greenhouse Gas Research Consortium (PGgRc)	The authors have read the journal's policy and have the following conflicts. The authors' institution, AgResearch Ltd., is a Crown Research Institute, and is funded by the Pastoral Greenhouse Gas Research Consortium (PGgRc) to develop means of mitigating ruminant methane emissions. PGgRc's members are AgResearch, Fonterra, Fert Research, PGG Wrightson, DairyNZ, Deer Research, Beef+Lamb New Zealand, Landcorp, NIWA, the Ministry of Agriculture and Forestry, and the Ministry of Science and Innovation (formerly Foundation for Research, Science and Technology). The publication of the data reported here is at the discretion of the PGgRc. The PGgRc did not control which data were presented or how these data were interpreted within this paper. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AKIN DE, 1990, J DAIRY SCI, V73, P3023, DOI 10.3168/jds.S0022-0302(90)78989-8; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BARR DJS, 1989, CAN J BOT, V67, P2815, DOI 10.1139/b89-361; BAUCHOP T, 1989, BIOSYSTEMS, V23, P53, DOI 10.1016/0303-2647(89)90008-7; BAUCHOP T, 1981, APPL ENVIRON MICROB, V42, P1103, DOI 10.1128/AEM.42.6.1103-1110.1981; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brookman JL, 2000, MICROBIOL-SGM, V146, P393, DOI 10.1099/00221287-146-2-393; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YC, 2007, MYCOLOGIA, V99, P125, DOI 10.3852/mycologia.99.1.125; Denman SE, 2008, LETT APPL MICROBIOL, V47, P492, DOI 10.1111/j.1472-765X.2008.02449.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Dollhopf SL, 2001, MICROB ECOL, V42, P495, DOI 10.1007/s00248-001-0027-7; DORE J, 1991, CAN J BOT, V69, P1964, DOI 10.1139/b91-246; Edwards JE, 2008, FEMS MICROBIOL ECOL, V66, P537, DOI 10.1111/j.1574-6941.2008.00563.x; ELLIOTT R, 1987, J AGR SCI, V109, P13, DOI 10.1017/S0021859600080928; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fliegerova K, 2004, FOLIA MICROBIOL, V49, P157, DOI 10.1007/BF02931392; Fliegerova K, 2010, FOLIA MICROBIOL, V55, P319, DOI 10.1007/s12223-010-0049-y; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; GOLD JJ, 1988, BIOSYSTEMS, V21, P403, DOI 10.1016/0303-2647(88)90039-1; Griffith GW, 2010, IMA FUNGUS, V1, P181, DOI 10.5598/imafungus.2010.01.02.11; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hausner G, 2000, CAN J BOT, V78, P917, DOI 10.1139/cjb-78-7-917; HEATH IB, 1983, CAN J BOT, V61, P295, DOI 10.1139/b83-033; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; HO YW, 1995, MYCOLOGIA, V87, P655, DOI 10.2307/3760810; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Janse I, 2004, J MICROBIOL METH, V57, P279, DOI 10.1016/j.mimet.2003.12.006; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; Joblin KN, 2002, CURR MICROBIOL, V45, P46, DOI 10.1007/s00284-001-0078-5; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kittelmann S, 2011, FEMS MICROBIOL ECOL, V75, P468, DOI 10.1111/j.1574-6941.2010.01022.x; LI JL, 1992, CAN J BOT, V70, P1738, DOI 10.1139/b92-215; Li XL, 1997, APPL ENVIRON MICROB, V63, P628, DOI 10.1128/AEM.63.2.628-635.1997; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Matsui H, 2008, CURR MICROBIOL, V57, P615, DOI 10.1007/s00284-008-9252-3; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nicholson MJ, 2010, ANAEROBE, V16, P66, DOI 10.1016/j.anaerobe.2009.05.003; Orpin CG., 1994, ANAEROBIC FUNGI, P1; Ozkose E, 2001, CAN J BOT, V79, P666, DOI 10.1139/cjb-79-6-666; Ramirez-Restrepo CA, 2010, ANIM FEED SCI TECH, V155, P33, DOI 10.1016/j.anifeedsci.2009.10.003; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sehgal JP, 2008, J ANIM FEED SCI, V17, P510, DOI 10.22358/jafs/66678/2008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Sundset M, 2009, MICROB ECOL, V57, P335, DOI 10.1007/s00248-008-9414-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEUNISSEN MJ, 1993, ANTON LEEUW INT J G, V63, P63, DOI 10.1007/BF00871733; TRINCI APJ, 1994, MYCOL RES, V98, P129, DOI 10.1016/S0953-7562(09)80178-0; Tripathi VK, 2007, ARCH ANIM NUTR, V61, P416, DOI 10.1080/17450390701556759; Tuckwell DS, 2005, MICROBIOL-SGM, V151, P1557, DOI 10.1099/mic.0.27689-0; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WUBAH DA, 1993, CRIT REV MICROBIOL, V19, P99, DOI 10.3109/10408419309113525	60	68	79	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36866	10.1371/journal.pone.0036866	http://dx.doi.org/10.1371/journal.pone.0036866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615827	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300034
J	Chang, Y; Ryu, S; Zhang, YY; Son, HJ; Kim, JY; Cho, J; Guallar, E				Chang, Yoosoo; Ryu, Seungho; Zhang, Yiyi; Son, Hee Jung; Kim, Jang-Young; Cho, Juhee; Guallar, Eliseo			A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers	PLOS ONE			English	Article							HEME OXYGENASE SYSTEM; FASTING HYPERBILIRUBINEMIA; BILIVERDIN REDUCTASE; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; HEPATIC STEATOSIS; ACIDS; PLASMA; LIPOPROTEINS; ANTIOXIDANT	Background: Serum bilirubin may have potent antioxidant and cytoprotective effects. Serum bilirubin levels are inversely associated with several cardiovascular and metabolic endpoints, but their association with nonalcoholic fatty liver disease (NAFLD) has not been investigated except for a single cross-sectional study in a pediatric population. We assessed the prospective association between serum bilirubin concentrations (total, direct, and indirect) and the risk for NAFLD. Methods and Findings: We performed a cohort study in 5,900 Korean men, 30 to 59 years of age, with no evidence of liver disease and no major risk factors for liver disease at baseline. Study participants were followed in annual or biennial health examinations between 2002 and 2009. The presence of fatty liver was determined at each visit by ultrasonography. We observed 1,938 incident cases of NAFLD during 28,101.8 person-years of follow-up. Increasing levels of serum direct bilirubin were progressively associated with a decreasing incidence of NAFLD. In age-adjusted models, the hazard ratio for NAFLD comparing the highest to the lowest quartile of serum direct bilirubin levels was 0.61 (95% CI 0.54-0.68). The association persisted after adjusting for multiple metabolic parameters (hazard ratio comparing the highest to the lowest quartile 0.86, 95% CI 0.76-0.98; P trend = 0.039). Neither serum total nor indirect bilirubin levels were significantly associated with the incidence of NAFLD. Conclusions: In this large prospective study, higher serum direct bilirubin levels were significantly associated with a lower risk of developing NAFLD, even adjusting for a variety of metabolic parameters. Further research is needed to elucidate the mechanisms underlying this association and to establish the role of serum direct bilirubin as a marker for NAFLD risk.	[Chang, Yoosoo; Ryu, Seungho] Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea; [Chang, Yoosoo; Zhang, Yiyi; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Chang, Yoosoo; Ryu, Seungho] Kangbuk Samsung Hosp, Hlth Screening Ctr, Seoul, South Korea; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Jang-Young] Yonsei Univ, Wonju Coll Med, Dept Cardiol, Wonju, South Korea; [Kim, Jang-Young] Yonsei Univ, Inst Genom Cohort, Wonju, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Comprehens Canc Ctr, Seoul, South Korea; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Area Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Chang, Y (corresponding author), Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea.	eguallar@jhsph.edu	Cho, Juhee/ABD-2280-2021; Guallar, Eliseo/D-3807-2014; zhang, yiyi/J-2592-2012	Guallar, Eliseo/0000-0002-4471-9565; Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646				Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bellentani S, 2008, J HEPATOL, V48, pS338, DOI 10.1016/j.jhep.2008.05.003; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Chitturi S, 2011, J GASTROEN HEPATOL, V26, P163, DOI 10.1111/j.1440-1746.2010.06548.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COWAN RE, 1977, CLIN SCI MOL MED, V53, P155, DOI 10.1042/cs0530155; COWAN RE, 1981, POSTGRAD MED J, V57, P9, DOI 10.1136/pgmj.57.663.9; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; FREI B, 1991, BIOCHEM J, V277, P133, DOI 10.1042/bj2770133; Gullu H, 2005, ARTERIOSCL THROM VAS, V25, P2289, DOI 10.1161/01.ATV.0000185806.61430.7c; Hernaez R, 2011, HEPATOLOGY; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Lin YC, 2009, PEDIATRICS, V124, pE1221, DOI 10.1542/peds.2008-3087; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Narasimhan S, 2010, CLIN BIOCHEM, V43, P815, DOI 10.1016/j.clinbiochem.2010.04.003; NAYLOR JM, 1980, P SOC EXP BIOL MED, V165, P86, DOI 10.3181/00379727-165-40938; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Ndisang JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE829, DOI 10.1152/ajpendo.90783.2008; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; ODIEVRE M, 1975, BIOL GASTRO-ENTEROL, V8, P93; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Salamone F, 2010, J HEPATOL, V53, P1146, DOI 10.1016/j.jhep.2010.06.013; SCHACHTER D, 1957, SCIENCE, V126, P507, DOI 10.1126/science.126.3272.507-a; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Sedlak TW, 2004, PEDIATRICS, V113, P1776, DOI 10.1542/peds.113.6.1776; SHEPHERD RE, 1979, AM J PHYSIOL, V237, pE504, DOI 10.1152/ajpendo.1979.237.6.E504; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tanaka M, 2009, ATHEROSCLEROSIS, V206, P287, DOI 10.1016/j.atherosclerosis.2009.02.010; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Vitek L, 2005, PEDIATRICS, V115, P1411, DOI 10.1542/peds.2004-1796; Vitek L, 2007, ADV CLIN CHEM, V43, P1, DOI 10.1016/S0065-2423(06)43001-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WU TW, 1991, BIOCHEM CELL BIOL, V69, P683, DOI 10.1139/o91-102; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x	53	26	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37241	10.1371/journal.pone.0037241	http://dx.doi.org/10.1371/journal.pone.0037241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615952	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300084
J	Chen, YJ; Kuo, CD; Chen, SH; Chen, WJ; Huang, WC; Chao, KSC; Liao, HF				Chen, Yu-Jen; Kuo, Cheng-Deng; Chen, Szu-Han; Chen, Wei-Jen; Huang, Wen-Chien; Chao, K. S. Clifford; Liao, Hui-Fen			Small-Molecule Synthetic Compound Norcantharidin Reverses Multi-Drug Resistance by Regulating Sonic Hedgehog Signaling in Human Breast Cancer Cells	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; IN-VITRO RESISTANCE; PATHWAY; GROWTH; METASTASIS; ACTIVATION; PHENOTYPE; PROTEIN	Multi-drug resistance (MDR), an unfavorable factor compromising treatment efficacy of anticancer drugs, involves upregulated ATP binding cassette (ABC) transporters and activated Sonic hedgehog (Shh) signaling. By preparing human breast cancer MCF-7 cells resistant to doxorubicin (DOX), we examined the effect and mechanism of norcantharidin (NCTD), a small-molecule synthetic compound, on reversing multidrug resistance. The DOX-prepared MCF-7R cells also possessed resistance to vinorelbine, characteristic of MDR. At suboptimal concentration, NCTD significantly inhibited the viability of DOX-sensitive (MCF-7S) and DOX-resistant (MCF-7R) cells and reversed the resistance to DOX and vinorelbine. NCTD increased the intracellular accumulation of DOX in MCF-7R cells and suppressed the upregulated the mdr-1 mRNA, P-gp and BCRP protein expression, but not the MRP-1. The role of P-gp was strengthened by partial reversal of the DOX and vinorelbine resistance by cyclosporine A. NCTD treatment suppressed the upregulation of Shh expression and nuclear translocation of Gli-1, a hallmark of Shh signaling activation in the resistant clone. Furthermore, the Shh ligand upregulated the expression of P-gp and attenuated the growth inhibitory effect of NCTD. The knockdown of mdr-1 mRNA had not altered the expression of Shh and Smoothened in both MCF-7S and MCF-7R cells. This indicates that the role of Shh signaling in MDR might be upstream to mdr-1/P-gp, and similar effect was shown in breast cancer MDA-MB-231 and BT-474 cells. This study demonstrated that NCTD may overcome multidrug resistance through inhibiting Shh signaling and expression of its downstream mdr-1/P-gp expression in human breast cancer cells.	[Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Chen, Yu-Jen; Liao, Hui-Fen] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan; [Kuo, Cheng-Deng; Liao, Hui-Fen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Szu-Han; Chen, Wei-Jen; Liao, Hui-Fen] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Huang, Wen-Chien] Mackay Mem Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Chao, K. S. Clifford] Columbia Univ, Dept Radiat Oncol, New York, NY USA	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chiayi University; Mackay Memorial Hospital; Columbia University	Chen, YJ (corresponding author), Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan.	liaohf@seed.net.tw	Kuo, Cheng-Deng/AAP-7010-2021	Kuo, Cheng-Deng/0000-0002-3989-1950	Taipei Veterans General Hospital [V97E2-005]; National Science Council of the Republic of China, Taipei, Taiwan [NSC99-2313-B-415-002-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council of the Republic of China, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (V97E2-005) from Taipei Veterans General Hospital and a grant (NSC99-2313-B-415-002-MY3) from the National Science Council of the Republic of China, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Carpenter RL, 2012, DISCOV MED, V13, P105; Chen YJ, 2005, ANTI-CANCER DRUG, V16, P293, DOI 10.1097/00001813-200503000-00008; Chen YJ, 2009, J CLIN ONCOL SOC, V25, P81; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Chen YJ, 2007, CELL CYCLE, V6, P1826, DOI 10.4161/cc.6.15.4545; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Faneyte IF, 2002, CLIN CANCER RES, V8, P1068; Feng YZ, 2007, CLIN CANCER RES, V13, P1389, DOI 10.1158/1078-0432.CCR-06-1407; Gupta Sachin, 2010, Ther Adv Med Oncol, V2, P237, DOI 10.1177/1758834010366430; Hines SJ, 1999, BREAST CANCER RES TR, V58, P1, DOI 10.1023/A:1006272527435; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Joshi M, 2011, INDIAN J PATHOL MICR, V54, P671, DOI 10.4103/0377-4929.91490; Legrand O, 1999, BLOOD, V94, P1046, DOI 10.1182/blood.V94.3.1046.415k03_1046_1056; Li Y, 2012, HISTOL HISTOPATHOL, V27, P475, DOI 10.14670/HH-27.475; Liao HF, 2007, FOOD CHEM TOXICOL, V45, P1678, DOI 10.1016/j.fct.2007.03.003; Lorusso Vito, 2012, Front Biosci (Schol Ed), V4, P31; McCluskey A, 2001, BIOORG MED CHEM LETT, V11, P2941, DOI 10.1016/S0960-894X(01)00594-7; Mechetner E, 1998, CLIN CANCER RES, V4, P389; PATEL NH, 1994, INVEST NEW DRUG, V12, P1, DOI 10.1007/BF00873229; Ray A, 2007, INT J ONCOL, V30, P1499; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Takeshita H, 2000, J BONE JOINT SURG AM, V82A, P963, DOI 10.2106/00004623-200007000-00008; Vasconcelos FC, 2007, LEUKEMIA RES, V31, P445, DOI 10.1016/j.leukres.2006.07.016; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Weigel MT, 2009, CANCER LETT, V273, P70, DOI 10.1016/j.canlet.2008.07.040; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Zheng LH, 2008, CANCER LETT, V272, P102, DOI 10.1016/j.canlet.2008.06.029	32	29	32	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37006	10.1371/journal.pone.0037006	http://dx.doi.org/10.1371/journal.pone.0037006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615870	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300061
J	Liu, XL; Zhao, ZD; Li, Z; Xu, CF; Sun, L; Chen, JL; Liu, WJ				Liu, Xiaoling; Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun			Cyclosporin A Inhibits the Influenza Virus Replication through Cyclophilin A-Dependent and -Independent Pathways	PLOS ONE			English	Article							IN-VITRO; RNA-POLYMERASE; MESSENGER-RNA; HUMAN-CELLS; PROTEIN; TYPE-1; QUANTIFICATION; IDENTIFICATION; INFECTIVITY; MACROPHAGES	The immunosuppressive drug cyclosporin A (CsA) has inhibitory effects on the replication of several viruses. The antiviral effects are through targeting the interaction between viral proteins and host factor cyclophilin A (CypA). CypA has been identified to interact with influenza A virus M1 protein and impair the early stage of the viral life cycle. In order to identify the effect of CsA on influenza virus replication, a CypA-depleted 293T cell line, which was named as 293T/CypA2, was constructed. The cytopathic effect (CPE) assay and the growth curve results indicated that CsA specifically suppressed the influenza A virus replication in a dose-dependent manner. CsA treatment had no effect on the viral genome replication and transcription but selectively suppressed the viral proteins expression. Further studies indicated that CsA could impair the nuclear export of viral mRNA in the absence of CypA. In addition, the antiviral activity of CsA was independent of calcineurin signaling. Finally, CsA could enhance the binding between CypA and M1. The above results suggested that CsA inhibited the replication of influenza A virus through CypA-dependent and -independent pathways.	[Liu, Xiaoling; Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Zhao, Zhendong; Li, Zheng; Xu, Chongfeng; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, XL (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; SUN, LEI/B-3288-2018; Chen, Ji-Long/AAJ-2134-2021	SUN, LEI/0000-0003-0141-2093; Chen, Ji-Long/0000-0002-4274-0563	National Natural Science Foundation of China [81101253]; National Basic Research Program of China [2011CB504705, 2012CB518900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81101253), the National Basic Research Program of China (www.973.gov.cn, Grant Nos. 2011CB504705, 2012CB518900). Wenjun Liu is the principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJ, 2007, TRAFFIC, V8, P1, DOI 10.1111/j.1600-0854.2006.00507.x; BRACK C, 1984, EXP CELL RES, V151, P314, DOI 10.1016/0014-4827(84)90382-3; Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Coley W, 2009, EXPERT OPIN BIOL TH, V9, P1369, DOI 10.1517/14712590903257781; DAMASO CRA, 1994, ARCH VIROL, V134, P303, DOI 10.1007/BF01310569; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fernandes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009815; Firpi RJ, 2006, LIVER TRANSPLANT, V12, P51, DOI 10.1002/lt.20532; Franke EK, 1996, VIROLOGY, V222, P279, DOI 10.1006/viro.1996.0421; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031063; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SCHILTKNECHT E, 1985, CELL IMMUNOL, V91, P227, DOI 10.1016/0008-8749(85)90046-2; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Sokolskaja E, 2010, J VIROL, V84, P4851, DOI 10.1128/JVI.01699-09; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; VAHLNE A, 1992, ARCH VIROL, V122, P61, DOI 10.1007/BF01321118; WAINBERG MA, 1988, BLOOD, V72, P1904; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014	34	39	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37277	10.1371/journal.pone.0037277	http://dx.doi.org/10.1371/journal.pone.0037277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615963	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300089
J	Wei, HE; Dobkin, C; Sheikh, AM; Malik, M; Brown, WT; Li, XH				Wei, Hongen; Dobkin, Carl; Sheikh, Ashfaq M.; Malik, Mazhar; Brown, W. Ted; Li, Xiaohong			The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; FMR1 KNOCKOUT MICE; SPECTRUM DISORDERS; NEURONAL MIGRATION; ALZHEIMERS-DISEASE; APP23 MODEL; RECEPTOR; CORTEX; BRAIN	Although the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism. Memantine is an uncompetitive antagonist of NMDA receptors and is widely prescribed for treatment of Alzheimer's disease treatment. Recently, it has been shown to improve language function, social behavior, and self-stimulatory behaviors of some autistic subjects. However the mechanism by which memantine exerts its effect remains to be elucidated. In this study, we used cultured cerebellar granule cells (CGCs) from Fmr1 knockout (KO) mice, a mouse model for fragile X syndrome (FXS) and syndromic autism, to examine the effects of memantine on dendritic spine development and synapse formation. Our results show that the maturation of dendritic spines is delayed in Fmr1-KO CGCs. We also detected reduced excitatory synapse formation in Fmr1-KO CGCs. Memantine treatment of Fmr1-KO CGCs promoted cell adhesion properties. Memantine also stimulated the development of mushroom-shaped mature dendritic spines and restored dendritic spine to normal levels in Fmr1-KO CGCs. Furthermore, we demonstrated that memantine treatment promoted synapse formation and restored the excitatory synapses to a normal range in Fmr1-KO CGCs. These findings suggest that memantine may exert its therapeutic capacity through a stimulatory effect on dendritic spine maturation and excitatory synapse formation, as well as promoting adhesion of CGCs.	[Wei, Hongen; Sheikh, Ashfaq M.; Malik, Mazhar; Li, Xiaohong] New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY USA; [Dobkin, Carl; Brown, W. Ted] New York State Inst Basic Res Dev Disabil, Dept Human Genet, New York, NY USA; [Wei, Hongen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Shanghai Jiao Tong University	Wei, HE (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, New York, NY USA.	xiaohongli99@gmail.com	Wei, Hongen/GWN-2577-2022; Cabrera, Mariel/GMX-2706-2022; Brown, William/GXN-2777-2022		NYS Office for People with Developmental Disabilities; Rural India Charitable Trust; Northfield Bank Foundation	NYS Office for People with Developmental Disabilities; Rural India Charitable Trust; Northfield Bank Foundation	This work was supported by the NYS Office for People with Developmental Disabilities, the Rural India Charitable Trust, and Northfield Bank Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; BAKKER CE, 1994, CELL, V78, P23; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Blanchard AP, 2008, CELL PHYSIOL BIOCHEM, V22, P205, DOI 10.1159/000149798; Bobee S, 2000, BEHAV BRAIN RES, V112, P107, DOI 10.1016/S0166-4328(00)00166-2; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Buxbaum JD, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-6; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chez MG, 2004, EPILEPSIA, V45, P152; Chez MG, 2004, J CHILD NEUROL, V19, P165; Chez MG, 2003, J PEDIAT NEUROL, V1, P83; Chez MG, 2004, ANN NEUROL S, V56, P109; Chez MG, 2007, J CHILD NEUROL, V22, P574, DOI 10.1177/0883073807302611; Contestabile A., 2002, CEREBELLUM, V1, P41; Deng J, 2009, OPEN NEUROSCI J, V3, P148; Desai NS, 2006, J NEUROPHYSIOL, V96, P1734, DOI 10.1152/jn.00221.2006; Devlin B, 2011, BRAIN RES, V1380, P78, DOI 10.1016/j.brainres.2010.11.026; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; El Idrissi A, 1999, J NEUROSCI, V19, P9459; ERDO SL, 1991, EUR J PHARMACOL, V198, P215, DOI 10.1016/0014-2999(91)90625-Z; Erickson CA, 2009, J AUTISM DEV DISORD, V39, P1629, DOI 10.1007/s10803-009-0807-3; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Hardan AY, 2002, J CHILD ADOL PSYCHOP, V12, P237, DOI 10.1089/104454602760386923; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hering H, 2003, J NEUROSCI, V23, P3262; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; KORNHUBER J, 1989, EUR J PHARMACOL, V166, P589, DOI 10.1016/0014-2999(89)90384-1; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Maekawa M, 2009, NEUROSCI RES, V63, P259, DOI 10.1016/j.neures.2008.12.006; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Matsuo N, 2008, SCIENCE, V319, P1104, DOI 10.1126/science.1149967; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; Michelsen KA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-107; Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027; Namba T, 2010, NEUROSCIENCE, V167, P372, DOI 10.1016/j.neuroscience.2010.01.033; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Perry EK, 2001, AM J PSYCHIAT, V158, P1058, DOI 10.1176/appi.ajp.158.7.1058; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017073; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Van Dam D, 2006, EUR NEUROPSYCHOPHARM, V16, P59, DOI 10.1016/j.euroneuro.2005.06.005; Van Dam D, 2005, PSYCHOPHARMACOLOGY, V180, P177, DOI 10.1007/s00213-004-2132-z; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Weiss LA, 2009, EXPERT REV MOL DIAGN, V9, P795, DOI 10.1586/ERM.09.59; Yun SH, 2011, J NEUROSCI RES, V89, P176, DOI 10.1002/jnr.22546	66	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36981	10.1371/journal.pone.0036981	http://dx.doi.org/10.1371/journal.pone.0036981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615862	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300056
J	Zaveri, A; Shah, J; Pradhan, S; Rodrigues, C; Barros, J; Ang, BT; Pietrobon, R				Zaveri, Amrapali; Shah, Jatin; Pradhan, Shreyasee; Rodrigues, Clarissa; Barros, Jacson; Ang, Beng Ti; Pietrobon, Ricardo			Center of Excellence in Research Reporting in Neurosurgery - Diagnostic Ontology	PLOS ONE			English	Article							QUALITY	Motivation: Evidence-based medicine (EBM), in the field of neurosurgery, relies on diagnostic studies since Randomized Controlled Trials (RCTs) are uncommon. However, diagnostic study reporting is less standardized which increases the difficulty in reliably aggregating results. Although there have been several initiatives to standardize reporting, they have shown to be sub-optimal. Additionally, there is no central repository for storing and retrieving related articles. Results: In our approach we formulate a computational diagnostic ontology containing 91 elements, including classes and sub-classes, which are required to conduct Systematic Reviews - Meta Analysis (SR-MA) for diagnostic studies, which will assist in standardized reporting of diagnostic articles. SR-MA are studies that aggregate several studies to come to one conclusion for a particular research question. We also report high percentage of agreement among five observers as a result of the interobserver agreement test that we conducted among them to annotate 13 articles using the diagnostic ontology. Moreover, we extend our existing repository CERR-N to include diagnostic studies. Availability: The ontology is available for download as an. owl file at: http://bioportal.bioontology.org/ontologies/3013.	[Zaveri, Amrapali] Univ Leipzig, Inst Informat, Leipzig, Saxony, Germany; [Zaveri, Amrapali; Shah, Jatin; Pradhan, Shreyasee; Rodrigues, Clarissa; Barros, Jacson; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA; [Rodrigues, Clarissa] Inst Cardiol RS, Porto Alegre, RS, Brazil; [Ang, Beng Ti] Natl Inst Neurosci, Singapore, Singapore; [Ang, Beng Ti] Duke NUS Grad Med Sch, Singapore, Singapore	Leipzig University; Duke University; Fundacao Universitaria de Cardiologia; National Neuroscience Institute (NNI); National University of Singapore	Zaveri, A (corresponding author), Univ Leipzig, Inst Informat, Leipzig, Saxony, Germany.	rpietro@duke.edu	Barros, Jacson V/J-5539-2014; Shah, Jatin/B-6039-2011	Barros, Jacson V/0000-0003-0169-9776; Zaveri, Amrapali/0000-0003-3239-4588; Shah, Jatin/0000-0002-2457-491X				Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bossuyt PMM, 2004, CLIN CHEM, V50, P465, DOI 10.1373/clinchem.2003.029736; Bruns DE, 2003, CLIN CHEM, V49, P19, DOI 10.1373/49.1.19; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Cook Chad, 2007, Account Res, V14, P1, DOI 10.1080/08989620601003471; Crippa JAS, 2002, BRAZ J MED BIOL RES, V35, P1209, DOI 10.1590/S0100-879X2002001000014; Fonseca F, 2007, J ASSOC INF SYST, V8, P129, DOI 10.17705/1jais.00114; Jarlais D, 2004, IMPROVING REPORTING, V94, P361; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mahoney J, 2007, CLIN CHEM, V53, P1122, DOI 10.1373/clinchem.2006.083493; Mol BW, 2003, SEMIN REPROD MED, V21, P17; Noy N.F., 2001, KSL0105, DOI DOI 10.1016/J.ARTMED.2004.01.014; Pai M, 2005, Indian J Med Microbiol, V23, P210; Rifai N, 2008, CLIN CHEM, P54; Rogers JE, 2006, METHOD INFORM MED, V45, P267; Schoeller K, 2009, ACTA NEUROCHIR, V151, P519, DOI 10.1007/s00701-009-0280-y; Sim I, 2005, PLOS MED, V2, P1090, DOI 10.1371/journal.pmed.0020365; Sim I, 2004, J BIOMED INFORM, V37, P108, DOI 10.1016/j.jbi.2004.03.001; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wilczynski NL, 2008, RADIOLOGY, V248, P817, DOI 10.1148/radiol.2483072067; Zaveri A, 2010, NEUROINFORMATICS, V8, P261, DOI 10.1007/s12021-010-9079-5	23	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36759	10.1371/journal.pone.0036759	http://dx.doi.org/10.1371/journal.pone.0036759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22629329	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339400033
J	Orio, P; Soudry, D				Orio, Patricio; Soudry, Daniel			Simple, Fast and Accurate Implementation of the Diffusion Approximation Algorithm for Stochastic Ion Channels with Multiple States	PLOS ONE			English	Article							THRESHOLD FLUCTUATIONS; ACTION-POTENTIALS; GATING CURRENTS; NOISE; MODEL; SIMULATION; BEHAVIOR; SYSTEMS; OSCILLATIONS; INFORMATION	Background: The phenomena that emerge from the interaction of the stochastic opening and closing of ion channels (channel noise) with the nonlinear neural dynamics are essential to our understanding of the operation of the nervous system. The effects that channel noise can have on neural dynamics are generally studied using numerical simulations of stochastic models. Algorithms based on discrete Markov Chains (MC) seem to be the most reliable and trustworthy, but even optimized algorithms come with a nonnegligible computational cost. Diffusion Approximation (DA) methods use Stochastic Differential Equations (SDE) to approximate the behavior of a number of MCs, considerably speeding up simulation times. However, model comparisons have suggested that DA methods did not lead to the same results as in MC modeling in terms of channel noise statistics and effects on excitability. Recently, it was shown that the difference arose because MCs were modeled with coupled gating particles, while the DA was modeled using uncoupled gating particles. Implementations of DA with coupled particles, in the context of a specific kinetic scheme, yielded similar results to MC. However, it remained unclear how to generalize these implementations to different kinetic schemes, or whether they were faster than MC algorithms. Additionally, a steady state approximation was used for the stochastic terms, which, as we show here, can introduce significant inaccuracies. Main Contributions: We derived the SDE explicitly for any given ion channel kinetic scheme. The resulting generic equations were surprisingly simple and interpretable allowing an easy, transparent and efficient DA implementation, avoiding unnecessary approximations. The algorithm was tested in a voltage clamp simulation and in two different current clamp simulations, yielding the same results as MC modeling. Also, the simulation efficiency of this DA method demonstrated considerable superiority over MC methods, except when short time steps or low channel numbers were used.	[Orio, Patricio] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Soudry, Daniel] Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel; [Soudry, Daniel] Technion Israel Inst Technol, Lab Network Biol, Haifa, Israel	Universidad de Valparaiso; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Orio, P (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	patricio.orio@uv.cl	Orio, Patricio/F-6207-2010	Orio, Patricio/0000-0003-0332-8098	Fondecyt [11090308]; Millennium Science Institute (Ministerio de Economia, Chile) [P09-022-F]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Science Institute (Ministerio de Economia, Chile)	This work was supported by Fondecyt Grant 11090308 to PO (Conicyt, Chile). The Centro Interdisciplinario de Neurociencia de Valparaiso is funded by Grant P09-022-F of the Millennium Science Institute (Ministerio de Economia, Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bhalla US, 2010, COMPUTATIONAL MODELI; Bruce IC, 2007, ANN BIOMED ENG, V35, P315, DOI 10.1007/s10439-006-9174-9; Bruce IC, 2009, ANN BIOMED ENG, V37, P824, DOI 10.1007/s10439-009-9635-z; Chow CC, 1996, BIOPHYS J, V71, P3013, DOI 10.1016/S0006-3495(96)79494-8; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; Faisal A, 2010, STOCHASTIC METHODS N; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Fernandez FR, 2008, J NEUROSCI, V28, P3790, DOI 10.1523/JNEUROSCI.5658-07.2008; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; FOX RF, 1994, PHYS REV E, V49, P3421, DOI 10.1103/PhysRevE.49.3421; Fox RF, 1997, BIOPHYS J, V72, P2068, DOI 10.1016/S0006-3495(97)78850-7; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gluckman BJ, 1996, PHYS REV LETT, V77, P4098, DOI 10.1103/PhysRevLett.77.4098; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; Goldwyn JH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041908; Golub G.H, 1996, J HOPKINS STUDIES MA; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koch Christof, 1999, P1; LECAR H, 1971, BIOPHYS J, V11, P1068, DOI 10.1016/S0006-3495(71)86278-1; Linaro D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001102; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Mino H, 2002, ANN BIOMED ENG, V30, P578, DOI 10.1114/1.1475343; MOLGEDEY L, 1992, PHYS REV LETT, V69, P3717, DOI 10.1103/PhysRevLett.69.3717; Motwani R, 1996, ACM COMPUT SURV, V28, P33, DOI 10.1145/234313.234327; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; Pakdaman K, 2010, ADV APPL PROBAB, V42, P761, DOI 10.1239/aap/1282924062; Rowat PF, 2004, J COMPUT NEUROSCI, V16, P87, DOI 10.1023/B:JCNS.0000014104.08299.8b; RUBINSTEIN JT, 1995, BIOPHYS J, V68, P779, DOI 10.1016/S0006-3495(95)80252-3; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Steinmetz PN, 2000, J COMPUT NEUROSCI, V9, P133, DOI 10.1023/A:1008967807741; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0	55	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36670	10.1371/journal.pone.0036670	http://dx.doi.org/10.1371/journal.pone.0036670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629320	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300009
J	Barclay, JL; Husse, J; Bode, B; Naujokat, N; Meyer-Kovac, J; Schmid, SM; Lehnert, H; Oster, H				Barclay, Johanna L.; Husse, Jana; Bode, Brid; Naujokat, Nadine; Meyer-Kovac, Judit; Schmid, Sebastian M.; Lehnert, Hendrik; Oster, Henrik			Circadian Desynchrony Promotes Metabolic Disruption in a Mouse Model of Shiftwork	PLOS ONE			English	Article							POSTPRANDIAL HORMONE; FOOD-INTAKE; BODY-MASS; RAT MODEL; WORK; SLEEP; NIGHT; GLUCOSE; OBESITY; CLOCK	Shiftwork is associated with adverse metabolic pathophysiology, and the rising incidence of shiftwork in modern societies is thought to contribute to the worldwide increase in obesity and metabolic syndrome. The underlying mechanisms are largely unknown, but may involve direct physiological effects of nocturnal light exposure, or indirect consequences of perturbed endogenous circadian clocks. This study employs a two-week paradigm in mice to model the early molecular and physiological effects of shiftwork. Two weeks of timed sleep restriction has moderate effects on diurnal activity patterns, feeding behavior, and clock gene regulation in the circadian pacemaker of the suprachiasmatic nucleus. In contrast, microarray analyses reveal global disruption of diurnal liver transcriptome rhythms, enriched for pathways involved in glucose and lipid metabolism and correlating with first indications of altered metabolism. Although altered food timing itself is not sufficient to provoke these effects, stabilizing peripheral clocks by timed food access can restore molecular rhythms and metabolic function under sleep restriction conditions. This study suggests that peripheral circadian desynchrony marks an early event in the metabolic disruption associated with chronic shiftwork. Thus, strengthening the peripheral circadian system by minimizing food intake during night shifts may counteract the adverse physiological consequences frequently observed in human shift workers.	[Barclay, Johanna L.; Husse, Jana; Bode, Brid; Naujokat, Nadine; Meyer-Kovac, Judit; Oster, Henrik] Max Planck Inst Biophys Chem, Gottingen, Germany; [Schmid, Sebastian M.; Lehnert, Hendrik; Oster, Henrik] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany	Max Planck Society; University of Lubeck	Barclay, JL (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	henrik.oster@mpibpc.mpg.de	Oster, Henrik/O-4426-2019; Schmid, Sebastian M/E-5354-2015; Barclay, Johanna/G-6293-2012; Oster, Henrik/D-2335-2013	Oster, Henrik/0000-0002-1414-7068; Barclay, Johanna/0000-0001-5737-1775; Oster, Henrik/0000-0002-1414-7068; Meyhofer, Sebastian/0000-0003-2034-5922	German Research Foundation (DFG) [SFB 654]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a project grant (SFB 654) of the German Research Foundation (DFG) to HO and HL; HO is an Emmy Noether fellow of the DFG and a Lichtenberg fellow of the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Naimi S, 2004, CHRONOBIOL INT, V21, P937, DOI 10.1081/CBI-200037171; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Di Lorenzo L, 2003, INT J OBESITY, V27, P1353, DOI 10.1038/sj.ijo.0802419; Folkard S, 2008, CHRONOBIOL INT, V25, P215, DOI 10.1080/07420520802106835; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gamble KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018395; Garaulet M, 2011, INT J OBES; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs M, 2007, J BIOL RHYTHM, V22, P368, DOI 10.1177/0748730407302843; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hasan S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.010; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Korkmaz A, 2009, REV ENDOCR METAB DIS, V10, P261, DOI 10.1007/s11154-009-9117-5; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2011, INT J OCCUP ENV HEAL, V17, P154, DOI 10.1179/oeh.2011.17.2.154; Lund J, 2001, J ENDOCRINOL, V171, P557, DOI 10.1677/joe.0.1710557; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Morikawa Y, 2008, J OCCUP HEALTH, V50, P270, DOI 10.1539/joh.L7116; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Oster H, 2003, GENE DEV, V17, P1366, DOI 10.1101/gad.256103; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Persson M, 2006, J Nurs Manag, V14, P414, DOI 10.1111/j.1365-2934.2006.00601.x; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rehman JU, 2010, EUR J ENDOCRINOL, V163, P383, DOI 10.1530/EJE-10-0297; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wong H, 2010, INT J NURS STUD, V47, P1021, DOI 10.1016/j.ijnurstu.2010.01.001; Wu HJ, 2008, BRAIN RES BULL, V77, P241, DOI 10.1016/j.brainresbull.2008.07.013; Yamanaka Y, 2008, GENES CELLS, V13, P497, DOI 10.1111/j.1365-2443.2008.01183.x; Yang ST, 2009, ENDOCRINOLOGY, V150, P2153, DOI 10.1210/en.2008-0705; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	53	176	178	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37150	10.1371/journal.pone.0037150	http://dx.doi.org/10.1371/journal.pone.0037150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629359	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343100014
J	Jeker, LT; Zhou, XY; Gershberg, K; de Kouchkovsky, D; Morar, MM; Stadthagen, G; Lund, AH; Bluestone, JA				Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Stadthagen, Gustavo; Lund, Anders H.; Bluestone, Jeffrey A.			MicroRNA 10a Marks Regulatory T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; RETINOIC-ACID; REG-CELLS; IN-VIVO; DIFFERENTIATION; SPECIFICATION; GENERATION; RESPONSES; DICER; LEADS	MicroRNAs (miRNAs) are crucial for regulatory T cell (Treg) stability and function. We report that microRNA-10a (miR-10a) is expressed in Tregs but not in other T cells including individual thymocyte subsets. Expression profiling in inbred mouse strains demonstrated that non-obese diabetic (NOD) mice with a genetic susceptibility for autoimmune diabetes have lower Treg-specific miR-10a expression than C57BL/6J autoimmune resistant mice. Inhibition of miR-10a expression in vitro leads to reduced FoxP3 expression levels and miR-10a expression is lower in unstable "exFoxP3" T cells. Unstable in vitro TGF-beta-induced, iTregs do not express miR-10a unless cultured in the presence of retinoic acid (RA) which has been associated with increased stability of iTreg, suggesting that miR-10a might play a role in stabilizing Treg. However, genetic ablation of miR-10a neither affected the number and phenotype of natural Treg nor the capacity of conventional T cells to induce FoxP3 in response to TGF beta, RA, or a combination of the two. Thus, miR-10a is selectively expressed in Treg but inhibition by antagomiRs or genetic ablation resulted in discordant effects on FoxP3.	[Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Jeker, Lukas T.; Zhou, Xuyu; Gershberg, Kseniya; de Kouchkovsky, Dimitri; Morar, Malika M.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Stadthagen, Gustavo; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen	Jeker, LT (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	Jeff.bluestone@ucsf.edu	Lund, Anders H./F-4786-2014; Zhou, Xuyu/L-7422-2019	Lund, Anders H./0000-0002-7407-3398; Zhou, Xuyu/0000-0002-6626-0898; Jeker, Lukas/0000-0002-3359-8796; de Kouchkovsky, Dimitri/0000-0002-9609-3226	National Institutes of Health [P01 AI35297, U19 AI056388, P30 DK63720]; Juvenile Diabetes Research Foundation; Swiss National Science Foundation (SNSF) [PBBSB-118644]; Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF [PASMP3-124274/1]; Roche Research Foundation; Novartis Foundation; ADA Mentor-Based Award; Lundbeck Foundation [R31-2007-1447] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035297, U19AI056388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF; Roche Research Foundation; Novartis Foundation(Novartis); ADA Mentor-Based Award; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 AI35297 and U19 AI056388 (to JAB), P30 DK63720 (for core support; http://www.nih.gov), and a Scholar Award from the Juvenile Diabetes Research Foundation (to JAB; http://www.jdrf.org/). LTJ was supported by the Swiss National Science Foundation (SNSF) (PBBSB-118644), and the Swiss Foundation for Grants in Biology and Medicine (SFGBM)/SNSF (PASMP3-124274/1; http://www.snf.ch), the Roche Research Foundation (http://www.research-foundation.org), and the Novartis Foundation (formerly Ciba-Geigy Jubilee Foundation, http://www.jubilaeumsstiftung.novartis.com). XZ was supported by an ADA Mentor-Based Award (http://www.diabetes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Jeker LT, 2010, J CLIN IMMUNOL, V30, P347, DOI 10.1007/s10875-010-9392-7; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Moltzahn F, 2011, CANCER RES, V71, P550, DOI 10.1158/0008-5472.CAN-10-1229; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	28	84	95	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36684	10.1371/journal.pone.0036684	http://dx.doi.org/10.1371/journal.pone.0036684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629323	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500023
J	Ye, F; Cheng, Q; Hu, YT; Zhang, J; Chen, HZ				Ye, Feng; Cheng, Qi; Hu, Yuting; Zhang, Jing; Chen, Huaizeng			PARP-1 Val762Ala Polymorphism Is Associated with Risk of Cervical Carcinoma	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; HPV VACCINATION; CANCER; REPAIR	PARP-1 is a nuclear enzyme that plays an important role in DNA repair, recombination, proliferation and the genome stability. The PARP-1 Val762Ala polymorphism has been associated with increased risk of developing cancers of the prostate, esophagus and lung. The aim of this study was to determine whether the PARP-1 Val762Ala polymorphism is associated with the risk of cervical carcinoma. MA-PCR was used to genotype the PARP-1 Val762Ala polymorphism in 539 women with cervical carcinoma, 480 women with CIN and 800 controls. The genotyping method was confirmed by the DNA sequencing analysis. The PARP-1 Val762Ala polymorphism was not associated with the risk of CIN. However, women carrying the PARP-1 Ala762Ala genotype were significantly susceptible to cervical carcinoma (OR: 2.70, 95% CI: 1.47-3.70), and the similar results were also found in squamous cell carcinoma (OR: 2.56, 95% CI: 1.47-3.70). In HPV positive population, the PARP-1 Ala762Ala genotype was also associated with increased risk of cervical carcinoma (OR: 5.56, 95% CI: 2.08-14.3). Our results indicate that the PARP-1 Ala762Ala genotype increases the risk of cervical carcinoma.	[Ye, Feng; Cheng, Qi; Hu, Yuting; Chen, Huaizeng] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jing] Zhejiang Univ, Sch Med, Womens Hosp, Dept Obstet & Gynecol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, F (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	chenhz@zju.edu.cn			Zhejiang Natural Science Foundation of China [Y204049, Y207162, Y2110200]; Science and Technology Project of Zhejiang Province, China [2005C23003]; National Nature Science Foundation of China [30973380]	Zhejiang Natural Science Foundation of China; Science and Technology Project of Zhejiang Province, China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Zhejiang Natural Science Foundation of China (Y204049, Y207162, Y2110200), from Science and Technology Project of Zhejiang Province, China (No. 2005C23003), and from National Nature Science Foundation of China (No. 30973380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 2009, INDIAN J MED RES, V130, P241; Cottet F, 2000, J MOL MED, V78, P431, DOI 10.1007/s001090050488; Georgieva S, 2009, J BUON, V14, P391; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumari SR, 1998, CANCER RES, V58, P5075; Lazcano-Ponce E, 2009, ARCH MED RES, V40, P486, DOI 10.1016/j.arcmed.2009.07.007; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peter M, 2010, J PATHOL, V221, P320, DOI 10.1002/path.2713; Saleem A, 2009, MINERVA MED, V100, P503; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Silins I, 2004, GYNECOL ONCOL, V93, P484, DOI 10.1016/j.ygyno.2004.01.044; Tong WM, 2002, CANCER RES, V62, P6990; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Yoshida T, 2009, VIRCHOWS ARCH, V455, P253, DOI 10.1007/s00428-009-0823-x; Zhang QB, 2009, MOL BIOL REP, V36, P1461, DOI 10.1007/s11033-008-9336-y; Zhang XM, 2005, CANCER RES, V65, P722; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	26	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37446	10.1371/journal.pone.0037446	http://dx.doi.org/10.1371/journal.pone.0037446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624032	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500117
J	Blaser, RE; Rosemberg, DB				Blaser, Rachel E.; Rosemberg, Denis B.			Measures of Anxiety in Zebrafish (Danio rerio): Dissociation of Black/White Preference and Novel Tank Test	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; SCOTOTAXIS; PREDATOR; FISH; TASK	The effects of wall color stimuli on diving, and the effects of depth stimuli on scototaxis, were assessed in zebrafish. Three groups of fish were confined to a black, a white, or a transparent tank, and tested for depth preference. Two groups of fish were confined to a deep or a shallow tank, and tested for black-white preference. As predicted, fish preferred the deep half of a split-tank over the shallow half, and preferred the black half of a black/white tank over the white half. Results indicated that the tank wall color significantly affected depth preference, with the transparent tank producing the strongest depth preference and the black tank producing the weakest preference. Tank depth, however, did not significantly affect color preference. Additionally, wall color significantly affected shuttling and immobility, while depth significantly affected shuttling and thigmotaxis. These results are consistent with previous indications that the diving response and scototaxis may reflect dissociable mechanisms of behavior. We conclude that the two tests are complementary rather than interchangeable, and that further research on the motivational systems underlying behavior in each of the two tests is needed.	[Blaser, Rachel E.] Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA; [Rosemberg, Denis B.] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-90046900 Porto Alegre, RS, Brazil; [Rosemberg, Denis B.] INCT EN, Porto Alegre, RS, Brazil	University of San Diego; Universidade Federal do Rio Grande do Sul	Blaser, RE (corresponding author), Univ San Diego, Dept Psychol Sci, San Diego, CA 92110 USA.	rblaser@sandiego.edu	Blaser, Rachel E/A-3341-2012; Rosemberg, Denis B/E-5971-2016	Blaser, Rachel E/0000-0002-4342-532X; Rosemberg, Denis/0000-0003-2538-8761	University of San Diego; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	University of San Diego; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by the University of San Diego. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Charles Heyser for his ideas regarding this manuscript. D. B. R. is a member of the Zebrafish Neuroscience Research Consortium (ZNRC) and recipient of fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Ahmed O, 2011, BEHAV BRAIN RES, V216, P166, DOI 10.1016/j.bbr.2010.07.028; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser R, ZEBRAFISH N IN PRESS; Blaser RE, 2012, ANIM BEHAV, V83, P953, DOI 10.1016/j.anbehav.2012.01.014; Blaser RE, 2011, PHYSIOL BEHAV, V104, P831, DOI 10.1016/j.physbeh.2011.07.029; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2009, GENES BRAIN BEHAV, V8, P586, DOI 10.1111/j.1601-183X.2009.00488.x; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Korpi NL, 2001, ENVIRON BIOL FISH, V61, P205, DOI 10.1023/A:1011091426030; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Parra KV, 2009, BEHAV BRAIN RES, V205, P336, DOI 10.1016/j.bbr.2009.06.037; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Stephenson JF, 2011, ZEBRAFISH, V8, P17, DOI 10.1089/zeb.2010.0671; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	30	186	188	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36931	10.1371/journal.pone.0036931	http://dx.doi.org/10.1371/journal.pone.0036931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615849	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200028
J	Jurek, B; Slattery, DA; Maloumby, R; Hillerer, K; Koszinowski, S; Neumann, ID; van den Burg, EH				Jurek, Benjamin; Slattery, David A.; Maloumby, Rodrigue; Hillerer, Katharina; Koszinowski, Sophie; Neumann, Inga D.; van den Burg, Erwin H.			Differential Contribution of Hypothalamic MAPK Activity to Anxiety-Like Behaviour in Virgin and Lactating Rats	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS; SYNAPTIC PLASTICITY; OXYTOCIN RECEPTOR; BRAIN OXYTOCIN; KINASE; VASOPRESSIN; EXPRESSION; MEMORY; MICE; AMYGDALA	The c-Raf - MEK1/2 - ERK1/2 mitogen-activated protein kinase (MAPK) intracellular signalling cascade in neurons plays important roles in the control of a variety of behaviours, including social behaviours and anxiety. These roles partially overlap with those described for oxytocin (OXT), and it has been shown that OXT activates the MAPK pathway in the hypothalamus (of male), and hippocampus (of female) rats. Here, by combining behavioural (light/dark box) and biochemical analyses (western blotting), we tested two hypotheses: (i) that OXT is anxiolytic within the hypothalamus of females, and (ii) that this effect, as well as that of lactation-associated anxiolysis, depends on the recruitment of the MAPK pathway. We found that, when injected bilaterally into the hypothalamic paraventricular nucleus (PVN), OXT decreased anxiety-like behaviour in virgins, and that this effect depended on phosphorylation of MEK1/2. MAPK pathway activation in lactation was evident by high phosphorylated (p) MEK1/2 levels, and nuclear translocation of ERK1. The high pMEK1/2 levels were necessary for the anxiolytic phenotype typically observed during lactation. Interestingly, exogenous OXT in lactating rats reduced pMEK1/2 levels without a concomitant effect on anxiety, indicating that OXT receptor activation can lead to recruitment of additional intracellular pathways to modulate MEK activity. Still other pathways could include MEK, but without subsequent activation of ERK, as we did not observe any increase in OXT-induced ERK phosphorylation. Together the results demonstrate that the MAPK pathway, especially MEK1/2, is critically involved in the regulation of anxiety-like behaviour in female rats.	[Jurek, Benjamin; Slattery, David A.; Maloumby, Rodrigue; Hillerer, Katharina; Koszinowski, Sophie; Neumann, Inga D.; van den Burg, Erwin H.] Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Germany	University of Regensburg	Jurek, B (corresponding author), Univ Regensburg, Dept Behav & Mol Neurobiol, Regensburg, Germany.		Jurek, Benjamin/L-3429-2019; Slattery, David/AAJ-1740-2020; Hillerer, Katharina/M-5107-2013	Jurek, Benjamin/0000-0001-7124-510X; Slattery, David/0000-0001-8753-5005; 	German Research Foundation (DFG) [NE 465/19-1, SL141/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support from the German Research Foundation (DFG grants NE 465/19-1 to EvB and DFG SL141/4-1 to DS) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Brandt KJ, 2010, J LEUKOCYTE BIOL, V88, P1191, DOI 10.1189/jlb.0510312; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Carter C S, 2001, Prog Brain Res, V133, P241; Chen G, 2011, MOL CANCER RES, V9, P78, DOI 10.1158/1541-7786.MCR-10-0216; Chen J, 2008, EXP NEUROL, V211, P529, DOI 10.1016/j.expneurol.2008.02.023; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; Hillerer KM, 2011, NEUROENDOCRINOLOGY; Jo C, 2011, J BIOL CHEM, V286, P18903, DOI 10.1074/jbc.M111.225128; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Labuschagne I, 2010, NEUROPSYCHOPHARMACOL, V35, P2403, DOI 10.1038/npp.2010.123; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Maiga O, 2011, FEBS J, V278, P2655, DOI 10.1111/j.1742-4658.2011.08192.x; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; NEUMANN I, 1993, NEUROENDOCRINOLOGY, V58, P637, DOI 10.1159/000126604; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Oliet SHR, 2002, J NEUROENDOCRINOL, V14, P241, DOI 10.1046/j.0007-1331.2001.00766.x; Paxinos G, 1998, RAT BRAIN STEROTAXIC; Pullikuth A, 2005, MOL CELL BIOL, V25, P5119, DOI 10.1128/MCB.25.12.5119-5133.2005; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Satoh Y, 2011, J NEUROSCI, V31, P11953, DOI 10.1523/JNEUROSCI.2349-11.2011; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; THEODOSIS DT, 1989, BRAIN RES, V484, P361, DOI 10.1016/0006-8993(89)90382-X; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Viviani D, 2011, SCIENCE, V333, P104, DOI 10.1126/science.1201043; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; Windle RJ, 2004, J NEUROSCI, V24, P2974, DOI 10.1523/JNEUROSCI.3432-03.2004; Zhong M, 2003, ENDOCRINOLOGY, V144, P2947, DOI 10.1210/en.2002-221039	44	61	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37060	10.1371/journal.pone.0037060	http://dx.doi.org/10.1371/journal.pone.0037060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615888	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200039
J	Ceh, J; Raina, JB; Soo, RM; van Keulen, M; Bourne, DG				Ceh, Janja; Raina, Jean-Baptiste; Soo, Rochelle M.; van Keulen, Mike; Bourne, David G.			Coral-Bacterial Communities before and after a Coral Mass Spawning Event on Ningaloo Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BIOGEOCHEMICAL RESPONSES; DIVERSITY; MUCUS	Bacteria associated with three coral species, Acropora tenuis, Pocillopora damicornis and Tubastrea faulkneri, were assessed before and after coral mass spawning on Ningaloo Reef in Western Australia. Two colonies of each species were sampled before and after the mass spawning event and two additional samples were collected for P. damicornis after planulation. A variable 470 bp region of the 16 S rRNA gene was selected for pyrosequencing to provide an understanding of potential variations in coral-associated bacterial diversity and community structure. Bacterial diversity increased for all coral species after spawning as assessed by Chao1 diversity indicators. Minimal changes in community structure were observed at the class level and data at the taxonomical level of genus incorporated into a PCA analysis indicated that despite bacterial diversity increasing after spawning, coral-associated community structure did not shift greatly with samples grouped according to species. However, interesting changes could be detected from the dataset; for example, a-Proteobacteria increased in relative abundance after coral spawning and particularly the Roseobacter clade was found to be prominent in all coral species, indicating that this group may be important in coral reproduction.	[Ceh, Janja; van Keulen, Mike] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA, Australia; [Ceh, Janja; Raina, Jean-Baptiste; Soo, Rochelle M.; Bourne, David G.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet Res, Townsville, Qld 4810, Australia; [Raina, Jean-Baptiste] James Cook Univ, JCU 3AIMS, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Murdoch University; Australian Institute of Marine Science; James Cook University; James Cook University	Ceh, J (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA, Australia.	J.Ceh@murdoch.edu.au	van Keulen, Mike/Q-9856-2019; Bourne, David G/B-5073-2008; Soo, Rochelle M/A-6505-2018	van Keulen, Mike/0000-0001-6235-5788; Bourne, David G/0000-0002-1492-8710; Soo, Rochelle M/0000-0002-8927-2066; Raina, Jean-Baptiste/0000-0002-7508-0004	Australian Institute for Marine Science; Murdoch University; Western Australian Marine Science Institute	Australian Institute for Marine Science; Murdoch University; Western Australian Marine Science Institute	Funding provided by Australian Institute for Marine Science, Murdoch University and Western Australian Marine Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright R, 2011, GLOBAL CHANGE BIOL, V17, P2478, DOI 10.1111/j.1365-2486.2011.02404.x; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2011, FEMS MICROBIOL ECOL, V75, P134, DOI 10.1111/j.1574-6941.2010.00986.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar R.C., 2011, BIOINFORMATICS; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Gower J.C., 2004, PROCRUSTES PROBLEMS; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hong MJ, 2009, APPL ENVIRON MICROB, V75, P7797, DOI 10.1128/AEM.01418-09; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Olson ND, 2009, J EXP MAR BIOL ECOL, V371, P140, DOI 10.1016/j.jembe.2009.01.012; Patten NL, 2008, AQUAT MICROB ECOL, V50, P209, DOI 10.3354/ame01179; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sharp KH, 2011, ISME J; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Vizcaino MI, 2010, MICROB ECOL, V59, P646, DOI 10.1007/s00248-010-9644-3; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wild C, 2008, CORAL REEFS, V27, P123, DOI 10.1007/s00338-007-0298-7	35	49	50	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36920	10.1371/journal.pone.0036920	http://dx.doi.org/10.1371/journal.pone.0036920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22629343	Green Published, Green Accepted, gold			2022-12-27	WOS:000305341300043
J	Chauhan, A; Lebeaux, D; Decante, B; Kriegel, I; Escande, MC; Ghigo, JM; Beloin, C				Chauhan, Ashwini; Lebeaux, David; Decante, Benoit; Kriegel, Irene; Escande, Marie-Christine; Ghigo, Jean-Marc; Beloin, Christophe			A Rat Model of Central Venous Catheter to Study Establishment of Long-Term Bacterial Biofilm and Related Acute and Chronic Infections	PLOS ONE			English	Article							ANTIBIOTIC-LOCK TECHNIQUE; BLOOD-STREAM INFECTIONS; IN-VIVO; CONTROLLED-TRIAL; ACCESS SYSTEM; BACTEREMIA; DIAGNOSIS; THERAPY; CANCER; MICE	Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro biofilm analyses led to promising anti-biofilm approaches, little is known about their translation to in vivo situations and on host contribution to the in vivo dynamics of infections on medical devices. Here we have developed an in vivo model of long-term bacterial biofilm infections in a pediatric totally implantable venous access port (TIVAP) surgically placed in adult rats. Using non-invasive and quantitative bioluminescence, we studied TIVAP contamination by clinically relevant pathogens, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus epidermidis, and we demonstrated that TIVAP bacterial populations display typical biofilm phenotypes. In our study, we showed that immunocompetent rats were able to control the colonization and clear the bloodstream infection except for up to 30% that suffered systemic infection and death whereas none of the immunosuppressed rats survived the infection. Besides, we mimicked some clinically relevant TIVAP associated complications such as port-pocket infection and hematogenous route of colonization. Finally, by assessing an optimized antibiotic lock therapy, we established that our in vivo model enables to assess innovative therapeutic strategies against bacterial biofilm infections.	[Chauhan, Ashwini; Lebeaux, David; Ghigo, Jean-Marc; Beloin, Christophe] Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France; [Decante, Benoit] Ctr Chirurg Marie Lannelongue, Lab Rech Chirurg, Le Plessis Robinson, France; [Kriegel, Irene] Hop Inst Curie, Serv Anesthesie Reanimat Douleur, Paris, France; [Escande, Marie-Christine] Hop Inst Curie, Lab Microbiol Med, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hopital Marie Lannelongue; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Chauhan, A (corresponding author), Inst Pasteur, Unite Genet Biofilms, Dept Microbiol, Paris, France.	cbeloin@pasteur.fr	BELOIN, Christophe/F-9284-2012; GHIGO, Jean-Marc/AAP-4011-2021; Lebeaux, David/ABB-2704-2020; Chauhan, Ashwini/C-9200-2012	BELOIN, Christophe/0000-0002-0344-3443; GHIGO, Jean-Marc/0000-0001-6528-118X; Chauhan, Ashwini/0000-0002-0555-8244; DECANTE, Benoit/0000-0003-1642-7589	PTR 279/PIC Institut Curie Infections Nosocomiales; AXA Research Fund	PTR 279/PIC Institut Curie Infections Nosocomiales; AXA Research Fund(AXA Research Fund)	This work was financially supported by the PTR 279/PIC Institut Curie Infections Nosocomiales. David Lebeaux was supported by a grant from the AXA Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astagneau P, 1999, INFECT CONT HOSP EP, V20, P494, DOI 10.1086/501658; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873; Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9; Chang LL, 2003, AM J INFECT CONTROL, V31, P34, DOI 10.1067/mic.2003.29; Cirioni O, 2006, J INFECT DIS, V193, P180, DOI 10.1086/498914; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Console G, 2007, J CHEMOTHERAPY, V19, P309, DOI 10.1179/joc.2007.19.3.309; Darouiche RO, 2005, ANN SURG, V242, P193, DOI 10.1097/01.sla.0000171874.29934.61; Del Pozo JL, 2006, INT J ARTIF ORGANS, V29, P379, DOI 10.1177/039139880602900407; Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077; Fallat ME, 1998, J PEDIATR SURG, V33, P1383, DOI 10.1016/S0022-3468(98)90013-6; Fatkenheuer G, 2003, ANN HEMATOL, V82, pS149, DOI 10.1007/s00277-003-0769-z; Fernandez-Hidalgo N, 2006, J ANTIMICROB CHEMOTH, V57, P1172, DOI 10.1093/jac/dkl103; Fernandez-Hidalgo N, 2010, J ANTIMICROB CHEMOTH, V65, P525, DOI 10.1093/jac/dkp499; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; Francolini I, 2010, FEMS IMMUNOLOGY MED, P1; Friedman ND, 2002, J INFECTION, V45, P47, DOI 10.1053/jinf.2002.0978; GROEGER JS, 1993, ANN INTERN MED, V119, P1168, DOI 10.7326/0003-4819-119-12-199312150-00003; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hanna H, 2004, INFECT CONT HOSP EP, V25, P646, DOI 10.1086/502455; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522; Kadurugamuwa Jagath L., 2008, V431, P225; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kokai-Kun JF, 2009, J ANTIMICROB CHEMOTH, V64, P94, DOI 10.1093/jac/dkp145; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; MESSING B, 1988, JPEN-PARENTER ENTER, V12, P185, DOI 10.1177/0148607188012002185; NIEDERHUBER JE, 1982, SURGERY, V92, P706; Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Rijnders BJ, 2005, J ANTIMICROB CHEMOTH, V55, P90, DOI 10.1093/jac/dkh488; Rupp ME, 1999, INFECT IMMUN, V67, P2656, DOI 10.1128/IAI.67.5.2656-2659.1999; Scott R.D., 2009, DIRECT MED COSTS HEA; Seifert H, 1997, CATHETER RELATED INF, P255; Simoes M, 2011, CURR MED CHEM, V18, P2129, DOI 10.2174/092986711795656216; Tavares E, 2005, CLIN DIAGN LAB IMMUN, V12, P1085, DOI 10.1128/CDLI.12.9.1085-1093.2005; Van Praagh ADG, 2011, ANTIMICROB AGENTS CH, V55, P4081, DOI 10.1128/AAC.00147-11; Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307; Wagner C, 2006, UNFALLCHIRURG, V109, P761, DOI 10.1007/s00113-006-1089-2; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	46	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37281	10.1371/journal.pone.0037281	http://dx.doi.org/10.1371/journal.pone.0037281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615964	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300095
J	Fonfria-Subiros, E; Acosta-Reyes, F; Saperas, N; Pous, J; Subirana, JA; Campos, JL				Fonfria-Subiros, Elsa; Acosta-Reyes, Francisco; Saperas, Nuria; Pous, Joan; Subirana, Juan A.; Lourdes Campos, J.			Crystal Structure of a Complex of DNA with One AT-Hook of HMGA1	PLOS ONE			English	Article							MOBILITY GROUP-PROTEIN; MINOR-GROOVE; B-DNA; CHROMOSOMAL-PROTEINS; NUCLEAR FUNCTION; BINDING; RECOGNITION; DODECAMER; SEQUENCES; GEOMETRY	We present here for the first time the crystal structure of an AT-hook domain. We show the structure of an AT-hook of the ubiquitous nuclear protein HMGA1, combined with the oligonucleotide d(CGAATTAATTCG)(2), which has two potential AATT interacting groups. Interaction with only one of them is found. The structure presents analogies and significant differences with previous NMR studies: the AT-hook forms hydrogen bonds between main-chain NH groups and thymines in the minor groove, DNA is bent and the minor groove is widened.	[Fonfria-Subiros, Elsa; Acosta-Reyes, Francisco; Saperas, Nuria; Subirana, Juan A.; Lourdes Campos, J.] Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain; [Pous, Joan] PCB CSIC, Inst Recerca Biomed Barcelona, Barcelona, Spain	Universitat Politecnica de Catalunya; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC)	Fonfria-Subiros, E (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Barcelona, Spain.	lourdes.campos@upc.edu	Campos, J.Lourdes/N-7336-2014; saperas, núria/P-7213-2015; Subirana, juan/L-7192-2014	Campos, J.Lourdes/0000-0002-4136-7082; saperas, núria/0000-0002-5419-7502; Subirana, juan/0000-0002-1706-9341; Acosta-Reyes, Francisco J./0000-0001-8524-1484	Spanish Ministerio de Ciencia e Innovacion [BFU2009-10380]; Generalitat de Catalunya [2009 SGR 1208]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants BFU2009-10380 from the Spanish Ministerio de Ciencia e Innovacion and 2009 SGR 1208 from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Chen B, 2010, BIOCHEMISTRY-US, V49, P1590, DOI 10.1021/bi901881c; Cleynen I, 2008, INT J ONCOL, V32, P289; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; DICKERSON RE, 1987, J BIOMOL STRUCT DYN, V5, P557, DOI 10.1080/07391102.1987.10506413; Dragan AI, 2003, J MOL BIOL, V327, P393, DOI 10.1016/S0022-2836(03)00050-0; DREW HR, 1981, J MOL BIOL, V151, P535, DOI 10.1016/0022-2836(81)90009-7; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Manabe T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; REEVES R, 1990, J BIOL CHEM, V265, P8573; Reeves Raymond, 2003, Prog Cell Cycle Res, V5, P279; Sgarra R, 2003, BIOCHEMISTRY-US, V42, P3575, DOI 10.1021/bi027338l; Sgarra R, 2010, BBA-GENE REGUL MECH, V1799, P37, DOI 10.1016/j.bbagrm.2009.08.009; Soler-Lopez M, 1999, J BIOL CHEM, V274, P23683, DOI 10.1074/jbc.274.34.23683; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009	25	39	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37120	10.1371/journal.pone.0037120	http://dx.doi.org/10.1371/journal.pone.0037120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615915	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300075
J	Hill, AE; Shachar-Hill, B; Skepper, JN; Powell, J; Shachar-Hill, Y				Hill, Adrian E.; Shachar-Hill, Bruria; Skepper, Jeremy N.; Powell, Janet; Shachar-Hill, Yair			An Osmotic Model of the Growing Pollen Tube	PLOS ONE			English	Article							INDUCED WATER POTENTIALS; POLARIZED CELL-GROWTH; TIP GROWTH; PECTIN METHYLESTERASES; SIGNALING NETWORKS; SAPROLEGNIA-FERAX; CALLOSE SYNTHASE; PLASMA-MEMBRANE; ROOT HAIRS; PLANT	Pollen tube growth is central to the sexual reproduction of plants and is a longstanding model for cellular tip growth. For rapid tip growth, cell wall deposition and hardening must balance the rate of osmotic water uptake, and this involves the control of turgor pressure. Pressure contributes directly to both the driving force for water entry and tip expansion causing thinning of wall material. Understanding tip growth requires an analysis of the coordination of these processes and their regulation. Here we develop a quantitative physiological model which includes water entry by osmosis, the incorporation of cell wall material and the spreading of that material as a film at the tip. Parameters of the model have been determined from the literature and from measurements, by light, confocal and electron microscopy, together with results from experiments made on dye entry and plasmolysis in Lilium longiflorum. The model yields values of variables such as osmotic and turgor pressure, growth rates and wall thickness. The model and its predictive capacity were tested by comparing programmed simulations with experimental observations following perturbations of the growth medium. The model explains the role of turgor pressure and its observed constancy during oscillations; the stability of wall thickness under different conditions, without which the cell would burst; and some surprising properties such as the need for restricting osmotic permeability to a constant area near the tip, which was experimentally confirmed. To achieve both constancy of pressure and wall thickness under the range of conditions observed in steady-state growth the model reveals the need for a sensor that detects the driving potential for water entry and controls the deposition rate of wall material at the tip.	[Hill, Adrian E.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Shachar-Hill, Bruria; Skepper, Jeremy N.; Powell, Janet] Univ Cambridge, Multiimaging Ctr, Cambridge, England; [Shachar-Hill, Yair] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	University of Cambridge; University of Cambridge; Michigan State University	Hill, AE (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	aeh1@hermes.cam.ac.uk	Shachar-Hill, Yair/B-6165-2013	Shachar-Hill, Yair/0000-0001-8793-5084	Michigan State University	Michigan State University	This work was supported by funding from Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie JM, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-14; Aouar L, 2010, SEX PLANT REPROD, V23, P15, DOI 10.1007/s00497-009-0110-7; BARTNICK.S, 1972, J GEN MICROBIOL, V73, P487, DOI 10.1099/00221287-73-3-487; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; BHALLA PL, 1984, ANN BOT-LONDON, V53, P125, DOI 10.1093/oxfordjournals.aob.a086661; Bosch M, 2006, PLANTA, V223, P736, DOI 10.1007/s00425-005-0131-x; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Boyer JS, 2001, J EXP BOT, V52, P1483, DOI 10.1093/jexbot/52.360.1483; Bushart TJ, 2007, ANN BOT-LONDON, V99, P9, DOI 10.1093/aob/mcl159; Cai G, 2005, CURR SCI INDIA, V89, P1853; CAILLOUX M, 1972, CAN J BOTANY, V50, P557, DOI 10.1139/b72-069; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Campas O, 2009, CURR BIOL, V19, P2102, DOI 10.1016/j.cub.2009.10.075; Certal AC, 2008, PLANT CELL, V20, P614, DOI 10.1105/tpc.106.047423; Chen LQ, 2007, J INTEGR PLANT BIOL, V49, P94, DOI 10.1111/j.1744-7909.2006.00418.x; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Cheung AY, 2007, J EXP BOT, V58, P75, DOI 10.1093/jxb/erl122; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Coons JE, 2005, COLLOID SURFACE A, V263, P258, DOI 10.1016/j.colsurfa.2005.01.008; COSGROVE DJ, 1985, PLANT PHYSIOL, V78, P347, DOI 10.1104/pp.78.2.347; DARIVARICCI D, 1972, CAN J BOT, V50, P2455, DOI 10.1139/b72-316; Derksen J, 1996, BOT ACTA, V109, P341, DOI 10.1111/j.1438-8677.1996.tb00582.x; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 1999, J CELL BIOL, V144, P483, DOI 10.1083/jcb.144.3.483; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Ferguson C, 1998, PLANTA, V206, P452, DOI 10.1007/s004250050421; Franklin-Tong VE, 1999, CURR OPIN PLANT BIOL, V2, P490, DOI 10.1016/S1369-5266(99)00017-5; Gavrilova OV, 2000, RUSS J PLANT PHYSL+, V47, P789, DOI 10.1023/A:1026615413753; GEITMANN A, 1995, PROTOPLASMA, V187, P168, DOI 10.1007/BF01280245; Geitmann A, 1995, J PLANT PHYSIOL, V147, P225, DOI 10.1016/S0176-1617(11)81509-9; GEITMANN A, 1997, THESIS; Geitmann A, 2006, CAN J BOT, V84, P581, DOI 10.1139/B05-173; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, PLANT SIGNAL BEHAV, V4, P136, DOI 10.4161/psb.4.2.7633; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Gierz G, 2001, J THEOR BIOL, V208, P151, DOI 10.1006/jtbi.2000.2209; Goriely Alain, 2008, Fungal Biology Reviews, V22, P77, DOI 10.1016/j.fbr.2008.05.001; HAROLD FM, 1995, CAN J BOT, V73, pS379; Harold RL, 1996, PROTOPLASMA, V191, P105, DOI 10.1007/BF01280830; HEATH IB, 1995, CAN J BOT, V73, pS131, DOI 10.1139/b95-236; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; HESLOPHARRISON J, 1968, CAN J BOTANY, V46, P1185, DOI 10.1139/b68-158; HESLOPHARRISON J, 1985, J CELL SCI, P287; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; HILL AE, 1972, J THEOR BIOL, V36, P255, DOI 10.1016/0022-5193(72)90096-3; Hill AE, 1995, INT REV CYTOL, V163, P1, DOI 10.1016/S0074-7696(08)62208-1; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Holdaway-Clarke TL, 2003, J EXP BOT, V54, P65, DOI 10.1093/jxb/54.380.65; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; KAMINSKYJ SGW, 1992, EXP MYCOL, V16, P64, DOI 10.1016/0147-5975(92)90042-P; Kato N, 2010, PLANT PHYSIOL, V152, P590, DOI 10.1104/pp.109.148700; Ketelaar T, 2008, J MICROSC-OXFORD, V231, P265, DOI 10.1111/j.1365-2818.2008.02031.x; KNOX RB, 1970, Z PFLANZENPHYSIOL, V62, P451; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; LI YQ, 1992, PLANTA, V188, P532, DOI 10.1007/BF00197045; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Li YQ, 1996, PLANTA, V200, P41; Liu J, 2010, PLOS ONE, V5; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Lord EM, 2001, MOL BIOL CELL, V12, p193A; Malho R, 2006, PROTOPLASMA, V228, P21, DOI 10.1007/s00709-006-0162-6; Manev ED, 2005, ADV COLLOID INTERFAC, V114, P133, DOI 10.1016/j.cis.2004.07.013; McKenna ST, 2009, PLANT CELL, V21, P3026, DOI 10.1105/tpc.109.069260; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; MONEY NP, 1993, PLANTA, V190, P426; NONAMI H, 1993, PLANT PHYSIOL, V102, P13, DOI 10.1104/pp.102.1.13; PASSIOURA JB, 1992, AUST J PLANT PHYSIOL, V19, P565, DOI 10.1071/PP9920565; Pickett-Heaps JD, 1998, P ROY SOC B-BIOL SCI, V265, P1453, DOI 10.1098/rspb.1998.0457; PICTON JM, 1983, J CELL SCI, V63, P303; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; RAE AL, 1985, PLANTA, V166, P128, DOI 10.1007/BF00397395; Rojas ER, 2011, BIOPHYS J, V101, P1844, DOI 10.1016/j.bpj.2011.08.016; SCHLUPMANN H, 1993, PLANTA, V191, P470, DOI 10.1007/BF00195748; Shabala S, 2006, J EXP BOT, V57, P171, DOI 10.1093/jxb/erj022; Sogo A, 2006, INT J PLANT SCI, V167, P933, DOI 10.1086/505756; Sommer A, 2008, NEW PHYTOL, V180, P787, DOI 10.1111/j.1469-8137.2008.02607.x; Sommer A, 2007, J MEMBRANE BIOL, V215, P111, DOI 10.1007/s00232-007-9011-6; STEER MW, 1989, NEW PHYTOL, V111, P323, DOI 10.1111/j.1469-8137.1989.tb00697.x; Stewman SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-32; Stone B., 2006, E LS, DOI [10.1038/npg.els.0004111, DOI 10.1038/NPG.ELS.0004111]; Tang AC, 2003, J EXP BOT, V54, P2479, DOI 10.1093/jxb/erg265; Tang AC, 2002, J EXP BOT, V53, P489, DOI 10.1093/jexbot/53.368.489; Tindemans SH, 2006, J THEOR BIOL, V238, P937, DOI 10.1016/j.jtbi.2005.07.004; WEISENSEEL MH, 1975, J CELL BIOL, V66, P556, DOI 10.1083/jcb.66.3.556; Winship LJ, 2011, TRENDS PLANT SCI, V16, P353, DOI 10.1016/j.tplants.2011.03.010; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Yim KO, 1998, PLANT PHYSIOL, V118, P83, DOI 10.1104/pp.118.1.83; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; ZHU GL, 1992, PLANT PHYSIOL, V100, P2071, DOI 10.1104/pp.100.4.2071; Zonia L, 2006, CELL BIOCHEM BIOPHYS, V46, P209, DOI 10.1385/CBB:46:3:209; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008; Zsivanovits G, 2004, CARBOHYD RES, V339, P1317, DOI 10.1016/j.carres.2004.02.027	104	41	44	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36585	10.1371/journal.pone.0036585	http://dx.doi.org/10.1371/journal.pone.0036585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615784	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341300020
J	Kurz, K; Fiegl, M; Holzner, B; Giesinger, J; Pircher, M; Weiss, G; Denz, HA; Fuchs, D				Kurz, Katharina; Fiegl, Michael; Holzner, Bernhard; Giesinger, Johannes; Pircher, Marianna; Weiss, Guenter; Denz, Hubert A.; Fuchs, Dietmar			Fatigue in Patients with Lung Cancer Is Related with Accelerated Tryptophan Breakdown	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMMUNE ACTIVATION; SERUM TRYPTOPHAN; INDOLEAMINE 2,3-DIOXYGENASE; HEMOGLOBIN LEVELS; INTERFERON-GAMMA; DEGRADATION; DEPRESSION; ANEMIA; METABOLISM	Background: Patients with cancer often suffer from fatigue and decreased quality of life which might be related to the breakdown of essential amino acid tryptophan. Methods: In 50 patients with lung cancer we examined fatigue and the deterioration of quality of life in patients using the Functional Assessment of Cancer Therapy Anemia (FACT-An) and -Fatigue (FACT-F) subscales of FACT-General and the Mental adjustment to Cancer (MAC) questionnaires. Results were compared with tryptophan breakdown as well as serum concentrations of immune activation markers. Results: Scores of psychological tests correlated significantly with tryptophan breakdown and with circulatory markers of inflammation. However, immune activation and tryptophan breakdown were not related to MAC scores. Conclusions: Tryptophan breakdown relates with fatigue and impaired quality of life in patients with lung cancer, while declining tryptophan levels are not associated with patients'coping strategies.	[Kurz, Katharina; Fuchs, Dietmar] Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria; [Kurz, Katharina; Weiss, Guenter] Med Univ, Div Clin Immunol & Infect Dis, Dept Internal Med, Innsbruck, Austria; [Fiegl, Michael] Med Univ, Div Hematol & Oncol, Dept Internal Med, Innsbruck, Austria; [Holzner, Bernhard] Med Univ, Dept Psychiat & Psychotherapy, Innsbruck, Austria; [Giesinger, Johannes; Pircher, Marianna; Denz, Hubert A.] Hosp Natters, Div Oncol, Natters Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Kurz, K (corresponding author), Med Univ, Bioctr, Div Biol Chem, Innsbruck, Austria.	dietmar.fuchs@i-med.ac.at	Giesinger, Johannes/C-3214-2011; Fuchs, Dietmar/AAL-8011-2021	Fuchs, Dietmar/0000-0003-1627-9563; Giesinger, Johannes/0000-0003-2744-5950; Weiss, Guenter/0000-0003-0709-2158; Holzner, Bernhard/0000-0002-3389-3621	Austrian National Bank [12693]	Austrian National Bank	The study was supported by the Austrian National Bank, project no. 12693. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile Walter F., 1996, Current Opinion in Oncology, V8, P182; Bower JE, 2002, PSYCHOSOM MED, V64, P604, DOI 10.1097/00006842-200207000-00010; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; BROWN RR, 1991, ADV EXP MED BIOL, V294, P425; Capuron L, 2011, BIOL PSYCHIAT, V70, P175, DOI 10.1016/j.biopsych.2010.12.006; Carr D, 2002, Evid Rep Technol Assess (Summ), P1; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chiarugi A, 2001, J NEUROCHEM, V77, P1310, DOI 10.1046/j.1471-4159.2001.00335.x; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Curt GA, 2000, SEMIN HEMATOL, V37, P14, DOI 10.1053/shem.2000.18119; Curt GA, 2000, ONCOLOGIST S, V5, P9, DOI DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-9; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; DENZ H, 1993, CLIN INVESTIGATOR, V71, P37, DOI 10.1007/BF00210961; Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001; FUCHS D, 1993, EUR J HAEMATOL, V50, P90; FUCHS D, 1991, IMMUNOL LETT, V28, P207, DOI 10.1016/0165-2478(91)90005-U; FUCHS D, 1991, EUR J HAEMATOL, V46, P65; HAYES JR, 1991, PRIMARY CARE, V18, P327; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Hickok JT, 1996, J PAIN SYMPTOM MANAG, V11, P370, DOI 10.1016/0885-3924(96)00008-5; Holzner B, 2002, ANN ONCOL, V13, P965, DOI 10.1093/annonc/mdf122; Huang A, 2002, BRIT J CANCER, V86, P1691, DOI 10.1038/sj.bjc.6600336; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; IWAGAKI H, 1995, IMMUNOL INVEST, V24, P467, DOI 10.3109/08820139509066843; Kurzrock R, 2001, CANCER, V92, P1684, DOI 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z; Miller AH, 2008, J CLIN ONCOL, V26, P971, DOI 10.1200/JCO.2007.10.7805; MORONI F, 1988, J NEUROCHEM, V51, P177, DOI 10.1111/j.1471-4159.1988.tb04852.x; Murr C, 2000, MED HYPOTHESES, V55, P137, DOI 10.1054/mehy.1999.1043; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pirl William F, 2004, J Natl Cancer Inst Monogr, P32; Portenoy R K, 2000, Oncologist, V5, P350, DOI 10.1634/theoncologist.5-5-350; Portenoy R K, 1999, Oncologist, V4, P1; Sarcletti M, 2003, EUR J HAEMATOL, V70, P17, DOI 10.1034/j.1600-0609.2003.02810.x; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2008, BRAIN BEHAV IMMUN, V22, P881, DOI 10.1016/j.bbi.2007.12.011; Schroecksnadel K, 2005, CANCER LETT, V223, P323, DOI 10.1016/j.canlet.2004.10.033; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Stone P, 1998, EUR J CANCER, V34, P1670, DOI 10.1016/S0959-8049(98)00167-1; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Thornton LM, 2009, PSYCHOSOM MED, V71, P715, DOI 10.1097/PSY.0b013e3181b0545c; Visser MRM, 1998, SUPPORT CARE CANCER, V6, P101, DOI 10.1007/s005200050142; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Watson M, 2008, PSYCHO-ONCOLOGY, V17, P1146, DOI 10.1002/pon.1345; WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026; Weiss G, 2004, EUR J HAEMATOL, V72, P130, DOI 10.1046/j.0902-4441.2003.00197.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WERNER ER, 1989, BIOCHEM J, V262, P861, DOI 10.1042/bj2620861; Widner B, 1997, CLIN CHEM, V43, P2424; Widner B, 2002, BRAIN BEHAV IMMUN, V16, P590, DOI 10.1016/S0889-1591(02)00006-5; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Yirmiya R, 2000, ANN NY ACAD SCI, V917, P478	56	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36956	10.1371/journal.pone.0036956	http://dx.doi.org/10.1371/journal.pone.0036956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615854	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300047
J	Signer-Hasler, H; Flury, C; Haase, B; Burger, D; Simianer, H; Leeb, T; Rieder, S				Signer-Hasler, Heidi; Flury, Christine; Haase, Bianca; Burger, Dominik; Simianer, Henner; Leeb, Tosso; Rieder, Stefan			A Genome-Wide Association Study Reveals Loci Influencing Height and Other Conformation Traits in Horses	PLOS ONE			English	Article							OPTIMUM RACING DISTANCE; THOROUGHBRED RACEHORSES; MISSING HERITABILITY; BREEDING VALUES; COMMON SNPS; SELECTION; INFORMATION; POPULATION; SEQUENCE; CATTLE	The molecular analysis of genes influencing human height has been notoriously difficult. Genome-wide association studies (GWAS) for height in humans based on tens of thousands to hundreds of thousands of samples so far revealed similar to 200 loci for human height explaining only 20% of the heritability. In domestic animals isolated populations with a greatly reduced genetic heterogeneity facilitate a more efficient analysis of complex traits. We performed a genome-wide association study on 1,077 Franches-Montagnes (FM) horses using similar to 40,000 SNPs. Our study revealed two QTL for height at withers on chromosomes 3 and 9. The association signal on chromosome 3 is close to the LCORL/NCAPG genes. The association signal on chromosome 9 is close to the ZFAT gene. Both loci have already been shown to influence height in humans. Interestingly, there are very large intergenic regions at the association signals. The two detected QTL together explain similar to 18.2% of the heritable variation of height in horses. However, another large fraction of the variance for height in horses results from ECA 1 (11.0%), although the association analysis did not reveal significantly associated SNPs on this chromosome. The QTL region on ECA 3 associated with height at withers was also significantly associated with wither height, conformation of legs, ventral border of mandible, correctness of gaits, and expression of the head. The region on ECA 9 associated with height at withers was also associated with wither height, length of croup and length of back. In addition to these two QTL regions on ECA 3 and ECA 9 we detected another QTL on ECA 6 for correctness of gaits. Our study highlights the value of domestic animal populations for the genetic analysis of complex traits.	[Signer-Hasler, Heidi; Flury, Christine] Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland; [Haase, Bianca; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Haase, Bianca] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Burger, Dominik; Rieder, Stefan] Swiss Natl Stud Farm SNSTF, Agroscope Liebefeld Posieux Res Stn Agroscope Lie, Avenches, Switzerland; [Simianer, Henner] Univ Gottingen, Dept Anim Sci, Gottingen, Germany	University of Bern; University of Sydney; Swiss Federal Research Station Agroscope; University of Gottingen	Signer-Hasler, H (corresponding author), Bern Univ Appl Sci, Sch Agr Forest & Food Sci, Zollikofen, Switzerland.	stefan.rieder@haras.admin.ch	Simianer, Henner/A-6574-2015; Leeb, Tosso/G-3187-2014	Simianer, Henner/0000-0002-7551-3797; Leeb, Tosso/0000-0003-0553-4880; Waud, Bianca/0000-0001-6493-9808; Flury, Christine/0000-0002-8649-5571	Swiss Federal Office for Agriculture; Fondation Sur-la-Croix; Swiss Foundation for Grants in Biology and Medicine	Swiss Federal Office for Agriculture; Fondation Sur-la-Croix; Swiss Foundation for Grants in Biology and Medicine	This study was financed by grants from the Swiss Federal Office for Agriculture, and the Fondation Sur-la-Croix. BH is funded by the Swiss Foundation for Grants in Biology and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bellone RR, 2010, ANIM GENET, V41, P100, DOI 10.1111/j.1365-2052.2010.02116.x; Binns MM, 2010, ANIM GENET, V41, P154, DOI 10.1111/j.1365-2052.2010.02126.x; Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x; Chowdhary BP, 2008, CHROMOSOME RES, V16, P109, DOI 10.1007/s10577-008-1204-z; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Habier D, 2010, J ANIM BREED GENET, V127, P336, DOI 10.1111/j.1439-0388.2010.00897.x; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hasler H, 2011, J ANIM BREED GENET, V128, P394, DOI 10.1111/j.1439-0388.2011.00932.x; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; KOENEN EPC, 1995, LIVEST PROD SCI, V43, P85, DOI 10.1016/0301-6226(95)00010-I; Kutalik Z, 2011, GENET EPIDEMIOL, V35, P341, DOI 10.1002/gepi.20582; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meuwissen THE, 2001, GENETICS, V157, P1819; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Poncet PA, 2006, J ANIM BREED GENET, V123, P114, DOI 10.1111/j.1439-0388.2006.00569.x; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rieder S, 2009, J ANIM BREED GENET, V126, P415, DOI 10.1111/j.1439-0388.2009.00832.x; Saastamoinen MT, 2000, GENETICS OF THE HORSE, P439, DOI 10.1079/9780851994291.0439; Sargolzaei M, 2006, P 8 WORLD C GEN APPL; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Tozaki T, 2012, ANIM GENET, V43, P42, DOI 10.1111/j.1365-2052.2011.02201.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2011, NAT GENET, V43, P397, DOI 10.1038/ng.819; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	37	107	115	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37282	10.1371/journal.pone.0037282	http://dx.doi.org/10.1371/journal.pone.0037282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615965	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300096
J	Squires, ZE; Wong, BBM; Norman, MD; Stuart-Fox, D				Squires, Zoe E.; Wong, Bob B. M.; Norman, Mark D.; Stuart-Fox, Devi			Multiple Fitness Benefits of Polyandry in a Cephalopod	PLOS ONE			English	Article							MICROSATELLITE DNA MARKERS; SQUID LOLIGO-PEALEII; GENETIC INCOMPATIBILITY; SPERM COMPETITION; OFFSPRING SIZE; EMBRYONIC-DEVELOPMENT; MARINE INVERTEBRATE; MATERNAL INVESTMENT; GIANT CUTTLEFISH; FEMALE FITNESS	Background: Sex differences in reproductive investment play a crucial role in sexual conflict. One intriguing aspect of sexual conflict is the evolution of female multiple mating (polyandry), particularly in systems where females receive no obvious direct benefits from males, and where mating is highly costly. Here, theory predicts that polyandrous females can increase their reproductive success by taking advantage of the genetic benefits of mating with multiple males. Cephalopods provide a model system for addressing this question, as all species mate multiply. Here we examine differences in reproductive success between monandrous, multiply mated (to the same male) and polyandrous female dumpling squid (Euprymna tasmanica). Methodology/Principal Findings: We mated females in the laboratory with two different males (polyandrous; controlling for mating order), or with a single male (monandrous). To control for mating frequency, we mated monandrous females either once (monandrous 1), or with the same male twice (monandrous 2), and measured reproductive success for each of the three treatments (polyandrous, monandrous 1, monandrous 2). Females mated to two different males produced eggs faster and had larger hatchlings relative to egg mass than females mated once with a single male. Conclusions/Significance: The benefits of polyandry demonstrated here are the first, to our knowledge, in any cephalopod. These benefits may outweigh the significant costs associated with mating and help to explain how multiple mating has evolved (or is maintained) in this group.	[Squires, Zoe E.; Stuart-Fox, Devi] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Norman, Mark D.] Museum Victoria, Dept Sci, Melbourne, Vic, Australia	University of Melbourne; Monash University; Museum Victoria	Squires, ZE (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	z.squires@student.unimelb.edu.au		Wong, Bob/0000-0001-9352-6500; Stuart-Fox, Devi/0000-0003-3362-1412; Squires, Zoe/0000-0002-3878-6753	Hermon Slade Foundation; Holsworth Wildlife Endowment; Museum Victoria [1854]; Victorian Marine Science Consortium	Hermon Slade Foundation; Holsworth Wildlife Endowment; Museum Victoria; Victorian Marine Science Consortium	This project has been funded by the Hermon Slade Foundation (http://www.hermonslade.org.au/), the Holsworth Wildlife Endowment (http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/), Museum Victoria (1854 Studentship http://museumvictoria.com.au/) and the Victorian Marine Science Consortium (http://www.vmsc.org.au/). These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Boletzky SV, 2003, ADV MAR BIOL, V44, P143, DOI 10.1016/S0065-2881(03)44003-0; BOUCHAUD O, 1990, COMP BIOCHEM PHYS B, V97, P611, DOI 10.1016/0305-0491(90)90168-S; Buresch KC, 2009, MAR ECOL PROG SER, V387, P197, DOI 10.3354/meps08052; Buresch KM, 2001, MAR ECOL PROG SER, V210, P161, DOI 10.3354/meps210161; Byrne PG, 2011, BEHAV ECOL, V22, P385, DOI 10.1093/beheco/arq153; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Chilvers BL, 2005, CAN J ZOOL, V83, P642, DOI 10.1139/Z05-048; Du WG, 2010, BIOL J LINN SOC, V101, P59, DOI 10.1111/j.1095-8312.2010.01492.x; Emery AM, 2001, MOL ECOL, V10, P1265, DOI 10.1046/j.1365-294X.2001.01258.x; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Fox CW, 2003, EVOL ECOL RES, V5, P273; Gowaty PA, 2010, P NATL ACAD SCI USA, V107, P13771, DOI 10.1073/pnas.1006174107; Griffith SC, 2010, EMU, V110, P251, DOI 10.1071/MU10006; Hanlon RT, 1999, MAR BIOL, V134, P719, DOI 10.1007/s002270050588; Hanlon RT, 1996, CEPHALOPOD BEHAV; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hoving HJT, 2007, BIOL BULL-US, V212, P177, DOI 10.2307/25066599; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kekalainen J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-20; Lewontin R, 1965, SELECTION COLONISING, P77; Maklakov AA, 2006, BIOL LETTERS, V2, P62, DOI 10.1098/rsbl.2005.0398; MANN T, 1966, NATURE, V211, P1279, DOI 10.1038/2111279a0; Marshall DJ, 2003, ECOLOGY, V84, P3131, DOI 10.1890/02-0311; Marshall DJ, 2007, BIOLOGY LETT, V3, P685, DOI 10.1098/rsbl.2007.0438; McCormick MI, 1999, OECOLOGIA, V118, P412, DOI 10.1007/s004420050743; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Naud MJ, 2006, MAR BIOL, V148, P559, DOI 10.1007/s00227-005-0109-z; Naud MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1047, DOI 10.1098/rspb.2004.3031; Omkar, 2010, J ASIA-PAC ENTOMOL, V13, P151, DOI 10.1016/j.aspen.2010.01.001; Pakkasmaa S, 2001, EVOL ECOL, V15, P143, DOI 10.1023/A:1013873810905; Pakkasmaa S, 2006, J COMP PHYSIOL B, V176, P387, DOI 10.1007/s00360-005-0057-4; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Shaw PW, 1997, MAR ECOL PROG SER, V160, P279, DOI 10.3354/meps160279; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; South A, 2011, BIOL REV, V86, P299, DOI 10.1111/j.1469-185X.2010.00145.x; Sprenger D, 2008, J ANIM ECOL, V77, P696, DOI 10.1111/j.1365-2656.2008.01376.x; Sprenger D, 2008, MAR BIOL, V153, P891, DOI 10.1007/s00227-007-0861-3; Steer MA, 2004, J EXP MAR BIOL ECOL, V307, P73, DOI 10.1016/j.jembe.2004.01.017; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Sykes AV, 2009, AQUACULT NUTR, V15, P38, DOI 10.1111/j.1365-2095.2008.00566.x; Tregenza T, 2003, NATURE, V423, P929, DOI 10.1038/423929a; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wedell N, 2009, BIOL LETTERS, V5, P678, DOI 10.1098/rsbl.2009.0452; Weigensberg I, 1998, J EVOLUTION BIOL, V11, P135, DOI 10.1007/s000360050071; Wolfner MF, 2009, J HERED, V100, P399, DOI 10.1093/jhered/esp013; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	54	24	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37074	10.1371/journal.pone.0037074	http://dx.doi.org/10.1371/journal.pone.0037074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615896	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300064
J	Yutin, N; Puigbo, P; Koonin, EV; Wolf, YI				Yutin, Natalya; Puigbo, Pere; Koonin, Eugene V.; Wolf, Yuri I.			Phylogenomics of Prokaryotic Ribosomal Proteins	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ANGSTROM RESOLUTION; ARCHAEAL GENOMES; EVOLUTION; SUBUNIT; LIFE; BACTERIAL; DOMAIN; TREES; EUKARYOTES	Archaeal and bacterial ribosomes contain more than 50 proteins, including 34 that are universally conserved in the three domains of cellular life (bacteria, archaea, and eukaryotes). Despite the high sequence conservation, annotation of ribosomal (r-) protein genes is often difficult because of their short lengths and biased sequence composition. We developed an automated computational pipeline for identification of r-protein genes and applied it to 995 completely sequenced bacterial and 87 archaeal genomes available in the RefSeq database. The pipeline employs curated seed alignments of r-proteins to run position-specific scoring matrix (PSSM)-based BLAST searches against six-frame genome translations, mitigating possible gene annotation errors. As a result of this analysis, we performed a census of prokaryotic r-protein complements, enumerated missing and paralogous r-proteins, and analyzed the distributions of ribosomal protein genes among chromosomal partitions. Phyletic patterns of bacterial and archaeal r-protein genes were mapped to phylogenetic trees reconstructed from concatenated alignments of r-proteins to reveal the history of likely multiple independent gains and losses. These alignments, available for download, can be used as search profiles to improve genome annotation of r-proteins and for further comparative genomics studies.	[Yutin, Natalya; Puigbo, Pere; Koonin, Eugene V.; Wolf, Yuri I.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yutin, N (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	wolf@ncbi.nlm.nih.gov	Puigbò, Pere/A-2214-2008; Puigbo, Pere/AAL-5286-2021	Puigbo, Pere/0000-0002-0072-8726; Wolf, Yuri/0000-0002-0247-8708	Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine); NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are supported by the Department of Health and Human Services intramural program (National Institutes of Health, National Library of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Battistuzzi FU, 2009, MOL BIOL EVOL, V26, P335, DOI 10.1093/molbev/msn247; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brochier C, 2002, TRENDS GENET, V18, P1, DOI 10.1016/S0168-9525(01)02522-7; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chen K, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-179; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Forterre P, 2002, THEOR POPUL BIOL, V61, P409, DOI 10.1006/tpbi.2002.1592; Fournier GP, 2010, MOL BIOL EVOL, V27, P1792, DOI 10.1093/molbev/msq057; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hughes T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-213; Izutsu K, 2001, J BACTERIOL, V183, P2765, DOI 10.1128/JB.183.9.2765-2773.2001; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kunisawa T, 2011, ANTON LEEUW INT J G, V99, P417, DOI 10.1007/s10482-010-9492-7; Lathe WC, 2000, TRENDS BIOCHEM SCI, V25, P474, DOI 10.1016/S0968-0004(00)01663-7; Lecompte O, 2002, NUCLEIC ACIDS RES, V30, P5382, DOI 10.1093/nar/gkf693; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; MAKAROVA KS, 2001, GENOME BIOL, V2; Mardanov AV, 2010, APPL ENVIRON MICROB, V76, P5652, DOI 10.1128/AEM.00599-10; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Matte-Tailliez O, 2002, MOL BIOL EVOL, V19, P631, DOI 10.1093/oxfordjournals.molbev.a004122; Mushegian A, 2005, RNA, V11, P1400, DOI 10.1261/rna.2180205; MYERS WM, 1946, GENETICS, V31, P225; Nishida H, 2011, GENOMICS, V98, P370, DOI 10.1016/j.ygeno.2011.08.001; Osipiuk J, 2001, ACTA CRYSTALLOGR D, V57, P1747, DOI 10.1107/S0907444901014019; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Roberts E, 2008, P NATL ACAD SCI USA, V105, P13953, DOI 10.1073/pnas.0804861105; Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P2212, DOI 10.1093/nar/30.10.2212; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Smith TF, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-16; Spring S, 1998, ARCH MICROBIOL, V169, P136, DOI 10.1007/s002030050553; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-66; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Veitia RA, 2010, FASEB J, V24, P994, DOI 10.1096/fj.09-146969; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Wang Jiachen, 2009, Archaea, V2, P241, DOI 10.1155/2009/971494; Williams D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-45; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Williamson JR, 2009, CELL, V139, P1041, DOI 10.1016/j.cell.2009.11.028; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolf YI, 1999, GENOME RES, V9, P689; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9	62	164	166	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36972	10.1371/journal.pone.0036972	http://dx.doi.org/10.1371/journal.pone.0036972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615861	Green Published, gold			2022-12-27	WOS:000305341300050
J	Robinson, PW; Costa, DP; Crocker, DE; Gallo-Reynoso, JP; Champagne, CD; Fowler, MA; Goetsch, C; Goetz, KT; Hassrick, JL; Huckstadt, LA; Kuhn, CE; Maresh, JL; Maxwell, SM; McDonald, BI; Peterson, SH; Simmons, SE; Teutschel, NM; Villegas-Amtmann, S; Yoda, K				Robinson, Patrick W.; Costa, Daniel P.; Crocker, Daniel E.; Pablo Gallo-Reynoso, Juan; Champagne, Cory D.; Fowler, Melinda A.; Goetsch, Chandra; Goetz, Kimberly T.; Hassrick, Jason L.; Hueckstaedt, Luis A.; Kuhn, Carey E.; Maresh, Jennifer L.; Maxwell, Sara M.; McDonald, Birgitte I.; Peterson, Sarah H.; Simmons, Samantha E.; Teutschel, Nicole M.; Villegas-Amtmann, Stella; Yoda, Ken			Foraging Behavior and Success of a Mesopelagic Predator in the Northeast Pacific Ocean: Insights from a Data-Rich Species, the Northern Elephant Seal	PLOS ONE			English	Article							MIROUNGA-LEONINA; MARINE PREDATOR; DIVING BEHAVIOR; TOP PREDATOR; MIGRATION; TRACKING; HABITAT; CONSEQUENCES; MOVEMENTS; BUOYANCY	The mesopelagic zone of the northeast Pacific Ocean is an important foraging habitat for many predators, yet few studies have addressed the factors driving basin-scale predator distributions or inter-annual variability in foraging and breeding success. Understanding these processes is critical to reveal how conditions at sea cascade to population-level effects. To begin addressing these challenging questions, we collected diving, tracking, foraging success, and natality data for 297 adult female northern elephant seal migrations from 2004 to 2010. During the longer post-molting migration, individual energy gain rates were significant predictors of pregnancy. At sea, seals focused their foraging effort along a narrow band corresponding to the boundary between the sub-arctic and sub-tropical gyres. In contrast to shallow-diving predators, elephant seals target the gyre-gyre boundary throughout the year rather than follow the southward winter migration of surface features, such as the Transition Zone Chlorophyll Front. We also assessed the impact of added transit costs by studying seals at a colony near the southern extent of the species' range, 1,150 km to the south. A much larger proportion of seals foraged locally, implying plasticity in foraging strategies and possibly prey type. While these findings are derived from a single species, the results may provide insight to the foraging patterns of many other meso-pelagic predators in the northeast Pacific Ocean.	[Robinson, Patrick W.; Costa, Daniel P.; Champagne, Cory D.; Fowler, Melinda A.; Goetsch, Chandra; Goetz, Kimberly T.; Hassrick, Jason L.; Hueckstaedt, Luis A.; Maresh, Jennifer L.; Maxwell, Sara M.; Peterson, Sarah H.; Teutschel, Nicole M.; Villegas-Amtmann, Stella] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA; [Pablo Gallo-Reynoso, Juan] Ctr Invest Alimentac & Desarrollo AC, Unidad Guaymas, Guaymas, Sonora, Mexico; [Kuhn, Carey E.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Seattle, WA USA; [McDonald, Birgitte I.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Simmons, Samantha E.] Marine Mammal Commiss, Bethesda, MD USA; [Simmons, Samantha E.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan	University of California System; University of California Santa Cruz; California State University System; Sonoma State University; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Santa Cruz; Nagoya University	Robinson, PW (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	robinson@biology.ucsc.edu	Goetz, Kimberly/AID-8232-2022; Huckstadt, Luis A./J-8532-2019; Hassrick, Jason/AAE-4905-2020; Huckstadt, Luis/A-5838-2018; McDonald, Birgitte I/I-3602-2019; Costa, Daniel/E-2616-2013	Huckstadt, Luis A./0000-0002-2453-7350; Huckstadt, Luis/0000-0002-2453-7350; McDonald, Birgitte I/0000-0001-5028-066X; Peterson, Sarah/0000-0003-2773-3901; Simmons, Samantha/0000-0003-0326-6990; Costa, Daniel/0000-0002-0233-5782; Gallo, Juan P./0000-0003-1156-6037; Maxwell, Sara/0000-0002-4425-9378	National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, N00014-10-1-0356]; National Science Foundation (NSF) [ANT-0838937]; National Oceanic and Atmospheric Administration Ocean (NOAA); International Association of Oil and Gas Producers [JIP2207-23]; California Sea Grant program; University of California Natural Reserve System; Moore Foundation; Packard Foundation; Sloan Foundation; Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; Myers Oceanographic Trust; Friends of the Long Marine Lab; Sooy Graduate Fellowship	National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Ocean (NOAA); International Association of Oil and Gas Producers; California Sea Grant program; University of California Natural Reserve System; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; Myers Oceanographic Trust; Friends of the Long Marine Lab; Sooy Graduate Fellowship	This research was conducted as part of the Tagging of Pacific Predators (TOPP) program and was supported in part by the National Ocean Partnership Program (N00014-02-1-1012); the Office of Naval Research (N00014-00-10880, N00014-03-1-0651, N00014-08-1-1195, and N00014-10-1-0356); the National Science Foundation (NSF) Office of Polar Programs grant ANT-0838937; the National Oceanic and Atmospheric Administration Ocean (NOAA) Exploration Program; the E&P Sound and Marine Life Joint Industry Project of the International Association of Oil and Gas Producers (JIP2207-23); California Sea Grant program; NSF pre-doctoral fellowships to BM, CG, JH, and SM; the University of California Natural Reserve System Mildred E. Mathias Fellowship; the Moore, Packard, and Sloan Foundations; the Ida Benson Lynn Endowed Chair in Ocean Health; Steve Blank; The Myers Oceanographic Trust; Friends of the Long Marine Lab; and the Sooy Graduate Fellowship. The findings and conclusions in the paper are those of the authors and do not necessarily represent the views of the National Marine Fisheries Service, NOAA. Reference to trade names does not imply endorsement by the National Marine Fisheries Service, NOAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, INTEGR COMP BIOL, V45, P305, DOI 10.1093/icb/45.2.305; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Boehlert GW, 2001, J ATMOS OCEAN TECH, V18, P1882, DOI 10.1175/1520-0426(2001)018<1882:APESUI>2.0.CO;2; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BOYD IL, 1991, POLAR BIOL, V11, P259, DOI 10.1007/BF00238460; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; COSTA DP, 1991, AM ZOOL, V31, P111; Crocker DE, 2006, MAR ECOL PROG SER, V309, P1, DOI 10.3354/meps309001; Crocker DE, 2001, ECOLOGY, V82, P3541, DOI 10.2307/2680171; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FROST BW, 1979, FISH B-NOAA, V76, P751; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hassrick JL, 2010, J EXP BIOL, V213, P585, DOI 10.1242/jeb.037168; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Holdsworth JC, 2009, MAR BIOL, V156, P505, DOI 10.1007/s00227-008-1104-y; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; le Boeuf B.J., 1988, P344; Le Boeuf BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-9; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Le Boeuf Burney J., 1994, P121; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REITER J, 1981, ANIM BEHAV, V29, P670, DOI 10.1016/S0003-3472(81)80002-4; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Simmons S. E., 2008, THESIS U CALIFORNIA; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Simmons Samantha E., 2010, Endangered Species Research, V10, P233, DOI 10.3354/esr00254; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; Webb PM, 1998, J EXP BIOL, V201, P2349; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	59	152	152	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36728	10.1371/journal.pone.0036728	http://dx.doi.org/10.1371/journal.pone.0036728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615801	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300031
J	Christie, DA; Kirchhof, MG; Vardhana, S; Dustin, ML; Madrenas, J				Christie, Darah A.; Kirchhof, Mark G.; Vardhana, Santosh; Dustin, Michael L.; Madrenas, Joaquin			Mitochondrial and Plasma Membrane Pools of Stomatin-Like Protein 2 Coalesce at the Immunological Synapse during T Cell Activation	PLOS ONE			English	Article							RAFT PROTEOME REVEALS; ATP SYNTHASE COMPLEX; LIPID RAFTS; ANTIGEN RECEPTOR; ASSOCIATION; PHOSPHORYLATION; PROHIBITINS; LIGATION; REQUIRES; SURFACE	Stomatin-like protein 2 (SLP-2) is a member of the stomatin - prohibitin - flotillin - HflC/K (SPFH) superfamily. Recent evidence indicates that SLP-2 is involved in the organization of cardiolipin-enriched microdomains in mitochondrial membranes and the regulation of mitochondrial biogenesis and function. In T cells, this role translates into enhanced T cell activation. Although the major pool of SLP-2 is associated with mitochondria, we show here that there is an additional pool of SLP-2 associated with the plasma membrane of T cells. Both plasma membrane-associated and mitochondria-associated pools of SLP-2 coalesce at the immunological synapse (IS) upon T cell activation. SLP-2 is not required for formation of IS nor for the re-localization of mitochondria to the IS because SLP-2-deficient T cells showed normal re-localization of these organelles in response to T cell activation. Interestingly, upon T cell activation, we found the surface pool of SLP-2 mostly excluded from the central supramolecular activation complex, and enriched in the peripheral area of the IS where signalling TCR microclusters are located. Based on these results, we propose that SLP-2 facilitates the compartmentalization not only of mitochondrial membranes but also of the plasma membrane into functional microdomains. In this latter location, SLP-2 may facilitate the optimal assembly of TCR signalosome components. Our data also suggest that there may be a net exchange of membrane material between mitochondria and plasma membrane, explaining the presence of some mitochondrial proteins in the plasma membrane.	[Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Ctr Human Immunol, Robarts Res Inst, London, ON, Canada; [Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Christie, Darah A.; Kirchhof, Mark G.; Madrenas, Joaquin] Univ Western Ontario, Dept Med, London, ON, Canada; [Vardhana, Santosh; Dustin, Michael L.] Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY USA; [Madrenas, Joaquin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University	Christie, DA (corresponding author), Univ Western Ontario, Ctr Human Immunol, Robarts Res Inst, London, ON, Canada.	joaquin.madrenas@mcgill.ca	Madrenas, Quim/P-5008-2019; Dustin, Michael/AAM-4611-2020	Vardhana, Santosha/0000-0002-3100-1298; Dustin, Michael/0000-0003-4983-6389	CIHR [82794]; United States National Institutes of Health [AI43542]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R37AI043542] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by grants from CIHR (82794) and the United States National Institutes of Health (AI43542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; [Anonymous], 2008, REV CHILENA INFECT O, V25, P387; Apt W, 2008, REV CHIL INFECTOL, V25, P384, DOI /S0716-10182008000500013; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Baroja ML, 1999, J IMMUNOL, V162, P2016; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Da Cruz S, 2010, CELL CALCIUM, V47, P11, DOI 10.1016/j.ceca.2009.10.005; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Gascoigne NRJ, 2004, CURR OPIN IMMUNOL, V16, P114, DOI 10.1016/j.coi.2003.11.008; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kirchhof MG, 2008, J IMMUNOL, V181, P1927, DOI 10.4049/jimmunol.181.3.1927; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Snyers L, 1997, EUR J CELL BIOL, V73, P281; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; Soubannier V, 2012, CURRENT BIOL CB; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tomas EM, 2002, IMMUNOL LETT, V83, P143, DOI 10.1016/S0165-2478(02)00075-5; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wang YQ, 2009, CANCER BIOL THER, V8, P1658, DOI 10.4161/cbt.8.17.9283; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	47	29	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37144	10.1371/journal.pone.0037144	http://dx.doi.org/10.1371/journal.pone.0037144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623988	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500065
J	Mantele, S; Otway, DT; Middleton, B; Bretschneider, S; Wright, J; Robertson, MD; Skene, DJ; Johnston, JD				Maentele, Simone; Otway, Daniella T.; Middleton, Benita; Bretschneider, Silvia; Wright, John; Robertson, M. Denise; Skene, Debra J.; Johnston, Jonathan D.			Daily Rhythms of Plasma Melatonin, but Not Plasma Leptin or Leptin mRNA, Vary between Lean, Obese and Type 2 Diabetic Men	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; ADIPOSE-TISSUE; CIRCADIAN-RHYTHMS; INSULIN; GLUCOSE; SECRETION; MTNR1B	Melatonin and leptin exhibit daily rhythms that may contribute towards changes in metabolic physiology. It remains unclear, however, whether this rhythmicity is altered in obesity or type 2 diabetes (T2DM). We tested the hypothesis that 24hour profiles of melatonin, leptin and leptin mRNA are altered by metabolic status in laboratory conditions. Men between 45-65 years old were recruited into lean, obese-non-diabetic or obese-T2DM groups. Volunteers followed strict sleep-wake and dietary regimes for 1 week before the laboratory study. They were then maintained in controlled light-dark conditions, semi-recumbent posture and fed hourly iso-energetic drinks during wake periods. Hourly blood samples were collected for hormone analysis. Subcutaneous adipose biopsies were collected 6-hourly for gene expression analysis. Although there was no effect of subject group on the timing of dim light melatonin onset (DLMO), nocturnal plasma melatonin concentration was significantly higher in obese-non-diabetic subjects compared to weight-matched T2DM subjects (p<0.01) and lean controls (p<0.05). Two T2DM subjects failed to produce any detectable melatonin, although did exhibit plasma cortisol rhythms comparable to others in the group. Consistent with the literature, there was a significant (p<0.001) effect of subject group on absolute plasma leptin concentration and, when expressed relative to an individual's 24-hour mean, plasma leptin showed significant (p<0.001) diurnal variation. However, there was no difference in amplitude or timing of leptin rhythms between experimental groups. There was also no significant effect of time on leptin mRNA expression. Despite an overall effect (p<0.05) of experimental group, post-hoc analysis revealed no significant pair-wise effects of group on leptin mRNA expression. Altered plasma melatonin rhythms in weight-matched T2DM and non-diabetic individuals supports a possible role of melatonin in T2DM aetiology. However, neither obesity nor T2DM changed 24-hour rhythms of plasma leptin relative to cycle mean, or expression of subcutaneous adipose leptin gene expression, compared with lean subjects.	[Maentele, Simone; Otway, Daniella T.; Middleton, Benita; Bretschneider, Silvia; Wright, John; Robertson, M. Denise; Skene, Debra J.; Johnston, Jonathan D.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Mantele, S (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	j.johnston@surrey.ac.uk	Johnston, Jonathan/AAS-6969-2021; Johnston, Jonathan D/H-6363-2011	Johnston, Jonathan D/0000-0001-8083-9794; Skene, Debra/0000-0001-8202-6180	Diabetes-UK [08/0003607]; BBSRC [BB/D526853/1]; Stockgrand Ltd., UK	Diabetes-UK(Diabetes UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Stockgrand Ltd., UK	This work was funded by Diabetes-UK (grant 08/0003607), BBSRC (grant BB/D526853/1) and Stockgrand Ltd., UK (studentship stipend to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT J, 1982, CLIN ENDOCRINOL, V16, P89, DOI 10.1111/j.1365-2265.1982.tb03151.x; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; FRASER S, 1983, CLIN CHEM, V29, P396; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hall JE, 2001, AM J HYPERTENS, V14, p103S, DOI 10.1016/S0895-7061(01)02077-5; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Hikichi T, 2011, CLIN OPHTHALMOL, V5, P655, DOI 10.2147/OPTH.S19559; Johnston JD, 2009, OBES REV, V10, P52, DOI 10.1111/j.1467-789X.2009.00665.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2012, MOL CELL ENDOCRINOL, V349, P45, DOI 10.1016/j.mce.2011.05.008; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Mulder H, 2009, DIABETOLOGIA, V52, P1240, DOI 10.1007/s00125-009-1359-y; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; OBRIEN IAD, 1986, CLIN ENDOCRINOL, V24, P359, DOI 10.1111/j.1365-2265.1986.tb01639.x; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Otway DT, 2009, CHRONOBIOL INT, V26, P1340, DOI 10.3109/07420520903412368; Peschke E, 2006, J PINEAL RES, V40, P135, DOI 10.1111/j.1600-079X.2005.00287.x; Peschke E, 2010, J PINEAL RES, V49, P373, DOI 10.1111/j.1600-079X.2010.00804.x; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Rahmouni K, 2010, CURR HYPERTENS REV, V6, P104, DOI 10.2174/157340210791170994; Read GF, 1977, ANN CLIN BIOCHEM, V14, P343; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Sinha MK, 1996, BIOCHEM BIOPH RES CO, V228, P733, DOI 10.1006/bbrc.1996.1724; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Tutuncu NB, 2005, J PINEAL RES, V39, P43, DOI 10.1111/j.1600-079X.2005.00213.x; Wagner GC, 2007, EUR J NEUROSCI, V25, P485, DOI 10.1111/j.1460-9568.2006.05291.x; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Zeman M, 2009, J HYPERTENS, V27, pS21, DOI 10.1097/01.hjh.0000358833.41181.f6; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zvonic S, 2006, DIABETES, V55, P692	43	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37123	10.1371/journal.pone.0037123	http://dx.doi.org/10.1371/journal.pone.0037123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623983	Green Published, gold			2022-12-27	WOS:000305343500060
J	McGuire, TF; Sajithlal, GB; Lu, J; Nicholls, RD; Prochownik, EV				McGuire, Terence F.; Sajithlal, Gangadharan B.; Lu, Jie; Nicholls, Robert D.; Prochownik, Edward V.			In Vivo Evolution of Tumor-Derived Endothelial Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENETIC ALTERATIONS; ARTERIAL DIFFERENTIATION; MOLECULAR-MECHANISMS; COPY-NUMBER; ANGIOGENESIS; BEVACIZUMAB; EXPRESSION; GROWTH; STROMA	The growth of a malignant tumor beyond a certain, limited size requires that it first develop an independent blood supply. In addition to providing metabolic support, this neovasculature also allows tumor cells to access the systemic circulation, thus facilitating metastatic dissemination. The neovasculature may originate either from normal blood vessels in close physical proximity to the tumor and/or from the recruitment of bone marrow-derived endothelial cell (EC) precursors. Recent studies have shown that human tumor vasculature ECs may also arise directly from tumor cells themselves and that the two populations have highly similar or identical karyotypes. We now show that, during the course of serial in vivo passage, these tumor-derived ECs (TDECs) progressively acquire more pronounced EC-like properties. These include higher-level expression of EC-specific genes and proteins, a greater capacity for EC-like behavior in vitro, and a markedly enhanced propensity to incorporate into the tumor vasculature. In addition, both vessel density and size are significantly increased in neoplasms derived from mixtures of tumor cells and serially passaged TDECs. A comparison of early-and late-passage TDECs using whole-genome single nucleotide polymorphism profiling showed the latter cells to have apparently evolved by a process of clonal expansion of a population with a distinct pattern of interstitial chromosomal gains and losses affecting a relatively small number of genes. The majority of these have established roles in vascular development, tumor suppression or epithelial-mesenchymal transition. These studies provide direct evidence that TDECs have a strong evolutionary capacity as a result of their inherent genomic instability. Consequently such cells might be capable of escaping anti-angiogenic cancer therapies by generating resistant populations.	[McGuire, Terence F.; Sajithlal, Gangadharan B.; Lu, Jie; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA; [Nicholls, Robert D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Birth Defect Labs,Div Genet, Pittsburgh, PA USA; [Nicholls, Robert D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Nicholls, Robert D.; Prochownik, Edward V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McGuire, TF (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Hematol Oncol, Pittsburgh, PA USA.	procev@chp.edu			National Institutes of Health [CA140624]; NATIONAL CANCER INSTITUTE [R01CA140624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from National Institutes of Health to EVP (CA140624). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelrahim M, 2010, INT J ONCOL, V36, P5, DOI 10.3892/ijo_00000470; Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; Cao YH, 2009, FRONT BIOSCI-LANDMRK, V14, P3962, DOI [10.2741/3504, 10.2735/3504]; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Davison EJ, 2005, GENE CHROMOSOME CANC, V44, P384, DOI 10.1002/gcc.20252; Dome B, 2008, CYTOM PART A, V73A, P186, DOI 10.1002/cyto.a.20480; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Haines BP, 2008, GENE EXPR PATTERNS, V8, P79, DOI 10.1016/j.modgep.2007.10.003; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jenab-Wolcott J, 2009, EXPERT OPIN BIOL TH, V9, P507, DOI [10.1517/14712590902817817, 10.1517/14712590902817817 ]; Johannsdottir HK, 2006, INT J CANCER, V119, P1052, DOI 10.1002/ijc.21934; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larrivee B., 2007, V180, P89; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Moinfar F, 2000, CANCER RES, V60, P2562; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Paterson RF, 2003, CANCER, V98, P1830, DOI 10.1002/cncr.11747; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Schildkraut JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010061; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; SHAKADO S, 1995, HEPATOLOGY, V22, P969, DOI 10.1016/0270-9139(95)90322-4; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Tamura K, 2009, CANCER RES, V69, P8133, DOI 10.1158/0008-5472.CAN-09-0775; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tonra JR, 2007, IMMUNOL INVEST, V36, P3, DOI 10.1080/08820130600991794; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5	55	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37138	10.1371/journal.pone.0037138	http://dx.doi.org/10.1371/journal.pone.0037138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623986	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305343500063
J	Roscher, C; Schumacher, J; Gubsch, M; Lipowsky, A; Weigelt, A; Buchmann, N; Schmid, B; Schulze, ED				Roscher, Christiane; Schumacher, Jens; Gubsch, Marlen; Lipowsky, Annett; Weigelt, Alexandra; Buchmann, Nina; Schmid, Bernhard; Schulze, Ernst-Detlef			Using Plant Functional Traits to Explain Diversity-Productivity Relationships	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOSYSTEM FUNCTION; SEED SIZE; BIODIVERSITY; GRASSLAND; COMMUNITIES; ECOLOGY; COMPLEMENTARITY; MECHANISMS; SELECTION	Background: The different hypotheses proposed to explain positive species richness-productivity relationships, i.e. selection effect and complementarity effect, imply that plant functional characteristics are at the core of a mechanistic understanding of biodiversity effects. Methodology/Principal Findings: We used two community-wide measures of plant functional composition, (1) community-weighted means of trait values (CWM) and (2) functional trait diversity based on Rao's quadratic diversity (FDQ) to predict biomass production and measures of biodiversity effects in experimental grasslands (Jena Experiment) with different species richness (2, 4, 8, 16 and 60) and different functional group number and composition (1 to 4; legumes, grasses, small herbs, tall herbs) four years after establishment. Functional trait composition had a larger predictive power for community biomass and measures of biodiversitity effects (40-82% of explained variation) than species richness per se (<1-13% of explained variation). CWM explained a larger amount of variation in community biomass (80%) and net biodiversity effects (70%) than FDQ (36 and 38% of explained variation respectively). FDQ explained similar proportions of variation in complementarity effects (24%, positive relationship) and selection effects (28%, negative relationship) as CWM (27% of explained variation for both complementarity and selection effects), but for all response variables the combination of CWM and FDQ led to significant model improvement compared to a separate consideration of different components of functional trait composition. Effects of FDQ were mainly attributable to diversity in nutrient acquisition and life-history strategies. The large spectrum of traits contributing to positive effects of CWM on biomass production and net biodiversity effects indicated that effects of dominant species were associated with different trait combinations. Conclusions/Significance: Our results suggest that the identification of relevant traits and the relative impacts of functional identity of dominant species and functional diversity are essential for a mechanistic understanding of the role of plant diversity for ecosystem processes such as aboveground biomass production.	[Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany; [Gubsch, Marlen; Buchmann, Nina] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Lipowsky, Annett; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, Jena, Germany; [Lipowsky, Annett; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; University of Zurich; Leipzig University	Roscher, C (corresponding author), UFZ Helmholtz Ctr Environm Res, Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	christiane.roscher@ufz.de	Buchmann, Nina/E-6095-2011; Schmid, Bernhard/C-8625-2009; Schulze, Ernst-Detlef/K-9627-2014	Buchmann, Nina/0000-0003-0826-2980; Schmid, Bernhard/0000-0002-8430-3214; 	German Science Foundation [FOR456, Ro2397/3-1]; University of Jena; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); University of Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The Jena Experiment is funded by the German Science Foundation (FOR456) with additional support from the University of Jena and the Max Planck Society. CR was additionally supported by the German Science Foundation (Ro2397/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Eriksson O, 1998, J ECOL, V86, P922, DOI 10.1046/j.1365-2745.1998.00309.x; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Kutschera L., 1992, WURZELATLAS MITTELEU; Kutschera L., 1982, WURZELATLAS MITTELEU; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; Leps J, 2004, BASIC APPL ECOL, V5, P529, DOI 10.1016/j.baae.2004.06.003; Leps J, 2006, PRESLIA, V78, P481; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lumley T., 2009, LEAPS REGRESSION SUB; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mason NWH, 2003, J VEG SCI, V14, P571, DOI 10.1111/j.1654-1103.2003.tb02184.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rothmaler R, 2005, EXKURSIONSFLORA DEUT, V4; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Weingessel A, 2011, QUADPROG FUNCTIONS S; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114	60	181	197	18	305	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36760	10.1371/journal.pone.0036760	http://dx.doi.org/10.1371/journal.pone.0036760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623961	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500025
J	Lim, PE; Tan, J; Suana, IW; Eamsobhana, P; Yong, HS				Lim, Phaik-Eem; Tan, Ji; Suana, I. Wayan; Eamsobhana, Praphathip; Yong, Hoi Sen			Distinct Genetic Lineages of Bactrocera caudata (Insecta: Tephritidae) Revealed by COI and 16S DNA Sequences	PLOS ONE			English	Article							OXIDASE-I GENE; FRUIT-FLIES; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; COMPUTER-PROGRAM; SPECIES DIPTERA; FLY; INCONGRUENCE; EVOLUTION; PRIMERS	The fruit fly Bactrocera caudata is a pest species of economic importance in Asia. Its larvae feed on the flowers of Cucurbitaceae such as Cucurbita moschata. To-date it is distinguished from related species based on morphological characters. Specimens of B. caudata from Peninsular Malaysia and Indonesia (Bali and Lombok) were analysed using the partial DNA sequences of cytochrome c oxidase subunit I (COI) and 16S rRNA genes. Both gene sequences revealed that B. caudata from Peninsular Malaysia was distinctly different from B. caudata of Bali and Lombok, without common haplotype between them. Phylogenetic analysis revealed two distinct clades, indicating distinct genetic lineage. The uncorrected 'p' distance for COI sequences between B. caudata of Malaysia-Thailand-China and B. caudata of Bali-Lombok was 5.65%, for 16S sequences from 2.76 to 2.99%, and for combined COI and 16S sequences 4.45 to 4.46%. The 'p' values are distinctly different from intraspecific 'p' distance (0-0.23%). Both the B. caudata lineages are distinctly separated from related species in the subgenus Zeugodacus - B. ascita, B. scutellata, B. ishigakiensis, B. diaphora, B. tau, B. cucurbitae, and B. depressa. Molecular phylogenetic analysis indicates that the B. caudata lineages are closely related to B. ascita sp. B, and form a clade with B. scutellata, B. ishigakiensis, B. diaphora and B. ascita sp. A. This study provides additional baseline for the phylogenetic relationships of Bactrocera fruit flies of the subgenus Zeugodacus. Both the COI and 16S genes could be useful markers for the molecular differentiation and phylogenetic analysis of tephritid fruit flies.	[Lim, Phaik-Eem; Tan, Ji; Yong, Hoi Sen] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Lim, Phaik-Eem; Tan, Ji] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Suana, I. Wayan] Mataram Univ, Fac Sci & Math, Mataram, Indonesia; [Eamsobhana, Praphathip] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Parasitol, Bangkok 10700, Thailand	Universiti Malaya; Universiti Malaya; Universitas Mataram; Mahidol University	Lim, PE (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	phaikeem@um.edu.my	Eamsobhana, Praphathip/H-3343-2012; Tan, Ji/J-1653-2017; LIM, Phaik Eem/B-5331-2010; Suana, I Wayan/J-2665-2012; Yong, Hoi Sen/C-1548-2010	LIM, Phaik Eem/0000-0001-9186-1487; Suana, I Wayan/0000-0003-1443-9017; Yong, Hoi Sen/0000-0002-9832-8826; Tan, Ji/0000-0002-1264-5442	University of Malaya under the special research fund [H-00000 5620009]	University of Malaya under the special research fund	This study received financial support (H-00000 5620009) from the University of Malaya under the special research fund provided by the Vice Chancellor. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Asian Fruit Fly IPM Project, 2012, FIELD EX GUID FRUIT; Carroll L.E., 2002, PEST FRUIT FLIES WOR; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drew R.A.I., 1989, World Crop Pests, V3A, P9; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; HARDY D E, 1983, Treubia, V29, P1; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; HARDY D.E, 1982, TREUBIA, V28, P173; Hu J, 2008, GENETICA, V134, P319, DOI 10.1007/s10709-007-9239-1; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jamnongluk W, 2003, GENOME, V46, P112, DOI 10.1139/G02-113; Jamnongluk W, 2003, GENETICA, V119, P19, DOI 10.1023/A:1024481032579; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; Mun J, 2003, MOL ECOL, V12, P2941, DOI 10.1046/j.1365-294X.2003.01978.x; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Nakahara Shigehito, 2008, Research Bulletin of the Plant Protection Service Japan, P1; Norrbom AL, 2004, DIPTERA DISSEMINATIO, V2; Roderick GK, 1996, ANNU REV ENTOMOL, V41, P325, DOI 10.1146/annurev.en.41.010196.001545; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shono H, 2000, FISHERIES SCI, V66, P608, DOI 10.1046/j.1444-2906.2000.00095.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith PT, 2003, MOL PHYLOGENET EVOL, V26, P8, DOI 10.1016/S1055-7903(02)00293-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON, 1997, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Yong HS, 1992, P NATIONAL IRPA SEMI, V1, P233; Zhang B, 2010, FLA ENTOMOL, V93, P369, DOI 10.1653/024.093.0308	37	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37276	10.1371/journal.pone.0037276	http://dx.doi.org/10.1371/journal.pone.0037276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615962	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200054
J	Hagstrom, AK; Lienard, MA; Groot, AT; Hedenstrom, E; Lofstedt, C				Hagstrom, Asa K.; Lienard, Marjorie A.; Groot, Astrid T.; Hedenstrom, Erik; Lofstedt, Christer			Semi-Selective Fatty Acyl Reductases from Four Heliothine Moths Influence the Specific Pheromone Composition	PLOS ONE			English	Article							SEX-PHEROMONE; HELICOVERPA-ARMIGERA; BOMBYX-MORI; BIOSYNTHESIS; LEPIDOPTERA; EVOLUTION; DESATURASE; NOCTUIDAE; SUBFLEXA; IDENTIFICATION	Background: Sex pheromones are essential in moth mate communication. Information on pheromone biosynthetic genes and enzymes is needed to comprehend the mechanisms that contribute to specificity of pheromone signals. Most heliothine moths use sex pheromones with (Z)-11-hexadecenal as the major component in combination with minor fatty aldehydes and alcohols. In this study we focus on four closely related species, Heliothis virescens, Heliothis subflexa, Helicoverpa armigera and Helicoverpa assulta, which use (Z)-11-hexadecenal, (Z)-9-tetradecanal, and (Z)-9-hexadecenal in different ratios in their pheromone blend. The components are produced from saturated fatty acid precursors by desaturation, beta-oxidation, reduction and oxidation. Results: We analyzed the composition of fatty acyl pheromone precursors and correlated it to the pheromone composition. Next, we investigated whether the downstream fatty-acyl reduction step modulates the ratio of alcohol intermediates before the final oxidation step. By isolating and functionally characterizing the Fatty Acyl Reductase (pgFAR) from each species we found that the pgFARs were active on a broad set of C8 to C16 fatty acyl substrates including the key pheromone precursors, Z9-14, Z9-16 and Z11-16:acyls. When presenting the three precursors in equal ratios to yeast cultures expressing any of the four pgFARs, all reduced (Z)-9-tetradecenoate preferentially over (Z)-11-hexadecenoate, and the latter over (Z)-9-hexadecenoate. Finally, when manipulating the precursor ratios in vitro, we found that the pgFARs display small differences in the biochemical activity on various substrates. Conclusions: We conclude that a pgFAR with broad specificity is involved in heliothine moth pheromone biosynthesis, functioning as a semi-selective funnel that produces species-specific alcohol product ratios depending on the fatty-acyl precursor ratio in the pheromone gland. This study further supports the key role of these in pheromone biosynthesis and emphasizes the interplay between the pheromone fatty acyl precursors and the Lepidoptera specific pgFARs in shaping the pheromone composition.	[Hagstrom, Asa K.; Lienard, Marjorie A.; Lofstedt, Christer] Lund Univ, Pheromone Grp, Dept Biol, Lund, Sweden; [Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosystem Dynam, Amsterdam, Netherlands; [Groot, Astrid T.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Hedenstrom, Erik] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden	Lund University; University of Amsterdam; Max Planck Society; Mid-Sweden University	Hagstrom, AK (corresponding author), Lund Univ, Pheromone Grp, Dept Biol, Lund, Sweden.	asa.hagstrom@biol.lu.se	Groot, Astrid/A-8954-2013; Löfstedt, Christer/G-2016-2014	Groot, Astrid/0000-0001-9595-0161; Löfstedt, Christer/0000-0002-3116-6922; Lienard, Marjorie/0000-0003-3193-3666	Swedish research council (VR)	Swedish research council (VR)(Swedish Research Council)	Funding provided by the Swedish research council (VR) http://www.vr.se/Formas, http://www.formas.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Seung Joon, 2002, Journal of Asia-Pacific Entomology, V5, P43, DOI 10.1016/S1226-8615(08)60131-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Beaulieu L, 2005, PROTEIN EXPRES PURIF, V43, P111, DOI 10.1016/j.pep.2005.05.012; Berg J.M., 2002, BIOCHEMISTRY-US, V5th, P209; Blagovic B, 2001, FOOD TECHNOL BIOTECH, V39, P175; Blomquist G.J., 2005, P705; Bouwman J, 2006, STANDARDIZATION IN V; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Choi MY, 2005, ARCH INSECT BIOCHEM, V59, P53, DOI 10.1002/arch.20051; Foster SP, 2005, ARCH INSECT BIOCHEM, V59, P80, DOI 10.1002/arch.20058; Groot AT, 2009, INSECT BIOCHEM MOLEC, V39, P568, DOI 10.1016/j.ibmb.2009.05.002; Groot AT, 2005, J CHEM ECOL, V31, P14, DOI 10.1007/s10886-005-0970-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; KLUN JA, 1982, ENVIRON ENTOMOL, V11, P1084, DOI 10.1093/ee/11.5.1084; KLUN JA, 1980, J CHEM ECOL, V6, P177, DOI 10.1007/BF00987536; Knipple DC, 2002, GENETICS, V162, P1737; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard Marjorie A., 2010, Communicative & Integrative Biology, V3, P586, DOI 10.4161/cib.3.6.13177; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Lienard MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-270; Liesener A, 2005, RAPID COMMUN MASS SP, V19, P2923, DOI 10.1002/rcm.2136; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Pi N, 2004, J AM SOC MASS SPECTR, V15, P233, DOI 10.1016/j.jasms.2003.10.009; Rafaeli A, 2005, ENTOMOL EXP APPL, V115, P7, DOI 10.1111/j.1570-7458.2005.00292.x; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Serra M, 2006, INSECT BIOCHEM MOLEC, V36, P634, DOI 10.1016/j.ibmb.2006.05.005; Sheck AL, 2006, J EVOLUTION BIOL, V19, P600, DOI 10.1111/j.1420-9101.2005.00999.x; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; TEAL PEA, 1986, J CHEM ECOL, V12, P107, DOI 10.1007/BF01045595; TEAL PEA, 1986, J CHEM ECOL, V12, P353, DOI 10.1007/BF01020561; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HL, 2005, INSECT BIOCHEM MOLEC, V35, P575, DOI 10.1016/j.ibmb.2005.01.018; Wang HL, 2008, J INSECT PHYSIOL, V54, P813, DOI 10.1016/j.jinsphys.2008.02.011; Wang HL, 2010, INSECT BIOCHEM MOLEC, V40, P742, DOI 10.1016/j.ibmb.2010.07.009; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	49	52	60	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37230	10.1371/journal.pone.0037230	http://dx.doi.org/10.1371/journal.pone.0037230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615947	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300089
J	Klein, N; Sander, PM; Stein, K; Le Loeuff, J; Carballido, JL; Buffetaut, E				Klein, Nicole; Sander, P. Martin; Stein, Koen; Le Loeuff, Jean; Carballido, Jose L.; Buffetaut, Eric			Modified Laminar Bone in Ampelosaurus atacis and Other Titanosaurs (Sauropoda): Implications for Life History and Physiology	PLOS ONE			English	Article							BEND-NATIONAL-PARK; ALAMOSAURUS-SANJUANENSIS; GROWTH-RATES; BODY-SIZE; HISTOLOGY; DINOSAURIA; DWARFISM	Background: Long bone histology of the most derived Sauropoda, the Titanosauria suggests that titanosaurian long bone histology differs from the uniform bone histology of basal Sauropoda. Here we describe the long bone histology of the titanosaur Ampelosaurus atacis and compare it to that of basal neosauropods and other titanosaurs to clarify if a special titanosaur bone histology exists. Methodology/Principal Findings: Ampelosaurus retains the laminar vascular organization of basal Sauropoda, but throughout most of cortical growth, the scaffolding of the fibrolamellar bone, which usually is laid down as matrix of woven bone, is laid down as parallel-fibered or lamellar bone matrix instead. The remodeling process by secondary osteons is very extensive and overruns the periosteal bone deposition before skeletal maturity is reached. Thus, no EFS is identifiable. Compared to the atypical bone histology of Ampelosaurus, the large titanosaur Alamosaurus shows typical laminar fibrolamellar bone. The titanosaurs Phuwiangosaurus, Lirainosaurus, and Magyarosaurus, although differing in certain features, all show this same low amount or absence of woven bone from the scaffolding of the fibrolamellar bone, indicating a clear reduction in growth rate resulting in a higher bone tissue organization. To describe the peculiar primary cortical bone tissue of Phuwiangosaurus, Ampelosaurus, Lirainosaurus, and Magyarosaurus, we here introduce a new term, "modified laminar bone" (MLB). Conclusions/Significance: Importantly, MLB is as yet not known from extant animals. At least in Lirainosaurus and Magyarosaurus the reduction of growth rate indicated by MLB is coupled with a drastic body size reduction and maybe also a reduction in metabolic rate, interpreted as a result of dwarfing on the European islands during the Late Cretaceous. Phuwiangosaurus and Ampelosaurus both show a similar reduction in growth rate but not in body size, possibly indicating also a reduced metabolic rate. The large titanosaur Alamosaurus, on the other hand, retained the plesiomorphic bone histology of basal neosauropods.	[Klein, Nicole; Sander, P. Martin; Stein, Koen] Univ Bonn, Steinmann Inst Paleontol, Bonn, Germany; [Le Loeuff, Jean] Musee Dinosaures, Esperaza, France; [Carballido, Jose L.] Museo Paleontol Egidio Feruglio, Trelew, Argentina; [Buffetaut, Eric] CNRS, Paris, France	University of Bonn; Centre National de la Recherche Scientifique (CNRS)	Klein, N (corresponding author), Univ Bonn, Steinmann Inst Paleontol, Bonn, Germany.	nklein@uni-bonn.de	Carballido, Jose/T-9932-2019; Stein, Koen HW/G-5731-2015	Carballido, Jose Luis/0000-0003-3227-8034; Stein, Koen/0000-0003-4246-3225	DFG (Deutsche Forschungsgemeinschaft) [FOR 533]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by the DFG (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffetaut E, 1999, CR ACAD SCI II A, V328, P203, DOI 10.1016/S1251-8050(99)80097-4; Carrano Matthew T., 2006, P225; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Company J, 2011, NATURWISSENSCHAFTEN, V98, P67, DOI 10.1007/s00114-010-0742-3; Company J, 2009, AMEGHINIANA, V46, P391; CORMACK DH, 1987, HAMS HISTOLOGY; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; Currey J.D., 2002, BONES STRUCTURE MECH; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; Curry-Rogers KA, 2005, SAUROPODS EVOLUTION, p[349, 50]; Dercourt J., 2000, PERITETHYS PALAEOGEO; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Francillon-Vieillot H., 1990, P471; Goloboff P, 2008, CLADISTICS, V24, P91; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2009, GEOL SOC SPEC PUBL, V315, P217, DOI 10.1144/SP315.15; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Le Loeuff J, 2005, LIFE O PAST, P115; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lehman TM, 2002, J PALEONTOL, V76, P156, DOI 10.1666/0022-3360(2002)076<0156:AJSOTS>2.0.CO;2; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Metcalfe I, 2009, GEOLOGICAL SOC SPECI, V355, P75; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Sander P. Martin, 2011, P276; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Sander PM., 1999, GEOWISSENSCHAFTLICHE, V2, P103; Scheyer TM, 2010, SEMIN CELL DEV BIOL, V21, P462, DOI 10.1016/j.semcdb.2009.11.005; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Stein K., 2009, METHODS FOSSIL PREPA, P69; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Vila B, 2012, PALAEOGEOGR IN PRESS; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Woodward HN, 2009, J VERTEBR PALEONTOL, V29, P807, DOI 10.1671/039.029.0310	41	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36907	10.1371/journal.pone.0036907	http://dx.doi.org/10.1371/journal.pone.0036907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615842	Green Published, gold			2022-12-27	WOS:000305341300041
J	Raponi, M; Douglas, AGL; Tammaro, C; Wilson, DI; Baralle, D				Raponi, Michela; Douglas, Andrew G. L.; Tammaro, Claudia; Wilson, David I.; Baralle, Diana			Evolutionary Constraint Helps Unmask a Splicing Regulatory Region in BRCA1 Exon 11	PLOS ONE			English	Article							SYNONYMOUS MUTATIONS; NUCLEAR-LOCALIZATION; PURIFYING SELECTION; SILENT SITES; EXPRESSION; VARIANTS; BREAST	Background: Alternative splicing across exon 11 produces several BRCA1 isoforms. Their proportion varies during the cell cycle, between tissues and in cancer suggesting functional importance of BRCA1 splicing regulation around this exon. Although the regulatory elements driving exon 11 splicing have never been identified, a selective constraint against synonymous substitutions (silent nucleotide variations that do not alter the amino acid residue sequence) in a critical region of BRCA1 exon 11 has been reported to be associated with the necessity to maintain regulatory sequences. Methodology/Principal Findings: Here we have designed a specific minigene to investigate the possibility that this bias in synonymous codon usage reflects the need to preserve the BRCA1 alternative splicing program. We report that in-frame deletions and translationally silent nucleotide substitutions in the critical region affect splicing regulation of BRCA1 exon 11. Conclusions/Significance: Using a hybrid minigene approach, we have experimentally validated the hypothesis that the need to maintain correct alternative splicing is a selective pressure against translationally silent sequence variations in the critical region of BRCA1 exon 11. Identification of the trans-acting factors involved in regulating exon 11 alternative splicing will be important in understanding BRCA1-associated tumorigenesis.	[Raponi, Michela; Douglas, Andrew G. L.; Tammaro, Claudia; Wilson, David I.; Baralle, Diana] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Douglas, Andrew G. L.; Baralle, Diana] Southampton Univ Hosp NHS Trust, Wessex Clin Genet Serv, Southampton, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Raponi, M (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	D.Baralle@soton.ac.uk	Tammaro, Claudia/ABG-8900-2020; raponi, michela/E-3500-2014; Wilson, David/A-6264-2010	raponi, michela/0000-0001-7570-828X; Wilson, David/0000-0001-8779-2060; Baralle, Diana/0000-0003-3217-4833; Tammaro, Claudia/0000-0003-1645-1781	EURASNET; Cancer research UK [19649]; National Institute for Health Research [ACF-2007-26-002] Funding Source: researchfish	EURASNET; Cancer research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work has been supported by EURASNET (http://www.eurasnet.info/) and Cancer research UK (19649) (http://www.cancerresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelior R, 2002, VIRCHOWS ARCH, V440, P261, DOI 10.1007/s004280100500; Brandao RD, 2011, BREAST CANCER RES TR, V129, P971, DOI 10.1007/s10549-011-1599-7; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; GOOD L, 1992, NUCLEIC ACIDS RES, V20, P4934, DOI 10.1093/nar/20.18.4934; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hurst LD, 2001, TRENDS GENET, V17, P62, DOI 10.1016/S0168-9525(00)02173-9; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu ML, 1996, CANCER RES, V56, P4578; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Orban TI, 2001, TRENDS GENET, V17, P252; Orban TI, 2001, BIOCHEM BIOPH RES CO, V280, P32, DOI 10.1006/bbrc.2000.4068; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609; Qin YL, 2011, J CELL PHYSIOL, V226, P3355, DOI 10.1002/jcp.22695; Ryan PD, 2010, PRINCIPLES OF CLINICAL CANCER GENETICS: A HANDBOOK FROM THE MASSACHUSETTS GENERAL HOSPITAL, P41, DOI 10.1007/978-0-387-93846-2_3; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37255	10.1371/journal.pone.0037255	http://dx.doi.org/10.1371/journal.pone.0037255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615956	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300092
J	Zhang, WS; Sargis, RM; Volden, PA; Carmean, CM; Sun, XJ; Brady, MJ				Zhang, Wenshuo; Sargis, Robert M.; Volden, Paul A.; Carmean, Christopher M.; Sun, Xiao J.; Brady, Matthew J.			PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE PEPCK; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POLYCHLORINATED-BIPHENYLS; AROMATIC-HYDROCARBONS; PRIMARY HEPATOCYTES; AH RECEPTOR; RAT-LIVER; GLUCONEOGENESIS; TOXICITY; INSULIN	Dioxins and dioxin-like compounds encompass a group of structurally related heterocyclic compounds that bind to and activate the aryl hydrocarbon receptor (AhR). The prototypical dioxin is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a highly toxic industrial byproduct that incites numerous adverse physiological effects. Global commercial production of the structurally similar polychlorinated biphenyls (PCBs), however, commenced early in the 20th century and continued for decades; dioxin-like PCBs therefore contribute significantly to total dioxin-associated toxicity. In this study, PCB 126, the most potent dioxin-like PCB, was evaluated with respect to its direct effects on hepatic glucose metabolism using primary mouse hepatocytes. Overnight treatment with PCB 126 reduced hepatic glycogen stores in a dose-dependent manner. Additionally, PCB 126 suppressed forskolin-stimulated gluconeogenesis from lactate. These effects were independent of acute toxicity, as PCB 126 did not increase lactate dehydrogenase release nor affect lipid metabolism or total intracellular ATP. Interestingly, provision of cells with glycerol instead of lactate as the carbon source completely restored hepatic glucose production, indicating specific impairment in the distal arm of gluconeogenesis. In concordance with this finding, PCB 126 blunted the forskolin-stimulated increase in phosphoenolpyruvate carboxykinase (PEPCK) mRNA levels without affecting glucose-6-phosphatase expression. Myricetin, a putative competitive AhR antagonist, reversed the suppression of PEPCK induction by PCB 126. Furthermore, other dioxin-like PCBs demonstrated similar effects on PEPCK expression in parallel with their ability to activate AhR. It therefore appears that AhR activation mediates the suppression of PEPCK expression by dioxin-like PCBs, suggesting a role for these pollutants as disruptors of energy metabolism.	[Zhang, Wenshuo; Sargis, Robert M.; Volden, Paul A.; Carmean, Christopher M.; Brady, Matthew J.] Univ Chicago, Dept Med, Kovler Ctr Biomed Discovery, Chicago, IL 60637 USA; [Sun, Xiao J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University of Chicago; University System of Maryland; University of Maryland Baltimore	Zhang, WS (corresponding author), Univ Chicago, Dept Med, Kovler Ctr Biomed Discovery, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mbrady@medicine.bsd.uchicago.edu		Zhang, Wenshuo/0000-0002-5124-799X	National Institutes of Health [F32-ES017397, K08-ES019176]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES019176, F32ES017397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by the National Institutes of Health (F32-ES017397 and K08-ES019176 awards to R. M. S.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bhavsar SP, 2008, ENVIRON INT, V34, P915, DOI 10.1016/j.envint.2008.02.001; Boess F, 2003, TOXICOL SCI, V73, P386, DOI 10.1093/toxsci/kfg064; Boll M, 1998, XENOBIOTICA, V28, P479, DOI 10.1080/004982598239407; CLORE JN, 1991, AM J PHYSIOL, V261, pE425, DOI 10.1152/ajpendo.1991.261.4.E425; DEML E, 1986, CARCINOGENESIS, V7, P1697, DOI 10.1093/carcin/7.10.1697; DeVito MJ, 1998, TOXICOL SCI, V46, P223, DOI 10.1006/toxs.1998.2530; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Fery F, 1996, AM J PHYSIOL-ENDOC M, V270, pE822, DOI 10.1152/ajpendo.1996.270.5.E822; GARRISON JC, 1973, J BIOL CHEM, V248, P5333; GORSKI JR, 1988, ARCH TOXICOL, V62, P146, DOI 10.1007/BF00570132; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; HARPER PA, 1991, MOL PHARMACOL, V40, P818; HSIA MTS, 1985, TOXICOL LETT, V25, P247, DOI 10.1016/0378-4274(85)90204-8; Jensen BA, 2010, AQUAT TOXICOL, V100, P238, DOI 10.1016/j.aquatox.2010.07.021; KENNEDY SW, 1993, ANAL BIOCHEM, V211, P102, DOI 10.1006/abio.1993.1239; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Lingohr MK, 2002, TOXICOL SCI, V68, P508, DOI 10.1093/toxsci/68.2.508; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Matsumura F, 1997, BIOCHEM PHARMACOL, V53, P1397, DOI 10.1016/S0006-2952(97)00036-1; MCCONNELL EE, 1985, ENVIRON HEALTH PERSP, V60, P29, DOI 10.2307/3429941; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; OKEY AB, 1994, TOXICOL LETT, V70, P1, DOI 10.1016/0378-4274(94)90139-2; OLSON JR, 1986, TOXICOL APPL PHARM, V85, P263, DOI 10.1016/0041-008X(86)90121-3; Patterson DG, 2008, CHEMOSPHERE, V73, pS261, DOI 10.1016/j.chemosphere.2007.08.074; Perez-Fuentetaja A, 2010, CHEMOSPHERE, V81, P541, DOI 10.1016/j.chemosphere.2010.06.033; Piaggi S, 2007, TOXICOL APPL PHARM, V220, P333, DOI 10.1016/j.taap.2007.01.017; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Satake S, 2002, DIABETES, V51, P1663, DOI 10.2337/diabetes.51.6.1663; Schmitz HJ, 1996, ENVIRON TOXICOL PHAR, V1, P73, DOI 10.1016/1382-6689(95)00011-9; Stahl B U, 1992, Arch Toxicol Suppl, V15, P151; Stahl BU, 1995, TOXICOLOGY, V103, P45, DOI 10.1016/0300-483X(95)03106-P; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; THOME JP, 1995, TOXICOLOGY, V98, P83, DOI 10.1016/0300-483X(94)02793-T; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Turrio-Baldassarri L, 2007, CHEMOSPHERE, V67, P1822, DOI 10.1016/j.chemosphere.2006.05.124; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; Viluksela M, 1995, TOXICOL APPL PHARM, V135, P308, DOI 10.1006/taap.1995.1237; Viluksela M, 1999, ARCH TOXICOL, V73, P323, DOI 10.1007/s002040050626; Walter GL, 2000, AQUAT TOXICOL, V50, P287, DOI 10.1016/S0166-445X(00)00095-3; Ward MP, 2010, ECOTOXICOLOGY, V19, P1513, DOI 10.1007/s10646-010-0536-6; WEBER LWD, 1995, TOXICOL APPL PHARM, V131, P155, DOI 10.1006/taap.1995.1057; WEBER LWD, 1991, TOXICOLOGY, V66, P133, DOI 10.1016/0300-483X(91)90214-L; Zhang S, 2003, ENVIRON HEALTH PERSP, V111, P1877, DOI 10.1289/ehp.6322	47	72	72	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37103	10.1371/journal.pone.0037103	http://dx.doi.org/10.1371/journal.pone.0037103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615911	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341300072
J	Azzouz, DF; Rak, JM; Fajardy, I; Allanore, Y; Tiev, KP; Farge-Bancel, D; Martin, M; Kanaan, SB; Pagni, PP; Hachulla, E; Harle, JR; Didelot, R; Granel, B; Cabane, J; Roudier, J; Lambert, NC				Azzouz, Doua F.; Rak, Justyna M.; Fajardy, Isabelle; Allanore, Yannick; Tiev, Kiet Phong; Farge-Bancel, Dominique; Martin, Marielle; Kanaan, Sami B.; Pagni, Philippe P.; Hachulla, Eric; Harle, Jean Robert; Didelot, Remi; Granel, Brigitte; Cabane, Jean; Roudier, Jean; Lambert, Nathalie C.			Comparing HLA Shared Epitopes in French Caucasian Patients with Scleroderma	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; ASSOCIATION; AUTOANTIBODIES; SUSCEPTIBILITY; EXPRESSION; DISEASE; GENES; DNA	Although many studies have analyzed HLA allele frequencies in several ethnic groups in patients with scleroderma (SSc), none has been done in French Caucasian patients and none has evaluated which one of the common amino acid sequences, (FLEDR71)-F-67, shared by HLA- DRB susceptibility alleles, or (71)TRAELDT(77), shared by HLA-DQB1 susceptibility alleles in SSc, was the most important to develop the disease. HLA- DRB and DQB typing was performed for a total of 468 healthy controls and 282 patients with SSc allowing FLEDR and TRAELDT analyses. Results were stratified according to patient's clinical subtypes and autoantibody status. Moreover, standardized HLA-DR beta 1 and DR beta 5 reverse transcriptase Taqman PCR assays were developed to quantify beta 1 and beta 5 mRNA in 20 subjects with HLA-DRB1*15 and/or DRB1*11 haplotypes. FLEDR motif is highly associated with diffuse SSc (chi(2) = 28.4, p<10-6) and with anti-topoisomerase antibody (ATA) production (chi(2) = 43.9, p<10-9) whereas TRAELDT association is weaker in both subgroups (chi(2) = 7.2, p = 0.027 and chi(2) = 14.6, p = 0.0007 respectively). Moreover, FLEDR motif-association among patients with diffuse SSc remains significant only in ATA subgroup. The risk to develop ATA positive SSc is higher with double dose FLEDR than single dose with respectively, adjusted standardised residuals of 5.1 and 2.6. The increase in FLEDR motif is mostly due to the higher frequency of HLA-DRB1*11 and DRB1*15 haplotypes. Furthermore, FLEDR is always carried by the most abundantly expressed beta chain: beta 1 in HLA DRB1*11 haplotypes and beta 5 in HLA-DRB1*15 haplotypes. In French Caucasian patients with SSc, FLEDR is the main presenting motif influencing ATA production in dcSSc. These results open a new field of potential therapeutic applications to interact with the FLEDR peptide binding groove and prevent ATA production, a hallmark of severity in SSc.	[Azzouz, Doua F.; Rak, Justyna M.; Martin, Marielle; Kanaan, Sami B.; Pagni, Philippe P.; Roudier, Jean; Lambert, Nathalie C.] INSERM, Lab Immunogenet Polyarthrite Rhumatoide, UMRs1097, F-13258 Marseille, France; [Fajardy, Isabelle; Hachulla, Eric] Hop Claude Huriez, Ctr Natl Reference Sclerodermie Syst, Serv Med Interne, Lille, France; [Allanore, Yannick] Univ Paris 05, Serv Rhumatol A, Hop Cochin, Paris, France; [Tiev, Kiet Phong] Hop St Antoine, Serv Med Interne, F-75571 Paris, France; [Farge-Bancel, Dominique] Hop St Louis, Serv Med Interne & Pathol Vasc, Paris, France; [Harle, Jean Robert] Hop La Concept, Serv Med Interne, Marseille, France; [Didelot, Remi] Ctr Examen Sante Assurance Maladie, Marseille, France; [Granel, Brigitte] Hop Nord Marseille, Serv Med Interne, Marseille, France; [Roudier, Jean] Hop St Marguerite, Serv Rhumatol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Azzouz, DF (corresponding author), INSERM, Lab Immunogenet Polyarthrite Rhumatoide, UMRs1097, F-13258 Marseille, France.	nathalie.lambert@inserm.fr	roudier, jean/A-8654-2011; Lambert, Nathalie C/P-6816-2016; HACHULLA, ERIC/R-8488-2018	roudier, jean/0000-0001-5435-8567; Lambert, Nathalie C/0000-0001-5817-8686; HACHULLA, ERIC/0000-0001-7432-847X	PRO-A INSERM [ASE06017ASA]; Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie (GFRS)	PRO-A INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association des Sclerodermiques de France (ASF); Groupe Francais de Recherche sur la Sclerodermie (GFRS)	Supported by PRO-A INSERM (grant # ASE06017ASA), Association des Sclerodermiques de France (ASF) and Groupe Francais de Recherche sur la Sclerodermie (GFRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; DANZE PM, 1995, APPL THEOR ELECTROPH, V5, P7; Faner R, 2010, EUR J IMMUNOL, V40, P91, DOI 10.1002/eji.200939225; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Ho KT, 2003, ARTHRITIS RES THER, V5, P80, DOI 10.1186/ar628; Karp DR, 2010, HUM MOL GENET, V19, P707, DOI 10.1093/hmg/ddp521; KUWANA M, 1993, J CLIN INVEST, V92, P1296, DOI 10.1172/JCI116703; LEROY EC, 1988, J RHEUMATOL, V15, P202; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; Mackie SL, 2011, GENES IMMUNITY; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Noble JA, 1996, AM J HUM GENET, V59, P1134; Prat E, 2005, J NEUROIMMUNOL, V167, P108, DOI 10.1016/j.jneuroim.2005.04.027; Rak JM, 2009, ARTHRITIS RHEUM-US, V60, P73, DOI 10.1002/art.24224; REVEILLE JD, 1992, J CLIN INVEST, V90, P973, DOI 10.1172/JCI115974; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; TAKEUCHI F, 1994, J RHEUMATOL, V21, P857; Tikly M, 2004, TISSUE ANTIGENS, V63, P487, DOI 10.1111/j.0001-2815.2004.00199.x; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Walker UA, 2007, ANN RHEUM DIS; WORDSWORTH P, 1992, AM J HUM GENET, V51, P585	24	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36870	10.1371/journal.pone.0036870	http://dx.doi.org/10.1371/journal.pone.0036870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615829	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336300043
J	Sikkeland, LIB; Dahl, CP; Ueland, T; Andreassen, AK; Gude, E; Edvardsen, T; Holm, T; Yndestad, A; Gullestad, L; Kongerud, J; Aukrust, P; Oie, E				Sikkeland, Liv I. Bjoner; Dahl, Christen P.; Ueland, Thor; Andreassen, Arne K.; Gude, Einar; Edvardsen, Thor; Holm, Torbjorn; Yndestad, Arne; Gullestad, Lars; Kongerud, Johny; Aukrust, Pal; Oie, Erik			Increased Levels of Inflammatory Cytokines and Endothelin-1 in Alveolar Macrophages from Patients with Chronic Heart Failure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MECHANISMS; EXPRESSION; RATS; CHF	Background: Pathophysiological interactions between heart and lungs in heart failure (HF) are well recognized. We investigated whether expression of different factors known to be increased in the myocardium and/or the circulation in HF is also increased in alveolar macrophages in HF. Methodology/Principal Findings: Lung function, hemodynamic parameters, gene expression in alveolar macrophages, and plasma levels in the pulmonary and femoral arteries of HF patients (n=20) were compared to control subjects (n=16). Our principal findings were: (1) Lung function was significantly lower in HF patients compared to controls (P<0.05). (2) mRNA levels of ET-1, tumor necrosis factor (TNF)-alpha and interleukin-6 (IL-6) were increased in alveolar macrophages from HF patients. (3) Plasma levels of ET-1, TNF alpha, IL-6 and MCP-1 were significantly increased in HF patients, whereas our data indicate a net pulmonary release of MCP-1 into the circulation in HF. Conclusions/Significance: Several important cytokines and ET-1 are induced in alveolar macrophages in human HF. Further studies should clarify whether increased synthesis of these factors affects pulmonary remodeling and, directly or indirectly, adversely affects the failing myocardium.	[Sikkeland, Liv I. Bjoner] Oslo Univ Hosp, Rikshosp, Dept Resp Med, Oslo, Norway; [Dahl, Christen P.; Andreassen, Arne K.; Gude, Einar; Edvardsen, Thor; Holm, Torbjorn; Gullestad, Lars; Oie, Erik] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Dahl, Christen P.; Ueland, Thor; Yndestad, Arne; Aukrust, Pal; Oie, Erik] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ueland, Thor] Oslo Univ Hosp, Rikshosp, Dept Endocrinol, Oslo, Norway; [Sikkeland, Liv I. Bjoner; Edvardsen, Thor; Gullestad, Lars; Kongerud, Johny; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Dahl, Christen P.; Edvardsen, Thor; Yndestad, Arne; Gullestad, Lars; Oie, Erik] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Sikkeland, LIB (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Resp Med, Oslo, Norway.	erik.oie@medisin.uio.no	Edvardsen, Thor/F-4079-2012	Edvardsen, Thor/0000-0002-3800-765X; Sikkeland, Liv Ingunn Bjoner/0000-0002-9989-1936	Center for Heart Failure Research, University of Oslo, Oslo, Norway	Center for Heart Failure Research, University of Oslo, Oslo, Norway	This work was supported by grants from Center for Heart Failure Research, University of Oslo, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2007, CARDIOVASC RES, V74, P323, DOI 10.1016/j.cardiores.2006.12.010; Butler J, 1999, J AM COLL CARDIOL, V34, P1802, DOI 10.1016/S0735-1097(99)00408-8; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Fabricio ASC, 2006, AM J PHYSIOL-REG I, V290, pR1515, DOI 10.1152/ajpregu.00604.2005; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Gullestad L, 2001, Heart Fail Monit, V2, P8; Hawkins NM, 2010, EUR J HEART FAIL, V12, P17, DOI 10.1093/eurjhf/hfp160; Iversen KK, 2008, J INTERN MED, V264, P361, DOI 10.1111/j.1365-2796.2008.01975.x; Kingsbury MP, 2003, BASIC RES CARDIOL, V98, P295, DOI 10.1007/s00395-003-0419-6; Krum H, 2001, Heart Fail Rev, V6, P341; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mascarenhas J, 2010, CURR OPIN PULM MED, V16, P106, DOI 10.1097/MCP.0b013e328335dc90; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oie E, 1998, AM J PHYSIOL-HEART C, V275, pH868; Oie E, 2010, BASIC RES CARDIOL, V105, P89, DOI 10.1007/s00395-009-0070-y; Sikkeland LIB, 2007, J OCCUP ENVIRON MED, V49, P1135, DOI 10.1097/JOM.0b013e31814b2e87; Sikkeland LIB, 2007, THORAX, V62, P558, DOI 10.1136/thx.2006.073544; Stenmark KR, 2005, J APPL PHYSIOL, V98, P715, DOI 10.1152/japplphysiol.00840.2004; Tetley Teresa D., 2005, Current Drug Targets - Inflammation and Allergy, V4, P607, DOI 10.2174/156801005774912824; Tong ZH, 2003, CHEST, V124, P1526, DOI 10.1378/chest.124.4.1526; von Lueder TG, 2004, CARDIOVASC RES, V63, P41, DOI 10.1016/j.cardiores.2004.03.016; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6	24	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36815	10.1371/journal.pone.0036815	http://dx.doi.org/10.1371/journal.pone.0036815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615818	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300039
J	Bergrath, S; Reich, A; Rossaint, R; Rortgen, D; Gerber, J; Fischermann, H; Beckers, SK; Brokmann, JC; Schulz, JB; Leber, C; Fitzner, C; Skorning, M				Bergrath, Sebastian; Reich, Arno; Rossaint, Rolf; Roertgen, Daniel; Gerber, Joachim; Fischermann, Harold; Beckers, Stefan K.; Brokmann, Joerg C.; Schulz, Joerg B.; Leber, Claas; Fitzner, Christina; Skorning, Max			Feasibility of Prehospital Teleconsultation in Acute Stroke - A Pilot Study in Clinical Routine	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR USE; WIRELESS TECHNOLOGY; POLICY STATEMENT; CARE; EMERGENCY; TELEMEDICINE; SYSTEMS; IMPLEMENTATION; PROJECT	Background: Inter-hospital teleconsultation improves stroke care. To transfer this concept into the emergency medical service (EMS), the feasibility and effects of prehospital teleconsultation were investigated. Methodology/Principal Findings: Teleconsultation enabling audio communication, real-time video streaming, vital data and still picture transmission was conducted between an ambulance and a teleconsultation center. Pre-notification of the hospital was carried out with a 14-item stroke history checklist via e-mail-to-fax. Beside technical assessments possible influences on prehospital and initial in-hospital time intervals, prehospital diagnostic accuracy and the transfer of stroke specific data were investigated by comparing telemedically assisted prehospital care (telemedicine group) with local regular EMS care (control group). All prehospital stroke patients over a 5-month period were included during weekdays (7.30 a.m. - 4.00 p.m.). In 3 of 18 missions partial dropouts of the system occurred; neurological co-evaluation via video transmission was conducted in 12 cases. The stroke checklist was transmitted in 14 cases (78%). Telemedicine group (n = 18) vs. control group (n = 47): Prehospital time intervals were comparable, but in both groups the door to brain imaging times were longer than recommended (median 59.5 vs. 57.5 min, p = 0.6447). The prehospital stroke diagnosis was confirmed in 61% vs. 67%, p = 0.8451. Medians of 14 (IQR 9) vs. 5 (IQR 2) stroke specific items were transferred in written form to the in-hospital setting, p < 0.0001. In 3 of 10 vs. 5 of 27 patients with cerebral ischemia thrombolytics were administered, p = 0.655. Conclusions: Teleconsultation was feasible but technical performance and reliability have to be improved. The approach led to better stroke specific information; however, a superiority over regular EMS care was not found and in-hospital time intervals were unacceptably long in both groups. The feasibility of prehospital tele-stroke consultation has future potential to improve emergency care especially when no highly trained personnel are on-scene.	[Bergrath, Sebastian; Rossaint, Rolf; Roertgen, Daniel; Fischermann, Harold; Beckers, Stefan K.; Brokmann, Joerg C.; Leber, Claas; Skorning, Max] Rhein Westfal TH Aachen, Dept Anesthesiol, Univ Hosp Aachen, Aachen, Germany; [Reich, Arno; Gerber, Joachim; Schulz, Joerg B.] Rhein Westfal TH Aachen, Dept Neurol, Univ Hosp Aachen, Aachen, Germany; [Beckers, Stefan K.] Rhein Westfal TH Aachen, Dept Intens Care Med & Intermediate Care, Univ Hosp Aachen, Aachen, Germany; [Fitzner, Christina] Rhein Westfal TH Aachen, Dept Med Stat, Univ Hosp Aachen, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Bergrath, S (corresponding author), Rhein Westfal TH Aachen, Dept Anesthesiol, Univ Hosp Aachen, Aachen, Germany.	sbergrath@ukaachen.de	Schulz, Jörg B/D-9786-2012; Fitzner, Christina/H-6431-2013; Bergrath, Sebastian/AAK-6999-2021; Beckers, Stefan K/C-6776-2011; Beckers, Stefan K./O-2943-2019	Schulz, Jörg B/0000-0002-8903-0593; Beckers, Stefan K/0000-0002-2896-7948; Beckers, Stefan K./0000-0002-2896-7948	German Federal Ministry of Economics and Technology [01MB07022]; Philips Healthcare (Hamburg, Germany); P3 communications (Aachen, Germany)	German Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Philips Healthcare (Hamburg, Germany); P3 communications (Aachen, Germany)	The study was conducted within the joint research project, "Med-on-@ix", funded by the German Federal Ministry of Economics and Technology, Project Number 01MB07022. Philips Healthcare (Hamburg, Germany) and P3 communications (Aachen, Germany) brought in their own financial resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all data in the study and the final responsibility for the decision to submit for publication. No author had financial relationships or other non-financial dependencies with the funding sponsors.; No author received funding from the commercial project partners (Philips Healthcare, P3 communications). The department of Anesthesiology of the University Hospital Aachen, Germany received funding from the German Federal Ministry of Economics and Technology. The authors SB, RR, DR, HF, JCB and MS are employed by this department. The author SKB was employed by this department during the study phase. The author CF was partially employed by the department of Anesthesiology during the study phase. The authors AR, JG, JBS and CL (or their department) received no funding at all. No author has other financial or non-financial dependencies or relationships with the commercial partners (Philips Healthcare, P3 communications) or the funding Ministry. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Acker JE, 2007, STROKE, V38, P3097, DOI 10.1161/STROKEAHA.107.186094; Adams GL, 2006, AM J CARDIOL, V98, P1160, DOI 10.1016/j.amjcard.2006.05.042; Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Alabama Department of Public Health, EMS TRAUM PAG; Audebert HJ, 2006, LANCET NEUROL, V5, P742, DOI 10.1016/S1474-4422(06)70527-0; Bergrath S, 2011, J TELEMED TELECARE, V17, P371, DOI 10.1258/jtt.2011.110203; Capampangan DJ, 2009, NEUROLOGIST, V15, P163, DOI 10.1097/NRL.0b013e3181a4b79c; Chatterjee P, 2011, STROKE, V42, P1074, DOI 10.1161/STROKEAHA.110.586610; Demaerschalk BM, 2010, STROKE, V41, P1251, DOI 10.1161/STROKEAHA.109.574509; Dhruva VN, 2007, J AM COLL CARDIOL, V50, P509, DOI 10.1016/j.jacc.2007.04.049; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; LaMonte M P, 2000, J Stroke Cerebrovasc Dis, V9, P128, DOI 10.1053/jscd.2000.5867; LaMonte Marian P, 2004, J Stroke Cerebrovasc Dis, V13, P148, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.004; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mazighi M, 2010, CURR OPIN NEUROL, V23, P31, DOI 10.1097/WCO.0b013e328334dafb; Meyer BC, 2008, LANCET NEUROL, V7, P787, DOI 10.1016/S1474-4422(08)70171-6; Reiner-Deitemyer V, 2011, STROKE, V42, P1295, DOI 10.1161/STROKEAHA.110.604710; Sanchez-Ross M, 2011, JACC-CARDIOVASC INTE, V4, P222, DOI 10.1016/j.jcin.2010.11.007; Schlachetzki F, 2012, CEREBROVASC DIS, V33, P262, DOI 10.1159/000334667; Schwamm LH, 2009, STROKE, V40, P2635, DOI 10.1161/STROKEAHA.109.192361; Schwamm LH, 2009, STROKE, V40, P2616, DOI 10.1161/STROKEAHA.109.192360; Sejersten M, 2008, AM J CARDIOL, V101, P941, DOI 10.1016/j.amjcard.2007.11.038; Skorning M, 2009, ANAESTHESIST, V58, P285, DOI 10.1007/s00101-008-1502-z; Van Wijngaarden JDH, 2011, QJM-INT J MED, V104, P785, DOI 10.1093/qjmed/hcr075; Walter S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013758; Ziegler V, 2008, ANAESTHESIST, V57, P677, DOI 10.1007/s00101-008-1395-x	29	75	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36796	10.1371/journal.pone.0036796	http://dx.doi.org/10.1371/journal.pone.0036796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629331	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500026
J	Choi, J; Shin, D; Kim, M; Park, J; Lim, S; Ryu, S				Choi, Jeongjoon; Shin, Dongwoo; Kim, Minjeong; Park, Joowon; Lim, Sangyong; Ryu, Sangryeol			LsrR-Mediated Quorum Sensing Controls Invasiveness of Salmonella typhimurium by Regulating SPI-1 and Flagella Genes	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; CELL-CELL COMMUNICATION; III SECRETION SYSTEM; SPECIALIZED TRANSDUCTION; TETRACYCLINE RESISTANCE; PATHOGENICITY ISLAND-1; STREPTOCOCCUS-PYOGENES; SENSOR KINASE; LUXS GENE	Bacterial cell-to-cell communication, termed quorum sensing (QS), controls bacterial behavior by using various signal molecules. Despite the fact that the LuxS/autoinducer-2 (AI-2) QS system is necessary for normal expression of Salmonella pathogenicity island-1 (SPI-1), the mechanism remains unknown. Here, we report that the LsrR protein, a transcriptional regulator known to be involved in LuxS/AI-2-mediated QS, is also associated with the regulation of SPI-1-mediated Salmonella virulence. We determined that LsrR negatively controls SPI-1 and flagella gene expressions. As phosphorylated AI-2 binds to and inactivates LsrR, LsrR remains active and decreases expression of SPI-1 and flagella genes in the luxS mutant. The reduced expression of those genes resulted in impaired invasion of Salmonella into epithelial cells. Expression of SPI-1 and flagella genes was also reduced by overexpression of the LsrR regulator from a plasmid, but was relieved by exogenous AI-2, which binds to and inactivates LsrR. These results imply that LsrR plays an important role in selecting infectious niche of Salmonella in QS dependent mode.	[Choi, Jeongjoon; Park, Joowon; Ryu, Sangryeol] Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea; [Choi, Jeongjoon; Park, Joowon; Ryu, Sangryeol] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Shin, Dongwoo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Samsung Biomed Res Inst, Suwon, South Korea; [Kim, Minjeong; Lim, Sangyong] Korea Atom Energy Res Inst, Radiat Res Div Biotechnol, Jeongeup, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Korea Atomic Energy Research Institute (KAERI)	Choi, J (corresponding author), Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea.	sangryu@snu.ac.kr	Choi, Jeongjoon/AAL-5387-2021	Choi, Jeongjoon/0000-0002-4137-6923	WCU (World Class University) program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R32-2008-000-10183-0]; Ministry of Education, Science and Technology through the Brain Korea 21 Project	WCU (World Class University) program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology through the Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by WCU (World Class University) program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (R32-2008-000-10183-0). JP was the recipient of a graduate fellowship provided by the Ministry of Education, Science and Technology through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearson BL, 2008, MICROB PATHOGENESIS, V44, P271, DOI 10.1016/j.micpath.2007.10.001; Burgess NA, 2002, MICROBIOL-SGM, V148, P763, DOI 10.1099/00221287-148-3-763; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi J, 2007, INFECT IMMUN, V75, P4885, DOI 10.1128/IAI.01942-06; Choi J, 2010, P NATL ACAD SCI USA, V107, P20506, DOI 10.1073/pnas.1000759107; Choi J, 2010, VACCINE, V28, P6436, DOI 10.1016/j.vaccine.2010.07.048; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Clarke MB, 2005, MOL MICROBIOL, V57, P1734, DOI 10.1111/j.1365-2958.2005.04792.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Eichelberg K, 2000, INFECT IMMUN, V68, P2735, DOI 10.1128/IAI.68.5.2735-2743.2000; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Husseiny MI, 2005, VACCINE, V23, P2580, DOI 10.1016/j.vaccine.2004.11.035; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Lim S, 2007, NUCLEIC ACIDS RES, V35, P1822, DOI 10.1093/nar/gkm060; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Lucas RL, 2000, MOL MICROBIOL, V36, P1024, DOI 10.1046/j.1365-2958.2000.01961.x; Lyon WR, 2001, MOL MICROBIOL, V42, P145, DOI 10.1046/j.1365-2958.2001.02616.x; Marouni MJ, 2003, INFECT IMMUN, V71, P5633, DOI 10.1128/IAI.71.10.5633-5639.2003; Meijler MM, 2004, ANGEW CHEM INT EDIT, V43, P2106, DOI 10.1002/anie.200353150; Miller J.H., 1972, EXPT MOL GENETICS; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Perego M, 1996, P NATL ACAD SCI USA, V93, P1549, DOI 10.1073/pnas.93.4.1549; Perrett CA, 2009, J BACTERIOL, V191, P7253, DOI 10.1128/JB.00727-09; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Thijs IM, 2010, CELL RES, V20, P966, DOI 10.1038/cr.2010.104; VanEngelenburg SB, 2008, CHEM BIOL, V15, P619, DOI 10.1016/j.chembiol.2008.04.014; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; WATANABE T, 1972, VIROLOGY, V50, P874, DOI 10.1016/0042-6822(72)90441-2; Winzer K, 2002, INFECT IMMUN, V70, P2245, DOI 10.1128/IAI.70.4.2245-2248.2002; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Yoon H, 2003, FEMS MICROBIOL LETT, V226, P391, DOI 10.1016/S0378-1097(03)00641-4	45	37	41	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37059	10.1371/journal.pone.0037059	http://dx.doi.org/10.1371/journal.pone.0037059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623980	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500057
J	Ibanez, A; Cetkovich, M; Petroni, A; Urquina, H; Baez, S; Gonzalez-Gadea, ML; Kamienkowski, JE; Torralva, T; Torrente, F; Strejilevich, S; Teitelbaum, J; Hurtado, E; Guex, R; Melloni, M; Lischinsky, A; Sigman, M; Manes, F				Ibanez, Agustin; Cetkovich, Marcelo; Petroni, Agustin; Urquina, Hugo; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Esteban Kamienkowski, Juan; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Hurtado, Esteban; Guex, Raphael; Melloni, Margherita; Lischinsky, Alicia; Sigman, Mariano; Manes, Facundo			The Neural Basis of Decision-Making and Reward Processing in Adults with Euthymic Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; MEDIAL FRONTAL-CORTEX; SUSTAINED ATTENTION; CINGULATE CORTEX; VALIDITY; BRAIN; NEUROECONOMICS; IMPULSIVITY; PERFORMANCE; IMPAIRMENT	Background: Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder (BD) share DSM-IV criteria in adults and cause problems in decision-making. Nevertheless, no previous report has assessed a decision-making task that includes the examination of the neural correlates of reward and gambling in adults with ADHD and those with BD. Methodology/Principal Findings: We used the Iowa gambling task (IGT), a task of rational decision-making under risk (RDMUR) and a rapid-decision gambling task (RDGT) which elicits behavioral measures as well as event-related potentials (ERPs: fERN and P3) in connection to the motivational impact of events. We did not observe between-group differences for decision-making under risk or ambiguity (RDMUR and IGT); however, there were significant differences for the ERP-assessed RDGT. Compared to controls, the ADHD group showed a pattern of impaired learning by feedback (fERN) and insensitivity to reward magnitude (P3). This ERP pattern (fERN and P3) was associated with impulsivity, hyperactivity, executive function and working memory. Compared to controls, the BD group showed fERN- and P3-enhanced responses to reward magnitude regardless of valence. This ERP pattern (fERN and P3) was associated with mood and inhibitory control. Consistent with the ERP findings, an analysis of source location revealed reduced responses of the cingulate cortex to the valence and magnitude of rewards in patients with ADHD and BD. Conclusions/Significance: Our data suggest that neurophysiological (ERPs) paradigms such as the RDGT are well suited to assess subclinical decision-making processes in patients with ADHD and BD as well as for linking the cingulate cortex with action monitoring systems.	[Ibanez, Agustin; Cetkovich, Marcelo; Urquina, Hugo; Luz Gonzalez-Gadea, Maria; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Melloni, Margherita; Lischinsky, Alicia; Manes, Facundo] Favaloro Univ, Lab Expt Psychol & Neurosci, Inst Cognit Neurol, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Cetkovich, Marcelo; Urquina, Hugo; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Torralva, Teresa; Torrente, Fernando; Strejilevich, Sergio; Teitelbaum, Julia; Melloni, Margherita; Lischinsky, Alicia; Manes, Facundo] Favaloro Univ, Inst Neurosci, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Petroni, Agustin; Baez, Sandra; Luz Gonzalez-Gadea, Maria; Sigman, Mariano] Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Ibanez, Agustin; Hurtado, Esteban] Univ Diego Portales, Lab Cognit & Social Neurosci, Santiago, Chile; [Petroni, Agustin; Esteban Kamienkowski, Juan; Sigman, Mariano] Univ Buenos Aires, Integrat Neurosci Lab, Dept Phys, Buenos Aires, DF, Argentina; [Hurtado, Esteban] Pontificia Univ Catolica Chile, Santiago, Chile; [Baez, Sandra] Pontificia Univ Catolica Argentina, Buenos Aires, DF, Argentina; [Urquina, Hugo] Univ Surcolombiana, Neiva, Colombia; [Guex, Raphael] Univ Geneva, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland	University Diego Portales; University of Buenos Aires; Pontificia Universidad Catolica de Chile; Pontifical Catholic University of Argentina; University of Geneva	Ibanez, A (corresponding author), Favaloro Univ, Lab Expt Psychol & Neurosci, Inst Cognit Neurol, Buenos Aires, DF, Argentina.	aibanez@neurologiacognitiva.org	Ibanez, Agustin/H-7976-2015; Torrente, Fernando/AAD-7885-2022	Ibanez, Agustin/0000-0001-6758-5101; Torrente, Fernando/0000-0001-7470-6979; Kamienkowski, Juan Esteban/0000-0002-5725-6539; Baez, Sandra/0000-0003-0875-1709; Petroni, Agustin/0000-0001-7352-6300; melloni, margherita/0000-0003-0931-8640; Strejilevich, Sergio Adrian/0000-0001-8410-7187	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program	This study was supported by grants Consejo Nacional de Investigaciones Cientificas y Tecnicas, Foundation Instituto de Neurologia Cognitiva and Human Frontiers Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley R, 1998, GUILFORD PRESS; BARRATT ES, 1969, J MED EDUC, V44, P604; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck AT., 1996, MANUAL BECK DEPRESSI; Benedetti F, 2007, ARCH GEN PSYCHIAT, V64, P179, DOI 10.1001/archpsyc.64.2.179; Biederman J, 2008, PSYCHOL MED, V38, P1045, DOI 10.1017/S0033291707001791; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Brooks JO, 2006, BIPOLAR DISORD, V8, P248, DOI 10.1111/j.1399-5618.2006.00310.x; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Chandler RA, 2009, BIOL PSYCHIAT, V66, P840, DOI 10.1016/j.biopsych.2009.05.011; Chang Kiki D, 2010, J Clin Psychiatry, V71, pe05, DOI 10.4088/JCP.8125tx7c; Christodouiou T, 2006, EUR PSYCHIAT, V21, P270, DOI 10.1016/j.eurpsy.2006.04.006; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2003, AM J PSYCHIAT, V160, P1061, DOI 10.1176/appi.ajp.160.6.1061; Fernandez-Duque D, 2007, JUDGM DECIS MAK, V2, P1; Fountoulakis KN, 2008, BRAIN RES REV, V59, P9, DOI 10.1016/j.brainresrev.2008.04.005; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gleichgerrcht E, 2011, SOC NEUROSCI-UK, V6, P113, DOI 10.1080/17470919.2010.506751; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jameson TL, 2004, PSYCHON B REV, V11, P515, DOI 10.3758/BF03196604; Jollant F, 2007, EUR PSYCHIAT, V22, P455, DOI 10.1016/j.eurpsy.2007.06.001; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Kaladjian A, 2009, PSYCHIAT RES-NEUROIM, V173, P45, DOI 10.1016/j.pscychresns.2008.08.003; Klassen LJ, 2010, J AFFECT DISORDERS, V124, P1, DOI 10.1016/j.jad.2009.06.036; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Luman M, 2010, BIOL PSYCHIAT, V68, P337, DOI 10.1016/j.biopsych.2009.12.037; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Manes FF, 2010, NAT REV NEUROL, V6, P347, DOI 10.1038/nrneurol.2010.34; Mantyla T, 2012, J ATTEN DISORD, V16, P164, DOI 10.1177/1087054709360494; Martino DJ, 2011, PSYCHOL MED, V41, P1319, DOI 10.1017/S0033291710001832; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Partington J, 1949, PSYCHOL CTR B, V1; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Rangel A, 2008, NEURON, V59, P525, DOI 10.1016/j.neuron.2008.08.003; Rey A, 1941, PSYCHOLOGIE, V8; Roiser J, 2009, PSYCHOL MED, V39, P785, DOI 10.1017/S0033291708004200; Rubinsztein JS, 2000, PSYCHOL MED, V30, P1025, DOI 10.1017/S0033291799002664; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Schecklmann M, 2008, J PSYCHIATR RES, V43, P98, DOI 10.1016/j.jpsychires.2008.02.005; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; Spielberg C, 1970, MANUAL STAIT TRAIT A; Taylor CT, 2008, J ANXIETY DISORD, V22, P868, DOI 10.1016/j.janxdis.2007.09.001; Torralva T, 2007, NEUROPSYCHOLOGIA, V45, P342, DOI 10.1016/j.neuropsychologia.2006.05.031; Torralva T, 2011, PSYCHIAT RES, V186, P261, DOI 10.1016/j.psychres.2010.08.007; Torralva T, 2009, J INT NEUROPSYCH SOC, V15, P777, DOI 10.1017/S1355617709990415; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Weber BJ, 2008, BRAIN RES, V1234, P104, DOI 10.1016/j.brainres.2008.07.105; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Wingo AP, 2007, J CLIN PSYCHIAT, V68, P1776, DOI 10.4088/JCP.v68n1118; Yechiam E, 2008, PSYCHIAT RES, V161, P142, DOI 10.1016/j.psychres.2007.07.001; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	71	67	67	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37306	10.1371/journal.pone.0037306	http://dx.doi.org/10.1371/journal.pone.0037306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624011	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500094
J	Lin, WC; Hsu, TW; Chen, CL; Wu, CWW; Lu, CH; Chen, HL; Li, SH; Yeh, PY; Cheng, YF; Lin, CP				Lin, Wei-Che; Hsu, Tun-Wei; Chen, Chao-Long; Wu, Changwei W.; Lu, Cheng-Hsien; Chen, Hsiu-Ling; Li, Shau-Hsuan; Yeh, Pin-Yang; Cheng, Yu-Fan; Lin, Ching-Po			Connectivity of Default-Mode Network Is Associated with Cerebral Edema in Hepatic Encephalopathy	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CHRONIC LIVER-DISEASE; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; FMRI; FLUCTUATIONS; CONSCIOUSNESS; ABNORMALITIES; EXPRESSION; CIRRHOSIS	Cerebral edema, a well-known feature of acute liver disease, can occur in cirrhotic patients regardless of hepatic encephalopathy (HE) and adversely affect prognosis. This study characterized and correlated functional HE abnormalities in the brain to cerebral edema using resting-state functional magnetic resonance imaging (rs-fMRI) and diffusion tensor imaging (DTI). Forty-one cirrhotic patients (16 without HE, 14 minimal HE, 11 overt HE) and 32 healthy controls were assessed. The HE grade in cirrhotic patients was evaluated by the West Haven criteria and neuro-psychological examinations. Functional connectivity correlation coefficient (fc-CC) of the default mode network (DMN) was determined by rs-fMRI, while the corresponding mean diffusivity (MD) was obtained from DTI. Correlations among inter-cortical fc-CC, DTI indices, Cognitive Ability Screening Instrument scores, and laboratory tests were also analyzed. Results showed that gradual reductions of HE-related consciousness levels, from "without HE" or "minimal HE" to "overt HE", correlated with decreased anterior-posterior fc-CC in DMN [F(4.415), p = 0.000)]. The MD values from regions with anterior-posterior fc-CC differences in DMN revealed significant differences between the overt HE group and other groups. Increased MD in this network was inversely associated with decreased fc-CC in DMN and linearly correlated with poor cognitive performance. In conclusion, cerebral edema can be linked to altered cerebral temporal architecture that modifies both within- and between-network connectivity in HE. Reduced fc-CC in DMN is associated with behavior and consciousness deterioration. Through appropriate targets, rs-fMRI technology may provide relevant supplemental information for monitoring HE and serve as a new biomarker for clinical diagnosis.	[Lin, Wei-Che; Chen, Hsiu-Ling; Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lin, Wei-Che; Chen, Chao-Long; Lu, Cheng-Hsien; Chen, Hsiu-Ling; Li, Shau-Hsuan; Cheng, Yu-Fan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lin, Wei-Che; Hsu, Tun-Wei; Chen, Hsiu-Ling; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Hsu, Tun-Wei] Taipei Vet Gen Hosp, Dept Diagnost Radiol, Taipei, Taiwan; [Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Inst Biomed Engn, Tao Yuan, Taiwan; [Lu, Cheng-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Li, Shau-Hsuan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Pin-Yang] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Yeh, Pin-Yang] Tsyr Huey Mental Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Lab Brain Connect, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; National Central University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University	Lin, WC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan.	cheng.yufan@msa.hinet.net; cplin@ym.edu.tw		Hsu, Tun-Wei/0000-0002-4614-6449; Hess, Christopher/0000-0002-5132-5302; Wu, Changwei W./0000-0001-8968-9366	National Health Research Institute [NHRI-EX100-9813EC]; National Science Council (NSC) [100-2628-E-010-002-MY3, NSC 97-2314-B-182A-104-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Health Research Institute (NHRI-EX100-9813EC) and National Science Council (NSC 100-2628-E-010-002-MY3 and NSC 97-2314-B-182A-104-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bai YM, 2009, SCHIZOPHR RES, V109, P167, DOI 10.1016/j.schres.2009.02.003; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Donovan JP, 1998, LANCET, V351, P719, DOI 10.1016/S0140-6736(97)07373-X; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; GUPTA RK, 1993, AM J GASTROENTEROL, V88, P670; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5; Haussinger D., 2002, J GASTROEN HEPATOL, V17, P256; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Jones EA, 1997, J NEUROL NEUROSUR PS, V63, P279, DOI 10.1136/jnnp.63.3.279; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Lin WC, 2012, AM J NEURORADIOL, V33, P239, DOI 10.3174/ajnr.A2769; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Tanigami H, 2005, NEUROSCIENCE, V131, P437, DOI 10.1016/j.neuroscience.2004.10.045; Tapert SF, 2004, ADDICT BEHAV, V29, P33, DOI 10.1016/j.addbeh.2003.07.003; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Zhang L, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21295, DOI 10.1002/HBM.21295]	41	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36986	10.1371/journal.pone.0036986	http://dx.doi.org/10.1371/journal.pone.0036986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623966	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500043
J	Wu, CC; Li, XB; Han, TS; Li, P; Wang, JG; Liu, GW; Wang, Z; Ge, CR; Gao, SZ				Wu, ChenChen; Li, XiaoBing; Han, TieSuo; Li, Peng; Wang, JianGuo; Liu, GuoWen; Wang, Zhe; Ge, ChangRong; Gao, ShiZheng			Dietary Pseudopurpurin Improves Bone Geometry Architecture and Metabolism in Red-Bone Guishan Goats	PLOS ONE			English	Article							OVARIECTOMIZED RATS; TRABECULAR BONE; ALIZARIN RED; STRENGTH; CALCIUM; INVITRO; MINERALIZATION; CALVARIA; MADDER	Red-colored bones were found initially in some Guishan goats in the 1980s, and they were designated red-boned goats. However, it is not understood what causes the red color in the bone, or whether the red material changes the bone geometry, architecture, and metabolism of red-boned goats. Pseudopurpurin was identified in the red-colored material of the bone in red-boned goats by high-performance liquid chromatography-electrospray ionization-mass spetrometry and nuclear magnetic resonance analysis. Pseudopurpurin is one of the main constituents of Rubia cordifolia L, which is eaten by the goats. The assessment of the mechanical properties and micro-computed tomography showed that the red-boned goats displayed an increase in the trabecular volume fraction, trabecular thickness, and the number of trabeculae in the distal femur. The mean thickness, inner perimeter, outer perimeter, and area of the femoral diaphysis were also increased. In addition, the trabecular separation and structure model index of the distal femur were decreased, but the bone mineral density of the whole femur and the mechanical properties of the femoral diaphysis were enhanced in the red-boned goats. Meanwhile, expression of alkaline phosphatase and osteocalcin mRNA was higher, and the ratio of the receptor activator of the nuclear factor kappa B ligand to osteoprotegerin was markedly lower in the bone marrow of the red-boned goats compared with common goats. To confirm further the effect of pseudopurpurin on bone geometry, architecture, and metabolism, Wistar rats were fed diets to which pseudopurpurin was added for 5 months. Similar changes were observed in the femurs of the treated rats. The above results demonstrate that pseudopurpurin has a close affinity with the mineral salts of bone, and consequently a high level of mineral salts in the bone cause an improvement in bone strength and an enhancement in the structure and metabolic functions of the bone.	[Wu, ChenChen; Li, XiaoBing; Han, TieSuo; Wang, JianGuo; Liu, GuoWen; Wang, Zhe] Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Jilin, Peoples R China; [Li, Peng] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Liaoning, Peoples R China; [Ge, ChangRong; Gao, ShiZheng] Yunnan Agr Univ, Coll Anim Food & Sci Technol, Yunnan, Peoples R China	Jilin University; Shenyang Agricultural University; Yunnan Agricultural University	Wu, CC (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Jilin, Peoples R China.	liuguowen2008@163.com; wangzhe500518@sohu.com	Li, Xiaobing/B-1267-2019; LI, Xiaobing/AAB-8762-2019	Li, Xiaobing/0000-0001-9105-6365; 	National Nature Science Foundation of China; Foundation of Yunnan Province [U0836601]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Yunnan Province	This work was supported by National Nature Science Foundation of China and the Foundation of Yunnan Province (No. U0836601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YJ, 2010, CALCIFIED TISSUE INT, V87, P365, DOI 10.1007/s00223-010-9410-z; Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; BRADBEER JN, 1992, J BONE MINER RES, V7, P905; Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2; Han XL, 2009, BONE, V44, P942, DOI 10.1016/j.bone.2008.12.005; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6; Kiel E. G., 1965, J SOC DYERS COLOUR, V81, P98, DOI [DOI 10.1111/J.1478-4408.1965.TB02647.X, 10.1111/j.1478-4408.1965.tb02647.x]; KIEL EG, 1963, J SOC DYERS COLOUR, V79, P61; Lancianese SL, 2008, BONE, V43, P1039, DOI 10.1016/j.bone.2008.07.247; Macklin CC, 1917, J MED RES, V4, P493; Muller R, 2004, J BONE MINER RES, V19, P1787, DOI 10.1359/JBMR.040809; NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x; Norton SA, 1998, J AM ACAD DERMATOL, V39, P484, DOI 10.1016/S0190-9622(98)70328-7; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; Richter D, 1937, BIOCHEM J, V31, P591, DOI 10.1042/bj0310591; Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7; SALTMAN PD, 1993, J AM COLL NUTR, V12, P384, DOI 10.1080/07315724.1993.10718327; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Turner CH, 2001, J BONE MINER RES, V16, P1532, DOI 10.1359/jbmr.2001.16.8.1532; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; van der Meulen MCH, 2001, BONE, V29, P101, DOI 10.1016/S8756-3282(01)00491-4	25	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37469	10.1371/journal.pone.0037469	http://dx.doi.org/10.1371/journal.pone.0037469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624037	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500122
J	Xu, XF; Yang, XD; Zhang, P; Chen, XY; Liu, HX; Li, ZZ				Xu, Xiaofeng; Yang, Xiangdong; Zhang, Ping; Chen, Xiuying; Liu, Huaxiang; Li, Zhenzhong			Effects of Exogenous Galanin on Neuropathic Pain State and Change of Galanin and Its Receptors in DRG and SDH after Sciatic Nerve-Pinch Injury in Rat	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; SPINAL-CORD; GROWTH-FACTOR; NEURONS; EXPRESSION; INVOLVEMENT; ACTIVATION; MECHANISMS; HORN; ANTINOCICEPTION	A large number of neuroanatomical, neurophysiologic, and neurochemical mechanisms are thought to contribute to the development and maintenance of neuropathic pain. However, mechanisms responsible for neuropathic pain have not been completely delineated. It has been demonstrated that neuropeptide galanin (Gal) is upregulated after injury in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) where it plays a predominantly antinociceptive role. In the present study, sciatic nerve-pinch injury rat model was used to determine the effects of exogenous Gal on the expression of the Gal and its receptors (GalR1, GalR2) in DRG and SDH, the alterations of pain behavior, nerve conduction velocity (NCV) and morphology of sciatic nerve. The results showed that exogenous Gal had antinociceptive effects in this nerve-pinch injury induced neuropathic pain animal model. It is very interesting that Gal, GalR1 and GalR2 change their expression greatly in DRG and SDH after nerve injury and intrathecal injection of exougenous Gal. Morphological investigation displays a serious damage after nerve-pinch injury and an amendatory regeneration after exogenous Gal treatment. These findings imply that Gal, via activation of GalR1 and/or GalR2, may have neuroprotective effects in reducing neuropathic pain behaviors and improving nerve regeneration after nerve injury.	[Xu, Xiaofeng; Zhang, Ping; Li, Zhenzhong] Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China; [Yang, Xiangdong] Shandong Univ, Qilu Hosp, Dept Nephrol, Jinan 250100, Peoples R China; [Chen, Xiuying] Shandong Univ, Affiliated Shandong Prov Hosp, Dept Electroencephalog, Jinan 250100, Peoples R China; [Liu, Huaxiang] Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Xu, XF (corresponding author), Shandong Univ, Sch Med, Dept Anat, Jinan 250100, Peoples R China.	zli@sdu.edu.cn			National Natural Science Foundation of China [81141060]; Science and Technology Development Project of Jinan Municipality of Shandong Province of China [200905041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Project of Jinan Municipality of Shandong Province of China	This work was supported by the National Natural Science Foundation of China (No. 81141060) and the Science and Technology Development Project of Jinan Municipality of Shandong Province of China (No. 200905041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2011, J NEUROCHEM, V117, P425, DOI 10.1111/j.1471-4159.2011.07204.x; Alier KA, 2008, PAIN, V137, P138, DOI 10.1016/j.pain.2007.08.030; An K, 2010, EUR J PAIN, V14, P595, DOI 10.1016/j.ejpain.2009.10.015; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Atlasi Mohammad Ali, 2009, Iranian Biomedical Journal, V13, P65; Brumovsky P, 2006, BRAIN RES, V1085, P111, DOI 10.1016/j.brainres.2006.02.088; Brumovsky P, 2006, J CHEM NEUROANAT, V31, P243, DOI 10.1016/j.jchemneu.2006.02.001; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Coronel MF, 2008, J CHEM NEUROANAT, V35, P94, DOI 10.1016/j.jchemneu.2007.07.001; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Flatters SJL, 2002, PAIN, V98, P249, DOI 10.1016/S0304-3959(02)00180-X; Gidal B, 2006, AM J MANAG CARE, V12, pS269; Guan Y, 2010, ANESTHESIOLOGY, V113, P1392, DOI 10.1097/ALN.0b013e3181fcd95c; Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4; Hobson SA, 2008, CELL MOL LIFE SCI, V65, P1806, DOI 10.1007/s00018-008-8154-7; Hua XY, 2005, NEUROPEPTIDES, V39, P211, DOI 10.1016/j.npep.2004.12.024; Hua XY, 2004, J PHARMACOL EXP THER, V308, P574, DOI 10.1124/jpet.103.058289; Hulse RP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-26; Jiang LY, 2010, J FORMOS MED ASSOC, V109, P438, DOI 10.1016/S0929-6646(10)60075-7; Jin WY, 2010, BRAIN RES, V1320, P16, DOI 10.1016/j.brainres.2009.12.060; Kato A, 2002, BRIT J PHARMACOL, V135, P1336, DOI 10.1038/sj.bjp.0704578; Kato R, 2002, J NEUROSCI, V22, P9410; Kerekes N, 2003, EUR J NEUROSCI, V18, P2957, DOI 10.1111/j.1460-9568.2003.03057.x; Landry M, 2006, J COMP NEUROL, V499, P391, DOI 10.1002/cne.21109; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Liu Z, 2008, IN VITRO CELL DEV-AN, V44, P379, DOI 10.1007/s11626-008-9118-9; Liu Z, 2009, PHARM BIOL, V47, P634, DOI 10.1080/13880200902915630; Lu Y, 2007, J PHYSIOL-LONDON, V582, P127, DOI 10.1113/jphysiol.2007.131565; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ohsawa M, 2010, EUR J PHARMACOL, V644, P1, DOI 10.1016/j.ejphar.2010.07.007; Patil SB, 2011, PAIN, V152, P924, DOI 10.1016/j.pain.2011.01.017; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pope RJP, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-67; Quintero L, 2011, PAIN, V152, P1909, DOI 10.1016/j.pain.2011.04.017; Ramos KM, 2007, DIABETES, V56, P1569, DOI 10.2337/db06-1269; Rose K, 2011, PAIN, V152, P742, DOI 10.1016/j.pain.2010.12.028; Shi TJS, 2006, EUR J NEUROSCI, V23, P627, DOI 10.1111/j.1460-9568.2006.04593.x; Shimoshige Y, 2010, BIOL PHARM BULL, V33, P67, DOI 10.1248/bpb.33.67; Vanelderen P, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.09.006; Vivoli E, 2010, NEUROSCIENCE, V167, P1168, DOI 10.1016/j.neuroscience.2010.03.017; Wilson-Gerwing TD, 2006, NEUROSCIENCE, V141, P2075, DOI 10.1016/j.neuroscience.2006.05.056; Wittau N, 2000, ONCOGENE, V19, P4199, DOI 10.1038/sj.onc.1203777; Xiong W, 2005, REGUL PEPTIDES, V132, P85, DOI 10.1016/j.regpep.2005.09.002; Xu XJ, 2010, EXPERIENTIA SUPPL, V102, P39, DOI 10.1007/978-3-0346-0228-0_4; Xu XF, 2012, BRAIN RES BULL, V87, P85, DOI 10.1016/j.brainresbull.2011.10.012; Zhang X, 1998, ANN NY ACAD SCI, V863, P402, DOI 10.1111/j.1749-6632.1998.tb10710.x	49	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37621	10.1371/journal.pone.0037621	http://dx.doi.org/10.1371/journal.pone.0037621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624057	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500146
J	Felix-Ortiz, AC; Febo, M				Felix-Ortiz, Ada C.; Febo, Marcelo			Gestational Valproate Alters BOLD Activation in Response to Complex Social and Primary Sensory Stimuli	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; 1A RECEPTOR AVPR1A; PRENATAL EXPOSURE; ANIMAL-MODEL; CONSCIOUS RATS; AUTISM; VASOPRESSIN; ACID; BEHAVIOR; MICE	Valproic acid (VPA) has been used clinically as an anticonvulsant medication during pregnancy; however, it poses a neurodevelopmental risk due to its high teratogenicity. We hypothesized that midgestational (GD) exposure to VPA will lead to lasting deficits in social behavior and the processing of social stimuli. To test this, animals were given a single IP injection of 600 mg/kg of VPA on GD 12.5. Starting on postnatal day 2 (PND2), animals were examined for physical and behavior abnormalities. Functional MRI studies were carried out after PND60. VPA and control animals were given vehicle or a central infusion of a V-1a antagonist 90 minutes before imaging. During imaging sessions, rats were presented with a juvenile test male followed by a primary visual stimulus (2 Hz pulsed light) to examine the effects of prenatal VPA on neural processing. VPA rats showed greater increases in BOLD signal response to the social stimulus compared to controls in the temporal cortex, thalamus, midbrain and the hypothalamus. Blocking the V-1a receptor reduced the BOLD response in VPA animals only. Neural responses to the visual stimulus, however, were lower in VPA animals. Blockade with the V-1a antagonist did not revert this latter effect. Our data suggest that prenatal VPA affects the processing of social stimuli and perhaps social memory, partly through a mechanism that may involve vasopressin V-1a neurotransmission.	[Felix-Ortiz, Ada C.; Febo, Marcelo] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Febo, Marcelo] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA	Northeastern University; State University System of Florida; University of Florida	Felix-Ortiz, AC (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	febo@ufl.edu	Febo, Marcelo/X-6769-2019; Febo, Marcelo/G-5718-2011	Febo, Marcelo/0000-0001-8981-4163; 	National Institutes of Health [DA019946]; Northeastern University development funds; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University development funds; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors (Felix-Ortiz and Febo) declare that this research was funded in part by National Institutes of Health grant DA019946 and Northeastern University development funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Brudzynski SM, 1996, BEHAV BRAIN RES, V80, P145, DOI 10.1016/0166-4328(96)00029-0; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Caffrey MK, 2010, NEUROPHARMACOLOGY, V58, P107, DOI 10.1016/j.neuropharm.2009.06.023; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Donaldson ZR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-180; Egashira N, 2007, BEHAV BRAIN RES, V178, P123, DOI 10.1016/j.bbr.2006.12.009; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Febo M, 2004, J NEUROSCI METH, V139, P167, DOI 10.1016/j.jneumeth.2004.04.028; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Ferris CF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-111; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hammock EAD, 2005, GENES BRAIN BEHAV, V4, P289, DOI 10.1111/j.1601-183X.2005.00119.x; Hellings JA, 2005, J NEUROPSYCH CLIN N, V17, P29, DOI 10.1176/appi.neuropsych.17.1.29; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Miyazaki K, 2005, INT J DEV NEUROSCI, V23, P287, DOI 10.1016/j.ijdevneu.2004.05.004; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Murray EK, 2011, J NEUROENDOCRINOL, V23, P906, DOI 10.1111/j.1365-2826.2011.02196.x; Nephew BC, 2009, EUR J NEUROSCI, V30, P934, DOI 10.1111/j.1460-9568.2009.06875.x; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rinaldi T, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.004.2008; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2001, POL J PHARMACOL, V53, P531; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Stodgell CJ, 2006, NEUROTOXICOL TERATOL, V28, P617, DOI 10.1016/j.ntt.2006.08.004; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walcott EC, 2011, J NEUROSCI, V31, P13097, DOI 10.1523/JNEUROSCI.1341-11.2011; Wigger A, 2004, NEUROPSYCHOPHARMACOL, V29, P1, DOI 10.1038/sj.npp.1300290; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Yirmiya N, 2006, MOL PSYCHIATR, V11, P488, DOI 10.1038/sj.mp.4001812; Zeskind Philip Sanford, 2011, Front Psychiatry, V2, P56, DOI 10.3389/fpsyt.2011.00056	51	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37313	10.1371/journal.pone.0037313	http://dx.doi.org/10.1371/journal.pone.0037313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615973	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200056
J	Johnson, DK; Homann, D				Johnson, Darlynn Korns; Homann, Dirk			Accelerated and Improved Quantification of Lymphocytic Choriomeningitis Virus (LCMV) Titers by Flow Cytometry	PLOS ONE			English	Article							PERSISTENT INFECTION; ALPHA-DYSTROGLYCAN; VIRAL PERSISTENCE; RECEPTOR FUNCTION; T-CELLS; IN-VIVO; INHIBITION; NUCLEOPROTEIN; INTERFERENCE; VARIANT	Lymphocytic choriomeningitis virus (LCMV), a natural murine pathogen, is a member of the Arenavirus family, may cause atypical meningitis in humans, and has been utilized extensively as a model pathogen for the study of virus-induced disease and immune responses. Historically, viral titers have been quantified by a standard plaque assay, but for non-cytopathic viruses including LCMV this requires lengthy incubation, so results cannot be obtained rapidly. Additionally, due to specific technical constraints of the plaque assay including the visual detection format, it has an element of subjectivity along with limited sensitivity. In this study, we describe the development of a FACS-based assay that utilizes detection of LCMV nucleoprotein (NP) expression in infected cells to determine viral titers, and that exhibits several advantages over the standard plaque assay. We show that the LCMV-NP FACS assay is an objective and reproducible detection method that requires smaller sample volumes, exhibits a similar to 20-fold increase in sensitivity to and produces results three times faster than the plaque assay. Importantly, when applied to models of acute and chronic LCMV infection, the LCMV-NP FACS assay revealed the presence of infectious virus in samples that were determined to be negative by plaque assay. Therefore, this technique represents an accelerated, enhanced and objective alternative method for detection of infectious LCMV that is amenable to adaptation for other viral infections as well as high throughput diagnostic platforms.	[Johnson, Darlynn Korns; Homann, Dirk] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Johnson, Darlynn Korns; Homann, Dirk] Natl Jewish Hlth, Denver, CO USA; [Johnson, Darlynn Korns; Homann, Dirk] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA	University of Colorado System; University of Colorado Denver; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Johnson, DK (corresponding author), Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA.	darlynn.kornsjohnson@ucdenver.edu; dirk.homann@ucdenver.edu		Homann, Dirk/0000-0002-7622-5754	National Institutes of Health [AG026518-01]; JDRF CDA [2-2007-240]; BDC PF grant; Diabetes and Endocrinology Research Center (DERC) [P30-DK057516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF CDA; BDC PF grant; Diabetes and Endocrinology Research Center (DERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant AG026518-01, JDRF CDA 2-2007-240 and a BDC P&F grant (DH), and the Diabetes and Endocrinology Research Center (DERC) grant P30-DK057516. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BORROW P, 1991, J EXP MED, V174, P203, DOI 10.1084/jem.174.1.203; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; COOPER P. D., 1961, ADVANCES IN VIRUS RES, V8, P319; Cordey S, 2011, J VIROL METHODS, V177, P118, DOI 10.1016/j.jviromet.2011.06.018; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Emonet S, 2007, EMERG INFECT DIS, V13, P472, DOI 10.3201/eid1303.061141; Homann D, 2004, J IMMUNOL, V172, P6239, DOI 10.4049/jimmunol.172.10.6239; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Imperiali M, 2005, J VIROL, V79, P14297, DOI 10.1128/JVI.79.22.14297-14308.2005; Imperiali M, 2008, J GEN VIROL, V89, P2713, DOI 10.1099/vir.0.2008/004721-0; Kunz S, 2009, VIROLOGY, V387, P245, DOI 10.1016/j.virol.2009.02.042; Labudova M, 2009, J VIROL, V83, P7842, DOI 10.1128/JVI.00309-09; Lee AM, 2008, VIROLOGY, V372, P107, DOI 10.1016/j.virol.2007.10.016; MARCUS PI, 1965, SCIENCE, V149, P983, DOI 10.1126/science.149.3687.983; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; Rai SK, 1996, J VIROL, V70, P7213, DOI 10.1128/JVI.70.10.7213-7218.1996; SALVATO M, 1988, VIROLOGY, V164, P517, DOI 10.1016/0042-6822(88)90566-1; SEDWICK W. D., 1967, J VIROL, V1, P1224; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; WAINWRIGHT SALLY, 1967, J VIROL, V1, P1091; WELSH RM, 1972, J GEN VIROL, V14, P177, DOI 10.1099/0022-1317-14-2-177; WELSH RM, 1979, VIROLOGY, V96, P503, DOI 10.1016/0042-6822(79)90107-7; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10	27	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37337	10.1371/journal.pone.0037337	http://dx.doi.org/10.1371/journal.pone.0037337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615984	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200063
J	Wander, K; O'Connor, K; Shell-Duncan, B				Wander, Katherine; O'Connor, Kathleen; Shell-Duncan, Bettina			Expanding the Hygiene Hypothesis: Early Exposure to Infectious Agents Predicts Delayed-Type Hypersensitivity to Candida among Children in Kilimanjaro	PLOS ONE			English	Article							DAY-CARE ATTENDANCE; INFLAMMATORY-BOWEL-DISEASE; FAMILY-SIZE; EARLY-LIFE; NUTRITIONAL-STATUS; SEX-DIFFERENCES; PARENTAL AGE; BIRTH-ORDER; SCHOOL-AGE; HAY-FEVER	Background: Multiple lines of evidence suggest that infections in early life prevent the development of pathological immune responses to allergens and autoantigens (the hygiene hypothesis). Early infections may also affect later immune responses to pathogen antigen. Methods: To evaluate an association between early infections and immune responses to pathogen antigen, delayed-type hypersensitivity (DTH) to Candida albicans was evaluated among 283 2- to 7-year-old children in Kilimanjaro, Tanzania. A questionnaire and physical examination were used to characterize variables reflecting early exposure to infectious agents (family size, house construction materials, BCG vaccination, hospitalization history). Logistic regression was used to evaluate the association between early exposure to infectious agents and DTH to C. albicans. Results: Triceps skinfold thickness (OR: 1.11; 95% CI: 1.01, 1.22) and age (OR: 1.27; 95% CI: 1.04, 1.55) were positively associated with DTH to C. albicans. Adjusted for age and sex, large family size (OR: 2.81; 95% CI: 1.04, 7.61), BCG vaccination scar (OR: 3.10; 95% CI: 1.10, 8.71), and hospitalization during infancy with an infectious disease (OR: 4.67; 95% CI: 1.00, 21.74) were positively associated with DTH to C. albicans. Conclusions: Early life infections were positively associated with later DTH to C. albicans. This result supports an expansion of the hygiene hypothesis to explain not only pathological immune responses to allergens, but also appropriate immune responses to pathogens. Immune system development may be responsive to early infections as an adaptive means to tailor reactivity to the local infectious disease ecology.	[Wander, Katherine; O'Connor, Kathleen; Shell-Duncan, Bettina] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [O'Connor, Kathleen] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wander, K (corresponding author), Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.	kwander@u.washington.edu	Wander, Katherine/AAL-1551-2020	Wander, Katherine/0000-0002-4913-5075	National Science Foundation Doctoral Dissertation Improvement Grant [0968742]; Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant [8065]; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [5R24 HD042828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant [0968742 to KW] and a Wenner-Gren Foundation for Anthropological Research Dissertation Fieldwork Grant [8065 to KW]. Partial support for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [5R24 HD042828, to the Center for Studies in Demography and Ecology at the University of Washington]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2006, AM J GASTROENTEROL, V101, P1005, DOI 10.1111/j.1572-0241.2006.00526.x; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Black C A, 1999, Dermatol Online J, V5, P7; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Calvani M, 2002, EUR RESPIR J, V20, P391, DOI 10.1183/09031936.02.00274502; Cardwell CR, 2008, DIABETIC MED, V25, P261, DOI 10.1111/j.1464-5491.2007.02351.x; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; D'Angeli MA, 2010, ARCH PEDIAT ADOL MED, V164, P732, DOI 10.1001/archpediatrics.2010.115; Guilherme Luiza, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940501015X; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.3.CO;2-V; Hampe J, 2003, INT J COLORECTAL DIS, V18, P413, DOI 10.1007/s00384-003-0484-1; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Infante-Rivard C, 2001, AM J EPIDEMIOL, V153, P653, DOI 10.1093/aje/153.7.653; Janson C, 2007, J ALLERGY CLIN IMMUN, V120, P673, DOI 10.1016/j.jaci.2007.05.003; Jarvis D, 1997, CLIN EXP ALLERGY, V27, P240; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; KNIKER WT, 1985, AM J DIS CHILD, V139, P840, DOI 10.1001/archpedi.1985.02140100102044; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Maizels RM, 2005, CURR OPIN IMMUNOL, V17, P656, DOI 10.1016/j.coi.2005.09.001; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 2010, CLIN EXP IMMUNOL, V160, P98, DOI 10.1111/j.1365-2249.2010.04130.x; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Matricardi PM, 1998, J ALLERGY CLIN IMMUN, V101, P439, DOI 10.1016/S0091-6749(98)70350-1; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Montgomery SM, 2004, EPIDEMIOLOGY, V15, P717, DOI 10.1097/01.ede.0000142138.46167.69; Montgomery SM, 2002, SCAND J GASTROENTERO, V37, P1301, DOI 10.1080/003655202761020588; Nestel P., 2002, ADJUSTING HEMOGLOBIN; NEUMANN CG, 1975, AM J CLIN NUTR, V28, P89, DOI 10.1093/ajcn/28.2.89; Nja F, 2003, ARCH DIS CHILD, V88, P566, DOI 10.1136/adc.88.7.566; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; ShellDuncan B, 1997, J TROP PEDIATRICS, V43, P25, DOI 10.1093/tropej/43.1.25; ShellDuncan B, 1997, AM J HUM BIOL, V9, P381, DOI 10.1002/(SICI)1520-6300(1997)9:3&lt;381::AID-AJHB10&gt;3.0.CO;2-I; Stene LC, 2001, BMJ-BRIT MED J, V323, P1; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; von Mutius E, 2001, EUR RESPIR J, V18, P872, DOI 10.1183/09031936.01.00268401; Wander KW, 2012, AM J HUM BI IN PRESS; WASHBURN TC, 1965, PEDIATRICS, V35, P57; Williams LK, 2004, J ALLERGY CLIN IMMUN, V113, P291, DOI 10.1016/j.jaci.2003.11.010; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Zaman K, 1997, ACTA PAEDIATR, V86, P923, DOI 10.1111/j.1651-2227.1997.tb15171.x	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37406	10.1371/journal.pone.0037406	http://dx.doi.org/10.1371/journal.pone.0037406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616000	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200072
J	Chiantore, MV; Vannucchi, S; Accardi, R; Tommasino, M; Percario, ZA; Vaccari, G; Affabris, E; Fiorucci, G; Romeo, G				Chiantore, Maria V.; Vannucchi, Serena; Accardi, Rosita; Tommasino, Massimo; Percario, Zulema A.; Vaccari, Gabriele; Affabris, Elisabetta; Fiorucci, Gianna; Romeo, Giovanna			Interferon-beta Induces Cellular Senescence in Cutaneous Human Papilloma Virus-Transformed Human Keratinocytes by Affecting p53 Transactivating Activity	PLOS ONE			English	Article							CERVICAL-CARCINOMA CELLS; ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; REPLICATIVE SENESCENCE; INDUCED APOPTOSIS; TRANSGENIC MICE; SQUAMOUS-CELL; E6 PROTEIN; IN-VIVO; PML	Interferon (IFN)-beta inhibits cell proliferation and affects cell cycle in keratinocytes transformed by both mucosal high risk Human Papilloma Virus (HPV) and cutaneous HPV E6 and E7 proteins. In particular, upon longer IFN-beta treatments, cutaneous HPV38 expressing cells undergo senescence. IFN-beta appears to induce senescence by upregulating the expression of the tumor suppressor PML, a well known IFN-induced gene. Indeed, experiments in gene silencing via specific siRNAs have shown that PML is essential in the execution of the senescence programme and that both p53 and p21 pathways are involved. IFN-beta treatment leads to a modulation of p53 phosphorylation and acetylation status and a reduction in the expression of the p53 dominant negative Delta Np73. These effects allow the recovery of p53 transactivating activity of target genes involved in the control of cell proliferation. Taken together, these studies suggest that signaling through the IFN pathway might play an important role in cellular senescence. This additional understanding of IFN antitumor action and mechanisms influencing tumor responsiveness or resistance appears useful in aiding further promising development of biomolecular strategies in the IFN therapy of cancer.	[Chiantore, Maria V.; Vannucchi, Serena; Fiorucci, Gianna; Romeo, Giovanna] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Accardi, Rosita; Tommasino, Massimo] Int Agcy Res Canc WHO, Infect & Canc Biol Grp, Lyon, France; [Percario, Zulema A.; Affabris, Elisabetta] Univ Roma Tre, Dept Biol, Rome, Italy; [Vaccari, Gabriele] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Fiorucci, Gianna] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Romeo, Giovanna] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); World Health Organization; International Agency for Research on Cancer (IARC); Roma Tre University; Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Chiantore, MV (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.romeo@uniroma1.it	Vaccari, Gabriele/A-9597-2010; Romeo, Giovanna/AAB-2613-2019; CHIANTORE, MARIA VINCENZA/C-2948-2016; Fiorucci, Gianna/B-3064-2013; romeo, giovanna/P-8348-2015	Vaccari, Gabriele/0000-0003-0215-3521; CHIANTORE, MARIA VINCENZA/0000-0001-5163-2698; Tommasino, Massimo/0000-0002-0890-8596; romeo, giovanna/0000-0002-7638-1001; AFFABRIS, Elisabetta/0000-0001-5142-8144	Ministero dell'Istruzione, dell'Universita e della Ricerca; Sapienza University	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Sapienza University	Research in our laboratory is currently funded in part by "Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN 2008) del Ministero dell'Istruzione, dell'Universita e della Ricerca" and Progetti Ateneo, Sapienza University, 2009 and 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2006, EMBO REP, V7, P334, DOI 10.1038/sj.embor.7400615; Allison SJ, 2009, AGING-US, V1, P316, DOI 10.18632/aging.100028; Bekisz J, 2010, PHARMACEUTICALS, V3, P994, DOI 10.3390/ph3040994; Boehm JS, 2005, CURR OPIN GENET DEV, V15, P13, DOI 10.1016/j.gde.2004.11.003; Bourdeau V, 2009, FRONT BIOSCI-LANDMRK, V14, P475, DOI 10.2741/3256; Buhlmann S, 2008, BBA-REV CANCER, V1785, P207, DOI 10.1016/j.bbcan.2008.01.002; Caldeira S, 2003, J VIROL, V77, P2195, DOI 10.1128/JVI.77.3.2195-2206.2003; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chiantore MV, 2009, CURR MED CHEM, V16, P287, DOI 10.2174/092986709787002691; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gabet AS, 2008, FASEB J, V22, P622, DOI 10.1096/fj.07-8389com; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Giampieri S, 2004, ONCOGENE, V23, P5864, DOI 10.1038/sj.onc.1207711; Giampieri S, 2004, BRIT J CANCER, V90, P2203, DOI 10.1038/sj.bjc.6601829; Hebner C, 2007, J VIROL, V81, P12740, DOI 10.1128/JVI.00987-07; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Iftner T, 2002, EMBO J, V21, P4741, DOI 10.1093/emboj/cdf443; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kim R, 2006, EJSO-EUR J SURG ONC, V32, P269, DOI 10.1016/j.ejso.2005.12.006; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michel A, 2006, J VIROL, V80, P11153, DOI 10.1128/JVI.00954-06; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Moller A, 2003, CANCER RES, V63, P4310; Pammer J, 2006, LAB INVEST, V86, P997, DOI 10.1038/labinvest.3700461; Pfefferle R, 2008, J INVEST DERMATOL, V128, P2310, DOI 10.1038/jid.2008.73; Rebbaa A, 2003, ONCOGENE, V22, P2805, DOI 10.1038/sj.onc.1206366; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sima N, 2007, GYNECOL ONCOL, V106, P299, DOI 10.1016/j.ygyno.2007.04.039; Stadler M, 1995, ONCOGENE, V11, P2565; Struijk L, 2008, J GEN VIROL, V89, P2303, DOI 10.1099/vir.0.83317-0; Testoni B, 2011, ONCOGENE, V30, P2670, DOI 10.1038/onc.2010.635; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Vannucchi S, 2000, ONCOGENE, V19, P5041, DOI 10.1038/sj.onc.1203883; Vannucchi S, 2007, CURR MED CHEM, V14, P667, DOI 10.2174/092986707780059616; Vannucchi S, 2005, ONCOGENE, V24, P2536, DOI 10.1038/sj.onc.1208403; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002; Zhang G, 2009, ONCOL REP, V21, P371, DOI 10.3892/or_00000232; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	52	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36909	10.1371/journal.pone.0036909	http://dx.doi.org/10.1371/journal.pone.0036909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615843	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300042
J	Nassar, D; Letavernier, E; Baud, L; Aractingi, S; Khosrotehrani, K				Nassar, Dany; Letavernier, Emmanuel; Baud, Laurent; Aractingi, Selim; Khosrotehrani, Kiarash			Calpain Activity Is Essential in Skin Wound Healing and Contributes to Scar Formation	PLOS ONE			English	Article							DISTINCT SIGNALING PATHWAYS; MARROW-DERIVED CELLS; SMOOTH MUSCLE ACTIN; MU-CALPAIN; MEDIATED PROTEOLYSIS; ADHESION DYNAMICS; ACTIVATION; FIBROBLASTS; MIGRATION; EXPRESSION	Wound healing is a multistep phenomenon that relies on complex interactions between various cell types. Calpains are ubiquitously expressed proteases regulating several processes including cellular adhesion and motility as well as inflammation and angiogenesis. Calpains can be targeted by inhibitors, and their inhibition was shown to reduce organ damage in various disease models. We aimed to assess the role of calpains in skin healing and the potential benefit of calpain inhibition on scar formation. We used a pertinent model where calpain activity is inhibited only in lesional organs, namely transgenic mice overexpressing calpastatin (CPST), a specific natural calpain inhibitor. CPST mice showed a striking delay in wound healing particularly in the initial steps compared to wild types (WT). CPST wounds displayed reduced proliferation in the epidermis and delayed re-epithelization. Granulation tissue formation was impaired in CPST mice, with a reduction in CD45+ leukocyte infiltrate and in CD31+ blood vessel density. Interestingly, wounds on WT skin grafted on CPST mice (WT/CPST) showed a similar delayed healing with reduced angiogenesis and inflammation compared to wounds on WT/WT mice demonstrating the implication of calpain activity in distant extra-cutaneous cells during wound healing. CPST wounds showed a reduction in alpha-smooth muscle actin (alpha SMA) expressing myofibroblasts as well as alpha SMA RNA expression suggesting a defect in granulation tissue contraction. At later stages of skin healing, calpain inhibition proved beneficial by reducing collagen production and wound fibrosis. In vitro, human fibroblasts exposed to calpeptin, a pancalpain inhibitor, showed reduced collagen synthesis, impaired TGF beta-induced differentiation into alpha SMA-expressing myofibroblasts, and were less efficient in a collagen gel contraction assay. In conclusion, calpains are major players in granulation tissue formation. In view of their specific effects on fibroblasts a late inhibition of calpains should be considered for scar reduction.	[Nassar, Dany; Aractingi, Selim; Khosrotehrani, Kiarash] Univ Paris 06, UMRS938, Paris, France; [Nassar, Dany; Aractingi, Selim; Khosrotehrani, Kiarash] INSERM, St Antoine Res Ctr, U938, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] INSERM, U702, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] Univ Paris 06, UMRS702, Paris, France; [Letavernier, Emmanuel; Baud, Laurent] Tenon Hosp, AP HP, Dept Physiol, Paris, France; [Aractingi, Selim] Tenon Hosp, AP HP, Dept Dermatol, Paris, France; [Khosrotehrani, Kiarash] Univ Queensland, Expt Dermatol Grp, UQ Ctr Clin Res, Brisbane, Qld, Australia	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Queensland	Nassar, D (corresponding author), Univ Paris 06, UMRS938, Paris, France.	dany.nassar@inserm.fr	Khosrotehrani, Kiarash/M-8025-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; Nassar, Dany/0000-0001-6780-0721; Aractingi, Selim/0000-0002-7766-2673	STEM-Pole Ile-de-France; Ramaciotti Foundation	STEM-Pole Ile-de-France; Ramaciotti Foundation	D. Nassar received a grant from STEM-Pole Ile-de-France. K. Khosrotehrani was supported by the Ramaciotti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bellocq A, 1999, J BIOL CHEM, V274, P36891, DOI 10.1074/jbc.274.52.36891; Blumbach K, 2010, J CELL SCI, V123, P3872, DOI 10.1242/jcs.063024; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Farahani RM, 2008, INT WOUND J, V5, P477, DOI 10.1111/j.1742-481X.2007.00402.x; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoang MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013612; Hsu CY, 2011, J BIOL CHEM, V286, P23222, DOI 10.1074/jbc.M110.197400; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Katsube M, 2008, J LEUKOCYTE BIOL, V84, P255, DOI 10.1189/jlb.0907664; Khosrotehrani K, 2011, AM J PATHOL, V178, P1870, DOI 10.1016/j.ajpath.2010.12.044; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MIYACHI Y, 1986, J INVEST DERMATOL, V86, P346, DOI 10.1111/1523-1747.ep12285556; Morris LM, 2010, WOUND REPAIR REGEN, V18, P383, DOI 10.1111/j.1524-475X.2010.00596.x; Noma H, 2009, IMMUNOLOGY, V128, pe487, DOI 10.1111/j.1365-2567.2008.03012.x; Okuno Y, 2011, BLOOD; Peltier J, 2006, J AM SOC NEPHROL, V17, P3415, DOI 10.1681/ASN.2006050542; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Rolfe KJ, 2007, WOUND REPAIR REGEN, V15, P897, DOI 10.1111/j.1524-475X.2007.00314.x; Satish L, 2005, MOL CELL BIOL, V25, P1922, DOI 10.1128/MCB.25.5.1922-1941.2005; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Tabata C, 2010, CLIN EXP IMMUNOL, V162, P560, DOI 10.1111/j.1365-2249.2010.04257.x; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Undyala VV, 2008, J CELL SCI, V121, P3581, DOI 10.1242/jcs.036152; Wiemer AJ, 2010, MOL IMMUNOL, V47, P894, DOI 10.1016/j.molimm.2009.10.002; Wilson L, 2002, BIOTECHNIQUES, V32, P548, DOI 10.2144/02323st07; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; Zhao Rui, 2009, Leg Med (Tokyo), V11 Suppl 1, pS155, DOI 10.1016/j.legalmed.2009.02.023	56	45	47	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37084	10.1371/journal.pone.0037084	http://dx.doi.org/10.1371/journal.pone.0037084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615899	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300066
J	Niu, J; Fu, CJ; Tan, WC				Niu, Jun; Fu, Ceji; Tan, Wenchang			Slip-Flow and Heat Transfer of a Non-Newtonian Nanofluid in a Microtube	PLOS ONE			English	Article							GRAETZ PROBLEM; FLUIDS	The slip-flow and heat transfer of a non-Newtonian nanofluid in a microtube is theoretically studied. The power-law rheology is adopted to describe the non-Newtonian characteristics of the flow, in which the fluid consistency coefficient and the flow behavior index depend on the nanoparticle volume fraction. The velocity profile, volumetric flow rate and local Nusselt number are calculated for different values of nanoparticle volume fraction and slip length. The results show that the influence of nanoparticle volume fraction on the flow of the nanofluid depends on the pressure gradient, which is quite different from that of the Newtonian nanofluid. Increase of the nanoparticle volume fraction has the effect to impede the flow at a small pressure gradient, but it changes to facilitate the flow when the pressure gradient is large enough. This remarkable phenomenon is observed when the tube radius shrinks to micrometer scale. On the other hand, we find that increase of the slip length always results in larger flow rate of the nanofluid. Furthermore, the heat transfer rate of the nanofluid in the microtube can be enhanced due to the non-Newtonian rheology and slip boundary effects. The thermally fully developed heat transfer rate under constant wall temperature and constant heat flux boundary conditions is also compared.	[Niu, Jun; Fu, Ceji; Tan, Wenchang] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China	Peking University	Niu, J (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	cjfu@pku.edu.cn; tanwch@mech.pku.edu.cn	Tan, Wenchang/I-9949-2014; Fu, Ceji/C-3262-2012		National Natural Science Foundation of China [10825208]; Wallance H. Coulter Foundation [16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wallance H. Coulter Foundation	This work was supported by the National Natural Science Foundation of China (Grant No. 10825208) and Georgia Tech-Emory-PKU Seed Grant of Wallance H. Coulter Foundation (Grant No. 16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhordari M, 2007, INT J HEAT FLUID FL, V28, P1027, DOI 10.1016/j.ijheatfluidflow.2007.02.007; Barron RF, 1997, INT J HEAT MASS TRAN, V40, P1817, DOI 10.1016/S0017-9310(96)00256-6; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Chang H, 2005, REV ADV MATER SCI, V10, P128; Cottin-Bizonne C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056102; Craig VSJ, 2002, PHYS REV LETT, V87; Ding YL, 2006, INT J HEAT MASS TRAN, V49, P240, DOI 10.1016/j.ijheatmasstransfer.2005.07.009; GORLA RSR, 1987, MECH RES COMMUN, V14, P355, DOI 10.1016/0093-6413(87)90056-5; Incropera F.P., 1996, FUNDAMENTALS HEAT MA; Jang SP, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824393; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Koo J, 2005, INT J HEAT MASS TRAN, V48, P2652, DOI 10.1016/j.ijheatmasstransfer.2005.01.029; Larrode FE, 2000, INT J HEAT MASS TRAN, V43, P2669, DOI 10.1016/S0017-9310(99)00324-5; Lee S, 1999, J HEAT TRANS-T ASME, V121, P280, DOI 10.1115/1.2825978; LYCHE BC, 1956, CHEM ENG SCI, V6, P35, DOI 10.1016/0009-2509(56)80008-0; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Navier C., 1823, MEM ACAD SCI I FRANC, V1, P414; Pak BC, 1998, EXP HEAT TRANSFER, V11, P151, DOI 10.1080/08916159808946559; Putra N, 2003, HEAT MASS TRANSFER, V39, P775, DOI [10.1007/s00231-002-0382-z, 10.1007/S00231-002-0382-z]; Santra AK, 2009, INT J THERM SCI, V48, P391, DOI 10.1016/j.ijthermalsci.2008.10.004; Thompson PA, 1997, NATURE, V389, P360, DOI 10.1038/38686; Xuan YM, 2003, J HEAT TRANS-T ASME, V125, P151, DOI 10.1115/1.1532008; Yang FQ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717019; Zhang Z.M., 2007, NANOMICROSCALE HEAT; Zhu YX, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.106102	25	51	52	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37274	10.1371/journal.pone.0037274	http://dx.doi.org/10.1371/journal.pone.0037274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615961	Green Published, gold			2022-12-27	WOS:000305336300088
J	Koch, AM; Antunes, PM; Klironomos, JN				Koch, Alexander M.; Antunes, Pedro M.; Klironomos, John N.			Diversity Effects on Productivity Are Stronger within than between Trophic Groups in the Arbuscular Mycorrhizal Symbiosis	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; FUNCTIONAL DIVERSITY; GENETIC-VARIABILITY; FUNGAL DIVERSITY; BIODIVERSITY; COLONIZATION; COMMUNITIES; FEEDBACK; POPULATION; STABILITY	Background: The diversity of plants and arbuscular mycorrhizal fungi (AMF) has been experimentally shown to alter plant and AMF productivity. However, little is known about how plant and AMF diversity interact to shape their respective productivity. Methodology/Principal Findings: We co-manipulated the diversity of both AMF and plant communities in two greenhouse studies to determine whether the productivity of each trophic group is mainly influenced by plant or AMF diversity, respectively, and whether there is any interaction between plant and fungal diversity. In both experiments we compared the productivity of three different plant species monocultures, or their respective 3-species mixtures. Similarly, in both studies these plant treatments were crossed with an AMF diversity gradient that ranged from zero (non-mycorrhizal controls) to a maximum of three and five taxonomically distinct AMF taxa, respectively. We found that within both trophic groups productivity was significantly influenced by taxon identity, and increased with taxon richness. These main effects of AMF and plant diversity on their respective productivities did not depend on each other, even though we detected significant individual taxon effects across trophic groups. Conclusions/Significance: Our results indicate that similar ecological processes regulate diversity-productivity relationships within trophic groups. However, productivity-diversity relationships are not necessarily correlated across interacting trophic levels, leading to asymmetries and possible biotic feedbacks. Thus, biotic interactions within and across trophic groups should be considered in predictive models of community assembly.	[Koch, Alexander M.; Antunes, Pedro M.; Klironomos, John N.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Koch, AM (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	akoch13@gmail.com	Madeira Antunes, Pedro/C-2949-2008	Madeira Antunes, Pedro/0000-0003-3596-6983	Swiss National Science Foundation [PBLAA-114210, PAOOA-119519]; Roche Research Foundation; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Natural Resources	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Natural Resources	AMK was supported by fellowships from the Swiss National Science Foundation (http://www.snf.ch, projects PBLAA-114210 and PAOOA-119519) and the Roche Research Foundation. The authors also thank the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) for financial support through a Discovery grant to JNK and PMA, and the Ontario Ministry of Natural Resources (http://www.mnr.gov.on.ca) for financial support to PMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Burrows RL, 2002, CAN J BOT, V80, P120, DOI [10.1139/B01-138, 10.1139/b01-138]; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Hoeksema JD, 2010, NEW PHYTOL, V187, P286, DOI 10.1111/j.1469-8137.2010.03305.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; KLIRONOMOS JN, 1993, CAN J BOT, V71, P1472, DOI 10.1139/b93-178; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2002, MYCORRHIZA, V12, P181, DOI 10.1007/s00572-002-0169-6; Klironomos J, 2011, NEW PHYTOL, V189, P366, DOI 10.1111/j.1469-8137.2010.03550.x; Koch AM, 2011, BIOL INVASIONS, V13, P1627, DOI 10.1007/s10530-010-9920-7; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; Konig S, 2010, APPL ENVIRON MICROB, V76, P3765, DOI 10.1128/AEM.02951-09; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MILLER MH, 1995, CRIT REV BIOTECHNOL, V15, P241, DOI 10.3109/07388559509147411; Molofsky J, 2002, ECOLOGY, V83, P21; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Sanders IR, 2010, ANNU REV GENET, V44, P271, DOI 10.1146/annurev-genet-102108-134239; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOL LETT, V14, P1001, DOI 10.1111/j.1461-0248.2011.01666.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6	51	17	20	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36950	10.1371/journal.pone.0036950	http://dx.doi.org/10.1371/journal.pone.0036950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629347	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100009
J	Kim, YC; Kim, BG; Lee, JH				Kim, Young-Chae; Kim, Byoung-Gie; Lee, Je-Ho			Thymosin beta(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production	PLOS ONE			English	Article							MESSENGER-RNA; CELL-DEATH; TELOMERASE ACTIVITY; ACTIN CYTOSKELETON; GENE-EXPRESSION; BETA-10 GENE; BAX GENE; STRESS; OVEREXPRESSION; JASPLAKINOLIDE	Thymosin beta(10) (T beta(10)) regulates actin dynamics as a cytoplasm G-actin sequestering protein. Previously, we have shown that T beta(10) diminishes tumor growth, angiogenesis, and proliferation by disrupting actin and by inhibiting Ras. However, little is known about its mechanism of action and biological function. In the present study, we establish a new gene therapy model using a genetically modified adenovirus, referred to as Ad.TERT.T beta(10), that can overexpress the T beta(10) gene in cancer cells. This was accomplished by replacing the native T beta(10) gene promoter with the human TERT promoter in Ad. TERT. T beta(10). We investigated the cancer suppression activity of T beta(10) and found that Ad.TERT.T beta(10) strikingly induced cancer-specific expression of T beta(10) as well as apoptosis in a co-culture model of human primary ovarian cancer cells and normal fibroblasts. Additionally, Ad.TERT.T beta(10) decreased mitochondrial membrane potential and increased reactive oxygen species (ROS) production. These effects were amplified by co-treatment with anticancer drugs, such as paclitaxel and cisplatin. These findings indicate that the rise in ROS production due to actin disruption by T beta(10) overexpression increases apoptosis of human ovarian cancer cells. Indeed, the cancer-specific overexpression of T beta(10) by Ad.TERT.T beta(10) could be a valuable anticancer therapeutic for the treatment of ovarian cancer without toxicity to normal cells.	[Kim, Young-Chae; Kim, Byoung-Gie; Lee, Je-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol,Mol Therapy Res Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol,Mol Therapy Res Ctr, Seoul, South Korea.	bksong.kim@samsung.com; mtrc25@yahoo.com		Kim, Young-Chae/0000-0002-5130-4413	Korean government	Korean government(Korean Government)	The funding source is the Korean government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi KNI, 2004, BLOOD, V103, P1319, DOI 10.1182/blood-2003-04-1015; Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Anadon R, 2001, BRAIN RES, V894, P255, DOI 10.1016/S0006-8993(01)02024-8; Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Bilsland AE, 2003, ONCOGENE, V22, P370, DOI 10.1038/sj.onc.1206168; Caers J, 2010, HAEMATOL-HEMATOL J, V95, P163, DOI 10.3324/haematol.2009.006411; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; Giovanni S, 2002, THYROID, V12, P765; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Gu J, 2000, CANCER RES, V60, P5359; Gu J, 2002, ONCOGENE, V21, P4757, DOI 10.1038/sj.onc.1205582; HALL AK, 1994, RENAL FAILURE, V16, P243, DOI 10.3109/08860229409044864; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Kim A, 2008, KOREAN J OBSTET GYNE, V51, P518; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lee SH, 2005, FEBS LETT, V579, P1027, DOI 10.1016/j.febslet.2005.01.005; Lee SH, 2005, CANCER RES, V65, P137; Lee SH, 2001, ONCOGENE, V20, P6700, DOI 10.1038/sj.onc.1204683; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Mu H, 2006, CELL MOTIL CYTOSKEL, V63, P222, DOI 10.1002/cm.20117; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; Oh J-M, 2008, CANC LETT IN PRESS; Oien KA, 2003, ONCOGENE, V22, P4287, DOI 10.1038/sj.onc.1206615; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rho SB, 2005, J BIOL CHEM, V280, P34003, DOI 10.1074/jbc.M501629200; Rho SB, 2004, FEBS LETT, V557, P57, DOI 10.1016/S0014-5793(03)01438-8; Ritz JM, 2005, CANCER RES, V65, P1187, DOI 10.1158/0008-5472.CAN-04-3046; Rosado JA, 2000, J PHYSIOL-LONDON, V526, P221, DOI 10.1111/j.1469-7793.2000.t01-2-00221.x; Santelli G, 1999, AM J PATHOL, V155, P799, DOI 10.1016/S0002-9440(10)65178-4; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Siebel CW, 1999, P NATL ACAD SCI USA, V96, P5440, DOI 10.1073/pnas.96.10.5440; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Tang MC, 2011, CANCER LETT, V308, P162, DOI 10.1016/j.canlet.2011.05.001; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; White SR, 2001, AM J RESP CELL MOL, V24, P282, DOI 10.1165/ajrcmb.24.3.3995; Yeung BHY, 2008, BRIT J CANCER, V99, P283, DOI 10.1038/sj.bjc.6604477; YU FX, 1993, J BIOL CHEM, V268, P502; Zou W, ONCOGENE, V23, P457	56	18	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35399	10.1371/journal.pone.0035399	http://dx.doi.org/10.1371/journal.pone.0035399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623951	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500005
J	Liu, JW; Sun, N; Bruce, MA; Wu, JC; Butte, MJ				Liu, Jianwei; Sun, Ning; Bruce, Marc A.; Wu, Joseph C.; Butte, Manish J.			Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							CLINICAL-APPLICATIONS; CARDIOMYOPATHIES; GENERATION	We describe a method using atomic force microscopy (AFM) to quantify the mechanobiological properties of pluripotent, stem cell-derived cardiomyocytes, including contraction force, rate, duration, and cellular elasticity. We measured beats from cardiomyocytes derived from induced pluripotent stem cells of healthy subjects and those with dilated cardiomyopathy, and from embryonic stem cell lines. We found that our AFM method could quantitate beat forces of single cells and clusters of cardiomyocytes. We demonstrate the dose-responsive, inotropic effect of norepinephrine and beta-adrenergic blockade of metoprolol. Cardiomyocytes derived from subjects with dilated cardiomyopathy showed decreased force and decreased cellular elasticity compared to controls. This AFM-based method can serve as a screening tool for the development of cardiac-active pharmacological agents, or as a platform for studying cardiomyocyte biology.	[Liu, Jianwei; Bruce, Marc A.; Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA; [Sun, Ning; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Liu, JW (corresponding author), Stanford Univ, Dept Pediat, Div Immunol & Allergy, Stanford, CA 94305 USA.	manish.butte@stanford.edu	Butte, Manish/T-8860-2019; Butte, Manish/AAM-8604-2020; Wu, Joseph/H-1067-2013	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; Sun, Ning/0000-0002-7861-3646; Bruce, Marc/0000-0003-3328-7231; Wu, Joseph/0000-0002-6068-8041	National Institutes of Health (NIH) [K08 AI079268]; NIH New Innovator Award [DP2OD004437, RC1 HL100490]; Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center [PHY-0830228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the National Institutes of Health (NIH) (K08 AI079268) to MJB, NIH New Innovator Award DP2OD004437 and RC1 HL100490 to JCW. This work was partially funded by the Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering Center, supported under Grant No. PHY-0830228 (to MJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLIGAND JL, 1993, P NATL ACAD SCI USA, V90, P347, DOI 10.1073/pnas.90.1.347; Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198; Hershberger RE, 2009, CIRC-HEART FAIL, V2, P253, DOI 10.1161/CIRCHEARTFAILURE.108.817346; Hockemeyer D, 2010, COLD SH Q B, V75, P201, DOI 10.1101/sqb.2010.75.021; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Oh YZ, 2012, HEART, V98, P443, DOI 10.1136/heartjnl-2011-301317; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Pelling AE, 2007, J MOL RECOGNIT, V20, P467, DOI 10.1002/jmr.832; Sabri A, 2003, J BIOL CHEM, V278, P23944, DOI 10.1074/jbc.M302718200; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; STICKLE D, 1989, MOL PHARMACOL, V36, P437; Sun N, 2012, SCI TRANSLA IN PRESS; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Van Acker H, 2010, INT J CARDIOL, V144, P307, DOI 10.1016/j.ijcard.2009.03.003; Wickham H, GGPLOT2 ELEGANT GRAP; Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	91	91	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37559	10.1371/journal.pone.0037559	http://dx.doi.org/10.1371/journal.pone.0037559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624048	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500135
J	Manera, V; Cavallo, A; Chiavarino, C; Schouten, B; Verfaillie, K; Becchio, C				Manera, Valeria; Cavallo, Andrea; Chiavarino, Claudia; Schouten, Ben; Verfaillie, Karl; Becchio, Cristina			Are You Approaching Me? Motor Execution Influences Perceived Action Orientation	PLOS ONE			English	Article							PERCEPTION; POINT; MODULATION; MECHANISMS; STIMULI; DEPTH	Human observers are especially sensitive to the actions of conspecifics that match their own actions. This has been proposed to be critical for social interaction, providing the basis for empathy and joint action. However, the precise relation between observed and executed actions is still poorly understood. Do ongoing actions change the way observers perceive others' actions? To pursue this question, we exploited the bistability of depth-ambiguous point-light walkers, which can be perceived as facing towards the viewer or as facing away from the viewer. We demonstrate that point-light walkers are perceived more often as facing the viewer when the observer is walking on a treadmill compared to when the observer is performing an action that does not match the observed behavior (e.g., cycling). These findings suggest that motor processes influence the perceived orientation of observed actions: Acting observers tend to perceive similar actions by conspecifics as oriented towards themselves. We discuss these results in light of the possible mechanisms subtending action-induced modulation of perception.	[Manera, Valeria; Cavallo, Andrea; Chiavarino, Claudia; Becchio, Cristina] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Manera, Valeria; Schouten, Ben; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium	University of Turin; KU Leuven	Manera, V (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.	cristina.becchio@unito.it	Chiavarino, Claudia/T-6784-2019; Manera, Valeria/O-3498-2016; Cavallo, Andrea/AAB-9615-2019; Manera, Valeria/H-7551-2012	Chiavarino, Claudia/0000-0001-9475-3764; Manera, Valeria/0000-0003-4490-4485; Cavallo, Andrea/0000-0002-3717-3760; Becchio, Cristina/0000-0002-6845-0521	Regione Piemonte, bando Scienze Umane e Sociali [4/2006]; Research Foundation Flanders (FWO) [FWO G.0621.07]	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte); Research Foundation Flanders (FWO)(FWO)	This research was supported by a grant from the Regione Piemonte, bando Scienze Umane e Sociali 2008, L.R. n. 4/2006, and by a grant from the Research Foundation Flanders (FWO), FWO G.0621.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Eder AB, 2009, J EXP PSYCHOL GEN, V138, P218, DOI 10.1037/a0015220; Grosjean M, 2009, PSYCHOL RES-PSYCH FO, V73, P3, DOI 10.1007/s00426-008-0146-6; Hamilton A, 2004, CURR BIOL, V14, P493, DOI 10.1016/j.cub.2004.03.007; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Miall RC, 2006, NEUROPSYCHOLOGIA, V44, P966, DOI 10.1016/j.neuropsychologia.2005.09.006; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Pierno AC, 2008, SOC NEUROSCI-UK, V3, P51, DOI 10.1080/17470910701563269; Pomianowska I, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00004; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Repp BH, 2007, PSYCHOL SCI, V18, P6, DOI 10.1111/j.1467-9280.2007.01839.x; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Springer A, 2011, BRAIN COGNITION, V76, P26, DOI 10.1016/j.bandc.2011.03.007; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Vanrie J, 2011, VIS COGN, V19, P1158, DOI 10.1080/13506285.2011.614381; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Zwickel J, 2010, PSYCHOL RES-PSYCH FO, V74, P152, DOI 10.1007/s00426-009-0226-2	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37514	10.1371/journal.pone.0037514	http://dx.doi.org/10.1371/journal.pone.0037514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624042	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500128
J	Maruska, KP; Ung, US; Fernald, RD				Maruska, Karen P.; Ung, Uyhun S.; Fernald, Russell D.			The African Cichlid Fish Astatotilapia burtoni Uses Acoustic Communication for Reproduction: Sound Production, Hearing, and Behavioral Significance	PLOS ONE			English	Article							AUDITORY-SENSITIVITY; HAPLOCHROMIS-BURTONI; LAKE MALAWI; SEASONAL PLASTICITY; FEMALE PREFERENCE; SIGNAL; EXPRESSION; COURTSHIP; RECOGNITION; POPULATIONS	Sexual reproduction in all animals depends on effective communication between signalers and receivers. Many fish species, especially the African cichlids, are well known for their bright coloration and the importance of visual signaling during courtship and mate choice, but little is known about what role acoustic communication plays during mating and how it contributes to sexual selection in this phenotypically diverse group of vertebrates. Here we examined acoustic communication during reproduction in the social cichlid fish, Astatotilapia burtoni. We characterized the sounds and associated behaviors produced by dominant males during courtship, tested for differences in hearing ability associated with female reproductive state and male social status, and then tested the hypothesis that female mate preference is influenced by male sound production. We show that dominant males produce intentional courtship sounds in close proximity to females, and that sounds are spectrally similar to their hearing abilities. Females were 2-5-fold more sensitive to low frequency sounds in the spectral range of male courtship sounds when they were sexually-receptive compared to during the mouthbrooding parental phase. Hearing thresholds were also negatively correlated with circulating sex-steroid levels in females but positively correlated in males, suggesting a potential role for steroids in reproductive-state auditory plasticity. Behavioral experiments showed that receptive females preferred to affiliate with males that were associated with playback of courtship sounds compared to noise controls, indicating that acoustic information is likely important for female mate choice. These data show for the first time in a Tanganyikan cichlid that acoustic communication is important during reproduction as part of a multimodal signaling repertoire, and that perception of auditory information changes depending on the animal's internal physiological state. Our results highlight the importance of examining non-visual sensory modalities as potential substrates for sexual selection contributing to the incredible phenotypic diversity of African cichlid fishes.	[Maruska, Karen P.; Ung, Uyhun S.; Fernald, Russell D.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Maruska, KP (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	maruska@stanford.edu			Stanford University Undergraduate Research Fund; National Institutes of Health [NIH F32NS061431, NIH NS 034950]; National Science Foundation (NSF) [IOS-0923588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034950, R01NS034950, F32NS061431, R37NS034950] Funding Source: NIH RePORTER	Stanford University Undergraduate Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by the Stanford University Undergraduate Research Fund (USU), National Institutes of Health (NIH F32NS061431 to KPM and NIH NS 034950 to RDF), and National Science Foundation (NSF IOS-0923588 to RDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Al-Mana D, 2008, NEUROSCIENCE, V153, P881, DOI 10.1016/j.neuroscience.2008.02.077; Amorim MCP, 2008, J FISH BIOL, V72, P1355, DOI 10.1111/j.1095-8649.2008.01802.x; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Amorim MCP, 2003, J FISH BIOL, V62, P658, DOI 10.1046/j.1095-8649.2003.00054.x; Amy M, 2009, ETHOLOGY, V115, P239, DOI 10.1111/j.1439-0310.2008.01579.x; Araya-Ajoy YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008137; Arch VS, 2009, HEAR RES; Blais J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-53; Bradbury Jack W., 1998, pi; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Clement TS, 2005, BEHAV ECOL, V16, P83, DOI 10.1093/beheco/arh134; Coleman SW, 2009, ACTA ETHOL, V12, P45, DOI 10.1007/s10211-008-0050-5; CORWIN JT, 1983, J COMP NEUROL, V217, P345, DOI 10.1002/cne.902170309; Crapon de Crapona M.-D., 1974, Experientia, V30, P1394; CRAPONDECAPRONA MD, 1980, Z TIERPSYCHOL, V52, P113; Danley PD, 2011, ENV BIOL FISH; Davidson J, 2007, AQUACULT ENG, V37, P125, DOI 10.1016/j.aquaeng.2007.03.003; Egger B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025601; Fay Richard R., 1999, Springer Handbook of Auditory Research, V11, P269; FAY RR, 1974, COMP BIOCHEM PHYSIOL, V49, P29, DOI 10.1016/0300-9629(74)90539-8; FAY RR, 1975, J EXP BIOL, V62, P379; Fernald RD, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P683; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; GREENWOOD PH, 1984, EVOLUTION FISH SPECI; Hankison SJ, 2003, BEHAV ECOL, V14, P282, DOI 10.1093/beheco/14.2.282; HEILIGENBERG W, 1972, Z VERGL PHYSIOL, V76, P168, DOI 10.1007/BF00455960; HIRATA NR, 1975, EXPERIENTIA, V31, P299, DOI 10.1007/BF01922548; Hofmann CM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000266; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kustan JM, 2011, P R SOC B; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Lechner W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018511; Lehtonen TK, 2011, P ROY SOC B-BIOL SCI, V278, P2318, DOI 10.1098/rspb.2010.2483; Lobel Phillip S., 2001, Journal of Aquariculture & Aquatic Sciences, V9, P167; Lobel PS, 1998, ENVIRON BIOL FISH, V52, P443, DOI 10.1023/A:1007467818465; Longrie N, 2008, J ZOOL, V275, P413, DOI 10.1111/j.1469-7998.2008.00457.x; Longrie N, 2009, J EXP BIOL, V212, P3395, DOI 10.1242/jeb.032946; Maan ME, 2006, AM NAT, V167, P947, DOI 10.1086/503532; Magrath RD, 2011, P BIOL SCI; Mann DA, 2001, J ACOUST SOC AM, V109, P3048, DOI 10.1121/1.1368406; Maruska KP, 2007, J EXP BIOL, V210, P3990, DOI 10.1242/jeb.004390; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; Maruska KP, 2011, HORM BEHAV, V59, P451, DOI 10.1016/j.yhbeh.2011.01.003; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maruska KP, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-58; Maruska KP, 2009, J COMP PHYSL A; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; Mclennan DA, 2003, BIOL J LINN SOC, V80, P555, DOI 10.1111/j.1095-8312.2003.00254.x; MYRBERG AA, 1965, SCIENCE, V149, P555, DOI 10.1126/science.149.3683.555; MYRBERG AA, 2006, COMMUNICATION FISHES, V1, P149; NELISSEN MHJ, 1978, BEHAVIOUR, V64, P137, DOI 10.1163/156853978X00477; Nelissen MHJ, 1977, ANN SOC R ZOOL BELG, V106, P155; Nosil Patrik, 2009, P127; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Renn SCP, 2009, INTEGR COMP BIOL, V49, P660, DOI 10.1093/icb/icp085; Rice AN, 2003, REV FISH BIOL FISHER, V13, P433, DOI 10.1007/s11160-004-8794-0; Ripley Jennifer L., 2002, Bioacoustics, V12, P238; Ripley JL, 2004, ENVIRON BIOL FISH, V71, P389, DOI 10.1007/s10641-004-4190-9; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Salzburger W, 2006, P ROY SOC B-BIOL SCI, V273, P257, DOI 10.1098/rspb.2005.3321; SCHELLART NAM, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P295; Scheuber H, 2004, P ROY SOC B-BIOL SCI, V271, P2453, DOI 10.1098/rspb.2004.2907; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Sturmbauer C., 2011, BIODIVERSITY HOTSPOT, P333, DOI DOI 10.1007/978-3-642-20992-5_18; TAVOLGA WN, 1974, J ACOUST SOC AM, V55, P1323, DOI 10.1121/1.1914704; Taylor RC, 2011, J EXP BIOL, V214, P815, DOI 10.1242/jeb.043638; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; TURNER GF, 1999, EVOLUTION BIOL DIVER, P217; Van Staaden MJ, 2011, CURR ZOOL, V57, P237, DOI 10.1093/czoolo/57.2.237; Verzijden MN, 2010, BEHAV ECOL, V21, P548, DOI 10.1093/beheco/arq018; WHITE SA, 1993, J NEUROSCI, V13, P434; Wysocki LE, 2009, J ACOUST SOC AM, V126, P2100, DOI 10.1121/1.3203562; Wysocki Lidia Eva, 2006, P177; YAN HY, 1992, J COMP PHYSIOL A, V171, P105	89	79	79	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37612	10.1371/journal.pone.0037612	http://dx.doi.org/10.1371/journal.pone.0037612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624055	Green Published, gold			2022-12-27	WOS:000305343500144
J	Blair, JE; Coffey, MD; Martin, FN				Blair, Jaime E.; Coffey, Michael D.; Martin, Frank N.			Species Tree Estimation for the Late Blight Pathogen, Phytophthora infestans, and Close Relatives	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENE TREES; MOLECULAR PHYLOGENY; HAPLOTYPE RECONSTRUCTION; BAYESIAN-ESTIMATION; NATURAL HYBRIDS; SP NOV.; DNA; MITOCHONDRIAL; COALESCENT	To better understand the evolutionary history of a group of organisms, an accurate estimate of the species phylogeny must be known. Traditionally, gene trees have served as a proxy for the species tree, although it was acknowledged early on that these trees represented different evolutionary processes. Discordances among gene trees and between the gene trees and the species tree are also expected in closely related species that have rapidly diverged, due to processes such as the incomplete sorting of ancestral polymorphisms. Recently, methods have been developed for the explicit estimation of species trees, using information from multilocus gene trees while accommodating heterogeneity among them. Here we have used three distinct approaches to estimate the species tree for five Phytophthora pathogens, including P. infestans, the causal agent of late blight disease in potato and tomato. Our concatenation-based "supergene" approach was unable to resolve relationships even with data from both the nuclear and mitochondrial genomes, and from multiple isolates per species. Our multispecies coalescent approach using both Bayesian and maximum likelihood methods was able to estimate a moderately supported species tree showing a close relationship among P. infestans, P. andina, and P. ipomoeae. The topology of the species tree was also identical to the dominant phylogenetic history estimated in our third approach, Bayesian concordance analysis. Our results support previous suggestions that P. andina is a hybrid species, with P. infestans representing one parental lineage. The other parental lineage is not known, but represents an independent evolutionary lineage more closely related to P. ipomoeae. While all five species likely originated in the New World, further study is needed to determine when and under what conditions this hybridization event may have occurred.	[Blair, Jaime E.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Coffey, Michael D.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Martin, Frank N.] USDA ARS, Salinas, CA USA	Franklin & Marshall College; University of California System; University of California Riverside; United States Department of Agriculture (USDA)	Blair, JE (corresponding author), Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA.	jaime.blair@fandm.edu	Blair, Jaime Elizabeth/GRE-9690-2022; Heveling, Josef/M-6143-2016	Blair, Jaime Elizabeth/0000-0002-4211-2938; Heveling, Josef/0000-0001-6550-7126	Fred C. Gloeckner Foundation; USDA-NRI [2005-35605-15393]; Franklin & Marshall College from the Commonwealth of Pennsylvania; Ben Franklin Technology Development Authority; Howard Hughes Medical Institute	Fred C. Gloeckner Foundation; USDA-NRI(United States Department of Agriculture (USDA)); Franklin & Marshall College from the Commonwealth of Pennsylvania; Ben Franklin Technology Development Authority; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This project was funded in part by the Fred C. Gloeckner Foundation (JEB) and the USDA-NRI Plant Biosecurity Program award number 2005-35605-15393 (MDC, FNM). JEB acknowledges support from grants to Franklin & Marshall College from the Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority, and from the Howard Hughes Medical Institute's Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad ZG, 1997, PLANT DIS, V81, P682, DOI 10.1094/PDIS.1997.81.6.682; Adler NE, 2004, PHYTOPATHOLOGY, V94, P154, DOI 10.1094/PHYTO.2004.94.2.154; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ane C, 2010, ESTIMATING SPECIES T; Ane C, 2007, MOL BIOL EVOL, V24, P412; Balke M, 2008, P NATL ACAD SCI USA, V105, P6356, DOI 10.1073/pnas.0710368105; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 2001, PLANT PATHOL, V50, P218, DOI 10.1046/j.1365-3059.2001.00553.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Cardenas M, 2012, PLANT PATHOL, V61, P215, DOI 10.1111/j.1365-3059.2011.02530.x; Chen Y, 1996, GENE, V181, P89, DOI 10.1016/S0378-1119(96)00469-6; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Douglas NA, 2007, AM J BOT, V94, P856, DOI 10.3732/ajb.94.5.856; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; Erwin D. C., 1996, Phytophthora diseases worldwide.; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2005, PHYLIP VERSION 3 6; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Forbes GA, 2012, PLANT PATHOL, V61, P221, DOI 10.1111/j.1365-3059.2011.02560.x; Fry WE, 2009, GENETICS GENOMICS DI; GALINDO-A J, 1985, Sydowia, V38, P87; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huang ZS, 2008, MOL ECOL, V17, P1930, DOI 10.1111/j.1365-294X.2008.03730.x; Huang ZS, 2010, MOL ECOL RESOUR, V10, P1066, DOI 10.1111/j.1755-0998.2010.02843.x; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; Ioos R, 2007, APPL ENVIRON MICROB, V73, P5587, DOI 10.1128/AEM.00721-07; Ioos R, 2007, MOL ECOL NOTES, V7, P133, DOI 10.1111/j.1471-8286.2006.01554.x; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Jacobsen F, 2011, MOL PHYLOGENET EVOL, V61, P460, DOI 10.1016/j.ympev.2011.06.017; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Krings M, 2011, MYCOLOGIA, V103, P445, DOI 10.3852/10-278; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martin FN, 2012, PHYTOPATHOLOGY, V102, P229, DOI 10.1094/PHYTO-04-11-0115; Martin FN, 2000, MYCOLOGIA, V92, P711, DOI 10.2307/3761428; Martin FN, 2004, PHYTOPATHOLOGY, V94, P621, DOI 10.1094/PHYTO.2004.94.6.621; Martin FN, 2008, CURR GENET, V54, P23, DOI 10.1007/s00294-008-0196-8; MCDONALD A, 1991, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V62, P65; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Moskin J, 2009, OUTBREAK FUNGUS THRE; Niederhauser JS, 1991, PHYTOPHTHORA; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Ordonez ME, 2000, PHYTOPATHOLOGY, V90, P197, DOI 10.1094/PHYTO.2000.90.2.197; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pennington RT, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P373; Peralta IE, 2007, GENETIC IMPROVEMENT, V2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rambaut A., 2009, TRACER VERSION 1 5; Rambaut A., 2010, TREEANNOTATOR VERSIO; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Savary S, 2011, PLANT DIS, V95, P1204, DOI 10.1094/PDIS-04-11-0316; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Serrano-Serrano ML, 2010, MOL PHYLOGENET EVOL, V54, P76, DOI 10.1016/j.ympev.2009.08.028; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D., 1998, PAUP 4 0 PHYLOGENETI; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Weir JT, 2011, MOL ECOL, V20, P4550, DOI 10.1111/j.1365-294X.2011.05294.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zadoks JC, 2008, ON THE POLITICAL ECONOMY OF PLANT DISEASE EPIDEMICS: CAPITA SELECTA IN HISTORICAL EPIDEMIOLOGY, P1, DOI 10.3920/978-90-8686-653-3; Zwickl DJ, THESIS U TEXAS AUSTI	101	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37003	10.1371/journal.pone.0037003	http://dx.doi.org/10.1371/journal.pone.0037003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615869	Green Published, gold			2022-12-27	WOS:000305341200030
J	Schutter, DJLG; Koolschijn, PCMP; Peper, JS; Crone, EA				Schutter, Dennis J. L. G.; Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.			The Cerebellum Link to Neuroticism: A Volumetric MRI Association Study in Healthy Volunteers	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; MAJOR DEPRESSION; DISORDER; SEGMENTATION; STIMULATION; EMOTION; ATROPHY; BRAIN	Prior research suggests an association between reduced cerebellar volumes and symptoms of depression and anxiety in patients with mood disorders. However, whether a smaller volume in itself reflects a neuroanatomical correlate for increased susceptibility to develop mood disorders remains unclear. The aim of the present study was to examine the relationship between cerebellar volume and neurotic personality traits in a non-clinical subject sample. 3T Structural magnetic resonance imaging scans were acquired, and trait depression and anxiety scales of the revised NEO personality inventory were assessed in thirty-eight healthy right-handed volunteers. Results showed that cerebellar volume corrected for total brain volume was inversely associated with depressive and anxiety-related personality traits. Cerebellar gray and white matter contributed equally to the observed associations. Our findings extend earlier clinical observations by showing that cerebellar volume covaries with neurotic personality traits in healthy volunteers. The results may point towards a possible role of the cerebellum in the vulnerability to experience negative affect. In conclusion, cerebellar volumes may constitute a clinico-neuroanatomical correlate for the development of depression-and anxiety-related symptoms.	[Schutter, Dennis J. L. G.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Schutter, Dennis J. L. G.; Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Koolschijn, P. Cedric M. P.; Peper, Jiska S.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Utrecht University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Schutter, DJLG (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	d.schutter@uu.nl		Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078	Netherlands Organization for Scientific Research (NWO) Innovational research grants [452-07-012, 451-10-007]; European Research Counsil (ERC) starting grant [2010-StG-263234]	Netherlands Organization for Scientific Research (NWO) Innovational research grants; European Research Counsil (ERC) starting grant	This work was supported by Netherlands Organization for Scientific Research (NWO) Innovational research grants 452-07-012 (DS) and 451-10-007 (JP), and an European Research Counsil (ERC) starting grant 2010-StG-263234 (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldacara L, 2011, J AFFECT DISORDERS, V135, P305, DOI 10.1016/j.jad.2011.06.059; Baldacara L, 2011, J PSYCHIATR RES, V45, P1627, DOI 10.1016/j.jpsychires.2011.07.013; Buck R, 1999, PSYCHOL REV, V106, P301, DOI 10.1037/0033-295X.106.2.301; Costa PT, 2007, REVISED NEO PERSONAL; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Bellis MD, 2006, BIOL PSYCHIAT, V60, P697, DOI 10.1016/j.biopsych.2006.04.035; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Ferrucci R, 2012, COGNITION EMOTION, V26, P786, DOI 10.1080/02699931.2011.619520; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; HAINES DE, 1984, J COMP NEUROL, V229, P559, DOI 10.1002/cne.902290409; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Hoekstra H. A., 1996, HANDLEIDING NEO PERS; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P517, DOI 10.1007/s00429-011-0346-5; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1573, DOI 10.1016/j.psyneuen.2010.02.017; PAVLIK A, 1984, DEV BRAIN RES, V12, P13, DOI 10.1016/0165-3806(84)90171-8; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2000, J NEUROLINGUIST, V13, P189, DOI 10.1016/S0911-6044(00)00011-7; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; TORVIK A, 1986, J NEUROL SCI, V75, P43, DOI 10.1016/0022-510X(86)90049-3; Van Haren NEM, 2010, EUR NEUROPSYCHOPHARM, V20, P454, DOI 10.1016/j.euroneuro.2010.02.009; YATES WR, 1987, AM J PSYCHIAT, V144, P465; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	34	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37252	10.1371/journal.pone.0037252	http://dx.doi.org/10.1371/journal.pone.0037252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615955	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200053
J	Vivekanand, P; Rebay, I				Vivekanand, Pavithra; Rebay, Ilaria			The SAM Domain of Human TEL2 Can Abrogate Transcriptional Output from TEL1 (ETV-6) and ETS1/ETS2	PLOS ONE			English	Article							SELF-ASSOCIATION; MAP KINASE; DROSOPHILA; YAN; PATHWAY; PROTEIN; FAMILY; PHOSPHORYLATION; REPRESSOR; DIFFERENTIATION	Regulation of gene expression downstream of the Receptor Tyrosine Kinase signaling pathway in Drosophila relies on a transcriptional effector network featuring two conserved Ets family proteins, Yan and Pointed, known as TEL1 (ETV6) and ETS1/ETS2, respectively, in mammals. As in Drosophila, both TEL1 and ETS1/ETS2 operate as Ras pathway transcriptional effectors and misregulated activity of either factor has been implicated in many human leukemias and solid tumors. Providing essential regulation to the Drosophila network, direct interactions with the SAM domain protein Mae attenuate both Yan-mediated repression and PointedP2-mediated transcriptional activation. Given the critical contributions of Mae to the Drosophila circuitry, we investigated whether the human Ets factors TEL1 and ETS1/ETS2 could be subject to analogous regulation. Here we demonstrate that the SAM domain of human TEL2 can inhibit the transcriptional activities of ETS1/2 and TEL1. Drosophila Mae can also attenuate human ETS1/ETS2 function, suggesting there could be cross-species conservation of underlying mechanism. In contrast, Mae is not an effective inhibitor of TEL1, suggesting the mode of TEL2SAM-mediated inhibition of TEL1 may be distinct from how Drosophila Mae antagonizes Yan. Together our results reveal both further similarities and new differences between the mammalian and Drosophila networks and more broadly suggest that SAM domain-mediated interactions could provide an effective mechanism for modulating output from the TEL1 and ETS1/2 oncogenes.	[Vivekanand, Pavithra; Rebay, Ilaria] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Vivekanand, P (corresponding author), Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA.	irebay@uchicago.edu			American Cancer Society [RPG-00-301-01-DD]; National Institutes of Health [R01 GM080372]	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Cancer Society grant RPG-00-301-01-DD and National Institutes of Health grant R01 GM080372. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1996, MECH DEVELOP, V59, P29, DOI 10.1016/0925-4773(96)00568-0; Baker DA, 2001, NATURE, V411, P330, DOI 10.1038/35077122; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gabay L, 1996, DEVELOPMENT, V122, P3355; Graham TGW, 2010, DEVELOPMENT, V137, P2265, DOI 10.1242/dev.044826; Green SM, 2010, J BIOL CHEM, V285, P18496, DOI 10.1074/jbc.M109.096958; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Kawagoe H, 2004, CANCER RES, V64, P6091, DOI 10.1158/0008-5472.CAN-04-0839; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Kwiatkowski BA, 1998, J BIOL CHEM, V273, P17525, DOI 10.1074/jbc.273.28.17525; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Maki K, 2004, MOL CELL BIOL, V24, P3227, DOI 10.1128/MCB.24.8.3227-3237.2004; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Potter MD, 2000, BLOOD, V95, P3341, DOI 10.1182/blood.V95.11.3341.011k44_3341_3348; Qiao F, 2006, EMBO J, V25, P70, DOI 10.1038/sj.emboj.7600924; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao F, 2005, SCI STKE, P1; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Tootle TL, 2003, DEVELOPMENT, V130, P845, DOI 10.1242/dev.00312; Vivekanand P, 2004, MECH DEVELOP, V121, P1469, DOI 10.1016/j.mod.2004.07.009; Yamada T, 2003, DEVELOPMENT, V130, P4085, DOI 10.1242/dev.00624; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang J, 2010, MOL CELL BIOL, V30, P1158, DOI 10.1128/MCB.01225-09	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37151	10.1371/journal.pone.0037151	http://dx.doi.org/10.1371/journal.pone.0037151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615925	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200045
J	Oliveira, HR; Campana, MG; Jones, H; Hunt, HV; Leigh, F; Redhouse, DI; Lister, DL; Jones, MK				Oliveira, Hugo R.; Campana, Michael G.; Jones, Huw; Hunt, Harriet V.; Leigh, Fiona; Redhouse, David I.; Lister, Diane L.; Jones, Martin K.			Tetraploid Wheat Landraces in the Mediterranean Basin: Taxonomy, Evolution and Genetic Diversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; WILD EMMER WHEAT; MICROSATELLITE MARKERS; TRITICUM-DICOCCOIDES; PHYLOGENETIC TREES; COMMON WHEAT; DURUM DESF.; A-GENOME; B-GENOME; DOMESTICATION	The geographic distribution of genetic diversity and the population structure of tetraploid wheat landraces in the Mediterranean basin has received relatively little attention. This is complicated by the lack of consensus concerning the taxonomy of tetraploid wheats and by unresolved questions regarding the domestication and spread of naked wheats. These knowledge gaps hinder crop diversity conservation efforts and plant breeding programmes. We investigated genetic diversity and population structure in tetraploid wheats (wild emmer, emmer, rivet and durum) using nuclear and chloroplast simple sequence repeats, functional variations and insertion site-based polymorphisms. Emmer and wild emmer constitute a genetically distinct population from durum and rivet, the latter seeming to share a common gene pool. Our population structure and genetic diversity data suggest a dynamic history of introduction and extinction of genotypes in the Mediterranean fields.	[Oliveira, Hugo R.; Redhouse, David I.; Jones, Martin K.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England; [Campana, Michael G.] Harvard Univ, Dept Human Evolut Biol, Cambridge, MA 02138 USA; [Jones, Huw; Leigh, Fiona] Natl Inst Agr Bot, Cambridge, England; [Oliveira, Hugo R.; Hunt, Harriet V.; Lister, Diane L.; Jones, Martin K.] McDonald Inst Archaeol Res, Cambridge, England	University of Cambridge; Harvard University; University of Cambridge	Oliveira, HR (corresponding author), Linkoping Univ, IFM, Linkoping, Sweden.	hro22camacuk@gmail.com	; Jones, Huw/N-3284-2017	Oliveira, Hugo/0000-0002-5038-073X; Leigh, Fiona/0000-0002-3221-5327; Redhouse, David/0000-0001-6668-2487; Campana, Michael/0000-0003-0461-6462; Jones, Huw/0000-0003-4307-9030	PhD grant by the Portuguese Science and Technology Foundation [SFRH/BD/21748/2005]; European Research Council project AGRIWESTMED [2305619]; Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica [HAR2008-09120/HIST]; Isaac Newton Trust Grant	PhD grant by the Portuguese Science and Technology Foundation; European Research Council project AGRIWESTMED; Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica; Isaac Newton Trust Grant	This works has been funded by: 1) PhD grant (ref. SFRH/BD/21748/2005) attributed to HO by the Portuguese Science and Technology Foundation; www.fct.pt. 2) The European Research Council (advanced grant no. 2305619) project AGRIWESTMED; http://erc.europa.eu/ 3) Consejo Superior de Investigaciones Cientificas project Origenes y expansion de la agricultura en el sur peninsular y norte de Marruecos: aportaciones desde la rqueobotanica y la genetica HAR2008-09120/HIST (Plan acional de I+D+i); www.csic.es. 4) Isaac Newton Trust Grant http://www.newtontrust.cam.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2009, EUPHYTICA, V166, P423, DOI 10.1007/s10681-008-9829-8; Blumler MA, 2003, PHYS GEOGR, V24, P414, DOI 10.2747/0272-3646.24.5.414; BROWN TA, 2006, DARWINS HARVEST NEW, P197; Caligari PD, WHEAT TAXONOMY LEGAC; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Carmona S, 2010, BIOL PLANTARUM, V54, P69, DOI 10.1007/s10535-010-0010-6; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cherry D., 1998, FRONTIER SOC ROMAN N; Chessel D, 2004, R NEWS, V4, P1; Columella LIM, AGR BOOK; Cooke RJ, 2003, EUPHYTICA, V132, P331, DOI 10.1023/A:1025046919570; Crawford AM, 1998, J MOL EVOL, V46, P256, DOI 10.1007/PL00006301; CRAWFORD DJ, 1979, WORLD ARCHAEOL, V11, P136, DOI 10.1080/00438243.1979.9979757; Decker M, 2009, J WORLD HIST, V20, P187; Dorofeev V.F., 1979, FLORA CULTIVATED PLA, V1; Dreisigacker S, 2005, CROP SCI, V45, P653, DOI 10.2135/cropsci2005.0653; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Goncharov NP, 2009, BREEDING SCI, V59, P492, DOI 10.1270/jsbbs.59.492; Hagenblad J, 2011, GENETIC RESOUR CROP, DOI [10.1007/s1722-011-9754-x, DOI 10.1007/S1722-011-9754-X]; Hollister JD, 2010, MOL BIOL EVOL, V27, P409, DOI 10.1093/molbev/msp249; Hood G, POPTOOLS 3 2; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Ishii T, 2001, THEOR APPL GENET, V103, P896, DOI 10.1007/s001220100715; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; Kato K, 1997, THEOR APPL GENET, V95, P546, DOI 10.1007/s001220050595; Leigh F, 2012, GENETIC RES IN PRESS; Li W, 2006, RUSS J GENET+, V42, P311, DOI 10.1134/S1022795406030124; Li Wei, 2008, Agricultural Sciences in China, V7, P1029, DOI 10.1016/S1671-2927(08)60143-1; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; MACKEY J, 1988, BIOL ZBL, V107, P369; MANTEL N, 1967, CANCER RES, V27, P209; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Padulosi S, 1995, P 1 INT WORKSH HULL; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Peterson R., 1965, WHEAT BOT CULTIVATIO; Pliny the Elder, 1945, NATURAL HIST; Pozzi Carlo, 2007, P453, DOI 10.1007/978-1-4020-6297-1_17; Prasad M, 2000, THEOR APPL GENET, V100, P584, DOI 10.1007/s001229900102; Pritchard JK, 2000, GENETICS, V155, P945; Raven S., 1993, ROME AFRICA; Rickman Geoffrey, 1980, CORN SUPPLY ANCIENT; Roder MS, 1998, GENETICS, V149, P2007; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Takezaki N, 1996, GENETICS, V144, P389; Teklu Y, 2007, GENET RESOUR CROP EV, V54, P543, DOI 10.1007/s10722-006-0011-7; Thuillet AC, 2005, GENETICS, V169, P1589, DOI 10.1534/genetics.104.029553; Tutin T, FLORA EUROPAEA, V5; Van Slageren MW, 1994, WAGENINGEN AGR U PAP; Watson A, 1983, AGR INNOVATION EARLY; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; Yifru T, 2006, PLANT BREEDING, V125, P125, DOI 10.1111/j.1439-0523.2006.01147.x; Zapata L, 2004, J WORLD PREHIST, V18, P283, DOI 10.1007/s10963-004-5621-4; Zhang LY, 2006, THEOR APPL GENET, V113, P407, DOI 10.1007/s00122-006-0304-4; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	70	55	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37063	10.1371/journal.pone.0037063	http://dx.doi.org/10.1371/journal.pone.0037063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959UR	22615891	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300061
J	Volkova, VV; Lanzas, C; Lu, Z; Grohn, YT				Volkova, Victoriya V.; Lanzas, Cristina; Lu, Zhao; Groehn, Yrjoe Tapio			Mathematical Model of Plasmid-Mediated Resistance to Ceftiofur in Commensal Enteric Escherichia coli of Cattle	PLOS ONE			English	Article							ANTIMICROBIAL DRUG-RESISTANCE; AMPC BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; SALMONELLA-ENTERICA; GENETIC DIVERSITY; BILIARY-EXCRETION; FEEDLOT CATTLE; SELECTION PRESSURE; DAIRY-CATTLE; BEEF-CATTLE	Antimicrobial use in food animals may contribute to antimicrobial resistance in bacteria of animals and humans. Commensal bacteria of animal intestine may serve as a reservoir of resistance-genes. To understand the dynamics of plasmid-mediated resistance to cephalosporin ceftiofur in enteric commensals of cattle, we developed a deterministic mathematical model of the dynamics of ceftiofur-sensitive and resistant commensal enteric Escherichia coli (E. coli) in the absence of and during parenteral therapy with ceftiofur. The most common treatment scenarios including those using a sustained-release drug formulation were simulated; the model outputs were in agreement with the available experimental data. The model indicated that a low but stable fraction of resistant enteric E. coli could persist in the absence of immediate ceftiofur pressure, being sustained by horizontal and vertical transfers of plasmids carrying resistance-genes, and ingestion of resistant E. coli. During parenteral therapy with ceftiofur, resistant enteric E. coli expanded in absolute number and relative frequency. This expansion was most influenced by parameters of antimicrobial action of ceftiofur against E. coli. After treatment (>5 weeks from start of therapy) the fraction of ceftiofur-resistant cells among enteric E. coli, similar to that in the absence of treatment, was most influenced by the parameters of ecology of enteric E. coli, such as the frequency of transfer of plasmids carrying resistance-genes, the rate of replacement of enteric E. coli by ingested E. coli, and the frequency of ceftiofur resistance in the latter.	[Volkova, Victoriya V.; Lu, Zhao; Groehn, Yrjoe Tapio] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Lanzas, Cristina] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN USA	Cornell University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Volkova, VV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	vv87@cornell.edu		Lanzas, Cristina/0000-0002-4039-0336	National Institute of Food and Agriculture of the United States Department of Agriculture [2010-51110-21083]	National Institute of Food and Agriculture of the United States Department of Agriculture	This work was funded by the National Institute of Food and Agriculture of the United States Department of Agriculture (grant # 2010-51110-21083). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Alexander TW, 2008, APPL ENVIRON MICROB, V74, P4405, DOI 10.1128/AEM.00489-08; Ambrose PG, 2007, CLIN INFECT DIS, V44, P79, DOI 10.1086/510079; Andrup L, 1999, MICROBIOL-UK, V145, P2001, DOI 10.1099/13500872-145-8-2001; Apley MD, 1998, J AM VET MED ASSOC, V212, P1209; Arana I, 1997, J APPL MICROBIOL, V83, P340, DOI 10.1046/j.1365-2672.1997.00244.x; Arana I, 1997, MICROB ECOL, V33, P41, DOI 10.1007/s002489900006; ARVIDSSON A, 1982, J ANTIMICROB CHEMOTH, V10, P207, DOI 10.1093/jac/10.3.207; ARVIDSSON A, 1988, EUR J CLIN INVEST, V18, P261, DOI 10.1111/j.1365-2362.1988.tb01256.x; Aslam M, 2004, LETT APPL MICROBIOL, V39, P523, DOI 10.1111/j.1472-765X.2004.01620.x; Aslam M, 2003, APPL ENVIRON MICROB, V69, P2794, DOI 10.1128/AEM.69.5.2794-2799.2003; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; BAKKEN JS, 1990, ANTIMICROB AGENTS CH, V34, P1276, DOI 10.1128/AAC.34.6.1276; Barlow M, 2002, ANTIMICROB AGENTS CH, V46, P1190, DOI 10.1128/AAC.46.5.1190-1198.2002; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P221, DOI 10.1128/AAC.40.1.221; Bauernfeind A, 1996, ANTIMICROB AGENTS CH, V40, P509, DOI 10.1128/AAC.40.2.509; BeconiBarker MG, 1996, ACS SYM SER, V636, P70; Bergstrom CT, 2000, GENETICS, V155, P1505; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Brown SA, 1999, J VET PHARMACOL THER, V22, P35, DOI 10.1046/j.1365-2885.1999.00182.x; Brown SA, 2000, J VET PHARMACOL THER, V23, P273, DOI 10.1046/j.1365-2885.2000.00271.x; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Call DR, 2006, J APPL MICROBIOL, V100, P15, DOI 10.1111/j.1365-2672.2005.02775.x; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Craig W A, 1990, Scand J Infect Dis Suppl, V74, P63; Czock D, 2007, J PHARMACOKINET PHAR, V34, P727, DOI 10.1007/s10928-007-9069-x; Daniels JB, 2007, APPL ENVIRON MICROB, V73, P8005, DOI 10.1128/AEM.01325-07; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Delsol AA, 2010, INT J FOOD MICROBIOL, V140, P249, DOI 10.1016/j.ijfoodmicro.2010.03.023; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; DRUSANO GL, 1991, SCAND J INFECT DIS, P235; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Dutil L, 2010, EMERG INFECT DIS, V16, P48, DOI 10.3201/eid1601.090729; FERNANDEZASTORGA A, 1992, APPL ENVIRON MICROB, V58, P392, DOI 10.1128/AEM.58.1.392-398.1992; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; GILBERTSON TJ, 1990, J AGR FOOD CHEM, V38, P890, DOI 10.1021/jf00093a064; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; HANBERGER H, 1992, SCAND J INFECT DIS, P1; Heider LC, 2009, FOODBORNE PATHOG DIS, V6, P1235, DOI 10.1089/fpd.2009.0294; Hoffmann-La Roche Limited, 2010, PROD MON; Hornish Rex E., 2002, Current Topics in Medicinal Chemistry, V2, P717, DOI 10.2174/1568026023393679; JAGLAN PS, 1989, J AGR FOOD CHEM, V37, P1112, DOI 10.1021/jf00088a066; Jiang XP, 2006, FOODBORNE PATHOG DIS, V3, P355, DOI 10.1089/fpd.2006.3.355; Ketyi I, 1994, Acta Microbiol Immunol Hung, V41, P189; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P443, DOI 10.1128/AEM.72.1.443-448.2006; Khachatryan AR, 2004, APPL ENVIRON MICROB, V70, P752, DOI 10.1128/AEM.70.2.752-757.2004; Lanzas C, 2010, NAT REV MICROBIOL, V8, P139, DOI 10.1038/nrmicro2268; LeJeune JT, 2006, J CLIN MICROBIOL, V44, P872, DOI 10.1128/JCM.44.3.872-875.2006; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Licht TR, 2006, ADV APPL MICROBIOL, V58, P77, DOI 10.1016/S0065-2164(06)58002-X; LINTON AH, 1977, J APPL BACTERIOL, V43, P465, DOI 10.1111/j.1365-2672.1977.tb00773.x; LIVERMORE DM, 1991, SCAND J INFECT DIS, P7; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; Mann S, 2011, FOODBORNE PATHOGENS; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MATTIE H, 1990, J INFECT DIS, V162, P717, DOI 10.1093/infdis/162.3.717; McCuddin Z, 2006, VET MICROBIOL, V114, P275, DOI 10.1016/j.vetmic.2005.12.004; McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771; MERLEMELET M, 1989, ANTIMICROB AGENTS CH, V33, P1506, DOI 10.1128/AAC.33.9.1506; Morley PS, 2011, FOODBORNE PATHOG DIS, V8, P87, DOI 10.1089/fpd.2010.0632; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Mouton JW, 2005, J ANTIMICROB CHEMOTH, V55, P601, DOI 10.1093/jac/dki079; Mouton JW, 2005, CLIN PHARMACOKINET, V44, P201, DOI 10.2165/00003088-200544020-00005; MUELA A, 1994, APPL ENVIRON MICROB, V60, P4273, DOI 10.1128/AEM.60.12.4273-4278.1994; Persoons D, 2011, EPIDEMIOL INFECT, V139, P765, DOI 10.1017/S0950268810001524; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Poole TL, 2011, FOODBORNE PATHOG DIS, V8, P535, DOI 10.1089/fpd.2010.0732; Ritter L, 1996, WHO FOOD ADDITIVES S, V36; Salmon SA, 1996, J VET DIAGN INVEST, V8, P332, DOI 10.1177/104063879600800309; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; Subbiah M, 2011, APPL ENVIRON MICROB, V77, P4486, DOI 10.1128/AEM.02788-10; SYMONDS HW, 1982, RES VET SCI, V32, P6, DOI 10.1016/S0034-5288(18)32428-7; TIPPER DJ, 1985, PHARMACOL THERAPEUT, V27, P1, DOI 10.1016/0163-7258(85)90062-2; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; United States Food and Drug Administration, 1990, ENV ASS EXC STER SUS; VOGELMAN B, 1988, J INFECT DIS, V157, P287, DOI 10.1093/infdis/157.2.287; Winokur PL, 2001, ANTIMICROB AGENTS CH, V45, P2716, DOI 10.1128/AAC.45.10.2716-2722.2001; XIA Y, 1990, GASTROENTEROLOGY, V99, P454, DOI 10.1016/0016-5085(90)91029-6	87	46	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36738	10.1371/journal.pone.0036738	http://dx.doi.org/10.1371/journal.pone.0036738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615803	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341300027
J	Chen, S; Xu, YX; Chen, YA; Li, XF; Mou, WJ; Wang, LN; Liu, YH; Reisfeld, RA; Xiang, R; Lv, D; Li, N				Chen, Si; Xu, Yingxi; Chen, Yanan; Li, Xuefei; Mou, Wenjun; Wang, Lina; Liu, Yanhua; Reisfeld, Ralph A.; Xiang, Rong; Lv, Dan; Li, Na			SOX2 Gene Regulates the Transcriptional Network of Oncogenes and Affects Tumorigenesis of Human Lung Cancer Cells	PLOS ONE			English	Article							STEM-CELLS; SIDE POPULATION; DEFINED FACTORS; BREAST-CANCER; SELF-RENEWAL; TUMOR-GROWTH; IN-VIVO; C-MYC; ADENOCARCINOMA; METASTASIS	Recent studies demonstrated that cancer stem cells (CSCs) have higher tumorigenesis properties than those of differentiated cancer cells and that transcriptional factor-SOX2 plays a vital role in maintaining the unique properties of CSCs; however, the function and underlying mechanism of SOX2 in carcinogenesis of lung cancer are still elusive. This study applied immunohistochemistry to analyze the expression of SOX2 in human lung tissues of normal individuals as well as patients with adenocarcinoma, squamous cell carcinoma, and large cell and small cell carcinoma and demonstrated specific overexpression of SOX2 in all types of lung cancer tissues. This finding supports the notion that SOX2 contributes to the tumorigenesis of lung cancer cells and can be used as a diagnostic probe. In addition, obviously higher expression of oncogenes c-MYC, WNT1, WNT2, and NOTCH1 was detected in side population (SP) cells than in non-side population (NSP) cells of human lung adenocarcinoma cell line-A549, revealing a possible mechanism for the tenacious tumorigenic potential of CSCs. To further elucidate the function of SOX2 in tumorigenesis of cancer cells, A549 cells were established with expression of luciferase and doxycycline-inducible shRNA targeting SOX2. We found silencing of SOX2 gene reduces the tumorigenic property of A549 cells with attenuated expression of c-MYC, WNT1, WNT2, and NOTCH1 in xenografted NOD/SCID mice. By using the RNA-Seq method, an additional 246 target cancer genes of SOX2 were revealed. These results present evidence that SOX2 may regulate the expression of oncogenes in CSCs to promote the development of human lung cancer.	[Chen, Si; Xu, Yingxi; Chen, Yanan; Li, Xuefei; Mou, Wenjun; Wang, Lina; Liu, Yanhua; Xiang, Rong; Lv, Dan; Li, Na] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Nankai University; Scripps Research Institute	Chen, S (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	lvdan@nankai.edu.cn; lina08@nankai.edu.cn	liu, yan/HCI-5542-2022; Xu, Yingxi/HGA-1792-2022; Mou, Wenjun/ABA-2988-2021	Mou, Wenjun/0000-0002-7781-7671	National Science Foundation of China [31000616, 30830096]; China Junior Faculty Funds [20090031120044]; China Fundamental Research Funds for the Central Universities [65011241]; Major State Basic Research Development Program of China (China 973 Program) [2007CB914804]; Tianjin Scientific & Technological Commission [08QTPTJC28700, 09ZCZDSF04000]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Junior Faculty Funds; China Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program of China (China 973 Program)(National Basic Research Program of China); Tianjin Scientific & Technological Commission	This work was funded by National Science Foundation of China grant 31000616 (to NL), China Junior Faculty Funds grant 20090031120044 (to NL) China Fundamental Research Funds for the Central Universities grant 65011241 (to NL), National Science Foundation of China grant 30830096 (to RX), Major State Basic Research Development Program of China (China 973 Program) 2007CB914804 (to RX), Support Project of Tianjin Scientific & Technological Commission for 973 Program 08QTPTJC28700 (to RX), and Key Project of Tianjin Scientific & Technological Commission for China-Sweden Cooperation Research Program 09ZCZDSF04000 (to RX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2011, CANCER RES, V71, P2212, DOI 10.1158/0008-5472.CAN-10-3590; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Garcia-Barrado MJ, 2001, EUR J PHARMACOL, V415, P105, DOI 10.1016/S0014-2999(01)00808-1; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jia XP, 2011, J MOL CELL BIOL, V3, P230, DOI 10.1093/jmcb/mjr002; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kruger JA, 2006, BLOOD, V108, P3906, DOI 10.1182/blood-2006-05-024687; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu DG, 2012, EUR J CANCER, V48, P1208, DOI 10.1016/j.ejca.2011.05.003; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsumoto S, 2009, LUNG CANCER, V66, P75, DOI 10.1016/j.lungcan.2008.12.010; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Pine SR, 2008, DIS MARKERS, V24, P257, DOI 10.1155/2008/396281; Sasai K, 2011, CANCER RES, V71, P2541, DOI 10.1158/0008-5472.CAN-10-2221; Sato N, 2010, CANCER RES, V70, P5326, DOI 10.1158/0008-5472.CAN-09-3879; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Xiang R, 2011, BRIT J CANCER, V104, P1931, DOI 10.1038/bjc.2011.210; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844	48	36	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36326	10.1371/journal.pone.0036326	http://dx.doi.org/10.1371/journal.pone.0036326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615765	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300015
J	Kelsall, IR; Langenick, J; MacKay, C; Patel, KJ; Alpi, AF				Kelsall, Ian R.; Langenick, Judith; MacKay, Craig; Patel, Ketan J.; Alpi, Arno F.			The Fanconi Anaemia Components UBE2T and FANCM Are Functionally Linked to Nucleotide Excision Repair	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; UV-INDUCED UBIQUITYLATION; UBIQUITIN LIGASE; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; CORE COMPLEX; PROTEIN; PATHWAY; IDENTIFICATION; DEFICIENT	The many proteins that function in the Fanconi anaemia (FA) monoubiquitylation pathway initiate replicative DNA crosslink repair. However, it is not clear whether individual FA genes participate in DNA repair pathways other than homologous recombination and translesion bypass. Here we show that avian DT40 cell knockouts of two integral FA genes - UBE2T and FANCM are unexpectedly sensitive to UV-induced DNA damage. Comprehensive genetic dissection experiments indicate that both of these FA genes collaborate to promote nucleotide excision repair rather than translesion bypass to protect cells form UV genotoxicity. Furthermore, UBE2T deficiency impacts on the efficient removal of the UV-induced photolesion cyclobutane pyrimidine dimer. Therefore, this work reveals that the FA pathway shares two components with nucleotide excision repair, intimating not only crosstalk between the two major repair pathways, but also potentially identifying a UBE2T-mediated ubiquitin-signalling response pathway that contributes to nucleotide excision repair.	[Kelsall, Ian R.; MacKay, Craig; Alpi, Arno F.] Univ Dundee, Scottish Inst Cell Signalling, Dundee, Scotland; [Langenick, Judith; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge, England	University of Dundee; MRC Laboratory Molecular Biology	Kelsall, IR (corresponding author), Univ Dundee, Scottish Inst Cell Signalling, Dundee, Scotland.	a.f.alpi@dundee.ac.uk		Alpi, Arno/0000-0002-9572-7266; Kelsall, Ian/0000-0002-7501-6504	Scottish Government; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Scottish Government to The Scottish Institute for Cell Signalling (SCILLS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huang M, 2010, MOL CELL, V39, P259, DOI 10.1016/j.molcel.2010.07.005; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Longerich S, 2009, J BIOL CHEM, V284, P23182, DOI 10.1074/jbc.C109.038075; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Schwab RA, 2010, EMBO J, V29, P806, DOI 10.1038/emboj.2009.385; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Simpson LJ, 2005, DNA REPAIR, V4, P503, DOI 10.1016/j.dnarep.2004.12.002; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645	53	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36970	10.1371/journal.pone.0036970	http://dx.doi.org/10.1371/journal.pone.0036970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615860	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300055
J	Walmagh, M; Briers, Y; dos Santos, SB; Azeredo, J; Lavigne, R				Walmagh, Maarten; Briers, Yves; dos Santos, Silvio Branco; Azeredo, Joana; Lavigne, Rob			Characterization of Modular Bacteriophage Endolysins from Myoviridae Phages OBP, 201 phi 2-1 and PVP-SE1	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILIZERS; PSEUDOMONAS-AERUGINOSA; PHI-KZ; PEPTIDOGLYCAN MATURATION; LYTIC TRANSGLYCOSYLASE; SEQUENCE; EVOLUTION; BINDING; IDENTIFICATION; SPECIFICITY	Peptidoglycan lytic enzymes (endolysins) induce bacterial host cell lysis in the late phase of the lytic bacteriophage replication cycle. Endolysins OBPgp279 (from Pseudomonas fluorescens phage OBP), PVP-SE1gp146 (Salmonella enterica serovar Enteritidis phage PVP-SE1) and 201 phi 2-1gp229 (Pseudomonas chlororaphis phage 201 phi 2-1) all possess a modular structure with an N-terminal cell wall binding domain and a C-terminal catalytic domain, a unique property for endolysins with a Gram-negative background. All three modular endolysins showed strong muralytic activity on the peptidoglycan of a broad range of Gram-negative bacteria, partly due to the presence of the cell wall binding domain. In the case of PVP-SE1gp146, this domain shows a binding affinity for Salmonella peptidoglycan that falls within the range of typical cell adhesion molecules (K-aff = 1.26 x 10(6) M-1). Remarkably, PVP-SE1gp146 turns out to be thermoresistant up to temperatures of 90 degrees C, making it a potential candidate as antibacterial component in hurdle technology for food preservation. OBPgp279, on the other hand, is suggested to intrinsically destabilize the outer membrane of Pseudomonas species, thereby gaining access to their peptidoglycan and exerts an antibacterial activity of 1 logarithmic unit reduction. Addition of 0.5 mM EDTA significantly increases the antibacterial activity of the three modular endolysins up to 2-3 logarithmic units reduction. This research work offers perspectives towards elucidation of the structural differences explaining the unique biochemical and antibacterial properties of OBPgp279, PVP-SE1gp146 and 201 phi 2-1gp229. Furthermore, these endolysins extensively enlarge the pool of potential antibacterial compounds used against multi-drug resistant Gram-negative bacterial infections.	[Walmagh, Maarten; Briers, Yves; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium; [Briers, Yves] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland; [dos Santos, Silvio Branco; Azeredo, Joana] Univ Minho, IBB, Ctr Biol Engn, Braga, Portugal	KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade do Minho	Walmagh, M (corresponding author), Katholieke Univ Leuven, Lab Gene Technol, Louvain, Belgium.	rob.lavigne@biw.kuleuven.be	Azeredo, Joana/A-2084-2012; Santos, Silvio/O-5491-2015	Santos, Silvio/0000-0003-0801-8080; Lavigne, Rob/0000-0001-7377-1314	"Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium) [SBO 083179]; European Molecular Biology Organization in Heidelberg (Germany) [ALTF 104-2009]; Fundacao para a Ciencia e Tecnologia (FCT) in Portugal [SFRH/BD/32278/2006, SFRH/BPD/75311/2010]	"Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium); European Molecular Biology Organization in Heidelberg (Germany); Fundacao para a Ciencia e Tecnologia (FCT) in Portugal(Portuguese Foundation for Science and Technology)	This work was funded by a predoctoral fellowship of the "Instituut voor aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen" (I.W.T., Belgium) (SBO 083179) (www.iwt.be), an EMBO Long-Term Fellowship (ALTF 104-2009) from the European Molecular Biology Organization in Heidelberg (Germany) (http://www.embo.org/programmes/fellowships), and two grants (SFRH/BD/32278/2006 grant and SFRH/BPD/75311/2010 grant) from the Fundacao para a Ciencia e Tecnologia (FCT) in Portugal (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archibald A. R., 1993, P381; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Briers Y, 2006, CELL MOL LIFE SCI, V63, P1899, DOI 10.1007/s00018-006-6183-7; Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Briers Y, 2009, BIOCHEM BIOPH RES CO, V383, P187, DOI 10.1016/j.bbrc.2009.03.161; Callewaert L, 2011, CURR OPIN BIOTECH, V22, P164, DOI 10.1016/j.copbio.2010.10.012; Cornelissen A, 2012, J VIROL, V86, P1844, DOI 10.1128/JVI.06330-11; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fokine A, 2008, J BIOL CHEM, V283, P7242, DOI 10.1074/jbc.M709398200; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Guha A, 2002, FOLIA MICROBIOL, V47, P379, DOI 10.1007/BF02818694; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; Kropinski AM, 2007, VIROLOGY, V369, P234, DOI 10.1016/j.virol.2007.07.027; Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y; LAROSE L, 1995, J BIOL CHEM, V270, P3858, DOI 10.1074/jbc.270.8.3858; Lavigne R, 2004, CELL MOL LIFE SCI, V61, P2753, DOI 10.1007/s00018-004-4301-y; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Morita M, 2001, J BIOSCI BIOENG, V91, P469, DOI 10.1263/jbb.91.469; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Nakimbugwe D, 2006, FEMS MICROBIOL LETT, V259, P41, DOI 10.1111/j.1574-6968.2006.00240.x; Orito Y, 2004, APPL MICROBIOL BIOT, V65, P105, DOI 10.1007/s00253-003-1522-1; Paradis-Bleau C, 2007, FEMS MICROBIOL LETT, V266, P201, DOI 10.1111/j.1574-6968.2006.00523.x; Pirnay JP, 2003, J CLIN MICROBIOL, V41, P1192, DOI 10.1128/JCM.41.3.1192-1202.2003; Prakash NAU, 2010, J MOL EVOL, V70, P466, DOI 10.1007/s00239-010-9345-z; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2012, APPL MICROBIOL BIOT, V93, P633, DOI 10.1007/s00253-011-3372-6; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Summer EJ, 2006, J BACTERIOL, V188, P255, DOI 10.1128/JB.188.1.255-268.2006; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; WEAVER LH, 1985, J MOL EVOL, V21, P97, DOI 10.1007/BF02100084; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x	41	71	82	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36991	10.1371/journal.pone.0036991	http://dx.doi.org/10.1371/journal.pone.0036991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615864	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300057
J	Carmona, M; Sepulveda, D; Cardenas, C; Nilo, L; Marshall, SH				Carmona, Marisela; Sepulveda, Dagoberto; Cardenas, Constanza; Nilo, Luis; Marshall, Sergio H.			Denaturing Gradient Gel Electrophoresis (DGGE) as a Powerful Novel Alternative for Differentiation of Epizootic ISA Virus Variants	PLOS ONE			English	Article							INFECTIOUS-SALMON-ANEMIA; ORTHOMYXO-LIKE VIRUS; GC-CLAMP; RT-PCR; DNA FRAGMENTS; CELL-LINE; IDENTIFICATION; SALAR; GENE; RECOMBINATION	Infectious Salmon Anemia is a devastating disease critically affecting world-wide salmon production. Chile has been particularly stricken by this disease which in all cases has been directly related with its causative agent, a novel orthomyxovirus which presents specific and distinctive infective features. Among these, two molecular markers have been directly associated with pathogenicity in two of the eight RNA sub genomic coding units of the virus: an insertion hot spot region present in viral segment 5 and a Highly Polymorphic Region (HPR) located in viral segment 6. Here we report the successful adaptation of a PCR-dependent denaturing gel electrophoresis technique (DGGE), which enables differentiation of selected reported HPR epizootic variants detected in Chile. At the same time, the technique allows us to distinguish one nucleotide differences in sequences associated with the intriguing, and still not well-understood, insertion events which tend to occur on RNA Segment 5. Thus, the versatility of the technique opens new opportunities for improved understanding of the complex biology of all ISA variants as well as possible applications to other highly variable pathogens.	[Carmona, Marisela; Sepulveda, Dagoberto; Nilo, Luis; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Lab Patologenos Acuicolas Nucl Biotecnol Curauma, Valparaiso, Chile; [Carmona, Marisela; Sepulveda, Dagoberto; Nilo, Luis; Marshall, Sergio H.] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Lab Genet Inmunol Mol, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso	Carmona, M (corresponding author), Pontificia Univ Catolica Valparaiso, Lab Patologenos Acuicolas Nucl Biotecnol Curauma, Campus Curauma, Valparaiso, Chile.	smarshal@ucv.cl	Cárdenas, Constanza/ABA-6477-2021	marshall, sergio/0000-0003-0438-8252; Cardenas Carvajal, Constanza/0000-0002-3673-9320; Sepulveda, Dagoberto/0000-0001-8553-5861	CORFO-Innova [09MCSS-6725]	CORFO-Innova	Funding provided by grant CORFO-Innova 09MCSS-6725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANGLANI F, 1990, AM J HUM GENET, V47, P169; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; Chakravarti Dhrubajyoti, 2008, J Biomol Tech, V19, P184; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Cottet L, 2011, VIRUS RES, V155, P10, DOI 10.1016/j.virusres.2010.10.021; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; DANNEVIG BH, 1995, J GEN VIROL, V76, P1353, DOI 10.1099/0022-1317-76-6-1353; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Friedman-Ohana R, 1998, P NATL ACAD SCI USA, V95, P6909, DOI 10.1073/pnas.95.12.6909; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Green S. J., 2009, MICROBIOLOGY HYDROCA, P4137; Griffiths S, 2001, DIS AQUAT ORGAN, V45, P19, DOI 10.3354/dao045019; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayes V M, 1999, Nucleic Acids Res, V27, pe29, DOI 10.1093/nar/27.20.e29; Heath S, 2000, DIS AQUAT ORGAN, V41, P19, DOI 10.3354/dao041019; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Kibenge FSB, 2001, DIS AQUAT ORGAN, V45, P9, DOI 10.3354/dao045009; Kibenge FSB, 2000, J GEN VIROL, V81, P143, DOI 10.1099/0022-1317-81-1-143; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; Merour E, 2011, J GEN VIROL, V92, P528, DOI 10.1099/vir.0.027417-0; Michaelsen A, 2006, INT BIODETER BIODEGR, V58, P133, DOI 10.1016/j.ibiod.2006.06.019; Mikalsen AB, 2001, DIS AQUAT ORGAN, V47, P175, DOI 10.3354/dao047175; Mjaaland S, 1997, J VIROL, V71, P7681, DOI 10.1128/JVI.71.10.7681-7686.1997; Mullins J.E., 1998, Bulletin of the European Association of Fish Pathologists, V18, P110; Munir K, 2004, J VIROL METHODS, V117, P37, DOI 10.1016/j.jviromet.2003.11.020; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; OLSEN DB, 1990, P NATL ACAD SCI USA, V87, P1451, DOI 10.1073/pnas.87.4.1451; Raynard RS, 2001, DIS AQUAT ORGAN, V46, P93, DOI 10.3354/dao046093; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rodger H.D., 1998, Bulletin of the European Association of Fish Pathologists, V18, P115; Rolland JB, 2003, J FISH DIS, V26, P511, DOI 10.1046/j.1365-2761.2003.00473.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmitt B, 2005, BIOLOGICALS, V33, P211, DOI 10.1016/j.biologicals.2005.08.007; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Snow M, 2003, VIRUS RES, V92, P99, DOI 10.1016/S0168-1702(02)00322-2; Stagg RM, 2001, 13 FRS MAR LAB, P13; Thornhill DJ, 2010, CORAL REEFS, V29, P83, DOI 10.1007/s00338-009-0550-4; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Top B, 1992, PCR Methods Appl, V2, P83, DOI 10.1101/gr.2.1.83; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37353	10.1371/journal.pone.0037353	http://dx.doi.org/10.1371/journal.pone.0037353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624020	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500104
J	Gabbay-Benziv, R; Ao, A; Fisch, B; Zhang, L; Oron, G; Kessler-Icekson, G; Ben-Haroush, A; Krissi, H; Abir, R				Gabbay-Benziv, Rinat; Ao, Asangla; Fisch, Benjamin; Zhang, Li; Oron, Galia; Kessler-Icekson, Gania; Ben-Haroush, Avi; Krissi, Haim; Abir, Ronit			Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; EARLY FOLLICULAR DEVELOPMENT; IN-VITRO; STIMULATING-HORMONE; HUMAN FETUSES; RAT OVARY; ADULTS; LOCALIZATION; EXPRESSION; CULTURE	Background: Ovarian cryopreservation is one option for fertility preservation in patients with cancer. The danger of reseeding malignancies could be eliminated by in vitro maturation of primordial follicles from the frozen-thawed tissue. However, the development of this system is hindered by uncertainties regarding factors that activate primordial follicles. Neuronal growth factors such as vasoactive intestinal peptide (VIP) play important roles in early mammalian folliculogenesis. There are no data on the expression of VIP and its vasoactive intestinal peptide pituitary adenylate cyclase 1 and 2 receptors (VPAC1-R and VPAC2-R) in human preantral follicles. Methodology/Principal Findings: Tissue samples from 14 human fetal ovaries and 40 ovaries from girls/women were prepared to test for the expression of VIP, VPAC1-R, and VPAC2-R on the protein (immunohistochemisty) and mRNA (reverse transcription polymerase chain reaction) levels. Immunohistochemistry staining was mostly weak, especially in fetal samples. The VIP protein was identified in oocytes and granulosa cells (GCs) in the fetal samples from 22 gestational weeks (GW) onwards. In girls/women, VIP follicular staining (oocytes and GCs) was identified in 45% of samples. VPAC1-R protein was identified in follicles in all fetal samples from 22GW onwards and in 63% of the samples from girls/women (GC staining only in 40%). VPAC2-R protein was identified in follicles in 33% of fetal samples and 47% of the samples from girls/women. The mRNA transcripts for VIP, VPAC1-R, and VPAC2-R were identified in ovarian extracts from fetuses and women. Conclusions: VIP and its two receptors are expressed in human ovarian preantral follicles. However, their weak staining suggests they have limited roles in early follicular growth. To elucidate if VIP activates human primordial follicles, it should be added to the culture medium.	[Gabbay-Benziv, Rinat; Fisch, Benjamin; Oron, Galia; Ben-Haroush, Avi; Abir, Ronit] Beilinson Womens Hosp, Rabin Med Ctr, Infertil & IVF Unit, Petah Tiqwa, Israel; [Gabbay-Benziv, Rinat; Fisch, Benjamin; Oron, Galia; Kessler-Icekson, Gania; Ben-Haroush, Avi; Krissi, Haim; Abir, Ronit] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ao, Asangla; Zhang, Li] McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; [Ao, Asangla] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Kessler-Icekson, Gania] Beilinson Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; McGill University; Royal Victoria Hospital; McGill University; Rabin Medical Center; Tel Aviv University	Gabbay-Benziv, R (corresponding author), Beilinson Womens Hosp, Rabin Med Ctr, Infertil & IVF Unit, Petah Tiqwa, Israel.	ronita@clalit.org.il	Gabbay-benziv, Rinat/AAE-7195-2020; ao, asangla/Q-5454-2019	Gabbay-benziv, Rinat/0000-0001-6887-6314; 				Abir R, 2006, HISTOL HISTOPATHOL, V21, P887, DOI 10.14670/HH-21.887; Abir R, 2005, MOL HUM REPROD, V11, P229, DOI 10.1093/molehr/gah164; Abir R, 2010, HUM REPROD, V25, P1708, DOI 10.1093/humrep/deq121; Barberi M, 2007, REPRODUCTION, V134, P281, DOI 10.1530/REP-07-0051; Ben-Haroush A, 2005, FERTIL STERIL, V84, P1257, DOI 10.1016/j.fertnstert.2005.05.018; Bruno JB, 2010, CELLS TISSUES ORGANS, V191, P414, DOI 10.1159/000272317; Cecconi S, 2004, ENDOCRINOLOGY, V145, P2071, DOI 10.1210/en.2003-1004; Dissen GA, 2002, MICROSC RES TECHNIQ, V59, P509, DOI 10.1002/jemt.10227; Fahenkrug J, 2010, RESULTS PROBL CELL D, V50, P221; Feigin E, 2008, CANC FEMALE ADOLESCE, P103; Friedman O, 2012, HUM REPROD, V27, P474, DOI 10.1093/humrep/der385; GEORGE FW, 1987, P NATL ACAD SCI USA, V84, P5803, DOI 10.1073/pnas.84.16.5803; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; HULSHOF SCJ, 1994, BIOL REPROD, V50, P553, DOI 10.1095/biolreprod50.3.553; Kristensen SG, 2011, HUM REPROD, V26, P157, DOI 10.1093/humrep/deq318; Laburthe M, 1996, ANN NY ACAD SCI, V805, P94; Laburthe M, 1996, ANN NY ACAD SCI, V26, P110; Mayerhofer A, 1997, ENDOCRINOLOGY, V138, P3320, DOI 10.1210/en.138.8.3320; Moody TW, 2011, CURR OPIN ENDOCRINOL, V18, P61, DOI 10.1097/MED.0b013e328342568a; Ojeda SR, 2000, MOL CELL ENDOCRINOL, V163, P67, DOI 10.1016/S0303-7207(99)00242-7; Oron G, 2011, FERTIL STERIL, V95, P2056, DOI 10.1016/j.fertnstert.2011.02.012; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070	26	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37015	10.1371/journal.pone.0037015	http://dx.doi.org/10.1371/journal.pone.0037015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623971	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500048
J	Kraus, M; Wang, YX; Aleksandrowicz, D; Bachman, E; Szewczak, AA; Walker, D; Xu, L; Bouthillette, M; Childers, KM; Dolinski, B; Haidle, AM; Kopinja, J; Lee, L; Lim, J; Little, KD; Ma, YH; Mathur, A; Mo, JR; O'Hare, E; Otte, RD; Taoka, BM; Wang, WX; Yin, H; Zabierek, AA; Zhang, WS; Zhao, SX; Zhu, J; Young, JR; Marshall, CG				Kraus, Manfred; Wang, Yuxun; Aleksandrowicz, Dan; Bachman, Eric; Szewczak, Alexander A.; Walker, Deborah; Xu, Lin; Bouthillette, Melaney; Childers, Kaleen M.; Dolinski, Brian; Haidle, Andrew M.; Kopinja, Johnny; Lee, Linda; Lim, Jongwon; Little, Kevin D.; Ma, Yanhong; Mathur, Anjili; Mo, Jan-Rung; O'Hare, Erin; Otte, Ryan D.; Taoka, Brandon M.; Wang, Wenxian; Yin, Hong; Zabierek, Anna A.; Zhang, Weisheng; Zhao, Shuxia; Zhu, Joe; Young, Jonathan R.; Marshall, C. Gary			Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera	PLOS ONE			English	Article							TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; MUTATION; EXPRESSION	A high percentage of patients with the myeloproliferative disorder polycythemia vera (PV) harbor a Val617 -> Phe activating mutation in the Janus kinase 2 (JAK2) gene, and both cell culture and mouse models have established a functional role for this mutation in the development of this disease. We describe the properties of MRLB-11055, a highly potent inhibitor of both the WT and V617F forms of JAK2, that has therapeutic efficacy in erythropoietin (EPO)-driven and JAK2V617F-driven mouse models of PV. In cultured cells, MRLB-11055 blocked proliferation and induced apoptosis in a manner consistent with JAK2 pathway inhibition. MRLB-11055 effectively prevented EPO-induced STAT5 activation in the peripheral blood of acutely dosed mice, and could prevent EPO-induced splenomegaly and erythrocytosis in chronically dosed mice. In a bone marrow reconstituted JAK2V617F-luciferase murine PV model, MRLB-11055 rapidly reduced the burden of JAK2V617F-expressing cells from both the spleen and the bone marrow. Using real-time in vivo imaging, we examined the kinetics of disease regression and resurgence, enabling the development of an intermittent dosing schedule that achieved significant reductions in both erythroid and myeloid populations with minimal impact on lymphoid cells. Our studies provide a rationale for the use of non-continuous treatment to provide optimal therapy for PV patients.	[Kraus, Manfred] Merck Res Labs, Dept DMPK, Boston, MA USA; Merck Res Labs, Dept Vitro Sci, Boston, MA USA; Merck Res Labs, Dept Vivo Sci, Boston, MA USA; Merck Res Labs, Dept Med Chem, Boston, MA USA; Merck Res Labs, Dept Basic Pharmaceut Sci, Boston, MA USA; Merck Res Labs, Dept Oncol, Boston, MA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Kraus, M (corresponding author), Merck Res Labs, Dept DMPK, Boston, MA USA.	jonathan_young@merck.com; christopher_marshall3@merck.com	MA, YAN/HHN-2912-2022; Walker, Deborah/GSE-2426-2022	Wang, Yuxun/0000-0002-4252-6102	Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	All of the research was funded by Merck & Co., Inc. The funders did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as the authors are employed by the funder.	Baffert F, 2010, MOL CANCER THER, V9, P1945, DOI 10.1158/1535-7163.MCT-10-0053; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Conklyn M, 2004, J LEUKOCYTE BIOL, V76, P1248, DOI 10.1189/jlb.0504282; Cortes J, 2008, BLOOD, V112, P1109; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lim J, 2009, United States patent application, Patent No. [WO 200907, 200907]; Lim J, 2011, J MED CHEM, V54, P7334, DOI 10.1021/jm200909u; Ma XM, 2008, AM J HEMATOL, V83, P359, DOI 10.1002/ajh.21129; Ma YH, 2009, BBA-MOL BASIS DIS, V1792, P1073, DOI 10.1016/j.bbadis.2009.08.011; Marrero MB, 2005, VASC PHARMACOL, V43, P307, DOI 10.1016/j.vph.2005.09.002; Mathur A, 2009, BIOCHEM PHARMACOL, V78, P382, DOI 10.1016/j.bcp.2009.04.025; Mesa RA, 2007, CANCER-AM CANCER SOC, V109, P68, DOI 10.1002/cncr.22365; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Pardanani AD, 2008, BLOOD, V112, P43, DOI 10.1182/blood.V112.11.97.97; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Penninga EI, 2006, DRUGS, V66, P2173, DOI 10.2165/00003495-200666170-00003; Rice L, 2006, ARCH PATHOL LAB MED, V130, P1151; Siu T., 2009, Inhibitors of Janus Kinases, Patent No. [WO 2009035575, 2009035575, WO 2009/ 035575 A1]; VERSTOVSEK S, 2008, BLOOD, V112, P1762; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37207	10.1371/journal.pone.0037207	http://dx.doi.org/10.1371/journal.pone.0037207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623993	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500073
J	Martins, AP; Marrone, A; Ciancetta, A; Cobo, AG; Echevarria, M; Moura, TF; Re, N; Casini, A; Soveral, G				Martins, Ana Paula; Marrone, Alessandro; Ciancetta, Antonella; Galan Cobo, Ana; Echevarria, Miriam; Moura, Teresa F.; Re, Nazzareno; Casini, Angela; Soveral, Graca			Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; WATER PERMEABILITY; BASOLATERAL MEMBRANE; SOLUTION CHEMISTRY; COLLECTING DUCT; FORCE-FIELD; GLYCEROL; CHANNEL; SELECTIVITY; MECHANISM	Aquaporins (AQPs) are membrane channels that conduct water and small solutes such as glycerol and are involved in many physiological functions. Aquaporin-based modulator drugs are predicted to be of broad potential utility in the treatment of several diseases. Until today few AQP inhibitors have been described as suitable candidates for clinical development. Here we report on the potent inhibition of AQP3 channels by gold(III) complexes screened on human red blood cells (hRBC) and AQP3-transfected PC12 cells by a stopped-flow method. Among the various metal compounds tested, Auphen is the most active on AQP3 (IC50 = 0.86 +/- 0.08 mu M in hRBC). Interestingly, the compound poorly affects the water permeability of AQP1. The mechanism of gold inhibition is related to the ability of Au(III) to interact with sulphydryls groups of proteins such as the thiolates of cysteine residues. Additional DFT and modeling studies on possible gold compound/AQP adducts provide a tentative description of the system at a molecular level. The mapping of the periplasmic surface of an homology model of human AQP3 evidenced the thiol group of Cys40 as a likely candidate for binding to gold(III) complexes. Moreover, the investigation of non-covalent binding of Au complexes by docking approaches revealed their preferential binding to AQP3 with respect to AQP1. The high selectivity and low concentration dependent inhibitory effect of Auphen (in the nanomolar range) together with its high water solubility makes the compound a suitable drug lead for future in vivo studies. These results may present novel metal-based scaffolds for AQP drug development.	[Martins, Ana Paula; Moura, Teresa F.; Soveral, Graca] Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal; [Marrone, Alessandro; Ciancetta, Antonella; Re, Nazzareno] Univ G DAnnunzio, Dipartimento Sci Farmaco, Chieti, Italy; [Galan Cobo, Ana; Echevarria, Miriam] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, IBiS, Seville, Spain; [Casini, Angela] Univ Groningen, Res Inst Pharm, Groningen, Netherlands; [Soveral, Graca] Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; G d'Annunzio University of Chieti-Pescara; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Groningen; Universidade de Lisboa	Martins, AP (corresponding author), Univ Nova Lisboa, REQUIMTE, Dept Quim, Fac Ciencias & Tecnol, Caparica, Portugal.	a.casini@rug.nl; gsoveral@ff.ul.pt	Ciancetta, Antonella/AAS-8478-2020; Casini, Angela/Q-1701-2019; IBIS, TERAPIA CELULA/P-3297-2015; Echevarría, Miriam/E-6682-2010; Moura, Teresa F/E-2485-2014; iMed.ULisboa, MetGen/B-5293-2014; Casini, Angela/E-6731-2014; Martins, Ana Paula/A-5657-2013; Soveral, Graça/L-1550-2013; Ciancetta, Antonella/L-9991-2017	Ciancetta, Antonella/0000-0002-7612-2050; Casini, Angela/0000-0003-1599-9542; Echevarría, Miriam/0000-0002-4758-9428; Casini, Angela/0000-0003-1599-9542; Martins, Ana Paula/0000-0002-5064-6171; Soveral, Graça/0000-0001-8487-110X; Ciancetta, Antonella/0000-0002-7612-2050; Martins, Ana Paula/0000-0002-4706-5456; Marrone, Alessandro/0000-0002-8311-8172; Fonseca de Moura, Teresa Maria/0000-0003-3069-0770; Galan Cobo, Ana/0000-0002-0988-1823	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/65046/2009]; COST [CM0902]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); COST(European Cooperation in Science and Technology (COST))	This work was supported from Fundacao para a Ciencia e a Tecnologia, Portugal, through a Ph.D. fellowship to APM (SFRH/BD/65046/2009). A. Casini thanks the University of Groningen (Rosalind Franklin fellowship). The authors thank COST CM0902 for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate F, 2000, INORG CHIM ACTA, V311, P1, DOI 10.1016/S0020-1693(00)00299-1; Aldinucci D, 2007, ANTI-CANCER DRUG, V18, P323, DOI 10.1097/CAD.0b013e328011ae98; [Anonymous], 2008, MAESTR 8 5; Bagnasco SM, 2006, J MEMBRANE BIOL, V212, P133, DOI 10.1007/s00232-006-0872-x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Bergamo A, 2012, J INORG BIOCHEM, V106, P90, DOI 10.1016/j.jinorgbio.2011.09.030; Brooks HL, 2000, MOL PHARMACOL, V57, P1021; Campos E, 2011, BIOCHEM BIOPH RES CO, V408, P477, DOI 10.1016/j.bbrc.2011.04.057; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; Casini A, 2008, J INORG BIOCHEM, V102, P564, DOI 10.1016/j.jinorgbio.2007.11.003; Casini A, 2012, J INORG BIOCHEM, V109, P97, DOI 10.1016/j.jinorgbio.2011.12.007; Casini A, 2009, J BIOL INORG CHEM, V14, P1139, DOI 10.1007/s00775-009-0558-9; Chen HN, 2007, BIOPHYS J, V92, P46, DOI 10.1529/biophysj.106.091934; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0; DENKER BM, 1988, J BIOL CHEM, V263, P15634; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao L, 2011, MOL ONCOL; Hara M, 2003, P NATL ACAD SCI USA, V100, P7360, DOI 10.1073/pnas.1230416100; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; HARIHARAN PC, 1972, CHEM PHYS LETT, V16, P217, DOI 10.1016/0009-2614(72)80259-8; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448975, 10.1063/1.448800, 10.1063/1.448799]; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Jelen S, 2011, J BIOL CHEM; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Ma B, 2004, ACTA PHARMACOL SIN, V25, P90; Mendes F, 2011, J MED CHEM, V54, P2196, DOI 10.1021/jm2000135; Messori L, 2000, J MED CHEM, V43, P3541, DOI 10.1021/jm990492u; Messori L, 2004, MET IONS BIOL SYST, V41, P2799; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Migliati ER, 2010, NEUROCRIT CARE, V13, P123, DOI 10.1007/s12028-010-9376-8; MOURA TF, 1984, J MEMBRANE BIOL, V81, P105, DOI 10.1007/BF01868975; Nakamura Y, 2011, ACS CHEM NEUROSCI, V2, P568, DOI 10.1021/cn2000525; Nielsen RJ, 2004, J AM CHEM SOC, V126, P7967, DOI 10.1021/ja031911m; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; Niu SQ, 2000, CHEM REV, V100, P353, DOI 10.1021/cr980404y; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Schrodinger LLC, 2009, JAG 7 7 7 5; Schrodinger LLC, 2008, SIT 2 2; Serratrice M, 2012, DALTON T, V41, P3287, DOI 10.1039/c2dt11913g; Shaw CF, 1989, COMMENTS INORG CHEM, V8, P233, DOI DOI 10.1080/02603598908035798; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; TSIPOURAS N, 1995, CLIN CHEM, V41, P87; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VANHOEK AN, 1990, J PHYSIOL-LONDON, V420, pP142; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Yang BX, 2008, BIOORGAN MED CHEM, V16, P7489, DOI 10.1016/j.bmc.2008.06.005; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zhang X, 2010, J CELL BIOCHEM, V109, P162, DOI 10.1002/jcb.22394	77	96	99	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37435	10.1371/journal.pone.0037435	http://dx.doi.org/10.1371/journal.pone.0037435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624030	gold, Green Published			2022-12-27	WOS:000305343500115
J	O'Grady, EP; Viteri, DF; Sokol, PA				O'Grady, Eoin P.; Viteri, Duber F.; Sokol, Pamela A.			A Unique Regulator Contributes to Quorum Sensing and Virulence in Burkholderia cenocepacia	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; CAENORHABDITIS-ELEGANS; CYSTIC-FIBROSIS; INTERSPECIES COMMUNICATION; TRANSCRIPTIONAL REGULATOR; RHIZOBIUM-LEGUMINOSARUM; COLONY MORPHOLOGY; BIOFILM FORMATION; GENES	Burkholderia cenocepacia causes chronic and life-threatening respiratory infections in immunocompromized people. The B. cenocepacia N-acyl-homoserine lactone (AHL)-dependent quorum sensing system relies on the production of AHLs by the synthases CepI and CciI while CepR, CciR and CepR2 control expression of many genes important for pathogenesis. Downstream from, and co-transcribed with cepI, lies BCAM1871 encoding a hypothetical protein that was uncharacterized prior to this study. Orthologs of B. cenocepacia BCAM1871 are uniquely found in Burkholderia spp and are conserved in their genomic locations in pathogenic Burkholderia. We observed significant effects on AHL activity upon mutation or overexpression of BCAM1871, although these effects were more subtle than those observed for CepI indicating BCAM1871 acts as an enhancer of AHL activity. Transcription of cepI, cepR and cciIR was significantly reduced in the BCAM1871 mutant. Swimming and swarming motilities as well as transcription of fliC, encoding flagellin, were significantly reduced in the BCAM1871 mutant. Protease activity and transcription of zmpA and zmpB, encoding extracellular zinc metalloproteases, were undetectable in the BCAM1871 mutant indicating a more significant effect of mutating BCAM1871 than cepI. Exogenous addition of OHL restored cepI, cepR and fliC transcription but had no effect on motility, protease activity or zmpA or zmpB transcription suggesting AHL-independent effects. The BCAM1871 mutant exhibited significantly reduced virulence in rat chronic respiratory and nematode infection models. Gene expression and phenotypic assays as well as vertebrate and invertebrate infection models showed that BCAM1871 significantly contributes to pathogenesis in B. cenocepacia.	[O'Grady, Eoin P.; Viteri, Duber F.; Sokol, Pamela A.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada	University of Calgary	O'Grady, EP (corresponding author), Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	psokol@ucalgary.ca			Cystic Fibrosis Canada; Canadian Institutes of Health Research [MOP-42510]; Cystic Fibrosis Canada fellowship	Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada fellowship	These studies were supported by research grants from the Cystic Fibrosis Canada and Canadian Institutes of Health Research (grant MOP-42510) to PAS. EPO was the recipient of a Cystic Fibrosis Canada fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2003, J BACTERIOL, V185, P6456, DOI 10.1128/JB.185.21.6456-6462.2003; Ausubel FM, 1988, MOL REPROD DEV; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Bernier SP, 2008, INFECT IMMUN, V76, P38, DOI 10.1128/IAI.00874-07; Bernier SP, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-59; BRENNER S, 1974, GENETICS, V77, P71; CASH HA, 1979, AM REV RESPIR DIS, V119, P453; Chambers CE, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-104; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Daniels R, 2006, P NATL ACAD SCI USA, V103, P14965, DOI 10.1073/pnas.0511037103; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dennis J J, 1995, Methods Mol Biol, V47, P125; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Edwards A, 2009, J BACTERIOL, V191, P3059, DOI 10.1128/JB.01650-08; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Frederix M, 2011, MOL MICROBIOL, V81, P994, DOI 10.1111/j.1365-2958.2011.07738.x; Gotschlich A, 2001, SYST APPL MICROBIOL, V24, P1, DOI 10.1078/0723-2020-00013; Hedl M, 2004, J BACTERIOL, V186, P1927, DOI 10.1128/JB.186.7.1927-1932.2004; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Huber B, 2002, MOL MICROBIOL, V46, P411, DOI 10.1046/j.1365-2958.2002.03182.x; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lewenza S, 2002, CAN J MICROBIOL, V48, P707, DOI 10.1139/W02-068; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Magalhaes M, 2003, J HOSP INFECT, V54, P120, DOI 10.1016/S0195-6701(03)00118-X; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweizer HP, 1996, MOLECULAR BIOLOGY OF PSEUDOMONADS, P229; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Speert David Paul, 2002, Paediatr Respir Rev, V3, P230, DOI 10.1016/S1526-0542(02)00185-9; Subramoni S, 2011, INFECT IMMUN, V79, P2984, DOI 10.1128/IAI.00170-11; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Subsin B, 2007, J BACTERIOL, V189, P968, DOI 10.1128/JB.01201-06; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Wei YP, 2011, MOL MICROBIOL, V79, P616, DOI 10.1111/j.1365-2958.2010.07469.x; Weingart CL, 2005, MOL MICROBIOL, V57, P452, DOI 10.1111/j.1365-2958.2005.04656.x; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998	71	19	19	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37611	10.1371/journal.pone.0037611	http://dx.doi.org/10.1371/journal.pone.0037611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624054	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500143
J	Nguyen, Q; Palfreyman, RW; Chan, LCL; Reid, S; Nielsen, LK				Quan Nguyen; Palfreyman, Robin W.; Chan, Leslie C. L.; Reid, Steven; Nielsen, Lars K.			Transcriptome Sequencing of and Microarray Development for a Helicoverpa zea Cell Line to Investigate In Vitro Insect Cell-Baculovirus Interactions	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; APOPTOSIS PROTEINS; GENE; RNA; EXPRESSION; MODEL; GENERATION; INHIBITOR; EVOLUTION; VERSATILE	The Heliothine insect complex contains some of the most destructive pests of agricultural crops worldwide, including the closely related Helicoverpa zea and H. armigera. Biological control using baculoviruses is practiced at a moderate level worldwide. In order to enable more wide spread use, a better understanding of cell-virus interactions is required. While many baculoviruses have been sequenced, none of the Heliothine insect genomes have been available. In this study, we sequenced, assembled and functionally annotated 29,586 transcripts from cultured H. zea cells using Illumina 100 bps and paired-end transcriptome sequencing (RNA-seq). The transcript sequences had high assembly coverage (64.5 times). 23,401 sequences had putative protein functions, and over 13,000 sequences had high similarities to available sequences in other insect species. The sequence database was estimated to cover at least 85% of all H. zea genes. The sequences were used to construct a microarray, which was evaluated on the infection of H. zea cells with H. Armigera single-capsid nucleopolyhedrovirus (HearNPV). The analysis revealed that up-regulation of apoptosis genes is the main cellular response in the early infection phase (18 hours post infection), while genes linked to four major immunological signalling pathways (Toll, IMD, Jak-STAT and JNK) were down-regulated. Only small changes (generally downwards) were observed for central carbon metabolism. The transcriptome and microarray platform developed in this study represent a greatly expanded resource base for H. zea insect- HearNPV interaction studies, in which key cellular pathways such as those for metabolism, immune response, transcription and replication have been identified. This resource will be used to develop better cell culture-based virus production processes, and more generally to investigate the molecular basis of host range and susceptibility, virus infectivity and virulence, and the ecology and evolution of baculoviruses.	[Quan Nguyen; Palfreyman, Robin W.; Chan, Leslie C. L.; Reid, Steven; Nielsen, Lars K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia	University of Queensland	Nguyen, Q (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	steven.reid@uq.edu.au	Nielsen, Lars K/A-5519-2011; Nguyen, Quan H/D-2026-2017; Palfreyman, Robin W/V-8516-2017	Nielsen, Lars K/0000-0001-8191-3511; Nguyen, Quan H/0000-0001-7870-5703; Palfreyman, Robin W/0000-0002-1088-7069	Australian Research Council [LP0989824]; University of Queenland; Australian Institute for Bioengineering and Nanotechnology	Australian Research Council(Australian Research Council); University of Queenland; Australian Institute for Bioengineering and Nanotechnology	This work was funded by the Australian Research Council Linkage Grant (no. LP0989824). QN's PhD Scholarship was provided by the University of Queenland and the Australian Institute for Bioengineering and Nanotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cory JS, 2003, ANNU REV ECOL EVOL S, V34, P239, DOI 10.1146/annurev.ecolsys.34.011802.132402; Courtiade J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-357; Deng YP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-264; Dong DJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-73; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang N, 2011, J VIROL, V85, P12547, DOI 10.1128/JVI.05766-11; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Jacobson A, 2009, J ECON ENTOMOL, V102, P2289, DOI 10.1603/029.102.0634; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo WY, 2011, CANCER GENE THER, V18, P637, DOI 10.1038/cgt.2011.35; Lyupina YV, 2011, VIROLOGY, V421, P34, DOI 10.1016/j.virol.2011.09.010; MacDonald SJ, 2011, MOL ECOL, V20, P2073, DOI 10.1111/j.1365-294X.2011.05031.x; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; MCINTOSH AH, 1983, APPL ENTOMOL ZOOL, V18, P262, DOI 10.1303/aez.18.262; Mena JA, 2011, EXPERT REV VACCINES, V10, P1063, DOI [10.1586/ERV.11.24, 10.1586/erv.11.24]; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moscardi F, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P415, DOI 10.1007/978-1-4419-7931-5_16; Nguyen Q, 2011, J VIROL METHODS, V175, P197, DOI 10.1016/j.jviromet.2011.05.011; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Oh S, 2010, APPL ENVIRON MICROB, V76, P2980, DOI 10.1128/AEM.02826-09; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sagisaka A, 2010, VIRUS RES, V147, P166, DOI 10.1016/j.virusres.2009.10.015; Schultz KLW, 2009, J VIROL, V83, P11123, DOI 10.1128/JVI.01199-09; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szewczyk B., 2009, Journal of Biopesticides, V2, P209; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Toung JM, 2011, GENOME RES, V21, P991, DOI 10.1101/gr.116335.110; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vandergaast R, 2011, J VIROL, V85, P8348, DOI 10.1128/JVI.00667-11; Vellozo AF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar008; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Xia Q, 2004, SCIENCE, V306, P1397; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; Zagrobelny M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-574; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611	58	26	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36324	10.1371/journal.pone.0036324	http://dx.doi.org/10.1371/journal.pone.0036324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629315	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500013
J	Peng, ZG; Shen, RL; Li, YW; Teng, KY; Shapiro, CL; Lin, HJL				Peng, Zhengang; Shen, Rulong; Li, Ying-Wei; Teng, Kun-Yu; Shapiro, Charles L.; Lin, Huey-Jen L.			Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding	PLOS ONE			English	Article							TAZAROTENE-INDUCED GENE-1; HIGH ALDEHYDE DEHYDROGENASE; RETINOID RESPONSE GENE; ACID RECEPTOR-BETA; CANCER-CELL-LINES; TUMOR-SUPPRESSOR; DNA METHYLATION; CHROMATIN MODIFICATIONS; TRANSCRIPTION FACTOR; STEM-CELLS	Background: The cis-acting promoter element responsible for epigenetic silencing of retinoic acid receptor responder 1 (RARRES1) by methylation is unclear. Likewise, how aberrant methylation interplays effectors and thus affects breast neoplastic features remains largely unknown. Methodology/Principal Findings: We first compared methylation occurring at the sequences (-664 similar to+420) flanking the RARRES1 promoter in primary breast carcinomas to that in adjacent benign tissues. Surprisingly, tumor cores displayed significantly elevated methylation occurring solely at the upstream region (-664 similar to-86), while the downstream element (-85 similar to+420) proximal to the transcriptional start site (+1) remained largely unchanged. Yet, hypermethylation at the former did not result in appreciable silencing effect. In contrast, the proximal sequence displayed full promoter activity and methylation of which remarkably silenced RARRES1 transcription. This phenomenon was recapitulated in breast cancer cell lines, in which methylation at the proximal region strikingly coincided with downregulation. We also discovered that CTCF occupancy was enriched at the unmethylayed promoter bound with transcription-active histone markings. Furthermore, knocking-down CTCF expression hampered RARRES1 expression, suggesting CTCF positively regulated RARRES1 transcription presumably by binding to unmethylated promoter poised at transcription-ready state. Moreover, RARRES1 restoration not only impeded cell invasion but also promoted death induced by chemotherapeutic agents, denoting its tumor suppressive effect. Its role of attenuating invasion agreed with data generated from clinical specimens revealing that RARRES1 was generally downregulated in metastatic lymph nodes compared to the tumor cores. Conclusion/Significance: This report delineated silencing of RARRES1 by hypermethylation is occurring at a proximal promoter element and is associated with a loss of binding to CTCF, an activator for RARRES1 expression. We also revealed the tumor suppressive roles exerted by RARRES1 in part by promoting breast epithelial cell death and by impeding cell invasion that is an important property for metastatic spread.	[Peng, Zhengang; Li, Ying-Wei; Teng, Kun-Yu; Lin, Huey-Jen L.] Ohio State Univ, Med Ctr, Sch Allied Med Profess, Div Med Technol, Columbus, OH 43210 USA; [Peng, Zhengang; Li, Ying-Wei; Teng, Kun-Yu; Lin, Huey-Jen L.] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Mol Biol & Canc Genet Program, Columbus, OH 43210 USA; [Shen, Rulong] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Med Ctr, Dept Med Oncol, Columbus, OH 43210 USA; [Lin, Huey-Jen L.] Univ Delaware, Dept Med Technol, Newark, DE USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Delaware	Peng, ZG (corresponding author), Ohio State Univ, Med Ctr, Sch Allied Med Profess, Div Med Technol, Columbus, OH 43210 USA.	hueyjenlin@gmail.com	Shen, Rulong/E-4079-2011		Department of Defense [BC073892]; Susan G. Komen Breast Cancer Foundation [KG081123]	Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by a Breast Cancer Idea Award from the Department of Defense (BC073892) and a grant from the Susan G. Komen Breast Cancer Foundation (KG081123) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dell G, 2001, Methods Mol Biol, V181, P251; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fujimoto R, 2011, PLANT J, V66, P831, DOI 10.1111/j.1365-313X.2011.04549.x; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jia L, 2008, CANCER CHEMOTH PHARM, V61, P63, DOI 10.1007/s00280-007-0446-3; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kwok WK, 2009, CANCER GENET CYTOGEN, V194, P58, DOI 10.1016/j.cancergencyto.2009.06.005; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Lin HJL, 2008, CANCER RES, V68, P10257, DOI 10.1158/0008-5472.CAN-08-0288; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Moriguchi K, 2007, CANCER LETT, V249, P178, DOI 10.1016/j.canlet.2006.08.014; Nagpal S, 1996, J INVEST DERMATOL, V106, P269, DOI 10.1111/1523-1747.ep12340668; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohnishi S, 2009, CELL PROLIFERAT, V42, P309, DOI 10.1111/j.1365-2184.2008.00592.x; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sakazume S, 2012, HUM GENET, V131, P121, DOI 10.1007/s00439-011-1051-4; Shutoh M, 2005, CANCER-AM CANCER SOC, V104, P1609, DOI 10.1002/cncr.21392; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Tamura G, 2009, PATHOL INT, V59, P895, DOI 10.1111/j.1440-1827.2009.02458.x; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zhang H, 2011, J CELL BIOL, V193, P475, DOI 10.1083/jcb.201101021; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36891	10.1371/journal.pone.0036891	http://dx.doi.org/10.1371/journal.pone.0036891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615834	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200024
J	Brenner, JL; Kemp, BJ; Abbott, AL				Brenner, John L.; Kemp, Benedict J.; Abbott, Allison L.			The mir-51 Family of microRNAs Functions in Diverse Regulatory Pathways in Caenorhabditiselegans	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; TARGET GENE; SMALL RNAS; ELEGANS; LET-7; EXPRESSION; HOMOLOG; MECHANISMS; HUNCHBACK; TIME	The mir-51 family of microRNAs (miRNAs) in C. elegans are part of the deeply conserved miR-99/100 family. While loss of all six family members (mir-51-56) in C. elegans results in embryonic lethality, loss of individual mir-51 family members results in a suppression of retarded developmental timing defects associated with the loss of alg-1. The mechanism of this suppression of developmental timing defects is unknown. To address this, we characterized the function of the mir-51 family in the developmental timing pathway. We performed genetic analysis and determined that mir-51 family members regulate the developmental timing pathway in the L2 stage upstream of hbl-1. Loss of the mir-51 family member, mir-52, suppressed retarded developmental timing defects associated with the loss of let-7 family members and lin-46. Enhancement of precocious defects was observed for mutations in lin-14, hbl-1, and mir-48(ve33), but not later acting developmental timing genes. Interestingly, mir-51 family members showed genetic interactions with additional miRNA-regulated pathways, which are regulated by the let-7 and mir-35 family miRNAs, lsy-6, miR-240/786, and miR-1. Loss of mir-52 likely does not suppress miRNA-regulated pathways through an increase in miRNA biogenesis or miRNA activity. We found no increase in the levels of four mature miRNAs, let-7, miR-58, miR-62 or miR-244, in mir-52 or mir-52/53/54/55/56 mutant worms. In addition, we observed no increase in the activity of ectopic lsy-6 in the repression of a downstream target in uterine cells in worms that lack mir-52. We propose that the mir-51 family functions broadly through the regulation of multiple targets, which have not yet been identified, in diverse regulatory pathways in C. elegans.	[Brenner, John L.; Kemp, Benedict J.; Abbott, Allison L.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Marquette University	Brenner, JL (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	allison.abbott@marquette.edu			National Institutes of Health [R15 GM084451]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM084451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Institutes of Health grant, R15 GM084451 awarded to ALA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We thank Luisa Cochella and Oliver Hobert for providing a strain carrying the otIs193 chromosomally-integrated transgene array.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abbott AL, 2011, CURR BIOL, V21, pR668, DOI 10.1016/j.cub.2011.07.027; Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; AMBROS V, 1987, GENE DEV, V1, P398, DOI 10.1101/gad.1.4.398; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; BRENNER S, 1974, GENETICS, V77, P71; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Didiano D, 2010, RNA, V16, P349, DOI 10.1261/rna.1931510; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Ding L, 2005, MOL CELL, V19, P437, DOI 10.1016/j.molcel.2005.07.013; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Eisenmann DM, 1997, GENETICS, V146, P553; Fay DS, 1999, DEV BIOL, V205, P240, DOI 10.1006/dbio.1998.9096; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund E, 2011, GENE DEV, V25, P1121, DOI 10.1101/gad.2038811; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Morita K, 2006, EMBO J, V25, P5794, DOI 10.1038/sj.emboj.7601451; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Pepper ASR, 2004, DEVELOPMENT, V131, P2049, DOI 10.1242/dev.01098; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren H, 2010, DEV BIOL, DOI [10.1016/j.ydbio.2010.07.002, DOI 10.1016/J.YD-BIO.2010.07.002]; Rougvie AE, 2001, NAT REV GENET, V2, P690, DOI 10.1038/35088566; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shaw WR, 2010, GENETICS, V185, P897, DOI 10.1534/genetics.110.117515; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; THOMAS JH, 1990, GENETICS, V124, P855; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhangt HJ, 2009, DEV DYNAM, V238, P595, DOI 10.1002/dvdy.21876	55	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37185	10.1371/journal.pone.0037185	http://dx.doi.org/10.1371/journal.pone.0037185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615936	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300087
J	Myohara, M				Myohara, Maroko			What Role Do Annelid Neoblasts Play? A Comparison of the Regeneration Patterns in a Neoblast-Bearing and a Neoblast-Lacking Enchytraeid Oligochaete	PLOS ONE			English	Article							STEM-CELLS; JAPONENSIS OLIGOCHAETA; PLANARIAN REGENERATION; GENE-EXPRESSION; GROWTH; GERM	The term 'neoblast' was originally coined for a particular type of cell that had been observed during annelid regeneration, but is now used to describe the pluripotent/totipotent stem cells that are indispensable for planarian regeneration. Despite having the same name, however, planarian and annelid neoblasts are morphologically and functionally distinct, and many annelid species that lack neoblasts can nonetheless substantially regenerate. To further elucidate the functions of the annelid neoblasts, a comparison was made between the regeneration patterns of two enchytraeid oligochaetes, Enchytraeus japonensis and Enchytraeus buchholzi, which possess and lack neoblasts, respectively. In E. japonensis, which can reproduce asexually by fragmentation and subsequent regeneration, neoblasts are present in all segments except for the eight anterior-most segments including the seven head-specific segments, and all body fragments containing neoblasts can regenerate a complete head and a complete tail, irrespective of the region of the body from which they were originally derived. In E. japonensis, therefore, no antero-posterior gradient of regeneration ability exists in the trunk region. However, when amputation was carried out within the head region, where neoblasts are absent, the number of regenerated segments was found to be dependent on the level of amputation along the body axis. In E. buchholzi, which reproduces only sexually and lacks neoblasts in all segments, complete heads were never regenerated and incomplete (hypomeric) heads could be regenerated only from the anterior region of the body. Such an antero-posterior gradient of regeneration ability was observed for both the anterior and posterior regeneration in the whole body of E. buchholzi. These results indicate that the presence of neoblasts correlates with the absence of an antero-posterior gradient of regeneration ability along the body axis, and suggest that the annelid neoblasts are more essential for efficient asexual reproduction than for the regeneration of missing body parts.	Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan	Myohara, M (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan.	myohara@affrc.go.jp			Japan Society for the Promotion of Science [20500382]; Narishige Zoological Science Award; Ministry of Agriculture, Forestry, and Fisheries, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Narishige Zoological Science Award; Ministry of Agriculture, Forestry, and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI No. 20500382) from the Japan Society for the Promotion of Science, by a Narishige Zoological Science Award and by a Grant-in-Aid (BioDesign Program) from the Ministry of Agriculture, Forestry, and Fisheries, Japan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2011, TRENDS CELL BIOL, V21, P304, DOI 10.1016/j.tcb.2011.01.005; Bely AE, 2006, INTEGR COMP BIOL, V46, P508, DOI 10.1093/icb/icj051; BILELLO AA, 1974, ROUX ARCH DEV BIOL, V174, P234; CHRISTENSEN BENT, 1964, VIDENSKABELIGE MEDDELEL SERDANSKNATURHIST FOREN KOBENHAVN, V127, P259; Crowell PS, 1937, J EXP ZOOL, V76, P1, DOI 10.1002/jez.1400760102; DozsaFarkas K, 1995, EUR J SOIL BIOL, V31, P207; Hartl D., 1989, PRINCIPLES POPULATIO; HERLANT-MEEWIS HENRIETTE, 1964, ADVANCE MORPHOGENESIS, V4, P155; Hyman LH, 1940, AM NAT, V74, P513, DOI 10.1086/280919; Jamieson BGM, 1981, ULTRASTRUCTURE OLIGO; Kawamoto S, 2005, J EXP ZOOL PART A, V303A, P615, DOI 10.1002/jez.a.205; Muller MCM, 2004, DEV GROWTH DIFFER, V46, P471; Myohara M, 2004, DEV DYNAM, V231, P349, DOI 10.1002/dvdy.20115; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Myohara M, 2006, DEV DYNAM, V235, P2051, DOI 10.1002/dvdy.20849; Nakamura Y, 1978, B NATL GRASSLAND RES, V12, P32; Nakamura Yoshio, 1999, Edaphologia, V62, P93; Nakamura Yoshio, 1993, Edaphologia, V50, P37; Nielsen C. O., 1959, Natura Jutlandica, V8-9, P1; Niva CC, 2008, DEV GENES EVOL, V218, P39, DOI 10.1007/s00427-007-0198-4; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Randolph H., 1891, ZOOL ANZ, V14, P154; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rossi L, 2008, CELL MOL LIFE SCI, V65, P16, DOI 10.1007/s00018-007-7426-y; Schmelz RM, 2000, ZOOL SCI, V17, P505, DOI 10.2108/zsj.17.505; Sugio M, 2008, GENE EXPR PATTERNS, V8, P227, DOI 10.1016/j.gep.2007.12.008; Tadokoro R, 2006, CURR BIOL, V16, P1012, DOI 10.1016/j.cub.2006.04.036; Takeo M, 2008, DEV DYNAM, V237, P1284, DOI 10.1002/dvdy.21518; Takeo M, 2010, INT J DEV BIOL, V54, P151, DOI 10.1387/ijdb.082790mt; Thouveny Y, 1998, CELLULAR AND MOLECULAR BASIS OF REGENERATION: FROM INVERTEBRATES TO HUMANS, P9; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Weisblat DA, 2006, CURR BIOL, V16, pR453, DOI 10.1016/j.cub.2006.05.034; Yoshida-Noro C, 2010, DEV GROWTH DIFFER, V52, P43, DOI 10.1111/j.1440-169X.2009.01149.x	35	18	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37319	10.1371/journal.pone.0037319	http://dx.doi.org/10.1371/journal.pone.0037319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615975	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300101
J	Pimentel, C; Vicente, C; Menezes, RA; Caetano, S; Carreto, L; Rodrigues-Pousada, C				Pimentel, Catarina; Vicente, Cristina; Menezes, Regina Andrade; Caetano, Soraia; Carreto, Laura; Rodrigues-Pousada, Claudina			The Role of the Yap5 Transcription Factor in Remodeling Gene Expression in Response to Fe Bioavailability	PLOS ONE			English	Article							VACUOLAR IRON STORAGE; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; YEAST; DEPRIVATION; ADAPTATION; METABOLISM; AFT1; LOCALIZATION; DEFICIENCY	The budding yeast Saccharomyces cerevisiae has developed several mechanisms to avoid either the drastic consequences of iron deprivation or the toxic effects of iron excess. In this work, we analysed the global gene expression changes occurring in yeast cells undergoing iron overload. Several genes directly or indirectly involved in iron homeostasis showed altered expression and the relevance of these changes are discussed. Microarray analyses were also performed to identify new targets of the iron responsive factor Yap5. Besides the iron vacuolar transporter CCC1, Yap5 also controls the expression of glutaredoxin GRX4, previously known to be involved in the regulation of Aft1 nuclear localization. Consistently, we show that in the absence of Yap5 Aft1 nuclear exclusion is slightly impaired. These studies provide further evidence that cells control iron homeostasis by using multiple pathways.	[Pimentel, Catarina; Vicente, Cristina; Menezes, Regina Andrade; Caetano, Soraia; Rodrigues-Pousada, Claudina] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Carreto, Laura] Univ Aveiro, Dept Biol, Ctr Environm & Marine Studies, P-3800 Aveiro, Portugal	Universidade Nova de Lisboa; Universidade de Aveiro	Pimentel, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	claudina@itqb.unl.pt	Echaniz, Regina Menezes/AAE-8041-2020; Menezes Echaniz, Regina/L-3792-2014; Pimentel, Catarina/G-2821-2014; Vicente, Cristina/ABD-3690-2020	Menezes Echaniz, Regina/0000-0003-0552-8480; Teixeira Vicente, Cristina/0000-0002-7882-9543; Caetano, Soraia/0000-0001-7427-5670; Pimentel, Catarina/0000-0002-5158-6414; Rodrigues-Pousada, Claudina/0000-0002-5075-3639	Fundacao Ciencia e Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC-BIA-MIC/108747/2008, SFRH/BPD/35052/2007, SFRH/BPD/26506/2006]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIC/108747/2008] Funding Source: FCT	Fundacao Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by Fundacao Ciencia e Tecnologia (FCT-http://www.fct.pt), through the projects PEst-OE/EQB/LA0004/2011 and PTDC-BIA-MIC/108747/2008 to CRP, and grants SFRH/BPD/35052/2007 (to CP) and SFRH/BPD/26506/2006 (to RAM). The DNA microarrays analyses were supported by the National Facility for DNA Microarrays (NFDM) located at the University of Aveiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertinato J, 2003, J BIOL CHEM, V278, P35071, DOI 10.1074/jbc.M302242200; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Darshan D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001687; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Ihrig J, 2010, EUKARYOT CELL, V9, P460, DOI 10.1128/EC.00213-09; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Menezes RA, 2004, FEBS LETT, V566, P141, DOI 10.1016/j.febslet.2004.04.019; Menezes RA, 2008, BIOCHEM J, V414, P301, DOI 10.1042/BJ20071537; Mockli N, 2004, BIOTECHNIQUES, V36, P872; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nevitt T, 2011, BIOMETALS; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Simon R, 2007, CANCER INFORM, V3, P11; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	49	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37434	10.1371/journal.pone.0037434	http://dx.doi.org/10.1371/journal.pone.0037434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616008	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300114
J	Sukati, S; Svasti, S; Stifanese, R; Averna, M; Panutdaporn, N; Penglong, T; Melloni, E; Fucharoen, S; Katzenmeier, G				Sukati, Suriyan; Svasti, Saovaros; Stifanese, Roberto; Averna, Monica; Panutdaporn, Nantika; Penglong, Tipparat; Melloni, Edon; Fucharoen, Suthat; Katzenmeier, Gerd			Clinical Severity of beta-thalassaemia/Hb E Disease Is Associated with Differential Activities of the Calpain-Calpastatin Proteolytic System	PLOS ONE			English	Article							RAT-BRAIN; THALASSEMIA; HEMOGLOBIN; PROTEINASE; APOPTOSIS; CELLS; MODULATION; DIVERSITY; PROTEASE; ERYTHROPOIESIS	Earlier observations in the literature suggest that proteolytic degradation of excess unmatched alpha-globin chains reduces their accumulation and precipitation in beta-thalassaemia erythroid precursor cells and have linked this proteolytic degradation to the activity of calpain protease. The aim of this study was to correlate the activity of calpain and its inhibitor, calpastatin, with different degrees of disease severity in b-thalassaemia. CD34(+) cells were enriched from peripheral blood of healthy individuals (control group) and patients with mild and severe clinical presentations of beta(0)-thalassaemia/Hb E disease. By ex vivo cultivation promoting erythroid cell differentiation for 7 days, proerythroblasts, were employed for the functional characterization of the calpain-calpastatin proteolytic system. In comparison to the control group, enzymatic activity and protein amounts of mu-calpain were found to be more than 3-fold increased in proerythroblasts from patients with mild clinical symptoms, whereas no significant difference was observed in patients with severe clinical symptoms. Furthermore, a 1.6-fold decrease of calpastatin activity and 3.2-fold accumulation of a 34 kDa calpain-mediated degradation product of calpastatin were observed in patients with mild clinical symptoms. The increased activity of calpain may be involved in the removal of excess alpha-globin chains contributing to a lower degree of disease severity in patients with mild clinical symptoms.	[Sukati, Suriyan; Svasti, Saovaros; Panutdaporn, Nantika; Penglong, Tipparat; Fucharoen, Suthat; Katzenmeier, Gerd] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand; [Svasti, Saovaros] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Stifanese, Roberto; Averna, Monica; Melloni, Edon] Univ Genoa, Biochem Sect, Dept Expt Med DI ME S, Genoa, Italy; [Stifanese, Roberto; Averna, Monica; Melloni, Edon] Univ Genoa, Ctr Excellence Biomed Res CEBR, Genoa, Italy	Mahidol University; Mahidol University; University of Genoa; University of Genoa	Sukati, S (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus, Nakhon Pathom, Thailand.	frkgz@mahidol.ac.th	AVERNA, MONICA/R-5719-2019; Svasti, Saovaros/AAH-6111-2020	AVERNA, MONICA/0000-0002-9463-7533; svasti, saovaros/0000-0001-8334-9838	National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection; Office Of The Higher Education Commission; Mahidol University under the National Research University Initiative; Ministero dell'Istruzione dell'Universita e della Ricerca; University of Genoa, Italy; Thailand Research Fund (TRF) [PhD/0193/2549]	National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection; Office Of The Higher Education Commission; Mahidol University under the National Research University Initiative; Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Genoa, Italy; Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This work was partially supported by a research team strengthening grant ("Disease Modifier Genes in Thalassaemia") from the National Science and Technology Development Agency of Thailand (NSTDA) under the BIOTEC subsection, the Office Of The Higher Education Commission and Mahidol University under the National Research University Initiative, and in part by grants from Ministero dell'Istruzione dell'Universita e della Ricerca (PRIN 2008, to EM), and from the University of Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Sandro Pontremoli, Department of Experimental Medicine (DI.ME.S.), Biochemistry Section, and Centre of Excellence for Biomedical Research (C.E.B.R), University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy, for his helpful suggestions and critical review of the manuscript. We thank Dr. Pranee Fucharoen, Thalassaemia Research Center, Institute of Molecular Biosciences, Mahidol University, for useful advice and intensive discussions. We would like to thank Dr. Roberta De Tullio for valuable advice with the calpastatin activity assay, for preparation, characterization and supply of the rat brain recombinant calpastatin RNCAST300 and Dr. Marco Pedrazzi from the Department of Experimental Medicine (DI.ME.S.), Biochemistry Section, and Centre of Excellence for Biomedical Research (C.E.B.R), University of Genoa, Viale Benedetto XV, 1-16132 Genoa, Italy, for help with the cell culture. A Royal Golden Jubilee PhD scholarship (PhD/0193/2549) from the Thailand Research Fund (TRF) to Suriyan Sukati is gratefully acknowledged.	Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bajaj G, 2006, BIOCHEM BIOPH RES CO, V345, P1558, DOI 10.1016/j.bbrc.2006.05.059; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Choi I, 2000, BLOOD, V95, P3742; Chong SS, 2000, CLIN CHEM, V46, P1692; CLEGG JB, 1972, NATURE-NEW BIOL, V240, P190, DOI 10.1038/newbio240190a0; De Tullio R, 2000, FEBS LETT, V475, P17, DOI 10.1016/S0014-5793(00)01613-6; Fucharoen S, 1998, ANN NY ACAD SCI, V850, P412, DOI 10.1111/j.1749-6632.1998.tb10507.x; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Loukopoulos D, 1980, Ann N Y Acad Sci, V344, P323, DOI 10.1111/j.1749-6632.1980.tb33672.x; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Macotpet G, 1987, Birth Defects Orig Artic Ser, V23, P257; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; Melloni E, 2000, BIOCHEM BIOPH RES CO, V272, P472, DOI 10.1006/bbrc.2000.2796; MELLONI E, 1984, BIOCHIM BIOPHYS ACTA, V788, P11, DOI 10.1016/0167-4838(84)90291-7; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; MURAKAMI T, 1981, J BIOCHEM-TOKYO, V90, P1809, DOI 10.1093/oxfordjournals.jbchem.a133659; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Olivieri NF, 2010, HEMATOL ONCOL CLIN N, V24, P1055, DOI 10.1016/j.hoc.2010.08.008; PONTREMOLI S, 1984, P NATL ACAD SCI-BIOL, V81, P6714, DOI 10.1073/pnas.81.21.6714; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; PONTREMOLI S, 1988, P NATL ACAD SCI USA, V85, P1740, DOI 10.1073/pnas.85.6.1740; Pootrakul P, 2000, BLOOD, V96, P2606, DOI 10.1182/blood.V96.7.2606.h8002606_2606_2612; Promboon A, 1987, Birth Defects Orig Artic Ser, V23, P249; Salamino F, 1997, FEBS LETT, V412, P433, DOI 10.1016/S0014-5793(97)00819-3; SCHWARZBENMEIR N, 1994, BIOCHEM J, V304, P365, DOI 10.1042/bj3040365; Shaeffer JR, 1997, BLOOD, V90, P1300, DOI 10.1182/blood.V90.3.1300.1300_1300_1308; Sherva R, BMC MED GENET, V11, P51; SPARATORE B, 1994, EUR J BIOCHEM, V225, P173, DOI 10.1111/j.1432-1033.1994.00173.x; Sripichai O, 2008, AM J HEMATOL, V83, P482, DOI 10.1002/ajh.21130; Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674; TAKANO E, 1993, ARCH BIOCHEM BIOPHYS, V303, P349, DOI 10.1006/abbi.1993.1294; Thein SL, 2004, BRIT J HAEMATOL, V124, P264, DOI 10.1046/j.1365-2141.2003.04769.x; Thein SL, 1998, BAILLIERE CLIN HAEM, V11, P91, DOI 10.1016/S0950-3536(98)80071-1; Thompson VF, 2000, METH MOL B, V144, P3; TULLIO RD, 1999, BIOCHEM J, V343, P467; Wannatung T, 2009, BRIT J HAEMATOL, V146, P557, DOI 10.1111/j.1365-2141.2009.07794.x; WASI P, 1985, ANN NY ACAD SCI, V445, P119, DOI 10.1111/j.1749-6632.1985.tb17181.x; WOOD WG, 1975, J CLIN INVEST, V55, P567, DOI 10.1172/JCI107964; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; YAMATO S, 1983, BIOCHEM BIOPH RES CO, V115, P715, DOI 10.1016/S0006-291X(83)80203-4	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37133	10.1371/journal.pone.0037133	http://dx.doi.org/10.1371/journal.pone.0037133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615919	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300077
J	Weston, DJ; Adams, NM; Russell, RA; Stephens, DA; Freemont, PS				Weston, David J.; Adams, Niall M.; Russell, Richard A.; Stephens, David A.; Freemont, Paul S.			Analysis of Spatial Point Patterns in Nuclear Biology	PLOS ONE			English	Article							IMAGES	There is considerable interest in cell biology in determining whether, and to what extent, the spatial arrangement of nuclear objects affects nuclear function. A common approach to address this issue involves analyzing a collection of images produced using some form of fluorescence microscopy. We assume that these images have been successfully pre-processed and a spatial point pattern representation of the objects of interest within the nuclear boundary is available. Typically in these scenarios, the number of objects per nucleus is low, which has consequences on the ability of standard analysis procedures to demonstrate the existence of spatial preference in the pattern. There are broadly two common approaches to look for structure in these spatial point patterns. First a spatial point pattern for each image is analyzed individually, or second a simple normalization is performed and the patterns are aggregated. In this paper we demonstrate using synthetic spatial point patterns drawn from predefined point processes how difficult it is to distinguish a pattern from complete spatial randomness using these techniques and hence how easy it is to miss interesting spatial preferences in the arrangement of nuclear objects. The impact of this problem is also illustrated on data related to the configuration of PML nuclear bodies in mammalian fibroblast cells.	[Weston, David J.; Adams, Niall M.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Adams, Niall M.] Univ Bristol, Heilbronn Inst Math Res, Bristol, Avon, England; [Russell, Richard A.] Fdn Trust, Moorfields Eye Hosp NHS, NIHR Biomed Res Ctr Ophthalmol, London, England; [Russell, Richard A.] UCL Inst Ophthalmol, London, England; [Stephens, David A.] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; McGill University; Imperial College London	Weston, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England.	david.weston@imperial.ac.uk		Stephens, David/0000-0001-9811-7140; Freemont, Paul/0000-0002-5658-8486	Biotechnology and Biological Sciences Research Council [BB/H013423/1]; BBSRC [BB/H013423/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by Biotechnology and Biological Sciences Research Council, grant number BB/H013423/1, http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NM, 2010, ADV NUCL ARCHITECTUR; Andrey P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000853; BADDELEY AJ, 1993, J R STAT SOC C-APPL, V42, P641; BARTHOLDI MF, 1991, J CELL SCI, V99, P255; Batty E, 2009, FRONT BIOSCI-LANDMRK, V14, P1182, DOI 10.2741/3302; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; CLARK RF, 1991, GENE EXPRESSION, V1, P61; Diggle P., 2003, STAT ANAL SPATIAL PO; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Grabarnik P, 2011, ECOL MODEL, V222, P3888, DOI 10.1016/j.ecolmodel.2011.10.005; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lehmussola A, 2007, IEEE T MED IMAGING, V26, P1010, DOI 10.1109/TMI.2007.896925; McManus KJ, 2006, PLOS COMPUT BIOL, V2, P1271, DOI 10.1371/journal.pcbi.0020139; Muller M, 2005, INTRO CONFOCAL FLUOR; Nagele RG, 1999, J CELL SCI, V112, P525; Parreira L, 1997, HUM GENET, V100, P588, DOI 10.1007/s004390050558; Peng T, 2011, CYTOM PART A, V79A, P383, DOI 10.1002/cyto.a.21066; Russell RA, 2009, THESIS DEP MATH IMPE; Russell RA, 2011, ADVANCES IN NUCLEAR ARCHITECTURE, P173, DOI 10.1007/978-90-481-9899-3_6; Russell RA, 2009, BIOPHYS J, V96, P3379, DOI 10.1016/j.bpj.2008.12.3956; Salsman J, 2011, VIROLOGY, V414, P119, DOI 10.1016/j.virol.2011.03.013; Shiels C, 2007, PLOS COMPUT BIOL, V3, P1161, DOI 10.1371/journal.pcbi.0030138; Stoyan D., 1994, METHODS GEOMETRICAL; Umande PP, 2011, ADVANCES IN NUCLEAR ARCHITECTURE, P59, DOI 10.1007/978-90-481-9899-3_2; Webster S, 2006, LECT NOTES STAT, P197; Xing YG, 1995, J CELL BIOL, V131, P1635, DOI 10.1083/jcb.131.6.1635	27	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36841	10.1371/journal.pone.0036841	http://dx.doi.org/10.1371/journal.pone.0036841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615822	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300032
J	Greenberg, J; Reiner, K; Meiran, N				Greenberg, Jonathan; Reiner, Keren; Meiran, Nachshon			"Mind the Trap'': Mindfulness Practice Reduces Cognitive Rigidity	PLOS ONE			English	Article							THERAPY; MEDITATION; DISORDER; TASK; ADOLESCENTS; DEPRESSION; CHILDREN	Two experiments examined the relation between mindfulness practice and cognitive rigidity by using a variation of the Einstellung water jar task. Participants were required to use three hypothetical jars to obtain a specific amount of water. Initial problems were solvable by the same complex formula, but in later problems ("critical'' or "trap'' problems) solving was possible by an additional much simpler formula. A rigidity score was compiled through perseverance of the complex formula. In Experiment 1, experienced mindfulness meditators received significantly lower rigidity scores than non-meditators who had registered for their first meditation retreat. Similar results were obtained in randomized controlled Experiment 2 comparing non-meditators who underwent an eight meeting mindfulness program with a waiting list group. The authors conclude that mindfulness meditation reduces cognitive rigidity via the tendency to be "blinded'' by experience. Results are discussed in light of the benefits of mindfulness practice regarding a reduced tendency to overlook novel and adaptive ways of responding due to past experience, both in and out of the clinical setting.	[Greenberg, Jonathan; Reiner, Keren; Meiran, Nachshon] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Greenberg, J (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	greenbej@bgu.ac.il	MEIRAN, NACHSHON/F-1864-2012; Meiran, Nachshon/AAH-3546-2020	Greenberg, Jonathan/0000-0002-4875-2207	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	The work was partly supported by a research grant to the third author from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson ND, 2007, CLIN PSYCHOL PSYCHOT, V14, P449, DOI 10.1002/cpp.544; Beljan P., 2011, SPECIAL POPULATIONS, P317; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Cangemi J, 2007, J MANAG DEV, V26, P401, DOI 10.1108/02621710710748239; Cepeda NJ, 2000, J ABNORM CHILD PSYCH, V28, P213, DOI 10.1023/A:1005143419092; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Chiesa A, 2011, J CLIN PSYCHOL, V67, P404, DOI 10.1002/jclp.20776; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Clark AJ, 1998, J SPECIALISTS GROUP, V23, P66, DOI [DOI 10.1080/01933929808411382, 10.1080/01933929808411382]; Coleman D., 2011, International Journal of Men's Health, V10, P240, DOI 10.3149/jmh.1003.240; COWEN E, 1953, J CONSULT PSYCHOL, V17, P100; ELLIS TE, 1986, PROF PSYCHOL-RES PR, V17, P125, DOI 10.1037/0735-7028.17.2.125; EVERETT J, 1991, CHILD PSYCHIAT HUM D, V22, P79, DOI 10.1007/BF00707786; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FISCHER M, 1990, J CONSULT CLIN PSYCH, V58, P580, DOI 10.1037/0022-006X.58.5.580; Garland EL, 2010, J PSYCHOACTIVE DRUGS, V42, P177, DOI 10.1080/02791072.2010.10400690; GrossIsseroff R, 1996, BIOL PSYCHIAT, V39, P733, DOI 10.1016/0006-3223(95)00179-4; Grossman P, 2011, CONTEMP BUDDHISM, V12, P219, DOI 10.1080/14639947.2011.564841; Harrer M. E., 2009, CONT HYPNOSIS, V26, P234, DOI [10.1002/ch.v26:4, DOI 10.1002/ch.388, DOI 10.1002/CH.V26:4]; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Heeren A., 2011, MINDFULNESS, V2, P8, DOI [10.1007/s12671-010-0037-y, DOI 10.1007/S12671-010-0037-Y]; Heeren A, 2009, BEHAV RES THER, V47, P403, DOI 10.1016/j.brat.2009.01.017; Hodgins HS, 2010, CONSCIOUS COGN, V19, P872, DOI 10.1016/j.concog.2010.04.002; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kingston T, 2007, PSYCHOL PSYCHOTHER-T, V80, P193, DOI 10.1348/147608306X116016; Levenson M, 1974, PSYCHOL ASSESSMENT S, P150; Linehan M. M., 1993, COGNITIVE BEHAV TREA; Luchins AS, 1942, PSYCHOL MONOGR; Lutz A, 2007, CAMB HANDB PSYCHOL, P499; Meiran N, 2011, PSYCHIAT RES, V185, P149, DOI 10.1016/j.psychres.2010.04.044; Meiran N, 2010, J EXP PSYCHOL LEARN, V36, P992, DOI 10.1037/a0019761; Miklowitz DJ, 2009, INT J COGN THER, V2, P373, DOI 10.1521/ijct.2009.2.4.373; Miro M. Teresa, 2011, REV PSICOPATOLOGIA P, V16, P1; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Nelson TS, 2002, ANONYMOUS CLIN EPIPH, P50; Nevo B, 2003, HIGH ABIL STUD, V14, P185, DOI 10.1080/1359813032000163906; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Ramel W, 2004, COGNITIVE THER RES, V28, P433, DOI 10.1023/B:COTR.0000045557.15923.96; Rapgay L, 2009, ANN NY ACAD SCI, V1172, P148, DOI 10.1111/j.1749-6632.2009.04405.x; Roemer L, 2002, CLIN PSYCHOL-SCI PR, V9, P54, DOI 10.1093/clipsy/9.1.54; Rokeach M., 1960, OPEN CLOSED MIND; Schultz PW, 1998, PERS INDIV DIFFER, V24, P305, DOI 10.1016/S0191-8869(97)00179-7; Schultz PW, 2002, GENET SOC GEN PSYCH, V128, P165; Schwartz Jeffrey, 1996, BRAIN LOCK FREE YOUR; Segal Z. V., 2002, MINDFULNESS BASED CO; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; SHEARIN EN, 1994, INT J EAT DISORDER, V16, P187, DOI 10.1002/1098-108X(199409)16:2&lt;187::AID-EAT2260160210&gt;3.0.CO;2-U; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Steele CM, 1996, ANONYMOUS READINGS S, P74; SULLIVAN EV, 1993, PSYCHIAT RES, V46, P175, DOI 10.1016/0165-1781(93)90019-D; Wanden-Berghe Rocio Guardiola, 2011, Eat Disord, V19, P34, DOI 10.1080/10640266.2011.533604; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Wells A., 2005, J RATIONAL EMOTIVE C, V23, P337, DOI [10.1007/s10942-005-0018-6, DOI 10.1007/S10942-005-0018-6]; Wenk-Sormaz H, 2005, ADV MIND BODY MED, V11, P48; Wenk-Sormaz H., 2005, ADV MIND BODY; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; Williams MC, 1994, NEUROPSYCHOLOGY, V8, P187; Zeidan F, 2010, CONSCIOUS COGN, V19, P597, DOI 10.1016/j.concog.2010.03.014; Zgierska A, 2009, SUBST ABUS, V30, P266, DOI 10.1080/08897070903250019; Zohar AH, 1995, NEUROPSYCHIATRY NEUR; Zylowska L, 2008, J ATTEN DISORD, V11, P737, DOI 10.1177/1087054707308502	66	104	105	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36206	10.1371/journal.pone.0036206	http://dx.doi.org/10.1371/journal.pone.0036206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615758	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300009
J	Iriarte-Diaz, J; Riskin, DK; Breuer, KS; Swartz, SM				Iriarte-Diaz, Jose; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.			Kinematic Plasticity during Flight in Fruit Bats: Individual Variability in Response to Loading	PLOS ONE			English	Article							HOVERING PERFORMANCE; HUMMINGBIRD FLIGHT; TRAINED KESTRELS; WING KINEMATICS; FLAPPING FLIGHT; ENERGY-COST; BODY-MASS; MORPHOLOGY; AERODYNAMICS; MECHANICS	All bats experience daily and seasonal fluctuation in body mass. An increase in mass requires changes in flight kinematics to produce the extra lift necessary to compensate for increased weight. How bats modify their kinematics to increase lift, however, is not well understood. In this study, we investigated the effect of a 20% increase in mass on flight kinematics for Cynopterus brachyotis, the lesser dog-faced fruit bat. We reconstructed the 3D wing kinematics and how they changed with the additional mass. Bats showed a marked change in wing kinematics in response to loading, but changes varied among individuals. Each bat adjusted a different combination of kinematic parameters to increase lift, indicating that aerodynamic force generation can be modulated in multiple ways. Two main kinematic strategies were distinguished: bats either changed the motion of the wings by primarily increasing wingbeat frequency, or changed the configuration of the wings by increasing wing area and camber. The complex, individual-dependent response to increased loading in our bats points to an underappreciated aspect of locomotor control, in which the inherent complexity of the biomechanical system allows for kinematic plasticity. The kinematic plasticity and functional redundancy observed in bat flight can have evolutionary consequences, such as an increase potential for morphological and kinematic diversification due to weakened locomotor trade-offs.	[Iriarte-Diaz, Jose; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Iriarte-Diaz, Jose] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; University of Chicago; Brown University	Iriarte-Diaz, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	jiriarte@alumni.brown.edu	Iriarte-Diaz, Jose/A-2486-2008; Breuer, Kenneth/P-7753-2016; Swartz, Sharon/B-9309-2011	Iriarte-Diaz, Jose/0000-0003-3566-247X; Breuer, Kenneth/0000-0002-5122-2231; Swartz, Sharon/0000-0001-5762-7435; Riskin, Daniel K./0000-0001-8742-8509	Air Force Office of Scientific Research (AFOSR); National Science Foundation; Bushnell Foundation	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Bushnell Foundation	This work was supported by the Air Force Office of Scientific Research (AFOSR), the National Science Foundation-Information Technology Research program, and the Bushnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz Y.I., 1971, P ASP S CLOS RANG PH, P1; ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Altshuler DL, 2003, J EXP BIOL, V206, P3139, DOI 10.1242/jeb.00540; Altshuler DL, 2004, P NATL ACAD SCI USA, V101, P17731, DOI 10.1073/pnas.0405260101; Barclay RMR, 2003, BAT ECOLOGY, P209; BEASLEY LJ, 1984, AM J PHYSIOL, V246, pR955, DOI 10.1152/ajpregu.1984.246.6.R955; Bergou A. J., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P1618, DOI 10.1109/ICCVW.2011.6130443; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Bishop KL, 2008, J EXP ZOOL PART A, V309A, P225, DOI 10.1002/jez.447; Bishop KL, 2007, J EXP BIOL, V210, P2593, DOI 10.1242/jeb.002071; Bullen RD, 2002, J EXP BIOL, V205, P2615; Calsbeek R, 2008, EVOL ECOL RES, V10, P197; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Chai P, 1997, J EXP BIOL, V200, P2757; Chai P, 1996, J EXP BIOL, V199, P2285; Chai P, 1999, AM NAT, V153, P398, DOI 10.1086/303179; Chai P, 1997, J EXP BIOL, V200, P921; Crenshaw HC, 2000, J EXP BIOL, V203, P961; Dudley R, 1996, J EXP BIOL, V199, P1881; Dudley R, 2002, J EXP BIOL, V205, P3669; DUDLEY R, 1995, J EXP BIOL, V198, P1065; FUNAKOSHI K, 1981, Japanese Journal of Ecology, V31, P67; Hambly C, 2004, J EXP BIOL, V207, P3969, DOI 10.1242/jeb.01234; Hayes JP, 1997, J MAMMAL, V78, P274, DOI 10.2307/1382882; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Henningsson P, 2012, J R SOC INT IN PRESS; Holzman R, 2011, AM NAT, V177, pE69, DOI 10.1086/658366; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; HUGHES PM, 1991, J EXP BIOL, V161, P285; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Iriarte-Diaz J, 2006, J EXP BIOL, V209, P4061, DOI 10.1242/jeb.02473; Iriarte-Diaz J, 2011, J EXP BIOL, V214, P1546, DOI 10.1242/jeb.037804; JONES C, 1972, J ZOOL, V167, P353; JONES G, 1986, BEHAV ECOL SOCIOBIOL, V19, P179; Koehl MAR, 1996, ANNU REV ECOL SYST, V27, P501, DOI 10.1146/annurev.ecolsys.27.1.501; Krams I, 2002, BEHAV ECOL SOCIOBIOL, V51, P345, DOI 10.1007/s00265-002-0452-8; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; KURTA A, 1987, S ZOOL SOC LOND, V57, P79; MacAyeal LC, 2011, J EXP BIOL, V214, P786, DOI 10.1242/jeb.050195; Miller KA, 2010, BIOL J LINN SOC, V99, P241, DOI 10.1111/j.1095-8312.2009.01364.x; NORBERG UM, 1976, J EXP BIOL, V65, P179; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; SPEAKMAN JR, 1987, RECENT ADV STUDY BAT, P367; Sterbing-D'Angelo S, 2011, P NATL ACAD SCI USA, V108, P11291, DOI 10.1073/pnas.1018740108; Swartz Sharon M., 2005, P110; Swartz Sharon M., 1998, P109; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; Toro E, 2004, AM NAT, V163, P844, DOI 10.1086/386347; TSUTAKAWA RK, 1977, BIOMETRICS, V33, P215; VIDELER JJ, 1988, J EXP BIOL, V134, P173; VIDELER JJ, 1988, J EXP BIOL, V134, P185; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Walker SM, 2010, J R SOC INTERFACE, V7, P131, DOI 10.1098/rsif.2009.0120; Walker SM, 2012, J R SOC INT IN PRESS; WilSon d.m., 2005, MAMMALS SPECIES WORL, V3rd; WIMSATT WA, 1969, J MAMMAL, V50, P233, DOI 10.2307/1378339; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Winter Y, 1999, J EXP BIOL, V202, P1917; Winter Y, 1998, J COMP PHYSIOL B, V168, P105, DOI 10.1007/s003600050126; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777; Zook J.M., 2007, P215; Zook J.M., 1986, MYOTIS, V23, P31	68	21	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36665	10.1371/journal.pone.0036665	http://dx.doi.org/10.1371/journal.pone.0036665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615790	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300026
J	Lahuerta, M; Lima, J; Nuwagaba-Biribonwoha, H; Okamura, M; Alvim, MF; Fernandes, R; Assan, A; Hoos, D; Elul, B; El-Sadr, WM; Nash, D				Lahuerta, Maria; Lima, Josue; Nuwagaba-Biribonwoha, Harriet; Okamura, Mie; Alvim, Maria Fernanda; Fernandes, Rufino; Assan, Americo; Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis			Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique	PLOS ONE			English	Article							RAPID SCALE-UP; CELL COUNT; TREATMENT SERVICE; RANDOMIZED-TRIAL; EARLY MORTALITY; ANTENATAL CARE; SOUTH-AFRICA; LOW-INCOME; HIV CARE; PROGRAM	Background: Despite recent changes to expand the ART eligibility criteria in sub-Saharan Africa, many patients still initiate ART in the advanced stages of HIV infection, which contributes to increased early mortality rates, poor patient outcomes, and onward transmission. Methods: To evaluate individual and clinic-level factors associated with late ART initiation in Mozambique, we conducted a retrospective sex-specific analysis of data from 36,411 adult patients who started ART between January 2005 and June 2009 at 25 HIV clinics in Mozambique. Late ART initiation was defined as CD4 count<100 cells/mu L or WHO stage IV. Mixed effects models were used to identify patient- and clinic-level factors associated with late ART initiation. Results: The proportion of patients initiating ART late decreased from 46% to 37% during 2005-2007, but remained constant (between 37-33%) from 2007-2009. Of those who initiated ART late (median CD4 = 57 cells/mu L), 5% were known to have died and 54% were lost to clinic within 6 months of ART initiation (compared with 2% and 47% among other patients starting ART [median CD4 = 192 cells/mu L]). In multivariate analysis, female sex and pregnancy at ART initiation (AOR(female_not_pregnant_vs._male) = 0.66, 95%CI [0.62-0.69]; AOR(pregnant_vs._non_pregnant) = 0.60, 95%CI [0.49-0.73]), younger and older age (AOR(15-25_vs.26-30) = 0.86, 95%CI [0.79-0.94], AOR(>45_vs.26-30) = 0.72, 95%CI [0.67-0.77]), entry into care via PMTCT (AOR(entry_through_PMTCT_vs.VCT) = 0.42, 95%CI [0.35-0.50]), marital status (AOR(married/in_union_vs.single) = 0.87, 95%CI [0.83-0.92]), education (AOR(secondary_or_higher_vs.primary) = 0.87, 95%CI [0.83-0.93]) and year of ART initiation were associated with a lower likelihood of late ART initiation. Clinic-level factors independently associated with a lower likelihood of late ART initiation included CD4 machine on-site (AOR(CD4_machine_onsite_vs.offsite) = 0.83, 95%CI [0.74-0.94]) and presence of PMTCT services onsite (AOR = 0.85, 95%CI [0.77-0.93]). Conclusion:: The risk of starting ART late remained persistently high. Efforts are needed to ensure identification and enrollment of patients at earlier stages of HIV disease. Individual and clinic level factors identified may provide clues for upstream structural interventions.	[Lahuerta, Maria; Nuwagaba-Biribonwoha, Harriet; Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis] ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Lima, Josue; Okamura, Mie; Alvim, Maria Fernanda; Fernandes, Rufino] ICAP Columbia Univ, Mailman Sch Publ Hlth, Maputo, Mozambique; [Assan, Americo] Minist Hlth, Maputo, Mozambique; [Hoos, David; Elul, Batya; El-Sadr, Wafaa M.; Nash, Denis] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University	Lahuerta, M (corresponding author), ICAP Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.	ml2842@columbia.edu	Nash, Denis/AFI-7485-2022	Nash, Denis/0000-0002-3280-5386	President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention; Doris Duke Charitable Foundation; Operations Research on AIDS Care and Treatment in Africa (ORACTA) program; National Institute of Mental Health [R01MH089831]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH089831] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Operations Research on AIDS Care and Treatment in Africa (ORACTA) program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by The President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention, the Doris Duke Charitable Foundation, Operations Research on AIDS Care and Treatment in Africa (ORACTA) program and by a research grant from the National Institute of Mental Health (Award Number R01MH089831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, STUD FAMILY PLANN, V38, P135; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Central Statistical Office Harare Zimbabwe, 2007, ZIMB DEM HLTH SURV 2; Central Statistical Office Mbabane, 2007, SWAZ DEM HLTH SURV 2; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Colebunders R, 2005, CLIN INFECT DIS, V41, P386, DOI 10.1086/431490; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Institut National de la Statistique du Rwanda (INSR) and ORC Macro, 2006, RWAND DEM HLTH SURV; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kenya Central Bureau of Statistics Ministry of Planning & National Development, 2003, KEN DEM HLTH SURV 20; Kigozi IM, 2009, J ACQUIR IMMUNE DEFI; Lahuerta M, 2011, JAIDS-J ACQ IMM DEF, V58, pE75, DOI 10.1097/QAI.0b013e31822ac0a9; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lugada E, 2010, J ACQUIR IMMUNE DEFI; MISAU, 2008, DEM IMP HIV AIDS MOZ; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Mozambique Ministry of Health (MISAU), 2010, INSIDA INQ NAC PREV; Mozambique Ministry of Health (MISAU), 2006, GUID ANT OPP INF TRE; Mozambique Ministry of Health (MISAU), 2010, GUID ANT OPP INF TRE; Mozambique Ministry of Health National ART, MOZ MIN HLTH NAT ART; Mozambique Ministry of Health National ART Data for Jul, 2010, MOZ MIN HLTH NAT ART; Mtapuri-Zinyowera S, J ACQUIR IMMUNE DEFI; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; National Bureau of Statistics Dar es Salaam Tanzania, 2005, TANZ DEM HLTH SURV 2; National Population Commission (NPC) [Nigeria] and ORC Macro, 2004, NIG DEM HLTH SURV 20; National Statistical Office (NSO) [Malawi] and ORC Macro, 2005, MAL DEM HLTH SURV 20; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UBOS, 2007, UG DEM HLTH SURV 200; [UNAIDS WHO], 2010, REP GLOB AIDS EP 201; United Nations General Assembly Special Session on HIV and AIDS, 2010, UN GEN ASS SPEC SESS; Van der Borght SF, 2010, AIDS CARE, V22, P195, DOI 10.1080/09540120903111486; Vermund SH, 2011, J ACQUIR IMMUNE DEFI, V58; Welty TK, 2005, JAIDS-J ACQ IMM DEF, V40, P486, DOI 10.1097/01.qai.0000163196.36199.89; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2010, ANT THER HIV INF INF	60	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37125	10.1371/journal.pone.0037125	http://dx.doi.org/10.1371/journal.pone.0037125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615917	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300073
J	Lalis, A; Leblois, R; Lecompte, E; Denys, C; ter Meulen, J; Wirth, T				Lalis, Aude; Leblois, Raphael; Lecompte, Emilie; Denys, Christiane; ter Meulen, Jan; Wirth, Thierry			The Impact of Human Conflict on the Genetics of Mastomys natalensis and Lassa Virus in West Africa	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; EMERGING INFECTIOUS-DISEASES; SIERRA-LEONE; POPULATION-STRUCTURE; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; EQUATORIAL-GUINEA; SIBSHIP INFERENCE; FEVER; SEQUENCES	Environmental changes have been shown to play an important role in the emergence of new human diseases of zoonotic origin. The contribution of social factors to their spread, especially conflicts followed by mass movement of populations, has not been extensively investigated. Here we reveal the effects of civil war on the phylogeography of a zoonotic emerging infectious disease by concomitantly studying the population structure, evolution and demography of Lassa virus and its natural reservoir, the rodent Mastomys natalensis, in Guinea, West Africa. Analysis of nucleoprotein gene sequences enabled us to reconstruct the evolutionary history of Lassa virus, which appeared 750 to 900 years ago in Nigeria and only recently spread across western Africa (170 years ago). Bayesian demographic inferences revealed that both the host and the virus populations have gone recently through severe genetic bottlenecks. The timing of these events matches civil war-related mass movements of refugees and accompanying environmental degradation. Forest and habitat destruction and human predation of the natural reservoir are likely explanations for the sharp decline observed in the rodent populations, the consequent virus population decline, and the coincident increased incidence of Lassa fever in these regions. Interestingly, we were also able to detect a similar pattern in Nigeria coinciding with the Biafra war. Our findings show that anthropogenic factors may profoundly impact the population genetics of a virus and its reservoir within the context of an emerging infectious disease.	[Lalis, Aude; Leblois, Raphael; Denys, Christiane; Wirth, Thierry] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Leblois, Raphael] Ctr Biol & Gest Populat, Montferrier Sur Lez, France; [Lecompte, Emilie] Lab Evolut & Diver Biol, Toulouse, France; [Lecompte, Emilie; ter Meulen, Jan] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Wirth, Thierry] Ecole Prat Hautes Etud, Lab Biol Integrat Populat, Paris, France	Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); Philipps University Marburg; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Lalis, A (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France.	wirth@mnhn.fr	Denys, Christiane/K-8144-2019; Lecompte, Emilie/AAG-7081-2020; Leblois, Raphael/A-8815-2008; Wirth, Thierry/B-4915-2008	Denys, Christiane/0000-0002-1519-1546; Leblois, Raphael/0000-0002-3051-4497; Wirth, Thierry/0000-0002-7371-0172	European Community (INCO-DEV) [ICA-CT2002-10050]; European Community [MEIF-CT2003-506686]; Howard Hughes Medical Institute	European Community (INCO-DEV)(European Commission); European Community(European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by the European Community (INCO-DEV grant ICA-CT2002-10050), a Marie Curie Intra-European fellowship within the 6th European Community Framework Programme (no. MEIF-CT2003-506686), and the Howard Hughes Medical Institute. The authors are particularly indebted to the "Projet de Recherches sur les Fievres Hemorragiques en Guinee" for their contribution in the fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 1999, GENETICS, V153, P2013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biek R, 2006, SCIENCE, V311, P538, DOI 10.1126/science.1121360; Bonner PC, 2007, AM J TROP MED HYG, V77, P169, DOI 10.4269/ajtmh.2007.77.169; Bowen MD, 2000, J VIROL, V74, P6992, DOI 10.1128/JVI.74.15.6992-7004.2000; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; DEMARTINI JC, 1975, B WORLD HEALTH ORGAN, V52, P651; Demby AH, 2001, VECTOR-BORNE ZOONOT, V1, P283, DOI 10.1089/15303660160025912; Denys C, 2009, ITAL J ZOOL, V76, P111, DOI 10.1080/11250000802616817; DIETRICH W, 1992, GENETICS, V131, P423; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; Gayer M, 2007, EMERG INFECT DIS, V13, P1625, DOI 10.3201/eid1311.061093; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes E, 2003, J GEN VIROL, V84, P2691, DOI 10.1099/vir.0.19277-0; Hood GM, POPTOOLS VERSION 3 2; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; LUKASHEVICH IS, 1993, J MED VIROL, V40, P210, DOI 10.1002/jmv.1890400308; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MCCORMICK JB, 1987, CURR TOP MICROBIOL, V134, P69; MCCORMICK JB, 1987, J INFECT DIS, V155, P445, DOI 10.1093/infdis/155.3.445; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; NEI M, 1978, GENETICS, V89, P583; Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SERIKAWA T, 1992, GENETICS, V131, P701; STEPHENSON EH, 1984, J MED VIROL, V14, P295, DOI 10.1002/jmv.1890140402; Storz JF, 2002, MOL BIOL EVOL, V19, P1981, DOI 10.1093/oxfordjournals.molbev.a004022; terMeulen J, 1996, AM J TROP MED HYG, V55, P661; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	52	30	31	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37068	10.1371/journal.pone.0037068	http://dx.doi.org/10.1371/journal.pone.0037068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615894	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300066
J	Dutka, TL; Verburg, E; Larkins, N; Hortemo, KH; Lunde, PK; Sejersted, OM; Lamb, GD				Dutka, Travis L.; Verburg, Esther; Larkins, Noni; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.; Lamb, Graham D.			ROS-Mediated Decline in Maximum Ca2+-Activated Force in Rat Skeletal Muscle Fibers following In Vitro and In Vivo Stimulation	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; NITRIC-OXIDE; CONTRACTILE APPARATUS; HYDROGEN-PEROXIDE; SARCOPLASMIC-RETICULUM; S-NITROSOGLUTATHIONE; CELLULAR MECHANISMS; CALCIUM SENSITIVITY; ISOFORM COMPOSITION; REACTIVE OXYGEN	We hypothesised that normal skeletal muscle stimulated intensely either in vitro or in situ would exhibit reactive oxygen species (ROS)-mediated contractile apparatus changes common to many pathophysiological conditions. Isolated soleus (SOL) and extensor digitorum longus (EDL) muscles of the rat were bubbled with 95% O-2 and stimulated in vitro at 31 degrees C to give isometric tetani (50 Hz for 0.5 s every 2 s) until maximum force declined to <= 30%. Skinned superficial slow-twitch fibers from the SOL muscles displayed a large reduction (similar to 41%) in maximum Ca2+-activated specific force (F-max), with Ca2+-sensitivity unchanged. Fibers from EDL muscles were less affected. The decrease in F-max in SOL fibers was evidently due to oxidation effects on cysteine residues because it was reversed if the reducing agent DTT was applied prior to activating the fiber. The GSH:GSSG ratio was similar to 3-fold lower in the cytoplasm of superficial fibers from stimulated muscle compared to control, confirming increased oxidant levels. The presence of Tempol and L-NAME during in vitro stimulation prevented reduction in F-max. Skinned fibers from SOL muscles stimulated in vivo at 37 degrees C with intact blood supply also displayed reduction in F-max, though to a much smaller extent (similar to 12%). Thus, fibers from muscles stimulated even with putatively adequate O-2 supply display a reversible oxidation-induced decrease in F-max without change in Ca2+-sensitivity, consistent with action of peroxynitrite (or possibly superoxide) on cysteine residues of the contractile apparatus. Significantly, the changes closely resemble the contractile deficits observed in a range of pathophysiological conditions. These findings highlight how readily muscle experiences ROS-related deficits, and also point to potential difficulties when defining muscle performance and fatigue.	[Dutka, Travis L.; Larkins, Noni; Lamb, Graham D.] La Trobe Univ, Dept Zool, Melbourne, Vic, Australia; [Verburg, Esther; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.] Univ Oslo, Expt Med Res Inst, Oslo, Norway; [Verburg, Esther; Hortemo, Kristin H.; Lunde, Per K.; Sejersted, Ole M.] Oslo Univ Hosp, Oslo, Norway	La Trobe University; University of Oslo; University of Oslo	Dutka, TL (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic, Australia.	t.dutka@latrobe.edu.au	Dutka, Travis/AAD-3644-2020		National Health and Medical Research Council of Australia [541938]; South-Eastern Norway Regional Health Authority; Anders Jahre's Fund for the Promotion of Science	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); South-Eastern Norway Regional Health Authority; Anders Jahre's Fund for the Promotion of Science	This project was supported and funded by the National Health and Medical Research Council of Australia (grant number 541938), the South-Eastern Norway Regional Health Authority and Anders Jahre's Fund for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BW, 2009, J APPL PHYSIOL, V106, P662, DOI 10.1152/japplphysiol.91109.2008; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P577, DOI 10.1111/j.1469-7793.1998.577bn.x; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; Bortolotto SK, 2000, AM J PHYSIOL-CELL PH, V279, pC1564, DOI 10.1152/ajpcell.2000.279.5.C1564; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; Callahan LA, 2001, AM J RESP CELL MOL, V24, P210, DOI 10.1165/ajrcmb.24.2.4075; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dutka TL, 2011, J PHYSIOL-LONDON, V589, P2181, DOI 10.1113/jphysiol.2010.200451; Dutka TL, 2011, J APPL PHYSIOL, V110, P705, DOI 10.1152/japplphysiol.00739.2010; Edwards JN, 2007, AM J PHYSIOL-CELL PH, V293, pC650, DOI 10.1152/ajpcell.00037.2007; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Ferreira LF, 2008, J APPL PHYSIOL, V104, P853, DOI 10.1152/japplphysiol.00953.2007; Frueh BR, 2001, J NEUROPHYSIOL, V85, P1027, DOI 10.1152/jn.2001.85.3.1027; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Halliwell B., 2007, FREE RADICALS BIOL M; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Hertelendi Z, 2009, J CELL MOL MED, V13, P2200, DOI 10.1111/j.1582-4934.2008.00445.x; Heunks LMA, 2001, J APPL PHYSIOL, V91, P2233, DOI 10.1152/jappl.2001.91.5.2233; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; JI LL, 1992, J APPL PHYSIOL, V73, P1854, DOI 10.1152/jappl.1992.73.5.1854; Lamb GD, 2003, J PHYSIOL-LONDON, V546, P149, DOI 10.1113/jphysiol.2002.027896; Lanone S, 2000, AM J RESP CRIT CARE, V162, P2308, DOI 10.1164/ajrccm.162.6.2001097; Lunde PK, 2006, CIRC RES, V98, P1514, DOI 10.1161/01.RES.0000226529.66545.e5; MACFARLANE NG, 1992, CIRC RES, V70, P1217, DOI 10.1161/01.RES.70.6.1217; Mihm MJ, 2001, CIRCULATION, V104, P174, DOI 10.1161/01.CIR.104.2.174; Murphy RM, 2008, J PHYSIOL-LONDON, V586, P2203, DOI 10.1113/jphysiol.2007.150516; O'Connell B, 2004, BIOCHEM J, V378, P269, DOI 10.1042/BJ20031170; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Place N, 2009, J PHYSL; Plant DR, 2000, J MUSCLE RES CELL M, V21, P747, DOI 10.1023/A:1010344008224; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; REID MB, 1992, J APPL PHYSIOL, V73, P1797, DOI 10.1152/jappl.1992.73.5.1797; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Spencer T, 2009, AM J PHYSIOL-CELL PH, V296, pC1015, DOI 10.1152/ajpcell.00251.2008; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Supinski G, 1999, J APPL PHYSIOL, V87, P783, DOI 10.1152/jappl.1999.87.2.783; Supinski G, 2000, AM J PHYSIOL-REG I, V278, pR891, DOI 10.1152/ajpregu.2000.278.4.R891; SUPINSKI G, 1994, J APPL PHYSIOL, V76, P2707, DOI 10.1152/jappl.1994.76.6.2707; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Szentesi P, 2005, J APPL PHYSIOL, V99, P2189, DOI 10.1152/japplphysiol.00542.2005; Tiago T, 2006, BIOCHEMISTRY-US, V45, P3794, DOI 10.1021/bi0518500; Trinh HH, 2006, CLIN EXP PHARMACOL P, V33, P591, DOI 10.1111/j.1440-1681.2006.04412.x; van der Poel C, 2002, J PHYSIOL-LONDON, V544, P765, DOI 10.1113/jphysiol.2002.024968; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907; Zhang SJ, 2006, J PHYSIOL-LONDON, V572, P551, DOI 10.1113/jphysiol.2005.104521	57	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35226	10.1371/journal.pone.0035226	http://dx.doi.org/10.1371/journal.pone.0035226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629297	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300001
J	Miller, KI; Qing, C; Sze, DMY; Neilan, BA				Miller, Kristin I.; Qing, Chen; Sze, Daniel Man Yuen; Neilan, Brett A.			Investigation of the Biosynthetic Potential of Endophytes in Traditional Chinese Anticancer Herbs	PLOS ONE			English	Article							POLYKETIDE SYNTHASE GENES; NONRIBOSOMAL PEPTIDE SYNTHETASES; PLANT ANTITUMOR AGENTS; FUNGAL ENDOPHYTES; NATURAL-PRODUCTS; ANTIMUTAGENIC ACTIVITY; FUTURE-PROSPECTS; ANTIBIOTICS; NRPS; INHIBITOR	Traditional Chinese medicine encompasses a rich empirical knowledge of the use of plants for the treatment of disease. In addition, the microorganisms associated with medicinal plants are also of interest as the producers of the compounds responsible for the observed plant bioactivity. The present study has pioneered the use of genetic screening to assess the potential of endophytes to synthesize bioactive compounds, as indicated by the presence of non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) genes. The total DNA extracts of 30 traditional Chinese herbs, were screened for functional genes involved in the biosynthesis of bioactive compounds. The four PCR screens were successful in targeting four bacterial PKS, six bacterial NRPS, ten fungal PKS and three fungal NRPS gene fragments. Analysis of the detected endophyte gene fragments afforded consideration of the possible bioactivity of the natural products produced by endophytes in medicinal herbs. This investigation describes a rapid method for the initial screening of medicinal herbs and has highlighted a subset of those plants that host endophytes with biosynthetic potential. These selected plants can be the focus of more comprehensive endophyte isolation and natural product studies.	[Miller, Kristin I.; Sze, Daniel Man Yuen] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Miller, Kristin I.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Qing, Chen] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Sch Pharmaceut Sci, Kunming, Peoples R China; [Sze, Daniel Man Yuen] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hung Hom Kowloon, Hong Kong, Peoples R China; [Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney; Kunming Medical University; Hong Kong Polytechnic University; University of New South Wales Sydney	Miller, KI (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	b.neilan@unsw.edu.au	Neilan, Brett A/I-5767-2012	Neilan, Brett A/0000-0001-6113-772X	Australia-China Special Fund for ST Cooperation [CH070067]; National Natural Science Foundation of China [30811120009]; International Cooperation Foundation of Yunnan Province of China [30811120009]; Australian Research Council [FF0883440]	Australia-China Special Fund for ST Cooperation(Australian GovernmentDepartment of Industry, Innovation and Science); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Foundation of Yunnan Province of China; Australian Research Council(Australian Research Council)	KIM and DMYS were supported by the Australia-China Special Fund for S&T Cooperation (CH070067) https://grants.innovation.gov.au/ISL/Pages/Doc. aspx?name = ChinaFund.htm. CQ was financially supported by the National Natural Science Foundation of China (No. 30811120009) and the International Cooperation Foundation of Yunnan Province of China (No. 30811120009). BAN was supported by a grant and fellowship from the Australian Research Council (FF0883440) http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ACTON N, 1985, PLANTA MED, V51, P441, DOI 10.1055/s-2007-969543; [Anonymous], 1998, CHINESE MAT MED CHEM; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6; Bayman P, 1997, NEW PHYTOL, V135, P143, DOI 10.1046/j.1469-8137.1997.00618.x; BIANCHI C, 1975, J PHARM SCI, V64, P1305, DOI 10.1002/jps.2600640809; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Brimble MA, 1999, NAT PROD REP, V16, P267, DOI 10.1039/a804287j; Burns BP, 2005, FEMS MICROBIOL LETT, V243, P293, DOI 10.1016/j.femsle.2004.12.019; Cankar K, 2005, FEMS MICROBIOL LETT, V244, P341, DOI 10.1016/j.femsle.2005.02.008; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Chen KK, 1924, J PHARMACOL EXP THER, V24, P339; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Davydov M, 2000, J ETHNOPHARMACOL, V72, P345, DOI 10.1016/S0378-8741(00)00181-1; de Bruijn I, 2008, J BACTERIOL, V190, P2777, DOI 10.1128/JB.01563-07; de Carvalho CCCR, 2005, APPL MICROBIOL BIOT, V67, P715, DOI 10.1007/s00253-005-1932-3; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gore ME, 2007, FOREST PATHOL, V37, P281, DOI 10.1111/j.1439-0329.2007.00509.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ho LK, 1996, J NAT PROD, V59, P330, DOI 10.1021/np960200h; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Huang KC, 1999, PHARM CHINESE HERBS; Ishida K, 2009, APPL ENVIRON MICROB, V75, P2017, DOI 10.1128/AEM.02258-08; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Johnson R, 2007, FUNGAL GENET BIOL, V44, P1180, DOI 10.1016/j.fgb.2007.04.009; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kodani S, 1998, J NAT PROD, V61, P1046, DOI 10.1021/np980106w; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kusari S, 2011, NAT PROD REP, V28, P1203, DOI 10.1039/c1np00030f; LEE H, 1988, MUTAT RES, V204, P229, DOI 10.1016/0165-1218(88)90093-6; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; LI XW, 1986, J BIOGEOGR, V13, P367, DOI 10.2307/2844964; Liao HL, 2008, MOL PLANT MICROBE IN, V21, P469, DOI 10.1094/MPMI-21-4-0469; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Lopez-Lazaro M, 2003, PLANTA MED, V69, P701, DOI 10.1055/s-2003-42789; Lu YR, 2002, PHYTOCHEMISTRY, V59, P117, DOI 10.1016/S0031-9422(01)00415-0; Mankelow DP, 2000, EXPERT OPIN THER PAT, V10, P1583, DOI 10.1517/13543776.10.10.1583; Marler TE, 2005, HORTSCIENCE, V40, P1607, DOI 10.21273/HORTSCI.40.6.1607; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mejia LC, 2008, BIOL CONTROL, V46, P4, DOI 10.1016/j.biocontrol.2008.01.012; Miyazawa M, 1999, J AGR FOOD CHEM, V47, P2163, DOI 10.1021/jf970930a; Moffitt MC, 2001, FEMS MICROBIOL LETT, V196, P207, DOI 10.1111/j.1574-6968.2001.tb10566.x; Moore BS, 2005, ANTON LEEUW INT J G, V87, P49, DOI 10.1007/s10482-004-6541-0; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; MORIKAWA M, 1993, J BACTERIOL, V175, P6459, DOI 10.1128/JB.175.20.6459-6466.1993; Murakami M, 1997, PHYTOCHEMISTRY, V44, P449, DOI 10.1016/S0031-9422(96)00437-2; Namwat W, 2002, GENE, V286, P283, DOI 10.1016/S0378-1119(02)00424-9; Neilan BA, 1999, J BACTERIOL, V181, P4089, DOI 10.1128/JB.181.13.4089-4097.1999; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NiceData, 2004, TRAD CHIN MED NAT SO; Nicholson TP, 2001, CHEM BIOL, V8, P157, DOI 10.1016/S1074-5521(00)90064-4; OKINO T, 1993, TETRAHEDRON LETT, V34, P501, DOI 10.1016/0040-4039(93)85112-A; PERDUE RE, 1970, AMER HORTICULT MAG, V49, P19; Puri SC, 2005, J NAT PROD, V68, P1717, DOI 10.1021/np0502802; Rajbhandari M, 2009, EVID-BASED COMPL ALT, V6, P517, DOI 10.1093/ecam/nem156; Rascher A, 2003, FEMS MICROBIOL LETT, V218, P223, DOI 10.1016/S0378-1097(02)01148-5; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Rounge TB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-141; Sauer M, 2002, MYCOL RES, V106, P460, DOI 10.1017/S095375620200566X; Staunton J, 2001, CURR OPIN CHEM BIOL, V5, P159, DOI 10.1016/S1367-5931(00)00185-X; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Bank H, 2001, BIOCHEM SYST ECOL, V29, P241, DOI 10.1016/S0305-1978(00)00064-8; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P2232, DOI 10.1128/AEM.71.5.2232-2238.2005; Weber T, 2003, J BIOTECHNOL, V106, P221, DOI 10.1016/j.jbiotec.2003.08.004; Wei W., 2002, COMBINATION APPL	79	56	61	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35953	10.1371/journal.pone.0035953	http://dx.doi.org/10.1371/journal.pone.0035953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629306	gold, Green Published			2022-12-27	WOS:000305345300004
J	Su, YW; Chen, X; Jiang, ZZ; Wang, T; Wang, C; Zhang, Y; Wen, J; Xue, M; Zhu, D; Zhang, Y; Su, YJ; Xing, TY; Zhang, CY; Zhang, LY				Su, Yu-Wen; Chen, Xi; Jiang, Zhen-Zhou; Wang, Tao; Wang, Cheng; Zhang, Yun; Wen, Jing; Xue, Mei; Zhu, Dan; Zhang, Yue; Su, Yi-Jing; Xing, Tong-Yue; Zhang, Chen-Yu; Zhang, Lu-Yong			A Panel of Serum MicroRNAs as Specific Biomarkers for Diagnosis of Compound- and Herb-Induced Liver Injury in Rats	PLOS ONE			English	Article							DIOSCOREA-BULBIFERA L.; ALANINE AMINOTRANSFERASE; CIRCULATING MICRORNAS; ALTERNATIVE MEDICINE; UNITED-STATES; PLASMA; PROFILES; CANCER; TRENDS	Background: Drug-induced liver injury (DILI) has been a public, economic and pharmaceutical issue for many years. Enormous effort has been made for discovering and developing novel biomarkers for diagnosing and monitoring both clinical and preclinical DILI at an early stage, though progress has been relatively slow. Additionally, herb-induced liver injury is an emerging cause of liver disease because herbal medicines are increasingly being used worldwide. Recently, circulating microRNAs (miRNAs) have shown potential to serve as novel, minimally invasive biomarkers to diagnose and monitor human cancers and other diseases at early stages. Methodology/Principal Findings: In order to identify candidate miRNAs as diagnostic biomarkers for DILI, miRNA expression profiles of serum and liver tissue from two parallel liver injury Sprague-Dawley rat models induced by a compound (acetaminophen, APAP) or an herb (Dioscorea bulbifera, DB) were screened in this study. The initial screens were performed on serum using a MicroRNA TaqMan low-density qPCR array and on liver tissue using a miRCURY LNA hybridization array and were followed by a TaqMan probe-based quantitative reverse transcription-PCR (qRT-PCR) assay to validate comparison with serum biochemical parameters and histopathological examination. Two sets of dysregulated miRNA candidates in serum and liver tissue were selected in the screening phase. After qRT-PCR validation, a panel of compound-and herb-related serum miRNAs was identified. Conclusions/Significance: We have demonstrated that this panel of serum miRNAs provides potential biomarkers for diagnosis of DILI with high sensitivity and specificity.	[Su, Yu-Wen; Zhang, Yun; Zhang, Yue; Zhang, Lu-Yong] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing, Jiangsu, Peoples R China; [Chen, Xi; Wang, Cheng; Wen, Jing; Su, Yi-Jing; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Jiang, Zhen-Zhou; Xue, Mei; Xing, Tong-Yue; Zhang, Lu-Yong] China Pharmaceut Univ, Minist Educ, Key Lab Drug Qual Control & Pharmacovigilance, Nanjing, Jiangsu, Peoples R China; [Wang, Tao; Zhu, Dan; Zhang, Lu-Yong] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University; China Pharmaceutical University; China Pharmaceutical University	Su, YW (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; lyzhang@cpu.edu.cn	Wang, Cheng/O-7206-2016	Wang, Cheng/0000-0002-1834-2119	Specific Fund for Public Interest Research of Traditional Chinese Medicine, Ministry of Finance, China [200707008]; Mega-projects of Science Research for the 11th Five-Year Plan [2009ZX09302-002]; Natural Science Fund of Jiangsu Province [SBK201122225]	Specific Fund for Public Interest Research of Traditional Chinese Medicine, Ministry of Finance, China; Mega-projects of Science Research for the 11th Five-Year Plan(National Key Technology R&D Program); Natural Science Fund of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Specific Fund for Public Interest Research of Traditional Chinese Medicine, Ministry of Finance, China (200707008), Mega-projects of Science Research for the 11th Five-Year Plan (2009ZX09302-002), and Natural Science Fund of Jiangsu Province (SBK201122225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tamimi HAS, 2008, JCR-J CLIN RHEUMATOL, V14, P363, DOI 10.1097/RHU.0b013e318190b4a6; Amacher DE, 2010, TOXICOL APPL PHARM, V245, P134, DOI 10.1016/j.taap.2010.02.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burhop K, 2004, ARTIF CELL BLOOD SUB, V32, P353, DOI 10.1081/LABB-200027429; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Chau TN, 2011, CLIN TOXICOL, V49, P34, DOI 10.3109/15563650.2010.537662; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2011, MICRORNAS IN CANCER TRANSLATIONAL RESEARCH, P499, DOI 10.1007/978-94-007-0298-1_21; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao HY, 2002, BIOL PHARM BULL, V25, P1241, DOI 10.1248/bpb.25.1241; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Larson Anne M, 2007, Clin Liver Dis, V11, P525, DOI 10.1016/j.cld.2007.06.006; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; McBurney RN, 2009, TOXICOL PATHOL, V37, P52, DOI 10.1177/0192623308329287; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Merrick BA, 2006, J PHARMACOL EXP THER, V318, P792, DOI 10.1124/jpet.106.102681; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MURRAY RDH, 1984, PHYTOCHEMISTRY, V23, P623, DOI 10.1016/S0031-9422(00)80394-5; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Su DJ, 2011, J HEALTH CARE POOR U, V22, P296, DOI 10.1353/hpu.2011.0002; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wai CT, 2007, LIVER INT, V27, P465, DOI 10.1111/j.1478-3231.2007.01461.x; Wang JM, 2010, BIOSCI TRENDS, V4, P79; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Yang H, 2004, TRADIT CHINESE MED, V23, P102; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]	41	75	89	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37395	10.1371/journal.pone.0037395	http://dx.doi.org/10.1371/journal.pone.0037395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624025	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500110
J	Ziegler, A; Schroder, L; Ogurreck, M; Faber, C; Stach, T				Ziegler, Alexander; Schroeder, Leif; Ogurreck, Malte; Faber, Cornelius; Stach, Thomas			Evolution of a Novel Muscle Design in Sea Urchins (Echinodermata: Echinoidea)	PLOS ONE			English	Article							ECHINUS ESCULENTUS L; STYLOCIDARIS-AFFINIS ECHINODERMATA; PARACENTROTUS-LIVIDUS LAMARCK; PERISTOMIAL MEMBRANE; ARISTOTLES LANTERN; COMPARATIVE MORPHOLOGY; FUNCTIONAL-MORPHOLOGY; MECHANICAL-BEHAVIOR; VARIABLE TENSILITY; COMPASS DEPRESSORS	The sea urchin (Echinodermata: Echinoidea) masticatory apparatus, or Aristotle's lantern, is a complex structure composed of numerous hard and soft components. The lantern is powered by various paired and unpaired muscle groups. We describe how one set of these muscles, the lantern protractor muscles, has evolved a specialized morphology. This morphology is characterized by the formation of adaxially-facing lobes perpendicular to the main orientation of the muscle, giving the protractor a frilled aspect in horizontal section. Histological and ultrastructural analyses show that the microstructure of frilled muscles is largely identical to that of conventional, flat muscles. Measurements of muscle dimensions in equally-sized specimens demonstrate that the frilled muscle design, in comparison to that of the flat muscle type, considerably increases muscle volume as well as the muscle's surface directed towards the interradial cavity, a compartment of the peripharyngeal coelom. Scanning electron microscopical observations reveal that the insertions of frilled and flat protractor muscles result in characteristic muscle scars on the stereom, reflecting the shapes of individual muscles. Our comparative study of 49 derived "regular" echinoid species using magnetic resonance imaging (MRI) shows that frilled protractor muscles are found only in taxa belonging to the families Toxopneustidae, Echinometridae, and Strongylocentrotidae. The onset of lobe formation during ontogenesis varies between species of these three families. Because frilled protractor muscles are best observed in situ, the application of a non-invasive imaging technique was crucial for the unequivocal identification of this morphological character on a large scale. Although it is currently possible only to speculate on the functional advantages which the frilled muscle morphology might confer, our study forms the anatomical and evolutionary framework for future analyses of this unusual muscle design among sea urchins.	[Ziegler, Alexander] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Schroeder, Leif] Leibniz Inst Mol Pharmacol, Mol Imaging Grp, Berlin, Germany; [Ogurreck, Malte] Helmholtz Zentrum Geesthacht, Inst Werkstoffforsch, Geesthacht, Germany; [Faber, Cornelius] Univ Klinikum Munster, Inst Klin Radiol, Munster, Germany; [Stach, Thomas] Free Univ Berlin, Inst Biol, Berlin, Germany	Harvard University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Munster; Free University of Berlin	Ziegler, A (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	aziegler@fas.harvard.edu	Schröder, Leif/H-6036-2011; Faber, Cornelius/Q-2689-2016	Schröder, Leif/0000-0003-4901-0325; Faber, Cornelius/0000-0001-7683-7710; Storm, Malte/0000-0002-1602-781X	Deutsche Forschungsgemeinschaft through a Forschungsstipendium	Deutsche Forschungsgemeinschaft through a Forschungsstipendium	This study was supported by the Deutsche Forschungsgemeinschaft through a Forschungsstipendium to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIETTI F, 1990, J ZOOL, V220, P345, DOI 10.1111/j.1469-7998.1990.tb04312.x; ANDRIETTI F, 1992, ECHINODERM RESEARCH 1991, P95; Asgaard U, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P279, DOI 10.1007/978-3-540-77598-0_15; Binyon J., 1972, PHYSL ECHINODERMS; BIRENHEIDE R, 1992, ECHINODERM RESEARCH 1991, P67; Birenheide R, 1996, BIOL BULL, V190, P218, DOI 10.2307/1542542; BOLTT RE, 1963, J EXP BIOL, V40, P713; BONASORO F, 1995, B ZOOL, V62, P121, DOI 10.1080/11250009509356060; BUCHANAN JB, 1969, J ZOOL, V159, P51; Candia Carnevali M D, 1988, ECHINODERM BIOL, P663; CARNEVALI MDC, 1993, ZOOMORPHOLOGY, V113, P173; CARNEVALI MDC, 1991, B ZOOL, V58, P1, DOI 10.1080/11250009109355726; CARNEVALI MDC, 1990, ECHINODERM RESEARCH, P207; Cavey Michael J., 1994, P345; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P651, DOI 10.1098/rspb.1966.0054; COBB JLS, 1977, CELL TISSUE RES, V182, P265; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P624, DOI 10.1098/rspb.1966.0052; COBB JLS, 1968, COMP BIOCHEM PHYSIOL, V24, P311, DOI 10.1016/0010-406X(68)90982-1; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P641, DOI 10.1098/rspb.1966.0053; Cuenot L, 1891, ARCH BIOL, VXI; de Ridder C., 1988, P675; de Ridder C., 1982, P57; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Ellers O, 1997, P ROY SOC B-BIOL SCI, V264, P1525, DOI 10.1098/rspb.1997.0211; Elphick MR, 2001, J EXP BIOL, V204, P875; EMIG C C, 1974, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V12, P128; EMIG CC, 1985, Z ZOOL SYST EVOL, V23, P184; Farmanfarmaian A., 1966, P245; GRUNBAUM H, 1978, B MAR SCI, V28, P181; HAMANN O, 1887, JENA Z NATURWISS, V21, P87; HANSON JL, 1986, MAR BIOL, V92, P125, DOI 10.1007/BF00392754; Hawkins HL, 1934, PHILOS T R SOC LON B, V223, P617, DOI 10.1098/rstb.1934.0014; Hill R.B., 1993, Echinoderm Studies, V4, P81; Hoffmann CK, 1871, NIEDERLANDISCHES ARC, V1, P11; Holland ND, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-39; Hyman LH, 1955, INVERTEBRATES ECHINO, VIV; Jackson R. T., 1912, MEMOIRS BOSTON SOC N, V7, P1, DOI DOI 10.5962/BHL.TITLE.4630; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Kier PM, 1974, PALEONTOLOGICAL SOC, V5, P1; Kroh A, 2012, WORLD ECHINOIDEA DAT; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lanzavecchia G., 1988, P649; Lavallard R., 1965, Boletim da Faculdade de Filosofia Ciencias e Letras Universidade de Sao Paulo (Zool), VNo. 25, P133; Lawrence JM, 2001, CAN J ZOOL, V79, P1251, DOI 10.1139/cjz-79-7-1251; Leydig F, 1854, ARCH ANATOM PHYSL, P296; LITTLEWOOD DTJ, 1995, PHILOS T R SOC B, V347, P213, DOI 10.1098/rstb.1995.0023; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1006/bijl.1996.0131; Loven S, 1892, BIH KONG SVENSK AKAD, V18, P1; MARKEL K, 1990, ZOOMORPHOLOGY, V109, P251, DOI 10.1007/BF00312192; MARKEL K, 1979, ZOOMORPHOLOGIE, V94, P1, DOI 10.1007/BF00994054; McKew M., 1999, P103; Meyer-Rochow VB, 2003, PROTOPLASMA, V220, P227, DOI 10.1007/s00709-002-0048-1; Mortensen T., 1943, MONOGRAPH ECHINOIDEA, VIII; Prouho H, 1888, RECHERCHES DOROCIDAR; Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822; Saita A., 1969, Rendiconti dell'Istituto Lombardo di Scienze e Lettere, VB103, P297; Schick JM, 1983, ECHINODERM STUDIES, P67; Smith AB., 1980, SPEC PAP PALAEONTOL, V25, P1; SMITH AB, 1990, SKELETAL BIOMINERALI, V1, P413; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; STAUBER M, 1988, ZOOMORPHOLOGY, V108, P137, DOI 10.1007/BF00363930; STAUBER M, 1993, ZOOMORPHOLOGY, V113, P137, DOI 10.1007/BF00403091; Strenger A, 1973, GROSSES ZOOLOGISCHES; Telford M, 1997, INVERTEBR BIOL, V116, P255, DOI 10.2307/3226902; Temereva E.N., 2001, RUS J MAR BIOL, V27, P156; Tiedemann F., 1816, ANATOMIE ROHREN HOLO; Valentin G, 1841, MONOGRAPHIES ECHINOD; Wilkie I.C., 1996, Echinoderm Studies, V5, P61; Wilkie IC, 1998, J COMP PHYSIOL B, V168, P204, DOI 10.1007/s003600050138; WILKIE IC, 1994, B ZOOL, V61, P39, DOI 10.1080/11250009409355857; Wilkie IC, 2000, ZOOMORPHOLOGY, V120, P119, DOI 10.1007/s004350000029; Wilkie IC, 1998, ZOOMORPHOLOGY, V118, P87, DOI 10.1007/s004350050060; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; WILKIE IC, 1993, COMP BIOCHEM PHYS A, V105, P493, DOI 10.1016/0300-9629(93)90425-4; Wilkie IC, 2002, J EXP BIOL, V205, P159; Ziegler A, 2013, P 7 EUR C E IN PRESS; Ziegler A, 2011, ZOOMORPHOLOGY, V130, P227, DOI 10.1007/s00435-011-0138-8; Ziegler A, 2011, METHODS MOL BIOL, V771, P633, DOI 10.1007/978-1-61779-219-9_32; Ziegler A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-313; Ziegler A, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-45; Ziegler A, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-10; Ziegler A, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-33	82	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37520	10.1371/journal.pone.0037520	http://dx.doi.org/10.1371/journal.pone.0037520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624043	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500130
J	Bocksteins, E; Labro, AJ; Snyders, DJ; Mohapatra, DP				Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.; Mohapatra, Durga P.			The Electrically Silent Kv6.4 Subunit Confers Hyperpolarized Gating Charge Movement in Kv2.1/Kv6.4 Heterotetrameric Channels	PLOS ONE			English	Article							SHAKER K+ CHANNELS; POTASSIUM CHANNELS; VOLTAGE SENSOR; ALPHA-SUBUNITS; ION CHANNELS; ACTIVATION; CURRENTS; MODULATION; MODEL; GATE	The voltage-gated K+ (Kv) channel subunit Kv6.4 does not form functional homotetrameric channels but co-assembles with Kv2.1 to form functional Kv2.1/Kv6.4 heterotetrameric channels. Compared to Kv2.1 homotetramers, Kv6.4 exerts a similar to 40 mV hyperpolarizing shift in the voltage-dependence of Kv2.1/Kv6.4 channel inactivation, without a significant effect on activation gating. However, the underlying mechanism of this Kv6.4-induced modulation of Kv2.1 channel inactivation, and whether the Kv6.4 subunit participates in the voltage-dependent gating of heterotetrameric channels is not well understood. Here we report distinct gating charge movement of Kv2.1/Kv6.4 heterotetrameric channels, compared to Kv2.1 homotetramers, as revealed by gating current recordings from mammalian cells expressing these channels. The gating charge movement of Kv2.1/Kv6.4 heterotetrameric channels displayed an extra component around the physiological K+ equilibrium potential, characterized by a second sigmoidal relationship of the voltage-dependence of gating charge movement. This distinct gating charge displacement reflects movement of the Kv6.4 voltage-sensing domain and has a voltage-dependency that matches the hyperpolarizing shift in Kv2.1/Kv6.4 channel inactivation. These results provide a mechanistic basis for the modulation of Kv2.1 channel inactivation gating kinetics by silent Kv6.4 subunits.	[Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, B-2020 Antwerp, Belgium; [Bocksteins, Elke; Mohapatra, Durga P.] Univ Iowa, Dept Pharmacol, Roy J & Lucile A Carver Coll Med, Iowa City, IA 52242 USA	University of Antwerp; University of Iowa	Bocksteins, E (corresponding author), Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, CDE, Univ Pl 1, B-2020 Antwerp, Belgium.	dirk.snyders@ua.ac.be; dp-mohapatra@uiowa.edu	Mohapatra, Durga/M-2133-2017; Snyders, Dirk/A-2713-2013	Mohapatra, Durga/0000-0001-5016-1281; Snyders, Dirk/0000-0001-7142-6672; Labro, Alain J/0000-0002-0871-7511	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [FWO-G.0256.08, FWO-G.0449.11]; Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy [IAP6/31]; University of Antwerp [TOP08]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy(Belgian Federal Science Policy Office); University of Antwerp	This work was supported by the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" grants FWO-G.0256.08 and FWO-G.0449.11, the IAP6/31 of the Interuniversity Attraction Poles Program - Belgian State - Belgian Science Policy and the TOP08 project special research fund (BOF) of the University of Antwerp (to D.J.S.), as well as by start-up research funds from The University of Iowa Office of the Vice President of Research, and a research grant from the Epilepsy Foundation and the American Epilepsy Society (190423; to D.P.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Gagnon DG, 2009, J GEN PHYSIOL, V133, P467, DOI 10.1085/jgp.200810082; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; TAGLIALATELA M, 1993, P NATL ACAD SCI USA, V90, P4758, DOI 10.1073/pnas.90.10.4758; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37143	10.1371/journal.pone.0037143	http://dx.doi.org/10.1371/journal.pone.0037143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615922	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200044
J	Bystrykh, LV				Bystrykh, Leonid V.			Generalized DNA Barcode Design Based on Hamming Codes	PLOS ONE			English	Article								The diversity and scope of multiplex parallel sequencing applications is steadily increasing. Critically, multiplex parallel sequencing applications methods rely on the use of barcoded primers for sample identification, and the quality of the barcodes directly impacts the quality of the resulting sequence data. Inspection of the recent publications reveals a surprisingly variable quality of the barcodes employed. Some barcodes are made in a semi empirical fashion, without quantitative consideration of error correction or minimal distance properties. After systematic comparison of published barcode sets, including commercially distributed barcoded primers from Illumina and Epicentre, methods for improved, Hamming code-based sequences are suggested and illustrated. Hamming barcodes can be employed for DNA tag designs in many different ways while preserving minimal distance and error-correcting properties. In addition, Hamming barcodes remain flexible with regard to essential biological parameters such as sequence redundancy and GC content. Wider adoption of improved Hamming barcodes is encouraged in multiplex parallel sequencing applications.	Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Sect Stem Cell Biol, Groningen, Netherlands	University of Groningen	Bystrykh, LV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Sect Stem Cell Biol, Groningen, Netherlands.	l.bystrykh@umcg.nl			European Union [SP3-People]; HEM_ID ITN grant	European Union(European Commission); HEM_ID ITN grant	The work is partially supported by Seventh Framework Programme of the European Union, SP3-People, HEM_ID ITN grant (Marie Curie grant for initial training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ben-Dor A, 2000, J COMPUT BIOL, V7, P503, DOI 10.1089/106652700750050916; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Frutos AG, 1997, NUCLEIC ACIDS RES, V25, P4748, DOI 10.1093/nar/25.23.4748; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Krishnan AR, 2011, ELECTRON LETT, V47, P236, DOI 10.1049/el.2010.3546; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Liu WB, 2003, J CHEM INF COMP SCI, V43, P2014, DOI 10.1021/ci025645s; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Nguyen Phuong, 2011, BMC Genomics, V12, P106, DOI 10.1186/1471-2164-12-106; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Qiu F, 2003, PLANT PHYSIOL, V133, P475, DOI 10.1104/pp.103.025015; REED IS, 1960, J SOC IND APPL MATH, V8, P300, DOI 10.1137/0108018; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368	21	57	119	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36852	10.1371/journal.pone.0036852	http://dx.doi.org/10.1371/journal.pone.0036852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615825	gold, Green Published			2022-12-27	WOS:000305341200023
J	Slattery, ML; Lundgreen, A; Welbourn, B; Corcoran, C; Wolff, RK				Slattery, Martha L.; Lundgreen, Abbie; Welbourn, Bill; Corcoran, Christopher; Wolff, Roger K.			Genetic Variation in Selenoprotein Genes, Lifestyle, and Risk of Colon and Rectal Cancer	PLOS ONE			English	Article							MAMMALIAN THIOREDOXIN REDUCTASES; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; ENERGY-BALANCE; LUNG-CANCER; SELENIUM; EXPRESSION; MUTATIONS; SELENOCYSTEINE; PROGNOSIS	Background: Associations between selenium and cancer have directed attention to role of selenoproteins in the carcinogenic process. Methods: We used data from two population-based case-control studies of colon (n = 1555 cases, 1956 controls) and rectal (n = 754 cases, 959 controls) cancer. We evaluated the association between genetic variation in TXNRD1, TXNRD2, TXNRD3, C11orf31 (SelH), SelW, SelN1, SelS, SepX, and SeP15 with colorectal cancer risk. Results: After adjustment for multiple comparisons, several associations were observed. Two SNPs in TXNRD3 were associated with rectal cancer (rs11718498 dominant OR 1.42 95% CI 1.16,1.74 pACT 0.0036 and rs9637365 recessive 0.70 95% CI 0.55,0.90 pACT 0.0208). Four SNPs in SepN1 were associated with rectal cancer (rs11247735 recessive OR 1.30 95% CI 1.04,1.63 pACT 0.0410; rs2072749 GGvsAA OR 0.53 95% CI 0.36,0.80 pACT 0.0159; rs4659382 recessive OR 0.58 95% CI 0.39,0.86 pACT 0.0247; rs718391 dominant OR 0.76 95% CI 0.62,0.94 pACT 0.0300). Interaction between these genes and exposures that could influence these genes showed numerous significant associations after adjustment for multiple comparisons. Two SNPs in TXNRD1 and four SNPs in TXNRD2 interacted with aspirin/NSAID to influence colon cancer; one SNP in TXNRD1, two SNPs in TXNRD2, and one SNP in TXNRD3 interacted with aspirin/NSAIDs to influence rectal cancer. Five SNPs in TXNRD2 and one in SelS, SeP15, and SelW1 interacted with estrogen to modify colon cancer risk; one SNP in SelW1 interacted with estrogen to alter rectal cancer risk. Several SNPs in this candidate pathway influenced survival after diagnosis with colon cancer (SeP15 and SepX1 increased HRR) and rectal cancer (SepX1 increased HRR). Conclusions: Findings support an association between selenoprotein genes and colon and rectal cancer development and survival after diagnosis. Given the interactions observed, it is likely that the impact of cancer susceptibility from genotype is modified by lifestyle.	[Slattery, Martha L.; Lundgreen, Abbie; Wolff, Roger K.] Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Welbourn, Bill; Corcoran, Christopher] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	Slattery, ML (corresponding author), Univ Utah, Dept Internal Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.	marty.slattery@hsc.utah.edu			National Cancer Institute [RO1 CA48998]; NATIONAL CANCER INSTITUTE [R01CA048998] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by the National Cancer Institute, RO1 CA48998 to Dr. Slattery.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Burk RF, 2003, J NUTR, V133, p1517S, DOI 10.1093/jn/133.5.1517S; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Damdimopoulos AE, 2004, J BIOL CHEM, V279, P38721, DOI 10.1074/jbc.M402753200; EDWARDS S, 1994, AM J EPIDEMIOL, V140, P1020, DOI 10.1093/oxfordjournals.aje.a117192; Fradejas N, 2011, GLIA, V59, P959, DOI 10.1002/glia.21168; Gresner P, 2009, LUNG CANCER, V65, P34, DOI 10.1016/j.lungcan.2008.10.023; Haug U, 2012, GENES CHROMOSOMES CA; Hesketh J, 2011, P NUTR SOC, V70, P365, DOI 10.1017/S0029665111000115; HOLM S, 1979, SCAND J STAT, V6, P65; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Kim YJ, 2005, BIOCHEM BIOPH RES CO, V330, P1095, DOI 10.1016/j.bbrc.2005.03.080; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Meplan C, 2012, MUTAGENESIS, V27, P177, DOI 10.1093/mutage/ger058; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Peters U, 2006, CANCER EPIDEM BIOMAR, V15, P315, DOI 10.1158/1055-9965.EPI-05-0471; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Poerschke RL, 2011, BIOCHEM PHARMACOL, V81, P211, DOI 10.1016/j.bcp.2010.09.024; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507; SLATTERY ML, 1994, J AM DIET ASSOC, V94, P761, DOI 10.1016/0002-8223(94)91944-5; Slattery ML, 1997, CANCER RES, V57, P75; Slattery ML, 2003, NUTR CANCER, V46, P166, DOI 10.1207/S15327914NC4602_09; Slattery ML, 2003, AM J EPIDEMIOL, V158, P214, DOI 10.1093/aje/kwg134; Slattery ML, 2002, CANCER EPIDEM BIOMAR, V11, P541; Slattery ML, 2001, MUTAT RES-FUND MOL M, V483, P73, DOI 10.1016/S0027-5107(01)00228-7; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Welbourn B, 2012, EXACT APPROACH TESTI; Welbourn B, 2012, MUTATION RES; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Zhou X, 2011, J NUTR BIOCH; Zhu XJ, 2011, ORAL ONCOL, V47, P609, DOI 10.1016/j.oraloncology.2011.05.006	39	33	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37312	10.1371/journal.pone.0037312	http://dx.doi.org/10.1371/journal.pone.0037312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615972	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200055
J	Liu, SJ; Hui, TH; Tan, SL; Hong, YH				Liu, Shaojun; Hui, Tan Heok; Tan, Sze Ley; Hong, Yunhan			Chromosome Evolution and Genome Miniaturization in Minifish	PLOS ONE			English	Article							PHYLOGENETIC POSITION; FISH; PAEDOCYPRIS; TELEOSTEI; SIZE; CYPRINIFORMES; OSTARIOPHYSI; CYPRINIDAE; KARYOTYPE; GENUS	Background: Paedocypris is a newly established genus of fish in Southeast Asia. Paedocypris is characterized by several unique features, including a tiny adult size (thus named miniature fish or minifish), fragmentary habitats of acidic peat blackwater swamps, an unusual reproduction mode and truncated development. These peculiarities lend themselves excellent for studying chromosome evolution and rapid speciation in vertebrates but also make them highly controversial for the phylogenetic position. Methodology and Principal Findings: We have established an organ procedure to prepare chromosome spreads from tiny organs of minifish and performed a cytogenetic study on two species of the genus Paedocypris, namely P. carbunculus (Pc) and P. sp. "Singkep" (Ps). We found 30 and 34 chromosomes in diploid cells of Pc and Ps, respectively, which are unusual in teleost fishes. The diploid metaphase has 5 pairs of metacentrics and 7 pairs of subtelocentrics in Pc compared to 3 pairs of metacentrics and 11 pairs of subtelocentrics in Ps, whereas the haploid metaphase contains 5 metacentrics and 7 subtelocentrics in Pc compared to 3 metacentrics and 11 subtelocentrics Ps. Chromosome behavior in first meiosis revealed the presence of a chromosomal ring consisting of 2 metacentrics in Pc, suggesting that centric fusion rather than fission was responsible for the karyotypic evolution from Ps to Pc. Flow cytometry revealed that Pc had a 45% nuclear staining intensity relative to medaka whose genome is 700 Mb in size and contains 0.81 pg DNA. The Pc genome should have 315 Mb in length and 0.36 pg of DNA, which represent one of the smallest values in vertebrates, suggesting genome miniaturization in this organism. Conclusions: Our data demonstrate that gross chromosome rearrangements and genome miniaturization have accompanied the evolution of Paedocypris fishes. Our data also place Paedocypris outside currently described taxa of the Cypriniformes.	[Liu, Shaojun; Hong, Yunhan] Hunan Normal Univ, Key Lab Prot Chem & Dev Biol State Educ Minist Ch, Coll Life Sci, Changsha, Hunan, Peoples R China; [Hui, Tan Heok; Tan, Sze Ley; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Hunan Normal University; National University of Singapore	Liu, SJ (corresponding author), Hunan Normal Univ, Key Lab Prot Chem & Dev Biol State Educ Minist Ch, Coll Life Sci, Changsha, Hunan, Peoples R China.	dbshyh@nus.edu.sg	Hong, Yunhan/D-4197-2009		National Research Foundation of Singapore [R-154-000-529-281]; National Natural Science Foundation of China [30930071]	National Research Foundation of Singapore(National Research Foundation, Singapore); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Research Foundation of Singapore (R-154-000-529-281) to YH and the National Natural Science Foundation of China (No. 30930071) to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI R, 1988, JPN J ICHTHYOL, V34, P515; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Britz R, 2008, RAFFLES B ZOOL, V56, P415; BUSH GL, 1977, P NATL ACAD SCI USA, V74, P3942, DOI 10.1073/pnas.74.9.3942; GOLD JR, 1987, GENOME, V29, P481, DOI 10.1139/g87-083; He SP, 2008, MOL PHYLOGENET EVOL, V47, P419, DOI 10.1016/j.ympev.2007.10.012; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; HONG Y, 1985, Acta Genetica Sinica, V12, P143; Hong Y, 1983, J WUHAN U NAT SCI ED, V2, P96; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hong YH, 1987, FRESHW FISH, V1, P35; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kottelat M, 2006, P ROY SOC B-BIOL SCI, V273, P895, DOI 10.1098/rspb.2005.3419; Lamatsch DK, 2000, CYTOMETRY, V39, P91, DOI 10.1002/(SICI)1097-0320(20000201)39:2<91::AID-CYTO1>3.0.CO;2-4; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Li MY, 2011, PROTEIN CELL, V2, P48, DOI 10.1007/s13238-011-1003-8; Li MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015910; Liu LX, 2009, GENE EXPR PATTERNS, V9, P541, DOI 10.1016/j.gep.2009.06.008; Lourenco LB, 2000, GENET MOL BIOL, V23; Mayden RL, 2010, MOL PHYLOGENET EVOL, V57, P152, DOI 10.1016/j.ympev.2010.04.008; Mayr E, POPULATIONS SPECIES; Monteiro R, 2009, GENET MOL BIOL, V32, P268, DOI 10.1590/S1415-47572009000200011; Noleto RB, 2009, MAR BIOTECHNOL, V11, P680, DOI 10.1007/s10126-009-9215-0; Perrin O, 2008, DATZ, V1, P24; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Uwa H, 1981, CHROM INF SERV, V31, P24; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; YU X, 1987, GENETICA, V72, P225, DOI 10.1007/BF00116227; Yu X, CHROMOSOMES CHINESE	30	11	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37305	10.1371/journal.pone.0037305	http://dx.doi.org/10.1371/journal.pone.0037305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615970	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300100
J	Loncarevic-Vasiljkovic, N; Pesic, V; Todorovic, S; Popic, J; Smiljanic, K; Milanovic, D; Ruzdijic, S; Kanazir, S				Loncarevic-Vasiljkovic, Natasa; Pesic, Vesna; Todorovic, Smilja; Popic, Jelena; Smiljanic, Kosara; Milanovic, Desanka; Ruzdijic, Sabera; Kanazir, Selma			Caloric Restriction Suppresses Microglial Activation and Prevents Neuroapoptosis Following Cortical Injury in Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FOOD RESTRICTION; DIETARY RESTRICTION; DAMAGE; AGE; NEURODEGENERATION; MECHANISMS; APOPTOSIS; CYTOKINES; CASPASES	Traumatic brain injury (TBI) is a widespread cause of death and a major source of adult disability. Subsequent pathological events occurring in the brain after TBI, referred to as secondary injury, continue to damage surrounding tissue resulting in substantial neuronal loss. One of the hallmarks of the secondary injury process is microglial activation resulting in increased cytokine production. Notwithstanding that recent studies demonstrated that caloric restriction (CR) lasting several months prior to an acute TBI exhibits neuroprotective properties, understanding how exactly CR influences secondary injury is still unclear. The goal of the present study was to examine whether CR (50% of daily food intake for 3 months) alleviates the effects of secondary injury on neuronal loss following cortical stab injury (CSI). To this end, we examined the effects of CR on the microglial activation, tumor necrosis factor-alpha (TNF-alpha) and caspase-3 expression in the ipsilateral (injured) cortex of the adult rats during the recovery period (from 2 to 28 days) after injury. Our results demonstrate that CR prior to CSI suppresses microglial activation, induction of TNF-alpha and caspase-3, as well as neurodegeneration following injury. These results indicate that CR strongly attenuates the effects of secondary injury, thus suggesting that CR may increase the successful outcome following TBI.	[Loncarevic-Vasiljkovic, Natasa; Pesic, Vesna; Todorovic, Smilja; Popic, Jelena; Smiljanic, Kosara; Milanovic, Desanka; Ruzdijic, Sabera; Kanazir, Selma] Univ Belgrade, Dept Neurobiol, Inst Biol Res, Belgrade, Serbia	University of Belgrade	Loncarevic-Vasiljkovic, N (corresponding author), Univ Belgrade, Dept Neurobiol, Inst Biol Res, Belgrade, Serbia.	selkan@ibiss.bg.ac.rs	Loncarevic-Vasiljkovic, Natasa/AFK-0840-2022; Loncarevic-Vasiljkovic, Natasa/AAF-7800-2022; Kanazir, Selma/E-5495-2015	Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Kanazir, Selma/0000-0002-7229-5296; Milanovic, Desanka/0000-0001-9799-0335; Popic, Jelena/0000-0002-0959-3856; Pesic, Vesna/0000-0002-1415-5834; Smiljanic, Kosara/0000-0002-6790-5491; Todorovic, Smilja/0000-0001-7155-4914	Ministry of Education and Science, Republic of Serbia [ON173056]	Ministry of Education and Science, Republic of Serbia	This work is funded by the Ministry of Education and Science, Republic of Serbia (grant No ON173056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chiba T, 2010, BIOCHEM BIOPH RES CO, V399, P98, DOI 10.1016/j.bbrc.2010.07.048; Chopek JW, 2010, MECH AGEING DEV, V131, P650, DOI 10.1016/j.mad.2010.09.001; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hiona A, 2004, ANN NY ACAD SCI, V1019, P96, DOI 10.1196/annals.1297.018; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lee LW, 2003, NEUROMOL MED, V4, P179, DOI 10.1385/NMM:4:3:179; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Pekovic S, 2006, NEUROBIOLOGICAL STUDIES - FROM GENES TO BEHAVIOUR 2006, P143; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reed JL, 2010, APPL PHYSIOL NUTR ME, V35, P573, DOI 10.1139/H10-046; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Sola E, 2009, OBES SURG, V19, P571, DOI 10.1007/s11695-008-9772-8; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Veenith T, 2009, WORLD J EMERG SURG, V2, P4; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	39	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37215	10.1371/journal.pone.0037215	http://dx.doi.org/10.1371/journal.pone.0037215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615943	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300079
J	Patchsung, M; Boonla, C; Amnattrakul, P; Dissayabutra, T; Mutirangura, A; Tosukhowong, P				Patchsung, Maturada; Boonla, Chanchai; Amnattrakul, Passakorn; Dissayabutra, Thasinas; Mutirangura, Apiwat; Tosukhowong, Piyaratana			Long Interspersed Nuclear Element-1 Hypomethylation and Oxidative Stress: Correlation and Bladder Cancer Diagnostic Potential	PLOS ONE			English	Article							DNA METHYLATION; LINE-1 METHYLATION; GLUTATHIONE DEPLETION; URINARY MARKERS; CARCINOMA; CARCINOGENESIS; TUMORIGENESIS; INFLAMMATION; ASSOCIATION; DEFICIENCY	Although, increased oxidative stress and hypomethylation of long interspersed nuclear element-1 (LINE-1) associate with bladder cancer (BCa) development, the relationship between these alterations is unknown. We evaluated the oxidative stress and hypomethylation of the LINE-1 in 61 BCa patients and 45 normal individuals. To measure the methylation levels and to differentiate the LINE-1 loci into hypermethylated, partially methylated and hypomethylated, peripheral blood cells, urinary exfoliated cells and cancerous tissues were evaluated by combined bisulfite restriction analysis PCR. The urinary total antioxidant status (TAS) and plasma protein carbonyl content were determined. The LINE-1 methylation levels and patterns, especially hypomethylated loci, in the blood and urine cells of the BCa patients were different from the levels and patterns in the healthy controls. The urinary TAS was decreased, whereas the plasma protein carbonyl content was increased in the BCa patients relative to the controls. A positive correlation between the methylation of LINE-1 in the blood-derived DNA and urinary TAS was found in both the BCa and control groups. The urinary hypomethylated LINE-1 loci and the plasma protein carbonyl content provided the best diagnostic potential for BCa prediction. Based on post-diagnostic samples, the combination test improved the diagnostic power to a sensitivity of 96% and a specificity of 96%. In conclusion, decreased LINE-1 methylation is associated with increased oxidative stress both in healthy and BCa subjects across the various tissue types, implying a dose-response association. Increases in the LINE-1 hypomethylation levels and the number of hypomethylated loci in both the blood-and urine-derived cells and increase in the oxidative stress were found in the BCa patients. The combination test of the urinary hypomethylated LINE-1 loci and the plasma protein carbonyl content may be useful for BCa screening and monitoring of treatment.	[Patchsung, Maturada; Boonla, Chanchai; Dissayabutra, Thasinas; Tosukhowong, Piyaratana] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand; [Amnattrakul, Passakorn] Chulalongkorn Univ, Fac Med, Dept Surg, Bangkok 10330, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Patchsung, M (corresponding author), Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand.	piyaratana_t@yahoo.com		Patchsung, Maturada/0000-0002-7831-2034; Boonla, Chanchai/0000-0002-6515-4321	Chulalongkorn University; Biochemistry and Molecular Biology of Metabolic Diseases Research Unit; Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund [HR 1162A]; National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok; Thai Red Cross Society; Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University	Chulalongkorn University(Chulalongkorn University); Biochemistry and Molecular Biology of Metabolic Diseases Research Unit; Office of the Higher Education Commission; Ratchadaphiseksomphot Endowment Fund; National Science and Technology Development Agency (NSTDA), Thailand; Four Seasons Hotel Bangkok; Thai Red Cross Society; Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University)	This work was supported by Ratchadapisake Sompote Fund, Chulalongkorn University (to PT), by the Biochemistry and Molecular Biology of Metabolic Diseases Research Unit and by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission and the Ratchadaphiseksomphot Endowment Fund (HR 1162A). AM is supported by Research Chair Grant 2011, National Science and Technology Development Agency (NSTDA), Thailand, and the Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination with the Thai Red Cross Society and Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay T, 2003, UROL INT, V71, P271, DOI 10.1159/000072677; Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Badjatia N, 2010, UROL ONCOL-SEMIN ORI, V28, P360, DOI 10.1016/j.urolonc.2008.12.010; Bartosz G, 2003, ADV CLIN CHEM, V37, P219, DOI 10.1016/S0065-2423(03)37010-6; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; CASTEGNA A, 2003, METHOD PHARMACOL TOX, P161; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Dey P, 2004, CLIN CHIM ACTA, V340, P57, DOI 10.1016/j.cccn.2003.11.008; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Hartnett L, 2012, CARCINOGENESIS; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Jurgens B, 1996, CANCER RES, V56, P5698; KAWAI K, 1993, CANCER RES, V53, P5172; Kitkumthorn N, 2012, CLIN CHIM ACTA  0201; Kitkumthorn N, 2011, CLIN EPIGENETICS, DOI [10.1007/s13148-13011-10032-13148, DOI 10.1007/S13148-13011-10032-13148]; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Lertratanangkoon K, 1996, CANCER RES, V56, P995; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Miller JW, 2008, NUTR REV, V66, pS59, DOI 10.1111/j.1753-4887.2008.00070.x; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mitra AP, 2010, NAT REV UROL, V7, P11, DOI 10.1038/nrurol.2009.236; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Opanuraks J, 2010, ASIAN BIOMED, V4, P703, DOI 10.2478/abm-2010-0092; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Salim EI, 2008, INT J CANCER, V123, P601, DOI 10.1002/ijc.23547; Singer H, 2012, HUM MOL GENET, V21, P219, DOI 10.1093/hmg/ddr456; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; van Tilborg AAG, 2009, INT J UROL, V16, P23, DOI 10.1111/j.1442-2042.2008.02174.x; Vrooman OPJ, 2008, EUR UROL, V53, P909, DOI 10.1016/j.eururo.2007.12.006; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yilmaz Ilker A., 2003, International Urology and Nephrology, V35, P345, DOI 10.1023/B:UROL.0000022920.93994.ba	48	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37009	10.1371/journal.pone.0037009	http://dx.doi.org/10.1371/journal.pone.0037009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615872	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300062
J	Viegas, CA; Costa, C; Andre, S; Viana, P; Ribeiro, R; Moreira-Santos, M				Viegas, Cristina A.; Costa, Catarina; Andre, Sandra; Viana, Paula; Ribeiro, Rui; Moreira-Santos, Matilde			Does S-Metolachlor Affect the Performance of Pseudomonas sp Strain ADP as Bioaugmentation Bacterium for Atrazine-Contaminated Soils?	PLOS ONE			English	Article							TOXICITY; METABOLITES; HERBICIDES; ALACHLOR; BIODEGRADATION; BIOSTIMULATION; MICROORGANISMS; DEGRADATION; ADSORPTION; PESTICIDES	Atrazine (ATZ) and S-metolachlor (S-MET) are two herbicides widely used, often as mixtures. The present work examined whether the presence of S-MET affects the ATZ-biodegradation activity of the bioaugmentation bacterium Pseudomonas sp. strain ADP in a crop soil. S-MET concentrations were selected for their relevance in worst-case scenarios of soil contamination by a commercial formulation containing both herbicides. At concentrations representative of application of high doses of the formulation (up to 50 mu g g(-1) of soil, corresponding to a dose approximately 50 x higher than the recommended field dose (RD)), the presence of pure S-MET significantly affected neither bacteria survival (similar to 10(7) initial viable cells g(-1) of soil) nor its ATZ-mineralization activity. Consistently, biodegradation experiments, in larger soil microcosms spiked with 20 x or 50 x RD of the double formulation and inoculated with the bacterium, revealed ATZ to be rapidly (in up to 5 days) and extensively (>96%) removed from the soil. During the 5 days, concentration of S-MET decreased moderately to about 60% of the initial, both in inoculated and non-inoculated microcosms. Concomitantly, an accumulation of the two metabolites S-MET ethanesulfonic acid and S-MET oxanilic acid was found. Despite the dissipation of almost all the ATZ from the treated soils, the respective eluates were still highly toxic to an aquatic microalgae species, being as toxic as those from the untreated soil. We suggest that this high toxicity may be due to the S-MET and/or its metabolites remaining in the soil.	[Viegas, Cristina A.] TUL, IST, Dept Bioengn, Lisbon, Portugal; [Viegas, Cristina A.; Costa, Catarina] TUL, IST, IBB, Ctr Biol & Chem Engn, Lisbon, Portugal; [Ribeiro, Rui; Moreira-Santos, Matilde] Univ Coimbra, Dept Life Sci, Inst Mar IMAR, Coimbra, Portugal; [Andre, Sandra; Viana, Paula] APA, Amadora, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra	Viegas, CA (corresponding author), TUL, IST, Dept Bioengn, Lisbon, Portugal.	cristina.viegas@ist.utl.pt	Costa, Catarina/K-4264-2014; Viegas, Cristina A/C-7815-2011; Moreira-Santos, Matilde/J-2609-2013; Ribeiro, Rui/C-7788-2012	Costa, Catarina/0000-0002-1974-3547; Viegas, Cristina A/0000-0003-1394-0731; Moreira-Santos, Matilde/0000-0001-7067-5028; Ribeiro, Rui/0000-0002-0883-1939	Fundo Europeu de Desenvolvimento Regional; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/AAC-AMB/111317/2009, PTDC/AMB/64230/2006, PPCDT/AMB/56039/2004]	Fundo Europeu de Desenvolvimento Regional; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundo Europeu de Desenvolvimento Regional and Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/), Portugal (Contracts PTDC/AAC-AMB/111317/2009, PTDC/AMB/64230/2006, PPCDT/AMB/56039/2004, and Ciencia 2007-FSE and POPH funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga DS, 2001, ENVIRON SCI TECHNOL, V35, P2455, DOI 10.1021/es991264s; Anhalt JC, 2000, J ENVIRON SCI HEAL B, V35, P417, DOI 10.1080/03601230009373280; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Chirnside AEM, 2009, SOIL BIOL BIOCHEM, V41, P2484, DOI 10.1016/j.soilbio.2009.09.005; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2, 10.1002/etc.5620200108]; Environment Canada, 1992, 1RM25 EC EPS; European Commission, 2004, REV REP ACT SUBST S; Gadagbui B, 2010, REGUL TOXICOL PHARM, V57, P220, DOI 10.1016/j.yrtph.2010.02.010; Garcia-Gonzalez V, 2003, APPL ENVIRON MICROB, V69, P6987, DOI 10.1128/AEM.69.12.6987-6993.2003; Graham WH, 1999, ENVIRON SCI TECHNOL, V33, P4471, DOI 10.1021/es990686z; Health Canada, 2008, PROP MAX RES LIM S M; Hildebrandt A, 2008, WATER RES, V42, P3315, DOI 10.1016/j.watres.2008.04.009; Junghans M, 2003, PEST MANAG SCI, V59, P1101, DOI 10.1002/ps.735; Krutz LJ, 2004, J ENVIRON QUAL, V33, P939, DOI 10.2134/jeq2004.0939; Lima D, 2009, CHEMOSPHERE, V74, P187, DOI 10.1016/j.chemosphere.2008.09.083; Liu HJ, 2006, ECOTOX ENVIRON SAFE, V63, P451, DOI 10.1016/j.ecoenv.2005.02.002; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Moorman TB, 2001, BIOL FERT SOILS, V33, P541, DOI 10.1007/s003740100367; OECD, 1984, GUID TEST CHEM 201 A, V201; Oh SM, 2003, J HEALTH SCI, V49, P65, DOI 10.1248/jhs.49.65; Papaefthimiou C, 2004, ENVIRON TOXICOL CHEM, V23, P1211, DOI 10.1897/03-48; Perez J, 2011, ECOTOXICOLOGY, V20, P1167, DOI 10.1007/s10646-011-0661-x; Qiu YP, 2009, ENVIRON POLLUT, V157, P2964, DOI 10.1016/j.envpol.2009.06.003; Rosa R, 2010, ENVIRON MONIT ASSESS, V161, P439, DOI 10.1007/s10661-009-0759-2; Sanderson JT, 2000, TOXICOL SCI, V54, P121, DOI 10.1093/toxsci/54.1.121; SAXENA A, 1987, APPL ENVIRON MICROB, V53, P390, DOI 10.1128/AEM.53.2.390-396.1987; Seybold CA, 1996, J ENVIRON QUAL, V25, P1179, DOI 10.2134/jeq1996.00472425002500060002x; Shaner DL, 2006, PEST MANAG SCI, V62, P617, DOI 10.1002/ps.1215; Silva E, 2004, ENVIRON SCI TECHNOL, V38, P632, DOI 10.1021/es0300822; Southwick LM, 2003, J AGR FOOD CHEM, V51, P5355, DOI 10.1021/jf034049a; The Pesticide Properties Database (PPDB) developed by the Agriculture & Environment Research Unit (AERU), FP6SSP022704 U HERTF; Viegas C.A., 2012, ADV ENVIRON RES, V6, P1; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Weber JB, 2004, CHEMOSPHERE, V55, P157, DOI 10.1016/j.chemosphere.2003.10.049; Whaley CM, 2009, WEED TECHNOL, V23, P193, DOI 10.1614/WT-08-123.1; White PM, 2010, SCI TOTAL ENVIRON, V408, P1393, DOI 10.1016/j.scitotenv.2009.11.012; Xu DM, 2010, ECOTOX ENVIRON SAFE, V73, P1925, DOI 10.1016/j.ecoenv.2010.07.035; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhao SH, 2003, J AGR FOOD CHEM, V51, P3043, DOI 10.1021/jf025954i	39	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37140	10.1371/journal.pone.0037140	http://dx.doi.org/10.1371/journal.pone.0037140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615921	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300075
J	Heldmann, M; Berding, G; Voges, J; Bogerts, B; Galazky, I; Muller, U; Baillot, G; Heinze, HJ; Munte, TF				Heldmann, Marcus; Berding, Georg; Voges, Juergen; Bogerts, Bernhard; Galazky, Imke; Mueller, Ulf; Baillot, Gunther; Heinze, Hans-Jochen; Muente, Thomas F.			Deep Brain Stimulation of Nucleus Accumbens Region in Alcoholism Affects Reward Processing	PLOS ONE			English	Article							ANTERIOR CINGULATE; DECISION-MAKING; PSYCHOLOGICAL DEPENDENCE; TEMPORAL POLE; RISK-TAKING; CORTEX; ACTIVATION; SENSITIZATION; HIPPOCAMPUS; OUTCOMES	The influence of bilateral deep brain stimulation (DBS) of the nucleus nucleus (NAcc) on the processing of reward in a gambling paradigm was investigated using H-2[O-15]-PET (positron emission tomography) in a 38-year-old man treated for severe alcohol addiction. Behavioral data analysis revealed a less risky, more careful choice behavior under active DBS compared to DBS switched off. PET showed win-and loss-related activations in the paracingulate cortex, temporal poles, precuneus and hippocampus under active DBS, brain areas that have been implicated in action monitoring and behavioral control. Except for the temporal pole these activations were not seen when DBS was deactivated. These findings suggest that DBS of the NAcc may act partially by improving behavioral control.	[Heldmann, Marcus; Galazky, Imke; Heinze, Hans-Jochen] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Heldmann, Marcus; Muente, Thomas F.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Berding, Georg; Baillot, Gunther] Hannover Med Sch, Dept Nucl Med, D-3000 Hannover, Germany; [Voges, Juergen] Univ Magdeburg, Dept Stereotact Neurosurg, D-39106 Magdeburg, Germany; [Bogerts, Bernhard; Mueller, Ulf] Univ Magdeburg, Dept Psychiat, D-39106 Magdeburg, Germany	Otto von Guericke University; University of Lubeck; Hannover Medical School; Otto von Guericke University; Otto von Guericke University	Heldmann, M (corresponding author), Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany.	marcus.heldmann@neuro.uni-luebeck.de	Münte, Thomas/C-2077-2014	Mueller, Ulf/0000-0002-4066-662X	DFG [SFB779]	DFG(German Research Foundation (DFG))	This work was supported by grants from the DFG (SFB779) to TFM, BB, and HJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2009, BRAIN, V132, P2396, DOI 10.1093/brain/awp170; Asari T, 2008, NEUROIMAGE, V41, P145, DOI 10.1016/j.neuroimage.2008.01.059; Axmacher N, 2010, NEURON, V65, P541, DOI 10.1016/j.neuron.2010.02.006; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blaizot X, 2010, CEREB CORTEX, V20, P2198, DOI 10.1093/cercor/bhp289; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Cohen MX, 2009, J NEUROSCI, V29, P7591, DOI 10.1523/JNEUROSCI.5335-08.2009; Cohen MX, 2009, NEUROPSYCHOPHARMACOL, V34, P1649, DOI 10.1038/npp.2008.222; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Gao GD, 2003, STEREOT FUNCT NEUROS, V81, P96, DOI 10.1159/000075111; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Geworski L, 2000, EUR J NUCL MED, V27, P161, DOI 10.1007/s002590050022; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Heinze HJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.022.2009; Huettel SA, 2006, COGN AFFECT BEHAV NE, V6, P141, DOI 10.3758/CABN.6.2.141; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Huijbers W, 2010, NEUROPSYCHOLOGIA, V48, P491, DOI 10.1016/j.neuropsychologia.2009.10.006; Ikemoto S, 2010, NEUROSCI BIOBEHAV RE; Jalabert M, 2009, PROG NEURO-PSYCHOPH, V33, P1336, DOI 10.1016/j.pnpbp.2009.07.010; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kanske P, 2010, CEREB CORTEX, P157; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Longe O, 2010, NEUROIMAGE, V49, P1849, DOI 10.1016/j.neuroimage.2009.09.019; Magno E, 2009, J COGNITIVE NEUROSCI, V21, P2328, DOI 10.1162/jocn.2008.21169; Marco-Pallares J, 2010, BRAIN RES; Munte TF, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.011.2007; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Piefke M, 2003, BRAIN, V126, P650, DOI 10.1093/brain/awg064; Qin JG, 2009, HUM BRAIN MAPP, V30, P1338, DOI 10.1002/hbm.20604; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Redish AD, 2007, ANN NY ACAD SCI, V1104, P324, DOI 10.1196/annals.1390.014; Riba J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002479; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Royet JP, 2000, J NEUROSCI, V20, P7752; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schroeter ML, 2010, NEUROPSYCHOLOGIA, V48, P185, DOI 10.1016/j.neuropsychologia.2009.09.004; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; SPM2, 2012, SPM2; Steele JD, 2008, BIOL PSYCHIAT, V63, P670, DOI 10.1016/j.biopsych.2007.07.019; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Tindell AJ, 2005, EUR J NEUROSCI, V22, P2617, DOI 10.1111/j.1460-9568.2005.04411.x; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Voon V, 2007, ARCH NEUROL-CHICAGO, V64, P212, DOI 10.1001/archneur.64.2.212; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Willems RM, 2010, SOC COGN AFFECT NEUR; Wu HM, 2010, NEUROSCI LETT, V473, P77, DOI 10.1016/j.neulet.2010.02.019	57	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36572	10.1371/journal.pone.0036572	http://dx.doi.org/10.1371/journal.pone.0036572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629317	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300008
J	Braun, TR; Been, LF; Singhal, A; Worsham, J; Ralhan, S; Wander, GS; Chambers, JC; Kooner, JS; Aston, CE; Sanghera, DK				Braun, Timothy R.; Been, Latonya F.; Singhal, Akhil; Worsham, Jacob; Ralhan, Sarju; Wander, Gurpreet S.; Chambers, John C.; Kooner, Jaspal S.; Aston, Christopher E.; Sanghera, Dharambir K.			A Replication Study of GWAS-Derived Lipid Genes in Asian Indians: The Chromosomal Region 11q23.3 Harbors Loci Contributing to Triglycerides	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; DIABETES-MELLITUS; VARIANTS; RISK; SUSCEPTIBILITY; DISEASE; TRAITS; APOA5	Recent genome-wide association scans (GWAS) and meta-analysis studies on European populations have identified many genes previously implicated in lipid regulation. Validation of these loci on different global populations is important in determining their clinical relevance, particularly for development of novel drug targets for treating and preventing diabetic dyslipidemia and coronary artery disease (CAD). In an attempt to replicate GWAS findings on a non-European sample, we examined the role of six of these loci (CELSR2-PSRC1-SORT1 rs599839; CDKN2A-2B rs1333049; BUD13-ZNF259 rs964184; ZNF259 rs12286037; CETP rs3764261; APOE-C1-C4-C2 rs4420638) in our Asian Indian cohort from the Sikh Diabetes Study (SDS) comprising 3,781 individuals (2,902 from Punjab and 879 from the US). Two of the six SNPs examined showed convincing replication in these populations of Asian Indian origin. Our study confirmed a strong association of CETP rs3764261 with high-density lipoprotein cholesterol (HDL-C) (p = 2.03 x 10(-26)). Our results also showed significant associations of two GWAS SNPs (rs964184 and rs12286037) from BUD13-ZNF259 near the APOA5-A4-C3-A1 genes with triglyceride (TG) levels in this Asian Indian cohort (rs964184: p = 1.74 x 10(-17); rs12286037: p = 1.58x10(-2)). We further explored 45 SNPs in a similar to 195 kb region within the chromosomal region 11q23.3 (encompassing the BUD13-ZNF259, APOA5-A4- C3-A1, and SIK3 genes) in 8,530 Asian Indians from the London Life Sciences Population (LOLIPOP) (UK) and SDS cohorts. Five more SNPs revealed significant associations with TG in both cohorts individually as well as in a joint meta-analysis. However, the strongest signal for TG remained with BUD13-ZNF259 (rs96184: p = 1.06 x 10(-39)). Future targeted deep sequencing and functional studies should enhance our understanding of the clinical relevance of these genes in dyslipidemia and hypertriglyceridemia (HTG) and, consequently, diabetes and CAD.	[Braun, Timothy R.; Been, Latonya F.; Singhal, Akhil; Worsham, Jacob; Aston, Christopher E.; Sanghera, Dharambir K.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Pediat, Oklahoma City, OK 73190 USA; [Ralhan, Sarju; Wander, Gurpreet S.] Hero Dayanand Med Coll, Cardiol Sect, Ludhiana, Punjab, India; [Ralhan, Sarju; Wander, Gurpreet S.] Hosp Heart Inst, Ludhiana, Punjab, India; [Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Aston, Christopher E.] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Dayanand Medical College & Hospital; Imperial College London; Imperial College London; University of Oklahoma System; University of Oklahoma Health Sciences Center	Braun, TR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Pediat, Oklahoma City, OK 73190 USA.	Dharambir-sanghera@ouhsc.edu		Sanghera, Dharambir/0000-0001-7203-8655	National Institute of Health [KO1 TW006087]; Fogarty International Center [R01 DK082766]; National Institute of Diabetes and Digestive and Kidney Diseases; University of Oklahoma Health Sciences Center, Oklahoma City, USA; MRC [G0700931, G0601966] Funding Source: UKRI; Medical Research Council [G0700931, G0601966, G0801056B] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [K01TW006087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082766] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Oklahoma Health Sciences Center, Oklahoma City, USA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health grant numbers KO1 TW006087, funded by the Fogarty International Center; R01 DK082766, funded by National Institute of Diabetes and Digestive and Kidney Diseases; and a seed grant from University of Oklahoma Health Sciences Center, Oklahoma City, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Bowden DW, 2008, ANN HUM GENET, V72, P598, DOI 10.1111/j.1469-1809.2008.00446.x; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Dorfmeister B, 2007, BBA-MOL BASIS DIS, V1772, P355, DOI 10.1016/j.bbadis.2006.11.008; Edmondson AC, 2008, CIRC-CARDIOVASC GENE, V1, P3, DOI 10.1161/CIRCGENETICS.108.815530; Evans D, 2011, ATHEROSCLEROSIS, V219, P715, DOI 10.1016/j.atherosclerosis.2011.09.030; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Ken-Dror G, 2010, J HUM GENET, V55, P300, DOI 10.1038/jhg.2010.27; Kendall DM, 2005, ENDOCRIN METAB CLIN, V34, P27, DOI 10.1016/j.ecl.2004.11.004; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kruglyak L, 1999, P NATL ACAD SCI USA, V96, P1170, DOI 10.1073/pnas.96.4.1170; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Oldroyd J, 2005, POSTGRAD MED J, V81, P486, DOI 10.1136/pgmj.2004.029124; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021188; Sanghera DK, 2009, J HUM GENET, V54, P162, DOI 10.1038/jhg.2009.7; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schierer A, 2012, PHARMACOGENET GENOM, V22, P95, DOI 10.1097/FPC.0b013e32834dc9ef; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7	46	53	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37056	10.1371/journal.pone.0037056	http://dx.doi.org/10.1371/journal.pone.0037056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623978	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500055
J	Liu, XX; Zhang, J; Liu, YH; Li, YM; Li, Z				Liu, Xinxue; Zhang, Jun; Liu, Yinghui; Li, Yangmei; Li, Zhu			The Association between Cesarean Delivery on Maternal Request and Method of Newborn Feeding in China	PLOS ONE			English	Article							INITIATION; OUTCOMES; SECTION; WOMEN; DURATION; BARRIER	Background: Cesarean delivery has increased significantly during the last decades. This study aimed to investigate the association between planned mode of delivery and method of feeding. Methodology/Principal Findings: A cohort was created retrospectively using data from a population-based maternal and child health surveillance system, which covers 27 study sites in China from 1993 to 2006. The cohort consisted of 431,704 women for analysis, including 22,462 women with planned cesarean delivery on maternal request (CDMR) and 409,242 women with planned vaginal delivery (VD). Logistic regression models were used to examine the association between mode of delivery and method of feeding adjusting for selected covariates. In this cohort, 398,176 (92.2%) women exclusively breastfed their baby, 28,798 (6.7%) women chose mixed feeding, and 4,730 (1.1%) women chose formula feeding before hospital discharge. Women who planned CDMR were less likely to exclusively breastfeed and more likely to formula feed their babies than those who planned VD. After adjusting for covariates, the odds ratios were 0.85 (95% CI: 0.81-0.89) for exclusive breastfeeding and 1.61 (95% CI: 1.45-1.79) for formula feeding. Associations between planned mode of delivery and method of feeding in the south, north, rural and urban areas yielded similar results. Conclusion: This study demonstrated that planned CDMR was associated with a lower rate of exclusive breastfeeding and a higher rate of formula feeding in a low-risk Chinese population.	[Liu, Xinxue; Li, Zhu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Liu, Yinghui] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Li, Yangmei] Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	Peking University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Peking University; University of Cambridge	Liu, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China.	lizhu3669@gmail.com		Liu, Xinxue/0000-0003-1107-0365	National Institute of Child Health and Human Development, National Institutes of Health, U.S.A.; Agency for Healthcare Research and Quality, U.S.A.	National Institute of Child Health and Human Development, National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality, U.S.A.(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Data cleaning and analysis for this paper was supported in part by the Intramural Research Program at the National Institute of Child Health and Human Development, National Institutes of Health, U.S.A. and Agency for Healthcare Research and Quality, U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Chapman DJ, 1999, J AM DIET ASSOC, V99, P450, DOI 10.1016/S0002-8223(99)00109-1; Chung W, 2008, PUBLIC HEALTH NUTR, V11, P225, DOI 10.1017/S136898000700047X; Fewtrell MS, 2007, AM J CLIN NUTR, V85, p635S, DOI 10.1093/ajcn/85.2.635S; Hamilton Brady E, 2006, Natl Vital Stat Rep, V55, P1; Kottmel A, 2012, ARCH GYNECOL OBSTET; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Leung GM, 2002, OBSTET GYNECOL, V99, P785, DOI 10.1016/S0029-7844(02)01940-3; LI Z, 2000, CHINA US COLLABORATI; Lin CH, 2008, J CLIN NURS, V17, P2838, DOI 10.1111/j.1365-2702.2008.02289.x; Liston FA, 2008, ARCH DIS CHILD-FETAL, V93, pF176, DOI 10.1136/adc.2006.112565; Perez-Rios N, 2008, J HUM LACT, V24, P293, DOI 10.1177/0890334408316078; PerezEscamilla R, 1996, AM J PUBLIC HEALTH, V86, P832, DOI 10.2105/AJPH.86.6.832; Qin C, 2011, MATERN CHILD HLTH J; Qiu Liqian, 2008, Asia Pac J Public Health, V20 Suppl, P220; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Stavrou EP, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-8; Stefos T, 2001, ACTA OBSTET GYN SCAN, V80, P34, DOI 10.1080/791201831; Tucker H.A., 1994, PHYSL REPROD, Vsecond, P1065; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Viswanathan Meera, 2006, Evid Rep Technol Assess (Full Rep), P1; Wang Bing-shun, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P246; World Health Organization, OPT DUR EXCL BREATF; World Health Organization United Nations Children's Fund, 2003, GLOB STRAT INF YOUNG; Xie RH, 2011, J WOMENS HEALTH, V20, P1881, DOI 10.1089/jwh.2011.2842; Xu FL, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-6; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x; Zhang J, 2008, OBSTET GYNECOL, V111, P1077, DOI 10.1097/AOG.0b013e31816e349e	28	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37336	10.1371/journal.pone.0037336	http://dx.doi.org/10.1371/journal.pone.0037336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624019	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500102
J	Shimma, S; Kubo, A; Satoh, T; Toyoda, M				Shimma, Shuichi; Kubo, Ayumi; Satoh, Takaya; Toyoda, Michisato			Detailed Structural Analysis of Lipids Directly on Tissue Specimens Using a MALDI-SpiralTOF-Reflectron TOF Mass Spectrometer	PLOS ONE			English	Article							CHARGE-REMOTE FRAGMENTATION; DOUBLE-BOND POSITION; INDUCED DISSOCIATION; MATRIX; IDENTIFICATION; BRAIN; BIOMOLECULES; DESIGN; IONS	Direct tissue analysis using a novel tandem time-of-flight (TOF-TOF) mass spectrometer is described. This system consists of a matrix-assisted laser desorption/ionization ion source, a spiral ion trajectory TOF mass spectrometer "SpiralTOF (STOF)'', a collision cell, and an offset parabolic reflectron (RTOF). The features of this system are high precursor ion selectivity due to a 17-m flight path length in STOF and elimination of post-source decay (PSD) ions. The acceleration energy is 20 keV, so that high-energy collision-induced dissociation (HE-CID) is possible. Elimination of PSD ions allows observation of the product ions inherent to the HE-CID process. By using this tandem TOF instrument, the product ion spectrum of lipids provided detailed structural information of fatty acid residues.	[Shimma, Shuichi] Osaka Univ, Venture Business Lab, Suita, Osaka, Japan; [Kubo, Ayumi; Satoh, Takaya] JEOL Ltd, Akishima, Tokyo, Japan; [Toyoda, Michisato] Osaka Univ, Grad Sch Sci, Project Res Ctr Fundamental Sci, Toyonaka, Osaka 560, Japan	Osaka University; Jeol Ltd; JEOL Japan; Osaka University	Shimma, S (corresponding author), Osaka Univ, Venture Business Lab, Suita, Osaka, Japan.	sshimma@ncc.go.jp	Toyoda, Michisato/N-6750-2013; Shimma, Shuichi/L-5975-2019	Toyoda, Michisato/0000-0001-5950-6039; 	Japan Society for the Promotion of Science [11020851]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (11020851, Grant-in-Aid for Young Scientists (B); to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgacem O, 2006, RAPID COMMUN MASS SP, V20, P1653, DOI 10.1002/rcm.2486; Chen LC, 2009, J MASS SPECTROM, V44, P1469, DOI 10.1002/jms.1632; Chen RB, 2010, ANAL BIOANAL CHEM, V397, P3185, DOI 10.1007/s00216-010-3723-7; Chughtai K, 2010, CHEM REV, V110, P3237, DOI 10.1021/cr100012c; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; CORNISH TJ, 1994, RAPID COMMUN MASS SP, V8, P781, DOI 10.1002/rcm.1290080924; Dill AL, 2011, CHEM COMMUN, V47, P2741, DOI 10.1039/c0cc03518a; Garrett TJ, 2010, METHODS MOL BIOL, V656, P209, DOI 10.1007/978-1-60761-746-4_12; Goodwin RJA, 2011, RAPID COMMUN MASS SP, V25, P969, DOI 10.1002/rcm.4939; Goodwin RJA, 2010, BIOANALYSIS, V2, P279, DOI 10.4155/BIO.09.180; Griffiths WJ, 1996, RAPID COMMUN MASS SP, V10, P21, DOI 10.1002/(SICI)1097-0231(19960115)10:1<21::AID-RCM428>3.0.CO;2-0; GROSS ML, 1992, INT J MASS SPECTROM, V118, P137, DOI 10.1016/0168-1176(92)85060-D; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; HILL JA, 1989, INT J MASS SPECTROM, V92, P211, DOI 10.1016/0168-1176(89)83029-0; Ho YP, 2002, RAPID COMMUN MASS SP, V16, P1582, DOI 10.1002/rcm.751; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; JENSEN NJ, 1985, J AM CHEM SOC, V107, P1863, DOI 10.1021/ja00293a010; KAUFMANN R, 1993, RAPID COMMUN MASS SP, V7, P902, DOI 10.1002/rcm.1290071010; Kolli VSK, 1996, RAPID COMMUN MASS SP, V10, P923, DOI 10.1002/(SICI)1097-0231(19960610)10:8<923::AID-RCM610>3.3.CO;2-5; Manicke NE, 2010, J MASS SPECTROM, V45, P223, DOI 10.1002/jms.1707; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Mitchell TW, 2009, J CHROMATOGR B, V877, P2722, DOI 10.1016/j.jchromb.2009.01.017; Satoh T, 2005, J AM SOC MASS SPECTR, V16, P1969, DOI 10.1016/j.jasms.2005.08.005; Satoh T, 2007, J AM SOC MASS SPECTR, V18, P1318, DOI 10.1016/j.jasms.2007.04.010; Satoh T, 2011, J AM SOC MASS SPECTR, V22, P797, DOI 10.1007/s13361-011-0090-3; Schwamborn K, 2010, MOL ONCOL, V4, P529, DOI 10.1016/j.molonc.2010.09.002; Seeley EH, 2011, TRENDS BIOTECHNOL, V29, P136, DOI 10.1016/j.tibtech.2010.12.002; Shimma S, 2008, J MASS SPECTROM, V43, P535, DOI 10.1002/jms.1352; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; STOFFYN PJ, 1966, J AM OIL CHEM SOC, V43, P69, DOI 10.1007/BF02641017; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Thomas MC, 2008, ANAL CHEM, V80, P303, DOI 10.1021/ac7017684; Vestal ML, 2005, METHOD ENZYMOL, V402, P79, DOI 10.1016/S0076-6879(05)02003-3; Wang HYJ, 2008, INT J MASS SPECTROM, V278, P143, DOI 10.1016/j.ijms.2008.04.005; WYSOCKI VH, 1991, INT J MASS SPECTROM, V104, P179, DOI 10.1016/0168-1176(91)80009-C; WYSOCKI VH, 1987, INT J MASS SPECTROM, V75, P181, DOI 10.1016/0168-1176(87)83054-9; Yang YH, 2009, ANAL BIOCHEM, V387, P133, DOI 10.1016/j.ab.2009.01.005	38	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37107	10.1371/journal.pone.0037107	http://dx.doi.org/10.1371/journal.pone.0037107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623981	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500058
J	Xu, DS; Yang, CZ; Proescholdt, M; Brundl, E; Brawanski, A; Fang, XP; Lee, CS; Weil, RJ; Zhuang, ZP; Lonser, RR				Xu, David S.; Yang, Chunzhang; Proescholdt, Martin; Bruendl, Elisabeth; Brawanski, Alexander; Fang, Xueping; Lee, Cheng S.; Weil, Robert J.; Zhuang, Zhengping; Lonser, Russell R.			Neuronatin in a Subset of Glioblastoma Multiforme Tumor Progenitor Cells Is Associated with Increased Cell Proliferation and Shorter Patient Survival	PLOS ONE			English	Article							SECONDARY GLIOBLASTOMAS; GENE; EXPRESSION; CLONING; DIFFERENTIATION; IDENTIFICATION; MUTATIONS; GROWTH; BRAIN; MS	Glioblastoma multiforme is the most common and malignant primary brain tumor. Recent evidence indicates that a subset of glioblastoma tumor cells have a stem cell like phenotype that underlies chemotherapy resistance and tumor recurrence. We utilized a new "multidimensional" capillary isoelectric focusing nano-reversed-phase liquid chromatography platform with tandem mass spectrometry to compare the proteomes of isolated glioblastoma tumor stem cell and differentiated tumor cell populations. This proteomic analysis yielded new candidate proteins that were differentially expressed. Specifically, two isoforms of the membrane proteolipid neuronatin (NNAT) were expressed exclusively within the tumor stem cells. We surveyed the expression of NNAT across 10 WHO grade II and III gliomas and 23 glioblastoma (grade IV) human tumor samples and found NNAT was expressed in a subset of primary glioblastoma tumors. Through additional in vitro studies utilizing the U87 glioma cell line, we found that expression of NNAT is associated with significant increases in cellular proliferation. Paralleling the in vitro results, when NNAT levels were evaluated in tumor specimens from a consecutive cohort of 59 glioblastoma patients, the presence of increased levels of NNAT were found to be a an independent risk factor (P = 0.006) for decreased patient survival through Kaplan-Meier and multivariate analysis. These findings indicate that NNAT may have utility as a prognostic biomarker, as well as a cell-surface target for chemotherapeutic agents.	[Xu, David S.; Yang, Chunzhang; Zhuang, Zhengping; Lonser, Russell R.] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Weil, Robert J.] Cleveland Clin Fdn, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA; [Proescholdt, Martin; Bruendl, Elisabeth; Brawanski, Alexander] Univ Regensburg, Med Ctr, Dept Neurosurg, Regensburg, Germany; [Fang, Xueping; Lee, Cheng S.] Calibrant Biosyst, Gaithersburg, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cleveland Clinic Foundation; University of Regensburg	Xu, DS (corresponding author), Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	zhuangp@ninds.nih.gov; Lonserr@ninds.nih.gov		Yang, Chunzhang/0000-0001-6433-0867; Xu, David/0000-0001-8987-4545	National Institutes of Neurological Disorders and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All work was funded through the intramural research program at the National Institutes of Neurological Disorders and Stroke as a part of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Chu K, 2005, DIABETES, V54, P1064, DOI 10.2337/diabetes.54.4.1064; Dou DX, 1996, BRAIN RES, V723, P8, DOI 10.1016/0006-8993(96)00167-9; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Maric D, 2003, J NEUROSCI, V23, P240; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siu IW, 2008, NEURO-ONCOLOGY, V10, P716, DOI 10.1215/15228517-2008-038; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P684, DOI 10.1097/00005072-199807000-00005; Ueki K, 1996, CANCER RES, V56, P150; Usui H, 1997, J MOL NEUROSCI, V9, P55, DOI 10.1007/BF02789395; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vrang N, 2010, OBESITY, V18, P1289, DOI 10.1038/oby.2009.361; Wang YJ, 2005, ANAL CHEM, V77, P6549, DOI 10.1021/ac050491b; Wang YJ, 2005, J PROTEOME RES, V4, P36, DOI 10.1021/pr049876l; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475	24	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37811	10.1371/journal.pone.0037811	http://dx.doi.org/10.1371/journal.pone.0037811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624064	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500153
J	Bougault, C; Aubert-Foucher, E; Paumier, A; Perrier-Groult, E; Huot, L; Hot, D; Duterque-Coquillaud, M; Mallein-Gerin, F				Bougault, Carole; Aubert-Foucher, Elisabeth; Paumier, Anne; Perrier-Groult, Emeline; Huot, Ludovic; Hot, David; Duterque-Coquillaud, Martine; Mallein-Gerin, Federic			Dynamic Compression of Chondrocyte-Agarose Constructs Reveals New Candidate Mechanosensitive Genes	PLOS ONE			English	Article							BOVINE ARTICULAR CHONDROCYTES; TGF-BETA; PRIMARY CILIA; MECHANICAL STIMULATION; ENDOTHELIAL-CELLS; PROTEIN; KINASE; FLOW; ADHESION; SHEAR	Articular cartilage is physiologically exposed to repeated loads. The mechanical properties of cartilage are due to its extracellular matrix, and homeostasis is maintained by the sole cell type found in cartilage, the chondrocyte. Although mechanical forces clearly control the functions of articular chondrocytes, the biochemical pathways that mediate cellular responses to mechanical stress have not been fully characterised. The aim of our study was to examine early molecular events triggered by dynamic compression in chondrocytes. We used an experimental system consisting of primary mouse chondrocytes embedded within an agarose hydrogel; embedded cells were pre-cultured for one week and subjected to short-term compression experiments. Using Western blots, we demonstrated that chondrocytes maintain a differentiated phenotype in this model system and reproduce typical chondrocyte-cartilage matrix interactions. We investigated the impact of dynamic compression on the phosphorylation state of signalling molecules and genome-wide gene expression. After 15 min of dynamic compression, we observed transient activation of ERK1/2 and p38 (members of the mitogen-activated protein kinase (MAPK) pathways) and Smad2/3 (members of the canonical transforming growth factor (TGF)-beta pathways). A microarray analysis performed on chondrocytes compressed for 30 min revealed that only 20 transcripts were modulated more than 2-fold. A less conservative list of 325 modulated genes included genes related to the MAPK and TGF-beta pathways and/or known to be mechanosensitive in other biological contexts. Of these candidate mechanosensitive genes, 85% were down-regulated. Down-regulation may therefore represent a general control mechanism for a rapid response to dynamic compression. Furthermore, modulation of transcripts corresponding to different aspects of cellular physiology was observed, such as non-coding RNAs or primary cilium. This study provides new insight into how chondrocytes respond to mechanical forces.	[Bougault, Carole; Aubert-Foucher, Elisabeth; Paumier, Anne; Perrier-Groult, Emeline; Mallein-Gerin, Federic] Univ Lyon 1, CNRS, FRE 3310 Dysfonctionnement Homeostasie Tissula, IBCP, F-69365 Lyon, France; [Huot, Ludovic; Hot, David] Ctr Infect & Immun Lille, U1019, UMR 8204, Inst Pasteur, Lille, France; [Duterque-Coquillaud, Martine] Univ Lille Nord France, Inst Pasteur, IFR142, CNRS UMR 8161,Inst Biol, Lille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Bougault, C (corresponding author), Univ Lyon 1, CNRS, FRE 3310 Dysfonctionnement Homeostasie Tissula, IBCP, F-69365 Lyon, France.	f.mallein-gerin@ibcp.fr	; Hot, David/M-6775-2016	Perrier-Groult, Emeline/0000-0002-0252-8461; Hot, David/0000-0002-2361-0616; Duterque-Coquillaud, Martine/0000-0003-3943-5629	CNRS; Universite de Lyon; ANR; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Lyon; ANR(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was financially supported by the CNRS, Universite de Lyon, and ANR TecSan 2006. CB was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808; Barlic A, 2008, J ORTHOP RES, V9, P9; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Bougault C, 2009, NAT PROTOC, V4, P928, DOI 10.1038/nprot.2009.63; Bougault C, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-71; BRUNNER A, 1991, DNA CELL BIOL, V10, P293, DOI 10.1089/dna.1991.10.293; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Q, 2007, J BIOL CHEM, V282, P26418, DOI 10.1074/jbc.M703341200; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chowdhury TT, 2003, ARCH BIOCHEM BIOPHYS, V417, P105, DOI 10.1016/S0003-9861(03)00340-0; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; Das RHJ, 2008, OSTEOARTHR CARTILAGE, V16, P385, DOI 10.1016/j.joca.2007.07.014; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; De Croos JNA, 2008, BIORHEOLOGY, V45, P459, DOI 10.3233/BIR-2008-0488; De Croos JNA, 2006, MATRIX BIOL, V25, P323, DOI 10.1016/j.matbio.2006.03.005; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fitzgerald JB, 2007, J BIOL CHEM, V17, P17; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Gouttenoire J, 2010, EUR J CELL BIOL, V89, P307, DOI 10.1016/j.ejcb.2009.10.018; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Hai T, 1999, GENE EXPRESSION, V7, P321; Ho AM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-35; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hyytiainen M, 2003, J CELL BIOL, V163, P1363, DOI 10.1083/jcb.200309105; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; JONES IL, 1982, CLIN ORTHOP RELAT R, P283; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kawanishi M, 2007, TISSUE ENG, V13, P957, DOI 10.1089/ten.2006.0176; Keryer G, 2008, J CLIN INVEST, V2011; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; Kido S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013090; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kisiday JD, 2009, ANN BIOMED ENG, V37, P1368, DOI 10.1007/s10439-009-9699-9; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Li KW, 2003, ARTHRITIS RHEUM-US, V48, P689, DOI 10.1002/art.10849; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Papachristou D, 2006, EUR J ORTHODONT, V28, P20, DOI 10.1093/ejo/cji101; Papachristou DJ, 2005, HISTOCHEM CELL BIOL, V124, P215, DOI 10.1007/s00418-005-0026-8; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; Resnick A, 2008, FRONT BIOSCI-LANDMRK, V13, P1665, DOI 10.2741/2790; Roosa SMM, 2011, BONE, V48, P543, DOI 10.1016/j.bone.2010.11.006; Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; TSCHAN T, 1993, J BIOL CHEM, V268, P5156; Turner NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1147, DOI 10.1016/j.bbrc.2008.10.131; van Bakel Harm, 2009, Briefings in Functional Genomics & Proteomics, V8, P424, DOI 10.1093/bfgp/elp037; Van der Heiden K, 2008, ATHEROSCLEROSIS, V196, P542, DOI 10.1016/j.atherosclerosis.2007.05.030; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wang P, 2011, ANN BIOMED ENG, V39, P1101, DOI 10.1007/s10439-010-0221-1; Wann AK, 2012, FASEB J, V2012, P13; Wells RG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.110pe13; Wiseman M, 2004, BIORHEOLOGY, V41, P283; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200	82	50	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36964	10.1371/journal.pone.0036964	http://dx.doi.org/10.1371/journal.pone.0036964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615857	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200029
J	Kim, TH; Kang, JW; Kim, KH; Kang, KW; Shin, MS; Jung, SY; Kim, AR; Jung, HJ; Choi, JB; Hong, KE; Lee, SD; Choi, SM				Kim, Tae-Hun; Kang, Jung Won; Kim, Kun Hyung; Kang, Kyung-Won; Shin, Mi-Suk; Jung, So-Young; Kim, Ae-Ran; Jung, Hee-Jung; Choi, Jin-Bong; Hong, Kwon Eui; Lee, Seung-Deok; Choi, Sun-Mi			Acupuncture for the Treatment of Dry Eye: A Multicenter Randomised Controlled Trial with Active Comparison Intervention (Artificial Teardrops)	PLOS ONE			English	Article							OCULAR SURFACE DISEASE; WORKSHOP 2007; SHAM ACUPUNCTURE; SUBCOMMITTEE; OUTCOMES; PLACEBO; PAIN; TEAR; EXPECTATIONS; MEDICINE	Purpose: To evaluate the effects of acupuncture compared to a control group using artificial tears. Methods: Setting & design: multicenter randomised controlled trial (three local research hospitals of South Korea). Study Population: 150 patients with moderate to severe dry eye. Intervention: Participants were randomly allocated into four weeks of acupuncture treatment (bilateral BL2, GB14, TE 23, Ex1, ST1, GB20, LI4, LI11 and single GV23) or to the artificial tears group (sodium carboxymethylcellulose). Main Outcome Measure(s): The ocular surface disease index (OSDI), tear film break-up time (TFBUT), Schirmer I test, visual analogue scale (VAS) for self-assessment of ocular discomfort, general assessment (by both acupuncture practitioners and participants) and quality of life (QOL) through the Measure Yourself Medical Outcome Profile2 (MYMOP-2). Results: There was no statistically significant difference between two groups for the improvement of dry eye symptoms as measured by OSDI (MD -16.11, 95% CI [-20.91, -11.32] with acupuncture and -15.37, 95% CI [-19.57, -11.16] with artificial tears; P = 0.419), VAS (acupuncture: -23.84 [-29.59, 218.09]; artificial tears: -22.2 [-27.24, 217.16], P = 0.530) or quality of life (acupuncture: -1.32 [-1.65, -0.99]; artificial tears: -0.96 [-1.32, -0.6], P = 0.42) immediately after treatment. However, compared with artificial tears group, the OSDI (acupuncture: -16.15 [-21.38, -10.92]; artificial tears: -10.76 [-15.25, -6.27], P = 0.030) and VAS (acupuncture: -23.88 [-30.9, -16.86]; artificial tears: -14.71 [-20.86, -8.55], P = 0.018) were significantly improved in the acupuncture group at 8 weeks after the end of acupuncture treatment. TFBUT measurements increased significantly in the acupuncture group after treatment. Conclusions: Acupuncture may have benefits on the mid-term outcomes related to dry eye syndrome compared with artificial tears.	[Kim, Tae-Hun; Kang, Jung Won; Kim, Kun Hyung; Kang, Kyung-Won; Shin, Mi-Suk; Jung, So-Young; Kim, Ae-Ran; Jung, Hee-Jung; Choi, Sun-Mi] Korea Inst Oriental Med, Acupuncture Moxibust & Meridian Res Ctr, Taejon, South Korea; [Kim, Tae-Hun] Kyung Hee Univ, Grad Sch, Coll Oriental Med, Dept Cardiovasc & Neurol Dis, Seoul, South Korea; [Kang, Jung Won] Kyung Hee Univ, Dept Acupuncture & Moxibust, Coll Oriental Med, Seoul, South Korea; [Kim, Kun Hyung] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Gyeongsangnam Do, South Korea; [Choi, Jin-Bong] Dongshin Univ, Dept Oriental Rehabil Med, Kwangju, South Korea; [Hong, Kwon Eui] Daejeon Univ, Dept Acupuncture & Moxibust, Taejon, South Korea; [Lee, Seung-Deok] Dongguk Univ, Dept Acupuncture & Moxibust, Goyang, South Korea	Korea Institute of Oriental Medicine (KIOM); Kyung Hee University; Kyung Hee University; Pusan National University; Dongshin University; Daejeon University; Dongguk University	Kim, TH (corresponding author), Korea Inst Oriental Med, Acupuncture Moxibust & Meridian Res Ctr, Taejon, South Korea.	smchoi@kiom.re.kr	Kim, Tae-Hun/G-8728-2014; CHOI, SUNMI/AAO-3449-2020; Choi, sunmi/A-2744-2014	Kim, Tae-Hun/0000-0002-8448-3219; 	Development of Acupuncture, Moxibustion and Meridian Standard Health Technology Project of the Korea Institute of Oriental Medicine [K11010]	Development of Acupuncture, Moxibustion and Meridian Standard Health Technology Project of the Korea Institute of Oriental Medicine	This study was supported by the Development of Acupuncture, Moxibustion and Meridian Standard Health Technology Project (K11010) of the Korea Institute of Oriental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Berman BM, 2010, NEW ENGL J MED, V363, P454, DOI 10.1056/NEJMct0806114; Bron AJ, 2007, OCUL SURF, V5, P108; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Egger M, 2003, Health Technol Assess, V7, P1; Foulks Gary N, 2003, Ocul Surf, V1, P107; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; Hardten DR, 2007, CURR MED RES OPIN, V23, P2083, DOI 10.1185/030079907X219670; [何慧琴 He Huiqin], 2004, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V20, P158; Jeon JH, 2010, J ALTERN COMPLEM MED, V16, P1291, DOI 10.1089/acm.2009.0537; Kim TH, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-107; Kim TH, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-112; Kwon D-H, 2009, J KOREAN ACUPUNCTURE, V27, P10; Lam DS, 2011, OPHTHALMOLOGY; Law SK, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006030.pub2; Lee MS, 2011, ACTA OPHTHALMOL, V89, P101, DOI 10.1111/j.1755-3768.2009.01855.x; Lemp MA, 2007, OCUL SURF, V5, P75; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Lemp Michael A, 2008, Am J Manag Care, V14, pS88; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Nepp J, 2002, ACUPUNCTURE ELECTRO, V27, P171, DOI 10.3727/036012902816025988; Oke SL, 2009, ANN NY ACAD SCI, V1172, P172, DOI 10.1196/annals.1393.013; Pang YJ, 2003, J TRADIT CHIN OPAHTH, V13, P18; Park JE, 2010, J ALTERN COMPLEM MED, V16, P959, DOI 10.1089/acm.2009.0415; Paterson C, 1996, BRIT MED J, V312, P1016; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Pflugfelder Stephen C, 2008, Am J Manag Care, V14, pS102; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shin MS, 2010, ACTA OPHTHALMOL, V88, pe328, DOI 10.1111/j.1755-3768.2010.02027.x; Smith JA, 2007, OCUL SURF, V5, P93; So DW, 2002, AM J PUBLIC HEALTH, V92, P1662, DOI 10.2105/AJPH.92.10.1662; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Wang Zhong-Lin, 2005, Zhongguo Zhen Jiu, V25, P460; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; White A, 2008, INTRO W MED ACUPUNCT, Vxviii, P240; Witt CM, 2010, AUTON NEUROSCI-BASIC, V157, P42, DOI 10.1016/j.autneu.2010.06.006; Witt CM, 2011, CHIN J INTEGR MED, V17, P166, DOI 10.1007/s11655-011-0662-x; Witt CM, 2011, EUR J PAIN, V15, P193, DOI 10.1016/j.ejpain.2010.06.008; World Health Organization, 2008, WHO STD AC POINT LOC; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363; Yuan J, 2009, COMPLEMENT THER MED, V17, P131, DOI 10.1016/j.ctim.2008.10.003; Zhao L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-87; 김웅재, 2007, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V48, P1614; 허준, 2006, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V47, P1901	48	37	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36638	10.1371/journal.pone.0036638	http://dx.doi.org/10.1371/journal.pone.0036638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615787	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200013
J	Paul, ES; Pope, SAJ; Fennell, JG; Mendl, MT				Paul, Elizabeth S.; Pope, Stuart A. J.; Fennell, John G.; Mendl, Michael T.			Social Anxiety Modulates Subliminal Affective Priming	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; ATTENTIONAL BIAS; MOOD AWARENESS; ANGRY FACES; IDENTIFICATION; JUDGMENTS; INDIVIDUALS; AMYGDALA; HAPPY; SEE	Background: It is well established that there is anxiety-related variation between observers in the very earliest, pre-attentive stage of visual processing of images such as emotionally expressive faces, often leading to enhanced attention to threat in a variety of disorders and traits. Whether there is also variation in early-stage affective (i.e. valenced) responses resulting from such images, however, is not yet known. The present study used the subliminal affective priming paradigm to investigate whether people varying in trait social anxiety also differ in their affective responses to very briefly presented, emotionally expressive face images. Methodology/Principal Findings: Participants (n = 67) completed a subliminal affective priming task, in which briefly presented and smiling, neutral and angry faces were shown for 10 ms durations (below objective and subjective thresholds for visual discrimination), and immediately followed by a randomly selected Chinese character mask (2000 ms). Ratings of participants' liking for each Chinese character indicated the degree of valenced affective response made to the unseen emotive images. Participants' ratings of their liking for the Chinese characters were significantly influenced by the type of face image preceding them, with smiling faces generating more positive ratings than neutral and angry ones (F(2,128) = 3.107, p<0.05). Self-reported social anxiety was positively correlated with ratings of smiling relative to neutral-face primed characters (Pearson's r =.323, p<0.01). Individual variation in self-reported mood awareness was not associated with ratings. Conclusions: Trait social anxiety is associated with individual variation in affective responding, even in response to the earliest, pre-attentive stage of visual image processing. However, the fact that these priming effects are limited to smiling and not angry (i.e. threatening) images leads us to propose that the pre-attentive processes involved in generating the subliminal affective priming effect may be different from those that generate attentional biases in anxious individuals.	[Paul, Elizabeth S.; Pope, Stuart A. J.; Mendl, Michael T.] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England; [Fennell, John G.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Bristol; University of Bristol	Paul, ES (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	e.paul@bristol.ac.uk	Mendl, Michael T/D-7220-2016; Fennell, John G/V-5947-2018	Mendl, Michael T/0000-0002-5302-1871; Fennell, John G/0000-0003-2991-3391	Biotechnology and Biological Sciences Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/C518949/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was provided by Biotechnology and Biological Sciences Research Council (UK) Animal Welfare Programme (http://www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anders S, 2004, NAT NEUROSCI, V7, P339, DOI 10.1038/nn1213; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; Coffey E, 2003, COGNITION EMOTION, V17, P671, DOI 10.1080/02699930302304; Dannlowski U, 2007, PSYCHIAT RES-NEUROIM, V154, P13, DOI 10.1016/j.pscychresns.2006.05.005; Dannlowski U, 2006, EUR ARCH PSY CLIN N, V256, P215, DOI 10.1007/s00406-005-0628-0; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2008, CURR BIOL, V18, pR1128, DOI 10.1016/j.cub.2008.11.002; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; EKMAN P, 1976, PICTURES FACIAL EFFE; ESTEVES F, 1994, COGNITION EMOTION, V8, P393, DOI 10.1080/02699939408408949; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Furmark T, 2002, ACTA PSYCHIAT SCAND, V105, P84, DOI 10.1034/j.1600-0447.2002.1r103.x; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Gilboa-Schetman E, 1999, COGN EMO, V13, P301; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Hermans D, 2003, CAN J EXP PSYCHOL, V57, P97, DOI 10.1037/h0087416; HOLENDER D, 1986, BEHAV BRAIN SCI, V9, P1, DOI 10.1017/S0140525X00021269; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; Hoschel K, 2001, SCHIZOPHRENIA BULL, V27, P317, DOI 10.1093/oxfordjournals.schbul.a006877; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koschack J, 2003, J NERV MENT DIS, V191, P175, DOI 10.1097/00005053-200303000-00006; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Machado-de-Sousa JP, 2010, J NEUROSCI METH, V193, P1, DOI 10.1016/j.jneumeth.2010.08.013; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Mogg K, 2004, J ABNORM PSYCHOL, V113, P160, DOI 10.1037/0021-843X.113.1.160; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MURPHY ST, 1995, J PERS SOC PSYCHOL, V69, P589, DOI 10.1037/0022-3514.69.4.589; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Ohman A, 1993, HDB EMOTIONS, P511; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Rolls E. T., 2005, EMOTION EXPLAINED; Rotteveel M, 2001, EMOTION, V1, P348, DOI 10.1037//1528-3542.1.4.348; Sato W, 2006, BRAIN COGNITION, V62, P261, DOI 10.1016/j.bandc.2006.06.006; Schneider W, 2000, E PRIME REFERENCE GU; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Staugaard SR, 2010, CLIN PSYCHOL REV, V30, P669, DOI 10.1016/j.cpr.2010.05.001; Stevens S, 2009, BRIT J CLIN PSYCHOL, V48, P125, DOI 10.1348/014466508X368856; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Suslow T, 2003, EUR ARCH PSY CLIN N, V253, P292, DOI 10.1007/s00406-003-0443-4; SWINKELS A, 1995, PERS SOC PSYCHOL B, V21, P934, DOI 10.1177/0146167295219008; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Wieser MJ, 2009, J ANXIETY DISORD, V23, P93, DOI 10.1016/j.janxdis.2008.04.004; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Winkielman P, 1997, COGNITION EMOTION, V11, P433, DOI 10.1080/026999397379872; Winkielman P, 2007, REV GEN PSYCHOL, V11, P179, DOI 10.1037/1089-2680.11.2.179; Wong PS, 2003, CONSCIOUS COGN, V12, P147, DOI 10.1016/S1053-8100(03)00007-2; Yoon KL, 2008, J ABNORM PSYCHOL, V117, P680, DOI 10.1037/0021-843X.117.3.680; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	13	13	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37011	10.1371/journal.pone.0037011	http://dx.doi.org/10.1371/journal.pone.0037011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615873	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200031
J	Li, LZ; Ben, YY; Yuan, SH; Jiang, SB; Xu, JQ; Zhang, XY				Li, Liangzhu; Ben, Yinyin; Yuan, Songhua; Jiang, Shibo; Xu, Jianqing; Zhang, Xiaoyan			Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1	PLOS ONE			English	Article							IN-VITRO; TOPICAL MICROBICIDES; VAGINAL MICROBICIDE; FUSION INHIBITOR; INFECTION; PREVENTION; SAFETY; MODEL; TOXICITY; PEPTIDE	Sifuvirtide is a proven effective HIV-1 entry inhibitor and its safety profile has been established for systemic administration. The present study evaluated the potential of sifuvirtide formulated in a universal gel for topical use as a microbicide candidate for preventing sexual transmission of HIV. Our data showed that sifuvirtide formulated in HEC gel is effective against HIV-1 B, C subtypes, CRF07_BC and CRF01_AE, the latter two recombinants represents the most prevalent strains in China. In addition, we demonstrated that sifuvirtide in gel is stable for at least 8 weeks even at 40 degrees C, and did not cause the disruption of integrity of mucosal epithelial surface, or the up-regulation of inflammatory cytokines both in vitro or in vivo. These results suggest that sifuvirtide gel is an effective, safe and stable product, and should be further tested as a vaginal or rectal microbicide in pre-clinical model or clinical trial for preventing HIV sexual transmission.	[Li, Liangzhu] Fudan Univ, Shanghai Med Coll, MOH MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Li, LZ (corresponding author), Fudan Univ, Shanghai Med Coll, MOH MOE Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	jianqingxu2008@gmail.com; zhang_xycn2002@yahoo.com.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Grand Program on Key Infectious Disease Control [2012ZX10001-007-008]; National Ministry of Science and Technology of China [2012CB519000]; Natural Science Foundation of China [81102282, 81171553]	National Grand Program on Key Infectious Disease Control; National Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Grand Program on Key Infectious Disease Control (2012ZX10001-007-008), National Ministry of Science and Technology of China (2012CB519000), and the Natural Science Foundation of China (81102282 and 81171553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dai SJ, 2005, ACTA PHARMACOL SIN, V26, P1274, DOI 10.1111/j.1745-7254.2005.00163.x; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Li LZ, 2010, CHINESE MED J-PEKING, V123, P3381, DOI 10.3760/cma.j.issn.0366-6999.2010.23.002; Li L, 2011, JAIDS-J ACQ IMM DEF, V56, P384, DOI 10.1097/QAI.0b013e31820a4a8d; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; Qiu Chao, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P394; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; UNAIDS, UNAIDS REP GLOB AIDS; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057	22	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37381	10.1371/journal.pone.0037381	http://dx.doi.org/10.1371/journal.pone.0037381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615996	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300107
J	Liu, XH; Zhang, B; Guo, Y; Liang, Q; Wu, CY; Wu, L; Tao, KX; Wang, GB; Chen, JY				Liu, Xinghua; Zhang, Bo; Guo, Yan; Liang, Qi; Wu, Changyao; Wu, Lei; Tao, Kaixiong; Wang, Guobin; Chen, Jianying			Down-Regulation of AP-4 Inhibits Proliferation, Induces Cell Cycle Arrest and Promotes Apoptosis in Human Gastric Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-4; IMMUNODEFICIENCY-VIRUS TYPE-1; LOOP-HELIX PROTEINS; ACTIVATOR PROTEIN-4; DNA-BINDING; RNA INTERFERENCE; ENHANCER-BINDING; MYC-HOMOLOGY; EXPRESSION; GENE	Background: AP-4 belongs to the basic helix-loop-helix leucine-zipper subgroup; it controls target gene expression, regulates growth, development and cell apoptosis and has been implicated in tumorigenesis. Our previous studies indicated that AP-4 was frequently overexpressed in gastric cancers and may be associated with the poor prognosis. The purpose of this study is to examine whether silencing of AP-4 can alter biological characteristics of gastric cancer cells. Methods: Two specific siRNAs targeting AP-4 were designed, synthesized, and transfected into gastric cancer cell lines and human normal mucosa cells. AP-4 expression was measured with real-time quantitative PCR and Western blot. Cell proliferation and chemo-sensitivity were detected by CCK-8 assay. Cell cycle assay and apoptosis assay were performed by flow cytometer, and relative expression of cell cycle regulators were detected by real-time quantitative PCR and Western blot, expression of the factors involved in the apoptosis pathway were examined in mRNA and protein level. Results: The expression of AP-4 was silenced by the siRNAs transfection and the effects of AP-4 knockdown lasted 24 to 96 hrs. The siRNA-mediated silencing of AP-4 suppressed the cellular proliferation, induced apoptosis and sensitized cancer cells to anticancer drugs. In addition, the expression level of p21, p53 and Caspase-9 were increased when AP-4 was knockdown, but the expression of cyclin D1, Bcl-2 and Bcl-xL was inhibited. It didn't induce cell cycle arrest when AP-4 was knockdown in p53 defect gastric cancer cell line Kato-III. Conclusions: These results illustrated that gene silencing of AP-4 can efficiently inhibited cell proliferation, triggered apoptosis and sensitized cancer cells to anticancer drugs in vitro, suggesting that AP-4 siRNAs mediated silencing has a potential value in the treatment of human gastric cancer.	[Liu, Xinghua; Zhang, Bo; Liang, Qi; Wu, Changyao; Wu, Lei; Tao, Kaixiong; Wang, Guobin; Chen, Jianying] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Guo, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, XH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China.	union_wang.guobin@yahoo.com.cn; unionchen@yahoo.com.cn			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Andriamanalijaona R, 2003, ARTHRITIS RHEUM, V48, P1569, DOI 10.1002/art.11020; Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bae Y, 2001, MOL CELL PROBE, V15, P313, DOI 10.1006/mcpr.2001.0375; Bi Feng, 2003, Current Gene Therapy, V3, P411, DOI 10.2174/1566523034578203; Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243; Campbell TN, 2005, CURR ISSUES MOL BIOL, V7, P1; Cao J, 2009, INT J SURG PATHOL, V17, P16, DOI 10.1177/1066896908315813; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; Correia M, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00696.x; Cui Y, 1998, GENE, V224, P97, DOI 10.1016/S0378-1119(98)00512-5; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FODOR E, 1991, BIOCHEMISTRY-US, V30, P8102, DOI 10.1021/bi00247a002; Friez M, 1999, J VIROL, V73, P1990, DOI 10.1128/JVI.73.3.1990-1997.1999; Glahder JA, 2003, J GEN VIROL, V84, P3429, DOI 10.1099/vir.0.19250-0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Karagiannis TC, 2004, CANCER BIOL THER, V3, P1069, DOI 10.4161/cbt.3.11.1309; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lee CC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-58; Lee SU, 2009, MOL CELLS, V28, P455, DOI 10.1007/s10059-009-0145-5; Lewis PJ, 2008, MICROBIOL-SGM, V154, P1837, DOI 10.1099/mic.0.2008/018549-0; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; [林天歆 Lin Tianxin], 2006, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V27, P19; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Perrimon N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003640; Philchenkov A, 2004, J CELL MOL MED, V8, P432, DOI 10.1111/j.1582-4934.2004.tb00468.x; Siegel PM, 2010, ONCOGENE, V29, P2753, DOI 10.1038/onc.2010.43; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Tsujimoto K, 2005, J BIOL CHEM, V280, P27638, DOI 10.1074/jbc.M501304200; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; UNK I, 1994, NUCLEIC ACIDS RES, V22, P4872; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Xinghua L, 2011, MED ONCOL; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340	50	28	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37096	10.1371/journal.pone.0037096	http://dx.doi.org/10.1371/journal.pone.0037096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615908	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300069
J	Svensson, JP; Fry, RC; Wang, EM; Somoza, LA; Samson, LD				Svensson, J. Peter; Fry, Rebecca C.; Wang, Emma; Somoza, Luis A.; Samson, Leona D.			Identification of Novel Human Damage Response Proteins Targeted through Yeast Orthology	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; MALIGNANT GLIOMA; CANCER-CELLS; AUTOPHAGY; GENOME; GENE; RADIATION; PATHWAYS	Studies in Saccharomyces cerevisiae show that many proteins influence cellular survival upon exposure to DNA damaging agents. We hypothesized that human orthologs of these S. cerevisiae proteins would also be required for cellular survival after treatment with DNA damaging agents. For this purpose, human homologs of S. cerevisiae proteins were identified and mapped onto the human protein-protein interaction network. The resulting human network was highly modular and a series of selection rules were implemented to identify 45 candidates for human toxicity-modulating proteins. The corresponding transcripts were targeted by RNA interference in human cells. The cell lines with depleted target expression were challenged with three DNA damaging agents: the alkylating agents MMS and 4-NQO, and the oxidizing agent t-BuOOH. A comparison of the survival revealed that the majority (74%) of proteins conferred either sensitivity or resistance. The identified human toxicity-modulating proteins represent a variety of biological functions: autophagy, chromatin modifications, RNA and protein metabolism, and telomere maintenance. Further studies revealed that MMS-induced autophagy increase the survival of cells treated with DNA damaging agents. In summary, we show that damage recovery proteins in humans can be identified through homology to S. cerevisiae and that many of the same pathways are represented among the toxicity modulators.	[Svensson, J. Peter; Fry, Rebecca C.; Wang, Emma; Somoza, Luis A.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Biol Engn Dept, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Svensson, JP (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	lsamson@mit.edu	Svensson, J Peter/B-4276-2008	Svensson, J Peter/0000-0002-5863-6250; Fry, Rebecca/0000-0003-0899-9018	National Institute of Environmental Health Sciences (NIEHS) [ES02109]; National Cancer Institutes (NCI) [CA55042, CA112967]; Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA055042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institutes (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institute of Environmental Health Sciences (NIEHS) (ES02109) and the National Cancer Institutes (NCI) (CA55042 and CA112967). Dr. Svensson was supported by a post-doctoral fellowship from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Ding ZB, 2011, CLIN CANCER RES, V17, P6229, DOI 10.1158/1078-0432.CCR-11-0816; Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Forand A, 2009, BIOL REPROD, V80, P860, DOI 10.1095/biolreprod.108.072884; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; GALIEGUEZOUITINA S, 1985, CANCER RES, V45, P520; GALIEGUEZOUITINA S, 1986, CANCER RES, V46, P1858; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hong MY, 2005, EXP BIOL MED, V230, P464; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; JONES CJ, 1989, CARCINOGENESIS, V10, P1197, DOI 10.1093/carcin/10.7.1197; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kiss H, 2001, GENOMICS, V73, P10, DOI 10.1006/geno.2000.6498; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Li CY, 2009, INT J CANCER, V124, P999, DOI 10.1002/ijc.24126; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meira LB, 2009, P NATL ACAD SCI USA, V106, P888, DOI 10.1073/pnas.0807030106; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Paglin S, 2001, CANCER RES, V61, P439; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perez RE, 2010, J CELL PHYSIOL, V225, P394, DOI 10.1002/jcp.22285; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Qi D, 2004, MOL CELL BIOL, V24, P8080, DOI 10.1128/MCB.24.18.8080-8089.2004; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Roth RB, 2002, CANCER RES, V62, P656; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Scharer OD, 2010, CHEM BIOL DNA DAMAGE; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suwaki N, 2010, ARCH BIOCHEM BIOPHYS, V497, P55, DOI 10.1016/j.abb.2010.03.003; Svensson JP, 2011, BMC SYSTEMS IN PRESS; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WADE MH, 1979, MUTAT RES, V59, P49, DOI 10.1016/0027-5107(79)90194-5; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37368	10.1371/journal.pone.0037368	http://dx.doi.org/10.1371/journal.pone.0037368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615993	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300106
J	Andersen, HR; Wohlfahrt-Veje, C; Dalgard, C; Christiansen, L; Main, KM; Nellemann, C; Murata, K; Jensen, TK; Skakkebaek, NE; Grandjean, P				Andersen, Helle R.; Wohlfahrt-Veje, Christine; Dalgard, Christine; Christiansen, Lene; Main, Katharina M.; Nellemann, Christine; Murata, Katsuyuki; Jensen, Tina K.; Skakkebaek, Niels E.; Grandjean, Philippe			Paraoxonase 1 Polymorphism and Prenatal Pesticide Exposure Associated with Adverse Cardiovascular Risk Profiles at School Age	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; CATCH-UP GROWTH; SERUM PARAOXONASE; BIRTH-WEIGHT; DEVELOPMENTAL EXPOSURE; GENETIC POLYMORPHISMS; Q192R POLYMORPHISM; DIABETES-MELLITUS; RURAL-POPULATION	Background: Prenatal environmental factors might influence the risk of developing cardiovascular disease later in life. The HDL-associated enzyme paraoxonase 1 (PON1) has anti-oxidative functions that may protect against atherosclerosis. It also hydrolyzes many substrates, including organophosphate pesticides. A common polymorphism, PON1 Q192R, affects both properties, but a potential interaction between PON1 genotype and pesticide exposure on cardiovascular risk factors has not been investigated. We explored if the PON1 Q192R genotype affects cardiovascular risk factors in school-age children prenatally exposed to pesticides. Methods: Pregnant greenhouse-workers were categorized as high, medium, or not exposed to pesticides. Their children underwent a standardized examination at age 6-to-11 years, where blood pressure, skin folds, and other anthropometric parameters were measured. PON1-genotype was determined for 141 children (88 pesticide exposed and 53 unexposed). Serum was analyzed for insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP3), insulin and leptin. Body fat percentage was calculated from skin fold thicknesses. BMI results were converted to age and sex specific Z-scores. Results: Prenatally pesticide exposed children carrying the PON1 192R-allele had higher abdominal circumference, body fat content, BMI Z-scores, blood pressure, and serum concentrations of leptin and IGF-I at school age than unexposed children. The effects were related to the prenatal exposure level. For children with the PON1 192QQ genotype, none of the variables was affected by prenatal pesticide exposure. Conclusion: Our results indicate a gene-environment interaction between prenatal pesticide exposure and the PON1 gene. Only exposed children with the R-allele developed adverse cardiovascular risk profiles thought to be associated with the R-allele.	[Andersen, Helle R.; Dalgard, Christine; Christiansen, Lene; Jensen, Tina K.; Grandjean, Philippe] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Wohlfahrt-Veje, Christine; Main, Katharina M.; Skakkebaek, Niels E.] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Nellemann, Christine] Tech Univ Denmark, Div Toxicol & Risk Assessment, Natl Food Inst, Soborg, Denmark; [Murata, Katsuyuki] Akita Univ, Grad Sch Med, Dept Environm Hlth Sci, Akita 010, Japan; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Southern Denmark; Rigshospitalet; University of Copenhagen; Technical University of Denmark; Akita University; Harvard University; Harvard T.H. Chan School of Public Health	Andersen, HR (corresponding author), Univ So Denmark, Inst Publ Hlth, Odense, Denmark.	hrandersen@health.sdu.dk	; Grandjean, Philippe/I-2962-2014	Wohlfahrt-Veje, Christine/0000-0002-8920-950X; Dalgard, Christine/0000-0001-8184-3429; Jensen, Tina Kold/0000-0003-2311-5778; Andersen, Helle Raun/0000-0002-9184-3593; Nellemann, Christine/0000-0002-4692-5127; Grandjean, Philippe/0000-0003-4046-9658; Main, Katharina Maria/0000-0001-7259-1039	Danish Environmental Protection Agency [669-00102]; Danish Council for Strategic Research [2101-08-0058]	Danish Environmental Protection Agency; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The study was supported by the Danish Environmental Protection Agency (project number 669-00102) and The Danish Council for Strategic Research, Program Commission on Health, Food and Welfare (project number 2101-08-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2008, ENVIRON HEALTH PERSP, V116, P566, DOI 10.1289/ehp.10790; Andersen HR, 2007, OCCUP ENVIRON MED, V64, P708, DOI 10.1136/oem.2006.031070; Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Banerjee I, 2010, EUR J EPIDEMIOL, V25, P449, DOI 10.1007/s10654-010-9470-4; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Bourguignon JP, 2010, MOL CELL ENDOCRINOL, V324, P110, DOI 10.1016/j.mce.2010.02.033; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; Christiansen L, 2004, EUR J HUM GENET, V12, P843, DOI 10.1038/sj.ejhg.5201235; Costa LG, 2003, J TOXICOL-CLIN TOXIC, V41, P37, DOI 10.1081/CLT-120018269; Dabrowski Slawomir, 2003, Int J Occup Med Environ Health, V16, P31; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Dalgard C, 2007, EUR J NUTR, V46, P354, DOI 10.1007/s00394-007-0675-6; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Grandjean P, 2004, J PEDIATR-US, V144, P169, DOI 10.1016/j.jpeds.2003.10.058; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Hanke W, 2003, INT ARCH OCC ENV HEA, V76, P614, DOI 10.1007/s00420-003-0471-4; HANSEN EJ, 1978, DISTRIBUTION LIVING; Hansen EJ, 1986, DANSKERNES LEVEVILKA; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Honour JW, 2007, J CLIN ENDOCR METAB, V92, P4340, DOI 10.1210/jc.2007-0851; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Langley-Evans SC, 2006, P NUTR SOC, V65, P97, DOI 10.1079/PNS2005478; Lassiter TL, 2008, NEUROTOXICOL TERATOL, V30, P125, DOI 10.1016/j.ntt.2007.10.004; Lassiter TL, 2010, BRAIN RES BULL, V81, P85, DOI 10.1016/j.brainresbull.2009.07.002; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Levario-Carrillo M, 2004, CHEMOSPHERE, V55, P1421, DOI 10.1016/j.chemosphere.2003.11.027; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Li WF, 2000, PHARMACOGENETICS, V10, P767, DOI 10.1097/00008571-200012000-00002; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness B, 2003, PHARMACOGENETICS, V13, P81, DOI 10.1097/00008571-200302000-00004; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; Manresa JM, 2006, EUR J CARDIOV PREV R, V13, P738, DOI 10.1097/01.hjr.0000224484.80349.3f; Mendonca MI, 2010, REV PORT CARDIOL, V29, P571; Moreno-Banda G, 2009, SCI TOTAL ENVIRON, V407, P5478, DOI 10.1016/j.scitotenv.2009.06.033; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Ong KK, 2010, ENDOCR DEV, V19, P53, DOI 10.1159/000316897; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Orton F, 2011, ENVIRON HEALTH PERSP, V119, P794, DOI [10.1289/ehp.1002895, 10.1289/ehp.1002897]; Rodriguez G, 2005, EUR J CLIN NUTR, V59, P1158, DOI 10.1038/sj.ejcn.1602226; Seo D, 2009, CURR ATHEROSCLER REP, V11, P182, DOI 10.1007/s11883-009-0029-3; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Slotkin TA, 2005, ENVIRON HEALTH PERSP, V113, P1291, DOI 10.1289/ehp.8133; Smink A, 2008, ACTA PAEDIATR, V97, P1465, DOI 10.1111/j.1651-2227.2008.00937.x; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Tsatsakis AM, 2009, TOXICOL LETT, V186, P66, DOI 10.1016/j.toxlet.2008.10.018; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Veiga L, 2011, EUR J ENDOCRINOL, V164, P213, DOI 10.1530/EJE-10-0825; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; Wohlfahrt-Veje C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-79	65	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36830	10.1371/journal.pone.0036830	http://dx.doi.org/10.1371/journal.pone.0036830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615820	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300040
J	Lerner, M; Haneklaus, M; Harada, M; Grander, D				Lerner, Mikael; Haneklaus, Moritz; Harada, Masako; Grander, Dan			MiR-200c Regulates Noxa Expression and Sensitivity to Proteasomal Inhibitors	PLOS ONE			English	Article							MANTLE-CELL LYMPHOMA; MESSENGER-RNA; INDUCED APOPTOSIS; CANCER-CELLS; MULTIPLE-MYELOMA; TARGETING BCL2; BORTEZOMIB; MICRORNAS; FAMILY; MCL-1	The pro-apoptotic p53 target Noxa is a BH3-only protein that antagonizes the function of selected anti-apoptotic Bcl-2 family members. While much is known regarding the transcriptional regulation of Noxa, its posttranscriptional regulation remains relatively unstudied. In this study, we therefore investigated whether Noxa is regulated by microRNAs. Using a screen combining luciferase reporters, bioinformatic target prediction analysis and microRNA expression profiling, we identified miR-200c as a negative regulator of Noxa expression. MiR-200c was shown to repress basal expression of Noxa, as well as Noxa expression induced by various stimuli, including proteasomal inhibition. Luciferase reporter experiments furthermore defined one miR-200c target site in the Noxa 3'UTR that is essential for this direct regulation. In spite of the miR-200c:Noxa interaction, miR-200c overexpression led to increased sensitivity to the clinically used proteasomal inhibitor bortezomib in several cell lines. This apparently contradictory finding was reconciled by the fact that in cells devoid of Noxa expression, miR-200c overexpression had an even more pronounced positive effect on apoptosis induced by proteasomal inhibition. Together, our data define miR-200c as a potentiator of bortezomib-induced cell death. At the same time, we show that miR-200c is a novel negative regulator of the pro-apoptotic Bcl-2 family member Noxa.	[Lerner, Mikael; Haneklaus, Moritz; Harada, Masako; Grander, Dan] Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lerner, M (corresponding author), Karolinska Inst, CCK, Dept Oncol Pathol, Stockholm, Sweden.	Mikael.Lerner@ki.se	Haneklaus, Moritz/AAE-4728-2020; Harada, Masako/V-4884-2019	Harada, Masako/0000-0003-0871-1125	Swedish Cancer Society; Cancerfonden; Barncancerfonden; Gustav V Jubileumsfond; Swedish Research Council; Karolinska Institutets Forskningsstiftelser; Karolinska Institute Foundations	Swedish Cancer Society(Swedish Cancer Society); Cancerfonden(Swedish Cancer Society); Barncancerfonden; Gustav V Jubileumsfond; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutets Forskningsstiftelser; Karolinska Institute Foundations(Karolinska Institutet)	This work was supported by grants from the Swedish Cancer Society, Cancerfonden, Barncancerfonden, Gustav V Jubileumsfond, the Swedish Research Council, Karolinska Institutets Forskningsstiftelser, and Karolinska Institute Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Baou M, 2010, HAEMATOL-HEMATOL J, V95, P1510, DOI 10.3324/haematol.2010.022368; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ishimaru D, 2010, J BIOL CHEM, V285, P27182, DOI 10.1074/jbc.M109.098830; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Sub KS, 2008, FUTURE ONCOL, V4, P149, DOI 10.2217/14796694.4.2.149; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thyrell L, 2002, ONCOGENE, V21, P1251, DOI 10.1038/sj.onc.1205179; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2011, CELL DEATH DIFFER; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	44	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36490	10.1371/journal.pone.0036490	http://dx.doi.org/10.1371/journal.pone.0036490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615771	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300018
J	Senter, P; Kirkland, JI; DeBlieux, DD; Madsen, S; Toth, N				Senter, Phil; Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott; Toth, Natalie			New Dromaeosaurids (Dinosauria: Theropoda) from the Lower Cretaceous of Utah, and the Evolution of the Dromaeosaurid Tail	PLOS ONE			English	Article							CREATION SCIENCE; YIXIAN FORMATION; BIRDS; MONGOLIA; ANATOMY; ALBERTA; ORIGIN; CHINA	Background: The Yellow Cat Member of the Cedar Mountain Formation (Early Cretaceous, Barremian? - Aptian) of Utah has yielded a rich theropod fauna, including the coelurosaur Nedcolbertia justinhofmanni, the therizinosauroid Falcarius utahensis, the troodontid Geminiraptor suarezarum, and the dromaeosaurid Utahraptor ostrommaysorum. Recent excavation has uncovered three new dromaeosaurid specimens. One specimen, which we designate the holotype of the new genus and species Yurgovuchia doellingi, is represented by a partial axial skeleton and a partial left pubis. A second specimen consists of a right pubis and a possibly associated radius. The third specimen consists of a tail skeleton that is unique among known Cedar Mountain dromaeosaurids. Methodology/Principal Findings: Y. doellingi resembles Utahraptor ostrommaysorum in that its caudal prezygapophyses are elongated but not to the degree present in most dromaeosaurids. The specimen represented by the right pubis exhibits a pronounced pubic tubercle, a velociraptorine trait that is absent in Y. doellingi. The specimen represented by the tail skeleton exhibits the extreme elongation of the caudal prezygapophyses that is typical of most dromaeosaurids. Here we perform a phylogenetic analysis to determine the phylogenetic position of Y. doellingi. Using the resulting phylogeny as a framework, we trace changes in character states of the tail across Coelurosauria to elucidate the evolution of the dromaeosaurid tail. Conclusions/Significance: The new specimens add to the known diversity of Dromaeosauridae and to the known diversity within the Yellow Cat paleofauna. Phylogenetic analysis places Y. doellingi in a clade with Utahraptor, Achillobator, and Dromaeosaurus. Character state distribution indicates that the presence of intermediate- length caudal prezygapophyses in that clade is not an evolutionarily precursor to extreme prezygapophyseal elongation but represents a secondary shortening of caudal prezygapophyses. It appears to represent part of a trend within Dromaeosauridae that couples an increase in tail flexibility with increasing size.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott] Utah Geol & Min Survey, Salt Lake City, UT USA; [Toth, Natalie] Utah Museum Nat Hist, Rio Tinto Ctr, Salt Lake City, UT USA	University of North Carolina; Fayetteville State University; Rio Tinto	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu						ACHENBACH J, 2003, NATL GEOGR, V203, P2; Allain R, 2000, J VERTEBR PALEONTOL, V20, P404, DOI 10.1671/0272-4634(2000)020[0404:ANGODD]2.0.CO;2; Aubrey W.M., 1998, UPPER JURASSIC MORRI, V22, P209; Aubrey WM, 1996, UTAH GEOLOGICAL ASS, V25, P211; AYERS J.D., 2004, THESIS OHIO U ATHENS; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; Barsbold R., 1983, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, P1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Burnham DA, 2004, LIFE O PAST, P67; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Colbert E. H., 1969, American Museum Novitates, VNo. 2380, P1; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Currie PJ, 2004, LIFE O PAST, P112; Czerkas SA, 2002, FEATHERED DINOSAURS, P98; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; Dal Sasso Cristiano, 2011, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V37, P1; DAMES W, 1884, PALAEONTOLOGISCHE AB, V2, P119; Doelling H.H., 2003, GEOLOGY UTAHS PARKS, V28, P11; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028964; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GREENHALGH B.W., 2007, CENTRAL UTAH DIVERSE, V36, P81; Harris J. D., 1998, NEW MEXICO MUSEUM NA, V14, P225; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F.von., 1914, ZENTRALBLATT MINER B, V1914, P154; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Ji S, 2007, ACTA GEOL SIN-ENGL, V81, P8; Kirkland J.I., 1993, HUNTERIA, V2, P1; Kirkland J.I., 1999, UTAH GEOLOGICAL SURV, V99-1, P201; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P239; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Kobayashi Y, 2005, LIFE O PAST, P97; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Le Loeuff Jean, 1998, Oryctos, V1, P105; [刘金远 Liu Jinyuan], 2004, [地质通报, Geological Bulletin of China], V23, P778; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; MADDISON WP, 1999, MACCLADE 3 08A; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Manning PL, 2006, BIOL LETTERS, V2, P110, DOI 10.1098/rsbl.2005.0395; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2009, P ROY SOC B-BIOL SCI, V276, P1101, DOI 10.1098/rspb.2008.1554; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Perle A., 1999, CONTRIBUTIONS DEP GE, V101, P1; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1972, CAN J EARTH SCI, V9, P375, DOI 10.1139/e72-031; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Senter P, 2011, J EVOLUTION BIOL, V24, P2197, DOI 10.1111/j.1420-9101.2011.02349.x; Senter P, 2010, J EVOLUTION BIOL, V23, P1732, DOI 10.1111/j.1420-9101.2010.02039.x; Senter Phil, 2004, Bulletin of Gunma Museum of Natural History, V8, P1; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014329; Senter Phil, 2009, Bulletin of Gunma Museum of Natural History, V13, P1; SUES HD, 1978, ZOOL J LINN SOC-LOND, V62, P381, DOI 10.1111/j.1096-3642.1978.tb01049.x; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sullivan R.M, 2011, NEW MEXICO MUSEUM NA, V53, P418; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tahara R, 2011, J VERTEBR PALEONTOL, V31, P127, DOI 10.1080/02724634.2011.539646; Taylor MP, 2011, ACTA PALAEONTOL POL, V56, P75, DOI 10.4202/app.2010.0073; Tidwell Virginia, 2001, P139; Tidwell W.D., 1998, COMMON FOSSIL PLANTS; Tidwell WD, 1996, GUIDEBOOK PALEOZOIC, P57; Toth N, 2010, THESIS S DAKOTA SCH; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2003, ACTA GEOL SIN-ENGL, V77, P294; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu Xing, 2010, Zootaxa, V2403, P1; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang X.-H., 2001, VERTEBRAT PALASIATIC, V39, P283; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	98	31	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36790	10.1371/journal.pone.0036790	http://dx.doi.org/10.1371/journal.pone.0036790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615813	gold, Green Published			2022-12-27	WOS:000305336300036
J	Standish, AJ; Salim, AA; Zhang, H; Capon, RJ; Morona, R				Standish, Alistair J.; Salim, Angela A.; Zhang, Hua; Capon, Robert J.; Morona, Renato			Chemical Inhibition of Bacterial Protein Tyrosine Phosphatase Suppresses Capsule Production	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; KINASE WZC; EXTRACELLULAR POLYSACCHARIDES; MOLECULAR CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; SEQUENCE-ANALYSIS; BIOSYNTHESIS	Capsule polysaccharide is a major virulence factor for a wide range of bacterial pathogens, including Streptococcus pneumoniae. The biosynthesis of Wzy-dependent capsules in both Gram-negative and -positive bacteria is regulated by a system involving a protein tyrosine phosphatase (PTP) and a protein tyrosine kinase. However, how the system functions is still controversial. In Streptococcus pneumoniae, a major human pathogen, the system is present in all but 2 of the 93 serotypes found to date. In order to study this regulation further, we performed a screen to find inhibitors of the phosphatase, CpsB. This led to the observation that a recently discovered marine sponge metabolite, fascioquinol E, inhibited CpsB phosphatase activity both in vitro and in vivo at concentrations that did not affect the growth of the bacteria. This inhibition resulted in decreased capsule synthesis in D39 and Type 1 S. pneumoniae. Furthermore, concentrations of Fascioquinol E that inhibited capsule also lead to increased attachment of pneumococci to a macrophage cell line, suggesting that this compound would inhibit the virulence of the pathogen. Interestingly, this compound also inhibited the phosphatase activity of the structurally unrelated Gram-negative PTP, Wzb, which belongs to separate family of protein tyrosine phosphatases. Furthermore, incubation with Klebsiella pneumoniae, which contains a homologous phosphatase, resulted in decreased capsule synthesis. Taken together, these data provide evidence that PTPs are critical for Wzy-dependent capsule production across a spectrum of bacteria, and as such represents a valuable new molecular target for the development of anti-virulence antibacterials.	[Standish, Alistair J.; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Salim, Angela A.; Zhang, Hua; Capon, Robert J.] Univ Queensland, Div Chem & Struct Biol, Inst Mol Biosci, St Lucia, Qld, Australia	University of Adelaide; University of Queensland	Standish, AJ (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	alistair.standish@adelaide.edu.au	Morona, Renato/B-7746-2013; Capon, Robert/G-9238-2012; Salim, Angela/J-4884-2014	Morona, Renato/0000-0001-7009-7440; Capon, Robert/0000-0002-8341-7754; Salim, Angela/0000-0002-8177-5689	Channel 7 Children's Research Foundation (CRF);  [565526]	Channel 7 Children's Research Foundation (CRF); 	This research was funded by Program Grant 565526 and a Channel 7 Children's Research Foundation (CRF) grant (www.crf.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; COOPER JM, 1983, J INFECT DIS, V147, P312, DOI 10.1093/infdis/147.2.312; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7045, DOI 10.1128/jb.175.21.7045-7055.1993; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Guildolin A, 1995, DEV BIOL STAND, V85, P267; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; Hanson BR, 2011, J BACTERIOL, V193, P411, DOI 10.1128/JB.01098-10; Harvey RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019650; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; LaPointe Gisele, 2008, BMC Biochemistry, V9, P10, DOI 10.1186/1471-2091-9-10; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; LIN WS, 1994, J BACTERIOL, V176, P7005, DOI 10.1128/JB.176.22.7005-7016.1994; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Morona JK, 2002, J BACTERIOL, V184, P577, DOI 10.1128/JB.184.2.577-583.2002; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Nelson AL, 2007, INFECT IMMUN, V75, P83, DOI 10.1128/IAI.01475-06; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; Presecan E, 1997, MICROBIOL-SGM, V143, P3313, DOI 10.1099/00221287-143-10-3313; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Zhang H, 2011, TETRAHEDRON, V67, P2591, DOI 10.1016/j.tet.2011.02.015; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	54	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36312	10.1371/journal.pone.0036312	http://dx.doi.org/10.1371/journal.pone.0036312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22629313	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300014
J	Okazaki, A; Sudo, Y; Takagi, S				Okazaki, Ayako; Sudo, Yuki; Takagi, Shin			Optical Silencing of C. elegans Cells with Arch Proton Pump	PLOS ONE			English	Article							NERVOUS-SYSTEM; INTERROGATION; ACTIVATION; EXPRESSION; MEMBRANE; FAMILY	Background: Optogenetic techniques using light-driven ion channels or ion pumps for controlling excitable cells have greatly facilitated the investigation of nervous systems in vivo. A model organism, C. elegans, with its small transparent body and well-characterized neural circuits, is especially suitable for optogenetic analyses. Methodology/Principal Findings: We describe the application of archaerhodopsin-3 (Arch), a recently reported optical neuronal silencer, to C. elegans. Arch::GFP expressed either in all neurons or body wall muscles of the entire body by means of transgenes were localized, at least partially, to the cell membrane without adverse effects, and caused locomotory paralysis of worms when illuminated by green light (550 nm). Pan-neuronal expression of Arch endowed worms with quick and sustained responsiveness to such light. Worms reliably responded to repeated periods of illumination and non-illumination, and remained paralyzed under continuous illumination for 30 seconds. Worms expressing Arch in different subsets of motor neurons exhibited distinct defects in the locomotory behavior under green light: selective silencing of A-type motor neurons affected backward movement while silencing of B-type motor neurons affected forward movement more severely. Our experiments using a heat-shock-mediated induction system also indicate that Arch becomes fully functional only 12 hours after induction and remains functional for more than 24 hour. Conclusions/Sgnificance: Arch can be used for silencing neurons and muscles, and may be a useful alternative to currently widely used halorhodopsin (NpHR) in optogenetic studies of C. elegans.	[Okazaki, Ayako; Sudo, Yuki; Takagi, Shin] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Okazaki, A (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648601, Japan.	i45116a@nucc.cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022	Sudo, Yuki/0000-0001-8155-9356	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23657100, 22300126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (ST), and from Japan Society for the Promotion of Science (AO). AO is a JSPS DC1 Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5902, DOI 10.1021/bi960129e; Brenner S, 1974, GENETICS, V77, P41; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hart AC, 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1]; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Jorgensen Erik M, 2005, WormBook, P1; Knopfel T, 2010, J NEUROSCI, V30, P14998, DOI 10.1523/JNEUROSCI.4190-10.2010; Kuroyanagi H, 2010, NAT PROTOC, V5, P1495, DOI 10.1038/nprot.2010.107; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nukazuka A, 2008, GENE DEV, V22, P1025, DOI 10.1101/gad.1644008; Rand JB, 2007, ACETYLCHOLINE C ELEG, DOI [doi/10.1895/wormbook.1.14.1, DOI 10.1895/WORMBOOK.1.14.1]; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	30	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35370	10.1371/journal.pone.0035370	http://dx.doi.org/10.1371/journal.pone.0035370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629299	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343100001
J	Yashiro, E; McManus, PS				Yashiro, Erika; McManus, Patricia S.			Effect of Streptomycin Treatment on Bacterial Community Structure in the Apple Phyllosphere	PLOS ONE			English	Article							RESISTANCE GENES; ANTIBIOTIC-RESISTANCE; PSEUDOMONAS-SYRINGAE; TRANSPOSON TN5393; PHYLLOPLANE; MANAGEMENT; DIVERSITY; PLASMIDS; IMPACT; SPREAD	We studied the effect of many years of streptomycin use in apple orchards on the proportion of phyllosphere bacteria resistant to streptomycin and bacterial community structure. Leaf samples were collected during early July through early September from four orchards that had been sprayed with streptomycin during spring of most years for at least 10 years and four orchards that had not been sprayed. The percentage of cultured phyllosphere bacteria resistant to streptomycin at non-sprayed orchards (mean of 65%) was greater than at sprayed orchards (mean of 50%) (P = 0.0271). For each orchard, a 16S rRNA gene clone library was constructed from leaf samples. Proteobacteria dominated the bacterial communities at all orchards, accounting for 71 of 104 OTUs (determined at 97% sequence similarity) and 93% of all sequences. The genera Massilia, Methylobacterium, Pantoea, Pseudomonas, and Sphingomonas were shared across all sites. Shannon and Simpson's diversity indices and Pielou's evenness index were similar among orchards regardless of streptomycin use. Analysis of Similarity (ANOSIM) indicated that long-term streptomycin treatment did not account for the observed variability in community structure among orchards (R = -0.104, P = 0.655). Other variables, including time of summer, temperature and time at sampling, and relative distance of the orchards from each other, also had no significant effect on bacterial community structure. We conclude that factors other than streptomycin exposure drive both the proportion of streptomycin-resistant bacteria and phylogenetic makeup of bacterial communities in the apple phyllosphere in middle to late summer.	[Yashiro, Erika; McManus, Patricia S.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yashiro, E (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	psm@plantpath.wisc.edu	Yashiro, Erika/G-6234-2016	Yashiro, Erika/0000-0002-2364-9908	United States Department of Agriculture Cooperative State Research, Education and Extension Service projects [WIS04828, WIS01425]; Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison	United States Department of Agriculture Cooperative State Research, Education and Extension Service projects; Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison	This work was supported by United States Department of Agriculture Cooperative State Research, Education and Extension Service projects WIS04828 and WIS01425 and the Vaughan-Bascom fund of the Department of Plant Pathology, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Boehme S, 2004, MOL NUTR FOOD RES, V48, P522, DOI 10.1002/mnfr.200400030; Brauer SL, 2006, FEMS MICROBIOL ECOL, V57, P206, DOI 10.1111/j.1574-6941.2006.00107.x; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; Duffy B, 2011, ACTA HORTIC, V896, P483; GOODMAN RN, 1961, AM J CLIN NUTR, V9, P269, DOI 10.1093/ajcn/9.3.269; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handelsman J, 2003, CURR OPIN MICROBIOL, V6, P271, DOI 10.1016/S1369-5274(03)00062-6; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Huang TC, 1999, J APPL MICROBIOL, V86, P741, DOI 10.1046/j.1365-2672.1999.00719.x; Huddleston AS, 1997, APPL ENVIRON MICROB, V63, P1288, DOI 10.1128/AEM.63.4.1288-1297.1997; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mayerhofer G, 2009, J ANTIMICROB CHEMOTH, V63, P1076, DOI 10.1093/jac/dkp055; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; McGhee GC, 2011, PHYTOPATHOLOGY, V101, P192, DOI 10.1094/PHYTO-04-10-0128; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; NORELLI JL, 1991, APPL ENVIRON MICROB, V57, P486, DOI 10.1128/AEM.57.2.486-491.1991; O'Brien TF, 2002, CLIN INFECT DIS, V34, pS78, DOI 10.1086/340244; Ottesen AR, 2009, J FOOD PROTECT, V72, P2321, DOI 10.4315/0362-028X-72.11.2321; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pezzella C, 2004, ANTIMICROB AGENTS CH, V48, P903, DOI 10.1128/AAC.48.3.903-908.2004; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pukall R, 1996, FEMS MICROBIOL ECOL, V20, P53, DOI 10.1016/0168-6496(96)00021-9; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Redford AJ, 2009, MICROB ECOL, V58, P189, DOI 10.1007/s00248-009-9495-y; Rezzonico F, 2009, ANTIMICROB AGENTS CH, V53, P3173, DOI 10.1128/AAC.00036-09; Rodriguez C, 2006, APPL ENVIRON MICROB, V72, P5870, DOI 10.1128/AEM.00963-06; Rodriguez-Sanchez C, 2008, BIOL FERT SOILS, V44, P589, DOI 10.1007/s00374-007-0242-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnabel EL, 1999, APPL ENVIRON MICROB, V65, P4898; SOBICZEWSKI P, 1991, PLANT DIS, V75, P1110, DOI 10.1094/PD-75-1110; SUNDIN GW, 1995, CAN J MICROBIOL, V41, P792, DOI 10.1139/m95-109; SUNDIN GW, 1995, APPL ENVIRON MICROB, V61, P2891, DOI 10.1128/AEM.61.8.2891-2897.1995; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Sundin GW, 2002, CURR MICROBIOL, V45, P63, DOI 10.1007/s00284-001-0100-y; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Tolba S, 2002, FEMS MICROBIOL ECOL, V42, P269, DOI 10.1111/j.1574-6941.2002.tb01017.x; van Overbeek LS, 2002, FEMS MICROBIOL ECOL, V42, P277, DOI 10.1111/j.1574-6941.2002.tb01018.x; Vanbroekhoven K, 2004, ENVIRON MICROBIOL, V6, P1123, DOI 10.1111/j.1462-2920.2004.00654.x; WAKSMAN SA, 1946, ANN NY ACAD SCI, V48, P73, DOI 10.1111/j.1749-6632.1946.tb31756.x; Wang HH, 2011, APPL ENVIRON MICROB, V77, P7093, DOI 10.1128/AEM.06565-11; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yashiro E, 2008, PHYTOPATHOLOGY, V98, pS177; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x	47	38	38	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37131	10.1371/journal.pone.0037131	http://dx.doi.org/10.1371/journal.pone.0037131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629357	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100013
J	Alberti, MO; Roth, JC; Ismail, M; Tsuruta, Y; Abraham, E; Pereboeva, L; Gerson, SL; Curiel, DT				Alberti, Michael O.; Roth, Justin C.; Ismail, Mourad; Tsuruta, Yuko; Abraham, Edward; Pereboeva, Larisa; Gerson, Stanton L.; Curiel, David T.			Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; FIBER PROTEINS; PHAGE DISPLAY; HI LOOP; VECTOR; DELIVERY; RECEPTOR; TROPISM; GENERATION; STRATEGY	The gene therapy field is currently limited by the lack of vehicles that permit efficient gene delivery to specific cell or tissue subsets. Native viral vector tropisms offer a powerful platform for transgene delivery but remain nonspecific, requiring elevated viral doses to achieve efficacy. In order to improve upon these strategies, our group has focused on genetically engineering targeting domains into viral capsid proteins, particularly those based on adenovirus serotype 5 (Ad5). Our primary strategy is based on deletion of the fiber knob domain, to eliminate broad tissue specificity through the human coxsackie-and-adenovirus receptor (hCAR), with seamless incorporation of ligands to re-direct Ad tropism to cell types that express the cognate receptors. Previously, our group and others have demonstrated successful implementation of this strategy in order to specifically target Ad to a number of surface molecules expressed on immortalized cell lines. Here, we utilized phage biopanning to identify a myeloid cell-binding peptide (MBP), with the sequence WTLDRGY, and demonstrated that MBP can be successfully incorporated into a knob-deleted Ad5. The resulting virus, Ad. MBP, results in specific binding to primary myeloid cell types, as well as significantly higher transduction of these target populations ex vivo, compared to unmodified Ad5. These data are the first step in demonstrating Ad targeting to cell types associated with inflammatory disease.	[Alberti, Michael O.; Roth, Justin C.; Pereboeva, Larisa; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Alberti, Michael O.; Roth, Justin C.; Pereboeva, Larisa; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL USA; [Ismail, Mourad; Gerson, Stanton L.] Case Western Reserve Univ, Dept Med, Div Hematol & Oncol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Ismail, Mourad; Gerson, Stanton L.] Case Western Reserve Univ, Natl Ctr Regenerat Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Case Western Reserve University	Alberti, MO (corresponding author), Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA.	jroth@peds.uab.edu; dcuriel@radonc.wustl.edu		Alberti, Michael/0000-0003-4269-4701	Gene Therapy Center at the University of Alabama at Birmingham (UAB); National Institutes of Health (NIH) [R42CA114921, R01CA073062]; UAB Medical Scientist Training Program [NIH T32GM008361]; NIH [T32CA059366, T32CA075930]; NATIONAL CANCER INSTITUTE [R01CA073062, T32CA059366, R42CA114921, T32CA075930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	Gene Therapy Center at the University of Alabama at Birmingham (UAB); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gene Therapy Center at the University of Alabama at Birmingham (UAB) and the National Institutes of Health (NIH) grants R42CA114921 to DTC and R01CA073062 to SLG. MOA was supported in part by the UAB Medical Scientist Training Program (NIH T32GM008361). JCR was supported in part by NIH T32CA059366 and NIH T32CA075930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousova N, 2003, J VIROL, V77, P11367, DOI 10.1128/JVI.77.21.11367-11377.2003; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Douglas JT, 1999, NAT BIOTECHNOL, V17, P470, DOI 10.1038/8647; Douglas JT, 1996, NAT BIOTECHNOL, V14, P1574, DOI 10.1038/nbt1196-1574; Glasgow JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008355; Haisma HJ, 2000, CANCER GENE THER, V7, P901, DOI 10.1038/sj.cgt.7700198; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Korokhov N, 2003, J VIROL, V77, P12931, DOI 10.1128/JVI.77.24.12931-12940.2003; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 2000, MOL THER, V1, P391, DOI 10.1006/mthe.2000.0062; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mizuguchi H, 2001, GENE THER, V8, P730, DOI 10.1038/sj.gt.3301453; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nicklin SA, 2001, MOL THER, V4, P534, DOI 10.1006/mthe.2001.0489; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Tallone T, 2001, P NATL ACAD SCI USA, V98, P7910, DOI 10.1073/pnas.141223398; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Ulasov IV, 2007, HUM GENE THER, V18, P118, DOI 10.1089/hum.2006.146; van Beusechem VW, 2000, GENE THER, V7, P1940, DOI 10.1038/sj.gt.3301323; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Watkins SJ, 1997, GENE THER, V4, P1004, DOI 10.1038/sj.gt.3300511; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E	37	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37812	10.1371/journal.pone.0037812	http://dx.doi.org/10.1371/journal.pone.0037812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624065	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500154
J	Alquezar, C; Esteras, N; Alzualde, A; Moreno, F; Ayuso, MS; de Munain, AL; Martin-Requero, A				Alquezar, Carolina; Esteras, Noemi; Alzualde, Ainhoa; Moreno, Fermin; Ayuso, Matilde S.; Lopez de Munain, Adolfo; Martin-Requero, Angeles			Inactivation of CDK/pRb Pathway Normalizes Survival Pattern of Lymphoblasts Expressing the FTLD-Progranulin Mutation c.709-1G > A	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; CELL-DEATH; NEURODEGENERATIVE DISEASES; IMMORTALIZED LYMPHOCYTES; SIGNALING PATHWAYS; DEMENTIA; GENE; APOPTOSIS	Background: Mutations in the progranulin (PGRN) gene, leading to haploinsufficiency, cause familial frontotemporal lobar degeneration (FTLD-TDP), although the pathogenic mechanism of PGRN deficit is largely unknown. Allelic loss of PGRN was previously shown to increase the activity of cyclin-dependent kinase (CDK) CDK6/pRb pathway in lymphoblasts expressing the c. 709-1G>A PGRN mutation. Since members of the CDK family appear to play a role in neurodegenerative disorders and in apoptotic death of neurons subjected to various insults, we investigated the role of CDK6/pRb in cell survival/death mechanisms following serum deprivation. Methodology/Principal Findings: We performed a comparative study of cell viability after serum withdrawal of established lymphoblastoid cell lines from control and carriers of c. 709-1G. A PGRN mutation, asymptomatic and FTLD-TDP diagnosed individuals. Our results suggest that the CDK6/pRb pathway is enhanced in the c. 709-1G. A bearing lymphoblasts. Apparently, this feature allows PGRN-deficient cells to escape from serum withdrawal-induced apoptosis by decreasing the activity of executive caspases and lowering the dissipation of mitochondrial membrane potential and the release of cytochrome c from the mitochondria. Inhibitors of CDK6 expression levels like sodium butyrate or the CDK6 activity such as PD332991 were able to restore the vulnerability of lymphoblasts from FTLD-TDP patients to trophic factor withdrawal. Conclusion/Significance: The use of PGRN-deficient lymphoblasts from FTLD-TDP patients may be a useful model to investigate cell biochemical aspects of this disease. It is suggested that CDK6 could be potentially a therapeutic target for the treatment of the FTLD-TDP.	[Alquezar, Carolina; Esteras, Noemi; Ayuso, Matilde S.; Martin-Requero, Angeles] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain; [Alzualde, Ainhoa; Lopez de Munain, Adolfo] Inst Biodonostia, Neurosci Area, San Sebastian, Spain; [Moreno, Fermin; Lopez de Munain, Adolfo] Hosp Donostia, Dept Neurol, San Sebastian, Spain; [Lopez de Munain, Adolfo] CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain; [Alquezar, Carolina; Ayuso, Matilde S.; Martin-Requero, Angeles] CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; CIBERNED; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Alquezar, C (corresponding author), CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid, Spain.	amrequero@cib.csic.es	Gallego, Noemi Esteras/AAW-1011-2021; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Alquezar, Carolina/K-8721-2014; Alquezar, Carolina/AAW-8716-2021; Ayuso, Matilde Sánchez/B-2777-2008; Martín-Requero, Angeles/K-3901-2014	Alquezar, Carolina/0000-0002-7602-3108; Alquezar, Carolina/0000-0002-7452-3176; Ayuso, Matilde Sánchez/0000-0003-2504-0925; Martín-Requero, Angeles/0000-0002-3416-9440; Esteras, Noemi/0000-0002-7938-6131; /0000-0002-9509-4032	Ministry of Education and Science [SAF2007-61701, SAF2010-15700, SAF2011-28603]; Fundacion Eugenio Rodriguez Pascual; Basque Government	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fundacion Eugenio Rodriguez Pascual; Basque Government(Basque Government)	This work has been supported by grants from Ministry of Education and Science (SAF2007-61701, SAF2010-15700, SAF2011-28603), Fundacion Eugenio Rodriguez Pascual, and Basque Government (Saiotek program 2008-2009). NE holds a fellowship of the JAE predoctoral program of the CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquezar C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.020; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bartolome F, 2007, CELL MOL LIFE SCI, V64, P1437, DOI 10.1007/s00018-007-7081-3; Bialopiotrowicz E, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.017; Bossu P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-65; Brodski Claude, 2002, Expert Rev Neurother, V2, P417, DOI 10.1586/14737175.2.3.417; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cairns NJ, 2003, NEUROSCI LETT, V341, P177, DOI 10.1016/S0304-3940(03)00100-9; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; de Munain AL, 2008, BIOL PSYCHIAT, V63, P946, DOI 10.1016/j.biopsych.2007.08.015; DeKosky ST, 2003, ANN NEUROL, V53, P81, DOI 10.1002/ana.10414; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Eckert A, 2001, DEMENT GERIATR COGN, V12, P98, DOI 10.1159/000051242; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Guerra RR, 2007, GROWTH FACTORS, V25, P280, DOI 10.1080/08977190701781222; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Harguindey S, 2007, CURR ALZHEIMER RES, V4, P53, DOI 10.2174/156720507779939841; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Ibarreta D, 1998, ANN NEUROL, V44, P216, DOI 10.1002/ana.410440212; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ino H, 2001, J NEUROSCI, V21, P6086, DOI 10.1523/JNEUROSCI.21-16-06086.2001; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; Kidd SK, 2010, BRAIN RES, V1354, P172, DOI 10.1016/j.brainres.2010.07.041; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Koh G, 2005, ARCH BIOCHEM BIOPHYS, V438, P70, DOI 10.1016/j.abb.2005.03.018; KOISTINEN P, 1987, SCAND J CLIN LAB INV, V47, P709; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Li L, 2011, INT J ALZHEIMERS DIS; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Menu E, 2008, CANCER RES, V68, P5519, DOI 10.1158/0008-5472.CAN-07-6404; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Moreno F, 2009, NEUROLOGY, V73, P1367, DOI 10.1212/WNL.0b013e3181bd82a7; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Munoz U, 2008, NEUROBIOL AGING, V29, P1474, DOI 10.1016/j.neurobiolaging.2007.03.013; Naderi W, 2006, MECH AGEING DEV, V127, P25, DOI 10.1016/j.mad.2005.08.006; Nagy Z, 2002, NEUROSCI LETT, V317, P81, DOI 10.1016/S0304-3940(01)02442-9; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Park DS, 2000, NEUROBIOL AGING, V21, P771, DOI 10.1016/S0197-4580(00)00220-7; Ricobaraza Ana, 2011, Front Biosci (Elite Ed), V3, P1375; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Sala SG, 2008, J PHARMACOL EXP THER, V324, P352, DOI 10.1124/jpet.107.128959; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Stieler J, 2012, NEUROBIOL AGING, V33, P234, DOI 10.1016/j.neurobiolaging.2010.03.001; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Uberti D, 2002, J CELL SCI, V115, P3131; Uberti D, 2006, NEUROBIOL AGING, V27, P1193, DOI 10.1016/j.neurobiolaging.2005.06.013; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	72	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37057	10.1371/journal.pone.0037057	http://dx.doi.org/10.1371/journal.pone.0037057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623979	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500056
J	Cai, HY; Kumar, N; Baudis, M				Cai, Haoyang; Kumar, Nitin; Baudis, Michael			arrayMap: A Reference Resource for Genomic Copy Number Imbalances in Human Malignancies	PLOS ONE			English	Article							GENETIC ALTERATIONS; CANCER GENOME; WIDE ANALYSIS; BREAST; PATTERNS; DATABASE; AMPLIFICATION; EXPRESSION; PLATFORMS; MUTATION	Background: The delineation of genomic copy number abnormalities (CNAs) from cancer samples has been instrumental for identification of tumor suppressor genes and oncogenes and proven useful for clinical marker detection. An increasing number of projects have mapped CNAs using high-resolution microarray based techniques. So far, no single resource does provide a global collection of readily accessible oncogenomic array data. Methodology/Principal Findings: We here present arrayMap, a curated reference database and bioinformatics resource targeting copy number profiling data in human cancer. The arrayMap database provides a platform for meta-analysis and systems level data integration of high-resolution oncogenomic CNA data. To date, the resource incorporates more than 40,000 arrays in 224 cancer types extracted from several resources, including the NCBI's Gene Expression Omnibus (GEO), EBI's ArrayExpress (AE), The Cancer Genome Atlas (TCGA), publication supplements and direct submissions. For the majority of the included datasets, probe level and integrated visualization facilitate gene level and genome wide data review. Results from multi-case selections can be connected to downstream data analysis and visualization tools. Conclusions/Significance: To our knowledge, currently no data source provides an extensive collection of high resolution oncogenomic CNA data which readily could be used for genomic feature mining, across a representative range of cancer entities. arrayMap represents our effort for providing a long term platform for oncogenomic CNA data independent of specific platform considerations or specific project dependence. The online database can be accessed at http//www.arraymap.org.	[Cai, Haoyang; Kumar, Nitin; Baudis, Michael] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Cai, HY (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.baudis@imls.uzh.ch	Baudis, Michael/J-4602-2012	Baudis, Michael/0000-0002-9903-4248	China Scholarship Council; Krebsliga Schweiz; University of Zurich	China Scholarship Council(China Scholarship Council); Krebsliga Schweiz; University of Zurich	HC is supported through a personal grant from the China Scholarship Council. NK and MB had received support through the Krebsliga Schweiz and the University of Zurich's Research Priority Program Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloza E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-37; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Baumbusch LO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-379; Bengtsson H., 2008, 745 U CAL DEP STAT; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bourdeaut F, 2011, AM J MED GENET A, V155A, P1763, DOI 10.1002/ajmg.a.34066; C F, 2005, 2005 M FED CLIN IMM; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Heinrichs S, 2007, GENOME BIOL, P1; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Jin K, 2011, P NATL ACAD SCI US; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Krasinskas AM, 2010, MODERN PATHOL, V23, P531, DOI 10.1038/modpathol.2009.186; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lubin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005735; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myllykangas S, 2006, ONCOGENE, V25, P7324, DOI 10.1038/sj.onc.1209717; Park NI, 2012, MOL ONCOLOGY; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Scheinin I, 2008, NUCLEIC ACIDS RES, V36, pD830, DOI 10.1093/nar/gkm802; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stallings RL, 2007, TRENDS GENET, V23, P278, DOI 10.1016/j.tig.2007.03.009; Stevens KN, 2012, 19P13 1 IS TRIPLE NE; van der Rhee JI, 2011, J AM ACAD DERMATOLOG; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Wiltshire RN, 2000, NEURO-ONCOLOGY, V2, P164, DOI 10.1093/neuonc/2.3.164; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74	48	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36944	10.1371/journal.pone.0036944	http://dx.doi.org/10.1371/journal.pone.0036944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629346	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305343500040
J	Chu, CY; Chen, CF; Rajendran, RS; Shen, CN; Chen, TH; Yen, CC; Chuang, CK; Lin, DS; Hsiao, CD				Chu, Che-Yu; Chen, Chi-Fang; Rajendran, R. Samuel; Shen, Chia-Ning; Chen, Te-Hao; Yen, Chueh-Chuan; Chuang, Chih-Kuang; Lin, Dar-Shong; Hsiao, Chung-Der			Overexpression of Akt1 Enhances Adipogenesis and Leads to Lipoma Formation in Zebrafish	PLOS ONE			English	Article							MATRIX GLA PROTEIN; INSULIN-RESISTANCE; SKELETAL-MUSCLE; TRANSGENIC ZEBRAFISH; ADIPOSE-TISSUE; DANIO-RERIO; OBESE GENE; STEM-CELLS; DIFFERENTIATION; EXPRESSION	Background: Obesity is a complex, multifactorial disorder influenced by the interaction of genetic, epigenetic, and environmental factors. Obesity increases the risk of contracting many chronic diseases or metabolic syndrome. Researchers have established several mammalian models of obesity to study its underlying mechanism. However, a lower vertebrate model for conveniently performing drug screening against obesity remains elusive. The specific aim of this study was to create a zebrafish obesity model by over expressing the insulin signaling hub of the Akt1 gene. Methodology/Principal Findings: Skin oncogenic transformation screening shows that a stable zebrafish transgenic of Tg(krt4Hsa.myrAkt1)(cy18) displays severely obese phenotypes at the adult stage. In Tg(krt4:Hsa.myrAkt1)(cy18), the expression of exogenous human constitutively active Akt1 (myrAkt1) can activate endogenous downstream targets of mTOR, GSK-3 alpha/beta, and 70S6K. During the embryonic to larval transitory phase, the specific over expression of myrAkt1 in skin can promote hypertrophic and hyperplastic growth. From 21 hour post-fertilization (hpf) onwards, myrAkt1 transgene was ectopically expressed in several mesenchymal derived tissues. This may be the result of the integration position effect. Tg(krt4:Hsa.myrAkt1)(cy18) caused a rapid increase of body weight, hyperplastic growth of adipocytes, abnormal accumulation of fat tissues, and blood glucose intolerance at the adult stage. Real-time RT-PCR analysis showed the majority of key genes on regulating adipogenesis, adipocytokine, and inflammation are highly upregulated in Tg(krt4:Hsa.myrAkt1)(cy18). In contrast, the myogenesis-and skeletogenesis-related gene transcripts are significantly downregulated in Tg(krt4:Hsa.myrAkt1)(cy18), suggesting that excess adipocyte differentiation occurs at the expense of other mesenchymal derived tissues. Conclusion/Significance: Collectively, the findings of this study provide direct evidence that Akt1 signaling plays an important role in balancing normal levels of fat tissue in vivo. The obese zebrafish examined in this study could be a new powerful model to screen novel drugs for the treatment of human obesity.	[Chu, Che-Yu; Chen, Chi-Fang; Rajendran, R. Samuel; Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Shen, Chia-Ning] Acad Sinica, Genome Res Ctr, Nankang, Taiwan; [Chen, Te-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Yen, Chueh-Chuan] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Yen, Chueh-Chuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chuang, Chih-Kuang] Mackay Mem Hosp, Div Genet & Metab, Dept Med Res, Taipei, Taiwan; [Lin, Dar-Shong] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Lin, Dar-Shong] Mackay Med Nursing & Management Coll, Taipei, Taiwan; [Lin, Dar-Shong] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	Chung Yuan Christian University; Academia Sinica - Taiwan; National Museum of Marine Biology & Aquarium; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taipei University of Technology; Chung Yuan Christian University	Chu, CY (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan.	dslin@ms1.mmh.org.tw; cdhsiao@cycu.edu.tw	SHEN, CHIA-NING/C-6878-2011; Hsiao, Chung-Der/W-4535-2019	SHEN, CHIA-NING/0000-0002-0747-217X; Hsiao, Chung-Der/0000-0002-6398-8672; R., Samuel Rajendran/0000-0003-1420-7064	National Science Council [NSC96-2321-B-033-002-MY2, NSC99-2320-B-033-001-MY3]; Mackay Memorial Hospital [MMH-CY-9905]; Center of Excellence for Cancer Research at Taipai Veterans General Hospital [DOH100-TD-C-111-007]; National Research Program for Biopharmaceuticals [DOH100-TD-PB-111-TM026]; Taiwan Clinical Oncology Research Foundation	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Center of Excellence for Cancer Research at Taipai Veterans General Hospital; National Research Program for Biopharmaceuticals; Taiwan Clinical Oncology Research Foundation	This work was supported by grants from the National Science Council(NSC96-2321-B-033-002-MY2 and NSC99-2320-B-033-001-MY3) and the Mackay Memorial Hospital (MMH-CY-9905) to CDH and DSL. Grants from the Center of Excellence for Cancer Research at Taipai Veterans General Hospital (DOH100-TD-C-111-007), National Research Program for Biopharmaceuticals (DOH100-TD-PB-111-TM026) and Taiwan Clinical Oncology Research Foundation to CCY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Christoffersen CT, 1998, BIOCHEM BIOPH RES CO, V246, P426, DOI 10.1006/bbrc.1998.8637; Chung WK, 1996, GENOME RES, V6, P1192, DOI 10.1101/gr.6.12.1192; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dani C, 1997, J CELL SCI, V110, P1279; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Despres J P, 2006, J Endocrinol Invest, V29, P77; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Drel VR, 2006, DIABETES, V55, P3335, DOI 10.2337/db06-0885; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gleeson M, 2007, ACTA DIABETOL, V44, P157, DOI 10.1007/s00592-007-0257-3; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gong ZY, 2002, DEV DYNAM, V223, P204, DOI 10.1002/dvdy.10051; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HENRIKSO.RC, 1967, EXPERIENTIA, V23, P357, DOI 10.1007/BF02144513; Hinault C, 2006, J NUTR BIOCHEM, V17, P374, DOI 10.1016/j.jnutbio.2006.02.008; Hsieh SC, 2009, MOL CARCINOGEN, V48, P545, DOI 10.1002/mc.20491; Huang DL, 2010, GENE CHROMOSOME CANC, V49, P810, DOI 10.1002/gcc.20788; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin A, 2007, ENDOCRINOLOGY, V148, P3419, DOI 10.1210/en.2006-1541; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishio SI, 2008, DEV DYNAM, V237, P1682, DOI 10.1002/dvdy.21559; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Ordovas JM, 2011, CURR OPIN LIPIDOL, V22, P129, DOI 10.1097/MOL.0b013e32834477a9; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PAVLOVITCH JH, 1991, AM J PHYSIOL, V261, pC964, DOI 10.1152/ajpcell.1991.261.6.C964; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Petit MMR, 1998, CANCER GENET CYTOGEN, V106, P18, DOI 10.1016/S0165-4608(98)00038-7; Pierron A, 2009, CANCER GENET CYTOGEN, V195, P66, DOI 10.1016/j.cancergencyto.2009.06.009; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Wang YK, 1997, DEVELOPMENT, V124, P2507; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	78	47	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36474	10.1371/journal.pone.0036474	http://dx.doi.org/10.1371/journal.pone.0036474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623957	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500017
J	Fabre, L; Zhang, J; Guigon, G; Le Hello, S; Guibert, V; Accou-Demartin, M; de Romans, S; Lim, C; Roux, C; Passet, V; Diancourt, L; Guibourdenche, M; Issenhuth-Jeanjean, S; Achtman, M; Brisse, S; Sola, C; Weill, FX				Fabre, Laetitia; Zhang, Jian; Guigon, Ghislaine; Le Hello, Simon; Guibert, Veronique; Accou-Demartin, Marie; de Romans, Saiana; Lim, Catherine; Roux, Chrystelle; Passet, Virginie; Diancourt, Laure; Guibourdenche, Martine; Issenhuth-Jeanjean, Sylvie; Achtman, Mark; Brisse, Sylvain; Sola, Christophe; Weill, Francois-Xavier			CRISPR Typing and Subtyping for Improved Laboratory Surveillance of Salmonella Infections	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; VARIABLE-NUMBER; IMMUNE-SYSTEM; REPEATS; BACTERIOPHAGE; TYPHIMURIUM; DNA; RESISTANCE; FRANCE; GENES	Laboratory surveillance systems for salmonellosis should ideally be based on the rapid serotyping and subtyping of isolates. However, current typing methods are limited in both speed and precision. Using 783 strains and isolates belonging to 130 serotypes, we show here that a new family of DNA repeats named CRISPR (clustered regularly interspaced short palindromic repeats) is highly polymorphic in Salmonella. We found that CRISPR polymorphism was strongly correlated with both serotype and multilocus sequence type. Furthermore, spacer microevolution discriminated between subtypes within prevalent serotypes, making it possible to carry out typing and subtyping in a single step. We developed a high-throughput subtyping assay for the most prevalent serotype, Typhimurium. An open web-accessible database was set up, providing a serotype/spacer dictionary and an international tool for strain tracking based on this innovative, powerful typing and subtyping tool.	[Fabre, Laetitia; Le Hello, Simon; Guibert, Veronique; Accou-Demartin, Marie; de Romans, Saiana; Lim, Catherine; Roux, Chrystelle; Guibourdenche, Martine; Issenhuth-Jeanjean, Sylvie; Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Zhang, Jian; Sola, Christophe] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR8621,IGEPE Team,Universud, Orsay, France; [Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University College Cork	Fabre, L (corresponding author), Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France.	fxweill@pasteur.fr	Le Hello, Simon/K-6584-2018; Brisse, Sylvain/M-8723-2013; Sola, Christophe/A-7992-2016	Le Hello, Simon/0000-0001-7993-4305; Brisse, Sylvain/0000-0002-2516-2108; Sola, Christophe/0000-0003-4672-2140; Achtman, Mark/0000-0001-6815-0070; DIANCOURT, Laure/0000-0002-9670-3274; Weill, Francois-Xavier/0000-0001-9941-5799	Institut Pasteur [354]; Institut de Veille Sanitaire; Science Foundation of Ireland [05/FE1/B882]	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Science Foundation of Ireland(Science Foundation Ireland)	This work was supported by the Institut Pasteur (permanent support for Research and Programme Transversal de Recherche 354) and by the Institut de Veille Sanitaire. The MLST data are publicly available from http://mlst.ucc.ie, which is currently funded by a grant from the Science Foundation of Ireland (05/FE1/B882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, PLOS PATHOG IN PRESS; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bender JB, 2001, NEW ENGL J MED, V344, P189, DOI 10.1056/NEJM200101183440305; Bone A, 2010, EUROSURVEILLANCE, V15, P2; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Fisher Ian S T, 2004, Euro Surveill, V9, P45; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hedberg CW, 2008, EMERG INFECT DIS, V14, P311, DOI 10.3201/eid1402.070666; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Hopkins KL, 2011, EURO SURVEILL, V16, ppii; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Larsson JT, 2009, EUROSURVEILLANCE, V14, P6; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Liu FY, 2011, APPL ENVIRON MICROB, V77, P1946, DOI 10.1128/AEM.02625-10; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; Mokrousov Igor, 2007, Biotechnology Journal, V2, P901, DOI 10.1002/biot.200700035; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; Torpdahl M, 2007, EMERG INFECT DIS, V13, P388, DOI 10.3201/eid1303.060460; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Weill FX, 2007, French Patent Application, Patent No. [FR07/09188, 0709188]; Weill FX, 2007, International Patent Application, Patent No. [PCT/IB2008/004004, 2008004004]; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	44	174	185	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36995	10.1371/journal.pone.0036995	http://dx.doi.org/10.1371/journal.pone.0036995			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623967	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500044
J	Su, Y; Tang, LY; Chen, LJ; He, JR; Su, FX; Lin, Y; Chen, WQ; Xie, XM; Ren, ZF				Su, Yi; Tang, Lu-Ying; Chen, Li-Juan; He, Jian-Rong; Su, Feng-Xi; Lin, Ying; Chen, Wei-Qing; Xie, Xiao-Ming; Ren, Ze-Fang			Joint Effects of Febrile Acute Infection and an Interferon-gamma Polymorphism on Breast Cancer Risk	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-CELL-ACTIVATION; IFN-GAMMA; TUMOR-DEVELOPMENT; FEVER; HYPERTHERMIA; EXPRESSION; MELANOMA; HISTORY; ASSOCIATION	Background: There is an inverse relationship between febrile infection and the risk of malignancies. Interferon gamma (IFN-gamma) plays an important role in fever induction and its expression increases with incubation at fever-range temperatures. Therefore, the genetic polymorphism of IFN-gamma may modify the association of febrile infection with breast cancer risk. Methodology and Principal Findings: Information on potential breast cancer risk factors, history of fever during the last 10 years, and blood specimens were collected from 839 incident breast cancer cases and 863 age-matched controls between October 2008 and June 2010 in Guangzhou, China. IFN-gamma (rs2069705) was genotyped using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry platform. Odds ratios (OR) and 95% confidence intervals (CIs) were calculated using multivariate logistic regression. We found that women who had experienced > 1 fever per year had a decreased risk of breast cancer [ORs and 95% CI: 0.77 (0.61-0.99)] compared to those with less than one fever a year. This association only occurred in women with CT/TT genotypes [0.54 (0.37-0.77)] but not in those with the CC genotype [1.09 (0.77-1.55)]. The association of IFN-gamma rs2069705 with the risk of breast cancer was not significant among all participants, while the CT/TT genotypes were significantly related to an elevated risk of breast cancer [1.32 (1.03-1.70)] among the women with < 1 fever per year and to a reduced risk of breast cancer [0.63 (0.40-0.99)] among women with >= 1 fever per year compared to the CC genotype. A marked interaction between fever frequencies and the IFN-gamma genotypes was observed (P for multiplicative and additive interactions were 0.005 and 0.058, respectively). Conclusions: Our findings indicate a possible link between febrile acute infection and a decreased risk of breast cancer, and this association was modified by IFN-gamma rs2069705.	[Su, Yi; Chen, Li-Juan; He, Jian-Rong; Chen, Wei-Qing; Ren, Ze-Fang] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Lu-Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Su, Feng-Xi] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Xiao-Ming] Sun Yat Sen Univ, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Su, Y (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn; renzef@mail.sysu.edu.cn		He, Jianrong/0000-0003-3837-5126	National Natural Science Foundation of China [81072383, 81172759]; Laboratory Opening Funds at Sun Yat-Sen University [KF2010440]; Key Program of National Natural Science Foundation of China [31030061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Laboratory Opening Funds at Sun Yat-Sen University; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81072383 and 81172759), the Laboratory Opening Funds at Sun Yat-Sen University (KF2010440), and the Key Program of National Natural Science Foundation of China (31030061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2011, CLIN VACCINE IMMUNOL, V18, P1150, DOI 10.1128/CVI.00051-11; ABEL U, 1991, J CANCER RES CLIN, V117, P339, DOI 10.1007/BF01630717; Atanackovic D, 2002, CANCER IMMUNOL IMMUN, V51, P603, DOI 10.1007/s00262-002-0327-x; Basu S, 2003, INT IMMUNOL, V15, P1053, DOI 10.1093/intimm/dxg104; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Cann SAH, 2002, MED HYPOTHESES, V58, P115, DOI 10.1054/mehy.2001.1469; DICKSON JA, 1979, LANCET, V1, P202, DOI 10.1016/S0140-6736(79)90594-4; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; DINARELLO CA, 1984, J CLIN INVEST, V74, P906, DOI 10.1172/JCI111508; Erdei E, 2010, CYTOKINE, V51, P18, DOI 10.1016/j.cyto.2010.03.014; Falk MH, 2001, INT J HYPERTHER, V17, P1, DOI 10.1080/02656730150201552; Goggins W, 2004, INT J CANCER, V111, P792, DOI 10.1002/ijc.20322; Gonullu G, 2007, SAUDI MED J, V28, P1728; Gregson AL, 2004, INFECT DIS; GROSSARTHMATICEK R, 1987, J CHRON DIS, V40, P967, DOI 10.1016/0021-9681(87)90147-0; Harigai M, 2008, J IMMUNOL, V181, P2211, DOI 10.4049/jimmunol.181.3.2211; Hasday JD, 2000, MICROBES INFECT, V2, P1891, DOI 10.1016/S1286-4579(00)01337-X; He JR, 2012, J INFECT DIS, V205, P64, DOI 10.1093/infdis/jir710; He JR, 2011, CANCER LETT, V309, P128, DOI 10.1016/j.canlet.2011.05.012; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; Ho WL, 2011, IRISH J MED SCI, V180, P901, DOI 10.1007/s11845-009-0297-5; Hobohm U, 2005, BRIT J CANCER, V92, P421, DOI 10.1038/sj.bjc.6602386; Hobohm U, 2001, CANCER IMMUNOL IMMUN, V50, P391; Hoption SA, 2006, CANCER DETECT PREV, V30, P83, DOI 10.1016/j.cdp.2005.11.001; Jurek AM, 2005, INT J EPIDEMIOL, V34, P680, DOI 10.1093/ije/dyi060; Kamali-Sarvestani E, 2005, CANCER LETT, V223, P113, DOI 10.1016/j.canlet.2004.09.025; Karakus N, 2011, DNA CELL BIOL, V30, P371, DOI 10.1089/dna.2010.1113; Karalyan Z, 2012, VET IMMUNOL IMMUNOP, V145, P551, DOI 10.1016/j.vetimm.2011.12.013; Kida Y, 2006, CANCER IMMUNOL IMMUN, V55, P1459, DOI 10.1007/s00262-006-0146-6; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Kleef R, 2001, NEUROIMMUNOMODULAT, V9, P55, DOI 10.1159/000049008; KOLMEL KF, 1992, MELANOMA RES, V2, P207; Kolmel KF, 1999, MELANOMA RES, V9, P511; KURZROCK R, 1986, CANCER TREAT REP, V70, P1357; LANE HC, 1985, ANN INTERN MED, V103, P714, DOI 10.7326/0003-4819-103-5-714; Lee HC, 2010, J CLIN IMMUNOL, V30, P68, DOI 10.1007/s10875-009-9330-8; Mastrangelo G, 1998, EUR J EPIDEMIOL, V14, P749, DOI 10.1023/A:1007560709013; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; MORIMOTO A, 1987, J PHYSIOL-LONDON, V391, P209, DOI 10.1113/jphysiol.1987.sp016734; Netea MG, 2000, CLIN INFECT DIS, V31, pS178, DOI 10.1086/317513; Ostberg JR, 2006, CANCER IMMUNOL IMMUN, V55, P292, DOI 10.1007/s00262-005-0689-y; Ren ZF, 2010, CANCER EPIDEMIOL, V34, P419, DOI 10.1016/j.canep.2010.04.011; ROBERTS NJ, 1991, REV INFECT DIS, V13, P462; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Schlehofer B, 1999, INT J CANCER, V82, P155, DOI 10.1002/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P; Scola L, 2006, ANN NY ACAD SCI, V1089, P104, DOI 10.1196/annals.1386.017; TRIEB K, 1994, CANCER LETT, V87, P65, DOI 10.1016/0304-3835(94)90410-3; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang HG, 2008, CANCER LETT, V271, P191, DOI 10.1016/j.canlet.2008.05.026	53	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37275	10.1371/journal.pone.0037275	http://dx.doi.org/10.1371/journal.pone.0037275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624006	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500089
J	Zhou, ZX; Zhang, C; Zhang, J; Tian, ZG				Zhou, Zhixia; Zhang, Cai; Zhang, Jian; Tian, Zhigang			Macrophages Help NK Cells to Attack Tumor Cells by Stimulatory NKG2D Ligand but Protect Themselves from NK Killing by Inhibitory Ligand Qa-1	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; POLY I-C; DENDRITIC CELLS; IFN-GAMMA; IMPROVES CYTOTOXICITY; INFECTED MACROPHAGES; VIRUS-INFECTION; CUTTING EDGE; CHAIN-B; EXPRESSION	Natural killer (NK) cells and their crosstalk with other immune cells are important for innate immunity against tumor. To explore the role of the interaction between NK cells and macrophages in the regulation of anti-tumor activities of NK cells, we here demonstrate that poly I:C-treated macrophages increased NK cell-mediated cytotoxicity against target tumor cells in NKG2D-dependent manner. In addition, IL-15, IL-18, and IFN-beta secreted by poly I:C-treated macrophages are also involved in NKG2D expression and NK cell activation. Interestingly, the increase in expression of NKG2D ligands on macrophages induced a highly NK cell-mediated cytotoxicity against tumor cells, but not against macrophages themselves. Notably, a high expression level of Qa-1, a NKG2A ligand, on macrophages may contribute to such protection of macrophages from NK cell-mediated killing. Furthermore, Qa-1 or NKG2A knockdown and Qa-1 antibody blockade caused the macrophages to be sensitive to NK cytolysis. These results suggested that macrophages may activate NK cells to attack tumor by NKG2D recognition whereas macrophages protect themselves from NK lysis via preferential expression of Qa-1.	[Zhou, Zhixia; Zhang, Cai; Zhang, Jian; Tian, Zhigang] Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Dept Microbiol & Immunol, Sch Life Sci, Hefei, Anhui, Peoples R China	Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, ZX (corresponding author), Shandong Univ, Inst Immunopharmacol & Immunotherapy, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China.	caizhangsd@sdu.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zhang, Jian/AAQ-3068-2021	Zhou, Zhixia/0000-0002-4080-5749	Natural Science Foundation of China [90713033, 30901307, 30772497]; National 973 Basic Science Program of China [2007CB815800]; Important National Science & Technology Specific Projects [2008ZX10002-008]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Science Program of China; Important National Science & Technology Specific Projects	This work was supported by grants from the Natural Science Foundation of China (#90713033, #30901307, and #30772497), the National 973 Basic Science Program of China (#2007CB815800) and the Important National Science & Technology Specific Projects (#2008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; Bellora F, 2010, P NATL ACAD SCI USA, V107, P21659, DOI 10.1073/pnas.1007654108; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Colmenero P, 2007, J IMMUNOL, V179, P4608, DOI 10.4049/jimmunol.179.7.4608; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Elhaik-Goldman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023472; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; Jiang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-12; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Klezovich-Benard M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002481; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Ota T, 2005, BLOOD, V106, P184, DOI 10.1182/blood-2004-11-4257; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Persson CM, 2008, SCAND J IMMUNOL, V67, P30, DOI 10.1111/j.1365-3083.2007.02034.x; Prajeeth CK, 2011, INFECT IMMUN, V79, P2699, DOI 10.1128/IAI.00079-11; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Romo N, 2011, J LEUKOCYTE BIOL, V90, P717, DOI 10.1189/jlb.0311171; Salem ML, 2006, VACCINE, V24, P5119, DOI 10.1016/j.vaccine.2006.04.010; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tjwa ET, 2012, J VIROL; Vivier E, 2002, SCIENCE, V296, P1248, DOI 10.1126/science.1072447; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wang HM, 2008, MOL IMMUNOL, V45, P1548, DOI 10.1016/j.molimm.2007.10.007; Wang J, 2006, J HEPATOL, V44, P446, DOI 10.1016/j.jhep.2005.08.015; Wang J, 2005, CELL MOL IMMUNOL, V2, P449; Watzl C, 2003, MICROBES INFECT, V5, P31, DOI 10.1016/S1286-4579(02)00057-6; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Zhang C, 2005, INT IMMUNOPHARMACOL, V5, P1057, DOI 10.1016/j.intimp.2005.02.003; Zhang C, 2008, HUM IMMUNOL, V69, P490, DOI 10.1016/j.humimm.2008.06.004; Zhang C, 2008, CYTOKINE, V42, P128, DOI 10.1016/j.cyto.2008.01.003; Zwirner NW, 2007, CYTOKINE GROWTH F R, V18, P159, DOI 10.1016/j.cytogfr.2007.01.013	48	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36928	10.1371/journal.pone.0036928	http://dx.doi.org/10.1371/journal.pone.0036928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629344	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500039
J	Cambra, I; Hernandez, D; Diaz, I; Martinez, M				Cambra, Ines; Hernandez, David; Diaz, Isabel; Martinez, Manuel			Structural Basis for Specificity of Propeptide-Enzyme Interaction in Barley C1A Cysteine Peptidases	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CYSTATIN GENE FAMILY; HUMAN PROCATHEPSIN L; HORDEUM-VULGARE; PROTEINASES; PROTEASE; INHIBITION; PAPAIN; SELECTIVITY; PROSEGMENT	C1A cysteine peptidases are synthesized as inactive proenzymes. Activation takes place by proteolysis cleaving off the inhibitory propeptide. The inhibitory capacity of propeptides from barley cathepsin L and B-like peptidases towards commercial and barley cathepsins has been characterized. Differences in selectivity have been found for propeptides from L-cathepsins against their cognate and non cognate enzymes. Besides, the propeptide from barley cathepsin B was not able to inhibit bovine cathepsin B. Modelling of their three-dimensional structures suggests that most propeptide inhibitory properties can be explained from the interaction between the propeptide and the mature cathepsin structures. Their potential use as biotechnological tools is discussed.	[Cambra, Ines; Hernandez, David; Diaz, Isabel; Martinez, Manuel] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain	Universidad Politecnica de Madrid	Cambra, I (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain.	m.martinez@upm.es	Martinez, Manuel/I-8743-2014; Diaz, Isabel/I-8840-2014	Martinez, Manuel/0000-0002-7826-5872; Diaz, Isabel/0000-0001-9865-902X	Ministerio de Economia y Competitividad [AGL2011-23650]; Universidad Politecnica de Madrid/Comunidad de Madrid [CCG10-UPM/AGR-5242]	Ministerio de Economia y Competitividad(Spanish Government); Universidad Politecnica de Madrid/Comunidad de Madrid	Financial support from the Ministerio de Economia y Competitividad (project AGL2011-23650) and from the Universidad Politecnica de Madrid/Comunidad de Madrid (project CCG10-UPM/AGR-5242) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Z, 2006, J EXP BOT, V57, P4245, DOI 10.1093/jxb/erl200; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Gutierrez-Gonzalez LH, 2006, ARCH BIOCHEM BIOPHYS, V446, P151, DOI 10.1016/j.abb.2005.12.005; Lalmanach G, 1998, J BIOL CHEM, V273, P25112, DOI 10.1074/jbc.273.39.25112; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Marra BM, 2009, PEPTIDES, V30, P825, DOI 10.1016/j.peptides.2009.01.022; Martinez M, 2003, J EXP BOT, V54, P951, DOI 10.1093/jxb/erg099; Martinez M, 2009, PLANT PHYSIOL, V151, P1531, DOI 10.1104/pp.109.146019; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Schilling K, 2009, BIOL CHEM, V390, P167, DOI 10.1515/BC.2009.023; Silva FB, 2007, PEPTIDES, V28, P1292, DOI 10.1016/j.peptides.2007.03.020; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Tsuji A, 2008, FEBS J, V275, P5429, DOI 10.1111/j.1742-4658.2008.06674.x; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Visal S, 1998, FEBS LETT, V434, P401, DOI 10.1016/S0014-5793(98)01018-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081	32	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37234	10.1371/journal.pone.0037234	http://dx.doi.org/10.1371/journal.pone.0037234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615948	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200052
J	Dearborn, RE; Dai, Y; Reed, B; Karian, T; Gray, J; Kunes, S				Dearborn, Richard E., Jr.; Dai, Yong; Reed, Brian; Karian, Tamar; Gray, Jessica; Kunes, Sam			Reph, a Regulator of Eph Receptor Expression in the Drosophila melanogaster Optic Lobe	PLOS ONE			English	Article							RHOMBOMERE-SPECIFIC EXPRESSION; PROTEIN-TYROSINE KINASE; NEURAL CREST MIGRATION; CELL-MIGRATION; RETINAL AXONS; SPLIT-ENDS; TRANSMEMBRANE LIGANDS; EYE DEVELOPMENT; GENETIC SCREEN; VISUAL-SYSTEM	Receptors of the Eph family of tyrosine kinases and their Ephrin ligands are involved in developmental processes as diverse as angiogenesis, axon guidance and cell migration. However, our understanding of the Eph signaling pathway is incomplete, and could benefit from an analysis by genetic methods. To this end, we performed a genetic modifier screen for mutations that affect Eph signaling in Drosophila melanogaster. Several dozen loci were identified on the basis of their suppression or enhancement of an eye defect induced by the ectopic expression of Ephrin during development; many of these mutant loci were found to disrupt visual system development. One modifier locus, reph (regulator of eph expression), was characterized in molecular detail and found to encode a putative nuclear protein that interacts genetically with Eph signaling pathway mutations. Reph is an autonomous regulator of Eph receptor expression, required for the graded expression of Eph protein and the establishment of an optic lobe axonal topographic map. These results reveal a novel component of the regulatory pathway controlling expression of eph and identify reph as a novel factor in the developing visual system.	[Dai, Yong; Reed, Brian; Gray, Jessica; Kunes, Sam] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Dearborn, Richard E., Jr.; Karian, Tamar] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA	Harvard University; Albany College of Pharmacy & Health Sciences	Dearborn, RE (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA.	richard.dearborn@acphs.edu			National Institutes of Health, National Eye Institute [EY10112, EY07030]; NATIONAL EYE INSTITUTE [R01EY010112, F32EY007030] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health, National Eye Institute grant EY10112 to S.K. and National Institutes of Health, National Eye Institute grant EY07030 to R.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Bossing T, 2002, DEVELOPMENT, V129, P4205; Boyle M, 2006, DEVELOPMENT, V133, P1845, DOI 10.1242/dev.02353; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruhl T, 2004, CIRC RES, V94, P743, DOI 10.1161/01.RES.0000120861.27064.09; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Friedman GC, 1996, J NEUROSCI, V16, P5498; Golic KG, 1996, GENETICS, V144, P1693; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Gu C, 2003, FEBS LETT, V540, P65, DOI 10.1016/S0014-5793(03)00223-0; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Itasaki N, 1991, DEVELOPMENT, V110, P331; Karim FD, 1996, GENETICS, V143, P315; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Kuang B, 2000, DEVELOPMENT, V127, P1517; KUNES S, 1993, J NEUROSCI, V13, P752; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; MARDON G, 1994, DEVELOPMENT, V120, P3473; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Meinertzhagen Ian A., 1993, P1363; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rebay I, 2000, GENETICS, V154, P695; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rong YS, 2001, GENETICS, V157, P1307; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J., 2002, MOL CLONING LAB MANU; Santiago A, 2002, DEVELOPMENT, V129, P3621; Schulte D, 1999, NEURON, V24, P541, DOI 10.1016/S0896-6273(00)81111-3; Schulte D, 2000, DEVELOPMENT, V127, P5033; Scully AL, 1999, MOL CELL NEUROSCI, V13, P337, DOI 10.1006/mcne.1999.0752; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Studer M, 1998, DEVELOPMENT, V125, P1025; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Therrien M, 2000, GENETICS, V156, P1231; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; XU T, 1993, DEVELOPMENT, V117, P1223; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	63	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37303	10.1371/journal.pone.0037303	http://dx.doi.org/10.1371/journal.pone.0037303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615969	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300099
J	Reder, NP; Tayo, BO; Salako, B; Ogunniyi, A; Adeyemo, A; Rotimi, C; Cooper, RS				Reder, Nicholas P.; Tayo, Bamidele O.; Salako, Babatunde; Ogunniyi, Adesola; Adeyemo, Adebowale; Rotimi, Charles; Cooper, Richard S.			Adrenergic Alpha-1 Pathway Is Associated with Hypertension among Nigerians in a Pathway-focused Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CONVERTING ENZYME-INHIBITORS; BLOOD-PRESSURE REGULATION; SUSCEPTIBILITY GENES; AFRICAN; RISK; POPULATIONS; DISEASES; THERAPY; LINKAGE	Background: The pathway-focused association approach offers a hypothesis driven alternative to the agnostic genome-wide association study. Here we apply the pathway-focused approach to an association study of hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP) in 1614 Nigerians with genome-wide data. Methods and Results: Testing of 28 pathways with biological relevance to hypertension, selected a priori, containing a total of 101 unique genes and 4,349 unique single-nucleotide polymorphisms (SNPs) showed an association for the adrenergic alpha 1 (ADRA1) receptor pathway with hypertension (p < 0.0009) and diastolic blood pressure (p < 0.0007). Within the ADRA1 pathway, the genes PNMT (hypertension P-gene < 0.004, DBP P-gene < 0.004, and SBP P-gene < 0.009, and ADRA1B (hypertension P-gene < 0.005, DBP P-gene < 0.02, and SBP P-gene < 0.02) displayed the strongest associations. Neither ADRA1B nor PNMT could be the sole mediator of the observed pathway association as the ADRA1 pathway remained significant after removing ADRA1B, and other pathways involving PNMT did not reach pathway significance. Conclusions: We conclude that multiple variants in several genes in the ADRA1 pathway led to associations with hypertension and DBP. SNPs in ADRA1B and PNMT have not previously been linked to hypertension in a genome-wide association study, but both genes have shown associations with hypertension through linkage or model organism studies. The identification of moderately significant (10(-2)> p > 10(-5)) SNPs offers a novel method for detecting the "missing heritability" of hypertension. These findings warrant further studies in similar and other populations to assess the generalizability of our results, and illustrate the potential of the pathway-focused approach to investigate genetic variation in hypertension.	[Reder, Nicholas P.; Tayo, Bamidele O.; Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Salako, Babatunde; Ogunniyi, Adesola] Univ Ibadan, Dept Med, Ibadan, Nigeria; [Adeyemo, Adebowale; Rotimi, Charles] NHGRI, NIH, Intramural Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA	Loyola University Chicago; University of Ibadan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Reder, NP (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA.	nireder@lumc.edu		Reder, Nicholas/0000-0001-6563-8644; Adeyemo, Adebowale/0000-0002-3105-3231	National Institutes of Health [R01HL053353]; Intramural Research Program of the National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053353] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grant numbers R01HL053353 and in part by the Intramural Research Program of the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Cooper, 1997, Blood Press Monit, V2, P35; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Ferdinand KC, 2009, J CLIN HYPERTENS, V11, P648, DOI 10.1111/j.1751-7176.2009.00187.x; HARRAP SB, 1994, LANCET, V344, P169, DOI 10.1016/S0140-6736(94)92762-6; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Kang SJ, 2010, HUM MOL GENET, V19, P2725, DOI 10.1093/hmg/ddq154; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Krushkal J, 1998, HUM MOL GENET, V7, P1379, DOI 10.1093/hmg/7.9.1379; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McCarthy MI, 2008, NAT GENET, V40, P1039, DOI 10.1038/ng0908-1039; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Papademetriou V, 2009, J CLIN HYPERTENS, V11, P621, DOI 10.1111/j.1751-7176.2009.00174.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafiq S, 2010, J CARDIOVASC TRANSL, V3, P189, DOI 10.1007/s12265-010-9183-9; Ritchie MD, 2011, ANN HUM GENET, V75, P172, DOI 10.1111/j.1469-1809.2010.00630.x; ROTIMI C, 1994, HYPERTENSION, V24, P591, DOI 10.1161/01.HYP.24.5.591; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37145	10.1371/journal.pone.0037145	http://dx.doi.org/10.1371/journal.pone.0037145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615923	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300078
J	Liang, GY; Gao, WJ; Liang, AJ; Ye, W; Peng, Y; Zhang, LM; Sharma, S; Su, PQ; Huang, DS				Liang, Guoyan; Gao, Wenjie; Liang, Anjing; Ye, Wei; Peng, Yan; Zhang, Liangming; Sharma, Swarkar; Su, Peiqiang; Huang, Dongsheng			Normal Leptin Expression, Lower Adipogenic Ability, Decreased Leptin Receptor and Hyposensitivity to Leptin in Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DEFICIENT OB/OB MICE; INCREASES BONE-FORMATION; GENOME-WIDE ASSOCIATION; ADIPOCYTE DIFFERENTIATION; MASS; GENES; GIRLS; FAT; AGE	Leptin has been suggested to play a role in the etiology of Adolescent Idiopathic Scoliosis (AIS), however, the leptin levels in AIS girls are still a discrepancy, and no in vitro study of leptin in AIS is reported. We took a series of case-control studies, trying to understand whether Leptin gene polymorphisms are involved in the etiology of the AIS or the change in leptin level is a secondary event, to assess the level of leptin receptor, and to evaluate the differences of response to leptin between AIS cases and controls. We screened all exons of Leptin gene in 45 cases and 45 controls and selected six tag SNPs to cover all the observed variations. Association analysis in 446 AIS patients and 550 healthy controls showed no association between the polymorphisms of Leptin gene and susceptibility/severity to AIS. Moreover, adipogenesis assay of bone mesenchymal stem cells (MSCs) suggested that the adipogenic ability of MSCs from AIS girls was lower than controls. After adjusting the differentiation rate, expressions of leptin and leptin receptor were similar between two groups. Meanwhile, osteogenesis assay of MSC showed the leptin level was similar after adjusting the differentiation rate, but the leptin receptor level was decreased in induced AIS osteoblasts. Immunocytochemistry and western blot analysis showed less leptin receptors expressed in AIS group. Furthermore, factorial designed studies with adipogenesis and osteogenesis revealed that the MSCs from patients have no response to leptin treatment. Our results suggested that Leptin gene variations are not associated with AIS and low serum leptin probably is a secondary outcome which may be related to the low capability of adipogenesis in AIS. The decreased leptin receptor levels may lead to the hyposensitivity to leptin. These findings implied that abnormal peripheral leptin signaling plays an important role in the pathological mechanism of AIS.	[Liang, Guoyan; Gao, Wenjie; Liang, Anjing; Ye, Wei; Peng, Yan; Zhang, Liangming; Huang, Dongsheng] Sun Yat Sen Univ, Dept Orthoped, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Sharma, Swarkar] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Su, Peiqiang] Sun Yat Sen Univ, Dept Spine Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Texas Scottish Rite Hospital for Children; Sun Yat Sen University	Liang, GY (corresponding author), Sun Yat Sen Univ, Dept Orthoped, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	spq88007@yahoo.com.cn; huangdongshen18@hotmail.com	Liang, Guoyan/AEL-4482-2022; SHARMA, SWARKAR/B-8096-2008; zhang, liangming/Q-9967-2016	SHARMA, SWARKAR/0000-0001-8857-5906; zhang, liangming/0000-0003-2282-4687	National Natural Science Foundation of China [81171674, 81071703]; Research Fund of Social Development of Guangdong Province [2010B031900023]; Research Fund of popular science of Guangzhou City [2011KP012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Social Development of Guangdong Province; Research Fund of popular science of Guangzhou City	This work was supported by the National Natural Science Foundation of China (No. 81171674); National Natural Science Foundation of China (No. 81071703); Research Fund of Social Development of Guangdong Province (No. 2010B031900023); Research Fund of popular science of Guangzhou City (No. 2011KP012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2011, BONE; Akther Asma, 2009, Mymensingh Med J, V18, pS140; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrios C, 2011, SPINE PHILA PA 1976; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Burwell RG, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-24; Cheng JCY, 2007, CLIN ORTHOP RELAT R, P38, DOI 10.1097/BLO.0b013e3180d09dcc; Cheung KMC, 2008, INT ORTHOP, V32, P729, DOI 10.1007/s00264-007-0393-y; Coen G, 2004, J NEPHROL, V17, P187; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Grivas TB, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-13; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Iwaniec UT, 2007, PEPTIDES, V28, P1012, DOI 10.1016/j.peptides.2007.02.001; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Liu Z, 1976, SPINE PHILA PA 1976; Lombardi G, 2011, ADV CLIN CHEM, V54, P165, DOI 10.1016/B978-0-12-387025-4.00007-8; Morocz M, 2011, SPINE, V36, pE123, DOI 10.1097/BRS.0b013e318a511b0e; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nduhirabandi F, 2012, ACTA PHYSL OXF; NORDWALL A, 1975, CLIN ORTHOP RELAT R, P6; Park WW, 2009, EUR SPINE J, V18, P1920, DOI 10.1007/s00586-009-1129-z; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Sadat-Ali M, 2008, EUR SPINE J, V17, P944, DOI 10.1007/s00586-008-0671-4; Sharma S, 2011, HUM MOL GENET, V20, P1456, DOI 10.1093/hmg/ddq571; Siu King Cheung C., 2003, SPINE, V28, P2152; Takahashi Y, 2011, NAT GENET, V43, P1237, DOI 10.1038/ng.974; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; van Harmelen V, 2003, INT J OBESITY, V27, P889, DOI 10.1038/sj.ijo.0802314; Wang WJ, 2011, J PEDIATR ORTHOPED, V31, pS14, DOI 10.1097/BPO.0b013e3181f73c12; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Wlodarski Krzysztof, 2009, Ortop Traumatol Rehabil, V11, P1; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Zhang LM, 2010, J PINEAL RES, V49, P364, DOI 10.1111/j.1600-079X.2010.00803.x	42	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36648	10.1371/journal.pone.0036648	http://dx.doi.org/10.1371/journal.pone.0036648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615788	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300025
J	Noguchi, T; Ikeda, M; Ohmiya, Y; Nakajima, Y				Noguchi, Takako; Ikeda, Masaaki; Ohmiya, Yoshihiro; Nakajima, Yoshihiro			A Dual-Color Luciferase Assay System Reveals Circadian Resetting of Cultured Fibroblasts by Co-Cultured Adrenal Glands	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; REPORTER SYSTEM; INDIVIDUAL FIBROBLASTS; PERIPHERAL-TISSUES; LIVING CELLS; MOUSE-LIVER; IN-VITRO; BIOLUMINESCENCE; RHYTHMS	In mammals, circadian rhythms of various organs and tissues are synchronized by pacemaker neurons in the suprachiasmatic nucleus (SCN) of the hypothalamus. Glucocorticoids released from the adrenal glands can synchronize circadian rhythms in other tissues. Many hormones show circadian rhythms in their plasma concentrations; however, whether organs outside the SCN can serve as master synchronizers to entrain circadian rhythms in target tissues is not well understood. To further delineate the function of the adrenal glands and the interactions of circadian rhythms in putative master synchronizing organs and their target tissues, here we report a simple co-culture system using a dual-color luciferase assay to monitor circadian rhythms separately in various explanted tissues and fibroblasts. In this system, circadian rhythms of organs and target cells were simultaneously tracked by the green-emitting beetle luciferase from Pyrearinus termitilluminans (ELuc) and the red-emitting beetle luciferase from Phrixothrix hirtus (SLR), respectively. We obtained tissues from the adrenal glands, thyroid glands, and lungs of transgenic mice that expressed ELuc under control of the promoter from a canonical clock gene, mBmal1. The tissues were co-cultured with Rat-1 fibroblasts as representative target cells expressing SLR under control of the mBmal1 promoter. Amplitudes of the circadian rhythms of Rat-1 fibroblasts were potentiated when the fibroblasts were co-cultured with adrenal gland tissue, but not when co-cultured with thyroid gland or lung tissue. The phases of Rat-1 fibroblasts were reset by application of adrenal gland tissue, whereas the phases of adrenal gland tissue were not influenced by Rat-1 fibroblasts. Furthermore, the effect of the adrenal gland tissue on the fibroblasts was blocked by application of a glucocorticoid receptor (GR) antagonist. These results demonstrate that glucocorticoids are strong circadian synchronizers for fibroblasts and that this co-culture system is a useful tool to analyze humoral communication between different tissues or cell populations.	[Noguchi, Takako; Nakajima, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan; [Ikeda, Masaaki] Saitama Med Univ, Res Ctr Genom Med, Mol Clock Project, Saitama, Japan; [Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan; [Ohmiya, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Saitama Medical University; Saitama Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Noguchi, T (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	y-nakajima@aist.go.jp	Nakajima, Yoshihiro/M-6935-2018; Ohmiya, Yoshihiro/J-7143-2013	Nakajima, Yoshihiro/0000-0002-7422-730X; Ohmiya, Yoshihiro/0000-0002-4944-509X	Japan Society for the Promotion of Science (JSPS) [21590266]; New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade and Industry (METI)	This study was supported by a Grant-in-Aid for Scientific Research (No. 21590266 to YN) from Japan Society for the Promotion of Science (JSPS), New Energy and Industrial Technology Development Organization (NEDO), and Ministry of Economy, Trade and Industry (METI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; ANDREWS RV, 1980, COMP BIOCHEM PHYS A, V67, P275, DOI 10.1016/0300-9629(80)90276-5; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carroll JA, 1996, DOMEST ANIM ENDOCRIN, V13, P339, DOI 10.1016/0739-7240(96)00047-1; Chrousos GP, 1998, ENDOCRINOLOGY, V139, P437, DOI 10.1210/endo.139.2.5857; Davis RE, 2007, ASSAY DRUG DEV TECHN, V5, P85, DOI 10.1089/adt.2006.048; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Hida N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005868; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kitayama Y, 2004, PLANT CELL PHYSIOL, V45, P109, DOI 10.1093/pcp/pch001; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Korf HW, 2006, MOL CELL ENDOCRINOL, V252, P57, DOI 10.1016/j.mce.2006.03.005; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Michelini E, 2009, MINERVA BIOTECNOL, V21, P87; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Nakajima Y, 2005, BIOTECHNIQUES, V38, P891, DOI 10.2144/05386ST03; Nakajima Y, 2004, FEBS LETT, V565, P122, DOI 10.1016/j.febslet.2004.03.083; Nakajima Y, 2010, EXPERT OPIN DRUG DIS, V5, P835, DOI 10.1517/17460441.2010.506213; Nakajima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010011; Nishide S, 2006, GENES CELLS, V11, P1173, DOI 10.1111/j.1365-2443.2006.01015.x; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Noguchi T, 2008, BRAIN RES, V1239, P119, DOI 10.1016/j.brainres.2008.08.082; Noguchi T, 2010, BIOCHEMISTRY-US, V49, P8053, DOI 10.1021/bi100545h; Noguchi T, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-40; Ogura R, 2005, PLANT BIOTECHNOL, V22, P151, DOI DOI 10.5511/plantbiotechnology.22.151; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Ota T, 2012, MOL CELL ENDOCRINOL, V349, P30, DOI 10.1016/j.mce.2011.08.010; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; PROVENCHER PH, 1991, J ENDOCRINOL, V130, P71, DOI 10.1677/joe.0.1300071; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Shimomura O, BIOLUMINESCENCE CHEM; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Takahashi T, 2011, TOXICOL SCI, V124, P359, DOI 10.1093/toxsci/kfr237; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Viviani VR, 1999, BIOCHEMISTRY-US, V38, P8271, DOI 10.1021/bi9900830; Viviani VR, 1999, PHOTOCHEM PHOTOBIOL, V70, P254, DOI 10.1111/j.1751-1097.1999.tb07997.x; Watanabe T, 2010, ANAL BIOCHEM, V402, P107, DOI 10.1016/j.ab.2010.03.014; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499; Yu WJ, 2002, BIOCHEM BIOPH RES CO, V290, P933, DOI 10.1006/bbrc.2001.6300; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	62	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37093	10.1371/journal.pone.0037093	http://dx.doi.org/10.1371/journal.pone.0037093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615906	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300071
J	Song, LY; Weng, D; Liu, FW; Chen, Y; Li, CY; Dong, L; Tang, W; Chen, J				Song, Laiyu; Weng, Dong; Liu, Fangwei; Chen, Ying; Li, Cuiying; Dong, Lei; Tang, Wen; Chen, Jie			Tregs Promote the Differentiation of Th17 Cells in Silica-Induced Lung Fibrosis in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; GAMMA-DELTA T; PULMONARY INFLAMMATION; NALP3 INFLAMMASOME; MURINE MODEL; TGF-BETA; SUPPRESSION; LYMPHOCYTES; ACTIVATION; CYTOKINES	Background: Silicosis is an occupational lung disease caused by inhalation of silica dust and characterized by lung inflammation and fibrosis. Previous study showed that Tregs regulate the process of silicosis by modulating the maintenance of immune homeostasis in the lung. Th17 cells share reciprocal developmental pathway with Tregs and play a pivotal role in the immunopathogenesis of many lung diseases by recruiting and activating neutrophils, but the regulatory function of Tregs on Th17 response in silica induced lung fibrosis remains to be explored. Methodology/Principal Findings: To evaluate the role of Th17 and IL-17 in the development of silicosis and their interaction with Tregs, Treg-depleted mice model was generated and exposed to silica to establish experimental model of silica-induced lung fibrosis. Here we showed that silica increased Th17 response in lung fibrosis. Tregs depletion enhanced the neutrophils accumulation and attenuated Th17 response in silica induced lung fibrosis. Both mRNA and protein results showed that Tregs exerted its modulatory function on Th17 cells and IL-17 by regulating TGF-b1 and IL-1 beta. Conclusion/Significance: Our study suggested that Tregs could promote Th17 cells differentiation by regulating TGF-beta 1 and IL-1b in silica induced lung fibrosis of mice, which further the understanding of the progress of silicosis and provide a new insight in the regulatory mechanism of Th17 by Tregs in lung inflammation.	[Song, Laiyu; Weng, Dong; Liu, Fangwei; Chen, Ying; Li, Cuiying; Dong, Lei; Tang, Wen; Chen, Jie] China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China	China Medical University	Song, LY (corresponding author), China Med Univ, Sch Publ Hlth, Div Pneumoconiosis, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Liu, FW/GQZ-5182-2022	Song, Laiyu/0000-0001-7979-8294	National Natural Science Foundation of China [81072274]; Program for Liaoning Excellent Talents in University [LR 201039]; Natural Science Foundation of Liaoning Province [20101136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Natural Science Foundation of China (grant number 81072274), the Program for Liaoning Excellent Talents in University (grant number LR 201039), and the Natural Science Foundation of Liaoning Province (grant number 20101136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Aliahmadi E, 2009, EUR J IMMUNOL, V39, P1221, DOI 10.1002/eji.200838742; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Bellinghausen I, 2003, J ALLERGY CLIN IMMUN, V111, P862, DOI 10.1067/mai.2003.1412; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cautivo KM, 2010, J IMMUNOL, V185, P7633, DOI 10.4049/jimmunol.0903452; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Dubin PJ, 2012, INFECT IMMUN, V80, P398, DOI 10.1128/IAI.05821-11; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Haeryfar SMM, 2005, J IMMUNOL, V174, P3344, DOI 10.4049/jimmunol.174.6.3344; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Knaapen AM, 2002, CARCINOGENESIS, V23, P1111, DOI 10.1093/carcin/23.7.1111; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuhlmann UC, 2009, LIFE SCI, V84, P1, DOI 10.1016/j.lfs.2008.10.001; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Liu F, 2010, PLOS ONE, V5; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; McNeill A, 2007, SCAND J IMMUNOL, V65, P63, DOI 10.1111/j.1365-3083.2006.01870.x; Morishima N, 2009, BIOCHEM BIOPH RES CO, V386, P105, DOI 10.1016/j.bbrc.2009.05.140; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Park Y, 2009, J LEUKOCYTE BIOL, V86, P1427, DOI 10.1189/jlb.0908542; Prince P, 2008, INT J TUBERC LUNG D, V12, P813; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; ROM WN, 1992, CHEST, V101, P779, DOI 10.1378/chest.101.3.779; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; STRIETER RM, 1994, J INVEST MED, V42, P640; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Suzuki NL, 1996, THORAX, V51, P1036, DOI 10.1136/thx.51.10.1036; UEKI A, 1994, IMMUNOLOGY, V82, P332; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wu P, 2006, INT J IMMUNOPATH PH, V19, P357, DOI 10.1177/039463200601900212; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728	56	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37286	10.1371/journal.pone.0037286	http://dx.doi.org/10.1371/journal.pone.0037286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615967	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300090
J	Tatarova, Z; Brabek, J; Rosel, D; Novotny, M				Tatarova, Zuzana; Brabek, Jan; Roesel, Daniel; Novotny, Marian			SH3 Domain Tyrosine Phosphorylation - Sites, Role and Evolution	PLOS ONE			English	Article							C-SRC; AUTOPHOSPHORYLATION SITE; CLUSTAL-W; PROTEIN; BINDING; ABL; KINASES; MECHANISM; RESIDUES; PEPTIDE	Background: SH3 domains are eukaryotic protein domains that participate in a plethora of cellular processes including signal transduction, proliferation, and cellular movement. Several studies indicate that tyrosine phosphorylation could play a significant role in the regulation of SH3 domains. Results: To explore the incidence of the tyrosine phosphorylation within SH3 domains we queried the PhosphoSite Plus database of phosphorylation sites. Over 100 tyrosine phosphorylations occurring on 20 different SH3 domain positions were identified. The tyrosine corresponding to c-Src Tyr-90 was by far the most frequently identified SH3 domain phosphorylation site. A comparison of sequences around this tyrosine led to delineation of a preferred sequence motif ALYD(Y/F). This motif is present in about 15% of human SH3 domains and is structurally well conserved. We further observed that tyrosine phosphorylation is more abundant than serine or threonine phosphorylation within SH3 domains and other adaptor domains, such as SH2 or WW domains. Tyrosine phosphorylation could represent an important regulatory mechanism of adaptor domains. Conclusions: While tyrosine phosphorylation typically promotes signaling protein interactions via SH2 or PTB domains, its role in SH3 domains is the opposite - it blocks or prevents interactions. The regulatory function of tyrosine phosphorylation is most likely achieved by the phosphate moiety and its charge interfering with binding of polyproline helices of SH3 domain interacting partners.	[Tatarova, Zuzana; Brabek, Jan; Roesel, Daniel; Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Charles University Prague	Tatarova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	marian@natur.cuni.cz	Tatarova, Zuzana/AAM-7616-2021; Rosel, Daniel/J-7507-2017; Brábek, Jan/J-9836-2017; Novotny, Marian/B-7036-2008; Tatarova, Zuzana/GSJ-0536-2022	Tatarova, Zuzana/0000-0002-3128-7214; Rosel, Daniel/0000-0001-7221-8672; Brábek, Jan/0000-0001-7754-7299; Novotny, Marian/0000-0001-8788-3202; Tatarova, Zuzana/0000-0002-3128-7214	Grant Agency of the Czech Republic [P305/10/0205]; League against Cancer Prague; Grant Agency of Charles University [642012]; project UNCE (UNiversity research CEntre) [204013]; Czech Ministry of Education Youth and Sport [MSM0021620858]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); League against Cancer Prague; Grant Agency of Charles University; project UNCE (UNiversity research CEntre); Czech Ministry of Education Youth and Sport(Ministry of Education, Youth & Sports - Czech Republic)	This research was supported by grants of the Grant Agency of the Czech Republic (P305/10/0205), League against Cancer Prague, by Grant Agency of Charles University, grant n. 642012, by project UNCE (UNiversity research CEntre) 204013 and in part by the Czech Ministry of Education Youth and Sport (MSM0021620858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2002, PROTEIN PEPTIDE LETT, V9, P185, DOI 10.2174/0929866023408760; Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Cesareni G., 2005, MODULAR PROTEIN DOMA; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; FABIAN H, 1994, J BIOMOL STRUCT DYN, V12, P573, DOI 10.1080/07391102.1994.10508760; Fernow I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-80; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Janostiak R, 2011, MOL BIOL CELL, V22, P4256, DOI 10.1091/mbc.E11-03-0207; Joseph RE, 2007, J MOL BIOL, V373, P1281, DOI 10.1016/j.jmb.2007.08.060; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kashiwakura J, 2002, BIOL PHARM BULL, V25, P718, DOI 10.1248/bpb.25.718; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazer G, 2010, J BIOL CHEM, V285, P23073, DOI 10.1074/jbc.M109.094508; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Sato M, 2011, FEBS LETT, V585, P834, DOI 10.1016/j.febslet.2011.02.012; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sriram G, 2011, ONCOGENE, V30, P4645, DOI 10.1038/onc.2011.170; Sylvester M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011708; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	45	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36310	10.1371/journal.pone.0036310	http://dx.doi.org/10.1371/journal.pone.0036310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615764	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300013
J	Cimini, E; Bonnafous, C; Bordoni, V; Lalle, E; Sicard, H; Sacchi, A; Berno, G; Gioia, C; D'Offizi, G; Comandini, UV; Vlassi, C; Capobianchi, MR; Martini, F; Agrati, C				Cimini, Eleonora; Bonnafous, Cecile; Bordoni, Veronica; Lalle, Eleonora; Sicard, Helene; Sacchi, Alessandra; Berno, Giulia; Gioia, Cristiana; D'Offizi, Gianpiero; Comandini, Ubaldo Visco; Vlassi, Chrysoula; Capobianchi, Maria Rosaria; Martini, Federico; Agrati, Chiara			Interferon-alpha Improves Phosphoantigen-Induced V gamma 9V delta 2 T-Cells Interferon-gamma Production during Chronic HCV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; NATURAL-KILLER-CELLS; VIRUS REPLICON; MESSENGER-RNA; IFN-GAMMA; IMMUNOTHERAPY; ACTIVATION; ANTIGENS; INTERLEUKIN-2; CYTOTOXICITY	In chronic HCV infection, treatment failure and defective host immune response highly demand improved therapy strategies. V gamma 9V delta 2 T-cells may inhibit HCV replication in vitro through IFN-gamma release after Phosphoantigen (PhAg) stimulation. The aim of our work was to analyze V gamma 9V delta 2 T-cell functionality during chronic HCV infection, studying the role of IFN-alpha on their function capability. IFN-gamma production by Vc gamma V delta 2 T-cells was analyzed in vitro in 24 HCV-infected patients and 35 healthy donors (HD) after PhAg stimulation with or without IFN-alpha. The effect of in vivo PhAg/IFN-alpha administration on plasma IFN-gamma levels was analyzed in M. fascicularis monkeys. A quantitative analysis of IFN-gamma mRNA level and stability in V gamma 9V delta 2 T-cells was also evaluated. During chronic HCV infection, V gamma 9V delta 2 T-cells showed an effector/activated phenotype and were significantly impaired in IFN-gamma production. Interestingly, IFN-alpha was able to improve their IFN-gamma response to PhAg both in vitro in HD and HCV-infected patients, and in vivo in Macaca fascicularis primates. Finally, IFN-alpha increased IFN-gamma-mRNA transcription and stability in PhAg-activated V gamma 9V delta 2 T-cells. Altogether our results show a functional impairment of V gamma 9V delta 2 T-cells during chronic HCV infection that can be partially restored by using IFN-alpha. A study aimed to evaluate the antiviral impact of PhAg/IFN-alpha combination may provide new insight in designing possible combined strategies to improve HCV infection treatment outcome.	[Cimini, Eleonora; Bordoni, Veronica; Sacchi, Alessandra; Berno, Giulia; Gioia, Cristiana; Martini, Federico; Agrati, Chiara] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Cellular Immunol Lab, Rome, Italy; [Lalle, Eleonora; Capobianchi, Maria Rosaria; Agrati, Chiara] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Virol Lab, Rome, Italy; [Bonnafous, Cecile; Sicard, Helene] Innate Pharma, Marseille, France; [D'Offizi, Gianpiero; Comandini, Ubaldo Visco; Vlassi, Chrysoula] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Cimini, E (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Cellular Immunol Lab, Rome, Italy.	federico.martini@inmi.it	bordoni, veronica/K-8614-2016; Sacchi, Alessandra/K-7782-2016; Cimini, Eleonora/K-8878-2016; Berno, Giulia/K-1991-2016; Agrati, Chiara/K-8806-2016	bordoni, veronica/0000-0002-1747-2245; Sacchi, Alessandra/0000-0003-4964-386X; Cimini, Eleonora/0000-0002-2659-0868; Berno, Giulia/0000-0003-0331-2627; lalle, eleonora/0000-0002-7063-9905; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Agrati, Chiara/0000-0002-5252-0927	Italian Ministry of Health [Current IRCCS Research Program]	Italian Ministry of Health [Current IRCCS Research Program]	This work was supported by the Italian Ministry of Health [Current IRCCS Research Program]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2003, J MED VIROL, V70, P581, DOI 10.1002/jmv.10433; Agrati C, 2006, J INFECT DIS, V193, P1606, DOI 10.1086/503438; Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Agrati C, 2009, J IMMUNOL, V182, P522, DOI 10.4049/jimmunol.182.1.522; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Castilletti C, 2005, VIROLOGY, V341, P163, DOI 10.1016/j.virol.2005.07.015; Conti L, 2005, J IMMUNOL, V174, P252, DOI 10.4049/jimmunol.174.1.252; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; De Francesco R, 2005, NATURE, V436, P953, DOI 10.1038/nature04080; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Farag MMS, 2011, CLIN EXP IMMUNOL, V165, P352, DOI 10.1111/j.1365-2249.2011.04431.x; Gan YH, 2001, MOL MED, V7, P636, DOI 10.1007/BF03401870; Gougeon ML, 2002, VACCINE, V20, P1938, DOI 10.1016/S0264-410X(02)00070-1; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; Jia YT, 2007, J GASTROEN HEPATOL, V22, P1278, DOI 10.1111/j.1440-1746.2007.04957.x; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; Kunzmann V, 2004, IMMUNOLOGY, V112, P369, DOI 10.1111/j.1365-2567.2004.01908.x; Larkin J, 2003, J INTERF CYTOK RES, V23, P247, DOI 10.1089/107999003321829962; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martini F, 2000, IMMUNOLOGY, V100, P481, DOI 10.1046/j.1365-2567.2000.00068.x; Mavropoulos A, 2005, BLOOD, V105, P282, DOI 10.1182/blood-2004-07-2782; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Par G, 2002, J HEPATOL, V37, P514, DOI 10.1016/S0168-8278(02)00218-0; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 2006, J INFECT DIS, V193, P1244, DOI 10.1086/502975; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Poccia F, 2005, MICROBES INFECT, V7, P518, DOI 10.1016/j.micinf.2004.12.009; Poccia F, 2009, AIDS, V23, P555, DOI 10.1097/QAD.0b013e3283244619; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Rodrigue-Gervais IG, 2010, J IMMUNOL, V184, P3134, DOI 10.4049/jimmunol.0902522; Sacchi A, 2009, J INFECT DIS, V199, P432, DOI 10.1086/596047; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tseng CTK, 2001, HEPATOLOGY, V33, P1312, DOI 10.1053/jhep.2001.24269; Wiegand J, 2007, ANTIVIR THER, V12, P303; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624	46	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37014	10.1371/journal.pone.0037014	http://dx.doi.org/10.1371/journal.pone.0037014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629350	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300019
J	Musunuru, K; Romaine, SPR; Lettre, G; Wilson, JG; Volcik, KA; Tsai, MY; Taylor, HA; Schreiner, PJ; Rotter, JI; Rich, SS; Redline, S; Psaty, BM; Papanicolaou, GJ; Ordovas, JM; Liu, K; Krauss, RM; Glazer, NL; Gabriel, SB; Fornage, M; Cupples, LA; Buxbaum, SG; Boerwinkle, E; Ballantyne, CM; Kathiresan, S; Rader, DJ				Musunuru, Kiran; Romaine, Simon P. R.; Lettre, Guillaume; Wilson, James G.; Volcik, Kelly A.; Tsai, Michael Y.; Taylor, Herman A., Jr.; Schreiner, Pamela J.; Rotter, Jerome I.; Rich, Stephen S.; Redline, Susan; Psaty, Bruce M.; Papanicolaou, George J.; Ordovas, Jose M.; Liu, Kiang; Krauss, Ronald M.; Glazer, Nicole L.; Gabriel, Stacey B.; Fornage, Myriam; Cupples, L. Adrienne; Buxbaum, Sarah G.; Boerwinkle, Eric; Ballantyne, Christie M.; Kathiresan, Sekar; Rader, Daniel J.			Multi-Ethnic Analysis of Lipid-Associated Loci: The NHLBI CARe Project	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; TRIGLYCERIDES; DESIGN; GENES; RISK	Background: Whereas it is well established that plasma lipid levels have substantial heritability within populations, it remains unclear how many of the genetic determinants reported in previous studies (largely performed in European American cohorts) are relevant in different ethnicities. Methodology/Principal Findings: We tested a set of similar to 50,000 polymorphisms from similar to 2,000 candidate genes and genetic loci from genome-wide association studies (GWAS) for association with low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) in 25,000 European Americans and 9,000 African Americans in the National Heart, Lung, and Blood Institute (NHLBI) Candidate Gene Association Resource (CARe). We replicated associations for a number of genes in one or both ethnicities and identified a novel lipid-associated variant in a locus harboring ICAM1. We compared the architecture of genetic loci associated with lipids in both African Americans and European Americans and found that the same genes were relevant across ethnic groups but the specific associated variants at each gene often differed. Conclusions/Significance: We identify or provide further evidence for a number of genetic determinants of plasma lipid levels through population association studies. In many loci the determinants appear to differ substantially between African Americans and European Americans.	[Musunuru, Kiran; Gabriel, Stacey B.] Broad Inst, Cambridge, MA USA; [Musunuru, Kiran; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA USA; [Musunuru, Kiran; Kathiresan, Sekar] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Romaine, Simon P. R.] Univ Leeds, Leeds, W Yorkshire, England; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Wilson, James G.; Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Volcik, Kelly A.; Fornage, Myriam; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Taylor, Herman A., Jr.; Buxbaum, Sarah G.] Jackson State Univ, Jackson, MS USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Rich, Stephen S.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Redline, Susan] Univ Hosp, Case Med Ctr, Cleveland, OH USA; [Redline, Susan] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Psaty, Bruce M.] Univ Washington, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Papanicolaou, George J.] NHLBI, NIH, Bethesda, MD 20892 USA; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, JM United States Dept Agr, Boston, MA 02111 USA; [Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Glazer, Nicole L.; Cupples, L. Adrienne] Boston Univ, Boston, MA 02215 USA; [Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Leeds; Universite de Montreal; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; Jackson State University; Cedars Sinai Medical Center; University of Virginia; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University of Washington; University of Washington Seattle; Group Health Cooperative; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; United States Department of Agriculture (USDA); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Boston University; Northwestern University; Feinberg School of Medicine; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine; University of Pennsylvania	Musunuru, K (corresponding author), Broad Inst, Cambridge, MA USA.	cmb@bcm.edu; sekar@broadinstitute.org; rader@mail.med.upenn.edu	Ballantyne, Christie/A-6599-2008; Buxbaum, Sarah G./E-1970-2013; Rotter, Jerome/AAY-6598-2021; Ordovas, Jose/B-8727-2013	Buxbaum, Sarah G./0000-0002-4886-3564; Schreiner, Pamela/0000-0002-9920-6257; Rich, Stephen/0000-0003-3872-7793; Ordovas, Jose/0000-0002-7581-5680; Glazer, Nicole/0000-0002-6397-609X; Tsai, Michael/0000-0001-7553-3408; Ballantyne, Christie/0000-0002-6432-1730; Cupples, L. Adrienne/0000-0003-0273-7965	T32 grant in Cell and Molecular Training for Cardiovascular Biology from the National Heart, Lung, and Blood Institute [K99-HL098364]; University of Virginia [R01-HL-071205]; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB072991, N01HB097060, N01HB073002, N01HB097071, N01HB072998, N01HB097062, N01HB073005, N01HB097072, N01HB073000, N01HB097069, N01HB097051, N01HB072996, N01HB072993, N01HB097068, N01HB073001, N01HB097061, N01HB072997, N01HB097053, N01HB097070, N01HB073004, N01HB073006, N01HB072992, N01HB072994, N01HB097073, N01HB097066, N01HB097058, N01HB097064, N01HB097056, N01HB072982, N01HB097054, N01HB072995, N01HB073003] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095168, N01HC048048, N01HC095163, N01HC035129, N01HC005187, N01HC025195, N01HC095171, N01HC095160, N01HC095166, N01HC085082, N01HC095165, N01HC048047, N01HC095100, N01HC095167, N01HC015103, N01HC095159, N01HC085086, N01HC085085, N01HC055021, N01HC055016, N01HC095169, N01HC085081, N01HC055222, N01HC055020, N01HC055015, N01HC095172, N01HC075150, N01HC085079, N01HC095161, N01HC045134, N01HC055018, N01HC048049, N01HC055022, N01HC055019, N01HC085083, N01HC095164, N01HC095170, N01HC095095, N01HC085084, N01HC085080, N01HC095162, N01HC048050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095160, K99HL098364, R01HL065226, U01HL063463, U01HL053938, U01HL053941, U01HL053934, R43HL095161, R01HL085083, R42HL055018, U01HL077813, U01HL053916, R01HL076784, R44HL095169, R01HL048049, U01HL064360, U01HL080295, R29HL048048, R01HL046380, R01HL048050, U01HL063429, R41HL055019, R43HL095169, U01HL053937, R01HL071205, R01HL095163, R41HL055018, R01HL048048, R01HL092577, R21HL095165, R13HL095166, R43HL095167, R41HL095172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	T32 grant in Cell and Molecular Training for Cardiovascular Biology from the National Heart, Lung, and Blood Institute; University of Virginia; DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The following nine parent studies have contributed parent study data, ancillary study data, and DNA samples through the Broad Institute of Massachusetts Institute of Technology and Harvard (N01-HC-65226): Atherosclerosis Risk in Communities: University of North Carolina at Chapel Hill (N01-HC-55015, N01-HC-55018), Baylor Medical College (N01-HC-55016), University of Mississippi Medical Center (N01-HC-55021), University of Minnesota (N01-HC-55019), Johns Hopkins University (N01-HC-55020), University of Texas, Houston (N01-HC-55022); Cardiovascular Health Study: University of Washington (N01-HC-85079, N01-HC-55222, U01-HL-080295), Wake Forest University (N01-HC-85080), Johns Hopkins University (N01-HC-85081, N01-HC-15103), University of Pittsburgh (N01-HC-85082), University of California, Davis (N01-HC-85083), University of California, Irvine (N01-HC-85084), New England Medical Center (N01-HC-85085), University of Vermont (N01-HC-85086), Georgetown University (N01-HC-35129), University of Wisconsin (N01-HC-75150); Cleveland Family Study: Case Western Reserve University (R01-HL-46380, M01-RR-00080); Cooperative Study of Sickle Cell Disease: University of Illinois (N01-HB-72982, N01-HB-97062), Howard University (N01-HB-72991, N01-HB-97061), University of Miami (N01-HB-72992, N01-HB-97064), Duke University (N01-HB-72993), George Washington University (N01-HB-72994), University of Tennessee (N01-HB-72995, N01-HB-97070), Yale University (N01-HB-72996, N01-HB-97072), Children's Hospital-Philadelphia (N01-HB-72997, N01-HB-97056), University of Chicago (N01-HB-72998, N01-HB-97053), Medical College of Georgia (N01-HB-73000, N01-HB-97060), Washington University (N01-HB-73001, N01-HB-97071), Jewish Hospital and Medical Center of Brooklyn (N01-HB-73002), Trustees of Health and Hospitals of the City of Boston, Inc., (N01-HB-73003), Children's Hospital-Oakland (N01-HB-73004, N01-HB-97054), University of Mississippi (N01-HB-73005), St. Luke's Hospital-New York (N01-HB-73006), Alta Bates-Herrick Hospital (N01-HB-97051), Columbia University (N01-HB-97058), St.; Jude's Children's Research Hospital (N01-HB-97066), Research Foundation, State University of New York-Albany (N01-HB-97068, N01-HB-97069), New England Research Institute (N01-HB-97073), Interfaith Medical Center-Brooklyn (N01-HB-97085); Coronary Artery Risk in Young Adults: University of Alabama at Birmingham (N01-HC-48047, N01-HC-95095), University of Minnesota (N01-HC-48048), Northwestern University (N01-HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205), Harbor-University of California Los Angeles Research and Education Institute (N01-HC-05187), University of California, Irvine (N01-HC-45134, N01-HC-95100) ;Framingham Heart Study: Boston University (N01-HC-25195, R01-HL-092577, R01-HL-076784, R01-AG-028321); Jackson Heart Study: Jackson State University (N01-HC-95170), University of Mississippi (N01-HC-95171), Tougaloo College (N01-HC-95172); Multi-Ethnic Study of Atherosclerosis: University of Washington (N01-HC-95159), University of California, Los Angeles (N01-HC-95160), Columbia University (N01-HC-95161), Johns Hopkins University (N01-HC-95162, N01-HC-95168), University of Minnesota (N01-HC-95163), Northwestern University (N01-HC-95164), Wake Forest University (N01-HC-95165), University of Vermont (N01-HC-95166), New England Medical Center (N01-HC-95167), Harbor-University of California Los Angeles Research and Education Institute (N01-HC-95169), Cedars-Sinai Medical Center (R01-HL-071205), University of Virginia (subcontract to R01-HL-071205); Sleep Heart Health Study: Johns Hopkins University (U01-HL-064360), Case Western University (U01-HL-063463), University of California, Davis (U01-HL-053916), University of Arizona (U01-HL-053938, U01-HL-053934), University of Pittsburgh (U01-HL-077813), Boston University (U01-HL-053941), MedStar Research Institute (U01-HL-063429), Johns Hopkins University (U01-HL-053937). This work was also supported in part by a T32 grant in Cell and Molecular Training for Cardiovascular Biology and K99-HL098364 from the National Heart, Lung, and Blood Institute (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kapur NK, 2008, VASC HEALTH RISK MAN, V4, P39, DOI 10.2147/VHRM.S1653; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	19	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36473	10.1371/journal.pone.0036473	http://dx.doi.org/10.1371/journal.pone.0036473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629316	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100005
J	Chu, CP; Bing, YH; Liu, H; Qiu, DL				Chu, Chun-Ping; Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai			Roles of Molecular Layer Interneurons in Sensory Information Processing in Mouse Cerebellar Cortex Crus II In Vivo	PLOS ONE			English	Article							FIBER RECEPTIVE-FIELDS; PURKINJE-CELLS; GRANULE CELL; SYNCHRONIZED ACTIVITY; SYNAPTIC CURRENTS; GABA(A) RECEPTORS; BASKET CELLS; PARALLEL; INHIBITION; RAT	Background: Cerebellar cortical molecular layer interneurons (MLIs) play essential roles in sensory information processing by the cerebellar cortex. However, recent experimental and modeling results are questioning traditional roles for molecular layer inhibition in the cerebellum. Methods and Main Results: Synaptic responses of MLIs and Purkinje cells (PCs), evoked by air-puff stimulation of the ipsilateral whisker pad were recorded from cerebellar cortex Crus II in urethane-anesthetized ICR mice by in vivo whole-cell patch-clamp recording techniques. Under current-clamp (I = 0), air-puff stimuli were found to primarily produce inhibition in PCs. In MLIs, this stimulus evoked spike firing regardless of whether they made basket-type synaptic connections or not. However, MLIs not making basket-type synaptic connections had higher rates of background activity and also generated spontaneous spike-lets. Under voltage-clamp conditions, excitatory postsynaptic currents (EPSCs) were recorded in MLIs, although the predominant response of recorded PCs was an inhibitory postsynaptic potential (IPSP). The latencies of EPSCs were similar for all MLIs, but the time course and amplitude of EPSCs varied with depth in the molecular layer. The highest amplitude, shortest duration EPSCs were recorded from MLIs deep in the molecular layer, which also made basket-type synaptic connections. Comparing MLI to PC responses, time to peak of PC IPSP was significantly slower than MLI recorded EPSCs. Blocking GABA(A) receptors uncovered larger EPSCs in PCs whose time to peak, half-width and 10-90% rising time were also significantly slower than in MLIs. Biocytin labeling indicated that the MLIs (but not PCs) are dye-coupled. Conclusions: These findings indicate that tactile face stimulation evokes rapid excitation in MLIs and inhibition occurring at later latencies in PCs in mouse cerebellar cortex Crus II. These results support previous suggestions that the lack of parallel fiber driven PC activity is due to the effect of MLI inhibition.	[Chu, Chun-Ping; Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai] Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China; [Bing, Yan-Hua; Liu, Heng; Qiu, De-Lai] Yanbian Univ, Coll Med, Dept Physiol & Pathophysiol, Yanji, Jilin Province, Peoples R China; [Chu, Chun-Ping] Yanbian Univ, Coll Basic Med, Funct Expt Ctr, Yanji, Jilin Province, Peoples R China	Yanbian University; Yanbian University; Yanbian University	Chu, CP (corresponding author), Yanbian Univ, Cellular Funct Res Ctr, Yanji, Jilin Province, Peoples R China.	dlqiu@ybu.edu.cn			National Natural Science Foundation of China [31060138]; Leading Academic Discipline Program, 211 Project of Yanbian University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Program, 211 Project of Yanbian University, China	This work was supported by the National Natural Science Foundation of China (31060138) and the Leading Academic Discipline Program, 211 Project of Yanbian University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brown ME, 2009, J NEUROPHYSIOL, V101, P474, DOI 10.1152/jn.90766.2008; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chu CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022752; Chu CP, 2011, NEUROSCI LETT, V487, P182, DOI 10.1016/j.neulet.2010.10.018; Cohen D, 1998, P NATL ACAD SCI USA, V95, P15032, DOI 10.1073/pnas.95.25.15032; Cohen D, 2000, J NEUROPHYSIOL, V83, P1932, DOI 10.1152/jn.2000.83.4.1932; Donato R, 2008, CELL CALCIUM, V44, P521, DOI 10.1016/j.ceca.2008.03.006; ECCLES JC, 1972, EXP BRAIN RES, V15, P261, DOI 10.1007/BF00235911; Eccles JC, 1967, CEREBELLUM NEURONAL; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hevers W, 2008, J NEUROSCI, V28, P5383, DOI 10.1523/JNEUROSCI.5443-07.2008; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Kolb FP, 1997, NEUROSCIENCE, V81, P1155, DOI 10.1016/S0306-4522(97)00255-8; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Lu H, 2005, J NEUROPHYSIOL, V94, P1849, DOI 10.1152/jn.01275.2004; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mathers DA, 2007, NEUROPHARMACOLOGY, V52, P1160, DOI 10.1016/j.neuropharm.2006.12.004; MEEK J, 1992, NEUROSCIENCE, V48, P249, DOI 10.1016/0306-4522(92)90489-O; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; ODONOGHUE DL, 1989, J NEUROSCI, V9, P2141; Palay S.L., 1974, CEREBELLAR CORTEX; Sakaba T, 2008, NEURON, V57, P406, DOI 10.1016/j.neuron.2007.11.029; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Stell BM, 2007, J NEUROSCI, V27, P9022, DOI 10.1523/JNEUROSCI.1954-07.2007; Sultan F, 1998, J COMP NEUROL, V393, P353; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; Walter JT, 2009, J NEUROSCI, V29, P8462, DOI 10.1523/JNEUROSCI.5718-08.2009	42	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37031	10.1371/journal.pone.0037031	http://dx.doi.org/10.1371/journal.pone.0037031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623975	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500052
J	Liu, WM; Pang, RTK; Cheong, AWY; Ng, EHY; Lao, KQ; Lee, KF; Yeung, WSB				Liu, Wei-Min; Pang, Ronald T. K.; Cheong, Ana W. Y.; Ng, Ernest H. Y.; Lao, Kaiqin; Lee, Kai-Fai; Yeung, William S. B.			Involvement of microRNA Lethal-7a in the Regulation of Embryo Implantation in Mice	PLOS ONE			English	Article							MOUSE PERIIMPLANTATION BLASTOCYSTS; CELL-SPECIFIC MICRORNAS; GROWTH-FACTOR-BETA; DELAYED-IMPLANTATION; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; SPATIAL REGULATION; EXPRESSION; INTEGRIN; UTERUS	MicroRNAs interact with multiple mRNAs resulting in their degradation and/or translational repression. This report used the delayed implantation model to determine the role of miRNAs in blastocysts. Dormant blastocysts in delayed implanting mice were activated by estradiol. Differential expression of 45 out of 238 miRNAs examined was found between the dormant and the activated blastocysts. Five of the nine members of the microRNA lethal-7 (let-7) family were down-regulated after activation. Human blastocysts also had a low expression of let-7 family. Forced-expression of a family member, let-7a in mouse blastocysts decreased the number of implantation sites (let-7a: 1.1 +/- 0.4; control: 3.8 +/- 0.4) in vivo, and reduced the percentages of blastocyst that attached (let-7a: 42.0 +/- 8.3%; control: 79.0 +/- 5.1%) and spreaded (let-7a: 33.5 +/- 2.9%; control: 67.3 +/- 3.8%) on fibronectin in vitro. Integrin-beta 3, a known implantation-related molecule, was demonstrated to be a target of let-7a by 3'-untranslated region reporter assay in cervical cancer cells HeLa, and Western blotting in mouse blastocysts. The inhibitory effect of forced-expression of let-7a on blastocyst attachment and outgrowth was partially nullified in vitro and in vivo by forced-expression of integrin-beta 3. This study provides the first direct evidence that let-7a is involved in regulating the implantation process partly via modulation of the expression of integrin-beta 3. (200 words).	[Liu, Wei-Min; Pang, Ronald T. K.; Cheong, Ana W. Y.; Ng, Ernest H. Y.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China; [Pang, Ronald T. K.; Lee, Kai-Fai; Yeung, William S. B.] Univ Hong Kong, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	University of Hong Kong; University of Hong Kong; Thermo Fisher Scientific; Applied Biosystems	Liu, WM (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China.	wsbyeung@hku.hk	Pang, Ronald/B-8039-2013; Lee, Calvin Kai Fai/C-4328-2009	Ng, Ernest/0000-0002-7688-4557; Lee, Calvin Kai Fai/0000-0001-5957-439X	GRF grant from the Research Grant Council, Hong Kong [HKU783910M]	GRF grant from the Research Grant Council, Hong Kong	This work is supported by a GRF grant from the Research Grant Council (HKU783910M), Hong Kong (http://www.ugc.edu.hk/eng/rgc/grf/application/cergia.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aplin AE, 1998, PHARMACOL REV, V50, P197; Aplin John D, 2004, Reprod Biol Endocrinol, V2, P48; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Bandi N, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-55; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basak S, 2002, BIOL REPROD, V66, P1784, DOI 10.1095/biolreprod66.6.1784; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fu TY, 2011, J REPROD DEVELOP, V57, P627, DOI 10.1262/jrd.11-018E; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Illera MJ, 2000, BIOL REPROD, V62, P1285, DOI 10.1095/biolreprod62.5.1285; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaneko Y, 2011, REPROD FERT DEVELOP, V23, P481, DOI 10.1071/RD10211; Katagiri S, 1998, J VET MED SCI, V60, P791, DOI 10.1292/jvms.60.791; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legler DF, 2001, J CELL SCI, V114, P1545; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Liu WM, 2007, FERTIL STERIL, V87, P664, DOI 10.1016/j.fertnstert.2006.07.1525; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mummery CL, 2001, MICROSC RES TECHNIQ, V52, P374, DOI 10.1002/1097-0029(20010215)52:4<374::AID-JEMT1022>3.0.CO;2-8; NIEDER GL, 1984, J EXP ZOOL, V231, P121, DOI 10.1002/jez.1402310116; O'Hara AJ, 2009, BLOOD, V113, P5938, DOI 10.1182/blood-2008-09-179168; Ouellet DL, 2006, J BIOMED BIOTECHNOL, V2006, P69616; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pang RTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027878; PARIA BC, 1992, DEV BIOL, V151, P91, DOI 10.1016/0012-1606(92)90216-4; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Rout UK, 2004, DEV BIOL, V268, P135, DOI 10.1016/j.ydbio.2003.12.010; SAKHUJATALWAR D, 1984, J REPROD FERTIL, V70, P185, DOI 10.1530/jrf.0.0700185; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schultz JF, 1997, DEV GENET, V21, P31, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;31::AID-DVG4&gt;3.0.CO;2-9; SCHULTZ JF, 1995, J BIOL CHEM, V270, P11522, DOI 10.1074/jbc.270.19.11522; Soares ML, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-28; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Spindler RE, 1996, J EXP ZOOL, V276, P132, DOI 10.1002/(SICI)1097-010X(19961001)276:2&lt;132::AID-JEZ6&gt;3.0.CO;2-P; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Wang J, 1999, BIOL REPROD, V60, P839, DOI 10.1095/biolreprod60.4.839; Wang J, 2007, DEV BIOL, V302, P143, DOI 10.1016/j.ydbio.2006.09.015; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Xia HF, 2010, J REPROD DEVELOP, V56, P73, DOI 10.1262/jrd.09-088K; Xia HF, 2010, INT J MOL SCI, V11, P719, DOI 10.3390/ijms11020719; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	74	60	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37039	10.1371/journal.pone.0037039	http://dx.doi.org/10.1371/journal.pone.0037039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623977	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500054
J	Schlecht, NF; Burk, RD; Nucci-Sack, A; Shankar, V; Peake, K; Lorde-Rollins, E; Porter, R; Linares, LO; Rojas, M; Strickler, HD; Diaz, A				Schlecht, Nicolas F.; Burk, Robert D.; Nucci-Sack, Anne; Shankar, Viswanathan; Peake, Ken; Lorde-Rollins, Elizabeth; Porter, Richard; Linares, Lourdes Oriana; Rojas, Mary; Strickler, Howard D.; Diaz, Angela			Cervical, Anal and Oral HPV in an Adolescent Inner-City Health Clinic Providing Free Vaccinations	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT VACCINE; EFFICACY; INFECTION; TRIAL; CANCER; WOMEN	Objectives: Published human papillomavirus (HPV) vaccine trials indicate efficacy is strongest for those naive to the vaccine-types. However, few high-risk young women have been followed and cervical HPV has been the predominant outcome measure. Methods: We collected cervical and anal swabs, as well as oral rinse specimens from 645 sexually active inner-city young females attending a large adolescent health-clinic in New York City that offers free care and HPV vaccination. Specimens were tested for HPV-DNA using a MY09/MY11-PCR system. Type-specific prevalence of HPV at each anatomic site was compared for individuals by vaccination dose using generalized estimating equation logistic regression models. Results: The majority of subjects reported being of non-Caucasian (92%) and/or Hispanic ethnicity (61%). Median age was 18 years (range: 14-20). All had practiced vaginal sex, a third (33%) practiced anal sex, and most (77%) had also engaged in oral sex. At enrollment, 21% had not received the vaccine and 51% had received three doses. Prevalent HPV infection at enrollment was detected in 54% of cervical, 42% of anal and 20% of oral specimens, with vaccine types present in 7%, 6% and 1% of specimens, respectively. Comparing prevalence for vaccine types, the detection of HPV in the cervix of vaccinated compared to unvaccinated adolescents was significantly reduced: HPV6/11 (odds ratio [OR] = 0.19, 95% CI: 0.06-0.75), HPV16 (OR = 0.31, 95% CI: 0.11-0.88) and HPV18 (OR = 0.14, 95% CI: 0.03-0.75). For anal HPV, the risk of detecting vaccine types HPV6/11 (OR = 0.27, 95% CI: 0.10-0.72) and HPV18(OR = 0.12, 95% CI: 0.01-1.16) were significantly reduced for vaccinated adolescents however, the risk for HPV16 was not significantly decreased (OR = 0.63, 95% CI: 0.18-2.20). Conclusion: HPV Prevalence is extremely high in inner-city female adolescents. Administration of the HPV vaccine reduced the risk for cervical HPV; however continued follow-up is required to assess the protection for HPV at all sites in young women with high exposure.	[Schlecht, Nicolas F.; Burk, Robert D.; Shankar, Viswanathan; Strickler, Howard D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Microbiol & Immunol, Bronx, NY 10467 USA; [Nucci-Sack, Anne; Peake, Ken; Lorde-Rollins, Elizabeth; Porter, Richard; Linares, Lourdes Oriana; Diaz, Angela] Mt Sinai Sch Med, Mt Sinai Adolescent Hlth Ctr, Dept Pediat, New York, NY USA; [Rojas, Mary] Maimonides Hosp, Dept Pediat, Infants & Childrens Hosp, Brooklyn, NY 11219 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Maimonides Medical Center; Yeshiva University; Albert Einstein College of Medicine	Schlecht, NF (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	nicolas.schlecht@einstein.yu.edu	Viswanathan, Shankar/AAX-5281-2020	Viswanathan, Shankar/0000-0003-3349-9090; Schlecht, Nicolas/0000-0003-2482-244X; Rojas, Mary/0000-0002-0542-4270	National Institute of Allergy and Infectious Diseases [AI072204]; NIH [AI51519]; Einstein Cancer Research Center from the National Cancer Institute [P30 CA013330]; Einstein-Montefiore Center for AIDS; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072204, P30AI051519, R01AI072204] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein Cancer Research Center from the National Cancer Institute; Einstein-Montefiore Center for AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institute of Allergy and Infectious Diseases (RO1 grant AI072204). Additional funding was provided in part by the Einstein-Montefiore Center for AIDS funded by the NIH (AI51519), the Einstein Cancer Research Center (P30 CA013330) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, N ENGL J MED, V356, P1915; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GREENLAND S, 1986, INT J EPIDEMIOL, V15, P413, DOI 10.1093/ije/15.3.413; Haupt RM, 2011, INT J CANCER, V129, P2632, DOI 10.1002/ijc.25940; Katki H, 2011, HPV VACCINE EFFICACY; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kovacic MB, 2006, CANCER RES, V66, P10112, DOI 10.1158/0008-5472.CAN-06-1812; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Olsson SE, 2009, HUM VACCINES, V5, P696, DOI 10.4161/hv.5.10.9515; Paavonen J, 2008, CURR MED RES OPIN, V24, P1623, DOI 10.1185/03007990802068151; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	22	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37419	10.1371/journal.pone.0037419	http://dx.doi.org/10.1371/journal.pone.0037419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624027	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500112
J	Tan, ZX; Li, FF; Qu, YY; Liu, J; Liu, GR; Zhou, J; Zhu, YL; Liu, SL				Tan, Zhen-Xuan; Li, Fei-Feng; Qu, You-Yang; Liu, Ji; Liu, Gui-Rong; Zhou, Jin; Zhu, Yu-Lan; Liu, Shu-Lin			Identification of a Known Mutation in Notch 3 in Familiar CADASIL in China	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; DIAGNOSTIC STRATEGIES; SUBCORTICAL INFARCTS; RISK-FACTORS; SPECTRUM; GENE; LEUKOENCEPHALOPATHY; DOMAINS	Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited disease leading to recurrent ischemic stroke and vascular dementia. Numerous mutations in the 23 exons of the NOTCH3 gene have been reported to cause CADASIL in Caucasian populations, but the full spectrum of genetic changes leading to this disease is yet to be known and, especially, very few reports are available on CADASIL in Asian populations. Methods and Results: We genotyped members of a 5-generational Han Chinese family with CADASIL patients and identified an R133C mutation in the NOTCH3 gene. Clinical analysis demonstrated that the penetrance of the mutation was not complete. Five of the mutation carriers, not exposed to the known vascular risk factors, did not show any clinical feature of CADASIL, suggesting the importance of environmental factors to the development of this disease. Conclusions: Members of a 5-generational Han Chinese family with CADASIL patients had an R133C mutation in the NOTCH3 gene but only individuals exposed to known vascular risk factors developed CADASIL.	[Tan, Zhen-Xuan; Li, Fei-Feng; Liu, Ji; Liu, Gui-Rong; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, Harbin, Peoples R China; [Qu, You-Yang; Zhu, Yu-Lan] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China; [Zhou, Jin; Liu, Shu-Lin] Harbin Med Univ, Clin Coll 1, Genet Detect Ctr, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Zhu, YL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Peoples R China.	lff-1981@163.com; ylz1962@yahoo.com.cn; slliu@ucalgary.ca			National Natural Science Foundation of China [NSFC30970078, NSFC30870098, 30970119, 81030029]; Natural Science Foundation of Heilongjiang Province of China; Heilongjiang Innovation Research Foundation for Graduate Studies [YJSCX2011-335HLJ]; Harbin Medical University; Specialized Research Fund for the Doctoral Program of Higher Education [20092307110001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Heilongjiang Innovation Research Foundation for Graduate Studies; Harbin Medical University; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by a grant of National Natural Science Foundation of China (NSFC30970078) and a grant of Natural Science Foundation of Heilongjiang Province of China to GRL; a grant from Heilongjiang Innovation Research Foundation for Graduate Studies (YJSCX2011-335HLJ) to ZXT; and a start-up grant from Harbin Medical University, grants of National Natural Science Foundation of China (NSFC30870098, 30970119, 81030029), and a Specialized Research Fund for the Doctoral Program of Higher Education (No.20092307110001) to SLL. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adib-Samii P, STROKE, V41, P630; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Choi JC, 2006, NEUROLOGY, V67, P2042, DOI 10.1212/01.wnl.0000246601.70918.06; Desmond DW, 1999, STROKE, V30, P1230, DOI 10.1161/01.STR.30.6.1230; Dichgans M, 2000, EUR J HUM GENET, V8, P280, DOI 10.1038/sj.ejhg.5200460; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Dotti MT, 2005, J NEUROL NEUROSUR PS, V76, P736, DOI 10.1136/jnnp.2004.048207; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Escary JL, 2000, HUM MUTAT, V16, P518; Federico A, 2005, NEUROL SCI, V26, P117, DOI 10.1007/s10072-005-0444-3; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mykkanen K, 2004, EUR J HUM GENET, V12, P813, DOI 10.1038/sj.ejhg.5201221; Opherk C, 2004, BRAIN, V127, P2533, DOI 10.1093/brain/awh282; Opherk C, 2009, HUM MOL GENET, V18, P2761, DOI 10.1093/hmg/ddp211; Pantoni L, 2004, EUR J NEUROL, V11, P782, DOI 10.1111/j.1468-1331.2004.00915.x; Pescini F, 2008, J NEUROL SCI, V267, P170, DOI 10.1016/j.jns.2007.10.017; Peters N, 2005, ARCH NEUROL-CHICAGO, V62, P1091, DOI 10.1001/archneur.62.7.1091; Rufa A, 2004, ARCH NEUROL-CHICAGO, V61, P577, DOI 10.1001/archneur.61.4.577; Singhal S, 2004, BRAIN, V127, P2031, DOI 10.1093/brain/awh223; Tang SC, 2005, J NEUROL SCI, V228, P125, DOI 10.1016/j.jns.2004.10.019; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364	26	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36590	10.1371/journal.pone.0036590	http://dx.doi.org/10.1371/journal.pone.0036590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623959	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500019
J	Wu, XW; Weng, LH; Li, XJ; Guo, C; Pal, SK; Jin, JM; Li, YP; Nelson, RA; Mu, B; Onami, SH; Wu, JJ; Ruel, NH; Wilczynski, SP; Gao, HL; Covarrubias, M; Figlin, RA; Weiss, LM; Wu, HQ				Wu, Xiwei; Weng, Lihong; Li, Xuejun; Guo, Chao; Pal, Sumanta K.; Jin, Jennifer M.; Li, Yuping; Nelson, Rebecca A.; Mu, Bing; Onami, Susan H.; Wu, Jeffrey J.; Ruel, Nora H.; Wilczynski, Sharon P.; Gao, Hanlin; Covarrubias, Maricela; Figlin, Robert A.; Weiss, Lawrence M.; Wu, Huiqing			Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis	PLOS ONE			English	Article							INTEGRATED STAGING SYSTEM; MICRORNA EXPRESSION LEVELS; DIFFERENTIAL EXPRESSION; CANCER; VALIDATION; SURVIVAL; INVASION	Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC) for the purpose of developing a miRNA expression signature to determine the risk of metastasis and prognosis. We used the microarray technology to profile miRNA expression of 78 benign kidney and ccRCC samples. Using 28 localized and metastatic ccRCC specimens as the training cohort and the univariate logistic regression and risk score methods, we developed a miRNA signature model in which the expression levels of miR-10b, miR-139-5p, miR-130b and miR-199b-5p were used to determine the status of ccRCC metastasis. We validated the signature in an independent 40-sample testing cohort of different stages of primary ccRCCs using the microarray data. Within the testing cohort patients who had at least 5 years follow-up if no metastasis developed, the signature showed a high sensitivity and specificity. The risk status was proven to be associated with the cancer-specific survival. Using the most stably expressed miRNA among benign and tumorous kidney tissue as the internal reference for normalization, we successfully converted his signature to be a quantitative PCR (qPCR)-based assay, which showed the same high sensitivity and specificity. The 4-miRNA is associated with ccRCC metastasis and prognosis. The signature is ready for and will benefit from further large clinical cohort validation and has the potential for clinical application.	[Wu, Xiwei; Covarrubias, Maricela] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Wu, Xiwei; Weng, Lihong; Li, Xuejun; Guo, Chao; Pal, Sumanta K.; Jin, Jennifer M.; Li, Yuping; Nelson, Rebecca A.; Mu, Bing; Onami, Susan H.; Wu, Jeffrey J.; Ruel, Nora H.; Wilczynski, Sharon P.; Gao, Hanlin; Covarrubias, Maricela; Figlin, Robert A.; Weiss, Lawrence M.; Wu, Huiqing] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Weng, Lihong; Guo, Chao; Jin, Jennifer M.; Li, Yuping; Wu, Jeffrey J.; Wilczynski, Sharon P.; Weiss, Lawrence M.; Wu, Huiqing] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA; [Li, Xuejun; Nelson, Rebecca A.; Mu, Bing; Ruel, Nora H.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA 91010 USA; [Pal, Sumanta K.; Onami, Susan H.; Figlin, Robert A.] City Hope Natl Med Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA 91010 USA; [Gao, Hanlin] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; City of Hope; City of Hope	Wu, XW (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	hwu@coh.org	Li, Yuping/J-3138-2018; Guo, Chao/B-2647-2010; Nelson, Rebecca/C-4438-2014	Guo, Chao/0000-0002-6673-0933; Ruel, Nora/0000-0002-4591-3618	City of Hope National Medical Center; Beckman Research Institute of City of Hope; California Cancer Specialists Medical Group	City of Hope National Medical Center; Beckman Research Institute of City of Hope; California Cancer Specialists Medical Group	This work was funded by City of Hope National Medical Center, Beckman Research Institute of City of Hope and California Cancer Specialists Medical Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Han KR, 2003, J UROLOGY, V170, P2221, DOI 10.1097/01.ju.0000096049.64863.a1; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Klein CA, 2008, SCIENCE, V321, P1785, DOI 10.1126/science.1164853; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinberg RA, 2008, CANCER CELL, V14, P283, DOI 10.1016/j.ccr.2008.09.009; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zisman A, 2001, J CLIN ONCOL, V19, P3792, DOI 10.1200/JCO.2001.19.17.3792	38	139	145	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35661	10.1371/journal.pone.0035661	http://dx.doi.org/10.1371/journal.pone.0035661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623952	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500006
J	Kim, J; Tsien, RW; Alger, BE				Kim, Jimok; Tsien, Richard W.; Alger, Bradley E.			An Improved Test for Detecting Multiplicative Homeostatic Synaptic Scaling	PLOS ONE			English	Article							HIPPOCAMPAL SYNAPSES; GAIN-CONTROL; PLASTICITY; DEPRIVATION; INACTIVITY; CIRCUITS; TRAFFICKING; RECEPTORS; AMPLITUDE; NEURONS	Homeostatic scaling of synaptic strengths is essential for maintenance of network "gain", but also poses a risk of losing the distinctions among relative synaptic weights, which are possibly cellular correlates of memory storage. Multiplicative scaling of all synapses has been proposed as a mechanism that would preserve the relative weights among them, because they would all be proportionately adjusted. It is crucial for this hypothesis that all synapses be affected identically, but whether or not this actually occurs is difficult to determine directly. Mathematical tests for multiplicative synaptic scaling are presently carried out on distributions of miniature synaptic current amplitudes, but the accuracy of the test procedure has not been fully validated. We now show that the existence of an amplitude threshold for empirical detection of miniature synaptic currents limits the use of the most common method for detecting multiplicative changes. Our new method circumvents the problem by discarding the potentially distorting subthreshold values after computational scaling. This new method should be useful in assessing the underlying neurophysiological nature of a homeostatic synaptic scaling transformation, and therefore in evaluating its functional significance.	[Kim, Jimok] Georgia Hlth Sci Univ, Grad Program Neurosci, Inst Mol Med & Genet, Augusta, GA USA; [Kim, Jimok] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Kim, Jimok; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Kim, Jimok; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Kim, Jimok; Alger, Bradley E.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Stanford University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Kim, J (corresponding author), Georgia Hlth Sci Univ, Inst Mol Med & Genet, Augusta, GA USA.	jimkim@georgiahealth.edu			National Institutes of Health [R01AG036794, R37MH071739, R01DA014625]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH071739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants R01AG036794 to J.K., R37MH071739 to R.W.T., and R01DA014625 to B.E.A. from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bartley AF, 2008, J NEUROPHYSIOL, V100, P1983, DOI 10.1152/jn.90635.2008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Hou Q, 2008, P NATL ACAD SCI USA, V105, P775, DOI 10.1073/pnas.0706447105; Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kim J, 2008, NEURON, V58, P925, DOI 10.1016/j.neuron.2008.05.009; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Mitra A, 2012, NAT NEUROSCI, V15, P250, DOI 10.1038/nn.3004; Moulder KL, 2006, J NEUROSCI, V26, P6618, DOI 10.1523/JNEUROSCI.5498-05.2006; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rabinowitch I, 2006, J NEUROSCI, V26, P13474, DOI 10.1523/JNEUROSCI.4333-06.2006; Rabinowitch I, 2006, J NEUROPHYSIOL, V96, P276, DOI 10.1152/jn.00074.2006; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tetzlaff C, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00047; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008	32	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37364	10.1371/journal.pone.0037364	http://dx.doi.org/10.1371/journal.pone.0037364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615990	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200067
J	Ashur-Fabian, O; Yerushalmi, GM; Mazaki-Tovi, S; Steinberg, DM; Goldshtein, I; Yackobovitch-Gavan, M; Schiff, E; Amariglio, N; Rechavi, G				Ashur-Fabian, Osnat; Yerushalmi, Gil M.; Mazaki-Tovi, Shali; Steinberg, David M.; Goldshtein, Inbal; Yackobovitch-Gavan, Michal; Schiff, Eyal; Amariglio, Ninette; Rechavi, Gideon			Cell Free Expression of hif1 alpha and p21 in Maternal Peripheral Blood as a Marker for Preeclampsia and Fetal Growth Restriction	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; MESSENGER-RNA; FACTOR-I; TROPHOBLAST DIFFERENTIATION; ANGIOGENIC FACTORS; NUCLEIC-ACIDS; BIRTH-WEIGHT; P53; APOPTOSIS; PLASMA	Preeclampsia, a severe unpredictable complication of pregnancy, occurs in 6% of pregnancies, usually in the second or third trimester. The specific etiology of preeclampsia remains unclear, although the pathophysiological hallmark of this condition appears to be an inadequate blood supply to the placenta. As a result of the impaired placental blood flow, intrauterine growth restriction (IUGR) and consequential fetal oxidative stress may occur. Consistent with this view, pregnancies complicated by preeclampsia and IUGR are characterized by up-regulation of key transcriptional regulators of the hypoxic response including, hif1 alpha and as well as p53 and its target genes. Recently, the presence of circulating cell-free fetal RNA has been documented in maternal plasma. We speculated that pregnancies complicated by preeclampsia and IUGR, will be associated with an abnormal expression of p53 and/or hif1 alpha related genes in the maternal plasma. Maternal plasma from 113 singleton pregnancies (72 normal and 41 complicated pregnancies) and 19 twins (9 normal and 10 complicated pregnancies) were collected and cell free RNA was extracted. The expression of 18 genes was measured by one step real-time RT-PCR and was analyzed for prevalence of positive/negative expression levels. Results indicate that, among the genes examined, cell free plasma expressions of p21 and hif1 alpha were more prevalent in pregnancies complicated by hypoxia and/or IUGR (p < 0.001). To conclude, we present in this manuscript data to support the association between two possible surrogate markers of hypoxia and common complications of pregnancy. More work is needed in order to implement these findings in clinical practice.	[Ashur-Fabian, Osnat; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Ashur-Fabian, Osnat; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Yerushalmi, Gil M.; Mazaki-Tovi, Shali; Schiff, Eyal] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Dept Obstet & Gynecol, Tel Hashomer, Israel; [Steinberg, David M.; Goldshtein, Inbal; Yackobovitch-Gavan, Michal] Tel Aviv Univ, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Ashur-Fabian, O (corresponding author), Meir Med Ctr, Kefar Sava, Israel.	osnataf@gmail.com	goldshtein, inbal/D-2113-2011; Ashur, Osnat/AAC-1417-2020	goldshtein, inbal/0000-0002-5317-2848; Ashur-Fabian, Osnat/0000-0001-8624-3182	Flight Attendants Medical Research Institute (FAMRI)	Flight Attendants Medical Research Institute (FAMRI)	This work was supported by the Flight Attendants Medical Research Institute (FAMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Barkehall-Thomas A, 2006, AUST NZ J OBSTET GYN, V46, P97, DOI 10.1111/j.1479-828X.2006.00535.x; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Diab AE, 2008, INT J GYNECOL OBSTET, V102, P146, DOI 10.1016/j.ijgo.2008.02.016; Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311; El-Salahy EM, 2001, CLIN BIOCHEM, V34, P323, DOI 10.1016/S0009-9120(01)00230-2; Farina A, 2006, PRENATAL DIAG, V26, P1115, DOI 10.1002/pd.1562; Hahn S, 2011, PLACENTA, V32, pS17, DOI 10.1016/j.placenta.2010.06.018; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kinzler WL, 2008, CURR OPIN OBSTET GYN, V20, P125, DOI 10.1097/GCO.0b013e3282f7320a; Kupferminc MJ, 1997, AM J REPROD IMMUNOL, V38, P302; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2007, NAT REV GENET, V8, P71, DOI 10.1038/nrg1982; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Markestad T, 1997, ACTA OBSTET GYN SCAN, V76, P50; Maron JL, 2007, J CLIN INVEST, V117, P3007, DOI 10.1172/JCI29959; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Ng EKO, 2002, CLIN CHEM, V48, P1212; Nishi H, 2004, ENDOCRINOLOGY, V145, P4113, DOI 10.1210/en.2003-1639; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Pang WWI, 2009, PRENATAL DIAG, V29, P495, DOI 10.1002/pd.2230; Patel J, 2010, PLACENTA, V31, P951, DOI 10.1016/j.placenta.2010.08.008; Poon LLM, 2000, CLIN CHEM, V46, P1832; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Purwosunu Y, 2009, AM J OBSTET GYNECOL, V200, P386; Romero R, 2007, AM J OBSTET GYNECOL, V197, P218, DOI 10.1016/j.ajog.2007.03.078; Scazzocchio E, 2011, CURR OPIN OBSTET GYN, V23, P65, DOI 10.1097/GCO.0b013e328344579c; Schaffer L, 2003, PLACENTA, V24, P941, DOI 10.1016/S0143-4004(03)00166-8; Semenza GL, 2010, ARTERIOSCL THROM VAS, V30, P648, DOI 10.1161/ATVBAHA.108.181644; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Spencer K, 2007, PRENATAL DIAG, V27, P258, DOI 10.1002/pd.1664; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stepan H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.052; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294	50	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37273	10.1371/journal.pone.0037273	http://dx.doi.org/10.1371/journal.pone.0037273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615960	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300094
J	Chen, SH; Wu, HL; Kao, JH; Hwang, LH				Chen, Shih-Hui; Wu, Hui-Lin; Kao, Jia-Horng; Hwang, Lih-Hwa			Persistent Hepatitis B Viral Replication in a FVB/N Mouse Model: Impact of Host and Viral Factors	PLOS ONE			English	Article							CHINESE HAN POPULATION; VIRUS-INFECTION; IMMUNE-RESPONSE; CORE ANTIGEN; PROMOTER POLYMORPHISMS; ADENOASSOCIATED VIRUS; T-CELLS; HBV-DNA; ASSOCIATION; GENE	The mechanism underlying the chronicity of hepatitis B virus (HBV) infection has long been an interesting question. However, this mechanism remains unclear largely due to the lack of an animal model that can support persistent HBV replication and allow for the investigation of the relevant immune responses. In this study, we used hydrodynamic injection to introduce HBV replicon DNA into the livers of three different mouse strains: BALB/c, C57BL/6, and FVB/N. Interestingly, we found that an HBV clone persistently replicated in the livers of FVB/N mice for up to 50 weeks but was rapidly cleared from the livers of BALB/c and C57BL/6 mice. Flow cytometric analysis and quantitative reverse transcription PCR analysis of the mouse livers indicated that after DNA injection, FVB/N mice had few intrahepatic activated cytotoxic T lymphocytes (CTLs) and produced low levels of alanine aminotransferase, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, and the CXCL9 and CXCL10 chemokines. These findings were in sharp contrast with those observed in BALB/c and C57BL/6 mice, reflecting a strong correlation between the degree of liver inflammation and viral clearance. Mutational analysis further demonstrated that a change of Asn-214 to Ser-214 in the HBV surface antigen rendered the persistent HBV clone clearable in FVB/N mice, which was accompanied by increased levels of activated CTL and upregulated expression of IFN-gamma, CXCL9, and CXCL10 in the livers. These results indicate that the heterogeneity of the host factors and viral sequences may influence the immune responses against HBV. An inadequate activation of immune or inflammatory responses can lead to persistent HBV replication in vivo.	[Chen, Shih-Hui; Hwang, Lih-Hwa] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan; [Wu, Hui-Lin; Hwang, Lih-Hwa] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Chen, Shih-Hui; Hwang, Lih-Hwa] Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 112, Taiwan; [Wu, Hui-Lin] Natl Yang Ming Univ, Hepatitis Res Ctr, Taipei 112, Taiwan; [Kao, Jia-Horng] Natl Yang Ming Univ, Grad Inst Clin Med, Taipei 112, Taiwan; [Kao, Jia-Horng] Natl Yang Ming Univ, Dept Internal Med, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, SH (corresponding author), Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan.	lhhwang@ym.edu.tw	Kao, Jia-Horng/AAB-8947-2019	Kao, Jia-Horng/0000-0002-2442-7952	National Science Council [NSC 100-2320-B-010-023-MY3]; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This project was supported by a grant from National Science Council, NSC 100-2320-B-010-023-MY3, and in part by a grant from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x; BERTOLETTI A, 1994, J EXP MED, V180, P933, DOI 10.1084/jem.180.3.933; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BURRELL CJ, 1984, HEPATOLOGY, V4, P20, DOI 10.1002/hep.1840040104; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2; Crispe I Nicholas, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0321s22; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; Deng GH, 2004, HEPATOLOGY, V40, P318, DOI 10.1002/hep.20318; Du T, 2006, J VIRAL HEPATITIS, V13, P618, DOI 10.1111/j.1365-2893.2006.00731.x; FERRARI C, 1990, J IMMUNOL, V145, P3442; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GOWANS EJ, 1985, INTERVIROLOGY, V24, P220, DOI 10.1159/000149646; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Guidotti LG, 1997, J VIROL, V71, P4804, DOI 10.1128/JVI.71.6.4804-4808.1997; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; GUNTHER S, 1995, J VIROL, V69, P5437; Hohler T, 1998, CLIN EXP IMMUNOL, V111, P579; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huang YH, 2011, INT J ONCOL, V39, P1511, DOI 10.3892/ijo.2011.1145; Iannacone M, 2007, J HEPATOL, V46, P719, DOI 10.1016/j.jhep.2007.01.007; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Penna A, 1997, HEPATOLOGY, V25, P1022, DOI 10.1002/hep.510250438; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; QUIROGA JA, 1987, LIVER, V7, P169; Seifert U, 2004, J CLIN INVEST, V114, P250, DOI 10.1172/JCI200420985; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Tan AT, 2008, J GASTROEN HEPATOL, V23, P833, DOI 10.1111/j.1440-1746.2008.05385.x; Thursz M, 2001, ANTIVIR RES, V52, P113, DOI 10.1016/S0166-3542(01)00175-9; THURSZ MR, 1995, NEW ENGL J MED, V332, P1065, DOI 10.1056/NEJM199504203321604; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WRIGHT TL, 1993, LANCET, V342, P1340, DOI 10.1016/0140-6736(93)92250-W; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zhi-Ming L, 2007, CROAT MED J, V48, P800, DOI 10.3325/cmj.2007.6.800	45	15	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36984	10.1371/journal.pone.0036984	http://dx.doi.org/10.1371/journal.pone.0036984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615863	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300051
J	Gregory, JA; Li, FW; Tomosada, LM; Cox, CJ; Topol, AB; Vinetz, JM; Mayfield, S				Gregory, James A.; Li, Fengwu; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Vinetz, Joseph M.; Mayfield, Stephen			Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission	PLOS ONE			English	Article							BLOCKING VACCINE CANDIDATE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; CODON ADAPTATION INDEX; PLASMODIUM-FALCIPARUM; CHLAMYDOMONAS-REINHARDTII; MONOCLONAL-ANTIBODY; RECOMBINANT PFS25; SEXUAL STAGES; EXPRESSION	Subunit vaccines are significantly more expensive to produce than traditional vaccines because they are based primarily on recombinant proteins that must be purified from the expression system. Despite the increased cost, subunit vaccines are being developed because they are safe, effective, and can elicit antibodies that confer protection against diseases that are not currently vaccine-preventable. Algae are an attractive platform for producing subunit vaccines because they are relatively inexpensive to grow, genetically tractable, easily scaled to large volumes, have a short generation time, and are devoid of inflammatory, viral, or prion contaminants often present in other systems. We tested whether algal chloroplasts can produce malaria transmission blocking vaccine candidates, Plasmodium falciparum surface protein 25 (Pfs25) and 28 (Pfs28). Antibodies that recognize Pfs25 and Pfs28 disrupt the sexual development of parasites within the mosquito midgut, thus preventing transmission of malaria from one human host to the next. These proteins have been difficult to produce in traditional recombinant systems because they contain tandem repeats of structurally complex epidermal growth factor-like domains, which cannot be produced in bacterial systems, and because they are not glycosylated, so they must be modified for production in eukaryotic systems. Production in algal chloroplasts avoids these issues because chloroplasts can fold complex eukaryotic proteins and do not glycosylate proteins. Here we demonstrate that algae are the first recombinant system to successfully produce an unmodified and aglycosylated version of Pfs25 or Pfs28. These antigens are structurally similar to the native proteins and antibodies raised to these recombinant proteins recognize Pfs25 and Pfs28 from P. falciparum. Furthermore, antibodies to algae-produced Pfs25 bind the surface of in-vitro cultured P. falciparum sexual stage parasites and exhibit transmission blocking activity. Thus, algae are promising organisms for producing cysteine-disulfide-containing malaria transmission blocking vaccine candidate proteins.	[Gregory, James A.; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Mayfield, Stephen] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Gregory, James A.; Tomosada, Lauren M.; Cox, Chesa J.; Topol, Aaron B.; Mayfield, Stephen] Univ Calif San Diego, San Diego Ctr Algae Biotechnol, La Jolla, CA 92093 USA; [Li, Fengwu; Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gregory, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	smayfield@ucsd.edu		Vinetz, Joseph/0000-0001-8344-2004; Gregory, James/0000-0002-7733-3212	San Diego Foundation; California energy commission [500-10-039]; U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI45999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999, K24AI068903] Funding Source: NIH RePORTER	San Diego Foundation; California energy commission; U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by funding from the San Diego Foundation, the California energy commission (500-10-039), and from the U.S. Public Health Service grant from the National Institute of Allergy and Infectious Diseases (AI45999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; Benedict M, 1997, CARE MAINTENANCE ANO; Bounkeua V, 2010, AM J TROP MED HYG, V83, P1187, DOI 10.4269/ajtmh.2010.10-0433; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; CARTER R, 1976, NATURE, V263, P57, DOI 10.1038/263057a0; Center for Disease Control, 2011, VACC IMM; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Dauvillee D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015424; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Dove A, 2002, NAT BIOTECHNOL, V20, P777, DOI 10.1038/nbt0802-777; Dreesen IAJ, 2010, J BIOTECHNOL, V145, P273, DOI 10.1016/j.jbiotec.2009.12.006; Duffy PE, 1997, INFECT IMMUN, V65, P1109, DOI 10.1128/IAI.65.3.1109-1113.1997; Duncan CJA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7728; Farrance CE, 2011, HUM VACCINES, V7, P191, DOI 10.4161/hv.7.0.14588; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; Ghosh AK, 2009, CURR OPIN MICROBIOL, V12, P394, DOI 10.1016/j.mib.2009.06.010; Gozar MMG, 1998, INFECT IMMUN, V66, P59, DOI 10.1128/IAI.66.1.59-64.1998; Gozar MMG, 2001, EXP PARASITOL, V97, P61, DOI 10.1006/expr.2000.4580; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; GWADZ RW, 1976, SCIENCE, V193, P1150, DOI 10.1126/science.959832; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; KASLOW DC, 1992, MEM I OSWALDO CRUZ, V87, P175, DOI 10.1590/S0074-02761992000700028; KASLOW DC, 1994, BIO-TECHNOL, V12, P494, DOI 10.1038/nbt0594-494; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Manuell AL, 2007, PLANT BIOTECHNOL J, V5, P402, DOI 10.1111/j.1467-7652.2007.00249.x; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Miyata T, 2010, INFECT IMMUN, V78, P3773, DOI 10.1128/IAI.00306-10; Mlambo G, 2010, VACCINE, V28, P7025, DOI 10.1016/j.vaccine.2010.08.022; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Qian F, 2009, MICROBES INFECT, V11, P408, DOI 10.1016/j.micinf.2008.12.009; Rasala Beth A, 2011, Bioeng Bugs, V2, P50, DOI 10.4161/bbug.2.1.13423; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Ravallion M, 2008, DOLLAR DAY REVISITED; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rigano MM, 2005, IMMUNOL CELL BIOL, V83, P271, DOI 10.1111/j.1440-1711.2005.01336.x; Saxena AK, 2006, NAT STRUCT MOL BIOL, V13, P90, DOI 10.1038/nsmb1024; Sharma Babita, 2008, In Silico Biology, V8, P193; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STURA EA, 1994, ACTA CRYSTALLOGR D, V50, P556, DOI 10.1107/S0907444994001782; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Yusibov V, 2011, HUM VACCINES, V7, P313, DOI 10.4161/hv.7.3.14207	47	100	102	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37179	10.1371/journal.pone.0037179	http://dx.doi.org/10.1371/journal.pone.0037179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615931	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300083
J	Jaspard, E; Macherel, D; Hunault, G				Jaspard, Emmanuel; Macherel, David; Hunault, Gilles			Computational and Statistical Analyses of Amino Acid Usage and Physico-Chemical Properties of the Twelve Late Embryogenesis Abundant Protein Classes	PLOS ONE			English	Article							SALSUGINEA DEHYDRINS TSDHN-1; DEVELOPMENTAL BIOCHEMISTRY; COTTONSEED EMBRYOGENESIS; ARABIDOPSIS-THALIANA; STRESS-PROTEINS; MAIZE DHN1; SEQUENCE; DESICCATION; BINDING; MEMBRANE	Late Embryogenesis Abundant Proteins (LEAPs) are ubiquitous proteins expected to play major roles in desiccation tolerance. Little is known about their structure - function relationships because of the scarcity of 3-D structures for LEAPs. The previous building of LEAPdb, a database dedicated to LEAPs from plants and other organisms, led to the classification of 710 LEAPs into 12 non-overlapping classes with distinct properties. Using this resource, numerous physico-chemical properties of LEAPs and amino acid usage by LEAPs have been computed and statistically analyzed, revealing distinctive features for each class. This unprecedented analysis allowed a rigorous characterization of the 12 LEAP classes, which differed also in multiple structural and physico-chemical features. Although most LEAPs can be predicted as intrinsically disordered proteins, the analysis indicates that LEAP class 7 (PF03168) and probably LEAP class 11 (PF04927) are natively folded proteins. This study thus provides a detailed description of the structural properties of this protein family opening the path toward further LEAP structure - function analysis. Finally, since each LEAP class can be clearly characterized by a unique set of physico-chemical properties, this will allow development of software to predict proteins as LEAPs.	[Jaspard, Emmanuel; Macherel, David] LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France; [Hunault, Gilles] LUNAM Univ, Lab Hemodynam Interact Fibrose & Invas Tumorale H, Univ Angers, UPRES 3859,IFR 132, Angers, France	INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers; Universite d'Angers	Jaspard, E (corresponding author), LUNAM Univ, SFR QUASAV 4207, Univ Angers, Inst Rech Hort & Semences,INRA,Agrocampus Ouest, Angers, France.	emmanuel.jaspard@univ-angers.fr	Macherel, David/B-2084-2012	Macherel, David/0000-0002-3352-2185	Region des Pays-de-la Loire (program COSAVE)	Region des Pays-de-la Loire (program COSAVE)(Region Pays de la Loire)	This work was supported by the Region des Pays-de-la Loire (program COSAVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Boucher V, 2010, PLANT CELL ENVIRON, V33, P418, DOI 10.1111/j.1365-3040.2009.02093.x; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cuming AC, 1999, SEED PROTEINS, P753; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GALAU GA, 1986, PLANT MOL BIOL, V7, P155, DOI 10.1007/BF00021327; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034; Gao J, 2010, BIOPOLYMERS, V93, P340, DOI 10.1002/bip.21342; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Haaning S, 2008, J BIOL CHEM, V283, P31142, DOI 10.1074/jbc.M805024200; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067; Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DX, 2009, BIOMACROMOLECULES, V10, P1469, DOI 10.1021/bm9002688; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu JT, 2009, P NATL ACAD SCI USA, V106, P19819, DOI 10.1073/pnas.0907710106; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popova AV, 2011, BBA-BIOMEMBRANES, V1808, P1879, DOI 10.1016/j.bbamem.2011.03.009; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; R Core Team, 2018, R LANG ENV STAT COMP; Rahman LN, 2011, AMINO ACIDS, V40, P1485, DOI 10.1007/s00726-010-0759-0; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Shih MD, 2004, PLANT MOL BIOL, V56, P689, DOI 10.1007/s11103-004-4680-3; Shih MD, 2010, PLANT CELL PHYSIOL, V51, P395, DOI 10.1093/pcp/pcq005; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Thalhammer A, 2010, BBA-BIOMEMBRANES, V1798, P1812, DOI 10.1016/j.bbamem.2010.05.015; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	85	45	45	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36968	10.1371/journal.pone.0036968	http://dx.doi.org/10.1371/journal.pone.0036968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615859	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300049
J	Shanks, RMQ; Stella, NA; Lahr, RM; Wang, SR; Veverka, TI; Kowalski, RP; Liu, XY				Shanks, Robert M. Q.; Stella, Nicholas A.; Lahr, Roni M.; Wang, Shaoru; Veverka, Tara I.; Kowalski, Regis P.; Liu, Xinyu			Serratamolide is a Hemolytic Factor Produced by Serratia marcescens	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; POLYMORPHONUCLEAR LEUKOCYTES; 2-COMPONENT SYSTEM; BIOFILM FORMATION; CORNEAL RESPONSE; EPITHELIAL-CELLS; SPREADING GROWTH; ALPHA-TOXIN; EXPRESSION	Serratia marcescens is a common contaminant of contact lens cases and lenses. Hemolytic factors of S. marcescens contribute to the virulence of this opportunistic bacterial pathogen. We took advantage of an observed hyper-hemolytic phenotype of crp mutants to investigate mechanisms of hemolysis. A genetic screen revealed that swrW is necessary for the hyper-hemolysis phenotype of crp mutants. The swrW gene is required for biosynthesis of the biosurfactant serratamolide, previously shown to be a broad-spectrum antibiotic and to contribute to swarming motility. Multicopy expression of swrW or mutation of the hexS transcription factor gene, a known inhibitor of swrW expression, led to an increase in hemolysis. Surfactant zones and expression from an swrW-transcriptional reporter were elevated in a crp mutant compared to the wild type. Purified serratamolide was hemolytic to sheep and murine red blood cells and cytotoxic to human airway and corneal limbal epithelial cells in vitro. The swrW gene was found in the majority of contact lens isolates tested. Genetic and biochemical analysis implicate the biosurfactant serratamolide as a hemolysin. This novel hemolysin may contribute to irritation and infections associated with contact lens use.	[Shanks, Robert M. Q.; Stella, Nicholas A.; Lahr, Roni M.; Veverka, Tara I.; Kowalski, Regis P.] Univ Pittsburgh, Dept Ophthalmol, Med Ctr, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA; [Wang, Shaoru; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shanks, RMQ (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Med Ctr, Charles T Campbell Lab Ophthalm Microbiol, Pittsburgh, PA 15260 USA.	shanksrm@upmc.edu	Liu, Xinyu/A-8933-2013; Shanks, Robert M. Q./AFO-0831-2022	Shanks, Robert M. Q./0000-0002-7699-5396; Lahr, Roni/0000-0002-7469-4565	Research to Prevent Blindness; NIH [AI085570, EY08098]; Eye and Ear Foundation of Pittsburgh; University of Pittsburgh CRDF; NATIONAL EYE INSTITUTE [P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085570] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye and Ear Foundation of Pittsburgh; University of Pittsburgh CRDF(University of Pittsburgh); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources for this study: 1. Research to Prevent Blindness Career Development Award (no number) (http://www.rpbusa.org/rpb/), 2. NIH Grant number AI085570 (http://www.niaid.nih.gov/Pages/default.aspx), 3. NIH Grant number EY08098 (http://www.nei.nih.gov/), 4. Eye and Ear Foundation of Pittsburgh (no grant number) (http://www.eyeandear.org/), 5. University of Pittsburgh CRDF (no grant number) (http://www.pitt.edu/offres/funding/crdf.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNESS R, 1988, J BACTERIOL, V170, P4361, DOI 10.1128/jb.170.9.4361-4364.1988; Bhakdi S, 1996, ARCH MICROBIOL, V165, P73, DOI 10.1007/s002030050300; Burke D., 2000, METHODS YEAST GENETI; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Dalla Serra M, 1999, MOL PLANT MICROBE IN, V12, P391, DOI 10.1094/MPMI.1999.12.5.391; Dwivedi D, 2008, J NAT PROD, V71, P637, DOI 10.1021/np7007126; Escobar-Diaz E, 2005, LEUKEMIA, V19, P572, DOI 10.1038/sj.leu.2403679; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; GIVSKOV M, 1992, MOL MICROBIOL, V6, P1363, DOI 10.1111/j.1365-2958.1992.tb00857.x; GIVSKOV M, 1993, MOL MICROBIOL, V8, P229, DOI 10.1111/j.1365-2958.1993.tb01567.x; GRIMONT PAD, 1978, J CLIN MICROBIOL, V8, P73; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hertle R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-16; Holden Brien A., 1996, CLAO Journal, V22, P47; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hume EBH, 2004, OCUL IMMUNOL INFLAMM, V12, P287, DOI 10.1080/092739490500318; HUTCHISON ML, 1995, MOL PLANT MICROBE IN, V8, P610, DOI 10.1094/MPMI-8-0610; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; KESSLER E, 1977, INVEST OPHTH VIS SCI, V16, P116; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; LETOFFE S, 1991, J BACTERIOL, V173, P2160; Li H, 2005, MICROBIOL IMMUNOL, V49, P303, DOI 10.1111/j.1348-0421.2005.tb03734.x; Li Y, 2011, CHEM COMMUN, V47, P8952, DOI 10.1039/c1cc13264d; Lin CS, 2010, INFECT IMMUN, V78, P4870, DOI 10.1128/IAI.00661-10; Lindum PW, 1998, J BACTERIOL, V180, P6384; Marquart ME, 2007, INVEST OPHTH VIS SCI, V48, P2661, DOI 10.1167/iovs.07-0017; Marty KB, 2002, INFECT IMMUN, V70, P1121, DOI 10.1128/IAI.70.3.1121-1128.2002; MATSUYAMA T, 1992, J BACTERIOL, V174, P1769, DOI 10.1128/jb.174.6.1769-1776.1992; MATSUYAMA T, 1989, FEMS MICROBIOL LETT, V61, P243, DOI 10.1016/0378-1097(89)90204-8; MENESTRINA G, 1994, TOXICOLOGY, V87, P249, DOI 10.1016/0300-483X(94)90254-2; MIYAZAKI Y, 1993, FEMS IMMUNOL MED MIC, V6, P265, DOI 10.1016/0928-8244(93)90002-L; MIYAZAKI Y, 1992, INT J BIOCHEM, V24, P1033, DOI 10.1016/0020-711X(92)90370-G; NAKANO MM, 1988, J BACTERIOL, V170, P5662, DOI 10.1128/jb.170.12.5662-5668.1988; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Shanks RMQ, 2009, PLASMID, V62, P88, DOI 10.1016/j.plasmid.2009.05.002; Shimuta K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-261; Soto-Cerrato V, 2005, BIOCHEM PHARMACOL, V71, P32, DOI 10.1016/j.bcp.2005.10.020; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Steppberger K, 2002, INFECTION, V30, P277, DOI 10.1007/s15010-002-2141-y; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Vonberg RP, 2007, J HOSP INFECT, V65, P15, DOI 10.1016/j.jhin.2006.09.018; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; WASSERMAN H, 1961, J AM CHEM SOC, V83, P4107, DOI 10.1021/ja01480a046; WASSERMAN HH, 1962, J AM CHEM SOC, V84, P2978, DOI 10.1021/ja00874a028; WILLIAMS RP, 1956, J BACTERIOL, V71, P115, DOI 10.1128/JB.71.1.115-120.1956; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Wu PZJ, 2005, CURR EYE RES, V30, P63, DOI 10.1080/02713680490894630	54	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36398	10.1371/journal.pone.0036398	http://dx.doi.org/10.1371/journal.pone.0036398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615766	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305341300015
J	Smit, DJA; Boersma, M; Schnack, HG; Micheloyannis, S; Boomsma, DI; Pol, HEH; Stam, CJ; de Geus, EJC				Smit, Dirk J. A.; Boersma, Maria; Schnack, Hugo G.; Micheloyannis, Sifis; Boomsma, Dorret I.; Pol, Hilleke E. Hulshoff; Stam, Cornelis J.; de Geus, Eco J. C.			The Brain Matures with Stronger Functional Connectivity and Decreased Randomness of Its Network	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD NETWORKS; AGE-RELATED-CHANGES; WHITE-MATTER; QUANTITATIVE-ANALYSIS; CORTICAL NETWORKS; EEG COHERENCE; SYNCHRONIZATION; CORTEX; VOLUME	We investigated the development of the brain's functional connectivity throughout the life span (ages 5 through 71 years) by measuring EEG activity in a large population-based sample. Connectivity was established with Synchronization Likelihood. Relative randomness of the connectivity patterns was established with Watts and Strogatz' (1998) graph parameters C (local clustering) and L (global path length) for alpha (similar to 10 Hz), beta (similar to 20 Hz), and theta (similar to 4 Hz) oscillation networks. From childhood to adolescence large increases in connectivity in alpha, theta and beta frequency bands were found that continued at a slower pace into adulthood (peaking at similar to 50 yrs). Connectivity changes were accompanied by increases in L and C reflecting decreases in network randomness or increased order (peak levels reached at similar to 18 yrs). Older age (55+) was associated with weakened connectivity. Semi-automatically segmented T1 weighted MRI images of 104 young adults revealed that connectivity was significantly correlated to cerebral white matter volume (alpha oscillations: r = 33, p<01; theta: r = 22, p<05), while path length was related to both white matter (alpha: max. r = 38, p<001) and gray matter (alpha: max. r = 36, p<001; theta: max. r = 36, p<001) volumes. In conclusion, EEG connectivity and graph theoretical network analysis may be used to trace structural and functional development of the brain.	[Smit, Dirk J. A.; Boomsma, Dorret I.; Stam, Cornelis J.; de Geus, Eco J. C.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Schnack, Hugo G.; Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Micheloyannis, Sifis] Univ Crete, Clin Neurophysiol Lab L Widen, Iraklion, Greece; [Boomsma, Dorret I.; de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Crete; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Smit, DJA (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	d.j.a.smit@vu.nl	de Geus, Eco J.C./M-9318-2015; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Boomsma, Dorret I/AAX-4470-2020	de Geus, Eco J.C./0000-0001-6022-2666; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Stam, Cornelis/0000-0001-9163-7274; Smit, Dirk/0000-0001-8301-8860	VU University Universitair Stimuleringsfonds [VU-USF 96/22]; Human Frontiers of Science Program [RG0154/1998-B]; Netherlands Organization for Scientific Research [NWO/SPI 56-464-14192, NWO/MagW VENI-451-08-026]	VU University Universitair Stimuleringsfonds; Human Frontiers of Science Program(Human Frontier Science Program); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by VU University Universitair Stimuleringsfonds (VU-USF 96/22), Human Frontiers of Science Program (RG0154/1998-B), Netherlands Organization for Scientific Research (NWO/SPI 56-464-14192 to D.B., NWO/MagW VENI-451-08-026 to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Britz J, 2010, NEUROIMAGE; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fransson P, 2010, CEREBRAL CORTEX; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Good C.D., 2002, 5 IEEE EMBS INT SUMM, P16, DOI DOI 10.1109/SSBI.2002.1233974; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; MiotNoirault E, 1997, J NEUROSCI METH, V72, P5, DOI 10.1016/S0165-0270(96)00148-3; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Musso F, 2010, NEUROIMAGE; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; PIVIK RT, 1993, PSYCHOPHYSIOLOGY, V30, P547, DOI 10.1111/j.1469-8986.1993.tb02081.x; Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Schnack HG, 2001, NEUROIMAGE, V13, P230, DOI 10.1006/nimg.2000.0669; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Smit DJA, 2008, HUM BRAIN MAPP, V29, P1368, DOI 10.1002/hbm.20468; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Talairach J., 1988, COPLANAR STEREOTAXIC; Teipel SJ, 2009, HUM BRAIN MAPP, V30, P2098, DOI 10.1002/hbm.20652; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1279, DOI 10.1016/j.neurobiolaging.2005.05.018; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; ZIPURSKY RB, 1992, ARCH GEN PSYCHIAT, V49, P195	76	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36896	10.1371/journal.pone.0036896	http://dx.doi.org/10.1371/journal.pone.0036896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615837	Green Published, gold			2022-12-27	WOS:000305336300047
J	Zhang, C; Xu, SF; Xu, D				Zhang, Chao; Xu, Shunfu; Xu, Dong			Risk Assessment of Gastric Cancer Caused by Helicobacter pylori Using CagA Sequence Markers	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; EPITHELIAL-CELLS; DUODENAL-ULCER; PROTEIN; REGION; EXPRESSION; INFECTION; STRAINS; DISEASE	Background: As a marker of Helicobacter pylori, Cytotoxin-associated gene A (cagA) has been revealed to be the major virulence factor causing gastroduodenal diseases. However, the molecular mechanisms that underlie the development of different gastroduodenal diseases caused by cagA-positive H. pylori infection remain unknown. Current studies are limited to the evaluation of the correlation between diseases and the number of Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs in the CagA strain. To further understand the relationship between CagA sequence and its virulence to gastric cancer, we proposed a systematic entropy-based approach to identify the cancer-related residues in the intervening regions of CagA and employed a supervised machine learning method for cancer and non-cancer cases classification. Methodology: An entropy-based calculation was used to detect key residues of CagA intervening sequences as the gastric cancer biomarker. For each residue, both combinatorial entropy and background entropy were calculated, and the entropy difference was used as the criterion for feature residue selection. The feature values were then fed into Support Vector Machines (SVM) with the Radial Basis Function (RBF) kernel, and two parameters were tuned to obtain the optimal F value by using grid search. Two other popular sequence classification methods, the BLAST and HMMER, were also applied to the same data for comparison. Conclusion: Our method achieved 76% and 71% classification accuracy for Western and East Asian subtypes, respectively, which performed significantly better than BLAST and HMMER. This research indicates that small variations of amino acids in those important residues might lead to the virulence variance of CagA strains resulting in different gastroduodenal diseases. This study provides not only a useful tool to predict the correlation between the novel CagA strain and diseases, but also a general new framework for detecting biological sequence biomarkers in population studies.	[Zhang, Chao; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Zhang, Chao; Xu, Shunfu; Xu, Dong] Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO USA; [Xu, Shunfu] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Nanjing Medical University	Zhang, C (corresponding author), Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA.	xushfu@njmu.edu.cn; xudong@missouri.edu	Zhang, Chao/G-6462-2012; Zhang, Chao/E-6476-2015	Zhang, Chao/0000-0001-8019-7998	U.S. National Institute of Health [R21/R33 GM078601]; International Exchange and Cooperation Office of Nanjing Medical University, China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Exchange and Cooperation Office of Nanjing Medical University, China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by U.S. National Institute of Health [grant number R21/R33 GM078601] and International Exchange and Cooperation Office of Nanjing Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; BLASER MJ, 1995, CANCER RES, V55, P2111; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; *IARC, 1994, MON EV CARC RISKS HU, V61, P1; Joachims T., 1999, ADV KERNEL METHODS S; Jones KR, 2009, J CLIN MICROBIOL; Lai YP, 2003, HELICOBACTER, V8, P235, DOI 10.1046/j.1523-5378.2003.00148.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Satomi S, 2006, J GASTROENTEROL, V41, P668, DOI 10.1007/s00535-006-1838-6; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Seo JH, 2004, LAB INVEST, V84, P49, DOI 10.1038/labinvest.3700010; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Xie XF, 2007, PATHOBIOLOGY, V74, P309, DOI 10.1159/000105814; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Zhang Zunwu, 2007, J Gastrointest Cancer, V38, P38, DOI 10.1007/s12029-008-9015-1	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36844	10.1371/journal.pone.0036844	http://dx.doi.org/10.1371/journal.pone.0036844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615823	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300042
J	Harnacke, D; Mitter, S; Lehner, M; Munzert, J; Deinzer, R				Harnacke, Daniela; Mitter, Simona; Lehner, Marc; Munzert, Joern; Deinzer, Renate			Improving Oral Hygiene Skills by Computer-Based Training: A Randomized Controlled Comparison of the Modified Bass and the Fones Techniques	PLOS ONE			English	Article							PLAQUE REMOVAL; CLINICAL-TRIAL; ADULTS; PERFORMANCE; GINGIVITIS; TOOTHBRUSH	Background: Gingivitis and other plaque-associated diseases have a high prevalence in western communities even though the majority of adults report daily oral hygiene. This indicates a lack of oral hygiene skills. Currently, there is no clear evidence as to which brushing technique would bring about the best oral hygiene skills. While the modified Bass technique is often recommended by dentists and in textbooks, the Fones technique is often recommended in patient brochures. Still, standardized comparisons of the effectiveness of teaching these techniques are lacking. Methodology/Principal Findings: In a final sample of n = 56 students, this multidisciplinary, randomized, examiner-blinded, controlled study compared the effects of parallel and standardized interactive computer presentations teaching either the Fones or the modified Bass technique. A control group was taught the basics of tooth brushing alone. Oral hygiene skills (remaining plaque after thorough oral hygiene) and gingivitis were assessed at baseline and 6, 12, and 28 weeks after the intervention. We found a significant groupxtime interaction for gingivitis (F(4/102) = 3.267; p = 0.016; epsilon = 0.957; eta(2) = 0.114) and a significant main effect of group for oral hygiene skills (F(2/51) = 7.088; p = 0.002; eta(2) = 0.218). Fones was superior to Bass; Bass did not differ from the control group. Group differences were most prominent after 6 and 12 weeks. Conclusions/Significance: The present trial indicates an advantage of teaching the Fones as compared to the modified Bass technique with respect to oral hygiene skills and gingivitis. Future studies are needed to analyze whether the disadvantage of teaching the Bass technique observed here is restricted to the teaching method employed. Trial Registration: German Clinical Trials Register DRKS00003488	[Harnacke, Daniela; Mitter, Simona; Lehner, Marc; Deinzer, Renate] Univ Giessen, Inst Med Psychol, Giessen, Germany; [Munzert, Joern] Univ Giessen, Inst Sports Sci, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Harnacke, D (corresponding author), Univ Giessen, Inst Med Psychol, Giessen, Germany.	renate.deinzer@psycho.med.uni-giessen.de		, Renate/0000-0002-2867-4029	GABA International, Therwill, Switzerland	GABA International, Therwill, Switzerland	This study was sponsored by GABA International, Therwill, Switzerland. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	American Dental Association, CLEAN YOUR TEETH GUM; ARAI T, 1977, Bulletin of Tokyo Medical and Dental University, V24, P177; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BERGENHOLTZ A, 1984, SCAND J DENT RES, V92, P344; Davies RM, 2003, BRIT DENT J, V195, P135, DOI 10.1038/sj.bdj.4810396; Deinzer R., 2008, IDZ INFORM, V1, P2; Dombret B, 2003, J CLIN PERIODONTOL, V30, P630, DOI 10.1034/j.1600-051X.2003.00281.x; Engelkamp J., 1998, MEMORY ACTIONS; Fitts PM., 1967, HUM PERFORM; FRANDSEN AM, 1972, SCAND J DENT RES, V80, P267; GIBSON JA, 1977, J PERIODONTOL, V48, P456, DOI 10.1902/jop.1977.48.8.456; Godard A, 2011, J CLIN PERIODONTOL, V38, P1099, DOI 10.1111/j.1600-051X.2011.01782.x; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Granrath N, 2007, EFFECTS DIFFERENT IN; Hellwege K, 2003, PRAXIS ZAHNMEDIZINIS, P102; Hoffmann T, 2006, 4 GERMAN ORAL HLTH S, P266; Janelle CM, 1997, RES Q EXERCISE SPORT, V68, P269, DOI 10.1080/02701367.1997.10608008; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; Kremers L, 1978, Dtsch Zahnarztl Z, V33, P58; McCracken GI, 2006, J CLIN PERIODONTOL, V33, P172, DOI 10.1111/j.1600-051X.2006.00877.x; Micheelis W, 2006, 4 GERMAN ORAL HLTH S, P375; Morris AJ, 2001, BRIT DENT J, V191, P186, DOI 10.1038/sj.bdj.4801135a; Poyato-Ferrera M, 2003, Int J Dent Hyg, V1, P110, DOI 10.1034/j.1601-5037.2003.00018.x; QUIGLEY GA, 1962, J AM DENT ASSOC, V65, P26, DOI 10.14219/jada.archive.1962.0184; Rateitschak K. H., 1989, PERIODONTOLOGY, P69; Renz A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005097.pub2; Saxer U P, 1975, SSO Schweiz Monatsschr Zahnheilkd, V85, P905; Schiffner U, 2007, J CLIN PERIODONTOL, V34, P1068, DOI 10.1111/j.1600-051X.2007.01150.x; Schlueter N, 2010, CLIN ORAL INVEST, V14, P99, DOI 10.1007/s00784-009-0269-1; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Staehle HJ, 2007, DTSCH ZAHNARZTL Z, V62, P616; TURESKY S, 1972, J PERIODONTOL, V43, P263, DOI 10.1902/jop.1972.43.5.263; van der Weijden GA, 2005, J CLIN PERIODONTOL, V32, P214, DOI 10.1111/j.1600-051X.2005.00795.x; Wulf G, 2010, MED EDUC, V44, P75, DOI 10.1111/j.1365-2923.2009.03421.x	34	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e37072	10.1371/journal.pone.0037072	http://dx.doi.org/10.1371/journal.pone.0037072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629353	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343100011
J	Grietens, KP; Toomer, E; Boock, AU; Hausmann-Muela, S; Peeters, H; Kanobana, K; Gryseels, C; Ribera, JM				Grietens, Koen Peeters; Toomer, Elizabeth; Boock, Alphonse Um; Hausmann-Muela, Susanna; Peeters, Hans; Kanobana, Kirezi; Gryseels, Charlotte; Ribera, Joan Muela			What Role Do Traditional Beliefs Play in Treatment Seeking and Delay for Buruli Ulcer Disease?-Insights from a Mixed Methods Study in Cameroon	PLOS ONE			English	Article							BURDEN	Background: Victims of Buruli ulcer disease (BUD) frequently report to specialized units at a late stage of the disease. This delay has been associated with local beliefs and a preference for traditional healing linked to a reportedly mystical origin of the disease. We assessed the role beliefs play in determining BUD sufferers' choice between traditional and biomedical treatments. Methods: Anthropological fieldwork was conducted in community and clinical settings in the region of Ayos and Akonolinga in Central Cameroon. The research design consisted of a mixed methods study, triangulating a qualitative strand based on ethnographic research and quantitative data obtained through a survey presented to all patients at the Ayos and Akonolinga hospitals (N = 79) at the time of study and in four endemic communities (N = 73) belonging to the hospitals' catchment area. Results: The analysis of BUD sufferers' health-seeking behaviour showed extremely complex therapeutic itineraries, including various attempts and failures both in the biomedical and traditional fields. Contrary to expectations, nearly half of all hospital patients attributed their illness to mystical causes, while traditional healers admitted patients they perceived to be infected by natural causes. Moreover, both patients in hospitals and in communities often combined elements of both types of treatments. Ultimately, perceptions regarding the effectiveness of the treatment, the option for local treatment as a cost prevention strategy and the characteristics of the doctor-patient relationship were more determinant for treatment choice than beliefs. Discussion: The ascription of delay and treatment choice to beliefs constitutes an over-simplification of BUD health-seeking behaviour and places the responsibility directly on the shoulders of BUD sufferers while potentially neglecting other structural elements. While more efficacious treatment in the biomedical sector is likely to reduce perceived mystical involvement in the disease, additional decentralization could constitute a key element to reduce delay and increase adherence to biomedical treatment.	[Grietens, Koen Peeters; Gryseels, Charlotte] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Boock, Alphonse Um] Aide Lepreux Emmaus Suisse, Yaounde, Cameroon; [Grietens, Koen Peeters; Toomer, Elizabeth; Hausmann-Muela, Susanna; Peeters, Hans; Ribera, Joan Muela] PASS Int, Tessenderlo, Belgium; [Peeters, Hans] Univ Leuven, Ctr Sociol Res, Louvain, Belgium; [Kanobana, Kirezi] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); KU Leuven; Institute of Tropical Medicine (ITM)	Grietens, KP (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	kpeeters@itg.be	Ribera, JM/B-8181-2009; Peeters Grietens, Koen/G-7028-2019	Ribera, JM/0000-0003-1042-6024; Peeters Grietens, Koen/0000-0001-6570-9887; muela ribera, joan/0000-0003-2111-6275; Gryseels, Charlotte/0000-0002-8963-4469	Aide aux Lepreux Emmaus Suisse	Aide aux Lepreux Emmaus Suisse	This study funded by Aide aux Lepreux Emmaus Suisse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Anthropological Association, 2018, COD ETH AM ANTHR ASS; American Anthropological Association, STAT ETHN I REV BOAR; Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; Aujoulat I, 2003, TROP MED INT HEALTH, V8, P750, DOI 10.1046/j.1365-3156.2003.01089.x; Geissler P W, 1998, Anthropol Med, V5, P63, DOI 10.1080/13648470.1998.9964549; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Jacobsen KH, 2010, INT J INFECT DIS, V14, pE677, DOI 10.1016/j.ijid.2009.11.013; Johnson P, 2005, PLOS MED, V2, P0282; Kibadi K, 2009, TROP MED INT HEALTH, V14, P1110, DOI 10.1111/j.1365-3156.2009.02324.x; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Muela S H, 1998, Anthropol Med, V5, P43, DOI 10.1080/13648470.1998.9964548; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; Noeske J, 2004, AM J TROP MED HYG, V70, P520, DOI 10.4269/ajtmh.2004.70.520; Porten K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000466; Pouillot R, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000101; Ribera JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000445; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Thomas F, 2008, MED ANTHROPOL, V27, P227, DOI 10.1080/01459740802222716; Um Boock A, 2004, LEPRA AID INTERNAL R; WHO, WHO BUR ULC DIS	22	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36954	10.1371/journal.pone.0036954	http://dx.doi.org/10.1371/journal.pone.0036954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623964	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500041
J	Hong, JR; Talapatra, S; Katz, J; Tester, PA; Waggett, RJ; Place, AR				Hong, Jiarong; Talapatra, Siddharth; Katz, Joseph; Tester, Patricia A.; Waggett, Rebecca J.; Place, Allen R.			Algal Toxins Alter Copepod Feeding Behavior	PLOS ONE			English	Article							DINOFLAGELLATE KARLODINIUM-VENEFICUM; KARENIA-BREVIS; CALANOID COPEPODS; PREY-SELECTION; ACARTIA-TONSA; DISTRIBUTIONS; RESISTANCE; CURRENTS; CAPTURE	Using digital holographic cinematography, we quantify and compare the feeding behavior of free-swimming copepods, Acartia tonsa, on nutritional prey (Storeatula major) to that occurring during exposure to toxic and non-toxic strains of Karenia brevis and Karlodinium veneficum. These two harmful algal species produce polyketide toxins with different modes of action and potency. We distinguish between two different beating modes of the copepod's feeding appendages-a "sampling beating" that has short durations (<100 ms) and involves little fluid entrainment and a longer duration "grazing beating" that persists up to 1200 ms and generates feeding currents. The durations of both beating modes have log-normal distributions. Without prey, A. tonsa only samples the environment at low frequency. Upon introduction of non-toxic food, it increases its sampling time moderately and the grazing period substantially. On mono algal diets for either of the toxic dinoflagellates, sampling time fraction is high but the grazing is very limited. A. tonsa demonstrates aversion to both toxic algal species. In mixtures of S. major and the neurotoxin producing K. brevis, sampling and grazing diminish rapidly, presumably due to neurological effects of consuming brevetoxins while trying to feed on S. major. In contrast, on mixtures of cytotoxin producing K. veneficum, both behavioral modes persist, indicating that intake of karlotoxins does not immediately inhibit the copepod's grazing behavior. These findings add critical insight into how these algal toxins may influence the copepod's feeding behavior, and suggest how some harmful algal species may alter top-down control exerted by grazers like copepods.	[Hong, Jiarong; Talapatra, Siddharth; Katz, Joseph] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Tester, Patricia A.] Natl Ocean & Atmospher Adm, Natl Ocean Serv, Beaufort, NC USA; [Waggett, Rebecca J.] Univ Tampa, Dept Biol, Tampa, FL 33606 USA; [Place, Allen R.] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Baltimore, MD 21201 USA	Johns Hopkins University; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; University of Tampa; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Hong, JR (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	katz@jhu.edu	Place, Allen R/F-9267-2013; Katz, Joseph/A-7624-2010	Katz, Joseph/0000-0001-9067-2473; Hong, Jiarong/0000-0001-7860-2181	National Science Foundation; Office of Naval Research; National Research Council (NRC); Center for Coastal Fisheries and Habitat Research (CCFHR); National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA); Div Of Chem, Bioeng, Env, & Transp Sys [0923391] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021949] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Research Council (NRC); Center for Coastal Fisheries and Habitat Research (CCFHR); National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support for the Johns Hopkins University (JHU) group has been provided in part by National Science Foundation, and in part by the Office of Naval Research, National Oceanographic Partnership Program (NOPP). Support for RJW was from National Research Council (NRC) Research Associateship Program (RAP) funded by the Center for Coastal Fisheries and Habitat Research (CCFHR) and National Centers for Coastal Ocean Science (NCCOS) of the National Oceanographic and Atmospheric Administration (NOAA). This is contribution #4649 from the University of Maryland Center for Environmental Sciences, contribution #12-231 from the Institute of Marine and Environmental Technology and contribution #685 from the Ecology and Oceanography of Harmful Algal Blooms (ECOHAB) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; Adolf JE, 2008, HARMFUL ALGAE, V8, P119, DOI 10.1016/j.hal.2008.08.003; AMOORE JE, 1991, CHEM SENSES, V3, P331; Ariens EJ, 1966, ADV DRUG RES, P235; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Breier CF, 2007, J PLANKTON RES, V29, P115, DOI 10.1093/plankt/fbl075; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Deeds JR, 2006, AFR J MAR SCI, V28, P421, DOI 10.2989/18142320609504190; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; FRIEDMAN MM, 1975, P NATL ACAD SCI USA, V72, P4185, DOI 10.1073/pnas.72.10.4185; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Glibert PM, 2009, AQUAT MICROB ECOL, V55, P17, DOI 10.3354/ame01279; GREENE CH, 1988, HYDROBIOLOGIA, V167, P295, DOI 10.1007/BF00026317; Hall NS, 2008, ESTUAR COAST, V31, P402, DOI 10.1007/s12237-008-9035-x; HUNTLEY M, 1986, MAR ECOL PROG SER, V28, P105, DOI 10.3354/meps028105; Ives J.D., 1985, P413; IVES JD, 1987, J EXP MAR BIOL ECOL, V112, P131, DOI 10.1016/0022-0981(87)90113-4; JONSSON PR, 1990, MAR ECOL PROG SER, V60, P35, DOI 10.3354/meps060035; Kenakin T., 2006, PHARM PRIMER THEORY; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Kiorboe T, 1999, MAR ECOL PROG SER, V179, P97, DOI 10.3354/meps179097; KOCH AL, 1969, J THEOR BIOL, V23, P251, DOI 10.1016/0022-5193(69)90040-X; KOEHL MAR, 1981, LIMNOL OCEANOGR, V26, P1062, DOI 10.4319/lo.1981.26.6.1062; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lester KM, 2008, CONT SHELF RES, V28, P99, DOI 10.1016/j.csr.2007.04.009; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Malkiel E, 2003, J EXP BIOL, V206, P3657, DOI 10.1242/jeb.00586; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; ROSENBERG GG, 1980, LIMNOL OCEANOGR, V25, P738, DOI 10.4319/lo.1980.25.4.0738; SAIZ E, 1995, MAR ECOL PROG SER, V122, P147, DOI 10.3354/meps122147; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Sheng J, 2007, P NATL ACAD SCI USA, V104, P17512, DOI 10.1073/pnas.0704658104; Sheng J, 2010, P NATL ACAD SCI USA, V107, P2082, DOI 10.1073/pnas.0912254107; Smayda TJ, 1992, FOOD CHAINS MODELS M, P257; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925; STRICKLER JR, 1977, LIMNOL OCEANOGR, V22, P165, DOI 10.4319/lo.1977.22.1.0165; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; Strickler V.R., 1984, P187; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Sunda WG, 2006, J PHYCOL, V42, P963, DOI 10.1111/j.1529-8817.2006.00261.x; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Turner J.T., 1989, Coastal and Estuarine Studies, P359; Turner Jefferson T., 1998, NATO ASI Series Series G Ecological Sciences, V41, P453; Vanderploeg Henry A., 1994, P205; Waggett RJ, 2008, MAR ECOL PROG SER, V366, P31, DOI 10.3354/meps07518; Waggett RJ, 2012, MAR ECOL PROG SER, V444, P15, DOI 10.3354/meps09401; Xu WB, 2001, P NATL ACAD SCI USA, V98, P11301, DOI 10.1073/pnas.191361398	51	40	43	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36845	10.1371/journal.pone.0036845	http://dx.doi.org/10.1371/journal.pone.0036845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629336	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500031
J	Nale, JY; Shan, JY; Hickenbotham, PT; Fawley, WN; Wilcox, MH; Clokie, MRJ				Nale, Janet Y.; Shan, Jinyu; Hickenbotham, Peter T.; Fawley, Warren N.; Wilcox, Mark H.; Clokie, Martha R. J.			Diverse Temperate Bacteriophage Carriage in Clostridium difficile 027 Strains	PLOS ONE			English	Article							R-TYPE PYOCIN; PSEUDOMONAS-AERUGINOSA; MOLECULAR CHARACTERIZATION; GENOMIC ORGANIZATION; TOXIN PRODUCTION; PHAGE; INDUCTION; PROPHAGES; EVOLUTION; INFECTION	Background: The hypervirulent Clostridium difficile ribotype 027 can be classified into subtypes, but it unknown if these differ in terms of severity of C. difficile infection (CDI). Genomic studies of C. difficile 027 strains have established that they are rich in mobile genetic elements including prophages. This study combined physiological studies, electron microscopy analysis and molecular biology to determine the potential role of temperate bacteriophages in disease and diversity of C. difficile 027. Methodology/Principal Findings: We induced prophages from 91 clinical C. difficile 027 isolates and used transmission electron microscopy and pulsed-field gel electrophoresis to characterise the bacteriophages present. We established a correlation between phage morphology and subtype. Morphologically distinct tailed bacteriophages belonging to Myoviridae and Siphoviridae were identified in 63 and three isolates, respectively. Dual phage carriage was observed in four isolates. In addition, there were inducible phage tail-like particles (PT-LPs) in all isolates. The capacity of two antibiotics mitomycin C and norfloxacin to induce prophages was compared and it was shown that they induced specific prophages from C. difficile isolates. A PCR assay targeting the capsid gene of the myoviruses was designed to examine molecular diversity of C. difficile myoviruses. Phylogenetic analysis of the capsid gene sequences from eight ribotypes showed that all sequences found in the ribotype 027 isolates were identical and distinct from other C. difficile ribotypes and other bacteria species. Conclusion/Significance: A diverse set of temperate bacteriophages are associated with C. difficile 027. The observed correlation between phage carriage and the subtypes suggests that temperate bacteriophages contribute to the diversity of C. difficile 027 and may play a role in severity of disease associated with this ribotype. The capsid gene can be used as a tool to identify C. difficile myoviruses present within bacterial genomes.	[Nale, Janet Y.; Shan, Jinyu; Hickenbotham, Peter T.; Clokie, Martha R. J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Fawley, Warren N.; Wilcox, Mark H.] Leeds Teaching Hosp Trust, Leeds Gen Infirm, Dept Microbiol, Old Med Sch, Leeds, W Yorkshire, England; [Clokie, Martha R. J.] Univ Leeds, Leeds, W Yorkshire, England	University of Leicester; Leeds General Infirmary; University of Leeds; University of Leeds	Nale, JY (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrjc1@le.ac.uk	Nale, Janet/ADL-6092-2022; Nale, Janet/GSN-8421-2022	Nale, Janet/0000-0003-0501-7402; Clokie, Martha/0000-0002-6069-8936	Medical Research Council New Investigator Research Grant [G0700855]; MRC [G0700855] Funding Source: UKRI; Medical Research Council [G0700855] Funding Source: researchfish	Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council New Investigator Research Grant (G0700855) to MRJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; BRADLEY DE, 1965, J GEN MICROBIOL, V41, P233, DOI 10.1099/00221287-41-2-233; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Casjens Sherwood, 2005, P39; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Fortier LC, 2007, APPL ENVIRON MICROB, V73, P7358, DOI 10.1128/AEM.00582-07; Goh S, 2005, J MED MICROBIOL, V54, P129, DOI 10.1099/jmm.0.45821-0; Goh S, 2005, APPL ENVIRON MICROB, V71, P1079, DOI 10.1128/AEM.71.2.1079-1083.2005; Goh S, 2007, MICROBIOL-SGM, V153, P676, DOI 10.1099/mic.0.2006/002436-0; Govind R, 2006, J BACTERIOL, V188, P2568, DOI 10.1128/JB.188.7.2568-2577.2006; Govind R, 2009, J VIROL, V83, P12037, DOI 10.1128/JVI.01256-09; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Horgan M, 2010, GENE, V462, P34, DOI 10.1016/j.gene.2010.04.010; INOUE K, 1968, J VIROL, V2, P537, DOI 10.1128/JVI.2.5.537-540.1968; Jenkins Lynda, 2004, Nurs Times, V100, P56; Jones DT, 2005, HDB CLOSTRIDIA, P878; KIRBY EP, 1967, P NATL ACAD SCI USA, V58, P1903, DOI 10.1073/pnas.58.5.1903; Kuijper E J, 2008, Euro Surveill, V13; Lee FKN, 1999, INFECT IMMUN, V67, P717, DOI 10.1128/IAI.67.2.717-725.1999; MAHONEY DE, 1985, J CLIN MICROBIOL, V21, P251, DOI 10.1128/JCM.21.2.251-254.1985; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Matsushiro A, 1999, J BACTERIOL, V181, P2257, DOI 10.1128/JB.181.7.2257-2260.1999; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; NAGY E, 1991, APMIS, V99, P321, DOI 10.1111/j.1699-0463.1991.tb05156.x; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; OKAMOTO K, 1968, J MOL BIOL, V34, P413, DOI 10.1016/0022-2836(68)90169-1; Romero P, 2004, VIROLOGY, V322, P239, DOI 10.1016/j.virol.2004.01.029; Sambrook J., 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sekulovic O, 2011, J BACTERIOL, V193, P2726, DOI 10.1128/JB.00787-10; Smarda J, 2005, APPL ENVIRON MICROB, V71, P8970, DOI 10.1128/AEM.71.12.8970-8973.2005; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; TAKEYA K, 1969, J GEN VIROL, V4, P145, DOI 10.1099/0022-1317-4-2-145; URATANI Y, 1984, J BACTERIOL, V157, P632, DOI 10.1128/JB.157.2.632-636.1984; Zimmer M, 2002, J BACTERIOL, V184, P4359, DOI 10.1128/JB.184.16.4359-4368.2002	39	36	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37263	10.1371/journal.pone.0037263	http://dx.doi.org/10.1371/journal.pone.0037263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624004	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500086
J	Fujinuma, J; Harrison, RD				Fujinuma, Junichi; Harrison, Rhett D.			Wild Pigs (Sus scrofa) Mediate Large-Scale Edge Effects in a Lowland Tropical Rainforest in Peninsular Malaysia	PLOS ONE			English	Article							HABITAT FRAGMENTATION; CLIDEMIA-HIRTA; PLANT INVASION; ENEMY RELEASE; IMPACTS; DISTURBANCE; DEFORESTATION; LANDSCAPES; MECHANISMS; DIVERSITY	Edge-effects greatly extend the area of tropical forests degraded through human activities. At Pasoh, Peninsular Malaysia, it has been suggested that soil disturbance by highly abundant wild pigs (Sus scrofa), which feed in adjacent Oil Palm plantations, may have mediated the invasion of Clidemia hirta (Melastomataceae) into the diverse tropical lowland rain forest. To investigate this hypothesis, we established three 1 km transects from the forest/Oil Palm plantation boundary into the forest interior. We recorded the distribution of soil disturbance by wild pigs, C. hirta abundance, and environmental variables. These data were analyzed using a hierarchical Bayesian model that incorporated spatial auto-correlation in the environmental variables. As predicted, soil disturbance by wild pigs declined with distance from forest edge and C. hirta abundance was correlated with the level of soil disturbance. Importantly there was no effect of distance on C. hirta abundance, after controlling for the effect of soil disturbance. Clidemia hirta abundance was also correlated with the presence of canopy openings, but there was no significant association between the occurrence of canopy openings and distance from the edge. Increased levels of soil disturbance and C. hirta abundance were still detectable approximately 1 km from the edge, demonstrating the potential for exceptionally large-scale animal mediated edge effects.	[Fujinuma, Junichi] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Harrison, Rhett D.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China	Hokkaido University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Fujinuma, J (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	rharrison@xtbg.org.cn		Fujinuma, Junichi/0000-0001-9004-4709; Harrison, Rhett/0000-0001-9055-3546				AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; [Anonymous], [No title captured]; APLET GH, 1991, VEGETATIO, V95, P55, DOI 10.1007/BF00124953; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; BATCHELER CL, 1983, PAC SCI, V37, P415; Blumenthal DM, 2006, ECOL LETT, V9, P887, DOI 10.1111/j.1461-0248.2006.00934.x; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Chacoff NP, 2006, J APPL ECOL, V43, P18, DOI 10.1111/j.1365-2664.2005.01116.x; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; DeWalt SJ, 2004, OECOLOGIA, V138, P521, DOI 10.1007/s00442-003-1462-6; Didham RK, 1998, OECOLOGIA, V116, P397, DOI 10.1007/s004420050603; Fine PVA, 2002, J TROP ECOL, V18, P687, DOI [10.1017/S0266467402002456, 10.1017/S00266467402002456]; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; GRAVES HB, 1984, J ANIM SCI, V58, P482, DOI 10.2527/jas1984.582482x; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Herrera JM, 2011, LANDSCAPE ECOL, V26, P125, DOI 10.1007/s10980-010-9541-7; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Ickes K, 2005, ECOLOGY, V86, P1540, DOI 10.1890/04-0867; Ickes K, 2001, BIOTROPICA, V33, P682, DOI 10.1111/j.1744-7429.2001.tb00225.x; Ickes K, 2001, J TROP ECOL, V17, P191, DOI 10.1017/S0266467401001134; Kinnaird MF, 2003, CONSERV BIOL, V17, P245, DOI 10.1046/j.1523-1739.2003.02040.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Malcolm JR, 1998, CLIMATIC CHANGE, V39, P487, DOI 10.1023/A:1005376603186; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Noguchi S, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P51; Okuda T, 2003, PASOH: ECOLOGY OF A LOWLAND RAIN FOREST IN SOUTHEAST ASIA, P15; Pereira R, 2002, FOREST ECOL MANAG, V168, P77, DOI 10.1016/S0378-1127(01)00732-0; Peters HA, 2001, BIOTROPICA, V33, P60, DOI 10.1111/j.1744-7429.2001.tb00157.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Prieur-Richard AH, 2000, AUSTRAL ECOL, V25, P1; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; RAMAKRISHNAN PS, 1989, BIOL INVASIONS GLOBA, P281; RENNER SS, 1989, ANN MO BOT GARD, V76, P496, DOI 10.2307/2399497; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Siemann E, 2009, FOREST ECOL MANAG, V258, P546, DOI 10.1016/j.foreco.2009.03.056; SINGER FJ, 1984, J WILDLIFE MANAGE, V48, P464, DOI 10.2307/3801179; SMITH CW, 1992, ALIEN PLANT INVASION, P241; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; WESTER L L, 1977, Environmental Conservation, V4, P35, DOI 10.1017/S0376892900024991; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	49	19	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37321	10.1371/journal.pone.0037321	http://dx.doi.org/10.1371/journal.pone.0037321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615977	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200058
J	Herrmann, J; Elnakady, YA; Wiedmann, RM; Ullrich, A; Rohde, M; Kazmaier, U; Vollmar, AM; Muller, R				Herrmann, Jennifer; Elnakady, Yasser A.; Wiedmann, Romina M.; Ullrich, Angelika; Rohde, Manfred; Kazmaier, Uli; Vollmar, Angelika M.; Mueller, Rolf			Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy	PLOS ONE			English	Article							BAX CONFORMATIONAL CHANGE; NATURAL-PRODUCTS; DRUG DISCOVERY; BIOLOGICAL-PROPERTIES; ANTICANCER AGENTS; TUBULIN POLYMERIZATION; DNA FRAGMENTATION; GLIDING BACTERIA; FLOW-CYTOMETRY; CYTOCHROME-C	Pretubulysin is a natural product that is found in strains of myxobacteria in only minute amounts. It represents the first enzyme-free intermediate in the biosynthesis of tubulysins and undergoes post-assembly acylation and oxidation reactions. Pretubulysin inhibits the growth of cultured mammalian cells, as do tubulysins, which are already in advanced preclinical development as anticancer and antiangiogenic agents. The mechanism of action of this highly potent compound class involves the depolymerization of microtubules, thereby inducing mitotic arrest. Supply issues with naturally occurring derivatives can now be circumvented by the total synthesis of pretubulysin, which, in contrast to tubulysin, is synthetically accessible in gram-scale quantities. We show that the simplified precursor is nearly equally potent to the parent compound. Pretubulysin induces apoptosis and inhibits cancer cell migration and tubulin assembly in vitro. Consequently, pretubulysin appears to be an ideal candidate for future development in preclinical trials and is a very promising early lead structure in cancer therapy.	[Herrmann, Jennifer; Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-6600 Saarbrucken, Germany; [Herrmann, Jennifer; Elnakady, Yasser A.; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-6600 Saarbrucken, Germany; [Wiedmann, Romina M.; Vollmar, Angelika M.] Univ Munich, Dept Pharm, Munich, Germany; [Ullrich, Angelika; Kazmaier, Uli] Univ Saarland, Inst Organ Chem, D-6600 Saarbrucken, Germany; [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Med Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; University of Munich; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research	Herrmann, J (corresponding author), Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-6600 Saarbrucken, Germany.	rolf.mueller@helmholtz-hzi.de	Müller, Rolf/B-1559-2008; Elnakady, Yasser A./N-6882-2019; Elnakady, Yasser Abbass/GYJ-1602-2022; Kazmaier, Uli/D-2947-2018	Müller, Rolf/0000-0002-1042-5665; Herrmann, Jennifer/0000-0003-3398-9938	Deutsche Forschungsgemeinschaft [FOR1406]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft (FOR1406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; BHALLA K, 1993, LEUKEMIA, V7, P563; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; BOLLAG DM, 1995, CANCER RES, V55, P2325; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burkhart JL, 2011, EUR J ORG CHEM, V2011, P3050, DOI 10.1002/ejoc.201100155; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Conlin A, 2007, NAT REV DRUG DISCOV, V6, P953, DOI 10.1038/nrd2469; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Domling A, 2005, MOL DIVERS, V9, P141, DOI 10.1007/s11030-005-1542-0; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elnakady YA, 2004, BIOCHEM PHARMACOL, V67, P927, DOI 10.1016/j.bcp.2003.10.029; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Garcia R, 2010, MOL PHYLOGENET EVOL, V57, P878, DOI 10.1016/j.ympev.2010.08.028; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hofle G., 1996, ANGEW CHEM, V108, P1671, DOI DOI 10.1098/RSPA.2013.0690; Hopkins CD, 2009, NAT PROD REP, V26, P585, DOI 10.1039/b813799b; IRSCHIK H, 1995, J ANTIBIOT, V48, P31, DOI 10.7164/antibiotics.48.31; IRSCHIK H, 1995, J ANTIBIOT, V48, P962, DOI 10.7164/antibiotics.48.962; JANSEN R, 1994, LIEBIGS ANN CHEM, P759; Khalil MW, 2006, CHEMBIOCHEM, V7, P678, DOI 10.1002/cbic.200500421; Kubicek K, 2010, ANGEW CHEM INT EDIT, V49, P4809, DOI 10.1002/anie.200906828; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Neri D, 2006, CHEMMEDCHEM, V1, P175, DOI 10.1002/cmdc.200500043; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Peltier HM, 2006, J AM CHEM SOC, V128, P16018, DOI 10.1021/ja067177z; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sandmann A, 2004, CHEM BIOL, V11, P1071, DOI 10.1016/j.chembiol.2004.05.014; SASSE F, 1993, J ANTIBIOT, V46, P741, DOI 10.7164/antibiotics.46.741; Sasse F, 2000, J ANTIBIOT, V53, P879, DOI 10.7164/antibiotics.53.879; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; Steinmetz H, 2004, ANGEW CHEM INT EDIT, V43, P4888, DOI 10.1002/anie.200460147; Ullrich A, 2009, EUR J ORG CHEM, V2009, P6367, DOI 10.1002/ejoc.200900999; Ullrich A, 2009, ANGEW CHEM INT EDIT, V48, P4422, DOI 10.1002/anie.200900406; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang ZY, 2007, CHEM BIOL DRUG DES, V70, P75, DOI 10.1111/j.1747-0285.2007.00541.x; Weiderhold KN, 2006, INT J CANCER, V118, P1032, DOI 10.1002/ijc.21424; Weissman KJ, 2010, NAT PROD REP, V27, P1276, DOI 10.1039/c001260m; Wenzel SC, 2009, CURR OPIN DRUG DISC, V12, P220; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Yamaguchi H, 2002, CANCER RES, V62, P466; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	56	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37416	10.1371/journal.pone.0037416	http://dx.doi.org/10.1371/journal.pone.0037416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616003	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200074
J	Borghesi, C; Raynal, JC; Bouchaud, JP				Borghesi, Christian; Raynal, Jean-Claude; Bouchaud, Jean-Philippe			Election Turnout Statistics in Many Countries: Similarities, Differences, and a Diffusive Field Model for Decision-Making	PLOS ONE			English	Article							LAW	We study in details the turnout rate statistics for 77 elections in 11 different countries. We show that the empirical results established in a previous paper for French elections appear to hold much more generally. We find in particular that the spatial correlation of turnout rates decay logarithmically with distance in all cases. This result is quantitatively reproduced by a decision model that assumes that each voter makes his mind as a result of three influence terms: one totally idiosyncratic component, one city-specific term with short-ranged fluctuations in space, and one long-ranged correlated field which propagates diffusively in space. A detailed analysis reveals several interesting features: for example, different countries have different degrees of local heterogeneities and seem to be characterized by a different propensity for individuals to conform to the cultural norm. We furthermore find clear signs of herding (i.e., strongly correlated decisions at the individual level) in some countries, but not in others.	[Borghesi, Christian] CNRS EHESS, CAMS, Paris, France; [Raynal, Jean-Claude] EHESS, Hist Div, Paris, France; [Bouchaud, Jean-Philippe] Capital Fund Management, Paris, France	Centre National de la Recherche Scientifique (CNRS)	Borghesi, C (corresponding author), CNRS EHESS, CAMS, Paris, France.	jean-philippe.bouchaud@cea.fr						Amaral LAN, 1998, PHYS REV LETT, V80, P1385, DOI 10.1103/PhysRevLett.80.1385; Araripe LE, 2009, PHYSICA A, V388, P4167, DOI 10.1016/j.physa.2009.06.023; Araujo NAM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012446; Blais A., 2000, VOTE NOT VOTE MERITS; Borghesi C, 2010, EUR PHYS J B, V75, P395, DOI 10.1140/epjb/e2010-00151-1; Borghesi C, 2012, ORDER DISORDER WEAK; Borghesi C., 2010, ETUDE PHYS ELECTIONS; Bussi M., 1998, ELEMENTS GEOGRAPHIE; Chou C-I, 2009, GROWTH MODEL VOTE DI; Costa RN, 1999, PHYS REV E, V60, P1067, DOI 10.1103/PhysRevE.60.1067; Fortunato S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138701; Franklin MarkN., 2004, VOTER TURNOUT DYNAMI, DOI DOI 10.1017/CBO9780511616884; Geys B., 2016, POLIT STUD REV, V4, P16; Geys B, 2006, ELECT STUD, V25, P637, DOI 10.1016/j.electstud.2005.09.002; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; Hernandez-Saldana H, 2009, PHYSICA A, V388, P2699, DOI 10.1016/j.physa.2009.03.016; Klimek Peter, 2012, ITS NOT VOTING THATS; Lyra ML, 2003, EUROPHYS LETT, V62, P131, DOI 10.1209/epl/i2003-00371-6; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Wyart M, 2003, PHYSICA A, V326, P241, DOI 10.1016/S0378-4371(03)00267-X	21	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36289	10.1371/journal.pone.0036289	http://dx.doi.org/10.1371/journal.pone.0036289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615762	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300014
J	Junaid, M; Chalayut, C; Torrejon, AS; Angsuthanasombat, C; Shutava, I; Lapins, M; Wikberg, JES; Katzenmeier, G				Junaid, Muhammad; Chalayut, Chakard; Torrejon, Anna Sehgelmeble; Angsuthanasombat, Chanan; Shutava, Iryna; Lapins, Maris; Wikberg, Jarl E. S.; Katzenmeier, Gerd			Enzymatic Analysis of Recombinant Japanese Encephalitis Virus NS2B(H)-NS3pro Protease with Fluorogenic Model Peptide Substrates	PLOS ONE			English	Article							NS3 PROTEASE; NS2B-NS3 PROTEASE; SERINE-PROTEASE; AMINO-ACIDS; DENGUE; SPECIFICITY; MUTAGENESIS; COFACTOR; COMPLEX; PROTEINASE	Background: Japanese encephalitis virus (JEV), a member of the Flaviviridae family, causes around 68,000 encephalitis cases annually, of which 20-30% are fatal, while 30-50% of the recovered cases develop severe neurological sequelae. Specific antivirals for JEV would be of great importance, particularly in those cases where the infection has become persistent. Being indispensable for flaviviral replication, the NS2B-NS3 protease is a promising target for design of anti-flaviviral inhibitors. Contrary to related flaviviral proteases, the JEV NS2B-NS3 protease is structurally and mechanistically much less characterized. Here we aimed at establishing a straightforward procedure for cloning, expression, purification and biochemical characterization of JEV NS2B(H)-NS3pro protease. Methodology/Principal Findings: The full-length sequence of JEV NS2B-NS3 genotype III strain JaOArS 982 was obtained as a synthetic gene. The sequence of NS2B(H)-NS3pro was generated by splicing by overlap extension PCR (SOE-PCR) and cloned into the pTrcHisA vector. Hexahistidine-tagged NS2B(H)-NS3pro, expressed in E. coli as soluble protein, was purified to >95% purity by a single-step immobilized metal affinity chromatography. SDS-PAGE and immunoblotting of the purified enzyme demonstrated NS2B(H)-NS3pro precursor and its autocleavage products, NS3pro and NS2B(H), as 36, 21, and 10 kDa bands, respectively. Kinetic parameters, K-m and k(cat), for fluorogenic protease model substrates, Boc-GRR-amc, Boc-LRR-amc, Ac-nKRR-amc, Bz-nKRR-amc, Pyr-RTKR-amc and Abz-(R)(4)SAG-nY-amide, were obtained using inner filter effect correction. The highest catalytic efficiency k(cat)/K-m was found for Pyr-RTKR-amc (k(cat)/K-m: 1962.96 +/- 85.0 M-1 s(-1)) and the lowest for Boc-LRR-amc (k(cat)/K-m: 3.74 +/- 0.3 M-1 s(-1)). JEV NS3pro is inhibited by aprotinin but to a lesser extent than DEN and WNV NS3pro. Conclusions/Significance: A simplified procedure for the cloning, overexpression and purification of the NS2B(H)-NS3pro was established which is generally applicable to other flaviviral proteases. Kinetic parameters obtained for a number of model substrates and inhibitors, are useful for the characterization of substrate specificity and eventually for the design of high-throughput assays aimed at antiviral inhibitor discovery.	[Junaid, Muhammad; Chalayut, Chakard; Angsuthanasombat, Chanan; Katzenmeier, Gerd] Mahidol Univ, Inst Mol Biosci, Lab Mol & Cellular Microbiol, Salaya, Nakornpathom, Thailand; [Junaid, Muhammad; Torrejon, Anna Sehgelmeble; Shutava, Iryna; Lapins, Maris; Wikberg, Jarl E. S.] Uppsala Univ, Div Pharmacol, Dept Pharmaceut Biosci, Uppsala, Sweden	Mahidol University; Uppsala University	Junaid, M (corresponding author), Mahidol Univ, Inst Mol Biosci, Lab Mol & Cellular Microbiol, Salaya, Nakornpathom, Thailand.	frkgz@mahidol.ac.th		Angsuthanasombat, Chanan/0000-0001-7891-9007; Lapins, Maris/0000-0002-0122-6680	Thailand Research Fund (TRF) [BRG4980008]; Swedish International Cooperation Agency (SIDA); University of Malakand, Pakistan; Department of Pharmaceutical Biosciences, Uppsala University	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Swedish International Cooperation Agency (SIDA); University of Malakand, Pakistan; Department of Pharmaceutical Biosciences, Uppsala University	This work was funded by grant BRG4980008 from the Thailand Research Fund (TRF, www.trf.or.th) to GK and by the Swedish International Cooperation Agency (SIDA, www.sida.se) to both GK and JW. A PhD scholarship from the University of Malakand, Pakistan, to MJ is gratefully acknowledged. IS was supported by a postdoctoral scholarship from the Department of Pharmaceutical Biosciences, Uppsala University, under the Visby programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beasley D, 2006, EXPERT OPINION BIOL, V8, P95; Bessaud M, 2006, VIRUS RES, V120, P79, DOI 10.1016/j.virusres.2006.01.021; Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63; Campbell GL, 2011, B WORLD HEALTH ORGAN, V10, P1; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200; Chappell KJ, 2005, J BIOL CHEM, V280, P2896, DOI 10.1074/jbc.M409931200; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005; Gouvea IE, 2007, ARCH BIOCHEM BIOPHYS, V457, P187, DOI 10.1016/j.abb.2006.11.005; Halstead SBJJ, 2008, VACCINES-BASEL, V5th; Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x; Iempridee T, 2008, BBA-GEN SUBJECTS, V1780, P989, DOI 10.1016/j.bbagen.2008.03.018; JAN LR, 1995, J GEN VIROL, V76, P573, DOI 10.1099/0022-1317-76-3-573; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Joy J, 2010, FEBS LETT, V584, P3149, DOI 10.1016/j.febslet.2010.05.062; Khumthong R, 2002, J BIOCHEM MOL BIOL, V35, P206; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Heng C, 2007, VIRUS RES, V127, P88, DOI 10.1016/j.virusres.2007.03.022; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Lohr K, 2007, J GEN VIROL, V88, P2223, DOI 10.1099/vir.0.82735-0; Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008; Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Ryan MD, 1998, J GEN VIROL, V79, P947, DOI 10.1099/0022-1317-79-5-947; Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374; Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06; Solomon T, 2003, J NEUROVIROL, V9, P274, DOI 10.1080/13550280390194037; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 2008, LANCET NEUROL, V7, P116, DOI 10.1016/S1474-4422(08)70004-8; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Yang TC, 2009, VIRUS RES, V143, P77, DOI 10.1016/j.virusres.2009.03.007; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	48	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36872	10.1371/journal.pone.0036872	http://dx.doi.org/10.1371/journal.pone.0036872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615830	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300044
J	Rios, X; Briggs, AW; Christodoulou, D; Gorham, JM; Seidman, JG; Church, GM				Rios, Xavier; Briggs, Adrian W.; Christodoulou, Danos; Gorham, Josh M.; Seidman, Jonathan G.; Church, George M.			Stable Gene Targeting in Human Cells Using Single-Strand Oligonucleotides with Modified Bases	PLOS ONE			English	Article							DNA OLIGONUCLEOTIDES; MISMATCH-REPAIR; SEQUENCE CORRECTION; STEM-CELLS; GENOME; REPLICATION; PROGRESSION; GENERATION; EFFICIENCY; NUCLEASES	Recent advances allow multiplexed genome engineering in E. coli, employing easily designed oligonucleotides to edit multiple loci simultaneously. A similar technology in human cells would greatly expedite functional genomics, both by enhancing our ability to test how individual variants such as single nucleotide polymorphisms (SNPs) are related to specific phenotypes, and potentially allowing simultaneous mutation of multiple loci. However, oligo-mediated targeting of human cells is currently limited by low targeting efficiencies and low survival of modified cells. Using a HeLa-based EGFP-rescue reporter system we show that use of modified base analogs can increase targeting efficiency, in part by avoiding the mismatch repair machinery. We investigate the effects of oligonucleotide toxicity and find a strong correlation between the number of phosphorothioate bonds and toxicity. Stably EGFP-corrected cells were generated at a frequency of similar to 0.05% with an optimized oligonucleotide design combining modified bases and reduced number of phosphorothioate bonds. We provide evidence from comparative RNA-seq analysis suggesting cellular immunity induced by the oligonucleotides might contribute to the low viability of oligo-corrected cells. Further optimization of this method should allow rapid and scalable genome engineering in human cells.	[Rios, Xavier; Briggs, Adrian W.; Christodoulou, Danos; Gorham, Josh M.; Seidman, Jonathan G.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rios, X (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969	National Institutes of Health-National Human Genome Research Institute [1P50 HG005550]; EMBO Long-Term fellowship [ALTF 91-2010]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health-National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EMBO Long-Term fellowship(European Molecular Biology Organization (EMBO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health-National Human Genome Research Institute [1P50 HG005550]. AWB is supported by an EMBO Long-Term fellowship [ALTF 91-2010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Aarts M, 2009, METHOD MOL BIOL, V530, P1; Aarts M, 2010, NUCLEIC ACIDS RES, V38, P6956, DOI 10.1093/nar/gkq589; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Chandrasekharan S, 2009, NAT BIOTECHNOL, V27, P140, DOI 10.1038/nbt0209-140; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Coscoy L, 2007, CELL, V131, P836, DOI 10.1016/j.cell.2007.11.012; Dekker M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng027; Dekker M, 2011, MUTAT RES-FUND MOL M, V715, P52, DOI 10.1016/j.mrfmmm.2011.07.008; Disterer P, 2009, GENE THER, V16, P824, DOI 10.1038/gt.2009.32; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Efimova E, 2003, CANCER RES, V63, P8768; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119; Fleck O, 1999, NAT GENET, V21, P314, DOI 10.1038/6838; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Liu CL, 2009, OLIGONUCLEOTIDES, V19, P281, DOI 10.1089/oli.2009.0191; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Mardis ER, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-112; Mazurek A, 2009, P NATL ACAD SCI USA, V106, P4177, DOI 10.1073/pnas.0808572106; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302454; Olsen PA, 2009, DNA REPAIR, V8, P298, DOI 10.1016/j.dnarep.2008.11.011; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.084004; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; SOLLU C, 2010, NUCL ACIDS RES; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang HH, NUCL ACIDS RES; Wu XS, 2005, P NATL ACAD SCI USA, V102, P2508, DOI 10.1073/pnas.0406991102; Yin WX, 2005, BIOCHEM BIOPH RES CO, V334, P1032, DOI 10.1016/j.bbrc.2005.06.193; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389	45	25	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36697	10.1371/journal.pone.0036697	http://dx.doi.org/10.1371/journal.pone.0036697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22615794	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400030
J	Jenkinson, G; Goutsias, J				Jenkinson, Garrett; Goutsias, John			Numerical Integration of the Master Equation in Some Models of Stochastic Epidemiology	PLOS ONE			English	Article							MATRIX; KINETICS	The processes by which disease spreads in a population of individuals are inherently stochastic. The master equation has proven to be a useful tool for modeling such processes. Unfortunately, solving the master equation analytically is possible only in limited cases (e.g., when the model is linear), and thus numerical procedures or approximation methods must be employed. Available approximation methods, such as the system size expansion method of van Kampen, may fail to provide reliable solutions, whereas current numerical approaches can induce appreciable computational cost. In this paper, we propose a new numerical technique for solving the master equation. Our method is based on a more informative stochastic process than the population process commonly used in the literature. By exploiting the structure of the master equation governing this process, we develop a novel technique for calculating the exact solution of the master equation - up to a desired precision - in certain models of stochastic epidemiology. We demonstrate the potential of our method by solving the master equation associated with the stochastic SIR epidemic model. MATLAB software that implements the methods discussed in this paper is freely available as Supporting Information S1.	[Jenkinson, Garrett; Goutsias, John] Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Jenkinson, G (corresponding author), Johns Hopkins Univ, Whitaker Biomed Engn Inst, Baltimore, MD 21218 USA.	goutsias@jhu.edu	Goutsias, John/A-3274-2010		DoD High Performance Computing Modernization Program through National Defense Science and Engineering Graduate (NDSEG) [32 CFR 168a]; National Science Foundation (NSF) [CCF-0849907]; Division of Computing and Communication Foundations [0830128] Funding Source: National Science Foundation	DoD High Performance Computing Modernization Program through National Defense Science and Engineering Graduate (NDSEG); National Science Foundation (NSF)(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported in part by the DoD High Performance Computing Modernization Program through the National Defense Science and Engineering Graduate (NDSEG) Fellowship 32 CFR 168a, and in part by the National Science Foundation (NSF) Grant CCF-0849907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, BMJ-BRIT MED J, V1, P587; Black AJ, 2010, J R SOC INTERFACE, V7, P1219, DOI 10.1098/rsif.2009.0514; Chen WY, 2005, J THEOR BIOL, V234, P455, DOI 10.1016/j.jtbi.2004.11.033; CRANK KN, 1988, J APPL PROBAB, V25, P808, DOI 10.2307/3214302; Farago I, 2010, COMPUT MATH APPL, V60, P2309, DOI 10.1016/j.camwa.2010.08.025; Fox GC, 1994, PARALLEL COMPUTING W; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Goutsias J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1889434; Haseltine EL, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2062048; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ, 2009, THEOR POPUL BIOL, V75, P133, DOI 10.1016/j.tpb.2009.01.003; Mayer J, 2009, COMPUTING, V86, P291, DOI 10.1007/s00607-009-0066-3; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; MURRAY JD, 2001, MATH BIOL, V1; Philippe B, 1995, COMPUTATIONS WITH MARKOV CHAINS, P95; Sidje RB, 1998, ACM T MATH SOFTWARE, V24, P130, DOI 10.1145/285861.285868; Sidje RB, 1999, COMPUT STAT DATA AN, V29, P345, DOI 10.1016/S0167-9473(98)00062-0; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Youssef M, 2011, J THEOR BIOL, V283, P136, DOI 10.1016/j.jtbi.2011.05.029	24	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36160	10.1371/journal.pone.0036160	http://dx.doi.org/10.1371/journal.pone.0036160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22615755	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500053
J	Hewett, PC; Haberland, N; Apicella, L; Mensch, BS				Hewett, Paul C.; Haberland, Nicole; Apicella, Lou; Mensch, Barbara S.			The (Mis)Reporting of Male Circumcision Status among Men and Women in Zambia and Swaziland: A Randomized Evaluation of Interview Methods	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; HIV PREVENTION; INFECTION; MODE	Background: To date, male circumcision prevalence has been estimated using surveys of men self-reporting their circumcision status. HIV prevention trials and observational studies involving female participants also collect data on partners' circumcision status as a risk factor for HIV/STIs. A number of studies indicate that reports of circumcision status may be inaccurate. This study assessed different methods for improving self-and partner reporting of circumcision status. Methods/Findings: The study was conducted in urban and rural Zambia and urban Swaziland. Men (N = 1264) aged 18-50 and their female partners (N = 1264), and boys (N = 840) aged 13-17 were enrolled. Participants were recruited from HIV counseling and testing sites, health centers, and surrounding communities. The study experimentally assessed methods for improving the reporting of circumcision status, including: a) a simple description of circumcision, b) a detailed description of circumcision, c) an illustration of a circumcised and uncircumcised penis, and d) computerized self-interviewing. Self-reports were compared to visual examination. For men, the error in reporting was largely unidirectional: uncircumcised men more often reported they were circumcised (2-7%), depending on setting. Fewer circumcised men misrepresented their status (0.05-5%). Misreporting by women was significantly higher (11-15%), with the error in both directions. A sizable number of women reported that they did not know their partner's circumcision status (3-8%). Computerized interviewing did not improve accuracy. Providing an illustration, particularly for illiterate participants, significantly improved reporting of circumcision status, decreasing misreporting among illiterate participants from 13% to 10%, although misreporting was not eliminated. Conclusions: Study results suggest that the prevalence of circumcision may be overestimated in Zambia and Swaziland; the error in reporting is higher among women than among men. Improved reporting when a description or illustration is provided suggests that the source of the error is a lack of understanding of male circumcision.	[Hewett, Paul C.] Populat Council, HIV AIDS Program, Lusaka, Zambia; [Haberland, Nicole; Mensch, Barbara S.] Populat Council, Poverty Gender & Youth Program, New York, NY 10021 USA; [Apicella, Lou] Populat Council, Ctr Biomed Res, New York, NY 10021 USA	Population Council; Population Council	Hewett, PC (corresponding author), Populat Council, HIV AIDS Program, Lusaka, Zambia.	phewett@popcouncil.org			Population Services International (PSI) through the MC; PSI; Bill & Melinda Gates Foundation	Population Services International (PSI) through the MC; PSI; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was conducted under a sub-grant from Population Services International (PSI) through the MC Partnership, which is sponsored by PSI with support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SWAZ DEM HLTH SURV 2; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bollen KA, 1989, STRUCTURAL EQUATIONS; Booth-Kewley S, 2007, COMPUT HUM BEHAV, V23, P463, DOI 10.1016/j.chb.2004.10.020; Brown JE, 2001, SEX TRANSM DIS, V28, P608, DOI 10.1097/00007435-200110000-00007; Buis ML, 2010, STATA J, V10, P305, DOI 10.1177/1536867X1001000211; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Central Statistical Office ( CSO) Ministry of Health ( MOH) University of Zambia MEASURE Evaluation, 2010, ZAMB SEX BEH SURV 20; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Diseker RA, 2001, SEX TRANSM DIS, V28, P330, DOI 10.1097/00007435-200106000-00005; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hewett PC, 2008, AM J EPIDEMIOL, V168, P202, DOI 10.1093/aje/kwn113; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; Lissouba P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-253; Maughan-Brown B, 2011, JAIDS-J ACQ IMM DEF, V58, P499, DOI 10.1097/QAI.0b013e31823584c1; Mensch BS, 2011, AIDS BEHAV, V15, P407, DOI 10.1007/s10461-010-9791-z; Mensch BS, 2008, STUD FAMILY PLANN, V39, P321, DOI 10.1111/j.1728-4465.2008.00178.x; Norton EC, 2004, STATA J, V4, P154, DOI 10.1177/1536867X0400400206; Risser JMH, 2004, AM J EPIDEMIOL, V159, P1095, DOI 10.1093/aje/kwh149; SCHLOSSBERGER NM, 1992, J ADOLESCENT HEALTH, V13, P293, DOI 10.1016/1054-139X(92)90162-5; Thomas A, 2010, 17 C RETR OPP INF SA; Tourangeau R, PSYCHOL SURVEY RESPO; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Weiss HA, 2008, TROP MED INT HEALTH, V13, P1054, DOI 10.1111/j.1365-3156.2008.02107.x; Westercamp M, 2011, AIDS CARE       0822; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Wilkerson JM, 2002, J APPL SOC PSYCHOL, V32, P544, DOI 10.1111/j.1559-1816.2002.tb00229.x; World Health Organization, 2007, NEW DAT MAL CIRC HIV	29	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36251	10.1371/journal.pone.0036251	http://dx.doi.org/10.1371/journal.pone.0036251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VQ	22629312	gold, Green Published			2022-12-27	WOS:000305345300006
J	Liu, F; Guo, J; Bai, PF; Duan, YH; Wang, XD; Cheng, YL; Feng, H; Huang, LL; Kang, ZS				Liu, Furong; Guo, Jun; Bai, Pengfei; Duan, Yinhui; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng			Wheat TaRab7 GTPase Is Part of the Signaling Pathway in Responses to Stripe Rust and Abiotic Stimuli	PLOS ONE			English	Article							PUCCINIA-STRIIFORMIS; COMPATIBLE INTERACTION; GENE-EXPRESSION; RAB7; RECRUITMENT; RESISTANCE; RILP; IDENTIFICATION; INHIBITION; MATURATION	Small GTP-binding proteins function as regulators of specific intercellular fundamental biological processes. In this study, a small GTP-binding protein Rab7 gene, designated as TaRab7, was identified and characterized from a cDNA library of wheat leaves infected with Puccinia striiformis f. sp. tritici (Pst) the wheat stripe rust pathogen. The gene was predicted to encode a protein of 206 amino acids, with a molecular mass of 23.13 KDa and an isoeletric point (pI) of 5.13. Further analysis revealed the presence of a conserved signature that is characteristic of Rab7, and phylogenetic analysis demonstrated that TaRab7 has the highest similarity to a small GTP binding protein gene (BdRab7-like) from Brachypodium distachyon. Quantitative real-time PCR assays revealed that the expression of TaRab7 was higher in the early stage of the incompatible interactions between wheat and Pst than in the compatible interaction, and the transcription level of TaRab7 was also highly induced by environmental stress stimuli. Furthermore, knocking down TaRab7 expression by virus induced gene silencing enhanced the susceptibility of wheat cv. Suwon 11 to an avirulent race CYR23. These results imply that TaRab7 plays an important role in the early stage of wheat-stripe rust fungus interaction and in stress tolerance.	[Liu, Furong; Guo, Jun; Bai, Pengfei; Duan, Yinhui; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liu, Furong; Guo, Jun; Bai, Pengfei; Wang, Xiaodong; Cheng, Yulin; Feng, Hao; Huang, Lili; Kang, Zhensheng] NW A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Duan, Yinhui] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Kang, ZS (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	Kangzs@nwsuaf.edu.cn	Wang, Xiaodong/AAN-2446-2021; Bai, Pengfei/GVU-7318-2022; Wang, Xiaodong/GVS-5446-2022	Bai, Pengfei/0000-0002-2281-2881; Kang, Zhensheng/0000-0001-5575-0122; Wang, Xiaodong/0000-0002-4304-5482	National Natural Science Foundation of China [30930064, 31171795]; earmarked fund for China Agriculture Research System [CARS-3-1-11]; 111 Project from Ministry of Education of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; 111 Project from Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was financially supported by National Natural Science Foundation of China (No. 30930064 and 31171795), the earmarked fund for China Agriculture Research System (No. CARS-3-1-11) and the 111 Project from Ministry of Education of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Cao ZhangJun, 2003, Acta Botanica Boreali-Occidentalia Sinica, V23, P64; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Duan YH, 2011, MOL BIOL REP, V38, P301, DOI 10.1007/s11033-010-0108-0; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Feng H, 2011, MOL BIOL REP, V38, P3857, DOI 10.1007/s11033-010-0501-8; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fujiwara M, 2006, PLANT PHYSIOL, V140, P734, DOI 10.1104/pp.105.068395; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Harrison RE, 2004, MOL BIOL CELL, V15, P3146, DOI 10.1091/mbc.E04-02-0092; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jambunathan N, 2003, PLANT PHYSIOL, V132, P1370, DOI 10.1104/pp.103.022970; Kang Z, 1984, ACTA CLLEGII SEPTENT, V4, P18; Kwon SI, 2009, J PLANT BIOL, V52, P79, DOI 10.1007/s12374-009-9011-4; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Ma JB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-586; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; Nahm MY, 2003, PLANT CELL PHYSIOL, V44, P1341, DOI 10.1093/pcp/pcg163; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pogue G. P., 1998, PLANT MOL BIOL MAN L, P1; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Stakman EC, 1962, US AGR RES SERV AR E, VE617, P1; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wang XJ, 2008, EUR J PLANT PATHOL, V120, P241, DOI 10.1007/s10658-007-9212-y; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	44	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37146	10.1371/journal.pone.0037146	http://dx.doi.org/10.1371/journal.pone.0037146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629358	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345300022
J	van de Lavoir, MC; Collarini, EJ; Leighton, PA; Fesler, J; Lu, DR; Harriman, WD; Thiyagasundaram, TS; Etches, RJ				van de lavoir, Marie-Cecile; Collarini, Ellen J.; Leighton, Philip A.; Fesler, Jeffrey; Lu, Daniel R.; Harriman, William D.; Thiyagasundaram, T. S.; Etches, Robert J.			Interspecific Germline Transmission of Cultured Primordial Germ Cells	PLOS ONE			English	Article							CHICKEN; SEX	In birds, the primordial germ cell (PGC) lineage separates from the soma within 24 h following fertilization. Here we show that the endogenous population of about 200 PGCs from a single chicken embryo can be expanded one million fold in culture. When cultured PGCs are injected into a xenogeneic embryo at an equivalent stage of development, they colonize the testis. At sexual maturity, these donor PGCs undergo spermatogenesis in the xenogeneic host and become functional sperm. Insemination of semen from the xenogeneic host into females from the donor species produces normal offspring from the donor species. In our model system, the donor species is chicken (Gallus domesticus) and the recipient species is guinea fowl (Numida meleagris), a member of a different avian family, suggesting that the mechanisms controlling proliferation of the germline are highly conserved within birds. From a pragmatic perspective, these data are the basis of a novel strategy to produce endangered species of birds using domesticated hosts that are both tractable and fecund.	[van de lavoir, Marie-Cecile; Collarini, Ellen J.; Leighton, Philip A.; Fesler, Jeffrey; Lu, Daniel R.; Harriman, William D.; Etches, Robert J.] Crystal Biosci Inc, Emeryville, CA USA; [Thiyagasundaram, T. S.] Management Nat Conservat, Dept Presidents Affairs, Abu Dhabi, U Arab Emirates		van de Lavoir, MC (corresponding author), Crystal Biosci Inc, Emeryville, CA USA.	lavoir@crystalbioscience.com						BLACKLER AW, 1972, DEV BIOL, V27, P385, DOI 10.1016/0012-1606(72)90177-7; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ishiguro S, 2009, J REPROD DEVELOP, V55, P183, DOI 10.1262/jrd.20107; Kang SJ, 2009, THERIOGENOLOGY, V72, P519, DOI 10.1016/j.theriogenology.2009.04.007; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P308, DOI 10.2141/jpsa.38.308; Liu CH, 2007, ANIM REPROD SCI, V101, P344, DOI 10.1016/j.anireprosci.2006.12.021; Liu CH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094409; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; Oliehoek PA, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-9; Ono Tamao, 1998, Animal Science and Technology, V69, P546; Pardue S, 2002, Methods for gamete production in birds, Patent No. [US 6,354, 242, 6354242]; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; REYNAUD G, 1969, J EMBRYOL EXP MORPH, V21, P485; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; van de Lavoir MC, 2006, METHOD ENZYMOL, V418, P38, DOI 10.1016/S0076-6879(06)18003-9; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wernery U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015824	22	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35664	10.1371/journal.pone.0035664	http://dx.doi.org/10.1371/journal.pone.0035664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629301	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343100002
J	Arikata, M; Itoh, Y; Okamatsu, M; Maeda, T; Shiina, T; Tanaka, K; Suzuki, S; Nakayama, M; Sakoda, Y; Ishigaki, H; Takada, A; Ishida, H; Soda, K; Pham, VL; Tsuchiya, H; Nakamura, S; Torii, R; Shimizu, T; Inoko, H; Ohkubo, I; Kida, H; Ogasawara, K				Arikata, Masahiko; Itoh, Yasushi; Okamatsu, Masatoshi; Maeda, Toshinaga; Shiina, Takashi; Tanaka, Keiko; Suzuki, Shingo; Nakayama, Misako; Sakoda, Yoshihiro; Ishigaki, Hirohito; Takada, Ayato; Ishida, Hideaki; Soda, Kosuke; Van Loi Pham; Tsuchiya, Hideaki; Nakamura, Shinichiro; Torii, Ryuzo; Shimizu, Takeshi; Inoko, Hidetoshi; Ohkubo, Iwao; Kida, Hiroshi; Ogasawara, Kazumasa			Memory Immune Responses against Pandemic (H1N1) 2009 Influenza Virus Induced by a Whole Particle Vaccine in Cynomolgus Monkeys Carrying Mafa-A1*052:02	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; CLASS-I; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; DENDRITIC CELLS; IFN-GAMMA; B-CELLS; INFECTION; MACAQUES; IDENTIFICATION	We made an H1N1 vaccine candidate from a virus library consisting of 144 (= 16 HAx9 NA) non-pathogenic influenza A viruses and examined its protective effects against a pandemic (2009) H1N1 strain using immunologically naive cynomolgus macaques to exclude preexisting immunity and to employ a preclinical study since preexisting immunity in humans previously vaccinated or infected with influenza virus might make comparison of vaccine efficacy difficult. Furthermore, macaques carrying a major histocompatibility complex class I molecule, Mafa-A1*052:02, were used to analyze peptide-specific CD8(+) T cell responses. Sera of macaques immunized with an inactivated whole particle formulation without addition of an adjuvant showed higher neutralization titers against the vaccine strain A/Hokkaido/2/1981 (H1N1) than did sera of macaques immunized with a split formulation. Neutralization activities against the pandemic strain A/Narita/1/2009 (H1N1) in sera of macaques immunized twice with the split vaccine reached levels similar to those in sera of macaques immunized once with the whole particle vaccine. After inoculation with the pandemic virus, the virus was detected in nasal samples of unvaccinated macaques for 6 days after infection and for 2.67 days and 5.33 days on average in macaques vaccinated with the whole particle vaccine and the split vaccine, respectively. After the challenge infection, recall neutralizing antibody responses against the pandemic virus and CD8(+) T cell responses specific for nucleoprotein peptide NP262-270 bound to Mafa-A1*052:02 in macaques vaccinated with the whole particle vaccine were observed more promptly or more vigorously than those in macaques vaccinated with the split vaccine. These findings demonstrated that the vaccine derived from our virus library was effective for pandemic virus infection in macaques and that the whole particle vaccine conferred more effective memory and broader cross-reactive immune responses to macaques against pandemic influenza virus infection than did the split vaccine.	[Arikata, Masahiko; Itoh, Yasushi; Nakayama, Misako; Ishigaki, Hirohito; Ishida, Hideaki; Van Loi Pham; Ogasawara, Kazumasa] Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga 52021, Japan; [Arikata, Masahiko; Shimizu, Takeshi] Shiga Univ Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Otsu, Shiga 52021, Japan; [Maeda, Toshinaga; Ohkubo, Iwao] Shiga Univ Med Sci, Div Mol Med Biochem, Otsu, Shiga 52021, Japan; [Tsuchiya, Hideaki; Nakamura, Shinichiro; Torii, Ryuzo] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan; [Okamatsu, Masatoshi; Sakoda, Yoshihiro; Soda, Kosuke; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Microbiol Lab, Dept Dis Control, Sapporo, Hokkaido, Japan; [Takada, Ayato; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Shiina, Takashi; Tanaka, Keiko; Suzuki, Shingo; Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Hokkaido University; Hokkaido University; Tokai University	Arikata, M (corresponding author), Shiga Univ Med Sci, Div Pathol & Dis Regulat, Dept Pathol, Otsu, Shiga 52021, Japan.	yasushii@belle.shiga-med.ac.jp	Takada, Ayato/A-6679-2012; Ishigaki, Hirohito/AAO-7458-2020; Okamatsu, Masatoshi/F-9124-2012; Kida, Hiroshi/F-7244-2012; Sakoda, Yoshihiro/A-5183-2012	Ishigaki, Hirohito/0000-0002-5249-8598; Shimizu, Takeshi/0000-0002-1344-7210; Itoh, Yasushi/0000-0001-7462-2193; Nakayama, Misako/0000-0001-8611-0662; Suzuki, Shingo/0000-0003-1880-582X; Shiina, Takashi/0000-0002-2067-6708	Regional Research and Development Resources Utilization Program; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan; Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases	Regional Research and Development Resources Utilization Program; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Zoonosis Control, Hokkaido University; Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Regional Research and Development Resources Utilization Program, Japan Science and Technology Agency, the Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan, for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University and the Japan Initiative for Global Research Network on Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WKLY EPIDEMIOL REC; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Herfst S, 2010, VET PATHOL, V47, P1040, DOI 10.1177/0300985810374836; Hofmann S, 2005, MOL CELL PROTEOMICS, V4, P1888, DOI 10.1074/mcp.M500076-MCP200; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Itoh Y, 2008, VACCINE, V26, P562, DOI 10.1016/j.vaccine.2007.11.031; Itoh Y, 2010, VACCINE, V28, P780, DOI 10.1016/j.vaccine.2009.10.067; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kang SM, 2011, J VIROL, V85, P11391, DOI 10.1128/JVI.00080-11; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; KAWANO Y, 1994, J IMMUNOL, V153, P4948; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kida H, 2006, DEV BIOLOGICALS, V124, P69; KIDA H, 1983, ARCH VIROL, V76, P91, DOI 10.1007/BF01311693; Kita YF, 2009, IMMUNOGENETICS, V61, P635, DOI 10.1007/s00251-009-0390-y; Kitano M, 2011, ANTIMICROB AGENTS CH, V55, P4961, DOI 10.1128/AAC.00412-11; Kitano M, 2010, VIROLOGY, V407, P178, DOI 10.1016/j.virol.2010.08.006; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Ohno S, 2006, VIRAL IMMUNOL, V19, P458, DOI 10.1089/vim.2006.19.458; Prieto-Lara E, 2010, VACCINE, V28, P4328, DOI 10.1016/j.vaccine.2010.03.068; Rapin N, 2008, IMMUNOGENETICS, V60, P759, DOI 10.1007/s00251-008-0330-2; Rueda P, 1999, VACCINE, V18, P325, DOI 10.1016/S0264-410X(99)00202-9; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Samad RAA, 2011, JPN J VET RES, V59, P23; Saurwein-Teissl M, 1998, CLIN EXP IMMUNOL, V114, P271; Sawai T, 2008, IMMUNOLOGY, V124, P155, DOI 10.1111/j.1365-2567.2007.02745.x; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Sidney J, 2000, J IMMUNOL, V165, P6387, DOI 10.4049/jimmunol.165.11.6387; Song JM, 2010, VIROLOGY, V405, P165, DOI 10.1016/j.virol.2010.05.034; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; TAKAMIYA Y, 1994, INT IMMUNOL, V6, P255; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Uda A, 2005, IMMUNOGENETICS, V57, P189, DOI 10.1007/s00251-005-0782-6; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Soto-Abraham MV, 2009, NEW ENGL J MED, V361, P2001, DOI 10.1056/NEJMc0907171; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Yoshino N, 2000, EXP ANIM TOKYO, V49, P97, DOI 10.1538/expanim.49.97	54	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37220	10.1371/journal.pone.0037220	http://dx.doi.org/10.1371/journal.pone.0037220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623997	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500077
J	Chen, MJ; Zeng, HM; Qiu, DW; Guo, LH; Yang, XF; Shi, HX; Zhou, TT; Zhao, J				Chen, Mingjia; Zeng, Hongmei; Qiu, Dewen; Guo, Lihua; Yang, Xiufen; Shi, Huaixing; Zhou, Tingting; Zhao, Jing			Purification and Characterization of a Novel Hypersensitive Response-Inducing Elicitor from Magnaporthe oryzae that Triggers Defense Response in Rice	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; PROTEIN ELICITOR; EARLY EVENTS; CELL-DEATH; OXIDATIVE STRESS; INNATE IMMUNITY; BLAST FUNGUS; ARABIDOPSIS; PLANTS	Background: Magnaporthe oryzae, the rice blast fungus, might secrete certain proteins related to plant-fungal pathogen interactions. Methodology/Principal Findings: In this study, we report the purification, characterization, and gene cloning of a novel hypersensitive response-inducing protein elicitor (MoHrip1) secreted by M. oryzae. The protein fraction was purified and identified by de novo sequencing, and the sequence matched the genomic sequence of a putative protein from M. oryzae strain 70-15 (GenBank accession No. XP_366602.1). The elicitor-encoding gene mohrip1 was isolated; it consisted of a 429 bp cDNA, which encodes a polypeptide of 142 amino acids with a molecular weight of 14.322 kDa and a pI of 4.53. The deduced protein, MoHrip1, was expressed in E. coli. And the expression protein collected from bacterium also forms necrotic lesions in tobacco. MoHrip1 could induce the early events of the defense response, including hydrogen peroxide production, callose deposition, and alkalization of the extracellular medium, in tobacco. Moreover, MoHrip1-treated rice seedlings possessed significantly enhanced systemic resistance to M. oryzae compared to the control seedlings. The real-time PCR results indicated that the expression of some pathogenesis-related genes and genes involved in signal transduction could also be induced by MoHrip1. Conclusion/Significance: The results demonstrate that MoHrip1 triggers defense responses in rice and could be used for controlling rice blast disease.	[Chen, Mingjia; Zeng, Hongmei; Qiu, Dewen; Guo, Lihua; Yang, Xiufen; Shi, Huaixing; Zhou, Tingting; Zhao, Jing] Chinses Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Chen, MJ (corresponding author), Chinses Acad Agr Sci, Inst Plant Protect, Minist Agr, Key Lab Integrated Pest Management Crops, Beijing, Peoples R China.	hmzeng@caas.net.cn		Chen, Mingjia/0000-0002-0943-3991	National Basic Research Program of China ("973" Program) [2011CB100700]; National Hi-Tech Research and Development Program of China ("863" Projects) [2011AA10A201]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China ("863" Projects)	This work was supported by a grant from National Basic Research Program of China ("973" Program, 2011CB100700) and the National Hi-Tech Research and Development Program of China ("863" Projects, 2011AA10A201). The URL for both funders is http://www.most.gov.cn/eng/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boka K, 2007, PLANT SIGNAL BEHAV, V2, P498, DOI 10.4161/psb.2.6.4582; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Brault M, 2004, PLANT PHYSIOL, V135, P231, DOI 10.1104/pp.104.039255; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Davis DA, 1998, PHYSIOL MOL PLANT P, V52, P259, DOI 10.1006/pmpp.1998.0150; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; DSilva I, 1997, J BIOL CHEM, V272, P3924, DOI 10.1074/jbc.272.7.3924; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ebel J, 1998, PLANTA, V206, P335, DOI 10.1007/s004250050409; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hwang SH, 2008, PLANTA, V227, P1141, DOI 10.1007/s00425-007-0687-8; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KANOH H, 1993, J PESTIC SCI, V18, P325; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Keller H, 1996, PLANT PHYSIOL, V110, P365, DOI 10.1104/pp.110.2.365; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Koga J, 1998, J BIOL CHEM, V273, P31985, DOI 10.1074/jbc.273.48.31985; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liu JL, 2010, MOL PLANT PATHOL, V11, P419, DOI [10.1111/J.1364-3703.2009.00607.X, 10.1111/j.1364-3703.2009.00607.x]; Mao J, 2010, ANN APPL BIOL, V156, P411, DOI 10.1111/j.1744-7348.2010.00398.x; Mishra AK, 2009, MICROBIOL RES, V164, P688, DOI 10.1016/j.micres.2008.09.001; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Nurnberger T, 1999, CELL MOL LIFE SCI, V55, P167, DOI 10.1007/s000180050283; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; Osman H, 2001, FEBS LETT, V489, P55, DOI 10.1016/S0014-5793(01)02078-6; Panstruga R, 2009, CELL, V136, P978, DOI 10.1016/j.cell.2009.02.020; Peng DH, 2011, MOL PLANT MICROBE IN, V24, P1239, DOI 10.1094/MPMI-01-11-0003; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pugin A, 1997, PLANT CELL, V9, P2077, DOI 10.1105/tpc.9.11.2077; Qiu DW, 2009, PLANT CELL REP, V28, P925, DOI 10.1007/s00299-009-0698-y; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Repka V, 2006, BIOL PLANTARUM, V50, P94, DOI 10.1007/s10535-005-0080-z; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sauerborn J, 2002, PHYTOPATHOLOGY, V92, P59, DOI 10.1094/PHYTO.2002.92.1.59; SCHAFFRATH U, 1995, PHYSIOL MOL PLANT P, V46, P293, DOI 10.1006/pmpp.1995.1023; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Stuiver MH, 2001, NATURE, V411, P865, DOI 10.1038/35081200; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Wang BN, 2012, APPL MICROBIOL BIOT, V93, P191, DOI 10.1007/s00253-011-3405-1; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xie XZ, 2011, MOL PLANT, V4, P688, DOI 10.1093/mp/ssr005; Yano A, 1998, MOL PLANT MICROBE IN, V11, P115, DOI 10.1094/MPMI.1998.11.2.115; Zhang W, 2011, MOL BIOL REP, V38, P2549, DOI 10.1007/s11033-010-0393-7; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003	71	51	59	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37654	10.1371/journal.pone.0037654	http://dx.doi.org/10.1371/journal.pone.0037654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624059	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500148
J	Friar, JL; Goldman, T; Perez-Mercader, J				Friar, James L.; Goldman, Terrance; Perez-Mercader, Juan			Genome Sizes and the Benford Distribution	PLOS ONE			English	Article							PROTEOMES; EVOLUTION; ORIGINS; LIFE; DNA	Background: Data on the number of Open Reading Frames (ORFs) coded by genomes from the 3 domains of Life show the presence of some notable general features. These include essential differences between the Prokaryotes and Eukaryotes, with the number of ORFs growing linearly with total genome size for the former, but only logarithmically for the latter. Results: Simply by assuming that the (protein) coding and non-coding fractions of the genome must have different dynamics and that the non-coding fraction must be particularly versatile and therefore be controlled by a variety of (unspecified) probability distribution functions (pdf's), we are able to predict that the number of ORFs for Eukaryotes follows a Benford distribution and must therefore have a specific logarithmic form. Using the data for the 1000+ genomes available to us in early 2010, we find that the Benford distribution provides excellent fits to the data over several orders of magnitude. Conclusions: In its linear regime the Benford distribution produces excellent fits to the Prokaryote data, while the full non-linear form of the distribution similarly provides an excellent fit to the Eukaryote data. Furthermore, in their region of overlap the salient features are statistically congruent. This allows us to interpret the difference between Prokaryotes and Eukaryotes as the manifestation of the increased demand in the biological functions required for the larger Eukaryotes, to estimate some minimal genome sizes, and to predict a maximal Prokaryote genome size on the order of 8-12 megabasepairs. These results naturally allow a mathematical interpretation in terms of maximal entropy and, therefore, most efficient information transmission.	[Friar, James L.; Goldman, Terrance] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Perez-Mercader, Juan] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Perez-Mercader, Juan] Santa Fe Inst, Santa Fe, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University; The Santa Fe Institute	Friar, JL (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	jperezmercader@fas.harvard.edu			National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; everis Foundation; Repsol S. A.	National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory; everis Foundation; Repsol S. A.	This work was carried out in part under the auspices of the National Nuclear Security Administration of the United States Department of Energy at Los Alamos National Laboratory under Contract No. DE-AC52-06NA25396. JP-M would like to thank the everis Foundation and Repsol S. A. for support, and the Theoretical Division of Los Alamos National Laboratory for its hospitality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2008, J THEOR BIOL, V252, P587, DOI 10.1016/j.jtbi.2008.02.005; Alberts B, 2008, MOL BIOL CELL; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Berger A, 2011, MATH INTELL, V33, P85, DOI 10.1007/s00283-010-9182-3; Brown TA, 2007, GENOMES; Cover T. M., 1991, ELEMENTS INFORM THEO; Davidson EH, 2006, REG GEN GEN REG; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goldenfeld N, 2011, ANNU REV CONDEN MA P, V2, P375, DOI 10.1146/annurev-conmatphys-062910-140509; Hamming R. W., 1973, NUMERICAL METHODS SC; HAMMING RW, 1970, AT&T TECH J, V49, P1609, DOI 10.1002/j.1538-7305.1970.tb04281.x; Hartl DL, 2012, GENETICS ANAL GENES; Hill TP, 1995, STAT SCI, V10, P354, DOI 10.1214/ss/1177009869; HILL TP, 1995, P AM MATH SOC, V123, P887, DOI 10.2307/2160815; Losich R., 2008, MOL BIOL GENE; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; McCoy MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006456; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Peterson SN, 2001, GENOME BIOL, V2; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Phillips R., 2008, PHYS BIOL CELL; PINKHAM RS, 1961, ANN MATH STAT, V32, P1223, DOI 10.1214/aoms/1177704862; Renyi A, 1991, FDN PROBABILITY; Shannon C.E., 1948, BELL SYSTEM TECHNICA, V27; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Wang ML, 2011, P NATL ACAD SCI USA, V108, P11954, DOI 10.1073/pnas.1017361108; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Yockey H.P., 2005, INFORM THEORY EVOLUT	35	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36624	10.1371/journal.pone.0036624	http://dx.doi.org/10.1371/journal.pone.0036624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629319	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500021
J	Mieloo, C; Raat, H; van Oort, F; Bevaart, F; Vogel, I; Donker, M; Jansen, W				Mieloo, Cathelijne; Raat, Hein; van Oort, Floor; Bevaart, Floor; Vogel, Ineke; Donker, Marianne; Jansen, Wilma			Validity and Reliability of the Strengths and Difficulties Questionnaire in 5-6 Year Olds: Differences by Gender or by Parental Education?	PLOS ONE			English	Article							CHILD-BEHAVIOR-CHECKLIST; COMMUNITY SAMPLE; SDQ; ADOLESCENTS; HEALTH	Introduction: The Strengths and Difficulties Questionnaire (SDQ) is a relatively short instrument developed to detect psychosocial problems in children aged 3-16 years. It addresses four dimensions: emotional problems, conduct problems, hyperactivity/inattention problems, peer problems that count up to the total difficulties score, and a fifth dimension; prosocial behaviour. The validity and reliability of the SDQ has not been fully investigated in younger age groups. Therefore, this study assesses the validity and reliability of the parent and teacher versions of the SDQ in children aged 5-6 years in the total sample, and in subgroups according to child gender and parental education level. Methods: The SDQ was administered as part of the Dutch regularly provided preventive health check for children aged 5-6 years. Parents provided information on 4750 children and teachers on 4516 children. Results: Factor analyses of the parent and teacher SDQ confirmed that the original five scales were present (parent RMSEA = 0.05; teacher RMSEA = 0.07). Interrater correlations between parents and teachers were small (ICCs of 0.21-0.44) but comparable to what is generally found for psychosocial problem assessments in children. These correlations were larger for males than for females. Cronbach's alphas for the total difficulties score were 0.77 for the parent SDQ and 0.81 for the teacher SDQ. Four of the subscales on the parent SDQ and two of the subscales on the teacher SDQ had an alpha <0.70. Alphas were generally higher for male children and for low parental education level. Discussion: The validity and reliability of the total difficulties score of the parent and teacher SDQ are satisfactory in all groups by informant, child gender, and parental education level. Our results support the use of the SDQ in younger age groups. However, some subscales are less reliable and we recommend only to use the total difficulties score for screening purposes.	[Mieloo, Cathelijne; Jansen, Wilma] Rotterdam Municipal Hlth Serv GGD Rotterdam Rijnm, Dept Youth Policy, Rotterdam, Netherlands; [Mieloo, Cathelijne; Raat, Hein; Vogel, Ineke; Donker, Marianne; Jansen, Wilma] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [van Oort, Floor; Bevaart, Floor] Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mieloo, C (corresponding author), Rotterdam Municipal Hlth Serv GGD Rotterdam Rijnm, Dept Youth Policy, Rotterdam, Netherlands.	c.mieloo@erasmusmc.nl	Jansen, Wilma/ABD-5066-2020; van Oort, Floor/G-2811-2013	Jansen, Wilma/0000-0002-4453-9054; 	Dutch Organization for Health Research and Care Innovation [ZonMW: 80-82435-98-8026]	Dutch Organization for Health Research and Care Innovation	This study was granted by the Dutch Organization for Health Research and Care Innovation (ZonMW: 80-82435-98-8026, www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; CBS, 2011, BEGR AUT; Corey DM, 1998, J GEN PSYCHOL, V125, P245, DOI 10.1080/00221309809595548; Du Yasong, 2008, Child Adolesc Psychiatry Ment Health, V2, P8, DOI 10.1186/1753-2000-2-8; Edmunds S, 2005, CHILD CARE HLTH DEV, V31, P143, DOI 10.1111/j.1365-2214.2004.00461.x; Field A. P, 2005, ENCY STAT BEHAV SCI, DOI DOI 10.1002/0470013192.BSA313; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Glanz S, 1992, PRIMER BIOSTATISTICS; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Goodman R, 2007, SOC PSYCH PSYCH EPID, V42, P322, DOI 10.1007/s00127-007-0169-0; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; Janssens A, 2009, EUR CHILD ADOLES PSY, V18, P691, DOI 10.1007/s00787-009-0030-y; Jû┬reskog KG., 1993, LISREL 8 USERS REFER; Kaplan D., 2009, STRUCTURAL EQUATION, V2; Klasen H, 2000, EUR CHILD ADOLES PSY, V9, P271, DOI 10.1007/s007870070030; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Koskelainen M, 2000, EUR CHILD ADOLES PSY, V9, P277, DOI 10.1007/s007870070031; Licence K, 2004, CHILD CARE HLTH DEV, V30, P623, DOI 10.1111/j.1365-2214.2004.00473.x; Marzocchi GM, 2004, EUR CHILD ADOLES PSY, V13, P40, DOI 10.1007/s00787-004-2007-1; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Muthen B., 2010, MPLUS USERS GUIDE; Nunnally J. C, 1994, PSYCHOMETRIC THEORY, V3rd; Perren S, 2007, EUR CHILD ADOLES PSY, V16, P209, DOI 10.1007/s00787-006-0588-6; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Streiner DL., 2001, HLTH MEASUREMENT SCA, V2nd; Van Leeuwen K, 2006, EUR J PSYCHOL ASSESS, V22, P189, DOI 10.1027/1015-5759.22.3.189; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Verhulst FC, 2005, ONTWIKKELING KIND	32	99	100	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36805	10.1371/journal.pone.0036805	http://dx.doi.org/10.1371/journal.pone.0036805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22629332	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500027
J	Mirza, M; Pang, MF; Zaini, MA; Haiko, P; Tammela, T; Alitalo, K; Philipson, L; Fuxe, J; Sollerbrant, K				Mirza, Momina; Pang, Mei-Fong; Zaini, Mohamad Amr; Haiko, Paula; Tammela, Tuomas; Alitalo, Kari; Philipson, Lennart; Fuxe, Jonas; Sollerbrant, Kerstin			Essential Role of the Coxsackie - and Adenovirus Receptor (CAR) in Development of the Lymphatic System in Mice	PLOS ONE			English	Article							EPITHELIAL TIGHT JUNCTIONS; ENDOTHELIAL-CELLS; VESSELS; FAMILY; DISEASE; LYMPHANGIOGENESIS; VASCULATURE; MATURATION; PLATELETS; ADHESION	The coxsackie- and adenovirus receptor (CAR) is a cell adhesion molecule predominantly associated with epithelial tight junctions in adult tissues. CAR is also expressed in cardiomyocytes and essential for heart development up to embryonic day 11.5, but not thereafter. CAR is not expressed in vascular endothelial cells but was recently detected in neonatal lymphatic vessels, suggesting that CAR could play a role in the development of the lymphatic system. To address this, we generated mice carrying a conditional deletion of the CAR gene (Cxadr) and knocked out CAR in the mouse embryo at different time points during post-cardiac development. Deletion of Cxadr from E12.5, but not from E13.5, resulted in subcutaneous edema, hemorrhage and embryonic death. Subcutaneous lymphatic vessels were dilated and structurally abnormal with gaps and holes present at lymphatic endothelial cell-cell junctions. Furthermore, lymphatic vessels were filled with erythrocytes showing a defect in the separation between the blood and lymphatic systems. Regionally, erythrocytes leaked out into the interstitium from leaky lymphatic vessels explaining the hemorrhage detected in CAR-deficient mouse embryos. The results show that CAR plays an essential role in development of the lymphatic vasculature in the mouse embryo by promoting appropriate formation of lymphatic endothelial cell-cell junctions.	[Mirza, Momina; Zaini, Mohamad Amr; Sollerbrant, Kerstin] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Mirza, Momina; Zaini, Mohamad Amr; Sollerbrant, Kerstin] Univ Hosp, Stockholm, Sweden; [Pang, Mei-Fong; Fuxe, Jonas] Karolinska Inst, Dept Med Biochem & Biophys, Vasc Biol Unit, Stockholm, Sweden; [Haiko, Paula; Tammela, Tuomas; Alitalo, Kari] Univ Helsinki, Mol Canc Biol Lab, Helsinki, Finland; [Philipson, Lennart] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Helsinki; Karolinska Institutet	Mirza, M (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	kerstin.sollerbrant@ki.se	Fuxe, Jonas/T-4433-2017; Pang, Mei-Fong/F-9162-2010; Alitalo, Kari K/J-5013-2014	Fuxe, Jonas/0000-0003-4576-9377; Alitalo, Kari K/0000-0002-7331-0902; /0000-0003-3675-6961; Pang, Mei Fong/0000-0002-3030-1272	Swedish Cancer Society; Samaritstiftelsen; Swedish Research Council; Swedish Childhood Cancer Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Samaritstiftelsen; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Karolinska Institutet(Karolinska Institutet)	KS was supported by grants from the Swedish Cancer Society and Samaritstiftelsen (to MM); JF was supported by the Swedish Research Council, the Swedish Childhood Cancer Foundation, the Karolinska Institutet and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bertozzi CC, 2010, ARTERIOSCL THROM VAS, V30, P2368, DOI 10.1161/ATVBAHA.110.217281; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hirata K, 2001, J BIOL CHEM, V276, P16223, DOI 10.1074/jbc.M100630200; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Othman M, 2007, BLOOD, V109, P2832, DOI 10.1182/blood-2006-06-032524; Pazirandeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020203; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Philipson L, 2004, CURR TOP MICROBIOL, V273, P87; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; Vigl B, 2009, EXP CELL RES, V315, P336, DOI 10.1016/j.yexcr.2008.10.020; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910	27	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37523	10.1371/journal.pone.0037523	http://dx.doi.org/10.1371/journal.pone.0037523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624044	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500131
J	Papura, D; Burban, C; van Helden, M; Giresse, X; Nusillard, B; Guillemaud, T; Kerdelhue, C				Papura, Daciana; Burban, Christian; van Helden, Maarten; Giresse, Xavier; Nusillard, Benoit; Guillemaud, Thomas; Kerdelhue, Carole			Microsatellite and Mitochondrial Data Provide Evidence for a Single Major Introduction for the Neartic Leafhopper Scaphoideus titanus in Europe	PLOS ONE			English	Article							FLAVESCENCE DOREE PHYTOPLASMA; GENETIC-VARIATION; GRAPEVINE YELLOWS; F-STATISTICS; NULL ALLELES; DIFFERENTIATION; INVASION; VECTOR; CICADELLIDAE; CONSEQUENCES	Scaphoideus titanus, a leafhopper native to North America and invasive in Europe, is the vector of the Flavescence doree phytoplasma, the causal agent of the most important form of grapevine yellows in European vineyards. We studied 10 polymorphic microsatellite loci and a 623 bp fragment of the mitochondrial cytochrome oxidase II gene in native S. titanus from north-eastern America and introduced European populations, to elucidate the colonization scenario. Consistent with their recent history, invasive European populations were less genetically diverse than American populations for both types of markers, suggesting a recent bottleneck. Significant isolation by distance was detected between American populations but not between European populations. None of the European mitochondrial haplotypes was found in the American vineyards, from which they are assumed to have originated. The precise source of the invasive S. titanus populations therefore remains unclear. Nevertheless, the high heterozygosity of North-East American populations (which contained 92% of the observed alleles) suggests that this region is part of the native range of S. titanus. Clustering population genetics analyses with microsatellite and mitochondrial data suggested that European populations originated from a single introduction event. Most of the introduced populations clustered with populations from Long Island, the Atlantic Coast winegrowing region in which Vitis aestivalis occurs.	[Papura, Daciana; van Helden, Maarten; Giresse, Xavier] Univ Bordeaux, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France; [Papura, Daciana; Giresse, Xavier] INRA, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France; [Burban, Christian; Kerdelhue, Carole] INRA Bordeaux, UMR BIOGECO 1202, Cestas, France; [Nusillard, Benoit] Irstea, UR EFNO, F-45290 Nogent Sur Vernisson, France; [Guillemaud, Thomas] INRA UNSA CNRS, UMR IBSV 1301, F-06903 Sophia Antipolis, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE; INRAE; INRAE; INRAE	Papura, D (corresponding author), Univ Bordeaux, ISVV, UMR SAVE 1065, F-33140 Villenave Dornon, France.	dpapura@bordeaux.inra.fr	Kerdelhue, Carole/GVS-0309-2022; guillemaud, thomas/B-4899-2012	guillemaud, thomas/0000-0003-0451-1644; Papura, Daciana/0000-0002-1147-9200; Kerdelhue, Carole/0000-0001-7667-902X	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This research was funded by the Institut National de la Recherche Agronomique http://www.inra.fr/. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No permission was required to collect the samples.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; Angelini E, 2004, EUR J PLANT PATHOL, V110, P193, DOI 10.1023/B:EJPP.0000015361.95661.37; Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4001, DOI 10.1128/AEM.02323-06; Avise J, 2004, MOL MARKERS NATURAL; Avise J.C., 2000, HIST FORMATION SPECI; Baggiolini M., 1968, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V40, P270; BALL E. D., 1932, JOUR WASHINGTON ACAD SCI, V22, P9; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Barnett DE, 1977, T AM ENTOMOL SOC, V102, P485; Batlle A, 1997, VITIS, V36, P211; Beanland L, 2006, ENVIRON ENTOMOL, V35, P332, DOI 10.1603/0046-225X-35.2.332; Beaumont MA, 2002, GENETICS, V162, P2025; Beirne B. P., 1956, MEM ENTOMOL SOC CAN, V88, P5; Bertin S, 2007, GENETICA, V131, P275, DOI 10.1007/s10709-006-9137-y; BONFILS J., 1960, Annales des Epiphyties, V11, P325; Boudon-Padieu E, 2002, ATTI GIORN FITOPATOL, V1, P15; Boudon-Padieu Elisabeth, 1996, Comptes Rendus de l'Academie d'Agriculture de France, V82, P5; Burban C, 1999, MOL ECOL, V8, P1593, DOI 10.1046/j.1365-294x.1999.00739.x; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; CAUDWELL A, 1983, AGRONOMIE, V3, P103, DOI 10.1051/agro:19830201; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clerc L., 1997, Revue Suisse de Viticulture, d'Arboriculture et d'Horticulture, V29, P245; Cornuet JM, 1996, GENETICS, V144, P2001; DeLong D. M., 1939, Proceedings of the Entomological Society of Washington, V41, P33; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Der Z, 2007, B INSECTOL, V60, P199; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2004, EVOLUTION, V58, P2021, DOI 10.1111/j.0014-3820.2004.tb00487.x; Estoup A, 2003, MOL ECOL, V12, P657, DOI 10.1046/j.1365-294X.2003.01761.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1996, GENETICS, V144, P1933; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; Hill GT, 2000, PLANT DIS, V84, P134, DOI 10.1094/PDIS.2000.84.2.134; Krnjajic S, 2007, B INSECTOL, V60, P197; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lessio F, 2006, J ECON ENTOMOL, V99, P578, DOI 10.1603/0022-0493-99.2.578; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAIXNER M, 1993, PLANT DIS, V77, P408, DOI 10.1094/PD-77-0408; Maixner M., 2005, BCPC Symposium Proceedings, V81, P141; Malembic-Maher S, 2007, B INSECTOL, V60, P329; Metcalf ZP, 1967, GEN CATALOGUE HOMOPT, P2129; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Moran NA, 2003, ENVIRON MICROBIOL, V5, P116, DOI 10.1046/j.1462-2920.2003.00391.x; NEI M, 1978, GENETICS, V89, P583; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Olivier CY, 2009, CAN ENTOMOL, V141, P425, DOI 10.4039/n08-CPA02; Ordish G., 1972, GREAT WINE BLIGHT; Osler R., 2002, Informatore Agrario, V58, P61; Papura D, 2006, MOL ECOL NOTES, V6, P1114, DOI 10.1111/j.1471-8286.2006.01454.x; Papura D, 2009, INFECT GENET EVOL, V9, P867, DOI 10.1016/j.meegid.2009.05.009; Pavan F., 1997, Informatore Agrario, V53, P73; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pons O, 1996, GENETICS, V144, P1237; Pouget R, 1990, HIST LUTTE PYLLOXERA; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Quartau J.A., 2001, IOBC-WPRS Bulletin, V24, P273; R Development Core Team, 2008, LANG ENV STAT COMP; Randi E, 1998, HEREDITY, V80, P429, DOI 10.1038/sj.hdy.6883180; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rousset F, 1997, GENETICS, V145, P1219; Russell JR, 1997, THEOR APPL GENET, V95, P714, DOI 10.1007/s001220050617; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schvester D, 1962, REV ZOOL AGR APPL, V91, P118; Seljak G, 2008, B INSECTOL, V61, P201; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Steffek R, 2006, EPPO B, V37, P191; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; VIDANO C., 1964, Italia Agricola, V101, P1031; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Zahniser JN, 2008, SYST BIODIVERS, V6, P1, DOI 10.1017/S1477200007002617	83	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36882	10.1371/journal.pone.0036882	http://dx.doi.org/10.1371/journal.pone.0036882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629338	Green Published, gold			2022-12-27	WOS:000305343500033
J	Vogelsang, M; Wang, YB; Veber, N; Mwapagha, LM; Parker, MI				Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal			The Cumulative Effects of Polymorphisms in the DNA Mismatch Repair Genes and Tobacco Smoking in Oesophageal Cancer Risk	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALLELE-SPECIFIC PCR; MICROSATELLITE INSTABILITY; LUNG-CANCER; HAPLOTYPE RECONSTRUCTION; PROTEIN FUNCTION; SOUTH-AFRICA; HUMAN GENOME; ADENOCARCINOMA; SUSCEPTIBILITY	The DNA mismatch repair (MMR) enzymes repair errors in DNA that occur during normal DNA metabolism or are induced by certain cancer-contributing exposures. We assessed the association between 10 single-nucleotide polymorphisms (SNPs) in 5 MMR genes and oesophageal cancer risk in South Africans. Prior to genotyping, SNPs were selected from the HapMap database, based on their significantly different genotypic distributions between European ancestry populations and four HapMap populations of African origin. In the Mixed Ancestry group, the MSH3 rs26279 G/G versus A/A or A/G genotype was positively associated with cancer (OR = 2.71; 95% CI: 1.34-5.50). Similar associations were observed for PMS1 rs5742938 (GG versus AA or AG: OR = 1.73; 95% CI: 1.07-2.79) and MLH3 rs28756991 (AA or GA versus GG: OR = 2.07; 95% IC: 1.04-4.12). In Black individuals, however, no association between MMR polymorhisms and cancer risk was observed in individual SNP analysis. The interactions between MMR genes were evaluated using the model-based multifactor-dimensionality reduction approach, which showed a significant genetic interaction between SNPs in MSH2, MSH3 and PMS1 genes in Black and Mixed Ancestry subjects, respectively. The data also implies that pathogenesis of common polymorphisms in MMR genes is influenced by exposure to tobacco smoke. In conclusion, our findings suggest that common polymorphisms in MMR genes and/or their combined effects might be involved in the aetiology of oesophageal cancer.	[Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Int Ctr Genet Engn & Biotechnol, Cape Town Component, South Africa; [Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Vogelsang, Matjaz; Wang, Yabing; Veber, Nika; Mwapagha, Lamech M.; Parker, M. Iqbal] Univ Cape Town, IIDMM, ZA-7925 Cape Town, South Africa; [Vogelsang, Matjaz] Natl Inst Chem, Dept Biosynth & Biotransformat, Ljubljana, Slovenia	University of Cape Town; University of Cape Town; National Institute of Chemistry - Slovenia	Vogelsang, M (corresponding author), Int Ctr Genet Engn & Biotechnol, Cape Town Component, South Africa.	iqbal.parker@uct.ac.za		Mwapagha, Lamech/0000-0003-1048-1787	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African MRC; University of Cape Town; ICGEB postdoctoral fellowship	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; International Centre for Genetic Engineering and Biotechnology (ICGEB); South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town; ICGEB postdoctoral fellowship	This work was supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation, the International Centre for Genetic Engineering and Biotechnology (ICGEB), the South African MRC and the University of Cape Town. MV is a recipient of an ICGEB postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; Calle ML, 2008, STAT MED, V27, P6532, DOI 10.1002/sim.3431; Cheung WY, 2009, GASTROENTEROL CLIN N, V38, P75, DOI 10.1016/j.gtc.2009.01.009; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Dandara C, 2006, CARCINOGENESIS, V27, P791, DOI 10.1093/carcin/bgi257; Dodd LE, 2006, CANCER EPIDEM BIOMAR, V15, P2216, DOI 10.1158/1055-9965.EPI-06-0455; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; Evans SC, 2004, CANCER LETT, V212, P241, DOI 10.1016/j.canlet.2004.03.011; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman W, QUANTO 1 1 COMPUTER; Germer Soren, 2003, Methods Mol Biol, V212, P197; Gleeson CM, 1996, CANCER RES, V56, P259; Hendricks D, 2002, IUBMB LIFE, V53, P263, DOI 10.1080/15216540212643; Hirao T, 2001, CANCER RES, V61, P612; Hirata H, 2008, J UROLOGY, V179, P2020, DOI 10.1016/j.juro.2008.01.009; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Ikeguchi M, 1999, ONCOLOGY-BASEL, V56, P164, DOI 10.1159/000011959; Jin ZH, 2006, J BIOL CHEM, V281, P14446, DOI 10.1074/jbc.M511914200; JORQUERA R, 1994, CARCINOGENESIS, V15, P389, DOI 10.1093/carcin/15.2.389; Kagawa Y, 2000, ANTICANCER RES, V20, P213; Kulke MH, 2001, CANCER-AM CANCER SOC, V91, P1451, DOI 10.1002/1097-0142(20010415)91:8<1451::AID-CNCR1152>3.0.CO;2-Z; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Layke JC, 2006, AM FAM PHYSICIAN, V73, P2187; Li DP, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-47, 10.1186/1471-2164-11-446]; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Liu CY, 2010, CARCINOGENESIS, V31, P1259, DOI 10.1093/carcin/bgq092; Lo YL, 2011, LUNG CANCER, V72, P280, DOI 10.1016/j.lungcan.2010.10.009; Lukanich Jeanne M, 2003, Semin Thorac Cardiovasc Surg, V15, P158; Calle ML, 2010, BIOINFORMATICS, V26, P2198, DOI 10.1093/bioinformatics/btq352; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MELTZER SJ, 1994, CANCER RES, V54, P3379; Michiels S, 2007, CARCINOGENESIS, V28, P1731, DOI 10.1093/carcin/bgm111; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Muzeau F, 1997, BRIT J CANCER, V75, P1336, DOI 10.1038/bjc.1997.226; Naidoo R, 2005, J CLIN PATHOL, V58, P281, DOI 10.1136/jcp.2003.014290; NAKASHIMA H, 1995, INT J CANCER, V64, P286, DOI 10.1002/ijc.2910640413; National Health Laboratory Service National Cancer Registry of South Africa, 2004, INC HIST DIAGN CANC; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OGASAWARA S, 1995, CANCER RES, V55, P891; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Dutra LA, 2008, ARQ BRAS ENDOCRINOL, V52, P1362, DOI 10.1590/S0004-27302008000800026; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Uchida N, 2001, INT J CANCER, V91, P687, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1106>3.3.CO;2-D; Uehara H, 2005, J SURG ONCOL, V92, P109, DOI 10.1002/jso.20332; Wang L, 1996, ONCOGENE, V12, P699; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wangkumhang P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-275; Wei QY, 1998, CANCER EPIDEM BIOMAR, V7, P309; Yanagi M, 2000, VIRCHOWS ARCH, V437, P605, DOI 10.1007/s004280000322; Yang Chun-xia, 2005, Asian Pac J Cancer Prev, V6, P48	63	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36962	10.1371/journal.pone.0036962	http://dx.doi.org/10.1371/journal.pone.0036962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623965	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500042
J	Alvarado, VY; Odokonyero, D; Duncan, O; Mirkov, TE; Scholthof, HB				Alvarado, Veria Y.; Odokonyero, Denis; Duncan, Olivia; Mirkov, T. Erik; Scholthof, Herman B.			Molecular and Physiological Properties Associated with Zebra Complex Disease in Potatoes and Its Relation with Candidatus Liberibacter Contents in Psyllid Vectors	PLOS ONE			English	Article							POLYPHENOL OXIDASE; DIFFERENTIAL EXPRESSION; BACTERICERA-COCKERELLI; SOLANUM-TUBEROSUM; CHIP; TRANSMISSION; SOLANACEARUM; PLANT; ENDOSYMBIONTS; TRANSCRIPTION	Zebra complex (ZC) disease on potatoes is associated with Candidatus Liberibacter solanacearum (CLs), an alpha-proteobacterium that resides in the plant phloem and is transmitted by the potato psyllid Bactericera cockerelli (Sulc). The name ZC originates from the brown striping in fried chips of infected tubers, but the whole plants also exhibit a variety of morphological features and symptoms for which the physiological or molecular basis are not understood. We determined that compared to healthy plants, stems of ZC-plants accumulate starch and more than three-fold total protein, including gene expression regulatory factors (e. g. cyclophilin) and tuber storage proteins (e. g., patatins), indicating that ZC-affected stems are reprogrammed to exhibit tuber-like physiological properties. Furthermore, the total phenolic content in ZC potato stems was elevated two-fold, and amounts of polyphenol oxidase enzyme were also high, both serving to explain the ZC-hallmark rapid brown discoloration of air-exposed damaged tissue. Newly developed quantitative and/or conventional PCR demonstrated that the percentage of psyllids in laboratory colonies containing detectable levels of CLs and its titer could fluctuate over time with effects on colony prolificacy, but presumed reproduction-associated primary endosymbiont levels remained stable. Potato plants exposed in the laboratory to psyllid populations with relatively low-CLs content survived while exposure of plants to high-CLs psyllids rapidly culminated in a lethal collapse. In conclusion, we identified plant physiological biomarkers associated with the presence of ZC and/or CLs in the vegetative potato plant tissue and determined that the titer of CLs in the psyllid population directly affects the rate of disease development in plants.	[Alvarado, Veria Y.; Odokonyero, Denis; Duncan, Olivia; Mirkov, T. Erik; Scholthof, Herman B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Mirkov, T. Erik] Texas A&M Syst, Texas AgriLife Res, Weslaco, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Alvarado, VY (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	valvarado@tamu.edu			Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program	Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program	Texas Department of Agriculture through The Texas Agrilife Research Zebra Chip Disease Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado VY, 2010, P 10 ANN ZEBR CHIP R, P24; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Binkley AM, 1929, SCIENCE, V70, P615, DOI 10.1126/science.70.1825.615; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CNAS, 2006, EC IMP ZEBR CHIP TEX; Crosslin JM, 2010, HIST MAKING POTATO Z; Czaninski Y, 1974, ELECT MICROSCOPY ENZ, P66; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Freire MA, 2005, GENE, V345, P271, DOI 10.1016/j.gene.2004.11.030; Goolsby J, 2010, 10 ANN ZEBR CHIP REP, P1; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HANNAPEL DJ, 1990, PLANT PHYSIOL, V94, P919, DOI 10.1104/pp.94.3.919; HANNAPEL DJ, 1985, PLANT PHYSIOL, V78, P700, DOI 10.1104/pp.78.4.700; Kaur S, 2004, DIS MANAG FRUITS VEG, V1, P233; Kielbowicz-Matuk A, 2007, PHYSIOL PLANTARUM, V131, P387, DOI 10.1111/j.1399-3054.2007.00968.x; Levy J, 2011, PHYTOPATHOLOGY, V101, P1285, DOI 10.1094/PHYTO-04-11-0121; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Li WB, 2009, J MICROBIOL METH, V78, P59, DOI 10.1016/j.mimet.2009.04.009; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; MARQUES L, 1994, PHYTOCHEMISTRY, V36, P1117, DOI 10.1016/S0031-9422(00)89623-5; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE., 2008, SUBPLANT SCI, V60, P27; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Navarre DA, 2009, AM J POTATO RES, V86, P88, DOI 10.1007/s12230-008-9060-0; Partington JC, 1999, PLANTA, V207, P449, DOI 10.1007/s004250050504; Pitman AR, 2011, EUR J PLANT PATHOL, V129, P389, DOI 10.1007/s10658-010-9702-1; Queiroz C, 2008, FOOD REV INT, V24, P361, DOI 10.1080/87559120802089332; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Secor GA, 2006, PLANT DIS, V90, P377, DOI 10.1094/PD-90-0377B; Sengoda VG, 2010, AM J POTATO RES, V87, P41, DOI 10.1007/s12230-009-9115-x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tamborindeguy C, 2010, 10 ANN ZEBR CHIP REP, P164; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wen A, 2009, PLANT DIS, V93, P1102, DOI 10.1094/PDIS-93-11-1102; WENZLER HC, 1989, PLANT MOL BIOL, V12, P41, DOI 10.1007/BF00017446; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; Zourelidou M, 2002, PLANT J, V30, P489, DOI 10.1046/j.1365-313X.2002.01302.x	46	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37345	10.1371/journal.pone.0037345	http://dx.doi.org/10.1371/journal.pone.0037345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615987	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200065
J	Wang, YR; Li, EC; Yu, N; Wang, XD; Cai, CF; Tang, BP; Chen, LQ; Van Wormhoudt, A				Wang, Yueru; Li, Erchao; Yu, Na; Wang, Xiaodan; Cai, Chunfang; Tang, Boping; Chen, Liqiao; Van Wormhoudt, Alain			Characterization and Expression of Glutamate Dehydrogenase in Response to Acute Salinity Stress in the Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							AMINO-ACID POOL; NA+-K+-ATPASE; LITOPENAEUS-VANNAMEI; PROLINE SYNTHESIS; OSMOTIC-STRESS; BLUE-CRAB; GILLS; SHRIMP; ACCLIMATION; METABOLISM	Background: Glutamate dehydrogenase (GDH) is a key enzyme for the synthesis and catabolism of glutamic acid, proline and alanine, which are important osmolytes in aquatic animals. However, the response of GDH gene expression to salinity alterations has not yet been determined in macro-crustacean species. Methodology/Principal Findings: GDH cDNA was isolated from Eriocheir sinensis. Then, GDH gene expression was analyzed in different tissues from normal crabs and the muscle of crabs following transfer from freshwater (control) directly to water with salinities of 16% and 30%, respectively. Full-length GDH cDNA is 2,349 bp, consisting of a 76 bp 5'-untranslated region, a 1,695 bp open reading frame encoding 564 amino acids and a 578 bp 3'-untranslated region. E. sinensis GDH showed 64-90% identity with protein sequences of mammalian and crustacean species. Muscle was the dominant expression source among all tissues tested. Compared with the control, GDH expression significantly increased at 6 h in crabs transferred to 16% and 30% salinity, and GDH expression peaked at 48 h and 12 h, respectively, with levels approximately 7.9 and 8.5 fold higher than the control. The free amino acid (FAA) changes in muscle, under acute salinity stress (16% and 30% salinities), correlated with GDH expression levels. Total FAA content in the muscle, which was based on specific changes in arginine, proline, glycine, alanine, taurine, serine and glutamic acid, tended to increase in crabs following transfer to salt water. Among these, arginine, proline and alanine increased significantly during salinity acclimation and accounted for the highest proportion of total FAA. Conclusions: E. sinensis GDH is a conserved protein that serves important functions in controlling osmoregulation. We observed that higher GDH expression after ambient salinity increase led to higher FAA metabolism, especially the synthesis of glutamic acid, which increased the synthesis of proline and alanine to meet the demand of osmoregulation at hyperosmotic conditions.	[Wang, Yueru; Li, Erchao; Yu, Na; Wang, Xiaodan; Chen, Liqiao] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Cai, Chunfang] Soochow Univ, Sch Basic Med & Biol Sci, Suzhou, Peoples R China; [Tang, Boping] Yancheng Teachers Univ, Sch Basic Med & Biol Sci, Jiangsu Prov Key Lab Coastal Wetland Bioresources, Yancheng, Peoples R China; [Van Wormhoudt, Alain] Museum Natl Hist Nat, Stn Biol Marine, UMR5178, Concarneau, France	East China Normal University; Soochow University - China; Yancheng Teachers University; Museum National d'Histoire Naturelle (MNHN)	Li, EC (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	ecli@bio.ecnu.edu.cn; lqchen@bio.ecnu.edu.cn	Wang, Xiaodan/AAH-1305-2021	Chen, Liqiao/0000-0003-0138-7828; LI, Erchao/0000-0001-8495-2241	National Natural Science Foundation of China [31172422, 31001098]; Special Fund for Agro-scientific Research in the Public Interest [201003020, 201203065]; National Basic Research Program (973 Program) [2009CB118702]; National Key Technology Support Program [2012BAD25B03]; Shanghai Committee of Science and Technology [09ZR1409800, 10JC1404100]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100076120006]; Shanghai Agriculture Science and Technology Key Grant [2-1]; Shanghai technology system for Chinese mitten-handed crab industry; E-Institute of Shanghai Municipal Education Commission [E03009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Basic Research Program (973 Program)(National Basic Research Program of China); National Key Technology Support Program(National Key Technology R&D Program); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Agriculture Science and Technology Key Grant; Shanghai technology system for Chinese mitten-handed crab industry; E-Institute of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	National Natural Science Foundation of China (No. 31172422; 31001098), Special Fund for Agro-scientific Research in the Public Interest (No. 201003020, 201203065), National Basic Research Program (973 Program, No. 2009CB118702), National Key Technology Support Program (2012BAD25B03), Shanghai Committee of Science and Technology (No. 09ZR1409800; 10JC1404100), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100076120006), Shanghai Agriculture Science and Technology Key Grant (No. 2-1, 2009), Shanghai technology system for Chinese mitten-handed crab industry, and partly by the E-Institute of Shanghai Municipal Education Commission (No. E03009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; BENACHENHOULAHFA N, 1993, J MOL EVOL, V36, P335; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; BURTON RS, 1991, J EXP ZOOL, V259, P166, DOI 10.1002/jez.1402590204; BURTON RS, 1992, BIOL BULL, V182, P409, DOI 10.2307/1542260; BURTON RS, 1986, J EXP ZOOL, V238, P55, DOI 10.1002/jez.1402380107; Chen JC, 1997, COMP BIOCHEM PHYS A, V117, P239, DOI 10.1016/S0300-9629(96)00237-X; Cuzon G, 2004, AQUACULTURE, V235, P513, DOI 10.1016/j.aquaculture.2003.12.022; DALLA VIA J, 1986, AQUACULTURE, V55, P307, DOI 10.1016/0044-8486(86)90171-7; Dittel AI, 2009, J EXP MAR BIOL ECOL, V374, P79, DOI 10.1016/j.jembe.2009.04.012; FLORKIN M, 1969, MOL APPROACHES ECOLO; Fry F.E.J., 1971, P1; Gilles R, 1997, COMP BIOCHEM PHYS A, V117, P279, DOI 10.1016/S0300-9629(96)00265-4; Gilles R., 1979, MECH OSMOREGULATION, P111; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hochachka P. W., 2002, BIOCH ADAPTATION; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kinne O., 1971, MARINE ECOLOGY ENV 2, V1, P821; Li EC, 2011, CHIN J OCEANOL LIMN, V29, P343, DOI 10.1007/s00343-011-0093-8; Li EC, 2009, J CRUSTACEAN BIOL, V29, P379, DOI 10.1651/08-3104.1; Lima AG, 1997, J EXP MAR BIOL ECOL, V215, P81, DOI 10.1016/S0022-0981(97)00016-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucu C, 2003, COMP BIOCHEM PHYS A, V135, P195; Mantel L.H., 1983, P53; MCDANIEL H, 1986, J BIOL CHEM, V261, P884; McNamara JC, 2004, MAR FRESHW BEHAV PHY, V37, P193, DOI 10.1080/10236240400006208; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; Mo JL, 1998, J CRUSTACEAN BIOL, V18, P442, DOI 10.2307/1549409; OLSOWSKI A, 1995, HELGOLANDER MEERESUN, V49, P727, DOI 10.1007/BF02368396; Onken H, 1998, COMP BIOCHEM PHYS A, V119, P883, DOI 10.1016/S1095-6433(98)00020-8; PEQUEUX A, 1995, J CRUSTACEAN BIOL, V15, P1, DOI 10.2307/1549010; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Rathmayer M, 2001, J COMP PHYSIOL B, V171, P271, DOI 10.1007/s003600100173; REGNAULT M, 1987, BIOL REV, V62, P1, DOI 10.1111/j.1469-185X.1987.tb00623.x; Rosas C, 2001, J EXP MAR BIOL ECOL, V259, P1, DOI 10.1016/S0022-0981(01)00222-2; ROUSTIAU S, 1985, BIOCHEM SYST ECOL, V13, P45, DOI 10.1016/0305-1978(85)90012-2; Somero G.N., 1983, P77; Spaargaren DH, 1971, NETH J SEA RES, V179, P268; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Towle DW, 2001, J EXP BIOL, V204, P4005; Via GJD, 1989, ARCH HYDROBIOL, V115, P125; VINCENTM.C, 1970, COMP BIOCHEM PHYSIOL, V35, P479, DOI 10.1016/0010-406X(70)90611-0; Willett CS, 2003, COMP BIOCHEM PHYS B, V135, P639, DOI 10.1016/S1096-4959(03)00145-3; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	45	36	41	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37316	10.1371/journal.pone.0037316	http://dx.doi.org/10.1371/journal.pone.0037316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615974	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200057
J	Benson, RBJ; Rich, TH; Vickers-Rich, P; Hall, M				Benson, Roger B. J.; Rich, Thomas H.; Vickers-Rich, Patricia; Hall, Mike			Theropod Fauna from Southern Australia Indicates High Polar Diversity and Climate-Driven Dinosaur Provinciality	PLOS ONE			English	Article							CARCHARODONTOSAURID DINOSAURIA; MEGARAPTOR-NAMUNHUAIQUII; MEGALOSAURUS-BUCKLANDII; CARNOSAUR DINOSAURIA; CRETACEOUS THEROPOD; PREDATORY DINOSAUR; EARLY EVOLUTION; SOFT-TISSUES; OSTEOLOGY; PATAGONIA	The Early Cretaceous fauna of Victoria, Australia, provides unique data on the composition of high latitude southern hemisphere dinosaurs. We describe and review theropod dinosaur postcranial remains from the Aptian-Albian Otway and Strzelecki groups, based on at least 37 isolated bones, and more than 90 teeth from the Flat Rocks locality. Several specimens of medium-and large-bodied individuals (estimated up to similar to 8.5 metres long) represent allosauroids. Tyrannosauroids are represented by elements indicating medium body sizes (similar to 3 metres long), likely including the holotype femur of Timimus hermani, and a single cervical vertebra represents a juvenile spinosaurid. Single specimens representing medium- and small-bodied theropods may be referrable to Ceratosauria, Ornithomimosauria, a basal coelurosaur, and at least three taxa within Maniraptora. Thus, nine theropod taxa may have been present. Alternatively, four distinct dorsal vertebrae indicate a minimum of four taxa. However, because most taxa are known from single bones, it is likely that small-bodied theropod diversity remains underestimated. The high abundance of allosauroids and basal coelurosaurs (including tyrannosauroids and possibly ornithomimosaurs), and the relative rarity of ceratosaurs, is strikingly dissimilar to penecontemporaneous dinosaur faunas of Africa and South America, which represent an arid, lower-latitude biome. Similarities between dinosaur faunas of Victoria and the northern continents concern the proportional representatation of higher clades, and may result from the prevailing temperate-polar climate of Australia, especially at high latitudes in Victoria, which is similar to the predominant warm-temperate climate of Laurasia, but distinct from the arid climate zone that covered extensive areas of Gondwana. Most dinosaur groups probably attained a near-cosmopolitan distribution in the Jurassic, prior to fragmentation of the Pangaean supercontinent, and some aspects of the hallmark 'Gondwanan' fauna of South America and Africa may therefore reflect climate-driven provinciality, not vicariant evolution driven by continental fragmentation. However, vicariance may still be detected at lower phylogenetic levels.	[Benson, Roger B. J.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Benson, Roger B. J.] UCL, Dept Earth Sci, London, England; [Rich, Thomas H.; Vickers-Rich, Patricia; Hall, Mike] Monash Univ, Sch Geosci, Melbourne, Vic 3004, Australia; [Rich, Thomas H.; Vickers-Rich, Patricia] Museum Victoria, Dept Palaeontol, Melbourne, Vic, Australia	University of Cambridge; University of London; University College London; Monash University; Museum Victoria	Benson, RBJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	rbb27@cam.ac.uk		Benson, Roger/0000-0001-8244-6177	National Geographic; Australian Research Council (ARC); Monash University; Museum Victoria; Atlas Copco; Leverhulme Foundation [RPG-129]	National Geographic(National Geographic Society); Australian Research Council (ARC)(Australian Research Council); Monash University(Monash University); Museum Victoria; Atlas Copco; Leverhulme Foundation	Substantial sampling of the Victorian dinosaur fauna would not have occurred without support from National Geographic, Atlas Copco, the Australian Research Council (ARC), Monash University, and Museum Victoria. RBJB's work on Cretaceous Biogeography and Latitudinal Climatic Variation is supported by a Research Project Grant from the Leverhulme Foundation (RPG-129) awarded to Paul Upchurch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' received funding for field collection of fossils from two commercial sources (Atlas Copco and National Geographic). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Agnolin FL, 2011, AN ACAD BRAS CIENC, V83, P117, DOI 10.1590/S0001-37652011000100008; Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; Allain R, 2005, J VERTEBR PALEONTOL, V25, P850, DOI 10.1671/0272-4634(2005)025[0850:TPAOTM]2.0.CO;2; Altangarel Perle, 1994, American Museum Novitates, V3105, P1; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Barrett PM, 2011, BIOL LETTERS, V7, P933, DOI 10.1098/rsbl.2011.0466; Barrett PM, 2010, ALCHERINGA, V34, P293, DOI 10.1080/03115511003664440; Barrett PM, 2010, ALCHERINGA, V34, P205, DOI 10.1080/03115511003655430; Barsbold R, 2000, ACTA PALAEONTOL POL, V45, P97; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benson RBJ, 2010, SCIENCE, V329, DOI 10.1126/science.1190195; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, SCIENCE, V327, P1613, DOI 10.1126/science.1187456; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Bonaparte J.F., 1987, Occasional Paper of the Tyrrell Museum of Palaeontology, P24; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte J.F., 1990, NATURAL HIST MUSEUM, V416, P1; Bonaparte J.F., 1986, 4 C ARG PAL BIOESTR, V4, P63; Bonaparte JF, 1999, GONDWANA ASSEMBLY NE, P218; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Britt BB., 1993, THESIS U CALGARY; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Brusatte SL, 2010, J IBER GEOL, V36, P275, DOI 10.5209/rev_JIGE.2010.v36.n2.12; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P902, DOI 10.1671/0272-4634(2007)27[902:ANSOCD]2.0.CO;2; Brusatte SL, 2012, B AM MUS NAT HIST, P1; Brusatte SL, 2011, AM MUS NOVIT, P1, DOI 10.1206/3717.2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Burnham DA, 2003, PALEONTOLOGICAL CONT, V13, P1; Calvo JO, 2004, AMEGHINIANA, V41, P565; Cantrill DJ, 2005, REV PALAEOBOT PALYNO, V137, P83, DOI 10.1016/j.revpalbo.2005.08.004; Carpenter K, 2005, LIFE O PAST, P23; Carrano M. T., 2010, SMITHSONIAN CONTRIBU, V95, P1; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano Matthew T., 2006, P225; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Carrano MT, 2012, J SYSTEMATIC PALAENT; Carvalho ID, 2010, PALAEOGEOGR PALAEOCL, V297, P252, DOI 10.1016/j.palaeo.2010.08.003; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Chiappe Luis M., 2002, P87; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Close RA, 2009, J VERTEBR PALEONTOL, V29, P616, DOI 10.1671/039.029.0214; Cogne JP, 2008, EARTH PLANET SC LETT, V273, P251, DOI 10.1016/j.epsl.2008.06.030; Constantine A, 1998, S AFR J SCI, V94, P137; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2006, Journal of the Paleontological Society of Korea, V22, P173; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Currie PJ, 1996, ALCHERINGA, V20, P73, DOI 10.1080/03115519608619225; Deperet C., 1925, CR Acad sci Paris, V181, P1108; EMBLETON BJJ, 1982, EARTH PLANET SC LETT, V58, P141, DOI 10.1016/0012-821X(82)90189-3; Fitzgerald EMG, NATURWISSEN IN PRESS; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Freire P.C., 2007, PALEONTOLOGIA CENARI, V1, P413; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gardner JD, 1999, SP PALAEONT, P87; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; Harris JD, 1998, NEW MEXICO MUSEUM NA, V13, P1, DOI DOI 10.1080/0022293460865417; Hathway B, 1999, AUST J EARTH SCI, V46, P593, DOI 10.1046/j.1440-0952.1999.00727.x; Herne MC, 2010, SCIENCE, V329, DOI 10.1126/science.1190100; Herngreen GFW, 1996, PALYNOLOGY PRINCIPLE, V3, P1157; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2001, P64; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P123, DOI 10.1006/zjls.2000.0254; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; HUXLEY T. H., 1868, ANN MAG NAT HIST, V2, P66; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; IDNURM M, 1985, GEOPHYS J ROY ASTR S, V83, P399, DOI 10.1111/j.1365-246X.1985.tb06494.x; Jell P.A., 1986, Memoir of the Association of Australasian Palaeontologists, V3, P111; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Jokat W, 2004, MAR GEOPHYS RES, V25, P283, DOI 10.1007/s11001-005-1337-9; Jokat W, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001802; Karhu AA., 1996, PALEONTOL J, V30, P583; Kellner Alexander W.A., 1999, Boletim do Museu Nacional Nova Serie Geologia, V49, P1; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; LELOEUFF J, 1991, GEOBIOS-LYON, V24, P585, DOI 10.1016/0016-6995(91)80022-R; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; LONG J.A., 1998, DINOSAURS AUSTR NZ O; Longman H. A., 1933, Memoirs of the Queensland Museum, V10, P131; Longrich N, 2008, PALAEONTOLOGY, V51, P983, DOI 10.1111/j.1475-4983.2008.00791.x; Lu JC, 2005, ACTA PALAEONTOLOGICA, V44, P412; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Madsen J.H., 1976, UTAH GEOLOGICAL SURV, V109; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 1995, THESIS U COPENHAGEN; Mannion PD, 2012, GLOBAL ECOL BIOGEOGR, DOI [10.1111/j.1466-8238.2011.00735.x, DOI 10.1111/J.1466-8238.2011.00735.X)]; Mannion PD, 2011, PALAEOGEOGR PALAEOCL, V299, P529, DOI 10.1016/j.palaeo.2010.12.003; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Mateus Octavio, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P111; Molnar R., 1980, Memoires de la Societe Geologique de France, V59, P131; Molnar R.E., 1980, Alcheringa, V4, P281, DOI 10.1080/03115518008558972; MOLNAR R E, 1980, Memoirs of the Queensland Museum, V20, P77; MOLNAR R E, 1986, Geobios (Villeurbanne), V19, P231, DOI 10.1016/S0016-6995(86)80046-8; MOLNAR RE, 1981, ALCHERINGA, V5, P141, DOI 10.1080/03115518108565427; MOLNAR RE, 1985, J PALEONTOL, V59, P1511; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell MA, 2009, AM MUS NOVIT, P1; Novas F. E., 2009, AGE DINOSAURS S AM; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 2004, LIFE O PAST, P150; Novas FE, 2002, AMEGHINIANA, V39, P245; Novas FE, 1997, J VERTEBR PALEONTOL, V17, P137, DOI 10.1080/02724634.1997.10010959; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas Fernando E., 2001, Asociacion Paleontologica Argentina Publicacion Especial, V7, P145; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; OSTROM J H, 1978, Zitteliana, V4, P73; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; Ostrom J.H., 1976, BREVIORA, V439, P1; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W. M., 1995, Palaeontologische Zeitschrift, V69, P475; Rauhut OWM, 2005, PALAEONTOLOGY, V48, P87, DOI 10.1111/j.1475-4983.2004.00436.x; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; RICH PV, 1988, SCIENCE, V242, P1403, DOI 10.1126/science.242.4884.1403; Rich T.H., 1989, Geological Society Special Publication, P121; Rich T.H., 2003, CENTURY AUSTR DINOSA; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich TH, 2004, B AM MUS NAT HIST, P36; RICH TH, 1994, RES EXPLOR, V10, P129; RICH TH, 2000, DINOSAURS DARKNESS; Rich Thomas H., 2003, Records of the Queen Victoria Museum, V113, P1; Rich Thomas H., 1999, National Science Museum Monographs, V15, P167; Rich Thomas H., 1997, P275; Rich Thomas H., 2009, Proceedings of the Royal Society of Victoria, V121, pV; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; Rich Thomas H., 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P231; Rich Thomas H., 2001, Records of the Queen Victoria Museum, V110, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; RICH THV, 1989, NATL GEOGR RES, V5, P15; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Salgado L, 2005, LIFE O PAST, P430; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Sampson SD, 2007, SOC VERTEBRATE PALEO, V8; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Skelton PW, 2003, CRETACEOUS WORLD; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith J.B., 2007, SOC VERTEBRATE PALEO, V8, P103; Smith ND, 2008, P ROY SOC B-BIOL SCI, V275, P2085, DOI 10.1098/rspb.2008.0504; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Stromer E., 1931, Abh bayer Akad Wiss Munchen (nf), V9, P1; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Stromer E., 1934, ABH BAYER AKAD WISS, V22, P1; Sues HD, 1997, J VERTEBR PALEONTOL, V17, P698, DOI 10.1080/02724634.1997.10011018; Sweetman SC, 2004, CRETACEOUS RES, V25, P353, DOI 10.1016/j.cretres.2004.01.004; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Vickers-Rich Patricia, 2002, P65; Vickers-Rich Patricia, 1997, P253; WAGSTAFF BE, 1989, NATL GEOGR RES, V5, P54; Waldman M, 1971, SPEC PAP PALAEONTOL, V9, P1; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; WARREN AA, 1991, ALCHERINGA, V15, P327, DOI 10.1080/03115519108619027; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Weishampel DB., 2004, DINOSAURIA; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; WELLES SP, 1983, J PALEONTOL, V57, P196; Wilson G.P., 2001, ASOCIACI N PALEONTOL, V7, P185; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Woodward AS, 1906, ANN MAGAZINE NATURAL, V18, P1, DOI DOI 10.1080/00222930608562567; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu Xing, 2002, Vertebrata Palasiatica, V40, P228; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; You Hailu, 2004, P478; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	217	75	80	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37122	10.1371/journal.pone.0037122	http://dx.doi.org/10.1371/journal.pone.0037122			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615916	Green Published, gold			2022-12-27	WOS:000305341300076
J	Brandt, C; Nielsen, AR; Fischer, CP; Hansen, J; Pedersen, BK; Plomgaard, P				Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter			Plasma and Muscle Myostatin in Relation to Type 2 Diabetes	PLOS ONE			English	Article							REGULATES GLUCOSE-UPTAKE; HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; ADIPOSE-TISSUE; ACUTE EXERCISE; HEALTHY-MEN; FAT MASS; OBESITY; ALPHA	Objective: Myostatin is a secreted growth factor expressed in skeletal muscle tissue, which negatively regulates skeletal muscle mass. Recent animal studies suggest a role for myostatin in insulin resistance. We evaluated the possible metabolic role of myostatin in patients with type 2 diabetes and healthy controls. Design: 76 patients with type 2 diabetes and 92 control subjects were included in the study. They were matched for age, gender and BMI. Plasma samples and biopsies from the vastus lateralis muscle were obtained to assess plasma myostatin and expression of myostatin in skeletal muscle. Results: Patients with type 2 diabetes had higher fasting glucose (8.9 versus 5.1 mmol/L, P<0.001), plasma insulin (68.2 versus 47.2 pmol/L, P<0.002) and HOMA2-IR (1.6 versus 0.9, P<0.0001) when compared to controls. Patients with type 2 diabetes had 1.4 (P<0.01) higher levels of muscle myostatin mRNA content than the control subjects. Plasma myostatin concentrations did not differ between patients with type 2 diabetes and controls. In healthy controls, muscle myostatin mRNA correlated with HOMA2-IR (r = 0.30, P<0.01), plasma IL-6 (r = 0.34, P<0.05) and VO2 max (r = -0.26, P<0.05), however, no correlations were observed in patients with type 2 diabetes. Conclusions: This study supports the idea that myostatin may have a negative effect on metabolism. However, the metabolic effect of myostatin appears to be overruled by other factors in patients with type 2 diabetes.	[Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter] Univ Copenhagen, Ctr Inflammat & Metab, Dept Infect Dis, Copenhagen, Denmark; [Brandt, Claus; Nielsen, Anders R.; Fischer, Christian P.; Hansen, Jakob; Pedersen, Bente K.; Plomgaard, Peter] Univ Copenhagen, Fac Hlth Sci, CMRC, Rigshospitalet, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Brandt, C (corresponding author), Univ Copenhagen, Ctr Inflammat & Metab, Dept Infect Dis, Copenhagen, Denmark.	cbrandt@inflammation-metabolism.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Brandt, Claus/AAB-2695-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Brandt, Claus/0000-0002-7871-7437; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Plomgaard, Peter/0000-0002-2404-2702; Fischer, Christian/0000-0002-0657-9143	Danish National Research Foundation [02-512-55]; Danish Council for Independent Research - Medical Sciences and Natural Sciences; Commission of the European Communities [223576 - MYOAGE]; Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research [09-067009, 09-075724]; Capital Region of Denmark	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences and Natural Sciences; Commission of the European Communities(European Commission); Danish Ministry of Science, Technology, and Innovation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Capital Region of Denmark	CIM is supported by a grant from the Danish National Research Foundation (# 02-512-55). This study was further supported by the Danish Council for Independent Research - Medical Sciences and Natural Sciences and the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Antony N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1296, DOI 10.1152/ajpendo.00331.2007; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Chen YW, 2010, INT J BIOCHEM CELL B, V42, P2072, DOI 10.1016/j.biocel.2010.09.017; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Fischer CP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1189, DOI 10.1152/ajpendo.00206.2004; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Lakshman KM, 2009, MOL CELL ENDOCRINOL, V302, P26, DOI 10.1016/j.mce.2008.12.019; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mitchell MD, 2006, J CLIN ENDOCR METAB, V91, P1434, DOI 10.1210/jc.2005-2361; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; STRAND P. O., 1954, J APPL PHYSIOL, V7, P218; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	31	71	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37236	10.1371/journal.pone.0037236	http://dx.doi.org/10.1371/journal.pone.0037236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615949	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300090
J	Cozzi, B; Podesta, M; Mazzariol, S; Zotti, A				Cozzi, Bruno; Podesta, Michela; Mazzariol, Sandro; Zotti, Alessandro			Fetal and Early Post-Natal Mineralization of the Tympanic Bulla in Fin Whales May Reveal a Hitherto Undiscovered Evolutionary Trait	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BONE-DENSITY; CETACEANS; TISSUES; MIDDLE	The evolution of the cetacean skeleton followed a path that differentiated this group from other terrestrial mammals about 50 million years ago [1], and debate is still going on about the relationships between Cetacea and Artiodactyla [2,3,4]. Some skeletal traits of the basilosaurids (the more advanced forms of Archaeocetes), such as the expansion of the peribullary air sinuses, dental modification and vertebral size uniformity [5] are maintained and further emphasized also in contemporary odontocetes and mysticetes. Using Dual-Energy X-Ray Absorptiometry here we report that the deposition of bone mineral in fetal and newborn specimens of the fin whale Balaenoptera physalus is remarkably higher in the bulla tympanica than in the adjacent basal skull or in the rest of the skeleton. Ossification of the tympanic bulla in fetal Artiodactyla (bovine, hippopotamus) is minimal, becomes sensible after birth and then progresses during growth, contrarily to the precocious mineralization that we observed in fin whales. Given the importance of the ear bones for the precise identification of phylogenetic relationship in therian evolution [6], this feature may indicate a specific evolutionary trait of fin whales and possibly other cetacean species or families. Early mineralization of the tympanic bulla allows immediate sound conduction in the aquatic medium and consequently holds potential importance for mother-calf relationship and postnatal survival.	[Cozzi, Bruno; Mazzariol, Sandro] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Podesta, Michela] Museum Nat Hist Milan, Milan, Italy; [Zotti, Alessandro] Univ Padua, Dept Anim Med, Radiol Unit, Clin Sect, Legnaro, PD, Italy	University of Padua; University of Padua	Cozzi, B (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	bruno.cozzi@unipd.it	Cozzi, Bruno/H-9618-2019; Zotti, Alessandro/I-4296-2012; Zotti, Alessandro/AHD-4502-2022	Cozzi, Bruno/0000-0002-7531-7040; Zotti, Alessandro/0000-0002-9279-5140; Mazzariol, Sandro/0000-0002-4756-1871				AMMANN P, 1992, J BONE MINER RES, V7, P311; Bloebaum RD, 1997, BONE, V20, P485, DOI 10.1016/S8756-3282(97)00015-X; BRAILLON PM, 1992, PEDIATR RES, V32, P77, DOI 10.1203/00006450-199207000-00015; Cozzi B, 2010, ANAT REC, V293, P235, DOI 10.1002/ar.21044; CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3; Currey JD, 1999, J EXP BIOL, V202, P3285; de Muizon C, 2009, CR PALEVOL, V8, P295, DOI 10.1016/j.crpv.2008.07.002; FELTS WJL, 1965, AM J ANAT, V116, P171, DOI 10.1002/aja.1001160109; FELTS WJL, 1966, AM J ANAT, V118, P103, DOI 10.1002/aja.1001180107; Fogelman I, 2000, J NUCL MED, V41, P2015; Geisler Jonathan H., 2005, Journal of Mammalian Evolution, V12, P145, DOI 10.1007/s10914-005-4963-8; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Haddad D, 2012, ZOOL ANZ, V251, P115, DOI 10.1016/j.jcz.2011.06.004; Koo WWK, 1998, J AM COLL NUTR, V17, P65, DOI 10.1080/07315724.1998.10720457; Koo WWK, 1996, J BONE MINER RES, V11, P997; Lees S, 1996, J ACOUST SOC AM, V99, P2421, DOI 10.1121/1.415430; Lockyer C, 1984, CAMBRIDGE REPORTS IN, P27; Moran MM, 2011, ANAT REC, V294, P1743, DOI 10.1002/ar.21388; Nummela S, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P553; PANATTONI GL, 1995, CALCIFIED TISSUE INT, V57, P74, DOI 10.1007/BF00299001; Rauschmann MA, 2006, J MORPHOL, V267, P1295, DOI 10.1002/jmor.10477; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Thewissen JGM, 2007, NATURE, V450, P1190, DOI 10.1038/nature06343; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; Uhen MD, 2007, ANAT REC, V290, P514, DOI 10.1002/ar.20545; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Walsh BM, 2011, ANAT REC, V294, P391, DOI 10.1002/ar.21340; Zotti A, 2004, J VET MED A, V51, P254, DOI 10.1111/j.1439-0442.2004.00630.x; Zotti A, 2010, J ANIM PHYSIOL AN N, V94, P615, DOI 10.1111/j.1439-0396.2009.00946.x; Zotti A, 2009, SKELETAL RADIOL, V38, P1123, DOI 10.1007/s00256-009-0647-4	30	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37110	10.1371/journal.pone.0037110	http://dx.doi.org/10.1371/journal.pone.0037110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615912	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300073
J	Curriu, M; Carrillo, J; Massanella, M; Garcia, E; Cunyat, F; Pena, R; Wienberg, P; Carrato, C; Areal, J; Bofill, M; Clotet, B; Blanco, J; Cabrera, C				Curriu, Marta; Carrillo, Jorge; Massanella, Marta; Garcia, Elisabet; Cunyat, Francesc; Pena, Ruth; Wienberg, Peter; Carrato, Cristina; Areal, Joan; Bofill, Margarita; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia			Susceptibility of Human Lymphoid Tissue Cultured ex vivo to Xenotropic Murine Leukemia Virus-Related Virus (XMRV) Infection	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; APOBEC3 CYTIDINE DEAMINASES; PROSTATE CARCINOMA-CELLS; RETROVIRUS XMRV; UNITED-STATES; ENDOGENOUS RETROVIRUSES; GAMMARETROVIRUS XMRV; CXCR4-TROPIC HIV-1; INTEGRATION SITES; VIRAL-INFECTIONS	Background: Xenotropic murine leukemia virus-related virus (XMRV) was generated after a recombination event between two endogenous murine leukemia viruses during the production of a prostate cancer cell line. Although the associations of the XMRV infection with human diseases appear unlikely, the XMRV is a retrovirus of undefined pathogenic potential, able to replicate in human cells in vitro. Since recent studies using animal models for infection have yielded conflicting results, we set out an ex vivo model for XMRV infection of human tonsillar tissue to determine whether XMRV produced by 22Rv1 cells is able to replicate in human lymphoid organs. Tonsil blocks were infected and infection kinetics and its pathogenic effects were monitored Results: XMRV, though restricted by APOBEC, enters and integrates into the tissue cells. The infection did not result in changes of T or B-cells, immune activation, nor inflammatory chemokines. Infectious viruses could be recovered from supernatants of infected tonsils by reinfecting DERSE XMRV indicator cell line, although these supernatants could not establish a new infection in fresh tonsil culture, indicating that in our model, the viral replication is controlled by innate antiviral restriction factors. Conclusions: Overall, the replication-competent retrovirus XMRV, present in a high number of laboratories, is able to infect human lymphoid tissue and produce infectious viruses, even though they were unable to establish a new infection in fresh tonsillar tissue. Hereby, laboratories working with cell lines producing XMRV should have knowledge and understanding of the potential biological biohazardous risks of this virus.	[Curriu, Marta; Carrillo, Jorge; Massanella, Marta; Garcia, Elisabet; Cunyat, Francesc; Pena, Ruth; Bofill, Margarita; Clotet, Bonaventura; Blanco, Julia; Cabrera, Cecilia] Univ Autonoma Barcelona, IrsiCaixa HIVACAT, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Germans Trias, E-08193 Barcelona, Spain; [Wienberg, Peter] Hosp Univ St Joan de Deu, Dept Otorhinolaryngol, Barcelona, Spain; [Carrato, Cristina] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain; [Areal, Joan] Hosp Badalona Germans Trias & Pujol, Dept Urol, Barcelona, Spain; [Bofill, Margarita] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Clotet, Bonaventura] Univ Autonoma Barcelona, Lluita SIDA Fdn, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Univ Germans Trias & Pujol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; ICREA; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Curriu, M (corresponding author), Univ Autonoma Barcelona, IrsiCaixa HIVACAT, Inst Recerca Ciencies Salut Germans Trias & Pujol, Hosp Germans Trias, Carretera Canyet S-N, E-08193 Barcelona, Spain.	ccabrera@irsicaixa.es	Cabrera, Cecilia/S-1113-2019; Carrato, Cristina/K-6923-2017; Blanco, Julià/A-5347-2008; Massanella, Marta/P-8619-2016; Carrillo, Jorge/AAL-9481-2021	Cabrera, Cecilia/0000-0002-9941-6828; Carrato, Cristina/0000-0002-1953-8287; Blanco, Julià/0000-0002-2225-0217; Massanella, Marta/0000-0002-3326-151X; Carrillo, Jorge/0000-0003-0221-5948; Cunyat, Francesc/0000-0002-1284-6324	Fundacion para la Investigacion en Urologia; "Rafael Molla y Rodrigo" scholarship; ayuda de investigacion Pedro Cifuentes Diaz; Health Department of the Catalan Government (Generalitat de Catalunya); Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract; Fondo de. Investigacion Sanitaria project [07/0418]; Sara Borrell postdoctoral program; ICREA Funding Source: Custom	Fundacion para la Investigacion en Urologia; "Rafael Molla y Rodrigo" scholarship; ayuda de investigacion Pedro Cifuentes Diaz; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract; Fondo de. Investigacion Sanitaria project; Sara Borrell postdoctoral program; ICREA(ICREA)	This work was supported by the Fundacion para la Investigacion en Urologia with a "Rafael Molla y Rodrigo" scholarship and the "ayuda de investigacion Pedro Cifuentes Diaz". C. Cabrera and JB are researchers from Fundacio Institut de Recerca en Ciencies de la Salut Germans Trias i Pujol supported by the Health Department of the Catalan Government (Generalitat de Catalunya). MC is supported by a Spanish AIDS network "Red Tematica Cooperativa de Investigacion en SIDA" contract. FC is supported by the Fondo de. Investigacion Sanitaria project 07/0418 and JC by the Sara Borrell postdoctoral program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHONG BG, 1976, BRIT J CANCER, V34, P203, DOI 10.1038/bjc.1976.144; Akgul B, 2011, MED MICROBIOL IMMUNO; Alberts B, 2011, SCIENCE; Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; BURTONBOY G, 1993, ARCH VIROL, V130, P289, DOI 10.1007/BF01309661; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cool M, 2011, VIROLOGY; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; de Boer EC, 2000, J UROLOGY, V163, P1999, DOI 10.1016/S0022-5347(05)67617-3; Deichmann M, 2005, ARCH DERMATOL RES, V296, P345, DOI 10.1007/s00403-004-0501-4; Del Prete GQ, 2012, J VIROL, V86, P3152, DOI 10.1128/JVI.06886-11; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; GAUTSCH JW, 1980, P NATL ACAD SCI-BIOL, V77, P2247, DOI 10.1073/pnas.77.4.2247; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Grivel JC, 2003, J VIROL, V77, P8280, DOI 10.1128/JVI.77.15.8280-8289.2003; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Katzourakis A, 2011, J VIROL; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; KOTLER M, 1977, ISRAEL J MED SCI, V13, P740; KOZAK CA, 1984, J VIROL, V51, P77, DOI 10.1128/JVI.51.1.77-80.1984; Levy JA, 1999, P NATL ACAD SCI USA, V96, P802, DOI 10.1073/pnas.96.3.802; Lo SC, 2012, P NATL ACAD SCI USA, V109, P346, DOI 10.1073/pnas.1119641109; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2011, IN VIVO, V25, P307; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Mi Z, 2011, TRANSFUSION; Nagabhushan M, 1996, CANCER RES, V56, P3042; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; OIE HK, 1976, J NATL CANCER I, V56, P423, DOI 10.1093/jnci/56.2.423; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2011, SCIENCE; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Raisch KP, 1998, VIROLOGY, V250, P135, DOI 10.1006/viro.1998.9363; Ravichandran V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-443; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Rusmevichientong A, 2011, J VIROL, V85, P12830, DOI 10.1128/JVI.05624-11; Sabunciyan S, 2011, MOL CELL PROBE, V25, P134, DOI 10.1016/j.mcp.2011.01.005; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shin CH, 2011, J VIROL; Silverman RH, 2011, SCIENCE, V334, P176, DOI 10.1126/science.334.6053.176-a; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; SUZUKI T, 1977, GANN, V68, P99; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; TODARO GJ, 1973, P NATL ACAD SCI USA, V70, P859, DOI 10.1073/pnas.70.3.859; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wolff D, 2011, CLIN LAB, V57, P631; YANIV A, 1980, INT J CANCER, V25, P205, DOI 10.1002/ijc.2910250207; Zhang YA, 2011, CANCER BIOL THER, V12, P617, DOI 10.4161/cbt.12.7.15955; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086	103	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37415	10.1371/journal.pone.0037415	http://dx.doi.org/10.1371/journal.pone.0037415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616002	Green Published, gold			2022-12-27	WOS:000305341300111
J	Singh, DP; Bhargavan, B; Chhunchha, B; Kubo, E; Kumar, A; Fatma, N				Singh, Dhirendra P.; Bhargavan, Biju; Chhunchha, Bhavana; Kubo, Eri; Kumar, Anil; Fatma, Nigar			Transcriptional Protein Sp1 Regulates LEDGF Transcription by Directly Interacting with Its Cis-Elements in GC-Rich Region of TATA-Less Gene Promoter	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; STRESS-RELATED GENES; ALPHA-B-CRYSTALLIN; GROWTH-FACTOR; ALTERNATIVE PROMOTERS; PROSTATE-CANCER; START SITES; HEAT-SHOCK; MESSENGER-RNA; EXPRESSION	LEDGF/p75 interacts with DNA/protein to regulate gene expression and function. Despite the recognized diversity of function of LEDGF/p75, knowledge of its transregulation is in its infancy. Here we report that LEDGF/p75 gene is TATA-less, contains GC-rich cis elements and is transcriptionally regulated by Sp1 involving small ubiquitin-like modifier (Sumo1). Using different cell lines, we showed that Sp1 overexpression increased the level of LEDGF/p75 protein and mRNA expression in a concentration-dependent fashion. In contrast, RNA interference depletion of intrinsic Sp1 or treatment with artemisinin, a Sp1 inhibitor, reduced expression of LEDGF/p75, suggesting Sp1-mediated regulation of LEDGF/p75. In silico analysis disclosed three evolutionarily conserved, putative Sp1 sites within LEDGF/p75 proximal promoter (-170/+1 nt). DNA-binding and transactivation assays using deletion and point mutation constructs of LEDGF/p75 promoter-CAT revealed that all Sp1 sites (-50/-43, -109/-102 and -146/-139) differentially regulate LEDGF/p75. Cotransfection studies with Sp1 in Drosophila cells that were Sp1-deficient, showed increased LEDGF/p75 transcription, while in lens epithelial cells (LECs) promoter activity was inhibited by artemisinin. These events were correlated with levels of endogenous Sp1-dependent LEDGF/p75 expression, and higher resistance to UVB-induced cell death. ChIP and transactivation assays showed that Sumoylation of Sp1 repressed its transcriptional activity as evidenced through its reduced binding to GC-box and reduced ability to activate LEDGF/p75 transcription. As whole, results revealed the importance of Sp1 in regulating expression of LEDGF/p75 gene and add to our knowledge of the factors that control LEDGF/p75 within cellular microenvironments, potentially providing a foundation for LEDGF/p75 expression-based transcription therapy.	[Singh, Dhirendra P.; Bhargavan, Biju; Chhunchha, Bhavana; Fatma, Nigar] Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68182 USA; [Kubo, Eri] Kansai Med Univ, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Kumar, Anil] Univ Missouri, Dept Pharmacol, Kansas City, MO 64110 USA	University of Nebraska System; University of Nebraska Medical Center; University of Missouri System; University of Missouri Kansas City	Singh, DP (corresponding author), Univ Nebraska, Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68182 USA.	dpsingh@unmc.edu		Chhunchha, Bhavana/0000-0001-9613-8765	National Eye Institute, NIH [EY013394, EY017613]; Research for Preventing Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY013394, R01EY017613] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research for Preventing Blindness (RPB); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Grants provided by the National Eye Institute, NIH (EY013394 and EY017613) (to DPS) and Research for Preventing Blindness (RPB) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Basu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030132; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BHAT SP, 1991, EUR J BIOCHEM, V202, P775, DOI 10.1111/j.1432-1033.1991.tb16432.x; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Bueno MTD, 2010, J MOL BIOL, V399, P221, DOI 10.1016/j.jmb.2010.03.063; Carey M, 2000, TRANSCRIPTIONAL REGU; Crawford DL, 1999, MOL BIOL EVOL, V16, P194, DOI 10.1093/oxfordjournals.molbev.a026102; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410; Desfarges S, 2011, J MOL BIOL, V414, P177, DOI 10.1016/j.jmb.2011.10.010; Fatma N, 2004, AM J PHYSIOL-CELL PH, V287, pC508, DOI 10.1152/ajpcell.00076.2004; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hubner K, 2010, BBA-GENE REGUL MECH, V1799, P442, DOI 10.1016/j.bbagrm.2010.02.001; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kubo E, 2003, HISTOCHEM CELL BIOL, V119, P289, DOI 10.1007/s00418-003-0518-3; Kubo E, 2010, AM J PHYSIOL-CELL PH, V298, pC342, DOI 10.1152/ajpcell.00336.2009; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Leoh LS, 2012, MOL CANC RE IN PRESS; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Llano M, 2009, CURR TOP MICROBIOL, V339, P125, DOI 10.1007/978-3-642-02175-6_7; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Meehan AM, 2010, BBA-GENE REGUL MECH, V1799, P182, DOI 10.1016/j.bbagrm.2009.10.001; NAGINENI CN, 1989, FEBS LETT, V249, P89, DOI 10.1016/0014-5793(89)80022-5; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Sharma P, 2003, J BIOL CHEM, V278, P20037, DOI 10.1074/jbc.M212016200; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Takamura Y, 2006, AM J PHYSIOL-CELL PH, V290, pC554, DOI 10.1152/ajpcell.00398.2005; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Whitten C, 2008, GENE, V413, P58, DOI 10.1016/j.gene.2008.01.020; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; Wobus M, 2008, GENE, V413, P67, DOI 10.1016/j.gene.2008.01.021; XU CF, 1995, HUM MOL GENET, V4, P2259, DOI 10.1093/hmg/4.12.2259; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841	58	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37012	10.1371/journal.pone.0037012	http://dx.doi.org/10.1371/journal.pone.0037012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615874	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300054
J	Sun, YB; Villa-Diaz, LG; Lam, RHW; Chen, WQ; Krebsbach, PH; Fu, JP				Sun, Yubing; Villa-Diaz, Luis G.; Lam, Raymond H. W.; Chen, Weiqiang; Krebsbach, Paul H.; Fu, Jianping			Mechanics Regulates Fate Decisions of Human Embryonic Stem Cells	PLOS ONE			English	Article							SYNTHETIC-POLYMER COATINGS; SELF-RENEWAL; DIFFERENTIATION; INHIBITION; SUBSTRATE; STIFFNESS; GROWTH	Research on human embryonic stem cells (hESCs) has attracted much attention given their great potential for tissue regenerative therapy and fundamental developmental biology studies. Yet, there is still limited understanding of how mechanical signals in the local cellular microenvironment of hESCs regulate their fate decisions. Here, we applied a microfabricated micromechanical platform to investigate the mechanoresponsive behaviors of hESCs. We demonstrated that hESCs are mechanosensitive, and they could increase their cytoskeleton contractility with matrix rigidity. Furthermore, rigid substrates supported maintenance of pluripotency of hESCs. Matrix mechanics-mediated cytoskeleton contractility might be functionally correlated with E-cadherin expressions in cell-cell contacts and thus involved in fate decisions of hESCs. Our results highlighted the important functional link between matrix rigidity, cellular mechanics, and pluripotency of hESCs and provided a novel approach to characterize and understand mechanotransduction and its involvement in hESC function.	[Sun, Yubing; Lam, Raymond H. W.; Chen, Weiqiang; Fu, Jianping] Univ Michigan, Integrated Biosyst & Biomech Lab, Ann Arbor, MI 48109 USA; [Sun, Yubing; Lam, Raymond H. W.; Chen, Weiqiang; Fu, Jianping] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Villa-Diaz, Luis G.; Krebsbach, Paul H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Krebsbach, Paul H.; Fu, Jianping] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, YB (corresponding author), Univ Michigan, Integrated Biosyst & Biomech Lab, Ann Arbor, MI 48109 USA.	jpfu@umich.edu	Diaz, Luis Villa/Q-3463-2017; Lam, Raymond H W/A-7026-2012; Fu, Jianping/C-9605-2009; Fu, Jianping/AAJ-7105-2020; Krebsbach, Paul H./AAC-4765-2021; Chen, Weiqiang/G-6064-2011; Sun, Yubing/H-2433-2011	Diaz, Luis Villa/0000-0001-5709-9054; Lam, Raymond H W/0000-0002-5188-3830; Fu, Jianping/0000-0001-9629-6739; Fu, Jianping/0000-0001-9629-6739; Chen, Weiqiang/0000-0002-9469-8328; Sun, Yubing/0000-0002-6831-3383	National Science Foundation (NSF) [CMMI 1129611]; National Institutes of Health [R01 DE016530]; NIDCR at the Dental School, University of Michigan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016530] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR at the Dental School, University of Michigan; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors acknowledge financial support from the National Science Foundation (NSF CMMI 1129611; Fu), National Institutes of Health grants R01 DE016530 (Krebsbach) and the NIDCR T32 tissue engineering and regeneration training program (Krebsbach) at the Dental School, University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	24	174	179	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37178	10.1371/journal.pone.0037178	http://dx.doi.org/10.1371/journal.pone.0037178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615930	Green Published, gold			2022-12-27	WOS:000305341300082
J	Sepp, T; Karu, U; Blount, JD; Sild, E; Manniste, M; Horak, P				Sepp, Tuul; Karu, Ulvi; Blount, Jonathan D.; Sild, Elin; Maenniste, Marju; Horak, Peeter			Coccidian Infection Causes Oxidative Damage in Greenfinches	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; EIMERIA-MAXIMA INFECTIONS; IMMUNE-RESPONSE; TRADE-OFF; TENELLA INFECTION; NITRIC-OXIDE; STRESS; CHICKENS; CAROTENOIDS; TOLTRAZURIL	The main tenet of immunoecology is that individual variation in immune responsiveness is caused by the costs of immune responses to the hosts. Oxidative damage resulting from the excessive production of reactive oxygen species during immune response is hypothesized to form one of such costs. We tested this hypothesis in experimental coccidian infection model in greenfinches Carduelis chloris. Administration of isosporan coccidians to experimental birds did not affect indices of antioxidant protection (TAC and OXY), plasma triglyceride and carotenoid levels or body mass, indicating that pathological consequences of infection were generally mild. Infected birds had on average 8% higher levels of plasma malondialdehyde (MDA, a toxic end-product of lipid peroxidation) than un-infected birds. The birds that had highest MDA levels subsequent to experimental infection experienced the highest decrease in infection intensity. This observation is consistent with the idea that oxidative stress is a causative agent in the control of coccidiosis and supports the concept of oxidative costs of immune responses and parasite resistance. The finding that oxidative damage accompanies even the mild infection with a common parasite highlights the relevance of oxidative stress biology for the immunoecological research.	[Sepp, Tuul; Karu, Ulvi; Sild, Elin; Maenniste, Marju; Horak, Peeter] Univ Tartu, Ctr Excellence FIBIR, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia; [Blount, Jonathan D.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, England	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Exeter	Sepp, T (corresponding author), Univ Tartu, Ctr Excellence FIBIR, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	tuul.sepp@ut.ee	Horak, Peeter/A-2351-2009; Blount, Jonathan/K-7695-2012	Horak, Peeter/0000-0002-1442-9903; Blount, Jonathan/0000-0002-0016-0130; Sepp, Tuul/0000-0002-8677-7069	Estonian Science Foundation [7737]; Estonian Ministry of Education and Science [0180004s09]; European Union through (Centre of Excellence FIBIR); Royal Society	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); European Union through (Centre of Excellence FIBIR); Royal Society(Royal Society of London)	The study was financed by Estonian Science Foundation (grant # 7737 to PH), the Estonian Ministry of Education and Science (target-financing project # 0180004s09) and by the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). JDB was supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PC, 2002, POULTRY SCI, V81, P41, DOI 10.1093/ps/81.1.41; Allen PC, 1997, POULTRY SCI, V76, P814, DOI 10.1093/ps/76.6.814; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Allen PC, 1996, POULTRY SCI, V75, P179, DOI 10.3382/ps.0750179; Allen PC, 1997, POULTRY SCI, V76, P822, DOI 10.1093/ps/76.6.822; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Cohen AA, 2010, FUNCT ECOL, V24, P997, DOI 10.1111/j.1365-2435.2010.01761.x; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Darius AK, 2004, PARASITOL RES, V92, P453, DOI 10.1007/s00436-003-1063-7; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Eley C, 1991, THESIS U SUSSEX; Eraslan G, 2004, B VET I PULAWY, V48, P251; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Gabrashanska M, 2009, TRACE ELEM ELECTROLY, V26, P17; Georgieva NV, 2006, VET J, V172, P488, DOI 10.1016/j.tvjl.2005.07.016; Greiner EC, 2008, PARASITIC DIS WILD B, P109; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Halliwell B., 2007, FREE RADICALS BIOL M; Horak P, 2006, J EVOLUTION BIOL, V19, P277, DOI 10.1111/j.1420-9101.2005.00988.x; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Kammer AR, 2011, J EXP BIOL, V214, P1248, DOI 10.1242/jeb.053207; Klasing K.C., 1999, OSTRICH, V69, P32; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koinarski V, 2006, B VET I PULAWY, V50, P55; Krautwald-Junghanns ME, 2009, J AVIAN MED SURG, V23, P1; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lillehoj HS, 2004, AVIAN DIS, V48, P244, DOI 10.1637/7054; Lim JongHwan, 2007, Journal of Veterinary Clinics, V24, P308; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; Mathis GF, 2003, AVIAN DIS, V47, P463, DOI 10.1637/0005-2086(2003)047[0463:CCWTIC]2.0.CO;2; McDougald LR, 1998, VET PARASITOL, V74, P91, DOI 10.1016/S0304-4017(97)00172-6; McGill I, 2010, VET REC, V167, P656, DOI 10.1136/vr.c5179; McGraw KJ, 2010, FUNCT ECOL, V24, P947, DOI 10.1111/j.1365-2435.2010.01772.x; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Min Wongi, 2004, J Vet Sci, V5, P279; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mougeot F, 2010, J EXP BIOL, V213, P400, DOI 10.1242/jeb.037101; Muehlenbein MP, 2010, AM J HUM BIOL, V22, P546, DOI 10.1002/ajhb.21045; Niki E, 2008, J AGR FOOD CHEM, V56, P8255, DOI 10.1021/jf800605x; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pap PL, 2011, AUK, V128, P330, DOI 10.1525/auk.2011.10142; Pap PL, 2009, J EXP BIOL, V212, P3228, DOI 10.1242/jeb.031948; Peters A, 2008, FUNCT ECOL, V22, P831, DOI 10.1111/j.1365-2435.2008.01437.x; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rodriguez-Estival J, 2010, ENVIRON RES, V110, P469, DOI 10.1016/j.envres.2010.03.008; Saks L, 2003, FUNCT ECOL, V17, P555, DOI 10.1046/j.1365-2435.2003.00765.x; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Segerstrom SC, 2010, ANN BEHAV MED, V40, P114, DOI 10.1007/s12160-010-9195-3; Sepp T, 2012, PHYSL BIOCH IN PRESS, P85; Sepp T, 2010, PHYSIOL BIOCHEM ZOOL, V83, P276, DOI 10.1086/648580; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Sild E, 2011, J EXP BIOL, V214, P3467, DOI 10.1242/jeb.062182; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stearns S.C., 1992, pi; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Voituron Y, 2006, CRYOBIOLOGY, V52, P74, DOI 10.1016/j.cryobiol.2005.09.006; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Wang ML, 2008, POULTRY SCI, V87, P2273, DOI 10.3382/ps.2008-00077; Zhu JJ, 2000, POULTRY SCI, V79, P619, DOI 10.1093/ps/79.5.619	75	30	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36495	10.1371/journal.pone.0036495	http://dx.doi.org/10.1371/journal.pone.0036495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615772	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300019
J	Huang, YH; Lin, KH; Chen, HC; Chang, ML; Hsu, CW; Lai, MW; Chen, TC; Lee, WC; Tseng, YH; Yeh, CT				Huang, Ya-Hui; Lin, Kwang-Huei; Chen, Hua-Chien; Chang, Ming-Ling; Hsu, Chao-Wei; Lai, Ming-Wei; Chen, Tse-Ching; Lee, Wei-Chen; Tseng, Yi-Hsin; Yeh, Chau-Ting			Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma	PLOS ONE			English	Article							NON-TUMOROUS TISSUES; EXPRESSION PROFILES; MICROARRAY ANALYSIS; CANCER; HEPATITIS; SURVIVAL; LIVER; DEREGULATION; PROGRESSION; SUPPRESSOR	Comparison of microRNA (miRNA) expression profiles in the noncancerous liver tissues adjacent to hepatocelluar carcinomas (HCCs) was a strategy to identify postoperative prognostic predictors in this study. Expression profiles of 270 miRNAs were determined in the paraneoplastic liver tissues of 12 HCC patients with known postoperative prognosis. A panel of candidate miRNA predictors was identified. The prognostic predictive value of these candidate miRNAs was then verified in 216 postoperative HCC patients. Univariate analysis identified 8 and 3 miRNA predictors for recurrence-free (RFS) and overall (OS) survivals, respectively. Multivariate analysis revealed high expression levels of miR-155 (HR, 2.002 [1.324-3.027]; P = .001), miR-15a (HR, 0.478 [0.248-0.920]; P = .027), miR-432 (HR, 1.816 [1.203-2.740]; P = .015), miR-486-3p (HR, 0.543 [0.330-0.893]; P = .016), miR-15b (HR, 1.074 [1.002-1.152]; P = .043) and miR-30b (HR, 1.102 [1.025-1.185]; P = .009) were significantly associated with RFS. When clinicopathological predictors were included, multivariate analysis revealed that tumor number and miR-432, miR-486-3p, and miR-30b expression levels remained significant as independent predictors for RFS. Additionally, expression knockdown of miR-155 in J7 and Mahlavu hepatoma cells resulted in decreased cell growth and enhanced cell death in xenograft tumors, suggesting an oncogenic effect of miR-155. In conclusion, significant prognostic miRNA predictors were identified through examination of miRNA expression levels in paraneoplastic liver tissues. Functional analysis of a miRNA predictor, miR-155, suggested that the prognostic miRNA predictors identified under this strategy could serve as potential molecular targets for anticancer therapy.	[Huang, Ya-Hui; Chang, Ming-Ling; Hsu, Chao-Wei; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan; [Lin, Kwang-Huei; Tseng, Yi-Hsin] Chang Gung Univ, Dept Biochem, Sch Med, Tao Yuan, Taiwan; [Chen, Hua-Chien] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Lai, Ming-Wei] Chang Gung Children Hosp, Dept Pediat Gastroenterol, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Dept Surg, Taipei 10591, Taiwan; [Lee, Wei-Chen] Chang Gung Mem Hosp, Div Gen Surg, Dept Surg, Taipei 10591, Taiwan; [Yeh, Chau-Ting] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, YH (corresponding author), Chang Gung Mem Hosp, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan.	chautingy@gmail.com			Chang Gung Medical Research Council [CMRPG381041, CMRPG381042]	Chang Gung Medical Research Council	The study is supported by a grant from Chang Gung Medical Research Council (CMRPG381041 and CMRPG381042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, DNA CELL BIOL, V26, P273, DOI 10.1089/dna.2006.0544; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Chen HY, 2011, MED ONCOL; Chung GE, 2010, ONCOL REP, V23, P113, DOI 10.3892/or_00000612; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025872; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; HSIEH KH, 1987, GUT, V28, P117, DOI 10.1136/gut.28.2.117; Huang XH, 2009, HEPATOL RES, V39, P786, DOI 10.1111/j.1872-034X.2009.00502.x; Huang YH, 2010, J CELL PHYSIOL, V222, P347, DOI 10.1002/jcp.21959; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Khaled HM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-32; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Li WX, 2008, INT J CANCER, V123, P1616, DOI 10.1002/ijc.23693; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; OEFINGER PE, 1981, J GEN VIROL, V53, P105, DOI 10.1099/0022-1317-53-1-105; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xie Q, 2011, CANCER; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	42	74	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37188	10.1371/journal.pone.0037188	http://dx.doi.org/10.1371/journal.pone.0037188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629365	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300024
J	Braem, MGM; Onland-Moret, NC; Schouten, LJ; Kruitwagen, RFPM; Lukanova, A; Allen, NE; Wark, PA; Tjonneland, A; Hansen, L; Brauner, CM; Overvad, K; Clavel-Chapelon, F; Chabbert-Buffet, N; Teucher, B; Floegel, A; Boeing, H; Trichopoulou, A; Adarakis, G; Plada, M; Rinaldi, S; Fedirko, V; Romieu, I; Pala, V; Galasso, R; Sacerdote, C; Palli, D; Tumino, R; Bueno-de-Mesquita, HB; Gram, IT; Gavrilyuk, O; Lund, E; Sanchez, MJ; Bonet, C; Chirlaque, MD; Larranaga, N; Gurrea, AB; Quiros, JR; Idahl, A; Ohlson, N; Lundin, E; Jirstrom, K; Butt, S; Tsilidis, KK; Khaw, KT; Wareham, N; Riboli, E; Kaaks, R; Peeters, PHM				Braem, Marieke G. M.; Onland-Moret, N. Charlotte; Schouten, Leo J.; Kruitwagen, Roy F. P. M.; Lukanova, Annekatrin; Allen, Naomi E.; Wark, Petra A.; Tjonneland, Anne; Hansen, Louise; Brauner, Christina Marie; Overvad, Kim; Clavel-Chapelon, Francoise; Chabbert-Buffet, Nathalie; Teucher, Birgit; Floegel, Anna; Boeing, Heiner; Trichopoulou, Antonia; Adarakis, George; Plada, Maria; Rinaldi, Sabina; Fedirko, Veronika; Romieu, Isabelle; Pala, Valeria; Galasso, Rocco; Sacerdote, Carlotta; Palli, Domenico; Tumino, Rosario; Bueno-de-Mesquita, H. Bas; Gram, Inger Torhild; Gavrilyuk, Oxana; Lund, Eiliv; Sanchez, Maria-Jose; Bonet, Catalina; Chirlaque, Maria-Dolores; Larranaga, Nerea; Barricarte Gurrea, Aurelio; Quiros, Jose R.; Idahl, Annika; Ohlson, Nina; Lundin, Eva; Jirstrom, Karin; Butt, Salma; Tsilidis, Konstantinos K.; Khaw, Kay-Tee; Wareham, Nick; Riboli, Elio; Kaaks, Rudolf; Peeters, Petra H. M.			Multiple Miscarriages Are Associated with the Risk of Ovarian Cancer: Results from the European Prospective Investigation into Cancer and Nutrition	PLOS ONE			English	Article							ABORTION; EPIDEMIOLOGY	While the risk of ovarian cancer clearly reduces with each full-term pregnancy, the effect of incomplete pregnancies is unclear. We investigated whether incomplete pregnancies (miscarriages and induced abortions) are associated with risk of epithelial ovarian cancer. This observational study was carried out in female participants of the European Prospective Investigation into Cancer and Nutrition (EPIC). A total of 274,442 women were followed from 1992 until 2010. The baseline questionnaire elicited information on miscarriages and induced abortions, reproductive history, and lifestyle-related factors. During a median follow-up of 11.5 years, 1,035 women were diagnosed with incident epithelial ovarian cancer. Despite the lack of an overall association (ever vs. never), risk of ovarian cancer was higher among women with multiple incomplete pregnancies (HR >= 4vs.0: 1.74, 95% CI: 1.20-2.70; number of cases in this category: n = 23). This association was particularly evident for multiple miscarriages (HR >= 4vs.0: 1.99, 95% CI: 1.06-3.73; number of cases in this category: n = 10), with no significant association for multiple induced abortions (HR >= 4vs.0: 1.46, 95% CI: 0.68-3.14; number of cases in this category: n = 7). Our findings suggest that multiple miscarriages are associated with an increased risk of epithelial ovarian cancer, possibly through a shared cluster of etiological factors or a common underlying pathology. These findings should be interpreted with caution as this is the first study to show this association and given the small number of cases in the highest exposure categories.	[Braem, Marieke G. M.; Onland-Moret, N. Charlotte; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schouten, Leo J.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands; [Kruitwagen, Roy F. P. M.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Obstet & Gynaecol, Med Ctr, Maastricht, Netherlands; [Lukanova, Annekatrin; Teucher, Birgit; Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Allen, Naomi E.; Tsilidis, Konstantinos K.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Wark, Petra A.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Tjonneland, Anne; Hansen, Louise] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Brauner, Christina Marie; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, F-94805 Villejuif, France; [Chabbert-Buffet, Nathalie] Univ Paris 06, Paris, France; [Chabbert-Buffet, Nathalie] Hosp Tenon, AP HP, Dept Gynecol, Paris, France; [Floegel, Anna; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Trichopoulou, Antonia] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-11527 Athens, Greece; [Trichopoulou, Antonia; Adarakis, George; Plada, Maria] Hellen Hlth Fdn, Athens, Greece; [Rinaldi, Sabina; Fedirko, Veronika; Romieu, Isabelle] Int Agcy Res Canc, Sect Nutr & Metab, Nutr Epidemiol Grp, F-69372 Lyon, France; [Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Nutr Epidemiol Unit, Milan, Italy; [Galasso, Rocco] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol Basilicata, Clin Epidemiol Unit, Biostat & Canc Registry, Rionero In Vulture, Italy; [Sacerdote, Carlotta] CPO Piemonte, Ctr Canc Prevent, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gram, Inger Torhild; Gavrilyuk, Oxana; Lund, Eiliv] Univ Tromso, Fac Hlth Sci, Inst Community Med, N-9001 Tromso, Norway; [Sanchez, Maria-Jose] Escuela Andaluza Salud Publ, Granada, Spain; [Sanchez, Maria-Jose; Chirlaque, Maria-Dolores; Larranaga, Nerea; Barricarte Gurrea, Aurelio] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Barcelona, Spain; [Bonet, Catalina] Catalan Inst Oncol, Canc Epidemiol Res Programme, Unit Nutr Environm & Canc, Barcelona, Spain; [Chirlaque, Maria-Dolores] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Larranaga, Nerea] Basque Govt, Publ Hlth Dept Gipuzkoa, Madrid, Spain; [Barricarte Gurrea, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Quiros, Jose R.] Publ Hlth & Hlth Planning Directorate, Asturias, Spain; [Idahl, Annika] Umea Univ, Dept Clin Sci Obstet & Gynecol, Umea, Sweden; [Idahl, Annika] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Ohlson, Nina; Lundin, Eva] Umea Univ, Dept Med Biosci, Umea, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Div Pathol, Dept Clin Sci, Lund, Sweden; [Butt, Salma] Lund Univ, Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Tsilidis, Konstantinos K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Khaw, Kay-Tee] Univ Cambridge, Cambridge, England; [Wareham, Nick] MRC, Epidemiol Unit Cambridge, Cambridge, England; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; Imperial College London; Danish Cancer Society; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; World Health Organization; International Agency for Research on Cancer (IARC); Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS CROB; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Catalan Institute of Oncology; Murcia Regional Health Council; Basque Government; Public Health Institute of Navarra; Umea University; Umea University; Umea University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Ioannina; University of Cambridge; Imperial College London	Braem, MGM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	m.g.m.braem@umcutrecht.nl	Sánchez, Maria-José/D-1087-2011; Pala, Valeria/K-4738-2016; Floegel, Anna/F-4854-2013; Schouten, Leo J/G-3713-2012; Onland-Moret, N. Charlotte/G-9185-2011; Galasso, Rocco/AAL-2150-2020; Teucher, Birgit/J-6380-2015; Schouten, Leo J/AAB-2275-2019; Clavel-Chapelon, Francoise/G-6733-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Khaw, Kay-Tee/AAZ-3209-2021; Wark, Petra/C-1752-2016	Sánchez, Maria-José/0000-0003-4817-0757; Pala, Valeria/0000-0001-5438-970X; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Galasso, Rocco/0000-0003-4831-6437; Schouten, Leo J/0000-0003-3361-7560; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; tumino, rosario/0000-0003-2666-414X; Tjonneland, Anne/0000-0003-4385-2097; Lund, Eiliv/0000-0002-8071-8711; Tsilidis, Konstantinos/0000-0002-8452-8472; Riboli, Elio/0000-0001-6795-6080; Floegel, Anna/0000-0001-9806-4288; Overvad, Kim/0000-0001-6429-7921; Kruitwagen, Roy F.P.M./0000-0002-1305-9541; Sacerdote, Carlotta/0000-0002-8008-5096; Larranaga, Nerea/0000-0002-9993-9880; PALLI, Domenico/0000-0002-5558-2437; Wark, Petra/0000-0003-1020-4640; Bonet, Catalina/0000-0003-0259-2591	Dutch Cancer Society [UU2008-4267]; European Commission (DG-SANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation; Stavros Niarchos Foundation; Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS); Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra, ISCIII RETIC (Spain) [RD06/0020]; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom); Medical Research Council [MC_U106179471, G0401527, G1000143] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); European Commission (DG-SANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany)(Deutsche Krebshilfe); Hellenic Health Foundation; Stavros Niarchos Foundation; Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy)(Fondazione AIRC per la ricerca sul cancro); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands)(Netherlands Government); Health Research Fund (FIS)(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra, ISCIII RETIC (Spain); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Dutch Cancer Society (UU2008-4267). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation, the Stavros Niarchos Foundation and the Hellenic Ministry of Health and Social Solidarity (Greece); Italian Association for Research on Cancer (AIRC) and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS), Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); Cancer Research United Kingdom, Medical Research Council (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BA, 1994, DEMOGRAPHY, V31, P115, DOI 10.2307/2061911; Christiansen OB, 1996, HUM REPROD UPDATE, V2, P271, DOI 10.1093/humupd/2.4.271; Dick MLB, 2009, CANCER CAUSE CONTROL, V20, P1571, DOI 10.1007/s10552-009-9402-3; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; La Vecchia C, 2001, EUR J CANCER PREV, V10, P125, DOI 10.1097/00008469-200104000-00002; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; MILLER H, 1969, FERTIL STERIL, V20, P433; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Potdar N, 2005, CURR OPIN OBSTET GYN, V17, P424, DOI 10.1097/01.gco.0000175363.20094.bd; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Riman T, 1998, CLIN ENDOCRINOL, V49, P695, DOI 10.1046/j.1365-2265.1998.00577.x; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Rookus MA, 1996, J NATL CANCER I, V88, P1759, DOI 10.1093/jnci/88.23.1759; Sueblinvong T, 2009, CURR TREAT OPTION ON, V10, P67, DOI 10.1007/s11864-009-0108-2; Tsilidis KK, 2011, BRIT J CANCER, V105, P1436, DOI 10.1038/bjc.2011.371	16	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37141	10.1371/journal.pone.0037141	http://dx.doi.org/10.1371/journal.pone.0037141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623987	Green Published, gold			2022-12-27	WOS:000305343500064
J	Chen, DP; Tseng, CP; Wang, WT; Sun, CF				Chen, Ding-Ping; Tseng, Ching-Ping; Wang, Wei-Ting; Sun, Chien-Feng			Genetic and Mechanistic Evaluation for the Mixed-Field Agglutination in B-3 Blood Type with IVS3+5G > A ABO Gene Mutation	PLOS ONE			English	Article							GROUP-A; TRANSFERASE; PROMOTER; ALLELE; CELL; GLYCOSYLTRANSFERASE; RECOMBINATION; TRANSCRIPTION; POLYMORPHISM; PHENOTYPES	Background: The ABO blood type B-3 is the most common B subtype in the Chinese population with a frequency of 1/900. Although IVS3+5G > A (rs55852701) mutation of B gene has been shown to associate with the development of B-3 blood type, genetic and mechanistic evaluation for the unique mixed-field agglutination phenotype has not yet been completely addressed. Methodology/Principal Findings: In this study, we analyzed 16 cases of confirmed B-3 individuals and found that IVS3+5G > A attributes to all cases of B-3. RT-PCR analyses revealed the presence of at least 7 types of aberrant B-3 splicing transcripts with most of the transcripts causing early termination and producing non-functional protein during translation. The splicing transcript without exon 3 that was predicted to generate functional B-3 glycosyltransferase lacking 19 amino acids at the N-terminal segment constituted only 0.9% of the splicing transcripts. Expression of the B-3 cDNA with exon 3 deletion in the K562 erythroleukemia cells revealed that the B-3 glycosyltransferase had only 40% of B-1 activity in converting H antigen to B antigen. Notably, the typical mixed-field agglutination of B-3-RBCs can be mimicked by adding anti-B antibody to the K562-B-3 cells. Conclusions/Significance: This study thereby demonstrates that both aberrant splicing of B transcripts and the reduced B-3 glycosyltransferase activity contribute to weak B expression and the mixed-field agglutination of B-3, adding to the complexity for the regulatory mechanisms of ABO gene expression.	[Chen, Ding-Ping; Wang, Wei-Ting; Sun, Chien-Feng] Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taoyuan County, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Kaohsiung, Taoyuan County, Taiwan; [Sun, Chien-Feng] Chang Gung Univ, Dept Pathol, Sch Med, Kaohsiung, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chen, DP (corresponding author), Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taoyuan County, Taiwan.	suncgj@adm.cgmh.org.tw		TSENG, CHING-PING/0000-0002-2587-210X	National Science Council, Taiwan [NSC 98-2320-B-182A-006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Grant NSC 98-2320-B-182A-006 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DP, 2011, ANN CLIN LAB SCI, V41, P346; Chen DP, 2005, VOX SANG, V88, P196, DOI 10.1111/j.1423-0410.2005.00608.x; Chester MA, 2001, TRANSFUS MED REV, V15, P177, DOI 10.1053/tmrv.2001.24591; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; Hou JW, 2006, ACTA PAEDIATR, V95, P1500, DOI 10.1080/08035250600617131; Hwang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025492; Irshaid NM, 1999, TRANSFUSION MED, V9, P219; Issitt, 1998, APPL BLOOD GROUP SER; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kominato Y, 2002, J BIOL CHEM, V277, P37936, DOI 10.1074/jbc.M204238200; Landsteiner K, 1900, ZENTRALBL BAKTERIOL, V27, P352; LINCHU M, 1986, TRANSFUSION, V26, P428, DOI 10.1046/j.1537-2995.1986.26587020118.x; Ogasawara K, 1996, BLOOD, V88, P2732, DOI 10.1182/blood.V88.7.2732.bloodjournal8872732; Ogasawara K, 1996, HUM GENET, V97, P777; Ogasawara K, 2001, IMMUNOGENETICS, V53, P190, DOI 10.1007/s002510100315; Olsson ML, 2000, TRANSFUSION, V40, p13S; Olsson ML, 2001, TRANSFUSION MED, V11, P295, DOI 10.1046/j.1365-3148.2001.00320.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Seltsam A, 2005, TRANSFUSION, V45, P1663, DOI 10.1111/j.1537-2995.2005.00558.x; Sun CF, 2003, VOX SANG, V85, P216, DOI 10.1046/j.1423-0410.2003.00349.x; Sun CF, 2003, TRANSFUSION, V43, P1138, DOI 10.1046/j.1537-2995.2003.00500.x; Symoens S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020121; Wakisaka KT, 2011, BBA-MOL BASIS DIS, V1812, P1452, DOI 10.1016/j.bbadis.2011.07.011; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146; YAMAMOTO F, 1995, GLYCOBIOLOGY, V5, P51, DOI 10.1093/glycob/5.1.51; YAMAMOTO FI, 1993, VOX SANG, V64, P116, DOI 10.1111/j.1423-0410.1993.tb02528.x; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yu LC, 2000, BIOCHEM BIOPH RES CO, V273, P459, DOI 10.1006/bbrc.2000.2962; Yu LC, 2002, BLOOD, V100, P1490, DOI 10.1182/blood-2002-01-0188; Zhu FM, 2008, TRANSFUSION, V48, P2476, DOI 10.1111/j.1537-2995.2008.01874.x	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37272	10.1371/journal.pone.0037272	http://dx.doi.org/10.1371/journal.pone.0037272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624005	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500088
J	Guimond, S; Massrieh, W				Guimond, Sylvain; Massrieh, Wael			Intricate Correlation between Body Posture, Personality Trait and Incidence of Body Pain: A Cross-Referential Study Report	PLOS ONE			English	Article							LOW-BACK-PAIN	Objective: Occupational back pain is a disorder that commonly affects the working population, resulting in disability, health-care utilization, and a heavy socioeconomic burden. Although the etiology of occupational pain remains largely unsolved, anecdotal evidence exists for the contribution of personality and posture to long-term pain management, pointing to a direct contribution of the mind-body axis. In the current study, we have conducted an extensive evaluation into the relationships between posture and personality. Method: We have sampled a random population of 100 subjects (50 men and 50 women) in the age range of 13-82 years based on their personality and biomechanical profiles. All subjects were French-Canadian, living in Canada between the Quebec and Sorel-Tracy areas. The Biotonix analyses and report were used on the subjects being tested in order to distinguish postural deviations. Personality was determined by using the Myers-Briggs Type Indicator questionnaire. Results: We establish a correlation between ideal and kyphosis-lordosis postures and extraverted personalities. Conversely, our studies establish a correlative relationship between flat back and sway-back postures with introverted personalities. Conclusion: Overall, our studies establish a novel correlative relationship between personality, posture and pain.	[Guimond, Sylvain] San Diego Univ Integrat Studies, San Diego, CA USA; [Massrieh, Wael] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada	McGill University	Guimond, S (corresponding author), Biotonix Inc, Quebec City, PQ, Canada.	waelmassrieh@gmail.com			San Diego University for Integrative Studies	San Diego University for Integrative Studies	Funding was provided by the San Diego University for Integrative Studies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2000, HLTH CARE COMMUNICAT; Andersson Gunnar B. J., 1997, P93; Argyle M, 1999, PSYCHOL INTERPERSONA; Briggs KC, 1998, MYERS BRIGGS TYPE IN; Briggs Myers I, 1980, GIFTS DIFFERING UNDE; Briggs-Myers I., 2003, MBTI MANUAL GUIDE DE, V3rd; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Garofalo JP, 1999, PSYCHOSOCIAL FACTORS, P164; Gori Luigi, 2005, Recenti Prog Med, V96, P89; Harrison DE, 2007, EUR SPINE J, V16, P213, DOI 10.1007/s00586-006-0081-4; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; HEILBRUN AB, 1988, J PERS ASSESS, V52, P420, DOI 10.1207/s15327752jpa5203_3; Johnson SM, 1993, TRANSFORMATION CHARA; Jung C.G., 1923, PSYCHOL TYPES; KAPLAN RM, 1994, HEALTH PSYCHOL, V13, P366, DOI 10.1037/0278-6133.13.4.366; Kendall K, 1983, MUSCLES TESTING FUNC; Marras WS, 2000, SPINE, V25, P3045, DOI 10.1097/00007632-200012010-00012; Missaoui B, 2008, NEUROPHYSIOL CLIN, V38, P447, DOI 10.1016/j.neucli.2008.09.004; Normand M, 2005, J MANIP PHYSIOL THER, V25, P246; Ono T, 2000, J DENT RES, V79, P1879, DOI 10.1177/00220345000790111101; Ryckman R. M., 2004, THEORIES PERSONALITY; Smith AJ, 2010, J ORTHOP SPORT PHYS, V40, P517, DOI 10.2519/jospt.2010.3369; Taylor SE, 1999, HLTH PSYCHOL; Wai EK, 2010, SPINE J, V10, P554, DOI 10.1016/j.spinee.2010.03.033	24	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37450	10.1371/journal.pone.0037450	http://dx.doi.org/10.1371/journal.pone.0037450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624034	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500119
J	Klinck, H; Mellinger, DK; Klinck, K; Bogue, NM; Luby, JC; Jump, WA; Shilling, GB; Litchendorf, T; Wood, AS; Schorr, GS; Baird, RW				Klinck, Holger; Mellinger, David K.; Klinck, Karolin; Bogue, Neil M.; Luby, James C.; Jump, William A.; Shilling, Geoffrey B.; Litchendorf, Trina; Wood, Angela S.; Schorr, Gregory S.; Baird, Robin W.			Near-Real-Time Acoustic Monitoring of Beaked Whales and Other Cetaceans Using a Seaglider (TM)	PLOS ONE			English	Article							CUVIERS ZIPHIUS-CAVIROSTRIS; ECHOLOCATION CLICKS; DIVING BEHAVIOR; CROSS-SEAMOUNT; KILLER WHALES; SITE FIDELITY; HAWAII; PATTERNS; MOVEMENTS; GLIDERS	In most areas, estimating the presence and distribution of cryptic marine mammal species, such as beaked whales, is extremely difficult using traditional observational techniques such as ship-based visual line transect surveys. Because acoustic methods permit detection of animals underwater, at night, and in poor weather conditions, passive acoustic observation has been used increasingly often over the last decade to study marine mammal distribution, abundance, and movements, as well as for mitigation of potentially harmful anthropogenic effects. However, there is demand for new, cost-effective tools that allow scientists to monitor areas of interest autonomously with high temporal and spatial resolution in near-real time. Here we describe an autonomous underwater vehicle - a glider - equipped with an acoustic sensor and onboard data processing capabilities to passively scan an area for marine mammals in near-real time. The glider was tested extensively off the west coast of the Island of Hawai'i, USA. The instrument covered approximately 390 km during three weeks at sea and collected a total of 194 h of acoustic data. Detections of beaked whales were successfully reported to shore in near-real time. Manual analysis of the recorded data revealed a high number of vocalizations of delphinids and sperm whales. Furthermore, the glider collected vocalizations of unknown origin very similar to those made by known species of beaked whales. The instrument developed here can be used to cost-effectively screen areas of interest for marine mammals for several months at a time. The near-real-time detection and reporting capabilities of the glider can help to protect marine mammals during potentially harmful anthropogenic activities such as seismic exploration for sub-sea fossil fuels or naval sonar exercises. Furthermore, the glider is capable of under-ice operation, allowing investigation of otherwise inaccessible polar environments that are critical habitats for many endangered marine mammal species.	[Klinck, Holger; Mellinger, David K.; Klinck, Karolin] Oregon State Univ, Hatfield Marine Sci Ctr, NOAA Pacific Marine Environm Lab, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Bogue, Neil M.; Luby, James C.; Jump, William A.; Shilling, Geoffrey B.; Litchendorf, Trina; Wood, Angela S.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Schorr, Gregory S.; Baird, Robin W.] Cascadia Res Collect, Olympia, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; University of Washington; University of Washington Seattle	Klinck, H (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, NOAA Pacific Marine Environm Lab, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	Holger.Klinck@oregonstate.edu	Klinck, Holger/X-5214-2019; Baird, Robin/Y-8230-2019	Klinck, Holger/0000-0003-1078-7268; Baird, Robin/0000-0002-9419-6336	Naval Postgraduate School (NPS) [N00244-08-1-0029, N00244-09-1-0079, N00244-10-1-0047]; Office of Naval Research (ONR) [N00014-08-1-0309, N00014-08-1-1082, N00014-10-1-0387, N00014-08-1-1198]; U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC); Wild Whale Research Foundation (WWRF)	Naval Postgraduate School (NPS); Office of Naval Research (ONR)(Office of Naval Research); U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC); Wild Whale Research Foundation (WWRF)	This work was supported by Naval Postgraduate School (NPS) grants N00244-08-1-0029, N00244-09-1-0079, and N00244-10-1-0047, and Office of Naval Research (ONR) grants N00014-08-1-0309, N00014-08-1-1082, N00014-10-1-0387, and N00014-08-1-1198. Cascadia Research Collective satellite tagging work was supported by the U.S. Navy (N45) through the Southwest Fisheries Science Center (NOAA/SWFSC) and by the Wild Whale Research Foundation (WWRF). NPS: http://www.nps.edu ONR: http://www.onr.navy.mil N45: http://www.navy.mil/local/n45 NOAA/SWFSC: http://swfsc.noaa.gov WWRF: http://www.wildwhaleresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; Aschettino JM, 2012, MAR MAMMAL SCI, V28, P666, DOI 10.1111/j.1748-7692.2011.00517.x; Baird R. W., 2003, P 15 BIENN C BIOL MA; Baird RW, 2008, MAR MAMMAL SCI, V24, P630, DOI 10.1111/j.1748-7692.2008.00211.x; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Benoit-Bird KJ, 2003, J ACOUST SOC AM, V114, P1888, DOI 10.1121/1.1612484; Dalebout ML, 2004, J HERED, V95, P459, DOI 10.1093/jhered/esh054; Eriksen CC, 2001, IEEE J OCEANIC ENG, V26, P424, DOI 10.1109/48.972073; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Klinck H, 2011, J ACOUST SOC AM, V129, P1807, DOI 10.1121/1.3531924; McDonald MA, 2009, J ACOUST SOC AM, V125, P624, DOI 10.1121/1.3050317; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mellinger DK, 2010, J ACOUST SOC AM, V128, P2299; Moore SE, 2007, MAR TECHNOL SOC J, V41, P53, DOI 10.4031/002533207787442033; Norris K.S., 1994, HAWAIIAN SPINNER DOL; Rankin S, 2011, J ACOUST SOC AM, V130, pEL339, DOI 10.1121/1.3646026; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; Rosi P, 2009, CURRENTS US NAVY WIN, P6; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Schorr Gregory S., 2010, Endangered Species Research, V10, P203, DOI 10.3354/esr00229; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Yack TM, 2010, APPL ACOUST, V71, P1043, DOI 10.1016/j.apacoust.2010.04.010; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277	30	69	71	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36128	10.1371/journal.pone.0036128	http://dx.doi.org/10.1371/journal.pone.0036128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629309	Green Published, gold			2022-12-27	WOS:000305343500010
J	Pin, C; Watson, AJM; Carding, SR				Pin, Carmen; Watson, Alastair J. M.; Carding, Simon R.			Modelling the Spatio-Temporal Cell Dynamics Reveals Novel Insights on Cell Differentiation and Proliferation in the Small Intestinal Crypt	PLOS ONE			English	Article							EPITHELIAL STEM-CELL; SELF-RENEWAL; PANETH CELLS; IN-VITRO; MOUSE; COMPACTION; CANCER; NOTCH; ORGANIZATION; HOMEOSTASIS	We developed a slow structural relaxation model to describe cellular dynamics in the crypt of the mouse small intestine. Cells are arranged in a three dimensional spiral the size of which dynamically changes according to cell production demands of adjacent villi. Cell differentiation and proliferation is regulated through Wnt and Notch signals, the strength of which depends on the local cell composition. The highest level of Wnt activity is associated with maintaining equipotent stem cells (SC), Paneth cells and common goblet-Paneth cell progenitors (CGPCPs) intermingling at the crypt bottom. Low levels of Wnt signalling area are associated with stem cells giving rise to secretory cells (CGPCPs, enteroendocrine or Tuft cells) and proliferative absorptive progenitors. Deciding between these two fates, secretory and stem/absorptive cells, depends on Notch signalling. Our model predicts that Notch signalling inhibits secretory fate if more than 50% of cells they are in contact with belong to the secretory lineage. CGPCPs under high Wnt signalling will differentiate into Paneth cells while those migrating out from the crypt bottom differentiate into goblet cells. We have assumed that mature Paneth cells migrating upwards undergo anoikis. Structural relaxation explains the localisation of Paneth cells to the crypt bottom in the absence of active forces. The predicted crypt generation time from one SC is 4-5 days with 10-12 days needed to reach a structural steady state. Our predictions are consistent with experimental observations made under altered Wnt and Notch signalling. Mutations affecting stem cells located at the crypt floor have a 50% chance of being propagated throughout the crypt while mutations in cells above are rarely propagated. The predicted recovery time of an injured crypt losing half of its cells is approximately 2 days.	[Pin, Carmen; Carding, Simon R.] Inst Food Res, Norwich, Norfolk, England; [Watson, Alastair J. M.; Carding, Simon R.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of East Anglia	Pin, C (corresponding author), Inst Food Res, Norwich, Norfolk, England.	carmen.pin@bbsrc.ac.uk	pin, carmen/C-8959-2014	Carding, Simon/0000-0002-2383-9701	Biotechnology and Biological Sciences Research Council (BBSRC) [44446, 44451]; BBSRC [BBS/E/F/00044446, BBS/E/F/00042262, BBS/E/F/00044406] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044406, BBS/E/F/00042262, BBS/E/F/00044446] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by the Biotechnology and Biological Sciences Research Council (BBSRC) strategic grants 44446 and 44451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Caglioti E, 1997, PHYS REV LETT, V79, P1575, DOI 10.1103/PhysRevLett.79.1575; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; CHWALINSKI S, 1989, AM J ANAT, V186, P397, DOI 10.1002/aja.1001860409; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Galle J, 2009, J MATH BIOL, V58, P261, DOI 10.1007/s00285-008-0172-4; Gerbe F, 2011, J CELL BIOL, V192, P767, DOI 10.1083/jcb.201010127; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; LOEFFLER M, 1986, CELL TISSUE KINET, V19, P627, DOI 10.1111/j.1365-2184.1986.tb00763.x; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V132, pA381; Nicodemi M, 1997, J PHYS A-MATH GEN, V30, pL379, DOI 10.1088/0305-4470/30/11/006; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; PAULUS U, 1993, J CELL SCI, V106, P473; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Peng GW, 1998, PHYS REV E, V57, P829, DOI 10.1103/PhysRevE.57.829; Piccioni M, 1999, PHYS REV E, V59, P3858, DOI 10.1103/PhysRevE.59.3858; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Takeda N, 2011, SCIENCE; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wright N. A., 1984, BIOL EPITHELIAL CELL, V1; WRIGHT NA, 1979, J CLIN PATHOL, V32, P462, DOI 10.1136/jcp.32.5.462; Wright NA, 1984, BIOL EPITHELIAL CELL, V2; Yan K. S., 2011, P NATL ACAD SCI US; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	61	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37115	10.1371/journal.pone.0037115	http://dx.doi.org/10.1371/journal.pone.0037115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623982	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500059
J	Tynan, GA; McNaughton, A; Jarnicki, A; Tsuji, T; Lavelle, EC				Tynan, Graham A.; McNaughton, Anne; Jarnicki, Andrew; Tsuji, Takao; Lavelle, Ed C.			Polymyxin B Inadequately Quenches the Effects of Contaminating Lipopolysaccharide on Murine Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; HEAT-SHOCK PROTEINS; GROUP BOX-1 PROTEIN; EPIDERMAL LANGERHANS CELLS; TUMOR-NECROSIS-FACTOR; INNATE IMMUNE-SYSTEM; HUMAN HEAT-SHOCK-PROTEIN-60; ENDOTOXIN CONTAMINATION; INFLAMMATORY RESPONSE; HUMAN NEUTROPHILS	Dendritic cell (DC) activation is commonly used as a measure of the immunomodulatory potential of candidate exogenous and endogenous molecules. Residual lipopolysaccharide (LPS) contamination is a recurring theme and the potency of LPS is not always fully appreciated. To address this, polymyxin B (PmB) is often used to neutralise contaminating LPS. However, the limited capacity of this antibiotic to successfully block these effects is neglected. Therefore, this study aimed to determine the minimum LPS concentration required to induce murine bone marrow-derived dendritic cell (BMDC) maturation and cytokine secretion and to assess the ability of PmB to inhibit these processes. LPS concentrations as low as 10 pg/ml and 20 pg/ml induced secretion of interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha respectively, while a concentration of 50 pg/ml promoted secretion of IL-12p40. A much higher threshold exists for IL-12p70 as an LPS concentration of 500 pg/ml was required to induce secretion of this cytokine. The efficacy of PmB varied substantially for different cytokines but this antibiotic was particularly limited in its ability to inhibit LPS-induced secretion of IL-6 and TNF-alpha. Furthermore, an LPS concentration of 50 pg/ml was sufficient to promote DC expression of costimulatory molecules and PmB was limited in its capacity to reverse this process when LPS concentrations of greater than 20 ng/ml were used. There is a common perception that LPS is heat resistant. However, heat treatment attenuated the ability of low concentrations of LPS to induce secretion of IL-6 and IL-12p40 by BMDCs, thus suggesting that heat-inactivation of protein preparations is also an ineffective control for discounting potential LPS contamination. Finally, LPS concentrations of less than 10 pg/ml were incapable of promoting secretion of IL-6 independently but could synergise with heat-labile enterotoxin (LT) to promote IL-6, indicating that reducing contaminating endotoxin concentrations to low pg/ml concentrations is essential to avoid misleading conclusions regarding candidate immunomodulators.	[Tynan, Graham A.; McNaughton, Anne; Lavelle, Ed C.] Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland; [Tynan, Graham A.; Lavelle, Ed C.] Trinity Coll Dublin, Immunol Res Ctr, Trinity Biomed Sci Inst, Dublin, Ireland; [Jarnicki, Andrew] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW 2308, Australia; [Tsuji, Takao] Fujita Hlth Univ, Dept Microbiol, Sch Med, Toyoake, Aichi, Japan	Trinity College Dublin; Trinity College Dublin; University of Newcastle; Fujita Health University	Tynan, GA (corresponding author), Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin, Ireland.	lavellee@tcd.ie	Lavelle, Ed/A-1716-2008	Lavelle, Ed/0000-0002-3167-1080	Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster [07/SRC/B1144]; Meningitis Research Foundation [0610.0]	Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster(Science Foundation Ireland); Meningitis Research Foundation(Meningitis Research Foundation (MRF))	This work was supported by Science Foundation Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster (07/SRC/B1144), and was also supported by the Meningitis Research Foundation (0610.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chen W, 1999, J IMMUNOL, V162, P3212; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kodaira Y, 2000, J IMMUNOL, V165, P1599, DOI 10.4049/jimmunol.165.3.1599; Krejcova D, 2009, NEUROENDOCRINOL LETT, V30, P106; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAJDE JA, 1993, PEPTIDES, V14, P629, DOI 10.1016/0196-9781(93)90155-A; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reed RC, 2003, J BIOL CHEM, V278, P31853, DOI 10.1074/jbc.M305480200; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; ROMANI N, 1989, J EXP MED, V169, P1169, DOI 10.1084/jem.169.3.1169; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	50	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37261	10.1371/journal.pone.0037261	http://dx.doi.org/10.1371/journal.pone.0037261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624003	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500085
J	Brown, MS; Sarnat, SE; DeMuth, KA; Brown, LAS; Whitlock, DR; Brown, SW; Tolbert, PE; Fitzpatrick, AM				Brown, Meredith S.; Sarnat, Stefanie Ebelt; DeMuth, Karen A.; Brown, Lou Ann S.; Whitlock, Denise R.; Brown, Shanae W.; Tolbert, Paige E.; Fitzpatrick, Anne M.			Residential Proximity to a Major Roadway Is Associated with Features of Asthma Control in Children	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; AMBIENT AIR-POLLUTION; BREATH CONDENSATE PH; RESPIRATORY SYMPTOMS; ALLERGIC SENSITIZATION; EXPOSURE; POPULATION; INFLAMMATION; INFECTIONS; OUTCOMES	Background: While several studies suggest that traffic-related air pollutants are detrimental for respiratory health, few studies have examined relationships between residential proximity to a major roadway and asthma control in children. Furthermore, a major limitation of existing research is reliance on self-reported outcomes. We therefore determined the spatial relationship between the distance from a major roadway and clinical, physiologic and inflammatory features of asthma in a highly characterized sample of asthmatic children 6-17 years of age across a wide range of severities. We hypothesized that a closer residential proximity to a major roadway would be associated with increased respiratory symptoms, altered pulmonary function and a greater magnitude of airway and systemic inflammation. Methodology/Principal Findings: 224 children 6-17 years with confirmed asthma completed questionnaires and underwent spirometry, plethysmography, exhaled nitric oxide determination, exhaled breath condensate collection and venipuncture. Residential distance from a major roadway was determined by mapping the geographic coordinates of the residential address in Geographic Information System software. The distance between the home address and the nearest major roadway was calculated according to the shortest distance between the two points (i.e., "as the crow flies"). Asthmatic children living in closer proximity to a major roadway had an increased frequency of wheezing associated with increased medication requirements and more hospitalizations even after controlling for potential confounders. These children also had increased airway resistance, increased airway inflammation reflected by a lower breath condensate pH, and higher plasma EGF concentrations. Conclusions/Significance: These findings suggest that closer residential proximity to a major roadway is associated with poorer asthma control in school-age children. Assessment of residential proximity to major roadways may be useful in the clinical evaluation of asthma in children.	[Brown, Meredith S.; DeMuth, Karen A.; Brown, Lou Ann S.; Whitlock, Denise R.; Brown, Shanae W.; Fitzpatrick, Anne M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Sarnat, Stefanie Ebelt; Tolbert, Paige E.] Emory Univ, Dept Environm & Occupat Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Brown, Lou Ann S.; Fitzpatrick, Anne M.] Childrens Healthcare Atlanta Ctr Dev Lung Biol, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Children's Healthcare of Atlanta (CHOA)	Brown, MS (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	anne.fitzpatrick@emory.edu	Tolbert, Paige E/A-5676-2015	Fitzpatrick, Anne/0000-0002-2933-5926	NIH [RO1 NR012021]; PHS [UL1RR025008]; Emory University; U.S. Environmental Protection Agency [RD834799]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Emory University; U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported in part by NIH RO1 NR012021, PHS Grant UL1RR025008 from the Clinical and Translational Science Award program, the Scholarly Inquiry and Research Program at Emory University, and U.S. Environmental Protection Agency Grant RD834799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Lung Association Epidemiology and Statistics Unit, 2012, EST PREV INC LUNG DI; American Lung Association Epidemiology and Statistics Unit, 2011, TRENDS ASTH MORB MOR; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Andersen ZJ, 2008, THORAX, V63, P710, DOI 10.1136/thx.2007.085480; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Blackwell A, 2007, GEORGIA ASTHMA SURVE; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Carraro S, 2005, ALLERGY, V60, P476, DOI 10.1111/j.1398-9995.2005.00718.x; Cazzola M, 2011, EUR RESPIR J, V38, P42, DOI 10.1183/09031936.00140310; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P153; Chang J, 2009, OCCUP ENVIRON MED, V66, P90, DOI 10.1136/oem.2008.039412; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Dales R, 2009, EUR RESPIR J, V34, P316, DOI 10.1183/09031936.00138908; Dales R, 2009, J OCCUP ENVIRON MED, V51, P654, DOI 10.1097/JOM.0b013e3181a0363c; DiMango E, 2009, AM J RESP CRIT CARE, V180, P809, DOI 10.1164/rccm.200904-0625OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Escamilla-Nunez MC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-74; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P282, DOI 10.1016/j.jaci.2010.10.036; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gent JF, 2009, ENVIRON HEALTH PERSP, V117, P1168, DOI 10.1289/ehp.0800335; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Holbrook JT, 2012, JAMA-J AM MED ASSOC, V307, P373, DOI 10.1001/jama.2011.2035; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Islam T, 2011, AM J RESP CRIT CARE; Kuehni CE, 2006, INT J EPIDEMIOL, V35, P779, DOI 10.1093/ije/dyl022; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; Kunzli N, 2000, EUR RESPIR J, V15, P131; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Li S, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-34; Liu L, 2011, CHEST, V139, P328, DOI 10.1378/chest.10-0163; Mann JK, 2010, ENVIRON HEALTH PERSP, V118, P1497, DOI 10.1289/ehp.0901292; Martins PC, 2012, EUR RESPIR J, V39, P246, DOI 10.1183/09031936.00025111; McConnell R, 2006, SCI TOTAL ENVIRON, V363, P166, DOI 10.1016/j.scitotenv.2005.06.028; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Meng YY, 2008, ANN EPIDEMIOL, V18, P343, DOI 10.1016/j.annepidem.2008.01.006; Michils A, 2008, EUR RESPIR J, V31, P539, DOI 10.1183/09031936.00020407; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Transportation Atlas Database. National Highway Planning Network The Bureau of Transportation Statistics, 2010, NAT TRANSP ATL DAT; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Nuvolone D, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-12; Paget-Brown AO, 2006, CHEST, V129, P426, DOI 10.1378/chest.129.2.426; Patel MM, 2009, AM J RESP CRIT CARE, V180, P1107, DOI 10.1164/rccm.200901-0122OC; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Renzetti G, 2009, PEDIATRICS, V123, P1051, DOI 10.1542/peds.2008-1153; Romieu I, 2008, J ALLERGY CLIN IMMUN, V121, P903, DOI 10.1016/j.jaci.2007.12.004; Rosenlund M, 2009, THORAX, V64, P573, DOI 10.1136/thx.2007.094953; Sarnat SE, 2012, ENVIRON HEALTH PERSP, V120, P437, DOI 10.1289/ehp.1003169; Schwartz J, 2004, PEDIATRICS, V113, P1037; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Spira-Cohen A, 2011, ENVIRON HEALTH PERSP, V119, P559, DOI 10.1289/ehp.1002653; Strickland MJ, 2010, AM J RESP CRIT CARE, V182, P307, DOI 10.1164/rccm.200908-1201OC; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Thakkar K, 2010, PEDIATRICS, V125, pE925, DOI 10.1542/peds.2009-2382; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; von Jagwitz M, 2011, J ALLERGY CLIN IMMUN, V128, P50, DOI 10.1016/j.jaci.2011.03.005	64	25	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37044	10.1371/journal.pone.0037044	http://dx.doi.org/10.1371/journal.pone.0037044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615884	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200036
J	Gong, X; Carmon, KS; Lin, QS; Thomas, A; Yi, J; Liu, QY				Gong, Xing; Carmon, Kendra S.; Lin, Qiushi; Thomas, Anthony; Yi, Jing; Liu, Qingyun			LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; COLORECTAL-CANCER; STEM-CELLS; WNT/BETA-CATENIN; CRYSTAL-STRUCTURES; HAIR FOLLICLE; WNT PATHWAY; NULL MICE; LRP6; COMPLEX	Background: LGR6 (leucine-rich repeat containing, G protein-coupled receptor 6) is a member of the rhodopsin-like seven transmembrane domain receptor superfamily with the highest homology to LGR4 and LGR5. LGR6 was found as one of the novel genes mutated in colon cancer through total exon sequencing and its promoter region is hypermethylated in 20-50% of colon cancer cases. In the skin, LGR6 marks a population of stem cells that can give rise to all cell lineages. Recently, we and others demonstrated that LGR4 and LGR5 function as receptors of R-spondins to potentiate Wnt/beta-catenin signaling. However, the binding affinity and functional response of LGR6 to R-spondins, and the activity of colon cancer mutants of LGR6 have not been determined. Principal Findings: We found that LGR6 also binds and responds to R-spondins 1-3 with high affinity to enhance Wnt/beta-catenin signaling through increased LRP6 phosphorylation. Similar to LGR4 and LGR5, LGR6 is not coupled to heterotrimeric G proteins or to beta-arrestin following R-spondin stimulation. Functional and expression analysis of three somatic mutations identified in colon cancer samples indicates that one mutant fails to bind and respond to R-spondin (loss-of-function), but the other two have no significant effect on receptor function. Overexpression of wild-type LGR6 in HeLa cells leads to increased cell migration following co-treatment with R-spondin1 and Wnt3a when compared to vector control cells or cells overexpressing the loss-of-function mutant. Conclusions: LGR6 is a high affinity receptor for R-spondins 1-3 and potentially functions as a tumor suppressor despite its positive effect on Wnt/beta-catenin signaling.	[Gong, Xing] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA; Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Gong, X (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA.	Qingyun.Liu@uth.tmc.edu	Yi, Jing/S-2586-2016	Yi, Jing/0000-0001-5037-1924; Carmon, Kendra/0000-0002-3244-6096	Cancer Prevention and Research Institute of Texas (CPRIT) [RP100678]	Cancer Prevention and Research Institute of Texas (CPRIT)	This work was supported in part by Grant RP100678 from the Cancer Prevention and Research Institute of Texas (CPRIT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Ben-Shlomo I, 2007, MOL ENDOCRINOL, V21, P2009, DOI 10.1210/me.2007-0087; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bordonaro M, 2008, ONCOL RES, V17, P1; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Lorenzi L, 2008, SEX DEV, V2, P84, DOI 10.1159/000129693; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Luo Ching-Wei, 2006, Chang Gung Med J, V29, P2; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	60	76	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37137	10.1371/journal.pone.0037137	http://dx.doi.org/10.1371/journal.pone.0037137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615920	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200043
J	Fan, WJ; Zhang, M; Zhang, HX; Zhang, P				Fan, Weijuan; Zhang, Min; Zhang, Hongxia; Zhang, Peng			Improved Tolerance to Various Abiotic Stresses in Transgenic Sweet Potato (Ipomoea batatas) Expressing Spinach Betaine Aldehyde Dehydrogenase	PLOS ONE			English	Article							PHOTOSYSTEM-II; GLYCINE BETAINE; CHOLINE OXIDASE; DROUGHT TOLERANCE; OXIDATIVE STRESS; WATER-STRESS; SALT STRESS; PLANTS; BIOSYNTHESIS; ACCUMULATION	Abiotic stresses are critical delimiters for the increased productivity and cultivation expansion of sweet potato (Ipomoea batatas), a root crop with worldwide importance. The increased production of glycine betaine (GB) improves plant tolerance to various abiotic stresses without strong phenotypic changes, providing a feasible approach to improve stable yield production under unfavorable conditions. The gene encoding betaine aldehyde dehydrogenase (BADH) is involved in the biosynthesis of GB in plants, and the accumulation of GB by the heterologous overexpression of BADH improves abiotic stress tolerance in plants. This study is to improve sweet potato, a GB accumulator, resistant to multiple abiotic stresses by promoted GB biosynthesis. A chloroplastic BADH gene from Spinacia oleracea (SoBADH) was introduced into the sweet potato cultivar Sushu-2 via Agrobacterium-mediated transformation. The overexpression of SoBADH in the transgenic sweet potato improved tolerance to various abiotic stresses, including salt, oxidative stress, and low temperature. The increased BADH activity and GB accumulation in the transgenic plant lines under normal and multiple environmental stresses resulted in increased protection against cell damage through the maintenance of cell membrane integrity, stronger photosynthetic activity, reduced reactive oxygen species (ROS) production, and induction or activation of ROS scavenging by the increased activity of free radical-scavenging enzymes. The increased proline accumulation and systemic upregulation of many ROS-scavenging genes in stress-treated transgenic plants also indicated that GB accumulation might stimulate the ROS-scavenging system and proline biosynthesis via an integrative mechanism. This study demonstrates that the enhancement of GB biosynthesis in sweet potato is an effective and feasible approach to improve its tolerance to multiple abiotic stresses without causing phenotypic defects. This strategy for trait improvement in sweet potato not only stabilizes yield production in normal soils in unpredictable climates but also provides a novel germplasm for sweet potato production on marginal lands.	[Fan, Weijuan; Zhang, Hongxia; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zhang, Min; Zhang, Peng] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhang, Min; Zhang, Peng] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Fan, WJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	zhangpeng@sibs.ac.cn	Peng Zhang, Dr./A-6423-2008	Peng Zhang, Dr./0000-0002-4868-1306	National High Technology Research and Development Program of China [2009AA10Z102]; Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration [G102410]; Shanghai Science and Technology Committee [09DZ2271800]; Chinese Academy of Sciences [KSCX2-EW-J-12]; Shanghai Key Laboratory of Bio-Energy Crops	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Key Laboratory of Bio-Energy Crops	This work was supported by grants from the National High Technology Research and Development Program of China (No. 2009AA10Z102), Shanghai Municipal Afforestation & City Appearance and Environmental Sanitation Administration (G102410), Shanghai Science and Technology Committee (No. 09DZ2271800) and the Chinese Academy of Sciences (KSCX2-EW-J-12). The Shanghai Key Laboratory of Bio-Energy Crops also supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taweel K, 2007, PLANT PHYSIOL, V145, P258, DOI 10.1104/pp.107.101733; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; [Anonymous], 1992, SWEET POTATO UNTAPPE; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; DHINDSA RS, 1981, J EXP BOT, V32, P79, DOI 10.1093/jxb/32.1.79; Dhir SK, 2009, COMPENDIUM TRANSGENI, P157; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; HANSON AD, 1979, CROP SCI, V19, P489, DOI 10.2135/cropsci1979.0011183X001900040015x; Hayashi H, 1997, PLANT J, V12, P133, DOI 10.1046/j.1365-313X.1997.12010133.x; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang J, 2000, PLANT PHYSIOL, V122, P747, DOI 10.1104/pp.122.3.747; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; Jewell MC, 2010, TRANSGENIC CROP PLANTS: VOL 2, P67, DOI 10.1007/978-3-642-04812-8_2; Jia GX, 2002, PLANT CELL REP, V21, P141, DOI 10.1007/s00299-002-0489-1; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Khan MS, 2009, PLANT BIOTECHNOL-NAR, V26, P125, DOI 10.5511/plantbiotechnology.26.125; Kim SH, 2005, BIOTECHNOL LETT, V27, P1841, DOI 10.1007/s10529-005-3891-2; Kim YH, 2008, PLANTA, V227, P867, DOI 10.1007/s00425-007-0663-3; Kou JianPing, 2008, Kezaisheng Nengyuan / Renewable Energy Resources, V26, P3; Lebot V, 2010, HANDB PLANT BREED, V7, P97, DOI 10.1007/978-0-387-92765-7_3; Makela P, 1996, PLANT SCI, V121, P221, DOI 10.1016/S0168-9452(96)04527-X; Martin F. W., 1982, Sweet potato. Proceedings of the first international symposium, Taiwan, 23-27 March 1981., P275; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; MOHANTY P, 1993, BIOCHIM BIOPHYS ACTA, V1144, P92, DOI 10.1016/0005-2728(93)90035-E; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; PAPAGEORGIOU GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P361, DOI 10.1016/S0005-2728(05)80148-3; Park EJ, 2004, PLANT J, V40, P474, DOI 10.1111/j.1365-313X.2004.02237.x; Park EJ, 2007, PLANT CELL ENVIRON, V30, P994, DOI 10.1111/j.1365-3040.2007.01694.x; Park EJ, 2007, PLANT BIOTECHNOL J, V5, P422, DOI 10.1111/j.1467-7652.2007.00251.x; Park EJ, 2006, J CROP IMPROV, V17, P69, DOI 10.1300/J411v17n01_04; Quan RD, 2004, PLANT BIOTECHNOL J, V2, P477, DOI 10.1111/j.1467-7652.2004.00093.x; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Sakamoto A, 2000, J EXP BOT, V51, P81, DOI 10.1093/jexbot/51.342.81; Sakamoto A, 2002, PLANT CELL ENVIRON, V25, P163, DOI 10.1046/j.0016-8025.2001.00790.x; Sakamoto A, 2001, PLANT PHYSIOL, V125, P180, DOI 10.1104/pp.125.1.180; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Su J, 2006, J EXP BOT, V57, P1129, DOI 10.1093/jxb/erj133; Sulpice R, 2003, PLANT J, V36, P165, DOI 10.1046/j.1365-313X.2003.01873.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tian YS, 2009, APPL ENERG, V86, pS77, DOI 10.1016/j.apenergy.2009.06.007; Tunnacliffe A, 2010, TOP CURR GENET, V21, P91, DOI 10.1007/978-3-642-12422-8_6; Uozumi N, 2010, SIGNAL COMMUN PLANTS, P1, DOI 10.1007/978-3-642-10494-7_1; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WERETILNYK EA, 1989, ARCH BIOCHEM BIOPHYS, V271, P56, DOI 10.1016/0003-9861(89)90255-5; Wu CZ, 2010, ENERGY, V35, P4445, DOI 10.1016/j.energy.2009.04.006; Yan LiangZheng, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P213; [杨俊 YANG Jun], 2011, [植物生理学报, Plant Physiology Journal], V47, P427; Yang J, 2011, PLANT SCI, V181, P701, DOI 10.1016/j.plantsci.2011.01.005; Yang XH, 2005, PLANT PHYSIOL, V138, P2299, DOI 10.1104/pp.105.063164; Yang XH, 2008, PLANT MOL BIOL, V66, P73, DOI 10.1007/s11103-007-9253-9; Zhang LA, 2011, BIORESOURCE TECHNOL, V102, P4573, DOI 10.1016/j.biortech.2010.12.115; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	72	140	157	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37344	10.1371/journal.pone.0037344	http://dx.doi.org/10.1371/journal.pone.0037344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615986	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300104
J	Hermesh, T; Moran, TM; Jain, D; Lopez, CB				Hermesh, Tamar; Moran, Thomas M.; Jain, Deepika; Lopez, Carolina B.			Granulocyte Colony-Stimulating Factor Protects Mice during Respiratory Virus Infections	PLOS ONE			English	Article							G-CSF; DEFICIENT MICE; BONE-MARROW; LUNG INJURY; ADAPTIVE IMMUNITY; CANDIDA-ALBICANS; NEUTROPHILS; CELLS; INDUCTION; LACKING	A burst in the production of pro-inflammatory molecules characterizes the beginning of the host response to infection. Cytokines, chemokines, and growth factors work in concert to control pathogen replication and activate innate and adaptive immune responses. Granulocyte colony-stimulating factor (G-CSF) mobilizes and activates hematopoietic cells from the bone marrow, and it has been shown to mediate the generation of effective immunity against bacterial and fungal infections. G-CSF is produced at high levels in the lungs during infection with influenza and parainfluenza viruses, but its role during these infections is unknown. Here we show that during infection of mice with a non-lethal dose of influenza or Sendai virus, G-CSF promotes the accumulation of activated Ly6G(+) granulocytes that control the extent of the lung pro-inflammatory response. Remarkably, these G-CSF-mediated effects facilitate viral clearance and sustain mouse survival.	[Hermesh, Tamar; Moran, Thomas M.; Lopez, Carolina B.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Hermesh, Tamar; Moran, Thomas M.; Lopez, Carolina B.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Jain, Deepika; Lopez, Carolina B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Jain, Deepika; Lopez, Carolina B.] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; University of Pennsylvania	Hermesh, T (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	lopezca@vet.upenn.edu	Lopez, Carolina/A-8887-2008	Lopez, Carolina/0000-0002-7669-6572	National Institutes of Health [AI082970, AI41111, AI083481, AI083284]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083284, R01AI041111, U01AI082970, R21AI083481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants AI082970 and AI41111 to TMM and AI083481 and AI083284 to CBL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Anderlini P, 2008, BLOOD, V111, P1767, DOI 10.1182/blood-2007-07-097543; Basu S, 2000, BLOOD, V95, P3725; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Basu S, 2008, GROWTH FACTORS, V26, P23, DOI 10.1080/08977190801987513; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Daley JM, 2007, J LEUKOCYTE BIOL; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Jain D, 2007, AM J PHYSIOL-LUNG C, V292, pL861, DOI 10.1152/ajplung.00145.2006; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Lopez CB, 2006, J VIROL, V80, P4538, DOI 10.1128/JVI.80.9.4538-4545.2006; Lopez CB, 2000, CELL IMMUNOL, V206, P107, DOI 10.1006/cimm.2000.1736; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Pamphilon D, 2008, TRANSFUSION, V48, P1495, DOI 10.1111/j.1537-2995.2008.01694.x; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; TAMURA M, 1987, BIOCHEM BIOPH RES CO, V142, P454, DOI 10.1016/0006-291X(87)90296-8; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	28	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37334	10.1371/journal.pone.0037334	http://dx.doi.org/10.1371/journal.pone.0037334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615983	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300103
J	Tabak, JA; Zayas, V				Tabak, Joshua A.; Zayas, Vivian			The Roles of Featural and Configural Face Processing in Snap Judgments of Sexual Orientation	PLOS ONE			English	Article							UPSIDE-DOWN FACES; INVERTED FACES; PERCEPTION; RECOGNITION; INFORMATION; CATEGORIZATION; INVERSION; ACCURACY	Research has shown that people are able to judge sexual orientation from faces with above-chance accuracy, but little is known about how these judgments are formed. Here, we investigated the importance of well-established face processing mechanisms in such judgments: featural processing (e.g., an eye) and configural processing (e.g., spatial distance between eyes). Participants judged sexual orientation from faces presented for 50 milliseconds either upright, which recruits both configural and featural processing, or upside-down, when configural processing is strongly impaired and featural processing remains relatively intact. Although participants judged women's and men's sexual orientation with above-chance accuracy for upright faces and for upside-down faces, accuracy for upside-down faces was significantly reduced. The reduced judgment accuracy for upside-down faces indicates that configural face processing significantly contributes to accurate snap judgments of sexual orientation.	[Tabak, Joshua A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Zayas, Vivian] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	University of Washington; University of Washington Seattle; Cornell University	Tabak, JA (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	tabak@uw.edu			National Science Foundation [DGE-0718124]; Association for Psychological Science; Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences	National Science Foundation(National Science Foundation (NSF)); Association for Psychological Science; Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences	This paper is based upon work supported by a National Science Foundation Graduate Research Fellowship awarded to Joshua A. Tabak under Grant No. DGE-0718124 (http://nsf.gov). This research program was funded in part by grants awarded to Joshua A. Tabak by the Association for Psychological Science (http://psychologicalscience.org) and Cornell University's Einhorn Family Charitable Trust Endowment, Cognitive Science Program, and College of Arts and Sciences (http://cornell.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WE AR TV; Bailey JM, 2003, PSYCHOL PERSPECTIVES, P50; Bailey JM, 2009, CONT PERSPECTIVES LE; Barton JJS, 2001, BRIT J PSYCHOL, V92, P527, DOI 10.1348/000712601162329; Baudouin JY, 2006, PERCEPTION, V35, P531, DOI 10.1068/p3403; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cellerino A, 2004, BRAIN RES BULL, V63, P443, DOI 10.1016/j.brainresbull.2004.03.010; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Diamond L. M., 2008, SEXUAL FLUIDITY UNDE; Diamond LM, 2004, CURR DIR PSYCHOL SCI, V13, P116, DOI 10.1111/j.0963-7214.2004.00287.x; Draine SC, 2009, INQUISIT 3 0 3 2; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; GREENWALD AG, 1980, AM PSYCHOL, V35, P603, DOI 10.1037//0003-066X.35.7.603; Hazan C., 2000, REV GEN PSYCHOL, V4, P186, DOI [10.1037/1089-2680.4.2.186, DOI 10.1037/1089-2680.4.2.186]; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Kinnish KK, 2005, ARCH SEX BEHAV, V34, P173, DOI 10.1007/s10508-005-1795-9; KLAYMAN J, 1995, PSYCHOL LEARN MOTIV, V32, P385, DOI DOI 10.1016/S0079-7421(08)60315-1; Leder H, 2001, PERCEPTION, V30, P73, DOI 10.1068/p2911; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Macrae CN, 2007, EUR J SOC PSYCHOL, V37, P793, DOI 10.1002/ejsp.406; Macrae CN, 2005, J PERS SOC PSYCHOL, V89, P686, DOI 10.1037/0022-3514.89.5.686; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Murray JE, 2000, PSYCHOL SCI, V11, P492, DOI 10.1111/1467-9280.00294; Prins N, RE PHASE SPECTRUM SC; RAE G, 1976, PERCEPT MOTOR SKILL, V42, P98, DOI 10.2466/pms.1976.42.1.98; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2011, PERS SOC PSYCHOL B, V37, P1499, DOI 10.1177/0146167211415630; Rule NO, 2011, PSYCHOL SCI, V22, P881, DOI 10.1177/0956797611412394; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Tabak JA, 2011, GAYDAR SEXUAL ORIENT; Tabak JA, 2010, 11 ANN M SOC PERS SO; Tickle NR, 2003, YOU CAN READ FACE BO; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	44	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36671	10.1371/journal.pone.0036671	http://dx.doi.org/10.1371/journal.pone.0036671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22629321	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300023
J	Xu, JF; Fan, X; Zhang, XW; Xu, D; Mou, SL; Cao, SN; Zheng, Z; Miao, JL; Ye, NH				Xu, Jianfang; Fan, Xiao; Zhang, Xiaowen; Xu, Dong; Mou, Shanli; Cao, Shaona; Zheng, Zhou; Miao, Jinlai; Ye, Naihao			Evidence of Coexistence of C-3 and C-4 Photosynthetic Pathways in a Green-Tide-Forming Alga, Ulva prolifera	PLOS ONE			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; MULTIPLE SEQUENCE ALIGNMENT; CARBON ASSIMILATION; PHAEODACTYLUM-TRICORNUTUM; CO2/O2 SPECIFICITY; MARINE DIATOMS; KRANZ ANATOMY; METABOLISM; EVOLUTIONARY; GENOME	Ulva prolifera, a typical green-tide-forming alga, can accumulate a large biomass in a relatively short time period, suggesting that photosynthesis in this organism, particularly its carbon fixation pathway, must be very efficient. Green algae are known to generally perform C-3 photosynthesis, but recent metabolic labeling and genome sequencing data suggest that they may also perform C-4 photosynthesis, so C-4 photosynthesis might be more wide-spread than previously anticipated. Both C-3 and C-4 photosynthesis genes were found in U. prolifera by transcriptome sequencing. We also discovered the key enzymes of C-4 metabolism based on functional analysis, such as pyruvate orthophosphate dikinase (PPDK), phosphoenolpyruvate carboxylase (PEPC), and phosphoenolpyruvate carboxykinase (PCK). To investigate whether the alga operates a C-4-like pathway, the expression of rbcL and PPDK and their enzyme activities were measured under various forms and intensities of stress (differing levels of salinity, light intensity, and temperature). The expression of rbcL and PPDK and their enzyme activities were higher under adverse circumstances. However, under conditions of desiccation, the expression of rbcL and ribulose-1, 5-biphosphate carboxylase (RuBPCase) activity was lower, whereas that of PPDK was higher. These results suggest that elevated PPDK activity may alter carbon metabolism and lead to a partial operation of C-4-type carbon metabolism in U. prolifera, probably contributing to its wide distribution and massive, repeated blooms in the Yellow Sea.	[Xu, Jianfang; Mou, Shanli; Zheng, Zhou; Miao, Jinlai] State Ocean Adm, Inst Oceanog 1, Key Lab Marine Bioact Substance, Qingdao, Peoples R China; [Fan, Xiao; Zhang, Xiaowen; Xu, Dong; Ye, Naihao] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Cao, Shaona] Qingdao Agr Univ, Qingdao, Peoples R China	State Oceanic Administration; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Qingdao Agricultural University	Xu, JF (corresponding author), State Ocean Adm, Inst Oceanog 1, Key Lab Marine Bioact Substance, Qingdao, Peoples R China.	yenh@ysfri.ac.cn			Shandong Science and Technology plan project [2011GHY11528]; Specialized Fund for the Basic Research Operating expenses Program [20603022012004]; National Natural Science Foundation of China [41176153]; Natural Science Foundation of Shandong Province [2009ZRA02075]; Qingdao Municipal Science and Technology plan project [11-3-1-5-hy, 10-3-4-11-1-jch]; National Marine Public Welfare Research Project [200805069]	Shandong Science and Technology plan project; Specialized Fund for the Basic Research Operating expenses Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Qingdao Municipal Science and Technology plan project; National Marine Public Welfare Research Project	This work was supported by Shandong Science and Technology plan project (2011GHY11528), the Specialized Fund for the Basic Research Operating expenses Program (20603022012004), National Natural Science Foundation of China (41176153), Natural Science Foundation of Shandong Province (2009ZRA02075), Qingdao Municipal Science and Technology plan project (11-3-1-5-hy), Qingdao Municipal Science and Technology plan project (10-3-4-11-1-jch), National Marine Public Welfare Research Project (200805069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018862; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BEER S, 1986, PLANT PHYSIOL, V81, P937, DOI 10.1104/pp.81.3.937; BEER S, 1990, PLANT PHYSIOL, V94, P1542, DOI 10.1104/pp.94.4.1542; Bischof K, 2002, PLANTA, V215, P502, DOI 10.1007/s00425-002-0774-9; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Brautigam A, 2008, PLANT PHYSIOL, V148, P568, DOI 10.1104/pp.108.121012; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Casati P, 2000, PLANT PHYSIOL, V123, P1611, DOI 10.1104/pp.123.4.1611; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Chen M, 2012, EUR J LIPID SCI TECH, V114, P205, DOI 10.1002/ejlt.201100120; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dong MT, 2012, PLANT MOL BIOL REP, V30, P10, DOI 10.1007/s11105-011-0311-8; DRECHSLER Z, 1991, PLANT PHYSIOL, V97, P1439, DOI 10.1104/pp.97.4.1439; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fleming ED, 2007, J PHYCOL, V43, P15, DOI 10.1111/j.1529-8817.2006.00297.x; Gerard VA, 1996, J PHYCOL, V32, P880, DOI 10.1111/j.0022-3646.1996.00880.x; Gowik U, 2011, PLANT CELL, V23, P2087, DOI 10.1105/tpc.111.086264; Gowik U, 2011, PLANT PHYSIOL, V155, P56, DOI 10.1104/pp.110.165308; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishimaru K, 1998, PHYSIOL PLANTARUM, V103, P340, DOI 10.1034/j.1399-3054.1998.1030306.x; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; JOSHI GV, 1974, PHOTOSYNTHETICA, V8, P51; KAREKAR MD, 1973, BOT MAR, V16, P216, DOI 10.1515/botm.1973.16.4.216; Keeley JE, 1998, OECOLOGIA, V116, P85, DOI 10.1007/s004420050566; Keeley JE, 1999, FUNCT ECOL, V13, P106, DOI 10.1046/j.1365-2435.1999.00294.x; KREMER BP, 1977, PLANTA, V133, P191, DOI 10.1007/BF00391918; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Liu XM, 2010, PLANT MOL BIOL REP, V28, P193, DOI 10.1007/s11105-009-0140-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2011, PHOTOSYNTH RES, V109, P191, DOI 10.1007/s11120-011-9623-7; McGinn PJ, 2008, PLANT PHYSIOL, V146, P300, DOI 10.1104/pp.107.110569; Mercado JM, 2009, ESTUAR COAST SHELF S, V85, P449, DOI 10.1016/j.ecss.2009.09.005; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Rao S, 2006, PLANT CELL PHYSIOL, V47, P1206, DOI 10.1093/pcp/pcj091; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Reiskind JB, 1997, PLANT CELL ENVIRON, V20, P211, DOI 10.1046/j.1365-3040.1997.d01-68.x; REISKIND JB, 1989, PLANT SCI, V61, P43, DOI 10.1016/0168-9452(89)90117-9; Riebesell U, 2000, NATURE, V407, P959, DOI 10.1038/35039665; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; SAYRE RT, 1979, PLANT PHYSIOL, V64, P293, DOI 10.1104/pp.64.2.293; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Tachibana M, 2011, PHOTOSYNTH RES, V109, P205, DOI 10.1007/s11120-011-9634-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Troughton J. H., 1974, Carnegie Institution Year Book, P768; Tsuji Y, 2009, PLANT CELL PHYSIOL, V50, P318, DOI 10.1093/pcp/pcn200; Ueno O, 2011, J EXP BOT, P1; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Voznesenskaya EV, 2003, AM J BOT, V90, P1669, DOI 10.3732/ajb.90.12.1669; Voznesenskaya EV, 2002, PLANT J, V31, P649, DOI 10.1046/j.1365-313X.2002.01385.x; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Wang WL, 2003, BOT BULL ACAD SINICA, V44, P107; Weber APM, 2010, CURR OPIN PLANT BIOL, V13, P257, DOI 10.1016/j.pbi.2010.01.007; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang X, 2011, LIMNOL OCEANOGR, V56, DOI [10.4319/lo.2011.56.1.0000, DOI 10.4319/LO.2011.56.1.0000]	73	61	72	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37438	10.1371/journal.pone.0037438	http://dx.doi.org/10.1371/journal.pone.0037438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616009	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300115
J	Chanes, L; Chica, AB; Quentin, R; Valero-Cabre, A				Chanes, Lorena; Chica, Ana B.; Quentin, Romain; Valero-Cabre, Antoni			Manipulation of Pre-Target Activity on the Right Frontal Eye Field Enhances Conscious Visual Perception in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; PREFRONTAL CORTEX; SPATIAL ATTENTION; PARIETAL CORTEX; BRAIN; MODULATION; SIGNALS; IMPROVES; LESIONS; MEMORY	The right Frontal Eye Field (FEF) is a region of the human brain, which has been consistently involved in visuo-spatial attention and access to consciousness. Nonetheless, the extent of this cortical site's ability to influence specific aspects of visual performance remains debated. We hereby manipulated pre-target activity on the right FEF and explored its influence on the detection and categorization of low-contrast near-threshold visual stimuli. Our data show that pre-target frontal neurostimulation has the potential when used alone to induce enhancements of conscious visual detection. More interestingly, when FEF stimulation was combined with visuo-spatial cues, improvements remained present only for trials in which the cue correctly predicted the location of the subsequent target. Our data provide evidence for the causal role of the right FEF pre-target activity in the modulation of human conscious vision and reveal the dependence of such neurostimulatory effects on the state of activity set up by cue validity in the dorsal attentional orienting network.	[Chanes, Lorena; Chica, Ana B.; Quentin, Romain; Valero-Cabre, Antoni] CNRS UMR 7225 INSERM UMRS 975 UPMC Paris VI, CRICM, Grp Dynam Cerebrales Plasticite & Reeduc, Equipe Cognit Neuroimagerie & Malad Cerveau, Paris, France; [Chica, Ana B.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Valero-Cabre, Antoni] Boston Univ, Sch Med, Dept Anat & Neurobiol, Lab Cerebral Dynam Plast & Rehabil, Boston, MA 02118 USA; [Valero-Cabre, Antoni] UOC, Cognit Neurosci & Informat Technol Res Program, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Granada; Boston University	Chanes, L (corresponding author), CNRS UMR 7225 INSERM UMRS 975 UPMC Paris VI, CRICM, Grp Dynam Cerebrales Plasticite & Reeduc, Equipe Cognit Neuroimagerie & Malad Cerveau, Paris, France.	avalerocabre@gmail.com	Chica, Ana B./L-6640-2014; Chica, Ana B./AAC-1677-2021; Chanes, Lorena/E-8950-2015	Chica, Ana B./0000-0001-5804-1591; Chica, Ana B./0000-0001-5804-1591; Chanes, Lorena/0000-0002-0581-2927; Valero-Cabre, Antoni/0000-0002-5033-2279; quentin, romain/0000-0001-7659-3605	FP6; ANR; Ecole des Neurosciences de Paris (ENP)	FP6(European Commission); ANR(French National Research Agency (ANR)); Ecole des Neurosciences de Paris (ENP)	This work was funded by FP6 and ANR project eraNET-NEURON BEYONDVIS, Marie Curie Intra-European Program (FP7), and PhD fellowship Ecole des Neurosciences de Paris (ENP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Baldassi S, 2005, J VISION, V5, P556, DOI 10.1167/5.6.7; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Chica AB, 2011, ATTEN PERCEPT PSYCHO, V73, P1065, DOI 10.3758/s13414-010-0082-6; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Galea JM, 2010, J COGNITIVE NEUROSCI, V22, P1158, DOI 10.1162/jocn.2009.21259; Gallate J, 2009, NEUROSCI LETT, V449, P151, DOI 10.1016/j.neulet.2008.11.021; Green DM, 1966, SIGNAL DETECTION THE; Grosbras MH, 2003, EUR J NEUROSCI, V18, P3121, DOI 10.1111/j.1460-9568.2003.03055.x; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; LATTO R, 1971, BRAIN RES, V30, P1, DOI 10.1016/0006-8993(71)90002-3; Libedinsky C, 2011, J NEUROSCI, V31, P64, DOI 10.1523/JNEUROSCI.3620-10.2011; Liu T, 2007, NEURON, V55, P313, DOI 10.1016/j.neuron.2007.06.030; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macmillan NA, 2005, DETECTION THEORY USE; Miniussi C, 2008, BRAIN STIMUL, V1, P326, DOI 10.1016/j.brs.2008.07.002; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; O'Shea J, 2004, CURR BIOL, V14, pR279, DOI 10.1016/j.cub.2004.03.024; Oliveri M, 2001, NEUROLOGY, V57, P1338, DOI 10.1212/WNL.57.7.1338; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Ruff CC, 2006, CURR BIOL, V16, P1479, DOI 10.1016/j.cub.2006.06.057; Silvanto J, 2007, NEUROPSYCHOLOGIA, V45, P3346, DOI 10.1016/j.neuropsychologia.2007.06.008; Silvanto J, 2007, EUR J NEUROSCI, V25, P1874, DOI 10.1111/j.1460-9568.2007.05440.x; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Tadin D, 2011, J NEUROSCI, V31, P1279, DOI 10.1523/JNEUROSCI.4121-10.2011; Thickbroom GW, 1996, J NEUROL SCI, V144, P114, DOI 10.1016/S0022-510X(96)00194-3; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Valero-Cabre A, 2005, EXP BRAIN RES, V163, P1, DOI 10.1007/s00221-004-2140-6; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	46	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36232	10.1371/journal.pone.0036232	http://dx.doi.org/10.1371/journal.pone.0036232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615759	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300010
J	Li, SJ; Wang, C; Yu, WH; Zhao, SH; Gong, YZ				Li, Shijun; Wang, Cui; Yu, Wenhua; Zhao, Shuhong; Gong, Yanzhang			Identification of Genes Related to White and Black Plumage Formation by RNA-Seq from White and Black Feather Bulbs in Ducks	PLOS ONE			English	Article							COAT COLOR; TYROSINASE GENE; KIT GENE; C-KIT; MELANOCYTE DEVELOPMENT; RETROVIRAL INSERTION; HAIR PIGMENTATION; MOLECULAR-BASIS; DOMINANT-WHITE; JAPANESE-QUAIL	To elucidate the genes involved in the formation of white and black plumage in ducks, RNA from white and black feather bulbs of an F-2 population were analyzed using RNA-Seq. A total of 2,642 expressed sequence tags showed significant differential expression between white and black feather bulbs. Among these tags, 186 matched 133 annotated genes that grouped into 94 pathways. A number of genes controlling melanogenesis showed differential expression between the two types of feather bulbs. This differential expression was confirmed by qPCR analysis and demonstrated that Tyr (Tyrosinase) and Tyrp1 (Tyrosinase-related protein-1) were expressed not in W-W (white feather bulb from white dorsal plumage) and W-WB (white feather bulb from white-black dorsal plumage) but in B-B (black feather bulb from black dorsal plumage) and B-WB (black feather bulb from white-black dorsal plumage) feather bulbs. Tyrp2 (Tyrosinase- related protein-2) gene did not show expression in the four types of feather bulbs but expressed in retina. C-kit (The tyrosine kinase receptor) expressed in all of the samples but the relative mRNA expression in B-B or B-WB was approximately 10 fold higher than that in W-W or W-WB. Additionally, only one of the two Mitf isoforms was associated with plumage color determination. Downregulation of c-Kit and Mitf in feather bulbs may be the cause of white plumage in the duck.	[Li, Shijun; Wang, Cui; Yu, Wenhua; Zhao, Shuhong; Gong, Yanzhang] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University	Li, SJ (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China.	poultry@mail.hzau.edu.cn			National Natural Science Foundation of China [31172201]; Fundamental Research Funds for the Central Universities [2011QC006]; Ministry of Education of China [IRT-0831]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China)	This research was supported by the National Natural Science Foundation of China (31172201), Fundamental Research Funds for the Central Universities (2011QC006), and the Creative Team Project of Ministry of Education of China (IRT-0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; Brooks SA, 2005, MAMM GENOME, V16, P893, DOI 10.1007/s00335-005-2472-y; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Chang CM, 2007, ANIM GENET, V38, P162, DOI 10.1111/j.1365-2052.2007.01581.x; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Commo S, 2004, PIGM CELL RES, V17, P488, DOI 10.1111/j.1600-0749.2004.00170.x; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; Delfgaauw J, 2003, GENE, V320, P117, DOI 10.1016/S0378-1119(03)00817-5; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Fontanesi L, 2010, ANIM GENET, V41, P478, DOI 10.1111/j.1365-2052.2010.02054.x; Fontanesi L, 2010, ANIM GENET, V41, P295, DOI 10.1111/j.1365-2052.2009.02007.x; Fontanesi L, 2011, ANIMAL GENETICS; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Gong Y, 2010, ANIM GENET, V41, P105, DOI 10.1111/j.1365-2052.2009.01967.x; Gunnarsson U, 2011, PIGM CELL MELANOMA R, V24, P268, DOI 10.1111/j.1755-148X.2011.00825.x; Haase B, 2009, ANIM GENET, V40, P623, DOI 10.1111/j.1365-2052.2009.01893.x; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hachiya A, 2009, J PATHOL, V218, P30, DOI 10.1002/path.2503; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hiragaki T, 2008, GENETICS, V178, P771, DOI 10.1534/genetics.107.077040; Hou L, 2000, DEVELOPMENT, V127, P5379; Huang HL, 2011, ANIM GENET, V42, P421, DOI 10.1111/j.1365-2052.2010.02161.x; Kang HY, 2009, J INVEST DERMATOL, V129, P243, DOI 10.1038/jid.2008.184; Karlsson AC, 2010, BRIT POULTRY SCI, V51, P170, DOI 10.1080/00071661003745802; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kos L, 1999, PIGM CELL RES, V12, P13, DOI 10.1111/j.1600-0749.1999.tb00503.x; Kurita K, 2005, J INVEST DERMATOL, V125, P538, DOI 10.1111/j.0022-202X.2005.23861.x; LANCASTER F. M., 1963, P317; LECOIN L, 1995, DEV DYNAM, V203, P106, DOI 10.1002/aja.1002030111; Li YL, 2011, MOL BIOL REP, V38, P1433, DOI 10.1007/s11033-010-0248-2; Marklund S, 1999, MAMM GENOME, V10, P283, DOI 10.1007/s003359900987; Minvielle F, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-15; Mochii M, 1998, DEV BIOL, V193, P47, DOI 10.1006/dbio.1997.8800; Moller MJ, 1996, MAMM GENOME, V7, P822, DOI 10.1007/s003359900244; MOTRO B, 1991, DEVELOPMENT, V113, P1207; Natt D, 2007, BEHAV GENET, V37, P399, DOI 10.1007/s10519-006-9125-0; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Niwa T, 2002, MECH DEVELOP, V118, P139, DOI 10.1016/S0925-4773(02)00256-3; Primot A, 2010, PIGM CELL MELANOMA R, V23, P93, DOI 10.1111/j.1755-148X.2009.00652.x; Sato S, 2007, POULTRY SCI, V86, P2126, DOI 10.1093/ps/86.10.2126; SCHMIDT A, 1994, P NATL ACAD SCI USA, V91, P4756, DOI 10.1073/pnas.91.11.4756; Seo BY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-81; Solano F, 2006, PIGM CELL RES, V19, P550, DOI 10.1111/j.1600-0749.2006.00334.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Terry RR, 2001, ANIM GENET, V32, P98, DOI 10.1046/j.1365-2052.2001.00737.x; Tobin D. J., 2008, International Journal of Cosmetic Science, V30, P233, DOI 10.1111/j.1468-2494.2008.00456.x; Tobita-Teramoto T, 2000, POULTRY SCI, V79, P46, DOI 10.1093/ps/79.1.46; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Wen B, 2010, PIGM CELL MELANOMA R, V23, P441, DOI 10.1111/j.1755-148X.2010.00699.x; Yoshida H, 1996, DEV DYNAM, V207, P222	59	63	79	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36592	10.1371/journal.pone.0036592	http://dx.doi.org/10.1371/journal.pone.0036592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615785	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300024
J	Ritz, B; Rhodes, SL; Bordelon, Y; Bronstein, J				Ritz, Beate; Rhodes, Shannon L.; Bordelon, Yvette; Bronstein, Jeff			alpha-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease	PLOS ONE			English	Article							ALLELIC VARIATION; ASSOCIATION; NACP-REP1; SNCA; SUSCEPTIBILITY; POLYMORPHISMS; RISK; DUPLICATION; HAPLOTYPES; LEVODOPA	Currently, there are no reported genetic predictors of motor symptom progression in Parkinson's disease (PD). In familial PD, disease severity is associated with higher alpha-synuclein (SNCA) expression levels, and in postmortem studies expression varies with SNCA genetic variants. Furthermore, SNCA is a well-known risk factor for PD occurrence. We recruited Parkinson's patients from the communities of three central California counties to investigate the influence of SNCA genetic variants on motor symptom progression in idiopathic PD. We repeatedly assessed this cohort of patients over an average of 5.1 years for motor symptom changes employing the Unified Parkinson's Disease Rating Scale (UPDRS). Of 363 population-based incident PD cases diagnosed less than 3 years from baseline assessment, 242 cases were successfully re-contacted and 233 were re-examined at least once. Of subjects lost to follow-up, 69% were due to death. Adjusting for covariates, risk of faster decline of motor function as measured by annual increase in motor UPDRS exam score was increased 4-fold in carriers of the REP1 263bp promoter variant (OR 4.03, 95%CI:1.57-10.4). Our data also suggest a contribution to increased risk by the G-allele for rs356165 (OR 1.66; 95%CI:0.96-2.88), and we observed a strong trend across categories when both genetic variants were considered (p for trend = 0.002). Our population-based study has demonstrated that SNCA variants are strong predictors of faster motor decline in idiopathic PD. SNCA may be a promising target for therapies and may help identify patients who will benefit most from early interventions. This is the first study to link SNCA to motor symptom decline in a longitudinal progression study.	[Ritz, Beate; Rhodes, Shannon L.] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA; [Ritz, Beate; Bordelon, Yvette; Bronstein, Jeff] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ritz, B (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA.	britz@ucla.edu	Ritz, Beate R/E-3043-2015		National Institutes of Health (NIH) [R01-ES010544, U54-ES012078, P01-ES016732, P50-NS038367, P30-ES07048]; Community Fast Track grant; MJFox Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012078, R01ES010544, P01ES016732, P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Community Fast Track grant; MJFox Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Study funding was provided by National Institutes of Health (NIH) grants R01-ES010544, U54-ES012078, P01-ES016732, and P50-NS038367. Initial pilot funding from NIH P30-ES07048, a Community Fast Track grant by the MJFox Foundation, and a pilot grant by the American Parkinson Disease Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Brighina L, 2008, NEUROLOGY, V70, P1461, DOI 10.1212/01.wnl.0000304049.31377.f2; Cardo LF, 2012, J MOL NEUROSCI, V47, P425, DOI 10.1007/s12031-011-9669-1; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chung SJ, 2011, MOVEMENT DISORD, V26, P280, DOI 10.1002/mds.23376; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Evans JR, 2011, J NEUROL NEUROSUR PS, V82, P1112, DOI 10.1136/jnnp.2011.240366; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fahn S, 1987, RECENT DEV PARKINSON; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Findley L, 2002, MOVEMENT DISORD, V17, P60; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foltynie T, 2004, BRAIN, V127, P550, DOI 10.1093/brain/awh067; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Gatto NM, 2010, NEUROEPIDEMIOLOGY, V35, P191, DOI 10.1159/000315157; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Hadjigeorgiou GM, 2006, MOVEMENT DISORD, V21, P534, DOI 10.1002/mds.20752; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ibanez P, 2009, ARCH NEUROL-CHICAGO, V66, P102, DOI 10.1001/archneurol.2008.555; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kang GA, 2005, MOVEMENT DISORD, V20, P1133, DOI 10.1002/mds.20513; Kay DM, 2008, AM J MED GENET B, V147B, P1222, DOI 10.1002/ajmg.b.30758; Kieburtz K, 1996, ANN NEUROL, V40, P99; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Louis ED, 1999, ARCH NEUROL-CHICAGO, V56, P334, DOI 10.1001/archneur.56.3.334; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Mata IF., 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI [10.1001/archneurol.2010.279, DOI 10.1001/archneurol.2010.279]; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Mutez E, 2011, HUM MUTAT, V32, pE2079, DOI 10.1002/humu.21459; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; OLANOW CW, 1995, ANN NEUROL, V38, P771, DOI 10.1002/ana.410380512; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Pankratz N, 2009, MOVEMENT DISORD, V24, P1125, DOI 10.1002/mds.22524; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Parsian AJ, 2007, PARKINSONISM RELAT D, V13, P343, DOI 10.1016/j.parkreldis.2006.12.006; Poewe W, 2006, NEUROLOGY, V66, pS2, DOI 10.1212/WNL.66.10_suppl_4.S2; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rajput A, 2009, MOVEMENT DISORD, V24, P2411, DOI 10.1002/mds.22795; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Schiess MC, 2000, PARKINSONISM RELAT D, V6, P69, DOI 10.1016/S1353-8020(99)00051-6; Schrag A, 2007, MOVEMENT DISORD, V22, P938, DOI 10.1002/mds.21429; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Tan EK, 2000, NEUROLOGY, V54, P1195, DOI 10.1212/WNL.54.5.1195; TANDBERG E, 1995, MOVEMENT DISORD, V10, P541, DOI 10.1002/mds.870100503; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Wickremaratchi MM, 2009, EUR J NEUROL, V16, P450, DOI 10.1111/j.1468-1331.2008.02514.x; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	76	90	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36199	10.1371/journal.pone.0036199	http://dx.doi.org/10.1371/journal.pone.0036199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615757	gold, Green Published			2022-12-27	WOS:000305336300008
J	Maji, S; Bruchez, MP				Maji, Suvrajit; Bruchez, Marcel P.			Inferring Biological Structures from Super-Resolution Single Molecule Images Using Generative Models	PLOS ONE			English	Article							GENERALIZED HOUGH TRANSFORM; ACTIN NETWORK; LOCALIZATION; SHAPE; ORGANIZATION; MULTISCALE; LINES; LIMIT	Localization-based super resolution imaging is presently limited by sampling requirements for dynamic measurements of biological structures. Generating an image requires serial acquisition of individual molecular positions at sufficient density to define a biological structure, increasing the acquisition time. Efficient analysis of biological structures from sparse localization data could substantially improve the dynamic imaging capabilities of these methods. Using a feature extraction technique called the Hough Transform simple biological structures are identified from both simulated and real localization data. We demonstrate that these generative models can efficiently infer biological structures in the data from far fewer localizations than are required for complete spatial sampling. Analysis at partial data densities revealed efficient recovery of clathrin vesicle size distributions and microtubule orientation angles with as little as 10% of the localization data. This approach significantly increases the temporal resolution for dynamic imaging and provides quantitatively useful biological information.	[Maji, Suvrajit; Bruchez, Marcel P.] Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Bruchez, Marcel P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Maji, S (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA.	bruchez@cmu.edu	Bruchez, Marcel P/C-2271-2009; Maji, Suvrajit/AAE-9937-2020	Bruchez, Marcel P/0000-0002-7370-4848; Maji, Suvrajit/0000-0001-5547-1975	National Institutes of Health [5R01-GM086237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant 5R01-GM086237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBE E, 1873, ARCH MIKROSK ANAT, V9, P412; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berlemont S, 2008, I S BIOMED IMAGING, P851, DOI 10.1109/ISBI.2008.4541130; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BLUM H, 1973, J THEOR BIOL, V38, P205, DOI 10.1016/0022-5193(73)90175-6; Cootes T. F., 1998, Computer Vision - ECCV'98. 5th European Conference on Computer Vision. Proceedings, P484, DOI 10.1007/BFb0054760; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Davies RH, 2002, IEEE T MED IMAGING, V21, P525, DOI 10.1109/TMI.2002.1009388; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Fudenberg G, 2009, IEEE T IMAGE PROCESS, V18, P471, DOI 10.1109/TIP.2008.2010212; Galamhos C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P554, DOI 10.1109/CVPR.1999.786993; Gomez-Luna J, 2011, ACT 22 JORN PAR, P359; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hinz S., 2005, INT C IM PROC, V3, pIII; ILLINGWORTH J, 1987, IEEE T PATTERN ANAL, V9, P690, DOI 10.1109/TPAMI.1987.4767964; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kassim AA, 1999, IMAGE VISION COMPUT, V17, P737, DOI 10.1016/S0262-8856(98)00156-5; Khoshelham K., 2007, ISPRS WORKSH LAS SCA, VXXXVI, P206; Kimura A., 2000, Transactions of the Institute of Electronics, Information and Communication Engineers D-II, VJ83D-II, P1256; Kimura A, 2004, ELECTRON COMM JPN 2, V87, P58, DOI 10.1002/ecjb.20095; Li HS, 2009, LECT NOTES COMPUT SC, V5762, P673; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; MOKHTARIAN F, 1992, IEEE T PATTERN ANAL, V14, P789, DOI 10.1109/34.149591; Olson CF, 1998, IMAGE VISION COMPUT, V16, P627, DOI 10.1016/S0262-8856(98)00083-3; Ping-Fu Fung, 1996, Proceedings of the 13th International Conference on Pattern Recognition, P511, DOI 10.1109/ICPR.1996.546877; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Resch GP, 2002, J CELL SCI, V115, P1877; Geninatti SR, 2009, 2009 INTERNATIONAL CONFERENCE ON RECONFIGURABLE COMPUTING AND FPGAS, P172, DOI 10.1109/ReConFig.2009.78; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sampat MP, 2009, IEEE T IMAGE PROCESS, V18, P2385, DOI 10.1109/TIP.2009.2025923; Schaub S, 2007, J CELL SCI, V120, P1491, DOI 10.1242/jcs.03379; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Stoitsis J, 2008, IEEE ENG MED BIO, P3146, DOI 10.1109/IEMBS.2008.4649871; Suetake N, 2006, SOFT COMPUT, V10, P1161, DOI 10.1007/s00500-005-0038-2; Svoboda D, 2009, CYTOM PART A, V75A, P494, DOI 10.1002/cyto.a.20714; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Toronto N, 2007, IEEE IMAGE PROC, P2073; Verkhovsky AB, 2003, MOL BIOL CELL, V14, P4667, DOI 10.1091/mbc.E02-10-0630; XU L, 1990, PATTERN RECOGN LETT, V11, P331, DOI 10.1016/0167-8655(90)90042-Z; Zelniker EE, 2006, IEEE T IMAGE PROCESS, V15, P865, DOI 10.1109/TIP.2005.863965; Zhang QP, 2007, IEEE T IMAGE PROCESS, V16, P310, DOI 10.1109/TIP.2006.887731; Zhao T, 2007, CYTOM PART A, V71A, P978, DOI 10.1002/cyto.a.20487; Zhou YJ, 2008, ULTRASOUND MED BIOL, V34, P1474, DOI 10.1016/j.ultrasmedbio.2008.02.009	49	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36973	10.1371/journal.pone.0036973	http://dx.doi.org/10.1371/journal.pone.0036973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629348	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300017
J	De Burghgraeve, T; Kaptein, SJF; Ayala-Nunez, NV; Mondotte, JA; Pastorino, B; Printsevskaya, SS; de Lamballerie, X; Jacobs, M; Preobrazhenskaya, M; Gamarnik, AV; Smit, JM; Neyts, J				De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Ayala-Nunez, Nilda V.; Mondotte, Juan A.; Pastorino, Boris; Printsevskaya, Svetlana S.; de Lamballerie, Xavier; Jacobs, Michael; Preobrazhenskaya, Maria; Gamarnik, Andrea V.; Smit, Jolanda M.; Neyts, Johan			An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro	PLOS ONE			English	Article							YELLOW-FEVER-VIRUS; DENGUE VIRUS; GLYCOPEPTIDE ANTIBIOTICS; SEMISYNTHETIC DERIVATIVES; HEPARAN-SULFATE; INHIBITION; INFECTION; BINDING; REPLICATION; TARGET	There is an urgent need for potent inhibitors of dengue virus (DENV) replication for the treatment and/or prophylaxis of infections with this virus. We here report on an aglycon analogue of the antibiotic teicoplanin (code name LCTA-949) that inhibits DENV-induced cytopathic effect (CPE) in a dose-dependent manner. Virus infection was completely inhibited at concentrations that had no adverse effect on the host cells. These findings were corroborated by quantification of viral RNA levels in culture supernatant. Antiviral activity was also observed against other flaviviruses such as the yellow fever virus and the tick-borne encephalitis virus (TBEV). In particular, potent antiviral activity was observed against TBEV. Time-of-drug-addition experiments indicated that LCTA-949 inhibits an early stage in the DENV replication cycle; however, a virucidal effect was excluded. This observation was corroborated by the fact that LCTA-949 lacks activity on DENV subgenomic replicon (that does not encode structural proteins) replication. Using a microsopy-based binding and fusion assay employing DiD-labeled viruses, it was shown that LCTA-949 targets the early stage (binding/entry) of the infection. Moreover, LCTA-949 efficiently inhibits infectivity of DENV particles pre-opsonized with antibodies, thus potentially also inhibiting antibody-dependent enhancement (ADE). In conclusion, LCTA-949 exerts in vitro activity against several flaviviruses and does so (as shown for DENV) by interfering with an early step in the viral replication cycle.	[De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Ayala-Nunez, Nilda V.; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Mondotte, Juan A.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Pastorino, Boris; de Lamballerie, Xavier] Univ Mediterrane, Emergence Pathol Virales UMR190, Marseille, France; [Printsevskaya, Svetlana S.; Preobrazhenskaya, Maria] Russian Acad Med Sci, Gause Inst New Antibiot, Moscow, Russia; [Jacobs, Michael] Royal Free & Univ Coll, Sch Med, Dept Med, London, England	KU Leuven; University of Groningen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Russian Academy of Medical Sciences; Russian Academy of Sciences; Gause Institute of New Antibiotics; University of London; University College London; UCL Medical School	De Burghgraeve, T (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	Johan.Neyts@rega.kuleuven.be	Neyts, Johan/U-8267-2017; Kaptein, Suzanne JF/O-8855-2018; Ayala-Nunez, Vanesa/AAI-3881-2021; Kaptein, Suzanne JF/O-4714-2019	Neyts, Johan/0000-0002-0033-7514; Kaptein, Suzanne JF/0000-0002-7935-0219; Kaptein, Suzanne JF/0000-0002-7935-0219; Preobrazhenskaya, Maria/0000-0001-9782-1101; pastorino, boris/0000-0001-5233-5193; Ayala-Nunez, Nilda Vanesa/0000-0001-8401-8723	EU FP7 project SILVER [260644]; GOA (geconcerteerde onderzoeksactie) [10/014]; Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW); Erasmus Mundus External Cooperation Window	EU FP7 project SILVER; GOA (geconcerteerde onderzoeksactie); Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Erasmus Mundus External Cooperation Window	This work was supported by EU FP7 project SILVER (no260644), GOA (geconcerteerde onderzoeksactie, no10/014), The Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW), and the Erasmus Mundus External Cooperation Window. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043; Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729; [Anonymous], 2009, WHOHTMNTDDEN20091; [Anonymous], YELL FEV; Balzarini J, 2003, J MED CHEM, V46, P2755, DOI 10.1021/jm0300882; Balzarini J, 2006, ANTIVIR RES, V72, P20, DOI 10.1016/j.antiviral.2006.03.005; Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869; Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10; Lin YL, 2002, ANTIVIR RES, V56, P93, DOI 10.1016/S0166-3542(02)00095-5; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Obeid S, 2011, J ANTIMICROB CHEMOTH, V66, P1287, DOI 10.1093/jac/dkr104; Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004; Preobrazhenskaya MN, 2006, ANTIVIR RES, V71, P227, DOI 10.1016/j.antiviral.2006.04.008; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	30	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37244	10.1371/journal.pone.0037244	http://dx.doi.org/10.1371/journal.pone.0037244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624001	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500083
J	Hirsch, BT; Stanton, MA; Maldonado, JE				Hirsch, Ben T.; Stanton, Margaret A.; Maldonado, Jesus E.			Kinship Shapes Affiliative Social Networks but Not Aggression in Ring-Tailed Coatis	PLOS ONE			English	Article							BROWN CAPUCHIN MONKEYS; INDIVIDUAL SPATIAL CHOICE; WHITE-NOSED COATIS; KIN SELECTION; NASUA-NASUA; REPRODUCTIVE SUCCESS; BEHAVIORAL SYNCHRONY; MICROSATELLITE LOCI; FEEDING COMPETITION; VIGILANCE BEHAVIOR	Animal groups typically contain individuals with varying degrees of genetic relatedness, and this variation in kinship has a major influence on patterns of aggression and affiliative behaviors. This link between kinship and social behavior underlies socioecological models which have been developed to explain how and why different types of animal societies evolve. We tested if kinship and age-sex class homophily in two groups of ring-tailed coatis (Nasua nasua) predicted the network structure of three different social behaviors: 1) association, 2) grooming, and 3) aggression. Each group was studied during two consecutive years, resulting in four group-years available for analysis (total of 65 individuals). Association patterns were heavily influenced by agonistic interactions which typically occurred during feeding competition. Grooming networks were shaped by mother-offspring bonds, female-female social relationships, and a strong social attraction to adult males. Mother-offspring pairs were more likely to associate and groom each other, but relatedness had no effect on patterns of aggressive behavior. Additionally, kinship had little to no effect on coalitionary support during agonistic interactions. Adult females commonly came to the aid of juveniles during fights with other group members, but females often supported juveniles who were not their offspring (57% of coalitionary interactions). These patterns did not conform to predictions from socioecological models.	[Hirsch, Ben T.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Hirsch, Ben T.] Smithsonian Trop Res Inst, Panama City, Panama; [Hirsch, Ben T.; Maldonado, Jesus E.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC USA; [Stanton, Margaret A.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Georgetown University; Smithsonian Institution; Smithsonian National Museum of Natural History	Hirsch, BT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	hirschb@si.edu	Maldonado, Jesus/AIE-8664-2022	Maldonado, Jesus/0000-0002-4282-1072; hirsch, ben/0000-0003-0142-7340	NSF doctoral dissertation improvement grant [BCS-0314525]; Smithsonian Institution postdoctoral fellowship program; Smithsonian Undersecretary for Science restricted endowment funds; Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute	NSF doctoral dissertation improvement grant(National Science Foundation (NSF)); Smithsonian Institution postdoctoral fellowship program(Smithsonian Institution); Smithsonian Undersecretary for Science restricted endowment funds; Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute	This study was funded by a NSF doctoral dissertation improvement grant (BCS-0314525), the Smithsonian Institution postdoctoral fellowship program, the Smithsonian Undersecretary for Science restricted endowment funds, and the Center for Conservation and Evolutionary Genetics at Smithsonian Conservation Biology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivaz AN, 2011, BEHAV ECOL, V22, P1353, DOI 10.1093/beheco/arr141; Borgatti S. P., 2006, UCINET WINDOWS SOFTW; BORRIES C, 1991, INT J PRIMATOL, V12, P231, DOI 10.1007/BF02547586; Bourke AFG, 2011, P ROY SOC B-BIOL SCI, V278, P3313, DOI 10.1098/rspb.2011.1465; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Chapais B, 2001, BEHAV ECOL SOCIOBIOL, V49, P493, DOI 10.1007/s002650100335; Chapais B, 2004, SOC ARISE MACAQUE MO; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Crofoot MC, 2011, AM J PRIMATOL, V73, P821, DOI 10.1002/ajp.20959; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2005, OECOLOGIA, V143, P211, DOI 10.1007/s00442-004-1796-8; Csardi G, INTERJOURNAL COMPLEX, P1695; DATTA S, 1988, ANIM BEHAV, V36, P754, DOI 10.1016/S0003-3472(88)80159-3; DATTA SB, 1991, AM NAT, V138, P201, DOI 10.1086/285212; Davis CS, 1998, MOL ECOL, V7, P1776, DOI 10.1046/j.1365-294x.1998.00515.x; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; Di Blanco Y, 2006, BEHAV ECOL SOCIOBIOL, V61, P173, DOI 10.1007/s00265-006-0248-3; Engh AL, 2000, ANIM BEHAV, V60, P323, DOI 10.1006/anbe.2000.1502; Fike JA, 2007, MOL ECOL NOTES, V7, P525, DOI 10.1111/j.1471-8286.2006.01643.x; Gardner A, 2011, J EVOLUTION BIOL, V24, P1020, DOI 10.1111/j.1420-9101.2011.02236.x; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; Gompper ME, 1997, ANIM BEHAV, V53, P781, DOI 10.1006/anbe.1996.0344; Hall CL, 1997, ANIM BEHAV, V53, P1069, DOI 10.1006/anbe.1996.0392; Henzi SP, 2010, P NATL ACAD SCI USA, V107, P2130, DOI 10.1073/pnas.0913294107; Hirsch B.T., 2007, THESIS STONY BROOK U; Hirsch BT, 2007, ETHOLOGY, V113, P446, DOI 10.1111/j.1439-0310.2007.01348.x; Hirsch BT, 2007, Q REV BIOL, V82, P9, DOI 10.1086/511657; Hirsch BT, 2011, MAMMALIA, V75, P301, DOI 10.1515/MAMM.2011.030; Hirsch BT, 2011, BEHAV ECOL SOCIOBIOL, V65, P581, DOI 10.1007/s00265-010-1058-1; Hirsch BT, 2011, BEHAV ECOL SOCIOBIOL, V65, P391, DOI 10.1007/s00265-010-1056-3; Hirsch BT, 2011, MOL ECOL, V20, P409, DOI 10.1111/j.1365-294X.2010.04940.x; Hirsch BT, 2010, ETHOLOGY, V116, P671, DOI 10.1111/j.1439-0310.2010.01783.x; Hirsch BT, 2009, J MAMMAL, V90, P136, DOI 10.1644/08-MAMM-A-050.1; Hirsch BT, 2002, BEHAV ECOL SOCIOBIOL, V52, P458, DOI 10.1007/s00265-002-0536-5; HRDY SB, 1976, SCIENCE, V193, P913, DOI 10.1126/science.193.4256.913; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; JANSON CH, 1990, ANIM BEHAV, V40, P922, DOI 10.1016/S0003-3472(05)80994-7; Janson CH, 2006, ECOLOGICAL PHYS BEHA, P285; Janson Charles H., 1992, P95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kays RW, 2000, MOL ECOL, V9, P743, DOI 10.1046/j.1365-294x.2000.00921.x; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Koprowski JL, 1996, J MAMMAL, V77, P1006, DOI 10.2307/1382781; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 2000, BIOL REV, V75, P477; Marshall JAR, 2011, TRENDS ECOL EVOL, V26, P325, DOI 10.1016/j.tree.2011.04.008; *MOL EC RES PRIM D, 2010, MOL ECOLOGY RESOURCE, V9, P1460; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palombit RA, 1997, ANIM BEHAV, V54, P599, DOI 10.1006/anbe.1996.0457; Pravosudova EV, 2001, CONDOR, V103, P821, DOI 10.1650/0010-5422(2001)103[0821:TIOKON]2.0.CO;2; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodel HG, 2009, PHYSIOL BEHAV, V97, P495, DOI 10.1016/j.physbeh.2009.04.005; Romero T, 2008, J COMP PSYCHOL, V122, P19, DOI 10.1037/0735-7036.122.1.19; Romero T, 2007, BEHAVIOUR, V144, P179, DOI 10.1163/156853907779947355; Romey WL, 2008, BEHAV ECOL, V19, P338, DOI 10.1093/beheco/arm138; Romey WL, 2007, BEHAV ECOL, V18, P910, DOI 10.1093/beheco/arm057; ROMEY WL, 1995, BEHAV ECOL SOCIOBIOL, V37, P195, DOI 10.1007/s002650050181; Ruckstuhl KE, 2001, BEHAVIOUR, V138, P1033, DOI 10.1163/156853901753286551; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SCHULMAN SR, 1980, AM NAT, V115, P580, DOI 10.1086/283581; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; SIRIPUNKAW CS, 2007, MOL ECOL NOTES, V8, P199; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Toth Z, 2009, BEHAV ECOL SOCIOBIOL, V63, P1189, DOI 10.1007/s00265-009-0768-8; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; van Schaik C.P., 1989, Special Publication of the British Ecological Society, P195; Wahaj SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P237, DOI 10.1007/s00265-004-0783-8; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WATTS DP, 1989, ETHOLOGY, V81, P1; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	80	37	37	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37301	10.1371/journal.pone.0037301	http://dx.doi.org/10.1371/journal.pone.0037301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624010	Green Published, Green Accepted, gold			2022-12-27	WOS:000305343500093
J	Stobb, M; Peterson, JM; Mazzag, B; Gahtan, E				Stobb, Michael; Peterson, Joshua M.; Mazzag, Borbala; Gahtan, Ethan			Graph Theoretical Model of a Sensorimotor Connectome in Zebrafish	PLOS ONE			English	Article							LATERAL-LINE SYSTEM; RETICULOSPINAL NEURONS; SMALL-WORLD; SCALE-FREE; FUNCTIONAL CONNECTIVITY; SPINAL NEURONS; YOUNG LARVAE; BRAIN; NETWORK; ORGANIZATION	Mapping the detailed connectivity patterns (connectomes) of neural circuits is a central goal of neuroscience. The best quantitative approach to analyzing connectome data is still unclear but graph theory has been used with success. We present a graph theoretical model of the posterior lateral line sensorimotor pathway in zebrafish. The model includes 2,616 neurons and 167,114 synaptic connections. Model neurons represent known cell types in zebrafish larvae, and connections were set stochastically following rules based on biological literature. Thus, our model is a uniquely detailed computational representation of a vertebrate connectome. The connectome has low overall connection density, with 2.45% of all possible connections, a value within the physiological range. We used graph theoretical tools to compare the zebrafish connectome graph to small-world, random and structured random graphs of the same size. For each type of graph, 100 randomly generated instantiations were considered. Degree distribution (the number of connections per neuron) varied more in the zebrafish graph than in same size graphs with less biological detail. There was high local clustering and a short average path length between nodes, implying a small-world structure similar to other neural connectomes and complex networks. The graph was found not to be scale-free, in agreement with some other neural connectomes. An experimental lesion was performed that targeted three model brain neurons, including the Mauthner neuron, known to control fast escape turns. The lesion decreased the number of short paths between sensory and motor neurons analogous to the behavioral effects of the same lesion in zebrafish. This model is expandable and can be used to organize and interpret a growing database of information on the zebrafish connectome.	[Stobb, Michael; Peterson, Joshua M.; Mazzag, Borbala] Humboldt State Univ, Dept Math, Arcata, CA 95521 USA; [Gahtan, Ethan] Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA; [Gahtan, Ethan] Humboldt State Univ, Dept Biol, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt	Stobb, M (corresponding author), Humboldt State Univ, Dept Math, Arcata, CA 95521 USA.	eg51@humboldt.edu			National Science Foundation (NSF) [0823358]; National Science Foundation-Research Experience for Undergraduates (NSF-REU) [0755582]; Direct For Biological Sciences [0823358] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation-Research Experience for Undergraduates (NSF-REU)(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding provided by National Science Foundation (NSF) Award #0823358 (EG) National Science Foundation-Research Experience for Undergraduates (NSF-REU) #0755582 (JMP and MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Costa LD, 2005, EUR PHYS J B, V48, P567, DOI 10.1140/epjb/e2006-00017-1; Dambly-Chaudiere C, 2003, BIOL CELL, V95, P579, DOI 10.1016/j.biolcel.2003.10.005; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; Fetcho JR, 2010, ANN NY ACAD SCI, V1198, P94, DOI 10.1111/j.1749-6632.2010.05539.x; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gompel N, 2001, DEVELOPMENT, V128, P387; Goulet J, 2008, J COMP PHYSIOL A, V194, P1, DOI 10.1007/s00359-007-0275-1; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kamali M, 2009, J MICROSC-OXFORD, V233, P114, DOI 10.1111/j.1365-2818.2008.03102.x; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Li CG, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.052901; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; MENDELSON B, 1986, DEV BIOL, V118, P309, DOI 10.1016/0012-1606(86)90098-9; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Nakayama H, 2004, J NEUROSCI, V24, P3199, DOI 10.1523/JNEUROSCI.4419-03.2004; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Piersa J, 2010, IEEE T NEURAL NETWOR, V21, P1747, DOI 10.1109/TNN.2010.2066989; Portillo IJG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006863; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Sankrithi NS, 2010, NEUROSCIENCE, V166, P970, DOI 10.1016/j.neuroscience.2010.01.003; Sato A, 2010, DEV DYNAM, V239, P2058, DOI 10.1002/dvdy.22324; Sohn Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001139; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2011, BRAIN CONNECTIVITY T; Sporns O., 2003, NEUROSCIENCE DATABAS, P171, DOI DOI 10.1007/978-1-4615-1079-6_12; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Srinivasan R, 2010, BIOINFORMATICS, V26, pi64, DOI 10.1093/bioinformatics/btq179; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vertes PE, 2010, HFSP J, V4, P153, DOI 10.2976/1.3386761; Walsh T, 1999, P 16 IJCAI ART INT; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460	58	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37292	10.1371/journal.pone.0037292	http://dx.doi.org/10.1371/journal.pone.0037292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624008	Green Published, gold			2022-12-27	WOS:000305343500091
J	Jennes, W; Kyongo, JK; Vanhommerig, E; Camara, M; Coppens, S; Seydi, M; Mboup, S; Heyndrickx, L; Kestens, L				Jennes, Wim; Kyongo, Jordan K.; Vanhommerig, Evelyn; Camara, Makhtar; Coppens, Sandra; Seydi, Moussa; Mboup, Souleymane; Heyndrickx, Leo; Kestens, Luc			Molecular Epidemiology of HIV-1 Transmission in a Cohort of HIV-1 Concordant Heterosexual Couples from Dakar, Senegal	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CONCURRENT SEXUAL PARTNERSHIPS; PHYLOGENETIC ANALYSIS; TYPE-1 TRANSMISSION; COHABITING COUPLES; HIGH-PREVALENCE; RURAL UGANDA; SOUTH-AFRICA; RISK-FACTORS; CONDOM USE	Background: A large number of HIV-1 infections in Africa occur in married couples. The predominant direction of intracouple transmission and the principal external origins of infection remain important issues of debate. Methods: We investigated HIV-1 transmission in 46 HIV-1 concordant positive couples from Dakar, Senegal. Intracouple transmission was confirmed by maximum-likelihood phylogenetic analysis and pairwise distance comparisons of HIV-1 env gp41 sequences from both partners. Standardized interview data were used to deduce the direction as well as the external sources of the intracouple transmissions. Results: Conservative molecular analyses showed linked viruses in 34 (74%) couples, unlinked viruses in 6 (13%) couples, and indeterminate results for 6 (13%) couples. The interview data corresponded completely with the molecular analyses: all linked couples reported internal transmission and all unlinked couples reported external sources of infection. The majority of linked couples (93%) reported the husband as internal source of infection. These husbands most frequently (82%) reported an occasional sexual relationship as external source of infection. Pairwise comparisons of the CD4 count, antiretroviral therapy status, and the proportion of gp41 ambiguous base pairs within transmission pairs correlated with the reported order of infection events. Conclusions: In this suburban Senegalese population, a majority of HIV-1 concordant couples showed linked HIV-1 transmission with the husband as likely index partner. Our data emphasize the risk of married women for acquiring HIV-1 as a result of the occasional sexual relationships of their husbands.	[Jennes, Wim; Kyongo, Jordan K.; Vanhommerig, Evelyn; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, B-2000 Antwerp, Belgium; [Camara, Makhtar; Mboup, Souleymane] Cheikh Anta Diop Univ, Ctr Hosp Univ Dantec, Dept Bacteriol Virol, Immunol Lab, Dakar, Senegal; [Coppens, Sandra; Heyndrickx, Leo] Inst Trop Med, Dept Biomed Sci, Virol Lab, B-2000 Antwerp, Belgium; [Seydi, Moussa] Cheikh Anta Diop Univ, Ctr Hosp Univ Fann, Dept Infect Dis, Dakar, Senegal	Institute of Tropical Medicine (ITM); University Cheikh Anta Diop Dakar; Institute of Tropical Medicine (ITM); University Cheikh Anta Diop Dakar	Jennes, W (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, B-2000 Antwerp, Belgium.	wjennes@itg.be	Jennes, Wim/M-2523-2013	Jennes, Wim/0000-0002-3125-6389	Belgian Fund for Scientific Research (FWO-Vlaanderen) [G.0660.06]; Belgian Development Cooperation	Belgian Fund for Scientific Research (FWO-Vlaanderen)(FWO); Belgian Development Cooperation	This work was supported by the Belgian Fund for Scientific Research (FWO-Vlaanderen, grant number G.0660.06, website: www.fwo.be) and the Belgian Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaschak S, 2000, CLIN INFECT DIS, V31, P1098, DOI 10.1086/318152; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Camara M, 2010, J INFECT DIS, V201, P835, DOI 10.1086/651000; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; CARAEL M, 1988, AIDS, V2, P201; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eshleman SH, 2011, J INFECT DIS; Ever-Silva WA, 2006, JAIDS-J ACQ IMM DEF, V41, P664, DOI 10.1097/01.qai.0000194736.66322.02; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; Gonzalez-Candelas F, 2005, AIDS, V19, P1552, DOI 10.1097/01.aids.0000180783.18177.98; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hollingsworth TD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000876; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Malamba SS, 2005, JAIDS-J ACQ IMM DEF, V39, P576; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Ramakrishnan R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-42; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Resik S, 2007, AIDS RES HUM RETROV, V23, P347, DOI 10.1089/aid.2006.0158; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Sturmer M, 2004, AIDS, V18, P2109, DOI 10.1097/00002030-200411050-00002; Tamura K, 2011, MOL BIOL EVOL; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2011, 2010 REP GLOB AIDS E; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yang CF, 1999, J CLIN MICROBIOL, V37, P2581, DOI 10.1128/JCM.37.8.2581-2586.1999	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37402	10.1371/journal.pone.0037402	http://dx.doi.org/10.1371/journal.pone.0037402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615999	Green Published, gold			2022-12-27	WOS:000305341200071
J	Fujimaki, K; Takahashi, T; Morinobu, S				Fujimaki, Koichiro; Takahashi, Terumichi; Morinobu, Shigeru			Association of Typical versus Atypical Antipsychotics with Symptoms and Quality of Life in Schizophrenia	PLOS ONE			English	Article							NEUROCOGNITIVE DEFICITS; RELIABILITY; PREDICTORS; OLANZAPINE; CLOZAPINE; COGNITION; PEOPLE; SCALE; DRUGS	Background: Several reports on patients with chronic schizophrenia suggest that atypical versus typical antipsychotics are expected to lead to better quality of life (QOL) and cognitive function. Our aim was to examine the association of chronic treatment with typical or atypical antipsychotics with cognitive function, psychiatric symptoms, QOL, and drug-induced extrapyramidal symptoms in long-hospitalized patients with schizophrenia. Methodology and Principal Findings: The Hasegawa Dementia Scale-Revised (HDS-R), Brief Psychiatric Rating Scale (BPRS), the Schizophrenia Quality of Life Scale, translated into Japanese (JSQLS), and the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS) were used to evaluate cognitive function, psychiatric symptoms, QOL, and drug-induced extrapyramidal symptoms. We examined the correlation between the dose of antipsychotics and each measure derived from these psychometric tests. The student t-test was used to compare scores obtained from psychometric tests between patients receiving typical and atypical antipsychotics. Results showed significant correlations between chlorpromazine (CPZ)-equivalent doses of typical antipsychotics and atypical antipsychotics, and the total BPRS score and BPRS subscale scores for positive symptoms. CPZ-equivalent doses of typical antipsychotics were correlated with the JSQLS subscale score for dysfunction of psycho-social activity and DIEPSS score. Furthermore, the total BPRS scores, BPRS subscale score for positive symptoms, the JSQLS subscale score for dysfunction of psycho-social activity, and the DIEPSS score were significantly higher in patients receiving typical antipsychotics than atypical antipsychotics. Conclusion and Significance: These findings suggest that long-term administration of typical antipsychotics has an unfavorable association with feelings of difficulties mixing in social situations in patients with chronic schizophrenia.	[Fujimaki, Koichiro] Prefectural Univ Hiroshima, Fac Hlth & Welf, Hiroshima, Japan; [Takahashi, Terumichi] Mihara Hosp, Hiroshima, Japan; [Morinobu, Shigeru] Hiroshima Univ, Programs Biomed Res, Div Frontier Med Sci, Dept Psychiat & Neurosci,Grad Sch Biomed Sci, Hiroshima, Japan	Hiroshima University	Fujimaki, K (corresponding author), Prefectural Univ Hiroshima, Fac Hlth & Welf, Hiroshima, Japan.	fujimaki@pu-hiroshima.ac.jp			Ministerio de Economia y Competitividad (MINECO) of Spain [PSI2008-03688, PSI2011-26314]	Ministerio de Economia y Competitividad (MINECO) of Spain	This work was supported by the grants PSI2008-03688 and PSI2011-26314 from the Ministerio de Economia y Competitividad (MINECO) of Spain (www.mineco.gob.es/stfls/mineco/investigacion.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki H, 2008, PSYCHIAT RES, V158, P19, DOI 10.1016/j.psychres.2006.05.017; Awad AG, 1997, QUAL LIFE RES, V6, P21; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; Crossley NA, 2010, BRIT J PSYCHIAT, V196, P434, DOI 10.1192/bjp.bp.109.066217; Dickerson FB, 1998, ACTA PSYCHIAT SCAND, V98, P124, DOI 10.1111/j.1600-0447.1998.tb10053.x; Drimer T, 2004, INT CLIN PSYCHOPHARM, V19, P27, DOI 10.1097/00004850-200401000-00005; Fitzgerald PB, 2001, ACTA PSYCHIAT SCAND, V103, P387, DOI 10.1034/j.1600-0447.2001.00254.x; Fukuda M, 2003, JAPANESE J CLIN PSYC, V6, P403; Green MF, 1996, AM J PSYCHIAT, V153, P321; HASEGAWA K, 1990, Tohoku Journal of Experimental Medicine, V161, P29; Heslegrave RJ, 1997, J PSYCHIATR NEUROSCI, V22, P235; Hirayasu Y, 2004, JAPANESE J CLIN PSYC, V7, P59; Huppert JD, 2001, SCHIZOPHR RES, V51, P171, DOI 10.1016/S0920-9964(99)00151-6; INADA T, 1996, EVALUATION DIAGNOSIS; Inagaki A., 2006, JAPANESE J CLIN PSYC, V9, P1443; Kaneda Y, 2002, PSYCHIAT RES, V113, P107, DOI 10.1016/S0165-1781(02)00240-8; Keefe RSE, 2006, J CLIN EXP NEUROPSYC, V28, P260, DOI 10.1080/13803390500360539; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kolakowska T., 1976, BRIEF PSYCHIATRIC RA; Kurtz MM, 2005, SCHIZOPHRENIA BULL, V31, P167, DOI 10.1093/schbul/sbi004; Lachar D, 2001, PSYCHOL ASSESSMENT, V13, P384, DOI 10.1037//1040-3590.13.3.384; LEE MA, 1994, J CLIN PSYCHIAT, V55, P82; Little JT, 1998, NEUROPSYCHOPHARMACOL, V19, P60; MALHOTRA AK, 1993, DRUG SAFETY, V9, P429, DOI 10.2165/00002018-199309060-00005; Miyamoto A, 2006, JAPANESE J CLIN PSYC, V9, P65; Mizusawa H, 1998, INTERNAL MED, V37, P493, DOI 10.2169/internalmedicine.37.493; Mortimer AM, 2007, INT J SOC PSYCHIATR, V53, P99, DOI 10.1177/0020764006075000; Norman RMG, 2000, ACTA PSYCHIAT SCAND, V102, P303, DOI 10.1034/j.1600-0447.2000.102004303.x; Reine G, 2003, ACTA PSYCHIAT SCAND, V108, P297, DOI 10.1034/j.1600-0447.2003.00132.x; Ritsner M, 2000, J CLIN PSYCHIAT, V61, P880, DOI 10.4088/JCP.v61n1113; Ritsner M, 2004, J CLIN PSYCHOPHARM, V24, P582, DOI 10.1097/01.jcp.0000144895.75728.2b; Sharma T, 2003, PSYCHOPHARMACOLOGY, V169, P398, DOI 10.1007/s00213-003-1506-y; Stip E, 1996, BIOL PSYCHIAT, V40, P434, DOI 10.1016/0006-3223(96)82520-0; Takashiba T, 2004, JAPANESE J CLIN PSYC, V7, P23; Tomotake M, 2006, PSYCHOL REP, V99, P477, DOI 10.2466/PR0.99.2.477-487; Wilkinson G, 2000, BRIT J PSYCHIAT, V177, P42, DOI 10.1192/bjp.177.1.42; ZEMISHLANY Z, 1991, SCHIZOPHR RES, V5, P81, DOI 10.1016/0920-9964(91)90056-W	38	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37087	10.1371/journal.pone.0037087	http://dx.doi.org/10.1371/journal.pone.0037087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615901	Green Published, gold			2022-12-27	WOS:000305341300068
J	Kapusinszky, B; Phan, TG; Kapoor, A; Delwart, E				Kapusinszky, Beatrix; Phan, Tung G.; Kapoor, Amit; Delwart, Eric			Genetic Diversity of the Genus Cosavirus in the Family Picornaviridae: A New Species, Recombination, and 26 New Genotypes	PLOS ONE			English	Article							SEQUENCES; CHILDREN	The proposed viral genus human Cosavirus (HCoSV) consists of diverse picornaviruses found at high prevalence in the feces of children from developing countries. We sequenced four near-full length genomes and 45 partial VP1 region from HCoSV in human feces from healthy children and children with acute flaccid paralysis in Pakistan, Nigeria and Tunisia and from healthy and diarrhetic adults in Nepal. Genetic analyses of the near-full length genomes revealed presence of a new candidate cosavirus species provisionally labelled as species F (HCoSV-F). A HCoSV genome showed evidence of recombination between species D and E viruses at the P1/P2 junction indicating that these viruses may be reclassified as a single highly diverse species. Based on genetic distance criteria for assigning genotypes corresponding to neutralization serotypes in enteroviruses we identified 26 new HCoSV genotypes belonging to species A, D, and E. The detection of a large number of HCoSV genotypes based on still limited geographic sampling indicates that the phenotypic effects of cosaviruses on infected subjects are likely to be as highly diverse as those of human enteroviruses.	[Kapusinszky, Beatrix; Phan, Tung G.; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Kapusinszky, Beatrix; Phan, Tung G.; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kapusinszky, Beatrix] Natl Ctr Epidemiol, Dept Viral Diagnost, Budapest, Hungary; [Kapoor, Amit] Columbia Univ, Ctr Infect & Immun, New York, NY USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Columbia University	Kapusinszky, B (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.	delwarte@medicine.ucsf.edu		Delwart, Eric/0000-0002-6296-4484; Phan, Tung/0000-0003-3517-3078	NHLBI [R01HL083254]; NIAID [R21AI081132]; Rosztoczy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rosztoczy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI R01HL083254 to ED and NIAID R21AI081132 to AK. BK was supported by a fellowship from the Rosztoczy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Dai XQ, 2010, J CLIN VIROL, V48, P228, DOI 10.1016/j.jcv.2010.03.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Khamrin P, 2012, VIRUS GENES, V44, P244, DOI 10.1007/s11262-011-0700-y; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pallansch MA, 2001, ENTEROVIRUSES POLIOV; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08	19	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36685	10.1371/journal.pone.0036685	http://dx.doi.org/10.1371/journal.pone.0036685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615791	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300024
J	Santos, SD; Clark, TG; Campino, S; Suarez-Mutis, MC; Rockett, KA; Kwiatkowski, DP; Fernandes, O				Santos, Simone da Silva; Clark, Taane G.; Campino, Susana; Suarez-Mutis, Martha Cecilia; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Fernandes, Octavio			Investigation of Host Candidate Malaria-Associated Risk/Protective SNPs in a Brazilian Amazonian Population	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; GENETIC POLYMORPHISMS; INNATE IMMUNITY; LINKAGE PHASE; VIVAX MALARIA; SUSCEPTIBILITY; VARIANTS; REGION; INFECTIONS; HAPLOTYPES	The Brazilian Amazon is a hypo-endemic malaria region with nearly 300,000 cases each year. A variety of genetic polymorphisms, particularly in erythrocyte receptors and immune response related genes, have been described to be associated with susceptibility and resistance to malaria. In order to identify polymorphisms that might be associated with malaria clinical outcomes in a Brazilian Amazonian population, sixty-four human single nucleotide polymorphisms in 37 genes were analyzed using a Sequenom massARRAY iPLEX platform. A total of 648 individuals from two malaria endemic areas were studied, including 535 malaria cases (113 individuals with clinical mild malaria, 122 individuals with asymptomatic infection and 300 individuals with history of previous mild malaria) and 113 health controls with no history of malaria. The data revealed significant associations (p < 0.003) between one SNP in the IL10 gene (rs1800896) and one SNP in the TLR4 gene (rs4986790) with reduced risk for clinical malaria, one SNP in the IRF1 gene (rs2706384) with increased risk for clinical malaria, one SNP in the LTA gene (rs909253) with protection from clinical malaria and one SNP in the TNF gene (RS1800750) associated with susceptibility to clinical malaria. Also, a new association was found between a SNP in the CTL4 gene (rs2242665), located at the major histocompatibility complex III region, and reduced risk for clinical malaria. This study represents the first association study from an Amazonian population involving a large number of host genetic polymorphisms with susceptibility or resistance to Plasmodium infection and malaria outcomes. Further studies should include a larger number of individuals, refined parameters and a fine-scale map obtained through DNA sequencing to increase the knowledge of the Amazonian population genetic diversity.	[Santos, Simone da Silva; Fernandes, Octavio] Fiocruz MS, IOC, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Suarez-Mutis, Martha Cecilia] Fiocruz MS, IOC, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, Brazil; [Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Fundacao Oswaldo Cruz; University of Oxford; Wellcome Centre for Human Genetics	Santos, SD (corresponding author), Fiocruz MS, IOC, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil.	simone@ioc.fiocruz.br	Campino, Susana/AAM-2577-2020; Suárez-Mutis, Martha/T-9260-2019; Clark, Taane G./AAM-2570-2020; Suarez-Mutis, Martha/B-9189-2015	Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Suarez-Mutis, Martha/0000-0003-2809-6799; Kwiatkowski, Dominic/0000-0002-5023-0176; santos, simone/0000-0003-1093-8919	National Council for Scientific and Technological Development [CNPq-DECIT 410581/2006-2, PAPES IVFIOCRUZ 400245/2006-0]; Wellcome Trust [WT077383/Z/05/Z, 6090770/Z/09/Z, 075491/Z/04, 090532/Z/09/Z]; Wellcome Trust Sanger Institute [077012/Z/05/Z]; UK Medical Research Council [G0600718, G0600230, G19/9]; International Atomic Energy Agency (IAEA); Medical Research Council [G0600718, G19/9, G0600230] Funding Source: researchfish; MRC [G19/9, G0600718, G0600230] Funding Source: UKRI	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was in part funded by the National Council for Scientific and Technological Development (CNPq-DECIT 410581/2006-2 and PAPES IVFIOCRUZ 400245/2006-0), the Wellcome Trust (WT077383/Z/05/Z, and 6090770/Z/09/Z) plus a core award to Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z) and the Wellcome Trust Sanger Institute (077012/Z/05/Z), the UK Medical Research Council (G0600718; G0600230), DPK is supported by the UK Medical Research Council (G19/9) and the International Atomic Energy Agency (IAEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Cabral AC, 2010, T ROY SOC TROP MED H, V104, P556, DOI 10.1016/j.trstmh.2010.03.008; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Clark IA, 1996, ADV PARASIT, V37, P1, DOI 10.1016/S0065-308X(08)60218-3; Clark IA, 2004, CLIN MICROBIOL REV, V17, P509, DOI 10.1128/CMR.17.3.509-539.2004; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dias C, 2008, SANTA ISABEL RIO NEG; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Fontes AM, 2011, GENET MOL BIOL, V34, P539, DOI 10.1590/S1415-47572011005000051; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kwiatkowski DP, 2005, TRENDS GENET, V21, P197, DOI 10.1016/j.tig.2005.02.002; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Leoratti FMS, 2008, J INFECT DIS, V198, P772, DOI 10.1086/590440; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Albuquerque SRL, 2010, PARASITOL RES, V106, P1049, DOI 10.1007/s00436-010-1745-x; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mangano VD, 2008, GENES IMMUN, V9, P122, DOI 10.1038/sj.gene.6364456; Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Mutis MCS, 2007, CAD SAUDE PUBLICA, V23, P105; Ouma C, 2008, HUM GENET, V124, P515, DOI 10.1007/s00439-008-0578-5; Ross P, 1998, NAT BIOTECHNOL, V16, P1347, DOI 10.1038/4328; Sabeti P, 2002, GENES IMMUN, V3, P286, DOI 10.1038/sj.gene.6363877; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Silva Andréa Leme da, 2008, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V3, P343; Smith TG, 2002, CLIN INVEST MED, V25, P262; Soares SC, 2008, GENET MOL RES, V7, P1011, DOI 10.4238/vol7-4gmr439; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; SVS, 2011, SIVEP MALARIA SIST I; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Weir BS., 1996, GENETIC DATA ANAL; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; YUTHAVONG Y, 1993, PARASITOL TODAY, V9, P241, DOI 10.1016/0169-4758(93)90065-N	40	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36692	10.1371/journal.pone.0036692	http://dx.doi.org/10.1371/journal.pone.0036692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615793	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305341300025
J	Brewer, MS; Sierwald, P; Bond, JE				Brewer, Michael S.; Sierwald, Petra; Bond, Jason E.			Millipede Taxonomy after 250 Years: Classification and Taxonomic Practices in a Mega-Diverse yet Understudied Arthropod Group	PLOS ONE			English	Article							HIGHER TAXA; PHYLOGENETIC ANALYSIS; DIVERGENT EVOLUTION; SPECIES COMPLEX; DIPLOPODA; BIODIVERSITY; POLYDESMIDA; SPIROBOLIDA; MYRIAPODA; XYSTODESMIDAE	Background: The arthropod class Diplopoda is a mega-diverse group comprising > 12,000 described millipede species. The history of taxonomic research within the group is tumultuous and, consequently, has yielded a questionable higher-level classification. Few higher-taxa are defined using synapomorphies, and the practice of single taxon descriptions lacking a revisionary framework has produced many monotypic taxa. Additionally, taxonomic and geographic biases render global species diversity estimations unreliable. We test whether the ordinal taxa of the Diplopoda are consistent with regards to underlying taxonomic diversity, attempt to provide estimates for global species diversity, and examine millipede taxonomic effort at a global geographic scale. Methodology/Principal Findings: A taxonomic distinctness metric was employed to assess uniformity of millipede ordinal taxa. We found that ordinal-level taxa are not uniform and are likely overinflated with higher-taxa when compared to related groups. Several methods of estimating global species richness were employed (Bayesian, variation in taxonomic productivity, extrapolation from nearly fully described taxa). Two of the three methods provided estimates ranging from 13,413-16,760 species. Variations in geographic diversity show biases to North America and Europe and a paucity of works on tropical taxa. Conclusions/Significance: Before taxa can be used in an extensible way, they must be definable with respect to the diversity they contain and the diagnostic characters used to delineate them. The higher classification for millipedes is shown to be problematic from a number of perspectives. Namely, the ordinal taxa are not uniform in their underlying diversity, and millipedes appear to have a disproportionate number of higher-taxa. Species diversity estimates are unreliable due to inconsistent taxonomic effort at temporal, geographic, and phylogenetic scales. Lack of knowledge concerning many millipede groups compounds these issues. Diplopods are likely not unique in this regard as these issues may persist in many other diverse yet poorly studied groups.	[Brewer, Michael S.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Sierwald, Petra] Field Museum, Dept Zool, Chicago, IL USA; [Bond, Jason E.] Auburn Univ, Museum Nat Hist, Dept Biol Sci, Auburn, AL 36849 USA	University of North Carolina; East Carolina University; Field Museum of Natural History (Chicago); Auburn University System; Auburn University	Brewer, MS (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	michaelsbrewer@gmail.com	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 05-29715]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation DEB 05-29715 nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; Bond JE, 2002, EVOLUTION, V56, P1123; Bond JE, 2003, INVERTEBR SYST, V17, P711, DOI 10.1071/IS03026; Bond JE, 2003, INVERTEBR SYST, V17, P515, DOI 10.1071/IS03004; Calix M., 2018, EUROPEAN RED LIST SA; Cardoso P, 2004, BIOL CONSERV, V117, P453, DOI 10.1016/j.biocon.2003.08.013; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; CLEMENTS JF, 2009, CLEMENTS CHECKLIST B; Cook O. F., 1895, Annals of the New York Academy of Sciences, Vix, P1; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; ENGHOFF H, 1984, Z ZOOL SYST EVOL, V22, P8; Enghoff H, 2011, CLADISTICS, V27, P606, DOI 10.1111/j.1096-0031.2011.00360.x; Frederiksen SB, 2012, J NAT HIST, V46, P599, DOI 10.1080/00222933.2011.651636; Gaston Kevin J., 1993, Biodiversity Letters, V1, P2, DOI 10.2307/2999642; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Harvey M.S, 2009, PSEUDOSCORPIONS WORL; Hoffman R.L., 1980, Catalogue of American Amphibians and Reptiles, P1; HUMPHRIES CJ, 1995, ANNU REV ECOL SYST, V26, P93, DOI 10.1146/annurev.es.26.110195.000521; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Loader C, 2010, LOCFIT LOCAL REGRESS, P15; Marek PE, 2007, ZOOTAXA, P27; Marek PE, 2006, MOL PHYLOGENET EVOL, V41, P704, DOI 10.1016/j.ympev.2006.05.043; Marek PE, 2010, ZOOL J LINN SOC-LOND, V159, P817, DOI 10.1111/j.1096-3642.2010.00633.x; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Minelli A, CHILOBASE WORLD CATA; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Prendergast JR, 1997, ECOGRAPHY, V20, P210, DOI 10.1111/j.1600-0587.1997.tb00363.x; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2001, ZOOL J LINN SOC-LOND, V132, P469, DOI 10.1006/zjls.2000.0277; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shear WA, 2010, ARTHROPOD STRUCT DEV, V39, P174, DOI 10.1016/j.asd.2009.11.002; Shelley RM, 2011, INSECTA MUNDI, V0158, P1; Shelley RM, 2007, ZOOTAXA, P343, DOI 10.11646/zootaxa.1668.1.18; Shokri MR, 2009, AQUAT CONSERV, V19, P626, DOI 10.1002/aqc.1013; Sierwald P, 2007, ANNU REV ENTOMOL, V52, P401, DOI 10.1146/annurev.ento.52.111805.090210; Sota T, 2010, P ROY SOC B-BIOL SCI, V277, P689, DOI 10.1098/rspb.2009.1822; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Tanabe T, 2008, AM NAT, V171, P692, DOI 10.1086/587075; Team RCD, 2009, R LANG ENV STAT COMP; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Warwick RM, 2008, J EXP MAR BIOL ECOL, V366, P184, DOI 10.1016/j.jembe.2008.07.023; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; Wesener T, 2009, CLADISTICS, V25, P545, DOI 10.1111/j.1096-0031.2009.00267.x; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Wilson HM, 2005, J PALEONTOL, V79, P1105, DOI 10.1666/0022-3360(2005)079[1105:TATAOP]2.0.CO;2; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2; Wilson SP, 2005, J R STAT SOC C-APPL, V54, P897, DOI 10.1111/j.1467-9876.2005.00513.x; Wojcieszek JM, 2012, EVOLUTION; Yu Y., 2011, RASP RECONSTRUCT ANC; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	59	49	53	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37240	10.1371/journal.pone.0037240	http://dx.doi.org/10.1371/journal.pone.0037240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615951	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300083
J	Kennedy, KD; AnithaChristy, SA; Buie, LK; Borras, T				Kennedy, K. David; AnithaChristy, S. A.; Buie, LaKisha K.; Borras, Teresa			Cystatin A, a Potential Common Link for Mutant Myocilin Causative Glaucoma	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; OPEN-ANGLE GLAUCOMA; ELEVATED INTRAOCULAR-PRESSURE; GENE-EXPRESSION PROFILE; IN-VITRO; CALCIFICATION PROCESS; EXTRACELLULAR-MATRIX; OLFACTOMEDIN DOMAIN; STEROID GLAUCOMA; CILIARY BODY	Myocilin (MYOC) is a 504 aa secreted glycoprotein induced by stress factors in the trabecular meshwork tissue of the eye, where it was discovered. Mutations in MYOC are linked to glaucoma. The glaucoma phenotype of each of the different MYOC mutation varies, but all of them cause elevated intraocular pressure (IOP). In cells, forty percent of wild-type MYOC is cleaved by calpain II, a cysteine protease. This proteolytic process is inhibited by MYOC mutants. In this study, we investigated the molecular mechanisms by which MYOC mutants cause glaucoma. We constructed adenoviral vectors with variants Q368X, R342K, D380N, K423E, and overexpressed them in human trabecular meshwork cells. We analyzed expression profiles with Affymetrix U133Plus2 GeneChips using wild-type and null viruses as controls. Analysis of trabecular meshwork relevant mechanisms showed that the unfolded protein response (UPR) was the most affected. Search for individual candidate genes revealed that genes that have been historically connected to trabecular meshwork physiology and pathology were altered by the MYOC mutants. Some of those had known MYOC associations (MMP1, PDIA4, CALR, SFPR1) while others did not (EDN1, MGP, IGF1, TAC1). Some, were top-changed in only one mutant (LOXL1, CYP1B1, FBN1), others followed a mutant group pattern. Some of the genes were new (RAB39B, STC1, CXCL12, CSTA). In particular, one selected gene, the cysteine protease inhibitor cystatin A (CSTA), was commonly induced by all mutants and not by the wild-type. Subsequent functional analysis of the selected gene showed that CSTA was able to reduce wild-type MYOC cleavage in primary trabecular meshwork cells while an inactive mutated CSTA was not. These findings provide a new molecular understanding of the mechanisms of MYOC-causative glaucoma and reveal CSTA, a serum biomarker for cancer, as a potential biomarker and drug for the treatment of MYOC-induced glaucoma.	[Kennedy, K. David; AnithaChristy, S. A.; Buie, LaKisha K.; Borras, Teresa] Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kennedy, KD (corresponding author), Univ N Carolina, Sch Med, Dept Ophthalmol, Chapel Hill, NC 27515 USA.	tborras@med.unc.edu	Core, Vector/CAF-4832-2022		National Institutes of Health (USA) [EY11906, EY13126, EY015873]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011906, R01EY015873, R01EY013126] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (USA) grants EY11906 (TB), EY13126 (TB), EY015873 (RHHA), and by a Research to Prevent Blindness unrestricted grant to the UNC Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Aroca-Aguilar JD, 2008, MOL VIS, V14, P2097; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Borras T, 2008, CURR TOP MEMBR, V62, P323, DOI 10.1016/S1063-5823(08)00411-0; Borras T, 2006, EXP EYE RES, V82, P1002, DOI 10.1016/j.exer.2005.11.005; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; Borras Teresa, 2008, P329, DOI 10.1007/978-1-59745-373-8_20; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Bruttini M, 2003, ARCH OPHTHALMOL-CHIC, V121, P1034, DOI 10.1001/archopht.121.7.1034; Buie L, 2010, INVEST OPHTHALMOL VI; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Chang KP, 2010, PROTEOMICS, V10, P2644, DOI 10.1002/pmic.200900620; Comes N, 2011, GENES CELLS, V16, P243, DOI 10.1111/j.1365-2443.2010.01483.x; Comes N, 2009, PHYSIOL GENOMICS, V38, P205, DOI 10.1152/physiolgenomics.90261.2008; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; ESCRIBANO J, 1995, J BIOCHEM-TOKYO, V118, P921, DOI 10.1093/jb/118.5.921; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Fautsch MP, 2004, MOL VIS, V10, P417; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Goldwich A, 2003, INVEST OPHTH VIS SCI, V44, P1953, DOI 10.1167/iovs.02-0863; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P352; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kleiner A, 2007, BIOPHYS J, V92, P2054, DOI 10.1529/biophysj.106.081257; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; MARTIN JR, 1995, J MOL BIOL, V246, P331, DOI 10.1006/jmbi.1994.0088; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Menaa F, 2011, MOLECULES, V16, P5402, DOI 10.3390/molecules16075402; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Mukaiyama H, 2010, APPL MICROBIOL BIOT, V86, P1135, DOI 10.1007/s00253-009-2393-x; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Polansky JR, 1991, GLAUCOMA UPDATE 4, P20; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Rozsa FW, 2006, MOL VIS, V12, P125; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Schlotzer-Schrehardt U, 2009, EXP EYE RES, V88, P776, DOI 10.1016/j.exer.2008.08.012; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1009, DOI 10.1007/s10571-005-8471-4; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Vittitow J, 2004, J CELL PHYSIOL, V201, P126, DOI 10.1002/jcp.20030; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wirtz MK, 2007, AM J OPHTHALMOL, V144, P75, DOI 10.1016/j.ajo.2007.03.037; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Xue W, 2006, INVEST OPHTH VIS SCI, V47, P997, DOI 10.1167/iovs.05-1106; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	77	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36301	10.1371/journal.pone.0036301	http://dx.doi.org/10.1371/journal.pone.0036301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615763	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300012
J	Li, Q; Yang, XH; Xu, ST; Cai, Y; Zhang, DL; Han, YJ; Li, L; Zhang, ZX; Gao, SB; Li, JS; Yan, JB				Li, Qing; Yang, Xiaohong; Xu, Shutu; Cai, Ye; Zhang, Dalong; Han, Yingjia; Li, Lin; Zhang, Zuxin; Gao, Shibin; Li, Jiansheng; Yan, Jianbing			Genome-Wide Association Studies Identified Three Independent Polymorphisms Associated with alpha-Tocopherol Content in Maize Kernels	PLOS ONE			English	Article							VITAMIN-E SUPPLEMENTATION; CELL-MEDIATED-IMMUNITY; GENETIC-VARIATION; BETA-CAROTENE; POPULATION; PLANTS; ARABIDOPSIS; INFERENCE; PROTEIN; LOCI	Tocopherols are a class of four natural compounds that can provide nutrition and function as antioxidant in both plants and animals. Maize kernels have low alpha-tocopherol content, the compound with the highest vitamin E activity, thus, raising the risk of vitamin E deficiency in human populations relying on maize as their primary vitamin E source. In this study, two insertion/deletions (InDels) within a gene encoding gamma-tocopherol methyltransferase, Zea mays VTE4 (ZmVTE4), and a single nucleotide polymorphism (SNP) located similar to 85 kb upstream of ZmVTE4 were identified to be significantly associated with alpha-tocopherol levels in maize kernels by conducting an association study with a panel of similar to 500 diverse inbred lines. Linkage analysis in three populations that segregated at either one of these three polymorphisms but not at the other two suggested that the three polymorphisms could affect alpha-tocopherol content independently. Furthermore, we found that haplotypes of the two InDels could explain similar to 33% of alpha-tocopherol variation in the association panel, suggesting ZmVTE4 is a major gene involved in natural phenotypic variation of alpha-tocopherol. One of the two InDels is located within the promoter region and associates with ZmVTE4 transcript level. This information can not only help in understanding the underlying mechanism of natural tocopherol variations in maize kernels, but also provide valuable markers for marker-assisted breeding of alpha-tocopherol content in maize kernels, which will then facilitate the improvement of maize as a better source of daily vitamin E nutrition.	[Li, Qing; Yang, Xiaohong; Xu, Shutu; Cai, Ye; Zhang, Dalong; Han, Yingjia; Li, Lin; Li, Jiansheng; Yan, Jianbing] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Zhang, Zuxin; Yan, Jianbing] Huazhong Agr Univ, Natl Key Lab Crop Improvement, Wuhan, Hubei, Peoples R China; [Gao, Shibin] Sichuan Agr Univ, Maize Res Inst, Yaan, Sichuan, Peoples R China	China Agricultural University; Huazhong Agricultural University; Sichuan Agricultural University	Li, Q (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	lijiansheng@cau.edu.cn; yjianbing@mail.hzau.edu.cn	Xu, Shutu/HII-5636-2022		National Hi-Tech Research and Development Program of China; Genetically Modified Varieties Breeding Science and Technology Projects of China	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Genetically Modified Varieties Breeding Science and Technology Projects of China	This research was supported by the National Hi-Tech Research and Development Program of China and the Genetically Modified Varieties Breeding Science and Technology Projects of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brigelius-Flohe R, 2002, AM J CLIN NUTR, V76, P703, DOI 10.1093/ajcn/76.4.703; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chander S, 2008, MOL BREEDING, V22, P353, DOI 10.1007/s11032-008-9180-8; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, GENETICS, V164, P1567; Ford ES, 1999, AM J EPIDEMIOL, V150, P290, DOI 10.1093/oxfordjournals.aje.a010001; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gilliland LU, 2006, P NATL ACAD SCI USA, V103, P18834, DOI 10.1073/pnas.0606221103; Gobert M, 2010, MEAT SCI, V85, P676, DOI 10.1016/j.meatsci.2010.03.024; Goffman FD, 2001, J AGR FOOD CHEM, V49, P4990, DOI 10.1021/jf010156y; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lee CYJ, 2000, J NUTR, V130, P2932, DOI 10.1093/jn/130.12.2932; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Mai TT, 2003, ASIA PAC J CLIN NUTR, V12, P178; Mene-Saffrane L, 2010, P NATL ACAD SCI USA, V107, P17815, DOI 10.1073/pnas.1006971107; MEYDANI SN, 1990, AM J CLIN NUTR, V52, P557, DOI 10.1093/ajcn/52.3.557; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Monsen ER, 2000, J AM DIET ASSOC, V100, P637, DOI 10.1016/S0002-8223(00)00189-9; Monteiro JP, 2009, NUTR RES, V29, P716, DOI 10.1016/j.nutres.2009.10.001; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Oldewage-Theron WH, 2010, CLIN NUTR, V29, P119, DOI 10.1016/j.clnu.2009.08.001; Pritchard JK, 2000, GENETICS, V155, P945; Provencher LM, 2001, PLANT CELL, V13, P1127, DOI 10.1105/tpc.13.5.1127; Rocheford TR, 2002, J AM COLL NUTR, V21, p191S, DOI 10.1080/07315724.2002.10719265; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Sattler SE, 2004, PLANT CELL, V16, P1419, DOI 10.1105/tpc.021360; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Traber MG, 1996, ANNU REV NUTR, V16, P321, DOI 10.1146/annurev.nu.16.070196.001541; Wilburn EE, 2008, J ANIM SCI, V86, P584, DOI 10.2527/jas.2007-0377; Wong JC, 2003, CROP SCI, V43, P2257, DOI 10.2135/cropsci2003.2257; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou Yi, 2009, Acta Agronomica Sinica, V35, P2073, DOI 10.3724/SP.J.1006.2009.02073	50	98	108	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36807	10.1371/journal.pone.0036807	http://dx.doi.org/10.1371/journal.pone.0036807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615816	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300037
J	Liu, YP; Yang, XN; Jazag, A; Pan, JS; Hu, TH; Liu, JJ; Guleng, B; Ren, JL				Liu, Yun-Peng; Yang, Xiao-Ning; Jazag, Amarsanaa; Pan, Jin-Shui; Hu, Tian-Hui; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin			HBsAg Inhibits the Translocation of JTB into Mitochondria in HepG2 Cells and Potentially Plays a Role in HCC Progression	PLOS ONE			English	Article							VIRUS X-PROTEIN; GROUND GLASS HEPATOCYTES; PRE-S MUTANTS; HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; SURFACE-ANTIGEN; KAPPA-B; GROWTH; ACTIVATION	Background and Aims: The expression of the jumping translocation breakpoint (JTB) gene is upregulated in malignant liver tissues; however, JTB is associated with unbalanced translocations in many other types of cancer that suppress JTB expression. No comprehensive analysis on its function in human hepatocellular carcinoma (HCC) has been performed to date. We aimed to define the biological consequences for interaction between JTB and HBsAg in HCC cell lines. Methods: We employed the stable transfection to establish small HBsAg expressing HepG2 cell line, and stably silenced the JTB expression using short hairpin RNA in HepG2 cell line. The effects of JTB and small HBsAg in vitro were determined by assessing cell apoptosis and motility. Results: Silencing of JTB expression promoted cancer cell motility and reduced cell apoptosis, which was significantly enhanced by HBs expression. Expression of HBsAg inhibited the translocation of JTB to the mitochondria. Furthermore, silencing of the JTB resulted in an increase in the phosphorylation of p65 in HepG2 cells and HepG2-HBs cells, whereas HBsAg expression decreased the phosphorylation of p65. The silencing of JTB in HepG2-HBs cells conferred increased advantages in cell motility and anti-apoptosis. Conclusion: HBsAg inhibited the translocation of JTB to the mitochondria and decreased the phosphorylation of p65 through the interaction with JTB, After JTB knockdown, HBsAg exhibited a stronger potential to promote tumor progression. Our data suggested that JTB act as a tumor suppressor gene in regards to HBV infection and its activation might be applied as a therapeutic strategy for in control of HBV related HCC development.	[Liu, Yun-Peng; Yang, Xiao-Ning; Pan, Jin-Shui; Liu, Jing-Jing; Guleng, Bayasi; Ren, Jian-Lin] Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China; [Hu, Tian-Hui; Guleng, Bayasi] Xiamen Univ, Coll Med, Xiamen, Fujian, Peoples R China; [Jazag, Amarsanaa] 3rd Gen Hosp, Natl Inst Med Res, Ulaanbaatar, Mongolia	Xiamen University; Xiamen University	Liu, YP (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastroenterol, Xiamen, Fujian, Peoples R China.	bayasi8@gmail.com; renjianl@xmu.edu.cn	Hu, T/G-3381-2010; Pan, Jin-Shui/AAL-3125-2020	Pan, Jin-Shui/0000-0002-9586-7760	National Natural Science Foundation of China [30971362, 81072013]; Fundamental Research Funds for the Central Universities in China [2010111082]; Key Projects for Technology Plan of Fujian Province in China [2009D020]; Foundation of Health Bureau of Fujian in China [2007CXB8, 3502z20077046]; Foundation of Health Bureau of Xiamen in China [2007CXB8, 3502z20077046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; Key Projects for Technology Plan of Fujian Province in China; Foundation of Health Bureau of Fujian in China; Foundation of Health Bureau of Xiamen in China	This work was supported by National Natural Science Foundation of China (No. 30971362 and 81072013); Fundamental Research Funds for the Central Universities in China (No. 2010111082); Key Projects for Technology Plan of Fujian Province in China (No. 2009D020); and Foundations of Health Bureau of Fujian and Xiamen in China (No. 2007CXB8 & No. 3502z20077046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; Fan YF, 2000, J GASTROEN HEPATOL, V15, P519, DOI 10.1046/j.1440-1746.2000.02187.x; Fan YF, 2001, HEPATOLOGY, V33, P277, DOI 10.1053/jhep.2001.21163; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Guleng B, 2005, WORLD J GASTROENTERO, V11, P5455, DOI 10.3748/wjg.v11.i35.5455; Hatakeyama S, 1999, ONCOGENE, V18, P2085, DOI 10.1038/sj.onc.1202510; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Itoh T, 1998, CANCER RES, V58, P1048; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Keung YK, 1998, CANCER GENET CYTOGEN, V106, P135, DOI 10.1016/S0165-4608(97)00316-6; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Pan JS, 2009, CANCER LETT, V285, P151, DOI 10.1016/j.canlet.2009.05.009; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; Polimeno L, 2000, DIGEST LIVER DIS, V32, P510, DOI 10.1016/S1590-8658(00)80009-2; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; Wong N, 2003, J HEPATOL, V38, P298, DOI 10.1016/S0168-8278(02)00412-9; World Health Organization, 2000, HEP B FACT SHEET NO; Yang JC, 2009, HEPATOLOGY, V49, P1962, DOI 10.1002/hep.22889; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	37	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36914	10.1371/journal.pone.0036914	http://dx.doi.org/10.1371/journal.pone.0036914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615844	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336300050
J	Santos, J; Sousa, MJ; Leao, C				Santos, Julia; Sousa, Maria Joao; Leao, Cecilia			Ammonium Is Toxic for Aging Yeast Cells, Inducing Death and Shortening of the Chronological Lifespan	PLOS ONE			English	Article							KINASE-A PATHWAY; MITOCHONDRIA-DEPENDENT APOPTOSIS; SACCHAROMYCES-CEREVISIAE; NUTRIENT AVAILABILITY; REGULATES APOPTOSIS; MOLECULAR-MECHANISM; STRESS RESISTANCE; BUDDING YEAST; SCH9; LONGEVITY	Here we show that in aging Saccharomyces cerevisiae (budding yeast) cells, NH4(+) induces cell death associated with shortening of chronological life span. This effect is positively correlated with the concentration of NH4(+) added to the culture medium and is particularly evident when cells are starved for auxotrophy-complementing amino acids. NH4(+)-induced cell death is accompanied by an initial small increase of apoptotic cells followed by extensive necrosis. Autophagy is inhibited by NH4(+), but this does not cause a decrease in cell viability. We propose that the toxic effects of NH4(+) are mediated by activation of PKA and TOR and inhibition of Sch9p. Our data show that NH4(+) induces cell death in aging cultures through the regulation of evolutionary conserved pathways. They may also provide new insights into longevity regulation in multicellular organisms and increase our understanding of human disorders such as hyperammonemia as well as effects of amino acid deprivation employed as a therapeutic strategy.	[Santos, Julia; Leao, Cecilia] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Santos, Julia; Leao, Cecilia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Sousa, Maria Joao] Univ Minho, Dept Biol, Mol & Environm Res Ctr CBMA, Braga, Portugal	Universidade do Minho; Universidade do Minho	Santos, J (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	mjsousa@bio.uminho.pt	Sousa, Maria João/H-8775-2013; Santos, Júlia M/D-4894-2013; Leao, Cecília/B-5051-2013; Sousa, Maria/HCI-9642-2022	Sousa, Maria João/0000-0001-9424-4150; Santos, Júlia M/0000-0002-4035-0692; Leao, Cecilia/0000-0003-1311-7884	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-ALI/102608/2008]; FCT [SFRH/BD/33314/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/102608/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal Grant PTDC/AGR-ALI/102608/2008. JS has a fellowship from FCT (SFRH/BD/33314/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Braissant O, 2010, MOL GENET METAB, V100, pS3, DOI 10.1016/j.ymgme.2010.02.010; Burtner CR, 2011, CELL CYCLE, V10, P1385, DOI 10.4161/cc.10.9.15464; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cagnon L, 2009, NEUROBIOL DIS, V33, P133, DOI 10.1016/j.nbd.2008.09.025; Camougrand N, 2008, METHOD ENZYMOL, V451, P89, DOI 10.1016/S0076-6879(08)03208-4; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Fortuna M, 2001, CURR PROTOC CYTOM; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Leadsham JE, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-92; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MAZON MJ, 1978, J BACTERIOL, V133, P780; Mendes-Ferreira A, 2004, J APPL MICROBIOL, V97, P540, DOI 10.1111/j.1365-2672.2004.02331.x; MITCHELL AP, 1983, J BIOL CHEM, V258, P119; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Thevelein JM, 2005, BIOCHEM SOC T, V33, P253, DOI 10.1042/BST0330253; Thevelein JM, 2000, ENZYME MICROB TECH, V26, P819, DOI 10.1016/S0141-0229(00)00177-0; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Ziyun Wu LS, 2011, EXPT GERONTOLOGY, V46, P915	60	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37090	10.1371/journal.pone.0037090	http://dx.doi.org/10.1371/journal.pone.0037090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615903	Green Published, gold			2022-12-27	WOS:000305336300069
J	Friedman, J; Alam, SM; Shen, XY; Xia, SM; Stewart, S; Anasti, K; Pollara, J; Fouda, GG; Yang, G; Kelsoe, G; Ferrari, G; Tomaras, GD; Haynes, BF; Liao, HX; Moody, MA; Permar, SR				Friedman, James; Alam, S. Munir; Shen, Xiaoying; Xia, Shi-Mao; Stewart, Shelley; Anasti, Kara; Pollara, Justin; Fouda, Genevieve G.; Yang, Guang; Kelsoe, Garnett; Ferrari, Guido; Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin; Moody, M. Anthony; Permar, Sallie R.			Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; CORECEPTOR-BINDING-SITE; BREAST-MILK; NEUTRALIZATION EPITOPES; TYROSINE SULFATION; SUBTYPE-B; HIV-1; GP41; IGA	Background: Generation of potent anti-HIV antibody responses in mucosal compartments is a potential requirement of a transmission-blocking HIV vaccine. HIV-specific, functional antibody responses are present in breast milk, and these mucosal antibody responses may play a role in protection of the majority of HIV-exposed, breastfeeding infants. Therefore, characterization of HIV-specific antibodies produced by B cells in milk could guide the development of vaccines that elicit protective mucosal antibody responses. Methods: We isolated B cells from colostrum of an HIV-infected lactating woman with a detectable neutralization response in milk and recombinantly produced and characterized the resulting HIV-1 Envelope (Env)-specific monoclonal antibodies (mAbs). Results: The identified HIV-1 Env-specific colostrum mAbs, CH07 and CH08, represent two of the first mucosally-derived anti-HIV antibodies yet to be reported. Colostrum mAb CH07 is a highly-autoreactive, weakly-neutralizing gp140-specific mAb that binds to linear epitopes in the gp120 C5 region and gp41 fusion domain. In contrast, colostrum mAb CH08 is a nonpolyreactive CD4-inducible (CD4i) gp120-specific mAb with moderate breadth of neutralization. Conclusions: These novel HIV-neutralizing mAbs isolated from a mucosal compartment provide insight into the ability of mucosal B cell populations to produce functional anti-HIV antibodies that may contribute to protection against virus acquisition at mucosal surfaces.	[Friedman, James; Alam, S. Munir; Shen, Xiaoying; Xia, Shi-Mao; Stewart, Shelley; Anasti, Kara; Pollara, Justin; Fouda, Genevieve G.; Ferrari, Guido; Tomaras, Georgia D.; Haynes, Barton F.; Liao, Hua-Xin; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27705 USA; [Yang, Guang; Kelsoe, Garnett] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Duke University	Friedman, J (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27705 USA.	sallie.permar@duke.edu	Fouda, Genevieve/AAR-9720-2020; Alam, S. Munir/AAC-6711-2019; Fouda, Genevieve/AAY-8099-2020; Moody, M/AAB-6947-2020; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Tomaras, Georgia/J-5041-2016	Moody, M/0000-0002-3890-5855; Ferrari, Guido/0000-0001-7747-3349; 	National Institutes of Health (NIH/NIAID/DAIDS); Center for HIV/AIDS Vaccine Immunology (CHAVI) [AI067854, AI07392, AI087992]; Doris Duke Foundation Clinical Scientist Development Award; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC) [38619]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068614, K08AI087992, T32AI007392, R01AI081579, UM1AI068614, U19AI067854, U01AI067854] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NIAID/DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Vaccine Immunology (CHAVI); Doris Duke Foundation Clinical Scientist Development Award; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH/NIAID/DAIDS) grants: the Center for HIV/AIDS Vaccine Immunology (CHAVI) AI067854, AI07392 (JP), and AI087992 (SRP); and the Doris Duke Foundation Clinical Scientist Development Award (SRP). Additional funding was provided by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD-VIMC grant 38619) (GDT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2004, AIDS RES HUM RETROV, V20, P836, DOI 10.1089/0889222041725181; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bonsignori M, 2011, J VIROL; Czinn S J, 1987, Adv Exp Med Biol, V216A, P305; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Ferrari G, 2011, J VIROL, V85, P7029, DOI 10.1128/JVI.00171-11; Fouda GG, 2011, J VIROL; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Haynes BF, 2011, TRENDS MOL MED, V17, P108, DOI 10.1016/j.molmed.2010.10.008; Haynes BF, 2010, NAT STRUCT MOL BIOL, V17, P543, DOI 10.1038/nsmb0510-543; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; LOPALCO L, 1993, EUR J IMMUNOL, V23, P2016, DOI 10.1002/eji.1830230844; MCDERMOTT MR, 1979, J IMMUNOL, V122, P1892; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Moody MA, 2010, J EXP MED, V207, P763, DOI 10.1084/jem.20091281; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Nadas A, 2004, AIDS RES HUM RETROV, V20, P55, DOI 10.1089/088922204322749503; Nyambi PN, 2000, J VIROL, V74, P7096, DOI 10.1128/JVI.74.15.7096-7107.2000; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Permar SR, 2008, J IMMUNOL, V181, P3643, DOI 10.4049/jimmunol.181.5.3643; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; ROUX ME, 1977, J EXP MED, V146, P1311, DOI 10.1084/jem.146.5.1311; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wilks AB, 2010, J IMMUNOL, V185, P7097, DOI 10.4049/jimmunol.1002751	49	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37648	10.1371/journal.pone.0037648	http://dx.doi.org/10.1371/journal.pone.0037648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624058	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500147
J	Kock, J; Rosler, C; Zhang, JJ; Blum, HE; Nassal, M; Thoma, C				Koeck, Josef; Roesler, Christine; Zhang, Jingjing; Blum, Hubert E.; Nassal, Michael; Thoma, Christian			Human Hepatitis B Virus Production in Avian Cells Is Characterized by Enhanced RNA Splicing and the Presence of Capsids Containing Shortened Genomes	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; ARGININE-RICH DOMAIN; CORE PROTEIN; REVERSE TRANSCRIPTION; PREGENOMIC RNA; TYROSINE RESIDUE; TRANSGENIC MICE; HEPG2 CELLS; HBV-DNA; REPLICATION	Experimental studies on hepatitis B virus (HBV) replication are commonly done with human hepatoma cells to reflect the natural species and tissue tropism of the virus. However, HBV can also replicate, upon transfection of virus coding plasmids, in cells of other species. In such cross-species transfection experiments with chicken LMH hepatoma cells, we previously observed the formation of HBV genomes with aberrant electrophoretic mobility, in addition to the those DNA species commonly seen in human HepG2 hepatoma cells. Here, we report that these aberrant DNA forms are mainly due to excessive splicing of HBV pregenomic RNA and the abundant synthesis of spliced DNA products, equivalent to those also made in human cells, yet at much lower level. Mutation of the common splice acceptor site abolished splicing and in turn enhanced production of DNA from full-length pgRNA in transfected LMH cells. The absence of splicing made other DNA molecules visible, that were shortened due to the lack of sequences in the core protein coding region. Furthermore, there was nearly full-length DNA in the cytoplasm of LMH cells that was not protected in viral capsids. Remarkably, we have previously observed similar shortened genomes and non-protected viral DNA in human HepG2 cells, yet exclusively in the nucleus where uncoating and final release of viral genomes occurs. Hence, two effects reflecting capsid disassembly in the nucleus in human HepG2 cells are seen in the cytoplasm of chicken LMH cells.	[Koeck, Josef; Roesler, Christine; Zhang, Jingjing; Blum, Hubert E.; Nassal, Michael; Thoma, Christian] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany	University of Freiburg	Kock, J (corresponding author), Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany.	josefkoeck@web.de; christian.thoma@uniklinik-freiburg.de	Zhang, Jing/HII-4294-2022; Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158	Forschungsmanagement of the Medical Faculty of the University of Freiburg [THO740/09]; Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses''; Fritz-Thyssen-Stiftung; Deutsche Forschungsgemeinschaft [TH 788/2 1, TH 788/2 2]	Forschungsmanagement of the Medical Faculty of the University of Freiburg; Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses''; Fritz-Thyssen-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in parts by the Forschungsmanagement of the Medical Faculty of the University of Freiburg (THO740/09), and by the Deutsche Forschungsgemeinschaft through FOR 1202 "Mechanisms of persistence of hepatotropic viruses'' (Na 154/12 1). JJZ was funded by a postdoctoral fellowship from the Fritz-Thyssen-Stiftung. CT is a recipient of a Heisenberg-Fellowship from the Deutsche Forschungsgemeinschaft (TH 788/2 1 and TH 788/2 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraham TM, 2008, VIROLOGY, V379, P30, DOI 10.1016/j.virol.2008.06.021; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BEAMES B, 1993, VIROLOGY, V194, P597, DOI 10.1006/viro.1993.1299; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BRANLANT C, 1980, NUCLEIC ACIDS RES, V8, P4143, DOI 10.1093/nar/8.18.4143; CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Habig JW, 2006, J MOL BIOL, V364, P32, DOI 10.1016/j.jmb.2006.08.095; Halverscheid L, 2008, J MED VIROL, V80, P583, DOI 10.1002/jmv.21115; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Lee GH, 2008, VIRUS RES, V136, P1, DOI 10.1016/j.virusres.2008.05.007; Lewellyn EB, PLOS ONE, V6, pe1; Loeb DD, 2002, J VIROL, V76, P10195, DOI 10.1128/JVI.76.20.10195-10202.2002; MASON WS, 1980, J VIROL, V36, P829, DOI 10.1128/JVI.36.3.829-836.1980; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Obert S, 1996, EMBO J, V15, P2565, DOI 10.1002/j.1460-2075.1996.tb00614.x; Preiss S, 2008, HEPATOLOGY, V48, P741, DOI 10.1002/hep.22386; Reifenberg K, 2002, J GEN VIROL, V83, P991, DOI 10.1099/0022-1317-83-5-991; ROSMORDUC O, 1995, HEPATOLOGY, V22, P10, DOI 10.1016/0270-9139(95)90346-1; Schultz U, 2004, ADV VIRUS RES, V63, P1, DOI 10.1016/S0065-3527(04)63001-6; STAPRANS S, 1991, J VIROL, V65, P1255, DOI 10.1128/JVI.65.3.1255-1262.1991; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUREAU C, 1986, CELL, V47, P37, DOI 10.1016/0092-8674(86)90364-8; TERRE S, 1991, J VIROL, V65, P5539; WEBER M, 1994, J VIROL, V68, P2994, DOI 10.1128/JVI.68.5.2994-2999.1994; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; YAGINUMA K, 1987, P NATL ACAD SCI USA, V84, P2678, DOI 10.1073/pnas.84.9.2678; ZOULIM F, 1994, J VIROL, V68, P6, DOI 10.1128/JVI.68.1.6-13.1994	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37248	10.1371/journal.pone.0037248	http://dx.doi.org/10.1371/journal.pone.0037248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624002	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500084
J	Lavaud, J; Materna, AC; Sturm, S; Vugrinec, S; Kroth, PG				Lavaud, Johann; Materna, Arne C.; Sturm, Sabine; Vugrinec, Sascha; Kroth, Peter G.			Silencing of the Violaxanthin De-Epoxidase Gene in the Diatom Phaeodactylum tricornutum Reduces Diatoxanthin Synthesis and Non-Photochemical Quenching	PLOS ONE			English	Article							TRANSTHYLAKOID PROTON GRADIENT; XANTHOPHYLL-CYCLE PIGMENTS; LIGHT-HARVESTING COMPLEX; DIADINOXANTHIN CYCLE; ENERGY-DISSIPATION; MARINE DIATOM; TRANSLATIONAL INHIBITION; PLANKTONIC DIATOMS; HIGHER-PLANTS; POOL SIZE	Diatoms are a major group of primary producers ubiquitous in all aquatic ecosystems. To protect themselves from photooxidative damage in a fluctuating light climate potentially punctuated with regular excess light exposures, diatoms have developed several photoprotective mechanisms. The xanthophyll cycle (XC) dependent non-photochemical chlorophyll fluorescence quenching (NPQ) is one of the most important photoprotective processes that rapidly regulate photosynthesis in diatoms. NPQ depends on the conversion of diadinoxanthin (DD) into diatoxanthin (DT) by the violaxanthin de-epoxidase (VDE), also called DD de-epoxidase (DDE). To study the role of DDE in controlling NPQ, we generated transformants of P. tricornutum in which the gene (Vde/Dde) encoding for DDE was silenced. RNA interference was induced by genetic transformation of the cells with plasmids containing either short (198 bp) or long (523 bp) antisense (AS) fragments or, alternatively, with a plasmid mediating the expression of a self-complementary hairpin-like construct (inverted repeat, IR). The silencing approaches generated diatom transformants with a phenotype clearly distinguishable from wildtype (WT) cells, i.e. a lower degree as well as slower kinetics of both DD de-epoxidation and NPQ induction. Real-time PCR based quantification of Dde transcripts revealed differences in transcript levels between AS transformants and WT cells but also between AS and IR transformants, suggesting the possible presence of two different gene silencing mediating mechanisms. This was confirmed by the differential effect of the light intensity on the respective silencing efficiency of both types of transformants. The characterization of the transformants strengthened some of the specific features of the XC and NPQ and confirmed the most recent mechanistic model of the DT/NPQ relationship in diatoms.	[Lavaud, Johann; Materna, Arne C.; Sturm, Sabine; Vugrinec, Sascha; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, Constance, Germany; [Lavaud, Johann] Univ La Rochelle, LIENSs UMR7266, CNRS, Inst Coastal & Environm Res, La Rochelle, France	University of Konstanz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Lavaud, J (corresponding author), Univ Konstanz, Fachbereich Biol, Constance, Germany.	sabine.sturm@uni-konstanz.de	Lavaud, Johann/N-6185-2014; Kroth, Peter G/A-9728-2008	Lavaud, Johann/0000-0002-4704-2502; Kroth, Peter G/0000-0003-4734-8955	Universitat Konstanz; European Commission [QLRT-2001-01226]; Deutsche Forschungsgemeinschaft [LA-2368/2-1]	Universitat Konstanz; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study has been funded by Universitat Konstanz (www.uni-konstanz.de), European Commission (http://cordis.europa.eu, project QLRT-2001-01226) and Deutsche Forschungsgemeinschaft (http://www.dfg.de, project LA-2368/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; ARSALANE W, 1994, PHOTOCHEM PHOTOBIOL, V60, P237, DOI 10.1111/j.1751-1097.1994.tb05097.x; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Bertrand M, 2010, PHOTOSYNTH RES, V106, P89, DOI 10.1007/s11120-010-9589-x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; CARON L, 1988, J EXP MAR BIOL ECOL, V123, P211, DOI 10.1016/0022-0981(88)90043-3; Casper-Lindley C, 1998, PHOTOSYNTH RES, V56, P277, DOI 10.1023/A:1006037516479; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; de Poll WHV, 2011, MAR ECOL PROG SER, V426, P119, DOI 10.3354/meps09000; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Frommolt R, 2008, MOL BIOL EVOL, V25, P2653, DOI 10.1093/molbev/msn206; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gisselsson A, 2004, PHYSIOL PLANTARUM, V122, P337, DOI 10.1111/j.1399-3054.2004.00415.x; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Goss R, 2009, J PLANT PHYSIOL, V166, P1839, DOI 10.1016/j.jplph.2009.05.017; Govindjee, 2002, PLANT CELL, V14, P1663, DOI 10.1105/tpc.140810; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Havir EA, 1997, PLANT SCI, V123, P57, DOI 10.1016/S0168-9452(97)04579-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Jakob T, 1999, PLANT BIOLOGY, V1, P76, DOI 10.1055/s-2007-978491; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kalituho L, 2007, PLANTA, V225, P423, DOI 10.1007/s00425-006-0356-3; Kropuenske LR, 2010, J PHYCOL, V46, P1138, DOI 10.1111/j.1529-8817.2010.00922.x; Kroth Peter G., 2007, V390, P257; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2003, BIOCHEMISTRY-US, V42, P5802, DOI 10.1021/bi027112i; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2007, FUNCT PLANT SCI BIOT, V1, P267; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Materna AC, 2009, J PHYCOL, V45, P838, DOI 10.1111/j.1529-8817.2009.00711.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mewes H, 2002, PLANT PHYSIOL, V130, P1527, DOI 10.1104/pp.006775; Mouget JL, 1999, EUR J PHYCOL, V34, P109, DOI 10.1017/S0967026299002073; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Oxborough K, 2004, J EXP BOT, V55, P1195, DOI 10.1093/jxb/erh145; Perkins RG, 2010, DEVEL APPL PHYCOL, V4, P237, DOI 10.1007/978-90-481-9268-7_12; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Sarthou G, 2005, J SEA RES, V53, P25, DOI 10.1016/j.seares.2004.01.007; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; TING CS, 1993, PLANT PHYSIOL, V101, P1323, DOI 10.1104/pp.101.4.1323; Verhoeven AS, 2001, PHOTOSYNTH RES, V67, P27, DOI 10.1023/A:1010684327864; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; WILLEMOES M, 1991, PHYSIOL PLANTARUM, V83, P449, DOI 10.1034/j.1399-3054.1991.830318.x; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	70	53	56	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36806	10.1371/journal.pone.0036806	http://dx.doi.org/10.1371/journal.pone.0036806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629333	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500028
J	Moreno-Navarrete, JM; Sabater, M; Ortega, F; Ricart, W; Fernandez-Real, JM				Maria Moreno-Navarrete, Jose; Sabater, Monica; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance	PLOS ONE			English	Article							DIET-INDUCED OBESITY; TIGHT JUNCTIONS; GUT MICROBIOTA; MICE; PATHOGENESIS; INFLAMMATION; MODULATOR; DISEASE	Zonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions. To investigate the relationship between intestinal permeability and obesity-associated metabolic disturbances in humans, we aimed to study circulating zonulin according to obesity and insulin resistance. Circulating zonulin (ELISA) was measured in 123 caucasian men in association with inflammatory and metabolic parameters ( including minimal model-measured insulin sensitivity). Circulating zonulin increased with body mass index (BMI), waist to hip ratio (WHR), fasting insulin, fasting triglycerides, uric acid and IL-6, and negatively correlated with HDL-cholesterol and insulin sensitivity. In multiple regression analysis, insulin sensitivity (p = 0.002) contributed independently to circulating zonulin variance, after controlling for the effects of BMI, fasting triglycerides and age. When circulating IL-6 was added to this model, only BMI (p = 0.01) contributed independently to circulating zonulin variance. In conclusion, the relationship between insulin sensitivity and circulating zonulin might be mediated through the obesity-related circulating IL-6 increase.	[Maria Moreno-Navarrete, Jose] CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; Inst Salud Carlos III, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III	Moreno-Navarrete, JM (corresponding author), CIBEROBN CB06 03 010, IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Sabater-Masdeu, Mònica/G-1168-2016; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Moreno-Navarrete, José María/ABG-5548-2021	Sabater-Masdeu, Mònica/0000-0001-9636-0921; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Ricart, Wifredo/0000-0002-3452-9098	Ministerio de Educacion y Ciencia [SAF2008-02073]	Ministerio de Educacion y Ciencia(Spanish Government)	This work was partially supported by research grants from the Ministerio de Educacion y Ciencia (SAF2008-02073). CIBEROBN Fisiopatologia de la Obesidad y Nutricion is an initiative from the Instituto de Salud Carlos III from Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fasano A, 2000, ANN NY ACAD SCI, V915, P214; FERRARIS RP, 1995, AM J CLIN NUTR, V62, P540, DOI 10.1093/ajcn/62.3.540; Ferraris RP, 1993, DIABETES, V123, P1062; Generoso M, 2003, J CHROMATOGR B, V783, P349, DOI 10.1016/S1570-0232(02)00766-3; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hansen D, 2010, EUR J APPL PHYSIOL, V109, P397, DOI 10.1007/s00421-010-1362-5; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Smecuol E, 2005, CLIN GASTROENTEROL H, V3, P335, DOI 10.1016/S1542-3565(04)00778-5; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Wang WL, 2000, J CELL SCI, V113, P4435; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132	20	173	177	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37160	10.1371/journal.pone.0037160	http://dx.doi.org/10.1371/journal.pone.0037160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629362	Green Published, gold			2022-12-27	WOS:000305343500067
J	Massaro, D; Savazzi, F; Di Dio, C; Freedberg, D; Gallese, V; Gilli, G; Marchetti, A				Massaro, Davide; Savazzi, Federica; Di Dio, Cinzia; Freedberg, David; Gallese, Vittorio; Gilli, Gabriella; Marchetti, Antonella			When Art Moves the Eyes: A Behavioral and Eye-Tracking Study	PLOS ONE			English	Article							RECOGNITION; JUDGMENTS; ATTENTION; MOTION; CORTEX; LEVEL; MODEL; FMRI	The aim of this study was to investigate, using eye-tracking technique, the influence of bottom-up and top-down processes on visual behavior while subjects, naive to art criticism, were presented with representational paintings. Forty-two subjects viewed color and black and white paintings (Color) categorized as dynamic or static (Dynamism) (bottom-up processes). Half of the images represented natural environments and half human subjects (Content); all stimuli were displayed under aesthetic and movement judgment conditions (Task) (top-down processes). Results on gazing behavior showed that content-related top-down processes prevailed over low-level visually-driven bottom-up processes when a human subject is represented in the painting. On the contrary, bottom-up processes, mediated by low-level visual features, particularly affected gazing behavior when looking at nature-content images. We discuss our results proposing a reconsideration of the definition of content-related top-down processes in accordance with the concept of embodied simulation in art perception.	[Massaro, Davide; Marchetti, Antonella] Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy; [Savazzi, Federica; Gilli, Gabriella] Univ Cattolica Sacro Cuore, Res Unit Psychol Art, Dept Psychol, I-20123 Milan, Italy; [Di Dio, Cinzia; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Freedberg, David; Gallese, Vittorio] Columbia Univ, Dept Art Hist & Archaeol, New York, NY USA; [Freedberg, David] Columbia Univ, Italian Acad Adv Studies Amer, New York, NY USA; [Gallese, Vittorio] IIT Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; University of Parma; Columbia University; Columbia University; Istituto Italiano di Tecnologia - IIT	Massaro, D (corresponding author), Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy.	davide.massaro@unicatt.it	Marchetti, Antonella/W-2226-2018; Li, Mengqi/AAG-6804-2021; MARCHETTI, Antonella/AAL-6051-2020; Di Dio, Cinzia/HGB-3168-2022; Massaro, Davide/K-1233-2019; Gallese, Vittorio/ABD-5097-2021	Marchetti, Antonella/0000-0001-9985-0539; MARCHETTI, Antonella/0000-0001-9985-0539; Massaro, Davide/0000-0002-4511-6897; Gallese, Vittorio/0000-0003-4815-3607	EU [TESIS-264828]; Universita Cattolica del Sacro Cuore [D1-2008]	EU(European Commission); Universita Cattolica del Sacro Cuore	This work was supported by the EU grant TESIS-264828 to VG. This research was also made possible by a D1-2008 research grant from the Universita Cattolica del Sacro Cuore to GG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas ZA, 2008, PERCEPTION, V37, P1187, DOI 10.1068/p5984; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; ANTES JR, 1974, J EXP PSYCHOL, V103, P62, DOI 10.1037/h0036799; Arnheim R., 1992, RESCUE ART 26 ESSAYS; Bell BA, 2010, SAS GLOB FOR 2010; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BOSELIE F, 1985, AM J PSYCHOL, V98, P1, DOI 10.2307/1422765; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2010, EXP BRAIN RES, V204, P447, DOI 10.1007/s00221-010-2283-6; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Cupchik GC, 2009, BRAIN COGNITION, V70, P84, DOI 10.1016/j.bandc.2009.01.003; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2012, ENCY HUMAN BEHAV; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Gori S, 2008, SPATIAL VISION, V21, P201, DOI 10.1163/156856808784532635; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2010, SPIE C SERIES, V7527, P36, DOI [10.1016/j.cag.2009.04.003, DOI 10.1016/J.CAG.2009.04.003]; Grundland M, 2007, PATTERN RECOGN, V40, P2891, DOI 10.1016/j.patcog.2006.11.003; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Hekker P., 2008, PRODUCT EXPERIENCE, P259, DOI [DOI 10.1016/B978-008045089-6.50013-7, 10.1016/B978-008045089-6.50013-7]; Hekkert P, 1996, ACTA PSYCHOL, V94, P117, DOI 10.1016/0001-6918(95)00055-0; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Jacobsen T, 2006, LEONARDO, V39, P155, DOI 10.1162/leon.2006.39.2.155; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P755, DOI 10.2466/PMS.95.7.755-766; Le Meur O, 2010, IEEE T IMAGE PROCESS, V19, P2801, DOI 10.1109/TIP.2010.2052262; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Livingstone M., 2002, VISION ART BIOL SEEI; LOCHER P, 1993, STUD VIS INFORM PROC, V4, P59; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Locher P, 2010, DES ISSUES, V26, P70, DOI 10.1162/DESI_a_00017; Locher PJ, 1996, CONTRIBUTION EYE MOV; Loucher P. L., 1995, EMPIR STUD ARTS, V13, P183, DOI DOI 10.2190/GMV3-PPWN-LU41-NQVU; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; MACKWORTH NH, 1967, PERCEPT PSYCHOPHYS, V2, P547, DOI 10.3758/BF03210264; MAGIDSON, 2002, CANADIAN J MARKETING, V20, P36; MARTINDALE C, 1988, J EXP PSYCHOL HUMAN, V14, P661, DOI 10.1037/0096-1523.14.4.661; Nodine C. F., 1982, REV RES VISUAL ARTS, V8, P43; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ramachandran V.S., 1999, J CONSCIOUSNESS STUD, V6, P15, DOI [10.1179/174327908X392906, DOI 10.1179/174327908X392906]; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Santella A., 2004, P EYE TRACKING RES A, P27, DOI DOI 10.1145/968363.968368; Smith K, 2008, COMPUT GRAPH FORUM, V27, P193, DOI 10.1111/j.1467-8659.2008.01116.x; Tatler BW, 2008, SPATIAL VISION, V21, P165, DOI 10.1163/156856808782713807; Tobii, 2008, TOB STUD US MAN; Vermunt J. K., 2000, LATENT GOLD USERS MA; Wallraven C., 2009, COMPUTATIONAL AESTHE, P137; Wolfflin H., 1994, EMPATHY FORM SPACE P, P149; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T; Zellner DA, 2010, FOOD QUAL PREFER, V21, P575, DOI 10.1016/j.foodqual.2010.02.007	62	103	103	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37285	10.1371/journal.pone.0037285	http://dx.doi.org/10.1371/journal.pone.0037285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22624007	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500090
J	Saias, T; Lerner, E; Greacen, T; Simon-Vernier, E; Emer, A; Pintaux, E; Guedeney, A; Dugravier, R; Tereno, S; Falissard, B; Tubach, F; Revah-Levy, A				Saias, Thomas; Lerner, Emilie; Greacen, Tim; Simon-Vernier, Elodie; Emer, Alessandra; Pintaux, Eleonore; Guedeney, Antoine; Dugravier, Romain; Tereno, Susana; Falissard, Bruno; Tubach, Florence; Revah-Levy, Anne		CAPEDP Study Grp	Evaluating Fidelity in Home-Visiting Programs a Qualitative Analysis of 1058 Home Visit Case Notes from 105 Families	PLOS ONE			English	Article							IMPLEMENTATION FIDELITY; YOUNG-CHILDREN; PREVENTION PROGRAM; INTERVENTION; ABUSE; OUTCOMES; VIOLENCE; NEGLECT	Objective: Implementation fidelity is a key issue in home-visiting programs as it determines a program's effectiveness in accomplishing its original goals. This paper seeks to evaluate fidelity in a 27-month program addressing maternal and child health which took place in France between 2006 and 2011. Method: To evaluate implementation fidelity, home visit case notes were analyzed using thematic qualitative and computer-assisted linguistic analyses. Results: During the prenatal period, home visitors focused on the social components of the program. Visitors discussed the physical changes in pregnancy, and psychological and social environment issues. Discussing immigration, unstable employment and financial related issues, family relationships and dynamics and maternity services, while not expected, were found in case notes. Conversely, health during pregnancy, early child development and postpartum mood changes were not identified as topics within the prenatal case notes. During the postnatal period, most components of the intervention were addressed: home visitors observed the mother's adaptation to the baby; routine themes such as psychological needs and medical-social networks were evaluated; information on the importance of social support and on adapting the home environment was given; home visitors counseled on parental authority, and addressed mothers' self-esteem issues; finally, they helped to find child care, when necessary. Some themes were not addressed or partially addressed: health education, child development, home environment, mother's education plans and personal routine, partner support and play with the child. Other themes were not expected, but found in the case notes: social issues, mother-family relationship, relation with services, couple issues, quality of maternal behavior and child's language development. Conclusions: In this program, home visitors experienced difficulties addressing some of the objectives because they gave precedence to the families" urgent needs. This research stresses the importance of training home visitors to adapt the intervention to the social, psychological and health needs of families.	[Saias, Thomas; Lerner, Emilie; Greacen, Tim; Emer, Alessandra] Etab Publ Sante Maison Blanche, Lab Rech, Paris, France; [Simon-Vernier, Elodie; Pintaux, Eleonore; Guedeney, Antoine; Dugravier, Romain; Tereno, Susana] Hop Bichat Claude Bernard, Serv Pedopsychiat, F-75877 Paris 18, France; [Guedeney, Antoine; Dugravier, Romain; Falissard, Bruno; Revah-Levy, Anne] Inst Natl Sante & Rech Med, PSIGIAM U669, Paris, France; [Tubach, Florence] Hop Bichat Claude Bernard, Unite Rech Clin Paris Nord, F-75877 Paris 18, France; [Saias, Thomas] Inst Natl Prevent & Educ Sante, St Denis, France; [Saias, Thomas] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Emer, Alessandra] Univ Trent, Labosdif, Rovereto, Italy; [Revah-Levy, Anne] Hop Argenteuil, Ctr Soins Psychotherapeut Transit Adolescents, Argenteuil, France; [Revah-Levy, Anne] Univ Paris 05, Univ Paris 11, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; University of Quebec; University of Quebec Montreal; University of Trento; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Saias, T (corresponding author), Etab Publ Sante Maison Blanche, Lab Rech, Paris, France.	th.saias@gmail.com	; Purper-Ouakil, Diane/AAC-5024-2019	Tereno, Susana/0000-0001-5258-7913; Azria, Elie/0000-0002-6159-6253; Guedeney, Antoine/0000-0002-2346-4495; revah-levy, anne/0000-0003-1805-6275; Purper-Ouakil, Diane/0000-0003-0454-1579	National Ministry of Health Hospital Clinical Research Programme [PHRC AOM 05056]; National Institute for Promotion and Health Education; Clinical Research and Development Department of the APHP	National Ministry of Health Hospital Clinical Research Programme; National Institute for Promotion and Health Education; Clinical Research and Development Department of the APHP	The project was financed with a grant from the National Ministry of Health Hospital Clinical Research Programme (PHRC AOM 05056) and the National Institute for Promotion and Health Education. The sponsor was the Clinical Research and Development Department of the APHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, ATTACHMENT LOSS ATTA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bilukha O, 2005, AM J PREV MED, V28, P11, DOI 10.1016/j.amepre.2004.10.004; Breitenstein SM, 2010, NURS RES, V59, P158, DOI 10.1097/NNR.0b013e3181dbb2e2; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Center for Early Education and Development, 2009, STEPS EFF ENJ PAR ST; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Eames C, 2008, CHILD CARE HLTH DEV, V34, P391, DOI 10.1111/j.1365-2214.2008.00828.x; Fixsen D., 2005, IMPLEMENTATION RES S; Florida State University Center for Prevention and Early Intervention Policy, 2007, PARTN HLTH BAB HOM V; Geeraert L, 2004, CHILD MALTREATMENT, V9, P277, DOI 10.1177/1077559504264265; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gomby DS, 2007, CHILD ABUSE NEGLECT, V31, P793, DOI 10.1016/j.chiabu.2007.07.001; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Gross D, 2001, FAM RELAT, V50, P246, DOI 10.1111/j.1741-3729.2001.00246.x; Guedeney A, 2011, CAPEDP RES REPORT; Gurlanick M, 1993, EARLY EDUC DEV, V4, P366; Hebbeler KM, 2002, EARLY CHILD RES Q, V17, P28, DOI 10.1016/S0885-2006(02)00128-X; Hiatt SW, 1997, J COMMUNITY PSYCHOL, V25, P77, DOI 10.1002/(SICI)1520-6629(199701)25:1<77::AID-JCOP6>3.0.CO;2-#; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Kahn J., 2010, WHAT WORKS HOME VISI; Kitzman HJ, 1997, J COMMUNITY PSYCHOL, V25, P95; Knoche LL, 2010, EARLY CHILD RES Q, V25, P299, DOI 10.1016/j.ecresq.2009.05.003; Lee CYS, 2008, PREV SCI, V9, P215, DOI 10.1007/s11121-008-0097-6; Lyons-Ruth K, 2004, J AM ACAD CHILD PSY, V43, P699, DOI 10.1097/01.chi.0000122730.72597.07; Mihalic SF, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-5; Olds D, 1997, J COMMUNITY PSYCHOL, V25, P9; Perepletchikova F, 2007, J CONSULT CLIN PSYCH, V75, P829, DOI 10.1037/0022-006X.75.6.829; Powers S, 1999, HOME VISITING REACHI; Reinert M, 2001, REV FRANCAISE PSYCHI, V5, P32; Spoth R, 2007, J FAM PSYCHOL, V21, P137, DOI 10.1037/0893-3200.21.2.137; Stevens J., 2005, J AGGRESS MALTREAT T, V11, P75, DOI DOI 10.1300/J146V11N04_04; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tandon SD, 2008, EARLY CHILD RES Q, V23, P419, DOI 10.1016/j.ecresq.2008.02.002; Von Klitzing K, 2011, INT PERSPECTIVES CHI; Weatherston D., 2000, ZERO 3, V21, P3; Woolfolk T., 2009, FAM RELAT, V28, P188; Yang S, 2009, INT J LAW PSYCHIAT, V32, P294, DOI 10.1016/j.ijlp.2009.06.003	40	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36915	10.1371/journal.pone.0036915	http://dx.doi.org/10.1371/journal.pone.0036915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22629341	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500037
J	Abad, C; Tan, YV; Cheung-Lau, G; Nobuta, H; Waschek, JA				Abad, Catalina; Tan, Yossan-Var; Cheung-Lau, Gardenia; Nobuta, Hiroko; Waschek, James A.			VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NF-KAPPA-B; TOLL-LIKE-RECEPTORS; IN-VIVO; TNF-ALPHA; PERITONEAL-MACROPHAGES; POLYPEPTIDE PACAP; INFLAMMATION; CELLS	Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide with immunomodulatory properties. The administration of this peptide has been shown to have beneficial effects in murine models of inflammatory diseases including septic shock, rheumatoid arthritis, multiple sclerosis (MS) and Crohn's disease. However, the role of the endogenous peptide in inflammatory disease remains obscure because VIP-deficient mice were recently found to exhibit profound resistance in a model of MS. In the present study, we analyzed the response of female VIP deficient (KO) mice to intraperitoneal lipopolysaccharide (LPS) administration. We observed significant resistance to LPS in VIP KO mice, as evidenced by lower mortality and reduced tissue damage. The increased survival was associated with decreased levels of proinflammatory cytokines (TNF alpha, IL-6 and IL-12) in sera and peritoneal suspensions of these mice. Moreover, the expression of TNF alpha and IL-6 mRNA was reduced in peritoneal cells, spleens and lungs from LPS-treated VIP KO vs. WT mice, suggesting that the resistance might be mediated by an intrinsic defect in the responsiveness of immune cells to endotoxin. In agreement with this hypothesis, peritoneal cells isolated from VIP KO naive mice produced lower levels of proinflammatory cytokines in response to LPS in vitro. Finally, decreased NF-kappa B pathway activity in peritoneal cells was observed both in vivo and in vitro, as determined by assay of phosphorylated I-kappa B. The results demonstrate that female VIP KO mice exhibit resistance to LPS-induced shock, explainable in part by the presence of an intrinsic defect in the responsiveness of inflammatory cells to endotoxin.	[Abad, Catalina; Tan, Yossan-Var; Cheung-Lau, Gardenia; Nobuta, Hiroko; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Cheung-Lau, Gardenia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Cheung-Lau, Gardenia] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abad, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA.	JWaschek@mednet.ucla.edu		Abad, Catalina/0000-0001-9144-9310	National Multiple Sclerosis Society [PP1233, RG3928]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was funded by the National Multiple Sclerosis Society Grants PP1233 and RG3928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Abad C, 2010, P NATL ACAD SCI USA, V107, P19555, DOI 10.1073/pnas.1007622107; Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Ait-Ali D, NEUROPHARMACOLOGY, V58, P208; Batoulis H, 2010, ANN ANAT, V192, P179, DOI 10.1016/j.aanat.2010.06.006; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BRANDTZAEG P, 1989, REGUL PEPTIDES, V24, P37, DOI 10.1016/0167-0115(89)90209-7; Cai YQ, 1997, ENDOCRINOLOGY, V138, P2515, DOI 10.1210/en.138.6.2515; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Delgado M, 1999, J IMMUNOL, V162, P4685; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Delgado M, 2008, BRAIN BEHAV IMMUN, V22, P1146, DOI 10.1016/j.bbi.2008.06.001; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Ellrichmann G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-15; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Ganea D, 2001, ARCH IMMUNOL THER EX, V49, P101; Gomariz RP, 2001, CURR PHARM DESIGN, V7, P89, DOI 10.2174/1381612013398374; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Hamidi SA, 2008, EUR RESPIR J, V31, P135, DOI 10.1183/09031936.00105807; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jean-Baptiste Eddy, 2007, J Intensive Care Med, V22, P63, DOI 10.1177/0885066606297123; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Li JM, 2011, J IMMUNOL, V187, P1057, DOI 10.4049/jimmunol.1100686; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; Martinez C, 1999, J NEUROIMMUNOL, V93, P126, DOI 10.1016/S0165-5728(98)00216-1; Martinez C, 1998, J NEUROIMMUNOL, V85, P155, DOI 10.1016/S0165-5728(98)00018-6; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stearns-Kurosawa DJ, 1991, ANNU REV PATHOL-MECH, V6, P19; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; ten Cate H, 2000, CRIT CARE MED, V28, pS9, DOI 10.1097/00003246-200009001-00003; Zhao KS, 1997, INFLAMMATION, V21, P379, DOI 10.1023/A:1027362303005	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36922	10.1371/journal.pone.0036922	http://dx.doi.org/10.1371/journal.pone.0036922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615845	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200025
J	Ahn, R; Ding, YC; Murray, J; Fasano, A; Green, PHR; Neuhausen, SL; Garner, C				Ahn, Richard; Ding, Yuan Chun; Murray, Joseph; Fasano, Alessio; Green, Peter H. R.; Neuhausen, Susan L.; Garner, Chad			Association Analysis of the Extended MHC Region in Celiac Disease Implicates Multiple Independent Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DERMATITIS-HERPETIFORMIS; HLA-DQ; LINKAGE ANALYSIS; RISK VARIANTS; POPULATION; DISORDERS; GENES; IDENTIFICATION; REPLICATION	Celiac disease is a common autoimmune disease caused by sensitivity to the dietary protein gluten. Forty loci have been implicated in the disease. All disease loci have been characterized as low-penetrance, with the exception of the high-risk genotypes in the HLA-DQA1 and HLA-DQB1 genes, which are necessary but not sufficient to cause the disease. The very strong effects from the known HLA loci and the genetically complex nature of the major histocompatibility complex (MHC) have precluded a thorough investigation of the region. The purpose of this study was to test the hypothesis that additional celiac disease loci exist within the extended MHC (xMHC). A set of 1898 SNPs was analyzed for association across the 7.6 Mb xMHC region in 1668 confirmed celiac disease cases and 517 unaffected controls. Conditional recursive partitioning was used to create an informative indicator of the known HLA-DQA1 and HLA-DQB1 high-risk genotypes that was included in the association analysis to account for their effects. A linkage disequilibrium-based grouping procedure was utilized to estimate the number of independent celiac disease loci present in the xMHC after accounting for the known effects. There was significant statistical evidence for four new independent celiac disease loci within the classic MHC region. This study is the first comprehensive association analysis of the xMHC in celiac disease that specifically accounts for the known HLA disease genotypes and the genetic complexity of the region.	[Ahn, Richard; Garner, Chad] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA; [Ding, Yuan Chun; Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Murray, Joseph] Mayo Clin, Dept Med & Immunol, Rochester, MN USA; [Fasano, Alessio] Univ Maryland, Sch Med, Ctr Celiac Res, Baltimore, MD 21201 USA; [Green, Peter H. R.] Columbia Univ, Celiac Dis Ctr, New York, NY USA	University of California System; University of California Irvine; City of Hope; Beckman Research Institute of City of Hope; Mayo Clinic; University System of Maryland; University of Maryland Baltimore; Columbia University	Ahn, R (corresponding author), Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92717 USA.	cgarner@uci.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261; murray, joseph/0000-0003-1941-9090; Ahn, Richard/0000-0002-9698-2752	National Institutes of Health [R01DK081645, R01DK057964, P30DK084567]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health (www.nih.gov), with grants R01DK081645, R01DK057964 and P30DK084567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Balas A, 1997, TISSUE ANTIGENS, V50, P52, DOI 10.1111/j.1399-0039.1997.tb02834.x; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Bouguerra F, 1997, GENET EPIDEMIOL, V14, P413, DOI 10.1002/(SICI)1098-2272(1997)14:4<413::AID-GEPI6>3.0.CO;2-3; Breiman L., 1984, CLASSIFICATION REGRE; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collin P, 1996, GUT, V38, P528, DOI 10.1136/gut.38.4.528; COOPER BT, 1978, BRIT MED J, V1, P537, DOI 10.1136/bmj.1.6112.537; DOHERTY DG, 1992, HUM IMMUNOL, V34, P53, DOI 10.1016/0198-8859(92)90085-2; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; FALCHUK ZM, 1972, LANCET, V2, P1310; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Feolo M, 2001, J IMMUNOL METHODS, V258, P65, DOI 10.1016/S0022-1759(01)00473-2; Garner CP, 2007, GENES IMMUN, V8, P108, DOI 10.1038/sj.gene.6364361; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; HALL RP, 1989, J INVEST DERMATOL, V93, P501, DOI 10.1111/1523-1747.ep12284056; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Katz KD, 2011, AM J GASTROENTEROL, V106, P1333, DOI 10.1038/ajg.2011.21; Kaukinen K, 1999, DIGEST DIS SCI, V44, P1428, DOI 10.1023/A:1026612121041; King AL, 2001, ANN HUM GENET, V65, P377, DOI 10.1017/S0003480001008703; LANGO A, 1993, EUR J IMMUNOGENET, V20, P453; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; MAZZILLI MC, 1992, HUM IMMUNOL, V33, P133, DOI 10.1016/0198-8859(92)90064-T; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Murray JA, 2003, CLIN GASTROENTEROL H, V1, P19, DOI 10.1053/jcgh.2003.50004; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; PARK MS, 1983, TISSUE ANTIGENS, V22, P263; Polvi A, 1998, HUM IMMUNOL, V59, P169, DOI 10.1016/S0198-8859(98)00008-1; Popat S, 2002, J MED GENET, V39, P328, DOI 10.1136/jmg.39.5.328; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2004, AM J MED GENET A, V130A, P345, DOI 10.1002/ajmg.a.30072; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; SACHS JA, 1986, GUT, V27, P515, DOI 10.1136/gut.27.5.515; SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910, DOI 10.1016/0016-5085(93)90912-V; Sollid LM, 1997, COELIAC DISEASE, P265; STOKES PL, 1972, LANCET, V2, P162; Tohkin M, 2013, PHARMACOGENOMICS J, V13, P60, DOI 10.1038/tpj.2011.41; TOSI R, 1983, CLIN IMMUNOL IMMUNOP, V28, P395, DOI 10.1016/0090-1229(83)90106-X; Van Belzen MJ, 2003, GASTROENTEROLOGY, V125, P1032, DOI 10.1016/S0016-5085(03)01205-8; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007; Zhong F, 1996, NAT GENET, V14, P329, DOI 10.1038/ng1196-329	49	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36926	10.1371/journal.pone.0036926	http://dx.doi.org/10.1371/journal.pone.0036926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615847	Green Published, gold			2022-12-27	WOS:000305341200026
J	Jiang, Y; Cui, L; Chen, WD; Shen, SH; Ding, LD				Jiang, Yong; Cui, Lin; Chen, Wen-de; Shen, Shi-hai; Ding, Li-dong			The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published Data	PLOS ONE			English	Article							ASSOCIATION DOMAIN FAMILY-1; DNA METHYLATION; POOR-PROGNOSIS; HYPERMETHYLATION; MARKER; SERUM; GENE	Purpose: Epigenetic alterations have been investigated as prognostic indicators in breast cancer but their translation into clinical practice has been impeded by a lack of appropriate validation. We present the results of a meta-analysis of the associations between RASSF1A promoter methylation status and both disease free survival (DFS) and overall survival (OS) in female breast cancer. Methods: Eligible studies were identified through searching the PubMed, Web of Science and Embase databases. Studies were pooled and summary hazard ratios (HR) with corresponding confidence intervals (CIs) were calculated. Funnel plots were also carried out to evaluate publication bias. Results: A total of 1795 patients from eight studies were included in the meta-analysis. There are eight studies which investigated DFS in 1795 cases. The relative hazard estimates ranged from 1.77-5.64 with a combined HR of 2.75 (95% CI 1.96-3.84). The HR of RASSF1A promoter methylation on DFS adjusted for other potential prognostic factors was 2.54 (95% CI 1.77-3.66). There has been five trials which analyzed the associations of RASSF1A promoter methylation status with OS in 1439 patients. The hazard estimates ranged from 1.21-6.90 with a combined random-effects estimates of 3.47 (95% CI 1.44-8.34). OS reported in multivariate analysis was evaluated in four series comprising 1346 cases and the summarized random-effects HR estimate was 3.35 (95% CI 1.14-9.85). Additionally, no publication bias was detected for both OS and DFS. Conclusion: The results of this meta-analysis suggest that RASSF1A promoter hypermethylation confers a higher risk of relapse and a worse survival in patients with breast cancer. Large prospective studies are now needed to establish the clinical utility of RASSF1A promoter methylation.	[Jiang, Yong; Cui, Lin] Yangzhou Univ, Affiliated Hosp, Jiangyan Peoples Hosp, Dept Oncol, Jiangyan, Peoples R China; [Chen, Wen-de; Shen, Shi-hai; Ding, Li-dong] Yangzhou Univ, Affiliated Hosp, Jiangyan Peoples Hosp, Dept Sci Res, Jiangyan, Peoples R China	Yangzhou University; Yangzhou University	Jiang, Y (corresponding author), Yangzhou Univ, Affiliated Hosp, Jiangyan Peoples Hosp, Dept Oncol, Jiangyan, Peoples R China.	cuilintz@126.com						Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; Buhmeida A, 2011, ANTICANCER RES, V31, P2975; Cho YH, 2011, BREAST CANC RES TREA; Dallol A, 2007, CANCER RES, V67, P492, DOI 10.1158/0008-5472.CAN-06-3604; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fiegl H, 2005, CANCER RES, V65, P1141, DOI 10.1158/0008-5472.CAN-04-2438; Gobel G, 2011, BREAST CANC RES TREA; Hamilton MG, 2011, J NEURO-ONCOL, V102, P255, DOI 10.1007/s11060-010-0307-5; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jo H, 2006, ONCOL RES, V16, P205, DOI 10.3727/000000006783981125; Karray-Chouayekh S, 2010, J CANCER RES CLIN, V136, P203, DOI 10.1007/s00432-009-0649-6; Kawai Y, 2010, ANN ONCOL, V21, P1612, DOI 10.1093/annonc/mdp577; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Kioulafa M, 2009, CLIN BIOCHEM, V42, P970, DOI 10.1016/j.clinbiochem.2009.04.003; Martins AT, 2011, BREAST CANCER RES TR, V129, P1, DOI 10.1007/s10549-010-1160-0; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Misawa A, 2009, BRIT J CANCER, V100, P399, DOI 10.1038/sj.bjc.6604887; Muller HM, 2003, CANCER RES, V63, P7641; Muller HM, 2004, ANN NY ACAD SCI, V1022, P44, DOI 10.1196/annals.1318.008; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Sharma G, 2009, CELL ONCOL, V31, P487, DOI 10.3233/CLO-2009-0507; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tommasi S, 2005, CANCER RES, V65, P92; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266	30	42	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36780	10.1371/journal.pone.0036780	http://dx.doi.org/10.1371/journal.pone.0036780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615811	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200020
J	Coultrap, SJ; Barcomb, K; Bayer, KU				Coultrap, Steven J.; Barcomb, Kelsey; Bayer, K. Ulrich			A Significant but Rather Mild Contribution of T286 Autophosphorylation to Ca2+/CaM-Stimulated CaMKII Activity	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM POTENTIATION; CA-2+ CALMODULIN; INHIBITORY AUTOPHOSPHORYLATION; II-ALPHA; MECHANISM; ACTIVATION; EXPRESSION; MAINTENANCE; PLASTICITY	Background: Autophosphorylation of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) at T286 generates partially Ca2+/CaM-independent "autonomous" activity, which is thought to be required for long-term potentiation (LTP), a form of synaptic plasticity thought to underlie learning and memory. A requirement for T286 autophosphorylation also for efficient Ca2+/CaM-stimulated CaMKII activity has been described, but remains controversial. Methodology/Principal Findings: In order to determine the contribution of T286 autophosphorylation to Ca2+/CaM-stimulated CaMKII activity, the activity of CaMKII wild type and its phosphorylation-incompetent T286A mutant was compared. As the absolute activity can vary between individual kinase preparations, the activity was measured in six different extracts for each kinase (expressed in HEK-293 cells). Consistent with measurements on purified kinase (from a baculovirus/Sf9 cell expression system), CaMKII T286A showed a mildly but significantly reduced rate of Ca2+/CaM-stimulated phosphorylation for two different peptide substrates (to similar to 75-84% of wild type). Additional slower CaMKII autophosphorylation at T305/306 inhibits stimulation by Ca2+/CaM, but occurs only minimally for CaMKII wild type during CaM-stimulated activity assays. Thus, we tested if the T286A mutant may show more extensive inhibitory autophosphorylation, which could explain its reduced stimulated activity. By contrast, inhibitory autophosphorylation was instead found to be even further reduced for the T286A mutant under our assay conditions. On a side note, the phospho-T305 antibody showed some basal background immuno-reactivity also with non-phosphorylated CaMKII, as indicated by T305/306A mutants. Conclusions/Significance: These results indicate that Ca2+/CaM-stimulated CaMKII activity is mildly (similar to 1.2-1.3fold) further increased by additional T286 autophosphorylation, but that this autophosphorylation is not required for the major part of the stimulated activity. This indicates that the phenotype of CaMKII T286A mutant mice is indeed due to the lack of autonomous activity, as the T286A mutant showed no dramatic reduction in stimulated activity.	[Coultrap, Steven J.; Barcomb, Kelsey; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Coultrap, SJ (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu		Barcomb, Kelsey/0000-0002-4050-0566	National Institutes of Health (NIH) [R01NS052644, T32GM007635]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The research was supported by National Institutes of Health (NIH) R01NS052644 (to KUB) and NIH T32GM007635 (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bayer KU, 2002, EMBO J, V21, P3590, DOI 10.1093/emboj/cdf360; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Coultrap SJ, 2012, NEUROMETHOD IN PRESS; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FONG YL, 1989, J BIOL CHEM, V264, P16759; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; HANSON PI, 1992, J BIOL CHEM, V267, P17216; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hardingham N, 2003, J NEUROSCI, V23, P4428; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; IKEDA A, 1991, J BIOL CHEM, V266, P11582; Ishida A, 1996, BBA-MOL CELL RES, V1311, P211, DOI 10.1016/0167-4889(95)00197-2; KATOH T, 1991, J BIOL CHEM, V266, P3039; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; KWIATKOWSKI AP, 1988, J BIOL CHEM, V263, P6484; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; OHSAKO S, 1991, J BIOCHEM-TOKYO, V109, P137, DOI 10.1093/oxfordjournals.jbchem.a123334; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 1997, J NEUROSCI, V17, P5357; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Radwanska K, 2011, P NATL ACAD SCI USA, V108, P18471, DOI 10.1073/pnas.1109680108; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009	57	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37176	10.1371/journal.pone.0037176	http://dx.doi.org/10.1371/journal.pone.0037176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615928	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300080
J	Liedigk, R; Yang, MY; Jablonski, NG; Momberg, F; Geissmann, T; Lwin, N; Hla, TH; Liu, ZJ; Wong, B; Ming, L; Long, YC; Zhang, YP; Nadler, T; Zinner, D; Roos, C				Liedigk, Rasmus; Yang, Mouyu; Jablonski, Nina G.; Momberg, Frank; Geissmann, Thomas; Lwin, Ngwe; Hla, Tony Htin; Liu, Zhijin; Wong, Bruce; Ming, Li; Long Yongcheng; Zhang, Ya-Ping; Nadler, Tilo; Zinner, Dietmar; Roos, Christian			Evolutionary History of the Odd-Nosed Monkeys and the Phylogenetic Position of the Newly Described Myanmar Snub-Nosed Monkey Rhinopithecus strykeri	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; NATURAL HYBRIDIZATION; MITOCHONDRIAL-DNA; ASIAN COLOBINES; UPPER MIOCENE; CYTOCHROME-B; PRIMATES; PLEISTOCENE; CLASSIFICATION; PHYLOGEOGRAPHY	Odd-nosed monkeys represent one of the two major groups of Asian colobines. Our knowledge about this primate group is still limited as it is highlighted by the recent discovery of a new species in Northern Myanmar. Although a common origin of the group is now widely accepted, the phylogenetic relationships among its genera and species, and the biogeographic processes leading to their current distribution are largely unknown. To address these issues, we have analyzed complete mitochondrial genomes and 12 nuclear loci, including one X chromosomal, six Y chromosomal and five autosomal loci, from all ten odd-nosed monkey species. The gene tree topologies and divergence age estimates derived from different markers were highly similar, but differed in placing various species or haplogroups within the genera Rhinopithecus and Pygathrix. Based on our data, Rhinopithecus represent the most basal lineage, and Nasalis and Simias form closely related sister taxa, suggesting a Northern origin of odd-nosed monkeys and a later invasion into Indochina and Sundaland. According to our divergence age estimates, the lineages leading to the genera Rhinopithecus, Pygathrix and Nasalis+Simias originated in the late Miocene, while differentiation events within these genera and also the split between Nasalis and Simias occurred in the Pleistocene. Observed gene tree discordances between mitochondrial and nuclear datasets, and paraphylies in the mitochondrial dataset for some species of the genera Rhinopithecus and Pygathrix suggest secondary gene flow after the taxa initially diverged. Most likely such events were triggered by dramatic changes in geology and climate within the region. Overall, our study provides the most comprehensive view on odd-nosed monkey evolution and emphasizes that data from differentially inherited markers are crucial to better understand evolutionary relationships and to trace secondary gene flow.	[Liedigk, Rasmus; Yang, Mouyu; Liu, Zhijin; Roos, Christian] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Yang, Mouyu] Fanjingshan Natl Nat Reserve, Jiangkou, Guizhou Provinc, Peoples R China; [Jablonski, Nina G.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Momberg, Frank] Fauna & Flora Int, Myanmar Programme, Yangon, Myanmar; [Geissmann, Thomas] Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; [Lwin, Ngwe; Hla, Tony Htin] BANCA, Yangon, Myanmar; [Liu, Zhijin; Wong, Bruce; Ming, Li] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Long Yongcheng] Nature Conservancy, Kunming, Peoples R China; [Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Nadler, Tilo] Endangered Primate Rescue Ctr, Frankfurt Zool Soc, Cuc Phuong National Pk, Ninh Binh Provi, Vietnam; [Zinner, Dietmar] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Roos, Christian] German Primate Ctr, Gene Bank Primates, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Zurich; Chinese Academy of Sciences; Institute of Zoology, CAS; Nature Conservancy; Chinese Academy of Sciences; Kunming Institute of Zoology; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Liedigk, R (corresponding author), German Primate Ctr, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu			European Union; Arcus Foundation; Arcadia Fund; Halcyon Land Sea Fund; German Primate Center (DPZ); Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL)	European Union(European Commission); Arcus Foundation; Arcadia Fund; Halcyon Land Sea Fund; German Primate Center (DPZ); Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL)	Field work that led to the discovery of the Myanmar snub-nosed monkey was financially supported by the European Union, Arcus Foundation, Arcadia Fund and the Halcyon Land & Sea Fund, administrated by FFI. Further financial support for this project was obtained from the German Primate Center (DPZ) and the Biodiversitatspakt of the Wissenschaftsgemeinschaft Gottfried-Wilhelm Leibniz (WGL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 2006, THESIS U TEXAS AUSTI; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Avise J, 2004, MOL MARKERS NATURAL; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaplin G., 2005, P CALIFORNIA ACAD SC, V56, P27; Colbert EH, 1953, B MUS NAT HIST, V102, P1024; Delson E., 1980, P10; Delson E., 2000, ENCY HUMAN EVOLUTION, P166; Drummond A.J., 2010, GENEIOUS VERSION 5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FERGUSON DK, 1993, P 3 C EV E AS ENV CT, P145; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Geissmann T, 2011, AM J PRIMATOL, V73, P96, DOI 10.1002/ajp.20894; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Groves C.P., 2001, PRIMATE TAXONOMY; Hallet B, 2001, J GEOPHYS RES-SOL EA, V106, P13697, DOI 10.1029/2000JB900335; Harrison T, 2007, AM J PHYS ANTHROPOL, P126; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jablonski N. G., 1998, NATURAL HIST DOUCS S; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; JABLONSKI NG, 1991, J HUM EVOL, V20, P51, DOI 10.1016/0047-2484(91)90045-W; JABLONSKI NG, 1993, FOLIA PRIMATOL, V60, P36, DOI 10.1159/000156674; JABLONSKI NG, 1993, FOLIA PRIMATOL, V60, P118, DOI 10.1159/000156681; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; Jablonski NG, 2011, AM J PHYS ANTHROPOL, V144, P174; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley J, 2002, CAM S BIO EVOL ANTHR, V33, P369; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; LEAKEY MG, 1993, THEROPITHECUS, P85, DOI 10.1017/CBO9780511565540.004; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Li M, 2004, INT J PRIMATOL, V25, P861, DOI 10.1023/B:IJOP.0000029126.27618.88; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Louys J, 2007, PALAEOGEOGR PALAEOCL, V243, P152, DOI 10.1016/j.palaeo.2006.07.011; Maddison W.P., MESQUITE MODULAR SYS; Meijaard E, 2006, DEV PRIMATOL, P305, DOI 10.1007/0-387-31710-4_11; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Osada N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025549; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; PENG YZ, 1993, FOLIA PRIMATOL, V60, P106; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pozzi L, 2011, J HUM EVOL, V61, P209, DOI 10.1016/j.jhevol.2011.02.008; Rambaut A., 2007, TRACE 1 4; Rambaut A., 2008, FIGTREE TREE FIGURE; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Roos Christian, 2004, P23; Roos Christian, 2001, Zoologische Garten, V71, P1; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Sterner KN, 2006, MOL PHYLOGENET EVOL, V40, P1, DOI 10.1016/j.ympev.2006.01.017; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tan C, ODD NOSED M IN PRESS; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; Zhang YP, 1998, PRIMATES, V39, P39, DOI 10.1007/BF02557742; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zinner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004859	70	44	50	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37418	10.1371/journal.pone.0037418	http://dx.doi.org/10.1371/journal.pone.0037418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616004	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305341300112
J	Yao, JY; Jia, L; Khan, N; Zheng, QD; Moncrief, A; Hauswirth, WW; Thompson, DA; Zacks, DN				Yao, Jingyu; Jia, Lin; Khan, Naheed; Zheng, Qiong-Duan; Moncrief, Ashley; Hauswirth, William W.; Thompson, Debra A.; Zacks, David N.			Caspase Inhibition with XIAP as an Adjunct to AAV Vector Gene-Replacement Therapy: Improving Efficacy and Prolonging the Treatment Window	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; X-LINKED INHIBITOR; RETINAL DEGENERATION; CELL-DEATH; RETINITIS-PIGMENTOSA; NEUROTROPHIC FACTOR; RD10 MOUSE; APOPTOSIS; PHOTORECEPTORS; PROTECTION	Purpose: AAV-mediated gene therapy in the rd10 mouse, with retinal degeneration caused by mutation in the rod cyclic guanosine monophosphate phosphodiesterase beta-subunit (PDE beta) gene, produces significant, but transient, rescue of photoreceptor structure and function. This study evaluates the ability of AAV-mediated delivery of X-linked inhibitor of apoptosis (XIAP) to enhance and prolong the efficacy of PDE beta gene-replacement therapy. Methods: Rd10 mice were bred and housed in darkness. Two groups of animals were generated: Group 1 received sub-retinal AAV5-XIAP or AAV5-GFP at postnatal age (P) 4 or 21 days; Group 2 received sub-retinal AAV5-XIAP plus AAV5-PDE beta, AAV5-GFP plus AAV5- PDE beta, or AAV- PDE beta alone at age P4 or P21. Animals were maintained for an additional 4 weeks in darkness before being moved to a cyclic-light environment. A subset of animals from Group 1 received a second sub-retinal injection of AAV8-733-PDE beta two weeks after being moved to the light. Histology, immunohistochemistry, Western blots, and electroretinograms were performed at different times after moving to the light. Results: Injection of AAV5-XIAP alone at P4 and 21 resulted in significant slowing of light-induced retinal degeneration, as measured by outer nuclear thickness and cell counts, but did not result in improved outer segment structure and rhodopsin localization. In contrast, co-injection of AAV5-XIAP and AAV5-PDE beta resulted in increased levels of rescue and decreased rates of retinal degeneration compared to treatment with AAV5-PDE beta alone. Mice treated with AAV5-XIAP at P4, but not P21, remained responsive to subsequent rescue by AAV8-733-PDE beta when injected two weeks after moving to a light-cycling environment. Conclusions: Adjunctive treatment with the anti-apoptotic gene XIAP confers additive protective effect to gene-replacement therapy with AAV5-PDE beta in the rd10 mouse. In addition, AAV5-XIAP, when given early, can increase the age at which gene-replacement therapy remains effective, thus effectively prolonging the window of opportunity for therapeutic intervention.	[Yao, Jingyu; Jia, Lin; Khan, Naheed; Zheng, Qiong-Duan; Moncrief, Ashley; Thompson, Debra A.; Zacks, David N.] Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Yao, JY (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, Sch Med, Ann Arbor, MI 48105 USA.	davzacks@umich.edu	Zacks, David/I-4394-2013	Thompson, Debra/0000-0003-3485-0794; Zacks, David/0000-0001-8592-5165; hauswirth, william/0000-0002-3244-4947	Foundation Fighting Blindness, Research to Prevent Blindness, UM [NEI-EY007003]; Foundation Fighting Blindness, Research to Prevent Blindness, UF [NEI-EY021721]; NATIONAL EYE INSTITUTE [F31EY007003, P30EY007003, P30EY021721, R01EY020823] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research to Prevent Blindness, UM; Foundation Fighting Blindness, Research to Prevent Blindness, UF; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Foundation Fighting Blindness, Research to Prevent Blindness, UM (NEI-EY007003) and UF (NEI-EY021721) Core Centers for Vision Research. DAT is a recipient of Research to Prevent Blindness Senior Scientific Investigator Award. DNZ is a recipient of the Research to Prevent Blindness Sybil B. Harrington Special Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cooper LB, 2006, OTOL NEUROTOL, V27, P484, DOI 10.1097/00129492-200606000-00009; Daiger SP SL, 2011, RETNET RETINAL INFOR; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Holcik M, 2011, APOPTOSIS, V4, P253; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kugler S, 2000, CELL DEATH DIFFER, V7, P815, DOI 10.1038/sj.cdd.4400712; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Pagon PA, 1988, SURV OPHTHALMOL, V13, P137; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Petrin D, 2003, INVEST OPHTH VIS SCI, V44, P2757, DOI 10.1167/iovs.02-0729; Renwick J, 2006, GENE THER, V13, P339, DOI 10.1038/sj.gt.3302683; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Straten G, 2002, NEUROBIOL DIS, V11, P123, DOI 10.1006/nbdi.2002.0543; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Yao JY, 2011, INVEST OPHTH VIS SCI, V52, P1567, DOI 10.1167/iovs.10-5998; Zadro-Lamoureux LA, 2009, INVEST OPHTH VIS SCI, V50, P1448, DOI 10.1167/iovs.08-2855	26	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37197	10.1371/journal.pone.0037197	http://dx.doi.org/10.1371/journal.pone.0037197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615940	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300088
J	Glasner, A; Zurunic, A; Meningher, T; Rovis, TL; Tsukerman, P; Bar-On, Y; Yamin, R; Meyers, AFA; Mandeboim, M; Jonjic, S; Mandelboim, O				Glasner, Ariella; Zurunic, Antonija; Meningher, Tal; Rovis, Tihana Lenac; Tsukerman, Pinchas; Bar-On, Yotam; Yamin, Rachel; Meyers, Adrienne F. A.; Mandeboim, Michal; Jonjic, Stipan; Mandelboim, Ofer			Elucidating the Mechanisms of Influenza Virus Recognition by Ncr1	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ACTIVATING RECEPTOR; INTERFERON-GAMMA; INFECTED CELLS; NK RECEPTORS; IN-VIVO; NKP46; NKP30; TUMOR; GLYCOSYLATION	Natural killer (NK) cells are innate cytotoxic lymphocytes that specialize in the defense against viral infection and oncogenic transformation. Their action is tightly regulated by signals derived from inhibitory and activating receptors; the later include proteins such as the Natural Cytotoxicity Receptors (NCRs: NKp46, NKp44 and NKp30). Among the NCRs, NKp46 is the only receptor that has a mouse orthologue named Ncr1. NKp46/Ncr1 is also a unique marker expressed on NK and on Lymphoid tissue inducer (LTI) cells and it was implicated in the control of various viral infections, cancer and diabetes. We have previously shown that human NKp46 recognizes viral hemagglutinin (HA) in a sialic acid-dependent manner and that the O-glycosylation is essential for the NKp46 binding to viral HA. Here we studied the molecular interactions between Ncr1 and influenza viruses. We show that Ncr1 recognizes influenza virus in a sialic acid dependent manner and that N-glycosylation is important for this binding. Surprisingly we demonstrate that none of the predicted N-glycosilated residues of Ncr1 are essential for its binding to influenza virus and we thus conclude that other, yet unidentified N-glycosilated residues are responsible for its recognition. We have demonstrated that N glycosylation play little role in the recognition of mouse tumor cell lines and also showed the in-vivo importance of Ncr1 in the control of influenza virus infection by infecting C57BL/6 and BALB/c mice knockout for Ncr1 with influenza.	[Glasner, Ariella; Tsukerman, Pinchas; Bar-On, Yotam; Yamin, Rachel; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada IMRIC, IL-91010 Jerusalem, Israel; [Zurunic, Antonija; Rovis, Tihana Lenac; Jonjic, Stipan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Ctr Prote, Rijeka, Croatia; [Meningher, Tal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Meyers, Adrienne F. A.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Lab HIV Viral Immunol, Winnipeg, MB, Canada; [Mandeboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel	Hebrew University of Jerusalem; University of Rijeka; Bar Ilan University; Public Health Agency of Canada; Chaim Sheba Medical Center	Glasner, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada IMRIC, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	lenac rovis, tihana/C-5857-2018; Lenac Rovis, Tihana/ABB-7451-2021; Glasner, Ari/HHC-5411-2022; Jonjic, Stipan/C-5657-2016	lenac rovis, tihana/0000-0002-3299-1334; Lenac Rovis, Tihana/0000-0002-3299-1334; Jonjic, Stipan/0000-0001-5003-3108; Tsukerman, Pinchas/0000-0002-5813-7048; Mandelboim, Ofer/0000-0002-9354-1855	Israeli Science Foundation; Israeli Science Foundation (Morasha); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees trust; ICRF; Israel Cancer Association [20100003]; Association for International Cancer Research (AICR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083201] Funding Source: NIH RePORTER	Israeli Science Foundation(Israel Science Foundation); Israeli Science Foundation (Morasha)(Israel Science Foundation); Croatia Israel Research Grant; MOST-DKFZ; Rosetrees trust(Rosetrees Trust); ICRF; Israel Cancer Association; Association for International Cancer Research (AICR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the Israeli Science Foundation, The Israeli Science Foundation (Morasha), The Croatia Israel Research Grant, The MOST-DKFZ Research grant, by the Rosetrees trust, by the ICRF, by the Israel Cancer Association (20100003) and by the Association for International Cancer Research (AICR), (all to OM). OM is a Crown professor of Molecular Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Chaushu S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002601; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUYGEN K, 1983, CELL IMMUNOL, V80, P329, DOI 10.1016/0008-8749(83)90121-1; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Magri G, 2011, BLOOD; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	40	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36837	10.1371/journal.pone.0036837	http://dx.doi.org/10.1371/journal.pone.0036837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615821	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300041
J	Johansson, R; Sjoberg, E; Sjogren, M; Johnsson, E; Carlbring, P; Andersson, T; Rousseau, A; Andersson, G				Johansson, Robert; Sjoberg, Elin; Sjogren, Magnus; Johnsson, Erik; Carlbring, Per; Andersson, Therese; Rousseau, Andreas; Andersson, Gerhard			Tailored vs. Standardized Internet-Based Cognitive Behavior Therapy for Depression and Comorbid Symptoms: A Randomized Controlled Trial	PLOS ONE			English	Article							MENTAL-DISORDERS; PRIMARY-CARE; SELF-HELP; ANXIETY; PSYCHOTHERAPY; METAANALYSIS; PREVALENCE; INVENTORY; SEVERITY; BURDEN	Background and Aims: Major depression can be treated by means of cognitive behavior therapy, delivered via the Internet as guided self-help. Individually tailored guided self-help treatments have shown promising results in the treatment of anxiety disorders. This randomized controlled trial tested the efficacy of an Internet-based individually tailored guided self-help treatment which specifically targeted depression with comorbid symptoms. The treatment was compared both to standardized (non-tailored) Internet-based treatment and to an active control group in the form of a monitored online discussion group. Both guided self-help treatments were based on cognitive behavior therapy and lasted for 10 weeks. The discussion group consisted of weekly discussion themes related to depression and the treatment of depression. Methods: A total of 121 participants with diagnosed major depressive disorder and with a range of comorbid symptoms were randomized to three groups. The tailored treatment consisted of a prescribed set of modules targeting depression as well as comorbid problems. The standardized treatment was a previously tested guided self-help program for depression. Results: From pre-treatment to post-treatment, both treatment groups improved on measures of depression, anxiety and quality of life. The results were maintained at a 6-month follow-up. Subgroup analyses showed that the tailored treatment was more effective than the standardized treatment among participants with higher levels of depression at baseline and more comorbidity, both in terms of reduction of depressive symptoms and on recovery rates. In the subgroup with lower baseline scores of depression, few differences were seen between treatments and the discussion group. Conclusions: This study shows that tailored Internet-based treatment for depression is effective and that addressing comorbidity by tailoring may be one way of making guided self-help treatments more effective than standardized approaches in the treatment of more severe depression.	[Johansson, Robert; Sjoberg, Elin; Sjogren, Magnus; Johnsson, Erik; Andersson, Therese; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Carlbring, Per] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Rousseau, Andreas] Linkoping Univ Hosp, Psychiat Clin, S-58185 Linkoping, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Andersson, Gerhard] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, Stockholm, Sweden	Linkoping University; Umea University; Linkoping University; Linkoping University; Karolinska Institutet	Johansson, R (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	robert.johansson@liu.se	Carlbring, Per/R-1220-2019; Andersson, Gerhard/J-8529-2012; Carlbring, Per/D-3628-2009	Carlbring, Per/0000-0002-2172-8813; Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; Johansson, Robert/0000-0001-5547-3866	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson Gerhard, 2011, Cognitive Behaviour Therapy, V40, P57, DOI 10.1080/16506073.2010.529457; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Barlow DH, 2004, BEHAV THER, V35, P205, DOI 10.1016/S0005-7894(04)80036-4; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Borenstein M., 2009, INTRO METAANALYSIS; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Carlbring P, 2011, BEHAV RES THER, V49, P18, DOI 10.1016/j.brat.2010.10.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cox BJ, 1996, BEHAV RES THER, V34, P949, DOI 10.1016/S0005-7967(96)00037-X; Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772; Cuijpers P, 2008, PSYCHOTHER RES, V18, P225, DOI 10.1080/10503300701442027; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Eskin M., 1996, INTRO SWEDISH VERSIO; First M. B., 1997, STRUCTURED CLIN INTE; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hollandare F, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1392; Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062; Kaldo V, 2008, BEHAV THER, V39, P348, DOI 10.1016/j.beth.2007.10.003; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Persons J., 2008, CASE FORMULATION APP; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Silfvernagel K, J MED INTER IN PRESS; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Sturmey P., 2008, BEHAV CASE FORMULATI; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Titov N, 2010, BEHAV RES THER, V48, P890, DOI 10.1016/j.brat.2010.05.014; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Vernmark K, 2010, BEHAV RES THER, V48, P368, DOI 10.1016/j.brat.2010.01.005	43	185	186	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36905	10.1371/journal.pone.0036905	http://dx.doi.org/10.1371/journal.pone.0036905			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615841	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300049
J	Kong, L; Herold, C; Stieltjes, B; Essig, M; Seidl, U; Wolf, RC; Wustenberg, T; Lasser, MM; Schmid, LA; Schnell, K; Hirjak, D; Thomann, PA				Kong, Li; Herold, Christina; Stieltjes, Bram; Essig, Marco; Seidl, Ulrich; Wolf, Robert Christian; Wuestenberg, Torsten; Laesser, Marc Montgomery; Schmid, Lena Anna; Schnell, Knut; Hirjak, Dusan; Thomann, Philipp Arthur			Reduced Gray to White Matter Tissue Intensity Contrast in Schizophrenia	PLOS ONE			English	Article							1ST EPISODE SCHIZOPHRENIA; VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; AGE-RELATED-CHANGES; CORTICAL THICKNESS; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; SIGNAL INTENSITY; ADULT BRAIN	Background: While numerous structural magnetic resonance imaging (MRI) studies revealed changes of brain volume or density, cortical thickness and fibre integrity in schizophrenia, the effect of tissue alterations on the contrast properties of neural structures has so far remained mostly unexplored. Methods: Whole brain high-resolution MRI at 3 Tesla was used to investigate tissue contrast and cortical thickness in patients with schizophrenia and healthy controls. Results: Patients showed significantly decreased gray to white matter contrast in large portions throughout the cortical mantle with preponderance in inferior, middle, superior and medial temporal areas as well as in lateral and medial frontal regions. The extent of these intensity contrast changes exceeded the extent of cortical thinning. Further, contrast changes remained significant after controlling for cortical thickness measurements. Conclusions: Our findings clearly emphasize the presence of schizophrenia related brain tissue changes that alter the imaging properties of brain structures. Intensity contrast measurements might not only serve as a highly sensitive metric but also as a potential indicator of a distinct pathological process that might be independent from volume or thickness alterations.	[Kong, Li; Hirjak, Dusan; Thomann, Philipp Arthur] Univ Heidelberg, Dept Gen Psychiat, Struct Neuroimaging Grp, Heidelberg, Germany; [Kong, Li; Herold, Christina; Seidl, Ulrich; Laesser, Marc Montgomery; Schmid, Lena Anna; Thomann, Philipp Arthur] Univ Heidelberg, Sect Geriatr Psychiat, Heidelberg, Germany; [Stieltjes, Bram; Essig, Marco] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Seidl, Ulrich; Wolf, Robert Christian; Schnell, Knut; Hirjak, Dusan; Thomann, Philipp Arthur] Univ Heidelberg, Dept Gen Psychiat, Ctr Psychosocial Med, Heidelberg, Germany; [Seidl, Ulrich] Klinikum Stuttgart, Ctr Mental Hlth, Stuttgart, Germany; [Wuestenberg, Torsten] Charite, Dept Psychiat, D-13353 Berlin, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Klinikum Stuttgart; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kong, L (corresponding author), Univ Heidelberg, Dept Gen Psychiat, Struct Neuroimaging Grp, Heidelberg, Germany.	philipp.thomann@med.uni-heidelberg.de	Hirjak, Dusan/W-2126-2019; Wolf, Robert Christian/AAG-9142-2020; Hirjak, Dusan/P-2777-2018	Wolf, Robert Christian/0000-0002-5358-5212; essig, marco/0000-0002-7964-2297; Wustenberg, Torsten/0000-0001-8408-2864	Dietmar Hopp Stiftung, St. Leon-Rot, Germany; China Scholarship Council	Dietmar Hopp Stiftung, St. Leon-Rot, Germany; China Scholarship Council(China Scholarship Council)	This work was supported in part by a grant from the Dietmar Hopp Stiftung, St. Leon-Rot, Germany for a study on autobiographical memory in schizophrenia under supervision of Johannes Schroder, Heidelberg, Germany. Li Kong received funding from the China Scholarship Council. No additional external funding was received for this study. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., SCALE ASSESSMENT POS; ANDREASEN NC, 1991, SCHIZOPHR RES, V5, P223, DOI 10.1016/0920-9964(91)90080-B; ANDREASEN NC, SCALE ASSESSMENT NEG; Baas PW, 1998, J CHEM NEUROANAT, V14, P175, DOI 10.1016/S0891-0618(98)00012-X; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Diwadkar VA, 2004, SCHIZOPHR RES, V67, P277, DOI 10.1016/S0920-9964(03)00098-7; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; GIRARD N, 1991, J NEURORADIOLOGY, V18, P291; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lehmbeck JT, 2006, NEUROREPORT, V17, P467, DOI 10.1097/01.wnr.0000209012.24341.7f; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Magnaldi S, 1993, EUR RADIOL, P513; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Phal PM, 2008, AM J ROENTGENOL, V191, P890, DOI 10.2214/AJR.07.3933; RAZ N, 1990, PSYCHOBIOLOGY, V18, P475; Roiz-Santianez R, 2010, PSYCHIAT RES-NEUROIM, V182, P216, DOI 10.1016/j.pscychresns.2010.03.001; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Scherk H, 2006, CURR OPIN PSYCHIATR, V19, P145, DOI 10.1097/01.yco.0000214339.06507.d8; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2005, INT REV NEUROBIOL, V67, P285, DOI 10.1016/S0074-7742(05)67009-2; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607	53	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37016	10.1371/journal.pone.0037016	http://dx.doi.org/10.1371/journal.pone.0037016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615876	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300063
J	Nere, A; Olcese, U; Balduzzi, D; Tononi, G				Nere, Andrew; Olcese, Umberto; Balduzzi, David; Tononi, Giulio			A Neuromorphic Architecture for Object Recognition and Motion Anticipation Using Burst-STDP	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; NEURAL-NETWORK MODEL; SYNAPTIC PLASTICITY; VISUAL-ATTENTION; FUNCTIONAL ARCHITECTURE; BIOPHYSICAL MODEL; RECEPTIVE-FIELDS; SPIKE-TIME; SLEEP; WAKEFULNESS	In this work we investigate the possibilities offered by a minimal framework of artificial spiking neurons to be deployed in silico. Here we introduce a hierarchical network architecture of spiking neurons which learns to recognize moving objects in a visual environment and determine the correct motor output for each object. These tasks are learned through both supervised and unsupervised spike timing dependent plasticity (STDP). STDP is responsible for the strengthening (or weakening) of synapses in relation to pre- and post-synaptic spike times and has been described as a Hebbian paradigm taking place both in vitro and in vivo. We utilize a variation of STDP learning, called burst-STDP, which is based on the notion that, since spikes are expensive in terms of energy consumption, then strong bursting activity carries more information than single (sparse) spikes. Furthermore, this learning algorithm takes advantage of homeostatic renormalization, which has been hypothesized to promote memory consolidation during NREM sleep. Using this learning rule, we design a spiking neural network architecture capable of object recognition, motion detection, attention towards important objects, and motor control outputs. We demonstrate the abilities of our design in a simple environment with distractor objects, multiple objects moving concurrently, and in the presence of noise. Most importantly, we show how this neural network is capable of performing these tasks using a simple leaky-integrate-and-fire (LIF) neuron model with binary synapses, making it fully compatible with state-of-the-art digital neuromorphic hardware designs. As such, the building blocks and learning rules presented in this paper appear promising for scalable fully neuromorphic systems to be implemented in hardware chips.	[Nere, Andrew] Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI USA; [Olcese, Umberto; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Balduzzi, David] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Balduzzi, David] Max Planck Inst Intelligent Syst, Dept Empir Inference, Tubingen, Germany	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Istituto Italiano di Tecnologia - IIT; Max Planck Society	Nere, A (corresponding author), Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI USA.	gtononi@wisc.edu	Balduzzi, David/O-2338-2013	Balduzzi, David/0000-0002-1466-7864; Olcese, Umberto/0000-0001-6968-2503	Defense Advanced Research Projects Agency, Defense Sciences Office	Defense Advanced Research Projects Agency, Defense Sciences Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This study was supported by Defense Advanced Research Projects Agency, Defense Sciences Office, Program: Systems of Neuromorphic Adaptive Plastic Scalable Electronics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Perez-Carrasco JA, 2010, IEEE T NEURAL NETWOR, V21, P609, DOI 10.1109/TNN.2009.2039943; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balduzzi D, WHAT CAN NEURO UNPUB; Beardsley SA, 1998, NETWORK-COMP NEURAL, V9, P467, DOI 10.1088/0954-898X/9/4/005; Beck C, 2010, J PHYSIOL-PARIS, V104, P61, DOI 10.1016/j.jphysparis.2009.11.005; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Brader JM, 2007, NEURAL COMPUT, V19, P2881, DOI 10.1162/neco.2007.19.11.2881; Bruderle Daniel, 2009, Front Neuroinform, V3, P17, DOI 10.3389/neuro.11.017.2009; Burkitt AN, 2004, NEURAL COMPUT, V16, P885, DOI 10.1162/089976604773135041; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2000, J NEUROSCI, V20, P9187; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Fieres J, 2006, IEEE IJCNN, P21; Fieres J, 2008, IEEE IJCNN, P969, DOI 10.1109/IJCNN.2008.4633916; Folowosele F, 2007, SPIKE BASED MAX NETW, P79; FUKUSHIMA K, 1986, BIOL CYBERN, V55, P5, DOI 10.1007/BF00363973; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grossberg S, 2001, VISION RES, V41, P2521, DOI 10.1016/S0042-6989(01)00131-6; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Indiveri G., 2004, P EUR S ART NEUR NET, P405; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jhuang H, 2007, IEEE I CONF COMP VIS, P1253; Kim K, 2009, IEEE J SOLID-ST CIRC, V44, P136, DOI 10.1109/JSSC.2008.2007157; Kim S, 2011, 2011 11TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS), P1; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Lowe D., 1999, P INT C COMP VIS, V2, P1150, DOI DOI 10.1109/ICCV.1999.790410; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Masquelier T, 2012, J COMPUT NEUROSCI, V32, P425, DOI 10.1007/s10827-011-0361-9; Meese TS, 2002, VISION RES, V42, P1073, DOI 10.1016/S0042-6989(02)00058-5; Merolla P, 2011, IEEE CUST INTEGR CIR; Mutch J, 2006, IEEE CVPR, V1, P11, DOI DOI 10.1109/CVPR.2006.200; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; Olcese U, 2010, J NEUROPHYSIOL, V104, P3476, DOI 10.1152/jn.00593.2010; Pack C, 2001, J COGNITIVE NEUROSCI, V13, P102, DOI 10.1162/089892901564207; Perrone JA, 1998, J NEUROSCI, V18, P5958; Peters R.J., 2007, 2007 IEEE C COMP VIS; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Schemmel J, 2010, IEEE INT SYMP CIRC S, P1947, DOI 10.1109/ISCAS.2010.5536970; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Shouval HZ, 2002, BIOL CYBERN, V87, P383, DOI 10.1007/s00422-002-0362-x; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Siagian C, 2009, IEEE T ROBOT, V25, P861, DOI 10.1109/TRO.2009.2022424; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Song DJ, 2010, IEEE T IMAGE PROCESS, V19, P174, DOI 10.1109/TIP.2009.2032939; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Standage D, 2007, BIOL CYBERN, V96, P615, DOI 10.1007/s00422-007-0152-6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; TONONI G, 1992, CEREB CORTEX, V2, P310, DOI 10.1093/cercor/2.4.310; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tsotsos JK, 2005, COMPUT VIS IMAGE UND, V100, P3, DOI 10.1016/j.cviu.2004.10.011; Tsotsos JK, 2011, COMPUTATIONAL PERSPECTIVE ON VISUAL ATTENTION, P1; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walther D, 2002, LECT NOTES COMPUT SC, V2525, P472; Yu AJ, 2002, NEURAL COMPUT, V14, P2857, DOI 10.1162/089976602760805313; Zemel RS, 1998, J NEUROSCI, V18, P531	80	21	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36958	10.1371/journal.pone.0036958	http://dx.doi.org/10.1371/journal.pone.0036958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615855	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300053
J	Johansen, NB; Vistisen, D; Brunner, EJ; Tabak, AG; Shipley, MJ; Wilkinson, IB; McEniery, CM; Roden, M; Herder, C; Kivimaki, M; Witte, DR				Johansen, Nanna B.; Vistisen, Dorte; Brunner, Eric J.; Tabak, Adam G.; Shipley, Martin J.; Wilkinson, Ian B.; McEniery, Carmel M.; Roden, Michael; Herder, Christian; Kivimaeki, Mika; Witte, Daniel R.			Determinants of Aortic Stiffness: 16-Year Follow-Up of the Whitehall II Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; MULTIPLE IMPUTATION; CARDIOVASCULAR EVENTS; PREDICTION; ADIPONECTIN; ADIPOSITY; PRESSURE	Background: Aortic stiffness is a strong predictor of cardiovascular disease endpoints. Cross-sectional studies have shown associations of various cardiovascular risk factors with aortic pulse wave velocity, a measure of aortic stiffness, but the long-term impact of these factors on aortic stiffness is unknown. Methods: In 3,769 men and women from the Whitehall II cohort, a wide range of traditional and novel cardiovascular risk factors were determined at baseline (1991-1993) and aortic pulse wave velocity was measured at follow-up (2007-2009). The prospective associations between each baseline risk factor and aortic pulse wave velocity at follow-up were assessed through sex stratified linear regression analysis adjusted for relevant confounders. Missing data on baseline determinants were imputed using the Multivariate Imputation by Chained Equations. Results: Among men, the strongest predictors were waist circumference, waist-hip ratio, heart rate and interleukin 1 receptor antagonist, and among women, adiponectin, triglycerides, pulse pressure and waist-hip ratio. The impact of 10 centimeter increase in waist circumference on aortic pulse wave velocity was twice as large for men compared with women (men: 0.40 m/s (95%-CI: 0.24; 0.56); women: 0.17 m/s (95%-CI: -0.01; 0.35)), whereas the opposite was true for the impact of a two-fold increase in adiponectin (men: -0.30 m/s (95%-CI: -0.51; -0.10); women: 0.61 m/s (95%-CI: -0.86; -0.35)). Conclusion: In this large prospective study, central obesity was a strong predictor of aortic stiffness. Additionally, heart rate in men and adiponectin in women predicted aortic pulse wave velocity suggesting that strategies to prevent aortic stiffening should be focused differently by sex.	[Johansen, Nanna B.; Vistisen, Dorte; Witte, Daniel R.] Steno Diabet Ctr AS, Gentofte, Denmark; [Brunner, Eric J.; Tabak, Adam G.; Shipley, Martin J.; Kivimaeki, Mika; Witte, Daniel R.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, Budapest, Hungary; [Wilkinson, Ian B.; McEniery, Carmel M.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Roden, Michael; Herder, Christian] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany	Steno Diabetes Center; University of London; University College London; Semmelweis University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Johansen, NB (corresponding author), Steno Diabet Ctr AS, Gentofte, Denmark.	nabj@steno.dk	Brunner, Eric/H-2114-2011; Roden, Michael/AAD-3843-2019; Witte, Daniel R/C-1722-2008; Kivimaki, Mika/B-3607-2012; Witte, Daniel/AAF-9535-2019; Tabak, Adam/A-5007-2012; Stefanadis, Christodoulos/ABH-2232-2020	Brunner, Eric/0000-0002-0595-4474; Witte, Daniel R/0000-0002-0769-2922; Kivimaki, Mika/0000-0002-4699-5627; Witte, Daniel/0000-0002-0769-2922; Vistisen, Dorte/0000-0001-5045-5351; Johansen, Nanna Borup/0000-0003-3764-8532; Stefanadis, Christodoulos/0000-0001-5974-6454; wilkinson, ian/0000-0001-6598-9399; Tabak, Adam/0000-0002-6234-3936	Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, United States, National Institutes of Health (NIH): National Institute on Aging, United States, NIH [R01 HL36310, R01 AG013196, R01 AG034454]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Medical Research Council New Investigator Award [G0501184]; Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany); Biomedical Research centre Award; European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes [74550801]; Pfizer; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [FS/12/8/29377, RG/07/008/23674, PG/11/63/29011] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G0501184, G19/35, G0100222] Funding Source: researchfish; MRC [G0501184, G0902037] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, United States, National Institutes of Health (NIH): National Institute on Aging, United States, NIH; Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany); Biomedical Research centre Award; European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes; Pfizer(Pfizer); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (R01 HL36310), United States, National Institutes of Health (NIH): National Institute on Aging (R01 AG013196; R01 AG034454), United States, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. MK is supported by the Academy of Finland and the BUPA Foundation, UK. Measurements of IL-1Ra and adiponectin were funded by a Medical Research Council New Investigator Award (G0501184). CH and MR are supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science, Research and Technology of the state North-Rhine Westphalia (Dusseldorf, Germany). IBW is a British Heart Foundation Senior Research Fellow, and CMM an Intermediate Fellow. Both are also supported by the Biomedical Research centre Award. NBJ is funded by an unrestricted grant from the European Foundation for the Study of Diabetes(EFSD)/Pfizer for Research into Cardiovascular Disease risk Reduction in Patients with Diabetes (74550801) (See funding program on www.europeandiabetesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Pfizer partly funded this study. NBJ, DV and DRW are employed by Steno Diabetes Center A/S, which is a research and teaching hospital collaborating with the Danish National Health Service and owned by Novo Nordisk A/S. NBJ, DV and DRW hold shares in Novo Nordisk A/S. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Boutouyrie P, 2010, HYPERTENSION, V55, P1314, DOI 10.1161/HYPERTENSIONAHA.109.148999; Britton A, 2004, ADDICTION, V99, P109, DOI 10.1111/j.1360-0443.2004.00530.x; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Cecelja M, 2009, HYPERTENSION, V54, P1328, DOI 10.1161/HYPERTENSIONAHA.109.137653; Dengo AL, 2010, HYPERTENSION, V55, P855, DOI 10.1161/HYPERTENSIONAHA.109.147850; Gavin JR, 1997, DIABETES CARE, V20, P1183; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Holewijn S, 2010, J INTERN MED, V267, P588, DOI 10.1111/j.1365-2796.2009.02192.x; Ichihara A, 2005, J HUM HYPERTENS, V19, P103, DOI 10.1038/sj.jhh.1001786; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lieb W, 2009, CIRCULATION, V119, P37, DOI 10.1161/CIRCULATIONAHA.108.816108; London GM, 2010, NEPHROL DIAL TRANSPL, V25, P3815, DOI 10.1093/ndt/gfq614; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Rubin DB, 2004, MULTIPLE IMPUTATION; Schnabel R, 2008, HYPERTENSION, V51, P1651, DOI 10.1161/HYPERTENSIONAHA.107.105668; Sie MPS, 2009, J HYPERTENS, V27, P1392, DOI 10.1097/HJH.0b013e32832a95b0; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Windham BG, 2010, AM J HYPERTENS, V23, P501, DOI 10.1038/ajh.2010.8; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173	37	65	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37165	10.1371/journal.pone.0037165	http://dx.doi.org/10.1371/journal.pone.0037165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629363	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300023
J	Zhu, LN; Zhao, SJ; Wu, B; Li, XZ; Kong, DM				Zhu, Li-Na; Zhao, Shu-Juan; Wu, Bin; Li, Xiao-Zeng; Kong, De-Ming			A New Cationic Porphyrin Derivative (TMPipEOPP) with Large Side Arm Substituents: A Highly Selective G-Quadruplex Optical Probe	PLOS ONE			English	Article							TELOMERIC DNA; BINDING	The discovery of uncommon DNA structures and speculation about their potential functions in genes has brought attention to specific DNA structure recognition. G-quadruplexes are four-stranded nucleic acid structures formed by G-rich DNA (or RNA) sequences. G-rich sequences with a high potential to form G-quadruplexes have been found in many important genomic regions. Porphyrin derivatives with cationic side arm substituents are important G-quadruplex-binding ligands. For example, 5,10,15,20-Tetrakis(N-methylpyridinium-4-yl)-21H, 23H-porphyrin (TMPyP4), interacts strongly with G-quadruplexes, but has poor selectivity for G-quadruplex versus duplex DNA. To increase the G-quadruplex recognition specificity, a new cationic porphyrin derivative, 5,10,15,20-tetra-{4-[2-(1-methyl-1-piperidinyl)ethoxy]phenyl}porphyrin (TMPipEOPP), with large side arm substituents was synthesized, and the interactions between TMPipEOPP and different DNA structures were compared. The results show that G-quadruplexes cause large changes in the UV-Vis absorption and fluorescence spectra of TMPipEOPP, but duplex and single-stranded DNAs do not, indicating that TMPipEOPP can be developed as a highly specific optical probe for discriminating G-quadruplex from duplex and single-stranded DNA. Visual discrimination is also possible. Job plot and Scatchard analysis suggest that a complicated binding interaction occurs between TMPipEOPP and G-quadruplexes. At a low [G-quadruplex]/[TMPipEOPP] ratio, one G-quadruplex binds two TMPipEOPP molecules by end-stacking and outside binding modes. At a high [G-quadruplex]/[TMPipEOPP] ratio, two G-quadruplexes bind to one TMPipEOPP molecule in a sandwich-like end-stacking mode.	[Zhu, Li-Na; Zhao, Shu-Juan; Wu, Bin; Li, Xiao-Zeng] Tianjin Univ, Dept Chem, Tianjin 300072, Peoples R China; [Kong, De-Ming] Nankai Univ, Key Lab Funct Polymer Mat, Minist Educ, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Zhu, LN (corresponding author), Tianjin Univ, Dept Chem, Tianjin 300072, Peoples R China.	linazhu@tju.edu.cn			Natural Science Foundation of China [20801040]; National Basic Research Program of China [2011CB707703]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the Natural Science Foundation of China (no. 20801040) and by the National Basic Research Program of China (no. 2011CB707703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzeer J, 2009, ANGEW CHEM INT EDIT, V48, P9362, DOI 10.1002/anie.200903685; [Anonymous], SMART CONTR SAINT IN; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bennett M, 2000, P NATL ACAD SCI USA, V97, P9476, DOI 10.1073/pnas.160271897; Bhasikuttan AC, 2007, ANGEW CHEM INT EDIT, V46, P9305, DOI 10.1002/anie.200703251; Cummaro A, 2011, BIOCHIMIE, V93, P1392, DOI 10.1016/j.biochi.2011.04.005; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Dixon IM, 2007, J AM CHEM SOC, V129, P1502, DOI 10.1021/ja065591t; Guo JH, 2009, TALANTA, V80, P607, DOI 10.1016/j.talanta.2009.07.034; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Kong DM, 2009, CHEM-EUR J, V15, P901, DOI 10.1002/chem.200801441; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Leopoldo M, 2009, DRUG DISCOV TODAY, V14, P706, DOI 10.1016/j.drudis.2009.03.015; Lombardo CM, 2010, CHEM COMMUN, V46, P9116, DOI 10.1039/c0cc02917c; Lu YJ, 2011, CHEM COMMUN, V47, P4971, DOI 10.1039/c1cc00020a; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Murat P, 2011, CHEM SOC REV, V40, P5293, DOI 10.1039/c1cs15117g; Nielsen MC, 2010, CURR MED CHEM, V17, P3438; Pan JX, 2009, J BIOL INORG CHEM, V14, P401, DOI 10.1007/s00775-008-0457-5; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P2406, DOI 10.1021/bi00279a016; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; SHELDRICK G, SHELXL 97 PROGRAM RE; Sheldrick G. M., SHELXS 97 PROGRAM SO; Shinohara K, 2010, J AM CHEM SOC, V132, P3778, DOI 10.1021/ja908897j; Teulade-Fichou MP, 2003, J AM CHEM SOC, V125, P4732, DOI 10.1021/ja021299j; Vialas C, 2000, BIOCHEMISTRY-US, V39, P9514, DOI 10.1021/bi000743x; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2010, BIOPHYS CHEM, V148, P51, DOI 10.1016/j.bpc.2010.02.009; Wei CY, 2009, PHYS CHEM CHEM PHYS, V11, P4025, DOI 10.1039/b901027k; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Wheelhouse RT, 1998, J AM CHEM SOC, V120, P3261, DOI 10.1021/ja973792e; Yamashita T, 2005, BIOORGAN MED CHEM, V13, P2423, DOI 10.1016/j.bmc.2005.01.041; Yang P, 2009, ANGEW CHEM INT EDIT, V48, P2188, DOI 10.1002/anie.200805613; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h	39	47	48	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35586	10.1371/journal.pone.0035586	http://dx.doi.org/10.1371/journal.pone.0035586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629300	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300002
J	Biskup, CS; Sanchez, CL; Arrant, A; Van Swearingen, AED; Kuhn, C; Zepf, FD				Biskup, Caroline Sarah; Sanchez, Cristina L.; Arrant, Andrew; Van Swearingen, Amanda E. D.; Kuhn, Cynthia; Zepf, Florian Daniel			Effects of Acute Tryptophan Depletion on Brain Serotonin Function and Concentrations of Dopamine and Norepinephrine in C57BL/6J and BALB/cJ Mice	PLOS ONE			English	Article							AMINO-ACID MIXTURES; RAT-BRAIN; BEHAVIORAL-INHIBITION; 5-HYDROXYINDOLE METABOLISM; PLASMA TRYPTOPHAN; REACTION-TIME; ADHD; NORADRENALINE; RELEASE; REGIONS	Acute tryptophan depletion (ATD) is a method of lowering brain serotonin (5-HT). Administration of large neutral amino acids (LNAA) limits the transport of endogenous tryptophan (TRP) across the blood brain barrier by competition with other LNAAs and subsequently decreases serotonergic neurotransmission. A recent discussion on the specificity and efficacy of the ATD paradigm for inhibition of central nervous 5-HT has arisen. Moreover, side effects such as vomiting and nausea after intake of amino acids (AA) still limit its use. ATD Moja-De is a revised mixture of AAs which is less nauseating than conventional protocols. It has been used in preliminary clinical studies but its effects on central 5-HT mechanisms and other neurotransmitter systems have not been validated in an animal model. We tested ATD Moja-De (TRP-) in two strains of mice: C57BL/6J, and BALB/cJ, which are reported to have impaired 5-HT synthesis and a more anxious phenotype relative to other strains of mice. ATD Moja-De lowered brain TRP, significantly decreased 5-HT synthesis as indexed by 5-HTP levels after decarboxlyase inhibition, and lowered 5-HT and 5-HIAA in both strains of mice, however more so in C57BL/6J than in BALB/cJ. Dopamine and its metabolites as well as norepinephrine were not affected. A balanced (TRP+) control mixture did not raise 5-HT or 5-HIAA. The present findings suggest that ATD Moja-De effectively and specifically suppresses central serotonergic function. These results also demonstrate a strain-specific effect of ATD Moja-De on anxiety-like behavior.	[Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52062 Aachen, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] Julich Res Ctr, Inst Neurosci & Med, Julich, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] JARA Translat Brain Med, Julich, Nordrhein Westf, Germany; [Biskup, Caroline Sarah; Sanchez, Cristina L.; Zepf, Florian Daniel] JARA Translat Brain Med, Aachen, Nordrhein Westf, Germany; [Arrant, Andrew; Van Swearingen, Amanda E. D.; Kuhn, Cynthia] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	RWTH Aachen University; Helmholtz Association; Research Center Julich; Duke University	Biskup, CS (corresponding author), Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-52062 Aachen, Nordrhein Westf, Germany.	fzepf@ukaachen.de	Zepf, Florian D/J-5236-2013; Sanchez, Cristina L/C-7615-2009; Van Swearingen, Amanda/AAS-9742-2020	Van Swearingen, Amanda/0000-0002-4287-9741; Arrant, Andrew/0000-0003-4706-9411; Sanchez, Cristina L./0000-0001-6380-4282	German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi); American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca ("Young Minds in Psychiatry Award"); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; GlaxoSmithKline Foundation; Raine Foundation for Medical Research (Raine Visiting Professorship)	German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi)(Federal Ministry for Economic Affairs and Energy (BMWi)); American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca ("Young Minds in Psychiatry Award"); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; GlaxoSmithKline Foundation(GlaxoSmithKline); Raine Foundation for Medical Research (Raine Visiting Professorship)	This study was funded by the German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi) with a grant to the senior author of this paper (FDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: In the past five years, FDZ was the recipient of an unrestricted award donated by the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and Astra Zeneca ("Young Minds in Psychiatry Award"). He has also received research support from the German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ), and from the Paul and Ursula Klein Foundation, which is unrelated to the present investigation. He was the recipient of a travel stipend donated by the GlaxoSmithKline Foundation and an unrestricted educational grant, travel support and speaker honoraria donated by Shire pharmaceuticals. FDZ also received support from the Raine Foundation for Medical Research (Raine Visiting Professorship). The other authors have nothing to disclose.	Ardis TC, 2009, J PSYCHOPHARMACOL, V23, P51, DOI 10.1177/0269881108089597; ASHCROFT GW, 1965, J NEUROCHEM, V12, P483, DOI 10.1111/j.1471-4159.1965.tb06775.x; Bel N, 1996, J NEUROCHEM, V67, P669; BENKELFAT C, 1994, ARCH GEN PSYCHIAT, V51, P687; BIGGIO G, 1974, LIFE SCI, V14, P1321, DOI 10.1016/0024-3205(74)90440-8; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; CARLSSON A, 1976, J NEURAL TRANSM, V39, P1, DOI 10.1007/BF01248762; Casanovas JM, 1997, BRIT J PHARMACOL, V122, P733, DOI 10.1038/sj.bjp.0701420; CHASE TN, 1969, J NEUROCHEM, V16, P607, DOI 10.1111/j.1471-4159.1969.tb06860.x; Crockett MJ, 2011, MOL PSYCHIAT; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; DASZUTA A, 1981, J PHYSIOLOGY PARIS, V77, P315; DASZUTA A, 1982, DEV NEUROSCI-BASEL, V5, P130, DOI 10.1159/000112670; Demisch L, 2002, EUR ARCH PSY CLIN N, V252, P25; Dingerkus V, 2012, J NEURAL TR IN PRESS; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; ECCLESTO.D, 1965, J NEUROCHEM, V12, P493, DOI 10.1111/j.1471-4159.1965.tb06776.x; FRANCESCONI RP, 1972, J NUTR, V102, P597, DOI 10.1093/jn/102.5.597; Invernizzi R, 1997, NEUROPHARMACOLOGY, V36, P467, DOI 10.1016/S0028-3908(97)00060-9; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kim S, 2002, BEHAV PROCESS, V60, P181, DOI 10.1016/S0376-6357(02)00085-2; Mendelsohn D, 2009, NEUROSCI BIOBEHAV R, V33, P926, DOI 10.1016/j.neubiorev.2009.03.006; MOJA EA, 1989, LIFE SCI, V44, P971, DOI 10.1016/0024-3205(89)90497-9; MOJA EA, 1988, LIFE SCI, V42, P1551, DOI 10.1016/0024-3205(88)90013-6; Moore P, 2000, NEUROPSYCHOPHARMACOL, V23, P601, DOI 10.1016/S0893-133X(00)00161-5; MORGAN WW, 1975, LIFE SCI, V17, P143, DOI 10.1016/0024-3205(75)90250-7; Sakowski SA, 2006, J NEUROCHEM, V96, P758, DOI 10.1111/j.1471-4159.2005.03604.x; SHEARD MH, 1971, BRAIN RES, V26, P455, DOI 10.1016/S0006-8993(71)80026-4; Siesser WB, 2010, NEUROSCI LETT, V481, P6, DOI 10.1016/j.neulet.2010.06.035; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Stadler C, 2007, NEUROPSYCHOBIOLOGY, V56, P104, DOI 10.1159/000112951; Stancampiano R, 1997, AM J PHYSIOL-REG I, V272, pR991, DOI 10.1152/ajpregu.1997.272.3.R991; Toker L, 2010, ISR J PSYCHIATR REL, V47, P46; van der Plasse G, 2007, PSYCHOPHARMACOLOGY, V195, P377, DOI 10.1007/s00213-007-0908-7; van Donkelaar EL, 2011, MOL PSYCHIATR, V16, P695, DOI 10.1038/mp.2011.9; van Donkelaar EL, 2010, NEUROCHEM INT, V56, P21, DOI 10.1016/j.neuint.2009.08.010; WURTMAN RJ, 1980, PHARMACOL REV, V32, P315; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P291, DOI 10.1002/hup.934; Zepf FD, 2008, PHARMACOPSYCHIATRY, V41, P60, DOI 10.1055/s-2007-1004593; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.896; Zepf F, 2009, J NEURAL TRANSM, V116, P105, DOI 10.1007/s00702-008-0146-0; Zepf FD, 2009, MED HYPOTHESES, V72, P47, DOI 10.1016/j.mehy.2008.06.046; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	45	59	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e35916	10.1371/journal.pone.0035916	http://dx.doi.org/10.1371/journal.pone.0035916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629305	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100004
J	Chuang, LY; Lin, YD; Chang, HW; Yang, CH				Chuang, Li-Yeh; Lin, Yu-Da; Chang, Hsueh-Wei; Yang, Cheng-Hong			An Improved PSO Algorithm for Generating Protective SNP Barcodes in Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMBINATIONAL POLYMORPHISMS; REPAIR GENES; ESTROGEN; SUSCEPTIBILITY; VARIANTS; ESR1; COMT	Background: Possible single nucleotide polymorphism (SNP) interactions in breast cancer are usually not investigated in genome-wide association studies. Previously, we proposed a particle swarm optimization (PSO) method to compute these kinds of SNP interactions. However, this PSO does not guarantee to find the best result in every implement, especially when high-dimensional data is investigated for SNP-SNP interactions. Methodology/Principal Findings: In this study, we propose IPSO algorithm to improve the reliability of PSO for the identification of the best protective SNP barcodes (SNP combinations and genotypes with maximum difference between cases and controls) associated with breast cancer. SNP barcodes containing different numbers of SNPs were computed. The top five SNP barcode results are retained for computing the next SNP barcode with a one-SNP-increase for each processing step. Based on the simulated data for 23 SNPs of six steroid hormone metabolisms and signalling-related genes, the performance of our proposed IPSO algorithm is evaluated. Among 23 SNPs, 13 SNPs displayed significant odds ratio (OR) values (1.268 to 0.848; p < 0.05) for breast cancer. Based on IPSO algorithm, the jointed effect in terms of SNP barcodes with two to seven SNPs show significantly decreasing OR values (0.84 to 0.57; p < 0.05 to 0.001). Using PSO algorithm, two to four SNPs show significantly decreasing OR values (0.84 to 0.77; p < 0.05 to 0.001). Based on the results of 20 simulations, medians of the maximum differences for each SNP barcode generated by IPSO are higher than by PSO. The interquartile ranges of the boxplot, as well as the upper and lower hinges for each n-SNP barcode (n = 3 similar to 10) are more narrow in IPSO than in PSO, suggesting that IPSO is highly reliable for SNP barcode identification. Conclusions/Significance: Overall, the proposed IPSO algorithm is robust to provide exact identification of the best protective SNP barcodes for breast cancer.	[Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Lin, Yu-Da; Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Ctr Excellence Environm Med, Canc Ctr,Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan	I Shou University; I Shou University; National Kaohsiung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chuang, LY (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	changhw@kmu.edu.tw; chyang@cc.kuas.edu.tw	Lin, Yu-da/M-7946-2013; Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013	Lin, Yu-da/0000-0001-5100-6072; Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072	National Science Council in Taiwan [NSC99-2622-E-151-019-CC3, NSC99-2221-E-151-056-, DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER014, KMU-M110001]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation	This work is partly supported by the National Science Council in Taiwan under grants NSC99-2622-E-151-019-CC3, NSC99-2221-E-151-056-, and DOH101-TD-C-111-002, and by the Kaohsiung Medical University Research Foundation (KMUER014 and KMU-M110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2002, MOL CELL ENDOCRINOL, V193, P121, DOI 10.1016/S0303-7207(02)00105-3; Auricchio F, 2008, STEROIDS, V73, P880, DOI 10.1016/j.steroids.2008.01.023; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Chen L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024495; Chen SH, 2008, GENET EPIDEMIOL, V32, P152, DOI 10.1002/gepi.20272; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Fortunati N, 2010, MOL CELL ENDOCRINOL, V316, P86, DOI 10.1016/j.mce.2009.09.012; Giovannelli P, 2011, FRONT BIOSCI-LANDMRK, V16, P2224, DOI 10.2741/3849; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kraft P, 2010, NAT GENET, V42, P819, DOI 10.1038/ng1010-819; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; Li JM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2772; Lin G.T., 2008, CHIN J PHYSL, V91, P1; Lin GT, 2009, OMICS, V13, P165, DOI 10.1089/omi.2008.0050; Low YL, 2006, NUTR CANCER, V56, P31, DOI 10.1207/s15327914nc5601_5; Mechanic LE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-146; Meindl A, 2009, BREAST CARE, V4, P93, DOI 10.1159/000211991; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Ricceri F, 2010, DNA REPAIR, V9, P191, DOI 10.1016/j.dnarep.2009.12.002; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Soto AM, 2001, J NATL CANCER I, V93, P1673, DOI 10.1093/jnci/93.22.1673; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Udler MS, 2009, INT J CANCER, V125, P2687, DOI 10.1002/ijc.24678; Yang CH, 2011, OMICS, V15, P399, DOI 10.1089/omi.2010.0028; Yang CH, 2009, CANCER EPIDEMIOL, V33, P147, DOI 10.1016/j.canep.2009.07.001; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yu JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2821; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	32	40	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37018	10.1371/journal.pone.0037018	http://dx.doi.org/10.1371/journal.pone.0037018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623973	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500050
J	Conlisk, E; Lawson, D; Syphard, AD; Franklin, J; Flint, L; Flint, A; Regan, HM				Conlisk, Erin; Lawson, Dawn; Syphard, Alexandra D.; Franklin, Janet; Flint, Lorraine; Flint, Alan; Regan, Helen M.			The Roles of Dispersal, Fecundity, and Predation in the Population Persistence of an Oak (Quercus engelmannii) under Global Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ALTERED FIRE REGIME; CLIMATE-CHANGE; SEEDLING RECRUITMENT; ACORN PREDATION; RANGE SHIFTS; FRAGMENTATION; PATTERNS; PRECIPITATION; PREDICTION	A species' response to climate change depends on the interaction of biotic and abiotic factors that define future habitat suitability and species' ability to migrate or adapt. The interactive effects of processes such as fire, dispersal, and predation have not been thoroughly addressed in the climate change literature. Our objective was to examine how life history traits, short-term global change perturbations, and long-term climate change interact to affect the likely persistence of an oak species - Quercus engelmannii (Engelmann oak). Specifically, we combined dynamic species distribution models, which predict suitable habitat, with stochastic, stage-based metapopulation models, which project population trajectories, to evaluate the effects of three global change factors - climate change, land use change, and altered fire frequency emphasizing the roles of dispersal and seed predation. Our model predicted dramatic reduction in Q. engelmannii abundance, especially under drier climates and increased fire frequency. When masting lowers seed predation rates, decreased masting frequency leads to large abundance decreases. Current rates of dispersal are not likely to prevent these effects, although increased dispersal could mitigate population declines. The results suggest that habitat suitability predictions by themselves may under-estimate the impact of climate change for other species and locations.	[Conlisk, Erin; Regan, Helen M.] Univ Calif Riverside, Dept Biol, Ctr Conservat Biol, Riverside, CA 92521 USA; [Lawson, Dawn] Space & Naval Warfare Syst Ctr Pacific, Environm Sci & Appl Syst Branch, San Diego, CA USA; [Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Franklin, Janet] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA; [Flint, Lorraine; Flint, Alan] USGS Calif Water Sci Ctr, Sacramento, CA USA	University of California System; University of California Riverside; Naval Information Warfare Center Pacific; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey	Conlisk, E (corresponding author), Univ Calif Riverside, Dept Biol, Ctr Conservat Biol, Riverside, CA 92521 USA.	erin.conlisk@gmail.com		Syphard, Alexandra/0000-0003-3070-0596	National Science Foundation 488 [NSF-DEB-0824708]; United States Department of Energy [DE-FC02-06ER64159]	National Science Foundation 488; United States Department of Energy(United States Department of Energy (DOE))	Funding provided by National Science Foundation 488 (NSF-DEB-0824708) and the United States Department of Energy (DE-FC02-06ER64159) grants funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2002, AM J BOT, V89, P119, DOI 10.3732/ajb.89.1.119; Akcakaya HR, 2005, RAMAS GIS; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2005, EC HUM WELL BEING SY; Barbour MG, 1989, N AM TERRESTRIAL VEG; BORCHERT MI, 1989, ECOLOGY, V70, P389, DOI 10.2307/1937544; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Bullock JM, 2012, J ECOL, V100, P104, DOI 10.1111/j.1365-2745.2011.01910.x; CALVEG [ESRI geodatabase of vegetation from 1997-2002 Landsat TM. CA Land Cover Mapping and Monitoring Program], 2004, CALVEG ESRI GEOD VEG; Candau J.T., 2002, THESIS U CALIFORNIA; Carmel Y, 2006, FRONT ECOL ENVIRON, V4, P178; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DARLEYHILL S, 1981, OECOLOGIA, V50, P231, DOI 10.1007/BF00348043; Davis FW, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00187.1; den Ouden J, 2004, SEED FATE PREDATION; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; ESPELTA JM, 1995, J VEG SCI, V6, P465, DOI 10.2307/3236344; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; Espelta JM, 2008, ECOLOGY, V89, P805, DOI 10.1890/07-0217.1; FLINT LE, 2012, ECOL PROCESS, V1, pNIL6, DOI DOI 10.1186/2192-1709-1-2; Franklin J, 2009, MAPPING SPECIES DIST; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Germaine HL, 1998, J VEG SCI, V9, P157, DOI 10.2307/3237114; Gomez JM, 2004, PLANT ECOL, V172, P287, DOI 10.1023/B:VEGE.0000026327.60991.f9; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Haidinger T. L., 1993, Madrono, V40, P141; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kelly Maggi, 2005, Madrono, V52, P191, DOI 10.3120/0024-9637(2005)52[191:DOAHDT]2.0.CO;2; KOENIG WD, 1994, CAN J FOREST RES, V24, P2105, DOI 10.1139/x94-270; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lawson D. M., 1993, THESIS SAN DIEGO STA; Lawson DM, 2010, GLOBAL CHANGE BIOL, V16, P2518, DOI 10.1111/j.1365-2486.2009.02143.x; Linacre NA, 2004, CONSERV BIOL, V18, P768, DOI 10.1111/j.1523-1739.2004.00067.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; McCarthy MA, 2001, ANIM CONSERV, V4, P351, DOI 10.1017/S136794300100141X; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Moore JE, 2007, OECOLOGIA, V151, P663, DOI 10.1007/s00442-006-0616-8; Nakamura M, 2010, AGR FOREST METEOROL, V150, P1026, DOI 10.1016/j.agrformet.2010.04.001; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pincetl S, 2008, REAL ESTATE REV, V37, P25; Plumb TR, 1986, P S MULT US MAN CAL; POLAKOW D, 1999, C P BUSHF 99 AUSTR B; Principe ZA, 2002, THESIS SAN DIEGO U; Regan HM, 2010, ECOLOGY, V91, P1114, DOI 10.1890/09-0287.1; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Scofield DG, 2010, J ECOL, V98, P561, DOI 10.1111/j.1365-2745.2010.01649.x; Snow GE, 1972, THESIS OREGON STATE; SORK VL, 1993, VEGETATIO, V108, P133; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2006, ECOL APPL, V16, P1744, DOI 10.1890/1051-0761(2006)016[1744:STEOFF]2.0.CO;2; Syphard AD, 2011, J ENVIRON MANAGE, V92, P1882, DOI 10.1016/j.jenvman.2011.03.014; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Wells ML, 2004, LANDSCAPE ECOL, V19, P139, DOI 10.1023/B:LAND.0000021713.81489.a7; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x	78	33	33	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36391	10.1371/journal.pone.0036391	http://dx.doi.org/10.1371/journal.pone.0036391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623955	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500015
J	Dussaubat, C; Brunet, JL; Higes, M; Colbourne, JK; Lopez, J; Choi, JH; Martin-Hernandez, R; Botias, C; Cousin, M; McDonnell, C; Bonnet, M; Belzunces, LP; Moritz, RFA; Le Conte, Y; Alaux, C				Dussaubat, Claudia; Brunet, Jean-Luc; Higes, Mariano; Colbourne, John K.; Lopez, Jacqueline; Choi, Jeong-Hyeon; Martin-Hernandez, Raquel; Botias, Cristina; Cousin, Marianne; McDonnell, Cynthia; Bonnet, Marc; Belzunces, Luc P.; Moritz, Robin F. A.; Le Conte, Yves; Alaux, Cedric			Gut Pathology and Responses to the Microsporidium Nosema ceranae in the Honey Bee Apis mellifera	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; COLONY COLLAPSE DISORDER; PICORNA-LIKE VIRUS; COMPLETE GENOME SEQUENCE; DEFORMED WING VIRUS; PARALYSIS VIRUS; MOLECULAR CHARACTERIZATION; HYPOPHARYNGEAL-GLAND; NUCLEOTIDE-SEQUENCE; IMMUNE-RESPONSE	The microsporidium Nosema ceranae is a newly prevalent parasite of the European honey bee (Apis mellifera). Although this parasite is presently spreading across the world into its novel host, the mechanisms by it which affects the bees and how bees respond are not well understood. We therefore performed an extensive characterization of the parasite effects at the molecular level by using genetic and biochemical tools. The transcriptome modifications at the midgut level were characterized seven days post-infection with tiling microarrays. Then we tested the bee midgut response to infection by measuring activity of antioxidant and detoxification enzymes (superoxide dismutases, glutathione peroxidases, glutathione reductase, and glutathione-S-transferase). At the gene-expression level, the bee midgut responded to N. ceranae infection by an increase in oxidative stress concurrent with the generation of antioxidant enzymes, defense and protective response specifically observed in the gut of mammals and insects. However, at the enzymatic level, the protective response was not confirmed, with only glutathione-S-transferase exhibiting a higher activity in infected bees. The oxidative stress was associated with a higher transcription of sugar transporter in the gut. Finally, a dramatic effect of the microsporidia infection was the inhibition of genes involved in the homeostasis and renewal of intestinal tissues (Wnt signaling pathway), a phenomenon that was confirmed at the histological level. This tissue degeneration and prevention of gut epithelium renewal may explain early bee death. In conclusion, our integrated approach not only gives new insights into the pathological effects of N. ceranae and the bee gut response, but also demonstrate that the honey bee gut is an interesting model system for studying host defense responses.	[Dussaubat, Claudia; Brunet, Jean-Luc; Cousin, Marianne; McDonnell, Cynthia; Bonnet, Marc; Belzunces, Luc P.; Le Conte, Yves; Alaux, Cedric] INRA, UR Abeilles & Environm 406, Avignon, France; [Higes, Mariano; Martin-Hernandez, Raquel; Botias, Cristina] JCCM, Bee Pathol Lab, Ctr Apicola Reg, Marchamalo, Spain; [Colbourne, John K.; Lopez, Jacqueline; Choi, Jeong-Hyeon] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA; [Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany	INRAE; Indiana University System; Indiana University Bloomington; Martin Luther University Halle Wittenberg	Dussaubat, C (corresponding author), INRA, UR Abeilles & Environm 406, Site Agroparc, Avignon, France.	cedric.alaux@avignon.inra.fr	Alaux, Cedric/B-4667-2013; Lopez, Jacqueline A/F-9712-2013; Martin-Hernandez, Raquel/J-7507-2013; Botías, Cristina/L-4918-2017; Le Conte, Yves M/B-3246-2016; Colbourne, John K/L-7748-2014; Higes, Mariano/N-9380-2017; BRUNET, Jean-Luc/ABE-9178-2021; Moritz, Robin FA/K-6053-2012; , Belzunces/P-7061-2019; Choi, Justin/F-8792-2014; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves/M-4442-2018	Alaux, Cedric/0000-0002-3045-2599; Martin-Hernandez, Raquel/0000-0002-1730-9368; Botías, Cristina/0000-0002-3891-9931; Le Conte, Yves M/0000-0002-8466-5370; Colbourne, John K/0000-0002-6966-2972; Higes, Mariano/0000-0001-7338-5851; BRUNET, Jean-Luc/0000-0002-3827-1135; Moritz, Robin FA/0000-0003-0791-887X; , Belzunces/0000-0003-1798-9962; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370	BEEDOC [RTD REG/E.4(2009)D/561221]; INRA Sante des Plantes et de l'Environnement department (AAP SPE); Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola); CONICYT/French Embassy of Chile; COLOSS short-term mission (COST Action) [FA0803]; Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain); INRA (INRA Sante des Plantes et de l'Environnement department); METACyt Initiative of Indiana University; Lilly Endowment, Inc.	BEEDOC; INRA Sante des Plantes et de l'Environnement department (AAP SPE); Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola)(Junta de Comunidades de Castilla-La Mancha); CONICYT/French Embassy of Chile; COLOSS short-term mission (COST Action); Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain); INRA (INRA Sante des Plantes et de l'Environnement department); METACyt Initiative of Indiana University; Lilly Endowment, Inc.	This work was co-funded by a BEEDOC grant (FP7, RTD REG/E.4(2009)D/561221), grants from INRA Sante des Plantes et de l'Environnement department (AAP SPE 2010) and Junta de Comunidades de Castilla-La Mancha (Consejeria de Agricultura, Medio Rural y Marino, Programa Nacional Apicola 2011-2013). C. Dussaubat was supported by a CONICYT/French Embassy of Chile grant and a COLOSS short-term mission (COST Action FA0803), R. Martin-Hernandez by the Instituto de Recursos Humanos para la Ciencia y la Tecnologia (Fundacion Parque Cientifico y Tecnologico de Albaceta, Spain), CM by the BEEDOC grant (FP7, RTD REG/E.4(2009)D/561221) and C. Alaux by an INRA young researcher position (INRA Sante des Plantes et de l'Environnement department). Work at the Center for Genomics and Bioinformatics was supported in part by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Atwood H. L., 1997, Invertebrate Neuroscience, V3, P81, DOI 10.1007/BF02480362; Becnel James J., 1999, P447; Bodyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1157, DOI 10.1023/A:1012441215506; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bounias M, 1996, ECOTOX ENVIRON SAFE, V35, P67, DOI 10.1006/eesa.1996.0082; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; COHN LA, 1994, AM J PHYSIOL, V266, pL397, DOI 10.1152/ajplung.1994.266.4.L397; Copenhaver PF, 2007, DEV DYNAM, V236, P1841, DOI 10.1002/dvdy.21138; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Medina FS, 2004, BIOCHEM PHARMACOL, V68, P2317, DOI 10.1016/j.bcp.2004.07.045; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fenoy S, 2009, APPL ENVIRON MICROB, V75, P6886, DOI 10.1128/AEM.01025-09; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; FRIES I, 1988, APIDOLOGIE, V19, P319, DOI 10.1051/apido:19880310; Fries I., 1995, CROSSINFECTIVITY NOS, P151; Fries I., 1997, HONEY BEE PESTS PRED, P59; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Gill EE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-296; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gonzalez IL, 1997, GENOME RES, V7, P65, DOI 10.1101/gr.7.1.65; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Huising MO, 2005, ENDOCRINOLOGY, V146, P2165, DOI 10.1210/en.2004-1514; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; KINNULA VL, 1992, AM J PHYSIOL, V262, pL708, DOI 10.1152/ajplung.1992.262.6.L708; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Martin-Hernandez R, 2009, APPL ENVIRON MICROB, V75, P2554, DOI 10.1128/AEM.02908-08; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mehta B, 2001, DEVELOPMENT, V128, P3161; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Palladino MJ, 2003, J NEUROSCI, V23, P1276, DOI 10.1523/JNEUROSCI.23-04-01276.2003; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Scanlon M, 2000, J EUKARYOT MICROBIOL, V47, P525, DOI 10.1111/j.1550-7408.2000.tb00085.x; Scharf ME, 2005, INSECT MOL BIOL, V14, P31, DOI 10.1111/j.1365-2583.2004.00527.x; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Team RDC, 2009, R LANG ENV STAT COMP; TSAI CC, 1995, DEVELOPMENT, V121, P453; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wang P, 2010, J CELL PHYSIOL, V222, P33, DOI 10.1002/jcp.21928; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008	99	169	178	4	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37017	10.1371/journal.pone.0037017	http://dx.doi.org/10.1371/journal.pone.0037017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623972	Green Published, gold			2022-12-27	WOS:000305343500049
J	Hudson, EP; Nikoshkov, A; Uhlen, M; Rockberg, J				Hudson, Elton P.; Nikoshkov, Andrej; Uhlen, Mathias; Rockberg, Johan			Automated Solid-Phase Subcloning Based on Beads Brought into Proximity by Magnetic Force	PLOS ONE			English	Article							PICHIA-PASTORIS; DNA-MOLECULES; IN-VITRO; CLONING; PCR; EXPRESSION; PRODUCTS; PROTEINS; EMULSION; TARGETS	In the fields of proteomics, metabolic engineering and synthetic biology there is a need for high-throughput and reliable cloning methods to facilitate construction of expression vectors and genetic pathways. Here, we describe a new approach for solid-phase cloning in which both the vector and the gene are immobilized to separate paramagnetic beads and brought into proximity by magnetic force. Ligation events were directly evaluated using fluorescent-based microscopy and flow cytometry. The highest ligation efficiencies were obtained when gene- and vector-coated beads were brought into close contact by application of a magnet during the ligation step. An automated procedure was developed using a laboratory workstation to transfer genes into various expression vectors and more than 95% correct clones were obtained in a number of various applications. The method presented here is suitable for efficient subcloning in an automated manner to rapidly generate a large number of gene constructs in various vectors intended for high throughput applications.	[Hudson, Elton P.; Nikoshkov, Andrej; Uhlen, Mathias; Rockberg, Johan] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Royal Institute of Technology; Royal Institute of Technology; Technical University of Denmark	Hudson, EP (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	johanr@biotech.kth.se	Hudson, Paul/ABH-8177-2020; Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Hudson, Elton/0000-0003-1899-7649	Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; VINNOVA ProNova center; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); VINNOVA ProNova center(Vinnova); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, Knut and Alice Wallenberg Foundation and the VINNOVA ProNova center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Ayra-Pardo Camilo, 1998, Biotecnologia Aplicada, V15, P173; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Castronovo M, 2008, NANO LETT, V8, P4140, DOI 10.1021/nl802370g; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Gan R, 2008, BIOTECHNOL PROGR, V24, P1107, DOI 10.1002/btpr.43; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kojima T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni143; Larsson M, 2000, J BIOTECHNOL, V80, P143, DOI 10.1016/S0168-1656(00)00258-3; Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/nmat2815, 10.1038/NMAT2815]; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Naimushin AN, 2001, BIOPOLYMERS, V58, P204, DOI 10.1002/1097-0282(200102)58:2<204::AID-BIP90>3.0.CO;2-1; NILSSON P, 1995, ANAL BIOCHEM, V224, P400, DOI 10.1006/abio.1995.1057; Peterson AW, 2001, NUCLEIC ACIDS RES, V29, P5163, DOI 10.1093/nar/29.24.5163; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Riccelli PV, 2001, NUCLEIC ACIDS RES, V29, P996, DOI 10.1093/nar/29.4.996; Rockberg J, 2008, NAT METHODS, V5, P1039, DOI 10.1038/nmeth.1272; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Roth ME, 2004, NAT BIOTECHNOL, V22, P418, DOI 10.1038/nbt948; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; STAHL S, 1988, NUCLEIC ACIDS RES, V16, P3025, DOI 10.1093/nar/16.7.3025; Steen J, 2006, PROTEIN EXPRES PURIF, V46, P173, DOI 10.1016/j.pep.2005.12.010; UHLEN M, 1989, NATURE, V340, P733, DOI 10.1038/340733a0; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Yeung SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl702	35	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37429	10.1371/journal.pone.0037429	http://dx.doi.org/10.1371/journal.pone.0037429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624028	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500113
J	Samonis, G; Karageorgopoulos, DE; Maraki, S; Levis, P; Dimopoulou, D; Spernovasilis, NA; Kofteridis, DP; Falagas, ME				Samonis, George; Karageorgopoulos, Drosos E.; Maraki, Sofia; Levis, Panagiotis; Dimopoulou, Dimitra; Spernovasilis, Nikolaos A.; Kofteridis, Diamantis P.; Falagas, Matthew E.			Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome	PLOS ONE			English	Article							MULTIDRUG-RESISTANT STRAINS; GRAM-NEGATIVE BACILLI; XANTHOMONAS-MALTOPHILIA; AGAR DILUTION; POLYMYXIN-B; PATHOGEN; MORTALITY; CRITERIA; THERAPY; COLONIZATION	Introduction: Stenotrophomonas maltophilia is acquiring increasing importance as a nosocomial pathogen. Methods: We retrospectively studied the characteristics and outcome of patients with any type of S. maltophilia infection at the University Hospital of Heraklion, Crete, Greece, between 1/2005-12/2010. S. maltophilia antimicrobial susceptibility was tested with the agar dilution method. Prognostic factors for all-cause in-hospital mortality were assessed with multivariate logistic regression. Results: Sixty-eight patients (median age: 70.5 years; 64.7% males) with S. maltophilia infection, not related to cystic fibrosis, were included. The 68 patients were hospitalized in medical (29.4%), surgical (26.5%), hematology/oncology departments (23.5%), or the intensive care units (ICU; 20.6%). The most frequent infection types were respiratory tract (54.4%), bloodstream (16.2%), skin/soft tissue (10.3%), and intra-abdominal (8.8%) infection. The S. maltophilia-associated infection was polymicrobial in 33.8% of the cases. In vitro susceptibility was higher to colistin (91.2%), trimethoprim/sulfamethoxazole and netilmicin (85.3% each), and ciprofloxacin (82.4%). The empirical and the targeted treatment regimens were microbiologically appropriate for 47.3% and 63.6% of the 55 patients with data available, respectively. Most patients received targeted therapy with a combination of agents other than trimethoprim/sulfamethoxazole. The crude mortality and the mortality and the S. maltophilia infection-related mortality were 14.7% and 4.4%, respectively. ICU hospitalization was the only independent prognostic factor for mortality. Conclusion: S. maltophilia infection in a general hospital can be associated with a good prognosis, except for the patients hospitalized in the ICU. Combination reigmens with fluoroquinolones, colistin, or tigecycline could be alternative treatment options to trimethoprim/sulfamethoxazole.	[Samonis, George; Dimopoulou, Dimitra; Spernovasilis, Nikolaos A.; Kofteridis, Diamantis P.] Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece; [Karageorgopoulos, Drosos E.; Levis, Panagiotis; Falagas, Matthew E.] Alfa Inst Biomed Sci, Athens, Greece; [Karageorgopoulos, Drosos E.] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Maraki, Sofia] Univ Hosp Heraklion, Dept Clin Microbiol, Iraklion, Crete, Greece; [Falagas, Matthew E.] Henry Dunant Hosp, Dept Med, Athens, Greece; [Falagas, Matthew E.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University Hospital of Heraklion; Alfa Institute Of Biomedical Sciences; University Hospital of Heraklion; Henry Dunant Hospital; Tufts University	Samonis, G (corresponding author), Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece.	m.falagas@aibs.gr	Karageorgopoulos, Drosos/K-9241-2018	Karageorgopoulos, Drosos/0000-0002-9959-9978				Araoka H, 2010, EUR J CLIN MICROBIOL, V29, P605, DOI 10.1007/s10096-010-0882-6; Betriu C, 2002, J ANTIMICROB CHEMOTH, V50, P758, DOI 10.1093/jac/dkf196; Blanquer D, 2008, J CHEMOTHERAPY, V20, P761, DOI 10.1179/joc.2008.20.6.761; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Del Toro MD, 2002, MEDICINE, V81, P228; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V62, P889, DOI 10.1093/jac/dkn301; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Garrison MW, 1996, ANTIMICROB AGENTS CH, V40, P2859, DOI 10.1128/AAC.40.12.2859; Gulmez D, 2010, J INFECT CHEMOTHER, V16, P322, DOI 10.1007/s10156-010-0068-2; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hu LF, 2011, INT J ANTIMICROB AG, V37, P230, DOI 10.1016/j.ijantimicag.2010.10.025; Kwa ALH, 2008, ANN ACAD MED SINGAP, V37, P826; LAING FPY, 1995, J CLIN MICROBIOL, V33, P513, DOI 10.1128/JCM.33.3.513-518.1995; Lambert T, 1999, ANTIMICROB AGENTS CH, V43, P2366, DOI 10.1128/AAC.43.10.2366; Leclercq R, 2011, CLIN MICROBIOL INFEC; LECSOBORNET M, 1992, ANTIMICROB AGENTS CH, V36, P669, DOI 10.1128/AAC.36.3.669; Li XZ, 2003, J ANTIMICROB CHEMOTH, V51, P803, DOI 10.1093/jac/dkg148; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Nicodemo AC, 2007, EUR J CLIN MICROBIOL, V26, P229, DOI 10.1007/s10096-007-0279-3; Nicodemo AC, 2004, J ANTIMICROB CHEMOTH, V53, P604, DOI 10.1093/jac/dkh128; Penzak SR, 1997, PHARMACOTHERAPY, V17, P293; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; San Gabriel P, 2004, ANTIMICROB AGENTS CH, V48, P168, DOI 10.1128/AAC.48.1.168-171.2004; Toleman MA, 2007, EMERG INFECT DIS, V13, P559, DOI 10.3201/eid1304.061378; Traub WH, 1998, CHEMOTHERAPY, V44, P164, DOI 10.1159/000007111; Valdezate S, 2005, J ANTIMICROB CHEMOTH, V56, P220, DOI 10.1093/jac/dki182; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Valdezate S, 2001, ANTIMICROB AGENTS CH, V45, P1581, DOI 10.1128/AAC.45.5.1581-1584.2001; VanCouwenberghe CJ, 1997, INFECT CONT HOSP EP, V18, P316, DOI 10.1086/647618; VARTIVARIAN S, 1994, ANTIMICROB AGENTS CH, V38, P624, DOI 10.1128/AAC.38.3.624; Vila J, 2002, ENFERM INFEC MICR CL, V20, P304, DOI 10.1016/S0213-005X(02)72803-6	38	74	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37375	10.1371/journal.pone.0037375	http://dx.doi.org/10.1371/journal.pone.0037375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624022	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500106
J	Badirou, I; Kurdi, M; Legendre, P; Rayes, J; Bryckaert, M; Casari, C; Lenting, PJ; Christophe, OD; Denis, CV				Badirou, Idinath; Kurdi, Mohamad; Legendre, Paulette; Rayes, Julie; Bryckaert, Marijke; Casari, Caterina; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.			In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; HUMAN VONWILLEBRAND-FACTOR; FACTOR-DEFICIENT MICE; GLYCOPROTEIN-IB-IX; THROMBUS FORMATION; FACTOR-VIII; A1 DOMAIN; PLASMA; CARBOHYDRATE; MUTATION	The objective of this project was to study the function of O-glycosylations in von Willebrand factor (VWF) life cycle. In total, 14 different murine Vwf cDNAs mutated on one or several O-glycosylations sites were generated: 9 individual mutants, 2 doublets, 2 clusters and 1 mutant with all 9 murine glycosylation sites mutated (Del-O-Gly). We expressed each mutated cDNA in VWF deficient-mice by hydrodynamic injection. An immunosorbent assay with Peanut Agglutinin (PNA) was used to verify the O-glycosylation status. Wild-type (WT) VWF expressed by hepatocytes after hydrodynamic injection was able to bind PNA with slightly higher affinity than endothelial-derived VWF. In contrast, the Del-O-Gly VWF mutant did not bind PNA, demonstrating removal of O-linked glycans. All mutants displayed a normal multimeric pattern. Two mutants, Del-OGly and T1255A/T1256A, led to expression levels 50% lower than those induced by WT VWF and their half-life in vivo was significantly reduced. When testing the capacity of each mutant to correct the bleeding time of VWF-deficient mice, we found that S1486A, T1255A, T1256A and the doublet T1255A/T1256A were unable to do so. In conclusion we have shown that O-glycosylations are dispensable for normal VWF multimerization and biosynthesis. It also appears that some O-glycosylation sites, particularly the T1255 and T1256 residues, are involved in the maintenance of VWF plasma levels and are essential for normal haemostasis. As for the S1486 residue, it seems to be important for platelet binding as demonstrated in vitro using perfusion experiments.	[Badirou, Idinath; Kurdi, Mohamad; Legendre, Paulette; Rayes, Julie; Bryckaert, Marijke; Casari, Caterina; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Legendre, Paulette; Bryckaert, Marijke; Lenting, Peter J.; Christophe, Olivier D.; Denis, Cecile V.] Univ Paris Sud, UMR S 770, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Badirou, I (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	cecile.denis@inserm.fr	casari, caterina/GXG-5273-2022; Lenting, Peter/AAH-5663-2019; Denis, Cecile/A-7649-2011; christophe, olivier/W-4268-2017; Casari, Caterina/O-7537-2019; Lenting, Peter/F-8269-2013	Lenting, Peter/0000-0002-7937-3429; Denis, Cecile/0000-0001-5152-9156; christophe, olivier/0000-0002-9080-6336; Casari, Caterina/0000-0002-8271-6795; Lenting, Peter/0000-0002-7937-3429; Bryckaert, Marijke/0000-0003-3398-0976; Rayes, Julie/0000-0003-0499-6880	Institut National de la Sante et de la Recherche Medicale; Laboratoires Francais de Fractionnement et des Biotechnologies (LFB); Agence Nationale de la Recherche [ANR-08-CEXC-018-01]; Groupe d'Etude sur l'Hemostase et la Thrombose; Societe Francaise d'Hematologie	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Laboratoires Francais de Fractionnement et des Biotechnologies (LFB); Agence Nationale de la Recherche(French National Research Agency (ANR)); Groupe d'Etude sur l'Hemostase et la Thrombose; Societe Francaise d'Hematologie	This study was funded by Institut National de la Sante et de la Recherche Medicale, by Laboratoires Francais de Fractionnement et des Biotechnologies (LFB) and by a grant from Agence Nationale de la Recherche (ANR-08-CEXC-018-01) to PJL. IB is a recipient of a Ph.D. grant from the Groupe d'Etude sur l'Hemostase et la Thrombose and from the Societe Francaise d'Hematologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auwerx J, 2008, VIROLOGY, V382, P10, DOI 10.1016/j.virol.2008.09.010; Canis K, 2010, J THROMB HAEMOST, V8, P137, DOI 10.1111/j.1538-7836.2009.03665.x; CAREW JA, 1992, J CLIN INVEST, V90, P2258, DOI 10.1172/JCI116112; Chitta MS, 2007, PLATELETS, V18, P182, DOI 10.1080/09537100600938816; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; Davies JA, 2008, J THROMB HAEMOST, V6, P97; Esch Jan Schulte am II, 2005, British Journal of Haematology, V128, P82, DOI 10.1111/j.1365-2141.2004.05253.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kauskot A, 2007, J BIOL CHEM, V282, P31990, DOI 10.1074/jbc.M701596200; Lenting PJ, 2004, J BIOL CHEM, V279, P12102, DOI 10.1074/jbc.M310436200; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Marx I, 2008, BLOOD, V112, P603, DOI 10.1182/blood-2008-02-142943; Marx I, 2008, ARTERIOSCL THROM VAS, V28, P419, DOI 10.1161/ATVBAHA.107.159442; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; McKinnon TAJ, 2010, BLOOD, V116, P640, DOI 10.1182/blood-2010-02-267450; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Obert B, 1999, THROMB HAEMOSTASIS, V82, P1382; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Plaimauer B, 2006, BLOOD, V107, P118, DOI 10.1182/blood-2005-06-2482; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Rayes J, 2010, BLOOD, V115, P4870, DOI 10.1182/blood-2009-11-254193; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SAMOR B, 1989, GLYCOCONJUGATE J, V6, P263, DOI 10.1007/BF01047846; Stoddart JH, 1996, BLOOD, V88, P1692; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Turecek PL, 2009, HAMOSTASEOLOGIE, V29, pS32; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; van Schooten CJM, 2007, BLOOD, V109, P2430, DOI 10.1182/blood-2006-06-032706; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, CURR PROTOC PROTEIN, P11; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WEISS HJ, 1977, J CLIN INVEST, V60, P390, DOI 10.1172/JCI108788; Yang L, 2009, J THROMB HAEMOST, V7, P1696, DOI 10.1111/j.1538-7836.2009.03578.x	34	32	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37508	10.1371/journal.pone.0037508	http://dx.doi.org/10.1371/journal.pone.0037508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616016	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200080
J	Elyazar, IRF; Gething, PW; Patil, AP; Rogayah, H; Sariwati, E; Palupi, NW; Tarmizi, SN; Kusriastuti, R; Baird, JK; Hay, SI				Elyazar, Iqbal R. F.; Gething, Peter W.; Patil, Anand P.; Rogayah, Hanifah; Sariwati, Elvieda; Palupi, Niken W.; Tarmizi, Siti N.; Kusriastuti, Rita; Baird, J. Kevin; Hay, Simon I.			Plasmodium vivax Malaria Endemicity in Indonesia in 2010	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; FALCIPARUM-MALARIA; RESISTANCE; CHLOROQUINE; RISK; DETERMINANTS; COMBINATION; INFECTIONS; PREVALENCE; DEFICIENCY	Background: Plasmodium vivax imposes substantial morbidity and mortality burdens in endemic zones. Detailed understanding of the contemporary spatial distribution of this parasite is needed to combat it. We used model based geostatistics (MBG) techniques to generate a contemporary map of risk of Plasmodium vivax malaria in Indonesia in 2010. Methods: Plasmodium vivax Annual Parasite Incidence data (2006-2008) and temperature masks were used to map P. vivax transmission limits. A total of 4,658 community surveys of P. vivax parasite rate (PvPR) were identified (1985-2010) for mapping quantitative estimates of contemporary endemicity within those limits. After error-checking a total of 4,457 points were included into a national database of age-standardized 1-99 year old PvPR data. A Bayesian MBG procedure created a predicted PvPR1-99 endemicity surface with uncertainty estimates. Population at risk estimates were derived with reference to a 2010 human population surface. Results: We estimated 129.6 million people in Indonesia lived at risk of P. vivax transmission in 2010. Among these, 79.3% inhabited unstable transmission areas and 20.7% resided in stable transmission areas. In western Indonesia, the predicted P. vivax prevalence was uniformly low. Over 70% of the population at risk in this region lived on Java and Bali islands, where little malaria transmission occurs. High predicted prevalence areas were observed in the Lesser Sundas, Maluku and Papua. In general, prediction uncertainty was relatively low in the west and high in the east. Conclusion: Most Indonesians living with endemic P. vivax experience relatively low risk of infection. However, blood surveys for this parasite are likely relatively insensitive and certainly do not detect the dormant liver stage reservoir of infection. The prospects for P. vivax elimination would be improved with deeper understanding of glucose-6-phosphate dehydrogenase deficiency (G6PDd) distribution, anti-relapse therapy practices and manageability of P. vivax importation risk, especially in Java and Bali.	[Elyazar, Iqbal R. F.; Baird, J. Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Rogayah, Hanifah; Sariwati, Elvieda; Palupi, Niken W.; Tarmizi, Siti N.; Kusriastuti, Rita] Indonesian Minist Hlth, Directorate Vector Borne Dis, Jakarta, Indonesia; [Baird, J. Kevin] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England	Eijkman Institute; University of Oxford; Ministry of Health - Indonesia; University of Oxford	Elyazar, IRF (corresponding author), Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.	iqbal.elyazar@gmail.com	Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/ABD-2110-2020	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; 	University of Oxford - Li Ka Shing Foundation Global Health Program; Oxford Tropical Network; Senior Research Fellowship from the Wellcome Trust [095066]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Wellcome Trust [091835, B9RJIXO]; Indonesian Ministry of Health; Wellcome Trust, U.K	University of Oxford - Li Ka Shing Foundation Global Health Program; Oxford Tropical Network; Senior Research Fellowship from the Wellcome Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome Trust); Indonesian Ministry of Health; Wellcome Trust, U.K(Wellcome Trust)	IE is funded by grants from the University of Oxford - Li Ka Shing Foundation Global Health Program and the Oxford Tropical Network. SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), which also supports PWG. SIH also acknowledges funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. APP is funded by a grant from the Wellcome Trust (#091835). HR, ES, NWP, SNT, and RK are funded by the Indonesian Ministry of Health. JKB is funded by a grant from the Wellcome Trust (#B9RJIXO). This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-241; Ashton RA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-297; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Baird JK, 2011, ANTIMICROB AGENTS CH, V55, P1827, DOI 10.1128/AAC.01296-10; Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; Baird JK, 2008, NEW ENGL J MED, V359, P2601, DOI 10.1056/NEJMe0808729; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Baird JK, 2011, LANCET, V376, P7; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; CIESIN/IFPRI/WB/CIAT, 2007, GLOB RUR URB MAPP PR; Clements ACA, 2006, PARASITOLOGY, V133, P711, DOI 10.1017/S0031182006001181; Cohen J.E., 1988, STAT POWER ANAL BEHA; *DEP KES, 2007, BUK SAK PEN KAS MAL; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Dogan HM, 2010, T ROY SOC TROP MED H, V104, P726, DOI 10.1016/j.trstmh.2010.08.003; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Elyazar IRF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021315; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Elyazar IRF, 2012, PARASITES VECT UNPUB; ENG LL, 1964, NATURE, V204, P88, DOI 10.1038/204088a0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2010, PARASITE VECTOR, V9, P2; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, P8; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hay SI, 2010, PLOS MED, V7, P6; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Howes RE, 2012, PLOS MED IN PRESS; Joshi H, 2008, TRENDS PARASITOL, V24, P228, DOI 10.1016/j.pt.2008.01.007; Looareesuwan S, 1999, ANN TROP MED PARASIT, V93, P225, DOI 10.1080/00034989958474; Maekawa Y, 2009, J AM MOSQUITO CONTR, V25, P203, DOI 10.2987/08-5824.1; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Matsuoka H, 2003, J HUM GENET, V48, P541, DOI 10.1007/s10038-003-0073-8; MATSUOKA H, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P530; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Myat-Phone-Kyaw, 1993, T R SOC TROP MED HGY, V87, P687; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Reid H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-150; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Shimizu H, 2005, J HUM GENET, V50, P420, DOI 10.1007/s10038-005-0271-7; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Tantular IS, 1999, TROP MED INT HEALTH, V4, P245, DOI 10.1046/j.1365-3156.1999.00395.x; Tatem AJ, 2009, MALARIA J, V8, P27; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; The malERA Consultative Group on Drugs, 2011, PLOS MED, V8, P1; Tjitra E, 1999, J CLIN MICROBIOL, V37, P2412, DOI 10.1128/JCM.37.8.2412-2417.1999; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; U.N.P.D, 2007, WORLD URB PROSP POP; U.N.P.D, 2008, WORLD POP PROSP 2008; Valecha N, 2009, AM J TROP MED HYG, V81, P758, DOI 10.4269/ajtmh.2009.09-0348; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; World Health Organization, 2010, 770191 WC WHO, V770, P191; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS	74	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37325	10.1371/journal.pone.0037325	http://dx.doi.org/10.1371/journal.pone.0037325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615978	Green Published, gold			2022-12-27	WOS:000305341200059
J	Najafov, A; Seker, T; Even, I; Hoxhaj, G; Selvi, O; Ozel, DE; Koman, A; Birgul-Iyison, N				Najafov, Ayaz; Seker, Tuncay; Even, Ipek; Hoxhaj, Gerta; Selvi, Osman; Ozel, Duygu Esen; Koman, Ahmet; Birgul-Iyison, Necla			MENA Is a Transcriptional Target of the Wnt/Beta-Catenin Pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CANCER CELL-LINES; BETA-CATENIN; BREAST-CANCER; TUMOR-SUPPRESSOR; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; ASSOCIATION ANALYSIS; COLON-CANCER; WNT PATHWAY	Wnt/beta-catenin signalling pathway plays important roles in embryonic development and carcinogenesis. Overactivation of the pathway is one of the most common driving forces in major cancers such as colorectal and breast cancers. The downstream effectors of the pathway and its regulation of carcinogenesis and metastasis are still not very well understood. In this study, which was based on two genome-wide transcriptomics screens, we identify MENA (ENAH, Mammalian enabled homologue) as a novel transcriptional target of the Wnt/beta-catenin signalling pathway. We show that the expression of MENA is upregulated upon overexpression of degradation-resistant beta-catenin. Promoters of all mammalian MENA homologues contain putative binding sites for Tcf4 transcription factor - the primary effector of the Wnt/beta-catenin pathway and we demonstrate functionality of these Tcf4-binding sites using luciferase reporter assays and overexpression of beta-catenin, Tcf4 and dominant-negative Tcf4. In addition, lithium chloride-mediated inhibition of GSK3 beta also resulted in increase in MENA mRNA levels. Chromatin immunoprecipitation showed direct interaction between beta-catenin and MENA promoter in Huh7 and HEK293 cells and also in mouse brain and liver tissues. Moreover, overexpression of Wnt1 and Wnt3a ligands increased MENA mRNA levels. Additionally, knock-down of MENA ortholog in D. melanogaster eyeful and sensitized eye cancer fly models resulted in increased tumor and metastasis formations. In summary, our study identifies MENA as novel nexus for the Wnt/beta-catenin and the Notch signalling cascades.	[Najafov, Ayaz; Seker, Tuncay; Even, Ipek; Hoxhaj, Gerta; Selvi, Osman; Koman, Ahmet; Birgul-Iyison, Necla] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Najafov, Ayaz] Univ Dundee, MRC Phosphorylat Unit, Dundee, Scotland; [Ozel, Duygu Esen] VIB, Dept Mol & Dev Genet, Louvain, Belgium	Bogazici University; University of Dundee; Flanders Institute for Biotechnology (VIB)	Najafov, A (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	a.najafov@dundee.ac.uk	Najafov, Ayaz/AFL-2815-2022; Najafov, Ayaz/AAY-9135-2021; Birgül Iyison, Necla/A-7389-2017	Najafov, Ayaz/0000-0002-1350-2056; Najafov, Ayaz/0000-0002-1350-2056; Hoxhaj, Gerta/0000-0001-6179-3583	Bogazici University; TUBITAK (The Scientific and Technological Research Council of Turkey)	Bogazici University(Bogazici University); TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This research project was sponsored by the Bogazici University and TUBITAK (The Scientific and Technological Research Council of Turkey, www.tubitak.gov.tr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2001, J BIOL CHEM, V276, P28443, DOI 10.1074/jbc.M009769200; Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blair IP, 2006, MOL PSYCHIATR, V11, P372, DOI 10.1038/sj.mp.4001784; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Gurzu S, 2008, ROM J MORPHOL EMBRYO, V49, P345; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; KANAI Y, 1995, BIOCHEM BIOPH RES CO, V208, P1067, DOI 10.1006/bbrc.1995.1443; Katsu T, 2003, NEUROSCI LETT, V353, P53, DOI 10.1016/j.neulet.2003.09.017; Kavak E, 2010, CELL SIGNAL, V22, P1523, DOI 10.1016/j.cellsig.2010.05.021; Kim J, 2005, BIOINFORMATICS, V21, P548, DOI 10.1093/bioinformatics/bti048; Kim K, 2001, CELL BIOL INT, V25, P421, DOI 10.1006/cbir.2000.0650; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Menzies AS, 2004, J NEUROSCI, V24, P8029, DOI 10.1523/JNEUROSCI.1057-04.2004; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pino MS, 2008, CLIN CANCER RES, V14, P4943, DOI 10.1158/1078-0432.CCR-08-0436; Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schroeder JA, 2002, J BIOL CHEM, V277, P22692, DOI 10.1074/jbc.M201975200; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Toyoda A, 2009, INT J ONCOL, V34, P53, DOI 10.3892/ijo_00000128; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; YANG SD, 1995, J CELL BIOCHEM, V59, P108, DOI 10.1002/jcb.240590112	43	16	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37013	10.1371/journal.pone.0037013	http://dx.doi.org/10.1371/journal.pone.0037013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615875	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200032
J	Yang, T; Zhuang, L; Fidalgo, AMR; Petrides, E; Terrando, N; Wu, XM; Sanders, RD; Robertson, NJ; Johnson, MR; Maze, M; Ma, DQ				Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Terrando, Niccolo; Wu, Xinmin; Sanders, Robert D.; Robertson, Nicola J.; Johnson, Mark R.; Maze, Mervyn; Ma, Daqing			Xenon and Sevoflurane Provide Analgesia during Labor and Fetal Brain Protection in a Perinatal Rat Model of Hypoxia-Ischemia	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; NITROUS-OXIDE; NEONATAL ASPHYXIA; COMPETITIVE-INHIBITION; GLYCINE SITE; IN-VITRO; INJURY; ISOFLURANE; DAMAGE; ENCEPHALOPATHY	It is not possible to identify all pregnancies at risk of neonatal hypoxic-ischemic encephalopathy (HIE). Many women use some form of analgesia during childbirth and some anesthetic agents have been shown to be neuroprotective when used as analgesics at subanesthetic concentrations. In this study we sought to understand the effects of two anesthetic agents with presumptive analgesic activity and known preconditioning-neuroprotective properties (sevoflurane or xenon), in reducing hypoxia-induced brain damage in a model of intrauterine perinatal asphyxia. The analgesic and neuroprotective effects at subanesthetic levels of sevoflurane (0.35%) or xenon (35%) were tested in a rat model of intrauterine perinatal asphyxia. Analgesic effects were measured by assessing maternal behavior and spinal cord dorsal horn neuronal activation using c-Fos. In separate experiments, intrauterine fetal asphyxia was induced four hours after gas exposure; on post-insult day 3 apoptotic cell death was measured by caspase-3 immunostaining in hippocampal neurons and correlated with the number of viable neurons on postnatal day (PND) 7. A separate cohort of pups was nurtured by a surrogate mother for 50 days when cognitive testing with Morris water maze was performed. Both anesthetic agents provided analgesia as reflected by a reduction in the number of stretching movements and decreased c-Fos expression in the dorsal horn of the spinal cord. Both agents also reduced the number of caspase-3 positive (apoptotic) neurons and increased cell viability in the hippocampus at PND7. These acute histological changes were mirrored by improved cognitive function measured remotely after birth on PND 50 compared to control group. Subanesthetic doses of sevoflurane or xenon provided both analgesia and neuroprotection in this model of intrauterine perinatal asphyxia. These data suggest that anesthetic agents with neuroprotective properties may be effective in preventing HIE and should be tested in clinical trials in the future.	[Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Sanders, Robert D.; Johnson, Mark R.; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Yang, Ting; Zhuang, Lei; Fidalgo, Antonio M. Rei; Petrides, Evgenia; Sanders, Robert D.; Johnson, Mark R.; Ma, Daqing] Chelsea & Westminster Hosp, London, England; [Yang, Ting] Beijing Univ, Dept Anesthesia & Intens Care, Hosp 1, Beijing 100871, Peoples R China; [Yang, Ting; Terrando, Niccolo; Wu, Xinmin; Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England	Imperial College London; Imperial College London; Peking University; University of California System; University of California San Francisco; University of London; University College London	Yang, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England.	d.ma@imperial.ac.uk	Terrando, Niccolo/Y-4349-2019; Fidalgo, António R/A-7402-2010; Ma, Daqing/GLT-2735-2022; Sanders, Robert/A-7844-2012; Robertson, Nicola/GWR-2021-2022	Terrando, Niccolo/0000-0003-1803-5853; Fidalgo, António R/0000-0003-3384-0017; Ma, Daqing/0000-0003-1235-0537; Sanders, Robert/0000-0003-0113-0328; Ma, Daqing/0000-0002-0688-2097	Action Medical Research, West Sussex, UK [SP4385]; Chinese Society of Anesthesiology, Beijing, China	Action Medical Research, West Sussex, UK; Chinese Society of Anesthesiology, Beijing, China	This work was supported by a grant (SP4385) from Action Medical Research, West Sussex, UK, to Dr. Ma. Drs. Yang and Zhuang were supported by the fellowship from the Chinese Society of Anesthesiology, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Benrath J, 2007, ANESTH ANALG, V104, P106, DOI 10.1213/01.ane.0000250368.27822.31; BERKLEY KJ, 1993, J NEUROPHYSIOL, V69, P533, DOI 10.1152/jn.1993.69.2.533; Catheline G, 2006, ANESTHESIOLOGY, V104, P1257, DOI 10.1097/00000542-200606000-00022; Chapman V, 1997, PHARM STUDIES NOCICE; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Duarte R, 2008, BRIT J ANAESTH, V100, P203, DOI 10.1093/bja/aem369; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fukuda T, 2002, ANESTH ANALG, V95, P1300, DOI 10.1097/00000539-200211000-00037; Kingery WS, 2002, ANESTHESIOLOGY, V96, P367, DOI 10.1097/00000542-200202000-00023; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Limatola V, 2010, NEUROSCIENCE, V165, P874, DOI 10.1016/j.neuroscience.2009.10.063; Lu Y, 2010, ANESTHESIOLOGY, V112, P1404, DOI 10.1097/ALN.0b013e3181d94de1; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2004, ANESTHESIOLOGY, V100, P1313, DOI 10.1097/00000542-200405000-00040; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V99, P748, DOI 10.1097/00000542-200309000-00034; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Miyazaki Y, 1999, ANESTH ANALG, V88, P893, DOI 10.1097/00000539-199904000-00038; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nishikawa Koichi, 2011, Masui, V60, P534; Payne RS, 2005, BRAIN RES, V1034, P147, DOI 10.1016/j.brainres.2004.12.006; Petersen-Felix S, 1998, BRIT J ANAESTH, V81, P742, DOI 10.1093/bja/81.5.742; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Tong CY, 2008, ANESTHESIOLOGY, V108, P1081, DOI 10.1097/ALN.0b013e318167afb3; Wang Hailian, 2011, Front Biosci (Elite Ed), V3, P604; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031; Yang T, 2011, BRAIN RES, V1383, P317, DOI 10.1016/j.brainres.2011.01.081; Yeo ST, 2007, BRIT J ANAESTH, V98, P105, DOI 10.1093/bja/ael326	40	40	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37020	10.1371/journal.pone.0037020	http://dx.doi.org/10.1371/journal.pone.0037020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615878	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200034
J	Lubura, M; Hesse, D; Neumann, N; Scherneck, S; Wiedmer, P; Schurmann, A				Lubura, Marko; Hesse, Deike; Neumann, Nancy; Scherneck, Stephan; Wiedmer, Petra; Schuermann, Annette			Non-Invasive Quantification of White and Brown Adipose Tissues and Liver Fat Content by Computed Tomography in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; ENERGY-EXPENDITURE; BODY-COMPOSITION; LIPID-LEVELS; HUMANS; CT; DISEASE; OBESITY; THERMOGENESIS; CONSEQUENCES	Objectives: Obesity and its distribution pattern are important factors for the prediction of the onset of diabetes in humans. Since several mouse models are suitable to study the pathophysiology of type 2 diabetes the aim was to validate a novel computed tomograph model (Aloka-Hitachi LCT-200) for the quantification of visceral, subcutaneous, brown and intrahepatic fat depots in mice. Methods: Different lean and obese mouse models (C57BL/6, B6. V-Lep(ob), NZO) were used to determine the most adequate scanning parameters for the detection of the different fat depots. The data were compared with those obtained after preparation and weighing the fat depots. Liver fat content was determined by biochemical analysis. Results: The correlations between weights of fat tissues on scale and weights determined by CT were significant for subcutaneous (r(2) = 0.995), visceral (r(2) = 0.990) and total white adipose tissue (r(2) = 0.992). Moreover, scans in the abdominal region, between lumbar vertebrae L4 to L5 correlated with whole-body fat distribution allowing experimenters to reduce scanning time and animal exposure to radiation and anesthesia. Test-retest reliability and measurements conducted by different experimenters showed a high reproducibility in the obtained results. Intrahepatic fat content estimated by CT was linearly related to biochemical analysis (r(2) = 0.915). Furthermore, brown fat mass correlated well with weighted brown fat depots (r(2) = 0.952). In addition, short-term cold-expose (4 degrees C, 4 hours) led to alterations in brown adipose tissue attributed to a reduction in triglyceride content that can be visualized as an increase in Hounsfield units by CT imaging. Conclusion: The 3D imaging of fat by CT provides reliable results in the quantification of total, visceral, subcutaneous, brown and intrahepatic fat in mice. This non-invasive method allows the conduction of longitudinal studies of obesity in mice and therefore enables experimenters to investigate the onset of complex diseases such as diabetes and obesity.	[Lubura, Marko; Hesse, Deike; Neumann, Nancy; Scherneck, Stephan; Wiedmer, Petra; Schuermann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Nutr, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Lubura, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Nutr, Nuthetal, Germany.	schuermann@dife.de	Hesse, Deike/F-5716-2018	Hesse, Deike/0000-0001-5915-8003; Schurmann, Annette/0000-0002-4113-4377; Scherneck, Stephan/0000-0002-2811-5040; Wiedmer, Petra/0000-0001-7284-7823	German Ministry of Education and Research (NGFN plus) [01990821, DZD-019-I-0922]; Deutsche Forschungsgemeinschaft [GK1208]	German Ministry of Education and Research (NGFN plus)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Ministry of Education and Research (NGFN plus - 01990821; DZD-019-I-0922) and by the Deutsche Forschungsgemeinschaft (GK1208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; Boll DT, 2009, RADIOGRAPHICS, V29, P1591, DOI 10.1148/rg.296095513; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Garbow JR, 2004, J LIPID RES, V45, P1364, DOI 10.1194/jlr.D400001-JLR200; Hill AM, 2007, OBESITY, V15, P504, DOI 10.1038/oby.2007.629; Hillebrand JJG, 2010, OBESITY, V18, P848, DOI 10.1038/oby.2009.341; Jensen A, 1995, REPROD FERT DEVELOP, V7, P1351, DOI 10.1071/RD9951351; Judex S, 2010, METHODS, V50, P14, DOI 10.1016/j.ymeth.2009.05.017; Karcaaltincaba M, 2007, EUR J RADIOL, V61, P33, DOI 10.1016/j.ejrad.2006.11.005; Katznelson L, 1998, AM J ROENTGENOL, V170, P423, DOI 10.2214/ajr.170.2.9456958; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; Kobayashi J, 2002, INT J OBESITY, V26, P398, DOI 10.1038/sj.ijo.0801921; Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kozak LP, 2010, INT J OBESITY, V34, pS23, DOI 10.1038/ijo.2010.179; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Nubel T, 2006, HORM RES, V65, P300, DOI 10.1159/000092847; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Paschos P, 2009, HIPPOKRATIA, V13, P9; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Weiss EP, 2007, J NUTR, V137, P1087, DOI 10.1093/jn/137.4.1087; World Health Organization, 2021, OB OV FACT SHEETS; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yki-Jarvinen H, 2002, J ROY SOC MED, V95, P39; Zhong L, 2009, J DIG DIS, V10, P315, DOI 10.1111/j.1751-2980.2009.00402.x; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	38	53	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37026	10.1371/journal.pone.0037026	http://dx.doi.org/10.1371/journal.pone.0037026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615880	Green Published, gold			2022-12-27	WOS:000305341300056
J	Ozyurt, J; Rietze, M; Thiel, CM				Ozyurt, Jale; Rietze, Mareike; Thiel, Christiane M.			Prefrontal Neural Activity When Feedback Is Not Relevant to Adjust Performance	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; TIME-ESTIMATION TASK; DECISION-MAKING; ORBITOFRONTAL CORTEX; REWARD PREDICTION; ERROR-DETECTION; MOTOR AREAS; BRAIN; DOPAMINE	It has been shown that the rostral cingulate zone (RCZ) in humans uses both positive and negative feedback to evaluate performance and to flexibly adjust behaviour. Less is known on how the feedback types are processed by the RCZ and other prefrontal brain areas, when feedback can only be used to evaluate performance, but cannot be used to adjust behaviour. The present fMRI study aimed at investigating feedback that can only be used to evaluate performance in a word-learning paradigm. One group of volunteers (N = 17) received informative, performance-dependent positive or negative feedback after each trial. Since new words had to be learnt in each trial, the feedback could not be used for task-specific adaptations. The other group (N = 17) always received non-informative feedback, providing neither information about performance nor about possible task-specific adaptations. Effects of the informational value of feedback were assessed between-subjects, comparing trials with positive and negative informative feedback to non-informative feedback. Effects of feedback valence were assessed by comparing neural activity to positive and negative feedback within the informative-feedback group. Our results show that several prefrontal regions, including the pre-SMA, the inferior frontal cortex and the insula were sensitive to both, the informational value and the valence aspect of the feedback with stronger activations to informative as compared to non-informative feedback and to informative negative compared to informative positive feedback. The only exception was RCZ which was sensitive to the informational value of the feedback, but not to feedback valence. The findings indicate that outcome information per se is sufficient to activate prefrontal brain regions, with the RCZ being the only prefrontal brain region which is equally sensitive to positive and negative feedback.	[Ozyurt, Jale; Rietze, Mareike; Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Inst Psychol, Biol Psychol Lab, Oldenburg, Germany; [Thiel, Christiane M.] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Ozyurt, J (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Psychol, Biol Psychol Lab, Oldenburg, Germany.	jale.oezyurt@uni-oldenburg.de		Ozyurt, Jale/0000-0002-7894-9932; , Christiane/0000-0003-4788-4301	German Ministry for Education and Research (BMBF) [GJ01068306]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant from the German Ministry for Education and Research (BMBF grant no: GJ01068306). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Bischoff-Grethe A, 2009, NEUROIMAGE, V44, P243, DOI 10.1016/j.neuroimage.2008.08.038; Brett M, 2006, P 8 INT FUNCT MAPP H, V16; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Elliott R, 2003, J NEUROSCI, V23, P303; Fiehler K, 2004, EUR J NEUROSCI, V19, P3081, DOI 10.1111/j.0953-816X.2004.03414.x; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Heller K. A, 1998, HDB DTSCH NORMEN STA, V1; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Marco-Pallares J, 2007, NEUROREPORT, V18, P1423, DOI 10.1097/WNR.0b013e3282e9a58c; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mies GW, 2011, NEUROIMAGE, V56, P2321, DOI 10.1016/j.neuroimage.2011.04.015; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rutledge RB, 2010, J NEUROSCI, V30, P13525, DOI 10.1523/JNEUROSCI.1747-10.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Taylor SF, 2006, J NEUROSCI, V26, P4063, DOI 10.1523/JNEUROSCI.4709-05.2006; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van der Veen FM, 2011, NEUROIMAGE, V54, P447, DOI 10.1016/j.neuroimage.2010.08.018; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Voon V, 2010, NEURON, V65, P135, DOI 10.1016/j.neuron.2009.12.027; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36509	10.1371/journal.pone.0036509	http://dx.doi.org/10.1371/journal.pone.0036509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615774	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300017
J	Fossoy, F; Moksnes, A; Roskaft, E; Antonov, A; Dyrcz, A; Moskat, C; Ranke, PS; Rutila, J; Vikan, JR; Stokke, BG				Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Antonov, Anton; Dyrcz, Andrzej; Moskat, Csaba; Ranke, Peter S.; Rutila, Jarkko; Vikan, Johan R.; Stokke, Bard G.			Sex Allocation in Relation to Host Races in the Brood-Parasitic Common Cuckoo (Cuculus canorus)	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; RATIO; EVOLUTION; EGGS; ACQUISITION; PHENOTYPE; SELECTION; BEHAVIOR; BIRDS; LOCI	Sex allocation theory and empirical evidence both suggest that natural selection should favour maternal control of offspring sex ratio in relation to their ability to invest in the offspring. Generalist parasites constitute a particularly interesting group to test this theory as different females commonly utilize different host species showing large variation in provisioning ability. The common cuckoo (Cuculus canorus) is a generalist brood parasite that lays its eggs in the nest of many different passerine birds, but each female tends to specialize on one particular host species giving rise to highly specialized host races. The different host species show large variation in their ability to invest in the parasitic offspring, presenting an opportunity for female cuckoos to bias offspring sex ratio in relation to host species quality. Here, we investigate host-race specific sex allocation controlling for maternal identity in the common cuckoo. We found no evidence of any significant relationship between host race and sex ratio in one sympatric population harbouring three different host races, or in a total of five geographically separated populations. There was also no significant association between host quality, as determined by species-specific female host body mass, and cuckoo sex ratio. Finally, we found no significant relationship between individual cuckoo maternal quality, as determined by her egg volume, and sex ratio within each host race. We conclude that the generalist brood-parasitic common cuckoo show no significant sex-ratio bias in relation to host race and discuss this finding in light of gene flow and host adaptations.	[Fossoy, Frode; Moksnes, Arne; Roskaft, Eivin; Antonov, Anton; Ranke, Peter S.; Vikan, Johan R.; Stokke, Bard G.] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Dyrcz, Andrzej] Univ Wroclaw, Dept Avian Ecol, PL-50138 Wroclaw, Poland; [Moskat, Csaba] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Rutila, Jarkko] Univ Eastern Finland, Dept Biol, Joensuu, Finland	Norwegian University of Science & Technology (NTNU); University of Wroclaw; Eotvos Lorand University; University of Eastern Finland	Fossoy, F (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway.	frode.fossoy@bio.ntnu.no	Fossoy, Frode/O-3073-2017; Røskaft, Eivin/N-7476-2019	Fossoy, Frode/0000-0002-7535-9574; Røskaft, Eivin/0000-0003-0262-8443; Ranke, Peter S./0000-0003-3757-8626	Research Council of Norway [177709/V40]	Research Council of Norway(Research Council of Norway)	The study was funded by the Research Council of Norway (grant no. 177709/V40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2007, MOL ECOL NOTES, V7, P678, DOI 10.1111/j.1471-8286.2006.01675.x; Antonov A, 2010, J EVOLUTION BIOL, V23, P1170, DOI 10.1111/j.1420-9101.2010.01982.x; Badyaev AV, 2008, J EVOLUTION BIOL, V21, P449, DOI 10.1111/j.1420-9101.2007.01498.x; Bantock TM, 2008, MOL ECOL RESOUR, V8, P519, DOI 10.1111/j.1471-8286.2007.01999.x; Bates D, 2011, R WEBSITE IME4 LINEA; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Cramp S, 1992, BIRDS W PALEARCTIC; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; Dolan AC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1527, DOI 10.1007/s00265-009-0787-5; Dyrcz A, 2007, ETHOLOGY, V113, P209, DOI 10.1111/j.1439-0310.2006.01308.x; Edvardsen E, 2001, CONDOR, V103, P829, DOI 10.1650/0010-5422(2001)103[0829:EMICPF]2.0.CO;2; Fisher RA, 1930, GENETICAL THEORY NAT; Fossoy F, 2011, P ROY SOC B-BIOL SCI, V278, P1639, DOI 10.1098/rspb.2010.2090; Gibbs HL, 1996, P ROY SOC B-BIOL SCI, V263, P89, DOI 10.1098/rspb.1996.0015; Gibbs HL, 1998, MOL ECOL, V7, P1437; Gibbs HL, 2000, NATURE, V407, P183, DOI 10.1038/35025058; Goerlich VC, 2010, PHYSIOL BIOCHEM ZOOL, V83, P490, DOI 10.1086/651315; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hargitai R, 2010, J AVIAN BIOL, V41, P177, DOI 10.1111/j.1600-048X.2009.04818.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kasumovic MM, 2002, AUK, V119, P561, DOI 10.1642/0004-8038(2002)119[0561:PSRVIT]2.0.CO;2; King BH, 1996, BEHAV ECOL, V7, P35, DOI 10.1093/beheco/7.1.35; Kleven O, 1999, BEHAV ECOL SOCIOBIOL, V47, P41, DOI 10.1007/s002650050647; Kruger O, 2007, P ROY SOC B-BIOL SCI, V274, P1553, DOI 10.1098/rspb.2007.0281; Marchetti K, 1998, SCIENCE, V282, P471, DOI 10.1126/science.282.5388.471; MOKSNES A, 1995, J ZOOL, V236, P625, DOI 10.1111/j.1469-7998.1995.tb02736.x; Moksnes A, 2008, J AVIAN BIOL, V39, P238, DOI 10.1111/j.2008.0908-8857.04158.x; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Payne RB, 2005, THE CUCKOOS; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; R Development Core Team, 2011, R WEBS R LANG ENV ST; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Rutila J, 2002, J AVIAN BIOL, V33, P414, DOI 10.1034/j.1600-048X.2002.02937.x; Rutkowska J, 2008, PHILOS T R SOC B, V363, P1675, DOI 10.1098/rstb.2007.0006; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Tonra CM, 2008, AUK, V125, P205, DOI 10.1525/auk.2008.125.1.205; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WEATHERHEAD PJ, 1989, AUK, V106, P358; WEATHERS WW, 1995, IBIS, V137, P532, DOI 10.1111/j.1474-919X.1995.tb03263.x; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Whittingham LA, 2000, MOL ECOL, V9, P1123, DOI 10.1046/j.1365-294x.2000.00980.x	46	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36884	10.1371/journal.pone.0036884	http://dx.doi.org/10.1371/journal.pone.0036884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615833	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000305336300046
J	Qin, JL; Huang, HA; Ruan, Y; Hou, XQ; Yang, ST; Wang, CY; Huang, G; Wang, TC; Feng, N; Gao, YW; Xia, XZ				Qin, Junling; Huang, Hainan; Ruan, Yang; Hou, Xiaoqiang; Yang, Songtao; Wang, Chengyu; Huang, Geng; Wang, Tiecheng; Feng, Na; Gao, Yuwei; Xia, Xianzhu			A Novel Recombinant Peste des Petits Ruminants-Canine Adenovirus Vaccine Elicits Long-Lasting Neutralizing Antibody Response against PPR in Goats	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRUS-INFECTION; PROTECTION; TYPE-2; IDENTIFICATION; GLYCOPROTEIN; PREVALENCE; PROTEINS; EFFICACY; CATTLE	Background: Peste des petits ruminants (PPR) is a highly contagious infectious disease of goats, sheep and small wild ruminant species with high morbidity and mortality rates. The Peste des petits ruminants virus (PPRV) expresses a hemagglutinin (H) glycoprotein on its outer envelope that is crucial for viral attachment to host cells and represents a key antigen for inducing the host immune response. Methodology/Principal Findings: To determine whether H can be exploited to generate an effective PPRV vaccine, a replication-competent recombinant canine adenovirus type-2 (CAV-2) expressing the H gene of PPRV (China/Tibet strain) was constructed by the in vitro ligation method. The H expression cassette, including the human cytomegalovirus (hCMV) promoter/enhancer and the BGH early mRNA polyadenylation signal, was inserted into the SspI site of the E3 region, which is not essential for proliferation of CAV-2. Infectious recombinant rCAV-2-PPRV-H virus was generated in transfected MDCK cells and used to immunize goats. All vaccinated animals produced antibodies upon primary injection that were effective in neutralizing PPRV in vitro. Higher antibody titer was obtained following booster inoculation, and the antibody was detectable in goats for at least seven months. No serious recombinant virus-related adverse effect was observed in immunized animals and no adenovirus could be isolated from the urine or feces of vaccinated animals. Results showed that the recombinant virus was safe and could stimulate a long-lasting immune response in goats. Conclusions/Significance: This strategy not only provides an effective PPR vaccine candidate for goats but may be a valuable mean by which to differentiate infected from vaccinated animals (the so-called DIVA approach).	[Qin, Junling; Xia, Xianzhu] Jilin Univ, Div Agr, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China; [Qin, Junling; Huang, Hainan; Ruan, Yang; Hou, Xiaoqiang; Yang, Songtao; Wang, Chengyu; Huang, Geng; Wang, Tiecheng; Feng, Na; Gao, Yuwei; Xia, Xianzhu] Acad Mil Med Sci, Vet Inst, Changchun, Peoples R China; [Ruan, Yang] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Peoples R China; [Huang, Hainan] Acad Anim Sci & Vet Med Jilin Prov, Changchun, Jilin, Peoples R China	Jilin University; Academy of Military Medical Sciences - China; Jilin Agricultural University	Qin, JL (corresponding author), Jilin Univ, Div Agr, Coll Anim Sci & Vet Med, Changchun 130023, Peoples R China.	gywtext@yahoo.com.cn; xiaxianzhu@gmail.com			National Public Benefit Research Sector [200903037]; 973 program [2011CB505002]	National Public Benefit Research Sector; 973 program(National Basic Research Program of China)	This work was supported by a grant from the National Public Benefit Research Sector (No. 200903037) and the 973 program (2011CB505002). We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Baron MD, 1999, J GEN VIROL, V80, P2031, DOI 10.1099/0022-1317-80-8-2031; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Berinstein A, 2000, VACCINE, V18, P2231, DOI 10.1016/S0264-410X(99)00561-7; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHARLTON KM, 1992, ARCH VIROL, V123, P169, DOI 10.1007/BF01317147; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Hu RL, 2007, VACCINE, V25, P5301, DOI 10.1016/j.vaccine.2007.05.024; Hu RL, 2006, MICROBES INFECT, V8, P1090, DOI 10.1016/j.micinf.2005.11.007; JONES L, 1993, VACCINE, V11, P961, DOI 10.1016/0264-410X(93)90386-C; Kwiatek O, 2007, J COMP PATHOL, V136, P111, DOI 10.1016/j.jcpa.2006.12.002; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Liu Y, 2008, VACCINE, V26, P5368, DOI 10.1016/j.vaccine.2008.08.001; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Morrison MD, 2002, VIROLOGY, V293, P26, DOI 10.1006/viro.2001.1262; OIE BB, 2008, MAN DIAGN TESTS VACC; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; QamarulIslam HA, 1996, VET REC, V139, P118; ROEDER PL, 1994, TROP ANIM HEALTH PRO, V26, P69, DOI 10.1007/BF02239901; ROMERO CH, 1995, VACCINE, V13, P36, DOI 10.1016/0264-410X(95)80008-2; Sambrook J., 2006, CONDENSED PROTOCOLS; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; SCHMIDT NJ, 1966, J IMMUNOL, V97, P64; Shou-feng Z, 2002, CHINESE J VET SCI, V06; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; Sinnathamby G, 2001, VACCINE, V19, P4816, DOI 10.1016/S0264-410X(01)00210-9; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; TAYLOR WP, 1990, VET MICROBIOL, V22, P341, DOI 10.1016/0378-1135(90)90021-M; TAYLOR WP, 1979, RES VET SCI, V27, P321, DOI 10.1016/S0034-5288(18)32800-5; Tham KM, 1998, NEW ZEAL VET J, V46, P102, DOI 10.1080/00480169.1998.36068; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817; Xia X, 2000, CHIN J VET MED, V34, P1; Xiao SB, 2004, VACCINE, V22, P345, DOI 10.1016/j.vaccine.2003.08.010; Yang ST, 2008, VACCINE, V26, P1482, DOI 10.1016/j.vaccine.2007.11.073	38	30	30	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37170	10.1371/journal.pone.0037170	http://dx.doi.org/10.1371/journal.pone.0037170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623990	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500069
J	Chen, XJ; Schick, A; Doebeli, M; Blachford, A; Wang, L				Chen, Xiaojie; Schick, Alana; Doebeli, Michael; Blachford, Alistair; Wang, Long			Reputation-Based Conditional Interaction Supports Cooperation in Well-Mixed Prisoner's Dilemmas	PLOS ONE			English	Article							INDIRECT RECIPROCITY; EVOLUTIONARY DYNAMICS; FINITE POPULATIONS; SNOWDRIFT GAME; ALTRUISM; CHROMODYNAMICS; SIMILARITY; STRATEGIES; SELECTION; NETWORKS	In the well-mixed prisoner's dilemma game, individuals are typically assumed to have no choice about whether to interact with other individuals in the population. In this paper, we instead consider reputation-based conditional interaction and its consequences for the evolution of cooperation. Each individual has a tolerance range, and only interacts with other individuals whose reputation lies within its tolerance range in a chosen sample of the population. Reputation contains information about the number of interaction partners an individual has just cooperated with. We find that the introduction of conditional interaction promotes cooperation in well-mixed populations, and there exist moderate tolerance ranges for which this effect is maximized. For a given tolerance range, there is a critical cost-to-benefit ratio below which cooperation can be promoted. Interestingly, we find that if cooperation evolves, different cooperators' interaction clusters are typically maintained in the population, each around a different reputation level. We further investigate some properties of these cooperators' clusters. Moreover, we examine the effects of the sample number on the evolution of cooperation. Our results highlight the importance of the detailed consideration of modes of interaction for the evolution of cooperation in well-mixed populations.	[Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Chen, Xiaojie; Schick, Alana; Doebeli, Michael; Blachford, Alistair] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Doebeli, Michael] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Wang, Long] Peking Univ, Coll Engn, Ctr Syst & Control, Beijing 100871, Peoples R China	International Institute for Applied Systems Analysis (IIASA); University of British Columbia; University of British Columbia; Peking University	Chen, XJ (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria.	chenx@iiasa.ac.at	Gao, Y./GWZ-3665-2022; Wang, Long/A-7798-2010; Blachford, Alistair/C-8833-2012	Wang, Long/0000-0001-5600-8157; 	NSERC (Canada); 973 Program [2012CB821203]; National Natural Science Foundation of China (NSFC) [61020106005, 10972002, 11161011]	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	MD acknowledges the support of NSERC (Canada). LW acknowledges the financial support from 973 Program (2012CB821203) and the National Natural Science Foundation of China (NSFC) (grant nos. 61020106005 and 10972002). This work was additionally supported by the National Natural Science Foundation of China (NSFC) (grant no. 11161011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 2004, EVOLUTION, V58, P1833; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; Fletcher JA, 2006, J EVOLUTION BIOL, V19, P1389, DOI 10.1111/j.1420-9101.2006.01146.x; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Masuda N, 2007, P R SOC B, V274, P689, DOI 10.1098/rspb.2006.3759; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Rand DG, 2009, P NATL ACAD SCI USA, V106, P6187, DOI 10.1073/pnas.0811552106; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; ROBINSON DT, 1992, SOC PSYCHOL QUART, V55, P12, DOI 10.2307/2786683; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Sigmund K, 2009, P NATL ACAD SCI USA, V106, P8405, DOI 10.1073/pnas.0903947106; Sullivan JL, 1999, ANNU REV PSYCHOL, V50, P625, DOI 10.1146/annurev.psych.50.1.625; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Traulsen A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046129; Traulsen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000270; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Woelfing B, 2009, J THEOR BIOL, V257, P689, DOI 10.1016/j.jtbi.2008.12.025; Yamagishi T, 1999, ADV GROUP, V16, P161; Zhang M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011121	60	23	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36260	10.1371/journal.pone.0036260	http://dx.doi.org/10.1371/journal.pone.0036260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615761	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305341200007
J	Grin'kina, NM; Karnabi, EE; Damania, D; Wadgaonkar, S; Muslimov, IA; Wadgaonkar, R				Grin'kina, Natalia M.; Karnabi, Eddy E.; Damania, Dushyant; Wadgaonkar, Sunil; Muslimov, Ilham A.; Wadgaonkar, Raj			Sphingosine Kinase 1 Deficiency Exacerbates LPS-Induced Neuroinflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; LUNG INJURY; FUNCTIONAL-CHARACTERIZATION; THERAPEUTIC TARGETS; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; PROGENITOR CELLS; NEONATAL-RAT	The pathogenesis of inflammation in the central nervous system (CNS), which contributes to numerous neurodegenerative diseases and results in encephalopathy and neuroinflammation, is poorly understood. Sphingolipid metabolism plays a crucial role in maintaining cellular processes in the CNS, and thus mediates the various pathological consequences of inflammation. For a better understanding of the role of sphingosine kinase activation during neuroinflammation, we developed a bacterial lipopolysaccharide (LPS)-induced brain injury model. The onset of the inflammatory response was observed beginning 4 hours after intracerebral injection of LPS into the lateral ventricles of the brain. A comparison of established neuroinflammatory parameters such as white matter rarefactions, development of cytotoxic edema, astrogliosis, loss of oligodendrocytes, and major cytokines levels in wild type and knockout mice suggested that the neuroinflammatory response in SphK1-/- mice was significantly upregulated. At 6 hours after intracerebroventricular injection of LPS in SphK1-/- mice, the immunoreactivity of the microglia markers and astrocyte marker glial fibrillary acidic protein (GFAP) were significantly increased, while the oligodendrocyte marker O4 was decreased compared to WT mice. Furthermore, western blotting data showed increased levels of GFAP. These results suggest that SphK1 activation is involved in the regulation of LPS induced brain injury. Research Highlights: N Lipopolysaccharide (LPS) intracerebral injection induces severe neuroinflammation. . Sphingosine kinase 1 deletion worsens the effect of the LPS. . Overexpression of SphK1 might be a potential new treatment approach to neuroinflammation.	[Grin'kina, Natalia M.; Karnabi, Eddy E.; Damania, Dushyant; Muslimov, Ilham A.; Wadgaonkar, Raj] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Karnabi, Eddy E.; Wadgaonkar, Sunil; Wadgaonkar, Raj] VA Med Ctr, Dept Res & Dev, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Grin'kina, NM (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	raj.wadgaonkar@downstate.edu						Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Arican N, 2006, LIFE SCI, V79, P1, DOI 10.1016/j.lfs.2005.12.035; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brown WR, 2000, ANN NY ACAD SCI, V903, P39, DOI 10.1111/j.1749-6632.2000.tb06348.x; Bryan L, 2008, BBA-MOL CELL BIOL L, V1781, P459, DOI 10.1016/j.bbalip.2008.04.008; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Carpenter S, 2007, CELL MICROBIOL, V9, P1891, DOI 10.1111/j.1462-5822.2007.00965.x; Don AS, 2009, BIOCHEM BIOPH RES CO, V380, P87, DOI 10.1016/j.bbrc.2009.01.075; Eklind S, 2006, PEDIATR RES, V60, P161, DOI 10.1203/01.pdr.0000228323.32445.7d; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; Karnabi E, 2009, BIOCHEM BIOPH RES CO, V384, P409, DOI 10.1016/j.bbrc.2009.04.150; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Lai WQ, 2009, J IMMUNOL, V183, P2097, DOI 10.4049/jimmunol.0804376; Lai WQ, 2008, J IMMUNOL, V181, P8010, DOI 10.4049/jimmunol.181.11.8010; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; McVerry BJ, 2004, AM J RESP CRIT CARE, V170, P987, DOI 10.1164/rccm.200405-684oc; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Melendez AJ, 2008, BBA-PROTEINS PROTEOM, V1784, P66, DOI 10.1016/j.bbapap.2007.07.013; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Miron VE, 2010, AM J PATHOL, V176, P2682, DOI 10.2353/ajpath.2010.091234; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Munoz L, 2009, TARGETING P38 MAPK P; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan Mike, 2008, Pract Neurol, V8, P26, DOI 10.1136/jnnp.2007.139428; Ohama T, 2008, AM J PHYSIOL-GASTR L, V295, pG766, DOI 10.1152/ajpgi.90423.2008; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pang Y, 2000, J NEUROSCI RES, V62, P510, DOI 10.1002/1097-4547(20001115)62:4<510::AID-JNR5>3.3.CO;2-6; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Pfeiffer RF, 2009, NEUROLOGY, V73, P1434, DOI 10.1212/WNL.0b013e3181c2f07d; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spain RI, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-74; Sugama S, 2009, J NEUROIMMUNOL, V207, P24, DOI 10.1016/j.jneuroim.2008.11.007; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Vlasenko LP, 2005, J IMMUNOL, V174, P6456, DOI 10.4049/jimmunol.174.10.6456; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Wu WC, 2004, MOL CELL BIOL, V24, P7359, DOI 10.1128/MCB.24.17.7359-7369.2004; Xiao YC, 2011, BLOOD, V118, P6057, DOI 10.1182/blood-2011-06-359448; Yong VW, 2009, NEURON, V64, P55, DOI 10.1016/j.neuron.2009.09.035; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309	68	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36475	10.1371/journal.pone.0036475	http://dx.doi.org/10.1371/journal.pone.0036475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615770	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200008
J	Jurman, G; Riccadonna, S; Visintainer, R; Furlanello, C				Jurman, Giuseppe; Riccadonna, Samantha; Visintainer, Roberto; Furlanello, Cesare			Algebraic Comparison of Partial Lists in Bioinformatics	PLOS ONE			English	Article							MICROARRAY DATA; GENE SELECTION; RANKED LISTS; CLASSIFICATION; STABILITY; CANCER; INTEGRATION; ALGORITHMS; PREDICTION; SIGNATURES	The outcome of a functional genomics pipeline is usually a partial list of genomic features, ranked by their relevance in modelling biological phenotype in terms of a classification or regression model. Due to resampling protocols or to a metaanalysis comparison, it is often the case that sets of alternative feature lists (possibly of different lengths) are obtained, instead of just one list. Here we introduce a method, based on permutations, for studying the variability between lists ("list stability") in the case of lists of unequal length. We provide algorithms evaluating stability for lists embedded in the full feature set or just limited to the features occurring in the partial lists. The method is demonstrated by finding and comparing gene profiles on a large prostate cancer dataset, consisting of two cohorts of patients from different countries, for a total of 455 samples.	[Jurman, Giuseppe; Riccadonna, Samantha; Visintainer, Roberto; Furlanello, Cesare] Fdn Bruno Kessler, Trento, Italy; [Visintainer, Roberto] Univ Trento, DISI, Trento, Italy	Fondazione Bruno Kessler; University of Trento	Jurman, G (corresponding author), Fdn Bruno Kessler, Trento, Italy.	jurman@fbk.eu	Riccadonna, Samantha/H-7247-2019; Jurman, Giuseppe/GRS-8221-2022	Riccadonna, Samantha/0000-0002-9737-8274; Jurman, Giuseppe/0000-0002-2705-5728; Furlanello, Cesare/0000-0002-5384-3605; Visintainer, Roberto/0000-0003-1289-6871	European Union; Italian Ministry of Health [conv. 42]; Autonomous Province of Trento (PAT) Project ENVIROCHANGE	European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Autonomous Province of Trento (PAT) Project ENVIROCHANGE	The authors acknowledge funding from the European Union FP7 Project HiPerDART, from the Italian Ministry of Health Project ISITAD RF 2007 conv. 42 and from the Autonomous Province of Trento (PAT) Project ENVIROCHANGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov SA, 2004, J SYMB COMPUT, V38, P1303, DOI 10.1016/j.jsc.2003.08.010; Albanese D, 2012, ARXIV12026548P; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bar-Ilan J, 2006, COMPUT NETW, V50, P1448, DOI 10.1016/j.comnet.2005.10.020; Bo TH, 2002, GENOME BIOL, V3; Borda J.-C., 1781, MEMOIRE ELECTIONS SC; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; Bousquet O, 2002, J MACH LEARN RES, V2, P499, DOI 10.1162/153244302760200704; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Cai D, 2008, IEEE T KNOWL DATA EN, V20, P1, DOI 10.1109/TKDE.2007.190669; Calders T, 2007, LECT NOTES ARTIF INT, V4702, P42; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Cheon GS, 2007, J KOREAN MATH SOC, V44, P487, DOI 10.4134/JKMS.2007.44.2.487; Corrada D, 2011, BRIEF BIOINFORM, V12, P588, DOI 10.1093/bib/bbr062; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes C, 2003, P NIPS 03, V16, P169; Critchlow D, 1985, 34 LNS; Desarkar MS, 2011, LECT NOTES COMPUT SC, V6744, P268, DOI 10.1007/978-3-642-21786-9_44; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032200; DIACONIS P, 1977, J ROY STAT SOC B MET, V39, P262, DOI 10.1111/j.2517-6161.1977.tb01624.x; Diaconis P., 1988, GROUP REPRESENTATION, V11; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fagin R, 2003, SIAM J DISCRETE MATH, V17, P134, DOI 10.1137/S0895480102412856; Furlanello C, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-54; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gobbi A, 2008, THESIS U TRENTO; Graham R.L., 1989, CONCRETE MATH FDN CO; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guzzetta G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S3; Hall P., 2008, P COMPUTATIONAL STAT, P433; Hall P, 2012, J AM STAT A IN PRESS; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; HOEFFDING W, 1951, ANN MATH STAT, V22, P558, DOI 10.1214/aoms/1177729545; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jurman G., 2009, CITESEER, P22; Jurman G, 2008, BIOINFORMATICS, V24, P258, DOI 10.1093/bioinformatics/btm550; Kalousis A, 2005, FIFTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P218, DOI 10.1109/ICDM.2005.135; Kauers M., 2006, P ISSAC 06, P177; Kauers M, 2006, DISCRETE MATH, V306, P2073, DOI 10.1016/j.disc.2006.04.005; Kendall M, 1962, GRIFFIN BOOKS STAT; Kossenkov AV, 2011, CLIN CANCER RES, V17, P5867, DOI 10.1158/1078-0432.CCR-11-0737; Krizek P, 2007, LECT NOTES COMPUT SC, V4673, P929; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Lance G. N., 1967, AUST COMPUT J, V1, P15; LANCE GN, 1966, COMPUT J, V9, P60, DOI 10.1093/comjnl/9.1.60; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Lin SL, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1534; Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mukherjee S, 2006, ADV COMPUT MATH, V25, P161, DOI 10.1007/s10444-004-7634-z; Neter J., 1996, APPL LINEAR STAT MOD; Pearson R, 2007, P GENSIP 07 IEEE, P1; Pique-Regi R., 2005, 2005 IEEE Computational Systems Bioinformatics Conference Workshops and Poster Abstracts, P112, DOI 10.1109/CSBW.2005.124; Pique-Regi R., 2006, P ICASSP 06 IEEE, V5, pV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saari D, 2001, CHAOTIC ELECT MATH L; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schimek M. G., 2011, P IASTED INT C COMP, P434, DOI [10.2316/P.2011.742-032, DOI 10.2316/P.2011.742-032]; Schimek MG, 2012, COMMUN STAT-SIMUL C, V41, P1152, DOI 10.1080/03610918.2012.625843; Schneider C., 2004, P ISSAC 04, P282; Schneider C, 2007, J ALGEBRA APPL, V6, P415, DOI 10.1142/S0219498807002302; Schowe B, 2011, STUD COMPUT INTELL, V373, P75; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shi W, 2010, PHARMACOGENOMICS J, V10, P310, DOI 10.1038/tpj.2010.35; Simicc S, 1998, MAT VESNIK, V50, P5; Simon R, 2008, CURR OPIN BIOTECH, V19, P26, DOI 10.1016/j.copbio.2007.10.008; Slawski M, 2012, GENESELECTOR STABILI; SMYTH GK, 2003, STAT APPL GENET MOL, V3; Soneson C, 2012, BIOSTATISTICS, V13, P129, DOI 10.1093/biostatistics/kxr023; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Taylor J, 2005, BIOSTATISTICS, V6, P111, DOI 10.1093/biostatistics/kxh021; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanderlooy S, 2008, MACH LEARN, V72, P247, DOI 10.1007/s10994-008-5070-x; Villarino M, 2004, ARXIVMATHCA0402354; Villarino M, 2006, ARXIVMATHCA0510585; Visintainer R, 2008, THESIS U TRENTO; Wang XS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-391; Witten D, 2007, COMPARISON FOLD CHAN; Xiao Y, 2007, EURASIP J BIOINFORM; Xiao Y, 2008, BIOCONDUCTORS DEDS P; Yang XN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-118; Yao C, 2008, INT CONF BIOMED, P265, DOI 10.1109/BMEI.2008.59; Yu L, 2012, IEEE ACM T COMPUT BI, V9, P262, DOI 10.1109/TCBB.2011.47; Zhang L, 2007, ICNC 2007: THIRD INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 1, PROCEEDINGS, P715	91	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36540	10.1371/journal.pone.0036540	http://dx.doi.org/10.1371/journal.pone.0036540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615778	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200011
J	Kuroda, T; Yasuda, S; Kusakawa, S; Hirata, N; Kanda, Y; Suzuki, K; Takahashi, M; Nishikawa, SI; Kawamata, S; Sato, Y				Kuroda, Takuya; Yasuda, Satoshi; Kusakawa, Shinji; Hirata, Naoya; Kanda, Yasunari; Suzuki, Kazuhiro; Takahashi, Masayo; Nishikawa, Shin-Ichi; Kawamata, Shin; Sato, Yoji			Highly Sensitive In Vitro Methods for Detection of Residual Undifferentiated Cells in Retinal Pigment Epithelial Cells Derived from Human iPS Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TERATOMA FORMATION; HUMAN FIBROBLASTS; DIFFERENTIATION; TUMORIGENICITY; GENERATION; INDUCTION; ANTIGENS; CULTURE; SURFACE	Human induced pluripotent stem cells (hiPSCs) possess the capabilities of self-renewal and differentiation into multiple cell types, and they are free of the ethical problems associated with human embryonic stem cells (hESCs). These characteristics make hiPSCs a promising choice for future regenerative medicine research. There are significant obstacles, however, preventing the clinical use of hiPSCs. One of the most obvious safety issues is the presence of residual undifferentiated cells that have tumorigenic potential. To locate residual undifferentiated cells, in vivo teratoma formation assays have been performed with immunodeficient animals, which is both costly and time-consuming. Here, we examined three in vitro assay methods to detect undifferentiated cells (designated an in vitro tumorigenicity assay): soft agar colony formation assay, flow cytometry assay and quantitative real-time polymerase chain reaction assay (qRT-PCR). Although the soft agar colony formation assay was unable to detect hiPSCs even in the presence of a ROCK inhibitor that permits survival of dissociated hiPSCs/hESCs, the flow cytometry assay using anti-TRA-1-60 antibody detected 0.1% undifferentiated hiPSCs that were spiked in primary retinal pigment epithelial (RPE) cells. Moreover, qRT-PCR with a specific probe and primers was found to detect a trace amount of Lin28 mRNA, which is equivalent to that present in a mixture of a single hiPSC and 5.0 x 10(4) RPE cells. Our findings provide highly sensitive and quantitative in vitro assays essential for facilitating safety profiling of hiPSC-derived products for future regenerative medicine research.	[Kuroda, Takuya; Yasuda, Satoshi; Kusakawa, Shinji; Suzuki, Kazuhiro; Sato, Yoji] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan; [Kuroda, Takuya; Takahashi, Masayo; Nishikawa, Shin-Ichi; Kawamata, Shin] Fdn Biomed Res & Innovat, Kobe, Hyogo, Japan; [Hirata, Naoya; Kanda, Yasunari] Natl Inst Hlth Sci, Div Pharmacol, Tokyo, Japan; [Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Nishikawa, Shin-Ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Res, Kobe, Hyogo, Japan; [Sato, Yoji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Qual Sci, Nagoya, Aichi, Japan	National Institute of Health Sciences - Japan; Institute for Biomedical Research & Innovation (IBRI); National Institute of Health Sciences - Japan; RIKEN; RIKEN; Nagoya City University	Kuroda, T (corresponding author), Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan.	yoji@nihs.go.jp	Kanda, Yasunari/AAD-7514-2019	Kanda, Yasunari/0000-0003-2527-3526; YASUDA, Satoshi/0000-0002-1011-0815; kawamata, shin/0000-0001-5148-1949	Strategic Fund for the Promotion of Science and Technology from Japan Science and Technology Agency; Research Grants from Japanese Ministry of Health, Labour and Welfare [H21-SAISEI-IPPAN-021, H23-SAISEI-IPPAN-004, H23-SAISEI-IPPAN-005, H23-IYAKU-IPPAN-001]; Grants-in-Aid for Scientific Research [23590322, 23791209] Funding Source: KAKEN	Strategic Fund for the Promotion of Science and Technology from Japan Science and Technology Agency; Research Grants from Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Strategic Fund for the Promotion of Science and Technology from Japan Science and Technology Agency, and Research Grants H21-SAISEI-IPPAN-021, H23-SAISEI-IPPAN-004&005 and H23-IYAKU-IPPAN-001 from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; LEVENBOOK IS, 1985, J BIOL STAND, V13, P135, DOI 10.1016/S0092-1157(85)80019-6; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Miller J.C., 2005, ESTADISTICA QUIMIOME, V5th; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Noaksson K, 2005, STEM CELLS, V23, P1460, DOI 10.1634/stemcells.2005-0093; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Pera MF, 2000, J CELL SCI, V113, P5; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Aken EH, 2003, INVEST OPHTH VIS SCI, V44, P463, DOI 10.1167/iovs.01-1096; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	29	100	110	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37342	10.1371/journal.pone.0037342	http://dx.doi.org/10.1371/journal.pone.0037342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615985	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200064
J	Guo, W; Liu, SP; Peng, JL; Wei, XH; Sun, Y; Qiu, YS; Gao, GW; Wang, P; Xu, YH				Guo, Wei; Liu, Shupeng; Peng, Jinliang; Wei, Xiaohui; Sun, Ye; Qiu, Yangsheng; Gao, Guangwei; Wang, Peng; Xu, Yuhong			Examining the Interactome of Huperzine A by Magnetic Biopanning	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; ATTENUATES MITOCHONDRIAL DYSFUNCTION; AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NATURAL-PRODUCTS; KINASE-C; BINDING; TARGET; IDENTIFICATION	Huperzine A is a bioactive compound derived from traditional Chinese medicine plant Qian Ceng Ta (Huperzia serrata), and was found to have multiple neuroprotective effects. In addition to being a potent acetylcholinesterase inhibitor, it was thought to act through other mechanisms such as antioxidation, antiapoptosis, etc. However, the molecular targets involved with these mechanisms were not identified. In this study, we attempted to exam the interactome of Huperzine A using a cDNA phage display library and also mammalian brain tissue extracts. The drugs were chemically linked on the surface of magnetic particles and the interactive phages or proteins were collected and analyzed. Among the various cDNA expressing phages selected, one was identified to encode the mitochondria NADH dehydrogenase subunit 1. Specific bindings between the drug and the target phages and target proteins were confirmed. Another enriched phage clone was identified as mitochondria ATP synthase, which was also panned out from the proteome of mouse brain tissue lysate. These data indicated the possible involvement of mitochondrial respiratory chain matrix enzymes in Huperzine A's pharmacological effects. Such involvement had been suggested by previous studies based on enzyme activity changes. Our data supported the new mechanism. Overall we demonstrated the feasibility of using magnetic biopanning as a simple and viable method for investigating the complex molecular mechanisms of bioactive molecules.	[Guo, Wei; Liu, Shupeng; Wei, Xiaohui; Sun, Ye; Qiu, Yangsheng; Gao, Guangwei; Wang, Peng] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Liu, Shupeng] Shanghai Univ, Inst Biomed Engn, Shanghai, Peoples R China; [Peng, Jinliang; Xu, Yuhong] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai University; Shanghai Jiao Tong University	Guo, W (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	yhxu@sjtu.edu.cn			Natural Science Foundation of China [30825045]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China no. 30825045 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarcrona M, 2005, INT J GERIATR PSYCH, V20, P101, DOI 10.1002/gps.1260; Berger G, 2003, J CHROMATOGR B, V797, P51, DOI 10.1016/S1570-0232(03)00482-3; Busch MHA, 1997, J CHROMATOGR A, V777, P311, DOI 10.1016/S0021-9673(97)00369-5; Butcher RA, 2005, CURR OPIN CHEM BIOL, V9, P25, DOI 10.1016/j.cbpa.2004.10.009; Cheng DH, 1996, NEUROREPORT, V8, P97, DOI 10.1097/00001756-199612200-00020; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Fimognari C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021544; Gao X, 2006, J NEUROSCI RES, V83, P1048, DOI 10.1002/jnr.20791; Gao X, 2009, FREE RADICAL BIO MED, V46, P1454, DOI 10.1016/j.freeradbiomed.2009.02.028; Gnanasekar M, 2009, INT J MOL MED, V24, P421, DOI 10.3892/ijmm_00000248; Guo W, 2011, BIOORG MED CHEM LETT, V21, P7175, DOI 10.1016/j.bmcl.2011.09.070; Hemendinger RA, 2008, NEUROTOX RES, V13, P49, DOI 10.1007/BF03033367; Hsieh HV, 2004, BIOSENS BIOELECTRON, V19, P653, DOI 10.1016/S0956-5663(03)00271-9; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Liu SP, 2006, COLLOID SURFACE B, V51, P101, DOI 10.1016/j.colsurfb.2006.05.023; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Luesch H, 2005, CHEM BIOL, V12, P55, DOI 10.1016/j.chembiol.2004.10.015; Maekawa N, 2011, BIOMED CHROMATOGR, V25, P466, DOI 10.1002/bmc.1469; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Nakamura Y, 2008, ANGEW CHEM INT EDIT, V47, P7289, DOI 10.1002/anie.200801820; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Ostergaard J, 2003, ELECTROPHORESIS, V24, P2903, DOI 10.1002/elps.200305526; PANG YP, 1994, J COMPUT AID MOL DES, V8, P669, DOI 10.1007/BF00124014; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Peng Y, 2007, NEUROSCIENCE, V150, P386, DOI 10.1016/j.neuroscience.2007.09.022; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Sato S, 2007, J AM CHEM SOC, V129, P873, DOI 10.1021/ja0655643; SAXENA A, 1994, PROTEIN SCI, V3, P1770, DOI 10.1002/pro.5560031017; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Tang LL, 2005, EUR J PHARMACOL, V519, P9, DOI 10.1016/j.ejphar.2005.06.026; Van Dorst B, 2011, TOXICOL IN VITRO, V25, P388, DOI 10.1016/j.tiv.2010.10.012; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; von Rechenberg M, 2005, PROTEOMICS, V5, P1764, DOI 10.1002/pmic.200301088; Wang GL, 2007, P NATL ACAD SCI USA, V104, P2068, DOI 10.1073/pnas.0610832104; Wang LS, 2002, BRAIN RES, V949, P162, DOI 10.1016/S0006-8993(02)02977-3; Wang R, 2005, NEUROSIGNALS, V14, P71, DOI 10.1159/000085387; Wang R, 2001, NEUROREPORT, V12, P2629, DOI 10.1097/00001756-200108280-00009; Wang R, 2001, EUR J PHARMACOL, V421, P149, DOI 10.1016/S0014-2999(01)01030-5; Wang XD, 2001, GENE DEV, V15, P2922; Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x; Xiao XQ, 2000, NEUROSCI LETT, V286, P155, DOI 10.1016/S0304-3940(00)01088-0; Yan J, 2009, BIOORGAN MED CHEM, V17, P6937, DOI 10.1016/j.bmc.2009.08.017; Yang L, 2010, PLOS ONE, V5, pA71, DOI 10.1371/journal.pone.0009568; Zhang HY, 2004, NEUROSCI LETT, V360, P21, DOI 10.1016/j.neulet.2004.01.055; Zheng CY, 2008, J NEUROSCI RES, V86, P2432, DOI 10.1002/jnr.21681	53	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37098	10.1371/journal.pone.0037098	http://dx.doi.org/10.1371/journal.pone.0037098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615909	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300070
J	Sako, K; Maki, Y; Kanai, T; Kato, E; Maekawa, S; Yasuda, S; Sato, T; Watahiki, MK; Yamaguchi, J				Sako, Kaori; Maki, Yuko; Kanai, Tomoyuki; Kato, Eriko; Maekawa, Shugo; Yasuda, Shigetaka; Sato, Takeo; Watahiki, Masaaki K.; Yamaguchi, Junji			Arabidopsis RPT2a, 19S Proteasome Subunit, Regulates Gene Silencing via DNA Methylation	PLOS ONE			English	Article							SUBSTRATE ENTRY; 20S PROTEASOME; HISTONE H3; GENOME; DEMETHYLATION; METHYLTRANSFERASES; GLYCOSYLASE/LYASE; RESOLUTION; THALIANA; PATTERNS	The ubiquitin/proteasome pathway plays a crucial role in many biological processes. Here we report a novel role for the Arabidopsis 19S proteasome subunit RPT2a in regulating gene activity at the transcriptional level via DNA methylation. Knockout mutation of the RPT2a gene did not alter global protein levels; however, the transcriptional activities of reporter transgenes were severely reduced compared to those in the wild type. This transcriptional gene silencing (TGS) was observed for transgenes under control of either the constitutive CaMV 35S promoter or the cold-inducible RD29A promoter. Bisulfite sequencing analysis revealed that both the transgene and endogenous RD29A promoter regions were hypermethylated at CG and non-CG contexts in the rpt2a mutant. Moreover, the TGS of transgenes driven by the CaMV 35S promoters was released by treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine, but not by application of the inhibitor of histone deacetylase Trichostatin A. Genetic crosses with the DNA methyltransferase met1 single or drm1drm2cmt3 triple mutants also resulted in a release of CaMV 35S transgene TGS in the rpt2a mutant background. Increased methylation was also found at transposon sequences, suggesting that the 19S proteasome containing AtRPT2a negatively regulates TGS at transgenes and at specific endogenous genes through DNA methylation.	[Sako, Kaori] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sako, K (corresponding author), Hokkaido Univ, Fac Sci, Sapporo, Hokkaido, Japan.	jjyama@sci.hokudai.ac.jp	Sako, Kaori/O-2952-2014; Yamaguchi, Junji/A-4339-2012; Sato, Takeo/J-5332-2012; Yamaguchi, Junji/AAG-9118-2021	Sako, Kaori/0000-0003-0868-6206; Maekawa, Shugo/0000-0002-6021-505X; Yasuda, Shigetaka/0000-0002-4602-6404	Ministry of Education, Culture, Sports, Science and Technology in Japan [2211450100, 23380198]; Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists; Otsuka Award; Grants-in-Aid for Scientific Research [23380198] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists; Otsuka Award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 2211450100 and 23380198 from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Akira Kanazawa for the bisulfite sequencing analysis. We are also grateful to Dr. Derek B. Goto (Hokkaido University) for critical reading of the manuscript. K. S. acknowledges Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (2008-2010) and also support by Otsuka Award (2011).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kanazawa A, 2007, PLANT BIOLOGY, V9, P435, DOI 10.1055/s-2006-924633; Kanazawa A, 2007, PLANT CELL PHYSIOL, V48, P638, DOI 10.1093/pcp/pcm028; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koues OI, 2009, BBA-GENE REGUL MECH, V1789, P691, DOI 10.1016/j.bbagrm.2009.07.006; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sonoda Y, 2009, PLANT J, V60, P68, DOI 10.1111/j.1365-313X.2009.03932.x; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zheng XW, 2008, NATURE, V455, P1259, DOI 10.1038/nature07305; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	32	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37086	10.1371/journal.pone.0037086	http://dx.doi.org/10.1371/journal.pone.0037086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615900	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300067
J	Donelson, N; Kim, EZ; Slawson, JB; Vecsey, CG; Huber, R; Griffith, LC				Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Huber, Robert; Griffith, Leslie C.			High-Resolution Positional Tracking for Long-Term Analysis of Drosophila Sleep and Locomotion Using the "Tracker'' Program	PLOS ONE			English	Article							AROUSAL; BEHAVIOR; GENES	Drosophila melanogaster has been used for decades in the study of circadian behavior, and more recently has become a popular model for the study of sleep. The classic method for monitoring fly activity involves counting the number of infrared beam crosses in individual small glass tubes. Incident recording methods such as this can measure gross locomotor activity, but they are unable to provide details about where the fly is located in space and do not detect small movements (i.e. anything less than half the enclosure size), which could lead to an overestimation of sleep and an inaccurate report of the behavior of the fly. This is especially problematic if the fly is awake, but is not moving distances that span the enclosure. Similarly, locomotor deficiencies could be incorrectly classified as sleep phenotypes. To address these issues, we have developed a locomotor tracking technique (the "Tracker'' program) that records the exact location of a fly in real time. This allows for the detection of very small movements at any location within the tube. In addition to circadian locomotor activity, we are able to collect other information, such as distance, speed, food proximity, place preference, and multiple additional parameters that relate to sleep structure. Direct comparisons of incident recording and our motion tracking application using wild type and locomotor-deficient (CASK-beta null) flies show that the increased temporal resolution in the data from the Tracker program can greatly affect the interpretation of the state of the fly. This is especially evident when a particular condition or genotype has strong effects on the behavior, and can provide a wealth of information previously unavailable to the investigator. The interaction of sleep with other behaviors can also be assessed directly in many cases with this method.	[Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; [Donelson, Nathan; Kim, Eugene Z.; Slawson, Justin B.; Vecsey, Christopher G.; Griffith, Leslie C.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA; [Huber, Robert] Bowling Green State Univ, Dept Biol Sci, JP Scott Ctr Neurosci Mind & Behav, Bowling Green, OH 43403 USA	Brandeis University; Brandeis University; University System of Ohio; Bowling Green State University	Donelson, N (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	griffith@brandeis.edu	Vecsey, Christopher/AAP-6002-2020	Huber, Robert/0000-0001-6122-9210; Griffith, Leslie/0000-0003-3164-9876	National Institutes of Health [MH067284, F32 MH090711, F31 NS064679, T32 NS007292]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, F31NS064679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health R01 grant MH067284 (to LCG), post-doctoral fellowship F32 MH090711 (to CGV), predoctoral fellowship F31 NS064679 (to JBS) and post-doctoral training grant T32 NS007292 (ND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bhatt MH, 2005, SEMIN NEUROL, V25, P39, DOI 10.1055/s-2005-867072; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Levine JD, 2002, BMC NEUROSCIENCE, V3; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sandrelli F, 2008, INSECT MOL BIOL, V17, P447, DOI 10.1111/j.1365-2583.2008.00832.x; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Slawson JB, 2011, GENETICS, V187, P171, DOI 10.1534/genetics.110.123406; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; van Swinderen B, 2003, BEHAV PROCESS, V64, P133, DOI 10.1016/S0376-6357(03)00131-1; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587	29	117	117	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37250	10.1371/journal.pone.0037250	http://dx.doi.org/10.1371/journal.pone.0037250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615954	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300085
J	Gentschev, I; Adelfinger, M; Josupeit, R; Rudolph, S; Ehrig, K; Donat, U; Weibel, S; Chen, NHG; Yu, YA; Zhang, Q; Heisig, M; Thamm, D; Stritzker, J; MacNeill, A; Szalay, AA				Gentschev, Ivaylo; Adelfinger, Marion; Josupeit, Rafael; Rudolph, Stephan; Ehrig, Klaas; Donat, Ulrike; Weibel, Stephanie; Chen, Nanhai G.; Yu, Yong A.; Zhang, Qian; Heisig, Martin; Thamm, Douglas; Stritzker, Jochen; MacNeill, Amy; Szalay, Aladar A.			Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma	PLOS ONE			English	Article							BREAST-TUMORS; NUDE-MICE; IN-VITRO; CANCER; VIROTHERAPY; GLV-1H68; NEUTROPHILS; REGRESSION; EFFICACY	Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for canine cancer therapy. In this study we describe the establishment of an in vivo model of canine soft tissue sarcoma (CSTS) using the new isolated cell line STSA-1 and the analysis of the virus-mediated oncolytic and immunological effects of two different Lister VACV LIVP1.1.1 and GLV-1h68 strains against CSTS. Cell culture data demonstrated that both tested VACV strains efficiently infected and destroyed cells of the canine soft tissue sarcoma line STSA-1. In addition, in our new canine sarcoma tumor xenograft mouse model, systemic administration of LIVP1.1.1 or GLV-1h68 viruses led to significant inhibition of tumor growth compared to control mice. Furthermore, LIVP1.1.1 mediated therapy resulted in almost complete tumor regression and resulted in long-term survival of sarcoma-bearing mice. The replication of the tested VACV strains in tumor tissues led to strong oncolytic effects accompanied by an intense intratumoral infiltration of host immune cells, mainly neutrophils. These findings suggest that the direct viral oncolysis of tumor cells and the virus-dependent activation of tumor-associated host immune cells could be crucial parts of anti-tumor mechanism in STSA-1 xenografts. In summary, the data showed that both tested vaccinia virus strains and especially LIVP1.1.1 have great potential for effective treatment of CSTS.	[Gentschev, Ivaylo; Ehrig, Klaas; Chen, Nanhai G.; Yu, Yong A.; Zhang, Qian; Stritzker, Jochen; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Gentschev, Ivaylo; Adelfinger, Marion; Josupeit, Rafael; Rudolph, Stephan; Ehrig, Klaas; Donat, Ulrike; Weibel, Stephanie; Stritzker, Jochen; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Chen, Nanhai G.; Yu, Yong A.; Zhang, Qian; Szalay, Aladar A.] Univ Calif San Diego, Moores Canc Ctr, Dept Radiat Oncol, La Jolla, CA 92093 USA; [Heisig, Martin] Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch MSZ, Wurzburg, Germany; [Thamm, Douglas] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [MacNeill, Amy] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign	Gentschev, I (corresponding author), Genelux Corp, San Diego Sci Ctr, San Diego, CA USA.	aaszalay@genelux.com	Thamm, Douglas H/I-5976-2013; Gentschev, Ivaylo/AAJ-5819-2021; Thamm, Douglas/AAG-3672-2020; MacNeill, Amy L./D-6066-2017; Gentschev, Ivaylo/F-9454-2011; Fiumefreddo, Andrea/T-2977-2019	Thamm, Douglas H/0000-0002-8914-7767; MacNeill, Amy L./0000-0002-1690-3787; Gentschev, Ivaylo/0000-0003-3743-6329; 	Research and Development Division of Genelux Corporation, San Diego, USA; University of Wurzburg, Germany; Genelux Corp., San Diego, USA; American Kennel Club Canine Health Foundation [01502-A]; Genelux Corporation	Research and Development Division of Genelux Corporation, San Diego, USA; University of Wurzburg, Germany; Genelux Corp., San Diego, USA; American Kennel Club Canine Health Foundation; Genelux Corporation	The research was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corp., San Diego, USA. This work also was supported in part by the American Kennel Club Canine Health Foundation (grant 01502-A). Individual employees of Genelux participated in the study as outlined in the Contributions section. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: IG QZ YAY NGC JS and AAS are employees and shareholders of Genelux Corporation. MA, KE and SW were supported by grants of Genelux Corporation. Sequences of the two Lister Vaccinia virus strains (LIVP1.1.1 and LIVP5.1.1.) tested in this study are subject of the patent application 'Clonal strains of attenuated vaccinia viruses and methods of use thereof (U.S. Application No. 61/517,297)'. There are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors (http://www.plosone.org/static/policies.action#sharing). The authors do not have any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products, etc. The title and the permit number for the patent are: 'Clonal strains of attenuated vaccinia viruses and methods of use thereof (U.S. Application No. 61/517,297)'.	Arendt M, 2009, VET COMP ONCOL, V7, P153, DOI 10.1111/j.1476-5829.2009.00187.x; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Chen NHG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-164; Dennis MM, 2011, VET PATHOL, V48, P73, DOI 10.1177/0300985810388820; Dobson JM, 2002, J SMALL ANIM PRACT, V43, P240, DOI 10.1111/j.1748-5827.2002.tb00066.x; Dorn R. C., 1976, Journal of the American Animal Hospital Association, V12, P307; Forrest LJ, 2000, J VET INTERN MED, V14, P578, DOI 10.1892/0891-6640(2000)014&lt;0578:PRFCST&gt;2.3.CO;2; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hemminki A, 2003, MOL THER, V7, P163, DOI 10.1016/S1525-0016(02)00049-7; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Kelly KJ, 2009, INT J CANCER, V124, P911, DOI 10.1002/ijc.24037; Kuntz CA, 1997, J AM VET MED ASSOC, V211, P1147; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Liptak J.M., 2007, SMALL ANIMAL CLIN ON, V4th ed., P425; McKnight JA, 2000, J AM VET MED ASSOC, V217, P205, DOI 10.2460/javma.2000.217.205; McSporran KD, 2009, VET PATHOL, V46, P928, DOI 10.1354/vp.08-VP-0277-M-FL; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; O'Donoghue LE, 2011, J VET DIAGN INVEST, V23, P780, DOI 10.1177/1040638711408064; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Seubert CM, 2011, CANCER GENE THER, V18, P42, DOI 10.1038/cgt.2010.49; Snyder SA, 2011, VET PATHOL, V48, P482, DOI 10.1177/0300985810383871; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Theilen GHMB, 1979, TUMORS SKIN SUBCUTAN; THRALL DE, 1995, SEMIN VET MED SURG, V10, P173; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Yu ZJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-45; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	40	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37239	10.1371/journal.pone.0037239	http://dx.doi.org/10.1371/journal.pone.0037239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615950	Green Published, gold			2022-12-27	WOS:000305336300082
J	McKenna, CC; Munjaal, RP; Lwigale, PY				McKenna, Chelsey C.; Munjaal, Ravi P.; Lwigale, Peter Y.			Distinct Roles for Neuropilin1 and Neuropilin2 during Mouse Corneal Innervation	PLOS ONE			English	Article							PERIPHERAL-NERVE PROJECTION; NEURAL CREST MIGRATION; TRIGEMINAL GANGLION; AXON GUIDANCE; SECRETED SEMAPHORINS; SYMPATHETIC INNERVATION; SENSORY NERVES; IN-VIVO; RECEPTORS; EXPRESSION	Trigeminal sensory innervation of the cornea is critical for protection and synthesis of neuropeptides required for normal vision. Little is known about axon guidance during mammalian corneal innervation. In contrast to the chick where a pericorneal nerve ring forms via Npn/Sema signaling, mouse corneal axons project directly into the presumptive cornea without initial formation of an analogous nerve ring. Here we show that during development of the mouse cornea, Npn1 is strongly expressed by the trigeminal ganglion whereas Npn2 is expressed at low levels. At the same time Sema3A and Sema3F are expressed in distinct patterns in the ocular tissues. Npn1(sema-/-) mutant corneas become precociously and aberrantly innervated by nerve bundles that project further into the corneal stroma. In contrast, stromal innervation was not affected in Npn2(-/-) mutants. The corneal epithelium was prematurely innervated in both Npn1(sema-/-) and Npn2(-/-) mutants. These defects were exacerbated in Npn1(sema-/-); Npn2(-/-) double mutants, which in addition showed ectopic innervation of the region between the optic cup and lens vesicle. Collectively, our data show that Sema3A/Npn1 and Sema3F/Npn2 signaling play distinct roles and both are required for proper innervation of the mouse cornea.	[McKenna, Chelsey C.; Munjaal, Ravi P.; Lwigale, Peter Y.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University	McKenna, CC (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	lwigale@rice.edu	Lwigale, Peter/AAV-2563-2020	Lwigale, Peter/0000-0003-1799-4905; McKenna, Chelsey/0000-0003-1444-5273	National Institutes of Health [EY018050]; NATIONAL EYE INSTITUTE [R00EY018050, K99EY018050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grant EY018050. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ARVIDSON B, 1977, ACTA NEUROPATHOL, V38, P49, DOI 10.1007/BF00691276; BEE JA, 1982, DEV BIOL, V92, P5, DOI 10.1016/0012-1606(82)90145-2; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chilton JK, 2003, DEV DYNAM, V228, P726, DOI 10.1002/dvdy.10396; Conrad AH, 2008, INVEST OPHTH VIS SCI, V49, P139, DOI 10.1167/iovs.07-0800; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fujisawa H, 1998, CURR OPIN NEUROBIOL, V8, P587, DOI 10.1016/S0959-4388(98)80085-8; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; JONES MA, 1991, J COMP NEUROL, V313, P132, DOI 10.1002/cne.903130110; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kubilus JK, 2010, DEV BIOL, V344, P172, DOI 10.1016/j.ydbio.2010.04.032; Lwigale PY, 2007, DEV BIOL, V306, P750, DOI 10.1016/j.ydbio.2007.04.012; Lwigale PY, 2001, DEV BIOL, V239, P323, DOI 10.1006/dbio.2001.0450; Lwigale PY, 2009, DEV BIOL; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; MARFURT CF, 1988, J COMP NEUROL, V272, P370, DOI 10.1002/cne.902720307; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; McKenna CC, 2011, INVEST OPHTH VIS SCI, V52, P30, DOI 10.1167/iovs.10-5902; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Melendez-Herrera E, 2006, BRAIN RES, V1067, P126, DOI 10.1016/j.brainres.2005.10.028; MORGAN C, 1987, J AUTONOM NERV SYST, V20, P179, DOI 10.1016/0165-1838(87)90115-9; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rochlin MW, 1998, J NEUROSCI, V18, P6840; Sahay A, 2003, J NEUROSCI, V23, P6671; Schwarz Q, 2008, DEVELOPMENT, V135, P1605, DOI 10.1242/dev.015412; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tanelian DL, 1997, NAT MED, V3, P1398, DOI 10.1038/nm1297-1398; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; WHITEAR M, 1960, J ANAT, V94, P387; ZANDER E, 1951, J ANAT, V85, P68	44	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37175	10.1371/journal.pone.0037175	http://dx.doi.org/10.1371/journal.pone.0037175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615927	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300077
J	Pauwels, K; del Pino, MMS; Feller, G; Van Gelder, P				Pauwels, Kris; Sanchez del Pino, Manuel M.; Feller, Georges; Van Gelder, Patrick			Decoding the Folding of Burkholderia glumae Lipase: Folding Intermediates En Route to Kinetic Stability	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; LIMITED PROTEOLYTIC SITES; MOLTEN GLOBULE STATE; STERIC CHAPERONE; PSEUDOMONAS-GLUMAE; PROTEASE; DENATURATION; SECRETION; SUBSTRATE; PROTEINS	The lipase produced by Burkholderia glumae folds spontaneously into an inactive near-native state and requires a periplasmic chaperone to reach its final active and secretion-competent fold. The B. glumae lipase-specific foldase (Lif) is classified as a member of the steric-chaperone family of which the propeptides of alpha-lytic protease and subtilisin are the best known representatives. Steric chaperones play a key role in conferring kinetic stability to proteins. However, until present there was no solid experimental evidence that Lif-dependent lipases are kinetically trapped enzymes. By combining thermal denaturation studies with proteolytic resistance experiments and the description of distinct folding intermediates, we demonstrate that the native lipase has a kinetically stable conformation. We show that a newly discovered molten globule-like conformation has distinct properties that clearly differ from those of the near-native intermediate state. The folding fingerprint of Lif-dependent lipases is put in the context of the protease-prodomain system and the comparison reveals clear differences that render the lipase-Lif systems unique. Limited proteolysis unveils structural differences between the near-native intermediate and the native conformation and sets the stage to shed light onto the nature of the kinetic barrier.	[Pauwels, Kris; Van Gelder, Patrick] VIB, Dept Biol Struct, Brussels, Belgium; [Pauwels, Kris; Van Gelder, Patrick] Vrije Univ Brussel, Brussels, Belgium; [Pauwels, Kris] Natl Inst Med Res, Mol Struct Div, London NW7 1AA, England; [Sanchez del Pino, Manuel M.] Ctr Invest Principe Felipe, Lab Proteo, Valencia, Spain; [Feller, Georges] Univ Liege, Biochem Lab, Ctr Prot Engn, Liege, Belgium; [Van Gelder, Patrick] Univ Ghent, Unit Struct Biol, L ProBE, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; MRC National Institute for Medical Research; Prince Felipe Research Center; University of Liege; Ghent University	Pauwels, K (corresponding author), VIB, Dept Biol Struct, Brussels, Belgium.	krpauwel@vib-vub.be	del Pino, Manuel M. Sánchez/I-3977-2015	del Pino, Manuel M. Sánchez/0000-0001-9696-7600; Van Gelder, Patrick/0000-0003-1785-4435; Pauwels, Kris/0000-0002-7341-0890	European Commission [QLRT-2001-02086]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen); EMBO long-term postdoctoral fellowship [ALTF 512-2008]	European Commission(European CommissionEuropean Commission Joint Research Centre); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO))	This research was sponsored by the European Commission-FP5 (QLRT-2001-02086). KP was the recipient of a PhD fellowship of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen) and an EMBO long-term postdoctoral fellowship (ALTF 512-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Cunningham EL, 1999, P NATL ACAD SCI USA, V96, P11008, DOI 10.1073/pnas.96.20.11008; D'Amico S, 2009, ANAL BIOCHEM, V385, P389, DOI 10.1016/j.ab.2008.11.016; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Drepper Thomas, 2006, Biotechnology Journal, V1, P777, DOI 10.1002/biot.200600059; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; El Khattabi M, 2003, J MOL CATAL B-ENZYM, V22, P329, DOI 10.1016/S1381-1177(03)00047-X; El Khattabi M, 2000, J BIOL CHEM, V275, P26885; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x; FRENKEN LGJ, 1992, APPL ENVIRON MICROB, V58, P3787, DOI 10.1128/AEM.58.12.3787-3791.1992; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Kuwajima K, 2000, MECH PROTEIN FOLDING, P212; LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023; NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q; Pauwels K, 2006, NAT STRUCT MOL BIOL, V13, P374, DOI 10.1038/nsmb1065; Pauwels K, 2005, ACTA CRYSTALLOGR F, V61, P791, DOI 10.1107/S1744309105023055; Pauwels K, 2008, PROTEIN EXPRES PURIF, V59, P342, DOI 10.1016/j.pep.2008.03.003; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Ptitsyn Oleg B., 1992, P243; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P1648, DOI 10.1021/bi00405a039; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Uversky VN, 1996, BIOPHYS CHEM, V60, P79, DOI 10.1016/0301-4622(96)00009-9	34	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36999	10.1371/journal.pone.0036999	http://dx.doi.org/10.1371/journal.pone.0036999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615867	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300059
J	Wu, ST; Li, RW; Li, WZ; Li, CJ				Wu, Sitao; Li, Robert W.; Li, Weizhong; Li, Cong-Jun			Transcriptome Characterization by RNA-seq Unravels the Mechanisms of Butyrate-Induced Epigenomic Regulation in Bovine Cells	PLOS ONE			English	Article							REPRESSIVE COMPLEX 2; EPITHELIAL-CELLS; SODIUM-BUTYRATE; GENE-EXPRESSION; CHROMATIN; APOPTOSIS; PATHWAY; BINDING; METHYLATION; INHIBITORS	Short-chain fatty acids (SCFAs), especially butyrate, affect cell differentiation, proliferation, and motility. Butyrate also induces cell cycle arrest and apoptosis through its inhibition of histone deacetylases (HDACs). In addition, butyrate is a potent inducer of histone hyper-acetylation in cells. Therefore, this SCFA provides an excellent in vitro model for studying the epigenomic regulation of gene expression induced by histone acetylation. In this study, we analyzed the differential in vitro expression of genes induced by butyrate in bovine epithelial cells by using deep RNA-sequencing technology (RNA-seq). The number of sequences read, ranging from 57,303,693 to 78,933,744, were generated per sample. Approximately 11,408 genes were significantly impacted by butyrate, with a false discovery rate (FDR) <0.05. The predominant cellular processes affected by butyrate included cell morphological changes, cell cycle arrest, and apoptosis. Our results provided insight into the transcriptome alterations induced by butyrate, which will undoubtedly facilitate our understanding of the molecular mechanisms underlying butyrate-induced epigenomic regulation in bovine cells.	[Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA; [Li, Robert W.; Li, Cong-Jun] USDA ARS, Bovine Funct Genom Lab, Beltsville, MD USA	University of California System; University of California San Diego; United States Department of Agriculture (USDA)	Wu, ST (corresponding author), Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA.	congjun.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Li, Weizhong/A-9735-2008	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403	National Human Genome Research Institute (NHGRI) [R01HG005978]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL were partly supported by Award R01HG005978 to WL from the National Human Genome Research Institute (NHGRI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Ajamian F, 2004, NEUROSCI LETT, V365, P64, DOI 10.1016/j.neulet.2004.04.087; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baldwin RL, 1999, SMALL RUMINANT RES, V32, P261, DOI 10.1016/S0921-4488(98)00188-6; Berger SP, 2007, NATURE, V449, P972, DOI 10.1038/449972a; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Hu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016221; Jones A, 2010, PROTEIN CELL, V1, P1056, DOI 10.1007/s13238-010-0142-7; Joseph J, 2005, INT J CANCER, V115, P11, DOI 10.1002/ijc.20842; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li CJ, 2005, J ANIM SCI, V83, P89; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Li CJ, 2000, J CELL SCI, V113, P887; Li CJ, 2002, MOL CELL BIOL, V22, P105, DOI 10.1128/MCB.22.1.105-116.2002; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi SL, 2006, WORLD J GASTROENTERO, V12, P1694, DOI 10.3748/wjg.v12.i11.1694; Shin JH, 2012, FUNCT INTEGR GENOMIC, V12, P119, DOI 10.1007/s10142-012-0263-6; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	48	33	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36940	10.1371/journal.pone.0036940	http://dx.doi.org/10.1371/journal.pone.0036940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615851	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300051
J	Inubushi, T; Iijima, K; Koizumi, M; Sakai, KL				Inubushi, Tomoo; Iijima, Kazuki; Koizumi, Masatoshi; Sakai, Kuniyoshi L.			Left Inferior Frontal Activations Depending on the Canonicity Determined by the Argument Structures of Ditransitive Sentences: An MEG Study	PLOS ONE			English	Article							BROCAS AREA; LANGUAGE; FMRI; COMPREHENSION; INFORMATION; EEG	To elucidate the relationships between syntactic and semantic processes, one interesting question is how syntactic structures are constructed by the argument structure of a verb, where each argument corresponds to a semantic role of each noun phrase (NP). Here we examined the effects of possessivity [sentences with or without a possessor] and canonicity [canonical or noncanonical word orders] using Japanese ditransitive sentences. During a syntactic decision task, the syntactic structure of each sentence would be constructed in an incremental manner based on the predicted argument structure of the ditransitive verb in a verb-final construction. Using magnetoencephalography, we found a significant canonicity effect on the current density in the left inferior frontal gyrus (IFG) at 530-550 ms after the verb onset. This effect was selective to canonical sentences, and significant even when the precedent NP was physically identical. We suggest that the predictive effects associated with syntactic processing became larger for canonical sentences, where the NPs and verb were merged with a minimum structural distance, leading to the left IFG activations. For monotransitive and intransitive verbs, in which structural computation of the sentences was simpler than that of ditransitive sentences, we observed a significant effect selective to noncanonical sentences in the temporoparietal regions during 480-670 ms. This effect probably reflects difficulty in semantic processing of noncanonical sentences. These results demonstrate that the left IFG plays a predictive role in syntactic processing, which depends on the canonicity determined by argument structures, whereas other temporoparietal regions would subserve more semantic aspects of sentence processing.	[Inubushi, Tomoo; Iijima, Kazuki; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan; [Inubushi, Tomoo; Iijima, Kazuki; Sakai, Kuniyoshi L.] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Inubushi, Tomoo; Iijima, Kazuki] Japan Soc Promot Sci, Kawaguchi, Saitama, Japan; [Koizumi, Masatoshi] Tohoku Univ, Dept Linguist, Aoba Ku, Sendai, Miyagi 980, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Society for the Promotion of Science; Tohoku University	Inubushi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp	Koizumi, Masatoshi/GNW-4181-2022; Iijima, Kazuki/S-2552-2017	Koizumi, Masatoshi/0000-0003-0719-7128; Iijima, Kazuki/0000-0001-9572-0980	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan [20220005, 22222001];  [22.10126]	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Scientific Research (S) (Nos. 20220005 and 22222001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (No. 22.10126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlmann J, 2007, HUM BRAIN MAPP, V28, P940, DOI 10.1002/hbm.20318; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Ben-Shachar M, 2004, NEUROIMAGE, V21, P1320, DOI 10.1016/j.neuroimage.2003.11.027; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Bresnan J, 2010, LANGUAGE, V86, P168; Bruening B, 2010, LINGUIST INQ, V41, P519, DOI 10.1162/LING_a_00012; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky N, 2011, LANG LEARN DEV, V7, P263, DOI 10.1080/15475441.2011.584041; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Comrie B., 1989, LANGUAGE UNIVERSALS, V2nd; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; FRAZIER L, 1989, J MEM LANG, V28, P331, DOI 10.1016/0749-596X(89)90037-5; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; FUKUI N, 1993, LINGUIST INQ, V24, P399; Green Georgia M., 1974, SEMANTICS SYNTACTIC; Grewe T, 2006, NEUROIMAGE, V32, P1395, DOI 10.1016/j.neuroimage.2006.04.213; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hoji H, 1986, ISSUES JAPANESE LING, P163; Hovav MR, 2008, J LINGUIST, V44, P129, DOI 10.1017/S0022226707004975; Iijima K, 2009, NEUROIMAGE, V44, P1387, DOI 10.1016/j.neuroimage.2008.10.041; Jaeggli Osvaldo, 1981, TOPICS ROMANCE SYNTA; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Karniski Walt, 1994, Brain Topography, V6, P203, DOI 10.1007/BF01187710; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kinno R, 2009, BRAIN LANG, V110, P71, DOI 10.1016/j.bandl.2009.05.001; Kishimoto H, 2008, J EAST ASIAN LINGUIS, V17, P141, DOI 10.1007/s10831-008-9023-y; Koizumi M, 2010, LINGUIST INQ, V41, P663, DOI 10.1162/LING_a_00016; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; LARSON RK, 1988, LINGUIST INQ, V19, P335; Marantz Alec., 1993, THEORETICAL ASPECTS, P113; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Miyagawa S, 2004, J EAST ASIAN LINGUIS, V13, P1, DOI 10.1023/B:JEAL.0000007345.64336.84; Nakamoto K., 2006, COGNITIVE STUDIES, V13, P334; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Pinker Steven., 1991, LEARNABILITY COGNITI; Radford A., 1997, SYNTACTIC THEORY STR; Ralph MAL, 2009, CEREB CORTEX, V19, P832, DOI 10.1093/cercor/bhn131; SADAKANE K, 1995, LINGUISTICS, V33, P5, DOI 10.1515/ling.1995.33.1.5; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; SAITO M, 1992, J EAST ASIAN LINGUIS, V1, P69, DOI 10.1007/BF00129574; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Sakai KL, 2004, CEREB CORTEX, V14, P1233, DOI 10.1093/cercor/bhh084; Santi A, 2012, NEUROPSYCHOLOGIA, V50, P821, DOI 10.1016/j.neuropsychologia.2012.01.017; Shetreet E, 2007, CEREB CORTEX, V17, P1958, DOI 10.1093/cercor/bhl105; Stowe Laurie A., 1986, LANG COGNITIVE PROC, V1, P227, DOI DOI 10.1080/01690968608407062; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Takano Y, 1998, NAT LANG LINGUIST TH, V16, P817, DOI 10.1023/A:1006031229239; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamaoka K, 2005, J PSYCHOLINGUIST RES, V34, P281, DOI 10.1007/s10936-005-3641-6; Thompson CK, 2007, J COGNITIVE NEUROSCI, V19, P1753, DOI 10.1162/jocn.2007.19.11.1753; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wilson SM, 2010, J NEUROSCI, V30, P16845, DOI 10.1523/JNEUROSCI.2547-10.2010; Yatsushiro K, 2003, J EAST ASIAN LINGUIS, V12, P141, DOI 10.1023/A:1022423427865	62	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37192	10.1371/journal.pone.0037192	http://dx.doi.org/10.1371/journal.pone.0037192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959VQ	22629366	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345300025
J	Lagler, H; Grabmeier-Pfistershammer, K; Touzeau-Romer, V; Tobudic, S; Ramharter, M; Wenisch, J; Gualdoni, GA; Redlberger-Fritz, M; Popow-Kraupp, T; Rieger, A; Burgmann, H				Lagler, Heimo; Grabmeier-Pfistershammer, Katharina; Touzeau-Roemer, Veronique; Tobudic, Selma; Ramharter, Michael; Wenisch, Judith; Gualdoni, Guido Andres; Redlberger-Fritz, Monika; Popow-Kraupp, Theresia; Rieger, Armin; Burgmann, Heinz			Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; HIV-1-INFECTED PATIENTS; SPLIT VIRION; VIRUS; ADULTS; PROTECTION; RESPONSES; SAFETY	Background: During the influenza pandemic of 2009/10, the whole-virion, Vero-cell-derived, inactivated, pandemic influenza A (H1N1) vaccine Celvapan (R) (Baxter) was used in Austria. Celvapan (R) is adjuvant-free and was the only such vaccine at that time in Europe. The objective of this observational, non-interventional, prospective single-center study was to evaluate the immunogenicity and tolerability of two intramuscular doses of this novel vaccine in HIV-positive individuals. Methods and Findings: A standard hemagglutination inhibition (HAI) assay was used for evaluation of the seroconversion rate and seroprotection against the pandemic H1N1 strain. In addition, H1N1-specific IgG antibodies were measured using a recently developed ELISA and compared with the HAI results. Tolerability of vaccination was evaluated up to one month after the second dose. A total of 79 HIV-infected adults with an indication for H1N1 vaccination were evaluated. At baseline, 55 of the 79 participants had an HAI titer >= 1:40 and two patients showed a positive IgG ELISA. The seroconversion rate was 31% after the first vaccination, increasing to 41% after the second; the corresponding seroprotection rates were 92% and 83% respectively. ELISA IgG levels were positive in 25% after the first vaccination and in 37% after the second. Among the participants with baseline HAI titers <1:40, 63% seroconverted. Young age was clearly associated with lower HAI titers at baseline and with higher seroconversion rates, whereas none of the seven patients >60 years of age had a baseline HAI titer <1:40 or seroconverted after vaccination. The vaccine was well tolerated. Conclusion: The non-adjuvanted pandemic influenza A (H1N1) vaccine was well tolerated and induced a measurable immune response in a sample of HIV-infected individuals.	[Lagler, Heimo; Tobudic, Selma; Ramharter, Michael; Wenisch, Judith; Gualdoni, Guido Andres; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Grabmeier-Pfistershammer, Katharina; Touzeau-Roemer, Veronique; Rieger, Armin] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Ramharter, Michael] Univ Tubingen, Dept Trop Med, Tubingen, Germany; [Redlberger-Fritz, Monika; Popow-Kraupp, Theresia] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Eberhard Karls University of Tubingen; Medical University of Vienna	Lagler, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Burgmann, Heinz/N-2409-2013; Ramharter, Michael/C-5273-2013	Gualdoni, Guido/0000-0001-9490-0197; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414; Lagler, Heimo/0000-0003-3240-7385; Burgmann, Heinz/0000-0002-2114-0999; Redlberger-Fritz, Monika/0000-0001-6265-557X; Ramharter, Michael/0000-0002-9259-1885				Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Bickel M, 2010, AIDS, V24, pF31, DOI 10.1097/QAD.0b013e3283398da1; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dikow R, 2011, AM J KIDNEY DIS, V57, P716, DOI 10.1053/j.ajkd.2010.11.031; Esposito S, 2011, VACCINE, V29, P1677, DOI 10.1016/j.vaccine.2010.12.047; European Committee for Proprietary Medicinal Products, 1997, CPMPBWP21496 EUR AG; European Medicines Agency, 2009, EMA8438072009; Evison J, 2009, CLIN INFECT DIS, V48, P1402, DOI 10.1086/598193; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Kajaste-Rudnitski A, 2011, AIDS, V25, P177, DOI 10.1097/QAD.0b013e328341afa8; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lagler H, 2011, VACCINE, V29, P6888, DOI 10.1016/j.vaccine.2011.07.050; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Mayr A, 1977, SEROLOGIE, V2, P207; Meyer S, 2011, TRANSPLANTATION, V91, P1031, DOI 10.1097/TP.0b013e3182115be0; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; Orlando G, 2010, AIDS, V24, P2142, DOI 10.1097/QAD.0b013e32833cfcb0; PARKMAN PD, 1977, J INFECT DIS, V136, pS722, DOI 10.1093/infdis/136.Supplement_3.S722; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; World Health Organization, 2009, STAT PRESS DIR GEN M	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2012	7	5							e36773	10.1371/journal.pone.0036773	http://dx.doi.org/10.1371/journal.pone.0036773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VD	22629330	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343100008
J	Chen, ZB; Tan, JY; Wen, Y; Niu, SNA; Wong, SM				Chen, Zibo; Tan, Jackie Yen; Wen, Yi; Niu, Shengniao; Wong, Sek-Man			A Game-Theoretic Model of Interactions between Hibiscus Latent Singapore Virus and Tobacco Mosaic Virus	PLOS ONE			English	Article							COINFECTION; ACCUMULATION; SYNERGISM	Mixed virus infections in plants are common in nature and their interactions affecting host plants would depend mainly on plant species, virus strains, the order of infection and initial amount of inoculum. Hence, the prediction of outcome of virus competition in plants is not easy. In this study, we applied evolutionary game theory to model the interactions between Hibiscus latent Singapore virus (HLSV) and Tobacco mosaic virus (TMV) in Nicotiana benthamiana under co-infection in a plant host. The accumulation of viral RNA was quantified using qPCR at 1, 2 and 8 days post infection (dpi), and two different methods were employed to predict the dominating virus. TMV was predicted to dominate the game in the long run and this prediction was confirmed by both qRT-PCR at 8 dpi and the death of co-infected plants after 15 dpi. In addition, we validated our model by using data reported in the literature. Ten out of fourteen reported co-infection outcomes agreed with our predictions. Explanations were given for the four interactions that did not agree with our model. Hence, it serves as a valuable tool in making long term predictions using short term data obtained in virus co-infections.	[Chen, Zibo; Tan, Jackie Yen; Wen, Yi; Niu, Shengniao; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chen, Zibo; Tan, Jackie Yen] Natl Univ Singapore, Undergrad Res Opportun Sci UROPS, Singapore 117548, Singapore; [Tan, Jackie Yen] Natl Univ Singapore, Univ Scholars Programme USP, Singapore 117548, Singapore; [Wong, Sek-Man] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Chen, ZB (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg	Wong, Sek-Man/I-2385-2012	Wong, Sek-Man/0000-0002-4620-3706; Chen, Zibo/0000-0003-2990-2895	National University of Singapore [R-154-000-493-112]	National University of Singapore(National University of Singapore)	This research work is supported by a research grant R-154-000-493-112 from National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2009, VIROLOGY, V387, P257, DOI 10.1016/j.virol.2009.01.046; [Anonymous], 1995, EVOLUTIONARY GAME TH; Fattouh F. A., 2003, Pakistan Journal of Plant Pathology, V2, P85; GOELET P, 1982, P NATL ACAD SCI-BIOL, V79, P5818, DOI 10.1073/pnas.79.19.5818; Grande-Perez A, 2005, P NATL ACAD SCI USA, V102, P4448, DOI 10.1073/pnas.0408871102; Kaufman PB., 2009, RECENT ADV PLANT BIO, V13, P333, DOI [10.1007/978-1-4419-0194-1_13, DOI 10.1007/978-1-4419-0194-1_13]; Kokkinos CD, 2006, PLANT DIS, V90, P1347, DOI 10.1094/PD-90-1347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin S, 2009, J GEN VIROL, V90, P2815, DOI 10.1099/vir.0.012351-0; Maynard Smith J., 1982, EVOLUTION THEORY GAM; McKinney HH, 1929, J AGRIC RES, V39, P0557; Mohamed E., 2010, J AM SCI, V6, P311; Murphy John F, 2006, Phytopathology, V96, P240, DOI 10.1094/PHYTO-96-0240; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nayudu M. V., 2008, PLANT VIRUSES; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; Scheets K, 1998, VIROLOGY, V242, P28, DOI 10.1006/viro.1997.8989; SEIFERS DL, 1995, PLANT DIS, V79, P1104, DOI 10.1094/PD-79-1104; Srinivasan KG, 2005, ARCH VIROL, V150, P153, DOI 10.1007/s00705-004-0404-x; Straffin P., 1993, GAME THEORY STRATEGY; Tatineni S, 2010, PHYTOPATHOLOGY, V100, P230, DOI 10.1094/PHYTO-100-3-0230; Turner PE, 2003, AM NAT, V161, P497, DOI 10.1086/367880; WADSWORTH GJ, 1988, ANAL BIOCHEM, V172, P279, DOI 10.1016/0003-2697(88)90443-5; Wintermantel WM, 2008, PHYTOPATHOLOGY, V98, P1340, DOI 10.1094/PHYTO-98-12-1340; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Xi DH, 2010, J PHYTOPATHOL, V158, P263, DOI 10.1111/j.1439-0434.2009.01607.x; Yang H, 2010, J PHYTOPATHOL, V158, P833, DOI 10.1111/j.1439-0434.2010.01694.x; Zeng R, 2007, ACTA BIOCH BIOPH SIN, V39, P431, DOI 10.1111/j.1745-7270.2007.00292.x	28	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37007	10.1371/journal.pone.0037007	http://dx.doi.org/10.1371/journal.pone.0037007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623970	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500047
J	Goodyear, A; Bielefeldt-Ohmann, H; Schweizer, H; Dow, S				Goodyear, Andrew; Bielefeldt-Ohmann, Helle; Schweizer, Herbert; Dow, Steven			Persistent Gastric Colonization with Burkholderia pseudomallei and Dissemination from the Gastrointestinal Tract following Mucosal Inoculation of Mice	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; IN-SITU HYBRIDIZATION; PSEUDOMONAS-PSEUDOMALLEI; BACTEREMIC MELIOIDOSIS; GASTRODUODENAL LESIONS; ALCOHOL-CONSUMPTION; DIABETES-MELLITUS; ENTERIC INFECTION; SELECTIVE MEDIA; MURINE MODEL	Melioidosis is a disease of humans caused by opportunistic infection with the soil and water bacterium Burkholderia pseudomallei. Melioidosis can manifest as an acute, overwhelming infection or as a chronic, recurrent infection. At present, it is not clear where B. pseudomallei resides in the mammalian host during the chronic, recurrent phase of infection. To address this question, we developed a mouse low-dose mucosal challenge model of chronic B. pseudomallei infection and investigated sites of bacterial persistence over 60 days. Sensitive culture techniques and selective media were used to quantitate bacterial burden in major organs, including the gastrointestinal (GI) tract. We found that the GI tract was the primary site of bacterial persistence during the chronic infection phase, and was the only site from which the organism could be consistently cultured during a 60-day infection period. The organism could be repeatedly recovered from all levels of the GI tract, and chronic infection was accompanied by sustained low-level fecal shedding. The stomach was identified as the primary site of GI colonization as determined by fluorescent in situ hybridization. Organisms in the stomach were associated with the gastric mucosal surface, and the propensity to colonize the gastric mucosa was observed with 4 different B. pseudomallei isolates. In contrast, B. pseudomallei organisms were present at low numbers within luminal contents in the small and large intestine and cecum relative to the stomach. Notably, inflammatory lesions were not detected in any GI tissue examined in chronically-infected mice. Only low-dose oral or intranasal inoculation led to GI colonization and development of chronic infection of the spleen and liver. Thus, we concluded that in a mouse model of melioidosis B. pseudomallei preferentially colonizes the stomach following oral inoculation, and that the chronically colonized GI tract likely serves as a reservoir for dissemination of infection to extra-intestinal sites.	[Goodyear, Andrew; Schweizer, Herbert; Dow, Steven] Colorado State Univ, Dept Microbiol Immunol & Pathol, Rocky Mt Reg Ctr Excellence Biodef & Emerging Inf, Ft Collins, CO 80523 USA; [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Brisbane, Qld 4072, Australia	Colorado State University; University of Queensland	Goodyear, A (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Rocky Mt Reg Ctr Excellence Biodef & Emerging Inf, Ft Collins, CO 80523 USA.	sdow@colostate.edu			National Institutes of Health [R21AI091991, AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091991, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R21AI091991, and grant AI065357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKMAL M, 1994, CLIN NEPHROL, V42, P198; Aldhous P, 2005, NATURE, V434, P692, DOI 10.1038/434692a; ASHDOWN LR, 1979, PATHOLOGY, V11, P293, DOI 10.3109/00313027909061954; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; Boehme MWJ, 2007, HEPATO-GASTROENTEROL, V54, P643; BRADFORD WD, 1974, ARCH PATHOL, V98, P17; Breitbach Katrin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS89, DOI 10.1016/S0035-9203(08)70022-1; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bujanda L, 2000, AM J GASTROENTEROL, V95, P3374, DOI 10.1111/j.1572-0241.2000.03347.x; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chang JH, 2009, DIGEST DIS SCI, V54, P578, DOI 10.1007/s10620-008-0399-3; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chou DW, 2007, J FORMOS MED ASSOC, V106, P1013, DOI 10.1016/S0929-6646(08)60077-7; COTTEW G. S., 1952, AUSTRALIAN VET JOUR, V28, P113, DOI 10.1111/j.1751-0813.1952.tb05138.x; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Dance DAB, 2005, EMERG INF DIS 21ST C, P99; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Dharakul T, 1996, J CLIN MICROBIOL, V34, P609, DOI 10.1128/JCM.34.3.609-614.1996; Dharakul T, 1999, J CLIN MICROBIOL, V37, P1906, DOI 10.1128/JCM.37.6.1906-1912.1999; Draper ADK, 2010, APPL ENVIRON MICROB, V76, P5305, DOI 10.1128/AEM.00287-10; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; FELDMAN M, 1991, DIGEST DIS SCI, V36, P866, DOI 10.1007/BF01297133; Finkelstein RA, 1965, SEATO AFRIMS ANN PRO, P228; Franke A, 2005, DIGEST DIS, V23, P204, DOI 10.1159/000090167; GILLIGAN PH, 1985, J CLIN MICROBIOL, V22, P5, DOI 10.1128/JCM.22.1.5-8.1985; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Goodyear A, 2010, J IMMUNOL, V184, P1445, DOI 10.4049/jimmunol.0900411; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Hagen RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/j.ijmm.2011.04.017; Heng Bee Hoon, 1998, Annals Academy of Medicine Singapore, V27, P478; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Howard K, 2005, WATER RES, V39, P1085, DOI 10.1016/j.watres.2004.12.028; Howard K, 2003, WATER RES, V37, P4425, DOI 10.1016/S0043-1354(03)00440-8; Inglis TJJ, 1998, LANCET, V352, P1600, DOI 10.1016/S0140-6736(05)61047-1; Isaacson RE, 1998, VET QUART, V20, pS68; Jayanetra P, 1974, Southeast Asian J Trop Med Public Health, V5, P487; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; KANAPHUN P, 1993, J INFECT DIS, V167, P230, DOI 10.1093/infdis/167.1.230; KAUFMANN A F, 1970, Journal of Wildlife Diseases, V6, P211; KETTERER PJ, 1986, AUST VET J, V63, P146, DOI 10.1111/j.1751-0813.1986.tb02953.x; Khedmat H, 2007, TRANSPL P, V39, P1003, DOI 10.1016/j.transproceed.2007.03.034; Knoll MR, 1998, ENDOSCOPY, V30, P293, DOI 10.1055/s-2007-1001257; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; LEVY AJ, 1947, AM J CLIN PATHOL, V17, P290; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; LLOYD JM, 1988, AUST VET J, V65, P191, DOI 10.1111/j.1751-0813.1988.tb14300.x; M'Fadyean J, 1904, J COMP PATHOL, V17, P295; Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740; Mayo M, 2011, EMERG INFECT DIS, V17, P1283, DOI 10.3201/eid1707.100614; MAYS EE, 1975, CHEST, V68, P261, DOI 10.1378/chest.68.2.261; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Mohawk KL, 2010, MICROB PATHOGENESIS, V48, P131, DOI 10.1016/j.micpath.2010.01.003; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moore Richard A, 2008, BMC Res Notes, V1, P11, DOI 10.1186/1756-0500-1-11; MORRISON RE, 1988, AM J MED, V84, P965, DOI 10.1016/0002-9343(88)90080-0; Mukhopadhyay A, 2004, J INFECTION, V48, P334, DOI 10.1016/j.jinf.2003.10.005; Nandi T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000845; Nardone G, 2005, HELICOBACTER, V10, P53, DOI 10.1111/j.1523-5378.2005.00291.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Noyes HE, 1968, SEATO AFRIMS ANN PRO, P83; OLDS R. J., 1955, Australian Veterinary Journal, V31, P273, DOI 10.1111/j.1751-0813.1955.tb05453.x; PATON JPJ, 1947, BRIT MED J, V1, P336, DOI 10.1136/bmj.1.4497.336; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Peacock SJ, 2005, J CLIN MICROBIOL, V43, P5359, DOI 10.1128/JCM.43.10.5359-5361.2005; Phuong Doan Mai, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS30, DOI 10.1016/S0035-9203(08)70009-9; Propst KL, 2010, INFECT IMMUN, V78, P3136, DOI 10.1128/IAI.01313-09; PUTHUCHEARY SD, 1992, T ROY SOC TROP MED H, V86, P683, DOI 10.1016/0035-9203(92)90191-E; PUTHUCHEARY SD, 1981, TROP GEOGR MED, V33, P19; Quatrini M, 2001, J CLIN GASTROENTEROL, V32, P215, DOI 10.1097/00004836-200103000-00006; Rajendram R, 2005, DIGEST DIS, V23, P214, DOI 10.1159/000090168; Ralph A, 2004, PEDIATR INFECT DIS J, V23, P1169, DOI 10.1097/01.inf.0000145548.79395.da; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; SCHADE C, 1994, GASTROENTEROLOGY, V107, P180, DOI 10.1016/0016-5085(94)90075-2; Shirazian S, 2010, NAT REV NEPHROL, V6, P480, DOI 10.1038/nrneph.2010.84; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Stanton AT, 1925, LANCET, V1, P10; Stanton AT, 1932, STUDIES I MED RES FE, P1; Strauss J M, 1969, Med J Malaya, V24, P94; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Thibault FM, 2004, J ANTIMICROB CHEMOTH, V54, P1134, DOI 10.1093/jac/dkh471; THIN RNT, 1970, Q J MED, V39, P115; THOMAS AD, 1981, AUST VET J, V57, P144, DOI 10.1111/j.1751-0813.1981.tb00492.x; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Tong SD, 1996, MICROBIOL IMMUNOL, V40, P451, DOI 10.1111/j.1348-0421.1996.tb01092.x; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; VANDERSAR A, 1948, AM J CLIN PATHOL, V18, P509; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wasse H, 2003, KIDNEY INT, V64, P1455, DOI 10.1046/j.1523-1755.2003.00225.x; West TE, 2010, AM J TROP MED HYG, V83, P1066, DOI 10.4269/ajtmh.2010.10-0306; Whitmore A, 1912, BRIT MED J, V1912, P1306; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P491, DOI 10.1016/0035-9203(95)90080-2; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7; WUTHIEKANUN V, 1990, J MED MICROBIOL, V33, P121, DOI 10.1099/00222615-33-2-121; Wuthiekanun V, 1996, J MED MICROBIOL, V45, P408, DOI 10.1099/00222615-45-6-408; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	113	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37324	10.1371/journal.pone.0037324	http://dx.doi.org/10.1371/journal.pone.0037324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624016	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343500099
J	Sanchez-Fernandez, MA; Sbacchi, S; Correa-Tapia, M; Naumann, R; Klemm, J; Chambon, P; Al-Robaiy, S; Blessing, M; Hoflack, B				Sanchez-Fernandez, Maria Arantzazu; Sbacchi, Silvia; Correa-Tapia, Miguel; Naumann, Ronald; Klemm, Jennifer; Chambon, Pierre; Al-Robaiy, Samiya; Blessing, Manfred; Hoflack, Bernard			Transgenic Mice for a Tamoxifen-Induced, Conditional Expression of the Cre Recombinase in Osteoclasts	PLOS ONE			English	Article							CATHEPSIN-K; BONE-RESORPTION; MOUSE; CELLS; DIFFERENTIATION; MUTAGENESIS; ACTIVATION; ARTHRITIS; GENE	Background: Studies on osteoclasts, the bone resorbing cells, have remained limited due to the lack of transgenic mice allowing the conditional knockout of genes in osteoclasts at any time during development or adulthood. Methodology/Principal Finding: We report here on the generation of transgenic mice which specifically express a tamoxifen-inducible Cre recombinase in osteoclasts. These mice, generated on C57BL/6 and FVB background, express a fusion Cre recombinase-ERT2 protein whose expression is driven by the promoter of cathepsin K (CtsK), a gene highly expressed in osteoclasts. We tested the cellular specificity of Cre activity in CtsKCreERT2 strains by breeding with Rosa26LacZ reporter mice. PCR and histological analyses of the CtsKCreERT2LacZ positive adult mice and E17.5 embryos show that Cre activity is restricted largely to bone tissue. In vitro, primary osteoclasts derived from the bone marrow of CtsKCreERT2+/-LacZ+/- adult mice show a Cre-dependent beta-galactosidase activity after tamoxifen stimulation. Conclusions/Significance: We have generated transgenic lines that enable the tamoxifen-induced, conditional deletion of loxP-flanked genes in osteoclasts, thus circumventing embryonic and postnatal gene lethality and avoiding gene deletion in other cell types. Such CtsKCreERT2 mice provide a convenient tool to study in vivo the different facets of osteoclast function in bone physiology during different developmental stages and adulthood of mice.	[Sanchez-Fernandez, Maria Arantzazu; Sbacchi, Silvia; Correa-Tapia, Miguel; Klemm, Jennifer; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Naumann, Ronald] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Chambon, Pierre] Univ Strasbourg, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS UMR7104,Inserm U964, Illkirch Graffenstaden, France; [Al-Robaiy, Samiya; Blessing, Manfred] Biotechnologish Biomed Zentrum, Leipzig, Germany	Technische Universitat Dresden; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sanchez-Fernandez, MA (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020		German Research Foundation [TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1, HO 2584/1-2, HO2584/10-1]; Ministry of Saxony [HWP-EFRE 4212/05-12/02]; TU-Dresden	German Research Foundation(German Research Foundation (DFG)); Ministry of Saxony; TU-Dresden	The authors' research was supported by grants from the German Research Foundation (TRR 83/1-2010, HO 2584/1-1, HO 2584/2-1, HO 2584/6-1, HO 2584/8-1, HO 2584/9-1, HO 2584/1-2, HO2584/10-1), European funds from the Ministry of Saxony (HWP-EFRE 4212/05-12/02) and by TU-Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kopp HG, 2007, HISTOL HISTOPATHOL, V22, P971, DOI 10.14670/HH-22.971; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Odgren PR, 2006, CONNECT TISSUE RES, V47, P229, DOI 10.1080/03008200600860086; Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	22	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37592	10.1371/journal.pone.0037592	http://dx.doi.org/10.1371/journal.pone.0037592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624050	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500139
J	Verbist, KC; Rose, DL; Cole, CJ; Field, MB; Klonowski, KD				Verbist, Katherine C.; Rose, David L.; Cole, Charles J.; Field, Mary B.; Klonowski, Kimberly D.			IL-15 Participates in the Respiratory Innate Immune Response to Influenza Virus Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD8(+) T-CELLS; HUMAN NK CELLS; IN-VIVO; TRANS-PRESENTATION; DENDRITIC CELLS; GENE-EXPRESSION; A VIRUS; ACTIVATION; RECEPTOR	Following influenza infection, natural killer (NK) cells function as interim effectors by suppressing viral replication until CD8 T cells are activated, proliferate, and are mobilized within the respiratory tract. Thus, NK cells are an important first line of defense against influenza virus. Here, in a murine model of influenza, we show that virally-induced IL-15 facilitates the trafficking of NK cells into the lung airways. Blocking IL-15 delays NK cell entry to the site of infection and results in a disregulated control of early viral replication. By the same principle, viral control by NK cells can be therapeutically enhanced via intranasal administration of exogenous IL-15 in the early days post influenza infection. In addition to controlling early viral replication, this IL-15-induced mobilization of NK cells to the lung airways has important downstream consequences on adaptive responses. Primarily, depletion of responding NK1.1+ NK cells is associated with reduced immigration of influenza-specific CD8 T cells to the site of infection. Together this work suggests that local deposits of IL-15 in the lung airways regulate the coordinated innate and adaptive immune responses to influenza infection and may represent an important point of immune intervention.	[Verbist, Katherine C.; Cole, Charles J.; Field, Mary B.; Klonowski, Kimberly D.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Rose, David L.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Verbist, KC (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	klonowsk@uga.edu		Verbist, Katherine/0000-0002-3511-5639	University of Georgia; National Institutes of Health [AI077038, AI081800]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077038, R01AI081800] Funding Source: NIH RePORTER	University of Georgia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the University of Georgia and the National Institutes of Health (AI077038 and AI081800 to KDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, J MOL BIOL, V367, P25, DOI 10.1016/j.jmb.2006.12.060; ALLAN W, 1990, J IMMUNOL, V144, P3980; Allavena P, 1997, J LEUKOCYTE BIOL, V61, P729, DOI 10.1002/jlb.61.6.729; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Assarsson E, 2000, J IMMUNOL, V165, P3673, DOI 10.4049/jimmunol.165.7.3673; Azimi N, 2000, J VIROL, V74, P7338, DOI 10.1128/JVI.74.16.7338-7348.2000; Barlic J, 2004, J BIOL CHEM, V279, P48520, DOI 10.1074/jbc.M406978200; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Castillo EF, 2010, BLOOD, V116, P2494, DOI 10.1182/blood-2010-03-277103; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Caufour P, 2001, MICROBES INFECT, V3, P181, DOI 10.1016/S1286-4579(01)01370-3; Chae DW, 1996, J IMMUNOL, V157, P2813; Crowe JE, 1999, CURR TOP MICROBIOL, V236, P191; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Doherty TM, 1996, J IMMUNOL, V156, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fouchier Ron Am, 2005, Curr Opin Infect Dis, V18, P141; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Ho LP, 2008, EUR J IMMUNOL, V38, P1913, DOI 10.1002/eji.200738017; Hocke AC, 2008, HISTOCHEM CELL BIOL, V130, P165, DOI 10.1007/s00418-008-0414-y; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kilbourne ED, 2004, VIRAL IMMUNOL, V17, P350, DOI 10.1089/0882824041857076; Kitaya K, 2005, J CLIN ENDOCR METAB, V90, P2932, DOI 10.1210/jc.2004-2447; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kos FJ, 1996, CELL IMMUNOL, V173, P1, DOI 10.1006/cimm.1996.0245; Kos FJ, 1996, IMMUNOL TODAY, V17, P174, DOI 10.1016/0167-5699(96)80616-5; Kulkarni RR, 2010, J LEUKOCYTE BIOL, V88, P635, DOI 10.1189/jlb.0410191; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; Meazza R, 1997, EUR J IMMUNOL, V27, P1049, DOI 10.1002/eji.1830270502; Morandi B, 2009, INT IMMUNOL, V21, P599, DOI 10.1093/intimm/dxp029; Muro S, 2001, J ALLERGY CLIN IMMUN, V108, P970, DOI 10.1067/mai.2001.119556; Onu A, 1997, J IMMUNOL, V158, P255; Perera LP, 1999, J IMMUNOL, V162, P2606; Shen CH, 2008, J IMMUNOL, V180, P171, DOI 10.4049/jimmunol.180.1.171; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P430, DOI 10.1016/S0952-7915(03)00067-0; Yamaji K, 2006, CANCER IMMUNOL IMMUN, V55, P394, DOI 10.1007/s00262-005-0005-x	54	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37539	10.1371/journal.pone.0037539	http://dx.doi.org/10.1371/journal.pone.0037539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624047	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500134
J	Guillet, C; Aboul-Soud, MAM; Le Menn, A; Viron, N; Pribat, A; Germain, V; Just, D; Baldet, P; Rousselle, P; Lemaire-Chamley, M; Rothan, C				Guillet, Carine; Aboul-Soud, Mourad A. M.; Le Menn, Aline; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Rousselle, Patrick; Lemaire-Chamley, Martine; Rothan, Christophe			Regulation of the Fruit-Specific PEP Carboxylase SlPPC2 Promoter at Early Stages of Tomato Fruit Development	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; GENE-EXPRESSION; FLAVERIA-TRINERVIA; CIS-ELEMENTS; TRANSCRIPTION FACTOR; LEADER INTRON; NITRIC-OXIDE; PLANT; ARABIDOPSIS; ETHYLENE	The SlPPC2 phosphoenolpyruvate carboxylase (PEPC; EC 4.1.1.31) gene from tomato (Solanum lycopersicum) is differentially and specifically expressed in expanding tissues of developing tomato fruit. We recently showed that a 1966 bp DNA fragment located upstream of the ATG codon of the SlPPC2 gene (GenBank AJ313434) confers appropriate fruit-specificity in transgenic tomato. In this study, we further investigated the regulation of the SlPPC2 promoter gene by analysing the SlPPC2 cis-regulating region fused to either the firefly luciferase (LUC) or the beta-glucuronidase (GUS) reporter gene, using stable genetic transformation and biolistic transient expression assays in the fruit. Biolistic analyses of 5' SlPPC2 promoter deletions fused to LUC in fruits at the 8th day after anthesis revealed that positive regulatory regions are mostly located in the distal region of the promoter. In addition, a 5' UTR leader intron present in the 1966 bp fragment contributes to the proper temporal regulation of LUC activity during fruit development. Interestingly, the SlPPC2 promoter responds to hormones (ethylene) and metabolites (sugars) regulating fruit growth and metabolism. When tested by transient expression assays, the chimeric promoter: LUC fusion constructs allowed gene expression in both fruit and leaf, suggesting that integration into the chromatin is required for fruit-specificity. These results clearly demonstrate that SlPPC2 gene is under tight transcriptional regulation in the developing fruit and that its promoter can be employed to drive transgene expression specifically during the cell expansion stage of tomato fruit. Taken together, the SlPPC2 promoter offers great potential as a candidate for driving transgene expression specifically in developing tomato fruit from various tomato cultivars.	[Guillet, Carine; Aboul-Soud, Mourad A. M.; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Lemaire-Chamley, Martine; Rothan, Christophe] INRA, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France; [Guillet, Carine; Aboul-Soud, Mourad A. M.; Viron, Nicolas; Pribat, Anne; Germain, Veronique; Just, Daniel; Baldet, Pierre; Lemaire-Chamley, Martine; Rothan, Christophe] Univ Bordeaux, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France; [Aboul-Soud, Mourad A. M.] Cairo Univ, Dept Biochem, Fac Agr, Giza, Egypt; [Aboul-Soud, Mourad A. M.] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Chair Med & Mol Genet Res, Riyadh, Saudi Arabia; [Le Menn, Aline; Rousselle, Patrick] INRA, Unite Genet & Ameliorat Fruits & Legumes, Montfavet, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Egyptian Knowledge Bank (EKB); Cairo University; King Saud University; INRAE	Guillet, C (corresponding author), INRA, Unite Mixte Rech Biol Fruit & Pathol 1332, Villenave Dornon, France.	maboulsoud@ksu.edu.sa	Aboul-Soud, Mourad/F-8111-2010	Aboul-Soud, Mourad/0000-0001-9395-0563; ROTHAN, Christophe/0000-0002-6831-2823; GERMAIN, Veronique/0000-0001-6322-1204; Baldet, Pierre/0000-0001-7351-1803; Lemaire-Chamley, Martine/0000-0002-7687-894X	Institut National de la Recherche Agronomique (INRA); Region Aquitaine; EUSOL European Integrated Project [FOOD-CT-2006-016214]	Institut National de la Recherche Agronomique (INRA); Region Aquitaine(Region Nouvelle-Aquitaine); EUSOL European Integrated Project	This work was supported by the Institut National de la Recherche Agronomique (INRA), by the Region Aquitaine, and by a grant from EUSOL European Integrated Project [FOOD-CT-2006-016214 to NV]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2010, J HORTIC SCI BIOTECH, V85, P516; Aboul-Soud MAM, 2009, PLANT SIGNAL BEHAV, V4, P191, DOI 10.4161/psb.4.3.8256; Aboul-Soud MAM, 2009, NEW PHYTOL, V183, P1163, DOI 10.1111/j.1469-8137.2009.02902.x; Aboul-Soud MAM, 2009, PLANT SCI, V176, P241, DOI 10.1016/j.plantsci.2008.10.010; Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; Balbi V, 2003, PLANT PHYSIOL, V131, P186, DOI 10.1104/pp.010132; Barry CS, 2001, PLANT PHYSIOL, V127, P58, DOI 10.1104/pp.127.1.58; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Catala C, 2000, PLANT PHYSIOL, V122, P527, DOI 10.1104/pp.122.2.527; Chen ZH, 2008, PLANT CELL ENVIRON, V31, P1844, DOI 10.1111/j.1365-3040.2008.01885.x; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Curi GC, 2005, J EXP BOT, V56, P2563, DOI 10.1093/jxb/eri250; Davuluri GR, 2005, NAT BIOTECHNOL, V23, P890, DOI 10.1038/nbt1108; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; Deikman J, 1998, PLANT MOL BIOL, V37, P1001, DOI 10.1023/A:1006091928367; Devaux C, 2003, J EXP BOT, V54, P1143, DOI 10.1093/jxb/erg113; Enfissi EMA, 2010, PLANT CELL, V22, P1190, DOI 10.1105/tpc.110.073866; Engelmann S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-4; Ernst K, 1997, PLANT MOL BIOL, V34, P427, DOI 10.1023/A:1005838020246; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; Gendreau E, 1999, PLANTA, V209, P513, DOI 10.1007/PL00008123; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Guillet C, 2002, PLANTA, V214, P717, DOI 10.1007/s00425-001-0687-z; HAMZA S, 1993, J EXP BOT, V44, P1837, DOI 10.1093/jxb/44.12.1837; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hartwell J, 1999, PLANT J, V20, P333, DOI 10.1046/j.1365-313X.1999.t01-1-00609.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HENSTRAND JM, 1989, PLANT PHYSIOL, V91, P157, DOI 10.1104/pp.91.1.157; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu WW, 2005, PLANT PHYSIOL, V138, P276, DOI 10.1104/pp.104.056770; Estornell LH, 2009, PLANT BIOTECHNOL J, V7, P298, DOI 10.1111/j.1467-7652.2009.00402.x; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Jeanneau M, 2002, J EXP BOT, V53, P1837, DOI 10.1093/jxb/erf061; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kausch AP, 2001, PLANT MOL BIOL, V45, P1, DOI 10.1023/A:1006487326533; Lemaire-Chamley M, 2005, PLANT PHYSIOL, V139, P750, DOI 10.1104/pp.105.063719; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Mahmoud EA, 2009, CURR ISSUES MOL BIOL, V11, pI55, DOI 10.21775/cimb.011.i55; Manzara T., 1994, Plant Molecular Biology Reporter, V12, P221, DOI 10.1007/BF02668745; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mathieu-Rivet E, 2010, PLANT J, V62, P727, DOI 10.1111/j.1365-313X.2010.04198.x; MEIER I, 1995, PLANT PHYSIOL, V107, P1105, DOI 10.1104/pp.107.4.1105; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Mounet F, 2009, PLANT PHYSIOL, V149, P1505, DOI 10.1104/pp.108.133967; Nafati M, 2011, PLANT J, V65, P543, DOI 10.1111/j.1365-313X.2010.04446.x; Neelam A, 2008, J EXP BOT, V59, P2337, DOI 10.1093/jxb/ern100; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; NICHOLASS FJ, 1995, PLANT MOL BIOL, V28, P423, DOI 10.1007/BF00020391; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Offermann S, 2008, GENETICS, V179, P1891, DOI 10.1534/genetics.108.087411; Offermann S, 2006, PLANT PHYSIOL, V141, P1078, DOI 10.1104/pp.106.080457; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Pego JV, 1999, PLANT PHYSIOL, V119, P1017, DOI 10.1104/pp.119.3.1017; Polko JK, 2012, NEW PHYTOL, V193, P339, DOI 10.1111/j.1469-8137.2011.03920.x; Powell J., 1985, Proceedings of the 2nd International Conference on Lasers in Manufacturing, P37; Proels RK, 2009, J EXP BOT, V60, P1555, DOI 10.1093/jxb/erp027; Rademacher T, 2002, PLANT J, V32, P25, DOI 10.1046/j.1365-313X.2002.01397.x; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Sanchez R, 2006, PLANTA, V223, P901, DOI 10.1007/s00425-005-0144-5; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Urwin NAR, 1997, PLANT MOL BIOL, V35, P929, DOI 10.1023/A:1005950915499; Vriezen WH, 2008, NEW PHYTOL, V177, P60, DOI 10.1111/j.1469-8137.2007.02254.x; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yamagata H, 2002, J BIOL CHEM, V277, P11582, DOI 10.1074/jbc.M109946200; Yamamoto N, 2005, GENE, V356, P127, DOI 10.1016/j.gene.2005.04.026; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; Yin T, 2009, J EXP BOT, V60, P169, DOI 10.1093/jxb/ern273; Zhao LX, 2009, J BIOSCIENCES, V34, P71, DOI 10.1007/s12038-009-0010-x; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	83	15	16	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36795	10.1371/journal.pone.0036795	http://dx.doi.org/10.1371/journal.pone.0036795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615815	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200021
J	Ogata, S; Miki, T; Seino, S; Tamai, S; Kasai, H; Nemoto, T				Ogata, Sho; Miki, Takashi; Seino, Susumu; Tamai, Seiichi; Kasai, Haruo; Nemoto, Tomomi			A Novel Function of Noc2 in Agonist-Induced Intracellular Ca2+ Increase during Zymogen-Granule Exocytosis in Pancreatic Acinar Cells	PLOS ONE			English	Article							EXOCRINE; PROTEIN; ENDOCRINE; SECRETION; INVOLVEMENT; PATHWAYS; RELEASE	Noc2, a putative Rab effector, contributes to secretory-granule exocytosis in neuroendocrine and exocrine cells. Here, using two-photon excitation live-cell imaging, we investigated its role in Ca2+-dependent zymogen granule (ZG) exocytosis in pancreatic acinar cells from wild-type (WT) and Noc2-knockout (KO) mice. Imaging of a KO acinar cell revealed an expanded granular area, indicating ZG accumulation. In our spatiotemporal analysis of the ZG exocytosis induced by agonist (cholecystokinin or acetylcholine) stimulation, the location and rate of progress of ZG exocytosis did not differ significantly between the two strains. ZG exocytosis from KO acinar cells was seldom observed at physiological concentrations of agonists, but was normal (vs. WT) at high concentrations. Flash photolysis of a caged calcium compound confirmed the integrity of the fusion step of ZG exocytosis in KO acinar cells. The decreased ZG exocytosis present at physiological concentrations of agonists raised the possibility of impaired elicitation of calcium spikes. When calcium spikes were evoked in KO acinar cells by a high agonist concentration: (a) they always started at the apical portion and traveled to the basal portion, and (b) calcium oscillations over the 10 mu M level were observed, as in WT acinar cells. At physiological concentrations of agonists, however, sufficient calcium spikes were not observed, suggesting an impaired [Ca2+](i)-increase mechanism in KO acinar cells. We propose that in pancreatic acinar cells, Noc2 is not indispensable for the membrane fusion of ZG per se, but instead performs a novel function favoring agonist-induced physiological [Ca2+](i) increases.	[Ogata, Sho; Kasai, Haruo; Nemoto, Tomomi] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Ogata, Sho; Kasai, Haruo; Nemoto, Tomomi] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi, Japan; [Ogata, Sho; Tamai, Seiichi] Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama, Japan; [Ogata, Sho] Natl Def Med Coll, Dept Pathol & Lab Med, Tokorozawa, Saitama 359, Japan; [Miki, Takashi; Seino, Susumu] Kobe Univ, Div Cellular & Mol Med, Grad Sch Med, Kobe, Hyogo 657, Japan; [Miki, Takashi] Chiba Univ, Dept Med Physiol, Grad Sch Med, Chiba, Japan; [Kasai, Haruo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan; [Nemoto, Tomomi] Hokkaido Univ, Lab Mol & Cellular Biophys, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Nemoto, Tomomi] Japan Sci & Technol Agcy JST, CREST, Sapporo, Hokkaido, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; Kobe University; Chiba University; University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST)	Ogata, S (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	sogata@ndmc.ac.jp	Nemoto, Tomomi/B-4412-2012; MIKI, Takashi/ABD-3995-2020	Nemoto, Tomomi/0000-0001-6102-1495; MIKI, Takashi/0000-0001-5741-1626; Kasai, Haruo/0000-0003-2327-9027	Scientific Research (KAKENHI); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Human Frontier Science Program Organization; Ichiro Kanehara Foundation; Kanehara Mochida Memorial Foundation for Pharmaceutical Research; CREST of JST; Grants-in-Aid for Scientific Research [21000009] Funding Source: KAKEN	Scientific Research (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program Organization(Human Frontier Science Program); Ichiro Kanehara Foundation; Kanehara Mochida Memorial Foundation for Pharmaceutical Research; CREST of JST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) and for the Strategic Research Program for Brain Sciences (Bioinformatics for brain sciences) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by research grants from the Human Frontier Science Program Organization, the Ichiro Kanehara Foundation, the Kanehara Mochida Memorial Foundation for Pharmaceutical Research, and CREST of JST. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	BEDI KS, 1974, ARCH ORAL BIOL, V19, P1127, DOI 10.1016/0003-9969(74)90241-6; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Cheviet S, 2004, TRENDS CELL BIOL, V14, P525, DOI 10.1016/j.tcb.2004.08.001; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Imai A, 2006, ARCH BIOCHEM BIOPHYS, V455, P127, DOI 10.1016/j.abb.2006.09.021; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Kiselyov K, 2002, ADV EXP MED BIOL, V506, P175; Kotake K, 1997, J BIOL CHEM, V272, P29407, DOI 10.1074/jbc.272.47.29407; Luo X, 2004, METHOD ENZYMOL, V389, P119; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Oshima A, 2005, CELL CALCIUM, V37, P349, DOI 10.1016/j.ceca.2004.12.003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petersen OH, 2003, CELL CALCIUM, V33, P337, DOI 10.1016/S0143-4160(03)00047-2; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; POORT C, 1969, GASTROENTEROLOGY, V57, P689; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c; Williams JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE405, DOI 10.1152/ajpendo.90874.2008; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37048	10.1371/journal.pone.0037048	http://dx.doi.org/10.1371/journal.pone.0037048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615885	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200038
J	Zannoli, M; Cass, J; Mamassian, P; Alais, D				Zannoli, Marina; Cass, John; Mamassian, Pascal; Alais, David			Synchronized Audio-Visual Transients Drive Efficient Visual Search for Motion-in-Depth	PLOS ONE			English	Article							DISPARITY; COMPUTATION; INTEGRATION; ATTENTION; VISION; SOUND; POP	In natural audio-visual environments, a change in depth is usually correlated with a change in loudness. In the present study, we investigated whether correlating changes in disparity and loudness would provide a functional advantage in binding disparity and sound amplitude in a visual search paradigm. To test this hypothesis, we used a method similar to that used by van der Burg et al. to show that non-spatial transient (square-wave) modulations of loudness can drastically improve spatial visual search for a correlated luminance modulation. We used dynamic random-dot stereogram displays to produce pure disparity modulations. Target and distractors were small disparity-defined squares (either 6 or 10 in total). Each square moved back and forth in depth in front of the background plane at different phases. The target's depth modulation was synchronized with an amplitude-modulated auditory tone. Visual and auditory modulations were always congruent (both sine-wave or square-wave). In a speeded search task, five observers were asked to identify the target as quickly as possible. Results show a significant improvement in visual search times in the square-wave condition compared to the sine condition, suggesting that transient auditory information can efficiently drive visual search in the disparity domain. In a second experiment, participants performed the same task in the absence of sound and showed a clear set-size effect in both modulation conditions. In a third experiment, we correlated the sound with a distractor instead of the target. This produced longer search times, indicating that the correlation is not easily ignored.	[Zannoli, Marina; Mamassian, Pascal] Univ Paris 05, Paris, France; [Zannoli, Marina; Mamassian, Pascal] CNRS, UMR 8158, Lab Psychol Percept, Paris, France; [Cass, John] Univ Western Sydney, Sch Psychol, Sydney, NSW, Australia; [Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Western Sydney University; University of Sydney	Zannoli, M (corresponding author), Univ Paris 05, Paris, France.	marinazannoli@gmail.com	Cass, John/AAC-7505-2021; Mamassian, Pascal/F-4781-2012	Mamassian, Pascal/0000-0002-1605-4607	French Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris Descartes	French Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris Descartes	This work was supported by a grant from the French Ministere de l'Enseignement Superieur et de la Recherche and by a travel grant from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2008, VISION RES, V48, P2537, DOI 10.1016/j.visres.2008.08.018; Assee A, 2007, VISION RES, V47, P2585, DOI 10.1016/j.visres.2007.07.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks KR, 2006, J VISION, V6, P1257, DOI 10.1167/6.11.9; Harris JM, 1998, NAT NEUROSCI, V1, P165, DOI 10.1038/418; Harris JM, 2008, SPATIAL VISION, V21, P531, DOI 10.1163/156856808786451462; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; MARR D, 1976, SCIENCE, V194, P283, DOI 10.1126/science.968482; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Neisser  U., 1964, VISUAL SEARCH; Nienborg H, 2005, J NEUROSCI, V25, P10207, DOI 10.1523/JNEUROSCI.2342-05.2005; Noesselt T, 2010, J NEUROSCI, V30, P13609, DOI 10.1523/JNEUROSCI.4524-09.2010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsirlin I, 2011, BROADCASTING IEEE T, P1; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Van der Burg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010664; Zannoli M, 2011, J VISION, V1, P11	20	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37190	10.1371/journal.pone.0037190	http://dx.doi.org/10.1371/journal.pone.0037190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615939	gold, Green Published			2022-12-27	WOS:000305341200049
J	Alkjaer, T; Raffalt, P; Petersen, NC; Simonsen, EB				Alkjaer, Tine; Raffalt, Peter; Petersen, Nicolas C.; Simonsen, Erik B.			Movement Behavior of High-Heeled Walking: How Does the Nervous System Control the Ankle Joint during an Unstable Walking Condition?	PLOS ONE			English	Article							RECIPROCAL INHIBITION; KNEE OSTEOARTHRITIS; POSTURAL STABILITY; NONLINEAR DYNAMICS; EMG ACTIVITY; GAIT; VARIABILITY; SHOES; MODULATION; KINEMATICS	The human locomotor system is flexible and enables humans to move without falling even under less than optimal conditions. Walking with high-heeled shoes constitutes an unstable condition and here we ask how the nervous system controls the ankle joint in this situation? We investigated the movement behavior of high-heeled and barefooted walking in eleven female subjects. The movement variability was quantified by calculation of approximate entropy (ApEn) in the ankle joint angle and the standard deviation (SD) of the stride time intervals. Electromyography (EMG) of the soleus (SO) and tibialis anterior (TA) muscles and the soleus Hoffmann (H-) reflex were measured at 4.0 km/h on a motor driven treadmill to reveal the underlying motor strategies in each walking condition. The ApEn of the ankle joint angle was significantly higher (p<0.01) during high-heeled (0.38+/-0.08) than during barefooted walking (0.28+/-0.07). During high-heeled walking, coactivation between the SO and TA muscles increased towards heel strike and the H-reflex was significantly increased in terminal swing by 40% (p<0.01). These observations show that high-heeled walking is characterized by a more complex and less predictable pattern than barefooted walking. Increased coactivation about the ankle joint together with increased excitability of the SO H-reflex in terminal swing phase indicates that the motor strategy was changed during high-heeled walking. Although, the participants were young, healthy and accustomed to high-heeled walking the results demonstrate that that walking on high-heels needs to be controlled differently from barefooted walking. We suggest that the higher variability reflects an adjusted neural strategy of the nervous system to control the ankle joint during high-heeled walking.	[Alkjaer, Tine; Raffalt, Peter; Petersen, Nicolas C.; Simonsen, Erik B.] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Petersen, Nicolas C.] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Alkjaer, T (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	talkjaer@sund.ku.dk	Petersen, Nicolas Caesar/ABD-2687-2021; Petersen, Nicolas Caesar/AAE-4354-2022; Petersen, Nicolas Caesar/F-7307-2014	Petersen, Nicolas Caesar/0000-0001-6206-8295; Petersen, Nicolas Caesar/0000-0001-6206-8295; Petersen, Nicolas Caesar/0000-0001-6206-8295; Raffalt, Peter/0000-0002-0119-9141; Alkjaer, Tine/0000-0002-9105-3882; Simonsen, Erik Bruun/0000-0002-6378-6595				Arampatzis A, 2006, J BIOMECH, V39, P1891, DOI 10.1016/j.jbiomech.2005.05.010; ARSENAULT AB, 1986, MED BIOL ENG COMPUT, V24, P337, DOI 10.1007/BF02442685; Barbieri E B, 1983, J Gerontol Nurs, V9, P165; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Bernstein N, 1967, COORDINATION REGULAT; Buzzi UH, 2004, MOTOR CONTROL, V8, P241, DOI 10.1123/mcj.8.3.241; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cignetti F, 2009, J BIOMECH, V42, P1452, DOI 10.1016/j.jbiomech.2009.04.012; Cronin NJ, 2012, J APPL PHYSL; Decker LM, 2011, KNEE SURG SPORT TR A, V19, P1620, DOI 10.1007/s00167-011-1484-2; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; EDAMURA M, 1991, J NEUROSCI, V11, P420; Esenyel M, 2003, J AM PODIAT MED ASSN, V93, P27, DOI 10.7547/87507315-93-1-27; Ferris DP, 2001, J PHYSIOL-LONDON, V530, P167, DOI 10.1111/j.1469-7793.2001.0167m.x; Finley JM, 2012, EXP BRAIN RES, V217, P53, DOI 10.1007/s00221-011-2972-9; Frey CC, 1995, AAOS INSTR COURS LEC, V44, P385; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hsue BJ, 2009, J ELECTROMYOGR KINES, V19, P1071, DOI 10.1016/j.jelekin.2008.09.005; Joseph J, 1968, Ann Phys Med, V9, P295; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kerrigan DC, 2001, LANCET, V357, P1097, DOI 10.1016/S0140-6736(00)04312-9; Kerrigan DC, 1998, LANCET, V351, P1399, DOI 10.1016/S0140-6736(97)11281-8; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Lavoie BA, 1997, J NEUROPHYSIOL, V78, P429, DOI 10.1152/jn.1997.78.1.429; LEE KH, 1990, ARCH PHYS MED REHAB, V71, P31; Linder M, 1998, INT J HEALTH SERV, V28, P201, DOI 10.2190/GA2M-FLA2-17FB-V5PE; Menz HB, 1999, J AM PODIAT MED ASSN, V89, P346, DOI 10.7547/87507315-89-7-346; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; NIELSEN J, 1993, J PHYSIOL-LONDON, V464, P575, DOI 10.1113/jphysiol.1993.sp019652; OPILACORREIA KA, 1990, ARCH PHYS MED REHAB, V71, P304; OPILACORREIA KA, 1990, ARCH PHYS MED REHAB, V71, P905; Perotto A. O., 2009, ANATOMICAL GUIDE ELE; Petersen N, 1999, J PHYSIOL-LONDON, V520, P605, DOI 10.1111/j.1469-7793.1999.00605.x; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Schneider C, 2000, J NEUROPHYSIOL, V83, P2881, DOI 10.1152/jn.2000.83.5.2881; Simonsen EB, 2011, J APPL BIOMECH; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Smith EO, 1999, FOOT ANKLE INT, V20, P55, DOI 10.1177/107110079902000113; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trimble MH, 2001, MUSCLE NERVE, V24, P1371, DOI 10.1002/mus.1158	44	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37390	10.1371/journal.pone.0037390	http://dx.doi.org/10.1371/journal.pone.0037390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615997	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300109
J	Clement, R; Blanc, P; Mauroy, B; Sapin, V; Douady, S				Clement, Raphael; Blanc, Pierre; Mauroy, Benjamin; Sapin, Vincent; Douady, Stephane			Shape Self-Regulation in Early Lung Morphogenesis	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; MOUSE LUNG; GROWTH; FGF10; MECHANISMS; EXPRESSION; DIFFUSION; SHH	The arborescent architecture of mammalian conductive airways results from the repeated branching of lung endoderm into surrounding mesoderm. Subsequent lung's striking geometrical features have long raised the question of developmental mechanisms involved in morphogenesis. Many molecular actors have been identified, and several studies demonstrated the central role of Fgf10 and Shh in growth and branching. However, the actual branching mechanism and the way branching events are organized at the organ scale to achieve a self-avoiding tree remain to be understood through a model compatible with evidenced signaling. In this paper we show that the mere diffusion of FGF10 from distal mesenchyme involves differential epithelial proliferation that spontaneously leads to branching. Modeling FGF10 diffusion from sub-mesothelial mesenchyme where Fgf10 is known to be expressed and computing epithelial and mesenchymal growth in a coupled manner, we found that the resulting laplacian dynamics precisely accounts for the patterning of FGF10-induced genes, and that it spontaneously involves differential proliferation leading to a self-avoiding and space-filling tree, through mechanisms that we detail. The tree's fine morphological features depend on the epithelial growth response to FGF10, underlain by the lung's complex regulatory network. Notably, our results suggest that no branching information has to be encoded and that no master routine is required to organize branching events at the organ scale. Despite its simplicity, this model identifies key mechanisms of lung development, from branching to organ-scale organization, and could prove relevant to the development of other branched organs relying on similar pathways.	[Clement, Raphael; Douady, Stephane] Univ Paris Diderot, Lab Matiere & Syst Complexes, CNRS, UMR 7057, Paris, France; [Clement, Raphael; Mauroy, Benjamin] Univ Nice Sophia Antipolis, Lab JA Dieudonne, CNRS, UMR 7531, Nice, France; [Blanc, Pierre; Sapin, Vincent] Auvergne Univ, Sch Med, EA R2D2, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); Universite de Franche-Comte	Clement, R (corresponding author), Univ Paris Diderot, Lab Matiere & Syst Complexes, CNRS, UMR 7057, Paris, France.	raphael.clement@unice.fr	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X; Clement, Raphael/0000-0002-1270-1934; BLANC, Pierre/0000-0003-3802-0923	CNRS interdisciplinary program; Ville de Nice: "Aide individuelle aux jeunes chercheurs"	CNRS interdisciplinary program; Ville de Nice: "Aide individuelle aux jeunes chercheurs"	Funding came from a 2007/CNRS interdisciplinary program "Interface physique, biologie et chimie: Soutien a la prise de risque. (http://www.dr19.cnrs.fr/Cnrs-Hebdo/Actualites/492/Suite.aspx) and a 2011/Ville de Nice: "Aide individuelle aux jeunes chercheurs" (http://www.coteazur.cnrs.fr/Services/Spv/Subventions Spv/SpvAidesVilleNice/SpvAidesVilleNiceAidePostDoc/;view). The funders had no role in study design, data collection and analysis, decision to publish, or publication of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Bokov P, 2010, RESP PHYSIOL NEUROBI, V173, P1, DOI 10.1016/j.resp.2010.05.011; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Florens M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178104; FUJIKAWA H, 1989, J PHYS SOC JPN, V58, P3875, DOI 10.1143/JPSJ.58.3875; Hirashima T, 2009, DEV DYNAM, V238, P2813, DOI 10.1002/dvdy.22108; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Lajeunesse E, 2000, J FLUID MECH, V419, P125, DOI 10.1017/S0022112000001324; LUBKIN SR, 1995, J MATH BIOL, V34, P77, DOI 10.1007/BF00180137; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mauroy B, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016007; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Miura T, 2002, MECH DEVELOP, V116, P29, DOI 10.1016/S0925-4773(02)00132-6; MULLINS WW, 1963, J APPL PHYS, V34, P323, DOI 10.1063/1.1702607; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; SAFFMAN PG, 1958, PROC R SOC LON SER-A, V245, P312, DOI 10.1098/rspa.1958.0085; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Unbekandt M, 2008, MECH DEVELOP, V125, P314, DOI 10.1016/j.mod.2007.10.013; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400	30	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36925	10.1371/journal.pone.0036925	http://dx.doi.org/10.1371/journal.pone.0036925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615846	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300044
J	Hervella, M; Plantinga, TS; Alonso, S; Ferwerda, B; Izagirre, N; Fontecha, L; Fregel, R; van der Meer, JWM; De-La-Rua, C; Netea, MG				Hervella, Montserrat; Plantinga, Theo S.; Alonso, Santos; Ferwerda, Bart; Izagirre, Neskuts; Fontecha, Lara; Fregel, Rosa; van der Meer, Jos W. M.; de-la-Rua, Concepcion; Netea, Mihai G.			The Loss of Functional Caspase-12 in Europe Is a Pre-Neolithic Event	PLOS ONE			English	Article							EVOLUTION; POPULATIONS; PERSISTENCE; GENE	Background: Caspase-12 (CASP12) modulates the susceptibility to sepsis. In humans, the "C" allele at CASP12 rs497116 has been associated with an increased risk of sepsis. Instead, the derived "T" allele encodes for an inactive caspase-12. Interestingly, Eurasians are practically fixed for the inactive variant, whereas in Sub-Saharan Africa the active variant is still common (similar to 24%). This marked structure has been explained as a function of the selective advantage that the inactive caspase-12 confers by increasing resistance to infection. As regards to both when positive selection started acting and as to the speed with which fixation was achieved in Eurasia, estimates depend on the method and assumptions used, and can vary substantially. Using experimental evidence, we propose that, least in Eurasia, the increase in the frequency of the T allele might be related to the selective pressure exerted by the increase in zoonotic diseases transmission caused by the interplay between increased human population densities and a closer contact with animals during the Neolithic. Methodolog/ Principal Findings: We genotyped CASP12 rs497116 in prehistoric individuals from 6 archaeological sites from the North of the Iberian Peninsula that date from Late Upper Paleolithic to Late Neolithic. DNA extraction was done from teeth lacking cavities or breakages using standard anti-contamination procedures, including processing of the samples in a positive pressure, ancient DNA-only chamber, quantitation of DNAs by qPCR, duplication, replication, genotyping of associated animals, or cloning of PCR products. Out of 50, 24 prehistoric individuals could finally be genotyped for rs497116. Only the inactive form of CASP12 was found. Conclusions/Significance: We demonstrate that the loss of caspase-12 in Europe predates animal domestication and that consequently CASP12 loss is unlikely to be related to the impact of zoonotic infections transmitted by livestock.	[Hervella, Montserrat; Alonso, Santos; Izagirre, Neskuts; Fontecha, Lara; de-la-Rua, Concepcion] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Plantinga, Theo S.; Ferwerda, Bart; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, Nijmegen, Netherlands; [Ferwerda, Bart] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Fregel, Rosa] Univ La Laguna, Dept Genet, E-38207 San Cristobal la Laguna, Spain; [van der Meer, Jos W. M.; Netea, Mihai G.] Nijmegen Ctr Infect Inflammat & Immun N4i, Nijmegen, Netherlands	University of Basque Country; Radboud University Nijmegen; University of Pennsylvania; Universidad de la Laguna	Hervella, M (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	montse.hervella@ehu.es	Afonso, Montse Hervella/X-4520-2019; Plantinga, Theo S./A-6895-2015; Alonso, Santos/L-8316-2014; van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014; Fregel, Rosa/H-4942-2015	Plantinga, Theo S./0000-0003-4990-6084; Alonso, Santos/0000-0003-0221-4048; van der Meer, Jos W.M./0000-0001-5120-3690; Fregel, Rosa/0000-0002-2951-6508; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; Ferwerda, Bart/0000-0002-7050-5931; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; HERVELLA AFONSO, MONTSERRAT/0000-0003-4594-2950	Vici grant of the Netherlands Organisation for Scientific Research [91810610]; Spanish Ministry of Science and Innovation [CGL-2007-65515]; Basque Government to Research Groups of the Basque University System [IT453-07, IT542-10]; University of the Basque Country, UPV/EHU [UFI 11/09]	Vici grant of the Netherlands Organisation for Scientific Research; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government to Research Groups of the Basque University System; University of the Basque Country, UPV/EHU	This work was supported by a Vici grant 91810610 of the Netherlands Organisation for Scientific Research to MGN, and by the Spanish Ministry of Science and Innovation, CGL-2007-65515 and grants IT453-07 and IT542-10 from the Basque Government to Research Groups of the Basque University System to CR, and (UFI 11/09) from the University of the Basque Country, UPV/EHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2003, INT CONGR SER, V1239, P585, DOI 10.1016/S0531-5131(02)00401-6; Altuna J, 2009, ARCHAEOFAUNA, V18, P137; Cooper A, 2000, SCIENCE, V289, P1139; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Ferwerda B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006870; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gillespie JH, 1998, POPULATION GENETICS; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hernandez RD, 2008, BIOINFORMATICS, V24, P2786, DOI 10.1093/bioinformatics/btn522; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Lamkanfi M, 2004, CELL DEATH DIFFER, V11, P365, DOI 10.1038/sj.cdd.4401364; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; McCall MBB, 2010, EUR CYTOKINE NETW, V21, P77, DOI 10.1684/ecn.2010.0187; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Plantinga TS, 2012, EUR J HUM GENET, V20, P778, DOI 10.1038/ejhg.2011.254; Roy S, 2008, P NATL ACAD SCI USA, V105, P4133, DOI 10.1073/pnas.0706658105; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116	27	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37022	10.1371/journal.pone.0037022	http://dx.doi.org/10.1371/journal.pone.0037022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615879	Green Published, gold			2022-12-27	WOS:000305341300055
J	Nam, SY; Ricles, LM; Suggs, LJ; Emelianov, SY				Nam, Seung Yun; Ricles, Laura M.; Suggs, Laura J.; Emelianov, Stanislav Y.			In vivo Ultrasound and Photoacoustic Monitoring of Mesenchymal Stem Cells Labeled with Gold Nanotracers	PLOS ONE			English	Article							NANOPARTICLES; TRANSPLANTATION; RESOLUTION; THERAPY; SIZE	Longitudinal monitoring of cells is required in order to understand the role of delivered stem cells in therapeutic neovascularization. However, there is not an imaging technique that is capable of quantitative, longitudinal assessment of stem cell behaviors with high spatial resolution and sufficient penetration depth. In this study, in vivo and in vitro experiments were performed to demonstrate the efficacy of ultrasound-guided photoacoustic (US/PA) imaging to monitor mesenchymal stem cells (MSCs) labeled with gold nanotracers (Au NTs). The Au NT labeled MSCs, injected intramuscularly in the lower limb of the Lewis rat, were detected and spatially resolved. Furthermore, our quantitative in vitro cell studies indicate that US/PA imaging is capable of high detection sensitivity (1 x 10(4) cells/mL) of the Au NT labeled MSCs. Finally, Au NT labeled MSCs captured in the PEGylated fibrin gel system were imaged in vivo, as well as in vitro, over a one week time period, suggesting that longitudinal cell tracking using US/PA imaging is possible. Overall, Au NT labeling of MSCs and US/PA imaging can be an alternative approach in stem cell imaging capable of noninvasive, sensitive, quantitative, longitudinal assessment of stem cell behaviors with high spatial and temporal resolutions at sufficient depths.	[Nam, Seung Yun; Ricles, Laura M.; Suggs, Laura J.; Emelianov, Stanislav Y.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Nam, Seung Yun; Emelianov, Stanislav Y.] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Nam, SY (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	emelian@mail.utexas.edu	Nam, Seung Yun/AGO-0393-2022	Nam, Seung Yun/0000-0002-9758-9442; Emelianov, Stanislav/0000-0002-7098-133X; /0000-0002-1419-8017	National Institutes of Health [CA1497403, EB008101]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015007, R01EB008101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health under grants CA1497403 and EB008101. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], Z13632005 ANSI; Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Emelianov SY, 2006, ULTRASON, P405; Emelianov SY, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3141939; Hu S, 2009, OPT EXPRESS, V17, P7688, DOI 10.1364/OE.17.007688; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Li SC, 2010, STEM CELL REV REP, V6, P317, DOI 10.1007/s12015-010-9130-9; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Lloyd J, 2010, CIRCULATION, V121, pE260; Mallidi S, 2007, OPT EXPRESS, V15, P6583, DOI 10.1364/OE.15.006583; Mallidi S, 2009, NANO LETT, V9, P2825, DOI 10.1021/nl802929u; Oraevsky AA, 2003, BIOMEDICAL PHOTONICS, V34, P1; Park S, 2008, OPT LETT, V33, P1291, DOI 10.1364/OL.33.001291; Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sheikh Ahmad Y, 2006, Curr Cardiol Rep, V8, P147, DOI 10.1007/s11886-006-0026-x; Su JLS, 2009, OPT EXPRESS, V17, P19894, DOI 10.1364/OE.17.019894; Wang B, 2009, NANO LETT, V9, P2212, DOI 10.1021/nl801852e; Wang LV, 2008, MED PHYS, V35, P5758, DOI 10.1118/1.3013698; Wu JC, 2007, J NUCL MED, V48, P1916, DOI 10.2967/jnumed.107.043299; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yoon SJ, 2010, OPT LETT, V35, P3751, DOI 10.1364/OL.35.003751; Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9; Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289; Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018; Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220; Zhou R, 2006, J AM COLL CARDIOL, V48, P2094, DOI 10.1016/j.jacc.2006.08.026	33	137	140	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37267	10.1371/journal.pone.0037267	http://dx.doi.org/10.1371/journal.pone.0037267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615959	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300093
J	Guiraud, JA; Tomalski, P; Kushnerenko, E; Ribeiro, H; Davies, K; Charman, T; Elsabbagh, M; Johnson, MH				Guiraud, Jeanne A.; Tomalski, Przemyslaw; Kushnerenko, Elena; Ribeiro, Helena; Davies, Kim; Charman, Tony; Elsabbagh, Mayada; Johnson, Mark H.		BASIS Team	Atypical Audiovisual Speech Integration in Infants at Risk for Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; ASPERGER-SYNDROME; PERCEPTION; ADULTS; INDIVIDUALS; INFORMATION; ATTENTION; FIXATION; CHILDREN; VOICE	The language difficulties often seen in individuals with autism might stem from an inability to integrate audiovisual information, a skill important for language development. We investigated whether 9-month-old siblings of older children with autism, who are at an increased risk of developing autism, are able to integrate audiovisual speech cues. We used an eyetracker to record where infants looked when shown a screen displaying two faces of the same model, where one face is articulating/ba/and the other/ga/, with one face congruent with the syllable sound being presented simultaneously, the other face incongruent. This method was successful in showing that infants at low risk can integrate audiovisual speech: they looked for the same amount of time at the mouths in both the fusible visual/ga/- audio/ba/and the congruent visual/ba/- audio/ba/displays, indicating that the auditory and visual streams fuse into a McGurk-type of syllabic percept in the incongruent condition. It also showed that low-risk infants could perceive a mismatch between auditory and visual cues: they looked longer at the mouth in the mismatched, non-fusible visual/ba/- audio/ga/display compared with the congruent visual/ga/- audio/ga/display, demonstrating that they perceive an uncommon, and therefore interesting, speech-like percept when looking at the incongruent mouth (repeated ANOVA: displays x fusion/mismatch conditions interaction: F(1,16) = 17.153, p = 0.001). The looking behaviour of high-risk infants did not differ according to the type of display, suggesting difficulties in matching auditory and visual information (repeated ANOVA, displays x conditions interaction: F(1,25) = 0.09, p = 0.767), in contrast to low-risk infants (repeated ANOVA: displays x conditions x low/high-risk groups interaction: F(1,41) = 4.466, p = 0.041). In some cases this reduced ability might lead to the poor communication skills characteristic of autism.	[Guiraud, Jeanne A.; Ribeiro, Helena; Davies, Kim; Elsabbagh, Mayada; Johnson, Mark H.] Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Tomalski, Przemyslaw; Kushnerenko, Elena] Univ E London, Sch Psychol, Inst Res Child Dev, London E15 4LZ, England; [Charman, Tony] Univ London, Inst Educ, Dept Psychol & Human Dev, Ctr Res Autism & Educ, London WC1N 1AZ, England	University of London; Birkbeck University London; University of East London; University of London; University College London; UCL Institute of Education	Guiraud, JA (corresponding author), Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.	jeanne_guiraud@hotmail.com	Charman, Tony/A-2085-2014; Tomalski, Przemyslaw/C-7694-2012; Kushnerenko, Elena/B-6486-2008	Charman, Tony/0000-0003-1993-6549; Tomalski, Przemyslaw/0000-0002-0390-5759; Elsabbagh, Mayada/0000-0002-7311-9059; Baron-Cohen, Simon/0000-0001-9217-2544; Johnson, Mark/0000-0003-4229-2585; Tucker, Leslie/0000-0002-9857-498X; Green, Jonathan/0000-0002-0143-181X	consortium of funders; MRC (Medical Research Council) [G0701484]; MRC [G0701484] Funding Source: UKRI; Autistica [7221] Funding Source: researchfish; Medical Research Council [G0701484] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	consortium of funders; MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autistica(Autistica); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The British Autism Study of Infant Siblings (BASIS) is supported by a consortium of funders led by Autistica (see www.basisnetwork.org). This project is additionally supported by MRC (Medical Research Council) grant G0701484 to MHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association, DIAGN STAT MAN MENT; Andersen TS, 2009, SPEECH COMMUN, V51, P184, DOI 10.1016/j.specom.2008.07.004; BINNIE CA, 1974, J SPEECH HEAR RES, V17, P619, DOI 10.1044/jshr.1704.619; Bosseler, 2003, J DEV LEARNING DISOR, V7, P111; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; DODD B, 1977, PERCEPTION, V6, P31, DOI 10.1068/p060031; Elsabbagh M, 2010, TRENDS COGN SCI, V14, P81, DOI 10.1016/j.tics.2009.12.005; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Guiraud JA, 2011, NEUROREPORT, V22, P845, DOI 10.1097/WNR.0b013e32834c0bec; Hindley P, 2005, PSYCHIATRY, V4, P45; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Howlin P, 2003, J AUTISM DEV DISORD, V33, P3, DOI 10.1023/A:1022270118899; Hus V, 2007, BIOL PSYCHIAT, V61, P438, DOI 10.1016/j.biopsych.2006.08.044; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Irwin JR, 2011, CHILD DEV, V82, P1397, DOI 10.1111/j.1467-8624.2011.01619.x; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; K Sekiyama, 2004, INTERSPEECH 2004; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Koning C, 2001, AUTISM, V5, P23, DOI 10.1177/1362361301005001003; Kushnerenko E, 2011, INDIVIDUAL IN PRESS; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Legerstee M, 1990, INFANT BEHAV DEV, V17, P829; LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F; LOVELAND KA, 1995, DEV PSYCHOPATHOL, V7, P409, DOI 10.1017/S095457940000660X; Massaro D.W., 1998, PERCEIVING TALKING F; MASSARO DW, 1986, J EXP CHILD PSYCHOL, V41, P93, DOI 10.1016/0022-0965(86)90053-6; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Megnin O, AUTISM RES IN PRESS; Mongillo EA, 2008, J AUTISM DEV DISORD, V38, P1349, DOI 10.1007/s10803-007-0521-y; Pare M, 2003, PERCEPT PSYCHOPHYS, V65, P553, DOI 10.3758/BF03194582; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; Rutter M., 2003, SOCIAL COMMUNICATION; S Ozonoff, PEDIATRICS IN PRESS; SEKIYAMA K, 1993, J PHONETICS, V21, P427, DOI 10.1016/S0095-4470(19)30229-3; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, V3rd, P335; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Tiippana K, 2004, EUR J COGN PSYCHOL, V16, P457, DOI 10.1080/09541440340000268; Tomalski P, 2011, EXPLORING E IN PRESS; Townsend J, 1996, J Int Neuropsychol Soc, V2, P541; Williams JHG, 2004, RES DEV DISABIL, V25, P559, DOI 10.1016/j.ridd.2004.01.008; ZELAZO PD, 2002, HDB CHILDHOOD COGNIT	51	31	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36428	10.1371/journal.pone.0036428	http://dx.doi.org/10.1371/journal.pone.0036428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615768	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305336300016
J	Mendoza-Naranjo, A; Cormie, P; Serrano, AE; Hu, R; O'Neill, S; Wang, CM; Thrasivoulou, C; Power, KT; White, A; Serena, T; Phillips, ARJ; Becker, DL				Mendoza-Naranjo, Ariadna; Cormie, Peter; Serrano, Antonio E.; Hu, Rebecca; O'Neill, Shay; Wang, Chiuhui Mary; Thrasivoulou, Christopher; Power, Kieran T.; White, Alexis; Serena, Thomas; Phillips, Anthony R. J.; Becker, David L.			Targeting Cx43 and N-Cadherin, Which Are Abnormally Upregulated in Venous Leg Ulcers, Influences Migration, Adhesion and Activation of Rho GTPases	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; CONNEXIN EXPRESSION; CELL-MIGRATION; INTERCELLULAR COMMUNICATION; HUMAN SKIN; PROTEIN CONNEXIN-43; WOUND REPAIR; MOUSE; ORGANIZATION; ASTROCYTES	Background: Venous leg ulcers can be very hard to heal and represent a significant medical need with no effective therapeutic treatment currently available. Principal Findings: In wound edge biopsies from human venous leg ulcers we found a striking upregulation of dermal N-cadherin, Zonula Occludens-1 and the gap junction protein Connexin43 (Cx43) compared to intact skin, and in stark contrast to the down-regulation of Cx43 expression seen in acute, healing wounds. We targeted the expression of these proteins in 3T3 fibroblasts to evaluate their role in venous leg ulcers healing. Knockdown of Cx43 and N-cadherin, but not Zonula Occludens-1, accelerated cell migration in a scratch wound-healing assay. Reducing Cx43 increased Golgi reorientation, whilst decreasing cell adhesion and proliferation. Furthermore, Connexin43 and N-cadherin knockdown led to profound effects on fibroblast cytoskeletal dynamics after scratch-wounding. The cells exhibited longer lamelipodial protrusions lacking the F-actin belt seen at the leading edge in wounded control cells. This phenotype was accompanied by augmented activation of Rac-1 and RhoA GTPases, as revealed by Forster Resonance Energy Transfer and pull down experiments. Conclusions: Cx43 and N-cadherin are potential therapeutic targets in the promotion of healing of venous leg ulcers, by acting at least in part through distinct contributions of cell adhesion, migration, proliferation and cytoskeletal dynamics.	[Mendoza-Naranjo, Ariadna; Cormie, Peter; Serrano, Antonio E.; Wang, Chiuhui Mary; Thrasivoulou, Christopher; Power, Kieran T.; Becker, David L.] UCL, Dept Cell & Dev Biol, London, England; [Hu, Rebecca; O'Neill, Shay; White, Alexis; Phillips, Anthony R. J.] CoDa Therapeut, Auckland, New Zealand; [Serena, Thomas] Newbridge Med Res Corp, Warren, PA USA	University of London; University College London	Mendoza-Naranjo, A (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	a.mendoza@ucl.ac.uk; d.becker@ucl.ac.uk	Wang, Chiuhui Mary/B-8277-2009; Becker, David Laurence/GZL-4411-2022; Serrano, Antonio/C-1348-2009; Thrasivoulou, Christopher/F-7087-2010	Wang, Chiuhui Mary/0000-0003-1163-0959; Serrano, Antonio/0000-0002-6728-0081; Thrasivoulou, Christopher/0000-0001-9425-8624	Action Medical Research; Henry Smith Charity	Action Medical Research; Henry Smith Charity	This work was supported in part by Action Medical Research, and the Henry Smith Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; BATTEN BE, 1979, ANAT REC, V194, P125, DOI 10.1002/ar.1091940109; Becker D, 2001, CELL COMMUN ADHES, V8, P355, DOI 10.3109/15419060109080753; BECKER DL, 1995, MICROSC RES TECHNIQ, V31, P364, DOI 10.1002/jemt.1070310506; BECKER DL, 1995, J CELL SCI, V108, P1455; Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Coutinho P, 2005, BRIT J PLAST SURG, V58, P658, DOI 10.1016/j.bjps.2004.12.022; Coutinho P, 2003, CELL BIOL INT, V27, P525, DOI 10.1016/S1065-6995(03)00077-5; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Francis R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026379; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; GUO HM, 1992, J INVEST DERMATOL, V99, P460, DOI 10.1111/1523-1747.ep12616154; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kretz M, 2004, EUR J CELL BIOL, V83, P647, DOI 10.1078/0171-9335-00422; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; McDonough WS, 1999, INT J DEV NEUROSCI, V17, P601, DOI 10.1016/S0736-5748(99)00024-6; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pollok S, 2010, J CELL MOL MED; Qiu C, 2003, CURR BIOL, V13, P1697, DOI 10.1016/j.cub.2003.09.007; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Saitoh M, 1997, CARCINOGENESIS, V18, P1319, DOI 10.1093/carcin/18.7.1319; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Walmsley S, 2002, ADV WOUND MANAGEMENT; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; Wang HH, 2008, DEV BIOL, V318, P112, DOI 10.1016/j.ydbio.2008.03.008; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wilby MJ, 1999, MOL CELL NEUROSCI, V14, P66, DOI 10.1006/mcne.1999.0766; Wright CS, 2009, WOUND REPAIR REGEN, V17, P240, DOI 10.1111/j.1524-475X.2009.00471.x; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; YONEMURA S, 1995, J CELL SCI, V108, P127	62	52	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37374	10.1371/journal.pone.0037374	http://dx.doi.org/10.1371/journal.pone.0037374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615994	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300093
J	Nakano, T; Lai, CY; Goto, S; Hsu, LW; Kawamoto, S; Ono, K; Chen, KD; Lin, CC; Chiu, KW; Wang, CC; Cheng, YF; Chen, CL				Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Kawamoto, Seiji; Ono, Kazuhisa; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long			Immunological and Regenerative Aspects of Hepatic Mast Cells in Liver Allograft Rejection and Tolerance	PLOS ONE			English	Article							DELTA T-CELLS; NUCLEAR HISTONE H1; RAT-LIVER; BONE-MARROW; HEPATOCYTE PROLIFERATION; TUMOR MICROENVIRONMENT; 70-PERCENT HEPATECTOMY; OPERATIONAL TOLERANCE; KNOCKOUT MICE; GROWTH-FACTOR	The precise roles of mast cells in liver allograft rejection and tolerance are still unknown. This study aimed to explore the roles of mast cells in immune regulation and liver regeneration for tolerance induction by using rat models of orthotopic liver transplantation (OLT).Stem cell factor (SCF) and its receptor c-Kit, which are critical to the migration and development of not only stem cells but also mast cells, significantly increased in the tolerogenic livers as compared with rejected livers. The significant elevation of mast cell tryptase, high-affinity IgE receptor, and histamine suggested the activation of mast cells in liver allografts at the tolerogenic phase after OLT. Immunohistochemical analysis using confocal microscope clearly showed colocalization of mast cells, Foxp3(+) Tregs, gamma delta T cells, and recipient-derived hepatic progenitor cells with higher expression of SCF, IL-9, IL-10, TGF-beta 1, and IL-17 related to immunoregulation and liver regeneration in the donor grafts of a tolerogenic OLT model. Cross-talk among mast cells and other cells was evaluated by in vitro studies demonstrating that syngeneic bone marrow-derived mast cells (BMMCs) co-cultured with naive splenocytes or primary hepatocytes significantly increased the population of splenic gamma delta T cells by mitogen stimulation or by mast cell degranulation, and also significantly induced the hepatocyte proliferation, respectively. Our results suggested that mast cells in the donor grafts may play important roles in the induction/maintenance of immune tolerance and liver regeneration resulting in the replacement of hepatic cells from donor to recipient.	[Nakano, Toshiaki] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Niao Sung, Taiwan; [Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan; [Nakano, Toshiaki; Lai, Chia-Yun; Goto, Shigeru; Hsu, Li-Wen; Chen, Kuang-Den; Lin, Chih-Che; Chiu, King-Wah; Wang, Chih-Chi; Cheng, Yu-Fan; Chen, Chao-Long] Kaohsiung Chang Gung Mem Hosp, Div Transplant Immunol, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Kawamoto, Seiji; Ono, Kazuhisa] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan; [Lai, Chia-Yun] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Neipu, Pingtung, Taiwan; [Goto, Shigeru] Iwao Hosp, Oita, Japan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Hiroshima University; National Pingtung University Science & Technology	Nakano, T (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Niao Sung, Taiwan.	toshi.nakano@msa.hinet.net; clchen@cgmh.org.tw	Kawamoto, Seiji/F-3423-2015	Kawamoto, Seiji/0000-0002-2056-4802; Nakano, Toshiaki/0000-0003-3701-3449; Chiu, King-Wah/0000-0003-2108-6539	National Science Council [NSC98-2320-B-182-029-MY3, NSC98-2314-B-182A-050-MY2, NSC98-2314-B-182A-058-MY3]; Chang Gung Memorial Hospital of Taiwan [CMRPD880011/2, CMRPD891671, CMRPG881081/2, CMRPG870901/2, CMRPG870051, CMRPG890721]; Grants-in-Aid for Scientific Research [22380190] Funding Source: KAKEN	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants from the National Science Council (NSC98-2320-B-182-029-MY3 to TN; NSC98-2314-B-182A-050-MY2 to Y-FC; NSC98-2314-B-182A-058-MY3 to C-LC) and the Chang Gung Memorial Hospital (CMRPD880011/2 and CMRPD891671 to TN; CMRPG881081/2 to K-DC; CMRPG870901/2 to K-WC; CMRPG870051 to C-CW; CMRPG890721 to Y-FC) of Taiwan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Zenah H, 2002, NEPHRON, V91, P112, DOI 10.1159/000057612; ANDRZEJEWSKI W, 1982, EUR SURG RES, V14, P428, DOI 10.1159/000128317; Armbrust T, 1997, J HEPATOL, V26, P1042, DOI 10.1016/S0168-8278(97)80113-4; Batts KP, 1999, LIVER TRANSPLANT SUR, V5, pS21; Bearman S I, 1997, Curr Opin Hematol, V4, P157; Boerma M, 2007, TRANSPLANT INT, V20, P256, DOI 10.1111/j.1432-2277.2006.00420.x; CALNE RY, 1979, LANCET, V2, P1033; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; Chu Z, 2010, TRANSPL P, V42, P2599, DOI 10.1016/j.transproceed.2010.04.026; Denecke C, 2012, TRANSPL IMMUNOL; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; Fiegel HC, 2003, HEPATOLOGY, V37, P148, DOI 10.1053/jhep.2003.50007; Gaca MDA, 1999, J HEPATOL, V30, P850, DOI 10.1016/S0168-8278(99)80139-1; GASSEL HJ, 1987, TRANSPLANT P, V19, P351; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Goto E, 2002, CLIN TRANSPLANT, V16, P7, DOI 10.1034/j.1399-0012.16.s8.1.x; GOUW ASH, 1987, TRANSPLANTATION, V43, P291, DOI 10.1097/00007890-198702000-00025; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Hu B, 2008, AM J PHYSIOL-GASTR L, V295, pG45, DOI 10.1152/ajpgi.00024.2008; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; KAMADA N, 1985, IMMUNOLOGY, V55, P241; KAMADA N, 1984, TRANSPLANTATION, V38, P217, DOI 10.1097/00007890-198409000-00004; KAMADA N, 1981, NATURE, V292, P840, DOI 10.1038/292840a0; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Khalil RMA, 1996, INFECT IMMUN, V64, P4960, DOI 10.1128/IAI.64.12.4960-4966.1996; Koshiba T, 2007, TRANSPL IMMUNOL, V17, P94, DOI 10.1016/j.trim.2006.10.004; Koskinen PK, 2001, TRANSPLANTATION, V71, P1741, DOI 10.1097/00007890-200106270-00007; Lajoie G, 1996, MODERN PATHOL, V9, P1118; Li JZ, 2011, INT IMMUNOPHARMACOL, V11, P962, DOI 10.1016/j.intimp.2011.02.010; LI QY, 1992, TRANSPLANTATION, V53, P1047, DOI 10.1097/00007890-199205000-00015; Lord R, 1995, Transpl Immunol, V3, P174, DOI 10.1016/0966-3274(95)80045-X; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; LUDWIG J, 1995, HEPATOLOGY, V22, P648; Martinez-Llordella M, 2007, AM J TRANSPLANT, V7, P309, DOI 10.1111/j.1600-6143.2006.01621.x; Matsunaga Y, 1999, AM J GASTROENTEROL, V94, P1923; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakano T, 2004, TRANSPLANTATION, V77, P1595, DOI 10.1097/01.tp.0000123079.10650.71; Nakano T, 2008, TRANSPL IMMUNOL, V19, P87, DOI 10.1016/j.trim.2008.04.001; Nakano T, 2007, TRANSPLANTATION, V83, P1122, DOI 10.1097/01.tp.0000258646.54562.c7; Nakano T, 2007, TRANSPL IMMUNOL, V17, P147, DOI 10.1016/j.trim.2007.01.003; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; O'Keeffe C, 2002, LIVER TRANSPLANT, V8, P50, DOI 10.1053/jlts.2002.30343; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Ren XD, 2003, J CLIN INVEST, V112, P1407, DOI 10.1172/JCI200317391; Ren XD, 2008, SURGERY, V143, P790, DOI 10.1016/j.surg.2008.03.021; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Shen Z, 2011, MED HYPOTHESES, V76, P178, DOI 10.1016/j.mehy.2010.09.011; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Tateno C, 2000, HEPATOLOGY, V31, P65, DOI 10.1002/hep.510310113; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Truta-Feles K, 2010, BRIT J PHARMACOL, V161, P1291, DOI 10.1111/j.1476-5381.2010.00639.x; van de Wetering J, 2011, CLIN TRANSPLANT, V25, P40, DOI 10.1111/j.1399-0012.2010.01311.x; Wu T, 2003, AM J TRANSPLANT, V3, P1173, DOI 10.1046/j.1600-6143.2003.00137.x; Yamashiro M, 1998, VIRCHOWS ARCH, V433, P471, DOI 10.1007/s004280050276; Yang ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008922; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122; Yousem SA, 1997, HUM PATHOL, V28, P179, DOI 10.1016/S0046-8177(97)90103-9; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhang W, 2010, CLIN EXP IMMUNOL, V161, P490, DOI 10.1111/j.1365-2249.2010.04190.x	66	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37202	10.1371/journal.pone.0037202	http://dx.doi.org/10.1371/journal.pone.0037202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615941	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300078
J	Garner, AL; Kim, SK; Zhu, J; Struss, AK; Watkins, R; Feske, BD; Kaufmann, GF; Janda, KD				Garner, Amanda L.; Kim, Sook Kyung; Zhu, Jie; Struss, Anjali Kumari; Watkins, Richard; Feske, Brent D.; Kaufmann, Gunnar F.; Janda, Kim D.			Stereochemical Insignificance Discovered in Acinetobacter baumannii Quorum Sensing	PLOS ONE			English	Article							TO-CELL COMMUNICATION; KETO-ENOL-TAUTOMERISM; ACYL CARRIER PROTEIN; PSEUDOMONAS-AERUGINOSA; HOMOSERINE LACTONE; YERSINIA-PSEUDOTUBERCULOSIS; AUTOINDUCER; MOLECULES; VIRULENCE; BIOSYNTHESIS	Stereochemistry is a key aspect of molecular recognition for biological systems. As such, receptors and enzymes are often highly stereospecific, only recognizing one stereoisomer of a ligand. Recently, the quorum sensing signaling molecules used by the nosocomial opportunistic pathogen, Acinetobacter baumannii, were identified, and the primary signaling molecule isolated from this species was N-(3-hydroxydodecanoyl)-L-homoserine lactone. A plethora of bacterial species have been demonstrated to utilize 3-hydroxy-acylhomoserine lactone autoinducers, and in virtually all cases, the (R)-stereoisomer was identified as the natural ligand and exhibited greater autoinducer activity than the corresponding (S)-stereoisomer. Using chemical synthesis and biochemical assays, we have uncovered a case of stereochemical insignificance in A. baumannii and provide a unique example where stereochemistry appears nonessential for acylhomoserine lactone-mediated quorum sensing signaling. Based on previously reported phylogenetic studies, we suggest that A. baumannii has evolutionarily adopted this unique, yet promiscuous quorum sensing system to ensure its survival, particularly in the presence of other proteobacteria.	[Garner, Amanda L.; Kim, Sook Kyung; Zhu, Jie; Struss, Anjali Kumari; Kaufmann, Gunnar F.; Janda, Kim D.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Garner, Amanda L.; Kim, Sook Kyung; Zhu, Jie; Struss, Anjali Kumari; Kaufmann, Gunnar F.; Janda, Kim D.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Garner, Amanda L.; Kim, Sook Kyung; Zhu, Jie; Struss, Anjali Kumari; Kaufmann, Gunnar F.; Janda, Kim D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Garner, Amanda L.; Janda, Kim D.] Scripps Res Inst, Worm Inst Res & Med, La Jolla, CA 92037 USA; [Watkins, Richard; Feske, Brent D.] Armstrong Atlantic State Univ, Dept Chem, Savannah, GA USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University System of Georgia; Armstrong Atlantic State University	Garner, AL (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	kdjanda@scripps.edu		Feske, Brent/0000-0002-9360-7949	National Institutes of Health [AI079503, DE18452, AI080715, AI085324]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080715, R21AI079503, R21AI085324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (Grants AI079503 and DE18452 to KDJ, and Grants AI080715 and AI085324 to GFK) and The Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROS MT, 1986, J MOL STRUCT, V142, P435, DOI 10.1016/0022-2860(86)85150-X; Bhargava N, 2010, CRIT REV MICROBIOL, V36, P349, DOI 10.3109/1040841X.2010.512269; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; BURDETT JL, 1964, J AM CHEM SOC, V86, P2105, DOI 10.1021/ja01065a003; CAO JG, 1993, J BACTERIOL, V175, P3856, DOI 10.1128/JB.175.12.3856-3862.1993; Case RJ, 2008, ISME J, V2, P345, DOI 10.1038/ismej.2008.13; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Churchill MEA, 2011, CHEM REV, V111, P68, DOI 10.1021/cr1000817; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Duan K, 2007, J BACTERIOL, V189, P4827, DOI 10.1128/JB.00043-07; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Garcia-Aljaro C, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-138; Garner AL, 2011, BIOORG MED CHEM LETT, V21, P2702, DOI 10.1016/j.bmcl.2010.11.122; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Hoye TR, 2007, NAT PROTOC, V2, P2451, DOI 10.1038/nprot.2007.354; Jog GJ, 2006, CHEM BIOL, V13, P123, DOI 10.1016/j.chembiol.2005.12.013; Kaufmann GF, 2006, J AM CHEM SOC, V128, P2802, DOI 10.1021/ja0578698; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kaufmann GF, 2008, MOL IMMUNOL, V45, P2710, DOI 10.1016/j.molimm.2008.01.010; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; MAJERUS PW, 1965, J BIOL CHEM, V240, P618; Mattmann ME, 2010, J ORG CHEM, V75, P6737, DOI 10.1021/jo101237e; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Perez F, 2008, EXPERT REV ANTI-INFE, V6, P269, DOI 10.1586/14787210.6.3.269; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; Schripsema J, 1996, J BACTERIOL, V178, P366, DOI 10.1128/jb.178.2.366-371.1996; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3; Thiel V, 2009, CHEMBIOCHEM, V10, P1861, DOI 10.1002/cbic.200900126; VOLPE JJ, 1976, PHYSIOL REV, V56, P339, DOI 10.1152/physrev.1976.56.2.339; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Yajima A, 2008, ORG LETT, V10, P2047, DOI 10.1021/ol8005198; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002	45	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e37102	10.1371/journal.pone.0037102	http://dx.doi.org/10.1371/journal.pone.0037102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629354	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345300020
J	Ali, MA; Adem, A; Chandranath, IS; Benedict, S; Pathan, JY; Nagelkerke, N; Nyberg, F; Lewis, LK; Yandle, TG; Nicholls, GM; Frampton, CM; Kazzam, E				Ali, Mahmoud Alhaj; Adem, Abdu; Chandranath, Irwin S.; Benedict, Sheela; Pathan, Javed Y.; Nagelkerke, Nicolas; Nyberg, Fred; Lewis, Lynley K.; Yandle, Tim G.; Nicholls, Gary M.; Frampton, Chris M.; Kazzam, Elsadig			Responses to Dehydration in the One-Humped Camel and Effects of Blocking the Renin-Angiotensin System	PLOS ONE			English	Article							SODIUM CONCENTRATION; ALDOSTERONE SECRETION; PLASMA SODIUM; II RECEPTORS; WATER; SHEEP; DESERT	Our objectives were to compare the levels of circulating electrolytes, hormones, and renal function during 20 days of dehydration in camels versus the level in non-dehydrated camels and to record the effect of blocking angiotensin II AT1 receptors with losartan during dehydration. Dehydration induced significant increments in serum sodium, creatinine, urea, a substantial fall in body weight, and a doubling in plasma arginine vasopressin (AVP) levels. Plasma aldosterone, however, was unaltered compared with time-matched controls. Losartan significantly enhanced the effect of dehydration to reduce body weight and increase serum levels of creatinine and urea, whilst also impairing the rise in plasma AVP and reducing aldosterone levels. We conclude that dehydration in the camel induces substantial increments in serum sodium, creatinine, urea and AVP levels; that aldosterone levels are altered little by dehydration; that blockade of angiotensin II type 1 receptors enhances the dehydration-induced fall in body weight and increase in serum creatinine and urea levels whilst reducing aldosterone and attenuating the rise in plasma AVP.	[Ali, Mahmoud Alhaj; Adem, Abdu; Chandranath, Irwin S.] United Arab Emirates Univ, Dept Pharmacol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Ali, Mahmoud Alhaj; Nyberg, Fred] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Benedict, Sheela; Pathan, Javed Y.; Kazzam, Elsadig] United Arab Emirates Univ, Dept Internal Med, Al Ain, U Arab Emirates; [Nagelkerke, Nicolas] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates; [Lewis, Lynley K.; Yandle, Tim G.; Nicholls, Gary M.; Frampton, Chris M.] Univ Otago, Dept Med, Christchurch Hosp, Christchurch, New Zealand	United Arab Emirates University; Uppsala University; United Arab Emirates University; United Arab Emirates University; Christchurch Hospital New Zealand; University of Otago	Ali, MA (corresponding author), United Arab Emirates Univ, Dept Pharmacol, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	abdu.adem@uaeu.ac.ae	Adem, Abdu/AAN-8271-2021; PATHAN, JAVED YASIN/GOE-4396-2022	Adem, Abdu/0000-0002-9289-5301; PATHAN, JAVED YASIN/0000-0002-5867-2833; Ali, Mahmoud/0000-0003-0614-9191	Faculty of Medicine and Health Sciences (FMHS); United Arab Emirates University (UAEU); HH Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences Grant	Faculty of Medicine and Health Sciences (FMHS); United Arab Emirates University (UAEU); HH Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences Grant	This study was supported by a grant to the research group from the Faculty of Medicine and Health Sciences (FMHS), United Arab Emirates University (UAEU) and from HH Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGOUMI M, 1993, GEN COMP ENDOCR, V89, P378, DOI 10.1006/gcen.1993.1045; BLAIRWES.JR, 1966, AUST J EXP BIOL MED, V44, P455, DOI 10.1038/icb.1966.43; BLAIRWEST JR, 1965, CIRC RES, V17, P386, DOI 10.1161/01.RES.17.5.386; Brooks VL, 1993, RENIN ANGIOTENSIN SY, P351; FINBERG JPM, 1978, J APPL PHYSIOL, V44, P926, DOI 10.1152/jappl.1978.44.6.926; INAGAMI T, 1994, J HYPERTENS, V12, pS83; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Klingbeil CK, 1986, AM J PHYSIOL, V14, pE52; Kohler-Rollefson I, 2001, FIELD MANUAL CAMEL D; MACFARLANE WV, 1963, NATURE, V197, P270, DOI 10.1038/197270a0; McKinley MJ, 2001, HYPERTENSION, V37, P1375, DOI 10.1161/01.HYP.37.6.1375; MERRILL DC, 1989, HYPERTENSION, V14, P164, DOI 10.1161/01.HYP.14.2.164; RIAD F, 1994, GEN COMP ENDOCR, V95, P240, DOI 10.1006/gcen.1994.1121; Rosenstrom U, 2004, J MED CHEM, V47, P859, DOI 10.1021/jm030921v; SCHALEKAMP MADH, 1976, J CLIN ENDOCR METAB, V43, P287, DOI 10.1210/jcem-43-2-287; Schmidt-Nielsen K., 1964, DESERT ANIMALS PHYSL; SCHMIDTNIELSEN B, 1956, AM J PHYSIOL, V185, P185, DOI 10.1152/ajplegacy.1956.185.1.185; SCHNEIDER EG, 1984, ENDOCRINOLOGY, V115, P2195, DOI 10.1210/endo-115-6-2195; SIEBERT BD, 1971, PHYSIOL ZOOL, V44, P225, DOI 10.1086/physzool.44.4.30152494; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Yagil R, 1993, Contrib Nephrol, V102, P161	21	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37299	10.1371/journal.pone.0037299	http://dx.doi.org/10.1371/journal.pone.0037299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624009	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500092
J	Muijres, FT; Johansson, LC; Bowlin, MS; Winter, Y; Hedenstrom, A				Muijres, Florian T.; Johansson, L. Christoffer; Bowlin, Melissa S.; Winter, York; Hedenstroem, Anders			Comparing Aerodynamic Efficiency in Birds and Bats Suggests Better Flight Performance in Birds	PLOS ONE			English	Article							NECTAR-FEEDING BAT; FLAPPING FLIGHT; LEPTONYCTERIS-CURASOAE; POWER REQUIREMENTS; WAKE STRUCTURE; VORTEX WAKE; WIND-TUNNEL; ENERGY-COST; KINEMATICS; MIGRATION	Flight is one of the energetically most costly activities in the animal kingdom, suggesting that natural selection should work to optimize flight performance. The similar size and flight speed of birds and bats may therefore suggest convergent aerodynamic performance; alternatively, flight performance could be restricted by phylogenetic constraints. We test which of these scenarios fit to two measures of aerodynamic flight efficiency in two passerine bird species and two New World leaf-nosed bat species. Using time-resolved particle image velocimetry measurements of the wake of the animals flying in a wind tunnel, we derived the span efficiency, a metric for the efficiency of generating lift, and the lift-to-drag ratio, a metric for mechanical energetic flight efficiency. We show that the birds significantly outperform the bats in both metrics, which we ascribe to variation in aerodynamic function of body and wing upstroke: Bird bodies generated relatively more lift than bat bodies, resulting in a more uniform spanwise lift distribution and higher span efficiency. A likely explanation would be that the bat ears and nose leaf, associated with echolocation, disturb the flow over the body. During the upstroke, the birds retract their wings to make them aerodynamically inactive, while the membranous bat wings generate thrust and negative lift. Despite the differences in performance, the wake morphology of both birds and bats resemble the optimal wake for their respective lift-to-drag ratio regimes. This suggests that evolution has optimized performance relative to the respective conditions of birds and bats, but that maximum performance is possibly limited by phylogenetic constraints. Although ecological differences between birds and bats are subjected to many conspiring variables, the different aerodynamic flight efficiency for the bird and bat species studied here may help explain why birds typically fly faster, migrate more frequently and migrate longer distances than bats.	[Muijres, Florian T.; Johansson, L. Christoffer; Bowlin, Melissa S.; Hedenstroem, Anders] Lund Univ, Dept Biol, Lund, Sweden; [Muijres, Florian T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bowlin, Melissa S.] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA; [Winter, York] Univ Med Berlin, Charite, NeuroCure Ctr, Berlin, Germany; [Winter, York] Humboldt Univ, D-10099 Berlin, Germany	Lund University; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Muijres, FT (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	fmuijres@uw.edu	Johansson, Christoffer/B-2189-2013; Hedenström, Anders/F-5377-2010; Muijres, Florian Titus/N-6483-2015	Johansson, Christoffer/0000-0002-1851-3635; Hedenström, Anders/0000-0002-1757-0945; Muijres, Florian Titus/0000-0002-5668-0653; Winter, York/0000-0002-7828-1872	Knut and Alice Wallenberg foundation; Swedish Research Council; Centre for Animal Movement Research (CAnMove); Swedish Research Council [349-2007-8690]; Lund University; Marie Curie Incoming International Fellowship	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research (CAnMove); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University; Marie Curie Incoming International Fellowship(European Commission)	This report received support from the Knut and Alice Wallenberg foundation to AH, from the Swedish Research Council to AH and LCJ, and from the Centre for Animal Movement Research (CAnMove) financed by a Linnaeus grant (349-2007-8690) from the Swedish Research Council and Lund University. MSB was supported by a Marie Curie Incoming International Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 1993, BIRD MIGRATION; Anderson John D, 1991, FUNDAMENTALS AERODYN; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; Fleming TH, 2003, BAT ECOLOGY, P156; Gardiner JD, 2011, CAN J ZOOL, V89, P90, DOI 10.1139/Z10-096; Gardiner JD, 2008, ACTA CHIROPTEROL, V10, P313, DOI 10.3161/150811008X414881; Hall KC, 1996, J FLUID MECH, V323, P285, DOI 10.1017/S0022112096000924; Hall KC, 1998, J AIRCRAFT, V35, P352, DOI 10.2514/2.2324; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Hedenstrom A, 2009, EXP FLUIDS, V46, P923, DOI 10.1007/s00348-009-0634-5; Hedenstrom A, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015001; HEITHAUS ER, 1975, ECOLOGY, V56, P841, DOI 10.2307/1936295; Henningsson P, 2011, J R SOC INTERFACE, V8, P807, DOI 10.1098/rsif.2010.0533; Hoerner S. F, 1965, HOERNER FLUID DYNAMI, V2nd; Horner MA, 1998, J ZOOL, V244, P575, DOI 10.1111/j.1469-7998.1998.tb00062.x; Hubel TY, 2012, J R SOC INTERFACE, V9, P1120, DOI 10.1098/rsif.2011.0838; Hubel TY, 2010, J EXP BIOL, V213, P3427, DOI 10.1242/jeb.043257; Johansson LC, 2009, J EXP BIOL, V212, P3365, DOI 10.1242/jeb.034454; Johansson LC, 2008, J EXP BIOL, V211, P2909, DOI 10.1242/jeb.018192; Johansson LC, 2010, J R SOC INTERFACE, V7, P61, DOI 10.1098/rsif.2008.0541; Koekkoek G, 2012, CR MECANIQUE, V340, P95, DOI 10.1016/j.crme.2011.11.013; Lauder George V., 1996, P55; Lighthill J., 1977, P365; Muijres FT, 2012, J R SOC INTERFACE, V9, P292, DOI 10.1098/rsif.2011.0238; Muijres FT, 2011, J R SOC INTERFACE, V8, P1418, DOI 10.1098/rsif.2011.0015; Muijres FT, 2011, EXP FLUIDS, V51, P511, DOI 10.1007/s00348-011-1067-5; Norberg R.A., 1985, P303; Norberg U., 1990, VERTEBRATE FLIGHT ME; Norberg U.M., 1975, SWIMMING FLYING NATU, P869, DOI DOI 10.1007/978-1-4757-1326-8_26; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1976, J EXP BIOL, V65, P179; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; Rosen M, 2007, J R SOC INTERFACE, V4, P659, DOI 10.1098/rsif.2007.0215; Saffman PG, 1995, VORTEX DYNAMICS; Sargatal J, 2006, HDB BIRDS WORLD OLD; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Spedding GR, 2010, J AIRCRAFT, V47, P120, DOI 10.2514/1.44247; Spedding GR, 2009, EXP FLUIDS, V46, P527, DOI 10.1007/s00348-008-0578-1; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; Tian XD, 2006, BIOINSPIR BIOMIM, V1, pS10, DOI 10.1088/1748-3182/1/4/S02; Tobalske BW, 2009, EXP FLUIDS, V46, P963, DOI 10.1007/s00348-009-0614-9; von Busse R, 2011, THESIS HUMBOLDT U BE; von Helversen O., 1986, BAT FLIGHT, P107; Wilkinson GS, 1996, MOL ECOL, V5, P329; Winter Y, 1998, J COMP PHYSIOL B, V168, P105, DOI 10.1007/s003600050126; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777	55	48	49	11	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37335	10.1371/journal.pone.0037335	http://dx.doi.org/10.1371/journal.pone.0037335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624018	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500101
J	Trnka, A; Prokop, P; Grim, T				Trnka, Alfred; Prokop, Pavol; Grim, Tomas			Uncovering Dangerous Cheats: How Do Avian Hosts Recognize Adult Brood Parasites?	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; GREAT REED WARBLERS; NEST DEFENSE; ACROCEPHALUS-ARUNDINACEUS; HAWK MIMICRY; ENEMY RECOGNITION; EGG EVICTION; RESPONSES; BEHAVIOR; CUES	Background: Co-evolutionary struggles between dangerous enemies (e. g., brood parasites) and their victims (hosts) lead to the emergence of sophisticated adaptations and counter-adaptations. Salient host tricks to reduce parasitism costs include, as front line defence, adult enemy discrimination. In contrast to the well studied egg stage, investigations addressing the specific cues for adult enemy recognition are rare. Previous studies have suggested barred underparts and yellow eyes may provide cues for the recognition of cuckoos Cuculus canorus by their hosts; however, no study to date has examined the role of the two cues simultaneously under a consistent experimental paradigm. Methodology/Principal Findings: We modify and extend previous work using a novel experimental approach - custom-made dummies with various combinations of hypothesized recognition cues. The salient recognition cue turned out to be the yellow eye. Barred underparts, the only trait examined previously, had a statistically significant but small effect on host aggression highlighting the importance of effect size vs. statistical significance. Conclusion: Relative importance of eye vs. underpart phenotypes may reflect ecological context of host-parasite interaction: yellow eyes are conspicuous from the typical direction of host arrival (from above), whereas barred underparts are poorly visible (being visually blocked by the upper part of the cuckoo's body). This visual constraint may reduce usefulness of barred underparts as a reliable recognition cue under a typical situation near host nests. We propose a novel hypothesis that recognition cues for enemy detection can vary in a context-dependent manner (e.g., depending on whether the enemy is approached from below or from above). Further we suggest a particular cue can trigger fear reactions (escape) in some hosts/populations whereas the same cue can trigger aggression (attack) in other hosts/populations depending on presence/absence of dangerous enemies that are phenotypically similar to brood parasites and costs and benefits associated with particular host responses.	[Trnka, Alfred; Prokop, Pavol] Univ Trnava, Dept Biol, Trnava, Slovakia; [Prokop, Pavol] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Grim, Tomas] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; [Grim, Tomas] Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic	University of Trnava; Slovak Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc	Trnka, A (corresponding author), Univ Trnava, Dept Biol, Trnava, Slovakia.	tomas.grim@upol.cz	Prokop, Pavol/ABD-9546-2020; Grim, Tomas/A-2852-2008	Prokop, Pavol/0000-0003-2016-7468; Grim, Tomas/0000-0002-5775-6269	Slovak Grant Agency for Science [1/0566/09]; Ministry of Education of the Czech Republic [MSM6198959212]; Human Frontier Science Program [RGY69/07]	Slovak Grant Agency for Science(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Human Frontier Science Program(Human Frontier Science Program)	The authors acknowledge financial support from the Slovak Grant Agency for Science grant no. 1/0566/09 (to AT and PP), the Ministry of Education of the Czech Republic grant no. MSM6198959212, and Human Frontier Science Program Award no. RGY69/07 (to TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 1996, IBIS, V138, P340, DOI 10.1111/j.1474-919X.1996.tb04349.x; Anderson MG, 2009, PLOS ONE, V4, pA67, DOI 10.1371/journal.pone.0007725; Bartol I, 2002, J AVIAN BIOL, V33, P420, DOI 10.1034/j.1600-048X.2002.02945.x; BAZIN RC, 1993, ETHOLOGY, V94, P326; Bos N, 2010, ANIM BEHAV, V80, P839, DOI 10.1016/j.anbehav.2010.08.001; BRISKIE JV, 1989, ETHOLOGY, V82, P61; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; Campobello D, 2011, ANIM BEHAV, V82, P885, DOI 10.1016/j.anbehav.2011.07.028; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Campobello D, 2010, ETHOLOGY, V116, P498, DOI 10.1111/j.1439-0310.2010.01764.x; Capek M, 2010, CONDOR, V112, P763, DOI 10.1525/cond.2010.100063; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; Cassey P, 2008, BIOL LETTERS, V4, P515, DOI 10.1098/rsbl.2008.0279; Davies NB, 2008, P ROY SOC B-BIOL SCI, V275, P1817, DOI 10.1098/rspb.2008.0331; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Gill SA, 2004, BEHAV ECOL SOCIOBIOL, V56, P71, DOI 10.1007/s00265-003-0736-7; Gill SA, 1997, ANIM BEHAV, V53, P1287, DOI 10.1006/anbe.1996.0362; Glutz von Blotzheim U., 1971, HDB VOGEL MITTELEURO, V4; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grim T, 2005, AUK, V122, P530, DOI 10.1642/0004-8038(2005)122[0530:HROBPI]2.0.CO;2; Grim T, 2001, BIOLOGIA, V56, P549; Grim T, 2008, J ORNITHOL, V149, P169, DOI 10.1007/s10336-007-0257-7; Grim T, 2006, EVOL ECOL RES, V8, P785; Grim T, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-14; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Grim T, 2009, BEHAV ECOL, V20, P1138, DOI 10.1093/beheco/arp108; Holen OH, 2006, AM NAT, V167, P377, DOI 10.1086/499567; Honza M, 2004, BIRD STUDY, V51, P256, DOI 10.1080/00063650409461361; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Honza M, 2010, BEHAVIOUR, V147, P741, DOI 10.1163/000579510X491081; KOHDA Y, 1990, ETHOLOGY, V84, P162; Komarek S., 2003, MIMICRY APOSEMATISM; Ligon RA, 2009, ANIM BEHAV, V77, P1267, DOI 10.1016/j.anbehav.2009.01.031; Lindholm AK, 2000, BEHAVIOUR, V137, P25, DOI 10.1163/156853900501854; Lombardi CM, 2009, AUSTRAL ECOL, V34, P447, DOI 10.1111/j.1442-9993.2009.01946.x; Lopez-de-Hierro MDG, 2010, BEHAV ECOL SOCIOBIOL, V64, P317, DOI 10.1007/s00265-009-0811-9; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; Moksnes A, 2000, IBIS, V142, P247, DOI 10.1111/j.1474-919X.2000.tb04864.x; MOKSNES A, 1993, BEHAV ECOL, V4, P120, DOI 10.1093/beheco/4.2.120; Molnar B, 1944, AQUILA, V51, P100; Moskat C, 2005, ANN ZOOL FENN, V42, P579; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; Polacikova L, 2010, BEHAVIOUR, V147, P465, DOI 10.1163/000579509X12584427339575; Pozgayova M, 2009, BEHAV PROCESS, V81, P34, DOI 10.1016/j.beproc.2008.12.019; Roskaft E, 2002, BEHAVIOUR, V139, P613, DOI 10.1163/15685390260136735; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SCHULER W, 1985, BEHAV ECOL SOCIOBIOL, V16, P249, DOI 10.1007/BF00310988; Sealy SG, 1998, OX ORN SER, V9, P194; SMITH S., 1955, BIRDS FIGHTING; Spottiswoode CN, 2012, BIOL LETTERS, V8, P241, DOI 10.1098/rsbl.2011.0739; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Thompson JD., 1994, COEVOLUTIONARY PROCE; Trnka A, 2012, ANIM BEHAV, V83, P263, DOI 10.1016/j.anbehav.2011.10.036; Trnka A, 2010, ETHOLOGY, V116, P1075, DOI 10.1111/j.1439-0310.2010.01821.x; Weidinger K, 2010, J ORNITHOL, V151, P729, DOI 10.1007/s10336-010-0512-1; Welbergen JA, 2008, ANIM BEHAV, V76, P811, DOI 10.1016/j.anbehav.2008.03.020; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041; Westhoff G, 2005, J COMP PHYSIOL A, V191, P873, DOI 10.1007/s00359-005-0010-8; Wisenden BD, 2004, ANIM BEHAV, V67, P59, DOI 10.1016/j.anbehav.2003.02.010; Wyllie I., 1981, CUCKOO; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	65	36	39	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37445	10.1371/journal.pone.0037445	http://dx.doi.org/10.1371/journal.pone.0037445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624031	Green Published, gold			2022-12-27	WOS:000305343500116
J	Welch, MD; Reed, SCO; Lamason, RL; Serio, AW				Welch, Matthew D.; Reed, Shawna C. O.; Lamason, Rebecca L.; Serio, Alisa W.			Expression of an Epitope-Tagged Virulence Protein in Rickettsia parkeri Using Transposon Insertion	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ACTIN-BASED MOTILITY; SPOTTED-FEVER; ARP2/3 COMPLEX; CONORII; PROWAZEKII; CELLS; RICKA; TRANSFORMATION; EVOLUTION	Despite recent advances in our ability to genetically manipulate Rickettsia, little has been done to employ genetic tools to study the expression and localization of Rickettsia virulence proteins. Using a mariner-based Himar1 transposition system, we expressed an epitope-tagged variant of the actin polymerizing protein RickA under the control of its native promoter in Rickettsia parkeri, allowing the detection of RickA using commercially-available antibodies. Native RickA and epitope-tagged RickA exhibited similar levels of expression and were specifically localized to bacteria. To further facilitate protein expression in Rickettsia, we also developed a plasmid for Rickettsia insertion and expression (pRIE), containing a variant Himar1 transposon with enhanced flexibility for gene insertion, and used it to generate R. parkeri strains expressing diverse fluorescent proteins. Expression of epitope-tagged proteins in Rickettsia will expand our ability to assess the regulation and function of important virulence factors.	[Welch, Matthew D.; Lamason, Rebecca L.; Serio, Alisa W.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Welch, Matthew D.; Reed, Shawna C. O.] Univ Calif Berkeley, Microbiol Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu		Reed, Shawna/0000-0002-9041-4869; Lamason, Rebecca/0000-0002-2762-7917	Public Health Service grant from the National Institute of Allergy and Infectious Diseases [AI-074760]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074760] Funding Source: NIH RePORTER	Public Health Service grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant AI-074760 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANACKER RL, 1987, J CLIN MICROBIOL, V25, P167, DOI 10.1128/JCM.25.1.167-171.1987; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008965; Balraj P, 2008, FEMS MICROBIOL LETT, V286, P257, DOI 10.1111/j.1574-6968.2008.01283.x; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Clark TR, 2011, INFECT IMMUN, V79, P1631, DOI 10.1128/IAI.00048-11; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Firat-Karalar EN, 2011, MOL BIOL CELL, V22, P4563, DOI 10.1091/mbc.E11-06-0585; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Policastro PF, 1997, J MED MICROBIOL, V46, P839, DOI 10.1099/00222615-46-10-839; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Reed SC, 2011, CELL MICROB IN PRESS; SCHAECHTER M, 1957, VIROLOGY, V3, P160, DOI 10.1016/0042-6822(57)90030-2; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Vellaiswamy M, 2011, NEW MICROBIOL, V34, P209; WALKER TS, 1984, INFECT IMMUN, V44, P205, DOI 10.1128/IAI.44.2.205-210.1984	39	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37310	10.1371/journal.pone.0037310	http://dx.doi.org/10.1371/journal.pone.0037310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624012	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500095
J	Ivaldi, C; Martin, BR; Kieffer-Jaquinod, S; Chapel, A; Levade, T; Garin, J; Journet, A				Ivaldi, Corinne; Martin, Brent R.; Kieffer-Jaquinod, Sylvie; Chapel, Agnes; Levade, Thierry; Garin, Jerome; Journet, Agnes			Proteomic Analysis of S-Acylated Proteins in Human B Cells Reveals Palmitoylation of the Immune Regulators CD20 and CD23	PLOS ONE			English	Article							ANTIGEN RECEPTOR; IDENTIFICATION; DATABASE; EXPRESSION; TARGET; LIGAND	S-palmitoylation is a reversible post-translational modification important for controlling the membrane targeting and function of numerous membrane proteins with diverse roles in signalling, scaffolding, and trafficking. We sought to identify novel palmitoylated proteins in B lymphocytes using acyl-biotin exchange chemistry, coupled with differential analysis by liquid-chromatography tandem mass spectrometry. In total, we identified 57 novel palmitoylated protein candidates from human EBV-transformed lymphoid cells. Two of them, namely CD20 and CD23 (low affinity immunoglobulin epsilon Fc receptor), are immune regulators that are effective/potential therapeutic targets for haematological malignancies, autoimmune diseases and allergic disorders. Palmitoylation of CD20 and CD23 was confirmed by heterologous expression of alanine mutants coupled with bioorthogonal metabolic labeling. This study demonstrates a new subset of palmitoylated proteins in B cells, illustrating the ubiquitous role of protein palmitoylation in immune regulation.	[Ivaldi, Corinne; Kieffer-Jaquinod, Sylvie; Chapel, Agnes; Garin, Jerome; Journet, Agnes] CEA, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Ivaldi, Corinne; Kieffer-Jaquinod, Sylvie; Chapel, Agnes; Garin, Jerome; Journet, Agnes] INSERM, U1038, Grenoble, France; [Ivaldi, Corinne; Kieffer-Jaquinod, Sylvie; Chapel, Agnes; Garin, Jerome; Journet, Agnes] Univ Grenoble 1, Grenoble, France; [Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Levade, Thierry] Fac Med Toulouse, INSERM, UMR1037, F-31073 Toulouse, France; [Levade, Thierry] Univ Toulouse 3, Ctr Rech Cancerol Toulouse, F-31062 Toulouse, France; [Levade, Thierry] Hop Purpan, Lab Biochim Metab, Inst Federatif Biol, Toulouse, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Ivaldi, C (corresponding author), CEA, IRTSV, Lab Biol Grande Echelle, Grenoble, France.	agnes.journet@cea.fr	Levade, Thierry/O-8948-2014; Martin, Brent/B-4370-2012	Martin, Brent/0000-0002-7136-2397; Journet, Agnes/0000-0001-8545-8827	Vaincre les Maladies Lysosomales; National Institutes of Health [R00CA151460]; NATIONAL CANCER INSTITUTE [R00CA151460] Funding Source: NIH RePORTER	Vaincre les Maladies Lysosomales; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CI was the recipient of a postdoctoral fellowship from the non-profit organization Vaincre les Maladies Lysosomales (http://www.vml-asso.org/lysosomal-storage-disorders/lysosomal-storage-disorders.html). BRM was supported by the National Institutes of Health (http://www.nih.gov/; grant # R00CA151460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Barcellini W, 2011, EUR J INTERN MED, V22, P220, DOI 10.1016/j.ejim.2010.12.016; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; Dowal L, 2011, BLOOD, V118, pE62, DOI 10.1182/blood-2011-05-353078; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fu X, 2008, J PROTEOME RES, V7, P845, DOI 10.1021/pr070271+; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gould H, 1991, Monogr Allergy, V29, P28; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kilmon MA, 2004, J IMMUNOL, V172, P1065, DOI 10.4049/jimmunol.172.2.1065; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Laurenti L, 2011, MINI-REV MED CHEM, V11, P508, DOI 10.2174/138955711795843374; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Merrick BA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006007; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Polyak MJ, 1998, J IMMUNOL, V161, P3242; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; TEDDER TF, 1985, J IMMUNOL, V135, P973; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	51	40	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37187	10.1371/journal.pone.0037187	http://dx.doi.org/10.1371/journal.pone.0037187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615937	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200047
J	Nosek, BA; Sriram, N; Umansky, E				Nosek, Brian A.; Sriram, N.; Umansky, Emily			Presenting Survey Items One at a Time Compared to All at Once Decreases Missing Data without Sacrificing Validity in Research with Internet Volunteers	PLOS ONE			English	Article							WEB SURVEY DESIGN; DOMINANCE	In two large web-based studies, across five distinct criteria, presenting survey items one-at-a-time was psychometrically either the same or better than presenting survey items all-at-once on a single web page to volunteer participants. In the one-at-a-time format, participants were no more likely to drop-out of the study (Criterion 1), and were much more likely to provide answers for the survey items (Criterion 2). Rehabilitating participants who otherwise would not have provided survey responses with the one-at-a-time format did not damage internal consistency of the measures (Criterion 3) nor did it negatively affect criterion validity (Criterion 4). Finally, the one-at-a-time format was more efficient with participants completing it more quickly than the all-at-once format (Criterion 5). In short, the one-at-a-time format results in less missing data with a shorter presentation time, and ultimately more power to detect relations among variables.	[Nosek, Brian A.; Sriram, N.; Umansky, Emily] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Virginia	Nosek, BA (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	nosek@virginia.edu		Nosek, Brian/0000-0001-6797-5476	Project Implicit	Project Implicit	Project Implicit supported this research (http://projectimplicit.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardac D, 2008, INSTR SCI, V36, P75, DOI 10.1007/s11251-007-9035-4; Couper MP, 2001, PUBLIC OPIN QUART, V65, P230, DOI 10.1086/322199; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Heerwegh D, 2002, SOC SCI COMPUT REV, V20, P471, DOI 10.1177/089443902237323; Kugler MB, 2010, SOC JUSTICE RES, V23, P117, DOI 10.1007/s11211-010-0112-5; Miles JNV, 1999, BRIT J PSYCHOL, V90, P145, DOI 10.1348/000712699161198; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Peytchev A, 2006, PUBLIC OPIN QUART, V70, P596, DOI 10.1093/poq/nfl028; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Pratto F., 2006, EUROPEAN REV SOCIAL, V17, P271, DOI [10.1080/10463280601055772, DOI 10.1080/10463280601055772]; Thorndike FP, 2009, COMPUT HUM BEHAV, V25, P393, DOI 10.1016/j.chb.2008.05.006; Toepoel V, 2009, FIELD METHOD, V21, P200, DOI 10.1177/1525822X08330261; Vehovar V., 2002, J COMPUTER MEDIATED, V7	17	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36771	10.1371/journal.pone.0036771	http://dx.doi.org/10.1371/journal.pone.0036771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615808	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341200018
J	Peltz, L; Gomez, J; Marquez, M; Alencastro, F; Atashpanjeh, N; Quang, T; Bach, T; Zhao, YX				Peltz, Lindsay; Gomez, Jessica; Marquez, Maribel; Alencastro, Frances; Atashpanjeh, Negar; Quang, Tara; Thuy Bach; Zhao, Yuanxiang			Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell Development	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYCLE ARREST; LIFE-SPAN; OSTEOBLASTIC DIFFERENTIATION; CHEMOPREVENTIVE AGENT; HIPPOCAMPAL-NEURONS; 3T3-L1 ADIPOCYTES; GROWTH-INHIBITION; SIRT1 ACTIVATION; TUMOR-GROWTH	Studies in the past have illuminated the potential benefit of resveratrol as an anticancer (pro-apoptosis) and life-extending (pro-survival) compound. However, these two different effects were observed at different concentration ranges. Studies of resveratrol in a wide range of concentrations on the same cell type are lacking, which is necessary to comprehend its diverse and sometimes contradictory cellular effects. In this study, we examined the effects of resveratrol on cell self-renewal and differentiation of human mesenchymal stem cells (hMSCs), a type of adult stem cells that reside in a number of tissues, at concentrations ranging from 0.1 to 10 mu M after both short- and long-term exposure. Our results reveal that at 0.1 mu M, resveratrol promotes cell self-renewal by inhibiting cellular senescence, whereas at 5 mu M or above, resveratrol inhibits cell self-renewal by increasing senescence rate, cell doubling time and S-phase cell cycle arrest. At 1 mu M, its effect on cell self-renewal is minimal but after long-term exposure it exerts an inhibitory effect, accompanied with increased senescence rate. At all concentrations, resveratrol promotes osteogenic differentiation in a dosage dependent manner, which is offset by its inhibitory effect on cell self-renewal at high concentrations. On the contrary, resveratrol suppresses adipogenic differentiation during short-term exposure but promotes this process after long-term exposure. Our study implicates that resveratrol is the most beneficial to stem cell development at 0.1 mu M and caution should be taken in applying resveratrol as an anticancer therapeutic agent or nutraceutical supplement due to its dosage dependent effect on hMSCs.	[Peltz, Lindsay; Gomez, Jessica; Marquez, Maribel; Alencastro, Frances; Atashpanjeh, Negar; Quang, Tara; Thuy Bach; Zhao, Yuanxiang] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	California State University System; California State Polytechnic University Pomona	Peltz, L (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	zhao@csupomona.edu		Zhao, Yuanxiang/0000-0003-1611-4590	National Science Foundation via an ADVANCE Institutional Transformation (IT) Award [0548426]; California State University Agricultural Research Institute (ARI) [11-4-192-11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM094078] Funding Source: NIH RePORTER	National Science Foundation via an ADVANCE Institutional Transformation (IT) Award; California State University Agricultural Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is partly supported by the National Science Foundation under grant no. 0548426 via an ADVANCE Institutional Transformation (IT) Award to California State Polytechnic University at Pomona and the California State University Agricultural Research Institute (ARI) grant number 11-4-192-11. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or ARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Auger C, 2005, J AGR FOOD CHEM, V53, P2015, DOI 10.1021/jf048177q; Azios NG, 2005, NEOPLASIA, V7, P128, DOI 10.1593/neo.04346; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benitez DA, 2007, J ANDROL, V28, P282, DOI 10.2164/jandrol.106.000968; Bertelli AAE, 1996, DRUG EXP CLIN RES, V22, P61; Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Burns J, 2002, J AGR FOOD CHEM, V50, P3337, DOI 10.1021/jf0112973; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2005, TOXICOL APPL PHARM, V202, P289, DOI 10.1016/j.taap.2004.06.023; Calabrese EJ, REGUL TOXICOL PHARM; Carbo N, 1999, BIOCHEM BIOPH RES CO, V254, P739, DOI 10.1006/bbrc.1998.9916; Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363; Chen T, AGING CELL; Clement MV, 1998, BLOOD, V92, P996; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Della Ragione F, 1998, BIOCHEM BIOPH RES CO, V250, P53, DOI 10.1006/bbrc.1998.9263; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Dienstknecht T, 2010, B EXP BIOL MED+, V150, P157, DOI 10.1007/s10517-010-1092-z; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Filippi-Chiela EC, PLOS ONE, V6; Fischer-Posovszky P, AM J CLIN NUTR, V92, P5; Fukui M, EUR J CANC, V46; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Gu J, 2006, J CARDIOVASC PHARM, V47, P711, DOI 10.1097/01.fjc.0000211764.52012.e3; Gyrd-Hansen M, NAT REV CANC, V10, P561; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Harikumar KB, INT J CANC, V127, P257; Hope C, 2008, MOL NUTR FOOD RES, V52, pS52, DOI 10.1002/mnfr.200700448; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; In Kyungmin, 2006, Cancer Res Treat, V38, P48, DOI 10.4143/crt.2006.38.1.48; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kimura Y, 2001, J NUTR, V131, P1844, DOI 10.1093/jn/131.6.1844; Lee SK, 2008, J AGR FOOD CHEM, V56, P7572, DOI 10.1021/jf801014p; Levenson AS, 2003, INT J CANCER, V104, P587, DOI 10.1002/ijc.10992; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Li Y, 2011, ACTA BIOMATER, V7, P751, DOI 10.1016/j.actbio.2010.09.008; Lu RQ, 1999, J CELL PHYSIOL, V179, P297, DOI 10.1002/(SICI)1097-4652(199906)179:3<297::AID-JCP7>3.0.CO;2-P; Miura T, 2000, PHARMACOL TOXICOL, V86, P203, DOI 10.1034/j.1600-0773.2000.d01-36.x; Muller C, 2009, BIOSCI BIOTECH BIOCH, V73, P1831, DOI 10.1271/bbb.90213; Nakagawa H, 2001, J CANCER RES CLIN, V127, P258, DOI 10.1007/s004320000190; Pandey PR, BREAST CANC RES TREA; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pizarro JG, 2011, NEUROCHEM RES, V36, P187, DOI 10.1007/s11064-010-0296-y; Qian SW, BMC DEV BIOL, V10, P47; Rayalam S, MOL NUTR FOOD RES, V55; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; Rimando AM, 2004, J AGR FOOD CHEM, V52, P4713, DOI 10.1021/jf040095e; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sanders TH, 2000, J AGR FOOD CHEM, V48, P1243, DOI 10.1021/jf990737b; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Shankar S, 2012, PLOS ONE, V6; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Szende B, 2000, EXP MOL MED, V32, P88, DOI 10.1038/emm.2000.16; Tessitore L, 2000, CARCINOGENESIS, V21, P1619, DOI 10.1093/carcin/21.8.1619; Udagawa N., 2002, PRINCIPLES BONE BIOL, V2nd ed.; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Vyas S, 2006, GROWTH FACTORS, V24, P79, DOI 10.1080/08977190500366068; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Q, 2004, NEUROCHEM RES, V29, P2105, DOI 10.1007/s11064-004-6883-z; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang ZR, 2005, INT J MOL MED, V16, P533; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Yang YP, J CELL PHYSL; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104; Zhou HB, 2009, EXP CELL RES, V315, P2953, DOI 10.1016/j.yexcr.2009.07.030	84	92	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37162	10.1371/journal.pone.0037162	http://dx.doi.org/10.1371/journal.pone.0037162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615926	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300079
J	Halloran, SK; Wexler, AS; Ristenpart, WD				Halloran, Siobhan K.; Wexler, Anthony S.; Ristenpart, William D.			A Comprehensive Breath Plume Model for Disease Transmission via Expiratory Aerosols	PLOS ONE			English	Article							INFLUENZA-VIRUS; GUINEA-PIG; ABSOLUTE-HUMIDITY; AIRBORNE TRANSMISSION; INFECTION; SURVIVAL; DEPOSITION; EPIDEMIC; KINETICS; DROPLETS	The peak in influenza incidence during wintertime in temperate regions represents a longstanding, unresolved scientific question. One hypothesis is that the efficacy of airborne transmission via aerosols is increased at lower humidities and temperatures, conditions that prevail in wintertime. Recent work with a guinea pig model by Lowen et al. indicated that humidity and temperature do modulate airborne influenza virus transmission, and several investigators have interpreted the observed humidity dependence in terms of airborne virus survivability. This interpretation, however, neglects two key observations: the effect of ambient temperature on the viral growth kinetics within the animals, and the strong influence of the background airflow on transmission. Here we provide a comprehensive theoretical framework for assessing the probability of disease transmission via expiratory aerosols between test animals in laboratory conditions. The spread of aerosols emitted from an infected animal is modeled using dispersion theory for a homogeneous turbulent airflow. The concentration and size distribution of the evaporating droplets in the resulting "Gaussian breath plume" are calculated as functions of position, humidity, and temperature. The overall transmission probability is modeled with a combination of the time-dependent viral concentration in the infected animal and the probability of droplet inhalation by the exposed animal downstream. We demonstrate that the breath plume model is broadly consistent with the results of Lowen et al., without invoking airborne virus survivability. The results also suggest that, at least for guinea pigs, variation in viral kinetics within the infected animals is the dominant factor explaining the increased transmission probability observed at lower temperatures.	[Halloran, Siobhan K.; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Air Qual Res Ctr, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Wexler, Anthony S.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Ristenpart, William D.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Halloran, SK (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021					Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Butler D, 2011, NATURE, V480, P421, DOI 10.1038/480421a; Chen SC, 2009, INDOOR AIR, V19, P401, DOI 10.1111/j.1600-0668.2009.00603.x; Csanady G.T., 1973, TURBULENT DIFFUSION; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Enserink M, 2011, SCIENCE, V334, P1192, DOI 10.1126/science.334.6060.1192; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; HEYDER J, 1986, J AEROSOL SCI, V17, P811, DOI 10.1016/0021-8502(86)90035-2; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mayer D, 2008, ATMOS ENVIRON, V42, P466, DOI 10.1016/j.atmosenv.2007.09.069; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Mortola J. P., 1995, REGULATION BREATHING, P1011; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Myatt TA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-55; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; RANZ WE, 1952, CHEM ENG PROG, V48, P141; RANZ WE, 1952, CHEM ENG PROG, V48, P173; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5; SCHREIDER JP, 1980, ANAT REC, V196, P313, DOI 10.1002/ar.1091960307; SCHREIDER JP, 1979, J AEROSOL SCI, V10, P599, DOI 10.1016/0021-8502(79)90022-3; SCHULMAN JL, 1962, NATURE, V195, P1129, DOI 10.1038/1951129a0; Seinfeld J., 1997, ATMOS CHEM PHYS; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wei Z, 2007, J VIROL METHODS, V144, P122, DOI 10.1016/j.jviromet.2007.04.008; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686	52	27	27	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37088	10.1371/journal.pone.0037088	http://dx.doi.org/10.1371/journal.pone.0037088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615902	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300068
J	Herzig, MC; Bidinosti, M; Schweizer, T; Hafner, T; Stemmelen, C; Weiss, A; Danner, S; Vidotto, N; Stauffer, D; Barske, C; Mayer, F; Schmid, P; Rovelli, G; van der Putten, PH; Shimshek, DR				Herzig, Martin C.; Bidinosti, Michael; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Weiss, Andreas; Danner, Simone; Vidotto, Nella; Stauffer, Daniela; Barske, Carmen; Mayer, Franziska; Schmid, Peter; Rovelli, Giorgio; van der Putten, P. Herman; Shimshek, Derya R.			High LRRK2 Levels Fail to Induce or Exacerbate Neuronal Alpha-Synucleinopathy in Mouse Brain	PLOS ONE			English	Article							REPEAT KINASE 2; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; G2019S MUTATION; MUTANT LRRK2; RISK-FACTORS; GENE; NEUROPATHOLOGY; PHOSPHORYLATION; LOCI	The G2019S mutation in the multidomain protein leucine-rich repeat kinase 2 (LRRK2) is one of the most frequently identified genetic causes of Parkinson's disease (PD). Clinically, LRRK2(G2019S) carriers with PD and idiopathic PD patients have a very similar disease with brainstem and cortical Lewy pathology (alpha-synucleinopathy) as histopathological hallmarks. Some patients have Tau pathology. Enhanced kinase function of the LRRK2(G2019S) mutant protein is a prime suspect mechanism for carriers to develop PD but observations in LRRK2 knock-out, G2019S knock-in and kinase-dead mutant mice suggest that LRRK2 steady-state abundance of the protein also plays a determining role. One critical question concerning the molecular pathogenesis in LRRK2(G2019S) PD patients is whether alpha-synuclein (aSN) has a contributory role. To this end we generated mice with high expression of either wildtype or G2019S mutant LRRK2 in brainstem and cortical neurons. High levels of these LRRK2 variants left endogenous aSN and Tau levels unaltered and did not exacerbate or otherwise modify alpha-synucleinopathy in mice that co-expressed high levels of LRRK2 and aSN in brain neurons. On the contrary, in some lines high LRRK2 levels improved motor skills in the presence and absence of aSN-transgene-induced disease. Therefore, in many neurons high LRRK2 levels are well tolerated and not sufficient to drive or exacerbate neuronal alpha-synucleinopathy.	[Herzig, Martin C.; Bidinosti, Michael; Schweizer, Tatjana; Hafner, Thomas; Stemmelen, Christine; Weiss, Andreas; Danner, Simone; Vidotto, Nella; Stauffer, Daniela; Barske, Carmen; Mayer, Franziska; Schmid, Peter; Rovelli, Giorgio; van der Putten, P. Herman; Shimshek, Derya R.] Novartis Pharma AG, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland	Novartis	Herzig, MC (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Dept Neurosci, Basel, Switzerland.	derya.shimshek@novartis.com	Herzig, Martin/R-4601-2016	Herzig, Martin/0000-0002-0500-353X; Shimshek, Derya/0000-0001-8602-7850	Novartis Pharma AG	Novartis Pharma AG	All authors are employees of Novartis Pharma AG who funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alegre-Abarrategui J, 2008, NEUROPATH APPL NEURO, V34, P272, DOI 10.1111/j.1365-2990.2007.00888.x; An XK, 2008, EUR J NEUROL, V15, P301, DOI 10.1111/j.1468-1331.2007.02052.x; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Carballo-Carbajal I, 2010, CELL SIGNAL, V22, P821, DOI 10.1016/j.cellsig.2010.01.006; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Daher JP, 2012, HUM MOL GENET; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Esposito Ennio, 2007, Expert Rev Neurother, V7, P677, DOI 10.1586/14737175.7.6.677; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Gaig C, 2007, J NEUROL NEUROSUR PS, V78, P626, DOI 10.1136/jnnp.2006.107904; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Jellinger KA, 2009, J NEUROL, V256, pS270, DOI 10.1007/s00415-009-5243-y; Kondo K, 2011, BIOL PHARM BULL, V34, P1078, DOI 10.1248/bpb.34.1078; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lee S, 2010, J NEUROSCI, V30, P16959, DOI 10.1523/JNEUROSCI.1807-10.2010; Lewis PA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002680; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Looyenga BD, 2011, P NATL ACAD SCI USA, V108, P1439, DOI 10.1073/pnas.1012500108; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Mata IF, 2011, MOVEMENT DISORD, V26, P819, DOI 10.1002/mds.23642; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Nichols WC, 2007, NEUROLOGY, V69, P1737, DOI 10.1212/01.wnl.0000278115.50741.4e; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poulopoulos M, 2011, J MOL NEUROSCI; Qing H, 2009, BIOCHEM BIOPH RES CO, V387, P149, DOI 10.1016/j.bbrc.2009.06.142; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Rieker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024834; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saunders-Pullman R, 2010, MOVEMENT DISORD, V25, P2536, DOI 10.1002/mds.23314; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Tan EK, 2007, CLIN GENET, V72, P387, DOI 10.1111/j.1399-0004.2007.00890.x; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Torkvist L, 2010, INFLAMM BOWEL DIS, V16, P907, DOI 10.1002/ibd.21105; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; Vitte J, 2010, J NEUROPATH EXP NEUR, V69, P959, DOI 10.1097/NEN.0b013e3181efc01c; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhou HX, 2011, INT J BIOL SCI, V7, P753, DOI 10.7150/ijbs.7.753; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	69	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36581	10.1371/journal.pone.0036581	http://dx.doi.org/10.1371/journal.pone.0036581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615783	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300023
J	Shrestha, UB; Gautam, S; Bawa, KS				Shrestha, Uttam Babu; Gautam, Shiva; Bawa, Kamaljit S.			Widespread Climate Change in the Himalayas and Associated Changes in Local Ecosystems	PLOS ONE			English	Article							VEGETATION INDEX; SPRING PHENOLOGY; NORTH-AMERICA; TRENDS; CHINA; PRECIPITATION; VICINITY; INDIA; NEPAL; WATER	Background: Climate change in the Himalayas, a biodiversity hotspot, home of many sacred landscapes, and the source of eight largest rivers of Asia, is likely to impact the well-being of similar to 20% of humanity. However, despite the extraordinary environmental, cultural, and socio-economic importance of the Himalayas, and despite their rapidly increasing ecological degradation, not much is known about actual changes in the two most critical climatic variables: temperature and rainfall. Nor do we know how changes in these parameters might impact the ecosystems including vegetation phenology. Methodology/Principal Findings: By analyzing temperature and rainfall data, and NDVI (Normalized Difference Vegetation Index) values from remotely sensed imagery, we report significant changes in temperature, rainfall, and vegetation phenology across the Himalayas between 1982 and 2006. The average annual mean temperature during the 25 year period has increased by 1.5 degrees C with an average increase of 0.06 degrees C yr(-1). The average annual precipitation has increased by 163 mm or 6.52 mmyr(-1). Since changes in temperature and precipitation are immediately manifested as changes in phenology of local ecosystems, we examined phenological changes in all major ecoregions. The average start of the growing season (SOS) seems to have advanced by 4.7 days or 0.19 days yr(-1) and the length of growing season (LOS) appears to have advanced by 4.7 days or 0.19 days yr(-1), but there has been no change in the end of the growing season (EOS). There is considerable spatial and seasonal variation in changes in climate and phenological parameters. Conclusions/Significance: This is the first time that large scale climatic and phenological changes at the landscape level have been documented for the Himalayas. The rate of warming in the Himalayas is greater than the global average, confirming that the Himalayas are among the regions most vulnerable to climate change.	[Shrestha, Uttam Babu; Bawa, Kamaljit S.] Univ Massachusetts, Boston, MA 02125 USA; [Shrestha, Uttam Babu] Harvard Univ, Harvard Univ Herbarium, Cambridge, MA 02138 USA; [Gautam, Shiva] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Biostat, Boston, MA 02215 USA; [Bawa, Kamaljit S.] Harvard Univ, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Bawa, Kamaljit S.] Ashoka Trust Res Ecol & Environm ATREE, Bangalore, Karnataka, India	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Shrestha, UB (corresponding author), Univ Massachusetts, Harbor Campus, Boston, MA 02125 USA.	ubshrestha@yahoo.com		Bawa, Kamal/0000-0001-6174-9777				Bagla P, 2009, SCIENCE, V326, P924, DOI 10.1126/science.326.5955.924; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Byg A, 2009, GLOBAL ENVIRON CHANG, V19, P156, DOI 10.1016/j.gloenvcha.2009.01.010; Chaudhary P, 2011, BIOL LETTERS, V7, P767, DOI 10.1098/rsbl.2011.0269; Chen XQ, 2001, INT J BIOMETEOROL, V45, P170, DOI 10.1007/s004840100102; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; de Beurs KM, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P177, DOI 10.1007/978-90-481-3335-2_9; De La Maza M, 2009, GLOBAL CHANGE BIOL, V15, P1116, DOI 10.1111/j.1365-2486.2008.01796.x; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Garrity SR, 2011, AGR FOREST METEOROL, V151, P1741, DOI 10.1016/j.agrformet.2011.07.008; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; INCCA, 2010, CLIM CHANG IND A 4X4; Inman M, 2010, NATURE, V1, P28, DOI DOI 10.1038/CLIMATE.2010.19; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Julien Y, 2009, INT J REMOTE SENS, V30, P3495, DOI 10.1080/01431160802562255; Kumar KR, 2006, CURR SCI INDIA, V90, P334; Kumar P. R., 2009, World Journal of Agricultural Sciences, V5, P18; Kumar V, 2010, QUATERN INT, V212, P64, DOI 10.1016/j.quaint.2009.08.006; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piaoa S, 2011, PLATEAU AGR FOR METE, V151, P1599; Racoviteanu AE, 2008, SENSORS-BASEL, V8, P3355, DOI 10.3390/s8053355; Sharma E., 2009, SUSTAINABLE MOUNTAIN, V55, P10; Sharma E., 2009, CLIMATE CHANGE IMPAC; Sharma KP, 2000, CLIMATIC CHANGE, V47, P141, DOI 10.1023/A:1005696808953; Shrestha AB, 1999, J CLIMATE, V12, P2775, DOI 10.1175/1520-0442(1999)012<2775:MTTITH>2.0.CO;2; Shrestha AB, 2000, INT J CLIMATOL, V20, P317, DOI 10.1002/(SICI)1097-0088(20000315)20:3&lt;317::AID-JOC476&gt;3.0.CO;2-G; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockli R, 2004, INT J REMOTE SENS, V25, P3303, DOI 10.1080/01431160310001618149; Tsering K, 2003, CLIMATE CHANGE STUDI; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; White MA, 2009, GLOBAL CHANGE BIOL, V15, P2335, DOI 10.1111/j.1365-2486.2009.01910.x; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	42	334	343	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36741	10.1371/journal.pone.0036741	http://dx.doi.org/10.1371/journal.pone.0036741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615804	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300032
J	Chowning, JT; Griswold, JC; Kovarik, DN; Collins, LJ				Chowning, Jeanne Ting; Griswold, Joan Carlton; Kovarik, Dina N.; Collins, Laura J.			Fostering Critical Thinking, Reasoning, and Argumentation Skills through Bioethics Education	PLOS ONE			English	Article							RETROSPECTIVE PRETEST; LEARN	Developing a position on a socio-scientific issue and defending it using a well-reasoned justification involves complex cognitive skills that are challenging to both teach and assess. Our work centers on instructional strategies for fostering critical thinking skills in high school students using bioethical case studies, decision-making frameworks, and structured analysis tools to scaffold student argumentation. In this study, we examined the effects of our teacher professional development and curricular materials on the ability of high school students to analyze a bioethical case study and develop a strong position. We focused on student ability to identify an ethical question, consider stakeholders and their values, incorporate relevant scientific facts and content, address ethical principles, and consider the strengths and weaknesses of alternate solutions. 431 students and 12 teachers participated in a research study using teacher cohorts for comparison purposes. The first cohort received professional development and used the curriculum with their students; the second did not receive professional development until after their participation in the study and did not use the curriculum. In order to assess the acquisition of higher-order justification skills, students were asked to analyze a case study and develop a well-reasoned written position. We evaluated statements using a scoring rubric and found highly significant differences (p < 0.001) between students exposed to the curriculum strategies and those who were not. Students also showed highly significant gains (p < 0.001) in self-reported interest in science content, ability to analyze socio-scientific issues, awareness of ethical issues, ability to listen to and discuss viewpoints different from their own, and understanding of the relationship between science and society. Our results demonstrate that incorporating ethical dilemmas into the classroom is one strategy for increasing student motivation and engagement with science content, while promoting reasoning and justification skills that help prepare an informed citizenry.	[Chowning, Jeanne Ting; Griswold, Joan Carlton; Kovarik, Dina N.] NW Assoc Biomed Res, Seattle, WA USA; [Collins, Laura J.] Ctr Res & Learning, Snohomish, WA USA		Chowning, JT (corresponding author), NW Assoc Biomed Res, Seattle, WA USA.	jchowning@nwabr.org		Chowning, Jeanne/0000-0001-5667-2103	National Center for Research Resources; Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health [R25OD011138]; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR025131] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R25OD011138] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The "Collaborations to Understand Research and Ethics" (CURE) program was supported by a Science Education Partnership Award grant (http://ncrrsepa.org) from the National Center for Research Resources and the Division of Program Coordination, Planning, and Strategic Initiatives of the National Institutes of Health through Grant Number R25OD011138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for the Advancement of Science (AAAS), 1990, SCI ALL AM; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Bell P., 2004, PROMOTING STUDENTS A; BRAY JH, 1984, EDUC PSYCHOL MEAS, V44, P781, DOI 10.1177/0013164484444002; Chowning J.T., 2005, SCI TEACH, V72, P46; Chowning Jeanne Ting, 2009, Sci Teach, V76, P36; Chowning JT, 2010, BIOETHICS, V101; Chowning JT, 2009, SCI TEACH, V76, P8; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Herrenkohl LR, 1998, COGNITION INSTRUCT, V16, P431, DOI 10.1207/s1532690xci1604_3; Hill LG, 2005, AM J EVAL, V26, P501, DOI 10.1177/1098214005281356; HOOGSTRATEN J, 1982, J EXP EDUC, V50, P200, DOI 10.1080/00220973.1982.11011824; Howard GS, 1979, APPL PSYCH MEAS, V3, P1, DOI [10.1177/014662167900300101, DOI 10.1177/014662167900300101]; Klatt J., 2005, 2005 JOINT CES AEA C; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Miller G, 2008, SCIENCE, V322, P186, DOI 10.1126/science.322.5899.186a; Moore D, 2009, AM J EVAL, V21, P341; National Board for Professional Teaching Standards, 2007, AD YOUNG AD SCI STAN; National Research Council, 2011, FRAM K 12 SCI ED PRA; National Research Council (NRC), 1996, NAT SCI ED STAND; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Pratt CC, 2000, AM J EVAL, V21, P341, DOI 10.1177/109821400002100305; Sadler TD, 2004, J RES SCI TEACH, V41, P513, DOI 10.1002/tea.20009; Sadler TD, 2009, J RES SCI TEACH, V46, P909, DOI 10.1002/tea.20327; Toulmin Stephen, 1958, USES ARGUMENT; United States National Commission for Protection of Human Subjects of Biomedical and Behavioral Research, 1978, DHEW PUBL; Zeidler DL, 2005, SCI EDUC, V89, P357, DOI 10.1002/sce.20048	27	23	23	10	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36791	10.1371/journal.pone.0036791	http://dx.doi.org/10.1371/journal.pone.0036791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TW	22615814	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200043
J	Estrada-Pena, A; Estrada-Sanchez, A; Estrada-Sanchez, D				Estrada-Pena, Agustin; Estrada-Sanchez, Adrian; Estrada-Sanchez, David			Occurrence Patterns of Afrotropical Ticks (Acari: Ixodidae) in the Climate Space Are Not Correlated with Their Taxonomic Relationships	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; ENVIRONMENTAL NICHE; SPECIES RANGES; DISTRIBUTIONS; CONSERVATISM; BIODIVERSITY; DIVERSITY; EVOLUTION; AFRICA; MODELS	Foci of tick species occur at large spatial scales. They are intrinsically difficult to detect because the effect of geographical factors affecting conceptual influence of climate gradients. Here we use a large dataset of occurrences of ticks in the Afrotropical region to outline the main associations of those tick species with the climate space. Using a principal components reduction of monthly temperature and rainfall values over the Afrotropical region, we describe and compare the climate spaces of ticks in a gridded climate space. The dendrogram of distances among taxa according to occurrences in the climate niche is used to draw functional groups, or clusters of species with similar occurrences in the climate space, as different from morphologically derived (taxonomical) groups. We aim to further define the drivers of species richness and endemism at such a grid as well as niche similarities (climate space overlap) among species. Groups of species, as defined from morphological traits alone, are uncorrelated with functional clusters. Taxonomically related species occur separately in the climate gradients. Species belonging to the same functional group share more niche among them than with species in other functional groups. However, niche equivalency is also low for species within the same taxonomic cluster. Thus, taxa evolving from the same lineage tend to maximize the occupancy of the climate space and avoid overlaps with other species of the same taxonomic group. Richness values are drawn across the gradient of seasonal variation of temperature, higher values observed in a portion of the climate space with low thermal seasonality. Richness and endemism values are weakly correlated with mean values of temperature and rainfall. The most parsimonious explanation for the different taxonomic groups that exhibit common patterns of climate space subdivision is that they have a shared biogeographic history acting over a group of ancestrally co-distributed organisms.	[Estrada-Pena, Agustin; Estrada-Sanchez, Adrian; Estrada-Sanchez, David] Univ Zaragoza, Fac Vet Med, Dept Parasitol, Zaragoza, Spain	University of Zaragoza	Estrada-Pena, A (corresponding author), Univ Zaragoza, Fac Vet Med, Dept Parasitol, Zaragoza, Spain.	aestrada@unizar.es		Estrada Pena, Agustin/0000-0001-7483-046X	national science funds	national science funds	The study was funded by national science funds. The funder had no role in study desugn, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2010, MAPPING SPECIES DIST; Apanaskevich DA, 2007, ONDERSTEPOORT J VET, V74, P181; Arthur D.R., 1965, TICKS GENUS IXODES A, P348; Batjes N.H., 2005, 200508 ISRIC WORLD S; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; CRACRAFT J, 1994, AM ZOOL, V34, P33; Cumming GS, 1999, B ENTOMOL RES, V89, P303, DOI 10.1017/S0007485399000450; Cumming GS, 2002, ECOLOGY, V83, P255, DOI 10.1890/0012-9658(2002)083[0255:CCAVAL]2.0.CO;2; Cumming GS, 1998, B ENTOMOL RES, V88, P379, DOI 10.1017/S0007485300042139; Cumming GS, 2000, J BIOGEOGR, V27, P425, DOI 10.1046/j.1365-2699.2000.00419.x; Estrada-Pena A, 2008, MED VET ENTOMOL, V22, P248, DOI 10.1111/j.1365-2915.2008.00745.x; Estrada-Pena A, 2006, MED VET ENTOMOL, V20, P189, DOI 10.1111/j.1365-2915.2006.00622.x; Estrada-Pena A, 2003, ONDERSTEPOORT J VET, V70, P79; Estrada-Pena A, 2010, ENTOMOL EXP APPL, V137, P132, DOI 10.1111/j.1570-7458.2010.01050.x; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoogstraal H., 1982, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V55, P5; MINSHULL JI, 1982, S AFR J WILDL RES, V12, P118; NORVAL RAI, 1994, EXP APPL ACAROL, V18, P383, DOI 10.1007/BF00051522; Olwoch JM, 2003, J BIOGEOGR, V30, P1221, DOI 10.1046/j.1365-2699.2003.00913.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Riddle BR, 1996, TRENDS ECOL EVOL, V11, P207, DOI 10.1016/0169-5347(96)10032-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Walker J.B., 2000, TROP ANIM HEALTH PRO; Walker J.B., 1974, IXODID TICKS KENYA R; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	34	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36976	10.1371/journal.pone.0036976	http://dx.doi.org/10.1371/journal.pone.0036976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629349	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345300018
J	Mukhopadhyay, J; Braig, HR; Rowton, ED; Ghosh, K				Mukhopadhyay, Jaba; Braig, Henk R.; Rowton, Edgar D.; Ghosh, Kashinath			Naturally Occurring Culturable Aerobic Gut Flora of Adult Phlebotomus papatasi, Vector of Leishmania major in the Old World	PLOS ONE			English	Article							GLASSY-WINGED SHARPSHOOTER; SP NOV.; BACILLUS-PUMILUS; VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; WASTE-WATER; GEN. NOV.; BACTERIA; DIPTERA; DIVERSITY	Background: Cutaneous leishmaniasis is a neglected, vector-borne parasitic disease and is responsible for persistent, often disfiguring lesions and other associated complications. Leishmania, causing zoonotic cutaneous leishmaniasis (ZCL) in the Old World are mainly transmitted by the predominant sand fly vector, Phlebotomus papatasi. To date, there is no efficient control measure or vaccine available for this widespread insect-borne infectious disease. Methodology/Principal Findings: A survey was carried out to study the abundance of different natural gut flora in P. papatasi, with the long-term goal of generating a paratransgenic sand fly that can potentially block the development of Leishmania in the sand fly gut, thereby preventing transmission of leishmania in endemic disease foci. Sand flies, in particular, P. papatasi were captured from different habitats of various parts of the world. Gut microbes were cultured and identified using 16S ribosomal DNA analysis and a phylogenetic tree was constructed. We found variation in the species and abundance of gut flora in flies collected from different habitats. However, a few Gram-positive, nonpathogenic bacteria including Bacillus flexus and B. pumilus were common in most of the sites examined. Conclusion/Significance: Our results indicate that there is a wide range of variation of aerobic gut flora inhabiting sand fly guts, which possibly reflect the ecological condition of the habitat where the fly breeds. Also, some species of bacteria (B. pumilus, and B. flexus) were found from most of the habitats. Important from an applied perspective of dissemination, our results support a link between oviposition induction and adult gut flora.	[Mukhopadhyay, Jaba; Rowton, Edgar D.; Ghosh, Kashinath] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA; [Ghosh, Kashinath] Walter Reed Army Inst Res, Div Expt Therapeut, Silver Spring, MD USA; [Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Bangor University	Mukhopadhyay, J (corresponding author), Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA.	Kashinath.ghosh@us.army.mil	Braig, Henk/I-5477-2013	Braig, Henk/0000-0001-9592-1141	Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research	Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research	This study was funded by the Department of Defense through the In-House Laboratory Independent Research program at the Walter Reed Army Institute of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S., 1929, ANN TROP MED & PARASITOL, V23, P1; Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Aksoy HM, 2008, J PLANT PATHOL, V90, P449; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; An SY, 2007, INT J SYST EVOL MICR, V57, P51, DOI 10.1099/ijs.0.64340-0; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Behrendt U, 2002, INT J SYST EVOL MICR, V52, P1441, DOI 10.1099/00207713-52-5-1441; Ben-Dov E, 2006, APPL ENVIRON MICROB, V72, P6902, DOI 10.1128/AEM.00849-06; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Bextine B, 2004, CURR MICROBIOL, V48, P327, DOI 10.1007/s00284-003-4178-2; Bohme K, 2011, ELECTROPHORESIS, V32, P2951, DOI 10.1002/elps.201100217; Bottone EJ, 2003, J MED MICROBIOL, V52, P69, DOI 10.1099/jmm.0.04935-0; Butler JF, 2010, FLA ENTOMOL, V93, P218, DOI 10.1653/024.093.0211; Caspi-Fluger A, 2010, ISR J PLANT SCI, V58, P113, DOI 10.1560/IJPS.58.2.113; Chakraborty U, 2006, J BASIC MICROB, V46, P186, DOI 10.1002/jobm.200510050; Chandel S, 2010, J PHYTOPATHOL, V158, P470, DOI 10.1111/j.1439-0434.2009.01635.x; Chang EP, 2009, J MICROBIOL IMMUNOL, V42, P329; Chatterjee S, 2010, AFR J BIOTECHNOL, V9, P6983; Chelbi I, 2008, VECTOR-BORNE ZOONOT, V8, P741, DOI 10.1089/vbz.2007.0265; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; Darriet F, 2002, J AM MOSQUITO CONTR, V18, P65; Davari B, 2010, IRAN J ARTHROPOD-BOR, V4, P50; de Oliveira Sandra Maria Pereira, 2000, Revista da Sociedade Brasileira de Medicina Tropical, V33, P319, DOI 10.1590/S0037-86822000000300012; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; DeGheldre Y, 1997, J CLIN MICROBIOL, V35, P152, DOI 10.1128/JCM.35.1.152-160.1997; Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DHIMAN RC, 1983, INDIAN J MED RES, V77, P29; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Doha S, 1980, J EGYPT SOC PARASITO, V20, P747; Doughari HJ, 2011, MICROBES ENVIRON, V26, P101, DOI 10.1264/jsme2.ME10179; Erickson DL, 2009, J MED ENTOMOL, V46, P1532, DOI 10.1603/033.046.0642; Evans JD, 2005, J APICULT RES, V44, P168; Feldmann H, 2011, NEW ENGL J MED, V364, P1561, DOI 10.1056/NEJMe1102671; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Fieck A, 2010, EXP PARASITOL, V125, P342, DOI 10.1016/j.exppara.2010.02.016; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Ghosh K, 2003, ISR J AQUACULT-BAMID, V55, P13; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Govindasamy V, 2010, MICROBIOL MONOGR, V18, P333, DOI 10.1007/978-3-642-13612-2_15; Guernaoui S, 2011, J VECTOR ECOL, V36, pS144, DOI 10.1111/j.1948-7134.2011.00124.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton JV, 2003, EMERG INFECT DIS, V9, P1355; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Hogg JC, 2001, PARASITOLOGY, V123, P441, DOI 10.1017/S0031182001008642; Husseneder Claudia, 2009, P361; Indiragandhi P, 2010, J KOREAN SOC APPL BI, V53, P605, DOI 10.3839/jksabc.2010.093; Jappe U, 2003, ACTA DERM-VENEREOL, V83, P241, DOI 10.1080/00015550310016463; Jhingran Anupam, 2008, P1; Kelley ST, 2011, GENETICA, V139, P541, DOI 10.1007/s10709-010-9498-0; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Killick-Kendrick R, 2002, WORLD CL PARASITES, V4, P33; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Kishore K, 2006, INDIAN J MED RES, V123, P467; Krishnamurthi S, 2009, INT J SYST EVOL MICR, V59, P1054, DOI 10.1099/ijs.0.65742-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lane RP, 1993, MED INSECTS ARACHNID, P79; Lantova L, 2010, J INVERTEBR PATHOL, V105, P182, DOI 10.1016/j.jip.2010.07.001; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; Lin C, 2010, J HAZARD MATER, V182, P771, DOI 10.1016/j.jhazmat.2010.06.101; Mandiki SNM, 2011, AQUAC RES, V42, P693, DOI 10.1111/j.1365-2109.2010.02744.x; Matsuura Y, 2009, ZOOL SCI, V26, P448, DOI 10.2108/zsj.26.448; Modi Govind B., 1999, P109; Molina CA, 2010, APPL ENVIRON MICROB, V76, P1320, DOI 10.1128/AEM.01624-09; Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI 10.1586/ERI.10.78; Morsy Tosson A., 1993, Journal of the Egyptian Society of Parasitology, V23, P109; Mramba F, 2007, J VECTOR ECOL, V32, P134, DOI 10.3376/1081-1710(2007)32[134:VCOSFS]2.0.CO;2; Muller GC, 2011, J VECTOR ECOL, V36, pS195, DOI 10.1111/j.1948-7134.2011.00131.x; Nada DV, 2010, ACTA VET-BEOGRAD, V60, P49, DOI 10.2298/AVB1001049D; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; NAMITA M, 1991, INDIAN J MED RES-A, V93, P328; NARUSE N, 1990, J ANTIBIOT, V43, P267, DOI 10.7164/antibiotics.43.267; Otranto D, 2010, PARASITE VECTOR, V3, DOI [10.1186/1756-3305-3-77, 10.1186/1756-3305-3-2, 10.1186/1756-3305-3-26]; PANDYA AP, 1980, INDIAN J MED RES, V72, P355; Papa A, 2011, CLIN MICROBIOL INFEC, V17, P585, DOI 10.1111/j.1469-0691.2010.03371.x; Parvizi P, 2003, MED VET ENTOMOL, V17, P351, DOI 10.1111/j.1365-2915.2003.00451.x; Patil PB, 2010, FEMS MICROBIOL LETT, V312, P110, DOI 10.1111/j.1574-6968.2010.02104.x; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; Perotti MA, 2011, J APPL ENTOMOL, V135, P514, DOI 10.1111/j.1439-0418.2011.01639.x; PICHINOTY F, 1984, ANN INST PASTEUR MIC, VB135, P21, DOI 10.1016/S0769-2609(84)80039-3; Pontes MH, 2011, APPL ENVIRON MICROB, V77, P1918, DOI 10.1128/AEM.02166-10; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raats D, 2007, INT J SYST EVOL MICR, V57, P255, DOI 10.1099/ijs.0.64502-0; Radjame K., 1997, Indian Journal of Experimental Biology, V35, P59; Ramirez JL, 2008, J ECON ENTOMOL, V101, P1519, DOI 10.1603/0022-0493(2008)101[1519:FOAGMB]2.0.CO;2; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Reva ON, 2002, INT J SYST EVOL MICR, V52, P101, DOI 10.1099/00207713-52-1-101; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutledge LC, 2009, MED VET ENTOMOL, P147; Sanchez-Contreras M, 2008, BIOTECHNOL GENET ENG, V25, P203, DOI 10.5661/bger-25-203; Sanchez-Gonzalez M, 2011, LETT APPL MICROBIOL, V52, P413, DOI 10.1111/j.1472-765X.2011.03021.x; Sanders M E, 2003, Compr Rev Food Sci Food Saf, V2, P101, DOI 10.1111/j.1541-4337.2003.tb00017.x; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; SCHLEIN Y, 1985, PARASITOLOGY, V90, P57, DOI 10.1017/S0031182000049015; Schmidt TR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-430; Seo JK, 2010, ASIAN AUSTRAL J ANIM, V23, P1657, DOI 10.5713/ajas.2010.r.08; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Singh RP, 2011, AQUAT BIOL, V12, P13, DOI 10.3354/ab00312; Sivagnaname N., 1997, Journal of Communicable Diseases, V29, P153; Subhadra B, 2010, J APPL MICROBIOL, V108, P831, DOI 10.1111/j.1365-2672.2009.04479.x; Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971; Swiecicka I, 2008, BIOCONTROL SCI TECHN, V18, P221, DOI 10.1080/09583150801942334; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarallo VD, 2010, ACTA TROP, V116, P227, DOI 10.1016/j.actatropica.2010.08.013; Tay BY, 2010, WORLD J MICROB BIOT, V26, P1015, DOI 10.1007/s11274-009-0264-3; Toledo AV, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.0129; Tozlu E, 2011, FRESEN ENVIRON BULL, V20, P918; Vasilev G.I., 1987, P208; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Votypka J, 2009, J EUKARYOT MICROBIOL, V56, P583, DOI 10.1111/j.1550-7408.2009.00438.x; Wasserberg G, 2011, J VECTOR ECOL, V36, pS138, DOI 10.1111/j.1948-7134.2011.00123.x; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07; WHO, 2011, LEISHM; Whon TW, 2010, J MICROBIOL, V48, P862, DOI 10.1007/s12275-010-0214-7; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Yildirim E, 2011, HORTSCIENCE, V46, P932, DOI 10.21273/HORTSCI.46.6.932; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhao CQ, 2010, J SOC LEATH TECH CH, V94, P21	131	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e35748	10.1371/journal.pone.0035748	http://dx.doi.org/10.1371/journal.pone.0035748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629302	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345300003
J	Fiaschi, T; Giannoni, E; Taddei, ML; Chiarugi, P				Fiaschi, Tania; Giannoni, Elisa; Taddei, Maria Letizia; Chiarugi, Paola			Globular Adiponectin Activates Motility and Regenerative Traits of Muscle Satellite Cells	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; IN-VIVO; STEM-CELLS; DYSTROPHIN EXPRESSION; PROGENITOR CELLS; MIGRATION; DIFFERENTIATION; IDENTIFICATION; POPULATION	Regeneration of adult injured skeletal muscle is due to activation of satellite cells, a population of stem cells resident beneath the basal lamina. Thus, information on soluble factors affecting satellite cell activation, as well as migration towards injury and fusion into new myofibers are essential. Here, we show that globular adiponectin (gAd), positively affects several features of muscle satellite cells. gAd activates satellite cells to exit quiescence and increases their recruitment towards myotubes. gAd elicits in satellite cells a specific motility program, involving activation of the small GTPase Rac1, as well as expression of Snail and Twist transcription factors driving a proteolytic motility, useful to reach the site of injury. We show that satellite cells produce autocrine full length adiponectin (fAd), which is converted to gAd by activated macrophages. In turns, gAd concurs to attract to the site of injury both satellite cells and macrophages and induces myogenesis in muscle satellite cells. Thus, these findings add a further role for gAd in skeletal muscle, including the hormone among factors participating in muscle regeneration.	[Fiaschi, Tania; Giannoni, Elisa; Taddei, Maria Letizia; Chiarugi, Paola] Univ Florence, Dept Biochem Sci, Florence, Italy	University of Florence	Fiaschi, T (corresponding author), Univ Florence, Dept Biochem Sci, Florence, Italy.	paola.chiarugi@unifi.it	Chiarugi, Paola/CDD-7988-2022; Giannoni, Elisa/AAE-2092-2020	Giannoni, Elisa/0000-0001-7136-1098; Chiarugi, Paola/0000-0001-7655-2969	Association Francaise contre les Myopathies; Italian Association for Cancer Research; Tuscany Tumor Institute; Tuscany Project TUMAR	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Tuscany Tumor Institute; Tuscany Project TUMAR	This work was supported by Association Francaise contre les Myopathies, Italian Association for Cancer Research, The Tuscany Tumor Institute and the Tuscany Project TUMAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Carmeli E, 2004, MUSCLE NERVE, V29, P191, DOI 10.1002/mus.10529; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Delaigle AM, 2006, DIABETOLOGIA, V49, P1311, DOI 10.1007/s00125-006-0210-y; Delfini MC, 2009, DEV BIOL, V333, P229, DOI 10.1016/j.ydbio.2009.05.544; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; El Fahime E, 2000, EXP CELL RES, V258, P279, DOI 10.1006/excr.2000.4962; Fiaschi T, 2007, HEPATOLOGY, V46, P130, DOI 10.1002/hep.21643; Fiaschi T, 2010, MOL BIOL CELL, V21, P848, DOI 10.1091/mbc.E09-04-0310; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lescaudron L, 1999, NEUROMUSCULAR DISORD, V9, P72, DOI 10.1016/S0960-8966(98)00111-4; Lewis MP, 2000, J MUSCLE RES CELL M, V21, P223, DOI 10.1023/A:1005670507906; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Takino T, 2006, EXP CELL RES, V312, P1381, DOI 10.1016/j.yexcr.2006.01.008; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang W, 2009, AM J PATHOL, V174, P541, DOI 10.2353/ajpath.2009.080509; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zimowska M, 2008, INT J DEV BIOL, V52, P307, DOI 10.1387/ijdb.072331mz	40	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34782	10.1371/journal.pone.0034782	http://dx.doi.org/10.1371/journal.pone.0034782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629295	Green Published, gold			2022-12-27	WOS:000305343500002
J	Murata, K; Kitaori, T; Oishi, S; Watanabe, N; Yoshitomi, H; Tanida, S; Ishikawa, M; Kasahara, T; Shibuya, H; Fujii, N; Nagasawa, T; Nakamura, T; Ito, H				Murata, Koichi; Kitaori, Toshiyuki; Oishi, Shinya; Watanabe, Naoki; Yoshitomi, Hiroyuki; Tanida, Shimei; Ishikawa, Masahiro; Kasahara, Takashi; Shibuya, Hideyuki; Fujii, Nobutaka; Nagasawa, Takashi; Nakamura, Takashi; Ito, Hiromu			Stromal Cell-Derived Factor 1 Regulates the Actin Organization of Chondrocytes and Chondrocyte Hypertrophy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; ENDOCHONDRAL OSSIFICATION; MYOCARDIAL-INFARCTION; MULTIPLE-MYELOMA; IN-VITRO; SDF-1; DIFFERENTIATION; MIGRATION	Stromal cell-derived factor 1 (SDF-1/CXCL12/PBSF) plays important roles in the biological and physiological functions of haematopoietic and mesenchymal stem cells. This chemokine regulates the formation of multiple organ systems during embryogenesis. However, its roles in skeletal development remain unclear. Here we investigated the roles of SDF-1 in chondrocyte differentiation. We demonstrated that SDF-1 protein was expressed at pre-hypertrophic and hypertrophic chondrocytes in the newly formed endochondral callus of rib fracture as well as in the growth plate of normal mouse tibia by immunohistochemical analysis. Using SDF-1(-/-) mouse embryo, we histologically showed that the total length of the whole humeri of SDF-1(-/-) mice was significantly shorter than that of wild- type mice, which was contributed mainly by shorter hypertrophic and calcified zones in SDF-1(-/-) mice. Actin cytoskeleton of hypertrophic chondrocytes in SDF-1(-/-) mouse humeri showed less F-actin and rounder shape than that of wild- type mice. Primary chondrocytes from SDF-1(-/-) mice showed the enhanced formation of philopodia and loss of F-actin. The administration of SDF-1 to primary chondrocytes of wild- type mice and SDF-1(-/-) mice promoted the formation of actin stress fibers. Organ culture of embryonic metatarsals from SDF-1(-/-) mice showed the growth delay, which was recovered by an exogenous administration of SDF-1. mRNA expression of type X collagen in metatarsals and in primary chondrocytes of SDF-1(-/-) mouse embryo was down-regulated while the administration of SDF-1 to metatarsals recovered. These data suggests that SDF-1 regulates the actin organization and stimulates bone growth by mediating chondrocyte hypertrophy.	[Murata, Koichi; Kitaori, Toshiyuki; Yoshitomi, Hiroyuki; Tanida, Shimei; Ishikawa, Masahiro; Kasahara, Takashi; Shibuya, Hideyuki; Nakamura, Takashi; Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Chemogenom, Kyoto, Japan; [Watanabe, Naoki] Tohoku Univ, Grad Sch Life Sci, Lab Single Mol Cell Biol, Aoba Ku, Sendai, Miyagi 980, Japan; [Nagasawa, Takashi] Kyoto Univ, Inst Frontier Med Sci, Dept Immunobiol & Hematol, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan	Kyoto University; Kyoto University; Tohoku University; Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto, Japan.	hiromu@kuhp.kyoto-u.ac.jp	Oishi, Shinya/C-1350-2011	Oishi, Shinya/0000-0002-2833-2539; Murata, Koichi/0000-0002-7896-3937; Nagasawa, Takashi/0000-0002-1085-0960	Ministry of Education of Japan [19591756, 21591942]; Grants-in-Aid for Scientific Research [22390096] Funding Source: KAKEN	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids from the Ministry of Education of Japan (No. 19591756 and No. 21591942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Avniel S, 2006, J INVEST DERMATOL, V126, P468, DOI 10.1038/sj.jid.5700069; Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Babarina AV, 2001, MATRIX BIOL, V20, P205, DOI 10.1016/S0945-053X(01)00132-9; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Grassi F, 2004, J CELL PHYSIOL, V199, P244, DOI 10.1002/jcp.10445; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Ito H, 1999, BIOCHEM BIOPH RES CO, V262, P443, DOI 10.1006/bbrc.1999.1197; Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stein CA, 2009, CLIN CANCER RES, V15, P2797, DOI 10.1158/1078-0432.CCR-08-2610; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Vicente-Manzanares Miguel, 2004, Methods Mol Biol, V239, P53; VONDERMARK K, 1977, J CELL BIOL, V73, P736, DOI 10.1083/jcb.73.3.736; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37163	10.1371/journal.pone.0037163	http://dx.doi.org/10.1371/journal.pone.0037163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623989	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500068
J	Younes, JA; van der Mei, HC; van den Heuvel, E; Busscher, HJ; Reid, G				Younes, Jessica A.; van der Mei, Henny C.; van den Heuvel, Edwin; Busscher, Henk J.; Reid, Gregor			Adhesion Forces and Coaggregation between Vaginal Staphylococci and Lactobacilli	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; BIOFILMS; MICROSCOPY; CELLS; SPECIFICITY	Urogenital infections are the most common ailments afflicting women. They are treated with dated antimicrobials whose efficacy is diminishing. The process of infection involves pathogen adhesion and displacement of indigenous Lactobacillus crispatus and Lactobacillus jensenii. An alternative therapeutic approach to antimicrobial therapy is to reestablish lactobacilli in this microbiome through probiotic administration. We hypothesized that lactobacilli displaying strong adhesion forces with pathogens would facilitate coaggregation between the two strains, ultimately explaining the elimination of pathogens seen in vivo. Using atomic force microscopy, we found that adhesion forces between lactobacilli and three virulent toxic shock syndrome toxin 1-producing Staphylococcus aureus strains, were significantly stronger (2.2-6.4 nN) than between staphylococcal pairs (2.2-3.4 nN), especially for the probiotic Lactobacillus reuteri RC-14 (4.0-6.4 nN) after 120 s of bond-strengthening. Moreover, stronger adhesion forces resulted in significantly larger coaggregates. Adhesion between the bacteria occurred instantly upon contact and matured within one to two minutes, demonstrating the potential for rapid anti-pathogen effects using a probiotic. Coaggregation is one of the recognized mechanisms through which lactobacilli can exert their probiotic effects to create a hostile micro-environment around a pathogen. With antimicrobial options fading, it therewith becomes increasingly important to identify lactobacilli that bind strongly with pathogens.	[Younes, Jessica A.; Reid, Gregor] Lawson Hlth Res Inst, London, ON, Canada; [Younes, Jessica A.; van der Mei, Henny C.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands; [Younes, Jessica A.; van der Mei, Henny C.; van den Heuvel, Edwin; Busscher, Henk J.] Univ Groningen, Groningen, Netherlands; [van den Heuvel, Edwin] Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Reid, Gregor] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Reid, Gregor] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada	Western University (University of Western Ontario); University of Groningen; University of Groningen; University of Groningen; Western University (University of Western Ontario); Western University (University of Western Ontario)	Younes, JA (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020; Van den Heuvel, Edwin/C-5166-2013; Reid, Gregor/ABE-8327-2020	Busscher, Henk/0000-0002-3644-5533; Van den Heuvel, Edwin/0000-0001-9157-7224; Reid, Gregor/0000-0001-9658-5696	Lawson Health Research Institute, London, Ontario, Canada; University Medical Center, Groningen, The Netherlands	Lawson Health Research Institute, London, Ontario, Canada; University Medical Center, Groningen, The Netherlands(Netherlands Government)	This study was funded by the Lawson Health Research Institute, London, Ontario, Canada, and the University Medical Center, Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MIXED EFFECTS MODELS; [Anonymous], 2006, SAS MIXED MODELS; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Dague E, 2010, LANGMUIR, V26, P11010, DOI 10.1021/la101862n; Doan TLL, 2011, BIOPHYS J, V101, P2843, DOI 10.1016/j.bpj.2011.10.034; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; MacPhee RA, 2010, EXPERT OPIN PHARMACO, V11, P2985, DOI 10.1517/14656566.2010.512004; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McMillan A, 2011, COLLOID SURFACE B, V86, P58, DOI 10.1016/j.colsurfb.2011.03.016; Muller DJ, 2009, CURR OPIN BIOTECH, V20, P4, DOI 10.1016/j.copbio.2009.02.005; Mumtaz Shamim, 2008, J Ayub Med Coll Abbottabad, V20, P113; Postollec F, 2006, J DENT RES, V85, P231, DOI 10.1177/154405910608500305; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REID G, 1990, CURR MICROBIOL, V20, P47, DOI 10.1007/BF02094024; Reid G, 2011, NAT REV MICROBIOL, V9, P27, DOI 10.1038/nrmicro2473; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Saunders S, 2007, COLLOID SURFACE B, V55, P138, DOI 10.1016/j.colsurfb.2006.11.040; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; van der Mei HC, 2010, COLLOID SURFACE B, V78, P372, DOI 10.1016/j.colsurfb.2010.03.018; Velraeds MMC, 1998, J MED MICROBIOL, V47, P1081, DOI 10.1099/00222615-47-12-1081; Waar K, 2005, MICROBIOL-SGM, V151, P2459, DOI 10.1099/mic.0.27877-0	29	78	84	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36917	10.1371/journal.pone.0036917	http://dx.doi.org/10.1371/journal.pone.0036917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629342	gold, Green Published			2022-12-27	WOS:000305343500038
J	Gebuis, T; Reynvoet, B				Gebuis, Titia; Reynvoet, Bert			The Role of Visual Information in Numerosity Estimation	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; MODEL; PRESCHOOLERS; COUNTS; ADULTS	Mainstream theory suggests that the approximate number system supports our non-symbolic number abilities (e. g. estimating or comparing different sets of items). It is argued that this system can extract number independently of the visual cues present in the stimulus (diameter, aggregate surface, etc.). However, in a recent report we argue that this might not be the case. We showed that participants combined information from different visual cues to derive their answers. While numerosity comparison requires a rough comparison of two sets of items (smaller versus larger), numerosity estimation requires a more precise mechanism. It could therefore be that numerosity estimation, in contrast to numerosity comparison, might rely on the approximate number system. To test this hypothesis, we conducted a numerosity estimation experiment. We controlled for the visual cues according to current standards: each single visual property was not informative about numerosity. Nevertheless, the results reveal that participants were influenced by the visual properties of the dot arrays. They gave a larger estimate when the dot arrays consisted of dots with, on average, a smaller diameter, aggregate surface or density but a larger convex hull. The reliance on visual cues to estimate numerosity suggests that the existence of an approximate number system that can extract numerosity independently of the visual cues is unlikely. Instead, we propose that humans estimate numerosity by weighing the different visual cues present in the stimuli.	[Gebuis, Titia; Reynvoet, Bert] Univ Louvain, Expt Psychol Lab, Louvain, Belgium; [Reynvoet, Bert] Univ Louvain, Subfac Psychol & Educ Sci, Louvain, Belgium		Gebuis, T (corresponding author), Univ Louvain, Expt Psychol Lab, Louvain, Belgium.	Titia.Gebuis@psy.kuleuven.be		Reynvoet, Bert/0000-0002-4898-2475	Marie Curie Intra European Fellowship	Marie Curie Intra European Fellowship(European Commission)	This research was supported by the Marie Curie Intra European Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 2005, CONTROL NONNUMERICAL; Gebuis T, J EXPT PSYCHOL GEN; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gilmore C, 2011, Q J EXP PSYCHOL, V64, P2099, DOI 10.1080/17470218.2011.574710; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Lemaire P, 2007, J GERONTOL B-PSYCHOL, V62, pP305, DOI 10.1093/geronb/62.6.P305; Lyons IM, J EXP PSYCH IN PRESS; MILLER AI, 1968, AM J PSYCHOL, V81, P83, DOI 10.2307/1420810; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275	21	125	126	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37426	10.1371/journal.pone.0037426	http://dx.doi.org/10.1371/journal.pone.0037426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22616007	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200075
J	Nieman, DC; Gillitt, ND; Henson, DA; Sha, W; Shanely, RA; Knab, AM; Cialdella-Kam, L; Jin, FX				Nieman, David C.; Gillitt, Nicholas D.; Henson, Dru A.; Sha, Wei; Shanely, R. Andrew; Knab, Amy M.; Cialdella-Kam, Lynn; Jin, Fuxia			Bananas as an Energy Source during Exercise: A Metabolomics Approach	PLOS ONE			English	Article							CYTOKINE MESSENGER-RNA; OXIDATIVE STRESS; PLASMA; CARBOHYDRATE; ANTIOXIDANT; PERFORMANCE; METABOLISM; DOPAMINE; INGESTION; ACID	This study compared the acute effect of ingesting bananas (BAN) versus a 6% carbohydrate drink (CHO) on 75-km cycling performance and post-exercise inflammation, oxidative stress, and innate immune function using traditional and metabolomics-based profiling. Trained cyclists (N = 14) completed two 75-km cycling time trials (randomized, crossover) while ingesting BAN or CHO (0.2 g/kg carbohydrate every 15 min). Pre-, post-, and 1-h-post-exercise blood samples were analyzed for glucose, granulocyte (GR) and monocyte (MO) phagocytosis (PHAG) and oxidative burst activity, nine cytokines, F-2-isoprostanes, ferric reducing ability of plasma (FRAP), and metabolic profiles using gas chromatography-mass spectrometry. Blood glucose levels and performance did not differ between BAN and CHO (2.41+/-0.22, 2.36+/-0.19 h, P = 0.258). F-2-isoprostanes, FRAP, IL-10, IL-2, IL-6, IL-8, TNF alpha, GR-PHAG, and MO-PHAG increased with exercise, with no trial differences except for higher levels during BAN for IL-10, IL-8, and FRAP (interaction effects, P = 0.003, 0.004, and 0.012). Of 103 metabolites detected, 56 had exercise time effects, and only one (dopamine) had a pattern of change that differed between BAN and CHOx Plots from the PLS-DA model visualized a distinct separation in global metabolic scores between time points [(RY)-Y-2(cum) = 0.869, Q(2)(cum) = 0.766]. Of the top 15 metabolites, five were related to liver glutathione production, eight to carbohydrate, lipid, and amino acid metabolism, and two were tricarboxylic acid cycle intermediates. BAN and CHO ingestion during 75-km cycling resulted in similar performance, blood glucose, inflammation, oxidative stress, and innate immune levels. Aside from higher dopamine in BAN, shifts in metabolites following BAN and CHO 75-km cycling time trials indicated a similar pattern of heightened production of glutathione and utilization of fuel substrates in several pathways.	[Nieman, David C.; Shanely, R. Andrew; Knab, Amy M.; Cialdella-Kam, Lynn] Appalachian State Univ, Human Performance Lab, Kannapolis, NC USA; [Gillitt, Nicholas D.; Jin, Fuxia] Dole Nutr Res Lab, Kannapolis, NC USA; [Henson, Dru A.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Sha, Wei] Univ N Carolina Charlotte, Bioinformat Serv Div, Kannapolis, NC USA	University of North Carolina; Appalachian State University; University of North Carolina; Appalachian State University; University of North Carolina; University of North Carolina Charlotte	Nieman, DC (corresponding author), Appalachian State Univ, Human Performance Lab, N Carolina Res Campus, Kannapolis, NC USA.	niemandc@appstate.edu	Nieman, David/AAC-9739-2022	Nieman, David/0000-0002-8305-1860; Cialdella-Kam, Lynn/0000-0001-9603-7163	Dole Foods (Westlake Village, CA); Dole Foods	Dole Foods (Westlake Village, CA); Dole Foods	This study was funded through a grant provided by Dole Foods (Westlake Village, CA). NDG and FJ are scientists in the Dole Nutrition Research Laboratory, and were a part of the research team conducting this study. They assisted in the analysis of samples, and banana flesh analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DCN, DAH, WS, RAS, AMK, and LCK have no conflicts of interest to report other than funding to the university from Dole Foods. NDG and FJ are scientists in the Dole Nutrition Research Laboratory, and were a part of the research team conducting this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Bennett RN, 2010, J AGR FOOD CHEM, V58, P7991, DOI 10.1021/jf1008692; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; DUNNE JW, 1983, LIFE SCI, V33, P1511, DOI 10.1016/0024-3205(83)90855-X; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; JONES NL, 1980, CLIN SCI, V59, P469, DOI 10.1042/cs0590469; Kanazawa K, 2000, J AGR FOOD CHEM, V48, P844, DOI 10.1021/jf9909860; Kuchel O, 1982, HYPERTENSION 2, V4, P11193; Lee R, 2010, ANAL CHEM, V82, P2959, DOI 10.1021/ac9029746; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Manach C, 2009, MOL NUTR FOOD RES, V53, P1303, DOI 10.1002/mnfr.200800516; Miccheli A, 2009, J AM COLL NUTR, V28, P553, DOI 10.1080/07315724.2009.10719787; Mitchell JB, 2000, J SPORT MED PHYS FIT, V40, P41; Miura Y, 1995, Hypertens Res, V18 Suppl 1, pS65, DOI 10.1291/hypres.18.SupplementI_S65; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Nieman D.., 2009, MED SPORTIVA, V13, P189, DOI [DOI 10.2478/V10036-009-0031-4, 10.2478/v10036-009-0031-4]; Nieman DC, 2008, NUTR REV, V66, P310, DOI 10.1111/j.1753-4887.2008.00038.x; Nieman David C, 2006, Res Sports Med, V14, P225, DOI 10.1080/15438620600854793; Nieman DC, 2012, J INTERF CYTOK RES, V32, P12, DOI 10.1089/jir.2011.0038; Nieman DC, 2005, MED SCI SPORT EXER, V37, P1283, DOI 10.1249/01.mss.0000175054.99588.b1; Nieman DC, 2003, J APPL PHYSIOL, V94, P1917, DOI 10.1152/japplphysiol.01130.2002; Pechlivanis A, 2010, J PROTEOME RES, V9, P6405, DOI 10.1021/pr100684t; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rietschier HL, 2011, J STRENGTH COND RES, V25, P3150, DOI 10.1519/JSC.0b013e31820f5089; *USDA, 2007, OX RAD ABS CAP ORAC; VANLOON GR, 1983, FED PROC, V42, P3012; Vincent JL, 2009, MINERVA ANESTESIOL, V75, P333	31	42	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37479	10.1371/journal.pone.0037479	http://dx.doi.org/10.1371/journal.pone.0037479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616015	gold, Green Published			2022-12-27	WOS:000305341200079
J	Wang, QQ; Zhao, N; Kennard, S; Lilly, B				Wang, Qingqing; Zhao, Ning; Kennard, Simone; Lilly, Brenda			Notch2 and Notch3 Function Together to Regulate Vascular Smooth Muscle Development	PLOS ONE			English	Article							NOTCH3-DEFICIENT MICE; EXPRESSION; MUTATION; PATHWAY; CELLS; CADASIL; JAGGED1	Notch signaling has been implicated in the regulation of smooth muscle differentiation, but the precise role of Notch receptors is ill defined. Although Notch3 receptor expression is high in smooth muscle, Notch3 mutant mice are viable and display only mild defects in vascular patterning and smooth muscle differentiation. Notch2 is also expressed in smooth muscle and Notch2 mutant mice show cardiovascular abnormalities indicative of smooth muscle defects. Together, these findings infer that Notch2 and Notch3 act together to govern vascular development and smooth muscle differentiation. To address this hypothesis, we characterized the phenotype of mice with a combined deficiency in Notch2 and Notch3. Our results show that when Notch2 and Notch3 genes are simultaneously disrupted, mice die in utero at mid-gestation due to severe vascular abnormalities. Assembly of the vascular network occurs normally as assessed by Pecam1 expression, however smooth muscle cells surrounding the vessels are grossly deficient leading to vascular collapse. In vitro analysis show that both Notch2 and Notch3 robustly activate smooth muscle differentiation genes, and Notch3, but not Notch2 is a target of Notch signaling. These data highlight the combined actions of the Notch receptors in the regulation of vascular development, and suggest that while these receptors exhibit compensatory roles in smooth muscle, their functions are not entirely overlapping.	[Wang, Qingqing; Zhao, Ning; Lilly, Brenda] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Zhao, Ning; Lilly, Brenda] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kennard, Simone] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Wang, QQ (corresponding author), Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Kennard, Simone/0000-0002-7564-9192; Zhao, Ning/0000-0001-6514-234X	National Institutes of Health (NIH) [R01 HL076428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076428] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant R01 HL076428 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gaengel K, 2009, ARTERIOSCLER THROMB; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hamada Y, 1999, DEVELOPMENT, V126, P3415; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; McCright B, 2001, DEVELOPMENT, V128, P491; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Varadkar P, 2008, DEV DYNAM, V237, P1144, DOI 10.1002/dvdy.21502	23	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37365	10.1371/journal.pone.0037365	http://dx.doi.org/10.1371/journal.pone.0037365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615991	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200068
J	Yi, H; Patel, AK; Sodhi, CP; Hackam, DJ; Hackam, AS				Yi, Hyun; Patel, Amit K.; Sodhi, Chhinder P.; Hackam, David J.; Hackam, Abigail S.			Novel Role for the Innate Immune Receptor Toll-Like Receptor 4 (TLR4) in the Regulation of the Wnt Signaling Pathway and Photoreceptor Apoptosis	PLOS ONE			English	Article							INDUCED RETINAL DEGENERATION; NF-KAPPA-B; MACULAR DEGENERATION; NEUROTROPHIC FACTOR; RAT RETINA; CELL-DEATH; NECROTIZING ENTEROCOLITIS; CEREBRAL-ISCHEMIA; DANGER SIGNALS; OUTER SEGMENTS	Recent evidence has implicated innate immunity in regulating neuronal survival in the brain during stroke and other neurodegenerations. Photoreceptors are specialized light-detecting neurons in the retina that are essential for vision. In this study, we investigated the role of the innate immunity receptor TLR4 in photoreceptors. TLR4 activation by lipopolysaccharide (LPS) significantly reduced the survival of cultured mouse photoreceptors exposed to oxidative stress. With respect to mechanism, TLR4 suppressed Wnt signaling, decreased phosphorylation and activation of the Wnt receptor LRP6, and blocked the protective effect of the Wnt3a ligand. Paradoxically, TLR4 activation prior to oxidative injury protected photoreceptors, in a phenomenon known as preconditioning. Expression of TNF alpha and its receptors TNFR1 and TNFR2 decreased during preconditioning, and preconditioning was mimicked by TNF alpha antagonists, but was independent of Wnt signaling. Therefore, TLR4 is a novel regulator of photoreceptor survival that acts through the Wnt and TNF alpha pathways.	[Yi, Hyun; Patel, Amit K.; Hackam, Abigail S.] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; [Sodhi, Chhinder P.; Hackam, David J.] Univ Pittsburgh, Dept Surg Pediat, Pittsburgh, PA USA	Bascom Palmer Eye Institute; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yi, H (corresponding author), Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA.	ahackam@med.miami.edu		Hackam, David/0000-0001-5195-8807	NEI [RO1 EY017837]; Karl Kirchgessner Foundation; Research to Prevent Blindness; NEI Center [P30EY014801]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017837, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Karl Kirchgessner Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NEI Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NEI RO1 EY017837, the Karl Kirchgessner Foundation and a Research to Prevent Blindness Special Scholar Award (ASH). Institutional support to Bascom Palmer Eye Institute was from a Research to Prevent Blindness Unrestricted Grant and NEI Center Core Grant P30EY014801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Barile GR, 2007, CURR MOL MED, V7, P758, DOI 10.2174/156652407783220778; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; CASPI RR, 1989, J AUTOIMMUN, V2, P709, DOI 10.1016/S0896-8411(89)80009-5; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; DEKOZAK Y, 1994, J NEUROIMMUNOL, V55, P1, DOI 10.1016/0165-5728(94)90141-4; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; El-Ghrably IA, 1999, BRIT J OPHTHALMOL, V83, P1296, DOI 10.1136/bjo.83.11.1296; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fragoso MA, 2011, CELL MOL NEUROBIOL, V31, P163, DOI 10.1007/s10571-010-9603-z; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hua F, 2007, J NEUROIMMUNOL, V190, P101, DOI 10.1016/j.jneuroim.2007.08.014; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kacimi R, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-7; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kilic U, 2008, NEUROBIOL DIS, V31, P33, DOI 10.1016/j.nbd.2008.03.002; Kindzelskii AL, 2004, J GEN PHYSIOL, V124, P139, DOI 10.1085/jgp.200409062; Ko MK, 2011, INVEST OPHTH VIS SCI, V52, P5824, DOI 10.1167/iovs.10-6357; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Leung PY, 2009, FUTUR NEUROL, V4, P201, DOI 10.2217/14796708.4.2.201; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lin S, 2009, MOL VIS, V15, P26; Liu CD, 1998, J NEUROSCI, V18, P1337; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2009, STROKE, V40, pS34, DOI 10.1161/STROKEAHA.108.534917; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mizukami M, 2009, EXP EYE RES, V89, P462, DOI 10.1016/j.exer.2009.04.011; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seigel G, 2000, MOL VIS, V6, P157; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Silva AK, 2010, MOL VIS, V16, P36; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tell S, 2006, BIOCHEM BIOPH RES CO, V349, P261, DOI 10.1016/j.bbrc.2006.08.044; TEZEL G, 2010, EXP EYE RES; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; WATSON J, 1977, J IMMUNOL, V118, P2088; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Xin Y, 2001, LIFE SCI, V69, P289, DOI 10.1016/S0024-3205(01)01122-5; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yi H, 2007, INVEST OPHTH VIS SCI, V48, P5733, DOI 10.1167/iovs.07-0097; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059	84	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36560	10.1371/journal.pone.0036560	http://dx.doi.org/10.1371/journal.pone.0036560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615780	gold, Green Accepted, Green Published			2022-12-27	WOS:000305341200012
J	Bailey, H; Fossette, S; Bograd, SJ; Shillinger, GL; Swithenbank, AM; Georges, JY; Gaspar, P; Stromberg, KHP; Paladino, FV; Spotila, JR; Block, BA; Hays, GC				Bailey, Helen; Fossette, Sabrina; Bograd, Steven J.; Shillinger, George L.; Swithenbank, Alan M.; Georges, Jean-Yves; Gaspar, Philippe; Stromberg, K. H. Patrik; Paladino, Frank V.; Spotila, James R.; Block, Barbara A.; Hays, Graeme C.			Movement Patterns for a Critically Endangered Species, the Leatherback Turtle (Dermochelys coriacea), Linked to Foraging Success and Population Status	PLOS ONE			English	Article							SEA-TURTLES; MARINE PREDATOR; PACIFIC; ZOOPLANKTON; BEHAVIOR; HABITATS; LOGGERHEAD; DICHOTOMY; CONTEXT	Foraging success for pelagic vertebrates may be revealed by horizontal and vertical movement patterns. We show markedly different patterns for leatherback turtles in the North Atlantic versus Eastern Pacific, which feed on gelatinous zooplankton that are only occasionally found in high densities. In the Atlantic, travel speed was characterized by two modes, indicative of high foraging success at low speeds (<15 km d(-1)) and transit at high speeds (20-45 km d(-1)). Only a single mode was evident in the Pacific, which occurred at speeds of 21 km d(-1) indicative of transit. The mean dive depth was more variable in relation to latitude but closer to the mean annual depth of the thermocline and nutricline for North Atlantic than Eastern Pacific turtles. The most parsimonious explanation for these findings is that Eastern Pacific turtles rarely achieve high foraging success. This is the first support for foraging behaviour differences between populations of this critically endangered species and suggests that longer periods searching for prey may be hindering population recovery in the Pacific while aiding population maintenance in the Atlantic.	[Bailey, Helen] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [Bailey, Helen; Bograd, Steven J.] NOAA, Natl Marine Fisheries Serv, SWFSC, Div Environm Res, Pacific Grove, CA USA; [Fossette, Sabrina; Hays, Graeme C.] Swansea Univ, Dept Biosci, Coll Sci, Swansea, W Glam, Wales; [Shillinger, George L.] Ctr Ocean Solut, Monterey, CA USA; [Shillinger, George L.; Swithenbank, Alan M.; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Georges, Jean-Yves] Univ Strasbourg, IPHC, Strasbourg, France; [Georges, Jean-Yves] CNRS, UMR7178, F-67037 Strasbourg, France; [Gaspar, Philippe] Collecte Localisat Satellites, Dept Marine Ecosyst, Satellite Oceanog Div, Ramonville St Agne, France; [Stromberg, K. H. Patrik] Swedish Meteorol & Hydrol Inst, S-60176 Norrkoping, Sweden; [Paladino, Frank V.] Indiana Purdue Univ, Dept Biol, Ft Wayne, IN USA; [Spotila, James R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Center for Environmental Science; National Oceanic Atmospheric Admin (NOAA) - USA; Swansea University; Stanford University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swedish Meteorological & Hydrological Institute; Purdue University System; Indiana University Purdue University Fort Wayne; Drexel University	Bailey, H (corresponding author), Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.	hbailey@umces.edu	Bailey, Helen/E-6813-2012; Bograd, Steven/AAA-4824-2021	Bailey, Helen/0000-0001-7445-4687; GEORGES, Jean Yves/0000-0003-1161-2275; Hays, Graeme/0000-0002-3314-8189; Fossette, Sabrina/0000-0001-8580-9084	Tagging of Pacific Predators program of the Census of Marine Life; Lenfest Ocean Program; Cinco Hermanos Fund; European Union; 'Programme Amazonie' held by Centre National de la Recherche Scientifique; Conservation of Migrating Species; WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative; AXA; NERC	Tagging of Pacific Predators program of the Census of Marine Life; Lenfest Ocean Program; Cinco Hermanos Fund; European Union(European Commission); 'Programme Amazonie' held by Centre National de la Recherche Scientifique; Conservation of Migrating Species; WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative; AXA; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Tagging of Pacific Predators program of the Census of Marine Life, the Lenfest Ocean Program, and the Cinco Hermanos Fund. Funding was also provided by the European Union FEDER Program, the 'Programme Amazonie' held by Centre National de la Recherche Scientifique, and the Conservation of Migrating Species and the WWF as part of the 'Trans-Atlantic Leatherback Conservation Initiative. S.F. was supported by an AXA "Young Talents" post-doctoral fellowship, and grant funding was also provided to G.C.H. by NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Bailey H, 2006, J ANIM ECOL, V75, P456, DOI 10.1111/j.1365-2656.2006.01066.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Croll DA, 2006, J ZOOL, V269, P506, DOI 10.1111/j.1469-7998.2006.00090.x; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Eckert S.A., 1986, Marine Turtle Newsletter, P1; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Fernandez-Alamo MA, 2006, PROG OCEANOGR, V69, P318, DOI 10.1016/j.pocean.2006.03.003; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Garcia H. E, 2010, WORLD OCEAN ATLAS 20; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatase H, 2008, CAN J ZOOL, V86, P595, DOI 10.1139/Z08-035; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Lum Lori Lee, 2006, Applied Herpetology, V3, P357, DOI 10.1163/157075406778905081; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Morreale SJ, 1996, NATURE, V384, P319, DOI 10.1038/384319a0; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Price E. R., 2006, ENDANGER SPECIES RES, V1, P41, DOI DOI 10.3354/ESR001041; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saba VS, 2008, DEEP-SEA RES PT I, V55, P646, DOI 10.1016/j.dsr.2008.02.006; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Shillinger GL, 2011, MAR ECOL PROG SER, V422, P275, DOI 10.3354/meps08884; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stromberg KHP, 2009, J MARINE SYST, V78, P18, DOI 10.1016/j.jmarsys.2009.02.004; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Wallace BP, 2006, MAR ECOL PROG SER, V318, P263, DOI 10.3354/meps318263; Wallace Bryan P., 2009, Endangered Species Research, V7, P11, DOI 10.3354/esr00177; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wilson C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014063; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231	55	42	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36401	10.1371/journal.pone.0036401	http://dx.doi.org/10.1371/journal.pone.0036401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615767	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300016
J	Lankau, EW; Bedon, LC; Mackie, RI				Lankau, Emily W.; Bedon, Lenin Cruz; Mackie, Roderick I.			Salmonella Strains Isolated from Galapagos Iguanas Show Spatial Structuring of Serovar and Genomic Diversity	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; POPULATION-STRUCTURE; ENTERIC PATHOGENS; ESCHERICHIA-COLI; BETA-DIVERSITY; GENE-TRANSFER; DISPERSAL; BIOGEOGRAPHY; DISTANCE; SURVIVAL	It is thought that dispersal limitation primarily structures host-associated bacterial populations because host distributions inherently limit transmission opportunities. However, enteric bacteria may disperse great distances during food-borne outbreaks. It is unclear if such rapid long-distance dispersal events happen regularly in natural systems or if these events represent an anthropogenic exception. We characterized Salmonella enterica isolates from the feces of free-living Galapagos land and marine iguanas from five sites on four islands using serotyping and genomic fingerprinting. Each site hosted unique and nearly exclusive serovar assemblages. Genomic fingerprint analysis offered a more complex model of S. enterica biogeography, with evidence of both unique strain pools and of spatial population structuring along a geographic gradient. These findings suggest that even relatively generalist enteric bacteria may be strongly dispersal limited in a natural system with strong barriers, such as oceanic divides. Yet, these differing results seen on two typing methods also suggests that genomic variation is less dispersal limited, allowing for different ecological processes to shape biogeographical patterns of the core and flexible portions of this bacterial species' genome.	[Lankau, Emily W.; Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Lankau, Emily W.] Univ Illinois, Coll Vet Med, Urbana, IL USA; [Bedon, Lenin Cruz] Armador Pirata, Isla Santa Cruz, Galapagos Islan, Ecuador; [Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lankau, EW (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	r-mackie@illinois.edu		Lankau, Emily/0000-0002-7094-7780	Conservation Medicine Center of Chicago Student Research Grant; United States Environmental Protection Agency [91684301-1]	Conservation Medicine Center of Chicago Student Research Grant; United States Environmental Protection Agency(United States Environmental Protection Agency)	Funding was provided by the Conservation Medicine Center of Chicago Student Research Grant (EW) and by the United States Environmental Protection Agency Science to Achieve Results Fellowship (EW; Research Assistance Agreement No. 91684301-1). This study has not been formally reviewed by the EPA. The views expressed in this paper are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre I, 2010, FOOD MICROBIOL, V27, P862, DOI 10.1016/j.fm.2010.05.008; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Bala A, 2003, MOL ECOL, V12, P917, DOI 10.1046/j.1365-294X.2003.01754.x; Ben-Darif E, 2010, J MICROBIOL METH, V81, P11, DOI 10.1016/j.mimet.2010.01.013; Beyer W, 1998, J CLIN MICROBIOL, V36, P1549, DOI 10.1128/JCM.36.6.1549-1554.1998; Boyer DG, 2008, AGR FOREST METEOROL, V148, P1395, DOI 10.1016/j.agrformet.2008.04.001; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Briones V, 2004, ENVIRON MICROBIOL, V6, P868, DOI 10.1111/j.1462-2920.2004.00631.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cook LG, 2005, J BIOGEOGR, V32, P741, DOI 10.1111/j.1365-2699.2005.01261.x; Corrente M, 2004, J APPL MICROBIOL, V96, P709, DOI 10.1111/j.1365-2672.2004.02186.x; Darwin C, 1859, ORIGIN SPECIES MEANS; Diamond J.M., 1976, P163; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Fakhr MK, 2005, J CLIN MICROBIOL, V43, P2215, DOI 10.1128/JCM.43.5.2215-2219.2005; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fontaneto D, 2008, MOL ECOL, V17, P3136, DOI 10.1111/j.1365-294X.2008.03806.x; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Franco A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023147; Fru EC, 2011, INT J SYST EVOL MICR, V61, P1725, DOI 10.1099/ijs.0.026914-0; Gandour M, 2008, GENET RES, V90, P167, DOI 10.1017/S0016672308009269; Geue L, 2002, VET MICROBIOL, V84, P79, DOI 10.1016/S0378-1135(01)00437-0; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Harris L.J., 2003, COMPR REV FOOD SCI F, V2, P78, DOI [10.1111/j.1541-4337.2003.tb00031, DOI 10.1111/J.1541-4337.2003.TB00031]; HEDLUND BP, 2003, MICROBIAL DIVERSITY; Hendry AP, 2002, TRENDS ECOL EVOL, V17, P502, DOI 10.1016/S0169-5347(02)02603-4; Hidalgo-Vila J, 2007, VET MICROBIOL, V119, P311, DOI 10.1016/j.vetmic.2006.08.012; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hudson CR, 2001, AVIAN DIS, V45, P875, DOI 10.2307/1592867; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Jackson MH, 2007, GALAPAGOS NATURAL HI; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Krebs CJ, 1994, ECOLOGY EXPT ANAL DI; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MAC ARTHUR ROBERT H., 1967; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Mitchell MA, 2000, PREV VET MED, V45, P297, DOI 10.1016/S0167-5877(00)00124-0; MORENO CM, 1995, ANTON LEEUW INT J G, V68, P191, DOI 10.1007/BF00871814; Nelson DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010785; Nowicki S., 2010, Morbidity and Mortality Weekly Report, V59, P557; Oksanen J., 2013, R PACKAGE VERSION 2, P292; OLSEN JE, 1994, J MED MICROBIOL, V40, P15, DOI 10.1099/00222615-40-1-15; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Pedersen K, 2009, ZOONOSES PUBLIC HLTH, V56, P238, DOI 10.1111/j.1863-2378.2008.01196.x; Popoff M.Y., 1997, ANTIGENIC FORMULAS S; Porcher E, 2006, GENET RES, V87, P1, DOI 10.1017/S0016672306007920; R Core Team, 2018, R LANG ENV STAT COMP; Rademaker JL, 1998, MOL MICROBIAL ECOLOG, P113; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; RHODES MW, 1988, APPL ENVIRON MICROB, V54, P2902, DOI 10.1128/AEM.54.12.2902-2907.1988; Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1; Safranek T., 2009, Morbidity and Mortality Weekly Report, V58, P500; SCHERER CA, 2001, PRINCIPLES BACTERIAL, P265; Semenov AM, 2010, MICROB ECOL, V60, P239, DOI 10.1007/s00248-010-9663-0; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steinfartz S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-297; Takacs-Vesbach C, 2008, ENVIRON MICROBIOL, V10, P1681, DOI 10.1111/j.1462-2920.2008.01584.x; Tankouo-Sandjong B, 2007, J MICROBIOL METH, V69, P23, DOI 10.1016/j.mimet.2006.11.013; Thaller MC, 2010, ENV MICROBIOL REP, V2, P179, DOI 10.1111/j.1758-2229.2009.00132.x; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vos M, 2008, CURR BIOL, V18, P386, DOI 10.1016/j.cub.2008.02.050; Weigel RM, 2004, VET MICROBIOL, V100, P205, DOI 10.1016/j.vetmic.2004.02.009; Wheeler E, 2011, ENV MICROBIOL REP, V3, P166, DOI 10.1111/j.1758-2229.2010.00203.x; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Wright S, 1943, GENETICS, V28, P114; Zhang N, 2002, PHYTOPATHOLOGY, V92, P1276, DOI 10.1094/PHYTO.2002.92.12.1276	86	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37302	10.1371/journal.pone.0037302	http://dx.doi.org/10.1371/journal.pone.0037302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615968	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300098
J	Adedeji, AO; Marchand, B; te Velthuis, AJW; Snijder, EJ; Weiss, S; Eoff, RL; Singh, K; Sarafianos, SG				Adedeji, Adeyemi O.; Marchand, Bruno; te Velthuis, Aartjan J. W.; Snijder, Eric J.; Weiss, Susan; Eoff, Robert L.; Singh, Kamalendra; Sarafianos, Stefan G.			Mechanism of Nucleic Acid Unwinding by SARS-CoV Helicase	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PROTEIN-PROTEIN INTERACTIONS; DNA-REPLICATION FORK; VIRUS NS3 HELICASE; ESCHERICHIA-COLI; RNA HELICASE; SUBSTRATE-SPECIFICITY; NUCLEOPROTEIN FILAMENTS; CORONAVIRUS HELICASE; KINETIC MECHANISM	The non-structural protein 13 (nsp13) of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) is a helicase that separates double-stranded RNA (dsRNA) or DNA (dsDNA) with a 5'-> 3' polarity, using the energy of nucleotide hydrolysis. We determined the minimal mechanism of helicase function by nsp13. We showed a clear unwinding lag with increasing length of the double-stranded region of the nucleic acid, suggesting the presence of intermediates in the unwinding process. To elucidate the nature of the intermediates we carried out transient kinetic analysis of the nsp13 helicase activity. We demonstrated that the enzyme unwinds nucleic acid in discrete steps of 9.3 base-pairs (bp) each, with a catalytic rate of 30 steps per second. Therefore the net unwinding rate is similar to 280 base-pairs per second. We also showed that nsp12, the SARS-CoV RNA-dependent RNA polymerase (RdRp), enhances (2-fold) the catalytic efficiency of nsp13 by increasing the step size of nucleic acid (RNA/RNA or DNA/DNA) unwinding. This effect is specific for SARS-CoV nsp12, as no change in nsp13 activity was observed when foot-and-mouth-disease virus RdRp was used in place of nsp12. Our data provide experimental evidence that nsp13 and nsp12 can function in a concerted manner to improve the efficiency of viral replication and enhance our understanding of nsp13 function during SARS-CoV RNA synthesis.	[Adedeji, Adeyemi O.; Marchand, Bruno; Singh, Kamalendra; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA; [te Velthuis, Aartjan J. W.; Snijder, Eric J.] Leiden Univ, Ctr Infect Dis, Med Ctr, Mol Virol Lab,Dept Med Microbiol, Leiden, Netherlands; [Weiss, Susan] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Eoff, Robert L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Missouri System; University of Missouri Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; University of Arkansas System; University of Arkansas Medical Sciences	Adedeji, AO (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA.	sarafianoss@missouri.edu	Snijder, Eric J./E-6073-2018; Adedeji, Adeyemi O/I-1327-2019; Velthuis, AJ te/H-7981-2019; Adedeji, Adeyemi/AAO-5703-2020	Snijder, Eric J./0000-0003-3297-2309; Velthuis, AJ te/0000-0002-5129-3953; Adedeji, Adeyemi/0000-0002-5153-1990; Sarafianos, Stefan G/0000-0002-5840-154X	National Institutes of Health [AI076119, AI094715, AI079801, AI074389]; Ministry of Knowledge and Economy, Republic of Korea; amfAR (American Foundation for AIDS Research); CIHR (Canadian Institutes for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801, R21AI094715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); amfAR (American Foundation for AIDS Research); CIHR (Canadian Institutes for Health Research)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants AI076119, AI094715, AI079801, and AI074389. We also acknowledge support by a grant from the Ministry of Knowledge and Economy, Bilateral International Collaborative Research and Development Program, Republic of Korea. Bruno Marchand was the recipient of an amfAR (American Foundation for AIDS Research) Mathilde Krim Fellowship and a CIHR (Canadian Institutes for Health Research) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Durk RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015049; Eccleston JF, 2008, METHOD CELL BIOL, V84, P445, DOI 10.1016/S0091-679X(07)84015; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; GEIDER K, 1981, ANNU REV BIOCHEM, V50, P233, DOI 10.1146/annurev.bi.50.070181.001313; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; LEE CG, 1992, J BIOL CHEM, V267, P4398; Lee NR, 2010, NUCLEIC ACIDS RES, V38, P7626, DOI 10.1093/nar/gkq647; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; LOHMAN TM, 1993, J BIOL CHEM, V268, P2269; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Pan JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003299; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Prentice E, 2004, J VIROL, V78, P9977, DOI 10.1128/JVI.78.18.9977-9986.2004; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Seybert A, 2000, RNA, V6, P1056, DOI 10.1017/S1355838200000728; Shadrick WR, 2010, J BIOL CHEM, V285, P17292, DOI 10.1074/jbc.M110.111427; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tanner JA, 2003, J BIOL CHEM, V278, P39578, DOI 10.1074/jbc.C300328200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tomko EJ, 2010, METHODS, V51, P269, DOI 10.1016/j.ymeth.2010.03.010; TURCHI JJ, 1992, NUCLEIC ACIDS RES, V20, P6075, DOI 10.1093/nar/20.22.6075; van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Yang Y, 2010, BIOCHEMISTRY-US, V49, P656, DOI 10.1021/bi901459c; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	63	102	103	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36521	10.1371/journal.pone.0036521	http://dx.doi.org/10.1371/journal.pone.0036521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615777	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300021
J	Kaufhold, F; Kadas, EM; Schmidt, C; Kunte, H; Hoffmann, J; Zimmermann, H; Oberwahrenbrock, T; Harms, L; Polthier, K; Brandt, AU; Paul, F				Kaufhold, Falko; Kadas, Ella Maria; Schmidt, Christoph; Kunte, Hagen; Hoffmann, Jan; Zimmermann, Hanna; Oberwahrenbrock, Timm; Harms, Lutz; Polthier, Konrad; Brandt, Alexander U.; Paul, Friedemann			Optic Nerve Head Quantification in Idiopathic Intracranial Hypertension by Spectral Domain OCT	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY; PAPILLEDEMA	Objective: To evaluate 3D spectral domain optical coherence tomography (SDOCT) volume scans as a tool for quantification of optic nerve head (ONH) volume as a potential marker for treatment effectiveness and disease progression in idiopathic intracranial hypertension (IIH). Design and Patients: Cross-sectional pilot trial comparing 19 IIH patients and controls matched for gender, age and body mass index. Each participant underwent SDOCT. A custom segmentation algorithm was developed to quantify ONH volume (ONHV) and height (ONHH) in 3D volume scans. Results: Whereas peripapillary retinal nerve fiber layer thickness did not show differences between controls and IIH patients, the newly developed 3D parameters ONHV and ONHH were able to discriminate between controls, treated and untreated patients. Both ONHV and ONHH measures were related to levels of intracranial pressure (ICP). Conclusion: Our findings suggest 3D ONH measures as assessed by SDOCT as potential diagnostic and progression markers in IIH and other disorders with increased ICP. SDOCT may promise a fast and easy diagnostic alternative to repeated lumbar punctures and could therefore ease monitoring of treatment or disease progression.	[Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Univsmedizin Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Univmedizin Berlin, Expt & Clin Res Ctr, Charite, Berlin, Germany; [Kaufhold, Falko; Kadas, Ella Maria; Zimmermann, Hanna; Oberwahrenbrock, Timm; Brandt, Alexander U.; Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany; [Schmidt, Christoph] Univmedizin Berlin, Inst Neuroradiol, Charite, Berlin, Germany; [Kunte, Hagen; Hoffmann, Jan; Harms, Lutz] Univmedizin Berlin, Dept Neurol, Charite, Berlin, Germany; [Harms, Lutz; Paul, Friedemann] Univmedizin Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Charite, Berlin, Germany; [Polthier, Konrad] Freie Univ, Math Geometry Proc Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Kaufhold, F (corresponding author), Univsmedizin Berlin, NeuroCure Clin Res Ctr, Berlin, Germany.	friedemann.paul@charite.de	Hoffmann, Jan/AAP-8376-2020; Paul, Friedemann/ABF-9415-2020	Csapo-Schmidt, Christoph/0000-0002-9021-8227; paul, friedemann/0000-0002-6378-0070; Zimmermann, Hanna/0000-0002-0276-8051	German Research Foundation (DFG) [257]; German Secretary of Economics (BMWi) [ZIM KF2286101FO9]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Secretary of Economics (BMWi)	The study was supported by a grant from the German Research Foundation (DFG Exc. 257) and a grant from the German Secretary of Economics (BMWi, ZIM KF2286101FO9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauerle J, 2011, J NEUROL, V258, P2014, DOI 10.1007/s00415-011-6059-0; Ball AK, 2006, LANCET NEUROL, V5, P433, DOI 10.1016/S1474-4422(06)70442-2; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2006, ANN NEUROL, V59, P963, DOI 10.1002/ana.20851; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Friedman DI, 2004, NEUROL CLIN, V22, P99, DOI 10.1016/S0733-8619(03)00096-3; Friedman DI, 2002, NEUROLOGY, V58, P1551, DOI 10.1212/WNL.58.10.1551; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; GU XZ, 1995, CURR EYE RES, V14, P173, DOI 10.3109/02713689509033512; Heidary G, 2010, SEMIN OPHTHALMOL, V25, P198, DOI 10.3109/08820538.2010.518462; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kadas EM, 2012, BILDVERARBE IN PRESS; Kesler A, 2004, NEUROLOGY, V63, P1737, DOI 10.1212/01.WNL.0000143067.40281.16; Ko MW, 2011, NEUROLOGY, V76, P1564, DOI 10.1212/WNL.0b013e3182190f51; Kupersmith MJ, 1998, NEUROLOGY, V50, P1094, DOI 10.1212/WNL.50.4.1094; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Shah VA, 2008, NEUROLOGY, V70, P634, DOI 10.1212/01.wnl.0000299893.43918.a8; Skau M, 2011, GRAEF ARCH CLIN EXP, V249, P723, DOI 10.1007/s00417-010-1527-2; Skau M, 2011, J NEUROL, V258, P277, DOI 10.1007/s00415-010-5750-x; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Waisbourd M, 2007, CLIN NEUROL IN PRESS; WALL M, 1991, BRAIN, V114, P155; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wolf A, 2008, CURR OPIN OPHTHALMOL, V19, P391, DOI 10.1097/ICU.0b013e328309f1b6; Wong GK, WORLD NEUROSURGERY, V75, P592; Yri HM, 2006, J NEUROLOGY	34	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36965	10.1371/journal.pone.0036965	http://dx.doi.org/10.1371/journal.pone.0036965			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615858	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305336300054
J	Feng, JY; Fang, WF; Wu, CL; Yu, CJ; Lin, MC; Ku, SC; Chen, YC; Chen, CW; Tu, CY; Su, WJ; Yang, KY				Feng, Jia-Yih; Fang, Wen-Feng; Wu, Chieh-Liang; Yu, Chong-Jen; Lin, Meng-Chih; Ku, Shih-Chi; Chen, Yu-Chun; Chen, Chang-Wen; Tu, Chih-Yen; Su, Wei-Juin; Yang, Kuang-Yao			Concomitant Pulmonary Tuberculosis in Hospitalized Healthcare-Associated Pneumonia in a Tuberculosis Endemic Area: A Multi-center Retrospective Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OUTCOMES; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; ADULTS	Background: In tuberculosis (TB) endemic areas, Mycobacterium tuberculosis is an important but easily misdiagnosed pathogen in community-acquired pneumonia (CAP). However, the occurrence of concomitant pulmonary tuberculosis (PTB) in hospitalized healthcare-associated pneumonia (HCAP) has never been investigated. Methods and Findings: Seven hundred and one hospitalized HCAP and 934 hospitalized CAP patients from six medical centers in Taiwan were included in this nationwide retrospective study. Concomitant PTB was defined as active PTB diagnosed within 60 days of admission due to HCAP or CAP. The predictors for concomitant PTB and the impact of PTB on the outcomes of pneumonia were investigated. Among the enrolled subjects, 21/701 (3%) of the HCAP patients and 25/934 (2.7%) of the CAP patients were documented to have concomitant PTB. In multivariate analysis, a history of previous anti-TB treatment (OR = 5.84, 95% CI: 2.29-20.37 in HCAP; OR = 3.33, 95% CI: 1.09-10.22 in CAP) and escalated pneumonia severity index (PSI) scores (OR = 1.014, 95% CI: 1.002-1.026, in HCAP; OR = 1.013, 95% CI: 1.001-1.026, in CAP) were independent predictors for concomitant PTB in both CAP and HCAP patients. Regarding treatment outcomes, HCAP patients with concomitant PTB were associated with more acute respiratory failure within 48 hours of admission (47.6% vs. 22.6%, p = 0.008), higher intensive care unit admission rate (61.9% vs. 35.7%, p = 0.014), longer hospitalization (39.6 +/- 34.1 vs. 23.7 +/- 27 days, p = 0.009), and higher in-hospital mortality (47.6% vs. 26.3%, p = 0.03) than those without concomitant PTB. Exposure to certain groups of antibiotics for the treatment of pneumonia was not associated with the occurrence of concomitant PTB. Conclusions: In HCAP patients, the occurrence of concomitant PTB is comparable with that in CAP patients and associated with higher PSI scores, more acute respiratory failure, and higher in-hospital mortality.	[Feng, Jia-Yih; Su, Wei-Juin; Yang, Kuang-Yao] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Feng, Jia-Yih] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Fang, Wen-Feng; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan; [Fang, Wen-Feng; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Fang, Wen-Feng; Lin, Meng-Chih] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi, Taiwan; [Wu, Chieh-Liang] Taichung Vet Gen Hosp, Dept Internal Med, Chiayi Branch, Taichung, Taiwan; [Wu, Chieh-Liang] China Med Univ, Dept Resp Therapy, Coll Hlth Care, Taichung, Taiwan; [Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yu, Chong-Jen] Natl Taiwan Univ, Sch Med, Taipei 10764, Taiwan; [Ku, Shih-Chi] Natl Taiwan Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei 100, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yilan, Taiwan; [Chen, Chang-Wen] Natl Cheng Kung Univ Hosp, Dept Internal Med, Med Intens Care Unit, Tainan 70428, Taiwan; [Tu, Chih-Yen] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Tu, Chih-Yen] China Med Univ, Sch Med, Taichung, Taiwan; [Tu, Chih-Yen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Taichung Veterans General Hospital; China Medical University Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University	Feng, JY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	kyyang@vghtpe.gov.tw	Fang, Wen-Feng/AAT-6296-2021; Chen, YuChun/L-1052-2019; Ku, Shih-Chi/AAN-5216-2021; Chen, Yu-Chun/B-1227-2012; Chen, Yu Chun/K-6635-2019	Fang, Wen-Feng/0000-0003-0350-9059; Chen, YuChun/0000-0002-4124-1949; Chen, Yu-Chun/0000-0002-4124-1949; KU, SHIH-CHI/0000-0002-4123-0967; Yu, Chong-Jen/0000-0001-5664-9392	Taiwan National Science Council [NSC 97-2314-B-075-046, NSC 100-2314-B-075-047-MY3]; Taipei Veterans General Hospital [V97C1-143, V98C1-072, V99C1-167, V100C-159, V99C1-181, V99A-023, V100A-002]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported, in part, by research grants from Taiwan National Science Council Research Grant (NSC 97-2314-B-075-046, NSC 100-2314-B-075-047-MY3), and Taipei Veterans General Hospital (V97C1-143, V98C1-072, V99C1-167, V100C-159, V99C1-181, V99A-023 and V100A-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; [Anonymous], 2011, GLOB TUB CONTR 2010; [Anonymous], 2009, TAIW TUB CONTR REP 2; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Carratala J, 2008, CURR OPIN INFECT DIS, V21, P168, DOI 10.1097/QCO.0b013e3282f4f248; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Chang KC, 2010, EUR RESPIR J, V35, P606, DOI 10.1183/09031936.00104209; Fang WF, 2011, CRIT CARE, V15, DOI 10.1186/cc9979; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Hui C, 2003, J FORMOS MED ASSOC, V102, P563; Kim HR, 2008, RESPIROLOGY, V13, P413, DOI 10.1111/j.1440-1843.2008.01282.x; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Liam CK, 2006, RESPIROLOGY, V11, P786, DOI 10.1111/j.1440-1843.2006.00947.x; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Micek ST, 2007, ANTIMICROB AGENTS CH, V51, P3568, DOI 10.1128/AAC.00851-07; Miller LG, 2000, CLIN INFECT DIS, V30, P293, DOI 10.1086/313651; Moran GJ, 2009, ANN EMERG MED, V53, P625, DOI 10.1016/j.annemergmed.2008.07.027; Nyamande K, 2007, INT J TUBERC LUNG D, V11, P1308; PENNER C, 1995, AM J RESP CRIT CARE, V151, P867; Shindo Y, 2009, CHEST, V135, P633, DOI 10.1378/chest.08-1357; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Walker C, 2010, THORAX, V65, P578, DOI 10.1136/thx.2009.128223; Wang JY, 2006, THORAX, V61, P903, DOI 10.1136/thx.2005.056887	25	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36832	10.1371/journal.pone.0036832	http://dx.doi.org/10.1371/journal.pone.0036832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629334	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345300013
J	Berzigotti, S; Benlafya, K; Sepulchre, J; Amoroso, A; Joris, B				Berzigotti, Stephanie; Benlafya, Kamal; Sepulchre, Jeremy; Amoroso, Ana; Joris, Bernard			Bacillus licheniformis BlaR1 L3 Loop Is a Zinc Metalloprotease Activated by Self-Proteolysis	PLOS ONE			English	Article							BETA-LACTAMASE SYNTHESIS; STAPHYLOCOCCUS-AUREUS; PENICILLIN-RECEPTOR; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; REPRESSOR BLAL; SENSOR DOMAIN; INDUCTION; THERMOLYSIN; RESISTANCE	In Bacillus licheniformis 749/I, BlaP beta-lactamase is induced by the presence of a beta-lactam antibiotic outside the cell. The first step in the induction mechanism is the detection of the antibiotic by the membrane-bound penicillin receptor BlaR1 that is composed of two functional domains: a carboxy-terminal domain exposed outside the cell, which acts as a penicillin sensor, and an amino-terminal domain anchored to the cytoplasmic membrane, which works as a transducer-transmitter. The acylation of BlaR1 sensor domain by the antibiotic generates an intramolecular signal that leads to the activation of the L3 cytoplasmic loop of the transmitter by a single-point cleavage. The exact mechanism of L3 activation and the nature of the secondary cytoplasmic signal launched by the activated transmitter remain unknown. However, these two events seem to be linked to the presence of a HEXXH zinc binding motif of neutral zinc metallopeptidases. By different experimental approaches, we demonstrated that the L3 loop binds zinc ion, belongs to Gluzincin metallopeptidase superfamily and is activated by self-proteolysis.	[Berzigotti, Stephanie; Benlafya, Kamal; Sepulchre, Jeremy; Amoroso, Ana; Joris, Bernard] Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium	University of Liege	Berzigotti, S (corresponding author), Univ Liege, Ctr Prot Engn, Dept Life Sci, Liege, Belgium.	bjoris@ulg.ac.be			Belgian Program on Interuniversity Poles of Attraction [P6/19]; Actions de Recherche Concertees [03/08-297]; Fonds de la Recherche Fondamentale Collective [6 2.4511.06, 2.4524.03]; Fonds de la recherche en Sciences Medicales [7 3.4586.05]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Actions de Recherche Concertees(University of Liege); Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Fonds de la recherche en Sciences Medicales(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This research was supported in part by Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State (Grant P6/19), the Actions de Recherche Concertees (Grant 03/08-297), the Fonds de la Recherche Fondamentale Collective (Grant 6 2.4511.06 and 2.4524.03), the Fonds de la recherche en Sciences Medicales (Grant 7 3.4586.05) and the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). Stephanie Berzigotti is a fellow of FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Clarke SR, 2001, MICROBIOL-UK, V147, P803, DOI 10.1099/00221287-147-4-803; Del Papa MF, 2007, J BACTERIOL, V189, P8835, DOI 10.1128/JB.01311-07; Demidyuk IV, 2008, PROTEIN J, V27, P343, DOI 10.1007/s10930-008-9143-2; Duval V, 2003, MOL MICROBIOL, V48, P1553, DOI 10.1046/j.1365-2958.2003.03520.x; Filee P, 2002, MOL MICROBIOL, V44, P685, DOI 10.1046/j.1365-2958.2002.02888.x; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Fukasawa K. M., 2011, J AMINO ACIDS; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; GONG ZY, 1994, BIOCHEMISTRY-US, V33, P15149, DOI 10.1021/bi00254a026; Gregory PD, 1997, MOL MICROBIOL, V24, P1025, DOI 10.1046/j.1365-2958.1997.4051770.x; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; HAUSRATH AC, 1994, J BIOL CHEM, V269, P18839; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; JORIS B, 1990, FEMS MICROBIOL LETT, V70, P107, DOI 10.1016/0378-1097(90)90111-3; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; KOBAYASHI T, 1987, J BACTERIOL, V169, P3873, DOI 10.1128/jb.169.9.3873-3878.1987; LEMOUAL H, 1991, J BIOL CHEM, V266, P15670; Lewis RA, 2000, J ANTIMICROB CHEMOTH, V45, P139, DOI 10.1093/jac/45.2.139; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; MAZEN A, 1988, ANAL BIOCHEM, V172, P39, DOI 10.1016/0003-2697(88)90408-3; MCEUEN AR, 1992, BIOCHEM BIOPH RES CO, V189, P813, DOI 10.1016/0006-291X(92)92275-3; McKinney TK, 2001, J BACTERIOL, V183, P6862, DOI 10.1128/JB.183.23.6862-6868.2001; Pelmenschikov V, 2002, J BIOL INORG CHEM, V7, P284, DOI 10.1007/s007750100295; Philippon A, 1998, CELL MOL LIFE SCI, V54, P341, DOI 10.1007/s000180050161; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; SALERNO AJ, 1988, FEBS LETT, V227, P61, DOI 10.1016/0014-5793(88)81414-5; Sambrook J., 2001, MOL CLONING LAB MANU; Sambrook J, 2001, PURIFICATION ANTIBOD, P1811; SHERRATT DJ, 1973, J GEN MICROBIOL, V76, P217, DOI 10.1099/00221287-76-1-217; Stapleton Paul D., 2002, Science Progress, V85, P57, DOI 10.3184/003685002783238870; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; ZHU YF, 1992, J BACTERIOL, V174, P6171, DOI 10.1128/JB.174.19.6171-6178.1992	39	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36400	10.1371/journal.pone.0036400	http://dx.doi.org/10.1371/journal.pone.0036400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623956	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500016
J	Guillaudeau, A; Durand, K; Bessette, B; Chaunavel, A; Pommepuy, I; Projetti, F; Robert, S; Caire, F; Rabinovitch-Chable, H; Labrousse, F				Guillaudeau, Angelique; Durand, Karine; Bessette, Barbara; Chaunavel, Alain; Pommepuy, Isabelle; Projetti, Fabrice; Robert, Sandrine; Caire, Francois; Rabinovitch-Chable, Helene; Labrousse, Francois			EGFR Soluble Isoforms and Their Transcripts Are Expressed in Meningiomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EXPRESSION; DEPENDENT PROBE AMPLIFICATION; CENTRAL-NERVOUS-SYSTEM; IN-SITU-HYBRIDIZATION; CELL LUNG CARCINOMAS; COLORECTAL-CANCER; OVARIAN-CANCER; GENE AMPLIFICATION; PROTEIN EXPRESSION	The EGFR (epidermal growth factor receptor) is involved in the oncogenesis of many tumors. In addition to the full-length EGFR (isoform a), normal and tumor cells produce soluble EGFR isoforms (sEGFR) that lack the intracellular domain. sEGFR isoforms b, c and d are encoded by EGFR variants 2 (v2), 3 (v3) and 4 (v4) mRNA resulting from gene alternative splicing. Accordingly, the results of EGFR protein expression analysis depend on the domain targeted by the antibodies. In meningiomas, EGFR expression investigations mainly focused on EGFR isoform a. sEGFR and EGFRvIII mutant, that encodes a constitutively active truncated receptor, have not been studied. In a 69 meningiomas series, protein expression was analyzed by immunohistochemistry using extracellular domain targeted antibody (ECD-Ab) and intracellular domain targeted antibody (ICD-Ab). EGFRv1 to v4 and EGFRvIII mRNAs were quantified by RT-PCR and EGFR amplification revealed by MLPA. Results were analyzed with respect to clinical data, tumor resection (Simpson grade), histological type, tumor grade, and patient outcome. Immunochemical staining was stronger with ECD-Ab than with ICD-Ab. Meningiomas expressed EGFRv1 to -v4 mRNAs but not EGFRvIII mutant. Intermediate or high ECD-Ab staining and high EGFRv1 to v4 mRNA levels were associated to a better progression free survival (PFS). PFS was also improved in women, when tumor resection was evaluated as Simpson 1 or 2, in grade I vs. grade II and III meningiomas and when Ki67 labeling index was lower than 10%. Our results suggest that, EGFR protein isoforms without ICD and their corresponding mRNA variants are expressed in meningiomas in addition to the whole isoform a. EGFRvIII was not expressed. High expression levels seem to be related to a better prognosis. These results indicate that the oncogenetic mechanisms involving the EGFR pathway in meningiomas could be different from other tumor types.	[Guillaudeau, Angelique; Durand, Karine; Chaunavel, Alain; Pommepuy, Isabelle; Projetti, Fabrice; Robert, Sandrine; Labrousse, Francois] Dupuytren Univ Hosp, Dept Pathol, Limoges, France; [Bessette, Barbara] Dupuytren Univ Hosp, Dept Cellular Homeostasis & Pathol, Limoges, France; [Caire, Francois] Dupuytren Univ Hosp, Dept Neurosurg, Limoges, France; [Rabinovitch-Chable, Helene] Dupuytren Univ Hosp, Dept Biochem & Mol Genet, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Guillaudeau, A (corresponding author), Dupuytren Univ Hosp, Dept Pathol, Limoges, France.	labrousse@unilim.fr	Bessette, Barbara/G-2317-2015	Bessette, Barbara/0000-0001-6673-3694; Durand, Karine/0000-0002-9738-3444; CHAUNAVEL, Alain/0000-0003-2419-8974; Projetti, Fabrice/0000-0002-9023-8543; Labrousse, Francois/0000-0002-3185-4856; ROBERT, Sandrine/0000-0003-1908-3144	Comite Departemental de la Ligue contre le Cancer de la Correze	Comite Departemental de la Ligue contre le Cancer de la Correze	This work was supported by grants from the "Comite Departemental de la Ligue contre le Cancer de la Correze'' (www.ligue-cancer.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanell J, 2005, CURR DRUG TARGETS, V6, P259, DOI 10.2174/1389450053765888; Albitar L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-166; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Ancot F, 2009, ONCOGENE, V28, P2185, DOI 10.1038/onc.2009.88; Andersson U, 2004, ACTA NEUROPATHOL, V108, P135, DOI 10.1007/s00401-004-0875-6; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Baron AT, 2009, CANCER TREAT RES, V149, P189, DOI 10.1007/978-0-387-98094-2_9; Baron AT, 2009, IDRUGS, V12, P302; Baron AT, 2001, CANCER EPIDEM BIOMAR, V10, P1175; BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; CADENA DL, 1993, PROTEIN EXPRES PURIF, V4, P177, DOI 10.1006/prep.1993.1024; Carroll RS, 1997, J NEUROSURG, V87, P315, DOI 10.3171/jns.1997.87.2.0315; CHAFFANET M, 1992, EUR J CANCER, V28A, P11, DOI 10.1016/0959-8049(92)90374-B; DEPALAZZO IEG, 1993, CANCER RES, V53, P3217; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Domingo G, 2010, EXPERT REV ANTICANC, V10, P1577, DOI [10.1586/era.10.141, 10.1586/ERA.10.141]; Estrada-Bernal A, 2011, J NEURO-ONCOL, V102, P353, DOI 10.1007/s11060-010-0345-z; Fiore DC, 2010, AM FAM PHYSICIAN, V82, P69; FLICKINGER TW, 1992, MOL CELL BIOL, V12, P883, DOI 10.1128/MCB.12.2.883; FOX SB, 1994, BREAST CANCER RES TR, V29, P41, DOI 10.1007/BF00666180; Gan HK, 2009, J CLIN NEUROSCI, V16, P748, DOI 10.1016/j.jocn.2008.12.005; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; Guillaudeau A, 2012, INT J ONCOL, V40, P1142, DOI 10.3892/ijo.2011.1287; Guillaudeau A, 2009, APPL IMMUNOHISTO M M, V17, P220, DOI 10.1097/PAI.0b013e31818db320; Halle C, 2011, CLIN CANCER RES, V17, P5501, DOI 10.1158/1078-0432.CCR-11-0297; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; HORSFALL DJ, 1989, AUST NZ J SURG, V59, P881, DOI 10.1111/j.1445-2197.1989.tb07033.x; HUNTS JH, 1985, SOMAT CELL MOLEC GEN, V11, P477, DOI 10.1007/BF01534841; ILEKIS JV, 1995, MOL REPROD DEV, V41, P149, DOI 10.1002/mrd.1080410205; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ionescu DN, 2005, CANCER, V103, P630, DOI 10.1002/cncr.20811; Jeuken J, 2006, J MOL DIAGN, V8, P433, DOI 10.2353/jmoldx.2006.060012; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; JOHNSON MD, 1994, HUM PATHOL, V25, P146, DOI 10.1016/0046-8177(94)90270-4; JONES NR, 1990, CANCER, V66, P152, DOI 10.1002/1097-0142(19900701)66:1<152::AID-CNCR2820660127>3.0.CO;2-5; Kong Yan-guo, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P427; Koutras AK, 2011, CURR MED CHEM, V18, P1599, DOI 10.2174/092986711795471338; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; LINGGOOD RM, 1995, J NEURO-ONCOL, V26, P45, DOI 10.1007/BF01054768; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maramotti S, 2011, LUNG CANC, V15; Markman B, 2010, ADV CLIN CHEM, V51, P71, DOI 10.1016/S0065-2423(10)51004-7; Mathieu A, 2010, LUNG CANCER, V69, P46, DOI 10.1016/j.lungcan.2009.09.003; Maurizi M, 1996, BRIT J CANCER, V74, P1253, DOI 10.1038/bjc.1996.525; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Modjtahedi H, 2005, CANCER METAST REV, V24, P129, DOI 10.1007/s10555-005-5052-4; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; Muller V, 2006, ANTICANCER RES, V26, P1479; Nagane Motoo, 2001, Cancer Letters, V162, pS17, DOI 10.1016/S0304-3835(00)00648-0; Norden AD, 2010, J NEURO-ONCOL, V96, P211, DOI 10.1007/s11060-009-9948-7; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Oh MJ, 2000, CLIN CANCER RES, V6, P4760; OKUDA K, 2008, J CANC RES CLIN ONCO; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahimi M, 2011, CANCER LETT, V306, P43, DOI 10.1016/j.canlet.2011.02.024; Reiter JL, 1996, NUCLEIC ACIDS RES, V24, P4050, DOI 10.1093/nar/24.20.4050; Reiter JL, 2001, GENOMICS, V71, P1, DOI 10.1006/geno.2000.6341; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; SANFILIPPO JS, 1993, SURG GYNECOL OBSTET, V177, P488; Sasaki H, 2007, ONCOL REP, V17, P319; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Smith JS, 2007, J NEUROSURG, V106, P1034, DOI 10.3171/jns.2007.106.6.1034; STEWART CJR, 1992, INT J GYNECOL PATHOL, V11, P266, DOI 10.1097/00004347-199210000-00004; van Dijk MC, 2005, DIAGN MOL PATHOL, V14, P9, DOI 10.1097/01.pas.0000146701.98954.47; Varella-Garcia M, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-19; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WEISMAN AS, 1987, CANCER RES, V47, P2172; Wen PY, 2010, J NEURO-ONCOL, V99, P365, DOI 10.1007/s11060-010-0349-8; Wernicke AG, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-46; WESTPHAL M, 1986, ACTA NEUROCHIR, V83, P62, DOI 10.1007/BF01420510; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wilken JA, 2011, BIOCHEMISTRY-US, V50, P4309, DOI 10.1021/bi200126j; You B, 2011, J CLIN PHARM; Zampino MG, 2008, CANCER CHEMOTH PHARM, V63, P139, DOI 10.1007/s00280-008-0722-x	79	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37204	10.1371/journal.pone.0037204	http://dx.doi.org/10.1371/journal.pone.0037204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623992	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343500072
J	Jia, PL; Zhao, ZM				Jia, Peilin; Zhao, Zhongming			Personalized Pathway Enrichment Map of Putative Cancer Genes from Next Generation Sequencing Data	PLOS ONE			English	Article							SOMATIC MUTATIONS; PATTERNS; GENOME	Background: Pathway analysis of a set of genes represents an important area in large-scale omic data analysis. However, the application of traditional pathway enrichment methods to next-generation sequencing (NGS) data is prone to several potential biases, including genomic/genetic factors (e.g., the particular disease and gene length) and environmental factors (e.g., personal life-style and frequency and dosage of exposure to mutagens). Therefore, novel methods are urgently needed for these new data types, especially for individual-specific genome data. Methodology: In this study, we proposed a novel method for the pathway analysis of NGS mutation data by explicitly taking into account the gene-wise mutation rate. We estimated the gene-wise mutation rate based on the individual-specific background mutation rate along with the gene length. Taking the mutation rate as a weight for each gene, our weighted resampling strategy builds the null distribution for each pathway while matching the gene length patterns. The empirical P value obtained then provides an adjusted statistical evaluation. Principal Findings/Conclusions: We demonstrated our weighted resampling method to a lung adenocarcinomas dataset and a glioblastoma dataset, and compared it to other widely applied methods. By explicitly adjusting gene-length, the weighted resampling method performs as well as the standard methods for significant pathways with strong evidence. Importantly, our method could effectively reject many marginally significant pathways detected by standard methods, including several long-gene-based, cancer-unrelated pathways. We further demonstrated that by reducing such biases, pathway crosstalk for each individual and pathway co-mutation map across multiple individuals can be objectively explored and evaluated. This method performs pathway analysis in a sample-centered fashion, and provides an alternative way for accurate analysis of cancer-personalized genomes. It can be extended to other types of genomic data (genotyping and methylation) that have similar bias problems.	[Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Jia, PL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Jia, Peilin/B-4519-2013		National Institutes of Health; 2009 NARSAD Maltz Investigator Award; 2010 NARSAD Young Investigator Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2009 NARSAD Maltz Investigator Award; 2010 NARSAD Young Investigator Award	This work was partially supported by grants from the National Institutes of Health, the 2009 NARSAD Maltz Investigator Award to ZZ, and the 2010 NARSAD Young Investigator Award to PJ. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu YY, 2011, HUM MUTAT, V32, P1028, DOI 10.1002/humu.21541; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Ladanyi M, 2008, MODERN PATHOL, V21, pS16, DOI 10.1038/modpathol.3801018; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Xia JF, 2012, HUM MUTAT, V33, pE2341, DOI 10.1002/humu.22096; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao ZM, 2003, GENE, V312, P207, DOI 10.1016/S0378-1119(03)00670-X	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37595	10.1371/journal.pone.0037595	http://dx.doi.org/10.1371/journal.pone.0037595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624051	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500140
J	Panther, E; Durk, T; Ferrari, D; Di Virgilio, F; Grimm, M; Sorichter, S; Cicko, S; Herouy, Y; Norgauer, J; Idzko, M; Muller, T				Panther, Elisabeth; Duerk, Thorsten; Ferrari, Davide; Di Virgilio, Francesco; Grimm, Melanie; Sorichter, Stephan; Cicko, Sanja; Herouy, Yared; Norgauer, Johannes; Idzko, Marco; Mueller, Tobias			AMP Affects Intracellular Ca2+ Signaling, Migration, Cytokine Secretion and T Cell Priming Capacity of Dendritic Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ADENOSINE 5'-MONOPHOSPHATE; 5'-ADENOSINE MONOPHOSPHATE; ENDOGENOUS ADENOSINE; RECEPTOR ACTIVATION; CHLORIDE SECRETION; A(2B) RECEPTOR; P2Y RECEPTORS; ASTHMA; INFLAMMATION	The nucleotide adenosine-5'-monophosphate (AMP) can be released by various cell types and has been shown to elicit different cellular responses. In the extracellular space AMP is dephosphorylated to the nucleoside adenosine which can then bind to adenosine receptors. However, it has been shown that AMP can also activate A(1) and A(2a) receptors directly. Here we show that AMP is a potent modulator of mouse and human dendritic cell (DC) function. AMP increased intracellular Ca2+ concentration in a time and dose dependent manner. Furthermore, AMP stimulated actin-polymerization in human DCs and induced migration of immature human and bone marrow derived mouse DCs, both via direct activation of A(1) receptors. AMP strongly inhibited secretion of TNF-alpha and IL-12p70, while it enhanced production of IL-10 both via activation of A(2a) receptors. Consequently, DCs matured in the presence of AMP and co-cultivated with naive CD4(+)CD45RA(+) T cells inhibited IFN-gamma production whereas secretion of IL-5 and IL-13 was up-regulated. An enhancement of Th2-driven immune response could also be observed when OVA-pulsed murine DCs were pretreated with AMP prior to co-culture with OVA-transgenic naive OTII T cells. An effect due to the enzymatic degradation of AMP to adenosine could be ruled out, as AMP still elicited migration and changes in cytokine secretion in bone-marrow derived DCs generated from CD73-deficient animals and in human DCs pretreated with the ecto-nucleotidase inhibitor 5'-(alpha, beta-methylene) diphosphate (APCP). Finally, the influence of contaminating adenosine could be excluded, as AMP admixed with adenosine desaminase (ADA) was still able to influence DC function. In summary our data show that AMP when present during maturation is a potent regulator of dendritic cell function and point out the role for AMP in the pathogenesis of inflammatory disorders.	[Panther, Elisabeth] Univ Med Ctr Freiburg, Dept Gastroenterol, Freiburg, Germany; [Duerk, Thorsten; Grimm, Melanie; Sorichter, Stephan; Cicko, Sanja; Idzko, Marco; Mueller, Tobias] Univ Med Ctr Freiburg, Dept Pneumol, Freiburg, Germany; [Ferrari, Davide; Di Virgilio, Francesco] Univ Ferrara, Sect Gen Pathol, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Ferrari, Davide; Di Virgilio, Francesco] Univ Ferrara, ICSI, I-44100 Ferrara, Italy; [Herouy, Yared] Univ Med Ctr Freiburg, Dept Dermatol, Freiburg, Germany; [Norgauer, Johannes] Univ Med Ctr Jena, Dept Dermatol, Jena, Germany	University of Freiburg; University of Freiburg; University of Ferrara; University of Ferrara; University of Freiburg	Panther, E (corresponding author), Univ Med Ctr Freiburg, Dept Gastroenterol, Freiburg, Germany.	tobias.mueller@uniklinik-freiburg.de	DI VIRGILIO, Francesco/O-4634-2019; Müller, Tobias/ABH-7263-2020; Di Virgilio, Francesco/J-3754-2018; Ferrari, Davide/F-5644-2015	DI VIRGILIO, Francesco/0000-0003-3566-1362; Müller, Tobias/0000-0002-9801-3496; Di Virgilio, Francesco/0000-0003-3566-1362; Ferrari, Davide/0000-0002-5727-9204	German Research Foundation [DFG ID7/4-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Emmy Noether Grant DFG ID7/4-1 from the German Research Foundation (to M.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2005, TRENDS PHARMACOL SCI, V26, P8, DOI 10.1016/j.tips.2004.10.010; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781; Berchtold S, 1999, FEBS LETT, V458, P424, DOI 10.1016/S0014-5793(99)01197-7; Choi SH, 2007, ALLERGY, V62, P1119, DOI 10.1111/j.1398-9995.2007.01412.x; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Fontinha BM, 2008, NEUROPHARMACOLOGY, V54, P924, DOI 10.1016/j.neuropharm.2008.01.011; Fossetta J, 2003, MOL PHARMACOL, V63, P342, DOI 10.1124/mol.63.2.342; Gao N, 2007, AM J PHYSIOL-GASTR L, V292, pG492, DOI 10.1152/ajpgi.00257.2006; Hieffiel W, 2008, CAN J PHYSIOL PHARM, V86, P46, DOI [10.1139/Y07-115, 10.1139/y07-115]; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Idzko M, 2007, J CLIN INVEST, V117, P464, DOI 10.1172/JCI28949; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; Jarvis GE, 1996, EUR J PHARMACOL, V315, P203, DOI 10.1016/S0014-2999(96)00637-1; la Sala A, 2002, BLOOD, V99, P1715, DOI 10.1182/blood.V99.5.1715; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Lewis MD, 1996, J CLIN ENDOCR METAB, V81, P1296, DOI 10.1210/jc.81.3.1296; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Manrique HA, 2008, EUR RESPIR J, V31, P1205, DOI 10.1183/09031936.00116207; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; MULLER T, 2010, AM J RESP CELL MOL B; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Polosa R, 1997, THORAX, V52, P919, DOI 10.1136/thx.52.10.919; Polosa R, 2009, TRENDS PHARMACOL SCI, V30, P528, DOI 10.1016/j.tips.2009.07.005; RESNICK MB, 1993, J IMMUNOL, V151, P5716; Rittiner JE, J BIOL CHEM; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Theron AJ, 2002, INFLAMM RES, V51, P594, DOI 10.1007/PL00012434; van den Berge M, 2004, J ALLERGY CLIN IMMUN, V114, P737, DOI 10.1016/j.jaci.2004.05.071; van den Berge M, 2002, CLIN EXP ALLERGY, V32, P824, DOI 10.1046/j.1365-2222.2002.01385.x; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wilson Constance N, 2009, Handb Exp Pharmacol, P329, DOI 10.1007/978-3-540-89615-9_11; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; WU SN, 1992, JPN J PHYSIOL, V42, P35, DOI 10.2170/jjphysiol.42.35	41	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37560	10.1371/journal.pone.0037560	http://dx.doi.org/10.1371/journal.pone.0037560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624049	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500136
J	Singh, A; Padmadas, SS; Mishra, US; Pallikadavath, S; Johnson, FA; Matthews, Z				Singh, Abhishek; Padmadas, Sabu S.; Mishra, Udaya S.; Pallikadavath, Saseendran; Johnson, Fiifi A.; Matthews, Zoe			Socio-Economic Inequalities in the Use of Postnatal Care in India	PLOS ONE			English	Article							MATERNAL HEALTH; NEONATAL SURVIVAL; SERVICES; PRADESH; PROGRAM	Objective: First, our objective was to estimate socio-economic inequalities in the use of postnatal care (PNC) compared with those in the use of care at birth and antenatal care. Second, we wanted to compare inequalities in the use of PNC between facility births and home births and to determine inequalities in the use of PNC among mothers with high-risk births. Methods and Findings: Rich-poor ratios and concentration indices for maternity care were estimated using the third round of the District Level Household Survey conducted in India in 2007-08. Binary logistic regression models were used to examine the socio-economic inequalities associated with use of PNC after adjusting for relevant socio-economic and demographic characteristics. PNC for both mothers and newborns was substantially lower than the care received during pregnancy and child birth. Only 44% of mothers in India at the time of survey received any care within 48 hours after birth. Likewise, only 45% of newborns received check-up within 24 hours of birth. Mothers who had home births were significantly less likely to have received PNC than those who had facility births, with significant differences across the socioeconomic strata. Moreover, the rich-poor gap in PNC use was significantly wider for mothers with birth complications. Conclusions: PNC use has been unacceptably low in India given the risks of mortality for mothers and babies shortly after birth. However, there is evidence to suggest that effective use of pregnancy and childbirth care in health facilities led to better PNC. There are also significant socio-economic inequalities in access to PNC even for those accessing facility-based care. The coverage of essential PNC is inadequate, especially for mothers from economically disadvantaged households. The findings suggest the need for strengthening PNC services to keep pace with advances in coverage for care at birth and prenatal services in India through targeted policy interventions.	[Singh, Abhishek] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India; [Padmadas, Sabu S.; Johnson, Fiifi A.; Matthews, Zoe] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; [Padmadas, Sabu S.; Johnson, Fiifi A.; Matthews, Zoe] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England; [Mishra, Udaya S.] Ctr Dev Studies, Thiruvananthapuram, India; [Pallikadavath, Saseendran] Univ Portsmouth, Sch Hlth Sci & Social Work, Global Hlth & Social Care Unit, Portsmouth, Hants, England	International Institute for Population Sciences; University of Southampton; University of Southampton; University of Portsmouth	Singh, A (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Bombay, Maharashtra, India.	abhi_iips@yahoo.co.in	Amoako Johnson, Fiifi/GWC-1466-2022; Matthews, Zoe/HGD-0506-2022; Singh, Abhishek/ABC-7813-2020	Singh, Abhishek/0000-0001-6263-4410; Matthews, Zoe/0000-0003-1533-6618; Padmadas, Sabu/0000-0002-6538-9374; Pallikadavath, Saseendran/0000-0002-2598-9949	ESRC [RES-238-25-0009]; Economic and Social Research Council [ES/H024700/1] Funding Source: researchfish; ESRC [ES/H024700/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was conducted as part of the UK Economic & Social Research Council (ESRC) Brazil-India Pathfinder Programme for Collaborative Analysis of Microdata Resources. The authors gratefully acknowledge the ESRC for facilitating the study and providing financial support (Grant reference: RES-238-25-0009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Anwar A., 2004, BANGLADESH INEQUALIT; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bhatia JC., 1995, HLTH TRANSITION REV, V5, P127; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Dilip TR, 2009, INT POP C IUSSP MARR; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Grover A, 2010, SPECIAL RAPPORTEUR R; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Halder Amal Krishna, 2007, World Health Popul, V9, P48; Howe LD, 2009, J EPIDEMIOL COMMUN H, V63, P871, DOI 10.1136/jech.2009.088021; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; Mavalankar D, 2008, B WORLD HEALTH ORGAN, V86, P243, DOI 10.2471/BLT.07.048454; Mavlankar DV, 1999, IMPLEMENTING REPROD; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; MoHFW, 1997, REPR CHILD HLTH PROG; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Ram F, 2006, J HLTH DEV, V2, P67; RamaRao S, 2001, HEALTH POLICY PLANN, V16, P256, DOI 10.1093/heapol/16.3.256; Rasaily R, 2008, INDIAN PEDIATR, V45, P991; RGI, 2011, SPEC B MAT MORT IND; RGI, 2010, COMP IND FERT MORT I; Ronsman C, 2006, MATERNAL MORTALITY W, P13; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sines E, 2007, CRITICAL OPPORTUNITY; Sunil TS, 2006, SOC SCI MED, V62, P1943, DOI 10.1016/j.socscimed.2005.09.004; VANDOORSLAER E, 1992, J HEALTH ECON, V11, P389, DOI 10.1016/0167-6296(92)90013-Q; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2004, HEALTH ECON, V13, P297, DOI 10.1002/hec.822; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 1998, BAS NEWB RES PRACT G	40	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37037	10.1371/journal.pone.0037037	http://dx.doi.org/10.1371/journal.pone.0037037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22623976	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000305343500053
J	Xu, W; Jiang, SQ; Xu, YY; Chen, B; Li, Y; Zong, F; Zhao, WH; Wu, JQ				Xu, Wei; Jiang, Shengqiang; Xu, Yuanyuan; Chen, Bo; Li, Yan; Zong, Feng; Zhao, Weihong; Wu, Jianqing			A Meta-Analysis of Caspase 9 Polymorphisms in Promoter and Exon Sequence on Cancer Susceptibility	PLOS ONE			English	Article							GENE; RISK; APOPTOSIS	Background: Caspases are important regulators and executioners in apoptosis pathway and have been defined as either tumor suppressors or oncogenes. Polymorphisms in promoter and exon of caspase 9 were shown to confer genetic susceptibility to multiple cancers, but the results were inconsistent. To accomplish a more precise estimation of the relationship, a meta-analysis was performed. Methodology/Principal Findings: We assessed published studies of the association between caspase 9 polymorphisms and cancer risk from nine studies with 5,528 subjects for rs4645978, six studies with 2,403 subjects for rs105276 and two studies for rs4645981. Overall meta-analysis indicated that no evidence of an association between rs4645978 and cancers was found. Through the stratified analysis, statistically significant reduced cancer risks were observed among Caucasians (AG vs AA: OR = 0.81, 95% CI = 0.66-0.99, P-heterogeneity = 0.150 and the dominant model: OR = 0.86, 95% CI = 0.75-0.99, P-heterogeneity = 0.290) and prostate cancer. As for rs105276, Ex5+32G>A polymorphism was found with protective effect in overall meta-analysis (AA vs GG: OR = 0.75, 95% CI = 0.60-0.92, P-heterogeneity = 0.887; A vs G: OR = 0.85, 95% CI = 0.77-0.95, P-heterogeneity = 0.739 and the recessive model: OR = 0.68, 95% CI = 0.56-0.82, P-heterogeneity = 0.309) and Asians group. While for rs4645981, a statistically significant increase in risk of lung cancer was shown in Asians (T vs C: OR = 1.23, 95% CI = 1.07-1.42, P-heterogeneity = 0.399 and the dominant model: OR = 1.22, 95% CI = 1.04-1.43, P-heterogeneity = 0.660). Conclusions/Significance: Our meta-analysis suggests that the caspase 9 rs4645978 most likely contributes to decreased susceptibility to cancer in Caucasians and prostate cancer. The A allele of rs105276 might be a protective factor for cancer, especially for Asians. However, it seems that rs4645981 confers increased susceptibility to lung cancer in Asians.	[Xu, Wei; Xu, Yuanyuan; Chen, Bo; Li, Yan; Zong, Feng; Zhao, Weihong; Wu, Jianqing] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China; [Jiang, Shengqiang] Hohai Univ, Sch Business, Nanjing, Peoples R China	Nanjing Medical University; Hohai University	Xu, W (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Peoples R China.	jwuny@njmu.edu.cn			National Natural Science Foundation of China [30971320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30971320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Andreoli V, 2009, J NEUROIMMUNOL, V210, P100, DOI 10.1016/j.jneuroim.2009.03.013; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang C-Q., 2007, WORLD CHIN J DIGESTO, V15, P3190, DOI DOI 10.11569/WCJD.V15.I30.3190; Gangwar R, 2009, ANN SURG ONCOL, V16, P2028, DOI 10.1245/s10434-009-0488-3; George GP, 2011, UROL ONCOL; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Grabe Niels, 2002, In Silico Biology, V2, pS1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He X., 2008, SHIJIE HUAREN XIAOHU, V16, P2371, DOI DOI 10.11569/WCJD.V16.I21.2371; Hirano A, 2001, GENES IMMUN, V2, P117, DOI 10.1038/sj.gene.6363728; Hosgood HD, 2008, HEMATOL ONCOL, V26, P148, DOI 10.1002/hon.852; Kesarwani P, 2011, BJU INT, V107, P471, DOI 10.1111/j.1464-410X.2010.09533.x; Lan Q, 2007, CARCINOGENESIS, V28, P823, DOI 10.1093/carcin/bgl196; Lee SY, 2010, J THORAC ONCOL, V5, P1152, DOI 10.1097/JTO.0b013e3181e04543; Liamarkopoulos E, 2011, GASTRIC CANCER, V14, P317, DOI 10.1007/s10120-011-0045-1; Liu CY, 2010, CARCINOGENESIS, V31, P1259, DOI 10.1093/carcin/bgq092; MANTEL N, 1959, J NATL CANCER I, V22, P719; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Park JY, 2006, HUM MOL GENET, V15, P1963, DOI 10.1093/hmg/ddl119; Theodoropoulos GE, 2011, INT J COLORECTAL DIS, V26, P1113, DOI 10.1007/s00384-011-1217-5; Theodoropoulos GE, 2010, PANCREAS, V39, P976, DOI 10.1097/MPA.0b013e3181d705d4; Wang YX, 2011, MED ONCOL; Wu H, 2009, THESIS GUANGXI MEDIC; Yi Lou, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P59; Yin M, 2010, CARCINOGENESIS, V31, P850, DOI 10.1093/carcin/bgq047	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37443	10.1371/journal.pone.0037443	http://dx.doi.org/10.1371/journal.pone.0037443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22616010	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200076
J	De Lucrezia, D; Slanzi, D; Poli, I; Polticelli, F; Minervini, G				De Lucrezia, Davide; Slanzi, Debora; Poli, Irene; Polticelli, Fabio; Minervini, Giovanni			Do Natural Proteins Differ from Random Sequences Polypeptides? Natural vs. Random Proteins Classification Using an Evolutionary Neural Network	PLOS ONE			English	Article							TRANSCRIPTS; DATABASE; GENOMES; REFSEQ	Are extant proteins the exquisite result of natural selection or are they random sequences slightly edited by evolution? This question has puzzled biochemists for long time and several groups have addressed this issue comparing natural protein sequences to completely random ones coming to contradicting conclusions. Previous works in literature focused on the analysis of primary structure in an attempt to identify possible signature of evolutionary editing. Conversely, in this work we compare a set of 762 natural proteins with an average length of 70 amino acids and an equal number of completely random ones of comparable length on the basis of their structural features. We use an ad hoc Evolutionary Neural Network Algorithm (ENNA) in order to assess whether and to what extent natural proteins are edited from random polypeptides employing 11 different structure-related variables (i.e. net charge, volume, surface area, coil, alpha helix, beta sheet, percentage of coil, percentage of alpha helix, percentage of beta sheet, percentage of secondary structure and surface hydrophobicity). The ENNA algorithm is capable to correctly distinguish natural proteins from random ones with an accuracy of 94.36%. Furthermore, we study the structural features of 32 random polypeptides misclassified as natural ones to unveil any structural similarity to natural proteins. Results show that random proteins misclassified by the ENNA algorithm exhibit a significant fold similarity to portions or subdomains of extant proteins at atomic resolution. Altogether, our results suggest that natural proteins are significantly edited from random polypeptides and evolutionary editing can be readily detected analyzing structural features. Furthermore, we also show that the ENNA, employing simple structural descriptors, can predict whether a protein chain is natural or random.	[De Lucrezia, Davide; Poli, Irene; Minervini, Giovanni] Univ Ca Foscari Venice, European Ctr Living Technol, Venice, Italy; [Slanzi, Debora; Poli, Irene] Univ Ca Foscari Venice, Dept Environm Sci Informat & Stat, Venice, Italy; [Polticelli, Fabio] Univ Roma Tre, Dept Biol, Rome, Italy; [Polticelli, Fabio] Natl Inst Nucl Phys, Roma Tre Sect, Rome, Italy	Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; Roma Tre University; Istituto Nazionale di Fisica Nucleare (INFN)	De Lucrezia, D (corresponding author), Univ Ca Foscari Venice, European Ctr Living Technol, Venice, Italy.	giovanni.minervini@ecltech.org	Polticelli, Fabio/A-4573-2009; Slanzi, Debora/I-6863-2015; Minervini, Giovanni/D-1200-2013	Polticelli, Fabio/0000-0002-7657-2019; Slanzi, Debora/0000-0002-4204-1009; Minervini, Giovanni/0000-0001-7013-5785; de lucrezia, davide/0000-0002-2561-1022	Fondazione di Venezia (Venice, Italy)	Fondazione di Venezia (Venice, Italy)	This work has been partially supported by the Fondazione di Venezia (Venice, Italy) through the DICE Project (Design Informative Combinatorial Experiments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chiarabelli C, 2007, ORIGINS LIFE EVOL B, V37, P357, DOI 10.1007/s11084-007-9075-4; Chiarabelli C, 2006, CHEM BIODIVERS, V3, P840, DOI 10.1002/cbdv.200690088; Crooks GE, 2004, PROTEINS, V57, P804, DOI 10.1002/prot.20262; Eigen M., 1992, STEPS LIFE; Evangelista G., 2007, BIOALGORITHMS MED SY, V3, P27; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Hayashi Y, 2003, J MOL EVOL, V56, P162, DOI 10.1007/s00239-002-2389-y; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Jacob M, 1969, SYMMETRY FUNCTION BI, P15; KAUFFMAN SA, 1992, J THEOR BIOL, V157, P1, DOI 10.1016/S0022-5193(05)80753-2; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Lavelle DT, 2010, BIOINFORMATICS, V26, P310, DOI 10.1093/bioinformatics/btp660; Luisi PL, 2003, PHILOS T R SOC A, V361, P1141, DOI 10.1098/rsta.2003.1189; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Minervini G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S22; Munteanu CR, 2008, J THEOR BIOL, V254, P775, DOI 10.1016/j.jtbi.2008.07.018; PANDE VS, 1994, P NATL ACAD SCI USA, V91, P12972, DOI 10.1073/pnas.91.26.12972; Poli I, 1991, CATANIA CLEUP, P597; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptitsyn O B, 1984, Mol Biol (Mosk), V18, P574; PTITSYN OB, 1986, J BIOMOL STRUCT DYN, V4, P137, DOI 10.1080/07391102.1986.10507651; PTITSYN OB, 1985, J MOL STRUC-THEOCHEM, V24, P45, DOI 10.1016/0166-1280(85)85183-6; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Weiss O, 2000, J THEOR BIOL, V206, P379, DOI 10.1006/jtbi.2000.2138; Weiss O, 1998, J THEOR BIOL, V190, P341, DOI 10.1006/jtbi.1997.0560	32	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36634	10.1371/journal.pone.0036634	http://dx.doi.org/10.1371/journal.pone.0036634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615786	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300021
J	Schad, J; Dechmann, DKN; Voigt, CC; Sommer, S				Schad, Julia; Dechmann, Dina K. N.; Voigt, Christian C.; Sommer, Simone			Evidence for the 'Good Genes' Model: Association of MHC Class II DRB Alleles with Ectoparasitism and Reproductive State in the Neotropical Lesser Bulldog Bat, Noctilio albiventris	PLOS ONE			English	Article							TRADE-OFFS; HOST-SPECIFICITY; FLIES DIPTERA; POPULATION; DIVERSITY; SELECTION; IMMUNITY; COST; SEX; PREFERENCES	The adaptive immune system has a major impact on parasite resistance and life history strategies. Immunological defence is costly both in terms of immediate activation and long-term maintenance. The 'good genes' model predicts that males with genotypes that promote a good disease resistance have the ability to allocate more resources to reproductive effort which favours the transmission of good alleles into future generations. Our study shows a correlation between immune gene constitution (Major Histocompatibility Complex, MHC class II DRB), ectoparasite loads (ticks and bat flies) and the reproductive state in a neotropical bat, Noctilio albiventris. Infestation rates with ectoparasites were linked to specific Noal-DRB alleles, differed among roosts, increased with body size and co-varied with reproductive state particularly in males. Non-reproductive adult males were more infested with ectoparasites than reproductively active males, and they had more often an allele (Noal-DRB*02) associated with a higher tick infestation than reproductively active males or subadults. We conclude that the individual immune gene constitution affects ectoparasite susceptibility, and contributes to fitness relevant trade-offs in male N. albiventris as suggested by the 'good genes' model.	[Schad, Julia; Voigt, Christian C.; Sommer, Simone] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Dechmann, Dina K. N.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Dechmann, Dina K. N.] Univ Konstanz, Dept Biol, Constance, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Max Planck Society; University of Konstanz	Schad, J (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	Sommer@izw-berlin.de		Dechmann, Dina/0000-0003-0043-8267	German Science Foundation [VO 890/11-1]; Leibniz Association	German Science Foundation(German Research Foundation (DFG)); Leibniz Association	Funding was received from the German Science Foundation (VO 890/11-1, www.dfg.de) and the Leibniz Association (www.leibniz-association.eu; www.izw-berlin.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JOD, 1986, PARASITOL TODAY, V2, P345, DOI 10.1016/0169-4758(86)90055-4; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008; Balding DJ, 2004, APPL LONGITUDINAL AN; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boonekamp JJ, 2008, BIOL LETTERS, V4, P741, DOI 10.1098/rsbl.2008.0347; BOOTH GD, 1994, USDA FOR SERV INT R, P1; Brunet-Rossini AK, 2009, ECOLOGICAL BEHAV MET; Christe P, 2003, J ANIM ECOL, V72, P866, DOI 10.1046/j.1365-2656.2003.00759.x; Christe P, 2000, ECOL LETT, V3, P307; Christe P, 2007, J ANIM ECOL, V76, P703, DOI 10.1111/j.1365-2656.2007.01255.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; Dick C.W., 2010, MANUAL CENTRAL AM DI, V2, P1249; Dick CW, 2007, INT J PARASITOL, V37, P871, DOI 10.1016/j.ijpara.2007.02.004; Ditchkoff SS, 2005, SOUTHWEST NAT, V50, P57, DOI 10.1894/0038-4909(2005)050&lt;0057:MEPIIP&gt;2.0.CO;2; Ditchkoff SS, 2001, EVOLUTION, V55, P616, DOI 10.1554/0014-3820(2001)055[0616:MHCAVI]2.0.CO;2; Doherty P C, 1975, Nature, V256, P50; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faul F., 1992, GPOWER PRIORI POSTHO; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Giorgi MS, 2004, OECOLOGIA, V138, P648, DOI 10.1007/s00442-003-1475-1; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Greiner S, 2010, GEN COMP ENDOCR, V168, P466, DOI 10.1016/j.ygcen.2010.06.008; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HEUSNER AA, 1985, ANNU REV NUTR, V5, P267, DOI 10.1146/annurev.nu.05.070185.001411; HOOD C S, 1983, Mammalian Species, P1, DOI 10.2307/3503897; Ilmonen P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-104; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KLEIN J, 1986, NATURAL HIST MAJOR H; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Krasnov BR, 2005, GLOBAL ECOL BIOGEOGR, V14, P167, DOI 10.1111/j.1466-822X.2005.00146.x; Krasnov BR, 2002, ANIM BEHAV, V64, P33, DOI 10.1006/anbe.2002.3030; Krutzsch Philip H., 2000, P91, DOI 10.1016/B978-012195670-7/50005-9; Kwak J, 2009, PHYSIOL BEHAV, V96, P184, DOI 10.1016/j.physbeh.2008.10.003; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Lourenco SI, 2008, PARASITOLOGY, V135, P1205, DOI 10.1017/S003118200800468X; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Marshall A.G., 1982, P369; McCallum ML, 2007, HERPETOLOGICA, V63, P269, DOI 10.1655/0018-0831(2007)63[269:PTBIAR]2.0.CO;2; Milinski M, 2010, P ROY SOC B-BIOL SCI, V277, P391, DOI 10.1098/rspb.2009.1501; Milleron RS, 2004, AM J TROP MED HYG, V70, P286, DOI 10.4269/ajtmh.2004.70.286; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Patterson BD, 2008, J TROP ECOL, V24, P387, DOI 10.1017/S0266467408005117; Patterson BD, 2007, J TROP ECOL, V23, P177, DOI 10.1017/S0266467406003816; Pearce RD, 2007, J PARASITOL, V93, P518, DOI 10.1645/GE-973R.1; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Presley SJ, 2004, THESIS TEXAS TU LUBB; Presley SJ, 2008, J TROP ECOL, V24, P75, DOI 10.1017/S0266467407004683; Presley SJ, 2007, J TROP ECOL, V23, P409, DOI 10.1017/S0266467407004245; R Core Team, 2021, R LANGUAGE ENV STAT; Racey PA, 2009, ECOLOGICAL BEHAV MET; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Santos PSC, 2010, IMMUNOGENETICS, V62, P569, DOI 10.1007/s00251-010-0468-6; Schad J, 2011, HEREDITY, V107, P115, DOI 10.1038/hdy.2010.173; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Sharifi M, 2008, J PARASITOL, V94, P622, DOI 10.1645/GE-1334.1; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STUDIER EH, 1984, J MAMMAL, V65, P711, DOI 10.2307/1380864; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; ter Hofstede HM, 2005, J ZOOL, V266, P333, DOI 10.1017/S095283690500693X; Untalan PM, 2007, VET PARASITOL, V145, P190, DOI 10.1016/j.vetpar.2006.12.003; Wenzel R.L., 1976, Science Bull Brigham Young Univ ( Biol), V20, P1; Wenzel R. L., 1966, P405; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; Wikel SK, 1999, ANNU REV ENTOMOL, V41, P1; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuur Alain F., 2009, P1	86	31	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37101	10.1371/journal.pone.0037101	http://dx.doi.org/10.1371/journal.pone.0037101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615910	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300071
J	van Horn, JD; Irimia, A; Torgerson, CM; Chambers, MC; Kikinis, R; Toga, AW				van Horn, John Darrell; Irimia, Andrei; Torgerson, Carinna M.; Chambers, Micah C.; Kikinis, Ron; Toga, Arthur W.			Mapping Connectivity Damage in the Case of Phineas Gage	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; FRONTOTEMPORAL DEMENTIA; EXECUTIVE DYSFUNCTION; UNCINATE FASCICULUS; PREFRONTAL CORTEX; NETWORK; LESIONS; GAGE,PHINEAS	White matter (WM) mapping of the human brain using neuroimaging techniques has gained considerable interest in the neuroscience community. Using diffusion weighted (DWI) and magnetic resonance imaging (MRI), WM fiber pathways between brain regions may be systematically assessed to make inferences concerning their role in normal brain function, influence on behavior, as well as concerning the consequences of network-level brain damage. In this paper, we investigate the detailed connectomics in a noted example of severe traumatic brain injury (TBI) which has proved important to and controversial in the history of neuroscience. We model the WM damage in the notable case of Phineas P. Gage, in whom a "tamping iron'' was accidentally shot through his skull and brain, resulting in profound behavioral changes. The specific effects of this injury on Mr. Gage's WM connectivity have not previously been considered in detail. Using computed tomography (CT) image data of the Gage skull in conjunction with modern anatomical MRI and diffusion imaging data obtained in contemporary right handed male subjects (aged 25-36), we computationally simulate the passage of the iron through the skull on the basis of reported and observed skull fiducial landmarks and assess the extent of cortical gray matter (GM) and WM damage. Specifically, we find that while considerable damage was, indeed, localized to the left frontal cortex, the impact on measures of network connectedness between directly affected and other brain areas was profound, widespread, and a probable contributor to both the reported acute as well as long-term behavioral changes. Yet, while significantly affecting several likely network hubs, damage to Mr. Gage's WM network may not have been more severe than expected from that of a similarly sized "average'' brain lesion. These results provide new insight into the remarkable brain injury experienced by this noteworthy patient.	[van Horn, John Darrell; Irimia, Andrei; Torgerson, Carinna M.; Chambers, Micah C.; Toga, Arthur W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging LONI, Los Angeles, CA 90095 USA; [Kikinis, Ron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,Dept Radiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital; Harvard Medical School	van Horn, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Lab Neuro Imaging LONI, Los Angeles, CA 90095 USA.	jvanhorn@loni.ucla.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John Darrell/0000-0003-1537-0816	NAMIC: Traumatic Brain Injury - Driving Biological Project [2U54EB005149-06]; Informatics Meta-Spaces for the Exploration of Human Neuroanatomy [1RC1MH088194]; Computational Anatomy and Multidimensional Modeling [P41RR013642]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088194] Funding Source: NIH RePORTER	NAMIC: Traumatic Brain Injury - Driving Biological Project; Informatics Meta-Spaces for the Exploration of Human Neuroanatomy; Computational Anatomy and Multidimensional Modeling; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by 2U54EB005149-06 "NAMIC: Traumatic Brain Injury - Driving Biological Project" to JVH, 1RC1MH088194 "Informatics Meta-Spaces for the Exploration of Human Neuroanatomy" to JVH, and P41RR013642 "Computational Anatomy and Multidimensional Modeling" to AWT. This work was performed as part of the Human Connectome Project (HCP; www.humanconnectomeproject.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi B, 2000, Neurosurg Focus, V8, pe1; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Aly M, 2011, BEHAV BRAIN RES, V225, P297, DOI 10.1016/j.bbr.2011.07.043; [Anonymous], 1868, PUBL MASS MED SOC; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Bigelow H. J., 1850, AM J MED SCI, V20, P13; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Cobb S, 1940, ARCH INTERN MED, V66, P1341, DOI 10.1001/archinte.1940.00190180153011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damasio AR, DESCARTES ERROR; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dinov I, 2010, FRONT NEUROINFORM, V3, P1; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dinov Ivo D, 2009, Front Neuroinform, V3, P22, DOI 10.3389/neuro.11.022.2009; Dunbar RIM, 2009, CORTEX, V45, P1119, DOI 10.1016/j.cortex.2009.05.005; Dupuy E, 1877, MED TIMES GAZ, Vii, P11; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2000, J HUM EVOL, V38, P695, DOI 10.1006/jhev.1999.0378; Ferrier D, 1878, Br Med J, V1, P443; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hamilton LS, 2008, NEUROREPORT, V19, P1705, DOI 10.1097/WNR.0b013e3283174415; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Johnson CP, 2011, J INT NEUROPSYCH SOC, P1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Knake S, 2009, EPILEPTIC DISORD; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Lee DY, 2006, J NEUROPSYCH CLIN N, V18, P191, DOI 10.1176/appi.neuropsych.18.2.191; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; MacKenzie-Graham AJ, 2008, NEUROIMAGE, V42, P178, DOI 10.1016/j.neuroimage.2008.04.186; MACMILLAN M, 1992, BRAIN COGNITION, V19, P72, DOI 10.1016/0278-2626(92)90038-N; MacMillan M, 2000, ODD KIND FAME STORIE; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald CR, 2005, J CLIN EXP NEUROPSYC, V27, P485, DOI 10.1080/13803390490520454; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Nobe MY, 2010, OPHTHAL PLAST RECONS, V26, P475, DOI 10.1097/IOP.0b013e3181cff655; Ordia JI, 2009, CLIN NEUROL NEUROSUR, V111, P368, DOI 10.1016/j.clineuro.2008.10.016; Ostry DJ, 1997, J SPEECH LANG HEAR R, V40, P1341, DOI 10.1044/jslhr.4006.1341; Pal D, 2011, CLIN NEUROL NEUROSUR; Pascual JM, 2009, ACTA NEUROCHIR, V151, P689, DOI 10.1007/s00701-009-0222-8; Phillips OR, 2009, SCHIZOPHR RES, V107, P30, DOI 10.1016/j.schres.2008.10.019; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Pijnenburg YAL, 2008, CLIN NEUROPHYSIOL, V119, P1732, DOI 10.1016/j.clinph.2008.02.024; Ratiu P, 2004, J NEUROTRAUM, V21, P637, DOI 10.1089/089771504774129964; Ratiu PF, 2004, NEW ENGL J MED, V351, pE21, DOI 10.1056/NEJMicm031024; Rosen B, 2010, P ORG HUM BRAIN MAPP; Rothschild MA, 2000, INT J LEGAL MED, V113, P349; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schoenemann PT, 2007, AM J PHYS ANTHROPOL, V132, P183, DOI 10.1002/ajpa.20499; Selvanathan S, 2007, J CLIN NEUROSCI, V14, P678, DOI 10.1016/j.jocn.2006.02.017; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Shields LBE, 1998, J FORENSIC SCI, V43, P1068; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; TUSA RJ, 1985, ANN NEUROL, V18, P583, DOI 10.1002/ana.410180512; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilgus J, 2009, J HIST NEUROSCI, V18, P340, DOI 10.1080/09647040903018402; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	88	82	83	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37454	10.1371/journal.pone.0037454	http://dx.doi.org/10.1371/journal.pone.0037454			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22616011	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300116
J	Zhou, WB; Ding, Q; Liang, XQ; He, ZY; Zha, XM; Liu, XA; Wang, S				Zhou, Wenbin; Ding, Qiang; Liang, Xiuqing; He, Zhongyuan; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui			The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; PREMENOPAUSAL WOMEN; YOUNG-WOMEN; DOCETAXEL; SURVIVAL; ANTHRACYCLINE; FERTILITY; THERAPY; DOXORUBICIN; TRIAL	Background: Chemotherapy-induced amenorrhea (CIA) is common in young breast cancer patients. The incidence of CIA associated with regimens involving epirubicin and taxane was not well known. Furthermore, previous studies suggested leucopenia and amenorrhea may reflect inter-individual variations in pharmacokinetics. The purpose of this study was to investigate the association between leucopenia after first cycle of chemotherapy and CIA in young breast cancer patients receiving epirubicin and taxane based chemotherapy. Furthermore, the incidence of CIA was also assessed. Methodology and Principal Findings: Between October 2008 and March 2010, 186 consecutive premenopausal patients, treated with epirubicin and taxane based chemotherapy, were recruited. Information about CIA was collected by telephone and out-patient clinic. Of these 186 patients, data from 165 patients were included and analyzed. Of all 165 patients, CIA occurred in 72 patients (43.64%). In multivariate analysis, age older than 40 y (OR: 16.10, 95% CI: 6.34-40.88, P < 0.001) and previous childbearing (OR: 3.17, 95% CI: 1.06-9.47, P = 0.038) were significantly associated with probability of CIA. Compared to patients treated without taxane, patients treated with taxane-contained regimens did not have a significantly higher rate of CIA (P > 0.05). The rate of CIA in leucopenia group (52.56%) was significantly higher than that in normal leukocyte group (34.62%) (P = 0.024). In patients treated with a FEC regimen (cyclophosphamide, epirubicin and 5-fluorouracil), the rate of CIA in leucopenia group (59.57%) was significantly higher than that in normal leukocyte group (36.84%) (P = 0.037). Conclusions: Age at diagnosis and previous childbearing were both found to significantly increase the risk of CIA, whereas additional taxane was not associated with increased rate of CIA. Importantly, leucopenia after first cycle of chemotherapy was associated with increased risk of CIA, which suggested that leucopenia may be an early predictor of chemotherapy-induced infertility.	[Zhou, Wenbin; Ding, Qiang; Liang, Xiuqing; He, Zhongyuan; Zha, Xiaoming; Liu, Xiaoan; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, WB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	liuxiaoan@126.com; ws0801@hotmail.com			National Natural Science Foundation of China [81071753, 81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81071753 and 81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008), and A project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perez-Fidalgo JA, 2010, BREAST CANCER RES TR, V120, P245, DOI 10.1007/s10549-009-0426-x; Amadori D, 2011, BREAST CANCER RES TR, V125, P775, DOI 10.1007/s10549-010-1257-5; Berliere M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-56; Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044; Cameron DA, 2003, BRIT J CANCER, V89, P1837, DOI 10.1038/sj.bjc.6601366; Di Cosimo S, 2004, ANN ONCOL, V15, P1065, DOI 10.1093/annonc/mdh266; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Fornier MN, 2005, CANCER-AM CANCER SOC, V104, P1575, DOI 10.1002/cncr.21385; Han HS, 2009, BREAST CANCER RES TR, V115, P335, DOI 10.1007/s10549-008-0071-9; Hulvat MC, 2009, CURR TREAT OPTION ON, V10, P308, DOI 10.1007/s11864-010-0116-2; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kitajima Y, 2006, ENDOCRINOLOGY, V147, P694, DOI 10.1210/en.2005-0700; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Knobf MT, 2006, ONCOLOGIST, V11, P96, DOI 10.1634/theoncologist.11-2-96; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Margolin S, 2011, ACTA ONCOL, V50, P35, DOI 10.3109/0284186X.2010.535847; Martin M, 2005, NEW ENGL J MED, V352, P2302, DOI 10.1056/NEJMoa043681; Mayers C, 2001, CANCER, V91, P2246, DOI 10.1002/1097-0142(20010615)91:12<2246::AID-CNCR1255>3.3.CO;2-W; Minisini AM, 2009, ANTI-CANCER DRUG, V20, P503, DOI 10.1097/CAD.0b013e3283243df3; Najafi S, 2011, MENOPAUSE, V18, P208, DOI 10.1097/gme.0b013e3181f3e6e7; Poikonen P, 1999, BRIT J CANCER, V80, P1763, DOI 10.1038/sj.bjc.6690594; Roche H, 2006, J CLIN ONCOL, V24, P5664, DOI 10.1200/JCO.2006.07.3916; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016/j.fertnstert.2009.02.043; Rosendahl M, 2009, EUR J CANCER, V45, P3198, DOI 10.1016/j.ejca.2009.09.019; Saarto T, 1997, BRIT J CANCER, V75, P301, DOI 10.1038/bjc.1997.49; Sakurai K, 2011, J CANCER RES CLIN, V137, P615, DOI 10.1007/s00432-010-0894-8; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Swain SM, 2010, NEW ENGL J MED, V362, P2053, DOI 10.1056/NEJMoa0909638; Swain SM, 2009, BREAST CANCER RES TR, V113, P315, DOI 10.1007/s10549-008-9937-0; Tham YL, 2007, AM J CLIN ONCOL-CANC, V30, P126, DOI 10.1097/01.coc.0000251398.57630.4f; Vanhuyse M, 2005, ANN ONCOL, V16, P1283, DOI 10.1093/annonc/mdi241; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Zhou WB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-281	33	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37249	10.1371/journal.pone.0037249	http://dx.doi.org/10.1371/journal.pone.0037249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615953	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300091
J	Letamendia, A; Quevedo, C; Ibarbia, I; Virto, JM; Holgado, O; Diez, M; Belmonte, JCI; Callol-Massot, C				Letamendia, Ainhoa; Quevedo, Celia; Ibarbia, Izaskun; Virto, Juan M.; Holgado, Olaia; Diez, Maria; Izpisua Belmonte, Juan Carlos; Callol-Massot, Carles			Development and Validation of an Automated High-Throughput System for Zebrafish In Vivo Screenings	PLOS ONE			English	Article							DRUG DISCOVERY; ANIMAL-MODELS; ANGIOGENESIS; HERG; RECEPTOR; GROWTH; HEART; REPOLARIZATION; COMBINATION; BRADYCARDIA	The zebrafish is a vertebrate model compatible with the paradigms of drug discovery. The small size and transparency of zebrafish embryos make them amenable for the automation necessary in high-throughput screenings. We have developed an automated high-throughput platform for in vivo chemical screenings on zebrafish embryos that includes automated methods for embryo dispensation, compound delivery, incubation, imaging and analysis of the results. At present, two different assays to detect cardiotoxic compounds and angiogenesis inhibitors can be automatically run in the platform, showing the versatility of the system. A validation of these two assays with known positive and negative compounds, as well as a screening for the detection of unknown anti-angiogenic compounds, have been successfully carried out in the system developed. We present a totally automated platform that allows for high-throughput screenings in a vertebrate organism.	[Letamendia, Ainhoa; Quevedo, Celia; Ibarbia, Izaskun; Virto, Juan M.; Holgado, Olaia; Diez, Maria; Callol-Massot, Carles] Biobide SL, San Sebastian, Guipuzcoa, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Letamendia, A (corresponding author), Biobide SL, San Sebastian, Guipuzcoa, Spain.	callol@biobide.es			EU [Health-F2-2008-201439-ZFCance;]; Basque Government [IT-2006/0000275, IN-2006/0000012]; Spanish Government [PTQ05-02-02889, PTQ05-02-02904, FIT-090100-2007-4, PLE2009-0147]	EU(European Commission); Basque Government(Basque Government); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by EU Health-F2-2008-201439-ZFCancer; Basque Government IT-2006/0000275 and IN-2006/0000012, and Spanish Government PTQ05-02-02889, PTQ05-02-02904, FIT-090100-2007-4, and PLE2009-0147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Camus S, 2012, ONCOGENE, V31, P4333, DOI 10.1038/onc.2011.594; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng Hsien C., 2006, Journal of Pharmacological and Toxicological Methods, V54, P278, DOI 10.1016/j.vascn.2006.01.002; Duan JJ, 2007, ACTA PHARMACOL SIN, V28, P959, DOI 10.1111/j.1745-7254.2007.00562.x; Evensen L, 2010, CURR PHARM DESIGN, V16, P3958, DOI 10.2174/138161210794455030; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Gjini E, 2011, DIS MODEL MECH, V4, P57, DOI 10.1242/dmm.005033; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Guo Liang, 2005, Journal of Pharmacological and Toxicological Methods, V52, P123, DOI 10.1016/j.vascn.2005.04.002; Guthrie H, 2005, J BIOMOL SCREEN, V10, P832, DOI 10.1177/1087057105280566; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Kalen M, 2009, CHEM BIOL, V16, P432, DOI 10.1016/j.chembiol.2009.02.010; Kalin RE, 2009, BLOOD, V114, P1110, DOI 10.1182/blood-2009-03-211771; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; Lansbury PT, 2004, NAT MED, V10, pS51, DOI 10.1038/nrn1435; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.0.CO;2-8; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Miyazawa K, 2011, J BIOCHEM, V150, P1, DOI 10.1093/jb/mvr053; Mohamed MK, 1999, AM J PHYSIOL-REG I, V276, pR1030, DOI 10.1152/ajpregu.1999.276.4.R1030; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Peravali R, 2011, BIOTECHNIQUES, V50, P319, DOI 10.2144/000113669; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P465, DOI 10.1016/j.drudis.2006.03.015; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P355, DOI 10.1016/j.drudis.2006.02.005; Schneider J, 2005, EUR J PHARMACOL, V512, P53, DOI 10.1016/j.ejphar.2005.01.042; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Tabo M, 2010, J TOXICOL SCI, V35, P687, DOI 10.2131/jts.35.687; Titus SA, 2009, ANAL BIOCHEM, V394, P30, DOI 10.1016/j.ab.2009.07.003; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Ward Gregg R., 2006, BMC Pharmacology, V6, P2, DOI 10.1186/1471-2210-6-2; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Wiens KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011324; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	57	70	71	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36690	10.1371/journal.pone.0036690	http://dx.doi.org/10.1371/journal.pone.0036690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615792	gold, Green Published			2022-12-27	WOS:000305336300027
J	Shiee, N; Bazin, PL; Zackowski, KM; Farrell, SK; Harrison, DM; Newsome, SD; Ratchford, JN; Caffo, BS; Calabresi, PA; Pham, DL; Reich, DS				Shiee, Navid; Bazin, Pierre-Louis; Zackowski, Kathleen M.; Farrell, Sheena K.; Harrison, Daniel M.; Newsome, Scott D.; Ratchford, John N.; Caffo, Brian S.; Calabresi, Peter A.; Pham, Dzung L.; Reich, Daniel S.			Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis	PLOS ONE			English	Article							RELAPSING-REMITTING MS; WHITE-MATTER; CORTICAL ATROPHY; LESION LOAD; VOLUME CHANGES; SPINAL-CORD; GRAY; DYSFUNCTION; SEGMENTATION; ALGORITHM	Background: Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partially correlates with both physical disability and cognitive impairment. Methodology/Principal Findings: Based on MRI scans of 60 MS cases and 37 healthy volunteers, we measured the volumes of white matter (WM) lesions, cortical gray matter (GM), cerebral WM, caudate nucleus, putamen, thalamus, ventricles, and brainstem using a validated and completely automated segmentation method. We correlated these volumes with the Expanded Disability Status Scale (EDSS), MS Severity Scale (MSSS), MS Functional Composite (MSFC), and quantitative measures of ankle strength and toe sensation. Normalized volumes of both cortical and subcortical GM structures were abnormally low in the MS group, whereas no abnormality was found in the volume of the cerebral WM. High physical disability was associated with low cerebral WM, thalamus, and brainstem volumes (partial correlation coefficients similar to 0.3-0.4) but not with low cortical GM volume. Thalamus volumes were inversely correlated with lesion load (r = 20.36, p<0.005). Conclusion: The GM is atrophic in MS. Although lower WM volume is associated with greater disability, as might be expected, WM volume was on average in the normal range. This paradoxical result might be explained by the presence of coexisting pathological processes, such as tissue damage and repair, that cause both atrophy and hypertrophy and that underlie the observed disability.	[Shiee, Navid; Pham, Dzung L.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Reich, Daniel S.] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA; [Bazin, Pierre-Louis] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Shiee, Navid; Pham, Dzung L.; Reich, Daniel S.] Johns Hopkins Univ, Neuroradiol Div, Dept Radiol, Baltimore, MD USA; [Shiee, Navid; Pham, Dzung L.; Reich, Daniel S.] Johns Hopkins Univ, Neuroradiol Div, Dept Radiol Sci, Baltimore, MD USA; [Zackowski, Kathleen M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Zackowski, Kathleen M.; Farrell, Sheena K.; Harrison, Daniel M.; Newsome, Scott D.; Ratchford, John N.; Calabresi, Peter A.; Reich, Daniel S.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Caffo, Brian S.; Reich, Daniel S.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Max Planck Society; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Shiee, N (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA.	daniel.reich@nih.gov	Pham, Dzung/AAR-8263-2020; Harrison, Daniel M/AAG-4218-2021; Calabrese, Massimiliano/I-6195-2012; Reich, Daniel S./E-5701-2010; Calabresi, Peter A./AAF-2288-2019	Harrison, Daniel M/0000-0001-8707-2004; Reich, Daniel S./0000-0002-2628-4334; Bazin, Pierre-Louis/0000-0002-0141-5510	National Institute of Neurological Disorders and Stroke [R01NS054255, R01NS070906, K99NS064098]; National Institute of Drug Abuse [K25DA025356]; Eunice Kennedy Shriver National Institute for Child Health and Development [5K01HD049476]; National Center for Research Resources [P41RR015241]; National Multiple Sclerosis Society [TR3760A3]; EMD Serono; MS Center of Brigham and Women's Hospital, Boston, MA; Bayer Schering Pharma; National MS Society; Biogen-IDEC; Nancy Davis Foundation for MS; Novartis; University of California-Los Angeles; Merck Pharmacueticals; Pfizer Pharmaceuticals; Teva; Vertex; Bayer; Genentech; Abbott Labs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD049476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054255, R01NS070906, ZIANS003119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K25DA025356] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Eunice Kennedy Shriver National Institute for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); EMD Serono; MS Center of Brigham and Women's Hospital, Boston, MA; Bayer Schering Pharma(Bayer AG); National MS Society(National Multiple Sclerosis Society); Biogen-IDEC(Biogen); Nancy Davis Foundation for MS; Novartis(Novartis); University of California-Los Angeles(University of California System); Merck Pharmacueticals(Merck & Company); Pfizer Pharmaceuticals(Pfizer); Teva(Teva Pharmaceutical Industries); Vertex(Vertex Pharmaceuticals); Bayer(Bayer AG); Genentech(Roche HoldingGenentech); Abbott Labs(Abbott Laboratories); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was partially supported by grants R01NS054255, R01NS070906, and K99NS064098 from, and the Intramural Research Program of, the National Institute of Neurological Disorders and Stroke; grant K25DA025356 from the National Institute of Drug Abuse; grant 5K01HD049476 from the Eunice Kennedy Shriver National Institute for Child Health and Development; grant P41RR015241 from the National Center for Research Resources; grant TR3760A3 from the National Multiple Sclerosis Society; and an unrestricted grant from EMD Serono for MRI data acquisition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; An unrestricted grant from EMD Serono for MRI data acquisition was received for this study. Daniel S. Harrison received fellowship funding from the Partners MS Center of Brigham and Women's Hospital, Boston, MA and research funding from Bayer Schering Pharma. Scott D. Newsome received fellowship funding from the National MS Society (Sylvia Lawry Physician Fellowship) and has received consultant fees from Biogen-IDEC. John N. Ratchford received research support from the Nancy Davis Foundation for MS and support for clinical trials from Novartis, Biogen-Idec, and the University of California-Los Angeles. Brian S. Caffo received funding from Merck Pharmacueticals and Pfizer Pharmaceuticals. Peter A. Calabresi received grants from Biogen-IDEC, Teva, Vertex, Bayer, Genentech, Abbott Labs, and EMD Serono. He received consulting fees from Novartis, Biogen-IDEC, and Teva. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altmann DR, 2009, NEUROLOGY, V72, P595, DOI 10.1212/01.wnl.0000335765.55346.fc; AREZZO J C, 1985, Neurology, V35, P169; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Battaglini M, 2011, HUM BRAIN M IN PRESS; Benedict RHB, 2006, ARCH NEUROL-CHICAGO, V63, P1301, DOI 10.1001/archneur.63.9.1301; Bermel RA, 2003, J NEUROL SCI, V208, P57, DOI 10.1016/S0022-510X(02)00425-2; Bermel RA, 2003, NEUROREPORT, V14, P335, DOI 10.1097/01.wnr.0000059773.23122.ce; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Brex PA, 2000, NEUROLOGY, V54, P1689, DOI 10.1212/WNL.54.8.1689; Carass A, 2011, NEUROIMAGE, V56, P1982, DOI 10.1016/j.neuroimage.2011.03.045; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Charil A, 2007, NEUROIMAGE, V34, P509, DOI 10.1016/j.neuroimage.2006.10.006; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Edwards SGM, 1999, BRAIN, V122, P291, DOI 10.1093/brain/122.2.291; Fischer J.S., 2001, MULTIPLE SCLEROSIS F; Fisher E, 2002, NEUROLOGY, V59, P1412, DOI 10.1212/01.WNL.0000036271.49066.06; Fisher E, 2007, MULTIPLE SCLEROSIS T; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Ge YL, 2000, RADIOLOGY, V214, P665, DOI 10.1148/radiology.214.3.r00mr30665; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; Hardmeier M, 2003, ARCH NEUROL-CHICAGO, V60, P1736, DOI 10.1001/archneur.60.12.1736; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Jasperse B, 2007, NEUROIMAGE, V38, P529, DOI 10.1016/j.neuroimage.2007.07.056; Lassmann H, 2008, J NEUROL SCI, V274, P45, DOI 10.1016/j.jns.2008.04.003; Liptak Z, 2008, AM J NEURORADIOL, V29, P1465, DOI 10.3174/ajnr.A1162; Mainero C, 2001, NEUROLOGY, V56, P1331, DOI 10.1212/WNL.56.10.1331; Quarantelli M, 2003, NEUROIMAGE, V18, P360, DOI 10.1016/S1053-8119(02)00018-6; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Roosendaal SD, 2011, MULT SCLER J, V17, P1098, DOI 10.1177/1352458511404916; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Sailer M, 2003, BRAIN, V126, P1734, DOI 10.1093/brain/awg175; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Sanfilipo MP, 2005, NEUROIMAGE, V26, P1068, DOI 10.1016/j.neuroimage.2005.03.008; Sastre-Garriga J, 2004, NEUROIMAGE, V22, P353, DOI 10.1016/j.neuroimage.2004.02.008; Sdika M, 2009, HUM BRAIN MAPP, V30, P1060, DOI 10.1002/hbm.20566; Sharma J, 2004, AM J NEURORADIOL, V25, P985; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sommer MA, 2003, CURR OPIN NEUROBIOL, V13, P663, DOI 10.1016/j.conb.2003.10.014; Tedeschi G, 2005, NEUROLOGY, V65, P280, DOI 10.1212/01.wnl.0000168837.87351.1f; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30; Valsasina P, 2005, NEUROLOGY, V65, P1126, DOI 10.1212/01.wnl.0000178982.53965.70; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	48	89	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37049	10.1371/journal.pone.0037049	http://dx.doi.org/10.1371/journal.pone.0037049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615886	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300065
J	Nguyen, TH; Maucort, G; Sullivan, RKP; Schenning, M; Lavidis, NA; McCluskey, A; Robinson, PJ; Meunier, FA				Nguyen, Tam H.; Maucort, Guillaume; Sullivan, Robert K. P.; Schenning, Mitja; Lavidis, Nickolas A.; McCluskey, Adam; Robinson, Phillip J.; Meunier, Frederic A.			Actin- and Dynamin-Dependent Maturation of Bulk Endocytosis Restores Neurotransmission following Synaptic Depletion	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTION; VESICLE ENDOCYTOSIS; TRANSMITTER RELEASE; BINDING PROTEIN; MEMBRANE; CYTOSKELETON; POOLS; INVAGINATION; LOCALIZATION; CLATHRIN	Bulk endocytosis contributes to the maintenance of neurotransmission at the amphibian neuromuscular junction by regenerating synaptic vesicles. How nerve terminals internalize adequate portions of the presynaptic membrane when bulk endocytosis is initiated before the end of a sustained stimulation is unknown. A maturation process, occurring at the end of the stimulation, is hypothesised to precisely restore the pools of synaptic vesicles. Using confocal time-lapse microscopy of FM1-43-labeled nerve terminals at the amphibian neuromuscular junction, we confirm that bulk endocytosis is initiated during a sustained tetanic stimulation and reveal that shortly after the end of the stimulation, nerve terminals undergo a maturation process. This includes a transient bulging of the plasma membrane, followed by the development of large intraterminal FM1-43-positive donut-like structures comprising large bulk membrane cisternae surrounded by recycling vesicles. The degree of bulging increased with stimulation frequency and the plasmalemma surface retrieved following the transient bulging correlated with the surface membrane internalized in bulk cisternae and recycling vesicles. Dyngo-4a, a potent dynamin inhibitor, did not block the initiation, but prevented the maturation of bulk endocytosis. In contrast, cytochalasin D, an inhibitor of actin polymerization, hindered both the initiation and maturation processes. Both inhibitors hampered the functional recovery of neurotransmission after synaptic depletion. Our data confirm that initiation of bulk endocytosis occurs during stimulation and demonstrates that a delayed maturation process controlled by actin and dynamin underpins the coupling between exocytosis and bulk endocytosis.	[Nguyen, Tam H.; Sullivan, Robert K. P.; Schenning, Mitja; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Maucort, Guillaume] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Sullivan, Robert K. P.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Schenning, Mitja; Lavidis, Nickolas A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Cell Signalling Unit, Childrens Med Res Inst, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nguyen, TH (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	f.meunier@uq.edu.au	Meunier, Frederic A/C-8161-2009; Sullivan, Robert KP/A-8639-2012; Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011	Meunier, Frederic A/0000-0001-6400-1107; Sullivan, Robert KP/0000-0003-3414-2448; Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X	Australian Research Council [DP0987669]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Discovery grant (DP0987669). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harper CB, 2011, J BIOL CHEM; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kidokoro Y, 2006, INT REV NEUROBIOL, V75, P145, DOI 10.1016/S0074-7742(06)75007-3; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Laakso JM, 2010, P NATL ACAD SCI USA, V107, P698, DOI 10.1073/pnas.0911426107; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Paillart C, 2003, J NEUROSCI, V23, P4092; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pucci AR, 2006, EXP PHYSIOL, V91, P171, DOI 10.1113/expphysiol.2005.032094; Quan A, 2007, MOL PHARMACOL, V72, P1425, DOI 10.1124/mol.107.034207; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Richards DA, 2004, J PHYSIOL-LONDON, V557, P77, DOI 10.1113/jphysiol.2004.062158; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Teng HB, 2007, J PHYSIOL-LONDON, V582, P243, DOI 10.1113/jphysiol.2007.130989; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wu LG, 1999, CAN J PHYSIOL PHARM, V77, P672, DOI 10.1139/cjpp-77-9-672; Wu W, 2007, P NATL ACAD SCI USA, V104, P10234, DOI 10.1073/pnas.0611512104; Wu XS, 2009, J NEUROSCI, V29, P11038, DOI 10.1523/JNEUROSCI.2367-09.2009	58	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2012	7	5							e36913	10.1371/journal.pone.0036913	http://dx.doi.org/10.1371/journal.pone.0036913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VQ	22629340	Green Published, gold			2022-12-27	WOS:000305345300015
J	Peng, YF; Li, XX; Li, CJ				Peng, Yunfeng; Li, Xuexian; Li, Chunjian			Temporal and Spatial Profiling of Root Growth Revealed Novel Response of Maize Roots under Various Nitrogen Supplies in the Field	PLOS ONE			English	Article							ZEA-MAYS L.; USE EFFICIENCY; MANAGEMENT STRATEGY; INTERACTIVE WATER; STAY-GREEN; LEAF-AREA; SOIL; NITRATE; SENESCENCE; FERTILIZATION	A challenge for Chinese agriculture is to limit the overapplication of nitrogen (N) without reducing grain yield. Roots take up N and participate in N assimilation, facilitating dry matter accumulation in grains. However, little is known about how the root system in soil profile responds to various N supplies. In the present study, N uptake, temporal and spatial distributions of maize roots, and soil mineral N (N-min) were thoroughly studied under field conditions in three consecutive years. The results showed that in spite of transient stimulation of growth of early initiated nodal roots, N deficiency completely suppressed growth of the later-initiated nodal roots and accelerated root death, causing an early decrease in the total root length at the rapid vegetative growth stage of maize plants. Early N excess, deficiency, or delayed N topdressing reduced plant N content, resulting in a significant decrease in dry matter accumulation and grain yield. Notably, N overapplication led to N leaching that stimulated root growth in the 40-50 cm soil layer. It was concluded that the temporal and spatial growth patterns of maize roots were controlled by shoot growth and local soil Nmin, respectively. Improving N management involves not only controlling the total amount of chemical N fertilizer applied, but also synchronizing crop N demand and soil N supply by split N applications.	[Peng, Yunfeng; Li, Xuexian; Li, Chunjian] China Agr Univ, Dept Plant Nutr, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China	China Agricultural University	Peng, YF (corresponding author), China Agr Univ, Dept Plant Nutr, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China.	lichj@cau.edu.cn			State Key Basic Research and Development Plan of China [2007CB109302]; National Natural Science Foundation of China [30671237, 31121062]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the State Key Basic Research and Development Plan of China (No. 2007CB109302), the National Natural Science Foundation of China (No: 30671237) and the Innovative Group Grant of National Natural Science Foundation of China (No. 31121062) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos B, 2006, SOIL SCI SOC AM J, V70, P1489, DOI 10.2136/sssaj2005.0216; Bohm W., 1979, METHODS STUDYING ROO; Boomsma CR, 2009, AGRON J, V101, P1426, DOI 10.2134/agronj2009.0082; Borrell A, 2001, ANN APPL BIOL, V138, P91, DOI 10.1111/j.1744-7348.2001.tb00088.x; Cantarero MG, 1999, CROP SCI, V39, P703, DOI 10.2135/cropsci1999.0011183X003900020017x; [陈国平 CHEN Guo-ping], 2009, [玉米科学, Maize Science], V17, P89; [陈国平 CHEN Guoping], 2008, [玉米科学, Maize Science], V16, P1; Chen X, 2006, NUTR CYCL AGROECOSYS, V74, P91, DOI 10.1007/s10705-005-1701-9; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2009, PLANT SOIL, V317, P267, DOI 10.1007/s11104-008-9807-x; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Dwyer LM, 1996, CAN J SOIL SCI, V76, P23, DOI 10.4141/cjss96-004; Echarte L, 2008, CROP SCI, V48, P656, DOI 10.2135/cropsci2007.06.0366; Gallais A, 2005, MAYDICA, V50, P531; [高强 GAO Qiang], 2007, [玉米科学, Maize Science], V15, P125; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Halvorson AD, 2005, AGRON J, V97, P1222, DOI 10.2134/agronj2004.0279; Herman DJ, 2006, SOIL SCI SOC AM J, V70, P1504, DOI 10.2136/sssaj2005.0113; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hong N, 2007, J ENVIRON QUAL, V36, P354, DOI 10.2134/jeq2006.0173; JACOBS BC, 1992, J EXP BOT, V43, P557, DOI 10.1093/jxb/43.4.557; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Li ShaoKun, 2009, Scientia Agricultura Sinica, V42, P1941; Li SK, REPORT SURVEY DEMAND; Liedgens M, 2000, CROP SCI, V40, P1665, DOI 10.2135/cropsci2000.4061665x; Liedgrens M, 2001, EUR J AGRON, V15, P131, DOI 10.1016/S1161-0301(01)00099-5; [刘志全 LIU Zhiquan], 2007, [玉米科学, Maize Science], V15, P144; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; Marschner P., 2011, MINERAL NUTR HIGHER; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; Niu JF, 2010, J PLANT NUTR SOIL SC, V173, P306, DOI 10.1002/jpln.200800316; Ogawa A, 2005, PLANT PROD SCI, V8, P173, DOI 10.1626/pps.8.173; Peng YF, 2010, FIELD CROP RES, V115, P85, DOI 10.1016/j.fcr.2009.10.006; Rajcan I, 1999, FIELD CROP RES, V60, P255, DOI 10.1016/S0378-4290(98)00143-9; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SHARP RE, 1979, PLANTA, V147, P43, DOI 10.1007/BF00384589; Subedi KD, 2005, CROP SCI, V45, P740, DOI 10.2135/cropsci2005.0740; Wang Y. J., 2008, THESIS SHANDONG AGR; Wells CE, 2002, J PLANT GROWTH REGUL, V21, P324, DOI 10.1007/s00344-003-0011-1; WIESLER F, 1993, PLANT SOIL, V151, P193, DOI 10.1007/BF00016284; WOLFE DW, 1988, AGRON J, V80, P865, DOI 10.2134/agronj1988.00021962008000060005x; WOLFE DW, 1988, AGRON J, V80, P859, DOI 10.2134/agronj1988.00021962008000060004x; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157	47	52	57	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37726	10.1371/journal.pone.0037726	http://dx.doi.org/10.1371/journal.pone.0037726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624062	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500151
J	Price, EP; Dale, JL; Cook, JM; Sarovich, DS; Seymour, ML; Ginther, JL; Kaufman, EL; Beckstrom-Sternberg, SM; Mayo, M; Kaestli, M; Glass, MB; Gee, JE; Wuthiekanun, V; Warner, JM; Baker, A; Foster, JT; Tan, P; Tuanyok, A; Limmathurotsakul, D; Peacock, SJ; Currie, BJ; Wagner, DM; Keim, P; Pearson, T				Price, Erin P.; Dale, Julia L.; Cook, James M.; Sarovich, Derek S.; Seymour, Meagan L.; Ginther, Jennifer L.; Kaufman, Emily L.; Beckstrom-Sternberg, Stephen M.; Mayo, Mark; Kaestli, Mirjam; Glass, Mindy B.; Gee, Jay E.; Wuthiekanun, Vanaporn; Warner, Jeffrey M.; Baker, Anthony; Foster, Jeffrey T.; Tan, Patrick; Tuanyok, Apichai; Limmathurotsakul, Direk; Peacock, Sharon J.; Currie, Bart J.; Wagner, David M.; Keim, Paul; Pearson, Talima			Development and Validation of Burkholderia pseudomallei-Specific Real-Time PCR Assays for Clinical, Environmental or Forensic Detection Applications	PLOS ONE			English	Article							III SECRETION SYSTEM; CAUSATIVE AGENT; MELIOIDOSIS; IDENTIFICATION; THAILANDENSIS; SOIL; DISCRIMINATION; PATHOGENICITY; PLASTICITY; BACTERIA	The bacterium Burkholderia pseudomallei causes melioidosis, a rare but serious illness that can be fatal if untreated or misdiagnosed. Species-specific PCR assays provide a technically simple method for differentiating B. pseudomallei from near-neighbor species. However, substantial genetic diversity and high levels of recombination within this species reduce the likelihood that molecular signatures will differentiate all B. pseudomallei from other Burkholderiaceae. Currently available molecular assays for B. pseudomallei detection lack rigorous validation across large in silico datasets and isolate collections to test for specificity, and none have been subjected to stringent quality control criteria (accuracy, precision, selectivity, limit of quantitation (LoQ), limit of detection (LoD), linearity, ruggedness and robustness) to determine their suitability for environmental, clinical or forensic investigations. In this study, we developed two novel B. pseudomallei specific assays, 122018 and 266152, using a dual-probe approach to differentiate B. pseudomallei from B. thailandensis, B. oklahomensis and B. thailandensis-like species; other species failed to amplify. Species specificity was validated across a large DNA panel (> 2,300 samples) comprising Burkholderia spp. and non-Burkholderia bacterial and fungal species of clinical and environmental relevance. Comparison of assay specificity to two previously published B. pseudomallei-specific assays, BurkDiff and TTS1, demonstrated comparable performance of all assays, providing between 99.7 and 100% specificity against our isolate panel. Last, we subjected 122018 and 266152 to rigorous quality control analyses, thus providing quantitative limits of assay performance. Using B. pseudomallei as a model, our study provides a framework for comprehensive quantitative validation of molecular assays and provides additional, highly validated B. pseudomallei assays for the scientific research community.	[Price, Erin P.; Dale, Julia L.; Cook, James M.; Sarovich, Derek S.; Seymour, Meagan L.; Ginther, Jennifer L.; Kaufman, Emily L.; Beckstrom-Sternberg, Stephen M.; Foster, Jeffrey T.; Tuanyok, Apichai; Wagner, David M.; Keim, Paul; Pearson, Talima] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Price, Erin P.; Sarovich, Derek S.; Mayo, Mark; Kaestli, Mirjam; Currie, Bart J.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Beckstrom-Sternberg, Stephen M.; Keim, Paul] Translat Genom Res Inst, Phoenix, AZ USA; [Glass, Mindy B.; Gee, Jay E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Warner, Jeffrey M.; Baker, Anthony] James Cook Univ, Sch Vet & Biomed Sci, Townsville, Qld 4811, Australia; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; James Cook University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Mahidol University; University of Cambridge	Price, EP (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	talima.pearson@nau.edu	Peacock, Sharon J/ABE-6331-2020; Price, Erin/N-2336-2013; Pearson, Talima/O-7840-2019; Anderson, Julia/W-6122-2019; Sarovich, Derek/H-5587-2019; Baker, Anthony/C-2433-2014	Price, Erin/0000-0002-1079-4882; Pearson, Talima/0000-0003-3696-041X; Anderson, Julia/0000-0001-5582-7206; Sarovich, Derek/0000-0002-6944-3980; Gee, Jay/0000-0003-4308-1659; Foster, Jeffrey/0000-0001-8235-8564; Limmathurotsakul, Direk/0000-0001-7240-5320; Baker, Anthony/0000-0001-5455-2271; Warner, Jeffrey/0000-0002-5869-8283; Wagner, David/0000-0003-2684-6007; Peacock, Sharon/0000-0002-1718-2782; , Mirjam/0000-0002-6053-5141	United States Department of Homeland Security [HSHQDC-10-C-00139]; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	United States Department of Homeland Security(United States Department of Homeland Security (DHS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the United States Department of Homeland Security (HSHQDC-10-C-00139). DL and VW were supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amornchai P, 2007, J CLIN MICROBIOL, V45, P3774, DOI 10.1128/JCM.00935-07; Araujo P, 2009, J CHROMATOGR B, V877, P2224, DOI 10.1016/j.jchromb.2008.09.030; Bowers JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015413; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; CURRIE B, 1993, MED J AUSTRALIA, V158, P609, DOI 10.5694/j.1326-5377.1993.tb137630.x; Currie BJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-68; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Dharakul T, 1996, J CLIN MICROBIOL, V34, P609, DOI 10.1128/JCM.34.3.609-614.1996; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Gal D, 2005, AM J TROP MED HYG, V73, P1162, DOI 10.4269/ajtmh.2005.73.1162; Gee JE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-54; Glass MB, 2009, AM J TROP MED HYG, V80, P1023, DOI 10.4269/ajtmh.2009.80.1023; Glass MB, 2006, INT J SYST EVOL MICR, V56, P2171, DOI 10.1099/ijs.0.63991-0; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kaestli M, 2012, J CLIN MICROBIOL; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Kaestli M, 2007, APPL ENVIRON MICROB, V73, P6891, DOI 10.1128/AEM.01038-07; Levy A, 2008, AM J TROP MED HYG, V78, P599, DOI 10.4269/ajtmh.2008.78.599; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Marshall K, 2010, SE ASIAN J TROP MED, V41, P904; Meumann EM, 2006, J CLIN MICROBIOL, V44, P3028, DOI 10.1128/JCM.00913-06; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Supaprom C, 2007, J CLIN MICROBIOL, V45, P2894, DOI 10.1128/JCM.00291-07; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; Thibault FM, 2004, J CLIN MICROBIOL, V42, P5871, DOI 10.1128/JCM.42.12.5871-5874.2004; Tomaso H, 2005, MOL CELL PROBE, V19, P9, DOI 10.1016/j.mcp.2004.08.001; Trung TT, 2011, APPL ENVIRON MICROB, V77, P6486, DOI 10.1128/AEM.00735-11; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; U'Ren JM, 2005, J CLIN MICROBIOL, V43, P5771, DOI 10.1128/JCM.43.11.5771-5774.2005; Urich RL, 2004, INFECT IMMUN, V72, P1150, DOI 10.1128/IAI.72.2.1150-1154.2004; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1239, DOI 10.1111/j.1348-0421.1992.tb02128.x	43	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37723	10.1371/journal.pone.0037723	http://dx.doi.org/10.1371/journal.pone.0037723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624061	Green Published, Green Accepted, gold			2022-12-27	WOS:000305343500150
J	Sovrano, VA; Rigosi, E; Vallortigara, G				Sovrano, Valeria Anna; Rigosi, Elisa; Vallortigara, Giorgio			Spatial Reorientation by Geometry in Bumblebees	PLOS ONE			English	Article							NONGEOMETRIC INFORMATION; LANDMARK INFORMATION; METRIC INFORMATION; CHILDRENS USE; BEES; MODULE; MODULARITY; ENVIRONMENTS; OPTIMIZATION; ORIENTATION	Human and non-human animals are capable of using basic geometric information to reorient in an environment. Geometric information includes metric properties associated with spatial surfaces (e.g., short vs. long wall) and left-right directionality or 'sense' (e.g. a long wall to the left of a short wall). However, it remains unclear whether geometric information is encoded by explicitly computing the layout of surface geometry or by matching images of the environment. View-based spatial encoding is generally thought to hold for insect navigation and, very recently, evidence for navigation by geometry has been reported in ants but only in a condition which does not allow the animals to use features located far from the goal. In this study we tested the spatial reorientation abilities of bumblebees (Bombus terrestris). After spatial disorientation, by passive rotation both clockwise and anticlockwise, bumblebees had to find one of the four exit holes located in the corners of a rectangular enclosure. Bumblebees systematically confused geometrically equivalent exit corners (i.e. corners with the same geometric arrangement of metric properties and sense, for example a short wall to the left of a long wall). However, when one wall of the enclosure was a different colour, bumblebees appeared to combine this featural information (either near or far from the goal) with geometric information to find the correct exit corner. Our results show that bumblebees are able to use both geometric and featural information to reorient themselves, even when features are located far from the goal.	[Sovrano, Valeria Anna; Rigosi, Elisa; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Rigosi, Elisa] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, Dept Sustainable Agroecosyst, San Michele All Adige, Italy; [Rigosi, Elisa] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, Dept Bioresources, San Michele All Adige, Italy	University of Trento; Fondazione Edmund Mach; Fondazione Edmund Mach	Sovrano, VA (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	valeriaanna.sovrano@unitn.it		Rigosi, Elisa/0000-0002-2283-1257	Provincia Autonoma di Trento; Fondazione Cassa di Risparmio di Trento e Rovereto	Provincia Autonoma di Trento(Autonomous Province of Trento); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	This work has been supported by the Provincia Autonoma di Trento and the Fondazione Cassa di Risparmio di Trento e Rovereto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shai N, 2011, BEHAV ECOL, V22, P317, DOI 10.1093/beheco/arq206; Brown AA, 2007, PSYCHOL SCI, V18, P569, DOI 10.1111/j.1467-9280.2007.01941.x; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chiandetti C, 2010, ANIM COGN, V13, P463, DOI 10.1007/s10071-009-0297-x; CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dawson MRW, 2010, COGNITION, V114, P207, DOI 10.1016/j.cognition.2009.09.006; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Gould JL, 2002, COGNITIVE ANIMAL, P41; GOULD JL, 1990, COGNITION, V37, P83, DOI 10.1016/0010-0277(90)90019-G; Gouteux S, 2001, J EXP PSYCHOL GEN, V130, P505, DOI 10.1037//0096-3445.130.3.505; Hermer L, 1996, COGNITION, V61, P195, DOI 10.1016/S0010-0277(96)00714-7; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Kelly DM, 2011, BIOL LETTERS, V7, P372, DOI 10.1098/rsbl.2010.1024; Kelly DM, 1998, J COMP PSYCHOL, V112, P259, DOI 10.1037/0735-7036.112.3.259; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Learmonth AE, 2002, PSYCHOL SCI, V13, P337, DOI 10.1111/1467-9280.00461; Learmonth AE, 2001, J EXP CHILD PSYCHOL, V80, P225, DOI 10.1006/jecp.2001.2635; Learmonth AE, 2008, DEVELOPMENTAL SCI, V11, P414, DOI 10.1111/j.1467-7687.2008.00686.x; Lee SA, 2008, DEVELOPMENTAL SCI, V11, P743, DOI 10.1111/j.1467-7687.2008.00724.x; Lee SA, 2006, PSYCHOL SCI, V17, P577, DOI 10.1111/j.1467-9280.2006.01747.x; Lee SA, 2012, BIOL LETTERS, V8, P492, DOI 10.1098/rsbl.2012.0067; Lee SA, 2011, PSYCHON B REV, V18, P192, DOI 10.3758/s13423-010-0035-z; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lihoreau M, 2012, BIOL LETTERS, V8, P13, DOI 10.1098/rsbl.2011.0661; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Maes JHR, 2009, BEHAV BRAIN RES, V201, P285, DOI 10.1016/j.bbr.2009.02.026; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Miglino O, 2001, COGN PROCESS, V3, P22; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; Sovrano VA, 2005, COGNITION, V97, P121, DOI 10.1016/j.cognition.2004.08.003; Sovrano VA, 2003, J EXP PSYCHOL ANIM B, V29, P199, DOI 10.1037/0097-7403.29.3.199; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Sovrano VA, 2007, ANIM COGN, V10, P47, DOI 10.1007/s10071-006-0029-4; Sovrano VA, 2006, PSYCHOL SCI, V17, P616, DOI 10.1111/j.1467-9280.2006.01753.x; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; VALLORTIGARA G, 1990, J COMP PSYCHOL, V104, P248, DOI 10.1037/0735-7036.104.3.248; Vallortigara G, 2005, DEVELOPMENTAL SCI, V8, P393, DOI 10.1111/j.1467-7687.2005.00427.x; Vallortigara G, 2004, J COGNITIVE NEUROSCI, V16, P390, DOI 10.1162/089892904322926737; Vallortigara G, 2009, VIENNA SER THEOR BIO, P83; Vallortigara G, 2009, CURR OPIN NEUROBIOL, V19, P20, DOI 10.1016/j.conb.2009.02.002; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; Wystrach A, 2011, J EXP PSYCHOL A 0523; Wystrach Antoine, 2009, Communicative & Integrative Biology, V2, P388; Wystrach A, 2009, CURR BIOL, V19, P61, DOI 10.1016/j.cub.2008.11.054	59	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37449	10.1371/journal.pone.0037449	http://dx.doi.org/10.1371/journal.pone.0037449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624033	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500118
J	Tilghman, RW; Blais, EM; Cowan, CR; Sherman, NE; Grigera, PR; Jeffery, ED; Fox, JW; Blackman, BR; Tschumperlin, DJ; Papin, JA; Parsons, JT				Tilghman, Robert W.; Blais, Edik M.; Cowan, Catharine R.; Sherman, Nicholas E.; Grigera, Pablo R.; Jeffery, Erin D.; Fox, Jay W.; Blackman, Brett R.; Tschumperlin, Daniel J.; Papin, Jason A.; Parsons, J. Thomas			Matrix Rigidity Regulates Cancer Cell Growth by Modulating Cellular Metabolism and Protein Synthesis	PLOS ONE			English	Article							ANCHORAGE-DEPENDENT FIBROBLASTS; BREAST-CANCER; MESSENGER-RNA; METASTATIC GROWTH; TUMOR-CELLS; DORMANCY; PHOSPHOFRUCTOKINASE; TRANSITION; TURNOVER; SURFACE	Background: Tumor cells in vivo encounter diverse types of microenvironments both at the site of the primary tumor and at sites of distant metastases. Understanding how the various mechanical properties of these microenvironments affect the biology of tumor cells during disease progression is critical in identifying molecular targets for cancer therapy. Methodology/Principal Findings: This study uses flexible polyacrylamide gels as substrates for cell growth in conjunction with a novel proteomic approach to identify the properties of rigidity-dependent cancer cell lines that contribute to their differential growth on soft and rigid substrates. Compared to cells growing on more rigid/stiff substrates (> 10,000 Pa), cells on soft substrates (150-300 Pa) exhibited a longer cell cycle, due predominantly to an extension of the G1 phase of the cell cycle, and were metabolically less active, showing decreased levels of intracellular ATP and a marked reduction in protein synthesis. Using stable isotope labeling of amino acids in culture (SILAC) and mass spectrometry, we measured the rates of protein synthesis of over 1200 cellular proteins under growth conditions on soft and rigid/stiff substrates. We identified cellular proteins whose syntheses were either preferentially inhibited or preserved on soft matrices. The former category included proteins that regulate cytoskeletal structures (e.g., tubulins) and glycolysis (e.g., phosphofructokinase-1), whereas the latter category included proteins that regulate key metabolic pathways required for survival, e.g., nicotinamide phosphoribosyltransferase, a regulator of the NAD salvage pathway. Conclusions/Significance: The cellular properties of rigidity-dependent cancer cells growing on soft matrices are reminiscent of the properties of dormant cancer cells, e.g., slow growth rate and reduced metabolism. We suggest that the use of relatively soft gels as cell culture substrates would allow molecular pathways to be studied under conditions that reflect the different mechanical environments encountered by cancer cells upon metastasis to distant sites.	[Tilghman, Robert W.; Cowan, Catharine R.; Sherman, Nicholas E.; Grigera, Pablo R.; Jeffery, Erin D.; Fox, Jay W.; Parsons, J. Thomas] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Blais, Edik M.; Blackman, Brett R.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Virginia; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health	Tilghman, RW (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	rt9c@virginia.edu		Papin, Jason/0000-0002-2769-5805; Jeffery, Erin/0000-0001-9511-7719; Sherman, Nicholas/0000-0003-3206-3113	National Institutes of Health (NIH)-National Cancer Institute (NCI) [CA40042]; NIH [1U54 GM64346]; Coulter Foundation Translational Partners Award; NIH-NCI [T32 CA09109]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coulter Foundation Translational Partners Award; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants National Institutes of Health (NIH)-National Cancer Institute (NCI) CA40042 (JTP) and NIH 1U54 GM64346 (JTP and JWF) (www.nih.gov) and funding from the Coulter Foundation Translational Partners Award (www.whcf.org) (JTP). EMB was supported by NIH-NCI T32 CA09109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; BENECKE BJ, 1978, CELL, V14, P931, DOI 10.1016/0092-8674(78)90347-1; BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; DUNAWAY GA, 1978, J BIOL CHEM, V253, P7460; FARMER SR, 1978, CELL, V15, P627, DOI 10.1016/0092-8674(78)90031-4; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; GEHNRICH SC, 1988, J BIOL CHEM, V263, P11755; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Grigera PR, 2012, J PROTEOMICS, V75, P2153, DOI 10.1016/j.jprot.2012.01.012; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Moon JS, 2011, J BIOL CHEM, V286, P23808, DOI 10.1074/jbc.M111.236737; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sunyer R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025009; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Terry NHA, 2006, NAT PROTOC, V1, P859, DOI 10.1038/nprot.2006.113; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483	40	41	44	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37231	10.1371/journal.pone.0037231	http://dx.doi.org/10.1371/journal.pone.0037231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623999	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500081
J	Tripovich, JS; Hall-Aspland, S; Charrier, I; Arnould, JPY				Tripovich, Joy S.; Hall-Aspland, Sophie; Charrier, Isabelle; Arnould, John P. Y.			The Behavioural Response of Australian Fur Seals to Motor Boat Noise	PLOS ONE			English	Article							VOCAL RATES; AMPLITUDE	Australian fur seals breed on thirteen islands located in the Bass Strait, Australia. Land access to these islands is restricted, minimising human presence but boat access is still permissible with limitations on approach distances. Thirty-two controlled noise exposure experiments were conducted on breeding Australian fur seals to determine their behavioural response to controlled in-air motor boat noise on Kanowna Island (39 degrees 10'S, 146 degrees 18'E). Our results show there were significant differences in the seals' behaviour at low (64-70 dB) versus high (75-85 dB) sound levels, with seals orientating themselves towards or physically moving away from the louder boat noise at three different sound levels. Furthermore, seals responded more aggressively with one another and were more alert when they heard louder boat noise. Australian fur seals demonstrated plasticity in their vocal responses to boat noise with calls being significantly different between the various sound intensities and barks tending to get faster as the boat noise got louder. These results suggest that Australian fur seals on Kanowna Island show behavioural disturbance to high level boat noise. Consequently, it is recommended that an appropriate level of received boat sound emissions at breeding fur seal colonies be below 74 dB and that these findings be taken into account when evaluating appropriate approach distances and speed limits for boats.	[Tripovich, Joy S.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Hall-Aspland, Sophie] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Charrier, Isabelle] Univ Paris 11, Ctr Neurosci, Orsay, France; [Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	University of Sydney; University of Tasmania; UDICE-French Research Universities; Universite Paris Saclay; Deakin University	Tripovich, JS (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	joytripovich@hotmail.com	Tripovich, Joy/AGJ-9233-2022	Tripovich, Joy/0000-0001-5690-789X; CHARRIER, Isabelle/0000-0003-4873-2342	Winifred Violet Scott Trust	Winifred Violet Scott Trust	This work was supported by the Winifred Violet Scott Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Back J, 2010, BEHAV RESPONSES AUST; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Burleigh A, 2008, TOO CLOSE COMFORT CO; Charrier I, 2011, J COMP PSYCHOL, V125, P385, DOI 10.1037/a0024513; Dobson A., 2001, INTRO GEN LINEAR MOD, DOI 10.1201/9781420057683; Fernandez-Juricic E, 2001, MAR MAMMAL SCI, V17, P387, DOI 10.1111/j.1748-7692.2001.tb01281.x; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Giese M, 1999, J FIELD ORNITHOL, V70, P49; Holst M, 2011, AQUAT MAMM, V37, P139, DOI 10.1578/AM.37.2.2011.139; Johnson B. C., 1977, ENV ASSESSMENT ALASK, V1, P422; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Kunc HP, 2008, ETHOLOGY, V114, P381, DOI 10.1111/j.1439-0310.2008.01484.x; Marler P., 2004, NATURES MUSIC SCI BI; Miller E.H., 1991, P128; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Patkin K, 2005, SUSTAINABILITY INTER, P1; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Pytte CL, 2003, ANIM BEHAV, V66, P703, DOI 10.1006/anbe.2003.2257; Rode KD, 2007, J WILDLIFE MANAGE, V71, P929, DOI 10.2193/2006-075; SCHUSTERMAN RJ, 1977, BEHAV BIOL, V20, P404, DOI 10.1016/S0091-6773(77)90964-6; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shaughnessy P. D., 2008, Tourism in Marine Environments, V5, P15, DOI 10.3727/154427308785855260; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Tripovich JS, 2008, MAR MAMMAL SCI, V24, P913, DOI 10.1111/j.1748-7692.2008.00229.x; Tripovich JS, 2005, BIOACOUSTICS, V15, P79, DOI 10.1080/09524622.2005.9753539; Tyack Peter L., 1999, P287; WICKENS PA, 1992, CAN J FISH AQUAT SCI, V49, P1396, DOI 10.1139/f92-155; Wilsons Promontory Marine National Park, 2006, WILS PROM MAR NAT PA	37	16	16	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37228	10.1371/journal.pone.0037228	http://dx.doi.org/10.1371/journal.pone.0037228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623998	gold, Green Published			2022-12-27	WOS:000305343500080
J	Li, M; Zhang, Q; Fu, PF; Li, P; Peng, AM; Zhang, GL; Song, XL; Tan, M; Li, X; Liu, Y; Wu, YP; Fan, SY; Wang, CH				Li, Ming; Zhang, Qian; Fu, Peifang; Li, Ping; Peng, Aimei; Zhang, Guoliang; Song, Xiaolian; Tan, Min; Li, Xuan; Liu, Yang; Wu, Yueping; Fan, Suyun; Wang, Changhui			Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-II; MULTITARGETED ANTIFOLATE; CLINICAL-TRIALS; CHEMOTHERAPY; CARBOPLATIN; CISPLATIN; LY231514; MULTICENTER; GEMCITABINE; CARCINOMA	To compare the efficacy and toxicities of pemetrexed plus platinum with other platinum regimens in patients with previously untreated advanced non-small cell lung cancer (NSCLC). Methods: A meta-analysis was performed using trials identified through PubMed, EMBASE, and Cochrane databases. Two investigators independently assessed the quality of the trials and extracted data. The outcomes included overall survival (OS), progression-free survival (PFS), response rate (RR), and different types of toxicity. Hazard ratios (HRs), odds ratios (ORs) and their 95% confidence intervals (CIs) were pooled using RevMan software. Results: Four trials involving 2,518 patients with previously untreated advanced NSCLC met the inclusion criteria. Pemetrexed plus platinum chemotherapy (PPC) improved survival compared with other platinum-based regimens (PBR) in patients with advanced NSCLC (HR = 0.91, 95% CI: 0.83-1.00, p = 0.04), especially in those with non-squamous histology (HR = 0.87, 95% CI: 0.77-0.98, p = 0.02). No statistically significant improvement in either PFS or RR was found in PPC group as compared with PBR group (HR = 1.03, 95% CI: 0.94-1.13, p = 0.57; OR = 1.15, 95% CI: 0.95-1.39, p = 0.15, respectively). Compared with PBR, PPC led to less grade 3-4 neutropenia and leukopenia but more grade 3-4 nausea. However, hematological toxicity analysis revealed significant heterogeneities. Conclusion: Our results suggest that PPC in the first-line setting leads to a significant survival advantage with acceptable toxicities for advanced NSCLC patients, especially those with non-squamous histology, as compared with other PRB. PPC could be considered as the first-line treatment option for advanced NSCLC patients, especially those with non-squamous histology.	[Li, Ming; Fu, Peifang; Li, Ping; Peng, Aimei; Zhang, Guoliang; Song, Xiaolian; Tan, Min; Li, Xuan; Liu, Yang; Wu, Yueping; Fan, Suyun; Wang, Changhui] Tongji Univ, Dept Resp Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Zhang, Qian] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Li, M (corresponding author), Tongji Univ, Dept Resp Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	wangch63@yahoo.com.cn			National Nature Science Foundation of China [81172229]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Nature Science Foundation of China (NO. 81172229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ceppi P, 2006, CANCER-AM CANCER SOC, V107, P1589, DOI 10.1002/cncr.22208; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ettinger DS, 2011, NCCN PRACTICE GUIDEL; Giovannetti E, 2008, MOL PHARMACOL, V73, P1290, DOI 10.1124/mol.107.042382; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Grossi F, 2009, ONCOLOGIST, V14, P497, DOI 10.1634/theoncologist.2008-0260; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Manegold C, 2000, ANN ONCOL, V11, P435, DOI 10.1023/A:1008336931378; Pao W, 2009, CLIN CANCER RES, V15, P5317, DOI 10.1158/1078-0432.CCR-09-0913; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PETERSON P, 2007, J THORAC ONCOL S4, V2, pS851, DOI DOI 10.1097/01.JTO.0000284677.33344.62; Rodrigues-Pereira J, 2011, J THORAC ONCOL, V6, P1907, DOI 10.1097/JTO.0b013e318226b5fa; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shepherd FA, 2001, CANCER, V92, P595, DOI 10.1002/1097-0142(20010801)92:3<595::AID-CNCR1359>3.0.CO;2-D; Shih C, 1998, ADV ENZYME REGUL, V38, P135, DOI 10.1016/S0065-2571(97)00017-4; Shih C, 1997, CANCER RES, V57, P1116; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Socinski MA, 2010, J THORAC ONCOL, V5, P1963, DOI 10.1097/JTO.0b013e3181fd42eb; Treat J, 2011, LUNG CANC       1122; WALLING J, 1994, RESP MED, V88, P649, DOI 10.1016/S0954-6111(05)80061-7; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zinner RG, 2005, CANCER-AM CANCER SOC, V104, P2449, DOI 10.1002/cncr.21480	27	35	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37229	10.1371/journal.pone.0037229	http://dx.doi.org/10.1371/journal.pone.0037229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615946	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200051
J	Zhang, J; Cheng, W; Wang, ZG; Zhang, ZQ; Lu, WL; Lu, GM; Feng, JF				Zhang, Jie; Cheng, Wei; Wang, ZhengGe; Zhang, ZhiQiang; Lu, WenLian; Lu, GuangMing; Feng, Jianfeng			Pattern Classification of Large-Scale Functional Brain Networks: Identification of Informative Neuroimaging Markers for Epilepsy	PLOS ONE			English	Article							FMRI; CONNECTIVITY; DISEASE; ASYMMETRIES; CORTEX; STATES; MRI	The accurate prediction of general neuropsychiatric disorders, on an individual basis, using resting-state functional magnetic resonance imaging (fMRI) is a challenging task of great clinical significance. Despite the progress to chart the differences between the healthy controls and patients at the group level, the pattern classification of functional brain networks across individuals is still less developed. In this paper we identify two novel neuroimaging measures that prove to be strongly predictive neuroimaging markers in pattern classification between healthy controls and general epileptic patients. These measures characterize two important aspects of the functional brain network in a quantitative manner: (i) coordinated operation among spatially distributed brain regions, and (ii) the asymmetry of bilaterally homologous brain regions, in terms of their global patterns of functional connectivity. This second measure offers a unique understanding of brain asymmetry at the network level, and, to the best of our knowledge, has not been previously used in pattern classification of functional brain networks. Using modern pattern-recognition approaches like sparse regression and support vector machine, we have achieved a cross-validated classification accuracy of 83.9% (specificity: 82.5%; sensitivity: 85%) across individuals from a large dataset consisting of 180 healthy controls and epileptic patients. We identified significantly changed functional pathways and subnetworks in epileptic patients that underlie the pathophysiological mechanism of the impaired cognitive functions. Specifically, we find that the asymmetry of brain operation for epileptic patients is markedly enhanced in temporal lobe and limbic system, in comparison with healthy individuals. The present study indicates that with specifically designed informative neuroimaging markers, resting-state fMRI can serve as a most promising tool for clinical diagnosis, and also shed light onto the physiology behind complex neuropsychiatric disorders. The systematic approaches we present here are expected to have wider applications in general neuropsychiatric disorders.	[Zhang, Jie; Lu, WenLian; Feng, Jianfeng] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Zhang, Jie; Lu, WenLian; Feng, Jianfeng] Fudan Univ, JinLing Hosp, Computat Translat Med Ctr, Shanghai 200433, Peoples R China; [Cheng, Wei] Zhejiang Normal Univ, Dept Math, Jinhua, Zhejiang, Peoples R China; [Wang, ZhengGe; Zhang, ZhiQiang; Lu, GuangMing] JinLing Hosp Nanjing, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	Fudan University; Fudan University; Zhejiang Normal University; University of Warwick	Zhang, J (corresponding author), Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China.	cjr.luguangming@vip.163.com; jianfeng64@gmail.com		feng, jianfeng/0000-0002-9328-5732; Cheng, Wei/0000-0003-1118-1743	Natural Scientific Foundation of China [61104143, 61004104, 30470510, 30800264, 30971019, 81171328, 81020108022]; JinLing Hospital Medical Science Projects of Medical Research [07z030, Q2008063]; Royal Society	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); JinLing Hospital Medical Science Projects of Medical Research; Royal Society(Royal Society of London)	This work was supported by grants from the Natural Scientific Foundation of China [61104143 and 61004104 to Jie Zhang, 30470510 to Guangming Lu, 30800264 to Zhiqiang Zhang, 30971019, 81171328 and 81020108022] and the JinLing Hospital Medical Science Projects of Medical Research [grant nos. 07z030 to Guangming Lu, Q2008063 to Zhiqiang Zhang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank Dr. Kai Zhang and Professor David Waxman for the helpful advice on the manuscript. J.F is a Royal Society Wolfson Research Merit Award holder.	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Bonelli SB, 2009, EPILEPSIA, V50, P217, DOI 10.1111/j.1528-1167.2008.01739.x; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Demirci O, 2008, BRAIN IMAGING BEHAV, V2, P207, DOI 10.1007/s11682-008-9028-1; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Douw L, 2009, NEUROIMAGE, V46, P584, DOI 10.1016/j.neuroimage.2009.02.034; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Duncan JS, 1997, BRAIN, V120, P339, DOI 10.1093/brain/120.2.339; Francks C, 2007, MOL PSYCHIATR, V12, P1129, DOI 10.1038/sj.mp.4002053; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Ge T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000570; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lundberg S, 1999, EPILEPSIA, V40, P1808, DOI 10.1111/j.1528-1157.1999.tb01603.x; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; MacQueen J., 1967, P BERK S MATH STAT P; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Power JD, 2011, NEUROIMAGE; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singh I, 2009, NATURE, V460, P202, DOI 10.1038/460202a; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Tao H, 2011, MOL PSYCHIAT; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomasi D, 2011, CEREBRAL CORTEX; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2011, NEUROIMAGE; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wang Z, 2009, NEUROIMAGE, V47, P281, DOI 10.1016/j.neuroimage.2009.03.069; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang K, 2010, BIOINFORMATICS, V26, pi97, DOI 10.1093/bioinformatics/btq181; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	50	50	51	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36733	10.1371/journal.pone.0036733	http://dx.doi.org/10.1371/journal.pone.0036733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615802	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200016
J	Ziegler, D; Mariotti, A; Pfluger, V; Saad, M; Vogel, G; Tonolla, M; Perret, X				Ziegler, Dominik; Mariotti, Anna; Pflueger, Valentin; Saad, Maged; Vogel, Guido; Tonolla, Mauro; Perret, Xavier			In Situ Identification of Plant-Invasive Bacteria with MALDI-TOF Mass Spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECIES-SPECIFIC IDENTIFICATION; RHIZOBIUM SP NGR234; SP. STRAIN NGR234; RAPID IDENTIFICATION; PHYLOGENETIC CLASSIFICATION; FREDII USDA257; NODULES; BROAD; DIFFERENTIATION	Rhizobia form a disparate collection of soil bacteria capable of reducing atmospheric nitrogen in symbiosis with legumes. The study of rhizobial populations in nature involves the collection of large numbers of nodules found on roots or stems of legumes, and the subsequent typing of nodule bacteria. To avoid the time-consuming steps of isolating and cultivating nodule bacteria prior to genotyping, a protocol of strain identification based on the comparison of MALDI-TOF MS spectra was established. In this procedure, plant nodules were considered as natural bioreactors that amplify clonal populations of nitrogen-fixing bacteroids. Following a simple isolation procedure, bacteroids were fingerprinted by analysing biomarker cellular proteins of 3 to 13 kDa using Matrix Assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) mass spectrometry. In total, bacteroids of more than 1,200 nodules collected from roots of three legumes of the Phaseoleae tribe (cowpea, soybean or siratro) were examined. Plants were inoculated with pure cultures of a slow-growing Bradyrhizobium japonicum strain G49, or either of two closely related and fast-growing Sinorhizobium fredii strains NGR234 and USDA257, or with mixed inoculants. In the fully automatic mode, correct identification of bacteroids was obtained for >97% of the nodules, and reached 100% with a minimal manual input in processing of spectra. These results showed that MALDI-TOF MS is a powerful tool for the identification of intracellular bacteria taken directly from plant tissues.	[Ziegler, Dominik; Mariotti, Anna; Saad, Maged; Tonolla, Mauro; Perret, Xavier] Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland; [Mariotti, Anna; Tonolla, Mauro] Inst Microbiol, Bellinzona, Switzerland; [Ziegler, Dominik; Pflueger, Valentin; Vogel, Guido] Mabritec AG, Riehen, Switzerland	University of Geneva	Ziegler, D (corresponding author), Univ Geneva, Dept Bot & Plant Biol, Geneva, Switzerland.	xavier.perret@unige.ch	Saad, Maged M./B-5546-2018	Saad, Maged M./0000-0002-5655-8674; Tonolla, Mauro/0000-0002-8861-7763	Swiss National Science Foundation [3100A0-116591]; University of Geneva; Mabritec AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva; Mabritec AG	XP acknowledges funding from the Swiss National Science Foundation (grant n<SUP>o</SUP>3100A0-116591) and the University of Geneva. DZ thanks Mabritec AG for financial support of the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAULCOMBE D, 1978, NUCLEIC ACIDS RES, V5, P4141, DOI 10.1093/nar/5.11.4141; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Broughton WJ, 2006, J BACTERIOL, V188, P3654, DOI 10.1128/JB.188.10.3654-3663.2006; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020223; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gage DJ, 2002, J BACTERIOL, V184, P7042, DOI 10.1128/JB.184.24.7042-7046.2002; Hahn D, 2011, SYST APPL MICROBIOL, V34, P63, DOI 10.1016/j.syapm.2010.11.009; HERON D S, 1989, Molecular Plant-Microbe Interactions, V2, P4, DOI 10.1094/MPMI-2-004; Herridge DF, 2008, PLANT SOIL, V311, P1, DOI 10.1007/s11104-008-9668-3; Hotta Y, 2010, J PROTEOME RES, V9, P6722, DOI 10.1021/pr100868d; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kereszt A, 2011, MOL PLANT MICROBE IN, V24, P1300, DOI 10.1094/MPMI-06-11-0152; KRISHNAN HB, 1992, MOL MICROBIOL, V6, P3321, DOI 10.1111/j.1365-2958.1992.tb02200.x; KUYKENDALL LD, 1978, APPL ENVIRON MICROB, V36, P915, DOI 10.1128/AEM.36.6.915-919.1978; LEWIN A, 1987, PLANT MOL BIOL, V8, P447, DOI 10.1007/BF00017990; LEWIN A, 1990, MOL PLANT MICROBE IN, V3, P317, DOI 10.1094/MPMI-3-317; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Patriarca EJ, 1996, MOL PLANT MICROBE IN, V9, P243, DOI 10.1094/MPMI-9-0243; PERRET X, 1994, NUCLEIC ACIDS RES, V22, P1335, DOI 10.1093/nar/22.8.1335; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Perret X, 1998, PLANT SOIL, V204, P21, DOI 10.1023/A:1004370725605; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Rezzonico F, 2010, APPL ENVIRON MICROB, V76, P4497, DOI 10.1128/AEM.03112-09; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Somasegaran P., 1985, METHODS LEGUME RHIZO; Sprent JI, 2007, PLANT PHYSIOL, V144, P575, DOI 10.1104/pp.107.096156; STANLEY J, 1988, MOL GEN GENET, V215, P32, DOI 10.1007/BF00331299; Stephan R, 2011, J MICROBIOL METH, V87, P150, DOI 10.1016/j.mimet.2011.08.016; Stephan R, 2010, J CLIN MICROBIOL, V48, P2846, DOI 10.1128/JCM.00156-10; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Sun LW, 2006, RAPID COMMUN MASS SP, V20, P3789, DOI 10.1002/rcm.2801; Teramoto K, 2007, ANAL CHEM, V79, P8712, DOI 10.1021/ac701905r; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x	44	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37189	10.1371/journal.pone.0037189	http://dx.doi.org/10.1371/journal.pone.0037189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615938	Green Published, gold			2022-12-27	WOS:000305341200048
J	Bishop, DVM; Barry, JG; Hardiman, MJ				Bishop, Dorothy V. M.; Barry, Johanna G.; Hardiman, Mervyn J.			Delayed Retention of New Word-Forms Is Better in Children than Adults Regardless of Language Ability: A Factorial Two-Way Study	PLOS ONE			English	Article							NONWORD REPETITION; PHONOLOGICAL MEMORY; ACQUISITION; IMPAIRMENT; PLASTICITY; PERIOD	Background: Nonword repetition, the ability to retain and repeat unfamiliar sequences of phonemes is usually impaired in children with specific language impairment (SLI), but it is unclear whether this explains slow language learning. Traditional nonword repetition tests involve a single presentation of nonwords for immediate repetition. Here we considered whether rate of learning of novel phonological sequences was impaired when the same items were presented repeatedly. Methodology/Principal Findings: Three complex nonwords were each presented for repetition five times in two sessions (A and B) seperated by one hour. We studied both adults and children from (i) families with a child with SLI and (ii) families whose children did not save SLI. This gave 2 x 2 design with familial SLI as one factor, and age (up to of above 18 years) as the other. Overall, participants from families with SLI were poorer at nonword repetition than their peers from typical-language families, and there was a trend for children with SLI to show less within-session learning than typically developing children. However, between-session retention, measured as the difference between the last trial from session 1 and the first trial of session 2, showed a significant age effect, eta(2) = .139, p = .004, regardless of family SLI status. Adult participants showed a decrease in score from the last trial of session A to the first trial of session B, whereas children maintained their level of performance, regardless of whether or not they had SLI. Conclusions/Significance: Poor nonword repetition in SLI appears to reflect inadequate encoding of phonological information, rather than problems retaining encoded information. Furthermore, the nonword learning task is consistent with the notion of a sensitive period in language learning: Children show better retention over a delay for new phonological sequences than adults, regardless of overall level of language ability.	[Bishop, Dorothy V. M.; Barry, Johanna G.; Hardiman, Mervyn J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	dorothy.bishop@psy.ox.ac.uk		Bishop, Dorothy/0000-0002-2448-4033; Barry, Johanna/0000-0002-3733-8721	Wellcome Trust [053335/Z/98/Z, 082498/Z/07/Z]; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust Programme Grant numbers 053335/Z/98/Z and 082498/Z/07/Z (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JG, 2007, GENES BRAIN BEHAV, V6, P66, DOI 10.1111/j.1601-183X.2006.00232.x; Barry JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006270; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bishop D.V.M., 2005, TEST RECEPTION GRAMM; Bishop DVM, 2006, Q J EXP PSYCHOL, V59, P1153, DOI 10.1080/17470210500489372; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Edwards J, 1998, APPL PSYCHOLINGUIST, V19, P279, DOI 10.1017/S0142716400010079; Estes KG, 2007, J SPEECH LANG HEAR R, V50, P177, DOI 10.1044/1092-4388(2007/015); Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013648; Gathercole S. E., 1993, WORKING MEMORY LANGU; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Huyck JJ, 2011, DEVELOPMENTAL SCI, V14, P614, DOI 10.1111/j.1467-7687.2010.01009.x; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Korkman M., 2007, NEPSY 2, V2nd; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; London SE, 2009, DEV NEUROBIOL, V69, P437, DOI 10.1002/dneu.20719; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; Metsala JL, 1999, J EDUC PSYCHOL, V91, P3, DOI 10.1037/0022-0663.91.1.3; Newbury DF, 2009, AM J HUM GENET, V85, P264, DOI 10.1016/j.ajhg.2009.07.004; RICE ML, 1994, J SPEECH HEAR RES, V37, P106, DOI 10.1044/jshr.3701.106; Torgesen J.K., 1999, TOWRE TEST WORD READ; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Wechsler D., 2011, WASI 2 WECHSLER ABBR	27	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37326	10.1371/journal.pone.0037326	http://dx.doi.org/10.1371/journal.pone.0037326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615979	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300102
J	Dupre, ME; Gu, DA; Vaupel, JW				Dupre, Matthew E.; Gu, Danan; Vaupel, James W.			Survival Differences among Native-Born and Foreign-Born Older Adults in the United States	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIAL-SECURITY; LIFE; POPULATIONS; HEALTH; DISPARITIES; EXPERIENCE; IMMIGRANTS; MEDICARE; TRENDS	Background: Studies show that the U.S. foreign-born population has lower mortality than the native-born population before age 65. Until recently, the lack of data prohibited reliable comparisons of U.S. mortality by nativity at older ages. This study provides reliable estimates of U.S. foreign-born and native-born mortality at ages 65 and older at the end of the 20th century. Life expectancies of the U.S. foreign born are compared to other developed nations and the foreign-born contribution to total life expectancy (TLE) in the United States is assessed. Methods: Newly available data from Medicare Part B records linked with Social Security Administration files are used to estimate period life tables for nearly all U.S. adults aged 65 and older in 1995. Age-specific survival differences and life expectancies are examined in 1995 by sex, race, and place of birth. Results: Foreign-born men and women had lower mortality at almost every age from 65 to 100 compared to native-born men and women. Survival differences by nativity were substantially greater for blacks than whites. Foreign-born blacks had the longest life expectancy of all population groups (18.73 [95% confidence interval {CI}, 18.15-19.30] years at age 65 for men and 22.76 [95% CI, 22.28-23.23] years at age 65 for women). The foreign-born population increased TLE in the United States at older ages, and by international comparison, the U.S. foreign born were among the longest-lived persons in the world. Conclusion: Survival estimates based on reliable Medicare data confirm that foreign-born adults have longer life expectancy at older ages than native-born adults in the United States.	[Dupre, Matthew E.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Dupre, Matthew E.] Duke Univ, Ctr Study Aging & Human Dev, Durham, NC USA; [Gu, Danan] UN, Populat Div, New York, NY 10017 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	Duke University; Duke University; Max Planck Society	Dupre, ME (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA.	matthew.dupre@duke.edu	Dupre, Matthew/ABG-6728-2021	Dupre, Matthew/0000-0002-0976-4715; Vaupel, James/0000-0003-0783-3905	National Institute on Aging [R01 AG18444]; NATIONAL INSTITUTE ON AGING [R01AG018444] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MED and JWV were supported by a grant from the National Institute on Aging (R01 AG18444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1996, RES SOCIOL HEALTH CA; [Anonymous], 2006, GENES BEHAV SOCIAL E; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Chiang CL, 1984, LIFE TABLE ITS APPL; Cho YT, 2004, INT MIGR REV, V38, P184, DOI 10.1111/j.1747-7379.2004.tb00193.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; COALE AJ, 1986, POP STUD-J DEMOG, V40, P389, DOI 10.1080/0032472031000142316; DULEEP HO, 1994, SOC SECUR BULL, V57, P37; ELFORD J, 1992, J EPIDEMIOL COMMUN H, V46, P1, DOI 10.1136/jech.46.1.1-a; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; Elo IT, 2004, DEMOGRAPHY, V41, P109, DOI 10.1353/dem.2004.0001; Elo IT, 1997, RACIAL AND ETHNIC DIFFERENCES IN THE HEALTH OF OLDER AMERICANS, P10; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; GREENBERG M, 1992, INT J EPIDEMIOL, V21, P324, DOI 10.1093/ije/21.2.324; He W, 2002, CURRENT POPULATION R, pP23; Hummer RA, 1999, SOC SCI QUART, V80, P136; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kannisto V, 1994, AGING MONOGRAPHSONPO; KESTENBAUM B, 1992, DEMOGRAPHY, V29, P565, DOI 10.2307/2061852; KESTENBAUM B, 1986, DEMOGRAPHY, V23, P87, DOI 10.2307/2061410; Kestenbaum B, 2002, N AM ACTUARIAL J, V6, P38, DOI DOI 10.1080/10920277.2002.10596055; Larsen L. J., 2003, CURRENT POPULATION R; Lauderdale DS, 2002, DEMOGRAPHY, V39, P529, DOI 10.1353/dem.2002.0028; Lollock L, 2001, CURRENT POPULATION R, pP20; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Markides KS, 2005, J GERONTOL B-PSYCHOL, V60, P68, DOI 10.1093/geronb/60.Special_Issue_2.S68; Martin LG, 1997, RACIAL AND ETHNIC DIFFERENCES IN THE HEALTH OF OLDER AMERICANS, P1; National Center for Health Statistics, 1998, VITAL STAT US A, VII; Parnell AM, 1999, DEMOGR RES, V1, P1; Preston SH, 1996, DEMOGRAPHY, V33, P193, DOI 10.2307/2061872; Preston SH, 1999, POP STUD-J DEMOG, V53, P165, DOI 10.1080/00324720308075; Preston SH, 2009, PSC WORKING PAPER SE, P09; Reagan PB, 2000, DEMOGRAPHY, V37, P339, DOI 10.2307/2648046; Schmidley AD, 2001, PROFILE FOREIGN BORN, pP23; Scribner R, 1996, AM J PUBLIC HEALTH, V86, P303, DOI 10.2105/AJPH.86.3.303; Singh GK, 2001, AM J PUBLIC HEALTH, V91, P392, DOI 10.2105/AJPH.91.3.392; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; SORLIE PD, 1993, JAMA-J AM MED ASSOC, V270, P2464, DOI 10.1001/jama.270.20.2464; Turra CM, 2008, POPUL RES POLICY REV, V27, P515, DOI 10.1007/s11113-008-9087-4; United Nations, 2009, WORLD POPULATION POL; United Nations, 2009, WORLD POP PROSP 2008; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224	44	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37177	10.1371/journal.pone.0037177	http://dx.doi.org/10.1371/journal.pone.0037177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615929	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341300081
J	Liu, XW; Cai, H; Sheng, WQ; Wang, YN				Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Wang, Yanong			Long-Term Results and Prognostic Factors of Gastric Cancer Patients with Microscopic Peritoneal Carcinomatosis	PLOS ONE			English	Article							RECURRENCE; OUTCOMES; LAVAGE; S-1	Background: Clinical significance of microscopic peritoneal carcinomatosis remained unclear. The aim of this study was to evaluate the prognostic value of microscopic peritoneal carcinomatosis in gastric cancer. Methods: From 1996 to 2007, 4426 patients underwent gastrectomy for gastric cancer at Fudan University Shanghai Cancer Center. The clinical and pathological data were reviewed to identify patients with microscopic peritoneal carcinomatosis (group 1). The clinicopathological features and prognosis were examined. Additionally, 242 stage-matched gastric cancer patients without microscopic peritoneal carcinomatosis (group 2) and 118 with macroscopic peritoneal carcinomatosis (group 3) were selected as control groups. Results: Microscopic peritoneal carcinomatosis was found in 121 patients. There were 85 males and 36 females (2.36:1). There was a higher incidence rate of large size tumor (>= 5 cm) (P = 0.045), Borrmann IV (P = 0.000), and serosal invasion (P = 0.000) in gastric cancer with microscopic peritoneal carcinomatosis compared with the control group. The 5-year survival rate of gastric cancer with microscopic peritoneal carcinomatosis was 24%, significantly poorer than that of the stage-matched control group but better than that of patients with macroscopic peritoneal carcinomatosis. The independent prognostic factors identified included pathological stage and operative curability. Conclusions: The presence of microscopic peritoneal carcinomatosis was associated with worse prognosis for gastric cancer, but curative surgery showed potential to improve prognosis.	[Liu, Xiaowen; Cai, Hong; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China; [Sheng, Weiqi] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Liu, Xiaowen; Cai, Hong; Sheng, Weiqi; Wang, Yanong] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, XW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma, Shanghai 200433, Peoples R China.	wangyn1111@hotmail.com						Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Kostic Zoran, 2006, Vojnosanit Pregl, V63, P349, DOI 10.2298/VSP0604349K; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; Oh CA, 2012, J SURG ONCOL, V105, P393, DOI 10.1002/jso.22091; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Saito H, 1999, SURGERY, V125, P195, DOI 10.1067/msy.2099.94407; Saito H, 2011, J SURG ONCOL, V104, P534, DOI 10.1002/jso.21983; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Sarela AI, 2006, ANN SURG, V243, P189, DOI 10.1097/01.sla.0000197382.43208.a5; Shibata A, 2006, CANC EPIDEMIOLOGY PR, P707; YAMADA E, 1980, INT SURG, V65, P387; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Yonemura Y., 1998, PERITONEAL DISSEMINA, P1	14	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37284	10.1371/journal.pone.0037284	http://dx.doi.org/10.1371/journal.pone.0037284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615966	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300097
J	Maiga, M; Siddiqui, S; Diallo, S; Diarra, B; Traore, B; Shea, YR; Zelazny, AM; Dembele, BPP; Goita, D; Kassambara, H; Hammond, AS; Polis, MA; Tounkara, A				Maiga, Mamoudou; Siddiqui, Sophia; Diallo, Souleymane; Diarra, Bassirou; Traore, Brehima; Shea, Yvonne R.; Zelazny, Adrian M.; Dembele, Bindongo P. P.; Goita, Drissa; Kassambara, Hamadoun; Hammond, Abdulrahman S.; Polis, Michael A.; Tounkara, Anatole			Failure to Recognize Nontuberculous Mycobacteria Leads to Misdiagnosis of Chronic Pulmonary Tuberculosis	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; SP-NOV.; RESPIRATORY SPECIMENS; INFECTIONS; IDENTIFICATION; EPIDEMIOLOGY; FORTUITUM; RELEVANCE; DIAGNOSIS; DISEASE	Background: Nontuberculous mycobacterial (NTM) infections cause morbidity worldwide. They are difficult to diagnose in resource-limited regions, and most patients receive empiric treatment for tuberculosis (TB). Our objective here is to evaluate the potential impact of NTM diseases among patients treated presumptively for tuberculosis in Mali. Methods: We re-evaluated sputum specimens among patients newly diagnosed with TB (naive) and those previously treated for TB disease (chronic cases). Sputum microscopy, culture and Mycobacterium tuberculosis drug susceptibility testing were performed. Identification of strains was performed using molecular probes or sequencing of secA1 and/or 16S rRNA genes. Results: Of 142 patients enrolled, 61 (43%) were clinically classified as chronic cases and 17 (12%) were infected with NTM. Eleven of the 142 (8%) patients had NTM disease alone (8 M. avium, 2 M. simiae and 1 M. palustre). All these 11 were from the chronic TB group, comprising 11/61 (18%) of that group and all were identified as candidates for second line treatment. The remaining 6/17 (35.30%) NTM infected patients had coinfection with M. tuberculosis and all 6 were from the TB treatment naive group. These 6 were candidates for the standard first line treatment regimen of TB. M. avium was identified in 11 of the 142 (8%) patients, only 3/11 (27.27%) of whom were HIV positive. Conclusions: NTM infections should be considered a cause of morbidity in TB endemic environments especially when managing chronic TB cases to limit morbidity and provide appropriate treatment.	[Maiga, Mamoudou; Diallo, Souleymane; Diarra, Bassirou; Traore, Brehima; Dembele, Bindongo P. P.; Goita, Drissa; Kassambara, Hamadoun; Hammond, Abdulrahman S.; Tounkara, Anatole] Univ Bamako Res Collaborat HIV TB, Project SEREFO NIAID, Bamako, Mali; [Siddiqui, Sophia; Polis, Michael A.] NIAID, CCRB, Div Clin Res, Bethesda, MD 20892 USA; [Shea, Yvonne R.; Zelazny, Adrian M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Maiga, M (corresponding author), Univ Bamako Res Collaborat HIV TB, Project SEREFO NIAID, Bamako, Mali.	ssiddiqui@niaid.nih.gov		Diarra, Bassirou/0000-0002-1795-9379; Polis, Michael/0000-0002-9151-2268; Traore, Brehima/0000-0001-9075-9157	National Institutes of Health, Bethesda, Maryland, USA; CLINICAL CENTER [ZIACL080013, ZIACL080012] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	National Institutes of Health, Bethesda, Maryland, USA funded this work conducted at the Mali International Centers for Excellence in Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, J CLIN MICROBIOL, V44, P3493, DOI 10.1128/JCM.00724-06; AlJarad N, 1996, THORAX, V51, P137, DOI 10.1136/thx.51.2.137; Buijtels PCAM, 2009, EMERG INFECT DIS, V15, P242, DOI 10.3201/eid1502.080006; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Crump JA, 2009, EMERG INFECT DIS, V15, P53, DOI 10.3201/eid1501.081093; Floyd MM, 2000, INT J SYST EVOL MICR, V50, P1811, DOI 10.1099/00207713-50-5-1811; Gerogianni I, 2008, INT J TUBERC LUNG D, V12, P807; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hatherill M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000021; Hemmersbach-Miller Marion, 2005, Can J Infect Dis Med Microbiol, V16, P183; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Katoch VM, 2004, INDIAN J MED RES, V120, P290; Kent PT, 1985, GUIDE LEVEL 3 LAB; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koivula T, 2004, MICROBES INFECT, V6, P1320, DOI 10.1016/j.micinf.2004.07.007; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Masaki T, 2006, MICROBIOL IMMUNOL, V50, P889, DOI 10.1111/j.1348-0421.2006.tb03865.x; Miguez-Burbano MJ, 2006, INT J INFECT DIS, V10, P47, DOI 10.1016/j.ijid.2004.11.005; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Park S, 2008, RESP MED, V102, P437, DOI 10.1016/j.rmed.2007.10.005; PECHERE M, 1995, ARCH INTERN MED, V155, P400, DOI 10.1001/archinte.155.4.400; Piersimoni C, 2008, LANCET INFECT DIS, V8, P323, DOI 10.1016/S1473-3099(08)70100-2; Porat MD, 2008, J ARTHROPLASTY, V23, P787, DOI 10.1016/j.arth.2007.07.010; Richter E, 2000, AIDS, V14, P1667, DOI 10.1097/00002030-200007280-00028; Torkko P, 2002, INT J SYST EVOL MICR, V52, P1519, DOI [10.1099/ijs.0.02089-0, 10.1099/00207713-52-5-1519]; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; van Ingen J, 2008, EUR RESPIR J, V31, P106, DOI 10.1183/09031936.00076107; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; van Ingen J, 2010, VET MICROBIOL, V144, P250, DOI 10.1016/j.vetmic.2009.12.047; Verghese Susan, 2007, J Commun Dis, V39, P257; Verweij KE, 2010, INT J TUBERC LUNG D, V14, P1127; Woo PCY, 2009, J MED MICROBIOL, V58, P1030, DOI 10.1099/jmm.0.008615-0; World Health Organisation website, 2009, 4 ED TREATM TUB GUID; Zelazny AM, 2005, J CLIN MICROBIOL, V43, P1051, DOI 10.1128/JCM.43.3.1051-1058.2005	36	73	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36902	10.1371/journal.pone.0036902	http://dx.doi.org/10.1371/journal.pone.0036902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615839	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341300040
J	Nunn, A; Cornwall, A; Chute, N; Sanders, J; Thomas, G; James, G; Lally, M; Trooskin, S; Flanigan, T				Nunn, Amy; Cornwall, Alexandra; Chute, Nora; Sanders, Julia; Thomas, Gladys; James, George; Lally, Michelle; Trooskin, Stacey; Flanigan, Timothy			Keeping the Faith: African American Faith Leaders' Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection	PLOS ONE			English	Article							HIV-RELATED STIGMA; BLACK-MEN; UNITED-STATES; SUBSTANCE USERS; PREVENTION; HEALTH; COMMUNITY; RISK; CHURCHES; SEX	In Philadelphia, 66% of new HIV infections are among African Americans and 2% of African Americans are living with HIV. The city of Philadelphia has among the largest numbers of faith institutions of any city in the country. Although faith-based institutions play an important role in the African American community, their response to the AIDS epidemic has historically been lacking. We convened 38 of Philadelphia's most influential African American faith leaders for in-depth interviews and focus groups examining the role of faith-based institutions in HIV prevention. Participants were asked to comment on barriers to engaging faith-based leaders in HIV prevention and were asked to provide normative recommendations for how African American faith institutions can enhance HIV/AIDS prevention and reduce racial disparities in HIV infection. Many faith leaders cited lack of knowledge about Philadelphia's racial disparities in HIV infection as a common reason for not previously engaging in HIV programs; others noted their congregations' existing HIV prevention and outreach programs and shared lessons learned. Barriers to engaging the faith community in HIV prevention included: concerns about tacitly endorsing extramarital sex by promoting condom use, lack of educational information appropriate for a faith-based audience, and fear of losing congregants and revenue as a result of discussing human sexuality and HIV/AIDS from the pulpit. However, many leaders expressed a moral imperative to respond to the AIDS epidemic, and believed clergy should play a greater role in HIV prevention. Many participants noted that controversy surrounding homosexuality has historically divided the faith community and prohibited an appropriate response to the epidemic; many expressed interest in balancing traditional theology with practical public health approaches to HIV prevention. Leaders suggested the faith community should: promote HIV testing, including during or after worship services and in clinical settings; integrate HIV/AIDS topics into health messaging and sermons; couch HIV/AIDS in social justice, human rights and public health language rather than in sexual risk behavior terms; embrace diverse approaches to HIV prevention in their houses of worship; conduct community outreach and host educational sessions for youth; and collaborate on a citywide, interfaith HIV testing and prevention campaign to combat stigma and raise awareness about the African American epidemic. Many African American faith-based leaders are poised to address racial disparities in HIV infection. HIV prevention campaigns should integrate leaders' recommendations for tailoring HIV prevention for a faith-based audience.	[Nunn, Amy; Lally, Michelle; Flanigan, Timothy] Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA; [Nunn, Amy; Cornwall, Alexandra; Chute, Nora; Sanders, Julia; Lally, Michelle; Flanigan, Timothy] Miriam Hosp, Div Infect Dis, Providence, RI 02906 USA; [Thomas, Gladys] Univ Penn, Ctr AIDS Res Community Advisory Board, Philadelphia, PA 19104 USA; [James, George] Council Relationships, Philadelphia, PA USA; [Trooskin, Stacey] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; University of Pennsylvania; University of Pennsylvania	Nunn, A (corresponding author), Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA.	amy_nunn@brown.edu	Lally, Michelle/I-4865-2016	Lally, Michelle/0000-0003-0716-4668	National Institutes of Health (NIH), Center for AIDS Research [P30-AI-42853]; Rhode Island Foundation; MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program; NIH/National Institute on Alcohol Abuse and Alcoholism [1K01AA020228]; Mylan, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA020228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program; NIH/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Mylan, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This manuscript was supported by grant number P30-AI-42853 from the National Institutes of Health (NIH), Center for AIDS Research; AN's medical research grant from the Rhode Island Foundation; the MAC AIDS Fund; Gilead Sciences, Inc.'s HIV FOCUS Program, and grant number 1K01AA020228 from the NIH/National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Amy Nunn receives consulting fees from Mylan, Inc., and grant support from Gilead Sciences Inc., HIV FOCUS Program. All other authors have no competing interests to report. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AIDS Activities Coordinating Office of the City of Philadelphia (AACO), 2008, PHIL HIV AIDS EP UPD; Akers Aletha Y, 2010, J Health Care Poor Underserved, V21, P1, DOI 10.1353/hpu.0.0280; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], 2007, HEIGHT NAT RESP HIV; [Anonymous], 2011, HIGH IMP HIV PREV CD; [Anonymous], US CENS 2010 CENS DA; Aral SO, 2008, LANCET, V372, P337, DOI 10.1016/S0140-6736(08)61118-6; Berkley-Patton J, 2010, AIDS EDUC PREV, V22, P218, DOI 10.1521/aeap.2010.22.3.218; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Buseh AG, 2006, J ASSOC NURSE AIDS C, V17, P3, DOI 10.1016/j.jana.2006.05.006; [CDC US Department of Health and Human Services], 2009, HIV AIDS AFR AM; CDC, 2011, CHAR ASS HIV INF HET; Chein I., 1981, INTRO SAMPLING; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coleman JD, 2011, AIDS PATIENT CARE ST, V25; Corbie-Smith G, HLTH PROMOT PRACT, V12, P293; Corbie-Smith G, 2010, J NATL MED ASSOC, V102, P823, DOI 10.1016/S0027-9684(15)30680-5; Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7; Davis NJ, 2008, THESIS COLUMBIA U NE; Derose KP, 2010, J URBAN HLTH; Foster PP, 2011, J NATL MED ASSOC, V103, P323, DOI 10.1016/S0027-9684(15)30313-8; Foster PP, 2009, AIDS CARE, V21, P1306, DOI 10.1080/09540120902803141; Francis SA, 2009, J RELIG HEALTH, V48, P164, DOI 10.1007/s10943-008-9177-y; Francis SA, 2009, J RELIG HEALTH, V48, P6, DOI 10.1007/s10943-008-9171-4; Fullilove R. E., 2006, AFRICAN AM HLTH DISP; Glaser B.G., 1968, DISCOV GROUNDED THEO; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Griffith DM, 2010, PUBLIC HEALTH REP, V125, P4, DOI 10.1177/00333549101250S102; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Jeffries WL, 2008, CULT HEALTH SEX, V10, P463, DOI 10.1080/13691050701877526; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Levin J, 2005, J NATL MED ASSOC, V97, P237; LEVIN JS, 1984, J NATL MED ASSOC, V76, P477; Lewis Y., 2002, HEALTH PROMOT PRACT, V3, P133, DOI DOI 10.1177/152483990200300209; Lincoln CE., 1990, BLACK CHURCH AFRICAN; MacMaster SA, 2007, HEALTH SOC WORK, V32, P151, DOI 10.1093/hsw/32.2.151; MacMaster SA, 2007, RES SOCIAL WORK PRAC, V17, P229, DOI 10.1177/1049731506296826; Marcus Marianne T, 2004, J Interprof Care, V18, P347, DOI 10.1080/13561820400011776; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McNeal C, 2007, J HUM BEHAV SOC ENVI, V15, P219, DOI 10.1300/J137v15n02_13; Merriam S.B., 2019, QUALITATIVE RES PRAC, V2nd ed.; Morse J., 2009, DEV GROUNDED THEORY, V1st; Muturi N, J HLTH COMMUN, V15, P388; Nanin J, 2009, AM J MENS HEALTH, V3, P150, DOI 10.1177/1557988308315154; Nunn A, 2011, J NATL MED ASS   NOV; Nunn A, 2012, AFRICAN AM WOMEN SPE; Nunn A, 2011, AIDS PATIENT CARE ST, V25, P229, DOI 10.1089/apc.2010.0313; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pattillo-McCoy M, 1998, AM SOCIOL REV, V63, P767, DOI 10.2307/2657500; Pew, 2008, PEW FOR US REL LANDS; Rice P. L., 2001, QUALITATIVE RES METH; Sengupta S, 2010, AIDS BEHAV; Shpaner M., 2010, HIV AIDS PHILADELPHI; Smith Justin, 2005, J Natl Med Assoc, V97, P1682; Tesoriero JM, 2000, PUBLIC HEALTH REP, V115, P544, DOI 10.1093/phr/115.6.544; THOMAS SB, 1994, AM J PUBLIC HEALTH, V84, P575, DOI 10.2105/AJPH.84.4.575; Tyrell CO, 2008, J PUBLIC HEALTH MAN, V14, P429, DOI 10.1097/01.PHH.0000333876.70819.14; Valera P, 2011, J BLACK STUD, V42, P106, DOI 10.1177/0021934709356385; Ward EG, 2005, CULT HEALTH SEX, V7, P493, DOI 10.1080/13691050500151248; Weiss RS, 1994, LEARNING STRANGERS A; Williams JK, CURR HIV AIDS REP, V7, P185; Williams M., 2011, J URBAN HLTH; Wilson PA, 2011, GLOB PUBLIC HEALTH, V6, pS227, DOI 10.1080/17441692.2011.605068; Wingood GM, 2007, WOMEN HEALTH, V46, P99, DOI 10.1300/J013v46n02_07; Woodyard J L, 2000, J Pastoral Care, V54, P451; Wooster J, HLTH PROMOT PRACT; Wooster J, 2011, HEALTH PROMOT PRACT, V12, P769, DOI 10.1177/1524839910362313	69	44	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36172	10.1371/journal.pone.0036172	http://dx.doi.org/10.1371/journal.pone.0036172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615756	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300013
J	Rajatonirina, S; Heraud, JM; Orelle, A; Randrianasolo, L; Razanajatovo, N; Rajaona, YR; Randrianarivo-Solofoniaina, AE; Rakotomanana, F; Richard, V				Rajatonirina, Soatiana; Heraud, Jean-Michel; Orelle, Arnaud; Randrianasolo, Laurence; Razanajatovo, Norosoa; Rajaona, Yolande Raoelina; Randrianarivo-Solofoniaina, Armand Eugene; Rakotomanana, Fanjasoa; Richard, Vincent			The Spread of Influenza A(H1N1)pdm09 Virus in Madagascar Described by a Sentinel Surveillance Network	PLOS ONE			English	Article							A H1N1; EPIDEMIOLOGY; CONTACTS; OUTBREAK	Background: The influenza A(H1N1)pdm09 virus has been a challenge for public health surveillance systems in all countries. In Antananarivo, the first imported case was reported on August 12, 2009. This work describes the spread of A(H1N1) pdm09 in Madagascar. Methods: The diffusion of influenza A(H1N1) pdm09 in Madagascar was explored using notification data from a sentinel network. Clinical data were charted to identify peaks at each sentinel site and virological data was used to confirm viral circulation. Results: From August 1, 2009 to February 28, 2010, 7,427 patients with influenza-like illness were reported. Most patients were aged 7 to 14 years. Laboratory tests confirmed infection with A(H1N1) pdm09 in 237 (33.2%) of 750 specimens. The incidence of patients differed between regions. By determining the epidemic peaks we traced the diffusion of the epidemic through locations and time in Madagascar. The first peak was detected during the epidemiological week 47-2009 in Antananarivo and the last one occurred in week 07-2010 in Tsiroanomandidy. Conclusion: Sentinel surveillance data can be used for describing epidemic trends, facilitating the development of interventions at the local level to mitigate disease spread and impact.	[Rajatonirina, Soatiana; Randrianasolo, Laurence; Rakotomanana, Fanjasoa; Richard, Vincent] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Heraud, Jean-Michel; Orelle, Arnaud; Razanajatovo, Norosoa] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Rajaona, Yolande Raoelina; Randrianarivo-Solofoniaina, Armand Eugene] Malagasy Minist Hlth, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Rajatonirina, S (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	vrichard@pasteur.sn	Heraud, Jean-Michel/O-1464-2013	Heraud, Jean-Michel/0000-0003-1107-0859; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075; Vincent, RICHARD/0000-0002-6961-1753	World Health Organization (WHO) Geneva (APW) [OD/AP-08-02451]; Sanofi-Pasteur; French Ministry of Health; United States Centers for Disease Control and Prevention [U51/IP000327-01]; United States Department of Health and Human Services via the International Network of Pasteur Institutes [6 IDSEP060001-01-01]; President Malaria Initiative program (USAIDS); National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000327] Funding Source: NIH RePORTER	World Health Organization (WHO) Geneva (APW); Sanofi-Pasteur; French Ministry of Health; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Department of Health and Human Services via the International Network of Pasteur Institutes; President Malaria Initiative program (USAIDS); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was feasible thanks to set-up of sentinel network supported by World Health Organization (WHO) Geneva (APW/Ref. OD/AP-08-02451), Sanofi-Pasteur, the French Ministry of Health, the United States Centers for Disease Control and Prevention (Cooperative Agreement Number: U51/IP000327-01), the United States Department of Health and Human Services (Grant Number 6 IDSEP060001-01-01) via the International Network of Pasteur Institutes, and the President Malaria Initiative program (USAIDS). The authors are therefore grateful to Wenqing Zhang from WHO Geneva, Beatrice Barret and Myriam Beigeaud from Sanofi Pasteur, and Kathleen Victoir and Marc Jouan from the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001519; ANDERSON R M, 1991; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], 2010, PAND H1N1 2009 UPDAT; [Anonymous], 2005, HHS PAND INFL PLAN; BONHOEFFER S, 1994, P ROY SOC B-BIOL SCI, V258, P133, DOI 10.1098/rspb.1994.0153; Cliff AD, 1981, SPATIAL PROCESSES MO, P6; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Harcourt SE, 2011, EPIDEMIOL INFECT, V8, P1, DOI DOI 10.1017/S095026881100046X; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Kwan-Gett TS, 2009, DISASTER MED PUBLIC, V3, pS109, DOI 10.1097/DMP.0b013e3181c6b818; Lagace-Wiens PRS, 2010, CRIT CARE MED, V38, pE1, DOI 10.1097/CCM.0b013e3181cbaf34; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rajatonirina S, 2011, J INFECT DEV COUNTR, V5, P156, DOI 10.3855/jidc.1318; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Wenger JD, 2011, CLIN INFECT DIS, V52, pS189, DOI 10.1093/cid/ciq037; World Health Organization Western Pacific Region, 2006, AV INFL INCL INFL A	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37067	10.1371/journal.pone.0037067	http://dx.doi.org/10.1371/journal.pone.0037067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615893	Green Published, gold			2022-12-27	WOS:000305341300062
J	Reilly, S; Planner, C; Hann, M; Reeves, D; Nazareth, I; Lester, H				Reilly, Siobhan; Planner, Claire; Hann, Mark; Reeves, David; Nazareth, Irwin; Lester, Helen			The Role of Primary Care in Service Provision for People with Severe Mental Illness in the United Kingdom	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; CONTINUITY; ILL; SCHIZOPHRENIA; PREVALENCE; VIEWS	Background: Severe mental illness is a serious and potentially life changing set of conditions. This paper describes and analyses patient characteristics and service usage over one year of a representative cohort of people with a diagnosis of severe mental illness across England, including contacts with primary and secondary care and continuity of care. Methods and Findings: Data were collected from primary care patient notes (n = 1150) by trained nurses from 64 practices in England, covering all service contacts from 1st April 2008 to 31st March 2009. The estimated national rate of patients seen only in primary care in the period was 31.1% (95% C. I. 27.2% to 35.3%) and the rates of schizophrenia and bipolar disorder were 56.8% (95% C. I. 52.3% to 61.2%) and 37.9% (95% C. I. 33.7% to 42.2%). In total, patients had 7,961 consultations within primary care and 1,993 contacts with mental health services (20% of the total). Unemployed individuals diagnosed more recently were more likely to have contact with secondary care. Of those seen in secondary care, 61% had at most two secondary care contacts in the period. Median annual consultation rates with GPs were lower than have been reported for previous years and were only slightly above the general population. Relational continuity in primary care was poor for 21% of patients (Modified Modified Continuity Index = <0.5), and for almost a third of new referrals to mental health services the primary care record contained no information on the referral outcome. Conclusions: Primary care is centrally involved in the care of people with serious mental illness, but primary care and cross-boundary continuity is poor for a substantial proportion. Research is needed to determine the impact of poor continuity on patient outcomes, and above all, the impact of new collaborative ways of working at the primary/secondary care interface.	[Reilly, Siobhan; Planner, Claire; Hann, Mark; Reeves, David] Univ Manchester, Hlth Sci Res Grp, Sch Primary Care Res, Natl Inst Hlth Res, Manchester, Lancs, England; [Nazareth, Irwin] UCL, Sch Med, Dept Primary Care & Populat Hlth, London W1N 8AA, England; [Lester, Helen] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Manchester; University of London; University College London; UCL Medical School; University of Birmingham	Reilly, S (corresponding author), Univ Manchester, Hlth Sci Res Grp, Sch Primary Care Res, Natl Inst Hlth Res, Manchester, Lancs, England.	h.e.lester@bham.ac.uk	Reeves, David/H-6203-2014	Reeves, David/0000-0001-6377-6859; Nazareth, Irwin/0000-0003-2146-9628; Reilly, Siobhan Theresa/0000-0003-4372-4415	National Institute for Health Research School for Primary Care Research	National Institute for Health Research School for Primary Care Research	This study was funded by the National Institute for Health Research School for Primary Care Research [http://www.nihr.ac.uk/research/Pages/programmes_primary_care_research.aspx]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2006, SDO13B2001 RD NAT CO; Bindman J, 1997, BRIT J PSYCHIAT, V171, P169, DOI 10.1192/bjp.171.2.169; Burns T, 2009, PSYCHOL MED, V39, P313, DOI 10.1017/S0033291708003747; Burns T, 1998, BRIT J GEN PRACT, V48, P1415; Care Quality Commission, 2011, COMM MENT HLTH SURV; Crawford MJ, 2004, SOC PSYCH PSYCH EPID, V39, P265, DOI 10.1007/s00127-004-0732-x; Freeman G, 2002, 081109009 RD NAT COO; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Harrison G, 2001, BRIT J PSYCHIAT, V178, P506, DOI 10.1192/bjp.178.6.506; Hippisley-Cox JVY, 2009, TRENDS CONSULTATION; Jeffreys SE, 1997, BRIT J PSYCHIAT, V170, P301, DOI 10.1192/bjp.170.4.301; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; Johnson S, 1997, SOC PSYCH PSYCH EPID, V32, P137; Kai J, 2000, BRIT J GEN PRACT, V50, P992; KENDRICK T, 1991, BRIT MED J, V302, P508, DOI 10.1136/bmj.302.6775.508; KENDRICK T, 1994, BRIT J GEN PRACT, V44, P301; Kendrick T, 2000, BRIT J GEN PRACT, V50, P121; Lang FH, 1997, BRIT J PSYCHIAT, V171, P165, DOI 10.1192/bjp.171.2.165; Lester HE, 2005, BMJ-BRIT MED J, V330, P1122, DOI 10.1136/bmj.38440.418426.8F; Lester H, 2011, PSYCHIAT SERV, V62, P882, DOI 10.1176/ps.62.8.pss6208_0882; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; NAZARETH ID, 1992, FAM PRACT, V9, P171, DOI 10.1093/fampra/9.2.171; Noble M, 2007, ENGLISH INDICES DEPR; Parks J., 2006, MORBIDITY MORTALITY; Reilly S, 2012, COCHRANE DATABASE SY; Rodgers J, 2003, QUALITY PRIMARY CARE, V11, P133; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salisbury C, 2009, BRIT J GEN PRACT, V59, P276, DOI 10.3399/bjgp09X420257; Saunders KE., 2010, ADV PSYCHIAT TREAT, V16, P318, DOI DOI 10.1192/APT.BP.107.004903; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100	30	89	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36468	10.1371/journal.pone.0036468	http://dx.doi.org/10.1371/journal.pone.0036468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615769	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305336300017
J	Takagi, M; Ishii, T; Barnes, AM; Weis, M; Amano, N; Tanaka, M; Fukuzawa, R; Nishimura, G; Eyre, DR; Marini, JC; Hasegawa, T				Takagi, Masaki; Ishii, Tomohiro; Barnes, Aileen M.; Weis, MaryAnn; Amano, Naoko; Tanaka, Mamoru; Fukuzawa, Ryuji; Nishimura, Gen; Eyre, David R.; Marini, Joan C.; Hasegawa, Tomonobu			A Novel Mutation in LEPRE1 That Eliminates Only the KDEL ER- Retrieval Sequence Causes Non-Lethal Osteogenesis Imperfecta	PLOS ONE			English	Article							PROLYL 3-HYDROXYLATION; CYCLOPHILIN-B; I COLLAGEN; LETHAL; IDENTIFICATION; CRTAP; DEFICIENCY; RECURRENCE; COL1A1	Prolyl 3-hydroxylase 1 (P3H1), encoded by the LEPRE1 gene, forms a molecular complex with cartilage-associated protein (CRTAP) and cyclophilin B (encoded by PPIB) in the endoplasmic reticulum (ER). This complex is responsible for one step in collagen post-translational modification, the prolyl 3-hydroxylation of specific proline residues, specifically alpha 1(I) Pro986. P3H1 provides the enzymatic activity of the complex and has a Lys-Asp-Glu-Leu (KDEL) ER-retrieval sequence at the carboxyl terminus. Loss of function mutations in LEPRE1 lead to the Pro986 residue remaining unmodified and lead to slow folding and excessive helical post-translational modification of type I collagen, which is seen in both dominant and recessive osteogenesis imperfecta (OI). Here, we present the case of siblings with non-lethal OI due to novel compound heterozygous mutations in LEPRE1 (c.484delG and c.2155dupC). The results of RNA analysis and real-time PCR suggest that mRNA with c.2155dupC escapes from nonsense-mediated RNA decay. Without the KDEL ER- retrieval sequence, the product of the c.2155dupC variant cannot be retained in the ER. This is the first report of a mutation in LEPRE1 that eliminates only the KDEL ER-retrieval sequence, whereas other functional domains remain intact. Our study shows, for the first time, that the KDEL ER- retrieval sequence is essential for P3H1 functionality and that a defect in KDEL is sufficient for disease onset.	[Takagi, Masaki; Ishii, Tomohiro; Amano, Naoko; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Takagi, Masaki] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Barnes, Aileen M.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA; [Tanaka, Mamoru] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, Tokyo, Japan; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol, Tokyo, Japan	Keio University; Tokyo Metropolitan Children's Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; Keio University; Tokyo Metropolitan Children's Medical Center; Tokyo Metropolitan Children's Medical Center	Takagi, M (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	thaseg@a6.keio.jp	Hasegawa, Tomonobu/L-3331-2013; Ishii, Tomohiro/B-8711-2019	Ishii, Tomohiro/0000-0001-7360-2465; Barnes, Aileen/0000-0001-8021-4997	Ministry of Health, Labour and Welfare of Japan [H22-Nanji-Ippan-194]; Japan Society for the Promotion of Science [22790999]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394, ZIAHD000408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794] Funding Source: NIH RePORTER	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Research on Intractable Diseases of Health and Labour Sciences Research Grants (Diagnosis and treatment of osteogenesis imperfect; H22-Nanji-Ippan-194) from the Ministry of Health, Labour and Welfare of Japan, and by a grant from the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists (B) (22790999)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chang WZ, 2010, HUM MOL GENET, V19, P223, DOI 10.1093/hmg/ddp481; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; COHENSOLAL L, 1991, HUM GENET, V87, P297; COHN DH, 1990, AM J HUM GENET, V46, P591; DELRIO LD, 1994, PEDIATR RES, V35, P362, DOI 10.1203/00006450-199403000-00018; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; THOMPSON EM, 1987, J MED GENET, V24, P390, DOI 10.1136/jmg.24.7.390; van Dijk FS, 2012, EUR J HUM GENET, V20, P11, DOI 10.1038/ejhg.2011.141; van Dijk FS, 2011, PEDIATR DEVEL PATHOL, V14, P228, DOI 10.2350/10-03-0806-CR.1; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Willing MC, 1996, AM J HUM GENET, V59, P799; Zhang ZL, 2011, J BONE MINE IN PRESS	28	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36809	10.1371/journal.pone.0036809	http://dx.doi.org/10.1371/journal.pone.0036809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615817	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336300038
J	Tso, C; Rye, KA; Barter, P				Tso, Colin; Rye, Kerry-Anne; Barter, Philip			Phenotypic and Functional Changes in Blood Monocytes Following Adherence to Endothelium	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; CELLS; EXPRESSION; ADHESION; DIFFERENTIATION; PROLIFERATION; CADHERIN; CULTURE; MARKER	Objective: Blood monocytes are known to express endothelial-like genes during co-culture with endothelium. In this study, the time-dependent change in the phenotype pattern of primary blood monocytes after adhering to endothelium is reported using a novel HLA-A2 mistyped co-culture model. Methods and Results: Freshly isolated human PBMCs were co-cultured with human umbilical vein endothelial cells or human coronary arterial endothelial cells of converse human leukocyte antigen A2 (HLA-A2) status. This allows the tracking of the PBMC-derived cells by HLA-A2 expression and assessment of their phenotype pattern over time. PBMCs that adhered to the endothelium at the start of the co-culture were predominantly CD11b+ blood monocytes. After 24 to 72 hours in co-culture, the endothelium-adherent monocytes acquired endothelial-like properties including the expression of endothelial nitric oxide synthase, CD105, CD144 and vascular endothelial growth factor receptor 2. The expression of monocyte/macrophage lineage antigens CD14, CD11b and CD36 were down regulated concomitantly. The adherent monocytes did not express CD115 after 1 day of co-culture. By day 6, the monocyte-derived cells expressed vascular cell adhesion molecule 1 in response to tumour necrosis factor alpha. Up to 10% of the PBMCs adhered to the endothelium. These monocyte-derived cells contributed up to 30% of the co-cultured cell layer and this was dose-dependent on the PBMC seeding density. Conclusions: Human blood monocytes undergo rapid phenotype change to resemble endothelial cells after adhering to endothelium.	[Tso, Colin; Rye, Kerry-Anne; Barter, Philip] Heart Res Inst, Lipid Res Grp, Newtown, NSW, Australia; [Rye, Kerry-Anne] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of Melbourne	Tso, C (corresponding author), Heart Res Inst, Lipid Res Grp, Newtown, NSW, Australia.	tsoc@hri.org.au			National Health and Medical Research Council of Australia [482800]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council of Australia program grant [no. 482800]; http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellik L, 2008, EXP CELL RES, V314, P2965, DOI 10.1016/j.yexcr.2008.07.016; BENNETT S, 1992, J IMMUNOL METHODS, V153, P201, DOI 10.1016/0022-1759(92)90323-L; Bohgaki M, 2007, INT J HEMATOL, V86, P42, DOI 10.1532/IJH97.06217; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Ellis JM, 2000, HUM IMMUNOL, V61, P334, DOI 10.1016/S0198-8859(99)00155-X; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Hughes DL, 2005, BRIT J HAEMATOL, V130, P791, DOI 10.1111/j.1365-2141.2005.05671.x; Huh HY, 1996, BLOOD, V87, P2020; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Pujol BF, 2000, DIFFERENTIATION, V65, P287, DOI 10.1046/j.1432-0436.2000.6550287.x; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; Rosenblat M, 2011, ATHEROSCLEROSIS; Sato T, 1999, CLIN EXP IMMUNOL, V115, P301, DOI 10.1046/j.1365-2249.1999.00784.x; Schmeisser A, 2001, CARDIOVASC RES, V49, P671, DOI 10.1016/S0008-6363(00)00270-4; Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537; STENT G, 1995, CLIN EXP IMMUNOL, V100, P366; Thomas-Ecker S, 2007, P NATL ACAD SCI USA, V104, P5539, DOI 10.1073/pnas.0700732104; Vasina EM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.94; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014	22	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37091	10.1371/journal.pone.0037091	http://dx.doi.org/10.1371/journal.pone.0037091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615904	gold, Green Published			2022-12-27	WOS:000305336300070
J	Dixit, A; Verkhivker, GM				Dixit, Anshuman; Verkhivker, Gennady M.			Probing Molecular Mechanisms of the Hsp90 Chaperone: Biophysical Modeling Identifies Key Regulators of Functional Dynamics	PLOS ONE			English	Article							ESCHERICHIA-COLI HSP90; N-TERMINAL DOMAIN; ATP-BINDING; CONFORMATIONAL DYNAMICS; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; ALLOSTERIC REGULATION; PRINCIPAL COMPONENT; STRUCTURAL-ANALYSIS; NOVOBIOCIN ANALOGS	Deciphering functional mechanisms of the Hsp90 chaperone machinery is an important objective in cancer biology aiming to facilitate discovery of targeted anti-cancer therapies. Despite significant advances in understanding structure and function of molecular chaperones, organizing molecular principles that control the relationship between conformational diversity and functional mechanisms of the Hsp90 activity lack a sufficient quantitative characterization. We combined molecular dynamics simulations, principal component analysis, the energy landscape model and structure-functional analysis of Hsp90 regulatory interactions to systematically investigate functional dynamics of the molecular chaperone. This approach has identified a network of conserved regions common to the Hsp90 chaperones that could play a universal role in coordinating functional dynamics, principal collective motions and allosteric signaling of Hsp90. We have found that these functional motifs may be utilized by the molecular chaperone machinery to act collectively as central regulators of Hsp90 dynamics and activity, including the inter-domain communications, control of ATP hydrolysis, and protein client binding. These findings have provided support to a long-standing assertion that allosteric regulation and catalysis may have emerged via common evolutionary routes. The interaction networks regulating functional motions of Hsp90 may be determined by the inherent structural architecture of the molecular chaperone. At the same time, the thermodynamics-based "conformational selection" of functional states is likely to be activated based on the nature of the binding partner. This mechanistic model of Hsp90 dynamics and function is consistent with the notion that allosteric networks orchestrating cooperative protein motions can be formed by evolutionary conserved and sparsely connected residue clusters. Hence, allosteric signaling through a small network of distantly connected residue clusters may be a rather general functional requirement encoded across molecular chaperones. The obtained insights may be useful in guiding discovery of allosteric Hsp90 inhibitors targeting protein interfaces with co-chaperones and protein binding clients.	[Dixit, Anshuman] Univ Kansas, Sch Pharm, Dept Pharmaceut Chem, Lawrence, KS 66045 USA; [Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Sch Computat Sci, Orange, CA USA; [Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Crean Sch Hlth & Life Sci, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Kansas; Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Dixit, A (corresponding author), Inst Life Sci, Dept Biotechnol, Bhubaneswar, Orissa, India.	gverkhiv@ucsd.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	University of Kansas	University of Kansas	This work is partly supported by funding from The University of Kansas. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amolins MW, 2009, MINI-REV MED CHEM, V9, P140, DOI 10.2174/138955709787316056; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Beck R, 2011, CURR MED CHEM, V18, P2816, DOI 10.2174/092986711796011256; Bron P, 2008, BIOL CELL, V100, P413, DOI 10.1042/BC20070149; Burlison JA, 2008, J ORG CHEM, V73, P2130, DOI 10.1021/jo702191a; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Darby JF, 2011, NATURE, V478, P334, DOI 10.1038/478334b; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026071; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dollins DE, 2005, J BIOL CHEM, V280, P30438, DOI 10.1074/jbc.M503761200; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Eleuteri AM, 2002, PROTEINS, V48, P169, DOI 10.1002/prot.10101; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gao ZH, 2010, CURR OPIN DRUG DISC, V13, P193; Garnier C, 2002, J BIOL CHEM, V277, P12208, DOI 10.1074/jbc.M111874200; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Graf C, 2009, EMBO J, V28, P602, DOI 10.1038/emboj.2008.306; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hollup SM, 2011, PROTEIN SCI, V20, P197, DOI 10.1002/pro.558; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huth JR, 2007, CHEM BIOL DRUG DES, V70, P1, DOI 10.1111/j.1747-0285.2007.00535.x; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Jiang YQ, 2010, J BIOL CHEM, V285, P21023, DOI 10.1074/jbc.M110.103390; Johnson BD, 2000, J BIOL CHEM, V275, P32499, DOI 10.1074/jbc.M005195200; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kidd BA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000484; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Le Bras G, 2007, J MED CHEM, V50, P6189, DOI 10.1021/jm0707774; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Luccioli S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046008; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maguid S, 2005, BIOPHYS J, V89, P3, DOI 10.1529/biophysj.104.053041; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McDonald E, 2006, CURR TOP MED CHEM, V6, P1091, DOI 10.2174/156802606777812004; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Millson SH, 2004, CELL STRESS CHAPERON, V9, P359, DOI 10.1379/CSC-29R1.1; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2011, STRUCTURE, V19, P445, DOI 10.1016/j.str.2011.03.007; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vaughan CK, 2009, FEBS J, V276, P199, DOI 10.1111/j.1742-4658.2008.06773.x; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Wayne N, 2011, METHODS MOL BIOL, V787, P33, DOI 10.1007/978-1-61779-295-3_3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2003, CURR CANCER DRUG TAR, V3, P297, DOI 10.2174/1568009033481868; Workman P, 2007, NAT MED, V13, P1415, DOI 10.1038/nm1207-1415; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang LW, 2009, BIOINFORMATICS, V25, P606, DOI 10.1093/bioinformatics/btp023; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yang LW, 2005, BIOINFORMATICS, V21, P2978, DOI 10.1093/bioinformatics/bti469; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao HP, 2011, J MED CHEM, V54, P3839, DOI 10.1021/jm200148p; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27; Zheng WJ, 2010, BIOPHYS J, V98, P3025, DOI 10.1016/j.bpj.2010.03.027; Zheng WJ, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-45; Zheng WJ, 2009, CURR PROTEIN PEPT SC, V10, P128, DOI 10.2174/138920309787847608	166	43	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37605	10.1371/journal.pone.0037605	http://dx.doi.org/10.1371/journal.pone.0037605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22624053	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343500142
J	Pereiro, P; Balseiro, P; Romero, A; Dios, S; Forn-Cuni, G; Fuste, B; Planas, JV; Beltran, S; Novoa, B; Figueras, A				Pereiro, Patricia; Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Forn-Cuni, Gabriel; Fuste, Berta; Planas, Josep V.; Beltran, Sergi; Novoa, Beatriz; Figueras, Antonio			High-Throughput Sequence Analysis of Turbot (Scophthalmus maximus) Transcriptome Using 454-Pyrosequencing for the Discovery of Antiviral Immune Genes	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; DUPLEX-SPECIFIC NUCLEASE; INNATE IMMUNITY; PRIMARY DEFENSE; SNP DETECTION; FISH; EXPRESSION; ANNOTATION; PROTEIN; IDENTIFICATION	Background: Turbot (Scophthalmus maximus L.) is an important aquacultural resource both in Europe and Asia. However, there is little information on gene sequences available in public databases. Currently, one of the main problems affecting the culture of this flatfish is mortality due to several pathogens, especially viral diseases which are not treatable. In order to identify new genes involved in immune defense, we conducted 454-pyrosequencing of the turbot transcriptome after different immune stimulations. Methodology/Principal Findings: Turbot were injected with viral stimuli to increase the expression level of immune-related genes. High-throughput deep sequencing using 454-pyrosequencing technology yielded 915,256 high-quality reads. These sequences were assembled into 55,404 contigs that were subjected to annotation steps. Intriguingly, 55.16% of the deduced protein was not significantly similar to any sequences in the databases used for the annotation and only 0.85% of the BLASTx top-hits matched S. maximus protein sequences. This relatively low level of annotation is possibly due to the limited information for this specie and other flatfish in the database. These results suggest the identification of a large number of new genes in turbot and in fish in general. A more detailed analysis showed the presence of putative members of several innate and specific immune pathways. Conclusions/Significance: To our knowledge, this study is the first transcriptome analysis using 454-pyrosequencing for turbot. Previously, there were only 12,471 EST and less of 1,500 nucleotide sequences for S. maximus in NCBI database. Our results provide a rich source of data (55,404 contigs and 181,845 singletons) for discovering and identifying new genes, which will serve as a basis for microarray construction, gene expression characterization and for identification of genetic markers to be used in several applications. Immune stimulation in turbot was very effective, obtaining an enormous variety of sequences belonging to genes involved in the defense mechanisms.	[Pereiro, Patricia; Balseiro, Pablo; Romero, Alejandro; Dios, Sonia; Forn-Cuni, Gabriel; Novoa, Beatriz; Figueras, Antonio] CSIC, IIM, Vigo, Spain; [Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; [Planas, Josep V.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Fuste, Berta; Beltran, Sergi] Univ Barcelona, CCiT UB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Barcelona; University of Barcelona; University of Barcelona	Pereiro, P (corresponding author), CSIC, IIM, Vigo, Spain.	antoniofigueras@iim.csic.es	Dios, Sonia/M-4201-2018; Novoa, Beatriz/K-3785-2014; Forn-Cuní, Gabriel/M-8498-2016; Figueras, Antonio/AAB-8921-2019; Pereiro, Patricia/AAS-9514-2020; Romero, Alejandro/R-4565-2019; Balseiro, Pablo/I-7406-2013; Figueras, Antonio/B-5133-2015; Beltran, Sergi/I-3408-2015	Dios, Sonia/0000-0002-2126-991X; Forn-Cuní, Gabriel/0000-0001-5976-4759; Figueras, Antonio/0000-0002-0617-0030; Pereiro, Patricia/0000-0002-8734-3334; Romero, Alejandro/0000-0002-9343-3352; Figueras, Antonio/0000-0002-0617-0030; Beltran, Sergi/0000-0002-2810-3445; Planas, Josep/0000-0002-6525-9617; Novoa, Beatriz/0000-0003-4888-8419; Balseiro, Pablo/0000-0002-9365-6775	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work has been supported by the funding from the project CSD2007-00002 "Aquagenomics" of the program Consolider-Ingenio 2010 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Biragyn A, 2005, CURR PROTEIN PEPT SC, V6, P53, DOI 10.2174/1389203053027601; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chang MX, 2005, PARASITOL RES, V96, P224, DOI 10.1007/s00436-005-1340-8; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; Concha MI, 2004, EUR J BIOCHEM, V271, P2984, DOI 10.1111/j.1432-1033.2004.04228.x; Concha MI, 2003, FISH SHELLFISH IMMUN, V14, P259, DOI 10.1006/fsim.2002.0435; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dios S, 2007, MOL IMMUNOL, V44, P2195, DOI 10.1016/j.molimm.2006.11.017; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ewart K. Vanya, 1993, Molecular Marine Biology and Biotechnology, V2, P20; Federation of European Aquaculture Producers (FEAP), 2008, PROD PRIC REP MEMB A; Feliciani C, 1996, CRIT REV ORAL BIOL M, V7, P300, DOI 10.1177/10454411960070040101; Food and Agriculture Organization of the United Nations (FAO), 2010, STAT WORLD FISH AQ; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P79, DOI 10.3354/dao039079; HALLQUIST NA, 1994, COMP BIOCHEM PHYS B, V108, P375, DOI 10.1016/0305-0491(94)90089-2; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Lu PP, 2011, LIFE SCI, V88, P839, DOI 10.1016/j.lfs.2011.03.003; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Marra MA, 1998, TRENDS GENET, V14, P4, DOI 10.1016/S0168-9525(97)01355-3; Millan A, 2010, MAR BIOTECHNOL, V12, P452, DOI 10.1007/s10126-009-9231-0; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Motizuki M, 2002, J BIOCHEM, V132, P115, DOI 10.1093/oxfordjournals.jbchem.a003187; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Nielsen JG, 1986, FISHES NE ATLANTIC M, P1287; Office International des Epizooties (OIE), 2009, MAN DIAGN TEST AQ AN; Pardo BG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-37; Park KC, 2009, FISH SHELLFISH IMMUN, V26, P91, DOI 10.1016/j.fsi.2008.03.010; Poisa-Beiro L, 2008, MOL IMMUNOL, V45, P218, DOI 10.1016/j.molimm.2007.04.016; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Ross K., 1994, Bulletin of the European Association of Fish Pathologists, V14, P213; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sarmasik Aliye, 2002, Turkish Journal of Biology, V26, P201; Serazin AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007976; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Smith VJ, 2010, MAR DRUGS, V8, P1213, DOI 10.3390/md8041213; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Townsend MJ, 2000, J CELL SCI, V113, P3549; Villarroel F, 2007, FISH SHELLFISH IMMUN, V23, P197, DOI 10.1016/j.fsi.2006.10.008; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wang C, 2008, J FISH DIS, V31, P505, DOI 10.1111/j.1365-2761.2008.00914.x; Wang H., 2003, CYTOKINE HDB, V4th ed., P837; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	79	91	99	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e35369	10.1371/journal.pone.0035369	http://dx.doi.org/10.1371/journal.pone.0035369			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629298	Green Published, gold			2022-12-27	WOS:000305343500004
J	Zheng, M; Lv, LL; Cao, YH; Liu, H; Ni, J; Dai, HY; Liu, D; Lei, XD; Liu, BC				Zheng, Min; Lv, Lin-Li; Cao, Yu-Han; Liu, Hong; Ni, Jie; Dai, Hou-Yong; Liu, Dan; Lei, Xiang-Dong; Liu, Bi-Cheng			A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY-DISEASE; PROGRESSION; PODOCYTES	Background: The initiation and progression of diabetic nephropathy (DN) is complex. Quantification of mRNA expression in urinary sediment has emerged as a novel strategy for studying renal diseases. Considering the numerous molecules involved in DN development, a high-throughput platform with parallel detection of multiple mRNAs is needed. In this study, we constructed a self-assembling mRNA array to analyze urinary mRNAs in DN patients with aims to reveal its potential in searching novel biomarkers. Methods: mRNA array containing 88 genes were fabricated and its performance was evaluated. A pilot study with 9 subjects including 6 DN patients and 3 normal controls were studied with the array. DN patients were assigned into two groups according to their estimate glomerular rate (eGFR): DNI group (eGFR > 60 ml/min/1.73 m(2), n = 3) and DNII group (eGFR<60 ml/min/1.73 m(2), n = 3). Urinary cell pellet was collected from each study participant. Relative abundance of these target mRNAs from urinary pellet was quantified with the array. Results: The array we fabricated displayed high sensitivity and specificity. Moreover, the Cts of Positive PCR Controls in our experiments were 24 +/- 0.5 which indicated high repeatability of the array. A total of 29 mRNAs were significantly increased in DN patients compared with controls (p < 0.05). Among these genes, alpha-actinin4, CDH2, ACE, FAT1, synaptopodin, COL4 alpha, twist, NOTCH3 mRNA expression were 15-fold higher than those in normal controls. In contrast, urinary TIMP-1 mRNA was significantly decreased in DN patients (p < 0.05). It was shown that CTGF, MCP-1, PAI-1, ACE, CDH1, CDH2 mRNA varied significantly among the 3 study groups, and their mRNA levels increased with DN progression (p<0.05). Conclusion: Our pilot study demonstrated that mRNA array might serve as a high-throughput and sensitive tool for detecting mRNA expression in urinary sediment. Thus, this primary study indicated that mRNA array probably could be a useful tool for searching new biomarkers for DN.	[Zheng, Min; Lv, Lin-Li; Cao, Yu-Han; Liu, Hong; Ni, Jie; Dai, Hou-Yong; Liu, Dan; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Lei, Xiang-Dong] CT Biosci, Chang Zhou, Peoples R China	Southeast University - China	Zheng, M (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	Liubc64@yahoo.com.cn			national key basic research project [2012CB517700]; China National Natural Scientific Fund [30870953]	national key basic research project(National Basic Research Program of China); China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC))	This study was supported by the national key basic research project grant (2012CB517700) and China National Natural Scientific Fund (No. 30870953) to B-CL as PI.http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins RC, 2010, AM J KIDNEY DIS, V55, P205, DOI 10.1053/j.ajkd.2009.12.001; Chang Shirley S, 2008, Pediatr Endocrinol Rev, V5 Suppl 4, P974; Chawla T, 2010, WORLD J DIABETES, V1, P141, DOI 10.4239/wjd.v1.i5.141; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Li MX, 2007, CHINESE MED J-PEKING, V120, P1925, DOI 10.1097/00029330-200711010-00015; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MacIsaac RJ, 2011, CURR OPIN NEPHROL HY, V20, P246, DOI 10.1097/MNH.0b013e3283456546; Menzel S, 2011, PEDIATR NEPHROL, V26, P1775, DOI 10.1007/s00467-010-1725-5; Munshi R, 2011, J AM SOC NEPHROL, V22, P165, DOI 10.1681/ASN.2010060641; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Petermann AT, 2003, KIDNEY INT, V64, P1222, DOI 10.1046/j.1523-1755.2003.00217.x; Rodder S, 2011, VIRCHOWS ARCH, V458, P487, DOI 10.1007/s00428-011-1052-7; Roepman P, 2010, BIOANALYSIS, V2, P249, DOI 10.4155/BIO.09.172; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Wu CC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/581928; Zheng M, 2011, CLIN ENDOCRINOL OXF; Zheng M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020431	24	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e34824	10.1371/journal.pone.0034824	http://dx.doi.org/10.1371/journal.pone.0034824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22629296	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343500003
J	Hasan, MZ; Kamil, AA; Mustafa, A; Baten, MA				Hasan, Md. Zobaer; Kamil, Anton Abdulbasah; Mustafa, Adli; Baten, Md. Azizul			Stochastic Frontier Model Approach for Measuring Stock Market Efficiency with Different Distributions	PLOS ONE			English	Article							MEASURING COST EFFICIENCY; TECHNICAL EFFICIENCY; LIFE-INSURANCE; BANKING	The stock market is considered essential for economic growth and expected to contribute to improved productivity. An efficient pricing mechanism of the stock market can be a driving force for channeling savings into profitable investments and thus facilitating optimal allocation of capital. This study investigated the technical efficiency of selected groups of companies of Bangladesh Stock Market that is the Dhaka Stock Exchange (DSE) market, using the stochastic frontier production function approach. For this, the authors considered the Cobb-Douglas Stochastic frontier in which the technical inefficiency effects are defined by a model with two distributional assumptions. Truncated normal and half-normal distributions were used in the model and both time-variant and time-invariant inefficiency effects were estimated. The results reveal that technical efficiency decreased gradually over the reference period and that truncated normal distribution is preferable to half-normal distribution for technical inefficiency effects. The value of technical efficiency was high for the investment group and low for the bank group, as compared with other groups in the DSE market for both distributions in time-varying environment whereas it was high for the investment group but low for the ceramic group as compared with other groups in the DSE market for both distributions in time-invariant situation.	[Hasan, Md. Zobaer; Kamil, Anton Abdulbasah] Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia; [Mustafa, Adli] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Baten, Md. Azizul] Univ Utara Malaysia, Sch Quantitat Sci, Dept Decis Sci, Sintok, Darul Aman, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Utara Malaysia	Hasan, MZ (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia.	raihan_stat@yahoo.com	Kamil, Anton Abdulbasah/A-9795-2011	Kamil, Anton Abdulbasah/0000-0001-5410-812X; Mustafa, Adli/0000-0003-0989-674X; HASAN, MD ZOBAER/0000-0002-6378-6333; Baten, Md. Azizul/0000-0001-9786-6369	Postgraduate Research Grant Scheme (PRGS) Universiti Sains Malaysia, Penang, Malaysia [1001/PJJAUH/844077]	Postgraduate Research Grant Scheme (PRGS) Universiti Sains Malaysia, Penang, Malaysia	The authors are grateful for the financial support provided by the Postgraduate Research Grant Scheme (PRGS) (Grant number: 1001/PJJAUH/844077), Universiti Sains Malaysia, Penang, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Alam MI, 1999, REV PACIFIC BASIN FI, V2, P301, DOI DOI 10.1142/S0219091599000175; Altunbas Y, 2001, J MONEY CREDIT BANK, V33, P926, DOI 10.2307/2673929; BANZ RW, 1981, J FINANC ECON, V9, P3, DOI 10.1016/0304-405X(81)90018-0; BATTESE GE, 1992, AGR ECON, V7, P185, DOI 10.1016/0169-5150(92)90049-5; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Bauer PW, 1998, J ECON BUS, V50, P85, DOI DOI 10.1016/S0148-6195(97)00072-6; Berger AN, 1997, EUR J OPER RES, V98, P175, DOI 10.1016/S0377-2217(96)00342-6; BUTLER KC, 1992, J BANK FINANC, V16, P197, DOI 10.1016/0378-4266(92)90085-E; CHAN LKC, 1991, J FINANC, V46, P1739, DOI 10.2307/2328571; Claessens S, 1996, CROSS SECTION STOCK; Coelli TJ, CEPA WORKING PAPERS; Cummins JD, 1998, J PROD ANAL, V10, P131, DOI 10.1023/A:1026402922367; ERRUNZA VR, 1985, J BANK FINANC, V9, P561, DOI 10.1016/0378-4266(85)90007-X; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; Fecher F., 1993, J PROD ANAL, V4, P77, DOI [DOI 10.1007/BF01073467, 10.1007/BF01073467]; FERRIER GD, 1990, J ECONOMETRICS, V46, P229, DOI 10.1016/0304-4076(90)90057-Z; Fishe R., 1993, J BUSINESS FINANCE A, V20, P881; Greene W.H., 2008, MEASUREMENT PRODUCTI, V1, P92, DOI DOI 10.1093/ACPROF:OSO/9780195183528.001.0001; Hassan MK, 2004, INT J APPL BUSINESS, V2; Hjalmarsson L, 1996, J PROD ANAL, V7, P303, DOI 10.1007/BF00157046; Islam MM, 1999, INT ADV EC RES, V5, P397; Kasman S, COMPARISON CHANCE CO; KIRKLEY JE, 1995, AM J AGR ECON, V77, P686, DOI 10.2307/1243235; Lakonishok J, 1988, REV FINANC STUD, V1, P403, DOI 10.1093/rfs/1.4.403; Maudos J., 2002, J INT FINANC MARK I, V12, P33, DOI DOI 10.1016/S1042-4431(01)00051-8; Mester LJ, 1996, J BANK FINANC, V20, P1025, DOI 10.1016/0378-4266(95)00047-X; Murthy KV., 2002, REV COMMER STUD, V20-21, P75; Nourredine K., 1998, J FINANC MANAG ANAL, V11, P48; Pastor JM, 1997, EUR J OPER RES, V98, P395, DOI 10.1016/S0377-2217(96)00355-4; Resti A, 1997, J BANK FINANC, V21, P221, DOI 10.1016/S0378-4266(96)00036-2; Strong N., 1992, J BUS FINAN ACCOUNT, V19, P533, DOI [10.1111/j.1468-5957.1992.tb00643.x, DOI 10.1111/JBFA.1992.19.ISSUE-4]; Uddin MGS, 2009, INT RES J FINANCE EC, V33, P87; Uddin MGS, 2007, S ASIAN J MANAGE SCI, V1, P123; Weill L, 2004, J PROD ANAL, V21, P133, DOI 10.1023/B:PROD.0000016869.09423.0c; YUENGERT AM, 1993, J BANK FINANC, V17, P483, DOI 10.1016/0378-4266(93)90047-H	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37047	10.1371/journal.pone.0037047	http://dx.doi.org/10.1371/journal.pone.0037047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22629352	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341200037
J	Zhang, XM; Yu, Q; Olsen, L; Bi, X				Zhang, Xinmin; Yu, Qun; Olsen, Lars; Bi, Xin			Functions of Protosilencers in the Formation and Maintenance of Heterochromatin in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRANSCRIPTIONALLY SILENT CHROMATIN; RESOLUTION STRUCTURAL-ANALYSIS; GENOME-WIDE ANALYSIS; DNA-REPLICATION; HISTONE ACETYLATION; TRANSACTIVATOR POTENTIATION; DIRECTIONAL ESTABLISHMENT; YEAST HETEROCHROMATIN; SUBTELOMERIC REGIONS; TELOMERE LENGTH	In Saccharomyces cerevisiae, transcriptionally silent heterochromatin at HML and HMR loci is established by silencers that recruit SIR complex and promote its propagation along chromatin. Silencers consist of various combinations of two or three binding sites for origin recognition complex (ORC), Abf1 and Rap1. A single ORC, Abf1 or Rap1 site cannot promote silencing, but can enhance silencing by a distant silencer, and is called a protosilencer. The mechanism of protosilencer function is not known. We examine the functions of ORC, Abf1 and Rap1 sites as components of the HMR-E silencer, and as protosilencers. We find that the Rap1 site makes a larger and unique contribution to HMR-E function compared to ORC and Abf1 sites. On the other hand, Rap1 site does not act as a protosilencer to assist HML-E silencer in forming heterochromatin, whereas ORC and Abf1 sites do. Therefore, different mechanisms may be involved in the roles of Rap1 site as a component of HMR-E and as a protosilencer. Heterochromatin formed by ORC or Abf1 site in collaboration with HML-E is not as stable as that formed by HMR-E and HML-E, but increasing the copy number of Abf1 site enhances heterochromatin stability. ORC and Abf1 sites acting as protosilencers do not modulate chromatin structure in the absence of SIR complex, which argues against the hypothesis that protosilencers serve to create a chromatin structure favorable for SIR complex propagation. We also investigate the function of ARS1 containing an ORC site and an Abf1 site as a protosilencer. We find that ARS1 inserted at HML enhances heterochromatin stability, and promotes de novo formation of a chromatin structure that partially resembles heterochromatin in an S phase dependent manner. Taken together, our results indicate that protosilencers aid in the formation and maintenance of heterochromatin structure.	[Zhang, Xinmin; Yu, Qun; Olsen, Lars; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Zhang, Xinmin] Jilin Univ, Sch Pharmaceut Sci, Changchun 130023, Jilin, Peoples R China	University of Rochester; Jilin University	Zhang, XM (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu		zhang, xinmin/0000-0003-1317-2736	National Institutes of Health [GM62484-10S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM62484-10S1 to XB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Bi X, 1999, GENE DEV, V13, P1089, DOI 10.1101/gad.13.9.1089; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Casey L, 2008, MOL BIOL CELL, V19, P608, DOI 10.1091/mbc.E07-04-0323; Cheng TH, 2000, GENE DEV, V14, P452; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Lebrun E, 2001, GENETICS, V158, P167; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Livingstone-Zatchej M, 2003, J BIOL CHEM, V278, P37471, DOI 10.1074/jbc.M306335200; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Miyake T, 2004, J BIOL CHEM, V279, P34865, DOI 10.1074/jbc.M405156200; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; Norris A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000301; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rivier DH, 1999, GENETICS, V151, P521; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Ryan MP, 1999, METHOD ENZYMOL, V304, P376; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Weber JM, 2010, NUCLEIC ACIDS RES, V38, P7991, DOI 10.1093/nar/gkq689; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Yu Q, 2009, J BIOL CHEM, V284, P740, DOI 10.1074/jbc.M806274200; Zou S, 1997, P NATL ACAD SCI USA, V94, P7412, DOI 10.1073/pnas.94.14.7412; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465; Zou YF, 2006, MOL CELL BIOL, V26, P7806, DOI 10.1128/MCB.01197-06; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	65	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e37092	10.1371/journal.pone.0037092	http://dx.doi.org/10.1371/journal.pone.0037092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615905	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341200041
J	Sakamoto, M; Moriyama, N; Mizuguchi, N; Muraoka, T; Kanosue, K				Sakamoto, Masanori; Moriyama, Noriyoshi; Mizuguchi, Nobuaki; Muraoka, Tetsuro; Kanosue, Kazuyuki			Modulation of Corticospinal Excitability during Acquisition of Action Sequences by Observation	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; HUMAN MOTOR CORTEX; HAND ACTIONS; IMITATION; FACILITATION; PREMOTOR; MOVEMENTS; COIL	Excitability of the corticospinal pathway increases during observation of an action. However, how corticospinal excitability changes during observation of sequential actions in the course of acquiring novel skills (observational learning) remains unexplored. To investigate this, we used a previously unpracticed sequence of ten hand postures. Participants were asked to repeat observation and replication of the sequence. This block of observation and replication was repeated 5 times. During observation of a given hand posture (OK sign), motor-evoked potentials (MEPs) elicited by transcranial magnetic stimulation were recorded from hand muscles. In experiment 1, the OK sign appeared in the 9th position of the sequence. Almost all participants could replicate the OK sign only at the 5th block of the experiment. MEP amplitude was greater than that in the control, and decreased with the stages. This suggested that during observational learning of sequential hand postures MEP changed with the progress of the learning. To evaluate this idea, we performed two additional experiments. In experiment 2, the OK sign appeared in the 2nd position. Almost all participants replicated the OK sign even in the 1st block. The MEP amplitude did not change across stages. In experiment 3, the OK sign appeared in the 9th position, but the order of other signs was randomized in every stage. Many participants were not able to replicate the OK sign even during the 5th block of the experiment. The MEP amplitude did not change across stages. These results suggest that: (1) During observational learning modulation of corticospinal excitability is associated with the learning process. (2) Corticospinal excitability decreases as learning progresses.	[Sakamoto, Masanori; Moriyama, Noriyoshi; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Sakamoto, Masanori] Kumamoto Univ, Fac Educ, Dept Phys Educ, Kumamoto, Japan; [Mizuguchi, Nobuaki; Kanosue, Kazuyuki] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Muraoka, Tetsuro] Nihon Univ, Coll Econ, Tokyo, Japan	Waseda University; Kumamoto University; Waseda University; Nihon University	Sakamoto, M (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	sakamoto@educ.kumamoto-u.ac.jp		Muraoka, Tetsuro/0000-0002-2303-1139	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grant-in-Aid for the Global COE "Sport Sciences for the Promotion of Active Life," Waseda University, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Avenanti A, 2007, CURR BIOL, V17, P2129, DOI 10.1016/j.cub.2007.11.045; Bhatt T, 2008, J NEUROPHYSIOL, V99, P843, DOI 10.1152/jn.00720.2007; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Buccino G, 2006, COGN BEHAV NEUROL, V19, P55, DOI 10.1097/00146965-200603000-00007; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sakamoto M, 2009, EXP BRAIN RES, V199, P17, DOI 10.1007/s00221-009-1962-7; SCHOFIELD WN, 1976, Q J EXP PSYCHOL, V28, P571, DOI 10.1080/14640747608400584; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Stefan K, 2005, J NEUROSCI, V25, P9339, DOI 10.1523/JNEUROSCI.2282-05.2005; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Vogt S, 2007, J SPORT SCI, V25, P497, DOI 10.1080/02640410600946779; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; WAPNER S, 1968, CHILD DEV, V39, P887, DOI 10.1111/j.1467-8624.1968.tb04469.x	30	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37061	10.1371/journal.pone.0037061	http://dx.doi.org/10.1371/journal.pone.0037061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615889	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300059
J	Allain, V; Fernandez, E; Hoyle, SD; Caillot, S; Jurado-Molina, J; Andrefouet, S; Nicol, SJ				Allain, Valerie; Fernandez, Emilie; Hoyle, Simon D.; Caillot, Sylvain; Jurado-Molina, Jesus; Andrefouet, Serge; Nicol, Simon J.			Interaction between Coastal and Oceanic Ecosystems of the Western and Central Pacific Ocean through Predator-Prey Relationship Studies	PLOS ONE			English	Article							FISH AGGREGATION DEVICES; TUNA KATSUWONUS-PELAMIS; CORAL-REEF FISHES; YELLOWFIN TUNA; THUNNUS-ALBACARES; FEEDING-HABITS; CONSUMPTION RATES; STOMACH CONTENTS; PELAGIC STAGES; DAILY RATION	The Western and Central Pacific Ocean sustains the highest tuna production in the world. This province is also characterized by many islands and a complex bathymetry that induces specific current circulation patterns with the potential to create a high degree of interaction between coastal and oceanic ecosystems. Based on a large dataset of oceanic predator stomach contents, our study used generalized linear models to explore the coastal-oceanic system interaction by analyzing predator-prey relationship. We show that reef organisms are a frequent prey of oceanic predators. Predator species such as albacore (Thunnus alalunga) and yellowfin tuna (Thunnus albacares) frequently consume reef prey with higher probability of consumption closer to land and in the western part of the Pacific Ocean. For surface-caught-predators consuming reef prey, this prey type represents about one third of the diet of predators smaller than 50 cm. The proportion decreases with increasing fish size. For predators caught at depth and consuming reef prey, the proportion varies with predator species but generally represents less than 10%. The annual consumption of reef prey by the yellowfin tuna population was estimated at 0.8 +/- 0.40CV million tonnes or 2.17x10(12)+/- 0.40CV individuals. This represents 6.1%+/- 60.17CV in weight of their diet. Our analyses identify some of the patterns of coastal-oceanic ecosystem interactions at a large scale and provides an estimate of annual consumption of reef prey by oceanic predators.	[Allain, Valerie; Fernandez, Emilie; Hoyle, Simon D.; Caillot, Sylvain; Jurado-Molina, Jesus; Nicol, Simon J.] Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia; [Andrefouet, Serge] Inst Rech Dev, Unite Rech CoReUs 227, Noumea, New Caledonia	Institut de Recherche pour le Developpement (IRD)	Allain, V (corresponding author), Secretariat Pacific Community, Ocean Fisheries Programme, Noumea, New Caledonia.	ValerieA@spc.int	Allain, Valerie/AAE-1449-2019; Hoyle, Simon D/G-1201-2015	Allain, Valerie/0000-0002-9874-3077; Hoyle, Simon D/0000-0002-1787-6565; Nicol, Simon/0000-0001-8193-8719	Pacific Islands Oceanic Fisheries Management Project; Global Environment Facility; Joint Institute for Marine and Atmospheric Research (JIMAR) [NA17RJ1230]; National Oceanic and Atmospheric Administration (NOAA); New Caledonia ZoNeCo	Pacific Islands Oceanic Fisheries Management Project; Global Environment Facility; Joint Institute for Marine and Atmospheric Research (JIMAR); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); New Caledonia ZoNeCo	This research is part of the Pacific Islands Oceanic Fisheries Management Project supported by Global Environment Facility. This project was co-funded by Cooperative Agreement NA17RJ1230 between the Joint Institute for Marine and Atmospheric Research (JIMAR) and the National Oceanic and Atmospheric Administration (NOAA). The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA of any of its subdivisions. Co-funding was provided by New Caledonia ZoNeCo programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2008, DEEP-SEA RES PT I, V55, P1035, DOI 10.1016/j.dsr.2008.04.004; Alverson F, 1963, INTERAM TROP TUNA CO, V7, P295; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1986, SMITHS SEA FISHES; Barut N. C., 1988, IPTP88WP18 FAOUNDP, P1; Bell, 2011, VULNERABILITY TROPIC; Bertrand A, 2002, MAR BIOL, V140, P1023, DOI 10.1007/s00227-001-0776-3; BOEHLERT GW, 1992, DEEP-SEA RES, V39, P439, DOI 10.1016/0198-0149(92)90082-5; Boltovskoy D., 1999, S ATLANTIC ZOOPLANKT; Borodulina O. D., 1974, J ICHTHYOL, V14; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; BROCK RE, 1985, B MAR SCI, V37, P40; BUCKLEY TW, 1994, B MAR SCI, V55, P445; Carpenter K. E., 1999, FAO SPECIES IDENTIFI; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Coutis PF, 1999, DEEP-SEA RES PT I, V46, P1633, DOI 10.1016/S0967-0637(99)00007-2; Cowen R. K, 2002, ECOLOGY CORAL REEF F, P149; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Domokos R, 2007, FISH OCEANOGR, V16, P555, DOI 10.1111/j.1365-2419.2007.00451.x; Essington TE, 2002, ECOL APPL, V12, P724; Garvey JE, 2006, AM FISH SOC, V11, P1; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; GRANDPERRIN R, 1971, CAH ORSTOM OCEANOGR, V9, P197; Grandperrin R, 1976, LIMNOL OCEANOGR, V21, P731; Griffiths SP, 2007, MAR FRESHWATER RES, V58, P376, DOI 10.1071/MF06197; Griffiths SP, 2009, ICES J MAR SCI, V66, P720, DOI 10.1093/icesjms/fsp065; HIDA TS, 1973, FISH B-NOAA, V71, P135; HUNTER JR, 1967, US FISH WLD S FISH B, V66, P13; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Kim Jong-Bin, 1997, Journal of the Korean Fisheries Society, V30, P719; KINGSFORD MJ, 1993, B MAR SCI, V53, P393; Kirby DS, 2005, NOUM NEW CAL W CENTR; Langley A, PONHP FED STAT MICR; Lehodey P., 1990, 22 C TECHN REG PECH, P1; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; LEIS JM, 1993, B MAR SCI, V53, P362; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Liddelow MJ, 2006, P 10 INT COR REEF S, P403; LimouzyParis CB, 1997, B MAR SCI, V60, P966; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Maldeniya R, 1996, ENVIRON BIOL FISH, V47, P101, DOI 10.1007/BF00002384; Menard F, 2006, MAR ECOL PROG SER, V323, P223, DOI 10.3354/meps323223; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moteki M, 2001, FISHERIES SCI, V67, P063; Mugo R, 2010, FISH OCEANOGR, V19, P382, DOI 10.1111/j.1365-2419.2010.00552.x; NAKAMURA EL, 1965, T AM FISH SOC, V94, P236, DOI 10.1577/1548-8659(1965)94[236:FAFHOS]2.0.CO;2; Olson RJ, 2002, FISH B-NOAA, V100, P279; OLSON RJ, 1986, CAN J FISH AQUAT SCI, V43, P1760, DOI 10.1139/f86-220; POLOVINA JJ, 1995, B MAR SCI, V56, P406; Poore GCB, 2004, MARINE DECAPOD CRUST; Ramirez-Mella JT, 2003, B MAR SCI, V72, P997; Reintjes J. W., 1953, FISH B US, V81, P91; Ronquillo I. A., 1953, PHILIPP J FISH, V2, P71; Rudershausen PJ, 2010, T AM FISH SOC, V139, P1335, DOI 10.1577/T09-105.1; SAITO S, 1970, BULL JAP SOC SCI FISH, V36, P578; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; Sharp G.D., 1978, P397; SHULMAN MJ, 1987, MAR ECOL PROG SER, V39, P233, DOI 10.3354/meps039233; Stefansson G, 1997, CAN J FISH AQUAT SCI, V54, P169, DOI 10.1139/f96-246; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Tester AL, 1957, US FISH WILD SERV SP, V250, P16; Watanabe H., 1958, REP NANKAI REG FISH, V7, P72; Williams P, 2011, PONHP FED STAT MICR; Wrobel D, 1998, PACIFIC COAST PELAGI; Young JW, 2010, MAR BIOL, V157, P2347, DOI 10.1007/s00227-010-1500-y; YOUNG PC, 1986, MAR ECOL PROG SER, V31, P209, DOI 10.3354/meps031209; Young R, 2008, DECAPODIFORMES LEACH	74	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36701	10.1371/journal.pone.0036701	http://dx.doi.org/10.1371/journal.pone.0036701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615796	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336300029
J	Andreou, D; Arkush, KD; Guegan, JF; Gozlan, RE				Andreou, Demetra; Arkush, Kristen D.; Guegan, Jean-Francois; Gozlan, Rodolphe E.			Introduced Pathogens and Native Freshwater Biodiversity: A Case Study of Sphaerothecum destruens	PLOS ONE			English	Article							FISH; INFECTION; PATHOLOGY; DISEASE	A recent threat to European fish diversity was attributed to the association between an intracellular parasite, Sphaerothecum destruens, and a healthy freshwater fish carrier, the invasive Pseudorasbora parva originating from China. The pathogen was found to be responsible for the decline and local extinction of the European endangered cyprinid Leucaspius delineatus and high mortalities in stocks of Chinook and Atlantic salmon in the USA. Here, we show that the emerging S. destruens is also a threat to a wider range of freshwater fish than originally suspected such as bream, common carp, and roach. This is a true generalist as an analysis of susceptible hosts shows that S. destruens is not limited to a phylogenetically narrow host spectrum. This disease agent is a threat to fish biodiversity as it can amplify within multiple hosts and cause high mortalities.	[Andreou, Demetra; Gozlan, Rodolphe E.] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Andreou, Demetra] Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Guegan, Jean-Francois] Univ Montpellier I, CNRS, Inst Rech Dev, Montpellier, France; [Guegan, Jean-Francois] Univ Montpellier 2, Montpellier, France; [Guegan, Jean-Francois] French Sch Publ Hlth, Interdisciplinary Ctr Climate Change Biodivers &, Montpellier, France	Bournemouth University; Cardiff University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Andreou, D (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	dandreou@bournemouth.ac.uk	Andreou, Demetra/AGF-2932-2022; Guegan, Jean-Francois/F-4346-2012	Guegan, Jean-Francois/0000-0002-7218-107X	Department for Environment, Food and Rural Affairs (DEFRA) [FC1176]	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (DEFRA), contract FC1176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou D, 2011, DIS AQUAT ORGAN, V95, P145, DOI 10.3354/dao02356; Andreou D, 2011, PARASITOLOGY, V138, P26, DOI 10.1017/S0031182010000983; Andreou D, 2009, J PARASITOL, V95, P1539, DOI 10.1645/GE-2124.1; Arkush KD, 2003, J EUKARYOT MICROBIOL, V50, P430, DOI 10.1111/j.1550-7408.2003.tb00269.x; Arkush KD, 1998, J AQUAT ANIM HEALTH, V10, P1, DOI 10.1577/1548-8667(1998)010&lt;0001:PAWTRA&gt;2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2006, MICROBES INFECT, V8, P1358, DOI 10.1016/j.micinf.2005.12.010; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; HARRELL LW, 1986, AQUACULTURE, V55, P249, DOI 10.1016/0044-8486(86)90167-5; HEDRICK RP, 1989, DIS AQUAT ORGAN, V7, P171, DOI 10.3354/dao007171; Krasnov BR, 2008, PARASITOL RES, V102, P1157, DOI 10.1007/s00436-008-0884-9; LELEK A, 1987, FRESHWATER FISHES EU; Mendonca HL, 2004, DIS AQUAT ORGAN, V61, P187, DOI 10.3354/dao061187; Mendoza L, 2002, ANNU REV MICROBIOL, V56, P315, DOI 10.1146/annurev.micro.56.012302.160950; Ostlund-Nilsson S, 2005, MAR ECOL PROG SER, V287, P209, DOI 10.3354/meps287209; Paley RK, 2012, PARASITOLOGY, V139, P904, DOI 10.1017/S0031182012000030; Peeler EJ, 2011, BIOL INVASIONS, V13, P1291, DOI 10.1007/s10530-010-9890-9; Pereira CN, 2005, J CLIN MICROBIOL, V43, P192, DOI 10.1128/JCM.43.1.192-198.2005; PRICE PW, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P21; R Development Core Team, 2009, R LANG ENV STAT COMP; Silva V, 2005, J CLIN MICROBIOL, V43, P1865, DOI 10.1128/JCM.43.4.1865-1868.2005; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thrusfield M., 2005, VET EPIDEMIOLOGY; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Wagner H, 2009, VEGAN COMMUNITY ECOL; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	31	53	54	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36998	10.1371/journal.pone.0036998	http://dx.doi.org/10.1371/journal.pone.0036998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615866	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305336300058
J	Coiret, G; Ster, J; Grewe, B; Wendling, F; Helmchen, F; Gerber, U; Benquet, P				Coiret, Guyllaume; Ster, Jeanne; Grewe, Benjamin; Wendling, Fabrice; Helmchen, Fritjof; Gerber, Urs; Benquet, Pascal			Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; ENDOCANNABINOID SYSTEM; SLICE CULTURES; IN-VIVO; GLUTAMATE; EPILEPSY; 4-AMINOPYRIDINE; NETWORKS; DEPOLARIZATION; INTERNEURONS	Astrocytes are integral functional components of synapses, regulating transmission and plasticity. They have also been implicated in the pathogenesis of epilepsy, although their precise roles have not been comprehensively characterized. Astrocytes integrate activity from neighboring synapses by responding to neuronally released neurotransmitters such as glutamate and ATP. Strong activation of astrocytes mediated by these neurotransmitters can promote seizure-like activity by initiating a positive feedback loop that induces excessive neuronal discharge. Recent work has demonstrated that astrocytes express cannabinoid 1 (CB1) receptors, which are sensitive to endocannabinoids released by nearby pyramidal cells. In this study, we tested whether this mechanism also contributes to epileptiform activity. In a model of 4-aminopyridine induced epileptic-like activity in hippocampal slice cultures, we show that pharmacological blockade of astrocyte CB1 receptors did not modify the initiation, but significantly reduced the maintenance of epileptiform discharge. When communication in astrocytic networks was disrupted by chelating astrocytic calcium, this CB1 receptor-mediated modulation of epileptiform activity was no longer observed. Thus, endocannabinoid signaling from neurons to astrocytes represents an additional significant factor in the maintenance of epileptiform activity in the hippocampus.	[Coiret, Guyllaume; Ster, Jeanne; Grewe, Benjamin; Helmchen, Fritjof; Gerber, Urs] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Wendling, Fabrice; Benquet, Pascal] Univ Rennes 1, INSERM, U1099, Lab Traitement Signal & Image, Rennes, France	University of Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Coiret, G (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	gerber@hifo.uzh.ch	Grewe, Benjamin/E-7044-2017; Wendling, Fabrice/F-8924-2013; Benquet, Pascal/ABC-6954-2020; WENDLING, Fabrice/P-9574-2019; Helmchen, Fritjof/A-6255-2008	Grewe, Benjamin/0000-0001-8560-2120; WENDLING, Fabrice/0000-0003-2428-9665; Ster, Jeanne/0000-0002-7277-9135; Helmchen, Fritjof/0000-0002-8867-9569; Benquet, Pascal/0000-0003-0217-5886	ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie); Swiss National Science Foundation [31-45547.95]	ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by "Region Bretagne'' (CREATE 2009, "EPIGONE" project; https://xnet1.region-bretagne.fr/Recherche/scripts/Accueil/Accueil.asp), by the ARCE foundation (Association pour la Recherche Clinique sur l'Epilepsie), and by the Swiss National Science Foundation, 31-45547.95 (http://www.snf. ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus K, 2008, BRIT J PHARMACOL, V154, P709, DOI 10.1038/bjp.2008.112; Ameri A, 2000, N-S ARCH PHARMACOL, V361, P265, DOI 10.1007/s002109900200; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Bruckner C, 2000, BRAIN RES, V859, P15, DOI 10.1016/S0006-8993(99)02348-3; Carlson G, 2002, NAT NEUROSCI, V5, P723, DOI 10.1038/nn879; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Demont-Guignard S, 2012, ANN NEUROLOGY; Demont-Guignard S, 2009, IEEE T BIO-MED ENG, V56, P2782, DOI 10.1109/TBME.2009.2028015; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gomez-Gonzalo M, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00008; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; Gonzalez-Sulser A, 2011, NEUROPHARMACOLOGY, V60, P1142, DOI 10.1016/j.neuropharm.2010.10.007; Gordon E, 2001, EPILEPSIA, V42, P1266, DOI 10.1046/j.1528-1157.2001.19301.x; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Juszczak GR, 2009, PROG NEURO-PSYCHOPH, V33, P181, DOI 10.1016/j.pnpbp.2008.12.014; Katona I, 1999, J NEUROSCI, V19, P4544; Le Beau FEN, 1998, J NEUROPHYSIOL, V79, P659, DOI 10.1152/jn.1998.79.2.659; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; PERREAULT P, 1992, J NEUROSCI, V12, P104; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Porter JT, 1996, J NEUROSCI, V16, P5073; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wallace MJ, 2001, EUR J PHARMACOL, V428, P51, DOI 10.1016/S0014-2999(01)01243-2	46	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37320	10.1371/journal.pone.0037320	http://dx.doi.org/10.1371/journal.pone.0037320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615976	Green Published, gold, Green Accepted			2022-12-27	WOS:000305336300092
J	Dedonder, SE; Cheng, CM; Willard, LH; Boyle, DL; Ganta, RR				Dedonder, Sarah E.; Cheng, Chuanmin; Willard, Lloyd H.; Boyle, Daniel L.; Ganta, Roman R.			Transmission Electron Microscopy Reveals Distinct Macrophage- and Tick Cell-Specific Morphological Stages Ehrlichia chaffeensis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MONOCLONAL-ANTIBODIES; ANAPLASMA-MARGINALE; CULTURE; INFECTION; DISEASES; HUMANS; AGENT; CANIS; RICKETTSIAE	Background: Ehrlichia chaffeensis is an emerging tick-borne rickettsial pathogen responsible for human monocytic ehrlichiosis. Despite the induction of an active host immune response, the pathogen has evolved to persist in its vertebrate and tick hosts. Understanding how the organism progresses in tick and vertebrate host cells is critical in identifying effective strategies to block the pathogen transmission. Our recent molecular and proteomic studies revealed differences in numerous expressed proteins of the organism during its growth in different host environments. Methodology/Principal Findings: Transmission electron microscopy analysis was performed to assess morphological changes in the bacterium within macrophages and tick cells. The stages of pathogen progression observed included the attachment of the organism to the host cells, its engulfment and replication within a morulae by binary fission and release of the organisms from infected host cells by complete host cell lysis or by exocytosis. E. chaffeensis grown in tick cells was highly pleomorphic and appears to replicate by both binary fission and filamentous type cell divisions. The presence of Ehrlichia-like inclusions was also observed within the nucleus of both macrophages and tick cells. This observation was confirmed by confocal microscopy and immunoblot analysis. Conclusions/Significance: Morphological differences in the pathogen's progression, replication, and processing within macrophages and tick cells provide further evidence that E. chaffeensis employs unique host-cell specific strategies in support of adaptation to vertebrate and tick cell environments.	[Dedonder, Sarah E.; Cheng, Chuanmin; Willard, Lloyd H.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Boyle, Daniel L.] Kansas State Univ, Coll Arts & Sci, Div Biol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Dedonder, SE (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	rganta@vet.ksu.edu			National Institutes of Health, USA [AI070908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health, USA (grant # AI070908). This manuscript is a contribution from the Kansas Agricultural Experiment Station, number 11-378-J, from Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; Bell-Sakyi L, 2000, J CLIN MICROBIOL, V38, P1238, DOI 10.1128/JCM.38.3.1238-1240.2000; Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P798; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; Chen SM, 1996, AM J TROP MED HYG, V54, P405, DOI 10.4269/ajtmh.1996.54.405; DAWSON JE, 1991, J INFECT DIS, V163, P564, DOI 10.1093/infdis/163.3.564; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ganta RR, 2009, FRONT BIOSCI-LANDMRK, V14, P3259, DOI 10.2741/3449; Ganta RR, 2002, INFECT IMMUN, V70, P380, DOI 10.1128/IAI.70.1.380-388.2002; Gayle A, 2001, AM FAM PHYSICIAN, V64, P461; HIDALGO RJ, 1989, AM J VET RES, V50, P2028; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Li JSY, 2001, J IMMUNOL, V166, P1855; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Liu Y, 2011, MICROBES INFECT, V13, P232, DOI 10.1016/j.micinf.2010.10.021; Munderloh UG, 1996, J CLIN MICROBIOL, V34, P664, DOI 10.1128/JCM.34.3.664-670.1996; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Plessis J L, 1975, Onderstepoort J Vet Res, V42, P1; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Popov VL, 1998, J MED MICROBIOL, V47, P235, DOI 10.1099/00222615-47-3-235; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; RIKIHISA Y, 1991, CLIN MICROBIOL REV, V4, P286, DOI 10.1128/CMR.4.3.286-308.1991; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; SELLS DM, 1976, INFECT IMMUN, V13, P273, DOI 10.1128/IAI.13.1.273-280.1976; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; SILVERMAN DJ, 1991, EUR J EPIDEMIOL, V7, P200, DOI 10.1007/BF00145667; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Thomas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015775; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	46	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36749	10.1371/journal.pone.0036749	http://dx.doi.org/10.1371/journal.pone.0036749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615806	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300035
J	Fung, FKC; Chan, DW; Liu, VWS; Leung, THY; Cheung, ANY; Ngan, HYS				Fung, Frederic K. C.; Chan, David W.; Liu, Vincent W. S.; Leung, Thomas H. Y.; Cheung, Annie N. Y.; Ngan, Hextan Y. S.			Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression	PLOS ONE			English	Article							CELLS; PATHWAY; BIOLOGY; TUMORS; CARCINOGENESIS; PROLIFERATION; CARCINOMA; GENES	Background: Paired-like homeodomain 2 (PITX2) is a bicoid homeodomain transcription factor which plays an essential role in maintaining embryonic left-right asymmetry during vertebrate embryogenesis. However, emerging evidence suggests that the aberrant upregulation of PITX2 may be associated with tumor progression, yet the functional role that PITX2 plays in tumorigenesis remains unknown. Principal Findings: Using real-time quantitative RT-PCR (Q-PCR), Western blot and immunohistochemical (IHC) analyses, we demonstrated that PITX2 was frequently overexpressed in ovarian cancer samples and cell lines. Clinicopathological correlation showed that the upregulated PITX2 was significantly associated with high-grade (P = 0.023) and clear cell subtype (P = 0.011) using Q-PCR and high-grade (P<0.001) ovarian cancer by IHC analysis. Functionally, enforced expression of PITX2 could promote ovarian cancer cell proliferation, anchorage-independent growth ability, migration/invasion and tumor growth in xenograft model mice. Moreover, enforced expression of PITX2 elevated the cell cycle regulatory proteins such as Cyclin-D1 and C-myc. Conversely, RNAi mediated knockdown of PITX2 in PITX2-high expressing ovarian cancer cells had the opposite effect. Conclusion: Our findings suggest that the increased expression PITX2 is involved in ovarian cancer progression through promoting cell growth and cell migration/invasion. Thus, targeting PITX2 may serve as a potential therapeutic modality in the management of high-grade ovarian tumor.	[Fung, Frederic K. C.; Chan, David W.; Liu, Vincent W. S.; Leung, Thomas H. Y.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Fung, FKC (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	Chan, David/O-9896-2018; Cheung, Annie Nga Yin/C-4231-2009	Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X; Cheung, Annie Nga Yin/0000-0002-1584-7568	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by the Wong Check She Charitable Foundation. This support is from private donations, and no funder's website is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Auersperg N, 1997, J CELL PHYSIOL, V173, P261, DOI 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Farley J, 2008, CELL RES, V18, P538, DOI 10.1038/cr.2008.52; Fukumoto M, 2006, PATHOL INT, V56, P233, DOI 10.1111/J.1440-1827.2006.01960.x; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang Y, 2010, CELL CYCLE, P9; Huang Y, 2010, CELL CYCLE, V9, P1333, DOI 10.4161/cc.9.7.11126; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Martin DM, 2002, DEV BIOL, V252, P84, DOI 10.1006/dbio.2002.0835; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Rodriguez-Leon J, 2008, P NATL ACAD SCI USA, V105, P11242, DOI 10.1073/pnas.0804904105; Saad Antonio F., 2010, Hormones & Cancer, V1, P277, DOI 10.1007/s12672-010-0054-2; Singh AP, 2008, LANCET ONCOL, V9, P1076, DOI 10.1016/S1470-2045(08)70277-8; Skidmore JM, 2008, MOL CELL NEUROSCI, V37, P696, DOI 10.1016/j.mcn.2007.12.015; Wang Y, 2007, CANCER RES, V67, P3698, DOI 10.1158/0008-5472.CAN-06-4000; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	32	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e37076	10.1371/journal.pone.0037076	http://dx.doi.org/10.1371/journal.pone.0037076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615897	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300067
J	Conte, V; Ulrich, F; Baum, B; Munoz, J; Veldhuis, J; Brodland, W; Miodownik, M				Conte, Vito; Ulrich, Florian; Baum, Buzz; Munoz, Jose; Veldhuis, Jim; Brodland, Wayne; Miodownik, Mark			A Biomechanical Analysis of Ventral Furrow Formation in the Drosophila Melanogaster Embryo	PLOS ONE			English	Article							GASTRULATION; MECHANICS; FORCES	The article provides a biomechanical analysis of ventral furrow formation in the Drosophila melanogaster embryo. Ventral furrow formation is the first large-scale morphogenetic movement in the fly embryo. It involves deformation of a uniform cellular monolayer formed following cellularisation, and has therefore long been used as a simple system in which to explore the role of mechanics in force generation. Here we use a quantitative framework to carry out a systematic perturbation analysis to determine the role of each of the active forces observed. The analysis confirms that ventral furrow invagination arises from a combination of apical constriction and apical-basal shortening forces in the mesoderm, together with a combination of ectodermal forces. We show that the mesodermal forces are crucial for invagination: the loss of apical constriction leads to a loss of the furrow, while the mesodermal radial shortening forces are the primary cause of the internalisation of the future mesoderm as the furrow rises. Ectodermal forces play a minor but significant role in furrow formation: without ectodermal forces the furrow is slower to form, does not close properly and has an aberrant morphology. Nevertheless, despite changes in the active mesodermal and ectodermal forces lead to changes in the timing and extent of furrow, invagination is eventually achieved in most cases, implying that the system is robust to perturbation and therefore over-determined.	[Conte, Vito] Inst Bioengn Catalonia, Barcelona, Spain; [Ulrich, Florian] New York Hosp, Skirball Inst Biomol Med, New York, NY 10021 USA; [Baum, Buzz] UCL, Med Res Council Lab Mol Cell Biol, London, England; [Munoz, Jose] Univ Politecn Cataluna, Lab Calcul Numer, Dept Appl Math 3, Barcelona, Spain; [Veldhuis, Jim; Brodland, Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Brodland, Wayne] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Miodownik, Mark] UCL, Dept Mech Engn, London, England	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; NewYork-Presbyterian Hospital; University of London; University College London; Universitat Politecnica de Catalunya; University of Waterloo; University of Waterloo; University of London; University College London	Conte, V (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	m.miodownik@ucl.ac.uk	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	Human Frontiers Science Program (HFSP); Natural Sciences and Engineering Research Council of Canada (NSERC); Engineering and Physical Science Research Council of UK; Royal Society; New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engineering and Physical Science Research Council of UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to WB and JV was provided by the Human Frontiers Science Program (HFSP); to WB and SN by the Natural Sciences and Engineering Research Council of Canada (NSERC); to MM and VC by the Engineering and Physical Science Research Council of UK; to BB from the Royal Society and Cancer Research UK; and to FU by the New Jersey Commission of Cancer Research (NJCCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CLAUSI DA, 1993, DEVELOPMENT, V118, P1013; Conte V, 2008, J MECH BEHAV BIOMED, V1, P188, DOI 10.1016/j.jmbbm.2007.10.002; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Costa M, 1993, DEV DROSOPHILA MELAN; Cranston PG, 2010, ANN BIOMED ENG, V38, P2937, DOI 10.1007/s10439-010-9998-1; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Munoz JJ, 2007, J BIOMECH, V40, P1372, DOI 10.1016/j.jbiomech.2006.05.006; Munoz JJ, 2010, BIOMECH MODEL MECHAN, V9, P451, DOI 10.1007/s10237-009-0187-9; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Roth S., 2004, P105; Schunn C.D., 2005, PSYCHOLOGIE KOGNITIO, P115; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; SWEETON D, 1991, DEVELOPMENT, V112, P775; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	32	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34473	10.1371/journal.pone.0034473	http://dx.doi.org/10.1371/journal.pone.0034473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511944	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600030
J	Chen, XJ; Liu, YK; Zhou, YH; Wang, L; Perc, M				Chen, Xiaojie; Liu, Yongkui; Zhou, Yonghui; Wang, Long; Perc, Matjaz			Adaptive and Bounded Investment Returns Promote Cooperation in Spatial Public Goods Games	PLOS ONE			English	Article							RISK SOCIAL DILEMMA; PRISONERS-DILEMMA; REPLICATOR DYNAMICS; EVOLUTIONARY GAMES; DIVERSITY PROMOTES; EMERGENCE; SELECTION; NETWORKS; TRAGEDY; REWARD	The public goods game is one of the most famous models for studying the evolution of cooperation in sizable groups. The multiplication factor in this game can characterize the investment return from the public good, which may be variable depending on the interactive environment in realistic situations. Instead of using the same universal value, here we consider that the multiplication factor in each group is updated based on the differences between the local and global interactive environments in the spatial public goods game, but meanwhile limited to within a certain range. We find that the adaptive and bounded investment returns can significantly promote cooperation. In particular, full cooperation can be achieved for high feedback strength when appropriate limitation is set for the investment return. Also, we show that the fraction of cooperators in the whole population can become larger if the lower and upper limits of the multiplication factor are increased. Furthermore, in comparison to the traditionally spatial public goods game where the multiplication factor in each group is identical and fixed, we find that cooperation can be better promoted if the multiplication factor is constrained to adjust between one and the group size in our model. Our results highlight the importance of the locally adaptive and bounded investment returns for the emergence and dominance of cooperative behavior in structured populations.	[Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Liu, Yongkui] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Zhou, Yonghui] Guizhou Normal Univ, Sch Math & Comp Sci, Guiyang, Peoples R China; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, Maribor, Slovenia	International Institute for Applied Systems Analysis (IIASA); Beihang University; Chang'an University; Chang'an University; Guizhou Normal University; Peking University; University of Maribor	Chen, XJ (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria.	chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Liu, Yongkui/R-9307-2017; Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022	Perc, Matjaz/0000-0002-3087-541X; Liu, Yongkui/0000-0003-2165-775X; Wang, Long/0000-0001-5600-8157; 	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [11161011]; 973 Program [2012CB821203]; NSFC [61020106005, 10972002]; Slovenian Research Agency [J1-4055]	Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University; Special Fund for the Basic Research Support Planning of Chang'an University; Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	YL acknowledges the financial support from the Special Fund for the Basic Scientific Research of Central Colleges, Chang'an University, the Special Fund for the Basic Research Support Planning of Chang'an University, and the Open Fund of Road Traffic Intelligent Detection and Equipment Engineering Research Center, Shaanxi Province (Grant no. CHD2010JC134). YZ acknowledges the financial support from the National Natural Science Foundation of China (NSFC) (grant no. 11161011). LW acknowledges the financial support from 973 Program (2012CB821203) and the NSFC (grant nos. 61020106005 and 10972002). MP acknowledges the financial support from the Slovenian Research Agency (grant J1-4055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Boza G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-336; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cardillo A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103034; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; Deng KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025496; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; Fort H, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48008; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Guan JY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056101; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; Hauert C, 2010, J THEOR BIOL, V267, P22, DOI 10.1016/j.jtbi.2010.08.009; Heitzig J, 2011, P NATL ACAD SCI USA, V108, P15739, DOI 10.1073/pnas.1106265108; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Huang ZG, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/28001; Janssen MA, 2006, J THEOR BIOL, V243, P134, DOI 10.1016/j.jtbi.2006.06.012; Kamimura Y, 2008, J THEOR BIOL, V252, P277, DOI 10.1016/j.jtbi.2008.02.017; Kogan L, 2004, J FINANC ECON, V73, P411, DOI 10.1016/j.jfineco.2003.12.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037102; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci E, 2008, LECT NOTES COMPUT SC, V5199, P539, DOI 10.1007/978-3-540-87700-4_54; Pestelacci E, 2010, LECT NOTES COMPUT SC, V6239, P512, DOI 10.1007/978-3-642-15871-1_52; Poncela J, 2009, NEW J PHYS, V11; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Sasaki T, 2007, P ROY SOC B-BIOL SCI, V274, P2639, DOI 10.1098/rspb.2007.0673; Sasaki T, 2011, J THEOR BIOL, V287, P109, DOI 10.1016/j.jtbi.2011.07.026; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; Short MB, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066114; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046106; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomochi M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026112; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Vukov J, 2011, J THEOR BIOL, V287, P37, DOI 10.1016/j.jtbi.2011.07.022; Wakano JY, 2007, J THEOR BIOL, V247, P616, DOI 10.1016/j.jtbi.2007.04.008; Wakano JY, 2009, P NATL ACAD SCI USA, V106, P7910, DOI 10.1073/pnas.0812644106; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; Wu T, 2009, EPL, V90, P20001; Wu T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026121; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Xu Z, 2010, EPL, V88, P30011; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	80	68	68	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36895	10.1371/journal.pone.0036895	http://dx.doi.org/10.1371/journal.pone.0036895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22928023	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305341300038
J	Zhang, LD; Yu, SW; Zuo, KJ; Luo, LJ; Tang, KX				Zhang, Lida; Yu, Shunwu; Zuo, Kaijing; Luo, Lijun; Tang, Kexuan			Identification of Gene Modules Associated with Drought Response in Rice by Network-Based Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COEXPRESSION NETWORKS; EXPRESSION DATA; TOOL; TOLERANCE; DATABASE; TRAITS; FAMILY; DNA	Understanding the molecular mechanisms that underlie plant responses to drought stress is challenging due to the complex interplay of numerous different genes. Here, we used network-based gene clustering to uncover the relationships between drought-responsive genes from large microarray datasets. We identified 2,607 rice genes that showed significant changes in gene expression under drought stress; 1,392 genes were highly intercorrelated to form 15 gene modules. These drought-responsive gene modules are biologically plausible, with enrichments for genes in common functional categories, stress response changes, tissue-specific expression and transcription factor binding sites. We observed that a gene module (referred to as module 4) consisting of 134 genes was significantly associated with drought response in both drought-tolerant and drought-sensitive rice varieties. This module is enriched for genes involved in controlling the response of the plant to water and embryonic development, including a heat shock transcription factor as the key regulator in the expression of ABRE-containing genes. These results suggest that module 4 is highly conserved in the ABA-mediated drought response pathway in different rice varieties. Moreover, our study showed that many hub genes clustered in rice chromosomes had significant associations with QTLs for drought stress tolerance. The relationship between hub gene clusters and drought tolerance QTLs may provide a key to understand the genetic basis of drought tolerance in rice.	[Zhang, Lida; Zuo, Kaijing; Tang, Kexuan] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Yu, Shunwu; Luo, Lijun] Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences	Zhang, LD (corresponding author), Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200030, Peoples R China.	kxtang@sjtu.edu.cn	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	Shanghai Science and Technology Commission [09DJ1400504]; Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Genetically Modified Organisms Breeding Major Projects of China; Shanghai Jiao Tong University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Key Project of Shanghai Science and Technology Commission (Grant No. 09DJ1400504), Genetically Modified Organisms Breeding Major Projects of China, and Chen Xing Young Scholar Award Program of Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ML, 2000, THEOR APPL GENET, V101, P756, DOI 10.1007/s001220051541; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Harrak H, 1999, PLANT PHYSIOL, V121, P557, DOI 10.1104/pp.121.2.557; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Jupiter D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-332; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Yue B, 2005, THEOR APPL GENET, V111, P1127, DOI 10.1007/s00122-005-0040-1; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	44	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e33748	10.1371/journal.pone.0033748	http://dx.doi.org/10.1371/journal.pone.0033748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	22662107	Green Submitted, gold, Green Published			2022-12-27	WOS:000305342300001
J	Li, XH; Ha, CT; Fu, DD; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang			REDD1 Protects Osteoblast Cells from Gamma Radiation-Induced Premature Senescence	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; MARROW STROMAL CELLS; NF-KAPPA-B; CELLULAR SENESCENCE; IN-VITRO; DNA-DAMAGE; LIFE-SPAN; P53; MTOR; STRESS	Radiotherapy is commonly used for cancer treatment. However, it often results in side effects due to radiation damage in normal tissue, such as bone marrow (BM) failure. Adult hematopoietic stem and progenitor cells (HSPC) reside in BM next to the endosteal bone surface, which is lined primarily by hematopoietic niche osteoblastic cells. Osteoblasts are relatively more radiation-resistant than HSPCs, but the mechanisms are not well understood. In the present study, we demonstrated that the stress response gene REDD1 (regulated in development and DNA damage responses 1) was highly expressed in human osteoblast cell line (hFOB) cells after gamma irradiation. Knockdown of REDD1 with siRNA resulted in a decrease in hFOB cell numbers, whereas transfection of PCMV6-AC-GFP-REDD1 plasmid DNA into hFOB cells inhibited mammalian target of rapamycin (mTOR) and p21 expression and protected these cells from radiation-induced premature senescence (PS). The PS in irradiated hFOB cells were characterized by significant inhibition of clonogenicity, activation of senescence biomarker SA-beta-gal, and the senescence-associated cytokine secretory phenotype (SASP) after 4 or 8 Gy irradiation. Immunoprecipitation assays demonstrated that the stress response proteins p53 and nuclear factor kappa B (NFkB) interacted with REDD1 in hFOB cells. Knockdown of NFkB or p53 gene dramatically suppressed REDD1 protein expression in these cells, indicating that REDD1 was regulated by both factors. Our data demonstrated that REDD1 is a protective factor in radiation-induced osteoblast cell premature senescence.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Li, XH (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	xiao@afrri.usuhs.mil			Armed Forces Radiobiology Research Institute [RAB2EI]; American Congressional Grant [G1B2EP]	Armed Forces Radiobiology Research Institute; American Congressional Grant	This study was supported by Armed Forces Radiobiology Research Institute intramural grant (RAB2EI) to MX and an American Congressional Grant (G1B2EP) to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, AGING-US, V1, P1008, DOI 10.18632/aging.100115; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hill R, 2008, CELL CYCLE, V7, P2535; Hotz ME, 2010, HEALTH PHYS, V98, P894, DOI 10.1097/HP.0b013e3181ab3e71; Katiyar S, 2009, EMBO REP, V10, P866, DOI 10.1038/embor.2009.93; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Singh VK, 2010, INT J RADIAT BIOL, V86, P12, DOI 10.3109/09553000903264515; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Xiao Mang, 2009, Curr Mol Pharmacol, V2, P122; Xiao M, 2009, EXP HEMATOL, V37, P52, DOI 10.1016/j.exphem.2008.09.001; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	40	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36604	10.1371/journal.pone.0036604	http://dx.doi.org/10.1371/journal.pone.0036604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22768107	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500020
J	Zhang, L; Ding, XB; Lu, RR; Feng, LG; Li, XF; Xiao, Y; Ruan, YH; Vermund, SH; Shao, YM; Qian, HZ				Zhang, Lan; Ding, Xianbin; Lu, Rongrong; Feng, Liangui; Li, Xuefeng; Xiao, Yan; Ruan, Yuhua; Vermund, Sten H.; Shao, Yiming; Qian, Han-Zhu			Predictors of HIV and Syphilis among Men Who Have Sex with Men in a Chinese Metropolitan City: Comparison of Risks among Students and Non-Students	PLOS ONE			English	Article							HIDDEN POPULATIONS; DRUG-USERS; PREVALENCE; INFECTIONS; BEHAVIOR; PROVINCE; MUNICIPALITY; ATTITUDES; HIV/AIDS; WORKERS	Background: Men who have sex with men (MSM) are at a substantial risk of HIV, given rising HIV prevalence in urban China. Adolescent and adult students often take HIV-related risk as part of sexual exploration. We compared the risks of HIV and syphilis infections and risky sexual behaviors between student and non-student among urban MSM. Methods: Respondent driven sampling approach was used to recruit men who were self-identified as MSM in Chongqing Metropolitan City in southwestern China in 2009. Each participant completed a computer-assisted self-interview which collected demographic and behavioral data, and provided blood specimens for HIV and syphilis testing. Multivariable logistic regression analyses identified predictors for HIV and syphilis infections while comparing student and non-student MSM. Results: Among 503 MSM participants, 36.4% were students, of whom 84.2% were in college. The adjusted prevalence of HIV infection was 5.5% (95% confidence interval [CI]: 2.1%-10.2%) in students and 20.9% (95% CI: 13.7%-27.5%) in non-students; the adjusted prevalence of syphilis was 4.4% (95% CI: 0.7%-9.0%) in students and 7.9% (95% CI: 3.6%-12.9%) in non-students (P = 0.12). Two groups had similar risky sexual behaviors such as number of sexual partners and exchanging sex for money. Multivariate analysis showed that students had lower HIV prevalence than non-students (adjusted odds ratio [AOR]: 0.3; 95% CI: 0.1-0.8) adjusting for age, ethnicity and other variables. Conclusion: Student MSM have lower HIV and similar syphilis prevalence compared with non-student MSM. However, due to a shorter duration of sexual experience and high prevalence of at-risk sexual behaviors among student MSM, HIV risk might be quite high in students as in non-students.	[Zhang, Lan; Vermund, Sten H.; Qian, Han-Zhu] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA; [Zhang, Lan; Li, Xuefeng; Ruan, Yuhua; Shao, Yiming] Chinese Ctr Dis Control, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ding, Xianbin; Lu, Rongrong; Feng, Liangui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Xiao, Yan] Joint United Nations Program HIV AIDS, China Off, Beijing, Peoples R China	Vanderbilt University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, L (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.	xiaoy1800@163.com; ruanyuhua92@gmail.com; han-zhu.qian@vanderbilt.edu	Tang, Kexuan/E-3555-2013; Vermund, Sten/AAD-3592-2020; Zhang, Lan/F-7687-2011	Tang, Kexuan/0000-0002-8748-9624; Vermund, Sten/0000-0001-7289-8698; 	United States National Institutes of Health [R01AI078933, D43TW001035, R01AI094562]; Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory for Infectious Disease Development Grant [2011SKLID102]; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094562, R01AI078933] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Development Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	United States National Institutes of Health (R01AI078933, D43TW001035, and R01AI094562), the Ministry of Science and Technology of China (2012ZX10001-002), and a Chinese State Key Laboratory for Infectious Disease Development Grant (2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Quader AS, 2006, J URBAN HEALTH, V83, pI1, DOI 10.1007/s11524-006-9108-8; Abdul-Quader AS, 2006, J URBAN HEALTH, V83, P459, DOI 10.1007/s11524-006-9052-7; Chongqing Municipal Goverment, 2007, ADV; Chow EP, 2011, AIDS BEHAV      0403; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Dosekun O, 2010, CURR OPIN HIV AIDS, V5, P291, DOI 10.1097/COH.0b013e32833a88a3; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2001, J DRUG ISSUES, V31, P543, DOI 10.1177/002204260103100209; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Jiang Y, 2010, INT J EPIDEMIOL, V39, pII72, DOI 10.1093/ije/dyq224; Kong TSK, 2009, CHINESE MALE HOMOSEX; Leiber E, 2009, AIDS EDUC PREV, V21, P415, DOI 10.1521/aeap.2009.21.5.415; Li Chun-mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P882; Li Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS48, DOI 10.1097/QAI.0b013e3181c7d72f; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Liu L, 2009, CURR HIV RES, V7, P390, DOI 10.2174/157016209788680642; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mahfoud Z, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000386733.02425.98; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Reisner SL, 2010, AIDS CARE, V22, P577, DOI 10.1080/09540120903311482; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Tao XR, 2010, SE ASIAN J TROP MED, V41, P358; Volz E, 2008, J OFF STAT, V24, P79; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang HS, 2004, AIDS BEHAV, V8, P105, DOI 10.1023/B:AIBE.0000030242.46843.71; Zhang K, 1999, AIDS CARE, V11, P581, DOI 10.1080/09540129947730; Zhang LL, 2010, SUBST USE MISUSE, V45, P2503, DOI 10.3109/10826084.2010.487234; Zheng Jian-Dong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P337; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x	50	79	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37211	10.1371/journal.pone.0037211	http://dx.doi.org/10.1371/journal.pone.0037211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VG	22662107	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500074
J	Bagala, F; Becker, C; Cappello, A; Chiari, L; Aminian, K; Hausdorff, JM; Zijlstra, W; Klenk, J				Bagala, Fabio; Becker, Clemens; Cappello, Angelo; Chiari, Lorenzo; Aminian, Kamiar; Hausdorff, Jeffrey M.; Zijlstra, Wiebren; Klenk, Jochen			Evaluation of Accelerometer-Based Fall Detection Algorithms on Real-World Falls	PLOS ONE			English	Article							TRIAXIAL ACCELEROMETER; OLDER-ADULTS; COMMUNITY; SYSTEM; PEOPLE; IMPACT; RISK	Despite extensive preventive efforts, falls continue to be a major source of morbidity and mortality among elders. Real-time detection of falls and their urgent communication to a telecare center may enable rapid medical assistance, thus increasing the sense of security of the elderly and reducing some of the negative consequences of falls. Many different approaches have been explored to automatically detect a fall using inertial sensors. Although previously published algorithms report high sensitivity (SE) and high specificity (SP), they have usually been tested on simulated falls performed by healthy volunteers. We recently collected acceleration data during a number of real-world falls among a patient population with a high-fall-risk as part of the SensAction-AAL European project. The aim of the present study is to bechmark the performance of thirteen published fall-detection algorithms when they are applied to the database of 29 real-world fall. To the best of our knowledge, this is the first systematic comparison of fall detection algorithms tested on real-world falls. We found that the SP average of the thirteen algorithms, was (mean +/- std) 83.0%+/- 30.3% (maximum value = 98%). The SE was considerably lower (SE = 57.0%+/- 27.3%, maximum value = 82.8%), much lower than the values obtained on simulated falls. The number of false alarms generated by the algorithms during 1-day monitoring of there representative fallers ranged from 3 to 85. The factors that affect the performance of the published algorithms, when they are applied to the real-world falls, are also discussed. These findings indicate the importance of testing fall-detection algorithms in real-life conditions in order to produce more effective automated alarm systems with higher acceptance. Further, the present results support the idea that a large, shared real-world fall database could, potentially, provide an enhanced understanding of the fall process and the information needed to design and evaluate a high-performance fall detector.	[Bagala, Fabio; Cappello, Angelo; Chiari, Lorenzo] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy; [Becker, Clemens; Klenk, Jochen] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measuremnt, CH-1015 Lausanne, Switzerland; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Zijlstra, Wiebren] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands	University of Bologna; Bosch; Robert Bosch Krankenhaus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Groningen	Bagala, F (corresponding author), Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy.	fabio.bagala@unibo.it	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	European Union [045622, 288940]; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has been partly funded by the European Union under grant agreements n. 045622 (FP6/2002-06; SensAction-AAL project) and n. 288940 (FP7/2007-13; FARSEEING project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan M, 2006, P ICTTA 06 DAM SYR A, P23; Anderson Derek, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6388; Benocci M, 2010, MICROELECTRON J, V41, P703, DOI 10.1016/j.mejo.2010.06.014; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Bourke AK, 2008, IEEE ENG MED BIO, P2844, DOI 10.1109/IEMBS.2008.4649795; Boyle J, 2008, IEEE ENG MED BIO, P1274, DOI 10.1109/IEMBS.2008.4649396; Chen J, P 27 IEEE EMBS ANN I, P3551; Culhane KM, 2004, CLIN REHABIL, V18, P335, DOI 10.1191/0269215504cr734oa; Degen T, 2003, SEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P184, DOI 10.1109/ISWC.2003.1241410; Diaz A, 2004, P ANN INT IEEE EMBS, V26, P2180; Doughty K, 2000, J TELEMED TELECARE, V6, P150, DOI 10.1258/1357633001934483; Golbe L, 2005, NEURODEGENER DIS, P663; Gurley RJ, 1996, NEW ENGL J MED, V334, P1710, DOI 10.1056/NEJM199606273342606; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hori T., 2005, P 7 INT C ENT INF SY, P110; Huang B, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P3619, DOI 10.1109/WCICA.2008.4593501; Hwang JY, 2004, P ANN INT IEEE EMBS, V26, P2204; Jia N, FALL DETECTION APPL; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Kangas M, 2011, GAIT POSTUR IN PRESS; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lee YS, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P2308; Lee Y, 2007, P ANN INT IEEE EMBS, P2315, DOI 10.1109/IEMBS.2007.4352789; Li Q, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P138, DOI [10.1109/P3644.45, 10.1109/BSN.2009.46]; Lin CW, P 16 ICCCN AUG 13 16, P1172; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; Lindemann U, 2010, MOVEMENT DISORD, V25, P1040, DOI 10.1002/mds.23023; Litvak D, 2008, IEEE ENG MED BIO, P4632, DOI 10.1109/IEMBS.2008.4650245; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lord R, 2001, FALLS OLDER PEOPLE R; MALLINSON WJW, 1985, AGE AGEING, V14, P174, DOI 10.1093/ageing/14.3.174; Nait-Charif H, 2004, INT C PATT RECOG, P323, DOI 10.1109/ICPR.2004.1333768; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Noury N, 2007, P ANN INT IEEE EMBS, P1663, DOI 10.1109/IEMBS.2007.4352627; Noury N, 2003, P ANN INT IEEE EMBS, V25, P3286, DOI 10.1109/IEMBS.2003.1280846; Noury N, 2008, IRBM, V29, P340, DOI 10.1016/j.irbm.2008.08.002; Nyan MN, 2006, MED ENG PHYS, V28, P842, DOI 10.1016/j.medengphy.2005.11.008; Nyan MN, 2008, J BIOMECH, V41, P3475, DOI 10.1016/j.jbiomech.2008.08.009; Perolle G., 2006, P MEDETEL, P65; Porter Eileen J, 2005, J Gerontol Nurs, V31, P26; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Sixsmith A, 2004, IEEE PERVAS COMPUT, V3, P42, DOI 10.1109/MPRV.2004.1316817; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Tamura T, 2009, IEEE T INF TECHNOL B, V13, P910, DOI 10.1109/TITB.2009.2033673; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; Vass DC, 2010, TRIALS, V10, P83; VELLAS B, 1987, AGE AGEING, V16, P189, DOI 10.1093/ageing/16.3.189; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Williams G, P 20 IEEE EMBS ANN I, P1151; Wu G, 2000, J BIOMECH, V33, P1497, DOI 10.1016/S0021-9290(00)00117-2; Zigel Y, 2009, IEEE T BIO-MED ENG, V56, P2858, DOI 10.1109/TBME.2009.2030171	60	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37062	10.1371/journal.pone.0037062	http://dx.doi.org/10.1371/journal.pone.0037062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22511944	Green Published, gold			2022-12-27	WOS:000305341300060
J	Wang, YX; Zeng, X; Iyer, NJ; Bryant, DW; Mockler, TC; Mahalingam, R				Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Bryant, Douglas W.; Mockler, Todd C.; Mahalingam, Ramamurthy			Exploring the Switchgrass Transcriptome Using Second-Generation Sequencing Technology	PLOS ONE			English	Article							MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MESSENGER-RNA; GENE; ARABIDOPSIS; PLANT; GERMINATION; RICE; IDENTIFICATION; ANNOTATION	Background: Switchgrass (Panicum virgatum L.) is a C4 perennial grass and widely popular as an important bioenergy crop. To accelerate the pace of developing high yielding switchgrass cultivars adapted to diverse environmental niches, the generation of genomic resources for this plant is necessary. The large genome size and polyploid nature of switchgrass makes whole genome sequencing a daunting task even with current technologies. Exploring the transcriptional landscape using next generation sequencing technologies provides a viable alternative to whole genome sequencing in switchgrass. Principal Findings: Switchgrass cDNA libraries from germinating seedlings, emerging tillers, flowers, and dormant seeds were sequenced using Roche 454 GS-FLX Titanium technology, generating 980,000 reads with an average read length of 367 bp. De novo assembly generated 243,600 contigs with an average length of 535 bp. Using the foxtail millet genome as a reference greatly improved the assembly and annotation of switchgrass ESTs. Comparative analysis of the 454-derived switchgrass EST reads with other sequenced monocots including Brachypodium, sorghum, rice and maize indicated a 70-80% overlap. RPKM analysis demonstrated unique transcriptional signatures of the four tissues analyzed in this study. More than 24,000 ESTs were identified in the dormant seed library. In silico analysis indicated that there are more than 2000 EST-SSRs in this collection. Expression of several orphan ESTs was confirmed by RT-PCR. Significance: We estimate that about 90% of the switchgrass gene space has been covered in this analysis. This study nearly doubles the amount of EST information for switchgrass currently in the public domain. The celerity and economical nature of second-generation sequencing technologies provide an in-depth view of the gene space of complex genomes like switchgrass. Sequence analysis of closely related members of the NAD(+)-malic enzyme type C4 grasses such as the model system Setaria viridis can serve as a viable proxy for the switchgrass genome.	[Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bryant, Douglas W.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oklahoma State University System; Oklahoma State University - Stillwater; Donald Danforth Plant Science Center	Wang, YX (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Sung, Wen-Wei/0000-0002-2375-0029	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Barbazuk WB, 2007, SNP MINING MAIZE 454; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masumoto C, 2010, P NATL ACAD SCI USA, V107, P5226, DOI 10.1073/pnas.0913127107; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Muthukumar B, 2004, MOL GENET GENOMICS, V271, P308, DOI 10.1007/s00438-004-0980-1; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Puckette M, 2009, J PLANT PHYSIOL, V166, P1284, DOI 10.1016/j.jplph.2009.01.009; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TANIGUCHI M, 1995, ARCH BIOCHEM BIOPHYS, V318, P295, DOI 10.1006/abbi.1995.1233; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2006, MOL ECOL NOTES, V6, P185, DOI 10.1111/j.1471-8286.2006.01187.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	67	72	77	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34225	10.1371/journal.pone.0034225	http://dx.doi.org/10.1371/journal.pone.0034225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22848356	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400061
J	Li, RG; Gao, S; Hernandez, AG; Wechter, WP; Fei, ZJ; Ling, KS				Li, Rugang; Gao, Shan; Hernandez, Alvaro G.; Wechter, W. Patrick; Fei, Zhangjun; Ling, Kai-Shu			Deep Sequencing of Small RNAs in Tomato for Virus and Viroid Identification and Strain Differentiation	PLOS ONE			English	Article							PEPINO-MOSAIC-VIRUS; 1ST REPORT; GREENHOUSE TOMATOES; NATURAL INFECTION; DISCOVERY; ALIGNMENT; EVOLUTION; PATHOGEN; INSIGHTS; REVEALS	Small RNAs (sRNA), including microRNAs (miRNA) and small interfering RNAs (siRNA), are produced abundantly in plants and animals and function in regulating gene expression or in defense against virus or viroid infection. Analysis of siRNA profiles upon virus infection in plant may allow for virus identification, strain differentiation, and de novo assembly of virus genomes. In the present study, four suspected virus-infected tomato samples collected in the U. S. and Mexico were used for sRNA library construction and deep sequencing. Each library generated between 5-7 million sRNA reads, of which more than 90% were from the tomato genome. Upon in-silico subtraction of the tomato sRNAs, the remaining highly enriched, virus-like siRNA pools were assembled with or without reference virus or viroid genomes. A complete genome was assembled for Potato spindle tuber viroid (PSTVd) using siRNA alone. In addition, a near complete virus genome (98%) also was assembled for Pepino mosaic virus (PepMV). A common mixed infection of two strains of PepMV (EU and US1), which shared 82% of genome nucleotide sequence identity, also could be differentially assembled into their respective genomes. Using de novo assembly, a novel potyvirus with less than 60% overall genome nucleotide sequence identity to other known viruses was discovered and its full genome sequence obtained. Taken together, these data suggest that the sRNA deep sequencing technology will likely become an efficient and powerful generic tool for virus identification in plants and animals.	[Li, Rugang; Wechter, W. Patrick; Ling, Kai-Shu] ARS, US Vegetable Lab, USDA, Charleston, SC USA; [Gao, Shan; Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Hernandez, Alvaro G.] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL USA; [Fei, Zhangjun] USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Li, RG (corresponding author), ARS, US Vegetable Lab, USDA, Charleston, SC USA.	zf25@Cornell.edu; kai.ling@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative [SCRI-600-25320]; National Science Foundation [IOS-1110080]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by a grant from the U.S. Department of Agriculture, National Institute of Food and Agriculture, Specialty Crop Research Initiative (SCRI-600-25320) to KSL and by National Science Foundation (IOS-1110080) to ZF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bao Y, 2008, ENCY VIROLOGY, V5, P342; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Cotillon AC, 2002, ARCH VIROL, V147, P2231, DOI 10.1007/s00705-002-0873-8; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Hagen C, 2011, ARCH VIROL, V156, P1209, DOI 10.1007/s00705-011-0979-y; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; JONES RAC, 1980, ANN APPL BIOL, V94, P61, DOI 10.1111/j.1744-7348.1980.tb03896.x; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling KS, 2010, PLANT DIS, V94, P1376, DOI 10.1094/PDIS-07-10-0516; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Ling KS, 2009, PLANT DIS, V93, P1075, DOI 10.1094/PDIS-93-10-1075B; Ling KS, 2009, PLANT DIS, V93, P839, DOI 10.1094/PDIS-93-8-0839B; Ling KS, 2007, VIRUS GENES, V34, P1, DOI 10.1007/s11262-006-0003-x; Ling KS, 2008, PLANT DIS, V92, P1683, DOI 10.1094/PDIS-92-12-1683; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Maroon-Lango CJ, 2005, ARCH VIROL, V150, P1187, DOI 10.1007/s00705-005-0495-z; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; The Tomato Genome Consortium, 2012, NATURE IN PRESS; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e37127	10.1371/journal.pone.0037127	http://dx.doi.org/10.1371/journal.pone.0037127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22623984	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343500061
J	Li, RW; Wu, ST; Baldwin, RL; Li, WZ; Li, CJ				Li, Robert W.; Wu, Sitao; Baldwin, Ransom L.; Li, Weizhong; Li, Congjun			Perturbation Dynamics of the Rumen Microbiota in Response to Exogenous Butyrate	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; HUMAN GUT; BUTYRIVIBRIO-FIBRISOLVENS; RUMINAL BUTYRATE; RESISTANT STARCH; LARGE-INTESTINE; FAST PROGRAM; DAIRY-COWS; MILK-YIELD; METABOLISM	The capacity of the rumen microbiota to produce volatile fatty acids (VFAs) has important implications in animal well-being and production. We investigated temporal changes of the rumen microbiota in response to butyrate infusion using pyrosequencing of the 16S rRNA gene. Twenty one phyla were identified in the rumen microbiota of dairy cows. The rumen microbiota harbored 54.5 +/- 6.1 genera (mean +/- SD) and 127.3 +/- 4.4 operational taxonomic units (OTUs), respectively. However, the core microbiome comprised of 26 genera and 82 OTUs. Butyrate infusion altered molar percentages of 3 major VFAs. Butyrate perturbation had a profound impact on the rumen microbial composition. A 72 h-infusion led to a significant change in the numbers of sequence reads derived from 4 phyla, including 2 most abundant phyla, Bacteroidetes and Firmicutes. As many as 19 genera and 43 OTUs were significantly impacted by butyrate infusion. Elevated butyrate levels in the rumen seemingly had a stimulating effect on butyrate-producing bacteria populations. The resilience of the rumen microbial ecosystem was evident as the abundance of the microorganisms returned to their pre-disturbed status after infusion withdrawal. Our findings provide insight into perturbation dynamics of the rumen microbial ecosystem and should guide efforts in formulating optimal uses of probiotic bacteria treating human diseases.	[Li, Robert W.; Baldwin, Ransom L.; Li, Congjun] ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA; [Wu, Sitao; Li, Weizhong] Univ Calif San Diego, Ctr Res Biol Syst, San Diego, CA 92103 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, USDA, Bovine Funct Genom Lab, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Cong-jun/J-8572-2014; Fei, Zhangjun/H-5152-2012; Ling, Kai-Shu/ABE-9461-2020; Li, Weizhong/A-9735-2008; Khafipour, Ehsan/E-4140-2016	Li, Cong-jun/0000-0003-1389-9820; Li, Weizhong/0000-0003-1804-9403; Li, Rugang/0000-0001-6514-496X; Khafipour, Ehsan/0000-0003-4673-7633; Fei, Zhangjun/0000-0001-9684-1450; Li, Ru/0000-0001-7332-7790	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005978] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; HUHTANEN P, 1993, J DAIRY SCI, V76, P1114, DOI 10.3168/jds.S0022-0302(93)77440-8; Kristensen NB, 2004, J ANIM SCI, V82, P2033; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Li CJ, 2008, GENE REGUL SYST BIO, V2, P113; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez S, 2003, J ANIM SCI, V81, P2609; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Mrazek J, 2006, FOLIA MICROBIOL, V51, P294, DOI 10.1007/BF02931817; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Ohkawara S, 2005, J NUTR, V135, P2878, DOI 10.1093/jn/135.12.2878; Ohkawara S, 2006, CLIN VACCINE IMMUNOL, V13, P1231, DOI 10.1128/CVI.00267-06; Pitt RE, 1996, J ANIM SCI, V74, P226; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sato T, 2008, FEMS MICROBIOL ECOL, V66, P528, DOI 10.1111/j.1574-6941.2008.00528.x; Silvi S, 1999, J APPL MICROBIOL, V86, P521, DOI 10.1046/j.1365-2672.1999.00696.x; STORRY JE, 1966, BRIT J NUTR, V20, P217, DOI 10.1079/BJN19660023; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015	35	279	296	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e29392	10.1371/journal.pone.0029392	http://dx.doi.org/10.1371/journal.pone.0029392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22623984	Green Published, Green Submitted, gold			2022-12-27	WOS:000301357100009
J	Liu, YJ; Ding, YC; Alonas, E; Zhao, WL; Santangelo, PJ; Jin, DY; Piper, JA; Teng, JL; Ren, QS; Xi, P				Liu, Yujia; Ding, Yichen; Alonas, Eric; Zhao, Wenli; Santangelo, Philip J.; Jin, Dayong; Piper, James A.; Teng, Junlin; Ren, Qiushi; Xi, Peng			Achieving lambda/10 Resolution CW STED Nanoscopy with a Ti:Sapphire Oscillator	PLOS ONE			English	Article							STIMULATED-EMISSION-DEPLETION; 2-PHOTON EXCITATION; MICROSCOPY; BREAKING; REVEALS; LIMIT	In this report, a Ti: Sapphire oscillator was utilized to realize synchronization-free stimulated emission depletion (STED) microscopy. With pump power of 4.6 W and sample irradiance of 310 mW, we achieved super-resolution as high as 71 nm. With synchronization-free STED, we imaged 200 nm nanospheres as well as all three cytoskeletal elements (microtubules, intermediate filaments, and actin filaments), clearly demonstrating the resolving power of synchronization-free STED over conventional diffraction limited imaging. It also allowed us to discover that, Dylight 650, exhibits improved performance over ATTO647N, a fluorophore frequently used in STED. Furthermore, we applied synchronization-free STED to image fluorescently-labeled intracellular viral RNA granules, which otherwise cannot be differentiated by confocal microscopy. Thanks to the widely available Ti:Sapphire oscillators in multiphoton imaging system, this work suggests easier access to setup super-resolution microscope via the synchronization-free STED.	[Liu, Yujia; Ren, Qiushi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Liu, Yujia; Ding, Yichen; Ren, Qiushi; Xi, Peng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Alonas, Eric; Santangelo, Philip J.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alonas, Eric; Santangelo, Philip J.] Emory Univ, Atlanta, GA 30322 USA; [Jin, Dayong; Piper, James A.] Macquarie Univ, Adv Cytometry Labs, MQphoton Res Ctr, Sydney, NSW 2109, Australia; [Zhao, Wenli; Teng, Junlin] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Shanghai Jiao Tong University; Peking University; University System of Georgia; Georgia Institute of Technology; Emory University; Macquarie University; Peking University	Liu, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xipeng@pku.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	"973" Major State Basic Research Development Program of China [2011CB809101, 2010CB933901, 2011CB707502]; National Natural Science Foundation of China [61178076]; PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	"973" Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PKU-GT/Emory University BME Seed Grant; Wallace H. Coulter Foundation; Olympus Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the "973" Major State Basic Research Development Program of China (2011CB809101, 2010CB933901, 2011CB707502), the National Natural Science Foundation of China (61178076), PKU-GT/Emory University BME Seed Grant funded by Wallace H. Coulter Foundation, and seed fund support from Olympus Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Buckers J, 2011, OPT EXPRESS, V19, P3130, DOI 10.1364/OE.19.003130; Cao YY, 2011, OPT EXPRESS, V19, P19486, DOI 10.1364/OE.19.019486; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2010, SPRINGER SER CHEM PH, V96, P365, DOI 10.1007/978-3-642-02597-6_19; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hirvonen LM, 2011, AUST J CHEM, V64, P41, DOI 10.1071/CH10333; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Hyeon C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2364190; Kasper R, 2010, SMALL, V6, P1379, DOI 10.1002/smll.201000203; Keller J, 2007, OPT EXPRESS, V15, P3361, DOI 10.1364/OE.15.003361; Moneron G, 2010, OPT EXPRESS, V18, P1302, DOI 10.1364/OE.18.001302; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Rankin BR, 2009, OPT EXPRESS, V17, P15679, DOI 10.1364/OE.17.015679; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Santangelo PJ, 2009, NAT METHODS, V6, P347, DOI [10.1038/nmeth.1316, 10.1038/NMETH.1316]; Scheul T, 2011, OPT EXPRESS, V19, P18036, DOI 10.1364/OE.19.018036; Schrof S, 2011, OPT EXPRESS, V19, P8066, DOI 10.1364/OE.19.008066; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang WC, 2010, APPL OPTICS, V49, P6703, DOI 10.1364/AO.49.006703; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Wurm CA, 2010, METHODS MOL BIOL, V591, P185, DOI 10.1007/978-1-60761-404-3_11; Xi P, 2008, OPT COMMUN, V281, P1841, DOI 10.1016/j.optcom.2007.09.066; Xi P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059629	38	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e40003	10.1371/journal.pone.0040003	http://dx.doi.org/10.1371/journal.pone.0040003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22615852	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800086
J	Fu, WX; Liu, Y; Lu, X; Niu, XY; Ding, XD; Liu, JF; Zhang, Q				Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin			A Genome-Wide Association Study Identifies Two Novel Promising Candidate Genes Affecting Escherichia coli F4ab/F4ac Susceptibility in Swine	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATION STRATIFICATION; INTESTINAL RECEPTOR; EPITHELIAL-CELLS; MILK-PRODUCTION; DAIRY-CATTLE; INTEGRIN; BINDING; PROTEIN; F4AC	Enterotoxigenic Escherichia coli (ETEC) expressing F4 fimbria is the major pathogenic bacteria causing diarrhoea in neonatal and post-weaning piglets. Previous studies have revealed that the susceptibility to ETEC F4ab/F4ac is an autosomal Mendelian dominant trait and the loci controlling the F4ab/F4ac receptor are located on SSC13q41, between markers SW207 and S0283. To pinpoint these loci and further validate previous findings, we performed a genome-wide association study (GWAS) using a two generation family-based population, consisting of 301 piglets with phenotypes of susceptibility to ETEC F4ab/F4ac by the vitro adhesion test. The DNA of all piglets and their parents was genotyped using the Illumina PorcineSNP60 BeadChip, and 50,972 and 50,483 SNPs were available for F4ab and F4ac susceptibility, respectively, in the association analysis after quality control. In summary, 28 and 18 significant SNPs (p < 0.05) were detected associated with F4ab and F4ac susceptibility respectively at genome-wide significance level. From these significant findings, two novel candidate genes, HEG1 and ITGB5, were firstly identified as the most promising genes underlying F4ab/F4ac susceptibility in swine according to their functions and positions. Our findings herein provide a novel evidence for unravelling genetic mechanism of diarrhoea risk in piglets.	[Fu, Wei-Xuan; Liu, Yang; Lu, Xin; Niu, Xiao-Yan; Ding, Xiang-Dong; Liu, Jian-Feng; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China; [Lu, Xin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Fu, WX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; qzhang@cau.edu.cn	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Natural Science Foundations of China [30972092, 30800776]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2009ZX08009-146B]; Natural Science Foundations of Beijing [6102016]; New-Century Training Programme Foundation for the Talents by the State Education Commission of China [NETC-10-0783]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Natural Science Foundations of Beijing; New-Century Training Programme Foundation for the Talents by the State Education Commission of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Natural Science Foundations of China (30972092, 30800776), the National High Technology Research and Development Program of China (863 Program 2011AA100302), the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (2009ZX08009-146B), the Natural Science Foundations of Beijing (6102016), New-Century Training Programme Foundation for the Talents by the State Education Commission of China (NETC-10-0783) and Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Aplin JD, 1996, MOL HUM REPROD, V2, P527, DOI 10.1093/molehr/2.7.527; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIJLSMA IGW, 1987, VET RES COMMUN, V11, P509, DOI 10.1007/BF00396368; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; CHHATWAL GS, 1987, INFECT IMMUN, V55, P1878, DOI 10.1128/IAI.55.8.1878-1883.1987; de Koning DJ, 1999, GENETICS, V152, P1679; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEORGES M, 1995, GENETICS, V139, P907; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Joller D, 2009, COMP MOL APPROACHES; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kasuga I, 2009, RESP MED, V103, P1672, DOI 10.1016/j.rmed.2009.05.008; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; Li Yuhua, 2007, Journal of Genetics and Genomics, V34, P591, DOI 10.1016/S1673-8527(07)60067-8; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Marquardt RR, 1999, FEMS IMMUNOL MED MIC, V23, P283, DOI 10.1016/S0928-8244(98)00147-3; Memmo LM, 1998, J CELL SCI, V111, P425; Mousa SA, 1999, J CELL BIOCHEM, V74, P135, DOI 10.1002/(SICI)1097-4644(19990701)74:1<135::AID-JCB15>3.3.CO;2-R; Pongpanich M, 2010, BIOINFORMATICS, V26, P1731, DOI 10.1093/bioinformatics/btq272; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Ren J, 2009, J ANIM BREED GENET, V126, P30, DOI 10.1111/j.1439-0388.2008.00751.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu CQ, 2011, ANN HUM GENET, V75, P418, DOI 10.1111/j.1469-1809.2010.00639.x; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	46	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2012	7	3							e32127	10.1371/journal.pone.0032127	http://dx.doi.org/10.1371/journal.pone.0032127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942MA	22615852	Green Published, gold, Green Submitted			2022-12-27	WOS:000304046900001
J	Liu, Y; Costa, MB; Gerhardinger, C				Liu, Yang; Costa, Montserrat Biarnes; Gerhardinger, Chiara			IL-1 beta Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1 beta Autostimulation	PLOS ONE			English	Article							PROTEIN-KINASE-C; INTERLEUKIN-1 INDUCES INTERLEUKIN-1; MULLER CELLS; MICROGLIAL ACTIVATION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; GENE-EXPRESSION; RETINOPATHY; BRAIN; INDUCTION	Many molecular and cellular abnormalities detected in the diabetic retina support a role for IL-1 beta-driven neuroinflammation in the pathogenesis of diabetic retinopathy. IL-1 beta is well known for its role in the induction and, through autostimulation, amplification of neuroinflammation. Upregulation of IL-1 beta has been consistently detected in the diabetic retina; however, the mechanisms and cellular source of IL-1 beta overexpression are poorly understood. The aim of this study was to investigate the effect of high glucose and IL-1 beta itself on IL-1 beta expression in microglial, macroglial (astrocytes and Muller cells) and retinal vascular endothelial cells; and to study the effect of diabetes on the expression of IL-1 beta in isolated retinal vessels and on the temporal pattern of IL-1 beta upregulation and glial reactivity in the retina of streptozotocin-diabetic rats. IL-1 beta was quantified by RealTime RT-PCR and ELISA, glial fibrillar acidic protein, alpha 2-macroglobulin, and ceruloplasmin by immunoblotting. We found that high glucose induced a 3-fold increase of IL-1 beta expression in retinal endothelial cells but not in macroglia and microglia. IL-1 beta induced its own synthesis in endothelial and macroglial cells but not in microglia. In retinal endothelial cells, the high glucose-induced IL-1 beta overexpression was prevented by calphostin C, a protein kinase C inhibitor. The retinal vessels of diabetic rats showed increased IL-1 beta expression as compared to non-diabetic rats. Retinal expression of IL-1 beta increased early after the induction of diabetes, continued to increase with progression of the disease, and was temporally associated with upregulation of markers of glial activation. These findings point to hyperglycemia as the trigger and to the endothelium as the origin of the initial retinal upregulation of IL-1 beta in diabetes; and to IL-1 beta itself, via autostimulation in endothelial and macroglial cells, as the mechanism of sustained IL-1 beta overexpression. Interrupting the vicious circle triggered by IL-1 beta autostimulation could limit the progression of diabetic retinopathy.	[Liu, Yang] Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School	Liu, Y (corresponding author), Harvard Univ, Schepens Eye Res Inst, Sch Med, Boston, MA 02115 USA.	chiara.gerhardinger@schepens.harvard.edu	Xi, Peng/A-9768-2012; jin, dayong/U-6740-2018; Jin, Dayong/D-9652-2011; Jin, Dayong/AAY-2402-2021	Xi, Peng/0000-0001-6626-4840; Jin, Dayong/0000-0003-1046-2666; Jin, Dayong/0000-0003-1046-2666; Liu, Jian-Feng/0000-0002-5766-7864; Piper, James/0000-0001-9503-6855	National Institutes of Health [R01EY016206]; NATIONAL EYE INSTITUTE [R01EY016206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01EY016206). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Asakawa H, 1997, J DIABETES COMPLICAT, V11, P176, DOI 10.1016/S1056-8727(97)00004-4; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; Carmo A, 2000, NITRIC OXIDE-BIOL CH, V4, P590, DOI 10.1006/niox.2000.0312; Chakrabarti S, 2000, DIABETES-METAB RES, V16, P393, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; DALTON BJ, 1989, ARTHRITIS RHEUM, V32, P279, DOI 10.1002/anr.1780320309; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gerhardinger C, 2009, DIABETES, V58, P1659, DOI 10.2337/db08-1008; GIULIAN D, 1988, J NEUROSCI, V8, P2485; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; HURME M, 1990, BLOOD, V76, P2198; Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; LEE SC, 1993, J IMMUNOL, V150, P2659; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Ramsauer M, 2002, FASEB J, V16, P1274, DOI 10.1096/fj.01-0814fje; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SHIBA T, 1993, AM J PHYSIOL, V265, pE783, DOI 10.1152/ajpendo.1993.265.5.E783; Sun W, 2005, DIABETES, V54, P3418, DOI 10.2337/diabetes.54.12.3418; Tham CS, 2003, INT J DEV NEUROSCI, V21, P431, DOI 10.1016/j.ijdevneu.2003.09.003; Toda Y, 2002, J IMMUNOL, V168, P1984, DOI 10.4049/jimmunol.168.4.1984; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; WARNER SJC, 1987, J EXP MED, V165, P1316, DOI 10.1084/jem.165.5.1316; WARNER SJC, 1987, J IMMUNOL, V139, P1911; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Yang L, 2011, INVEST OPHTH VIS SCI, V50, P2319; Yego ECK, 2009, INVEST OPHTH VIS SCI, V50, P1920, DOI 10.1167/iovs.08-2082; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6	52	239	252	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36949	10.1371/journal.pone.0036949	http://dx.doi.org/10.1371/journal.pone.0036949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615852	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300046
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
